Citrus Sinensis ID: 001591

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------105
Protein Sequence
MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA
Secondary Structure (PSIPRED)
cccccccHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccccccccEEEccccccccccccEEEEEccccccEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEEcccccccccccEEEcccccccccccHHHHHccccccEEEccccccccccccccccccccEEEcccccccccccHHHccccccccEEccccccEEcccHHHHcccccccEEcccccccccccccccccccccccccccccccccccHHHHccccccEEEcccccccccccccccccccccEEccccccccccccccccccccccEEEccccEEEEEccccccccccccEEEcccccccccccccccccccccccEEEcccccccccccccccccccccEEEccccEEEEcccHHHHcccccccEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHcccccEEEEEccccccccHHHHHHHHcccccccEEEEccccEEEEEEEccccEEEEEEEEcccccccHHHHHHHHHHccccccccccEEEEEEEcccEEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHccccccccccEEcccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHccccccEEEccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
ccccccccHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHcccccccccccccccccccEEEEcccccccccccEEEEEEEccccccccccHHHcccccccEEEcccccccccccHHHHcccccEEEEcccccccccccHHHccccccEEEEEccccccccccccccccccEEEEEccccccccccHHHHHccccccEEEcccccccccccccccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEEccccccccccccccHccccccEEEEEcccccccccccHccccccEEEEEEccccccccccHHHHccccccEEEcccccccccccHHHcccccEEEEEcccccccccccHHHHccccccEEEcccccccccccccEEEcccccccccccccccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEcccccccccccccHcccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEcccccccccccHHHHHHHHccccHHHEEEccccEEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHcHHHHHEEEcccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEEHHHEEEEccccHHHHcccHHHHccccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccEEccHHHcccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
MVVLGFVPMTCLKWLFLAFFVCSclglqtpfqscdpsdLLALKEFAgnltngsiitswsnesmccqwdgvvcghgstgsnagrvTMLILprkglkgiiprslghlnqlkLLDLScnhlegvvpvelsnlkqlevldlshnmlsgpvsgMLAGLNLIQSLnvssnsfngslfelgefsnlavfnisnnsftgkLNSRIWSASKEIQILDLSMnhfmgslqgldhspslkqlhvdnnllggdlpdslysmsSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFgnqfsgklpnvlgnlTQLEFFVAhsnsfsgplplslslcsklhvldlrnnsltgpidlnfsglsslctldlatnhfsgplpnslsdchdlKILSLAKNelsgqvpesfgKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTtliltknfvgeeipenvggFESLMVLALGncglkghipVWLLRCKKLQVLdlswnhfdgnippwigqmENLFyldfsnntltgeipKSLTELKSLIssnctssnptasagiplyvkhnrstnglpynqassfppsvflsnnringtippeigqlkhlhvldlsrnnitgtipssiseirnlevldlssndlhgsipgsfeklTFLSKFSvannhlqgtiptggqfysfpnssfegnpglcgeidspcdsmhaklkpvipsgsnskfgpgsiIAITFSIGVGIALLLAVTLLKMsrrdsgcpiddldedmgrpqrLSEALASSKLVlfqnsdckdltvsDLLKStnnfnqaniigcgGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGycrhgndrLLIYSYMENGSLDYWLhesvdkdsvlKWDVRLKIAQGAARGLAYLHKvcephivhrdvkssnilldEKFEAHLAdfglsrllrpydthvttdlvgtlgyippeysqtltatcrgdvYSFGVVLLELLtgrrpvevckgkncrDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKcidqdprrrpfIEEVVTWLdgigidaa
Flexible Loop (DISEMBL)
MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLtgrrpvevckgkncrDLVSWVfqmksekreveiidasiwHKDREKQLLEMLEIACKcidqdprrrpFIEEVVtwldgigidaa
Low Complexity Region (SEG)
MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHsnsfsgplplslslcsklHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEsfgkltsllflslsnnsfnhlsGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA
Disordered region (IsUnstruct)
*VVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLD****LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLT*L******************IPLYVK******************SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFE**PGLCGEI**********************FGPGSIIAITFSIGVGIALLLAVTLLKMS****************************KLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM**EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI***
Disordered Region (DISOPRED)
******VPMTCLKWLFLAFFVCSCLGLQTPF**CDPSDLLALKEFA************SNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDS*************************IIAITFSIGVGIALLLAVTLLKMSRRD*************************KLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG*MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV********L*SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI***
Disordered Region (DISEMBL)
MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA
Disordered Region (DISPRO)
**VLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDS***************KFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCP******************ASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1048	2.2.26 [Sep-21-2011]
Q9FN37	1036	Phytosulfokine receptor 2	yes	no	0.975	0.986	0.664	0.0
Q8LPB4	1021	Phytosulfokine receptor 1	N/A	no	0.948	0.973	0.492	0.0
Q9ZVR7	1008	Phytosulfokine receptor 1	no	no	0.947	0.985	0.490	0.0
Q9C7S5	1095	Tyrosine-sulfated glycope	no	no	0.975	0.933	0.450	0.0
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.951	0.855	0.337	1e-148
Q9LJF3	1164	Receptor-like protein kin	no	no	0.905	0.815	0.342	1e-147
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.888	0.778	0.371	1e-143
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.924	0.773	0.341	1e-143
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.889	0.746	0.347	1e-141
Q9ZPS9	1143	Serine/threonine-protein	no	no	0.927	0.850	0.333	1e-141

>sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1

 Score = 1337 bits (3461), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 692/1041 (66%), Positives = 834/1041 (80%), Gaps = 19/1041 (1%)

Query: 15   LFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGH 74
            L L FFV S +      Q C P+DL AL+E AG L N S+  SW N S CC+WDGV C  
Sbjct: 5    LLLVFFVGSSVS-----QPCHPNDLSALRELAGALKNKSVTESWLNGSRCCEWDGVFC-E 58

Query: 75   GSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEV 134
            GS  S  GRVT L+LP KGL+G+I +SLG L +L++LDLS N L+G VP E+S L+QL+V
Sbjct: 59   GSDVS--GRVTKLVLPEKGLEGVISKSLGELTELRVLDLSRNQLKGEVPAEISKLEQLQV 116

Query: 135  LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLN 194
            LDLSHN+LSG V G+++GL LIQSLN+SSNS +G L ++G F  L + N+SNN F G+++
Sbjct: 117  LDLSHNLLSGSVLGVVSGLKLIQSLNISSNSLSGKLSDVGVFPGLVMLNVSNNLFEGEIH 176

Query: 195  SRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 253
              + S+S  IQ+LDLSMN  +G+L GL + S S++QLH+D+N L G LPD LYS+  L+ 
Sbjct: 177  PELCSSSGGIQVLDLSMNRLVGNLDGLYNCSKSIQQLHIDSNRLTGQLPDYLYSIRELEQ 236

Query: 254  VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 313
            +SLS N  SG+LS+ +SNL+ L+ L+I  N+FS  +P+V GNLTQLE     SN FSG  
Sbjct: 237  LSLSGNYLSGELSKNLSNLSGLKSLLISENRFSDVIPDVFGNLTQLEHLDVSSNKFSGRF 296

Query: 314  PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 373
            P SLS CSKL VLDLRNNSL+G I+LNF+G + LC LDLA+NHFSGPLP+SL  C  +KI
Sbjct: 297  PPSLSQCSKLRVLDLRNNSLSGSINLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPKMKI 356

Query: 374  LSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE 433
            LSLAKNE  G++P++F  L SLLFLSLSNNSF   S T++VLQ C+NL+TLIL+KNF+GE
Sbjct: 357  LSLAKNEFRGKIPDTFKNLQSLLFLSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGE 416

Query: 434  EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 493
            EIP NV GF++L +LALGNCGL+G IP WLL CKKL+VLDLSWNHF G IP WIG+ME+L
Sbjct: 417  EIPNNVTGFDNLAILALGNCGLRGQIPSWLLNCKKLEVLDLSWNHFYGTIPHWIGKMESL 476

Query: 494  FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASS 553
            FY+DFSNNTLTG IP ++TELK+LI  N T+S  T S+GIPLYVK N+S+NGLPYNQ S 
Sbjct: 477  FYIDFSNNTLTGAIPVAITELKNLIRLNGTASQMTDSSGIPLYVKRNKSSNGLPYNQVSR 536

Query: 554  FPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 613
            FPPS++L+NNR+NGTI PEIG+LK LH+LDLSRNN TGTIP SIS + NLEVLDLS N L
Sbjct: 537  FPPSIYLNNNRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHL 596

Query: 614  HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMH 673
            +GSIP SF+ LTFLS+FSVA N L G IP+GGQFYSFP+SSFEGN GLC  IDSPCD + 
Sbjct: 597  YGSIPLSFQSLTFLSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLM 656

Query: 674  AKLKPVIPSGSN------SKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDL 727
            + +  + P GS+       KFG  SI+ +T S+ +GI LLL+V LL++SR+D    I+D+
Sbjct: 657  SNM--LNPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDV 714

Query: 728  DEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT 787
            DE+      +S+AL  SK+VLF +  CKDL+V +LLKSTNNF+QANIIGCGGFGLVYKA 
Sbjct: 715  DEET--ISGVSKALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKAN 772

Query: 788  LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN 847
              +G+KAAVKRLSGDCGQMEREFQAEVEALSRA+HKNLVSLQGYC+HGNDRLLIYS+MEN
Sbjct: 773  FPDGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMEN 832

Query: 848  GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF 907
            GSLDYWLHE VD +  L WDVRLKIAQGAARGLAYLHKVCEP+++HRDVKSSNILLDEKF
Sbjct: 833  GSLDYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKF 892

Query: 908  EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 967
            EAHLADFGL+RLLRPYDTHVTTDLVGTLGYIPPEYSQ+L ATCRGDVYSFGVVLLEL+TG
Sbjct: 893  EAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTG 952

Query: 968  RRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDP 1027
            RRPVEVCKGK+CRDLVS VFQMK+EKRE E+ID +I     E+ +LEMLEIACKCID +P
Sbjct: 953  RRPVEVCKGKSCRDLVSRVFQMKAEKREAELIDTTIRENVNERTVLEMLEIACKCIDHEP 1012

Query: 1028 RRRPFIEEVVTWLDGIGIDAA 1048
            RRRP IEEVVTWL+ + +++ 
Sbjct: 1013 RRRPLIEEVVTWLEDLPMESV 1033

Phytosulfokine receptor with a serine/threonine-protein kinase activity.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1

 Score =  918 bits (2373), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 518/1051 (49%), Positives = 683/1051 (64%), Gaps = 57/1051 (5%)

Query: 15   LFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWS-NESM-----CCQWD 68
            L L  F    + + +   +C+ +DL AL+ F   L   S I  W  NES      CC W 
Sbjct: 10   LILVGFCVQIVVVNSQNLTCNSNDLKALEGFMRGLE--SSIDGWKWNESSSFSSNCCDWV 67

Query: 69   GVVCGHG-STG----SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVP 123
            G+ C    S G    + +GRV  L L R+ L G +  S+  L+QLK              
Sbjct: 68   GISCKSSVSLGLDDVNESGRVVELELGRRKLSGKLSESVAKLDQLK-------------- 113

Query: 124  VELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFN 183
                      VL+L+HN LSG ++  L  L+ ++ L++SSN F+G    L    +L V N
Sbjct: 114  ----------VLNLTHNSLSGSIAASLLNLSNLEVLDLSSNDFSGLFPSLINLPSLRVLN 163

Query: 184  ISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQ-GLDHSPSLKQLHVDNNLLGGDLP 242
            +  NSF G + + + +    I+ +DL+MN+F GS+  G+ +  S++ L + +N L G +P
Sbjct: 164  VYENSFHGLIPASLCNNLPRIREIDLAMNYFDGSIPVGIGNCSSVEYLGLASNNLSGSIP 223

Query: 243  DSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFF 302
              L+ +S+L  ++L  N  SG LS K+  L++L  L I  N+FSGK+P+V   L +L +F
Sbjct: 224  QELFQLSNLSVLALQNNRLSGALSSKLGKLSNLGRLDISSNKFSGKIPDVFLELNKLWYF 283

Query: 303  VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLP 362
             A SN F+G +P SLS    + +L LRNN+L+G I LN S +++L +LDLA+N FSG +P
Sbjct: 284  SAQSNLFNGEMPRSLSNSRSISLLSLRNNTLSGQIYLNCSAMTNLTSLDLASNSFSGSIP 343

Query: 363  NSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLT 422
            ++L +C  LK ++ AK +   Q+PESF    SL  LS SN+S  ++S  L +LQ C+NL 
Sbjct: 344  SNLPNCLRLKTINFAKIKFIAQIPESFKNFQSLTSLSFSNSSIQNISSALEILQHCQNLK 403

Query: 423  TLILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG 481
            TL+LT NF  EE+P      F++L VL + +C L+G +P WL     LQ+LDLSWN   G
Sbjct: 404  TLVLTLNFQKEELPSVPSLQFKNLKVLIIASCQLRGTVPQWLSNSPSLQLLDLSWNQLSG 463

Query: 482  NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNR 541
             IPPW+G + +LFYLD SNNT  GEIP SLT L+SL+S       P  S   P + K N 
Sbjct: 464  TIPPWLGSLNSLFYLDLSNNTFIGEIPHSLTSLQSLVSKENAVEEP--SPDFPFFKKKNT 521

Query: 542  STNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIR 601
            +  GL YNQ SSFPP + LS N +NG+I PE G L+ LHVL+L  NN++G IP+++S + 
Sbjct: 522  NAGGLQYNQPSSFPPMIDLSYNSLNGSIWPEFGDLRQLHVLNLKNNNLSGNIPANLSGMT 581

Query: 602  NLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 661
            +LEVLDLS N+L G+IP S  KL+FLS FSVA N L G IPTG QF +FPNSSFEGN GL
Sbjct: 582  SLEVLDLSHNNLSGNIPPSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGL 641

Query: 662  CGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSG 721
            CGE  SPC   H   +    S   SK     I+A+    G+G   LL VTLL + R  S 
Sbjct: 642  CGEHASPC---HITDQSPHGSAVKSKKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTSR 698

Query: 722  CPIDDLDEDMGRPQRLSEA----LASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANIIG 776
              +D        P++ ++A    L S  +VLF N D   +L++ D+LKST++FNQANIIG
Sbjct: 699  GEVD--------PEKKADADEIELGSRSVVLFHNKDSNNELSLDDILKSTSSFNQANIIG 750

Query: 777  CGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN 836
            CGGFGLVYKATL +GTK A+KRLSGD GQM+REFQAEVE LSRAQH NLV L GYC + N
Sbjct: 751  CGGFGLVYKATLPDGTKVAIKRLSGDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKN 810

Query: 837  DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV 896
            D+LLIYSYM+NGSLDYWLHE VD    L W  RL+IA+GAA GLAYLH+ CEPHI+HRD+
Sbjct: 811  DKLLIYSYMDNGSLDYWLHEKVDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDI 870

Query: 897  KSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
            KSSNILL + F AHLADFGL+RL+ PYDTHVTTDLVGTLGYIPPEY Q   AT +GDVYS
Sbjct: 871  KSSNILLSDTFVAHLADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYS 930

Query: 957  FGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML 1016
            FGVVLLELLTGRRP++VCK +  RDL+SWV QMK+EKRE EI D  I+ KD  +++L +L
Sbjct: 931  FGVVLLELLTGRRPMDVCKPRGSRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVL 990

Query: 1017 EIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1047
            EIAC+C+ ++P+ RP  +++V+WL+ I + +
Sbjct: 991  EIACRCLGENPKTRPTTQQLVSWLENIDVSS 1021

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score =  909 bits (2349), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 511/1042 (49%), Positives = 686/1042 (65%), Gaps = 49/1042 (4%)

Query: 11   CLKWLFLAFFVCSCLGLQTPFQS-CDPSDLLALKEFAGNLT---NGSIITSWSNESMCCQ 66
            C+  +FL   +C     ++   S C P DL AL++F  +L    +G I +S S +  CC 
Sbjct: 7    CVIVIFLTELLCFFYSSESQTTSRCHPHDLEALRDFIAHLEPKPDGWINSSSSTD--CCN 64

Query: 67   WDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL 126
            W G+ C      +N GRV  L L  K L G +  SLG L+++++L+LS N ++  +P+ +
Sbjct: 65   WTGITC----NSNNTGRVIRLELGNKKLSGKLSESLGKLDEIRVLNLSRNFIKDSIPLSI 120

Query: 127  SNLKQLEVLDLSHNMLSGPVSGMLAGLNL--IQSLNVSSNSFNGSLFELGEFSNLAVFNI 184
             NLK L+ LDLS N LSG   G+   +NL  +QS ++SSN FNGS               
Sbjct: 121  FNLKNLQTLDLSSNDLSG---GIPTSINLPALQSFDLSSNKFNGS--------------- 162

Query: 185  SNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHVDNNLLGGDLPD 243
                    L S I   S +I+++ L++N+F G+   G      L+ L +  N L G++P+
Sbjct: 163  --------LPSHICHNSTQIRVVKLAVNYFAGNFTSGFGKCVLLEHLCLGMNDLTGNIPE 214

Query: 244  SLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFV 303
             L+ +  L  + +  N  SG LS +I NL+SL  L +  N FSG++P+V   L QL+FF+
Sbjct: 215  DLFHLKRLNLLGIQENRLSGSLSREIRNLSSLVRLDVSWNLFSGEIPDVFDELPQLKFFL 274

Query: 304  AHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN 363
              +N F G +P SL+    L++L+LRNNSL+G + LN + + +L +LDL TN F+G LP 
Sbjct: 275  GQTNGFIGGIPKSLANSPSLNLLNLRNNSLSGRLMLNCTAMIALNSLDLGTNRFNGRLPE 334

Query: 364  SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 423
            +L DC  LK ++LA+N   GQVPESF    SL + SLSN+S  ++S  L +LQ CKNLTT
Sbjct: 335  NLPDCKRLKNVNLARNTFHGQVPESFKNFESLSYFSLSNSSLANISSALGILQHCKNLTT 394

Query: 424  LILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGN 482
            L+LT NF GE +P++    FE L VL + NC L G +P WL    +LQ+LDLSWN   G 
Sbjct: 395  LVLTLNFHGEALPDDSSLHFEKLKVLVVANCRLTGSMPRWLSSSNELQLLDLSWNRLTGA 454

Query: 483  IPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 542
            IP WIG  + LFYLD SNN+ TGEIPKSLT+L+SL S N + + P  S   P ++K N S
Sbjct: 455  IPSWIGDFKALFYLDLSNNSFTGEIPKSLTKLESLTSRNISVNEP--SPDFPFFMKRNES 512

Query: 543  TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 602
               L YNQ   FPP++ L +N ++G I  E G LK LHV DL  N ++G+IPSS+S + +
Sbjct: 513  ARALQYNQIFGFPPTIELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTS 572

Query: 603  LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 662
            LE LDLS+N L GSIP S ++L+FLSKFSVA N+L G IP+GGQF +FPNSSFE N  LC
Sbjct: 573  LEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESN-HLC 631

Query: 663  GEIDSPCDSMHAKLKPVIPSGSNSKFGP-GSIIAITFSIGVGIALLLAVTLLKMSRRDSG 721
            GE   PC         +I     S+ G  G  I I F  G    L L   ++  +RR SG
Sbjct: 632  GEHRFPCS--EGTESALIKRSRRSRGGDIGMAIGIAF--GSVFLLTLLSLIVLRARRRSG 687

Query: 722  CPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFG 781
                +++E     ++    + S  +VLFQ++D K+L+  DLL STN+F+QANIIGCGGFG
Sbjct: 688  EVDPEIEESESMNRKELGEIGSKLVVLFQSND-KELSYDDLLDSTNSFDQANIIGCGGFG 746

Query: 782  LVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI 841
            +VYKATL +G K A+K+LSGDCGQ+EREF+AEVE LSRAQH NLV L+G+C + NDRLLI
Sbjct: 747  MVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLI 806

Query: 842  YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNI 901
            YSYMENGSLDYWLHE  D  ++LKW  RL+IAQGAA+GL YLH+ C+PHI+HRD+KSSNI
Sbjct: 807  YSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNI 866

Query: 902  LLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVL 961
            LLDE F +HLADFGL+RL+ PY+THV+TDLVGTLGYIPPEY Q   AT +GDVYSFGVVL
Sbjct: 867  LLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVL 926

Query: 962  LELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACK 1021
            LELLT +RPV++CK K CRDL+SWV +MK E R  E+ D  I+ K+ +K++  +LEIAC 
Sbjct: 927  LELLTDKRPVDMCKPKGCRDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACL 986

Query: 1022 CIDQDPRRRPFIEEVVTWLDGI 1043
            C+ ++P++RP  +++V+WLD +
Sbjct: 987  CLSENPKQRPTTQQLVSWLDDV 1008

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C7S5|PSYR1_ARATH Tyrosine-sulfated glycopeptide receptor 1 OS=Arabidopsis thaliana GN=PSYR1 PE=2 SV=1

 Score =  856 bits (2211), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 483/1072 (45%), Positives = 668/1072 (62%), Gaps = 50/1072 (4%)

Query: 8    PMTCLKWLFLAFFV--CSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCC 65
            P++    LF+  +V   S   L      C+  D  +L  F+GN+++      W++   CC
Sbjct: 20   PLSPHMVLFVLLYVLSISVFFLTVSEAVCNLQDRDSLLWFSGNVSSPVSPLHWNSSIDCC 79

Query: 66   QWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVE 125
             W+G+ C      S   RVT +IL  +GL G +P S+  L +L  LDLS N L G +P  
Sbjct: 80   SWEGISCDK----SPENRVTSIILSSRGLSGNLPSSVLDLQRLSRLDLSHNRLSGPLPPG 135

Query: 126  -LSNLKQLEVLDLSHNMLSG--PVSGMLA----GLNLIQSLNVSSNSFNG-----SLFEL 173
             LS L QL VLDLS+N   G  P+         G+  IQ++++SSN   G     S+F  
Sbjct: 136  FLSALDQLLVLDLSYNSFKGELPLQQSFGNGSNGIFPIQTVDLSSNLLEGEILSSSVFLQ 195

Query: 174  GEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHV 232
            G F NL  FN+SNNSFTG + S + +AS ++  LD S N F G L Q L     L  L  
Sbjct: 196  GAF-NLTSFNVSNNSFTGSIPSFMCTASPQLTKLDFSYNDFSGDLSQELSRCSRLSVLRA 254

Query: 233  DNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV 292
              N L G++P  +Y++  L+ + L VN  SG++   I+ LT L  L ++ N   G++P  
Sbjct: 255  GFNNLSGEIPKEIYNLPELEQLFLPVNRLSGKIDNGITRLTKLTLLELYSNHIEGEIPKD 314

Query: 293  LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID-LNFSGLSSLCTLD 351
            +G L++L     H N+  G +P+SL+ C+KL  L+LR N L G +  ++FS   SL  LD
Sbjct: 315  IGKLSKLSSLQLHVNNLMGSIPVSLANCTKLVKLNLRVNQLGGTLSAIDFSRFQSLSILD 374

Query: 352  LATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGT 411
            L  N F+G  P+++  C  +  +  A N+L+GQ+     +L SL F + S+N   +L+G 
Sbjct: 375  LGNNSFTGEFPSTVYSCKMMTAMRFAGNKLTGQISPQVLELESLSFFTFSDNKMTNLTGA 434

Query: 412  LSVLQQCKNLTTLILTKNFVGEEIPEN-----VGGFESLMVLALGNCGLKGHIPVWLLRC 466
            LS+LQ CK L+TLI+ KNF  E +P N       GF SL +  +G C L G IP WL++ 
Sbjct: 435  LSILQGCKKLSTLIMAKNFYDETVPSNKDFLRSDGFPSLQIFGIGACRLTGEIPAWLIKL 494

Query: 467  KKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSN 526
            ++++V+DLS N F G IP W+G + +LFYLD S+N LTGE+PK L +L++L+S     + 
Sbjct: 495  QRVEVMDLSMNRFVGTIPGWLGTLPDLFYLDLSDNFLTGELPKELFQLRALMSQKAYDAT 554

Query: 527  PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR 586
                  +P++V  N  T    YNQ SS PP++++  N + GTIP E+GQLK LH+L+L  
Sbjct: 555  ERNYLELPVFVNPNNVTTNQQYNQLSSLPPTIYIKRNNLTGTIPVEVGQLKVLHILELLG 614

Query: 587  NNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQ 646
            NN +G+IP  +S + NLE LDLS+N+L G IP S   L FLS F+VANN L G IPTG Q
Sbjct: 615  NNFSGSIPDELSNLTNLERLDLSNNNLSGRIPWSLTGLHFLSYFNVANNTLSGPIPTGTQ 674

Query: 647  FYSFPNSSFEGNPGLCGEID-SPCDSMHAKLKPVIPSGSNSKFGPGSI-------IAITF 698
            F +FP ++FEGNP LCG +  + CD             S +K G G +       + +  
Sbjct: 675  FDTFPKANFEGNPLLCGGVLLTSCDPTQH---------STTKMGKGKVNRTLVLGLVLGL 725

Query: 699  SIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSK-----LVLFQNS- 752
              GV + L+L   L+   RR +    ++ + ++      SE    S      ++LF NS 
Sbjct: 726  FFGVSLILVLLALLVLSKRRVNPGDSENAELEINSNGSYSEVPPGSDKDISLVLLFGNSR 785

Query: 753  -DCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQ 811
             + KDLT+ +LLK+T+NF+QANIIGCGGFGLVYKATL NGTK AVK+L+GD G ME+EF+
Sbjct: 786  YEVKDLTIFELLKATDNFSQANIIGCGGFGLVYKATLDNGTKLAVKKLTGDYGMMEKEFK 845

Query: 812  AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
            AEVE LSRA+H+NLV+LQGYC H + R+LIYS+MENGSLDYWLHE+ +  + L W  RL 
Sbjct: 846  AEVEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSLDYWLHENPEGPAQLDWPKRLN 905

Query: 872  IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
            I +GA+ GLAY+H++CEPHIVHRD+KSSNILLD  F+A++ADFGLSRL+ PY THVTT+L
Sbjct: 906  IMRGASSGLAYMHQICEPHIVHRDIKSSNILLDGNFKAYVADFGLSRLILPYRTHVTTEL 965

Query: 932  VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS 991
            VGTLGYIPPEY Q   AT RGDVYSFGVV+LELLTG+RP+EV + K  R+LV+WV  MK 
Sbjct: 966  VGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKRPMEVFRPKMSRELVAWVHTMKR 1025

Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            + +  E+ D  +     E+ +L +L+IAC C++Q+P +RP I++VV WL  I
Sbjct: 1026 DGKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQNPMKRPNIQQVVDWLKNI 1077

Tyrosine-sulfated glycopeptide receptor with a serine/threonine-protein kinase activity. Regulates, in response to tyrosine-sulfated glycopeptide binding, a signaling cascade involved in cellular proliferation and plant growth. Not involved in PSK perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  526 bits (1355), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 377/1116 (33%), Positives = 571/1116 (51%), Gaps = 119/1116 (10%)

Query: 39   LLALKEFAGNLTNGSIITSWSNESM--CCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKG 96
            LLA K+ +      +++ +W  ES    C W GV C      S+ GR+  L L   GL G
Sbjct: 38   LLAFKQNSVKSDPNNVLGNWKYESGRGSCSWRGVSC------SDDGRIVGLDLRNSGLTG 91

Query: 97   IIP----RSLGHLNQLKL--------------------LDLSCNHLE------------- 119
             +      +L +L  L L                    LDLS N +              
Sbjct: 92   TLNLVNLTALPNLQNLYLQGNYFSSGGDSSGSDCYLQVLDLSSNSISDYSMVDYVFSKCS 151

Query: 120  GVVPVELSN-------------LKQLEVLDLSHNMLSG--PVSGMLAGLNLIQSLNVSSN 164
             +V V +SN             L+ L  +DLS+N+LS   P S +      ++ L+++ N
Sbjct: 152  NLVSVNISNNKLVGKLGFAPSSLQSLTTVDLSYNILSDKIPESFISDFPASLKYLDLTHN 211

Query: 165  SFNGSLFEL--GEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLD 222
            + +G   +L  G   NL  F++S N+ +G          K ++ L++S N+  G +   +
Sbjct: 212  NLSGDFSDLSFGICGNLTFFSLSQNNLSGDKFPITLPNCKFLETLNISRNNLAGKIPNGE 271

Query: 223  HSPS---LKQLHVDNNLLGGDLPDSLYSM-SSLQHVSLSVNNFSGQLSEKISNLTSLRHL 278
            +  S   LKQL + +N L G++P  L  +  +L  + LS N FSG+L  + +    L++L
Sbjct: 272  YWGSFQNLKQLSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNL 331

Query: 279  IIFGNQFSGKLPN-VLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPI 337
             +  N  SG   N V+  +T + +     N+ SG +P+SL+ CS L VLDL +N  TG +
Sbjct: 332  NLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNV 391

Query: 338  DLNFSGLSSLCTLD---LATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTS 394
               F  L S   L+   +A N+ SG +P  L  C  LK + L+ NEL+G +P+    L +
Sbjct: 392  PSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPN 451

Query: 395  LLFLSLSNNSFNHLSGTL--SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGN 452
            L  L +  N   +L+GT+   V  +  NL TLIL  N +   IPE++    +++ ++L +
Sbjct: 452  LSDLVMWAN---NLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSS 508

Query: 453  CGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLT 512
              L G IP  +    KL +L L  N   GN+P  +G  ++L +LD ++N LTG++P  L 
Sbjct: 509  NRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELA 568

Query: 513  ELKSLISSNCTSSNPTA-----------SAG---------------IPLY--VKHNRSTN 544
                L+     S    A            AG               +P+       R  +
Sbjct: 569  SQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYS 628

Query: 545  GLPYNQASSFPPSVF--LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 602
            G+     S+    ++  +S N ++G IPP  G + +L VL+L  N ITGTIP S   ++ 
Sbjct: 629  GMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKA 688

Query: 603  LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 662
            + VLDLS N+L G +PGS   L+FLS   V+NN+L G IP GGQ  +FP S +  N GLC
Sbjct: 689  IGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLC 748

Query: 663  GEIDSPCDSMHAKLKPVIPS--GSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDS 720
            G    PC S  A  +P+               I  I FS    + L++A+  ++  ++  
Sbjct: 749  GVPLRPCGS--APRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKE 806

Query: 721  GCPIDDLDEDMGRPQRLSEALASSKLVLFQN-----SDCKDLTVSDLLKSTNNFNQANII 775
                +   E +      S  L+S    L  N        + LT + LL++TN F+   ++
Sbjct: 807  Q-KREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMV 865

Query: 776  GCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG 835
            G GGFG VYKA L +G+  A+K+L    GQ +REF AE+E + + +H+NLV L GYC+ G
Sbjct: 866  GSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVG 925

Query: 836  NDRLLIYSYMENGSLDYWLHESVDKDS--VLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
             +RLL+Y YM+ GSL+  LHE   K     L W  R KIA GAARGLA+LH  C PHI+H
Sbjct: 926  EERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIH 985

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRG 952
            RD+KSSN+LLDE FEA ++DFG++RL+   DTH++ + L GT GY+PPEY Q+   T +G
Sbjct: 986  RDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKG 1045

Query: 953  DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS-IWHKDREKQ 1011
            DVYS+GV+LLELL+G++P++  +     +LV W  Q+  EKR  EI+D   +  K  + +
Sbjct: 1046 DVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVE 1105

Query: 1012 LLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1047
            L   L+IA +C+D  P +RP + +++     +  D 
Sbjct: 1106 LFHYLKIASQCLDDRPFKRPTMIQLMAMFKEMKADT 1141

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  523 bits (1346), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 374/1091 (34%), Positives = 568/1091 (52%), Gaps = 142/1091 (13%)

Query: 65   CQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIP----------RSL------------ 102
            C W GV C      S+ GRV  L L   GL G +           RSL            
Sbjct: 65   CTWRGVSC------SSDGRVIGLDLRNGGLTGTLNLNNLTALSNLRSLYLQGNNFSSGDS 118

Query: 103  --GHLNQLKLLDLSCNHL--EGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLN-LIQ 157
                   L++LDLS N L    +V    S    L  ++ SHN L+G +    +  N  I 
Sbjct: 119  SSSSGCSLEVLDLSSNSLTDSSIVDYVFSTCLNLVSVNFSHNKLAGKLKSSPSASNKRIT 178

Query: 158  SLNVSSNSFNGSLFEL--------------------GEFS--------NLAVFNISNNSF 189
            ++++S+N F+  + E                     G+FS        NL VF++S NS 
Sbjct: 179  TVDLSNNRFSDEIPETFIADFPNSLKHLDLSGNNVTGDFSRLSFGLCENLTVFSLSQNSI 238

Query: 190  TGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH---SPSLKQLHVDNNLLGGDLPDSLY 246
            +G       S  K ++ L+LS N  +G + G D+     +L+QL + +NL  G++P  L 
Sbjct: 239  SGDRFPVSLSNCKLLETLNLSRNSLIGKIPGDDYWGNFQNLRQLSLAHNLYSGEIPPELS 298

Query: 247  SM-SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGK-LPNVLGNLTQLEFFVA 304
             +  +L+ + LS N+ +GQL +  ++  SL+ L +  N+ SG  L  V+  L+++     
Sbjct: 299  LLCRTLEVLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYL 358

Query: 305  HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLD---LATNHFSGPL 361
              N+ SG +P+SL+ CS L VLDL +N  TG +   F  L S   L+   +A N+ SG +
Sbjct: 359  PFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTV 418

Query: 362  PNSLSDCHDLKILSLAKNELSGQVPE---SFGKLTSLLFLSLSNNSFNHLSGTL--SVLQ 416
            P  L  C  LK + L+ N L+G +P+   +  KL+ L+  +      N+L+G +  S+  
Sbjct: 419  PVELGKCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWA------NNLTGGIPESICV 472

Query: 417  QCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSW 476
               NL TLIL  N +   +PE++    +++ ++L +  L G IPV + + +KL +L L  
Sbjct: 473  DGGNLETLILNNNLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLGN 532

Query: 477  NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTA------- 529
            N   GNIP  +G  +NL +LD ++N LTG +P  L     L+     S    A       
Sbjct: 533  NSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEGG 592

Query: 530  -----SAGIPLY-------VKH---------NRSTNGLPYNQASSFPPSVF--LSNNRIN 566
                 + G+  +       ++H          R  +G+     SS    ++  LS N ++
Sbjct: 593  TDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVS 652

Query: 567  GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTF 626
            G+IP   G + +L VL+L  N +TGTIP S   ++ + VLDLS NDL G +PGS   L+F
Sbjct: 653  GSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSF 712

Query: 627  LSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNS 686
            LS   V+NN+L G IP GGQ  +FP + +  N GLCG    PC S         P+ S++
Sbjct: 713  LSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSGSR------PTRSHA 766

Query: 687  KFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALA---- 742
                 S IA   S G+  + +  V L+    R        + +   + ++  E+L     
Sbjct: 767  HPKKQS-IATGMSAGIVFSFMCIVMLIMALYR-----ARKVQKKEKQREKYIESLPTSGS 820

Query: 743  ------------SSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTN 790
                        S  +  F+    + LT + LL++TN F+  ++IG GGFG VYKA L +
Sbjct: 821  SSWKLSSVHEPLSINVATFEKP-LRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLAD 879

Query: 791  GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            G+  A+K+L    GQ +REF AE+E + + +H+NLV L GYC+ G +RLL+Y YM+ GSL
Sbjct: 880  GSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSL 939

Query: 851  DYWLHESVDKDSV-LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA 909
            +  LHE   K  + L W  R KIA GAARGLA+LH  C PHI+HRD+KSSN+LLD+ F A
Sbjct: 940  ETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVA 999

Query: 910  HLADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR 968
             ++DFG++RL+   DTH++ + L GT GY+PPEY Q+   T +GDVYS+GV+LLELL+G+
Sbjct: 1000 RVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGK 1059

Query: 969  RPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS-IWHKDREKQLLEMLEIACKCIDQDP 1027
            +P++  +     +LV W  Q+  EKR  EI+D   +  K  + +LL  L+IA +C+D  P
Sbjct: 1060 KPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRP 1119

Query: 1028 RRRPFIEEVVT 1038
             +RP + +V+T
Sbjct: 1120 FKRPTMIQVMT 1130

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  511 bits (1315), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 374/1007 (37%), Positives = 547/1007 (54%), Gaps = 76/1007 (7%)

Query: 105  LNQLKLLDLSCNHLEG--VVPVELSN-LKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 161
            LN L++LDLS N + G  VV   LS+   +L+ L +S N +SG V  +   +NL + L+V
Sbjct: 172  LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNL-EFLDV 229

Query: 162  SSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL 221
            SSN+F+  +  LG+ S L   +IS N  +G   SR  S   E+++L++S N F+G +  L
Sbjct: 230  SSNNFSTGIPFLGDCSALQHLDISGNKLSGDF-SRAISTCTELKLLNISSNQFVGPIPPL 288

Query: 222  DHSPSLKQLHVDNNLLGGDLPDSLY-SMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLII 280
                SL+ L +  N   G++PD L  +  +L  + LS N+F G +     + + L  L +
Sbjct: 289  PLK-SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 347

Query: 281  FGNQFSGKLP-NVLGNLTQLEFFVAHSNSFSGPLPLSLS-LCSKLHVLDLRNNSLTGPID 338
              N FSG+LP + L  +  L+      N FSG LP SL+ L + L  LDL +N+ +GPI 
Sbjct: 348  SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 407

Query: 339  LNF--SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLL 396
             N   +  ++L  L L  N F+G +P +LS+C +L  L L+ N LSG +P S G L+ L 
Sbjct: 408  PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 467

Query: 397  FLSLSNNSFNHLSGTL-SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 455
             L L     N L G +   L   K L TLIL  N +  EIP  +    +L  ++L N  L
Sbjct: 468  DLKLW---LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 524

Query: 456  KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELK 515
             G IP W+ R + L +L LS N F GNIP  +G   +L +LD + N   G IP ++ +  
Sbjct: 525  TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 584

Query: 516  SLISSNCTSSNPTA------------SAGIPLYVKHNRST--NGLPYNQASSFPPSVF-- 559
              I++N  +                  AG  L  +  RS   N L      +    V+  
Sbjct: 585  GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 644

Query: 560  ----------------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNL 603
                            +S N ++G IP EIG + +L +L+L  N+I+G+IP  + ++R L
Sbjct: 645  HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 704

Query: 604  EVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCG 663
             +LDLSSN L G IP +   LT L++  ++NN+L G IP  GQF +FP + F  NPGLCG
Sbjct: 705  NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 764

Query: 664  EIDSPCDSMHAK----------LKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTL- 712
                 CD  +A            +P   +GS +     S + I   I VG  +       
Sbjct: 765  YPLPRCDPSNADGYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKK 824

Query: 713  ---LKMSRRDSGCPIDDLDEDMG-RPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNN 768
               L+M     G   D    +   +   + EAL S  L  F+    + LT +DLL++TN 
Sbjct: 825  EAELEMYAEGHGNSGDRTANNTNWKLTGVKEAL-SINLAAFEKP-LRKLTFADLLQATNG 882

Query: 769  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            F+  ++IG GGFG VYKA L +G+  A+K+L    GQ +REF AE+E + + +H+NLV L
Sbjct: 883  FHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPL 942

Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
             GYC+ G++RLL+Y +M+ GSL+  LH+       L W  R KIA G+ARGLA+LH  C 
Sbjct: 943  LGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCS 1002

Query: 889  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLT 947
            PHI+HRD+KSSN+LLDE  EA ++DFG++RL+   DTH++ + L GT GY+PPEY Q+  
Sbjct: 1003 PHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1062

Query: 948  ATCRGDVYSFGVVLLELLTGRRPVEVCK-GKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
             + +GDVYS+GVVLLELLTG+RP +    G N  +LV WV Q  ++ R  ++ D  +  +
Sbjct: 1063 CSTKGDVYSYGVVLLELLTGKRPTDSPDFGDN--NLVGWVKQ-HAKLRISDVFDPELMKE 1119

Query: 1007 DR--EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD----GIGIDA 1047
            D   E +LL+ L++A  C+D    RRP + +V+        G GID+
Sbjct: 1120 DPALEIELLQHLKVAVACLDDRAWRRPTMVQVMAMFKEIQAGSGIDS 1166

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  509 bits (1312), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 377/1105 (34%), Positives = 545/1105 (49%), Gaps = 136/1105 (12%)

Query: 41   ALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTML---ILPRKGLKGI 97
             + E  GNL N  ++   S     C+  G++       S  GR+  L   IL    L+G 
Sbjct: 159  TIPETFGNLVNLQMLALAS-----CRLTGLIP------SRFGRLVQLQTLILQDNELEGP 207

Query: 98   IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
            IP  +G+   L L   + N L G +P EL+ LK L+ L+L  N  SG +   L  L  IQ
Sbjct: 208  IPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQ 267

Query: 158  SLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 216
             LN+  N   G +   L E +NL   ++S+N+ TG ++   W  + +++ L L+ N   G
Sbjct: 268  YLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMN-QLEFLVLAKNRLSG 326

Query: 217  SL--------------------------QGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSS 250
            SL                            + +  SLK L + NN L G +PDSL+ +  
Sbjct: 327  SLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVE 386

Query: 251  LQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS 310
            L ++ L+ N+  G LS  ISNLT+L+   ++ N   GK+P  +G L +LE    + N FS
Sbjct: 387  LTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFS 446

Query: 311  GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHD 370
            G +P+ +  C++L  +D   N L+G I  +   L  L  L L  N   G +P SL +CH 
Sbjct: 447  GEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQ 506

Query: 371  LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF---------------------NHLS 409
            + ++ LA N+LSG +P SFG LT+L    + NNS                      N  +
Sbjct: 507  MTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFN 566

Query: 410  GTLS------------------------VLQQCKNLTTLILTKNFVGEEIPENVGGFESL 445
            G++S                         L +  NL  L L KN     IP   G    L
Sbjct: 567  GSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISEL 626

Query: 446  MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG 505
             +L +    L G IPV L  CKKL  +DL+ N+  G IP W+G++  L  L  S+N   G
Sbjct: 627  SLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVG 686

Query: 506  EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNG--LPYNQASSFPPSVF---- 559
             +P  +  L ++++     ++   S  IP  + + ++ N   L  NQ S   PS      
Sbjct: 687  SLPTEIFSLTNILTLFLDGNSLNGS--IPQEIGNLQALNALNLEENQLSGPLPSTIGKLS 744

Query: 560  ------LSNNRINGTIPPEIGQLKHLH-VLDLSRNNITGTIPSSISEIRNLEVLDLSSND 612
                  LS N + G IP EIGQL+ L   LDLS NN TG IPS+IS +  LE LDLS N 
Sbjct: 745  KLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQ 804

Query: 613  LHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSM 672
            L G +PG    +  L   +++ N+L+G +    QF  +   +F GN GLCG   S C+  
Sbjct: 805  LVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRA 862

Query: 673  HAKLKPVIPSGSNSKFGPGSIIAIT-FSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDM 731
             +K        +     P +++ I+  S    IAL++ V +L   +       D   +  
Sbjct: 863  GSK--------NQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNH-----DLFKKVR 909

Query: 732  GRPQRLSEALASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTN 790
            G     S   +SS+  LF N   K D+   D++++T+  N+  +IG GG G VYKA L N
Sbjct: 910  GGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKN 969

Query: 791  GTKAAVKR-LSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND--RLLIYSYMEN 847
            G   AVK+ L  D     + F  EV+ L   +H++LV L GYC    D   LLIY YM N
Sbjct: 970  GETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMAN 1029

Query: 848  GSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE 905
            GS+  WLH  E+  K  VL W+ RLKIA G A+G+ YLH  C P IVHRD+KSSN+LLD 
Sbjct: 1030 GSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDS 1089

Query: 906  KFEAHLADFGLSRLLRP-YDTHVTTD--LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLL 962
              EAHL DFGL+++L   YDT+  ++    G+ GYI PEY+ +L AT + DVYS G+VL+
Sbjct: 1090 NIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLM 1149

Query: 963  ELLTGRRPVEVCKGKNCRDLVSWVFQM-----KSEKREVEIIDASIWH--KDREKQLLEM 1015
            E++TG+ P E    +   D+V WV  +      SE RE ++ID+ +       E+   ++
Sbjct: 1150 EIVTGKMPTEAMFDEET-DMVRWVETVLDTPPGSEARE-KLIDSELKSLLPCEEEAAYQV 1207

Query: 1016 LEIACKCIDQDPRRRPFIEEVVTWL 1040
            LEIA +C    P+ RP   +   +L
Sbjct: 1208 LEIALQCTKSYPQERPSSRQASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  503 bits (1295), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 366/1052 (34%), Positives = 522/1052 (49%), Gaps = 120/1052 (11%)

Query: 83   RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 142
            RV  LIL    L+G IP  LG+ + L +   + N L G +P EL  L+ LE+L+L++N L
Sbjct: 192  RVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSL 251

Query: 143  SGPVSGMLAGLNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSAS 201
            +G +   L  ++ +Q L++ +N   G + + L +  NL   ++S N+ TG++    W+ S
Sbjct: 252  TGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMS 311

Query: 202  KEIQILDLSM--NHFMGSLQG--------------------------LDHSPSLKQLHVD 233
               Q+LDL +  NH  GSL                            L    SLKQL + 
Sbjct: 312  ---QLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLS 368

Query: 234  NNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVL 293
            NN L G +P++L+ +  L  + L  N   G LS  ISNLT+L+ L+++ N   GKLP  +
Sbjct: 369  NNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEI 428

Query: 294  GNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLA 353
              L +LE    + N FSG +P  +  C+ L ++D+  N   G I  +   L  L  L L 
Sbjct: 429  SALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLR 488

Query: 354  TNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF-------- 405
             N   G LP SL +CH L IL LA N+LSG +P SFG L  L  L L NNS         
Sbjct: 489  QNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSL 548

Query: 406  -------------NHLSGTLS------------------------VLQQCKNLTTLILTK 428
                         N L+GT+                          L   +NL  L L K
Sbjct: 549  ISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGK 608

Query: 429  NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 488
            N +  +IP  +G    L +L + +  L G IP+ L+ CKKL  +DL+ N   G IPPW+G
Sbjct: 609  NQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLG 668

Query: 489  QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTN--GL 546
            ++  L  L  S+N     +P  L     L+  +   ++   S  IP  + +  + N   L
Sbjct: 669  KLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGS--IPQEIGNLGALNVLNL 726

Query: 547  PYNQASSFPPSVF----------LSNNRINGTIPPEIGQLKHLH-VLDLSRNNITGTIPS 595
              NQ S   P             LS N + G IP EIGQL+ L   LDLS NN TG IPS
Sbjct: 727  DKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPS 786

Query: 596  SISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSF 655
            +I  +  LE LDLS N L G +PGS   +  L   +V+ N+L G +    QF  +P  SF
Sbjct: 787  TIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSF 844

Query: 656  EGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKM 715
             GN GLCG   S C+ + +  K    S  +       I AI+    +G+ ++L + L   
Sbjct: 845  LGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVI----ISAISALTAIGL-MILVIALFFK 899

Query: 716  SRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANI 774
             R D    +             S+A   +   LF+N   K D+   D++++T+N ++  +
Sbjct: 900  QRHDFFKKVGHGSTAYTSSSSSSQA---THKPLFRNGASKSDIRWEDIMEATHNLSEEFM 956

Query: 775  IGCGGFGLVYKATLTNGTKAAVKR-LSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            IG GG G VYKA L NG   AVK+ L  D     + F  EV+ L R +H++LV L GYC 
Sbjct: 957  IGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCS 1016

Query: 834  HGND--RLLIYSYMENGSLDYWLHESV----DKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
              ++   LLIY YM+NGS+  WLHE       K  +L W+ RL+IA G A+G+ YLH  C
Sbjct: 1017 SKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDC 1076

Query: 888  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP---YDTHVTTDLVGTLGYIPPEYSQ 944
             P IVHRD+KSSN+LLD   EAHL DFGL+++L      +T   T    + GYI PEY+ 
Sbjct: 1077 VPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAY 1136

Query: 945  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV---FQMKSEKREVEIIDA 1001
            +L AT + DVYS G+VL+E++TG+ P +   G    D+V WV    ++    R+ ++ID 
Sbjct: 1137 SLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEM-DMVRWVETHLEVAGSARD-KLIDP 1194

Query: 1002 SI--WHKDREKQLLEMLEIACKCIDQDPRRRP 1031
             +       E    ++LEIA +C    P+ RP
Sbjct: 1195 KLKPLLPFEEDAACQVLEIALQCTKTSPQERP 1226

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1

 Score =  502 bits (1292), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 374/1122 (33%), Positives = 555/1122 (49%), Gaps = 150/1122 (13%)

Query: 35   DPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGL 94
            D   LL+ K    +  N +I+++WS     CQ+ GV C         GRVT + L   GL
Sbjct: 39   DSLSLLSFKTMIQDDPN-NILSNWSPRKSPCQFSGVTC-------LGGRVTEINLSGSGL 90

Query: 95   KGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLN 154
             GI+       N    LD                   L VL LS N      + +L    
Sbjct: 91   SGIV-----SFNAFTSLD------------------SLSVLKLSENFFVLNSTSLLLLPL 127

Query: 155  LIQSLNVSSNSFNGSLFE--LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 212
             +  L +SS+   G+L E    ++SNL    +S N+FTGKL + ++ +SK++Q LDLS N
Sbjct: 128  TLTHLELSSSGLIGTLPENFFSKYSNLISITLSYNNFTGKLPNDLFLSSKKLQTLDLSYN 187

Query: 213  HFMGSLQGL----DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEK 268
            +  G + GL        S+  L    N + G + DSL + ++L+ ++LS NNF GQ+ + 
Sbjct: 188  NITGPISGLTIPLSSCVSMTYLDFSGNSISGYISDSLINCTNLKSLNLSYNNFDGQIPKS 247

Query: 269  ISNLTSLRHLIIFGNQFSGKLPNVLGNLTQ-LEFFVAHSNSFSGPLPLSLSLCSKLHVLD 327
               L  L+ L +  N+ +G +P  +G+  + L+      N+F+G +P SLS CS L  LD
Sbjct: 248  FGELKLLQSLDLSHNRLTGWIPPEIGDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSLD 307

Query: 328  LRNNSLTGPI-DLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVP 386
            L NN+++GP  +       SL  L L+ N  SG  P S+S C  L+I   + N  SG +P
Sbjct: 308  LSNNNISGPFPNTILRSFGSLQILLLSNNLISGDFPTSISACKSLRIADFSSNRFSGVIP 367

Query: 387  ESF-GKLTSLLFLSLSNN---------------------SFNHLSGTLSV-LQQCKNLTT 423
                    SL  L L +N                     S N+L+GT+   +   + L  
Sbjct: 368  PDLCPGAASLEELRLPDNLVTGEIPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKLEQ 427

Query: 424  LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCK---------------- 467
             I   N +  EIP  +G  ++L  L L N  L G IP     C                 
Sbjct: 428  FIAWYNNIAGEIPPEIGKLQNLKDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTGEV 487

Query: 468  --------KLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSL------TE 513
                    +L VL L  N+F G IPP +G+   L +LD + N LTGEIP  L        
Sbjct: 488  PKDFGILSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPGSKA 547

Query: 514  LKSLISSNCTS-----SNPTASAG--------IPLYVKHNRSTNGLPYNQASSFPP-SVF 559
            L  L+S N  +      N     G         P  +    S     + +  S P  S+F
Sbjct: 548  LSGLLSGNTMAFVRNVGNSCKGVGGLVEFSGIRPERLLQIPSLKSCDFTRMYSGPILSLF 607

Query: 560  ----------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLS 609
                      LS N++ G IP EIG++  L VL+LS N ++G IP +I +++NL V D S
Sbjct: 608  TRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSHNQLSGEIPFTIGQLKNLGVFDAS 667

Query: 610  SNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPC 669
             N L G IP SF  L+FL +  ++NN L G IP  GQ  + P + +  NPGLCG     C
Sbjct: 668  DNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGVPLPEC 727

Query: 670  DSMHAKLKPVIPSGSNSKFGPGSI-----IAITFSIGVGIALLLAVTLLKMSRRDSGCPI 724
             + + +L      G  +K G  +      I +   I      +L V  + +  R      
Sbjct: 728  KNGNNQLPAGTEEGKRAKHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARRRDADD 787

Query: 725  DDLDEDMG--------RPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIG 776
              +   +         + ++  E L S  +  FQ    + L  S L+++TN F+ A++IG
Sbjct: 788  AKMLHSLQAVNSATTWKIEKEKEPL-SINVATFQR-QLRKLKFSQLIEATNGFSAASMIG 845

Query: 777  CGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN 836
             GGFG V+KATL +G+  A+K+L     Q +REF AE+E L + +H+NLV L GYC+ G 
Sbjct: 846  HGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE 905

Query: 837  DRLLIYSYMENGSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
            +RLL+Y +M+ GSL+  LH   + +K  +L W+ R KIA+GAA+GL +LH  C PHI+HR
Sbjct: 906  ERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHR 965

Query: 895  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGD 953
            D+KSSN+LLD+  EA ++DFG++RL+   DTH++ + L GT GY+PPEY Q+   T +GD
Sbjct: 966  DMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGD 1025

Query: 954  VYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK------- 1006
            VYS GVV+LE+L+G+RP +  +  +  +LV W      E + +E+ID  +  +       
Sbjct: 1026 VYSIGVVMLEILSGKRPTDKEEFGDT-NLVGWSKMKAREGKHMEVIDEDLLKEGSSESLN 1084

Query: 1007 DRE--------KQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            ++E        K++L  LEIA +C+D  P +RP + +VV  L
Sbjct: 1085 EKEGFEGGVIVKEMLRYLEIALRCVDDFPSKRPNMLQVVASL 1126

Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1048
224117138	1052	predicted protein [Populus trichocarpa]	0.992	0.988	0.772	0.0
255574664	1050	Phytosulfokine receptor precursor, putat	0.999	0.997	0.772	0.0
224128288	1050	predicted protein [Populus trichocarpa]	0.998	0.996	0.757	0.0
225461500	1053	PREDICTED: phytosulfokine receptor 2-lik	1.0	0.995	0.736	0.0
147805140	1021	hypothetical protein VITISV_006966 [Viti	0.969	0.995	0.717	0.0
356546862	1133	PREDICTED: phytosulfokine receptor 2-lik	0.967	0.894	0.710	0.0
356544058	1058	PREDICTED: phytosulfokine receptor 2-lik	0.994	0.984	0.698	0.0
356543354	1052	PREDICTED: phytosulfokine receptor 2-lik	0.997	0.993	0.682	0.0
358248168	1043	phytosulfokine receptor 2-like precursor	0.988	0.993	0.683	0.0
297792807	1036	hypothetical protein ARALYDRAFT_495467 [	0.975	0.986	0.673	0.0

>gi|224117138|ref|XP_002317487.1| predicted protein [Populus trichocarpa] gi|222860552|gb|EEE98099.1| predicted protein [Populus trichocarpa]

 Score = 1607 bits (4161), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 804/1041 (77%), Positives = 908/1041 (87%), Gaps = 1/1041 (0%)

Query: 1    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSN 60
            MVV+   PM  L+  F A F+CS  GL+T  QSCDP+D LALKEFAGNLTNGSIITSWSN
Sbjct: 1    MVVVESAPMIFLRCAFFACFLCSSWGLKTIAQSCDPNDSLALKEFAGNLTNGSIITSWSN 60

Query: 61   ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 120
            ++ CCQWDGVVCG    GS   RVTMLIL RKGL+G+IPRS+GHL+QLK LDLSCNHL+G
Sbjct: 61   KADCCQWDGVVCGSNINGSIHRRVTMLILSRKGLQGLIPRSIGHLDQLKSLDLSCNHLQG 120

Query: 121  VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 180
             +P+ELS+LKQ+EVLDLSHN+LSG VSG+L+GL  IQSLN+SSN F   LFELG + NL 
Sbjct: 121  GLPLELSSLKQMEVLDLSHNLLSGQVSGVLSGLISIQSLNISSNLFREDLFELGGYPNLV 180

Query: 181  VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGG 239
            VFNISNNSFTG + S+I S+SK IQI+DLSMNH +G+L GL + S SL+QLH+D+N L G
Sbjct: 181  VFNISNNSFTGPVTSQICSSSKGIQIVDLSMNHLVGNLAGLYNCSKSLQQLHLDSNSLSG 240

Query: 240  DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 299
             LPD +YS  +L+H S+S NNFSGQLS+++S L+SL+ L+I+GN+FSG +PN  GNLT L
Sbjct: 241  SLPDFIYSTLALEHFSISNNNFSGQLSKEVSKLSSLKTLVIYGNRFSGHIPNAFGNLTHL 300

Query: 300  EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG 359
            E FVAHSN  SGPLP +LS CSKLH+LDLRNNSLTGP+DLNF+G+ SLCTLDLA NHFSG
Sbjct: 301  EHFVAHSNMLSGPLPSTLSFCSKLHILDLRNNSLTGPVDLNFAGMPSLCTLDLAANHFSG 360

Query: 360  PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCK 419
            PLPNSLSDC +L+ILSLAKNEL+G++P SF KL+SLLFLSLSNNS   LSG L+VLQ C+
Sbjct: 361  PLPNSLSDCRELEILSLAKNELTGKIPVSFAKLSSLLFLSLSNNSLVDLSGALTVLQHCQ 420

Query: 420  NLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 479
            NL+TLILTKNFVGEEIP NV GF++LMVLA GNC LKGHIPVWLL C+KL+VLDLSWNH 
Sbjct: 421  NLSTLILTKNFVGEEIPRNVSGFQNLMVLAFGNCALKGHIPVWLLSCRKLEVLDLSWNHL 480

Query: 480  DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 539
            DGNIP WIGQMENLFYLD SNN+LTGEIPKSLT+LKSLIS+N +S + TASAGIPLYVK 
Sbjct: 481  DGNIPSWIGQMENLFYLDLSNNSLTGEIPKSLTDLKSLISANSSSPHLTASAGIPLYVKR 540

Query: 540  NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 599
            N+S +GLPY QASSFPPS+ LSNNRINGTIPPE+G+LK LHVLDLSRNNITGTIP+S S+
Sbjct: 541  NQSASGLPYKQASSFPPSILLSNNRINGTIPPEVGRLKDLHVLDLSRNNITGTIPNSFSQ 600

Query: 600  IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNP 659
            + NLE+LD SSN+LHGSIP S EKLTFLSKFSVANNHL+G IPTGGQFYSFP SSFEGNP
Sbjct: 601  MENLEILDFSSNNLHGSIPPSLEKLTFLSKFSVANNHLRGQIPTGGQFYSFPCSSFEGNP 660

Query: 660  GLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRD 719
            GLCG I SPC++++  LKP IPSGS  +FG  +I++IT +IGVG+AL+LA+ L KMSRR+
Sbjct: 661  GLCGVIISPCNAINNTLKPGIPSGSERRFGRSNILSITITIGVGLALVLAIVLHKMSRRN 720

Query: 720  SGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGG 779
             G PI DL+E+   P RLSEAL SSKLVLFQNSDCK+L+V+DLLKSTNNFNQANIIGCGG
Sbjct: 721  VGDPIGDLEEEGSLPHRLSEALRSSKLVLFQNSDCKELSVADLLKSTNNFNQANIIGCGG 780

Query: 780  FGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL 839
            FGLVYKA   N TKAA+KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN RL
Sbjct: 781  FGLVYKANFPNDTKAAIKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNYRL 840

Query: 840  LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSS 899
            LIYSYMENGSLDYWLHESVD  SVLKW+VRLKIAQGAA GLAYLHKVCEPHIVHRDVKSS
Sbjct: 841  LIYSYMENGSLDYWLHESVDGTSVLKWEVRLKIAQGAACGLAYLHKVCEPHIVHRDVKSS 900

Query: 900  NILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGV 959
            NILLDE FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL ATCRGDVYSFGV
Sbjct: 901  NILLDENFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLMATCRGDVYSFGV 960

Query: 960  VLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIA 1019
            VLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE EIID +IW KD +KQL EMLEIA
Sbjct: 961  VLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREAEIIDPAIWDKDHQKQLFEMLEIA 1020

Query: 1020 CKCIDQDPRRRPFIEEVVTWL 1040
            C+C+D DPR+RP IEEVV+WL
Sbjct: 1021 CRCLDPDPRKRPLIEEVVSWL 1041

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255574664|ref|XP_002528241.1| Phytosulfokine receptor precursor, putative [Ricinus communis] gi|223532327|gb|EEF34126.1| Phytosulfokine receptor precursor, putative [Ricinus communis]

 Score = 1598 bits (4137), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 811/1050 (77%), Positives = 906/1050 (86%), Gaps = 3/1050 (0%)

Query: 1    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSN 60
            M+VLG  PM+ LKW+FLA F+ S LGL T  + CDPSD LALKEFAGNLTNGSIIT+WS+
Sbjct: 1    MMVLGIAPMSFLKWVFLACFIYSSLGLNTLTKFCDPSDFLALKEFAGNLTNGSIITAWSD 60

Query: 61   ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 120
            +S CC WDGVVCG+   GS   RVTML+LPRKGLKGII RSLG L+QLK LDLSCNHL+G
Sbjct: 61   KSNCCHWDGVVCGNNGNGSTVSRVTMLMLPRKGLKGIISRSLGRLDQLKSLDLSCNHLQG 120

Query: 121  VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 180
             +P++ S LKQLEVLDLSHNMLSG VSG+L+GL+ +QS N+SSN F   + ELG F N+ 
Sbjct: 121  EMPMDFSRLKQLEVLDLSHNMLSGQVSGVLSGLSSLQSFNISSNLFKEDVSELGGFPNVV 180

Query: 181  VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGG 239
            VFN+SNNSFTG++ S   S+S  IQ+LDLSMNH +GSL+GL + S SL+QL +D+N L G
Sbjct: 181  VFNMSNNSFTGQIPSHFCSSSSGIQVLDLSMNHLVGSLEGLYNCSKSLQQLQLDSNSLSG 240

Query: 240  DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 299
             LPD LYSMSSLQ  S+S NNFSGQLS+++S L+SL+ L+I+GN+FSG +P+V  NLTQL
Sbjct: 241  SLPDYLYSMSSLQQFSISNNNFSGQLSKELSKLSSLKTLVIYGNRFSGHIPDVFDNLTQL 300

Query: 300  EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG 359
            E FVAHSN  SGPLP +L+LCS+L +LDLRNNSLTGPI+LNF+ +  L TLDLATNH SG
Sbjct: 301  EQFVAHSNLLSGPLPSTLALCSELCILDLRNNSLTGPINLNFTAMPRLSTLDLATNHLSG 360

Query: 360  PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCK 419
             LPNSLSDC +LKILSLAKNELSG +P+SF  LTSLL L+LSNNSF  LSG LSV+Q+CK
Sbjct: 361  QLPNSLSDCRELKILSLAKNELSGHIPKSFANLTSLLVLTLSNNSFTDLSGALSVMQECK 420

Query: 420  NLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 479
            NLTTLILTKNFVGEEIP NV GF+SLMVLALGNC L+G IP WLL C+KL+VLDLSWNH 
Sbjct: 421  NLTTLILTKNFVGEEIPRNVSGFQSLMVLALGNCALRGQIPDWLLNCRKLEVLDLSWNHL 480

Query: 480  DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 539
            DGN+PPWIGQMENLFYLDFSNN+LTG IPKSLTELKSLI  NC+S N T SA IPLYVK 
Sbjct: 481  DGNVPPWIGQMENLFYLDFSNNSLTGGIPKSLTELKSLIYMNCSSYNLT-SAIIPLYVKR 539

Query: 540  NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 599
            NRS NGL YNQASSFPPS+ LSNNRI+G I PEIGQLK LHVLDLSRN +TG IPSSISE
Sbjct: 540  NRSANGLQYNQASSFPPSILLSNNRISGKIWPEIGQLKELHVLDLSRNELTGIIPSSISE 599

Query: 600  IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNP 659
            + NLEVLDLSSN L+GSIP SFEKLTFLS+FSVANNHL+G IPTGGQF SFP SSFEGN 
Sbjct: 600  MENLEVLDLSSNGLYGSIPPSFEKLTFLSRFSVANNHLKGQIPTGGQFSSFPTSSFEGNL 659

Query: 660  GLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRD 719
            GLCG I SPC+ +   LKP I SGSNS FG  +I+ IT +IGVG+AL+LA+ LLK+SRRD
Sbjct: 660  GLCGGIVSPCNVITNMLKPGIQSGSNSAFGRANILGITITIGVGLALILAIVLLKISRRD 719

Query: 720  S-GCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCG 778
              G P DDLDE++ RP RLSEAL SSKLVLFQNSDCKDLTV+DLLK+TNNFNQANIIGCG
Sbjct: 720  YVGDPFDDLDEEVSRPHRLSEALGSSKLVLFQNSDCKDLTVADLLKATNNFNQANIIGCG 779

Query: 779  GFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 838
            GFGLVYKA+L NG KAA+KRLSGDCGQMEREF+AEVEALSRAQHKNLVSLQGYCRHGNDR
Sbjct: 780  GFGLVYKASLPNGAKAAIKRLSGDCGQMEREFRAEVEALSRAQHKNLVSLQGYCRHGNDR 839

Query: 839  LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 898
            LLIYSYMENGSLDYWLHE  D  S LKW+VRLKIAQGAA GLAYLHKVCEPHIVHRDVKS
Sbjct: 840  LLIYSYMENGSLDYWLHECADGASFLKWEVRLKIAQGAASGLAYLHKVCEPHIVHRDVKS 899

Query: 899  SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 958
            SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG
Sbjct: 900  SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 959

Query: 959  VVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1018
            VVLLELLTGRRPVEVCKGKNCRDLVSW+FQMK EKRE EIID+SIW+KD EKQL EMLEI
Sbjct: 960  VVLLELLTGRRPVEVCKGKNCRDLVSWMFQMKYEKRETEIIDSSIWNKDLEKQLSEMLEI 1019

Query: 1019 ACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1048
            AC+C+DQDPRRRP I+EVV+WLDGIGI  A
Sbjct: 1020 ACRCLDQDPRRRPLIDEVVSWLDGIGIQGA 1049

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224128288|ref|XP_002329127.1| predicted protein [Populus trichocarpa] gi|222869796|gb|EEF06927.1| predicted protein [Populus trichocarpa]

 Score = 1569 bits (4063), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 795/1050 (75%), Positives = 907/1050 (86%), Gaps = 4/1050 (0%)

Query: 1    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSN 60
            M ++   PMT L+ +F A F+CS  GL+T  QSCDP+D+ ALKEFAG LTNGSIITSWS+
Sbjct: 1    MAMVETAPMTFLRSVFFACFLCSSWGLKTTTQSCDPNDMRALKEFAGKLTNGSIITSWSS 60

Query: 61   ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 120
            ++ CCQW+GVVC     GS   RVTMLIL + GL+G+IP SLG L+QLK ++LS N L G
Sbjct: 61   KTDCCQWEGVVCRSNINGSIHSRVTMLILSKMGLQGLIPPSLGRLDQLKSVNLSFNQLSG 120

Query: 121  VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 180
             +P ELS+LKQLE LDLSHN+LSG VSG+L+ L  I++LN+SSN F   L ELG + NL 
Sbjct: 121  GLPSELSSLKQLEDLDLSHNLLSGQVSGVLSRLLSIRTLNISSNLFKEDLLELGGYPNLV 180

Query: 181  VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGG 239
             FN+SNNSFTG+++S+I S+S+ IQILDLS NH +G L+GL + S SL+QLH+D+N L G
Sbjct: 181  AFNMSNNSFTGRISSQICSSSEGIQILDLSANHLVGDLEGLFNCSRSLQQLHLDSNSLSG 240

Query: 240  DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 299
             LPD LYSMS+LQH S+  NNFSGQLS+++S L +L++L+I+GNQFSG +PN   NLT L
Sbjct: 241  SLPDFLYSMSALQHFSIPNNNFSGQLSKEVSKLFNLKNLVIYGNQFSGHIPNAFVNLTYL 300

Query: 300  EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG 359
            E FVAHSN  SGPLP +LS CSKLH+LDLRNNSLTGPIDLNFSG+ SLCTLDLA+NH SG
Sbjct: 301  EQFVAHSNMLSGPLPSTLSFCSKLHILDLRNNSLTGPIDLNFSGMPSLCTLDLASNHLSG 360

Query: 360  PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCK 419
            PLPNSLS C +LKILSL KNEL+G++PESF  L+SLLFLSLSNNSF  LSG L+VLQQC+
Sbjct: 361  PLPNSLSVCRELKILSLVKNELTGKIPESFANLSSLLFLSLSNNSFVDLSGALTVLQQCQ 420

Query: 420  NLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 479
            NL+TLILTKNFVGEEIP NV GF +LMVLA GNC LKG IPVWLLRC+KL+VLDLSWNH 
Sbjct: 421  NLSTLILTKNFVGEEIPRNVSGFRNLMVLAFGNCALKGQIPVWLLRCRKLEVLDLSWNHL 480

Query: 480  DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 539
            DG+IP WIGQMENLFYLDFSNN+LTGEIP SLT+LKSL  +N +S + TAS+GIPLYVK 
Sbjct: 481  DGSIPSWIGQMENLFYLDFSNNSLTGEIPLSLTQLKSL--ANSSSPHLTASSGIPLYVKR 538

Query: 540  NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 599
            N+S +GL YNQASSFPPS+ LSNNRI GTIPPE+G+L+ LHV DLSRNNITGTIPSS S+
Sbjct: 539  NQSASGLQYNQASSFPPSILLSNNRITGTIPPEVGRLQDLHVFDLSRNNITGTIPSSFSQ 598

Query: 600  IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNP 659
            + NLEVLDLSSN+L+GSIP S EKLTFLSKFSVANNHL+G IP+GGQFYSFP+SSFEGNP
Sbjct: 599  MENLEVLDLSSNNLYGSIPPSLEKLTFLSKFSVANNHLRGQIPSGGQFYSFPSSSFEGNP 658

Query: 660  GLCGEIDSPCDSMHAKLKPVIPSGSNS-KFGPGSIIAITFSIGVGIALLLAVTLLKMSRR 718
            GLCG I SPC+ ++  +KP IPSGS+S +FG G+I++IT +I VG+AL+LAV L KMSRR
Sbjct: 659  GLCGVIVSPCNVINNMMKPGIPSGSDSSRFGRGNILSITITIVVGLALVLAVVLHKMSRR 718

Query: 719  DSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCG 778
            + G PI DL+E++  P RLSEAL SSKLVLFQNSDCKDLTV DLLKSTNNFNQANIIGCG
Sbjct: 719  NVGDPIGDLEEEVSLPHRLSEALRSSKLVLFQNSDCKDLTVPDLLKSTNNFNQANIIGCG 778

Query: 779  GFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 838
            GFGLVYKA L NGTKAA+KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR
Sbjct: 779  GFGLVYKANLPNGTKAAIKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 838

Query: 839  LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 898
            LLIYSYMENGSLDYWLHESVD  SVLKW+VRLKIAQGAA GLAYLHKVCEPHIVHRDVKS
Sbjct: 839  LLIYSYMENGSLDYWLHESVDGGSVLKWEVRLKIAQGAACGLAYLHKVCEPHIVHRDVKS 898

Query: 899  SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 958
            SNILLDEKFEAHLADFGLSRLL PYDTHVTTDLVGTLGYIPPEYSQTL ATCRGDVYSFG
Sbjct: 899  SNILLDEKFEAHLADFGLSRLLCPYDTHVTTDLVGTLGYIPPEYSQTLMATCRGDVYSFG 958

Query: 959  VVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1018
            VVLLELLTGRRPVEVCKGKNCR+LVSW+FQMKSEKRE EIID++IW KDR+KQL EMLEI
Sbjct: 959  VVLLELLTGRRPVEVCKGKNCRNLVSWLFQMKSEKREAEIIDSAIWGKDRQKQLFEMLEI 1018

Query: 1019 ACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1048
            AC+C+DQDPRRRP IEEVV+WLDGIG  AA
Sbjct: 1019 ACRCLDQDPRRRPLIEEVVSWLDGIGFQAA 1048

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225461500|ref|XP_002282588.1| PREDICTED: phytosulfokine receptor 2-like [Vitis vinifera]

 Score = 1535 bits (3974), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 776/1053 (73%), Positives = 866/1053 (82%), Gaps = 5/1053 (0%)

Query: 1    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTP--FQSCDPSDLLALKEFAGNLTNGSIITSW 58
            MV+L F PMT LKW  LA  VCS L LQ P   QSCDP+DL ALKEFAGNLTNGSI   W
Sbjct: 1    MVMLEFTPMTFLKWALLACLVCSSLSLQIPNLTQSCDPNDLRALKEFAGNLTNGSIFFLW 60

Query: 59   SNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHL 118
            SN+S CC+WDGV C   + GS A RVT LILP KGLKG+   +LG L+ LK LDLS N L
Sbjct: 61   SNDSHCCRWDGVGCEDSNNGSVASRVTSLILPHKGLKGVNLTALGRLDHLKFLDLSSNQL 120

Query: 119  EGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSN 178
            +G +P+ELSNL QLEVLDLS+N L GPVS  L GL  I+SLN+SSN F+G    +G F N
Sbjct: 121  DGELPMELSNLHQLEVLDLSYNKLLGPVSRSLLGLKSIKSLNISSNLFSGDFLGVGGFLN 180

Query: 179  LAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS--PSLKQLHVDNNL 236
            L VFNISNN F G ++S+  S+S  IQ++DLSMNHF G L+GL +    SL+ LHVD N 
Sbjct: 181  LVVFNISNNFFNGSISSQFCSSSNAIQMIDLSMNHFTGGLEGLGNCSFTSLQNLHVDYNS 240

Query: 237  LGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNL 296
            L G LP+ L+S+ SL+ +S+  NNFSG LS K+S L SL+ L+IFGN+F G +PNV GNL
Sbjct: 241  LSGQLPEFLFSLPSLEQLSIPGNNFSGHLSRKLSKLHSLKALVIFGNRFRGPIPNVFGNL 300

Query: 297  TQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNH 356
            TQLE  +AHSNSF G LP +L+LCSKL VLDLRNNSLTG IDLNF+GL  LC LDLATNH
Sbjct: 301  TQLEILIAHSNSFYGVLPSTLALCSKLRVLDLRNNSLTGRIDLNFTGLPHLCALDLATNH 360

Query: 357  FSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQ 416
            FSG LPN+LS C +LK+LSLAKN+L G VPESF  L  L  L+LSNNSF +L+  LSVLQ
Sbjct: 361  FSGFLPNTLSSCRELKLLSLAKNDLRGPVPESFANLKYLSVLTLSNNSFVNLTEALSVLQ 420

Query: 417  QCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSW 476
            QCKNLTTLILTKNF GEEIP+NV GFESLM+ ALG C L+G IP WLL CKKLQVLDLSW
Sbjct: 421  QCKNLTTLILTKNFHGEEIPKNVKGFESLMIFALGYCALRGQIPYWLLNCKKLQVLDLSW 480

Query: 477  NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLY 536
            NH DG+IPPWIG+MENLFYLDFSNN+LTG IPKSLTELKSLI + C SSN T SAGIPLY
Sbjct: 481  NHLDGSIPPWIGEMENLFYLDFSNNSLTGRIPKSLTELKSLIFTKCNSSNITTSAGIPLY 540

Query: 537  VKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSS 596
            VK N+S NGL YNQ SSFPPS+FLSNNRINGTI PEIG+LK LHVLDLSRNNITGTIP S
Sbjct: 541  VKRNQSANGLQYNQVSSFPPSIFLSNNRINGTIWPEIGKLKQLHVLDLSRNNITGTIPDS 600

Query: 597  ISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFE 656
            IS + NLEVLDLS NDLHG IP S  KLTFLSKFSVA+N L+G IPTGGQF SFPNSSFE
Sbjct: 601  ISNMGNLEVLDLSCNDLHGEIPSSLNKLTFLSKFSVADNQLRGMIPTGGQFLSFPNSSFE 660

Query: 657  GNPGLCGEIDSPCDSMHA-KLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKM 715
            GNPGLCGE+  PCD+      KP I + SN KFG GSI  IT S+GVGIALLLAV  L+M
Sbjct: 661  GNPGLCGEVYIPCDTDDTMDPKPEIRASSNGKFGQGSIFGITISVGVGIALLLAVVWLRM 720

Query: 716  SRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANII 775
            SRRD G PI DLDE++ RP RLSE L SSKLVLFQNS CKDL+V+DLLKSTNNFNQANII
Sbjct: 721  SRRDVGDPIVDLDEEISRPHRLSEVLGSSKLVLFQNSGCKDLSVADLLKSTNNFNQANII 780

Query: 776  GCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG 835
            GCGGFGLVYKA L +GT+AA+KRLSGDCGQMEREF+AEVEALSRAQHKNLVSLQGYCRHG
Sbjct: 781  GCGGFGLVYKANLPDGTRAAIKRLSGDCGQMEREFRAEVEALSRAQHKNLVSLQGYCRHG 840

Query: 836  NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRD 895
            NDRLLIYSYMENGSLDYWLHE VD  S L WD R+KIAQGA RGLAYLHKVCEP +VHRD
Sbjct: 841  NDRLLIYSYMENGSLDYWLHERVDGGSFLTWDTRVKIAQGAGRGLAYLHKVCEPSVVHRD 900

Query: 896  VKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVY 955
            +KSSNILLDE FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT +GDVY
Sbjct: 901  IKSSNILLDETFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATFKGDVY 960

Query: 956  SFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEM 1015
            SFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK+E +I+D+S+W KDREKQ LE+
Sbjct: 961  SFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKKEEQIMDSSVWDKDREKQFLEV 1020

Query: 1016 LEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1048
            L IAC+CIDQDPR+RP I++VV+WLD +G +  
Sbjct: 1021 LGIACRCIDQDPRQRPSIDQVVSWLDAVGKEGV 1053

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147805140|emb|CAN68931.1| hypothetical protein VITISV_006966 [Vitis vinifera]

 Score = 1471 bits (3808), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 750/1045 (71%), Positives = 838/1045 (80%), Gaps = 29/1045 (2%)

Query: 9    MTCLKWLFLAFFVCSCLGLQTP--FQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQ 66
            MT LKW  LA  VCS L LQ P   QSCDP+DL ALKEFAGNLTNGSI   WSN+S CC+
Sbjct: 1    MTFLKWALLACLVCSSLSLQIPNLTQSCDPNDLRALKEFAGNLTNGSIFFLWSNDSHCCR 60

Query: 67   WDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL 126
            WDGV C   + GS A RVT LILP KGLKG+   +LG L+ LK LDLS N L+G +P+EL
Sbjct: 61   WDGVGCEDSNNGSVASRVTSLILPHKGLKGVNLTALGRLDHLKFLDLSSNQLDGELPMEL 120

Query: 127  SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISN 186
            S L QLEVLDLS+N L GPVS  L GL  I+SLN+S N F+G    +G F NL VFNISN
Sbjct: 121  SXLHQLEVLDLSYNKLLGPVSRSLLGLKSIKSLNISXNLFSGDFLGVGGFLNLVVFNISN 180

Query: 187  NSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS--PSLKQLHVDNNLLGGDLPDS 244
            N F G ++S+  S+S  IQ++DLSMNHF G L+GL +    SL+ LHVD N L G LP+ 
Sbjct: 181  NFFNGSISSQFCSSSNAIQMIDLSMNHFTGGLEGLGNCSFTSLQNLHVDYNSLSGQLPEF 240

Query: 245  LYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 304
            L+S+ SL+ +S+  NNFSG LS K+S L SL+ L+IFGN+F G +PNV GNLTQLE  +A
Sbjct: 241  LFSLPSLEQLSIPGNNFSGHLSRKLSKLHSLKALVIFGNRFRGPIPNVFGNLTQLEILIA 300

Query: 305  HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS 364
            HSNSF G LP +L+LCSKL VLDLRNNSLTG IDLNF+GL  LC LDLATNHFSG LPN+
Sbjct: 301  HSNSFYGVLPSTLALCSKLRVLDLRNNSLTGRIDLNFTGLPHLCALDLATNHFSGFLPNT 360

Query: 365  LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 424
            LS C +LK+LSLAKN+L G VPESF  L  L  L+LSNNSF +L+  LSVLQQCKNLTTL
Sbjct: 361  LSSCRELKLLSLAKNDLRGPVPESFANLKYLSVLTLSNNSFVNLTEALSVLQQCKNLTTL 420

Query: 425  ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 484
            ILTKNF GEEIP+NV GFESLM+ ALGNC L+G IP WLL CKKLQVLDLSWNH DG+IP
Sbjct: 421  ILTKNFHGEEIPKNVKGFESLMIFALGNCALRGQIPYWLLNCKKLQVLDLSWNHLDGSIP 480

Query: 485  PWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTN 544
            PWIG+MENLFYLDFSNN+LTG IPKSLTELKSLI + C SSN T SAGIPLYVK N+S N
Sbjct: 481  PWIGEMENLFYLDFSNNSLTGRIPKSLTELKSLIFTKCNSSNITTSAGIPLYVKRNQSAN 540

Query: 545  GLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLE 604
             L YNQ SSFPPS+ LSNNRINGTI PEIG+LK LHVLDLSRNNITGTIP SIS + NLE
Sbjct: 541  ALQYNQVSSFPPSIXLSNNRINGTIWPEIGKLKQLHVLDLSRNNITGTIPDSISNMGNLE 600

Query: 605  VLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGE 664
            VLDLS NDLHG IP S  KLTFLSKFSVA+N L+G IPTGGQF SFPNSSFEGNPGLCGE
Sbjct: 601  VLDLSCNDLHGXIPSSLNKLTFLSKFSVADNQLRGMIPTGGQFLSFPNSSFEGNPGLCGE 660

Query: 665  IDSPCDSMHA-KLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCP 723
            +  PCD+      KP I + SN                        V  L+MSRRD G P
Sbjct: 661  VYIPCDTDDTMDPKPEIRASSN------------------------VVWLRMSRRDVGDP 696

Query: 724  IDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLV 783
            I DLDE++ RP RLSE L SSKLVLFQNS CKDL+V+DLLKSTNNFNQANIIGCGGFGLV
Sbjct: 697  IVDLDEEISRPHRLSEVLGSSKLVLFQNSGCKDLSVADLLKSTNNFNQANIIGCGGFGLV 756

Query: 784  YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS 843
            YKA L +GT+AA+KRLSGDCGQMEREF+AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS
Sbjct: 757  YKANLPDGTRAAIKRLSGDCGQMEREFRAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS 816

Query: 844  YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL 903
            YMENGSLDYWLHE VD  S L WD R+KIAQGA RGLAYLHKVCEP +VHRD+KSSNILL
Sbjct: 817  YMENGSLDYWLHERVDGGSFLTWDTRVKIAQGAGRGLAYLHKVCEPSVVHRDIKSSNILL 876

Query: 904  DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLE 963
            DE FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT +GDVYSFGVVLLE
Sbjct: 877  DETFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATFKGDVYSFGVVLLE 936

Query: 964  LLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCI 1023
            LLTGRRPVEVCKGKNCRDLVSWVFQMKSEK+E +I+D+S+W KDREKQ LE+L IAC+CI
Sbjct: 937  LLTGRRPVEVCKGKNCRDLVSWVFQMKSEKKEEQIMDSSVWDKDREKQFLEVLGIACRCI 996

Query: 1024 DQDPRRRPFIEEVVTWLDGIGIDAA 1048
            DQDPR+RP I++VV+WLD +G +  
Sbjct: 997  DQDPRQRPSIDQVVSWLDAVGKEGV 1021

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356546862|ref|XP_003541841.1| PREDICTED: phytosulfokine receptor 2-like [Glycine max]

 Score = 1425 bits (3689), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 725/1020 (71%), Positives = 842/1020 (82%), Gaps = 6/1020 (0%)

Query: 34   CDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGH---GSTGSNAGRVTMLILP 90
            CDP DL ALKEFAGNLT+GSIIT+W N++ CC W GVVC +    + G+ A RVT LILP
Sbjct: 113  CDPHDLSALKEFAGNLTSGSIITAWPNDTFCCNWLGVVCANVTGDAGGTVASRVTKLILP 172

Query: 91   RKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGML 150
            +  L G I  SL  L+QL +L+LS NHL+G +PVE S LKQL+ LD+SHNMLSGPV+G L
Sbjct: 173  KMSLNGTISPSLAQLDQLNVLNLSFNHLKGALPVEFSKLKQLKFLDVSHNMLSGPVAGAL 232

Query: 151  AGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLS 210
            +GL  I+ LN+SSN   G+LF  GEF +L   N+SNNSFTG  +S+I SASK++  LDLS
Sbjct: 233  SGLQSIEVLNISSNLLTGALFPFGEFPHLLALNVSNNSFTGGFSSQICSASKDLHTLDLS 292

Query: 211  MNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS 270
            +NHF G L+GLD+  SL++LH+D+N   G LPDSLYSMS+L+ +++  NN SGQLSE++S
Sbjct: 293  VNHFDGGLEGLDNCTSLQRLHLDSNAFTGHLPDSLYSMSALEELTVCANNLSGQLSEQLS 352

Query: 271  NLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRN 330
             L++L+ L++ GN+FSG+ PNV GNL QLE   AH+NSF GPLP +L+LCSKL VL+LRN
Sbjct: 353  KLSNLKTLVVSGNRFSGEFPNVFGNLLQLEELEAHANSFFGPLPSTLALCSKLRVLNLRN 412

Query: 331  NSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFG 390
            NSL+G I LNF+GLS+L TLDLATNHF GPLP SLS+C  LK+LSLA+N L+G VPES+ 
Sbjct: 413  NSLSGQIGLNFTGLSNLQTLDLATNHFFGPLPTSLSNCRKLKVLSLARNGLNGSVPESYA 472

Query: 391  KLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG-GFESLMVLA 449
             LTSLLF+S SNNS  +LS  +SVLQQCKNLTTL+LTKNF GE I E+V   FESLM+LA
Sbjct: 473  NLTSLLFVSFSNNSIQNLSVAVSVLQQCKNLTTLVLTKNFRGEVISESVTVEFESLMILA 532

Query: 450  LGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPK 509
            LGNCGLKGHIP WL  C+KL VLDLSWNH +G++P WIGQM++LFYLDFSNN+LTGEIPK
Sbjct: 533  LGNCGLKGHIPSWLSNCRKLAVLDLSWNHLNGSVPSWIGQMDSLFYLDFSNNSLTGEIPK 592

Query: 510  SLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTI 569
             L ELK L+ +NC   N  A A IPL+VK N S +GL YNQASSFPPS+ LSNN ++G I
Sbjct: 593  GLAELKGLMCANCNRENLAAFAFIPLFVKRNTSVSGLQYNQASSFPPSILLSNNILSGNI 652

Query: 570  PPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSK 629
             PEIGQLK LHVLDLSRNNI GTIPS+ISE+ NLE LDLS NDL G IP SF  LTFLSK
Sbjct: 653  WPEIGQLKALHVLDLSRNNIAGTIPSTISEMENLESLDLSYNDLSGEIPPSFNNLTFLSK 712

Query: 630  FSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFG 689
            FSVA+N L+G IPTGGQF SFP+SSFEGN GLC EIDSPC  ++    P   SGS+ K G
Sbjct: 713  FSVAHNRLEGPIPTGGQFLSFPSSSFEGNLGLCREIDSPCKIVN-NTSPNNSSGSSKKRG 771

Query: 690  PGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDM-GRPQRLSEALASSKLVL 748
              +++ IT SIG+G+ALLLA+ LLKMS+RD   P+D+ DE++ GRP+RLSEALASSKLVL
Sbjct: 772  RSNVLGITISIGIGLALLLAIILLKMSKRDDDKPMDNFDEELNGRPRRLSEALASSKLVL 831

Query: 749  FQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER 808
            FQNSDCKDLTV+DLLKSTNNFNQANIIGCGGFGLVYKA L NG KAAVKRLSGDCGQMER
Sbjct: 832  FQNSDCKDLTVADLLKSTNNFNQANIIGCGGFGLVYKAYLPNGAKAAVKRLSGDCGQMER 891

Query: 809  EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV 868
            EFQAEVEALSRAQHKNLVSL+GYCRHGNDRLLIYSY+ENGSLDYWLHE VD++S LKWD 
Sbjct: 892  EFQAEVEALSRAQHKNLVSLKGYCRHGNDRLLIYSYLENGSLDYWLHECVDENSALKWDS 951

Query: 869  RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 928
            RLK+AQGAARGLAYLHK CEP IVHRDVKSSNILLD+ FEAHLADFGLSRLL+PYDTHVT
Sbjct: 952  RLKVAQGAARGLAYLHKGCEPFIVHRDVKSSNILLDDNFEAHLADFGLSRLLQPYDTHVT 1011

Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 988
            TDLVGTLGYIPPEYSQTLTAT RGDVYSFGVVLLELLTGRRPVEV KGKNCR+LVSWV+Q
Sbjct: 1012 TDLVGTLGYIPPEYSQTLTATFRGDVYSFGVVLLELLTGRRPVEVIKGKNCRNLVSWVYQ 1071

Query: 989  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1048
            MKSE +E EI D  IWHKD EKQLLE+L IACKC++QDPR+RP IE VV+WLD +  D +
Sbjct: 1072 MKSENKEQEIFDPVIWHKDHEKQLLEVLAIACKCLNQDPRQRPSIEIVVSWLDSVRFDGS 1131

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356544058|ref|XP_003540472.1| PREDICTED: phytosulfokine receptor 2-like [Glycine max]

 Score = 1410 bits (3649), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 735/1052 (69%), Positives = 860/1052 (81%), Gaps = 10/1052 (0%)

Query: 1    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQS---CDPSDLLALKEFAGNLTNGSIITS 57
            MV+L    +T L+W FLA  +C  LGL         CDP DL ALKEFAGNLT+GSIIT+
Sbjct: 1    MVLLRCFSVTLLQWCFLACLLCLSLGLNNNNNQALSCDPHDLSALKEFAGNLTSGSIITA 60

Query: 58   WSNESMCCQWDGVVCGH---GSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLS 114
            WSN+++CC W GVVC +    + G+ A RVT LILP  GL G I  SL  L+QL LL+LS
Sbjct: 61   WSNDTVCCNWLGVVCANVTGAAGGTVASRVTKLILPEMGLNGTISPSLAQLDQLNLLNLS 120

Query: 115  CNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELG 174
             NHL+GV+PVE S LK L+ LD+SHNMLSGP +G L+GL  I+ LN+SSN   G+LF  G
Sbjct: 121  FNHLKGVLPVEFSKLKLLKYLDVSHNMLSGPAAGALSGLQSIEVLNISSNLLTGALFPFG 180

Query: 175  EFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH-SPSLKQLHVD 233
            EF +L   N+SNNSFTG+ +S+I  A K++  LDLS+NHF G L+GLD+ + SL++LH+D
Sbjct: 181  EFPHLLALNVSNNSFTGRFSSQICRAPKDLHTLDLSVNHFDGGLEGLDNCATSLQRLHLD 240

Query: 234  NNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVL 293
            +N   G LPDSLYSMS+L+ +++  NN SGQL++ +S L++L+ L++ GN+FSG+ PNV 
Sbjct: 241  SNAFAGSLPDSLYSMSALEELTVCANNLSGQLTKHLSKLSNLKTLVVSGNRFSGEFPNVF 300

Query: 294  GNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLA 353
            GNL QLE   AH+NSFSGPLP +L+LCSKL VLDLRNNSL+GPI LNF+GLS+L TLDLA
Sbjct: 301  GNLLQLEELQAHANSFSGPLPSTLALCSKLRVLDLRNNSLSGPIGLNFTGLSNLQTLDLA 360

Query: 354  TNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLS 413
            TNHF GPLP SLS C +LK+LSLA+N L+G VPE++G LTSLLF+S SNNS  +LSG +S
Sbjct: 361  TNHFIGPLPTSLSYCRELKVLSLARNGLTGSVPENYGNLTSLLFVSFSNNSIENLSGAVS 420

Query: 414  VLQQCKNLTTLILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLLRCKKLQVL 472
            VLQQCKNLTTLIL+KNF GEEI E+V  GFESLM+LALGNCGLKGHIP WL  C+KL VL
Sbjct: 421  VLQQCKNLTTLILSKNFHGEEISESVTVGFESLMILALGNCGLKGHIPSWLFNCRKLAVL 480

Query: 473  DLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAG 532
            DLSWNH +G++P WIGQM++LFYLDFSNN+LTGEIP  LTELK L+ +NC   N  A A 
Sbjct: 481  DLSWNHLNGSVPSWIGQMDSLFYLDFSNNSLTGEIPIGLTELKGLMCANCNRENLAAFAF 540

Query: 533  IPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGT 592
            IPL+VK N S +GL YNQASSFPPS+ LSNN ++G I PEIGQLK LH LDLSRNNITGT
Sbjct: 541  IPLFVKRNTSVSGLQYNQASSFPPSILLSNNILSGNIWPEIGQLKALHALDLSRNNITGT 600

Query: 593  IPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 652
            IPS+ISE+ NLE LDLS NDL G IP SF  LTFLSKFSVA+NHL G IPTGGQF SFP+
Sbjct: 601  IPSTISEMENLESLDLSYNDLSGEIPPSFNNLTFLSKFSVAHNHLDGPIPTGGQFLSFPS 660

Query: 653  SSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTL 712
            SSFEGN GLC EIDSPC  ++    P   SGS+ K G  +++ IT SIG+G+ALLLA+ L
Sbjct: 661  SSFEGNQGLCREIDSPCKIVN-NTSPNNSSGSSKKRGRSNVLGITISIGIGLALLLAIIL 719

Query: 713  LKMSRRDSGCPIDDLDEDM-GRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQ 771
            L++S+R+    +D+ DE++  RP R SEAL SSKLVLFQNSDCKDLTV+DLLKSTNNFNQ
Sbjct: 720  LRLSKRNDDKSMDNFDEELNSRPHRSSEALVSSKLVLFQNSDCKDLTVADLLKSTNNFNQ 779

Query: 772  ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
            ANIIGCGGFGLVYKA L NGTKAA+KRLSGDCGQMEREFQAEVEALSRAQHKNLVSL+GY
Sbjct: 780  ANIIGCGGFGLVYKAYLPNGTKAAIKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLKGY 839

Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
            CRHGN+RLLIYSY+ENGSLDYWLHE VD+ S LKWD RLKIAQGAARGLAYLHK CEP I
Sbjct: 840  CRHGNERLLIYSYLENGSLDYWLHECVDESSALKWDSRLKIAQGAARGLAYLHKGCEPFI 899

Query: 892  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
            VHRDVKSSNILLD+KFEAHLADFGLSRLL+PYDTHVTTDLVGTLGYIPPEYSQTLTAT R
Sbjct: 900  VHRDVKSSNILLDDKFEAHLADFGLSRLLQPYDTHVTTDLVGTLGYIPPEYSQTLTATFR 959

Query: 952  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1011
            GDVYSFGVVLLELLTGRRPVEV KGKNCR+L+SWV+QMKSE +E EI D +IWHKD EKQ
Sbjct: 960  GDVYSFGVVLLELLTGRRPVEVIKGKNCRNLMSWVYQMKSENKEQEIFDPAIWHKDHEKQ 1019

Query: 1012 LLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            LLE+L IACKC++QDPR+RP IE VV+WLD +
Sbjct: 1020 LLEVLAIACKCLNQDPRQRPSIEVVVSWLDSV 1051

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356543354|ref|XP_003540126.1| PREDICTED: phytosulfokine receptor 2-like [Glycine max]

 Score = 1354 bits (3504), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 717/1050 (68%), Positives = 842/1050 (80%), Gaps = 5/1050 (0%)

Query: 1    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSN 60
            MV+    PM  ++W FLA  +C  +GL+TP +SCD  DLLALKEFAGNLT GSIIT WS+
Sbjct: 1    MVLQRCYPMAFVQWGFLACLLCFSVGLETPARSCDKHDLLALKEFAGNLTKGSIITEWSD 60

Query: 61   ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 120
            + +CC+W GV C     G++A RV+ LILP  GL G+I  SL +L++LK L+LS N L+G
Sbjct: 61   DVVCCKWIGVYCDDVVDGADASRVSKLILPGMGLNGMISSSLAYLDKLKELNLSFNRLQG 120

Query: 121  VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 180
             +  E SNLKQLEVLDLSHNMLSGPV G L+GL  IQ LN+SSN F G LF      +L+
Sbjct: 121  ELSSEFSNLKQLEVLDLSHNMLSGPVGGALSGLQSIQILNISSNLFVGDLFRFRGLQHLS 180

Query: 181  VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH-SPSLKQLHVDNNLLGG 239
              NISNNSFT + NS+I S+SK I ILD+S NHF G L+ L + S SL++L +D+NL  G
Sbjct: 181  ALNISNNSFTDQFNSQICSSSKGIHILDISKNHFAGGLEWLGNCSMSLQELLLDSNLFSG 240

Query: 240  DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 299
             LPDSLYSMS+L+ +S+S+NN SGQLS+ +SNL+SL+ LII GN FSG+LPNV GNL  L
Sbjct: 241  TLPDSLYSMSALKQLSVSLNNLSGQLSKDLSNLSSLKSLIISGNHFSGELPNVFGNLLNL 300

Query: 300  EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG 359
            E  + +SNSFSG LP +L+LCSKL VLDLRNNSLTG + LNF+ LS+L TLDL +NHF+G
Sbjct: 301  EQLIGNSNSFSGSLPSTLALCSKLRVLDLRNNSLTGSVGLNFARLSNLFTLDLGSNHFNG 360

Query: 360  PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCK 419
             LPNSLS CH+L +LSLAKNEL+GQ+PES+  L+SLL LSLSNNSF +LS    VLQQCK
Sbjct: 361  SLPNSLSYCHELTMLSLAKNELTGQIPESYANLSSLLTLSLSNNSFENLSEAFYVLQQCK 420

Query: 420  NLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH 478
            NLTTL+LTKNF GEEIPEN+   FESL+VLALGNCGLKG IP WLL C KL+VLDLSWNH
Sbjct: 421  NLTTLVLTKNFHGEEIPENLTASFESLVVLALGNCGLKGRIPSWLLNCPKLEVLDLSWNH 480

Query: 479  FDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK 538
             +G++P WIGQM +LFYLD SNN+LTGEIPK LTEL+ LIS N   S+  ASA IPLYVK
Sbjct: 481  LEGSVPSWIGQMHHLFYLDLSNNSLTGEIPKGLTELRGLISPNYHISSLFASAAIPLYVK 540

Query: 539  HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSIS 598
             N+S +GL YN ASSFPPS++LSNNR++GTI PEIG+LK LH+LDLSRNNITGTIPSSIS
Sbjct: 541  RNKSASGLQYNHASSFPPSIYLSNNRLSGTIWPEIGRLKELHILDLSRNNITGTIPSSIS 600

Query: 599  EIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGN 658
            E++NLE LDLS+N L G+IP SF  LTFLSKFSVA NHL G IP GGQF SFPNSSFEGN
Sbjct: 601  EMKNLETLDLSNNTLVGTIPRSFNSLTFLSKFSVAYNHLWGLIPIGGQFSSFPNSSFEGN 660

Query: 659  PGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRR 718
             GLCGE    C   + +    + +    KF   +I+ IT  +GVG+ALLLAV LL+MS+R
Sbjct: 661  WGLCGETFHRC---YNEKDVGLRANHVGKFSKSNILGITIGLGVGLALLLAVILLRMSKR 717

Query: 719  DSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCG 778
            D   P D+ DE++  P R+ EALASSKLVLFQNSDCKDLTV DLLKST+NFNQ NIIGCG
Sbjct: 718  DEDKPADNFDEELSWPNRMPEALASSKLVLFQNSDCKDLTVEDLLKSTSNFNQENIIGCG 777

Query: 779  GFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 838
            GFGLVYK  L NGTK A+K+LSG CGQ+EREFQAEVEALSRAQHKNLVSL+GYC+H NDR
Sbjct: 778  GFGLVYKGNLPNGTKVAIKKLSGYCGQVEREFQAEVEALSRAQHKNLVSLKGYCQHFNDR 837

Query: 839  LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 898
            LLIYSY+ENGSLDYWLHES D +S LKWDVRLKIAQGAA GLAYLHK CEPHIVHRD+KS
Sbjct: 838  LLIYSYLENGSLDYWLHESEDGNSALKWDVRLKIAQGAAHGLAYLHKECEPHIVHRDIKS 897

Query: 899  SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 958
            SNILLD+KFEA+LADFGLSRLL+PYDTHV+TDLVGTLGYIPPEYSQ L AT +GD+YSFG
Sbjct: 898  SNILLDDKFEAYLADFGLSRLLQPYDTHVSTDLVGTLGYIPPEYSQVLKATFKGDIYSFG 957

Query: 959  VVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1018
            VVL+ELLTGRRP+EV   +  R+LVSWV QMK E RE EI D+ IWHKD EKQLL++L I
Sbjct: 958  VVLVELLTGRRPIEVTVSQRSRNLVSWVLQMKYENREQEIFDSVIWHKDNEKQLLDVLVI 1017

Query: 1019 ACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1048
            ACKCID+DPR+RP IE VV+WLD +G D +
Sbjct: 1018 ACKCIDEDPRQRPHIELVVSWLDNVGFDGS 1047

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248168|ref|NP_001239830.1| phytosulfokine receptor 2-like precursor [Glycine max] gi|223452341|gb|ACM89498.1| leucine-rich repeat transmembrane protein kinase [Glycine max]

 Score = 1347 bits (3486), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 712/1042 (68%), Positives = 835/1042 (80%), Gaps = 6/1042 (0%)

Query: 9    MTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWD 68
            M  + W FLA  +C  +GL+T  +SCD  DL+ALKEFAGNLT GSIIT WS++ +CC+W 
Sbjct: 1    MAFVLWGFLACLLCFSVGLETLARSCDKHDLMALKEFAGNLTKGSIITEWSDDVVCCKWT 60

Query: 69   GVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSN 128
            GV C     G  A RV+ LILP   L G I  SL +L++LK L+LS N L+G +  E SN
Sbjct: 61   GVYCDDVVDGVAASRVSKLILPGMDLNGTISSSLAYLDKLKELNLSFNRLQGELSSEFSN 120

Query: 129  LKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNS 188
            LKQL+VLDLSHNMLSGPV G  +GL  IQ LN+SSNSF G LF  G   +L+  NISNNS
Sbjct: 121  LKQLQVLDLSHNMLSGPVGGAFSGLQSIQILNISSNSFVGDLFHFGGLQHLSALNISNNS 180

Query: 189  FTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH-SPSLKQLHVDNNLLGGDLPDSLYS 247
            FTG+ NS+I S SK I ILD+S NHF G L+ L + S SL++LH+D+NL  G LPDSLYS
Sbjct: 181  FTGQFNSQICSTSKGIHILDISKNHFAGGLEWLGNCSTSLQELHLDSNLFSGPLPDSLYS 240

Query: 248  MSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSN 307
            MS+L+ +S+SVNN SGQLS+++SNL+SL+ LII GN FS +LPNV GNL  LE  + ++N
Sbjct: 241  MSALEQLSVSVNNLSGQLSKELSNLSSLKSLIISGNHFSEELPNVFGNLLNLEQLIGNTN 300

Query: 308  SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 367
            SFSG LP +L+LCSKL VLDLRNNSLTG + LNFSGLS+L TLDL +NHF+G LPNSLS 
Sbjct: 301  SFSGSLPSTLALCSKLRVLDLRNNSLTGSVALNFSGLSNLFTLDLGSNHFNGSLPNSLSY 360

Query: 368  CHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 427
            CH+L +LSLAKNEL+GQ+PES+  LTSLL LSLSNNSF +LSG L VLQQCKNLTTL+LT
Sbjct: 361  CHELTMLSLAKNELTGQIPESYANLTSLLTLSLSNNSFENLSGALYVLQQCKNLTTLVLT 420

Query: 428  KNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPW 486
            KNF GEEIPE +   F+SL+VLALGNCGLKG IP WLL C KL+VLDLSWNH  G++P W
Sbjct: 421  KNFHGEEIPEKLTASFKSLVVLALGNCGLKGRIPAWLLNCPKLEVLDLSWNHLKGSVPSW 480

Query: 487  IGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGL 546
            IGQM+ LFYLD SNN+LTGEIPK LT+L+ LISSN   S+  ASA IPLYVK N+S +GL
Sbjct: 481  IGQMDRLFYLDLSNNSLTGEIPKGLTQLRGLISSNYHISSLFASAAIPLYVKRNKSASGL 540

Query: 547  PYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVL 606
             YN ASSFPPS++LSNNR++GTI PEIG+LK LH+LDLSRNNITGTIPSSISE++NLE L
Sbjct: 541  QYNHASSFPPSIYLSNNRLSGTIWPEIGRLKELHILDLSRNNITGTIPSSISEMKNLETL 600

Query: 607  DLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEID 666
            DLS N L G+IP SF  LTFLSKFSVA NHL G IP GGQF SFPNSSFEGN GLCGEI 
Sbjct: 601  DLSYNSLVGTIPPSFNSLTFLSKFSVAYNHLWGLIPIGGQFSSFPNSSFEGNWGLCGEIF 660

Query: 667  SPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDD 726
              C+     L+    +    KF   +I+ IT  +GVG+ALLLAV LL++S+RD   P+D+
Sbjct: 661  HHCNEKDVGLR----ANHVGKFSKSNILGITIGLGVGLALLLAVILLRVSKRDEDKPVDN 716

Query: 727  LDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKA 786
            +DE++  P R  EAL SSKLV F+NSDCKDLTV DLLKST NFNQ NIIGCGGFGLVYK 
Sbjct: 717  IDEELSCPNRRPEALTSSKLVFFKNSDCKDLTVEDLLKSTGNFNQENIIGCGGFGLVYKG 776

Query: 787  TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME 846
             L NGTK A+K+LSG CGQ+EREFQAEVEALSRAQHKNLVSL+GYC+H +DRLLIYSY+E
Sbjct: 777  NLPNGTKVAIKKLSGYCGQVEREFQAEVEALSRAQHKNLVSLKGYCQHFSDRLLIYSYLE 836

Query: 847  NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK 906
            NGSLDYWLHES D +S LKWD RLKIA+GAA GLAYLHK CEPHIVHRD+KSSNILLD+K
Sbjct: 837  NGSLDYWLHESEDGNSALKWDARLKIAKGAAHGLAYLHKECEPHIVHRDIKSSNILLDDK 896

Query: 907  FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
            F+A+LADFGLSRLL+PYDTHV+TDLVGTLGYIPPEYSQ L AT +GD+YSFGVVL+ELLT
Sbjct: 897  FKAYLADFGLSRLLQPYDTHVSTDLVGTLGYIPPEYSQVLKATFKGDIYSFGVVLVELLT 956

Query: 967  GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQD 1026
            GRRPVEV  G+  R+LVSWV Q+KSE RE EI D+ IWHKD EKQLLE+L IACKCID+D
Sbjct: 957  GRRPVEVIIGQRSRNLVSWVLQIKSENREQEIFDSVIWHKDNEKQLLEVLAIACKCIDED 1016

Query: 1027 PRRRPFIEEVVTWLDGIGIDAA 1048
            PR+RP IE VV+WLD +G D +
Sbjct: 1017 PRQRPHIELVVSWLDNVGFDGS 1038

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297792807|ref|XP_002864288.1| hypothetical protein ARALYDRAFT_495467 [Arabidopsis lyrata subsp. lyrata] gi|297310123|gb|EFH40547.1| hypothetical protein ARALYDRAFT_495467 [Arabidopsis lyrata subsp. lyrata]

 Score = 1347 bits (3485), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 701/1041 (67%), Positives = 839/1041 (80%), Gaps = 19/1041 (1%)

Query: 15   LFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGH 74
            L LAFFV S + L     +C P+DL AL+EFAG L N S+   W N S CC+WDGV C  
Sbjct: 5    LLLAFFVGSSVSL-----TCHPNDLSALREFAGALKNMSVTEPWLNGSRCCEWDGVFCEG 59

Query: 75   GSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEV 134
            G     +GRVT L+L  KGL+G+I  SLG L++L++LDLS N L+G +PVE+S L+QLEV
Sbjct: 60   GDV---SGRVTKLVLSDKGLEGVISGSLGELSELRVLDLSRNQLKGDLPVEISKLEQLEV 116

Query: 135  LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLN 194
            LDLSHN+LSG V G ++GL LIQSLN+SSNS +G+L ++G F  L +FN+SNN F G+++
Sbjct: 117  LDLSHNLLSGSVLGAVSGLKLIQSLNISSNSLSGNLSDVGVFPGLVMFNVSNNLFEGEIH 176

Query: 195  SRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 253
              + S+S EIQ+LDLSMN  +G+L GL + S S+++LHV++N L G LPD LY +  L+ 
Sbjct: 177  PELCSSSGEIQVLDLSMNRLVGNLDGLYNCSKSIQRLHVNSNGLTGQLPDYLYLIRDLEQ 236

Query: 254  VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 313
            +S+S N  SGQLS+ +SNL+ L+ L+I  N+FSG +P+V GNLTQLE     SN FSG  
Sbjct: 237  LSVSGNYLSGQLSQNLSNLSGLKSLLISENRFSGVIPDVFGNLTQLEHLDVSSNKFSGRF 296

Query: 314  PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 373
            P SLS CSKL VLDLRNNSL+G I+LNF+G + LC LDLA+NHFSGPLP+SL  C  +KI
Sbjct: 297  PPSLSQCSKLRVLDLRNNSLSGSINLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPKMKI 356

Query: 374  LSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE 433
            LSLAKNE SG++P++F  L SLLFLSLSNNSF   S T++VLQ C+NL+TLIL+KNF+GE
Sbjct: 357  LSLAKNEFSGKIPDTFKNLDSLLFLSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGE 416

Query: 434  EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 493
            EIP NV GF +L  LALGNCGL+G IP WLL CKKL+VLDLSWNH  G IP WIG+ME+L
Sbjct: 417  EIPSNVTGFNNLATLALGNCGLRGQIPSWLLNCKKLEVLDLSWNHIYGTIPHWIGKMESL 476

Query: 494  FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASS 553
            FY+DFSNNTLTGEIP ++TELK+LI  NCT+S  T S+GIPLYVK N+S++GLPYNQ S 
Sbjct: 477  FYIDFSNNTLTGEIPVAITELKNLIHLNCTASQMTTSSGIPLYVKRNKSSSGLPYNQVSR 536

Query: 554  FPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 613
            FPPS++L+NNR+NGTI PEIG+LK LH+LDLSRNN +G IP SIS + NLEVLDLS N L
Sbjct: 537  FPPSIYLNNNRLNGTILPEIGRLKELHMLDLSRNNFSGRIPDSISGLDNLEVLDLSYNHL 596

Query: 614  HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDS-M 672
            +GSIP SF+ LTFLSKFSVA N L G IP+GGQFYSFP+SSFEGN GLC  IDSPCD  M
Sbjct: 597  YGSIPLSFQSLTFLSKFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLM 656

Query: 673  HAKLKPVIPSGSNS---KFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDE 729
               L P  PS SN+   +FG  SI+ +T S+ +GI LLL+V LL++SR+DS   I+D+DE
Sbjct: 657  SNMLNPKGPSRSNNTGGRFGRSSIVVLTISLAIGITLLLSVILLRISRKDSDDRINDVDE 716

Query: 730  DM--GRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT 787
            +   G P+    AL  SK+VLF +  CKDL+V +LLKSTNNF+QANIIGCGGFGLVYKA 
Sbjct: 717  ETISGVPK----ALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKAN 772

Query: 788  LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN 847
              +G+KAAVKRLSGDCGQMEREFQAEVEALSRA+HKNLVSLQGYC+HGNDRLLIYS+MEN
Sbjct: 773  FPDGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMEN 832

Query: 848  GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF 907
            GSLDYWLHE VD +  LKWDVRLKIAQGAARGLAYLHKVCEP+++HRDVKSSNILLDEKF
Sbjct: 833  GSLDYWLHERVDGNMTLKWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKF 892

Query: 908  EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 967
            EAHLADFGL+RLLRPYDTHVTTDLVGTLGYIPPEYSQ+L ATCRGDVYSFGVVLLEL+TG
Sbjct: 893  EAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTG 952

Query: 968  RRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDP 1027
            RRPVEVCKGK+CRDLVSWVFQMKSEKRE E+ID +I     EK +LEMLEIACKCID +P
Sbjct: 953  RRPVEVCKGKSCRDLVSWVFQMKSEKREAELIDTTIRENVNEKTVLEMLEIACKCIDHEP 1012

Query: 1028 RRRPFIEEVVTWLDGIGIDAA 1048
            RRRP IEEVVTWL+ + +++ 
Sbjct: 1013 RRRPLIEEVVTWLEDLPMESV 1033

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1048
TAIR|locus:2154709	1036	PSKR2 "phytosylfokine-alpha re	0.976	0.987	0.640	0.0
TAIR|locus:2051628	1008	PSKR1 "phytosulfokin receptor	0.881	0.916	0.488	5.1e-232
TAIR|locus:2207056	1095	PSY1R "PSY1 receptor" [Arabido	0.894	0.855	0.443	1.1e-211
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.883	0.795	0.344	5.6e-132
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.847	0.761	0.343	1.7e-128
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.929	0.817	0.333	3.4e-125
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.897	0.753	0.342	5.5e-125
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.879	0.736	0.339	5.7e-123
TAIR|locus:2005498	1196	BRI1 "BRASSINOSTEROID INSENSIT	0.871	0.763	0.349	7.2e-123
TAIR|locus:2041150	1143	BRL2 "BRI1-like 2" [Arabidopsi	0.879	0.806	0.334	1.9e-122

TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 3390 (1198.4 bits), Expect = 0., P = 0.
 Identities = 665/1038 (64%), Positives = 804/1038 (77%)

Query:    15 LFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGH 74
             L L FFV S +      Q C P+DL AL+E AG L N S+  SW N S CC+WDGV C  
Sbjct:     5 LLLVFFVGSSVS-----QPCHPNDLSALRELAGALKNKSVTESWLNGSRCCEWDGVFC-E 58

Query:    75 GSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEV 134
             GS  S  GRVT L+LP KGL+G+I +SLG L +L++LDLS N L+G VP E+S L+QL+V
Sbjct:    59 GSDVS--GRVTKLVLPEKGLEGVISKSLGELTELRVLDLSRNQLKGEVPAEISKLEQLQV 116

Query:   135 LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLN 194
             LDLSHN+LSG V G+++GL LIQSLN+SSNS +G L ++G F  L + N+SNN F G+++
Sbjct:   117 LDLSHNLLSGSVLGVVSGLKLIQSLNISSNSLSGKLSDVGVFPGLVMLNVSNNLFEGEIH 176

Query:   195 SRIWSASKEIQILDLSMNHFMGSLQGLDH-SPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 253
               + S+S  IQ+LDLSMN  +G+L GL + S S++QLH+D+N L G LPD LYS+  L+ 
Sbjct:   177 PELCSSSGGIQVLDLSMNRLVGNLDGLYNCSKSIQQLHIDSNRLTGQLPDYLYSIRELEQ 236

Query:   254 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXXXXXXX 313
             +SLS N  SG+LS+ +SNL+ L+ L+I  N+FS  +P+V GNLTQLE             
Sbjct:   237 LSLSGNYLSGELSKNLSNLSGLKSLLISENRFSDVIPDVFGNLTQLEHLDVSSNKFSGRF 296

Query:   314 XXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 373
                        VLDLRNNSL+G I+LNF+G + LC LDLA+NHFSGPLP+SL  C  +KI
Sbjct:   297 PPSLSQCSKLRVLDLRNNSLSGSINLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPKMKI 356

Query:   374 LSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSVLQQCKNLTTLILTKNFVGE 433
             LSLAKNE  G++P+                       T++VLQ C+NL+TLIL+KNF+GE
Sbjct:   357 LSLAKNEFRGKIPDTFKNLQSLLFLSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGE 416

Query:   434 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 493
             EIP NV GF++L +LALGNCGL+G IP WLL CKKL+VLDLSWNHF G IP WIG+ME+L
Sbjct:   417 EIPNNVTGFDNLAILALGNCGLRGQIPSWLLNCKKLEVLDLSWNHFYGTIPHWIGKMESL 476

Query:   494 FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASS 553
             FY+DFSNNTLTG IP ++TELK+LI  N T+S  T S+GIPLYVK N+S+NGLPYNQ S 
Sbjct:   477 FYIDFSNNTLTGAIPVAITELKNLIRLNGTASQMTDSSGIPLYVKRNKSSNGLPYNQVSR 536

Query:   554 FPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 613
             FPPS++L+NNR+NGTI PEIG+LK LH+LDLSRNN TGTIP SIS + NLEVLDLS N L
Sbjct:   537 FPPSIYLNNNRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHL 596

Query:   614 HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMH 673
             +GSIP SF+ LTFLS+FSVA N L G IP+GGQFYSFP+SSFEGN GLC  IDSPCD + 
Sbjct:   597 YGSIPLSFQSLTFLSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLM 656

Query:   674 AK-LKPVIPSGSNS---KFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDE 729
             +  L P   S  N+   KFG  SI+ +T S+ +GI LLL+V LL++SR+D    I+D+DE
Sbjct:   657 SNMLNPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDVDE 716

Query:   730 DMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT 789
             +      +S+AL  SK+VLF +  CKDL+V +LLKSTNNF+QANIIGCGGFGLVYKA   
Sbjct:   717 ET--ISGVSKALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFP 774

Query:   790 NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS 849
             +G+KAAVKRLSGDCGQMEREFQAEVEALSRA+HKNLVSLQGYC+HGNDRLLIYS+MENGS
Sbjct:   775 DGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGS 834

Query:   850 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA 909
             LDYWLHE VD +  L WDVRLKIAQGAARGLAYLHKVCEP+++HRDVKSSNILLDEKFEA
Sbjct:   835 LDYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEA 894

Query:   910 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRR 969
             HLADFGL+RLLRPYDTHVTTDLVGTLGYIPPEYSQ+L ATCRGDVYSFGVVLLEL+TGRR
Sbjct:   895 HLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRR 954

Query:   970 PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1029
             PVEVCKGK+CRDLVS VFQMK+EKRE E+ID +I     E+ +LEMLEIACKCID +PRR
Sbjct:   955 PVEVCKGKSCRDLVSRVFQMKAEKREAELIDTTIRENVNERTVLEMLEIACKCIDHEPRR 1014

Query:  1030 RPFIEEVVTWLDGIGIDA 1047
             RP IEEVVTWL+ + +++
Sbjct:  1015 RPLIEEVVTWLEDLPMES 1032

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2238 (792.9 bits), Expect = 5.1e-232, P = 5.1e-232
 Identities = 458/937 (48%), Positives = 611/937 (65%)

Query:   111 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL 170
             L+L    L G +   L  L ++ VL+LS N +   +   +  L  +Q+L++SSN  +G +
Sbjct:    81 LELGNKKLSGKLSESLGKLDEIRVLNLSRNFIKDSIPLSIFNLKNLQTLDLSSNDLSGGI 140

Query:   171 FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQ 229
                     L  F++S+N F G L S I   S +I+++ L++N+F G+   G      L+ 
Sbjct:   141 PTSINLPALQSFDLSSNKFNGSLPSHICHNSTQIRVVKLAVNYFAGNFTSGFGKCVLLEH 200

Query:   230 LHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKL 289
             L +  N L G++P+ L+ +  L  + +  N  SG LS +I NL+SL  L +  N FSG++
Sbjct:   201 LCLGMNDLTGNIPEDLFHLKRLNLLGIQENRLSGSLSREIRNLSSLVRLDVSWNLFSGEI 260

Query:   290 PNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCT 349
             P+V   L QL+FF+                    ++L+LRNNSL+G + LN + + +L +
Sbjct:   261 PDVFDELPQLKFFLGQTNGFIGGIPKSLANSPSLNLLNLRNNSLSGRLMLNCTAMIALNS 320

Query:   350 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXX 409
             LDL TN F+G LP +L DC  LK ++LA+N   GQVPE                      
Sbjct:   321 LDLGTNRFNGRLPENLPDCKRLKNVNLARNTFHGQVPESFKNFESLSYFSLSNSSLANIS 380

Query:   410 GTLSVLQQCKNLTTLILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLLRCKK 468
               L +LQ CKNLTTL+LT NF GE +P++    FE L VL + NC L G +P WL    +
Sbjct:   381 SALGILQHCKNLTTLVLTLNFHGEALPDDSSLHFEKLKVLVVANCRLTGSMPRWLSSSNE 440

Query:   469 LQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPT 528
             LQ+LDLSWN   G IP WIG  + LFYLD SNN+ TGEIPKSLT+L+SL S N + + P 
Sbjct:   441 LQLLDLSWNRLTGAIPSWIGDFKALFYLDLSNNSFTGEIPKSLTKLESLTSRNISVNEP- 499

Query:   529 ASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNN 588
              S   P ++K N S   L YNQ   FPP++ L +N ++G I  E G LK LHV DL  N 
Sbjct:   500 -SPDFPFFMKRNESARALQYNQIFGFPPTIELGHNNLSGPIWEEFGNLKKLHVFDLKWNA 558

Query:   589 ITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFY 648
             ++G+IPSS+S + +LE LDLS+N L GSIP S ++L+FLSKFSVA N+L G IP+GGQF 
Sbjct:   559 LSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQ 618

Query:   649 SFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGP-GSIIAITFSIGVGIALL 707
             +FPNSSFE N  LCGE   PC         +I     S+ G  G  I I F   V +  L
Sbjct:   619 TFPNSSFESNH-LCGEHRFPCSE--GTESALIKRSRRSRGGDIGMAIGIAFG-SVFLLTL 674

Query:   708 LAVTLLKMSRRDSGC-PIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKST 766
             L++ +L+  RR     P  +  E M R + L E + S  +VLFQ++D K+L+  DLL ST
Sbjct:   675 LSLIVLRARRRSGEVDPEIEESESMNRKE-LGE-IGSKLVVLFQSND-KELSYDDLLDST 731

Query:   767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
             N+F+QANIIGCGGFG+VYKATL +G K A+K+LSGDCGQ+EREF+AEVE LSRAQH NLV
Sbjct:   732 NSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLV 791

Query:   827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
              L+G+C + NDRLLIYSYMENGSLDYWLHE  D  ++LKW  RL+IAQGAA+GL YLH+ 
Sbjct:   792 LLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEG 851

Query:   887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
             C+PHI+HRD+KSSNILLDE F +HLADFGL+RL+ PY+THV+TDLVGTLGYIPPEY Q  
Sbjct:   852 CDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEYGQAS 911

Query:   947 TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
              AT +GDVYSFGVVLLELLT +RPV++CK K CRDL+SWV +MK E R  E+ D  I+ K
Sbjct:   912 VATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRDLISWVVKMKHESRASEVFDPLIYSK 971

Query:  1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
             + +K++  +LEIAC C+ ++P++RP  +++V+WLD +
Sbjct:   972 ENDKEMFRVLEIACLCLSENPKQRPTTQQLVSWLDDV 1008

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP;IDA

GO:0009611 "response to wounding" evidence=IGI

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 2032 (720.4 bits), Expect = 1.1e-211, Sum P(2) = 1.1e-211
 Identities = 437/985 (44%), Positives = 605/985 (61%)

Query:    83 RVTMLILPRKGLKGIIPRS-LGHLNQLKLLDLSCNHLEGVVPVELS------NLKQLEVL 135
             R++ L L    L G +P   L  L+QL +LDLS N  +G +P++ S       +  ++ +
Sbjct:   117 RLSRLDLSHNRLSGPLPPGFLSALDQLLVLDLSYNSFKGELPLQQSFGNGSNGIFPIQTV 176

Query:   136 DLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNS 195
             DLS N+L G +              +SS     S+F  G F NL  FN+SNNSFTG + S
Sbjct:   177 DLSSNLLEGEI--------------LSS-----SVFLQGAF-NLTSFNVSNNSFTGSIPS 216

Query:   196 RIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHV 254
              + +AS ++  LD S N F G L Q L     L  L    N L G++P  +Y++  L+ +
Sbjct:   217 FMCTASPQLTKLDFSYNDFSGDLSQELSRCSRLSVLRAGFNNLSGEIPKEIYNLPELEQL 276

Query:   255 SLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXXXXXXXX 314
              L VN  SG++   I+ LT L  L ++ N   G++P  +G L++L     H         
Sbjct:   277 FLPVNRLSGKIDNGITRLTKLTLLELYSNHIEGEIPKDIGKLSKLSSLQLHVNNLMGSIP 336

Query:   315 XXXXXXXXXHVLDLRNNSLTGPID-LNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 373
                        L+LR N L G +  ++FS   SL  LDL  N F+G  P+++  C  +  
Sbjct:   337 VSLANCTKLVKLNLRVNQLGGTLSAIDFSRFQSLSILDLGNNSFTGEFPSTVYSCKMMTA 396

Query:   374 LSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSVLQQCKNLTTLILTKNFVGE 433
             +  A N+L+GQ+                        G LS+LQ CK L+TLI+ KNF  E
Sbjct:   397 MRFAGNKLTGQISPQVLELESLSFFTFSDNKMTNLTGALSILQGCKKLSTLIMAKNFYDE 456

Query:   434 EIPENVG-----GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 488
              +P N       GF SL +  +G C L G IP WL++ ++++V+DLS N F G IP W+G
Sbjct:   457 TVPSNKDFLRSDGFPSLQIFGIGACRLTGEIPAWLIKLQRVEVMDLSMNRFVGTIPGWLG 516

Query:   489 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 548
              + +LFYLD S+N LTGE+PK L +L++L+S     +       +P++V  N  T    Y
Sbjct:   517 TLPDLFYLDLSDNFLTGELPKELFQLRALMSQKAYDATERNYLELPVFVNPNNVTTNQQY 576

Query:   549 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 608
             NQ SS PP++++  N + GTIP E+GQLK LH+L+L  NN +G+IP  +S + NLE LDL
Sbjct:   577 NQLSSLPPTIYIKRNNLTGTIPVEVGQLKVLHILELLGNNFSGSIPDELSNLTNLERLDL 636

Query:   609 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEID-S 667
             S+N+L G IP S   L FLS F+VANN L G IPTG QF +FP ++FEGNP LCG +  +
Sbjct:   637 SNNNLSGRIPWSLTGLHFLSYFNVANNTLSGPIPTGTQFDTFPKANFEGNPLLCGGVLLT 696

Query:   668 PCD-SMHAKLKPVIPSGS-NSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPID 725
              CD + H+  K  +  G  N     G ++ + F + + I +LLA+ +L   R + G   +
Sbjct:   697 SCDPTQHSTTK--MGKGKVNRTLVLGLVLGLFFGVSL-ILVLLALLVLSKRRVNPG-DSE 752

Query:   726 DLDEDMGRPQRLSEALASSK-----LVLFQNS--DCKDLTVSDLLKSTNNFNQANIIGCG 778
             + + ++      SE    S      ++LF NS  + KDLT+ +LLK+T+NF+QANIIGCG
Sbjct:   753 NAELEINSNGSYSEVPPGSDKDISLVLLFGNSRYEVKDLTIFELLKATDNFSQANIIGCG 812

Query:   779 GFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 838
             GFGLVYKATL NGTK AVK+L+GD G ME+EF+AEVE LSRA+H+NLV+LQGYC H + R
Sbjct:   813 GFGLVYKATLDNGTKLAVKKLTGDYGMMEKEFKAEVEVLSRAKHENLVALQGYCVHDSAR 872

Query:   839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 898
             +LIYS+MENGSLDYWLHE+ +  + L W  RL I +GA+ GLAY+H++CEPHIVHRD+KS
Sbjct:   873 ILIYSFMENGSLDYWLHENPEGPAQLDWPKRLNIMRGASSGLAYMHQICEPHIVHRDIKS 932

Query:   899 SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 958
             SNILLD  F+A++ADFGLSRL+ PY THVTT+LVGTLGYIPPEY Q   AT RGDVYSFG
Sbjct:   933 SNILLDGNFKAYVADFGLSRLILPYRTHVTTELVGTLGYIPPEYGQAWVATLRGDVYSFG 992

Query:   959 VVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1018
             VV+LELLTG+RP+EV + K  R+LV+WV  MK + +  E+ D  +     E+ +L +L+I
Sbjct:   993 VVMLELLTGKRPMEVFRPKMSRELVAWVHTMKRDGKPEEVFDTLLRESGNEEAMLRVLDI 1052

Query:  1019 ACKCIDQDPRRRPFIEEVVTWLDGI 1043
             AC C++Q+P +RP I++VV WL  I
Sbjct:  1053 ACMCVNQNPMKRPNIQQVVDWLKNI 1077

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0004888 "transmembrane signaling receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1294 (460.6 bits), Expect = 5.6e-132, P = 5.6e-132
 Identities = 343/996 (34%), Positives = 522/996 (52%)

Query:    77 TGSNAGRVTMLILPRKGLKGIIPRSL--GHLNQLKLLDLSCNHLEGVVP-VELSNLKQLE 133
             + SN  R+T + L        IP +      N LK LDLS N++ G    +     + L 
Sbjct:   171 SASNK-RITTVDLSNNRFSDEIPETFIADFPNSLKHLDLSGNNVTGDFSRLSFGLCENLT 229

Query:   134 VLDLSHNMLSG---PVSGMLAGLNLIQSLNVSSNSFNGSL---FELGEFSNLAVFNISNN 187
             V  LS N +SG   PVS  L+   L+++LN+S NS  G +      G F NL   ++++N
Sbjct:   230 VFSLSQNSISGDRFPVS--LSNCKLLETLNLSRNSLIGKIPGDDYWGNFQNLRQLSLAHN 287

Query:   188 SFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHVDNNLLGGDLPDSLY 246
              ++G++   +    + +++LDLS N   G L Q      SL+ L++ NN L GD   ++ 
Sbjct:   288 LYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVV 347

Query:   247 S-MSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 305
             S +S + ++ L  NN SG +   ++N ++LR L +  N+F+G++P+   +L         
Sbjct:   348 SKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQS------- 400

Query:   306 XXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL 365
                                 L + NN L+G + +      SL T+DL+ N  +G +P  +
Sbjct:   401 --------------SSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKEI 446

Query:   366 SDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTL-SVLQQCKNLTTL 424
                  L  L +  N L+G +PE                      G+L   + +C N+  +
Sbjct:   447 WTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNNNLLT--GSLPESISKCTNMLWI 504

Query:   425 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 484
              L+ N +  EIP  +G  E L +L LGN  L G+IP  L  CK L  LDL+ N+  GN+P
Sbjct:   505 SLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLP 564

Query:   485 PWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTAS-AGIPLY-VKH--- 539
               +     L        +++G   K    +++   ++C  +       GI    ++H   
Sbjct:   565 GELASQAGLVM----PGSVSG---KQFAFVRNEGGTDCRGAGGLVEFEGIRAERLEHFPM 617

Query:   540 ------NRSTNGLPYNQASSFPPSVFL--SNNRINGTIPPEIGQLKHLHVLDLSRNNITG 591
                    R  +G+     SS    ++L  S N ++G+IP   G + +L VL+L  N +TG
Sbjct:   618 VHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTG 677

Query:   592 TIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFP 651
             TIP S   ++ + VLDLS NDL G +PGS   L+FLS   V+NN+L G IP GGQ  +FP
Sbjct:   678 TIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFP 737

Query:   652 NSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAV- 710
              + +  N GLCG    PC S     +        S    G    I FS    + L++A+ 
Sbjct:   738 LTRYANNSGLCGVPLPPCSSGSRPTRSHAHPKKQS-IATGMSAGIVFSFMCIVMLIMALY 796

Query:   711 TLLKMSRRDSGCP--IDDLDEDMGRPQRLS---EALASSKLVLFQNSDCKDLTVSDLLKS 765
                K+ +++      I+ L        +LS   E L S  +  F+    + LT + LL++
Sbjct:   797 RARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPL-SINVATFEKP-LRKLTFAHLLEA 854

Query:   766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 825
             TN F+  ++IG GGFG VYKA L +G+  A+K+L    GQ +REF AE+E + + +H+NL
Sbjct:   855 TNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNL 914

Query:   826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV-LKWDVRLKIAQGAARGLAYLH 884
             V L GYC+ G +RLL+Y YM+ GSL+  LHE   K  + L W  R KIA GAARGLA+LH
Sbjct:   915 VPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLH 974

Query:   885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 943
               C PHI+HRD+KSSN+LLD+ F A ++DFG++RL+   DTH++   L GT GY+PPEY 
Sbjct:   975 HSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYY 1034

Query:   944 QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS- 1002
             Q+   T +GDVYS+GV+LLELL+G++P++  +     +LV W  Q+  EKR  EI+D   
Sbjct:  1035 QSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPEL 1094

Query:  1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038
             +  K  + +LL  L+IA +C+D  P +RP + +V+T
Sbjct:  1095 VTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMT 1130

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
 Identities = 321/935 (34%), Positives = 484/935 (51%)

Query:   132 LEVLDLSHNMLSGPVSGMLAGL-NLIQSLNVSSNSFNGSLFE--LGEFSNLAVFNISNNS 188
             L+ LDL+HN LSG  S +  G+   +   ++S N+ +G  F   L     L   NIS N+
Sbjct:   203 LKYLDLTHNNLSGDFSDLSFGICGNLTFFSLSQNNLSGDKFPITLPNCKFLETLNISRNN 262

Query:   189 FTGKL-NSRIWSASKEIQILDLSMNHFMGSLQG-LDH-SPSLKQLHVDNNLLGGDLPDSL 245
               GK+ N   W + + ++ L L+ N   G +   L     +L  L +  N   G+LP   
Sbjct:   263 LAGKIPNGEYWGSFQNLKQLSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQF 322

Query:   246 YSMSSLQHVSLSVNNFSGQ-LSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 304
              +   LQ+++L  N  SG  L+  +S +T + +L +  N  SG +P  L N + L     
Sbjct:   323 TACVWLQNLNLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDL 382

Query:   305 HXXXXXXXXXXXXXXXXXXHVLD---LRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPL 361
                                 VL+   + NN L+G + +      SL T+DL+ N  +GP+
Sbjct:   383 SSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPI 442

Query:   362 PNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSVLQQCKNL 421
             P  +    +L  L +  N L+G +PE                         S+  +C N+
Sbjct:   443 PKEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESI-SRCTNM 501

Query:   422 TTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG 481
               + L+ N +  +IP  +G    L +L LGN  L G++P  L  CK L  LDL+ N+  G
Sbjct:   502 IWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTG 561

Query:   482 NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTAS-AGIP------ 534
             ++P  +     L        +++G   K    +++   ++C  +       GI       
Sbjct:   562 DLPGELASQAGLVM----PGSVSG---KQFAFVRNEGGTDCRGAGGLVEFEGIRAERLER 614

Query:   535 LYVKHN----RSTNGLPYNQASSFPPSVF--LSNNRINGTIPPEIGQLKHLHVLDLSRNN 588
             L + H+    R  +G+     S+    ++  +S N ++G IPP  G + +L VL+L  N 
Sbjct:   615 LPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNR 674

Query:   589 ITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFY 648
             ITGTIP S   ++ + VLDLS N+L G +PGS   L+FLS   V+NN+L G IP GGQ  
Sbjct:   675 ITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLT 734

Query:   649 SFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPS--GSNSKFGPGSIIAITFSIGVGIAL 706
             +FP S +  N GLCG    PC S  A  +P+               I  I FS    + L
Sbjct:   735 TFPVSRYANNSGLCGVPLRPCGS--APRRPITSRIHAKKQTVATAVIAGIAFSFMCFVML 792

Query:   707 LLAV-TLLKMSRRDSGCP--IDDLDEDMGRPQRLS---EALASSKLVLFQNSDCKDLTVS 760
             ++A+  + K+ +++      I+ L        +LS   E L S  +  F+    + LT +
Sbjct:   793 VMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPL-SINVATFEKP-LRKLTFA 850

Query:   761 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA 820
              LL++TN F+   ++G GGFG VYKA L +G+  A+K+L    GQ +REF AE+E + + 
Sbjct:   851 HLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKI 910

Query:   821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS--VLKWDVRLKIAQGAAR 878
             +H+NLV L GYC+ G +RLL+Y YM+ GSL+  LHE   K     L W  R KIA GAAR
Sbjct:   911 KHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAAR 970

Query:   879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGY 937
             GLA+LH  C PHI+HRD+KSSN+LLDE FEA ++DFG++RL+   DTH++   L GT GY
Sbjct:   971 GLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGY 1030

Query:   938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
             +PPEY Q+   T +GDVYS+GV+LLELL+G++P++  +     +LV W  Q+  EKR  E
Sbjct:  1031 VPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAE 1090

Query:   998 IIDAS-IWHKDREKQLLEMLEIACKCIDQDPRRRP 1031
             I+D   +  K  + +L   L+IA +C+D  P +RP
Sbjct:  1091 ILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRP 1125

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1230 (438.0 bits), Expect = 3.4e-125, P = 3.4e-125
 Identities = 344/1030 (33%), Positives = 517/1030 (50%)

Query:    40 LALKEFAGNLTN--GSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGI 97
             + L  F+G + +  G+I    +  +  C ++G +    S   +  ++ +   P   LK  
Sbjct:   193 MGLNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNP---LKCS 249

Query:    98 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
             IP+S G L+ L +L+L    L G++P EL N K L+ L LS N LSGP+   L+ + L+ 
Sbjct:   250 IPKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLL- 308

Query:   158 SLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 216
             + +   N  +GSL   +G++  L    ++NN F+G++   I      ++ L L+ N   G
Sbjct:   309 TFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPM-LKHLSLASNLLSG 367

Query:   217 SL-QGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 275
             S+ + L  S SL+ + +  NLL G + +     SSL  + L+ N  +G + E +  L  L
Sbjct:   368 SIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-L 426

Query:   276 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTG 335
               L +  N F+G++P  L   T L  F A                     L L +N LTG
Sbjct:   427 MALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTG 486

Query:   336 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXX 395
              I      L+SL  L+L  N F G +P  L DC  L  L L  N L GQ+P+        
Sbjct:   487 EIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQL 546

Query:   396 XXXXXXXXXXXXXXGTL--SVLQQCK--NLTTLI------LTKNFVGEEIPENVGGFESL 445
                            +   +   Q +  +L+ L       L+ N +   IPE +G    L
Sbjct:   547 QCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVL 606

Query:   446 MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG 505
             + ++L N  L G IP  L R   L +LDLS N   G+IP  +G    L  L+ +NN L G
Sbjct:   607 VEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNG 666

Query:   506 EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRI 565
              IP+S   L SL+  N T +       +P  + + +    +             LS N +
Sbjct:   667 HIPESFGLLGSLVKLNLTKNK--LDGPVPASLGNLKELTHMD------------LSFNNL 712

Query:   566 NGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLT 625
             +G +  E+  ++ L  L + +N  TG IPS +  +  LE LD+S N L G IP     L 
Sbjct:   713 SGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLP 772

Query:   626 FLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEI-DSPCDSMHAKLKPVIPSGS 684
              L   ++A N+L+G +P+ G       +   GN  LCG +  S C     KL+       
Sbjct:   773 NLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLR------- 825

Query:   685 NSKFG-PGSIIAITFSIGVGIALLLAVTLLK-MSRRDSGCPIDD------LDEDMG--RP 734
              S +G  G ++  T  + V +  L    + K + +RD    +++      +D+++     
Sbjct:   826 -SAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSG 884

Query:   735 QRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA 794
              R  E L S  + +F+    K + + D++++T++F++ NIIG GGFG VYKA L      
Sbjct:   885 SRSREPL-SINIAMFEQPLLK-VRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTV 942

Query:   795 AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWL 854
             AVK+LS    Q  REF AE+E L + +H NLVSL GYC    ++LL+Y YM NGSLD+WL
Sbjct:   943 AVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWL 1002

Query:   855 HESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 914
                     VL W  RLKIA GAARGLA+LH    PHI+HRD+K+SNILLD  FE  +ADF
Sbjct:  1003 RNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADF 1062

Query:   915 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV- 973
             GL+RL+   ++HV+T + GT GYIPPEY Q+  AT +GDVYSFGV+LLEL+TG+ P    
Sbjct:  1063 GLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPD 1122

Query:   974 CKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1033
              K     +LV W  Q  ++ + V++ID  +     +   L +L+IA  C+ + P +RP +
Sbjct:  1123 FKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNM 1182

Query:  1034 EEVVTWLDGI 1043
              +V+  L  I
Sbjct:  1183 LDVLKALKEI 1192

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1228 (437.3 bits), Expect = 5.5e-125, P = 5.5e-125
 Identities = 339/990 (34%), Positives = 504/990 (50%)

Query:    75 GSTGSNAGRVTML---ILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQ 131
             G   S  G ++ L    L    L+G+IP+SL  L  L+ LDLS N+L G +P E  N+ Q
Sbjct:   253 GEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQ 312

Query:   132 LEVLDLSHNMLSGPVSGMLAGLNL-IQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSF 189
             L  L L++N LSG +   +   N  ++ L +S    +G +  EL +  +L   ++SNNS 
Sbjct:   313 LLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSL 372

Query:   190 TGKLNSRIWSASKEIQILDLSMNHFMGSLQ-GLDHSPSLKQLHVDNNLLGGDLPDSLYSM 248
              G +   ++    E+  L L  N   G+L   + +  +L+ L + +N L G LP  + ++
Sbjct:   373 AGSIPEALFELV-ELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISAL 431

Query:   249 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXX 308
               L+ + L  N FSG++ ++I N TSL+ + +FGN F G++P  +G L +L         
Sbjct:   432 RKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNE 491

Query:   309 XXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC 368
                            ++LDL +N L+G I  +F  L  L  L L  N   G LP+SL   
Sbjct:   492 LVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISL 551

Query:   369 HDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSVLQQCKNLTTLILTK 428
              +L  ++L+ N L+G +                          L  L   +NL  L L K
Sbjct:   552 RNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEI--PLE-LGNSQNLDRLRLGK 608

Query:   429 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 488
             N +  +IP  +G    L +L + +  L G IP+ L+ CKKL  +DL+ N   G IPPW+G
Sbjct:   609 NQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLG 668

Query:   489 QMENLFYLDFSNNTLTGEIPKSL---TELK--SLISSNCTSSNPTASAGIP----LYVKH 539
             ++  L  L  S+N     +P  L   T+L   SL  ++   S P     +     L +  
Sbjct:   669 KLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDK 728

Query:   540 NRSTNGLPYNQAS-SFPPSVFLSNNRINGTIPPEIGQLKHLH-VLDLSRNNITGTIPSSI 597
             N+ +  LP      S    + LS N + G IP EIGQL+ L   LDLS NN TG IPS+I
Sbjct:   729 NQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTI 788

Query:   598 SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEG 657
               +  LE LDLS N L G +PGS   +  L   +V+ N+L G +    QF  +P  SF G
Sbjct:   789 GTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLG 846

Query:   658 NPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSR 717
             N GLCG   S C+ + +  K     G +++     I AI+    +G+ ++L + L    R
Sbjct:   847 NTGLCGSPLSRCNRVRSNNKQ---QGLSAR-SVVIISAISALTAIGL-MILVIALFFKQR 901

Query:   718 RDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANIIG 776
              D    +             S + A+ K  LF+N   K D+   D++++T+N ++  +IG
Sbjct:   902 HDFFKKVGH--GSTAYTSSSSSSQATHK-PLFRNGASKSDIRWEDIMEATHNLSEEFMIG 958

Query:   777 CGGFGLVYKATLTNGTKAAVKR-LSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG 835
              GG G VYKA L NG   AVK+ L  D     + F  EV+ L R +H++LV L GYC   
Sbjct:   959 SGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSK 1018

Query:   836 ND--RLLIYSYMENGSLDYWLHESVD----KDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
             ++   LLIY YM+NGS+  WLHE       K  +L W+ RL+IA G A+G+ YLH  C P
Sbjct:  1019 SEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVP 1078

Query:   890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY-DTHVTTD--LVGTLGYIPPEYSQTL 946
              IVHRD+KSSN+LLD   EAHL DFGL+++L    DT+  ++     + GYI PEY+ +L
Sbjct:  1079 PIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSL 1138

Query:   947 TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV---FQMKSEKREVEIIDASI 1003
              AT + DVYS G+VL+E++TG+ P +   G    D+V WV    ++    R+ ++ID  +
Sbjct:  1139 KATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEM-DMVRWVETHLEVAGSARD-KLIDPKL 1196

Query:  1004 WH--KDREKQLLEMLEIACKCIDQDPRRRP 1031
                    E    ++LEIA +C    P+ RP
Sbjct:  1197 KPLLPFEEDAACQVLEIALQCTKTSPQERP 1226

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1209 (430.6 bits), Expect = 5.7e-123, P = 5.7e-123
 Identities = 333/982 (33%), Positives = 500/982 (50%)

Query:    94 LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
             L+G+IP+ L  L  L+ LDLS N+L GV+  E   + QLE L L+ N LSG +   +   
Sbjct:   276 LQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSN 335

Query:   154 NL-IQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSM 211
             N  ++ L +S    +G +  E+    +L + ++SNN+ TG++   ++    E+  L L+ 
Sbjct:   336 NTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLV-ELTNLYLNN 394

Query:   212 NHFMGSLQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS 270
             N   G+L   + +  +L++  + +N L G +P  +  +  L+ + L  N FSG++  +I 
Sbjct:   395 NSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIG 454

Query:   271 NLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRN 330
             N T L+ +  +GN+ SG++P+ +G L  L                         V+DL +
Sbjct:   455 NCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLAD 514

Query:   331 NSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXX 390
             N L+G I  +F  L++L    +  N   G LP+SL +  +L  ++ + N+ +G +     
Sbjct:   515 NQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCG 574

Query:   391 XXXXXXXXXXXXXXXXXXXGTLSV-LQQCKNLTTLILTKN-FVGEEIPENVGGFESLMVL 448
                                G + + L +  NL  L L KN F G  IP   G    L +L
Sbjct:   575 SSSYLSFDVTENGFE----GDIPLELGKSTNLDRLRLGKNQFTGR-IPRTFGKISELSLL 629

Query:   449 ALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 508
              +    L G IPV L  CKKL  +DL+ N+  G IP W+G++  L  L  S+N   G +P
Sbjct:   630 DISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLP 689

Query:   509 KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY--NQASSFPPSVF------- 559
               +  L ++++     ++   S  IP  + + ++ N L    NQ S   PS         
Sbjct:   690 TEIFSLTNILTLFLDGNSLNGS--IPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLF 747

Query:   560 ---LSNNRINGTIPPEIGQLKHLH-VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG 615
                LS N + G IP EIGQL+ L   LDLS NN TG IPS+IS +  LE LDLS N L G
Sbjct:   748 ELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVG 807

Query:   616 SIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAK 675
              +PG    +  L   +++ N+L+G +    QF  +   +F GN GLCG   S C+   +K
Sbjct:   808 EVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSK 865

Query:   676 LKPVIPSGSNSKFGPGSIIAIT-FSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRP 734
                     +     P +++ I+  S    IAL++ V +L   +       D   +  G  
Sbjct:   866 --------NQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNH-----DLFKKVRGGN 912

Query:   735 QRLSEALASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTK 793
                S   +SS+  LF N   K D+   D++++T+  N+  +IG GG G VYKA L NG  
Sbjct:   913 SAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGET 972

Query:   794 AAVKR-LSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND--RLLIYSYMENGSL 850
              AVK+ L  D     + F  EV+ L   +H++LV L GYC    D   LLIY YM NGS+
Sbjct:   973 IAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSV 1032

Query:   851 DYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE 908
               WLH  E+  K  VL W+ RLKIA G A+G+ YLH  C P IVHRD+KSSN+LLD   E
Sbjct:  1033 WDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIE 1092

Query:   909 AHLADFGLSRLLRP-YDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL 965
             AHL DFGL+++L   YDT+    T   G+ GYI PEY+ +L AT + DVYS G+VL+E++
Sbjct:  1093 AHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIV 1152

Query:   966 TGRRPVEVCKGKNCRDLVSWVFQMK-----SEKREVEIIDASIWH--KDREKQLLEMLEI 1018
             TG+ P E    +   D+V WV  +      SE RE ++ID+ +       E+   ++LEI
Sbjct:  1153 TGKMPTEAMFDEET-DMVRWVETVLDTPPGSEARE-KLIDSELKSLLPCEEEAAYQVLEI 1210

Query:  1019 ACKCIDQDPRRRPFIEEVVTWL 1040
             A +C    P+ RP   +   +L
Sbjct:  1211 ALQCTKSYPQERPSSRQASEYL 1232

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1208 (430.3 bits), Expect = 7.2e-123, P = 7.2e-123
 Identities = 339/970 (34%), Positives = 500/970 (51%)

Query:   108 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
             L+ LD+S N+    +P  L +   L+ LD+S N LSG  S  ++    ++ LN+SSN F 
Sbjct:   224 LEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 282

Query:   168 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSL 227
             G +  L    +L   +++ N FTG++   +  A   +  LDLS NHF G++     S SL
Sbjct:   283 GPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 341

Query:   228 -KQLHVDNNLLGGDLP-DSLYSMSSLQHVSLSVNNFSGQLSEKISNLT-SLRHLIIFGNQ 284
              + L + +N   G+LP D+L  M  L+ + LS N FSG+L E ++NL+ SL  L +  N 
Sbjct:   342 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 401

Query:   285 FSGK-LPNVLGNL--TQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNF 341
             FSG  LPN+  N   T  E ++ +                    L L  N L+G I  + 
Sbjct:   402 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS-LHLSFNYLSGTIPSSL 460

Query:   342 SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXX 401
               LS L  L L  N   G +P  L     L+ L L  N+L+G++P               
Sbjct:   461 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 520

Query:   402 XXXXXXXXGTLSV-LQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 460
                     G +   + + +NL  L L+ N     IP  +G   SL+ L L      G IP
Sbjct:   521 NNRLT---GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 577

Query:   461 VWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISS 520
               + +    Q   ++ N   G    +I           + N L  +  +S  +L  L + 
Sbjct:   578 AAMFK----QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS-EQLNRLSTR 632

Query:   521 NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLH 580
             N    N T+     +Y  H   T     N +  F   + +S N ++G IP EIG + +L 
Sbjct:   633 N--PCNITSR----VYGGHTSPT--FDNNGSMMF---LDMSYNMLSGYIPKEIGSMPYLF 681

Query:   581 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGT 640
             +L+L  N+I+G+IP  + ++R L +LDLSSN L G IP +   LT L++  ++NN+L G 
Sbjct:   682 ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 741

Query:   641 IPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAK--LKPVIPSGSNSKFGPGSI-IAIT 697
             IP  GQF +FP + F  NPGLCG     CD  +A          G       GS+ + + 
Sbjct:   742 IPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHGRRPASLAGSVAMGLL 801

Query:   698 FSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRP-QR-----------LSEALASSK 745
             FS      L+L    ++  RR     ++   E  G    R           + EAL S  
Sbjct:   802 FSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTGVKEAL-SIN 860

Query:   746 LVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ 805
             L  F+    + LT +DLL++TN F+  ++IG GGFG VYKA L +G+  A+K+L    GQ
Sbjct:   861 LAAFEKP-LRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQ 919

Query:   806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK 865
              +REF AE+E + + +H+NLV L GYC+ G++RLL+Y +M+ GSL+  LH+       L 
Sbjct:   920 GDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLN 979

Query:   866 WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 925
             W  R KIA G+ARGLA+LH  C PHI+HRD+KSSN+LLDE  EA ++DFG++RL+   DT
Sbjct:   980 WSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDT 1039

Query:   926 HVTTD-LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK-GKNCRDLV 983
             H++   L GT GY+PPEY Q+   + +GDVYS+GVVLLELLTG+RP +    G N  +LV
Sbjct:  1040 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDN--NLV 1097

Query:   984 SWVFQMKSEKREVEIIDASIWHKDR--EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              WV Q  ++ R  ++ D  +  +D   E +LL+ L++A  C+D    RRP + +V+    
Sbjct:  1098 GWVKQ-HAKLRISDVFDPELMKEDPALEIELLQHLKVAVACLDDRAWRRPTMVQVMAMFK 1156

Query:  1042 ----GIGIDA 1047
                 G GID+
Sbjct:  1157 EIQAGSGIDS 1166

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

GO:0010224 "response to UV-B" evidence=IGI

GO:0005768 "endosome" evidence=IDA

GO:0046982 "protein heterodimerization activity" evidence=IPI

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0010268 "brassinosteroid homeostasis" evidence=IEP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0043234 "protein complex" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0009911 "positive regulation of flower development" evidence=IGI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IEP;IMP

GO:0010584 "pollen exine formation" evidence=IMP

GO:0048657 "tapetal cell differentiation" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0005496 "steroid binding" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1204 (428.9 bits), Expect = 1.9e-122, P = 1.9e-122
 Identities = 323/966 (33%), Positives = 490/966 (50%)

Query:    84 VTMLILPRKGLKGIIPRSL-GHLNQLKLLDLSCNHLEGVVPVELS-NLKQLEVLDLSHNM 141
             +T L L   GL G +P +     + L  + LS N+  G +P +L  + K+L+ LDLS+N 
Sbjct:   129 LTHLELSSSGLIGTLPENFFSKYSNLISITLSYNNFTGKLPNDLFLSSKKLQTLDLSYNN 188

Query:   142 LSGPVSGMLAGLNLIQS---LNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRI 197
             ++GP+SG+   L+   S   L+ S NS +G + + L   +NL   N+S N+F G++  + 
Sbjct:   189 ITGPISGLTIPLSSCVSMTYLDFSGNSISGYISDSLINCTNLKSLNLSYNNFDGQI-PKS 247

Query:   198 WSASKEIQILDLSMNHFMGSLQGL--DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVS 255
             +   K +Q LDLS N   G +     D   SL+ L +  N   G +P+SL S S LQ + 
Sbjct:   248 FGELKLLQSLDLSHNRLTGWIPPEIGDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSLD 307

Query:   256 LSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFF-VAHXXXXXXXX 313
             LS NN SG     I  +  SL+ L++  N  SG  P  +     L     +         
Sbjct:   308 LSNNNISGPFPNTILRSFGSLQILLLSNNLISGDFPTSISACKSLRIADFSSNRFSGVIP 367

Query:   314 XXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 373
                         L L +N +TG I    S  S L T+DL+ N+ +G +P  + +   L+ 
Sbjct:   368 PDLCPGAASLEELRLPDNLVTGEIPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKLEQ 427

Query:   374 LSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSV-LQQCKNLTTLILTKNFVG 432
                  N ++G++P                       G +      C N+  +  T N + 
Sbjct:   428 FIAWYNNIAGEIPPEIGKLQNLKDLILNNNQLT---GEIPPEFFNCSNIEWVSFTSNRLT 484

Query:   433 EEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMEN 492
              E+P++ G    L VL LGN    G IP  L +C  L  LDL+ NH  G IPP +G+   
Sbjct:   485 GEVPKDFGILSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPG 544

Query:   493 LFYLD--FSNNTLT--GEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK--HNRSTNGL 546
                L    S NT+     +  S   +  L+  +     P     IP        R  +G 
Sbjct:   545 SKALSGLLSGNTMAFVRNVGNSCKGVGGLVEFS--GIRPERLLQIPSLKSCDFTRMYSGP 602

Query:   547 PYNQASSFPPSVFL--SNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLE 604
               +  + +    +L  S N++ G IP EIG++  L VL+LS N ++G IP +I +++NL 
Sbjct:   603 ILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSHNQLSGEIPFTIGQLKNLG 662

Query:   605 VLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGE 664
             V D S N L G IP SF  L+FL +  ++NN L G IP  GQ  + P + +  NPGLCG 
Sbjct:   663 VFDASDNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGV 722

Query:   665 IDSPCDSMHAKLKPVIPSGSNSKFGP------GSIIAITFSIGVGIALLLAVTLLKMSRR 718
                 C + + +L      G  +K G        SI+         + +L+   +   +RR
Sbjct:   723 PLPECKNGNNQLPAGTEEGKRAKHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARR 782

Query:   719 ---DSGCPIDDLDE----DMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQ 771
                D    +  L         + ++  E L S  +  FQ    + L  S L+++TN F+ 
Sbjct:   783 RDADDAKMLHSLQAVNSATTWKIEKEKEPL-SINVATFQRQ-LRKLKFSQLIEATNGFSA 840

Query:   772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
             A++IG GGFG V+KATL +G+  A+K+L     Q +REF AE+E L + +H+NLV L GY
Sbjct:   841 ASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 900

Query:   832 CRHGNDRLLIYSYMENGSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
             C+ G +RLL+Y +M+ GSL+  LH   + +K  +L W+ R KIA+GAA+GL +LH  C P
Sbjct:   901 CKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIP 960

Query:   890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTA 948
             HI+HRD+KSSN+LLD+  EA ++DFG++RL+   DTH++   L GT GY+PPEY Q+   
Sbjct:   961 HIIHRDMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 1020

Query:   949 TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008
             T +GDVYS GVV+LE+L+G+RP +  +  +  +LV W      E + +E+ID  +  +  
Sbjct:  1021 TAKGDVYSIGVVMLEILSGKRPTDKEEFGDT-NLVGWSKMKAREGKHMEVIDEDLLKEGS 1079

Query:  1009 EKQLLE 1014
              + L E
Sbjct:  1080 SESLNE 1085

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0010233 "phloem transport" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009734 "auxin mediated signaling pathway" evidence=RCA;IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FN37	PSKR2_ARATH	2, ., 7, ., 1, 1, ., 1	0.6647	0.9751	0.9864	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1048
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-118
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-34
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-20
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-04
COG5238	388	COG5238, RNA1, Ran GTPase-activating protein (RanG	3e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	6e-04
PLN03210	1153	PLN03210, PLN03210, Resistant to P	6e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.002
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.003
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.004
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  386 bits (993), Expect = e-118
 Identities = 291/1001 (29%), Positives = 475/1001 (47%), Gaps = 113/1001 (11%)

Query: 55   ITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLS 114
            +++W++ +  C W G+ C      +N+ RV  + L  K + G I  ++  L  ++ ++LS
Sbjct: 48   LSNWNSSADVCLWQGITC------NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLS 101

Query: 115  CNHLEGVVPVELSNL-KQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLF-E 172
             N L G +P ++      L  L+LS+N  +G +      +  +++L++S+N  +G +  +
Sbjct: 102  NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPND 159

Query: 173  LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHV 232
            +G FS+L V ++  N   GK+ + + + +                        SL+ L +
Sbjct: 160  IGSFSSLKVLDLGGNVLVGKIPNSLTNLT------------------------SLEFLTL 195

Query: 233  DNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV 292
             +N L G +P  L  M SL+ + L  NN SG++  +I  LTSL HL +  N  +G +P+ 
Sbjct: 196  ASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255

Query: 293  LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDL 352
            LGNL  L++   + N  SGP+P S+    KL  LDL +NSL+G I      L +L  L L
Sbjct: 256  LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL 315

Query: 353  ATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL 412
             +N+F+G +P +L+    L++L L  N+ SG++P++ GK  +L  L LS N+   L+G +
Sbjct: 316  FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN---LTGEI 372

Query: 413  -SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 471
               L    NL  LIL  N +  EIP+++G   SL  + L +    G +P    +   +  
Sbjct: 373  PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432

Query: 472  LDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSL--TELKSLISSNCTSSNPTA 529
            LD+S N+  G I      M +L  L  + N   G +P S     L++L  S         
Sbjct: 433  LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLS--------- 483

Query: 530  SAGIPLYVKHNRSTNGLPYNQASSFPP--SVFLSNNRINGTIPPEIGQLKHLHVLDLSRN 587
                      N+ +  +P  +  S      + LS N+++G IP E+   K L  LDLS N
Sbjct: 484  ---------RNQFSGAVP-RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533

Query: 588  NITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQF 647
             ++G IP+S SE+  L  LDLS N L G IP +   +  L + ++++NHL G++P+ G F
Sbjct: 534  QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF 593

Query: 648  YSFPNSSFEGNPGLCGEIDS----PCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVG 703
             +   S+  GN  LCG   +    PC       K V  +       P     IT ++G  
Sbjct: 594  LAINASAVAGNIDLCGGDTTSGLPPC-------KRVRKT-------PSWWFYITCTLGAF 639

Query: 704  IALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLL 763
            + L L        R  +   +  ++ + G          + +L  F +   K +T++D+L
Sbjct: 640  LVLALVAFGFVFIRGRNNLELKRVENEDG----------TWELQFFDSKVSKSITINDIL 689

Query: 764  KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
             S     + N+I  G  G  YK  ++ NG +  VK ++ D   +     A++  L   QH
Sbjct: 690  SSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIADMGKL---QH 742

Query: 823  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
             N+V L G CR      LI+ Y+E  +L   L         L W+ R KIA G A+ L +
Sbjct: 743  PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRF 795

Query: 883  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
            LH  C P +V  ++    I++D K E HL      RL  P      T    +  Y+ PE 
Sbjct: 796  LHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPET 849

Query: 943  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002
             +T   T + D+Y FG++L+ELLTG+ P +   G +   +V W     S+      ID S
Sbjct: 850  RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWIDPS 908

Query: 1003 IWHKD--REKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
            I       + +++E++ +A  C   DP  RP   +V+  L+
Sbjct: 909  IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (420), Expect = 7e-46
 Identities = 87/270 (32%), Positives = 122/270 (45%), Gaps = 26/270 (9%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
             +G G FG VYKA     G   AVK L    +  + ++  + E+  L R  H N+V L  
Sbjct: 6    KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 831  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                 +   L+  Y E G L  +L         L  D   KIA    RGL YLH      
Sbjct: 66   AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE---YSQTLT 947
            I+HRD+K  NILLDE     +ADFGL++      +   T  VGT  Y+ PE         
Sbjct: 119  IIHRDLKPENILLDENGVVKIADFGLAK-KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 948  ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007
                 DV+S GV+L ELLTG+ P     G+N  D +  + ++     E +      W   
Sbjct: 178  PKV--DVWSLGVILYELLTGKPP---FSGENILDQLQLIRRILGPPLEFDE---PKWSSG 229

Query: 1008 REKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             E    E  ++  KC+++DP +RP  EE++
Sbjct: 230  SE----EAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  163 bits (415), Expect = 1e-45
 Identities = 79/224 (35%), Positives = 104/224 (46%), Gaps = 23/224 (10%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
           +G GGFG VY A     G K A+K +   D   +  E   E+E L +  H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 833 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
              N   L+  Y E GSL   L E    +  L  D  L+I      GL YLH      I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 893 HRDVKSSNILLDEK-FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQTLTATC 950
           HRD+K  NILLD    +  LADFGLS+LL   D  +   +VGT  Y+ PE        + 
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 951 RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 994
           + D++S GV+L EL               +DL+  + Q   EKR
Sbjct: 174 KSDIWSLGVILYEL------------PELKDLIRKMLQKDPEKR 205

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  161 bits (409), Expect = 2e-44
 Identities = 78/272 (28%), Positives = 112/272 (41%), Gaps = 36/272 (13%)

Query: 773  NIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
              +G G FG VY A     G   A+K +      +       E++ L + +H N+V L  
Sbjct: 5    EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 831  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                 +   L+  Y E G L   L +   +  + + + R  + Q     L YLH      
Sbjct: 65   VFEDEDKLYLVMEYCEGGDLFDLLKK---RGRLSEDEARFYLRQ-ILSALEYLHSK---G 117

Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE------YSQ 944
            IVHRD+K  NILLDE     LADFGL+R L P      T  VGT  Y+ PE      Y  
Sbjct: 118  IVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYG- 174

Query: 945  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004
                    D++S GV+L ELLTG+ P          D +  +F+   + +          
Sbjct: 175  -----KAVDIWSLGVILYELLTGKPPFP------GDDQLLELFKKIGKPKPPFPPPEWDI 223

Query: 1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
              +  K L+       K + +DP +R   EE 
Sbjct: 224  SPE-AKDLIR------KLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  154 bits (392), Expect = 4e-42
 Identities = 75/274 (27%), Positives = 113/274 (41%), Gaps = 29/274 (10%)

Query: 774  IIGCGGFGLVYKATLTNGTKA-----AVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 827
             +G G FG VYK  L           AVK L  D   Q   EF  E   + +  H N+V 
Sbjct: 6    KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
            L G C       ++  YME G L  +L         L     L  A   ARG+ YL    
Sbjct: 66   LLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 888  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 947
              + +HRD+ + N L+ E     ++DFGLSR L   D +        + ++ PE  +   
Sbjct: 122  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 948  ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
             T + DV+SFGV+L E+ T G +P     G +  +++ ++       +            
Sbjct: 180  FTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLEYLKNGYRLPQPPNCPP------ 230

Query: 1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                   E+ ++  +C  +DP  RP   E+V  L
Sbjct: 231  -------ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  153 bits (388), Expect = 1e-41
 Identities = 78/277 (28%), Positives = 119/277 (42%), Gaps = 34/277 (12%)

Query: 774  IIGCGGFGLVYKATLTNG-----TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 827
             +G G FG VYK TL         + AVK L  D   Q   EF  E   + +  H N+V 
Sbjct: 6    KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
            L G C      +++  YM  G L  +L ++  +   L     L  A   ARG+ YL    
Sbjct: 66   LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 888  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 947
              + +HRD+ + N L+ E     ++DFGLSR L   D +        + ++ PE  +   
Sbjct: 123  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 948  ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
             T + DV+SFGV+L E+ T G  P     G +  +++ ++   K   R            
Sbjct: 181  FTSKSDVWSFGVLLWEIFTLGEEPYP---GMSNAEVLEYL---KKGYR------------ 222

Query: 1007 DREKQLL---EMLEIACKCIDQDPRRRPFIEEVVTWL 1040
               K      E+ ++  +C  +DP  RP   E+V  L
Sbjct: 223  -LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  151 bits (385), Expect = 4e-41
 Identities = 79/285 (27%), Positives = 118/285 (41%), Gaps = 58/285 (20%)

Query: 775  IGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSL 828
            +G G FG VYK TL        TK AVK L     + ER EF  E   + +  H N+V L
Sbjct: 7    LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
             G C  G    ++  YM  G L  +L         L     L++A   A+G+ YL     
Sbjct: 67   LGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK-- 121

Query: 889  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE-- 941
             + VHRD+ + N L+ E     ++DFGLSR +   D +         G +P     PE  
Sbjct: 122  -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR----KRGGGKLPIKWMAPESL 176

Query: 942  -YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 999
               +  + +   DV+SFGV+L E+ T G +P     G +  +++  +             
Sbjct: 177  KDGKFTSKS---DVWSFGVLLWEIFTLGEQP---YPGMSNEEVLELL------------- 217

Query: 1000 DASIWHKDREKQLL-------EMLEIACKCIDQDPRRRPFIEEVV 1037
                   +   +L        E+ E+  +C   DP  RP   E+V
Sbjct: 218  -------EDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  143 bits (362), Expect = 5e-38
 Identities = 83/281 (29%), Positives = 121/281 (43%), Gaps = 39/281 (13%)

Query: 773  NIIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
              +G G FG VYK  L       T+ AVK L  D  + ER +F  E   + +  H N+V 
Sbjct: 1    KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHES-----VDKDSVLKWDVRLKIAQGAARGLAY 882
            L G C       L+  YME G L  +L +S       + S L     L  A   A+G+ Y
Sbjct: 61   LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 883  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP--- 939
            L        VHRD+ + N L+ E     ++DFGLSR +   D +       T G +P   
Sbjct: 121  LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173

Query: 940  --PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
              PE  +    T + DV+SFGV+L E+ T G  P     G +  +++ ++       R+ 
Sbjct: 174  MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP---GLSNEEVLEYL-------RKG 223

Query: 997  EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
              +    +  D      E+ E+   C   DP  RP   E+V
Sbjct: 224  YRLPKPEYCPD------ELYELMLSCWQLDPEDRPTFSELV 258

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (331), Expect = 6e-34
 Identities = 69/211 (32%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 773 NIIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
            ++G G FG VY A     G   AVK   LSGD  +     + E+  LS  QH N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 830 GYCRH-GNDRLLIY-SYMENGSL-----DYW-LHESVDKDSVLKWDVRLKIAQGAARGLA 881
           G  R    + L I+  Y+  GSL      +  L E V         +R    Q    GLA
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---------IRKYTRQ-ILEGLA 115

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGYIPP 940
           YLH      IVHRD+K +NIL+D      LADFG ++ L        T  + GT  ++ P
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 941 E-YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E            D++S G  ++E+ TG+ P
Sbjct: 173 EVIRGEE-YGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  124 bits (313), Expect = 2e-31
 Identities = 83/294 (28%), Positives = 124/294 (42%), Gaps = 65/294 (22%)

Query: 773  NIIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVS 827
             +IG G FG V +  L    K     A+K L +G   +   +F  E   + +  H N++ 
Sbjct: 10   KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
            L+G        ++I  YMENGSLD +L E    D        + + +G A G+ YL ++ 
Sbjct: 70   LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 888  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEY 942
                VHRD+ + NIL++      ++DFGLSR L   +   TT   G  G IP     PE 
Sbjct: 127  ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--G--GKIPIRWTAPEA 179

Query: 943  SQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001
                  T   DV+SFG+V+ E+++ G RP                 Q        ++I A
Sbjct: 180  IAYRKFTSASDVWSFGIVMWEVMSYGERPYW-----------DMSNQ--------DVIKA 220

Query: 1002 --------------SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                          S  +     QL  ML+    C  +D   RP   ++V+ LD
Sbjct: 221  VEDGYRLPPPMDCPSALY-----QL--MLD----CWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (296), Expect = 2e-29
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG GGFG VYKA     G + A+K +  +  + + +   E++ L + +H N+V   G   
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SY 66

Query: 834 HGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLK------IAQGAARGLAYLHKV 886
              D L ++  +   GSL         KD +   +  L       + +   +GL YLH  
Sbjct: 67  LKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
               I+HRD+K++NILL    E  L DFGLS  L   DT     +VGT  ++ PE     
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGK 172

Query: 947 TATCRGDVYSFGVVLLELLTGRRP 970
               + D++S G+  +EL  G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (298), Expect = 9e-29
 Identities = 74/270 (27%), Positives = 112/270 (41%), Gaps = 23/270 (8%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGD---CGQMEREFQAEVEALSRAQH-KNLVSLQG 830
            +G G FG VY A        A+K L+       +    F  E++ L+   H  N+V L  
Sbjct: 8    LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 831  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
            + +      L+  Y++ GSL+  L +   K   L     L I       L YLH      
Sbjct: 66   FFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH---SKG 121

Query: 891  IVHRDVKSSNILLDEK-FEAHLADFGLSRLLRPYDTHV-----TTDLVGTLGYIPPEYSQ 944
            I+HRD+K  NILLD       L DFGL++LL    +        +  VGT GY+ PE   
Sbjct: 122  IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 945  TLT---ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001
             L+   A+   D++S G+ L ELLTG  P E  K  +              +     + +
Sbjct: 182  GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----KIILELPTPSLAS 237

Query: 1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031
             +   + E       ++  K + +DP+ R 
Sbjct: 238  PLSPSNPELISKAASDLLKKLLAKDPKNRL 267

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  111 bits (280), Expect = 4e-27
 Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 36/222 (16%)

Query: 775 IGCGGFGLVYKATLTNG------TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 827
           +G G FG V+     +          AVK L         ++F+ E E L+  QH+N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR-----------LKIAQGA 876
             G C  G+  ++++ YME+G L+ +L  S   D+                  L+IA   
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFL-RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
           A G+ YL      H VHRD+ + N L+       + DFG+SR     D + TTD     G
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVY-TTDYYRVGG 182

Query: 937 -------YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                  ++PPE       T   DV+SFGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  111 bits (279), Expect = 4e-27
 Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 27/262 (10%)

Query: 775  IGCGGFGLVYKATL-TNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSLQG-Y 831
            +G G  G+VYK      G   A+K++      +  ++   E++ L   +   +V   G +
Sbjct: 9    LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
             + G   +++  YM+ GSL   L + V K  + VL       IA+   +GL YLH   + 
Sbjct: 69   YKEGEISIVL-EYMDGGSLAD-LLKKVGKIPEPVLA-----YIARQILKGLDYLHT--KR 119

Query: 890  HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            HI+HRD+K SN+L++ K E  +ADFG+S++L        T  VGT+ Y+ PE  Q  + +
Sbjct: 120  HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQGESYS 178

Query: 950  CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE 1009
               D++S G+ LLE   G+ P       +  +L+  +         +   + S       
Sbjct: 179  YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI--CDGPPPSLPAEEFSP------ 230

Query: 1010 KQLLEMLEIACKCIDQDPRRRP 1031
                E  +    C+ +DP++RP
Sbjct: 231  ----EFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  110 bits (277), Expect = 8e-27
 Identities = 77/281 (27%), Positives = 119/281 (42%), Gaps = 55/281 (19%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKR--LSGDCGQMEREF-QAEVEALSRAQHKNLVSLQG 830
            IG G FG VY     ++G    +K   LS    + ERE    EV+ L +  H N++    
Sbjct: 8    IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIK--- 63

Query: 831  YCRH--GNDRLLI-YSYMENGSLDYWLHESVDK------DSVLKWDVRLKIAQGAARGLA 881
            Y        +L I   Y + G L   + +   +      + +L W V+L +A      L 
Sbjct: 64   YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LK 117

Query: 882  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
            YLH      I+HRD+K  NI L       L DFG+S++L      +   +VGT  Y+ PE
Sbjct: 118  YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYYLSPE 173

Query: 942  ------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
                  Y+       + D++S G VL EL T + P E   G+N  +L      +K  K +
Sbjct: 174  LCQNKPYNY------KSDIWSLGCVLYELCTLKHPFE---GENLLELA-----LKILKGQ 219

Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
               I +   +    + L+         + +DP  RP I ++
Sbjct: 220  YPPIPSQ--YSSELRNLVS------SLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-26
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)

Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLS--GDCGQMEREFQAEVEALSRAQHKN 824
           N+   ++IG G FG+VYK   L  G   A+K++S      +  +    E++ L   +H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAAR 878
           +V   G     +   +I  Y ENGSL   +       ES+         V + + Q   +
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---------VAVYVYQ-VLQ 110

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GLAYLH   E  ++HRD+K++NIL  +     LADFG++  L          +VGT  ++
Sbjct: 111 GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWM 166

Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            PE  +   A+   D++S G  ++ELLTG  P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  108 bits (271), Expect = 4e-26
 Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 7/205 (3%)

Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           F     +G G FG V++    N  + A+K L  D    +++FQ EV+AL R +HK+L+SL
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
              C  G    +I   ME GSL  +L     +  VL     + +A   A G+AYL    E
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ--VLPVASLIDMACQVAEGMAYLE---E 122

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA 948
            + +HRD+ + NIL+ E     +ADFGL+RL++  D ++++D      +  PE +   T 
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHGTF 181

Query: 949 TCRGDVYSFGVVLLELLT-GRRPVE 972
           + + DV+SFG++L E+ T G+ P  
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYP 206

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  108 bits (272), Expect = 5e-26
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)

Query: 773 NIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLV 826
             +G G FG V            G + AVK L+     Q   +F+ E+E L    H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 827 SLQGYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
             +G C    G    LI  Y+ +GSL  +L    D+ ++ +    L  +    +G+ YL 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR---LLLFSSQICKGMDYLG 126

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP----- 939
                  +HRD+ + NIL++ +    ++DFGL+++L     +     V   G  P     
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY---VKEPGESPIFWYA 180

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE  +T   +   DV+SFGV L EL T   P
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (270), Expect = 8e-26
 Identities = 77/268 (28%), Positives = 123/268 (45%), Gaps = 30/268 (11%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
            +G G  G+V K      G   AVK  RL  +   ++++   E++ L +     +V   G 
Sbjct: 9    LGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
              +  D  +   YM+ GSLD  L E   +  + +L      KIA    +GL YLH+    
Sbjct: 68   FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKH-- 120

Query: 890  HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
             I+HRDVK SNIL++ + +  L DFG+S  L   ++   T  VGT  Y+ PE  Q    +
Sbjct: 121  KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF-VGTSSYMAPERIQGNDYS 177

Query: 950  CRGDVYSFGVVLLELLTGRRPV--EVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007
             + D++S G+ L+EL TGR P   E        +L+ ++      +     + +  +  D
Sbjct: 178  VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR-----LPSGKFSPD 232

Query: 1008 REKQLLEMLEIACKCIDQDPRRRPFIEE 1035
                     +    C+ +DPR RP  +E
Sbjct: 233  -------FQDFVNLCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (265), Expect = 3e-25
 Identities = 70/209 (33%), Positives = 95/209 (45%), Gaps = 16/209 (7%)

Query: 771 QANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVS 827
           + N IG G FG VY A  L  G   AVK  R+  +  +  +E   E++ L   +H NLV 
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
             G   H     +   Y   G+L+  L      D  +   +R+   Q    GLAYLH   
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---IRVYTLQ-LLEGLAYLH--- 116

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT---DLVGTLGYIPPEYSQ 944
              IVHRD+K +NI LD      L DFG +  L+   T +      L GT  Y+ PE   
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 945 TLTATCRG---DVYSFGVVLLELLTGRRP 970
                  G   D++S G V+LE+ TG+RP
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  104 bits (260), Expect = 1e-24
 Identities = 65/214 (30%), Positives = 111/214 (51%), Gaps = 14/214 (6%)

Query: 765 STNNFNQANIIGCGGFGLVYKATL-TNGTK---AAVKRLSGDCGQMER-EFQAEVEALSR 819
             ++  +  +IG G FG V++  L   G K    A+K L     + +R +F +E   + +
Sbjct: 3   HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ 62

Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
             H N++ L+G        ++I  YMENG+LD +L +   + S  +    + + +G A G
Sbjct: 63  FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAG 119

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGY 937
           + YL    + + VHRD+ + NIL++   E  ++DFGLSR+L   P  T+ T+     + +
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
             PE       T   DV+SFG+V+ E+++ G RP
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 2e-24
 Identities = 76/264 (28%), Positives = 117/264 (44%), Gaps = 29/264 (10%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    TK AVK L    G M  E F  E + + + +H  LV L   C 
Sbjct: 14   LGAGQFGEVWMGTWNGTTKVAVKTLKP--GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L     +   L+    + +A   A G+AYL      + +H
Sbjct: 72   EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
            RD+ + NIL+ E     +ADFGL+RL+    Y           + +  PE +     T +
Sbjct: 127  RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184

Query: 952  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010
             DV+SFG++L E++T GR P     G   R+++  V +     R     +          
Sbjct: 185  SDVWSFGILLTEIVTYGRVPYP---GMTNREVLEQVERGYRMPRPPNCPE---------- 231

Query: 1011 QLLEMLEIACKCIDQDPRRRPFIE 1034
               E+ ++  +C D+DP  RP  E
Sbjct: 232  ---ELYDLMLQCWDKDPEERPTFE 252

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  103 bits (259), Expect = 3e-24
 Identities = 73/271 (26%), Positives = 117/271 (43%), Gaps = 19/271 (7%)

Query: 767  NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKN 824
                + + +G G  G V K  L   G   A+K ++ D     +++   E+E     +   
Sbjct: 1    EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 825  LVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
            +V   G     +   +     Y E GSLD    +   +   +   V  KIA+   +GL+Y
Sbjct: 61   IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 883  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
            LH      I+HRD+K SNILL  K +  L DFG+S  L      +     GT  Y+ PE 
Sbjct: 121  LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPER 174

Query: 943  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR--DLVSWVFQMKSEKREVEIID 1000
             Q    +   DV+S G+ LLE+   R P            +L+S++  M + + + E  +
Sbjct: 175  IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031
               W +       E  +   +C+++DP RRP
Sbjct: 235  GIKWSE-------EFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 8e-24
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 39/215 (18%)

Query: 773 NIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE---FQA--EVEALSRAQHKNLV 826
             IG G +G VYKA     G   A+K++  +    E+E     A  E++ L + +H N+V
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRME---NEKEGFPITAIREIKLLQKLRHPNIV 61

Query: 827 SLQGYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR------ 878
            L+     +      +++ YM++           D   +L     +K  +   +      
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDH-----------DLTGLLD-SPEVKFTESQIKCYMKQL 109

Query: 879 --GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
             GL YLH      I+HRD+K SNIL++      LADFGL+R     ++   T+ V TL 
Sbjct: 110 LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166

Query: 937 YIPPEYSQTLTATCRG---DVYSFGVVLLELLTGR 968
           Y PPE    L AT  G   D++S G +L EL  G+
Sbjct: 167 YRPPEL--LLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  101 bits (254), Expect = 9e-24
 Identities = 63/234 (26%), Positives = 95/234 (40%), Gaps = 21/234 (8%)

Query: 768 NFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLS-GDCGQME--REFQAEVEALSRAQHK 823
           +F    +IG G FG V            A+K ++   C +    R    E   L    H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAARGLA 881
            LV+L    +   +  L+   +  G L Y L + V   ++ V  W   + +A      L 
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA------LE 114

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           YLH      I+HRD+K  NILLDE+   H+ DF ++  + P    +TT   GT GY+ PE
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--DTLTTSTSGTPGYMAPE 169

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
                  +   D +S GV   E L G+RP       + R +   +   +     
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYR----GHSRTIRDQIRAKQETADV 219

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 3e-23
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V++    N T  AVK L    G M+ ++F AE + + + +H  L+ L   C 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 ++   M+ GSL  +L         LK    + +A   A G+AYL      + +H
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLE---AQNYIH 126

Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N+L+ E     +ADFGL+R+++   Y+          + +  PE +     + +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184

Query: 952 GDVYSFGVVLLELLT-GRRP 970
            DV+SFG++L E++T GR P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG V       G K AVK L  D     + F AE   ++  +H NLV L G    
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
           GN   ++  YM  GSL  +L       +V+    +L  A     G+ YL    E + VHR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126

Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL--GYIPPEYSQTLTATCRG 952
           D+ + N+L+ E   A ++DFGL++     +     D  G L   +  PE  +    + + 
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQD-SGKLPVKWTAPEALREKKFSTKS 180

Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 99.9 bits (249), Expect = 2e-22
 Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 31/216 (14%)

Query: 773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQG 830
           N IG G  G VYK      G   A+K + G+    + R+   E+E L    H N+V    
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 831 YCRHGNDRLLIYSYMENGSLD--YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
              H  +  ++  +M+ GSL+  +   E    D          +A+    G+AYLH+   
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD----------VARQILSGIAYLHR--- 186

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTLGYIPPEYSQ 944
            HIVHRD+K SN+L++      +ADFG+SR+L       T D     VGT+ Y+ PE   
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ-----TMDPCNSSVGTIAYMSPERIN 241

Query: 945 T-----LTATCRGDVYSFGVVLLELLTGRRPVEVCK 975
           T           GD++S GV +LE   GR P  V +
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 96.9 bits (241), Expect = 5e-22
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 16/207 (7%)

Query: 774 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +IG G FG V +  L    K     A+K L SG   +  R+F +E   + +  H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           +G        ++I  +MENG+LD +L ++  + +V++    + + +G A G+ YL    E
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL---SE 124

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLG--YIPPEYSQ 944
            + VHRD+ + NIL++      ++DFGLSR L     D   T+ L G +   +  PE   
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 945 TLTATCRGDVYSFGVVLLELLT-GRRP 970
               T   DV+S+G+V+ E+++ G RP
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.0 bits (240), Expect = 6e-22
 Identities = 60/204 (29%), Positives = 85/204 (41%), Gaps = 20/204 (9%)

Query: 775 IGCGGFGLVY--KATLTNGT---KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V   +   T      K   K+      ++E     E   LSR  H  +V L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59

Query: 830 GYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            Y     ++L L+  Y   G L   L +        +   R   A+     L YLH +  
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAE-IVLALEYLHSL-- 112

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY--SQTL 946
             I++RD+K  NILLD      L DFGL++ L   +   T    GT  Y+ PE    +  
Sbjct: 113 -GIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGKGY 170

Query: 947 TATCRGDVYSFGVVLLELLTGRRP 970
                 D +S GV+L E+LTG+ P
Sbjct: 171 GKAV--DWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.0 bits (239), Expect = 7e-22
 Identities = 82/269 (30%), Positives = 123/269 (45%), Gaps = 33/269 (12%)

Query: 775  IGCGGFGLVYKA-TLTNGTKAAVKRLS-GDCGQMERE----FQAEVEALSRAQHKNLVSL 828
            +G G FG VY+   L +G   AVK +S  D GQ  +E     + E+  LS+ QH N+V  
Sbjct: 8    LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 829  QGYCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
             G  R   D L I+   +  GSL   L +       +   +RL   Q    GL YLH   
Sbjct: 68   LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQ-ILLGLEYLH--- 119

Query: 888  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY-SQTL 946
            + + VHRD+K +NIL+D      LADFG+++ +  +         G+  ++ PE  +Q  
Sbjct: 120  DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQG 177

Query: 947  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
                  D++S G  +LE+ TG+ P    +G      V+ VF++   K    I D    H 
Sbjct: 178  GYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPPIPD----HL 227

Query: 1007 DREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              E +   +     KC+ +DP  RP   E
Sbjct: 228  SDEAKDFIL-----KCLQRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 825
            N  +   IG G  G VYKAT    G + A+K++       E     E+  +   +H N+
Sbjct: 22  KNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNI 77

Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA------RG 879
           V        G++  ++  YM+ GSL          D + +  VR+   Q A       +G
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQIAYVCREVLQG 128

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L YLH     +++HRD+KS NILL +     LADFG +  L    +   + +VGT  ++ 
Sbjct: 129 LEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMA 184

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE  +      + D++S G++ +E+  G  P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 95.3 bits (237), Expect = 2e-21
 Identities = 69/227 (30%), Positives = 98/227 (43%), Gaps = 31/227 (13%)

Query: 767 NNFNQANIIGCGGFGLVYKAT---LTNG---TKAAVKRLSGDCG-QMEREFQAEVEALSR 819
           NN      IG G FG V++A    L      T  AVK L  +    M+ +FQ E   ++ 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD--------YWLHESVDKDSV-------- 863
             H N+V L G C  G    L++ YM  G L+                  S         
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 864 --LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 921
             L    +L IA+  A G+AYL    E   VHRD+ + N L+ E     +ADFGLSR + 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 922 PYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
             D +     D +  + ++PPE       T   DV+++GVVL E+ +
Sbjct: 182 SADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 46/282 (16%)

Query: 769  FNQANIIGCGGFGLVYKATLT-NGTKA----AVKRLSGDCG-QMEREFQAEVEALSRAQH 822
              +  ++G G FG VYK      G K     A+K L  +   +  +E   E   ++   H
Sbjct: 9    LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 823  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKIAQGAARG 879
             ++V L G C   +   LI   M  G L  ++    D      +L W V++      A+G
Sbjct: 69   PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121

Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
            ++YL    E  +VHRD+ + N+L+       + DFGL++LL   +     +     G +P
Sbjct: 122  MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE----GGKVP 174

Query: 940  -----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 993
                  E       T + DV+S+GV + EL+T G +P E        DL+      K E+
Sbjct: 175  IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-----KGER 229

Query: 994  REV-EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIE 1034
                 I    ++          M+ + C  ID + R   F E
Sbjct: 230  LPQPPICTIDVY----------MVLVKCWMIDAESRPT-FKE 260

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 93.4 bits (232), Expect = 6e-21
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 10/198 (5%)

Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK A+K L    G M  E F AE   + + QH  LV L     
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  YMENGSL  +L     +   L  +  + +A   A G+A++      + +H
Sbjct: 72  Q-EPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD++++NIL+ E     +ADFGL+RL+   +          + +  PE     T T + D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 954 VYSFGVVLLELLT-GRRP 970
           V+SFG++L E++T GR P
Sbjct: 186 VWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.0 bits (233), Expect = 7e-21
 Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 38/288 (13%)

Query: 775  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G G FG V+ A   N          AVK L        ++F  E E L+  QH+++V  
Sbjct: 13   LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD----------VRLKIAQGAAR 878
             G C  G+  ++++ YM++G L+ +L      D+VL  +            L IAQ  A 
Sbjct: 73   YGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 879  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGY 937
            G+ YL      H VHRD+ + N L+ E     + DFG+SR +   D + V    +  + +
Sbjct: 132  GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
            +PPE       T   DV+S GVVL E+ T G++P              W +Q+ + +   
Sbjct: 189  MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------W-YQLSNNEVIE 233

Query: 997  EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044
             I    +  + R     E+ ++   C  ++P  R  I+E+ + L  + 
Sbjct: 234  CITQGRVLQRPRTCP-KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.5 bits (232), Expect = 1e-20
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 45/293 (15%)

Query: 775  IGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G G FG V+ A   N +        AVK L        ++FQ E E L+  QH+++V  
Sbjct: 13   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLH------------ESVDKDSVLKWDVRLKIAQGA 876
             G C  G+  ++++ YM++G L+ +L             +       L     L IA   
Sbjct: 73   YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 877  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTL 935
            A G+ YL      H VHRD+ + N L+       + DFG+SR +   D + V    +  +
Sbjct: 133  ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 936  GYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKR 994
             ++PPE       T   DV+SFGV+L E+ T G++P              W FQ+ +   
Sbjct: 190  RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------W-FQLSNT-- 232

Query: 995  EVEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044
              E+I+     +  E+  +   E+ +I   C  ++P++R  I+E+   L  +G
Sbjct: 233  --EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 93.1 bits (231), Expect = 1e-20
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-----------WDVRLKIAQGAA 877
            G C  G   L+++ YM +G L+ +L        +L                L IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLG 936
            G+ YL  +   H VHRD+ + N L+ +     + DFG+SR +   D + V    +  + 
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
           ++PPE       T   D++SFGVVL E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 31/270 (11%)

Query: 768  NFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEV--EA--LSRAQH 822
            +F   N IG G FG+V+K     +    A+K++  D  +M R  + E   EA  L++   
Sbjct: 1    DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQI--DLSKMNRREREEAIDEARVLAKLDS 58

Query: 823  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
              ++             ++  Y ENG L   L     +   L  D   +       GLA+
Sbjct: 59   SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAH 116

Query: 883  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
            LH      I+HRD+KS N+ LD      + D G+++LL   +T+    +VGT  Y+ PE 
Sbjct: 117  LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPEL 172

Query: 943  SQTLTATCRGDVYSFGVVLLELLTGRRPVEV-CKGKNCRDLVSWVFQMKSEKREVEIIDA 1001
             +      + DV++ GVVL E  TG+ P +   +G     ++  VF   S+    ++   
Sbjct: 173  CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQ- 231

Query: 1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031
                            +  +C+ +D R+RP
Sbjct: 232  ----------------LIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 72/291 (24%), Positives = 115/291 (39%), Gaps = 66/291 (22%)

Query: 773  NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQM-EREFQ---AEVEALSRAQHKNLVS 827
              IG G FG V K    ++G     K +  D G M E+E Q   +EV  L   +H N+V 
Sbjct: 6    ETIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKHPNIV- 62

Query: 828  LQGYCRHGNDR--LLIYSYME---NGSLD------YWLHESVDKDSVLKWDVRLKIAQGA 876
               Y     DR    +Y  ME    G L           + ++++ + +   +L +A   
Sbjct: 63   --RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA--- 117

Query: 877  ARGLAYLH--KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               L   H        ++HRD+K +NI LD      L DFGL+++L  +D+      VGT
Sbjct: 118  ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYVGT 173

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP----------VEVCKGKNCRDLVS 984
              Y+ PE    ++   + D++S G ++ EL     P           ++ +GK  R +  
Sbjct: 174  PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-FRRIPY 232

Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
                  S                      E+ E+    ++ DP +RP  EE
Sbjct: 233  ----RYSS---------------------ELNEVIKSMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 30/207 (14%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLS------GDCGQMEREFQAEVEALSRAQHKNLVS 827
           IG G +G+VYKA     G   A+K++       G      RE    ++ L    H N++ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE----IKLLKELNHPNIIK 62

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L    RH  D  L++ +M+            D+   L   +         +GLA+ H   
Sbjct: 63  LLDVFRHKGDLYLVFEFMDTD----LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS-- 116

Query: 888 EPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
             H I+HRD+K  N+L++ +    LADFGL+R          T  V T  Y  PE    L
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPE----L 169

Query: 947 TATCRG-----DVYSFGVVLLELLTGR 968
               +G     D++S G +  ELL+ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.5 bits (227), Expect = 3e-20
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 774 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +IG G FG V    L    K     A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           +G        +++  YMENGSLD +L +   + +V++    + + +G A G+ YL  +  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLSDM-- 125

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIP-----PE 941
              VHRD+ + NIL++      ++DFGLSR+L   P   + T       G IP     PE
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG-----GKIPIRWTAPE 179

Query: 942 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                  T   DV+S+G+V+ E+++ G RP
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 24/217 (11%)

Query: 775 IGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 827
           +G G FG VYK  LT      + T  A+K L  +   ++++EF+ E E +S  QH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWL-----HESV-------DKDSVLKWDVRLKIAQG 875
           L G C       +++ Y+ +G L  +L     H  V          S L     L IA  
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGT 934
            A G+ YL      H VHRD+ + N L+ E     ++DFGLSR +   D + V +  +  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
           + ++PPE       T   D++SFGVVL E+ + G +P
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 95.7 bits (238), Expect = 4e-20
 Identities = 60/184 (32%), Positives = 87/184 (47%), Gaps = 30/184 (16%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
           L N  + G IP +I +L+HL  ++LS N+I G IP S+  I +LEVLDLS N  +GSIP 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 620 SFEKLTFLSKFSVANNHLQGTIPT--GGQFYSFPNSSFEGNPGLCGEIDS--PCDSMHAK 675
           S  +LT L   ++  N L G +P   GG+     + +F  N GLCG I     C      
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IPGLRACG----- 538

Query: 676 LKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQ 735
             P +  G+         I I F + V    L+   +    RR          +++ R Q
Sbjct: 539 --PHLSVGAK--------IGIAFGVSVAFLFLVICAMCWWKRR----------QNILRAQ 578

Query: 736 RLSE 739
           R++ 
Sbjct: 579 RIAA 582

Length = 623

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 10/204 (4%)

Query: 773 NIIGCGGFGLVYKA-TLTNGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQG 830
            +IG G   +VY A  L N  K A+KR+  + C     E + EV+A+S+  H N+V    
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
               G++  L+  Y+  GSL   + +S      L   +   + +   +GL YLH      
Sbjct: 67  SFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQ 123

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYD--THVTTDLVGTLGYIPPE-YSQTL 946
           I HRD+K+ NILL E     +ADFG+S  L    D    V    VGT  ++ PE   Q  
Sbjct: 124 I-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 947 TATCRGDVYSFGVVLLELLTGRRP 970
               + D++SFG+  +EL TG  P
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.8 bits (226), Expect = 7e-20
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 39/212 (18%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSG----DCG--QMEREFQAEVEALSRAQHKNLVS 827
           IG G  G+V+KA     G   A+K+++          Q  RE    ++AL   QH  +V 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVK 63

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR--------G 879
           L     HG+  +L+  YM +      L E      VL+ D    + +   +        G
Sbjct: 64  LLDVFPHGSGFVLVMEYMPSD-----LSE------VLR-DEERPLPEAQVKSYMRMLLKG 111

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           +AY+H      I+HRD+K +N+L+       +ADFGL+RL    +  + +  V T  Y  
Sbjct: 112 VAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRA 168

Query: 940 PEY---SQTLTATCRGDVYSFGVVLLELLTGR 968
           PE    ++        D+++ G +  ELL G 
Sbjct: 169 PELLYGARKYDPGV--DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 18/202 (8%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVKRLS--GDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
            +G G +G VYKA     G   A+K +    D  ++ +E       L +     +V   G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISI----LKQCDSPYIVKYYG 65

Query: 831 YCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
                 D  ++  Y   GS  D  + +  +K   L  +    I     +GL YLH     
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSD--IMKITNK--TLTEEEIAAILYQTLKGLEYLHSN--- 118

Query: 890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTA 948
             +HRD+K+ NILL+E+ +A LADFG+S  L   DT    + ++GT  ++ PE  Q +  
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 949 TCRGDVYSFGVVLLELLTGRRP 970
             + D++S G+  +E+  G+ P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.6 bits (222), Expect = 9e-20
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G FGLV+        K A+K +    G M E +F  E + + +  H  LV L G C 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
             +   L++ +ME+G L  +L     +      +  L +      G+AYL       ++H
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 950
           RD+ + N L+ E     ++DFG++R +   D   T+   GT   + +  PE       + 
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSS-TGTKFPVKWSSPEVFSFSKYSS 180

Query: 951 RGDVYSFGVVLLELLT-GRRPVE 972
           + DV+SFGV++ E+ + G+ P E
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 19/245 (7%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG+V+          A+K +    G M E +F  E + + +  H NLV L G C 
Sbjct: 12   LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM NG L  +L E   +   L  +  L +       + YL        +H
Sbjct: 70   KQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 950
            RD+ + N L+ E     ++DFGL+R +   D   T+   GT   + + PPE       + 
Sbjct: 124  RDLAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSS-QGTKFPVKWAPPEVFDYSRFSS 180

Query: 951  RGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM---KSEKREVEIIDASIWHK 1006
            + DV+SFGV++ E+ + G+ P E        + VS  +++   K    EV  I  S WH+
Sbjct: 181  KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240

Query: 1007 DREKQ 1011
              E +
Sbjct: 241  KPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.6 bits (219), Expect = 3e-19
 Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 28/270 (10%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L  Y  
Sbjct: 14   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69

Query: 834  HGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
               + + I + YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + V
Sbjct: 70   VSEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 124

Query: 893  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
            HRD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + 
Sbjct: 125  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 953  DVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1011
            DV+SFG++L EL T GR P      +   D V   ++M       E              
Sbjct: 185  DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------------- 230

Query: 1012 LLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
               + ++ C+C  ++P  RP  E +  +L+
Sbjct: 231  --SLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 32/272 (11%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    TK AVK L    G M  E F  E + + + +H  LV L     
Sbjct: 14   LGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L +   +   LK    + +A   A G+AY+ ++   + +H
Sbjct: 72   E-EPIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIERM---NYIH 125

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++S+NIL+ +     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 126  RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV---FQMKSEKREVEIIDASIWHKDRE 1009
            V+SFG++L EL+T GR P     G N R+++  V   ++M   +      D  I      
Sbjct: 186  VWSFGILLTELVTKGRVPY---PGMNNREVLEQVERGYRMPCPQ------DCPI------ 230

Query: 1010 KQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                 + E+  +C  +DP  RP  E + ++L+
Sbjct: 231  ----SLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 5e-19
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 21/211 (9%)

Query: 767 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHK 823
           N +    ++G G +G+V K      G   A+K+   S D   +++    EV+ L + +H+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGL 880
           N+V+L+   R      L++ Y+E   L+  L  S   +  D+V     R  I Q   + +
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAV-----RSYIWQ-LLQAI 113

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           AY H     +I+HRD+K  NIL+ E     L DFG +R LR       TD V T  Y  P
Sbjct: 114 AYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 941 EYSQTLTATCRG---DVYSFGVVLLELLTGR 968
           E    +  T  G   DV++ G ++ ELL G 
Sbjct: 171 EL--LVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 7e-19
 Identities = 67/220 (30%), Positives = 97/220 (44%), Gaps = 22/220 (10%)

Query: 766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHK 823
           T  F    +IG G +G VYKA     G   A+K +       E E + E   L + + H 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHP 63

Query: 824 NLVSLQGYCRHGN-----DRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           N+ +  G     N     D+L L+      GS+   +     K   LK +    I +   
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTL 935
           RGLAYLH   E  ++HRD+K  NILL +  E  L DFG+S  L   D+ +      +GT 
Sbjct: 124 RGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGTP 177

Query: 936 GYIPPE-----YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            ++ PE          +   R DV+S G+  +EL  G+ P
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 87.0 bits (216), Expect = 7e-19
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 16/210 (7%)

Query: 775 IGCGGFGLVYKAT--LTNGT--KAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V K    + +G   + AVK L        ++EF  E   +++  H  +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
           G C+ G   +L+      G L  +L     +  +   D++    Q  A G+AYL      
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQ-VAMGMAYLE---SK 114

Query: 890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLT 947
           H VHRD+ + N+LL  + +A ++DFG+SR L     +      G   L +  PE      
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 948 ATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
            + + DV+S+GV L E  + G +P    KG
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 9e-19
 Identities = 75/270 (27%), Positives = 119/270 (44%), Gaps = 35/270 (12%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            IG G FG VYK  L   T+ AVK   S     ++R+F  E E L +  H N+V L G C 
Sbjct: 3    IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-KVCEPHIV 892
                  ++   +  GSL  +L +  ++ +V K    L+++  AA G+ YL  K C    +
Sbjct: 63   QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK---LLQMSLDAAAGMEYLESKNC----I 115

Query: 893  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTLT 947
            HRD+ + N L+ E     ++DFG+S   R  +  + T +   L  IP     PE      
Sbjct: 116  HRDLAARNCLVGENNVLKISDFGMS---REEEGGIYT-VSDGLKQIPIKWTAPEALNYGR 171

Query: 948  ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
             T   DV+S+G++L E  + G  P      +  R+ +   ++M + +   E         
Sbjct: 172  YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE--------- 222

Query: 1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                   E+  +  +C   DP  RP   E+
Sbjct: 223  -------EIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 1e-18
 Identities = 66/217 (30%), Positives = 96/217 (44%), Gaps = 48/217 (22%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA----EVEALSRAQHKNLVSL 828
            +G G +G+VYKA     G   A+K++  D    E    +    E+  L   +H N+V L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDK------DSVLKWDVRLKIAQGAARGLAY 882
                      L++ Y +    D  L + +DK       +++K      I     RGLAY
Sbjct: 64  LDVIHTERKLYLVFEYCDM---D--LKKYLDKRPGPLSPNLIK-----SIMYQLLRGLAY 113

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYI 938
            H      I+HRD+K  NIL++      LADFGL+R     LR Y TH     V TL Y 
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THE----VVTLWYR 165

Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       YS  +      D++S G +  E++TG+
Sbjct: 166 APEILLGSKHYSTAV------DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.4 bits (216), Expect = 1e-18
 Identities = 82/298 (27%), Positives = 137/298 (45%), Gaps = 49/298 (16%)

Query: 767  NNFNQANIIGCGGFGLVYKATL-TNGTK--AAVKRLSGDCGQME-REFQAEVEALSR-AQ 821
            N+    ++IG G FG V KA +  +G +  AA+KR+     + + R+F  E+E L +   
Sbjct: 7    NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVR 869
            H N+++L G C H     L   Y  +G+L  +L +S  ++ D          S L     
Sbjct: 67   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 870  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
            L  A   ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 127  LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------ 177

Query: 930  DLVGTLGYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 983
             +  T+G +P  +    +      T   DV+S+GV+L E+++ G  P   C G  C +L 
Sbjct: 178  -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC-GMTCAELY 233

Query: 984  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + Q    ++ +   D             E+ ++  +C  + P  RP   +++  L+
Sbjct: 234  EKLPQGYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 11/197 (5%)

Query: 773 NIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           + +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
           C       +I  +M  G+L  +L E  ++   +   V L +A   +  + YL K    + 
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLREC-NRQE-VNAVVLLYMATQISSAMEYLEK---KNF 125

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
           +HRD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFS 183

Query: 950 CRGDVYSFGVVLLELLT 966
            + DV++FGV+L E+ T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 47/273 (17%)

Query: 775  IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG-YC 832
            IG G +G VYKA  +  G   A+K +  + G      Q E+  L   +H N+V+  G Y 
Sbjct: 11   IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 833  RHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
            R   D+L I   Y   GSL      +      L       + +   +GLAYLH   E   
Sbjct: 71   R--RDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLH---ETGK 122

Query: 892  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT---TDLVGTLGYIPPEYSQTLTA 948
            +HRD+K +NILL E  +  LADFG+S  L    T         +GT  ++ PE +     
Sbjct: 123  IHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAVE-- 176

Query: 949  TCRG------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002
              +G      D+++ G+  +EL   + P            +  +  M    R + +I  S
Sbjct: 177  -RKGGYDGKCDIWALGITAIELAELQPP------------MFDLHPM----RALFLISKS 219

Query: 1003 IWH----KDREKQLLEMLEIACKCIDQDPRRRP 1031
             +     KD+EK      +   KC+ +DP++RP
Sbjct: 220  NFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 29/215 (13%)

Query: 774 IIGCGGFGLVYKA-TLTNGTKAAVK------RLSGDCGQMERE----FQAEVEALSRAQH 822
           +IG G +G VY A  +T G   AVK       ++G     +++     ++E+E L    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLD--YWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            N+V   G+        +   Y+  GS+      +   ++  V          +    GL
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF------FTEQVLEGL 121

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP-YDTHVTTDLVGTLGYIP 939
           AYLH      I+HRD+K+ N+L+D      ++DFG+S+     YD      + G++ ++ 
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 940 PE----YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE    YSQ  +A  + D++S G V+LE+  GRRP
Sbjct: 179 PEVIHSYSQGYSA--KVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 70/269 (26%), Positives = 117/269 (43%), Gaps = 25/269 (9%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+     N TK AVK L    G M  + F  E   +   QH  LV L     
Sbjct: 14   LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  +I  YM  GSL  +L    D+   +     +  +   A G+AY+ +    + +H
Sbjct: 72   KEEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++N+L+ E     +ADFGL+R++   +          + +  PE     + T + D
Sbjct: 127  RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L E++T G+ P     G +  D++S + +     R              E   
Sbjct: 187  VWSFGILLYEIVTYGKIPY---PGMSNSDVMSALQRGYRMPR-------------MENCP 230

Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
             E+ +I   C  +    RP  + + + LD
Sbjct: 231  DELYDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 34/222 (15%)

Query: 763 LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA-------EV 814
            +S   F + N IG G +G+VY+A   T+G   A+K++     +M+ E          E+
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLREI 57

Query: 815 EALSRAQHKNLVSL----QGYCRHGNDRLLIYSYMEN--GSLDYWLHESVDKDSVLKWDV 868
             L   +H N+V L     G  +H +   L+  Y E    SL       +D       + 
Sbjct: 58  TLLLNLRHPNIVELKEVVVG--KHLDSIFLVMEYCEQDLASL-------LDNMPTPFSES 108

Query: 869 RLK-IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 927
           ++K +     RGL YLH+     I+HRD+K SN+LL +K    +ADFGL+R        +
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165

Query: 928 TTDLVGTLGYIPPEYS-QTLTATCRGDVYSFGVVLLELLTGR 968
           T  +V TL Y  PE      T T   D+++ G +L ELL  +
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 17/213 (7%)

Query: 767 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLS--GDCGQMEREFQA---EVEALSRA 820
            N+ +  ++G G FG VY    +  G + AVK++    D  + ++E  A   E++ L   
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 821 QHKNLVSLQGYCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
           QH+ +V   G C   ++ L I+  YM  GS+     + +     L   V  K  +    G
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEG 116

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGY 937
           + YLH      IVHRD+K +NIL D      L DFG S+ L+   +  T    + GT  +
Sbjct: 117 VEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           + PE         + DV+S G  ++E+LT + P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 28/270 (10%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    TK A+K L    G M  E F  E + + + +H  LV L  Y  
Sbjct: 14   LGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 834  HGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
               + + I + +M  GSL  +L E   K   LK    + +A   A G+AY+ ++   + +
Sbjct: 70   VSEEPIYIVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYIERM---NYI 124

Query: 893  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
            HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE +     T + 
Sbjct: 125  HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 953  DVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1011
            DV+SFG++L EL+T GR P      +   + V   ++M   +   E              
Sbjct: 185  DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE-------------S 231

Query: 1012 LLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
            L E++++   C  +DP  RP  E + ++L+
Sbjct: 232  LHELMKL---CWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 8e-18
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 9/165 (5%)

Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK 865
           + ++   E++ +   +   +VS  G   + N+  +   +M+ GSLD        K   + 
Sbjct: 46  VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK----KGGPIP 101

Query: 866 WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 925
            ++  KIA     GL YL+ V    I+HRD+K SNIL++ + +  L DFG+S  L     
Sbjct: 102 VEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---N 156

Query: 926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            +    VGT  Y+ PE  Q    T + DV+S G+ ++EL  G+ P
Sbjct: 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 9e-18
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 13/202 (6%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG VYKA     G  AA K +  +  +   +F  E++ LS  +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
           + N   ++  + + G+LD  + E    +  L       + +     L +LH      ++H
Sbjct: 73  YENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLH---SHKVIH 126

Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT---- 949
           RD+K+ NILL    +  LADFG+S   +       T  +GT  ++ PE     T      
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPY 185

Query: 950 -CRGDVYSFGVVLLELLTGRRP 970
             + D++S G+ L+EL     P
Sbjct: 186 DYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 79/285 (27%), Positives = 121/285 (42%), Gaps = 40/285 (14%)

Query: 773  NIIGCGGFGLVYKATLT----NGTKAAVKRLS--GDCGQMEREFQAEVEALSRAQHKNLV 826
             +IG G FG VY  TL          AVK L+   D  ++E +F  E   +    H N++
Sbjct: 1    RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVL 59

Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWL----HESVDKDSVLKWDVRLKIAQGAARGLA 881
            SL G C       L++  YM++G L  ++    H    KD +             A+G+ 
Sbjct: 60   SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI-------GFGLQVAKGME 112

Query: 882  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGYI 938
            YL        VHRD+ + N +LDE F   +ADFGL+R +     Y  H  T     + ++
Sbjct: 113  YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 939  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
              E  QT   T + DV+SFGV+L EL+T  R        +  D+  ++ Q +   +    
Sbjct: 170  ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVYLLQGRRLLQPEYC 227

Query: 999  IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
             D              + E+   C    P  RP   E+V+ ++ I
Sbjct: 228  PDP-------------LYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 80/296 (27%), Positives = 124/296 (41%), Gaps = 56/296 (18%)

Query: 774  IIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLV 826
             +G G FG V KAT          T  AVK L  +    E R+  +E   L +  H +++
Sbjct: 7    TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHES-------------VDKDSVLKWDVR---- 869
             L G C      LLI  Y + GSL  +L ES              +   +   D R    
Sbjct: 67   KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 870  ---LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 926
               +  A   +RG+ YL    E  +VHRD+ + N+L+ E  +  ++DFGLSR +   D++
Sbjct: 127  GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 927  VTTDLVGTLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCR 980
            V      + G IP      E       T + DV+SFGV+L E++T G  P      +   
Sbjct: 184  VKR----SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239

Query: 981  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            +L+   ++M+  +   E                EM  +   C  Q+P +RP   ++
Sbjct: 240  NLLKTGYRMERPENCSE----------------EMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 22/216 (10%)

Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS------GDCGQMEREFQAEVEALSRA 820
            + +   +G G F   Y+A  +  GT  AVK+++       +  ++    + E+  ++R 
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H +++ + G     +   L   +M  GS+ + L     K    K  V +   +   RGL
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGL 116

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFE-AHLADFGLSRLLRPYDT---HVTTDLVGTLG 936
           +YLH   E  I+HRDVK +N+L+D   +   +ADFG +  L    T        L+GT+ 
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 937 YIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRP 970
           ++ PE    +    +C  DV+S G V++E+ T + P
Sbjct: 174 FMAPEVLRGEQYGRSC--DVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 43/234 (18%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSR-AQ 821
           ++F    IIG G F  V  A       + A+K L       E++ +    E E L+R   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 822 HKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAAR 878
           H  ++ L  Y     + L  +  Y  NG L  ++ +  S+D+        R   A+    
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-----CTRFYAAE-ILL 113

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL------- 931
            L YLH      I+HRD+K  NILLD+     + DFG +++L P  +  +          
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 932 ------------VGTLGYIPPEYSQTLT---ATCRGDVYSFGVVLLELLTGRRP 970
                       VGT  Y+ PE    L    A    D+++ G ++ ++LTG+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+ AT    TK AVK +    G M  E F AE   +   QH  LV L     
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKW-DVRLKIAQGAARGLAYLHKVCEPHI 891
                 +I  +M  GSL D+   +   K  + K  D   +IA+G    +A++ +    + 
Sbjct: 72  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG----MAFIEQ---RNY 123

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           +HRD++++NIL+       +ADFGL+R++   +          + +  PE     + T +
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 952 GDVYSFGVVLLELLT-GRRP 970
            DV+SFG++L+E++T GR P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 24/231 (10%)

Query: 808  REFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKW 866
            R+   E+  LS  QH N+++   +    N  L+   Y   G+L D  + +   K  + + 
Sbjct: 44   RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ---KGQLFEE 100

Query: 867  DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 926
            ++ L         ++Y+HK     I+HRD+K+ NI L +     L DFG+S++L    + 
Sbjct: 101  EMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157

Query: 927  VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
              T +VGT  Y+ PE  Q +    + D+++ G VL ELLT +R  +     N  +LV  +
Sbjct: 158  AET-VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD---ATNPLNLVVKI 213

Query: 987  FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             Q               +         E++ +    + QDP +RP  +EV+
Sbjct: 214  VQ-------------GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 72/287 (25%), Positives = 108/287 (37%), Gaps = 55/287 (19%)

Query: 775  IGCGGFGLVYKATLTNGT----KAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQ 829
            +G G FG+V +   +         AVK L  D    +  +F  E   +    H+NL+ L 
Sbjct: 3    LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 830  GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVL---KWDVRLKIAQGAARGLAYLHKV 886
            G     +  +++      GSL   L +       L     D  ++IA G    + YL   
Sbjct: 63   GVVLT-HPLMMVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANG----MRYLE-- 114

Query: 887  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQ 944
                 +HRD+ + NILL    +  + DFGL R L   + H   +  L     +  PE  +
Sbjct: 115  -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 945  TLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
            T T +   DV+ FGV L E+ T G  P     G                        + I
Sbjct: 174  TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------------------------SQI 209

Query: 1004 WHK-DREKQLLEMLEIAC---------KCIDQDPRRRPFIEEVVTWL 1040
              K D+E + LE  E AC         +C   +P  RP    +  +L
Sbjct: 210  LKKIDKEGERLERPE-ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.9 bits (202), Expect = 7e-17
 Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 775 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
           +G G FG V  Y     N   G   AVK L  +CGQ     ++ E+  L    H+N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 829 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           +G C     +   LI  Y+  GSL DY     ++   +L +      AQ    G+AYLH 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF------AQQICEGMAYLH- 124

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 943
               H +HRD+ + N+LLD      + DFGL++ +     +  V  D    + +   E  
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 944 QTLTATCRGDVYSFGVVLLELLT 966
           +    +   DV+SFGV L ELLT
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 68/250 (27%), Positives = 112/250 (44%), Gaps = 29/250 (11%)

Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQA-EVEALSRAQHKN 824
           +F     +G G +G VYK   L++    A+K +  G   Q ERE    E+  L+   H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           ++S +     GN   ++  Y   G L   + +   K  ++      +I     RGL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
              E  I+HRD+KS+NILL       + D G+S++L+    ++    +GT  Y+ PE  +
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEVWK 174

Query: 945 TLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK-------NCRDL---VS 984
               + + D++S G +L E+ T   P E          V +GK         +DL   + 
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234

Query: 985 WVFQMKSEKR 994
            + Q+K + R
Sbjct: 235 SMLQVKPKLR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 81.6 bits (202), Expect = 9e-17
 Identities = 67/205 (32%), Positives = 94/205 (45%), Gaps = 16/205 (7%)

Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQME-REFQAEVEALSRAQH-KNLVSLQGY 831
           IG G FG V K      GT  AVKR+     + E +    +++ + R+     +V   G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 832 CRHGNDRLLIYSYMENGSLD--Y-WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
                D  +    M+  SLD  Y +++E     SV+  ++  KIA    + L YL +  E
Sbjct: 72  LFREGDCWICMELMDI-SLDKFYKYVYEV--LKSVIPEEILGKIAVATVKALNYLKE--E 126

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA 948
             I+HRDVK SNILLD      L DFG+S  L   D+   T   G   Y+ PE       
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 949 T---CRGDVYSFGVVLLELLTGRRP 970
                R DV+S G+ L E+ TG+ P
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 78/268 (29%), Positives = 120/268 (44%), Gaps = 73/268 (27%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVKRLSGDCGQMERE-FQA----EVEA 816
           +  + F+    IG G +G VYKA    T G   A+K++  D    E+E F      E++ 
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRLD---NEKEGFPITAIREIKI 59

Query: 817 LSRAQHKNLVSLQGYCRHGNDRL----------LIYSYM--------ENGSLDYWLHESV 858
           L +  H+N+V+L+       D L          L++ YM        E+G + +      
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF------ 113

Query: 859 DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 918
            +D +  +  +L        GL Y HK    + +HRD+K SNILL+ K +  LADFGL+R
Sbjct: 114 SEDHIKSFMKQL------LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Query: 919 LLRPYDTHVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           L    ++   T+ V TL Y PPE       Y   +      DV+S G +L EL T ++P 
Sbjct: 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAI------DVWSCGCILGELFT-KKP- 216

Query: 972 EVCKGKNCRDLVSWVFQMKSEKREVEII 999
                         +FQ   E  ++E+I
Sbjct: 217 --------------IFQANQELAQLELI 230

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 77/274 (28%), Positives = 120/274 (43%), Gaps = 42/274 (15%)

Query: 774  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYC 832
            ++G G FG V+K TL + T  AVK    D  Q ++ +F +E   L +  H N+V L G C
Sbjct: 2    LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 833  RHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-KVCE 888
                 R  IY  ME    G    +L +  D+   LK    +K A  AA G+AYL  K C 
Sbjct: 62   ---TQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESKNC- 114

Query: 889  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 943
               +HRD+ + N L+ E     ++DFG+S   R  D  + +     L  IP     PE  
Sbjct: 115  ---IHRDLAARNCLVGENNVLKISDFGMS---RQEDDGIYSS--SGLKQIPIKWTAPEAL 166

Query: 944  QTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002
                 +   DV+S+G++L E  + G  P      +  R+ V   ++M   ++  +     
Sbjct: 167  NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPD----- 221

Query: 1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                       ++ ++  +C D  P  RP   E+
Sbjct: 222  -----------DVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.8 bits (202), Expect = 1e-16
 Identities = 76/288 (26%), Positives = 124/288 (43%), Gaps = 38/288 (13%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
            NN +    +G G FG V +AT           K AVK L       ERE   +E++ +S 
Sbjct: 35   NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 820  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
               H+N+V+L G C  G   L+I  Y   G L  +L     ++S L  +  L  +   A+
Sbjct: 95   LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAK 152

Query: 879  GLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGT 934
            G+A+L  K C    +HRD+ + N+LL       + DFGL+R +     +V      L   
Sbjct: 153  GMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--P 206

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPV-EVCKGKNCRDLVSWVFQMKSE 992
            + ++ PE       T   DV+S+G++L E+ + G  P   +        L+   ++M   
Sbjct: 207  VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266

Query: 993  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            +                    E+ +I   C D DP +RP  +++V  +
Sbjct: 267  EHAPA----------------EIYDIMKTCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 77/299 (25%), Positives = 125/299 (41%), Gaps = 55/299 (18%)

Query: 774  IIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMEREFQ---AEVEALSR-AQHK 823
             +G G FG V KA           +  AVK L  D    E++     +E+E +    +HK
Sbjct: 19   PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHK 76

Query: 824  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWL--------HESVDKDSVLKWDVRLK---- 871
            N+++L G C       ++  Y  +G+L  +L        + S D     +  +  K    
Sbjct: 77   NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 872  IAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 930
             A   ARG+ +L  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  T 
Sbjct: 137  FAYQVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT- 191

Query: 931  LVGTLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 984
               T G +P     PE       T + DV+SFGV+L E+ T G  P      +    L  
Sbjct: 192  ---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-- 246

Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                +K   R  +  + +           E+  +   C  + P +RP  +++V  LD +
Sbjct: 247  ----LKEGYRMEKPQNCT----------QELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 44/287 (15%)

Query: 775  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            +G G FG+VY+            T+ A+K ++ +    ER EF  E   +      ++V 
Sbjct: 14   LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
            L G    G   L++   M  G L  +L       E+            +++A   A G+A
Sbjct: 74   LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 882  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
            YL        VHRD+ + N ++ E     + DFG++R +   D +      G  G +P  
Sbjct: 134  YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 186

Query: 940  ---PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
               PE  +    T + DV+SFGVVL E+ T               L    +Q  S +  +
Sbjct: 187  WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQGLSNEEVL 231

Query: 997  E-IIDASIWHKDREKQLLE-MLEIACKCIDQDPRRRPFIEEVVTWLD 1041
            + +ID    H D  +   + +LE+   C   +P+ RP   E+V+ L 
Sbjct: 232  KFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 65/255 (25%), Positives = 113/255 (44%), Gaps = 38/255 (14%)

Query: 768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKR---LSGDCGQMEREFQAEVEALSRAQHKN 824
            +     IG G FG +Y A   + ++  V +   L+    + +   + EV  L++ +H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARGL 880
           +V+     +      ++  Y + G L   ++        +D +L W V++ +      GL
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
            ++H   +  I+HRD+KS NI L +    A L DFG++R L      +    VGT  Y+ 
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYLS 170

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKG----------KNC 979
           PE  Q      + D++S G VL EL T + P E          +C+G          ++ 
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDL 230

Query: 980 RDLVSWVFQMKSEKR 994
           R L+S +F++    R
Sbjct: 231 RSLISQLFKVSPRDR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.0 bits (201), Expect = 2e-16
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 57/226 (25%)

Query: 773 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQH 822
             IG G +G+V  A     G K A+K++S         F   ++A         L   +H
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRH 58

Query: 823 KNLVSLQGYCRHG-----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           +N++ L    R       ND  ++   ME            D   V+K    L       
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELME-----------TDLHKVIKSPQPLTDDHIQY 107

Query: 878 ------RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--T 929
                 RGL YLH     +++HRD+K SNIL++   +  + DFGL+R + P +      T
Sbjct: 108 FLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 930 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           + V T  Y  PE       Y++ +      D++S G +  ELLT +
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAI------DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 68/238 (28%), Positives = 100/238 (42%), Gaps = 40/238 (16%)

Query: 773 NIIGCGGFGLVYKATLT--NGTKA----AVKRLSGDC-GQMEREFQAEVEALSRAQHKNL 825
             +G G FG VY+      +G       AVK L   C  Q E +F  E   +S+  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGLAY 882
           V L G       R ++   M  G L  +L E+    ++ S L     L  A+  A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY-- 937
           L    E H +HRD+ + N LL  K     A +ADFG++R           D+     Y  
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----------DIYRASYYRK 177

Query: 938 ----------IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 984
                     +PPE       T + DV+SFGV+L E+ + G  P      +   + V+
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 30/271 (11%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG+V+        K A+K ++   G M E +F  E + + +  H  LV L G C 
Sbjct: 12   LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  +MENG L  +L +   +   L  D+ L + Q    G+ YL +      +H
Sbjct: 70   QQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER---NSFIH 123

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD+ + N L+       ++DFG++R +   +   ++     + + PPE       + + D
Sbjct: 124  RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFGV++ E+ T G+ P                F+ KS    VE+I      +    +L
Sbjct: 184  VWSFGVLMWEVFTEGKMP----------------FEKKSNYEVVEMISRG--FRLYRPKL 225

Query: 1013 LEML--EIACKCIDQDPRRRPFIEEVVTWLD 1041
              M   E+   C  + P  RP   E++  + 
Sbjct: 226  ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 18/201 (8%)

Query: 773 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQG 830
            I+G G  G VYKA  L      AVK +  D   +++++  +E+E L +     ++   G
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 831 YCRHGNDRLLIYSYMENGSLD-YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
                N   +   +M+ GSLD Y           +   V  +IA    +GL YL  +   
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL--- 114

Query: 890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            I+HRDVK SN+L++ + +  L DFG+S  L      +    VGT  Y+ PE        
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYG 171

Query: 950 CRGDVYSFGVVLLELLTGRRP 970
              DV+S G+  +EL  GR P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 80.8 bits (200), Expect = 4e-16
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 43/214 (20%)

Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 824
           +G G +G V  A  T  G K A+K+LS       R FQ+ + A         L    H+N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 825 LVSLQGYCRHGNDRLLIYS--YMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLA 881
           ++ L          L  +   Y+    +   L+ ++ K   L  D ++  + Q   RGL 
Sbjct: 76  VIGLLD-VFTPASSLEDFQDVYLVTHLMGADLN-NIVKCQKLSDDHIQFLVYQ-ILRGLK 132

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y+H      I+HRD+K SNI ++E  E  + DFGL+R          T  V T  Y  PE
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPE 185

Query: 942 -------YSQTLTATCRGDVYSFGVVLLELLTGR 968
                  Y+QT+      D++S G ++ ELLTG+
Sbjct: 186 IMLNWMHYNQTV------DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 73/272 (26%), Positives = 114/272 (41%), Gaps = 30/272 (11%)

Query: 774  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
             IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G   
Sbjct: 13   TIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 834  HGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 L I + YM  GSL  +L       SVL  D  LK +      + YL      + V
Sbjct: 70   EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFV 124

Query: 893  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
            HRD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + 
Sbjct: 125  HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKS 180

Query: 953  DVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1011
            DV+SFG++L E+ + GR P      K+    V   ++M +      ++            
Sbjct: 181  DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV------------ 228

Query: 1012 LLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                 ++  +C   D   RP   ++   L+ I
Sbjct: 229  ----YDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.7 bits (194), Expect = 6e-16
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)

Query: 768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKN 824
            + +  ++G G FG+V+        K  + +        + E  A   E + L    H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLH----ESVDKDSVLKWDVRLKIAQGAARGL 880
           ++            +++  Y   G+L  ++       +D+D++L + V++ +A       
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
             LH V    I+HRD+K+ NILLD+ K    + DFG+S++L       T  +VGT  YI 
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYIS 169

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           PE  +      + D+++ G VL EL + +R  E
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 20/215 (9%)

Query: 769 FNQAN-----IIGCGGFGLVYKATLTNG------TKAAVKRLSG-DCGQMEREFQAEVEA 816
           F ++N      +G G FG V+ A           T   VK L       ++ EF+ E++ 
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-----VRLK 871
             +  HKN+V L G CR      +I  Y + G L  +L  +  KD  LK        ++ 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
           +    A G+ +L        VHRD+ + N L+  + E  ++   LS+ +   + +   + 
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           +  L ++ PE  Q    + + DV+SFGV++ E+ T
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.0 bits (195), Expect = 7e-16
 Identities = 83/292 (28%), Positives = 126/292 (43%), Gaps = 43/292 (14%)

Query: 775  IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
            +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 12   LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 830  GYCRHGNDRL---LIYSYMENGSLDYWL---HESVDKDSVLKWDVRLKIAQGAARGLAYL 883
            G C +   R    L+  Y+  GSL  +L    E +D   +L +      A    +G+ YL
Sbjct: 72   GVC-YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY------ASQICKGMEYL 124

Query: 884  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP---- 939
                    VHRD+ + NIL++ +    + DFGL+++L P D       V   G  P    
Sbjct: 125  G---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYK--VREPGESPIFWY 178

Query: 940  -PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
             PE       +   DV+SFGVVL EL T          K+C     ++  M ++K+   I
Sbjct: 179  APESLTESKFSVASDVWSFGVVLYELFT------YSD-KSCSPPAEFMRMMGNDKQGQMI 231

Query: 999  IDASIWHKDREKQL-------LEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            +   I       +L        E+  I  +C + DP +RP   E+   ++ I
Sbjct: 232  VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.3 bits (195), Expect = 7e-16
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 775 IGCGGFGLVYKATLTNGTK-AAVKRLSGDCGQMEREFQ---AEVEALSRAQHKNLVSLQG 830
           IG G FG VY AT ++  +  AVK++S    Q   ++Q    EV+ L + +H N +  +G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                +   L+  Y    + D      V K  + + ++   I  GA +GLAYLH      
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIA-AITHGALQGLAYLHSHN--- 141

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC 950
           ++HRD+K+ NILL E  +  LADFG +    P ++      VGT  ++ PE    + A  
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTPYWMAPE---VILAMD 193

Query: 951 RG------DVYSFGVVLLELLTGRRPV 971
            G      DV+S G+  +EL   + P+
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 7e-16
 Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 46/215 (21%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA--------EVEALSRAQ-HKN 824
           +G G FG VY A     G   A+K+       M+++F +        EV++L +   H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKK-------MKKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 825 LVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           +V L+   R  ND L  ++ YME G+L Y L +        +  +R  I Q    GLA++
Sbjct: 60  IVKLKEVFRE-NDELYFVFEYME-GNL-YQLMKDRKGKPFSESVIRSIIYQILQ-GLAHI 115

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR---PYDTHVTTDLVGTLGYIPP 940
           HK       HRD+K  N+L+       +ADFGL+R +R   PY     TD V T  Y  P
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-----TDYVSTRWYRAP 167

Query: 941 E-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           E       YS  +      D+++ G ++ EL T R
Sbjct: 168 EILLRSTSYSSPV------DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 78.4 bits (194), Expect = 7e-16
 Identities = 78/259 (30%), Positives = 105/259 (40%), Gaps = 53/259 (20%)

Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQ-----AEVEALSRAQHKNLVSL 828
           I  G +G V+ A   + G   A+K +      M R+ Q      E + LS+AQ   +V L
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 829 QGYCRHGNDRL-LIYSYMENGSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
             Y   G   L L+  Y+  G L   L    S+D+D       R+ IA+     L YLH 
Sbjct: 59  Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-----RIYIAEIVL-ALEYLHS 111

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-------LLRPYDTHVTTDLVGTLGYI 938
                I+HRD+K  NIL+D      L DFGLS+       +    D      +VGT  YI
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 939 PPEY--SQTLTATCRGDVYSFGVVLLELLTGRRP-----VE-----VCKGK--------- 977
            PE    Q  + T   D +S G +L E L G  P      E     +  GK         
Sbjct: 169 APEVILGQGHSKTV--DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226

Query: 978 --NCRDLVSWVFQMKSEKR 994
                DL+S +     EKR
Sbjct: 227 SDEAIDLISKLLVPDPEKR 245

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.1 bits (195), Expect = 8e-16
 Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 30/208 (14%)

Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHKNLVSLQG 830
           IG G FG VY A         A+K++S    Q   ++Q    EV  L + +H N +  +G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 831 -YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR-LKIA---QGAARGLAYLHK 885
            Y R     L+    ME     Y L  + D   V K  ++ ++IA    GA +GLAYLH 
Sbjct: 83  CYLREHTAWLV----ME-----YCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
                 +HRD+K+ NILL E     LADFG + L+ P ++      VGT  ++ PE    
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILA 185

Query: 946 LTA---TCRGDVYSFGVVLLELLTGRRP 970
           +       + DV+S G+  +E L  R+P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 59/203 (29%), Positives = 82/203 (40%), Gaps = 19/203 (9%)

Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGD---CGQMEREFQAEVEALSRAQHKNLVSLQG 830
           +G GGFG V    + +     A+K +          +    +E E L    H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 831 YCRHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
             +   D+  IY  ME    G L   L    D+    ++  R  IA        YLH   
Sbjct: 61  TFK---DKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIAC-VVLAFEYLH--- 110

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 947
              I++RD+K  N+LLD      L DFG ++ L       T    GT  Y+ PE      
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILNKG 168

Query: 948 ATCRGDVYSFGVVLLELLTGRRP 970
                D +S G++L ELLTGR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 36/233 (15%)

Query: 773 NIIGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVS 827
           ++IG G FG V +A +        AA+K L     + + R+F  E+E L +   H N+++
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVRLKIAQG 875
           L G C +     +   Y   G+L  +L +S  ++ D          S L     L+ A  
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
            A G+ YL    E   +HRD+ + N+L+ E   + +ADFGLSR    Y       +  T+
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-------VKKTM 177

Query: 936 GYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 982
           G +P  +    +      T + DV+SFGV+L E+++ G  P   C G  C +L
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP--YC-GMTCAEL 227

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 52/135 (38%), Positives = 71/135 (52%), Gaps = 23/135 (17%)

Query: 844 YMENGSLDYWLHESVDKDSVLKWDVRL------KIAQGAARGLAYLHKVCEPH-IVHRDV 896
           +M+ GSLD           VLK   R+      KI+    RGL YL    E H I+HRDV
Sbjct: 80  HMDGGSLD----------QVLKKAGRIPENILGKISIAVLRGLTYLR---EKHKIMHRDV 126

Query: 897 KSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
           K SNIL++ + E  L DFG+S  L   D+   +  VGT  Y+ PE  Q    T + D++S
Sbjct: 127 KPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTHYTVQSDIWS 183

Query: 957 FGVVLLELLTGRRPV 971
            G+ L+E+  GR P+
Sbjct: 184 LGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 79/303 (26%), Positives = 129/303 (42%), Gaps = 58/303 (19%)

Query: 775  IGCGGFGLVY------------KATLTNGTK-----AAVKRLSGDCGQMER-EFQAEVEA 816
            +G G FG V+            KA   N         AVK L  D     R +F  EV+ 
Sbjct: 13   LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 817  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR------- 869
            LSR    N+  L G C       +I  YMENG L+ +L + V + S L  + +       
Sbjct: 73   LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 870  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VT 928
            L +A   A G+ YL      + VHRD+ + N L+ + +   +ADFG+SR L   D + V 
Sbjct: 133  LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGKNCRDLVSWV 986
                  + ++  E       T + DV++FGV L E+LT    +P                
Sbjct: 190  GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP---------------- 233

Query: 987  FQMKSEKREVEIIDASIWHKDREKQLL---------EMLEIACKCIDQDPRRRPFIEEVV 1037
            ++  ++++ +E  +A  + +D  +Q+          ++ E+  +C  +D   RP   E+ 
Sbjct: 234  YEHLTDQQVIE--NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291

Query: 1038 TWL 1040
             +L
Sbjct: 292  LFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 32/216 (14%)

Query: 773 NIIGCGGFGLVYKATLT-NGTK--AAVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVS 827
           ++IG G FG V KA +  +G +  AA+KR+     + + R+F  E+E L +   H N+++
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVRLKIAQG 875
           L G C H     L   Y  +G+L  +L +S  ++ D          S L     L  A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
            ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y       +  T+
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------VKKTM 170

Query: 936 GYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT 966
           G +P  +    +      T   DV+S+GV+L E+++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 70/247 (28%), Positives = 115/247 (46%), Gaps = 23/247 (9%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG+V           A+K +    G M E EF  E + + +  H+ LV L G C 
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM NG L  +L E   +    +    L++ +    G+AYL        +H
Sbjct: 70   KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLE---SKQFIH 123

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 950
            RD+ + N L+D++    ++DFGLSR +   D   T+  VG+   + + PPE       + 
Sbjct: 124  RDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLLYSKFSS 180

Query: 951  RGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIW 1004
            + DV++FGV++ E+ + G+ P E        + VS     +   + SEK  V  I  S W
Sbjct: 181  KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEK--VYAIMYSCW 238

Query: 1005 HKDREKQ 1011
            H+  E++
Sbjct: 239  HEKAEER 245

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM---EREF---QAEVEALSRAQH 822
           + +  ++G G +G VY      G   AVK++  D   +   E+E+   Q EV+ L   +H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
            N+V   G C   N   +   ++  GS+       +++   L   V  K  +    G+AY
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSIS----SILNRFGPLPEPVFCKYTKQILDGVAY 117

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLV----GTLGY 937
           LH  C   +VHRD+K +N++L       L DFG +R L     H T ++++    GT  +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           + PE         + D++S G  + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.0 bits (187), Expect = 6e-15
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)

Query: 774 IIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE---------FQAEVEALSRAQHK 823
           +IG G FG VY     ++G   AVK++         +            E+  L   QH+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 824 NLVSLQGYCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
           N+V   G      D L I+  Y+  GS+   L+     +  L   VR  + Q   +GL Y
Sbjct: 67  NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVRQ-ILKGLNY 121

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-----LVGTLGY 937
           LH      I+HRD+K +NIL+D K    ++DFG+S+ L        T+     L G++ +
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC 974
           + PE  +  + T + D++S G +++E+LTG+ P   C
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.7 bits (186), Expect = 7e-15
 Identities = 66/280 (23%), Positives = 104/280 (37%), Gaps = 37/280 (13%)

Query: 775  IGCGGFGLVYKA---TLTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 830
            IG G FG V         +  +  VK L       E+  F  EV+      H N++   G
Sbjct: 3    IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 831  YCRHGNDRLLIYSYMENGSLDYWL-----HESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
             C      LL+  +   G L  +L       +         DV  ++A   A GL +LH+
Sbjct: 63   QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMACEVASGLLWLHQ 118

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE--- 941
                  +H D+   N  L       + D+GL+    P D ++T D     L ++ PE   
Sbjct: 119  A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 942  --YSQTLTA--TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
                  L    T + +++S GV + EL T   +P      +     V     +K  K ++
Sbjct: 176  IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235

Query: 997  EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            ++  +  W+           E+   C   DP  RP  EEV
Sbjct: 236  DLKYSDRWY-----------EVMQFCW-LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.3 bits (185), Expect = 8e-15
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 775 IGCGGFGLVYKATL----TNGTKAAVKRLS-GDCGQMER-EFQAEVEALSRAQHKNLVSL 828
           IG G FG   KA L     +G +  +K ++       ER E + EV  LS  +H N+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARGLAYLH 884
           Q       +  ++  Y E G L   ++        +D +L W V++ +A         L 
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LK 115

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL----VGTLGYIPP 940
            V +  I+HRD+KS NI L +     L DFG++R+L     + T +L    +GT  Y+ P
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCIGTPYYLSP 170

Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
           E  +      + D+++ G VL E+ T +   E    KN
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 75.4 bits (185), Expect = 8e-15
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 17/242 (7%)

Query: 774  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            IIG G FG V +   T G K AVK +   C    + F  E   +++  HKNLV L G   
Sbjct: 13   IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            H N   ++   M  G+L  +L       +++     L+ +   A G+ YL       +VH
Sbjct: 70   H-NGLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD+ + NIL+ E   A ++DFGL+R+       V    +  + +  PE  +    + + D
Sbjct: 124  RDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL-PVKWTAPEALKHKKFSSKSD 179

Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKR---EVEIIDASIWHKDRE 1009
            V+S+GV+L E+ + GR P      K  ++ V   ++M+  +    +V ++  S W  + +
Sbjct: 180  VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPK 239

Query: 1010 KQ 1011
            K+
Sbjct: 240  KR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.5 bits (189), Expect = 8e-15
 Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 58/298 (19%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLS---GDCGQMEREFQAEVEALSR-AQHKNLVSLQ 829
            +G G +G+V+KA         A+K++     +    +R F+ E+  L     H N+V L 
Sbjct: 15   LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73

Query: 830  GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAARGLAYLHKV 886
               +  ND+   L++ YME    D  LH +V + ++L+ DV  + I     + L Y+H  
Sbjct: 74   NVIKAENDKDIYLVFEYMET---D--LH-AVIRANILE-DVHKRYIMYQLLKALKYIH-- 124

Query: 887  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD----THVTTDLVGTLGYIPPE- 941
               +++HRD+K SNILL+      LADFGL+R L   +      V TD V T  Y  PE 
Sbjct: 125  -SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183

Query: 942  ------YSQTLTATCRGDVYSFGVVLLELLTGR-------------RPVEVCKGKNCRDL 982
                  Y++ +      D++S G +L E+L G+             + +EV    +  D+
Sbjct: 184  LLGSTRYTKGV------DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 983  VSWVFQMKSEKREVEIIDASIWHKDREKQLL-----EMLEIACKCIDQDPRRRPFIEE 1035
             S    +KS      +       +    +LL     + L++  K +  +P +R   EE
Sbjct: 238  ES----IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.2 bits (187), Expect = 9e-15
 Identities = 52/159 (32%), Positives = 82/159 (51%), Gaps = 9/159 (5%)

Query: 813 EVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           E++ L       +V   G      +  +   +M+ GSLD  L E+      +  ++  K+
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA----KRIPEEILGKV 108

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
           +    RGLAYL +  +  I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    V
Sbjct: 109 SIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFV 163

Query: 933 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           GT  Y+ PE  Q    + + D++S G+ L+EL  GR P+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 20/229 (8%)

Query: 756 DLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEV 814
           D+ +S L      F    ++G G +G VYK   +  G  AA+K +     + E E + E+
Sbjct: 5   DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEI 63

Query: 815 EALSR-AQHKNLVSLQG-YCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD 867
             L + + H+N+ +  G + +     H +   L+  +   GS+   +  +  K + LK D
Sbjct: 64  NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKED 121

Query: 868 VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 927
               I +   RGLA+LH      ++HRD+K  N+LL E  E  L DFG+S  L       
Sbjct: 122 WIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178

Query: 928 TTDLVGTLGYIPPEY-----SQTLTATCRGDVYSFGVVLLELLTGRRPV 971
            T  +GT  ++ PE      +   T   R D++S G+  +E+  G  P+
Sbjct: 179 NT-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 40/275 (14%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA--LSRAQHKNLVSLQG 830
            ++G G +G V      T+G +  +K+L+           AE EA  LS+ +H N+V+ + 
Sbjct: 7    VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR- 65

Query: 831  YCRHGNDRLL--IYSYMENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLH 884
                G D LL  +  + E G L + L E   K    + V++W V++ +A      L YLH
Sbjct: 66   ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH 119

Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
               E HI+HRD+K+ N+ L       + D G++R+L       +T L+GT  Y+ PE   
Sbjct: 120  ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFS 175

Query: 945  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI- 1003
                  + DV++ G  + E+ T +         N +D+ S V++         II+  + 
Sbjct: 176  NKPYNYKSDVWALGCCVYEMATLKHAF------NAKDMNSLVYR---------IIEGKLP 220

Query: 1004 -WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
               KD   +L E++      + + P +RP ++ ++
Sbjct: 221  PMPKDYSPELGELIA---TMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.3 bits (187), Expect = 1e-14
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 769 FNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQ---AEVEALSRAQHKN 824
           F     IG G FG VY A      +  A+K++S    Q   ++Q    EV+ L R +H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
            +  +G     +   L+  Y    + D      V K  + + ++   I  GA +GLAYLH
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIA-AITHGALQGLAYLH 142

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
                +++HRD+K+ NILL E  +  LADFG + +  P ++      VGT  ++ PE   
Sbjct: 143 ---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPE--- 191

Query: 945 TLTATCRG------DVYSFGVVLLELLTGRRPV 971
            + A   G      DV+S G+  +EL   + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 76/274 (27%), Positives = 117/274 (42%), Gaps = 33/274 (12%)

Query: 769  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 825
            F +   IG G FG VYK  + N TK  V     D  + E E    Q E+  LS+     +
Sbjct: 6    FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 826  VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                G    G    +I  Y+  GS LD        K   L+      I +   +GL YLH
Sbjct: 65   TRYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLH 118

Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 943
                   +HRD+K++N+LL E+ +  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 119  ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
            +      + D++S G+  +EL  G  P          DL          K     ++   
Sbjct: 174  KQSAYDFKADIWSLGITAIELAKGEPPNS--------DLHPMRVLFLIPKNSPPTLEGQ- 224

Query: 1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             +    K+ +E       C+++DPR RP  +E++
Sbjct: 225  -YSKPFKEFVE------ACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 825
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 826 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
               G    G    +I  Y+  GS LD       D+  +        + +   +GL YLH
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLH 118

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 943
                  +HRD+K++N+LL E+ +  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 119 ---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           Q      + D++S G+  +EL  G  P
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 34/212 (16%)

Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRL------SGDCGQMEREFQAEVEALSRAQHKNLVS 827
           +G G + +VYKA     G   A+K++          G +      E++ L   +H N++ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDG-INFTALREIKLLQELKHPNIIG 66

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA------RGLA 881
           L     H ++  L++ +ME   L     E V KD      + L  A   +      RGL 
Sbjct: 67  LLDVFGHKSNINLVFEFME-TDL-----EKVIKDK----SIVLTPADIKSYMLMTLRGLE 116

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           YLH      I+HRD+K +N+L+       LADFGL+R     +  +T  +V T  Y  PE
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172

Query: 942 YSQTLTATCRG---DVYSFGVVLLELLTGRRP 970
                 A   G   D++S G +  ELL  R P
Sbjct: 173 L--LFGARHYGVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 13/201 (6%)

Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSLQG 830
           +G GGFG V    +   G   A K+L     +  +  Q    E + L +   + +VSL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 831 YCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
           Y     D L L+ + M  G L Y ++  V +    +       AQ    GL +LH   + 
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQ-IICGLEHLH---QR 114

Query: 890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            IV+RD+K  N+LLD+     ++D GL+  L+           GT GY+ PE  Q     
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 950 CRGDVYSFGVVLLELLTGRRP 970
              D ++ G  L E++ GR P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 74.7 bits (183), Expect = 3e-14
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHKNLVSLQG 830
           IG G FG VY A  + N    A+K++S    Q   ++Q    EV  L + +H N +  +G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                +   L+  Y    + D      V K  + + ++   +  GA +GLAYLH     +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIA-AVTHGALQGLAYLHS---HN 135

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC 950
           ++HRDVK+ NILL E     L DFG + ++ P +       VGT  ++ PE    + A  
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPE---VILAMD 187

Query: 951 RG------DVYSFGVVLLELLTGRRPV 971
            G      DV+S G+  +EL   + P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 74.7 bits (183), Expect = 3e-14
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 22/233 (9%)

Query: 762 LLKSTNNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDCG-QMEREFQAEVE 815
           +LK T    +  ++G G FG VYK        T     A+K L+   G +   EF  E  
Sbjct: 3   ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61

Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   H +LV L G C     +L +   M +G L  ++HE  D      +L W V++  
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI-- 118

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
               A+G+ YL    E  +VHRD+ + N+L+       + DFGL+RLL   +     D  
Sbjct: 119 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Query: 933 GT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 983
              + ++  E       T + DV+S+GV + EL+T G +P +    +   DL+
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 48/223 (21%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G+V K   +  GT  AVKR+           +A V   S+ Q + L+ L    R
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI-----------RATVN--SQEQKRLLMDLDISMR 55

Query: 834 HGNDRLLIYSY------------ME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
             +    +  Y            ME  + SLD +  +  DK   +  D+  KIA    + 
Sbjct: 56  SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L YLH   +  ++HRDVK SN+L++   +  L DFG+S  L   D+   T   G   Y+ 
Sbjct: 116 LEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMA 171

Query: 940 PE----------YSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           PE          Y        + DV+S G+ ++EL TGR P +
Sbjct: 172 PERINPELNQKGYD------VKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 46/226 (20%)

Query: 769 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS---GDCG---QMEREFQAEVEALSRAQ 821
           + +   IG G +G VYKA  L  G   A+K++     + G      RE  A ++ L   +
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59

Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD----------SVLKWDVRLK 871
           H N+V L   C HG          +       + E VD+D            L  +    
Sbjct: 60  HPNIVRLLDVC-HGPR-------TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD 111

Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TD 930
           + +   RG+ +LH      IVHRD+K  NIL+    +  +ADFGL+R+   Y   +  T 
Sbjct: 112 LMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTS 165

Query: 931 LVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           +V TL Y  PE      Y+  +      D++S G +  EL   RRP
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPV------DMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 76/295 (25%), Positives = 125/295 (42%), Gaps = 56/295 (18%)

Query: 775  IGCGGFGLVYKATL-----TNGTKAAVKRLSG-DCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G   FG +YK  L      +    A+K L   +  Q   EFQ E   ++   H N+V L
Sbjct: 13   LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWL-----HESV----DKDSVLKWDVR----LKIAQG 875
             G         +++ Y+  G L  +L     H  V    D+D  +K  +     L IA  
Sbjct: 73   LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 876  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGT 934
             A G+ YL        VH+D+ + NIL+ E+    ++D GLSR +   D + V    +  
Sbjct: 133  IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 993
            + ++PPE       +   D++SFGVVL E+ + G +P                +   S +
Sbjct: 190  IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP----------------YYGFSNQ 233

Query: 994  REVEIIDASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWL 1040
              +E++        R++QLL         M  +  +C  + P RRP  +++ T L
Sbjct: 234  EVIEMV--------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 21/216 (9%)

Query: 773 NIIGCGGFGLVYKATLTN----GT---KAAVKRL-SGDCGQMEREFQAEVEALSRAQHKN 824
           N +G G FG VY+ T T+    G+   + AVK L  G   Q ++EF  E   +S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGLA 881
           +V L G C     + +I   ME G L  +L ++        +L     L I    A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEA-----HLADFGLSRLLRPYDTH-VTTDLVGTL 935
           YL ++   H +HRD+ + N L+ EK         + DFGL+R +   D +    + +  +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
            ++ PE       T + DV+SFGV++ E+LT G++P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 20/219 (9%)

Query: 768 NFNQANIIGCGGFG--LVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHK 823
            +N   ++G G FG  L+ +   ++  K A+K  RL      +E   + E   L++ +H 
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHP 58

Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARG 879
           N+V+ +          ++  Y + G L   +     K    D++L+W V++ +      G
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------G 112

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           + ++H   E  ++HRD+KS NI L +  +  L DFG +RLL     +  T  VGT  Y+P
Sbjct: 113 VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVP 168

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
           PE  + +    + D++S G +L EL T + P +    KN
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 74.2 bits (182), Expect = 4e-14
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 47/273 (17%)

Query: 795  AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYW 853
            AVK L  D  +  R +F  EV+ LSR +  N++ L G C   +   +I  YMENG L+ +
Sbjct: 50   AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109

Query: 854  L--HESVDKDS-------------VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 898
            L  H   DK+               + +   L +A   A G+ YL  +   + VHRD+ +
Sbjct: 110  LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLAT 166

Query: 899  SNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSF 957
             N L+ E     +ADFG+SR L   D + +    V  + ++  E       T   DV++F
Sbjct: 167  RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226

Query: 958  GVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID-ASIWHKDREKQLL--- 1013
            GV L E+L       +CK            Q   E  + ++I+ A  + +D+ +Q+    
Sbjct: 227  GVTLWEILM------LCKE-----------QPYGELTDEQVIENAGEFFRDQGRQVYLFR 269

Query: 1014 ------EMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                   + E+  +C  +D R RP   ++  +L
Sbjct: 270  PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 73.6 bits (180), Expect = 4e-14
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 17/213 (7%)

Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-----FQAEVEALSRAQ 821
           N+ +  ++G G FG VY    +  G + A K++  D    E        + E++ L   Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 822 HKNLVSLQGYCR-HGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
           H+ +V   G  R      L I+  YM  GS+     + +     L   V  K  +    G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGY 937
           ++YLH      IVHRD+K +NIL D      L DFG S+ L+      T    + GT  +
Sbjct: 119 MSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           + PE         + DV+S G  ++E+LT + P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)

Query: 766 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN 824
            +   +  ++G G +G+VY A  L+   + A+K +     +  +    E+   S  +H+N
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARGL 880
           +V   G         +    +  GSL   L        D +  + +  + +I +G    L
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILEG----L 121

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
            YLH   +  IVHRD+K  N+L++       ++DFG S+ L   +   T    GTL Y+ 
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMA 177

Query: 940 PEYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 970
           PE    +    RG     D++S G  ++E+ TG+ P
Sbjct: 178 PE---VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.0 bits (180), Expect = 8e-14
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 58/233 (24%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVE 815
           +S + + + N I  G +G+VY+A     G   A+K+L     +ME+E +        E+ 
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREIN 56

Query: 816 ALSRAQHKNLVSLQ----GYCRHGNDRLLIYSYMENGSLDYWLHE-----SVDKDSVLKW 866
            L + QH N+V+++    G   + +   ++  Y+E        H+        K   L+ 
Sbjct: 57  ILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVE--------HDLKSLMETMKQPFLQS 106

Query: 867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRP 922
           +V+  + Q    G+A+LH   +  I+HRD+K+SN+LL+ +    + DFGL+R     L+P
Sbjct: 107 EVKCLMLQ-LLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162

Query: 923 YDTHVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           Y     T LV TL Y  PE       YS   TA    D++S G +  ELLT +
Sbjct: 163 Y-----TQLVVTLWYRAPELLLGAKEYS---TAI---DMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.2 bits (185), Expect = 1e-13
 Identities = 41/124 (33%), Positives = 65/124 (52%), Gaps = 3/124 (2%)

Query: 67  WDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL 126
           W G  C   ST      +  L L  +GL+G IP  +  L  L+ ++LS N + G +P  L
Sbjct: 404 WSGADCQFDST-KGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL 462

Query: 127 SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFEL--GEFSNLAVFNI 184
            ++  LEVLDLS+N  +G +   L  L  ++ LN++ NS +G +     G   + A FN 
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522

Query: 185 SNNS 188
           ++N+
Sbjct: 523 TDNA 526

Length = 623

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 76/262 (29%), Positives = 116/262 (44%), Gaps = 62/262 (23%)

Query: 765 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-F----QAEVEALS 818
              ++     +G G FG VYKA  +  G   A+K++       E++ F      E++ L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILK 62

Query: 819 RAQHKNLVSL--QGYCRHGN---DRLLIYS---YMENGSLDYWLHESVDKDSVLKWDVRL 870
           + +H N+V L      R       R  +Y    YM++  L   L             V+L
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP---------SVKL 112

Query: 871 KIAQGAA------RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
             +Q          G+ YLH   E HI+HRD+K++NIL+D +    +ADFGL+   RPYD
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA---RPYD 166

Query: 925 -------------THVTTDLVGTLGYIPPEY----SQTLTATCRGDVYSFGVVLLELLTG 967
                        T   T+LV T  Y PPE      +  TA    D++  G V  E+ T 
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV---DIWGIGCVFAEMFT- 222

Query: 968 RRPVEVCKGKNCRDLVSWVFQM 989
           RRP  + +GK+  D +  +F++
Sbjct: 223 RRP--ILQGKSDIDQLHLIFKL 242

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)

Query: 774 IIGCGGFGLVYKATLT--NGT--KAAVKRLSGD-CGQME-REFQAEVEALSRAQHKNLVS 827
           I+G G FG V +  L+  +G+  K AVK +  D     E  EF +E   +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 828 LQGYCRHGNDR------LLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARG 879
           L G C   +        ++I  +M++G L  +L  S       K  ++  LK     A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT-LGYI 938
           + YL      + +HRD+ + N +L E     +ADFGLS+ +   D +    +    + +I
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
             E       T + DV++FGV + E+ T G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 35/219 (15%)

Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKN 824
            +   + IG G +G+V  AT    G K A+K++S    Q   +R  + E++ L R +H+N
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHEN 64

Query: 825 LVSLQGYCRHG-----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAAR 878
           ++ +    R       ND  ++   ME       L++ + K   L  D ++  + Q   R
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETD-----LYK-LIKTQHLSNDHIQYFLYQ-ILR 117

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLG 936
           GL Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  
Sbjct: 118 GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 937 YIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           Y  PE       Y++ +      D++S G +L E+L+ R
Sbjct: 175 YRAPEIMLNSKGYTKAI------DIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 40/153 (26%), Positives = 63/153 (41%), Gaps = 23/153 (15%)

Query: 879  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
            G+  LH+     I+HRD+K  N+L+D+     L DFGLSR             VGT  Y+
Sbjct: 109  GVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYL 160

Query: 939  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
             PE    +      D +S G V+ E L G  P          +    VF      R +  
Sbjct: 161  APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-------ETPDAVFD-NILSRRIN- 211

Query: 999  IDASIWHKDREKQLL-EMLEIACKCIDQDPRRR 1030
                 W ++ ++    E +++  + +  DP +R
Sbjct: 212  -----WPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 34/216 (15%)

Query: 774 IIGCGGFGLVYKATLT-NGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQHKNLVSLQG 830
            IG G +G+V  A  T +G K A+K++    D   + +    E++ L   +H N+++++ 
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71

Query: 831 YCR----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLAYLHK 885
             R       D  ++   ME+      LH  +  D  L  + +R  + Q   RGL Y+H 
Sbjct: 72  ILRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQ-LLRGLKYIHS 125

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYD-THVTTDLVGTLGYIPPE- 941
                ++HRD+K SN+L++E  E  + DFG++R L   P +  +  T+ V T  Y  PE 
Sbjct: 126 AN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182

Query: 942 ------YSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
                 Y+  +      D++S G +  E+L GRR +
Sbjct: 183 LLSLPEYTTAI------DMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)

Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 825
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 826 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
               G         +I  Y+  GS LD      +D+  +        I +   +GL YLH
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLH 118

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 943
                  +HRD+K++N+LL E  E  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 119 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           +      + D++S G+  +EL  G  P
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 17/213 (7%)

Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQA---EVEALSRAQ 821
           N+    ++G G FG VY       G + AVK++    D  +  +E  A   E++ L   +
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 822 HKNLVSLQGYCR-HGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
           H  +V   G  R     +L I+  YM  GS+     + +     L  +V  +  +   +G
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGY 937
           ++YLH      IVHRD+K +NIL D      L DFG S+ ++      T    + GT  +
Sbjct: 119 VSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           + PE         + DV+S    ++E+LT + P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 64/212 (30%), Positives = 90/212 (42%), Gaps = 29/212 (13%)

Query: 774 IIGCGGFGLVYKATLTNGTKA--AVKRLSGD---------CGQMEREFQAEVEALSRAQH 822
           ++G G FG V  A L  GT    AVK L  D         C   E+     V AL+  +H
Sbjct: 2   VLGKGSFGKVLLAEL-KGTDELYAVKVLKKDVILQDDDVECTMTEKR----VLALAG-KH 55

Query: 823 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             L  L   C    DRL  +  Y+  G L + +     +            A     GL 
Sbjct: 56  PFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQ 110

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPP 940
           +LH   E  I++RD+K  N+LLD +    +ADFG+ +  +    T  T+   GT  YI P
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAP 165

Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           E           D ++ GV+L E+L G+ P E
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 16/205 (7%)

Query: 775 IGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           +G G +G VYK     T  T A  + RL  D  +   +   E++ L +A    +V   G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF-NQIIMELDILHKAVSPYIVDFYGA 67

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                   +   YM+ GSLD      V  + + + DV  +I     +GL +L +  E +I
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLKE--EHNI 124

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY------SQT 945
           +HRDVK +N+L++   +  L DFG+S  L      +    +G   Y+ PE       +Q 
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 946 LTATCRGDVYSFGVVLLELLTGRRP 970
            T T + DV+S G+ +LE+  GR P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE--FQAEVEALSRAQHKN 824
           NF +   IG G  G+V  AT  + G + AVK++     Q  RE  F  EV  +   QH N
Sbjct: 23  NFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFN-EVVIMRDYQHPN 77

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           +V +      G++  ++  ++E G+L D   H  ++++ +        +     + L++L
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFL 131

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
           H      ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE  
Sbjct: 132 HA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPEVI 187

Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
             L      D++S G++++E++ G  P
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 30/206 (14%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           IG G +G+V+K      G   A+K+   S D   +++    E+  L + +H NLV+L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHE------SVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
            R      L++ Y ++ ++   L+E       V +  + K      I     + + + HK
Sbjct: 69  FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKK------IIWQTLQAVNFCHK 118

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY--- 942
               + +HRDVK  NIL+ ++ +  L DFG +R+L        TD V T  Y  PE    
Sbjct: 119 ---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRWYRAPELLVG 174

Query: 943 -SQTLTATCRGDVYSFGVVLLELLTG 967
            +Q        DV++ G V  ELLTG
Sbjct: 175 DTQYGPPV---DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 18/215 (8%)

Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVS 827
           F    ++G G +G VYK       + A  ++    G  E E + E+  L + + H+N+ +
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 828 LQGYCRHGN-----DRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             G     N     D+L L+  +   GS+   +  +  K + LK +    I +   RGL+
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLS 125

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           +LH   +  ++HRD+K  N+LL E  E  L DFG+S  L        T  +GT  ++ PE
Sbjct: 126 HLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPE 181

Query: 942 Y-----SQTLTATCRGDVYSFGVVLLELLTGRRPV 971
                 +   T   + D++S G+  +E+  G  P+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 15/183 (8%)

Query: 795 AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYW 853
           AVK L  D  +  R +F  E++ +SR ++ N++ L G C   +   +I  YMENG L+ +
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107

Query: 854 LHE---------SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD 904
           L +         + +  SV   ++ L +A   A G+ YL  +   + VHRD+ + N L+ 
Sbjct: 108 LSQREIESTFTHANNIPSVSIANL-LYMAVQIASGMKYLASL---NFVHRDLATRNCLVG 163

Query: 905 EKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLE 963
             +   +ADFG+SR L   D + +    V  + ++  E       T   DV++FGV L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 964 LLT 966
           + T
Sbjct: 224 MFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 4e-13
 Identities = 67/239 (28%), Positives = 93/239 (38%), Gaps = 45/239 (18%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMERE----FQAEVEALSRA 820
           ++F    +IG G FG V+       T    A+K L      ++R      +AE + L+ A
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVR-DKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILADA 58

Query: 821 QHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
               +V L  Y     + L L+  YM  G L   L   + KD   +   R  IA+     
Sbjct: 59  DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELVL-A 113

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS--------RLLRPYDTHVTTDL 931
           L  +HK+     +HRD+K  NIL+D      LADFGL         R     D+H     
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 932 --------------------VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                               VGT  YI PE  +        D +S GV+L E+L G  P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 48/218 (22%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLV 826
           IG G +G+VYKA     G   A+K++     ++E E +        E+  L    H N+V
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI-----RLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL--KIAQGAARGLAYLH 884
            L       N   L++ +     LD  L + +D   +   D  L         +G+AY  
Sbjct: 62  RLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY-- 114

Query: 885 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 939
             C  H ++HRD+K  N+L+D +    LADFGL+R     +R Y TH     V TL Y  
Sbjct: 115 --CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THE----VVTLWYRA 167

Query: 940 PE-------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE       YS   T     D++S G +  E++  RRP
Sbjct: 168 PEILLGSRQYS---TPV---DIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 43/112 (38%), Positives = 56/112 (50%), Gaps = 12/112 (10%)

Query: 871 KIAQGAARGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLS-RLLRPYDTHVT 928
           K+     + L YL    E H ++HRDVK SNILLD      L DFG+S RL+   D+   
Sbjct: 118 KMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAK 171

Query: 929 TDLVGTLGYIPPEYSQTLTAT----CRGDVYSFGVVLLELLTGRRPVEVCKG 976
           T   G   Y+ PE             R DV+S G+ L+EL TG+ P + CK 
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 7e-13
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRA 820
           ++F + + +G G  G+V+K +         ++L           Q+ RE Q     L   
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQV----LHEC 60

Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
               +V   G      +  +   +M+ GSLD    + + K   +   +  K++    +GL
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGL 116

Query: 881 AYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
            YL    E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ 
Sbjct: 117 TYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMS 170

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           PE  Q    + + D++S G+ L+E+  GR P+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 71.8 bits (176), Expect = 7e-13
 Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 23/156 (14%)

Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL----VGTL 935
            L  +H V   H++HRD+KS+NILL       L DFG S++   Y   V+ D+     GT 
Sbjct: 153  LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM---YAATVSDDVGRTFCGTP 209

Query: 936  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
             Y+ PE  +    + + D++S GV+L ELLT +RP +   G+N  +++      + +   
Sbjct: 210  YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVMHKTLAGRYDPLP 266

Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031
              I               EM EI    +  DP+RRP
Sbjct: 267  PSISP-------------EMQEIVTALLSSDPKRRP 289

Length = 496

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 70.0 bits (171), Expect = 8e-13
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 16/202 (7%)

Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +G G FG V    Y     N G + AVK L     G    + + E+E L    H+N+V  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 829 QGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           +G C         LI  ++ +GSL  +L  + +K   +    +LK A    +G+ YL   
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG-- 126

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT--DLVGTLGYIPPEYSQ 944
                VHRD+ + N+L++ + +  + DFGL++ +     + T   DL   + +  PE   
Sbjct: 127 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 945 TLTATCRGDVYSFGVVLLELLT 966
                   DV+SFGV L ELLT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 70/230 (30%), Positives = 100/230 (43%), Gaps = 24/230 (10%)

Query: 774 IIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL---- 828
           IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     +LVS     
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSLVSTGDCP 57

Query: 829 ----QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
                 Y  H  D+L  I   M  G L Y L +        + ++R    +    GL ++
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ---HGVFSEKEMRFYATE-IILGLEHM 113

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
           H      +V+RD+K +NILLDE     ++D GL+        H +   VGT GY+ PE  
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 167

Query: 944 QTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 992
           Q  TA     D +S G +L +LL G  P    K K+  ++      +  E
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 69.7 bits (170), Expect = 9e-13
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 775 IGCGGFGLVYKATLTNG-------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 826
           +G G FG+VY+  +  G       T+ A+K ++      ER EF  E   +      ++V
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGL 880
            L G    G   L+I   M  G L  +L      ++ + V       K+ Q A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP- 939
           AYL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P 
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPV 185

Query: 940 ----PEYSQTLTATCRGDVYSFGVVLLELLT 966
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 69.6 bits (170), Expect = 9e-13
 Identities = 71/229 (31%), Positives = 98/229 (42%), Gaps = 21/229 (9%)

Query: 757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           L +  L   T+ +     IG G +G VYK T   +G+ AAVK L      ++ E +AE  
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYN 70

Query: 816 AL-SRAQHKNLVSLQGYCRH-----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR 869
            L S   H N+V   G         G    L+      GS+   +   +     L   + 
Sbjct: 71  ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130

Query: 870 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
             I  GA  GL +LH      I+HRDVK +NILL  +    L DFG+S  L        T
Sbjct: 131 SYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187

Query: 930 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
             VGT  ++ PE       Y  +  A C  DV+S G+  +EL  G  P+
Sbjct: 188 S-VGTPFWMAPEVIACEQQYDYSYDARC--DVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 70.2 bits (172), Expect = 9e-13
 Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 34/225 (15%)

Query: 767 NNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMERE---FQAEVEALSR 819
            +F+  +++G G FG V     KAT   G   A+K +       +     F+ E + LS 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 820 AQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQG 875
           +    +  LQ Y     D L L+  Y   G L   L+   +  D+D    +   L +A  
Sbjct: 58  SNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA-- 114

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS-RLLRPYDTHVTTDL-VG 933
                  +H V +   VHRD+K  N+L+D      LADFG + RL    +  V + L VG
Sbjct: 115 -------IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA--NKMVNSKLPVG 165

Query: 934 TLGYIPPEYSQTLTATCRG------DVYSFGVVLLELLTGRRPVE 972
           T  YI PE   T+    +G      D +S GV+  E++ GR P  
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 70.4 bits (172), Expect = 1e-12
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 19/228 (8%)

Query: 768 NFNQANIIGCGGFG---LVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA---- 820
           NF    ++G G +G   LV K T  +  K    ++      +++    E     R     
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 821 --QHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
             Q   LV+L  Y      +L LI  Y+  G +   L++   +D+  + +VR    +   
Sbjct: 61  VRQSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGE-II 115

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
             L +LHK+    IV+RD+K  NILLD +    L DFGLS+     +   T    GT+ Y
Sbjct: 116 LALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 938 IPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
           + PE  +      +  D +S G+++ ELLTG  P  +   +N +  VS
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 20/191 (10%)

Query: 792 TKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGS 849
           TK AVK L  D  + +  +  +E+E +    +HKN+++L G C       +I  Y   G+
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110

Query: 850 L------------DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDV 896
           L            +Y  + +   +  L +   +  A   ARG+ YL  K C    +HRD+
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC----IHRDL 166

Query: 897 KSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVY 955
            + N+L+ E     +ADFGL+R +   D +  TT+    + ++ PE       T + DV+
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226

Query: 956 SFGVVLLELLT 966
           SFGV+L E+ T
Sbjct: 227 SFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 1e-12
 Identities = 67/227 (29%), Positives = 100/227 (44%), Gaps = 51/227 (22%)

Query: 773 NIIGC---GGFGLVYKATLTN---GTKAAVKRLSGDCGQME-------REFQAEVEALSR 819
            I GC   G +G VYKA   N   G + A+K+  GD  Q         RE      AL R
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREI-----ALLR 57

Query: 820 A-QHKNLVSLQGYCRHGNDRL--LIYSYMENGSLDYW----LHESVDKDSVLKWDVRLKI 872
             +H+N+VSL        D+   L++ Y E+   D W     H    + S+    V+  +
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLL 114

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLSRLLR-PYDTHV 927
            Q    G+ YLH      ++HRD+K +NIL+     E+    + D GL+RL   P     
Sbjct: 115 WQ-ILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 928 TTD-LVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLT 966
             D +V T+ Y  PE       Y++ +      D+++ G +  ELLT
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAI------DIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 34/277 (12%)

Query: 775  IGCGGFGLVYKATLTNGT---KAAVKRLS-GDCGQMERE-FQAEVEALSRAQHKNLVSLQ 829
            +G G FG V +  L       K AVK +    C + E E F +E   +    H N++ L 
Sbjct: 7    LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 830  GYCRHGNDR------LLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAARGLA 881
            G C    +       ++I  +M++G L  +L  S   D    L   + +K     A G+ 
Sbjct: 67   GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 882  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT-LGYIPP 940
            YL        +HRD+ + N +L+E     +ADFGLS+ +   D +    +    + +I  
Sbjct: 127  YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 941  EYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 999
            E       T + DV+SFGV + E+ T G+ P     G    ++  ++ Q    K+  + +
Sbjct: 184  ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY---PGVENSEIYDYLRQGNRLKQPPDCL 240

Query: 1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            D              +  +   C   +P+ RP  E +
Sbjct: 241  DG-------------LYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 16/205 (7%)

Query: 774 IIGCGGFGLVYKATLTNGTK----AAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSL 828
           I+G G FG + +  L   +K     A+  L   C  +  R F AE   L +  H N+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           +G    GN  +++  YM NG+LD +L +   +    +    + +  G A G+ YL    E
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPGLASGMKYL---SE 125

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG--TLGYIPPEYSQTL 946
              VH+ + +  +L++      ++ F   RL       + T + G   + +  PE  Q  
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             +   DV+SFG+V+ E+++ G RP
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)

Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGD--CGQMEREFQA---EVEALSRAQ 821
           N+    ++G G FG VY       G + AVK++  D    +  +E  A   E++ L    
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 822 HKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
           H+ +V   G  R   +R L     +M  GS+     + +     L  +V  K  +    G
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGY 937
           ++YLH      IVHRD+K +NIL D      L DFG S+ L+      T    + GT  +
Sbjct: 119 VSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           + PE         + D++S G  ++E+LT + P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.5 bits (170), Expect = 2e-12
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 18/208 (8%)

Query: 766 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQH 822
           TN +     +G G FGLV  A     G   A+K++        + +    E++ L   +H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 823 KNLVSLQG-YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           +N++SL   +     D   IY   E    D  LH  +    + K  ++  + Q   RGL 
Sbjct: 69  ENIISLSDIFISPLED---IYFVTELLGTD--LHRLLTSRPLEKQFIQYFLYQ-ILRGLK 122

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y+H      +VHRD+K SNIL++E  +  + DFGL+   R  D  + T  V T  Y  PE
Sbjct: 123 YVHSA---GVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQM-TGYVSTRYYRAPE 175

Query: 942 YSQTLTA-TCRGDVYSFGVVLLELLTGR 968
              T        D++S G +  E+L G+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 12/181 (6%)

Query: 795 AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYW 853
           AVK L  D  +  R +F  E++ +SR +  N++ L   C   +   +I  YMENG L+ +
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109

Query: 854 LHESVDKDSVLKWDVR-------LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK 906
           L     +++  K DV        + +A   A G+ YL  +   + VHRD+ + N L+ + 
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKN 166

Query: 907 FEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL 965
           +   +ADFG+SR L   D + +    V  + ++  E       T   DV++FGV L E+L
Sbjct: 167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Query: 966 T 966
           T
Sbjct: 227 T 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 72/219 (32%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 774 IIGCGGFGLVY---KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ- 829
           IIG GGFG VY   KA    G   A+K L     +M+   Q E  AL+     +LVS   
Sbjct: 1   IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMK---QGETLALNERIMLSLVSTGD 55

Query: 830 -------GYCRHGNDRL-LIYSYMENGSLDYWLHE-SVDKDSVLKWDVRLKIAQGAARGL 880
                   Y  H  D+L  I   M  G L Y L +  V  ++    ++R   A+    GL
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----EMRFYAAE-IILGL 110

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT GY+ P
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 164

Query: 941 EYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
           E  Q   A     D +S G +L +LL G  P    K K+
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 68/295 (23%), Positives = 127/295 (43%), Gaps = 43/295 (14%)

Query: 769  FNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQH 822
            F    ++G G FG V +A L     +  K AVK L  D        EF  E   +    H
Sbjct: 1    FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 823  KNLVSLQGYCRHGNDR------LLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQ 874
             N++ L G       +      ++I  +M++G L  +L  S   ++   L     ++   
Sbjct: 61   PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 875  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
              A G+ YL      + +HRD+ + N +L+E     +ADFGLS+ +   D +      G 
Sbjct: 121  DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ----GC 173

Query: 935  LGYIPPEYS--QTLTA---TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQ 988
               +P ++   ++L     T   DV++FGV + E++T G+ P     G    ++ +++ +
Sbjct: 174  ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY---AGVENSEIYNYLIK 230

Query: 989  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                K+  + ++             ++ E+ C+C   +P+ RP  + +   L+ I
Sbjct: 231  GNRLKQPPDCLE-------------DVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 39/211 (18%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE----FQA--EVEALSRAQHKNLVS 827
           +G G +  VYK  +   G   A+K +      +E E    F A  E   L   +H N+V+
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIR-----LEHEEGAPFTAIREASLLKDLKHANIVT 67

Query: 828 LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDK-DSVLKWD-VRLKIAQGAARGLAYLH 884
           L     H    L L++ Y++       L + +D     L    VRL + Q   RGLAY H
Sbjct: 68  LHDII-HTKKTLTLVFEYLDTD-----LKQYMDDCGGGLSMHNVRLFLFQ-LLRGLAYCH 120

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP---- 940
           +     ++HRD+K  N+L+ E+ E  LADFGL+R  +   +   ++ V TL Y PP    
Sbjct: 121 Q---RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLL 176

Query: 941 ---EYSQTLTATCRGDVYSFGVVLLELLTGR 968
              EYS +L      D++  G +  E+ TGR
Sbjct: 177 GSTEYSTSL------DMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG VYKA     G  AA K +     +   ++  E+E L+   H  +V L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 ++  +   G++D  + E    D  L       I +     L YLH +    I+H
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIH 133

Query: 894 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPE--YSQTLT 947
           RD+K+ N+LL    +  LADFG+S    + L+  D+      +GT  ++ PE    +T+ 
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-----FIGTPYWMAPEVVMCETMK 188

Query: 948 AT---CRGDVYSFGVVLLEL 964
            T    + D++S G+ L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 54/163 (33%), Positives = 84/163 (51%), Gaps = 21/163 (12%)

Query: 813 EVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           EV  L   +H N+V+L           L++ Y+++  L  +L    +  S+   +V++ +
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSM--HNVKIFM 109

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            Q   RGL+Y HK     I+HRD+K  N+L++EK E  LADFGL+R  +   T   ++ V
Sbjct: 110 FQ-LLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEV 164

Query: 933 GTLGYIPP-------EYSQTLTATCRGDVYSFGVVLLELLTGR 968
            TL Y PP       EYS  +      D++  G +L E+ TGR
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPI------DMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 12/123 (9%)

Query: 867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 926
           +VR+ IA+     L +LH++    I++RD+K  NILLD +    L DFGLS+     +  
Sbjct: 106 EVRVYIAE-IVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161

Query: 927 VTTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRD 981
                 GT+ Y+ PE  +  +    G     D +S GV+  ELLTG  P  V   +N + 
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGS---GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218

Query: 982 LVS 984
            +S
Sbjct: 219 EIS 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 30/224 (13%)

Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTK----AAVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
               A+G+ YL    E  +VHRD+ + N+L+       + DFGL++LL   +     +  
Sbjct: 119 ----AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE-- 169

Query: 933 GTLGYIPP-----EYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
              G +P      E       T + DV+S+GV + EL+T G +P
Sbjct: 170 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 12/198 (6%)

Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
            G++  ++  ++E G+L D   H  ++++ +        +     + L+ LH      ++
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLKALSVLHA---QGVI 138

Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L      
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 953 DVYSFGVVLLELLTGRRP 970
           D++S G++++E++ G  P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 21/200 (10%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG VYKA     G  AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
           + N+  ++  +   G++D  + E   +  + +  +R+ + +     L YLH   E  I+H
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLEL--ERPLTEPQIRV-VCKQTLEALNYLH---ENKIIH 126

Query: 894 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
           RD+K+ NIL     +  LADFG+S    R ++  D+      +GT  ++ PE     T+ 
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYWMAPEVVMCETSK 181

Query: 950 CR-----GDVYSFGVVLLEL 964
            R      DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.5 bits (165), Expect = 5e-12
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 17/208 (8%)

Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKN 824
           NF Q   +G G +  VYK    T G   A+K   L  + G      + E+  +   +H+N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V L       N  +L++ YM+     Y   ++      L  +          +G+A+ H
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYM--DTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDLVGTLGYIPPEY- 942
              E  ++HRD+K  N+L++++ E  LADFGL+R    P +T  + ++V TL Y  P+  
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TLWYRAPDVL 172

Query: 943 --SQTLTATCRGDVYSFGVVLLELLTGR 968
             S+T + +   D++S G ++ E++TGR
Sbjct: 173 LGSRTYSTSI--DIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 6e-12
 Identities = 72/231 (31%), Positives = 108/231 (46%), Gaps = 33/231 (14%)

Query: 774 IIGCGGFG---LVYKATLTN-GTKAAVKRLSGDC--------GQMEREFQAEVEALSRAQ 821
           ++G G FG   LV K T  + G   A+K L             +MER+  AEV       
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56

Query: 822 HKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           H  +V L  Y      +L LI  ++  G L   L + V      + DV+  +A+  A  L
Sbjct: 57  HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALAL 111

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGTLGYIP 939
            +LH +    I++RD+K  NILLDE+    L DFGLS+     D         GT+ Y+ 
Sbjct: 112 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMA 166

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           PE       T   D +SFGV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ---GKDRKETMTMILKAK 214

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.4 bits (164), Expect = 6e-12
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 12/198 (6%)

Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  AT  + G + AVK++     Q       EV  +    H+N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
            G++  ++  ++E G+L D   H  ++++ +        +     R L+YLH      ++
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHN---QGVI 140

Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L      
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 953 DVYSFGVVLLELLTGRRP 970
           D++S G++++E++ G  P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 57/237 (24%)

Query: 767 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALS 818
           + + +   IG G FG V+KA         A+K++      ME E +        E++ L 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPITALREIKILQ 66

Query: 819 RAQHKNLVSLQGYCR-----HGNDRLLIYSYME-----------NGSLDYWLHESVDKDS 862
             +H+N+V+L   CR     +   +   Y   E           N ++ + L E      
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE------ 120

Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---L 919
            +K     K+ +    GL Y+H+     I+HRD+K++NIL+ +     LADFGL+R   L
Sbjct: 121 -IK-----KVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSL 171

Query: 920 LRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRPV 971
            +    +  T+ V TL Y PPE    L    R      D++  G ++ E+ T R P+
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPE----LLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.5 bits (162), Expect = 7e-12
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)

Query: 775 IGCGGFGLVYKATLTNGTK---AAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 830
           +G G FG V K       K    A+K L  +  +  R E   E E + +  +  +V + G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
            C      +L+      G L+ +L  S  KD +   +V   + Q  + G+ YL      +
Sbjct: 63  VCE-AEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQ-VSMGMKYLE---GKN 115

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLTA 948
            VHRD+ + N+LL  +  A ++DFGLS+ L   D++      G   L +  PE       
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 949 TCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
           + R DV+S+G+ + E  + G++P +  KG
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKG 204

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 35/282 (12%)

Query: 766  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQAEVEALSRA 820
              NF     IG G F +VYKA  L +G   A+K++      D    +   + E++ L + 
Sbjct: 1    LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 821  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES------VDKDSVLKWDVRLKIAQ 874
             H N++         N+  ++    + G L   +         + + ++ K+ V+L    
Sbjct: 60   DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL---- 115

Query: 875  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
                 L ++H      I+HRD+K +N+ +       L D GL R      T     LVGT
Sbjct: 116  --CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGT 169

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 994
              Y+ PE         + D++S G +L E+   + P    K  N   L     + K EK 
Sbjct: 170  PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSL----CK-KIEKC 223

Query: 995  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            +   + A  +     ++L +++     CI+ DP +RP I  V
Sbjct: 224  DYPPLPADHY----SEELRDLVSR---CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.8 bits (163), Expect = 9e-12
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 45/222 (20%)

Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKN 824
           NF +   IG G +G+VYKA     G   A+K  RL  +   +      E+  L    H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA----R 878
           +V L       N   L++ +         LH+ + K  D+     + L + +       +
Sbjct: 61  IVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111

Query: 879 GLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVG 933
           GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R     +R Y TH     V 
Sbjct: 112 GLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THE----VV 162

Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS   TA    D++S G +  E++T R
Sbjct: 163 TLWYRAPEILLGCKYYS---TAV---DIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.5 bits (170), Expect = 9e-12
 Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 34/202 (16%)

Query: 791 GTKAAVKRLSGDCGQMERE---FQAEVEALSRAQHKNLVSL--QGYCRHGNDRLL-IYSY 844
           G + A+K L  D  + E +   F+ E    +R  H N+V+L   G        L  ++ Y
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA--PPGLLFAVFEY 60

Query: 845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH---IVHRDVKSSNI 901
           +   +L            VL  D  L   +     L  L  +   H   IVHRD+K  NI
Sbjct: 61  VPGRTLR----------EVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNI 110

Query: 902 LL---DEKFEAHLADFGLSRLLRPYDTH--------VTTDLVGTLGYIPPEYSQTLTATC 950
           ++     +  A + DFG+  LL               TT+++GT  Y  PE  +    T 
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLP--GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 951 RGDVYSFGVVLLELLTGRRPVE 972
             D+Y++G++ LE LTG+R V+
Sbjct: 169 NSDLYAWGLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 1e-11
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 39/211 (18%)

Query: 775 IGCGGFGLVYK--ATLTNGTKAAVKRLSGDCGQMEREFQA------EVEALSRAQHKNLV 826
           +G G +  VYK  + LT+    A+K +     ++E E  A      EV  L   +H N+V
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEI-----RLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLAYLH 884
           +L           L++ Y     LD  L + +D   +S+   +V+L + Q   RGL Y H
Sbjct: 68  TLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQ-LLRGLNYCH 121

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP---- 940
           +     ++HRD+K  N+L++E+ E  LADFGL+R  +   T   ++ V TL Y PP    
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 941 ---EYSQTLTATCRGDVYSFGVVLLELLTGR 968
              +YS  +      D++  G +  E+ TGR
Sbjct: 178 GSTDYSTQI------DMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 46/216 (21%)

Query: 775 IGCGGFGLVYKAT--LTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNL 825
           IG G +G+VYKA   +TN T  A+K++     ++E+E +        E+  L   QH N+
Sbjct: 10  IGEGTYGVVYKARDRVTNET-IALKKI-----RLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 826 VSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRL--KIAQGAARGLAY 882
           V LQ    H   RL L++ Y     LD  L + +D       + RL         RG+AY
Sbjct: 64  VRLQDVV-HSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 883 LHKVCEPH-IVHRDVKSSNILLDEKFEA-HLADFGLSRLLR-PYDTHVTTDLVGTLGYIP 939
               C  H ++HRD+K  N+L+D +  A  LADFGL+R    P  T   T  V TL Y  
Sbjct: 118 ----CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVTLWYRA 171

Query: 940 PE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           PE       YS  +      D++S G +  E++  +
Sbjct: 172 PEILLGSRHYSTPV------DIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)

Query: 769 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME-REFQAEVEALSR---AQHK 823
           + +  +IG G +G VY+   +  G   A+K ++ D    +  + Q EV  LS+   +Q  
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           N+    G    G    +I  Y E GS+      ++ K   +       I +     L Y+
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSV-----RTLMKAGPIAEKYISVIIREVLVALKYI 117

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
           HKV    ++HRD+K++NIL+       L DFG++ LL    +  +T  VGT  ++ PE  
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVI 173

Query: 944 QTLTA-TCRGDVYSFGVVLLELLTGRRP 970
                   + D++S G+ + E+ TG  P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 43/271 (15%)

Query: 775  IGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVS 827
            +G GGFG V     +AT   G   A K+L+    +  + ++    E   L++   + +VS
Sbjct: 1    LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57

Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHK 885
            L    +   D  L+ + M  G L Y ++ +VD+++    + R     AQ    GL +LH 
Sbjct: 58   LAYAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQ-IISGLEHLH- 114

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
              +  I++RD+K  N+LLD      ++D GL+  L+   +  T    GT G++ PE  Q 
Sbjct: 115  --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQG 171

Query: 946  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE--IIDASI 1003
                   D ++ GV L E++  R P    +G+            K E +E++  I++ S+
Sbjct: 172  EEYDFSVDYFALGVTLYEMIAARGPFR-ARGE------------KVENKELKQRILNDSV 218

Query: 1004 WHKDR----EKQLLEMLEIACKCIDQDPRRR 1030
             + D+     K   E L      + +DP +R
Sbjct: 219  TYPDKFSPASKSFCEAL------LAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 65/265 (24%), Positives = 107/265 (40%), Gaps = 34/265 (12%)

Query: 775  IGCGGFGLVYKATL-TNGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYC 832
            IG G FG V+   L  + T  AVK         ++ +F  E   L +  H N+V L G C
Sbjct: 3    IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 833  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                   ++   ++ G    +L     +   LK    +++ + AA G+ YL      H +
Sbjct: 63   TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLE---SKHCI 116

Query: 893  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTLT 947
            HRD+ + N L+ EK    ++DFG+SR     +        G +  IP     PE      
Sbjct: 117  HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 948  ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
             +   DV+SFG++L E  + G  P                +   S ++  E I+  +   
Sbjct: 173  YSSESDVWSFGILLWEAFSLGAVP----------------YANLSNQQTREAIEQGVRLP 216

Query: 1007 DREKQLLEMLEIACKCIDQDPRRRP 1031
              E     +  +  +C + DP +RP
Sbjct: 217  CPELCPDAVYRLMERCWEYDPGQRP 241

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 61/242 (25%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 824
           +G G +G V  A     G K A+K+LS       R FQ+E+ A         L   QH+N
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLS-------RPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHE-SVDKDSVLKWDVRLKIAQGAA 877
           ++ L              D  L+  YM+        H  S DK   L + +         
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------L 127

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---T 934
            GL Y+H      I+HRD+K  N+ ++E  E  + DFGL+R       H   ++ G   T
Sbjct: 128 CGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVT 177

Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 987
             Y  PE       Y+QT+      D++S G ++ E+LTG+    + KGK+  D ++ + 
Sbjct: 178 RWYRAPEVILNWMHYNQTV------DIWSVGCIMAEMLTGK---TLFKGKDYLDQLTQIL 228

Query: 988 QM 989
           ++
Sbjct: 229 KV 230

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 50/287 (17%)

Query: 780  FGLVYKATLTNGTKA------AVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            FG VYK  L            A+K L     G +  EF+ E    SR QH N+V L G  
Sbjct: 18   FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77

Query: 833  RHGNDRLLIYSYMENGSLDYWL-----HE---SVDKDSVLKWDVR----LKIAQGAARGL 880
                   +I+SY  +  L  +L     H    S D D  +K  +     + I    A G+
Sbjct: 78   TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137

Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT----LG 936
             +L      H+VH+D+ + N+L+ +K    ++D GL R +   D +    L+G     + 
Sbjct: 138  EFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNSLLPIR 191

Query: 937  YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
            ++ PE       +   D++S+GVVL E+ + G +P   C G + +D++  +       R+
Sbjct: 192  WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YC-GYSNQDVIEMI-----RNRQ 243

Query: 996  VEII--DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            V     D   W          +  +  +C ++ P RRP  +++ + L
Sbjct: 244  VLPCPDDCPAW----------VYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 31/227 (13%)

Query: 766 TNNFNQANIIGCGGFGLVYKAT-LTNGTK----AAVKRLSGDCGQMEREFQAEVE---AL 817
                +  ++G G FG V+K   +  G       A+K +    G+  + FQ   +   A+
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAM 63

Query: 818 SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQ 874
               H  +V L G C  G    L+      GSL   + +   S+D   +L W V++    
Sbjct: 64  GSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI---- 118

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
             A+G+ YL +     +VHR++ + NILL       +ADFG++ LL P D         T
Sbjct: 119 --AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173

Query: 935 -LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-------GRRPVEV 973
            + ++  E       T + DV+S+GV + E+++       G RP EV
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 23/210 (10%)

Query: 767 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEA--LSRAQ 821
           +++ +   +G G +  VYK  +  NG   A+K  RL  + G     F A  EA  L   +
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT---PFTAIREASLLKGLK 61

Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDVRLKIAQGAARG 879
           H N+V L           L++ Y+      Y     +DK    +   +V+L + Q   RG
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHTDLCQY-----MDKHPGGLHPENVKLFLFQ-LLRG 115

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L+Y+H   + +I+HRD+K  N+L+ +  E  LADFGL+R  +   +H  ++ V TL Y P
Sbjct: 116 LSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRP 171

Query: 940 PE--YSQTLTATCRGDVYSFGVVLLELLTG 967
           P+     T  +TC  D++  G + +E++ G
Sbjct: 172 PDVLLGSTEYSTCL-DMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 778 GGFGLVYKATLTNGT-----KAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 831
           G FG ++   L +       +  VK +     +++      E   L    H+N++ +   
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 832 CRHGNDR-LLIYSYMENGSLDYWL----HESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           C    +   ++Y YM  G+L  +L        +    L     + +A   A G++YLHK 
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG-TLGYIPPEYSQT 945
               ++H+D+ + N ++DE+ +  + D  LSR L P D H   D     + ++  E    
Sbjct: 137 ---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193

Query: 946 LTATCRGDVYSFGVVLLELLT 966
              +   DV+SFGV+L EL+T
Sbjct: 194 KEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 26/211 (12%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQ---HKNLVSL 828
           IG G +G VYKA    +G   A+K +     +  +      EV  L R +   H N+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 829 QGYCRHG-NDR----LLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIAQGAARGLA 881
              C     DR     L++ +     +D  L   +DK     L  +    + +   RGL 
Sbjct: 68  MDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPP 940
           +LH  C   IVHRD+K  NIL+    +  LADFGL+R+   Y   +  T +V TL Y  P
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAP 176

Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           E     T     D++S G +  E+   R+P+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.7 bits (160), Expect = 3e-11
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 49/217 (22%)

Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 824
           +G G +G V  A     G K A+K+L        R FQ+E+ A         L   +H+N
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMKHEN 75

Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             +D  L+  +M         HE + +D +     +  + Q   +
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRI-----QFLVYQ-MLK 129

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K  N+ ++E  E  + DFGL+   R  D+ +T  +V T  Y 
Sbjct: 130 GLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVV-TRWYR 182

Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ E+LTG+
Sbjct: 183 APEVILNWMHYTQTV------DIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 774 IIGCGGFGLVYKATLTN-GTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
           ++G G +G+V K      G   A+K+   S D   +++    E+  L + +H+NLV+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
             R      L++ ++++  LD         D      VR  + Q   RG+ + H     +
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR---VRKYLFQ-ILRGIEFCHS---HN 120

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
           I+HRD+K  NIL+ +     L DFG +R L  P +  V TD V T  Y  PE     T  
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKY 178

Query: 950 CRG-DVYSFGVVLLELLTG 967
            R  D+++ G ++ E+LTG
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 49/163 (30%), Positives = 83/163 (50%), Gaps = 21/163 (12%)

Query: 813 EVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           EV  L   +H N+V+L           L++ Y++   L  ++ +  +  S+   +V++ +
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSM--HNVKIFL 110

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            Q   RGLAY H+     ++HRD+K  N+L++E+ E  LADFGL+R  +   T   ++ V
Sbjct: 111 YQ-ILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEV 165

Query: 933 GTLGYIPP-------EYSQTLTATCRGDVYSFGVVLLELLTGR 968
            TL Y PP       EYS  +      D++  G +  E+ +GR
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQI------DMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 35/209 (16%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE----FQAEVEA--LSRAQHKNLVS 827
           +G G +  VYK  +  NG   A+K +S     M+ E    F A  EA  L   +H N+V 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVIS-----MKTEEGVPFTAIREASLLKGLKHANIVL 67

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L            ++ YM      Y +        +  ++VRL + Q   RGLAY+H   
Sbjct: 68  LHDIIHTKETLTFVFEYMHTDLAQYMIQHP---GGLHPYNVRLFMFQ-LLRGLAYIHG-- 121

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDLVGTLGYIPP------ 940
             HI+HRD+K  N+L+    E  LADFGL+R    P  T+ +   V TL Y PP      
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE--VVTLWYRPPDVLLGA 178

Query: 941 -EYSQTLTATCRGDVYSFGVVLLELLTGR 968
            +YS  L      D++  G + +E+L G+
Sbjct: 179 TDYSSAL------DIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 46/294 (15%)

Query: 762  LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTK----AAVKRLSGDCG-QMEREFQAEVE 815
            +LK T    +  ++G G FG VYK   + +G       A+K L  +   +  +E   E  
Sbjct: 3    ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 816  ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
             ++      +  L G C     +L +   M  G L  ++ E+ D+     +L W V++  
Sbjct: 62   VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI-- 118

Query: 873  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
                A+G++YL +V    +VHRD+ + N+L+       + DFGL+RLL   +T    D  
Sbjct: 119  ----AKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-- 169

Query: 933  GTLGYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV 986
               G +P ++    +      T + DV+S+GV + EL+T G +P +    +   DL+   
Sbjct: 170  --GGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL--- 224

Query: 987  FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQD--PRRRPFIEEVVT 1038
                 EK E  +    I   D     + M+ + C  ID +  PR R  ++E   
Sbjct: 225  -----EKGE-RLPQPPICTID-----VYMIMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 75/277 (27%), Positives = 111/277 (40%), Gaps = 31/277 (11%)

Query: 775  IGCGGFGLVYKATLTNG---TKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQG 830
            IG G FG V    + +G    +  VK L      Q + +F  E +     QH NL+   G
Sbjct: 3    IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 831  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL--KIAQGAARGLAYLHKVCE 888
             C      LL+  +   G L  +L  S  K  ++  D     ++A   A GL +LHK   
Sbjct: 63   QCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118

Query: 889  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE-----Y 942
             + +H D+   N LL       + D+GLS      D +VT D L   L +I PE     +
Sbjct: 119  NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 943  SQTLTA--TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 999
               L    T   +V+S GV + EL   G +P      +          Q+K  K  +++ 
Sbjct: 179  GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238

Query: 1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
             +  W+           E+   C  Q P +RP  EEV
Sbjct: 239  LSDRWY-----------EVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 46/197 (23%), Positives = 92/197 (46%), Gaps = 10/197 (5%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G V+ A  +  G + A+K+++      +     E+  +   ++ N+V+      
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G++  ++  Y+  GSL   + E+   ++ +       + +   + L +LH      ++H
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLHA---NQVIH 138

Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+KS N+LL       L DFG    + P  +  +T +VGT  ++ PE         + D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 954 VYSFGVVLLELLTGRRP 970
           ++S G++ +E++ G  P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.2 bits (159), Expect = 5e-11
 Identities = 61/239 (25%), Positives = 92/239 (38%), Gaps = 65/239 (27%)

Query: 773 NIIGCGGFGLVYKATLTN-GTKAAVKRLS---------------GDCGQMEREFQA--EV 814
             +G G +G V KA  T  G   A+K++                G CG     F    E+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI---HFTTLREL 71

Query: 815 EALSRAQHKNLVSLQG-YCRHG--NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
           + ++  +H+N++ L   Y      N   L+   M +           D   V+   +RL 
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFIN---LVMDIMAS-----------DLKKVVDRKIRLT 117

Query: 872 IAQGAA------RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR------L 919
            +Q          GL  LHK    + +HRD+  +NI ++ K    +ADFGL+R       
Sbjct: 118 ESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174

Query: 920 LRPYDTHVT-------TDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGR 968
                   T       T  V TL Y  PE    + A       D++S G +  ELLTG+
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYRAPEL--LMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 6e-11
 Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 448 LALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEI 507
           L L N GL+G IP  + + + LQ ++LS N   GNIPP +G + +L  LD S N+  G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 508 PKSLTELKSL----ISSNCTSSN-PTASAGIPLY 536
           P+SL +L SL    ++ N  S   P A  G  L+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH 516

Length = 623

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 6e-11
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)

Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 77

Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 78  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 131

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 132 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 184

Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 185 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 6e-11
 Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREF-QAEVEALSRAQHKNLVSLQGYC 832
           IG G FG VYKA         A+K +  +  + E E  Q E++ LS+ +   +    G  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68

Query: 833 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
             G+   +I  Y   GS    L     K   L       I +    GL YLH   E   +
Sbjct: 69  LKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLH---EEGKI 120

Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT---DLVGTLGYIPPEYSQTLTAT 949
           HRD+K++NILL E+ +  LADFG+S  L    T   +     VGT  ++ PE  +     
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQL----TSTMSKRNTFVGTPFWMAPEVIKQSGYD 176

Query: 950 CRGDVYSFGVVLLELLTGRRP 970
            + D++S G+  +EL  G  P
Sbjct: 177 EKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 64.3 bits (156), Expect = 6e-11
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 23/225 (10%)

Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD-CGQMEREFQA--EVEALSRAQHKN 824
           F Q  ++G GGFG V    +   G   A K+L      + + E  A  E + L +   + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 825 LVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           +VSL  Y     D L L+ + M  G L + ++     ++  +    +  A     GL  L
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDL 118

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGYI 938
           H+     IV+RD+K  NILLD+     ++D GL+        HV         VGT+GY+
Sbjct: 119 HQ---ERIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGYM 168

Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 983
            PE  +    T   D ++ G +L E++ G+ P +  K K  R+ V
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 64.7 bits (157), Expect = 7e-11
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 21/215 (9%)

Query: 768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQHK 823
           +F    +IG G FG V    L N  K    ++      ++R     F+ E + L    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAY 882
            + +L    +  N+  L+  Y   G L   L +  D+   L  D+ R  +A+     +  
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYLAEM----VIA 114

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
           +  V + H VHRD+K  NIL+D      LADFG    L    T  ++  VGT  YI PE 
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 943 SQTLT-------ATCRGDVYSFGVVLLELLTGRRP 970
            Q +          C  D +S GV + E+L G  P
Sbjct: 175 LQAMEDGKGKYGPEC--DWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 64.2 bits (156), Expect = 7e-11
 Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 10/197 (5%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G VY A  +  G + A+K+++      +     E+  +   +H N+V+      
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G++  ++  Y+  GSL   + E+   +  +       + +   + L +LH      ++H
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLH---SNQVIH 138

Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+KS NILL       L DFG    + P  +  +T +VGT  ++ PE         + D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 954 VYSFGVVLLELLTGRRP 970
           ++S G++ +E++ G  P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.0 bits (155), Expect = 7e-11
 Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 13/215 (6%)

Query: 757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           ++V D  K    F +   IG G  G VY A  +  G + A+K+++      +     E+ 
Sbjct: 12  VSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEIL 68

Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
            +   ++ N+V+       G++  ++  Y+  GSL   + E+   +  +       + + 
Sbjct: 69  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRE 123

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
             + L +LH      ++HRD+KS NILL       L DFG    + P  +  +T +VGT 
Sbjct: 124 CLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTP 179

Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            ++ PE         + D++S G++ +E++ G  P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.7 bits (155), Expect = 8e-11
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)

Query: 775 IGCGGFGLVYKATLTNGTKA--AVKRLS---GDCGQMEREFQAEVEAL--------SRAQ 821
           +G G FG VYK    N  +   A+K ++      G+ +RE    +  +         + +
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 822 HKNLVSLQGYCRH--GNDRL-LIYSYMENGSLDYWL------HESVDKDSVLKWDVRLKI 872
           H N+V    Y +    NDRL ++   +E   L           +   ++ +    V++ +
Sbjct: 68  HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
           A      L YLHK  E  IVHRD+  +NI+L E  +  + DFGL++  +P      T +V
Sbjct: 125 A------LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVV 174

Query: 933 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           GT+ Y  PE  +      + DV++FG +L ++ T
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.1 bits (156), Expect = 8e-11
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 774 IIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA-QHKNLVSL 828
           ++G G FG V  A L  +G   AVK L  D    + + +    E   LS A  H  L  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 829 QGYCRHGNDRLL-IYSYMENGSLDYWLHES--VDKDSVLKWDVRLKIAQGAARGLAYLHK 885
              C    DRL  +  ++  G L + + +S   D+     +   +  A      L +LH 
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA------LMFLH- 113

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
             +  I++RD+K  N+LLD +    LADFG+ +    ++   T+   GT  YI PE  Q 
Sbjct: 114 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQE 170

Query: 946 LTATCRGDVYSFGVVLLELLTGRRPVE 972
           +      D ++ GV+L E+L G  P E
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 17/209 (8%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEAL-SRAQHKNLVSLQGY- 831
           IG G +G V+K     NG+KAAVK L      ++ E +AE   L + + H N+V   G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 832 ----CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
                ++G+   L+      GS+   +   + +   ++  +   I   A  GL +LH   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--- 141

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY---SQ 944
               +HRDVK +NILL  +    L DFG+S  L        T  VGT  ++ PE     Q
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVIACEQ 200

Query: 945 TLTAT--CRGDVYSFGVVLLELLTGRRPV 971
            L +T   R DV+S G+  +EL  G  P+
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.2 bits (159), Expect = 1e-10
 Identities = 31/80 (38%), Positives = 46/80 (57%)

Query: 311 GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHD 370
           G +P  +S    L  ++L  NS+ G I  +   ++SL  LDL+ N F+G +P SL     
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 371 LKILSLAKNELSGQVPESFG 390
           L+IL+L  N LSG+VP + G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 25/218 (11%)

Query: 775 IGCGGFGLVYKATLTNGTKAAV------KRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +G GGFG V    + N  K         KRL    G  E+    E E L +     +V+L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG--EKMALLEKEILEKVNSPFIVNL 58

Query: 829 QGYCRHGNDRL-LIYSYMENGSLDYWLHE----SVDKDSVLKWDVRLKIAQGAARGLAYL 883
             Y       L L+ S M  G L Y ++      ++ + V+ +  ++        G+ +L
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI------TCGILHL 111

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
           H +    IV+RD+K  N+LLD++    L+D GL+  L+  D    T   GT GY+ PE  
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEIL 166

Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD 981
           +    +   D ++ G  + E++ GR P +  K K  ++
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 63.3 bits (155), Expect = 1e-10
 Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 29/215 (13%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGD----CGQMEREFQAEVEALSRAQ 821
           ++F     +G G FG V         K  A+K LS        Q+E     E   L   +
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL-NEKRILQSIR 59

Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGL 880
           H  LV+L G  +  ++  L+  Y+  G L   L     K       V R   AQ     L
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVL-AL 114

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            YLH +    IV+RD+K  N+LLD      + DFG ++ ++      T  L GT  Y+ P
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----RTYTLCGTPEYLAP 167

Query: 941 EYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 970
           E         +G     D ++ G+++ E+L G  P
Sbjct: 168 EIIL-----SKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 18/187 (9%)

Query: 795 AVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY 852
           AVK L  D  + +  +  +E+E +    +HKN+++L G C       +I  Y   G+L  
Sbjct: 51  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110

Query: 853 WLHESVDKDSVLKWDVR------------LKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
           +L           +D+             +      ARG+ YL        +HRD+ + N
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARN 167

Query: 901 ILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGV 959
           +L+ E     +ADFGL+R +   D +  TT+    + ++ PE       T + DV+SFGV
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 227

Query: 960 VLLELLT 966
           ++ E+ T
Sbjct: 228 LMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 57/224 (25%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLV 826
           IG G +G+VYK      G   A+K++     ++E E +        E+  L   QH N+V
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIREISLLKELQHPNIV 62

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
            LQ      +   LI+ ++   S+D   + +S+ K   +           A    +YL++
Sbjct: 63  CLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMD----------AELVKSYLYQ 109

Query: 886 V------CEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGT 934
           +      C    ++HRD+K  N+L+D K    LADFGL+R     +R Y TH     V T
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY-THE----VVT 164

Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           L Y  PE       YS         D++S G +  E+ T ++P+
Sbjct: 165 LWYRAPEVLLGSPRYS------TPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 64.2 bits (156), Expect = 1e-10
 Identities = 97/399 (24%), Positives = 154/399 (38%), Gaps = 62/399 (15%)

Query: 111 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL 170
           L+LS N L  ++P  LS L  L++L  S  + S   S  L  L  + SL+++ N    ++
Sbjct: 52  LNLSSNTLL-LLPSSLSRLLSLDLLSPS-GISSLDGSENLLNLLPLPSLDLNLNRLRSNI 109

Query: 171 FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQL 230
            EL E +NL   ++ NN+ T  +   I      ++ LDLS N                  
Sbjct: 110 SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI---------------- 152

Query: 231 HVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLP 290
                     LP  L ++ +L+++ LS N+ S  L + +SNL++L +L + GN+ S  LP
Sbjct: 153 --------ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLP 202

Query: 291 NVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTL 350
             +  L+ LE     +NS    L  SLS    L  L+L NN L                 
Sbjct: 203 PEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE---------------- 245

Query: 351 DLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF-NHLS 409
                     LP S+ +  +L+ L L+ N++S     S G LT+L  L LS NS  N L 
Sbjct: 246 ---------DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALP 294

Query: 410 GTLSVLQQCKNLTTLILTKN--FVGEEIPENVGGFESLMVLALGNC--GLKGHIPVWLLR 465
               +L   + L  L+LT     +            S    +       L+    +W L 
Sbjct: 295 LIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLD 354

Query: 466 CKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLT 504
               +     +   + N    +  +              
Sbjct: 355 NALDESNLNRYIVKNPNAIGSLLDLVKKHVNQLLEKVNY 393

Length = 394

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 774 IIGCGGFGLVYKATLTNGTK-AAVKRLSGD---------CGQMEREFQAEVEALSRAQHK 823
           ++G G FG V  A L    +  A+K L  D         C  +ER     V AL+  +H 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERR----VLALA-WEHP 56

Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA--RG 879
            L  L  +C       L +   Y+  G L + +  S       ++D        A    G
Sbjct: 57  FLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSS------GRFDEARARFYAAEIICG 108

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L +LHK     I++RD+K  N+LLD+     +ADFG+ +     +   +T   GT  YI 
Sbjct: 109 LQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE  +        D +SFGV+L E+L G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 13/215 (6%)

Query: 757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 13  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69

Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
            +   ++ N+V+       G++  ++  Y+  GSL   + E+   +  +       + + 
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRE 124

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
             + L +LH      ++HRD+KS NILL       L DFG    + P  +   + +VGT 
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTP 180

Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            ++ PE         + D++S G++ +E++ G  P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 30/210 (14%)

Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRL---SGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
           IG G +G V+KA         A+KR+     D G      + E+  L   +HKN+V L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66

Query: 831 YCRHGNDRL-LIYSYMENGSLDYW--LHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
              H + +L L++ Y +     Y+   +  +D + V  +  +L       +GLA+ H   
Sbjct: 67  VL-HSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCH--- 116

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIPPE-- 941
             +++HRD+K  N+L+++  E  LADFGL+R     +R Y   V      TL Y PP+  
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVL 171

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           +   L +T   D++S G +  EL    RP+
Sbjct: 172 FGAKLYSTSI-DMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 67/286 (23%), Positives = 113/286 (39%), Gaps = 47/286 (16%)

Query: 768  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----------GDCGQMEREFQAEVEA 816
            NF     IG G F  VY+AT L +G   A+K++            DC +       E++ 
Sbjct: 3    NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-------EIDL 55

Query: 817  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES------VDKDSVLKWDVRL 870
            L +  H N++         N+  ++    + G L   +         + + +V K+ V+L
Sbjct: 56   LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115

Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 930
                     L ++H      ++HRD+K +N+ +       L D GL R      T     
Sbjct: 116  ------CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHS 165

Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
            LVGT  Y+ PE         + D++S G +L E+   + P    K             + 
Sbjct: 166  LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLY 214

Query: 991  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            S  +++E  D      D   +  E+ ++   CI+ DP +RP I  V
Sbjct: 215  SLCKKIEQCDYPPLPSDHYSE--ELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 62/214 (28%), Positives = 90/214 (42%), Gaps = 35/214 (16%)

Query: 774 IIGCGGFGLVYKATLTN--GTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
            IG G FG VY+    +    K   AVK          RE F  E   + +  H ++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 829 QGYCRHGNDRLLIYSYME---NGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAY 882
            G          ++  ME    G L  +L     S+D  S++ +  +L  A      LAY
Sbjct: 73  IGVITENP----VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA------LAY 122

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL--GYIPP 940
           L        VHRD+ + N+L+       L DFGLSR L   D        G L   ++ P
Sbjct: 123 LESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE--DESYYKASKGKLPIKWMAP 177

Query: 941 E---YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
           E   + +  +A+   DV+ FGV + E+L  G +P
Sbjct: 178 ESINFRRFTSAS---DVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 20/191 (10%)

Query: 792 TKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGS 849
              AVK L  D    +  +  +E+E +    +HKN+++L G C       ++  Y   G+
Sbjct: 45  VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104

Query: 850 L------------DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDV 896
           L            DY        +  L +   +  A   ARG+ YL  + C    +HRD+
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDL 160

Query: 897 KSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVY 955
            + N+L+ E     +ADFGL+R +   D +  TT+    + ++ PE       T + DV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220

Query: 956 SFGVVLLELLT 966
           SFGV+L E+ T
Sbjct: 221 SFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS---------VLKWDVRLKIAQGAAR 878
           L G    G   L++   M +G L  +L  S+  ++          L+    +++A   A 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQ--EMIQMAAEIAD 130

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           G+AYL+       VHRD+ + N ++   F   + DFG++R +   D +      G  G +
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLL 183

Query: 939 P-----PEYSQTLTATCRGDVYSFGVVLLELLT 966
           P     PE  +    T   D++SFGVVL E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 61/228 (26%), Positives = 89/228 (39%), Gaps = 22/228 (9%)

Query: 750 QNSDCKDLTVSDLLKSTNNFNQANIIGC---GGFGLVYKATL---TNGTKAAVKRLSGDC 803
               C+  + SD         Q NI+     G  G V+  T        K  VK ++G  
Sbjct: 74  CQEPCETTSSSDPASVVRM--QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG- 130

Query: 804 GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV 863
               +    E++ L    H+ +++L    R  +    +   M     D  L   VD+   
Sbjct: 131 ----KTPGREIDILKTISHRAIINLIHAYRWKS---TVCMVMPKYKCD--LFTYVDRSGP 181

Query: 864 LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS-RLLRP 922
           L  +  + I +     LAYLH      I+HRDVK+ NI LDE   A L DFG + +L   
Sbjct: 182 LPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            DT       GTL    PE         + D++S G+VL E+      
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 35/87 (40%), Positives = 50/87 (57%), Gaps = 3/87 (3%)

Query: 326 LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQV 385
           L L N  L G I  + S L  L +++L+ N   G +P SL     L++L L+ N  +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 386 PESFGKLTSLLFLSLSNNSFNHLSGTL 412
           PES G+LTSL  L+L+ NS   LSG +
Sbjct: 483 PESLGQLTSLRILNLNGNS---LSGRV 506

Length = 623

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 50/292 (17%)

Query: 769  FNQANIIGCGGFGLV----YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALS------ 818
            F    ++G GGFG V     +AT   G   A K+L     + +R  + + EA++      
Sbjct: 2    FRHYRVLGKGGFGEVCACQVRAT---GKMYACKKL-----EKKRIKKRKGEAMALNEKQI 53

Query: 819  --RAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE----SVDKDSVLKWDVRLK 871
              +   + +VSL  Y     D L L+ + M  G L + ++       D++  + +   + 
Sbjct: 54   LEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEIT 112

Query: 872  IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
                   GL  LH+     IV+RD+K  NILLD+     ++D GL+  +   +T      
Sbjct: 113  C------GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR 161

Query: 932  VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD----LVSWVF 987
            VGT+GY+ PE  +    T   D +  G ++ E++ G+ P    K K  R+     V    
Sbjct: 162  VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221

Query: 988  QMKSEK--REVEIIDASIWHKDREKQLLEMLEIACKCI-DQDPRRRPFIEEV 1036
            +  SEK       I   +  KD   +L       C+    ++ +  PF    
Sbjct: 222  EEYSEKFSEAARSICRQLLTKDPGFRL------GCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 19/191 (9%)

Query: 811 QAEVEALSRA-QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHES--VDKDSVLKW 866
           Q E     +A  H  LV L   C     RL  +  Y+  G L + +     + ++    +
Sbjct: 43  QTEKHVFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY 101

Query: 867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDT 925
              + +A      L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT
Sbjct: 102 SAEISLA------LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152

Query: 926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS- 984
             T+   GT  YI PE  +        D ++ GV++ E++ GR P ++    +  D  + 
Sbjct: 153 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 210

Query: 985 -WVFQMKSEKR 994
            ++FQ+  EK+
Sbjct: 211 DYLFQVILEKQ 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.5 bits (152), Expect = 4e-10
 Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 36/217 (16%)

Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
           +GCG  GLV+ A  ++   + AVK++   D   ++   + E++ + R  H N+V +    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEVL 71

Query: 833 RHGNDRL--LIYSYMENGSLDYWLHESVDKD--SVLKWD------VRLKIAQGAARGLAY 882
                 L   + S  E  S+ Y + E ++ D  +VL+         RL + Q   RGL Y
Sbjct: 72  GPSGSDLTEDVGSLTELNSV-YIVQEYMETDLANVLEQGPLSEEHARLFMYQ-LLRGLKY 129

Query: 883 LHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYI 938
           +H     +++HRD+K +N+ ++ E     + DFGL+R++ P+ +H   ++  LV T  Y 
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYR 185

Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            P        Y++ +      D+++ G +  E+LTG+
Sbjct: 186 SPRLLLSPNNYTKAI------DMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 16/210 (7%)

Query: 775 IGCGGFGLVYKA---TLTNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V K       +    AVK L  D     ++ E   E   + +  +  +V + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
           G C      +L+    E G L+ +L     K+  +      ++    + G+ YL    E 
Sbjct: 63  GICE-AESWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLE---ET 114

Query: 890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLT 947
           + VHRD+ + N+LL  +  A ++DFGLS+ L   + +      G   + +  PE      
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 948 ATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
            + + DV+SFGV++ E  + G++P +  KG
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 38/273 (13%)

Query: 769  FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD-CGQMEREFQA--EVEALSRAQHKN 824
            F Q  ++G GGFG V    +   G   A KRL      + + E  A  E + L +   + 
Sbjct: 2    FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 825  LVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE----SVDKDSVLKWDVRLKIAQGAARG 879
            +V+L  Y     D L L+ + M  G L + ++       +++  L +      A     G
Sbjct: 62   VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY------AAEILCG 114

Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
            L  LH+    + V+RD+K  NILLD+     ++D GL+  ++  +       VGT+GY+ 
Sbjct: 115  LEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMA 169

Query: 940  PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR--EVE 997
            PE       T   D +  G ++ E++ G+ P    K K  R+ V        ++R  E E
Sbjct: 170  PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--------DRRVLETE 221

Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRR 1030
             + ++ + ++  K + +ML      + +DP++R
Sbjct: 222  EVYSAKFSEE-AKSICKML------LTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 44/241 (18%)

Query: 768 NFNQANIIGCGGFGLVYKATLTNG------------TKAAV--KRLSGDCGQMEREFQAE 813
           NF    ++G G +G V+     +G             KA +  K  + +  + ER+    
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 814 VEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           +      Q   LV+L  Y    + +L LI  Y+  G L   L     ++   + +V++  
Sbjct: 61  IR-----QSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYS 111

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            +     L +LHK+    I++RD+K  NILLD      L DFGLS+     +        
Sbjct: 112 GE-IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC 167

Query: 933 GTLGYIPPEYSQTLTATCRG---------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 983
           GT+ Y+ P+         RG         D +S GV++ ELLTG  P  V   KN +  +
Sbjct: 168 GTIEYMAPD-------IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI 220

Query: 984 S 984
           S
Sbjct: 221 S 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.1 bits (151), Expect = 5e-10
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 39/214 (18%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAEVEALSRAQHKNLVS--- 827
           IG G FG+V+  T   +G + A+K++     +    +R F+ E++ L   +H N++S   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66

Query: 828 -LQ----GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLA 881
            LQ               IY   E    D  LH+ +     L  D V++ + Q   RGL 
Sbjct: 67  ILQPPHIDPFEE------IYVVTELMQSD--LHKIIVSPQPLSSDHVKVFLYQ-ILRGLK 117

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           YLH      I+HRD+K  N+L++      + DFGL+R+  P ++   T  V T  Y  PE
Sbjct: 118 YLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174

Query: 942 -------YSQTLTATCRGDVYSFGVVLLELLTGR 968
                  Y+  +      D++S G +  ELL  R
Sbjct: 175 ILMGSRHYTSAV------DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.7 bits (147), Expect = 6e-10
 Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 31/206 (15%)

Query: 775 IGCGGFGLVYKATLTNGTKA-------AVKRLS-GDCGQMEREFQAEVEA--LSRAQHKN 824
           +G G FG VY   L    KA        +K +  G+    E   QA  EA  LS+  H  
Sbjct: 8   LGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNE-TVQANQEAQLLSKLDHPA 63

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE------SVDKDSVLKWDVRLKIAQGAAR 878
           +V         +   +I  Y E   LD  L E      ++ ++ V +W ++L +      
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           G+ Y+H   +  I+HRD+K+ NI L       + DFG+SRLL      + T   GT  Y+
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGTPYYM 172

Query: 939 PPEYSQTLTATCRGDVYSFGVVLLEL 964
            PE  +      + D++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.8 bits (147), Expect = 8e-10
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 21/224 (9%)

Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD-CGQMEREFQA--EVEALSRAQHKN 824
           F    ++G GGFG V    +   G   A K+L      + + E  A  E   L +   + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 825 LVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE----SVDKDSVLKWDVRLKIAQGAARG 879
           +VSL  Y     D L L+ + M  G L + ++       D+   + +   L        G
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL------CCG 114

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L  L +     IV+RD+K  NILLD++    ++D GL+  +   +T      VGT+GY+ 
Sbjct: 115 LEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMA 169

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 983
           PE       T   D +  G ++ E++ G+ P    K +  R+ V
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 41/124 (33%), Positives = 64/124 (51%), Gaps = 22/124 (17%)

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 938
           L +LH   E  I++RD+K  N+LLD +    L D+G+ +  +RP DT  T+   GT  YI
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYI 163

Query: 939 PPEYSQTLTATCRGDVYSF-------GVVLLELLTGRRPVEVCKGKNCRDLVS--WVFQM 989
            PE         RG+ Y F       GV++ E++ GR P ++    +  D  +  ++FQ+
Sbjct: 164 APE-------ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV 216

Query: 990 KSEK 993
             EK
Sbjct: 217 ILEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 10/197 (5%)

Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  A    +G + AVK +     Q       EV  +   QH+N+V +     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G +  ++  +++ G+L       +   + L  +    + +   + L YLH      ++H
Sbjct: 89  VGEELWVLMEFLQGGAL-----TDIVSQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140

Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+KS +ILL       L+DFG    +   D      LVGT  ++ PE           D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 954 VYSFGVVLLELLTGRRP 970
           ++S G++++E++ G  P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 65/206 (31%), Positives = 89/206 (43%), Gaps = 21/206 (10%)

Query: 774 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQ---AEVEALSRA-QHKNLVSL 828
           ++G G FG V+ A L       A+K L  D   M+ + +    E   LS A +H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 829 QGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA--RGLAYLH 884
             YC       L +   Y+  G L + +       S  K+D+       A    GL +LH
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQ------SCHKFDLPRATFYAAEIICGLQFLH 113

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
                 IV+RD+K  NILLD      +ADFG+ +     D   T    GT  YI PE   
Sbjct: 114 ---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILL 169

Query: 945 TLTATCRGDVYSFGVVLLELLTGRRP 970
                   D +SFGV+L E+L G+ P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 50/154 (32%), Positives = 69/154 (44%), Gaps = 25/154 (16%)

Query: 879  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
            GL +LH      I++RD+K  N++LD      +ADFG+ +     D   +T   GT  YI
Sbjct: 108  GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYI 163

Query: 939  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
             PE  Q L  T   D +SFGV+L E+L G+ P                F    E    E 
Sbjct: 164  APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----------------FHGDDEDELFES 207

Query: 999  IDASIWHKDR--EKQLLEMLEIACKCIDQDPRRR 1030
            I     H  R   K+  ++LE   K  ++DP RR
Sbjct: 208  IRVDTPHYPRWITKESKDILE---KLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 6/116 (5%)

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGY 937
            L +LH   E  I++RD+K  N+LLD      L D+G+ +  L P DT  T+   GT  Y
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162

Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 993
           I PE  +        D ++ GV++ E++ GR P ++       +   ++FQ+  EK
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 41/224 (18%)

Query: 768 NFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGD---------CGQMEREFQAEVEA 816
           +FN   ++G G FG V  A    GT    A+K L  D         C  +E+     V A
Sbjct: 1   DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKR----VLA 55

Query: 817 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
           L       L  L   C    DRL  +  Y+  G L Y + + V K    K    +  A  
Sbjct: 56  LPGKPP-FLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQ-VGK---FKEPHAVFYAAE 109

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGT 934
            A GL +LH      I++RD+K  N++LD +    +ADFG+ +  +    T  T    GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGT 164

Query: 935 LGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             YI PE      Y +++      D ++FGV+L E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 33/214 (15%)

Query: 774 IIGCGGFGLVYKATLTNGTKA--AVKRLSGD---------CGQMEREFQAEVEALSRAQH 822
           ++G G FG V  A L  GT    A+K L  D         C   E+     + AL+ A+H
Sbjct: 2   VLGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKR----ILALA-AKH 55

Query: 823 KNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI-AQGAARGL 880
             L +L   C    DRL  +  Y+  G L + +  S   D     + R +  A      L
Sbjct: 56  PFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLAL 109

Query: 881 AYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 938
            +LH+    H +++RD+K  NILLD +    LADFG+ +  +    T  TT   GT  YI
Sbjct: 110 MFLHR----HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163

Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
            PE  Q L      D ++ GV++ E++ G+ P E
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 31/88 (35%), Positives = 49/88 (55%)

Query: 230 LHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKL 289
           L +DN  L G +P+ +  +  LQ ++LS N+  G +   + ++TSL  L +  N F+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 290 PNVLGNLTQLEFFVAHSNSFSGPLPLSL 317
           P  LG LT L     + NS SG +P +L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 28/68 (41%), Positives = 46/68 (67%)

Query: 227 LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFS 286
           L+ +++  N + G++P SL S++SL+ + LS N+F+G + E +  LTSLR L + GN  S
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503

Query: 287 GKLPNVLG 294
           G++P  LG
Sbjct: 504 GRVPAALG 511

Length = 623

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 4e-09
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 53/219 (24%)

Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T    K AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLS-------RPFQSLIHARRTYRELRLLKHMKHEN 75

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWD------VRLKIAQGA 876
           ++ L        D     + +EN +  Y +      D ++++K        V+  I Q  
Sbjct: 76  VIGLL-------DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ-L 127

Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
            RGL Y+H      I+HRD+K SN+ ++E  E  + DFGL+   R  D  + T  V T  
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEM-TGYVATRW 180

Query: 937 YIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           Y  PE       Y+QT+      D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 21/216 (9%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQH 822
           ++F    +IG G FG V    + +  +    ++      ++R     F+ E   L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLA 881
           + + +L    +  N   L+  Y   G L   L +  D+   L  D+ R  IA+     LA
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYIAEMV---LA 114

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
            +H + + H VHRD+K  N+LLD      LADFG    +    T  ++  VGT  YI PE
Sbjct: 115 -IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 942 YSQTLT-------ATCRGDVYSFGVVLLELLTGRRP 970
             Q +          C  D +S GV + E+L G  P
Sbjct: 174 ILQAMEDGMGKYGPEC--DWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.4 bits (144), Expect = 5e-09
 Identities = 63/230 (27%), Positives = 94/230 (40%), Gaps = 36/230 (15%)

Query: 759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMERE----FQAE 813
           ++ L     +F+   +IG G FG V      +  +  A+K LS     ++R     F  E
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF-EMIKRSDSAFFWEE 93

Query: 814 VEALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSL-----DYWLHESVDKDSVLKW 866
            + ++ A  + +V L       +D+ L  +  YM  G L     +Y + E        KW
Sbjct: 94  RDIMAHANSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--------KW 143

Query: 867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 926
             R   A+     L  +H +     +HRDVK  N+LLD+     LADFG    +      
Sbjct: 144 -ARFYTAE-VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198

Query: 927 VTTDLVGTLGYIPPEYSQTLTAT------CRGDVYSFGVVLLELLTGRRP 970
                VGT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 5e-09
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 19/209 (9%)

Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMERE--FQAEVEALSRAQHK 823
           +  +   +G G FG V+      +    A+K ++  +  ++++E     E   L    H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 824 NLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            ++ L  +    + R L  +  Y+  G L  +L  S    +       L  A      L 
Sbjct: 62  FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG----LFYASEIVCALE 115

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           YLH      IV+RD+K  NILLD++    L DFG ++ LR      T  L GT  Y+ PE
Sbjct: 116 YLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPE 168

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             Q+       D ++ G+++ E+L G  P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.9 bits (143), Expect = 5e-09
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 39/216 (18%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSG------DCGQMEREFQAEVEALSRAQHKNLVS 827
           IG G +G+V  A       K A+K+++       D  +  RE    ++ L    H+N+++
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE----IKLLRHLDHENVIA 68

Query: 828 LQGYC-----RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLA 881
           ++           ND  ++Y  M     D  LH+ +     L  D  +  + Q   RGL 
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQ-LLRGLK 122

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPP 940
           Y+H     +++HRD+K SN+LL+   +  + DFGL+R     +     T+ V T  Y  P
Sbjct: 123 YIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWYRAP 177

Query: 941 EYSQTLTATCRG-----DVYSFGVVLLELLTGRRPV 971
           E    L   C       DV+S G +  ELL GR+P+
Sbjct: 178 E----LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 20/212 (9%)

Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           +F     IG G +G VYKA  +  G  AA+K +  + G+     Q E+  +   +H N+V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 827 SLQG-YCRHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +  G Y R   D+L I   +   GSL    H +      L       +++   +GL YLH
Sbjct: 70  AYFGSYLRR--DKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLH 123

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
              +   +HRD+K +NILL +     LADFG+S  +        +  +GT  ++ PE + 
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAA 179

Query: 945 T-----LTATCRGDVYSFGVVLLELLTGRRPV 971
                     C  D+++ G+  +EL   + P+
Sbjct: 180 VERKGGYNQLC--DIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.5 bits (141), Expect = 7e-09
 Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 27/217 (12%)

Query: 768 NFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGD---------CGQMEREFQAEVEA 816
           +FN   ++G G FG V  A    GT    A+K L  D         C  +E+     V A
Sbjct: 1   DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKR----VLA 55

Query: 817 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
           LS  +   L  L   C    DRL  +  Y+  G L Y + + V +    K    +  A  
Sbjct: 56  LS-GKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYQIQQ-VGR---FKEPHAVFYAAE 109

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
            A GL +LH      I++RD+K  N++LD +    +ADFG+ +    +D   T    GT 
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTP 165

Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
            YI PE           D ++FGV+L E+L G+ P E
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 29/213 (13%)

Query: 775 IGCGGFGLVYKA-TLTNGTK-AAVKRLSGDCGQMEREFQ--------AEVEALSRAQHKN 824
           IG G +G V+KA  L NG +  A+KR+     Q   E          A +  L   +H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 825 LVSLQGYCR-HGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
           +V L   C     DR     L++ +++     Y   + V +  V    ++  + Q   RG
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQ-LLRG 122

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYI 938
           L +LH      +VHRD+K  NIL+    +  LADFGL+R+   Y      T +V TL Y 
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYR 176

Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
            PE     +     D++S G +  E+   R+P+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.1 bits (140), Expect = 8e-09
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 26/164 (15%)

Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDV 868
           +HKN+++L G C       +I  Y   G+L            DY    +   +  L +  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 869 RLKIAQGAARGLAYLH-KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 927
            +  A   ARG+ YL  + C    +HRD+ + N+L+ E     +ADFGL+R +   D + 
Sbjct: 136 LVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 928 TTDLVGTLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT 966
            T    + G +P     PE       T + DV+SFG+++ E+ T
Sbjct: 192 KT----SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.1 bits (140), Expect = 9e-09
 Identities = 66/206 (32%), Positives = 91/206 (44%), Gaps = 21/206 (10%)

Query: 774 IIGCGGFGLVYKATLTNGTK-AAVKRLSGDC---GQMEREFQAEVEALSR-AQHKNLVSL 828
           +IG G FG V  A      K  AVK L        + E+   +E   L +  +H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 829 QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
             +     D+L  +  Y+  G L Y L     +   L+   R   A+  A  L YLH + 
Sbjct: 62  H-FSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAE-IASALGYLHSL- 115

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPPE--YSQ 944
             +IV+RD+K  NILLD +    L DFGL +  +    T  T+   GT  Y+ PE  + Q
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171

Query: 945 TLTATCRGDVYSFGVVLLELLTGRRP 970
               T   D +  G VL E+L G  P
Sbjct: 172 PYDRTV--DWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.2 bits (141), Expect = 9e-09
 Identities = 65/219 (29%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 769 FNQANIIGCGGFGLVYKATLTNGTKA-AVKRLS-GDCGQMEREFQAEVEAL--------- 817
           F    ++G G FG V  A      +  A+K L  GD   + R+   EVE+L         
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARD---EVESLMCEKRIFET 55

Query: 818 -SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
            +  +H  LV+L   C    D +  +  Y   G L   +H  V  +    +      A  
Sbjct: 56  ANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-----YAAC 109

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGT 934
              GL YLH   E  IV+RD+K  N+LLD +    +ADFGL +  +   D   T+   GT
Sbjct: 110 VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGT 164

Query: 935 LGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRP 970
             ++ PE    LT T      D +  GV++ E+L G  P
Sbjct: 165 PEFLAPE---VLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 1e-08
 Identities = 28/77 (36%), Positives = 47/77 (61%)

Query: 435 IPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLF 494
           IP ++     L  + L    ++G+IP  L     L+VLDLS+N F+G+IP  +GQ+ +L 
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 495 YLDFSNNTLTGEIPKSL 511
            L+ + N+L+G +P +L
Sbjct: 494 ILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.1 bits (140), Expect = 1e-08
 Identities = 75/252 (29%), Positives = 112/252 (44%), Gaps = 12/252 (4%)

Query: 105 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 164
           L  L  LDL  N++  + P+       L+ LDLS N +   +   L  L  +++L++S N
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173

Query: 165 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 224
             +     L   SNL   ++S N  +  L   I   S  ++ LDLS N  +  L  L + 
Sbjct: 174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA-LEELDLSNNSIIELLSSLSNL 231

Query: 225 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 284
            +L  L + NN L  DLP+S+ ++S+L+ + LS NN    +S  + +LT+LR L + GN 
Sbjct: 232 KNLSGLELSNNKL-EDLPESIGNLSNLETLDLS-NNQISSIS-SLGSLTNLRELDLSGNS 288

Query: 285 FSGKLP-NVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG 343
            S  LP   L  L                  L L L S L   ++ +N  T       S 
Sbjct: 289 LSNALPLIALLLLLLELLLNLLLTL----KALELKLNSILLNNNILSNGETS-SPEALSI 343

Query: 344 LSSLCTLDLATN 355
           L SL  L    N
Sbjct: 344 LESLNNLWTLDN 355

Length = 394

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.4 bits (144), Expect = 1e-08
 Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 33/233 (14%)

Query: 774 IIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMER---EFQAEVEALSRAQHKNLVSLQ 829
           +IG GG G VY A       + A+K++  D  +       F  E +  +   H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
             C  G+       Y+E  +L   L     K+S+ K    L         L+  HK+C  
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK---ELAEKTSVGAFLSIFHKICAT 125

Query: 890 ----H---IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL----------- 931
               H   ++HRD+K  NILL    E  + D+G + + +  +     D+           
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNICYSS 184

Query: 932 -------VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGK 977
                  VGT  Y+ PE    + A+   D+Y+ GV+L ++LT   P    KG+
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Length = 932

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 1e-08
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 30/212 (14%)

Query: 774 IIGCGGFGLVYKATLTNGT------------KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
           ++G GG+G V++     G             KA + R   D        +AE   L   +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT----KAERNILEAVK 58

Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H  +V L    + G    LI  Y+  G L  ++H  ++++ +   D         +  L 
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMH--LEREGIFMEDTACFYLSEISLALE 114

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           +LH+     I++RD+K  NILLD +    L DFGL +    ++  VT    GT+ Y+ PE
Sbjct: 115 HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPE 170

Query: 942 YSQTLTATCRG---DVYSFGVVLLELLTGRRP 970
               L  +  G   D +S G ++ ++LTG  P
Sbjct: 171 ---ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 65/205 (31%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 774 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA-----LSRAQHKNLVS 827
           +IG G FG V  A    +G   AVK L      + R+ Q  + A     L   +H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI-VLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 828 LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           L  Y     ++L  +  ++  G L + L     + S  +   R   A+  A  L YLH +
Sbjct: 61  LH-YSFQTTEKLYFVLDFVNGGELFFHLQR---ERSFPEPRARFYAAE-IASALGYLHSI 115

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPPEYSQT 945
              +IV+RD+K  NILLD +    L DFGL +  +   DT  TT   GT  Y+ PE  + 
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRK 170

Query: 946 LTATCRGDVYSFGVVLLELLTGRRP 970
                  D +  G VL E+L G  P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 40/276 (14%)

Query: 775  IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG--Y 831
            +G G +G VYKA  L  G  AAVK +  + G      Q E+  +   +H N+V+  G   
Sbjct: 17   VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 832  CRHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIA---QGAARGLAYLHKVC 887
             R   ++L I   Y   GSL    H       V      L+IA   +   +GLAYLH   
Sbjct: 77   SR---EKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 888  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-- 945
            +   +HRD+K +NILL +  +  LADFG++  +        +  +GT  ++ PE +    
Sbjct: 127  K---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEVAAVEK 182

Query: 946  ---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002
                   C  D+++ G+  +EL   + P+      +   + +     KS  +  ++ D +
Sbjct: 183  NGGYNQLC--DIWAVGITAIELAELQPPM-----FDLHPMRALFLMSKSNFQPPKLKDKT 235

Query: 1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038
             W           ++I+   + ++P++RP  E ++T
Sbjct: 236  KW----SSTFHNFVKIS---LTKNPKKRPTAERLLT 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 61/253 (24%), Positives = 106/253 (41%), Gaps = 37/253 (14%)

Query: 797  KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE 856
            K+       +    + E++ L R    N++ + G+     D L   S +       +L E
Sbjct: 52   KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111

Query: 857  SVDKDSVLKWDVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILLDEKFEAHLADFG 915
             +DK+  L +  +L +A    +GL  L+K   +P   ++++ S + L+ E ++  +   G
Sbjct: 112  VLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHG 168

Query: 916  LSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTA--TCRGDVYSFGVVLLELLTGRRPV 971
            L ++L   P+        V  + Y   +    + +  T + D+YS GVVL E+ TG+ P 
Sbjct: 169  LEKILSSPPFKN------VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222

Query: 972  EVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEM-LEIAC---KCIDQDP 1027
            E    K                   EI D  I   +  K  L+  LEI C    C   D 
Sbjct: 223  ENLTTK-------------------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDS 263

Query: 1028 RRRPFIEEVVTWL 1040
             +RP I+E++  L
Sbjct: 264  IKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 66/211 (31%), Positives = 93/211 (44%), Gaps = 31/211 (14%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA-----LSRAQHKNLVS 827
           +IG G FG V  A    +G   AVK L       ++E Q  + A     L   +H  LV 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVG 60

Query: 828 LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           L  Y     D+L  +  Y+  G L + L     + S  +   R   A+  A  L YLH +
Sbjct: 61  LH-YSFQTADKLYFVLDYVNGGELFFHLQR---ERSFPEPRARFYAAE-IASALGYLHSL 115

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPPE---- 941
              +I++RD+K  NILLD +    L DFGL +  +    T  T+   GT  Y+ PE    
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRK 170

Query: 942 --YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             Y +T+      D +  G VL E+L G  P
Sbjct: 171 QPYDRTV------DWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 3e-08
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 31/211 (14%)

Query: 774 IIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEA-----LSRAQHKNLVS 827
           +IG G FG V  A   ++G+  AVK L       ++E Q  + A     L   +H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60

Query: 828 LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           L  Y     ++L  +  Y+  G L + L     +   L+   R   A+  A  + YLH +
Sbjct: 61  LH-YSFQTAEKLYFVLDYVNGGELFFHLQR---ERCFLEPRARFYAAE-VASAIGYLHSL 115

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPPE---- 941
              +I++RD+K  NILLD +    L DFGL +  + P +T  T+   GT  Y+ PE    
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRK 170

Query: 942 --YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             Y +T+      D +  G VL E+L G  P
Sbjct: 171 EPYDRTV------DWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 3e-08
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 15/182 (8%)

Query: 811 QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVR 869
           ++E+  L+   H  +V      +  +  LLI  Y   G L+  + + + +    + ++V 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 870 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
           L   Q     L  +H      ++HRD+KS+NI L       L DFG S+    Y   V+ 
Sbjct: 173 LLFYQ-IVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSL 225

Query: 930 DL----VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           D+     GT  Y+ PE  +    + + D++S GV+L ELLT  RP    KG + R+++  
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQ 282

Query: 986 VF 987
           V 
Sbjct: 283 VL 284

Length = 478

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 13/210 (6%)

Query: 768 NFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHK 823
           +FN   ++G G FG V  A         A+K L  D    + + +    E   L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 824 NLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
             ++    C    DRL  +  Y+  G L Y + + V K    K    +  A   + GL +
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGK---FKEPQAVFYAAEISVGLFF 116

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
           LH+     I++RD+K  N++LD +    +ADFG+ +     D   T    GT  YI PE 
Sbjct: 117 LHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEI 172

Query: 943 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
                     D +++GV+L E+L G+ P +
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 66/279 (23%), Positives = 107/279 (38%), Gaps = 52/279 (18%)

Query: 775  IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQME---------REFQAEVEALSRAQHKN 824
            +G G F  +YK  L        V         ++           F      +S+  HK+
Sbjct: 3    LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 825  LVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSV-LKWDVRLKIAQGAARGLAY 882
            LV L G C R  N  +++  Y++ G LD +LH    K++V L W  +L +A+  A  L Y
Sbjct: 63   LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHRE--KNNVSLHW--KLDVAKQLASALHY 116

Query: 883  LHKVCEPHIVHRDVKSSNILL--DEKFE-----AHLADFGLSRLLRPYDTHVTTDLVGTL 935
            L    +  +VH +V   NIL+      E       L+D G+   +   +     + V  +
Sbjct: 117  LE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-----ERVERI 168

Query: 936  GYIPPEYSQTLTATCR--GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 993
             +I PE  +   A+     D +SFG  LLE+           G+    L +     K   
Sbjct: 169  PWIAPECIRNGQASLTIAADKWSFGTTLLEIC--------SNGE--EPLSTLSSSEKERF 218

Query: 994  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1032
             +    D          +L  ++    +C   DP +RP 
Sbjct: 219  YQ----DQHRLPMPDCAELANLIN---QCWTYDPTKRPS 250

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 44/233 (18%)

Query: 775 IGCGGFGLVYKATLTNGTKA---AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG- 830
           +G G +G VYKA   +G      A+K++ G    M      E+  L   +H N++SLQ  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66

Query: 831 YCRHGNDRL-LIYSYMENGSLDYW----LHESVDKDSVLKWDVRLKIAQGAARGLAY--- 882
           +  H + ++ L++ Y E+   D W     H +   +        +++ +G  + L Y   
Sbjct: 67  FLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKK-----PVQLPRGMVKSLLYQIL 118

Query: 883 --LHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLSRLLR-PYDTHVTTD-LVGT 934
             +H +    ++HRD+K +NIL+     E+    +AD G +RL   P       D +V T
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR 980
             Y  PE       Y++ +      D+++ G +  ELLT   P+  C+ ++ +
Sbjct: 179 FWYRAPELLLGARHYTKAI------DIWAIGCIFAELLTS-EPIFHCRQEDIK 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 44/171 (25%), Positives = 85/171 (49%), Gaps = 21/171 (12%)

Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK 865
            E  F+A    +S+  HK+LV   G C  G++ +++  Y++ GSLD +L ++ +  ++  
Sbjct: 43  SESFFEA-ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS- 100

Query: 866 WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--------LADFGLS 917
           W  +L++A+  A  L +L    +  + H +V + N+LL  + +          L+D G+S
Sbjct: 101 W--KLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Query: 918 RLLRPYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTG 967
             + P +      L+  + ++PPE        +   D +SFG  L E+ +G
Sbjct: 156 ITVLPKEI-----LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 5e-08
 Identities = 34/95 (35%), Positives = 44/95 (46%), Gaps = 9/95 (9%)

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
           +  V +   VHRD+K  N+LLD+     LADFG    L    T  +   VGT  YI PE 
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174

Query: 943 SQTLT-------ATCRGDVYSFGVVLLELLTGRRP 970
            Q +          C  D +S GV + E+L G  P
Sbjct: 175 LQAMEDGKGRYGPEC--DWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 20/211 (9%)

Query: 425 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 484
           +   +     +P ++    SL +L+             LL    L  LDL+ N    NI 
Sbjct: 52  LNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRLRSNIS 110

Query: 485 PWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTN 544
             + ++ NL  LD  NN +T +IP  +  LKS +                L +  N+  +
Sbjct: 111 E-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKE--------------LDLSDNKIES 154

Query: 545 GLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLE 604
                +      ++ LS N ++  +P  +  L +L+ LDLS N I+  +P  I  +  LE
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212

Query: 605 VLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 635
            LDLS+N +   +  S   L  LS   ++NN
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 49.9 bits (120), Expect = 6e-08
 Identities = 23/60 (38%), Positives = 28/60 (46%)

Query: 83  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 142
            +  L L    L  I   +   L  LK+LDLS N+L  + P   S L  L  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.6 bits (134), Expect = 6e-08
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 38/216 (17%)

Query: 774 IIGCGGFGLVYKA--TLTNGTKAAVKRLS------GDCGQMEREFQAEVEALSRAQHKNL 825
           +IG G +G+V  A  T T G K A+K+++       D  ++ RE    ++ L   +H ++
Sbjct: 7   VIGKGSYGVVCSAIDTHT-GEKVAIKKINDVFEHVSDATRILRE----IKLLRLLRHPDI 61

Query: 826 VSLQGYC-----RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           V ++        R   D  +++  ME+      LH+ +  +  L  +          R L
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT---TDLVGTLGY 937
            Y+H     ++ HRD+K  NIL +   +  + DFGL+R+    DT      TD V T  Y
Sbjct: 117 KYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF-NDTPTAIFWTDYVATRWY 172

Query: 938 IPPE-----YSQTLTATCRGDVYSFGVVLLELLTGR 968
             PE     +S+   A    D++S G +  E+LTG+
Sbjct: 173 RAPELCGSFFSKYTPAI---DIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 26/171 (15%)

Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV-LKWDVRLKIAQG 875
           +S+  H +L  + G C  G++ +++  ++E+G LD  L +  +K  V + W  ++ +AQ 
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAW--KITVAQQ 125

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT------T 929
            A  L+YL    + ++VH +V + NILL       LA+ G S  ++  D  V+       
Sbjct: 126 LASALSYLE---DKNLVHGNVCAKNILLARL---GLAE-GTSPFIKLSDPGVSFTALSRE 178

Query: 930 DLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLEL-------LTGRRPVE 972
           + V  + +I PE      + +   D +SFG  LLE+       L  R P E
Sbjct: 179 ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 65/286 (22%), Positives = 110/286 (38%), Gaps = 47/286 (16%)

Query: 768  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----------GDCGQMEREFQAEVEA 816
            NF     IG G F  VY+AT L +    A+K++            DC +       E++ 
Sbjct: 3    NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-------EIDL 55

Query: 817  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWL------HESVDKDSVLKWDVRL 870
            L +  H N++         N+  ++    + G L   +         + + +V K+ V+L
Sbjct: 56   LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 930
                     + ++H      ++HRD+K +N+ +       L D GL R      T     
Sbjct: 116  ------CSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHS 165

Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
            LVGT  Y+ PE         + D++S G +L E+   + P    K             + 
Sbjct: 166  LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLF 214

Query: 991  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            S  +++E  D      +   + L   E+   CI  DP +RP I  V
Sbjct: 215  SLCQKIEQCDYPPLPTEHYSEKLR--ELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.9 bits (134), Expect = 9e-08
 Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 31/185 (16%)

Query: 790 NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI-------- 841
            G++AA+        Q+E E    + AL R  H+N++ ++   R   +  +I        
Sbjct: 202 AGSRAAI--------QLENE----ILALGRLNHENILKIEEILRSEANTYMITQKYDFDL 249

Query: 842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNI 901
           YS+M + + D+       KD  L    R  I +     + Y+H   +  ++HRD+K  NI
Sbjct: 250 YSFMYDEAFDW-------KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENI 298

Query: 902 LLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVL 961
            L+   +  L DFG +              VGT+    PE           D++S G++L
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358

Query: 962 LELLT 966
           L++L+
Sbjct: 359 LDMLS 363

Length = 501

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.0 bits (132), Expect = 1e-07
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 22/220 (10%)

Query: 760 SDLLKSTN-NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEAL 817
           +D+ +S N ++   NIIG G FG+VY+A  +    K A+K++  D     RE       +
Sbjct: 58  NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IM 113

Query: 818 SRAQHKNLVSLQGY----CRHGNDRLL----IYSYMENGSLDYWLHESVDKDSVLKWDVR 869
               H N++ L+ Y    C   N++ +    +  ++      Y  H + +  ++  + V+
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK 173

Query: 870 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVT 928
           L   Q   R LAY+H      I HRD+K  N+L+D       L DFG ++ L      V+
Sbjct: 174 LYSYQ-LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229

Query: 929 TDLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTG 967
              + +  Y  PE     T  T   D++S G ++ E++ G
Sbjct: 230 --YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 45/206 (21%), Positives = 76/206 (36%), Gaps = 22/206 (10%)

Query: 778 GGFGLVYKATLTNGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNLVSLQGYCRHG 835
                + K      T  AVK+++ D    E     Q E+    + QH N++         
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 836 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRD 895
           ++  ++   M  GS +  L ++   + + +  +   I +     L Y+H       +HR 
Sbjct: 72  SELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAF-ILKDVLNALDYIHSK---GFIHRS 126

Query: 896 VKSSNILLDEKFEAHLADFGLSRLLRPYDTH---------VTTDLVGTLGYIPPE-YSQT 945
           VK+S+ILL    +  L+     R       H              V  L ++ PE   Q 
Sbjct: 127 VKASHILLSGDGKVVLSGL---RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183

Query: 946 LTA-TCRGDVYSFGVVLLELLTGRRP 970
           L     + D+YS G+   EL  G  P
Sbjct: 184 LQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)

Query: 768 NFNQANIIGCGGFGLVYKATLTNGT--KAAVKRLSG----DCGQMEREFQAEVEALSRAQ 821
           +FN    +G G FG V  AT  N      A+KR          Q++  F +E + L+   
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYIN 89

Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H   V+L G  +  +   L+  ++  G    +L     ++     DV    A        
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFE 145

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           YL  +   +IV+RD+K  N+LLD+     + DFG ++++   DT   T L GT  YI PE
Sbjct: 146 YLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPE 198

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
               +      D ++ G+ + E+L G  P
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 74/271 (27%), Positives = 117/271 (43%), Gaps = 25/271 (9%)

Query: 392 LTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF-ESLMVLAL 450
           L +LL L   + + N L   +S L +  NLT+L L  N +  +IP  +G    +L  L L
Sbjct: 89  LLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNI-TDIPPLIGLLKSNLKELDL 147

Query: 451 GNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKS 510
            +  ++  +P  L     L+ LDLS+N    ++P  +  + NL  LD S N ++ ++P  
Sbjct: 148 SDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPE 204

Query: 511 LTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIP 570
             EL S +     S+N      +   + + ++ +GL             LSNN++     
Sbjct: 205 -IELLSALEELDLSNNSIIE--LLSSLSNLKNLSGLE------------LSNNKLEDLPE 249

Query: 571 PEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKF 630
             IG L +L  LDLS N I+    SS+  + NL  LDLS N L  ++P     L  L   
Sbjct: 250 S-IGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALP--LIALLLLLLE 304

Query: 631 SVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 661
            + N  L              N++   N   
Sbjct: 305 LLLNLLLTLKALELKLNSILLNNNILSNGET 335

Length = 394

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 35/91 (38%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L  LHK    ++++RD+K  NILLD +    L DFGL + L   D   T    GT  Y+ 
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLA 161

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE       T   D ++ GV+L E+LTG  P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 17/204 (8%)

Query: 775 IGCGGFGLVYKATL---TNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 830
           IG G FG V  + +   T   +  VK L  +    E+ EF  + +     QH N++   G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
            C      LL++ Y E G L  +L +        +  +  ++A   A G+ ++HK    +
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPE-----YS 943
            +H D+   N  L       + D+G+    R  + ++ T+      L ++ PE     + 
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178

Query: 944 QTLTA--TCRGDVYSFGVVLLELL 965
             +TA  T   +V++ GV L EL 
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 5/88 (5%)

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            GL YLH      I+HRDVK+ NI +++  +  + D G ++   P        L GT+  
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVET 222

Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELL 965
             PE         + D++S G+VL E+L
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 44/233 (18%)

Query: 775 IGCGGFGLVYKATLTNGT---KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           +G G +G VYKA   +G    + A+K++ G    M      E+  L   +H N+++LQ  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66

Query: 832 CRHGNDR--LLIYSYMENGSLDYW----LHESVDKDSVLKWDVRLKIAQGAARGLAY--- 882
               +DR   L++ Y E+   D W     H +   +        +++ +   + L Y   
Sbjct: 67  FLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKK-----PMQLPRSMVKSLLYQIL 118

Query: 883 --LHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLSRLLR-PYDTHVTTD-LVGT 934
             +H +    ++HRD+K +NIL+     E+    +AD G +RL   P       D +V T
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR 980
             Y  PE       Y++ +      D+++ G +  ELLT   P+  C+ ++ +
Sbjct: 179 FWYRAPELLLGARHYTKAI------DIWAIGCIFAELLTS-EPIFHCRQEDIK 224

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 3e-07
 Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 61/236 (25%)

Query: 775 IGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQMEREFQAEVEALSRA----------- 820
           +G G +G+V  A           A+K+++         F  ++ A  RA           
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKIT-------NVFSKKILA-KRALRELKLLRHFR 59

Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDVRLKIAQGAA- 877
            HKN+  L        D  +++    N    Y   E ++ D   +++    L  A   + 
Sbjct: 60  GHKNITCLY-------DMDIVFPGNFNEL--YLYEELMEADLHQIIRSGQPLTDAHFQSF 110

Query: 878 -----RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT---T 929
                 GL Y+H     +++HRD+K  N+L++   E  + DFGL+R             T
Sbjct: 111 IYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 930 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
           + V T  Y  PE       Y++ +      DV+S G +L ELL GR+P  V KGK+
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAI------DVWSVGCILAELL-GRKP--VFKGKD 214

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 10/205 (4%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTK-AAVKRLSGDCGQMEREFQA--EVEALSRAQHK 823
           N F    ++G G +G+V K       +  A+K+        E +     E++ L   + +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           N+V L+   R      L++ Y+E   L+  L E    + V    VR  I Q   + + + 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLEL-LEEM--PNGVPPEKVRSYIYQ-LIKAIHWC 116

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
           HK     IVHRD+K  N+L+       L DFG +R L        T+ V T  Y  PE  
Sbjct: 117 HK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 944 QTLTATCRGDVYSFGVVLLELLTGR 968
                    D++S G +L EL  G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 30/211 (14%)

Query: 775 IGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQ---AEVEALSRAQHKN---LVS 827
           IG G FG VY+    +  +  A+K LS      ++E      E   L R        +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLAYLHKV 886
           L+   +  +D  L+  YM  G L +W    + K+     D  +  IA+     L +LHK 
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGEL-FW---HLQKEGRFSEDRAKFYIAE-LVLALEHLHKY 115

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE----- 941
               IV+RD+K  NILLD      L DFGLS+     D   T    GT  Y+ PE     
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 942 --YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             Y++ +      D +S GV++ E+  G  P
Sbjct: 172 KGYTKHV------DFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 73/271 (26%), Positives = 107/271 (39%), Gaps = 73/271 (26%)

Query: 767 NNFNQANIIGCGGFG---LVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEA----LSR 819
           ++F    +IG G FG   LV K     G   A+K+L      +E+E  A V A    L+ 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKD--TGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAE 57

Query: 820 AQHKNLVSLQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           A +  +V L  Y    ++    LI  Y+  G +   L   + KD+  + + R  IA+   
Sbjct: 58  ADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAE-TI 111

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD------- 930
             +  +HK+     +HRD+K  N+LLD K    L+DFGL   L+   +H T         
Sbjct: 112 LAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTEFYRILSHA 166

Query: 931 --------------------------------LVGTLGYIPPE-YSQT-LTATCRGDVYS 956
                                            VGT  YI PE + QT     C  D +S
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC--DWWS 224

Query: 957 FGVVLLELLTG------RRPVEVC-KGKNCR 980
            GV++ E+L G        P E   K  N +
Sbjct: 225 LGVIMYEMLVGYPPFCSDNPQETYRKIINWK 255

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 44/233 (18%)

Query: 817  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
            + +  HK++V L G C    + +++  ++E G LD ++H    K  VL    + K+A+  
Sbjct: 58   MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQL 114

Query: 877  ARGLAYLHKVCEPHIVHRDVKSSNILL-DEKFEAHLADF-GLSRLLRPYDTHVTTDLVGT 934
            A  L+YL    +  +VH +V + NILL  E  +     F  LS    P       + V  
Sbjct: 115  ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER 171

Query: 935  LGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 993
            + +I PE    +   +   D +SFG  L E+              C +            
Sbjct: 172  IPWIAPECVEDSKNLSIAADKWSFGTTLWEI--------------CYN------------ 205

Query: 994  REVEIIDASIWHKDR--EKQLL-------EMLEIACKCIDQDPRRRPFIEEVV 1037
             E+ + D ++  K+R  E Q +       E+ ++   C++ DP +RPF   ++
Sbjct: 206  GEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 19/205 (9%)

Query: 774 IIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHKNLV 826
           ++G G FG V     KAT   G   A+K L  +    + E      E   L  ++H  L 
Sbjct: 2   LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 827 SLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           +L+ Y    +DRL  +  Y   G L + L     ++ V   D            L YLH 
Sbjct: 59  ALK-YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHS 113

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
             E ++V+RD+K  N++LD+     + DFGL +     D        GT  Y+ PE  + 
Sbjct: 114 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLED 170

Query: 946 LTATCRGDVYSFGVVLLELLTGRRP 970
                  D +  GVV+ E++ GR P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.2 bits (126), Expect = 4e-07
 Identities = 50/163 (30%), Positives = 70/163 (42%), Gaps = 35/163 (21%)

Query: 822 HKNLVSLQGYCRHG-NDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARG 879
           + N + L  Y        +LI  Y+++G L D    E   K S  +  V+  I Q     
Sbjct: 68  NPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAE--VKKIIRQ-LVEA 121

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDLV--GTLG 936
           L  LHK    +I+H D+K  N+L D  K   +L D+GL +        + T     GTL 
Sbjct: 122 LNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLD 171

Query: 937 YIPPEYSQTLTATCRGDVY--SF-----GVVLLELLTGRRPVE 972
           Y  PE         +G  Y  SF     GV+  ELLTG+ P +
Sbjct: 172 YFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.8 bits (126), Expect = 5e-07
 Identities = 46/159 (28%), Positives = 66/159 (41%), Gaps = 10/159 (6%)

Query: 813 EVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
           E   L   +H  L SL+ Y     DRL  +  Y+  G L + L     ++ V   D    
Sbjct: 45  ESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRF 99

Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
                   L YLH      IV+RD+K  N++LD+     + DFGL +     D       
Sbjct: 100 YGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTF 155

Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            GT  Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.1 bits (125), Expect = 7e-07
 Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 24/166 (14%)

Query: 813 EVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRL 870
           E   L   +H  L +L+ Y    +DRL  +  Y   G L  + H S  ++ V   D  R 
Sbjct: 45  ESRVLQNTRHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLS--RERVFSEDRARF 99

Query: 871 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 930
             A+     L YLH  C+  +V+RD+K  N++LD+     + DFGL +        + T 
Sbjct: 100 YGAE-IVSALGYLHS-CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 154

Query: 931 LVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             GT  Y+ PE      Y + +      D +  GVV+ E++ GR P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 51.7 bits (124), Expect = 7e-07
 Identities = 63/241 (26%), Positives = 101/241 (41%), Gaps = 63/241 (26%)

Query: 767 NNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDC----GQMEREFQAEVEALS 818
            +F    +I  G +G VY    K T     + A+K+++        Q+++ F  E + L+
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQ---RFAMKKINKQNLILRNQIQQVF-VERDILT 56

Query: 819 RAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWD-------VR 869
            A++  +VS+  +C     R L  +  Y+E G          D  ++LK          R
Sbjct: 57  FAENPFVVSM--FCSFETKRHLCMVMEYVEGG----------DCATLLKNIGALPVDMAR 104

Query: 870 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL------LRPY 923
           +  A+     L YLH      IVHRD+K  N+L+       L DFGLS++         Y
Sbjct: 105 MYFAE-TVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160

Query: 924 DTHVTTD--------LVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRR 969
           + H+  D        + GT  YI PE      Y + +      D ++ G++L E L G  
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV------DWWAMGIILYEFLVGCV 214

Query: 970 P 970
           P
Sbjct: 215 P 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.5 bits (126), Expect = 1e-06
 Identities = 34/111 (30%), Positives = 47/111 (42%), Gaps = 26/111 (23%)

Query: 350 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLS 409
           L L      G +PN +S    L+ ++L+ N + G +P S G +TSL  L LS NSFN   
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS- 481

Query: 410 GTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 460
                                    IPE++G   SL +L L    L G +P
Sbjct: 482 -------------------------IPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.4 bits (111), Expect = 1e-06
 Identities = 23/60 (38%), Positives = 32/60 (53%)

Query: 107 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSF 166
            LK LDLS N L  +       L  L+VLDLS N L+       +GL  ++SL++S N+ 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 7/89 (7%)

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           YLH      I++RD+K  N+LLD K    + DFG ++ +       T  L GT  Y+ PE
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             Q+       D ++ GV+L E + G  P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)

Query: 759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 814
           + DL     ++    +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           + ++ A    +V L  +    +DR L  +  YM  G L   ++   + D   KW  R   
Sbjct: 95  DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYT 148

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL- 931
           A+     L  +H +     +HRDVK  N+LLD+     LADFG    +   +  V  D  
Sbjct: 149 AE-VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTA 203

Query: 932 VGTLGYIPPEYSQTLTA------TCRGDVYSFGVVLLELLTGRRP 970
           VGT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.2 bits (125), Expect = 1e-06
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 17/152 (11%)

Query: 775 IGCGGFGLVYKATLTNGTK----AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
           I  G FG VY     N +K      VK+       M  + QAE +AL+ ++   +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
             +  N+  L+  Y+  G +   LH     D++  +K+     I++  A  L YLH+   
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-----ISE-VALALDYLHR--- 122

Query: 889 PH-IVHRDVKSSNILLDEKFEAHLADFGLSRL 919
            H I+HRD+K  N+L+  +    L DFGLS++
Sbjct: 123 -HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.4 bits (123), Expect = 2e-06
 Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 2/82 (2%)

Query: 256 LSVNN--FSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 313
           L ++N    G +   IS L  L+ + + GN   G +P  LG++T LE      NSF+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 314 PLSLSLCSKLHVLDLRNNSLTG 335
           P SL   + L +L+L  NSL+G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSG 504

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 2e-06
 Identities = 27/58 (46%), Positives = 35/58 (60%), Gaps = 2/58 (3%)

Query: 557 SVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 613
           S+ LSNNR+   IP      L +L VLDLS NN+T   P + S + +L  LDLS N+L
Sbjct: 4   SLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 24/224 (10%)

Query: 759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 814
           +  L     +++   +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           + ++ A    +V L  +C   +D+ L  +  YM  G L   ++   + D   KW  +   
Sbjct: 95  DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL---VNLMSNYDVPEKW-AKFYT 148

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
           A+     L  +H +    ++HRDVK  N+LLD+     LADFG    +           V
Sbjct: 149 AE-VVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204

Query: 933 GTLGYIPPEYSQTLTA------TCRGDVYSFGVVLLELLTGRRP 970
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 42/211 (19%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQ-AEVEALSR-AQHKNLVSLQGY 831
           IG G F  V KA +   G   A+K +      +E+     E++AL R + H N++ L   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL--- 63

Query: 832 CRHGNDRL-----LIYSYMENGSLDYWL----HESVDKDSVLKWDVRLKIAQGAARGLAY 882
                DR      L++  M+  +L Y L       + +  V  +  +L       + L +
Sbjct: 64  IEVLFDRKTGRLALVFELMD-MNL-YELIKGRKRPLPEKRVKSYMYQL------LKSLDH 115

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE- 941
           +H+     I HRD+K  NIL+ +     LADFG  R +  Y     T+ + T  Y  PE 
Sbjct: 116 MHR---NGIFHRDIKPENILIKDD-ILKLADFGSCRGI--YSKPPYTEYISTRWYRAPEC 169

Query: 942 ------YSQTLTATCRGDVYSFGVVLLELLT 966
                 Y   +      D+++ G V  E+L+
Sbjct: 170 LLTDGYYGPKM------DIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 51/223 (22%)

Query: 769 FNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEA---------LS 818
           + Q   IG G  G+V  A  T  G   AVK+LS       R FQ +  A         L 
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYRELVLLK 75

Query: 819 RAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDVRL 870
              HKN++SL      Q       D  L+   M+  +L   +H  +D +  S L + +  
Sbjct: 76  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLLYQMLC 134

Query: 871 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR------LLRPYD 924
                   G+ +LH      I+HRD+K SNI++       + DFGL+R      ++ PY 
Sbjct: 135 --------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY- 182

Query: 925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 967
                  V T  Y  PE    +      D++S G ++ EL+ G
Sbjct: 183 -------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.8 bits (119), Expect = 4e-06
 Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 36/171 (21%)

Query: 877  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT- 934
            ARG+ +L  + C    +HRD+ + NILL E     + DFGL+R     D +   D V   
Sbjct: 183  ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLAR-----DIYKDPDYVRKG 233

Query: 935  -----LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN--CRDLVSWV 986
                 L ++ PE       T + DV+SFGV+L E+ + G  P    +     CR L    
Sbjct: 234  DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT 293

Query: 987  FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             +M++ +                    E+  I   C   +P  RP   E+V
Sbjct: 294  -RMRAPEYATP----------------EIYSIMLDCWHNNPEDRPTFSELV 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.5 bits (106), Expect = 5e-06
 Identities = 22/60 (36%), Positives = 32/60 (53%)

Query: 578 HLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 637
           +L  LDLS N +T     +   + NL+VLDLS N+L    P +F  L  L    ++ N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 5e-06
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 22/164 (13%)

Query: 877  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGT 934
            A+G+++L  K C    +HRD+ + NILL       + DFGL+R +R    +V   +    
Sbjct: 224  AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 993
            + ++ PE       T   DV+S+G++L E+ + G  P                  M  + 
Sbjct: 280  VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP---------------GMPVDS 324

Query: 994  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
            +  ++I         E    EM +I   C D DP +RP  +++V
Sbjct: 325  KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.5 bits (118), Expect = 6e-06
 Identities = 34/92 (36%), Positives = 44/92 (47%), Gaps = 8/92 (8%)

Query: 767 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
           +N      +G G FG V +AT        N  + AVK L       ERE   +E++ LS 
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 820 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
             QHKN+V+L G C HG   L+I  Y   G L
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.8 bits (116), Expect = 7e-06
 Identities = 43/159 (27%), Positives = 66/159 (41%), Gaps = 10/159 (6%)

Query: 813 EVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
           E   L   +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +    
Sbjct: 45  ESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARF 99

Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
                   L YLH      +V+RD+K  N++LD+     + DFGL +     D       
Sbjct: 100 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTF 155

Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            GT  Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 9e-06
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 26/169 (15%)

Query: 877  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGT 934
            A+G+ +L  + C    +HRD+ + NILL E     + DFGL+R + +  D     D    
Sbjct: 189  AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMKS 991
            L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR       ++K 
Sbjct: 245  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-------RLKE 297

Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
              R           +  +    EM +    C   +P +RP   E+V  L
Sbjct: 298  GTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 39/148 (26%), Positives = 61/148 (41%), Gaps = 17/148 (11%)

Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--YSQTLTA 948
             +HRD+K  N L+D      L DFGLS+ +  Y   V    VG+  Y+ PE    +    
Sbjct: 122  YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV----VGSPDYMAPEVLRGKGYDF 177

Query: 949  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008
            T   D +S G +L E L G  P     G    +        ++ K   E +   ++   R
Sbjct: 178  TV--DYWSLGCMLYEFLCGFPPFS---GSTPNET------WENLKYWKETLQRPVYDDPR 226

Query: 1009 EKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                 E  ++  K I+   RR   +E++
Sbjct: 227  FNLSDEAWDLITKLINDPSRRFGSLEDI 254

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 1e-05
 Identities = 62/246 (25%), Positives = 86/246 (34%), Gaps = 48/246 (19%)

Query: 769 FNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMEREFQ---AEVEALSRAQHK 823
           F +  ++G G  G V+   L  GT    A+K L         + +    E E L+   H 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRL-KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGL 880
            L +L  Y     +  L     Y   G  + +          L  +V R   A+     L
Sbjct: 62  FLPTL--YASFQTETYLCLVMDYCPGG--ELFRLLQRQPGKCLSEEVARFYAAEVLL-AL 116

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV------------- 927
            YLH      IV+RD+K  NILL E     L+DF LS+        V             
Sbjct: 117 EYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 928 ---------------TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
                          +   VGT  YI PE           D ++ G++L E+L G  P  
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF- 232

Query: 973 VCKGKN 978
             KG N
Sbjct: 233 --KGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 48/179 (26%), Positives = 70/179 (39%), Gaps = 46/179 (25%)

Query: 877  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT- 934
            ARG+ +L  + C    +HRD+ + NILL E     + DFGL+R     D +   D V   
Sbjct: 184  ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLAR-----DIYKDPDYVRKG 234

Query: 935  -----LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPV-------EVCKGKNCRD 981
                 L ++ PE       T + DV+SFGV+L E+ + G  P        E C+      
Sbjct: 235  SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR----- 289

Query: 982  LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                  +  +  R  E     I+             I   C   DP+ RP    +V  L
Sbjct: 290  -----LKDGTRMRAPENATPEIY------------RIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 65/248 (26%), Positives = 86/248 (34%), Gaps = 35/248 (14%)

Query: 221 LDHSPSLKQLHVDNNLLGGD------LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLT- 273
           L   PSLK+L +  N  G        L   L     LQ + LS N         + +L  
Sbjct: 47  LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLR 106

Query: 274 --SLRHLIIFGNQFS-GKLPNVLGNLTQ----LEFFVAHSNSFSG----PLPLSLSLCSK 322
             SL+ L +  N      L  +   L      LE  V   N   G     L  +L     
Sbjct: 107 SSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRD 166

Query: 323 LHVLDLRNNSLTGP-IDLNFSGLSSLC---TLDLATNHF----SGPLPNSLSDCHDLKIL 374
           L  L+L NN +    I     GL + C    LDL  N      +  L  +L+    L++L
Sbjct: 167 LKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVL 226

Query: 375 SLAKNELSGQ-----VPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN---LTTLIL 426
           +L  N L+                SLL LSLS N      G   + +       L  L L
Sbjct: 227 NLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT-DDGAKDLAEVLAEKESLLELDL 285

Query: 427 TKNFVGEE 434
             N  GEE
Sbjct: 286 RGNKFGEE 293

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 47.7 bits (114), Expect = 2e-05
 Identities = 54/212 (25%), Positives = 79/212 (37%), Gaps = 36/212 (16%)

Query: 204 IQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGD--------LPDSLYSMSSL 251
           +Q LDLS N       G L+ L  S SL++L ++NN LG          L D   ++  L
Sbjct: 83  LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142

Query: 252 QHVSLSVNNFSGQLSEKISNL----TSLRHLIIFGNQFSG----KLPNVLGNLTQLEFFV 303
               L  N   G   E ++        L+ L +  N         L   L     LE   
Sbjct: 143 V---LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199

Query: 304 AHSNSF----SGPLPLSLSLCSKLHVLDLRNNSLTGPI-----DLNFSGLSSLCTLDLAT 354
            ++N      +  L  +L+    L VL+L +N+LT            S   SL TL L+ 
Sbjct: 200 LNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSC 259

Query: 355 NHF----SGPLPNSLSDCHDLKILSLAKNELS 382
           N      +  L   L++   L  L L  N+  
Sbjct: 260 NDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 41/225 (18%)

Query: 767 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHK 823
           + + +   IG G +G VYKA     G   A+K  RL  D   +      E+  L      
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 824 N----LVSLQGYCRHGNDRLLIYSYME--NGSLDYWL-------HESVDKDSVLKWDVRL 870
                L+ ++ +    N +  +Y   E  +  L  ++          +   ++  +  +L
Sbjct: 61  IYIVRLLDVE-HVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 871 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTT 929
                   G+A+ HK     ++HRD+K  N+L+D +K    +AD GL R         T 
Sbjct: 120 LK------GVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170

Query: 930 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTG 967
           ++V TL Y  PE       YS  +      D++S G +  E+   
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPV------DIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.9 bits (111), Expect = 4e-05
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 9/102 (8%)

Query: 870 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
           L I +   R + YLH   E  I+HRD+K+ NI ++   +  L DFG +    P D +   
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDIN-AN 238

Query: 930 DLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGR 968
              G  G I     + L     G   D++S G+VL E+ T  
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.1 bits (112), Expect = 5e-05
 Identities = 65/298 (21%), Positives = 100/298 (33%), Gaps = 110/298 (36%)

Query: 768 NFNQANIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           +F     +G G FG+VYKA+L N       K  +K+ + + G        E+    R + 
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT-EYGA------VEIWMNERVRR 185

Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLD----YWL---HESVD------KDSVLKWDVR 869
               +    C        +Y ++E  S      YWL   +E         +     ++V 
Sbjct: 186 ----ACPNSCAD-----FVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236

Query: 870 ---LKIAQGAARGLAYLHKVCEP------------H---IVHRDVKSSNILLDEKFEAHL 911
              L   Q   +GL   +K+ +             H   IVHRDVK  NI+  E      
Sbjct: 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG----- 291

Query: 912 ADFGLSRLLRPYDTHVTTDLVGTLGYIP------PEYS---------QTLTATC------ 950
                S   +  D     DL   + YIP      P Y+         QT +A        
Sbjct: 292 -----SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 346

Query: 951 ------------RGDVYSFGVVLLE-----------LLTGRRPVEVCKGKNCRDLVSW 985
                       R D+YS G++ L+           L+   R ++        DLV+W
Sbjct: 347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRND----YDLVAW 400

Length = 566

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.3 bits (110), Expect = 5e-05
 Identities = 36/131 (27%), Positives = 46/131 (35%), Gaps = 45/131 (34%)

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-------------------- 921
            +HK+     +HRD+K  NIL+D      L DFGL    R                    
Sbjct: 116 SVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172

Query: 922 PYDTHVTTD----------------------LVGTLGYIPPEYSQTLTATCRGDVYSFGV 959
           P +     D                      LVGT  YI PE       T   D +S GV
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232

Query: 960 VLLELLTGRRP 970
           +L E+L G+ P
Sbjct: 233 ILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 58/244 (23%), Positives = 96/244 (39%), Gaps = 49/244 (20%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQH 822
           ++F    +IG G FG V      +       ++      +E+E     +AE + L  A  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
             +V +    +   +  LI  ++  G +   L   + KD++ +   +  IA+     +  
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAE-TVLAIDA 116

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR---------------PYD--- 924
           +H++     +HRD+K  N+LLD K    L+DFGL   L+               P D   
Sbjct: 117 IHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 925 ----------------THVTTDLVGTLGYIPPE-YSQT-LTATCRGDVYSFGVVLLELLT 966
                             +    VGT  YI PE + QT     C  D +S GV++ E+L 
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLI 231

Query: 967 GRRP 970
           G  P
Sbjct: 232 GYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 44/153 (28%), Positives = 64/153 (41%), Gaps = 19/153 (12%)

Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARG 879
           N+V L  Y    +   L+  + E G L  W H S    + ++ V +W   + +A      
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFLNIPEECVKRWAAEMVVA------ 97

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L  LH      IV RD+  +NILLD++    L  F     +         + V  + Y  
Sbjct: 98  LDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---SCDGEAVENM-YCA 150

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           PE       T   D +S G +L ELLTG+  VE
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 49/243 (20%)

Query: 768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQHK 823
           +F    +IG G FG V      +       ++      +E+E     +AE + L  A   
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
            +V +    +   +  LI  ++  G +   L   + KD++ + + +  IA+     +  +
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAE-TVLAIDSI 117

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL---------SRLLRPYDTHVTTDL--- 931
           H++     +HRD+K  N+LLD K    L+DFGL         +   R  +  + +D    
Sbjct: 118 HQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 932 ----------------------VGTLGYIPPE-YSQT-LTATCRGDVYSFGVVLLELLTG 967
                                 VGT  YI PE + QT     C  D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Query: 968 RRP 970
             P
Sbjct: 233 YPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.8 bits (106), Expect = 2e-04
 Identities = 32/108 (29%), Positives = 59/108 (54%), Gaps = 8/108 (7%)

Query: 866 WDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPY 923
            D+ L+ +   A+G+ +L  K C    +HRDV + N+LL +   A + DFGL+R ++   
Sbjct: 212 DDL-LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266

Query: 924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
           +  V  +    + ++ PE       T + DV+S+G++L E+ + G+ P
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 31/152 (20%), Positives = 52/152 (34%), Gaps = 16/152 (10%)

Query: 774 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC- 832
           ++  G    VY     +     +K         +RE   EV  L     K L   +    
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61

Query: 833 -RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                   L+  ++E  +LD    E  +            IA+  A  LA LH++    +
Sbjct: 62  GESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVL 110

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPY 923
            H D+   NIL+D+     + D+  +    P 
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 31/165 (18%)

Query: 767 NNFNQANIIGCGGFG---LVYKATLTNGTKAAVKRLSGDCGQMEREFQ-----AEVEALS 818
            +F+   +IG G FG   LV K     G   A+K L     +M ++ Q     AE + L+
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKS--EMFKKDQLAHVKAERDVLA 56

Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV------RLKI 872
            +    +VSL    +      LI  ++  G L   L         +K+D       R  +
Sbjct: 57  ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTRFYM 107

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS 917
           A+     +  +HK+     +HRD+K  NIL+D      L+DFGLS
Sbjct: 108 AE-CVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 56/237 (23%), Positives = 86/237 (36%), Gaps = 54/237 (22%)

Query: 409 SGTLSVLQQCKNLTTLILTKNFVGEE----IPENVGGFESLMVLALGNC----------- 453
            G +  L+    L  + L+ N +G E    +   +    +L V+   +            
Sbjct: 20  KGVVEELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYS 79

Query: 454 GLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTE 513
            L   +   LL+C +LQ +DLS N F    P                    G++  S T+
Sbjct: 80  NLVMLLKA-LLKCPRLQKVDLSDNAFGSEFPE-----------------ELGDLISSSTD 121

Query: 514 LKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYN-QASSFPP--SVFLSNNRI-NGTI 569
           L  L  +N     P A   I   + H      L YN +A+  P    V    NR+ NG+ 
Sbjct: 122 LVHLKLNNN-GLGPIAGGRIGKALFH------LAYNKKAADKPKLEVVICGRNRLENGSK 174

Query: 570 PPEIGQLK---HLHVLDLSRNNI-----TGTIPSSISEIRNLEVLDLSSN--DLHGS 616
                 L+   +L  + + +N I     T      +    +LEVLDL  N   L GS
Sbjct: 175 ELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGS 231

Length = 388

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.8 bits (103), Expect = 4e-04
 Identities = 36/129 (27%), Positives = 51/129 (39%), Gaps = 8/129 (6%)

Query: 509 KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGT 568
            S T L    S +   S    S      +  + +   L         PS+ L+ NR+   
Sbjct: 55  SSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNL------LPLPSLDLNLNRLRSN 108

Query: 569 IPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLS 628
           I   + +L +L  LDL  NNIT   P       NL+ LDLS N +  S+P     L  L 
Sbjct: 109 ISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLK 166

Query: 629 KFSVANNHL 637
              ++ N L
Sbjct: 167 NLDLSFNDL 175

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 18/59 (30%), Positives = 27/59 (45%), Gaps = 2/59 (3%)

Query: 371 LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
           LK L L+ N L+     +F  L +L  L LS N+   +S          +L +L L+ N
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE--AFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 20/60 (33%), Positives = 29/60 (48%)

Query: 226 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 285
           +LK L + NN L      +   + +L+ + LS NN +    E  S L SLR L + GN  
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 5e-04
 Identities = 20/57 (35%), Positives = 30/57 (52%)

Query: 349 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF 405
           +LDL+ N  +     +     +LK+L L+ N L+   PE+F  L SL  L LS N+ 
Sbjct: 4   SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.5 bits (102), Expect = 5e-04
 Identities = 39/130 (30%), Positives = 63/130 (48%), Gaps = 14/130 (10%)

Query: 841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSS 899
           + S  E    D  ++ES      L +   +  +   A G+ +L  K C    VHRD+ + 
Sbjct: 217 LPSAPERTRRDTLINES----PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAAR 268

Query: 900 NILLDEKFEAHLADFGLSR-LLRP--YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
           N+L+ E     + DFGL+R ++R   Y +  +T L   L ++ PE       T   DV+S
Sbjct: 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWS 326

Query: 957 FGVVLLELLT 966
           FG++L E+ T
Sbjct: 327 FGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.6 bits (102), Expect = 6e-04
 Identities = 57/246 (23%), Positives = 95/246 (38%), Gaps = 32/246 (13%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE---FQAEVEALSRAQHK 823
           N +     IG G FG V+        +    +     G  ERE      EV  +   +HK
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 824 NLVS-LQGYCRHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           N+V  +  +    N +L I   + + G L   + +       ++    + I +     LA
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 882 YLHKVCE----PHIVHRDVKSSNILLDEKFE-----------------AHLADFGLSRLL 920
           Y H + +      ++HRD+K  NI L                      A + DFGLS+ +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 921 RPYDTHVTTDLVGTLGYIPPE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
                 +    VGT  Y  PE    +T +   + D+++ G ++ EL +G+ P    K  N
Sbjct: 193 GI--ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH--KANN 248

Query: 979 CRDLVS 984
              L+S
Sbjct: 249 FSQLIS 254

Length = 1021

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 6e-04
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 39/218 (17%)

Query: 774 IIGCGGFGLVYKAT------LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 827
           +IGCGGFG VY+        + N   A ++ L  +   ME          +     + ++
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVME------TLVYNNIYDIDKIA 72

Query: 828 LQGYCRHGN-DRLLIYSYMENGSLDY-----------WLHESVDK--DSVLKWDVRL--K 871
           L  +    N D L I  Y   GS               L E+  +    +   + +L   
Sbjct: 73  L--WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN 130

Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---- 927
           I +     L Y+H   E  I H D+K  NI++D     ++ D+G++     +  H+    
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187

Query: 928 -TTDL-VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLE 963
              DL  GTL Y   +       T RGD+ S G  +L+
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 43.7 bits (103), Expect = 6e-04
 Identities = 89/342 (26%), Positives = 146/342 (42%), Gaps = 51/342 (14%)

Query: 98  IPRSLGHLNQLKLLDLS-CNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 156
           +P S+ +LN+L+ LD+S C +LE ++P  + NLK L  L+LS        S + +  ++ 
Sbjct: 673 LPSSIQYLNKLEDLDMSRCENLE-ILPTGI-NLKSLYRLNLSG------CSRLKSFPDI- 723

Query: 157 QSLNVSSNSFNGSLFELGEF-SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM 215
            S N+S    + +  E  EF SNL + N+         + ++W   + +Q L   M    
Sbjct: 724 -STNISWLDLDETAIE--EFPSNLRLENLDELILCEMKSEKLW---ERVQPLTPLMTML- 776

Query: 216 GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 275
                   SPSL +L + +     +LP S+ ++  L+H+ +        L   I NL SL
Sbjct: 777 --------SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESL 827

Query: 276 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 335
             L + G       P++  N++ L      S +    +P  +   S L  LD+   +   
Sbjct: 828 ESLDLSGCSRLRTFPDISTNISDLNL----SRTGIEEVPWWIEKFSNLSFLDMNGCNNLQ 883

Query: 336 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 395
            + LN S L  L T+D              SDC  L   S   N    +V  +   + S 
Sbjct: 884 RVSLNISKLKHLETVD-------------FSDCGALTEASW--NGSPSEVAMATDNIHSK 928

Query: 396 LFLSLSNNSFNHLSGTL-SVLQQCKNLTTLILTKNFVGEEIP 436
           L  ++  N  N  +    ++LQQ      LIL+    GEE+P
Sbjct: 929 LPSTVCINFINCFNLDQEALLQQQSIFKQLILS----GEEVP 966

syringae 6; Provisional. Length = 1153

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 8e-04
 Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 61/223 (27%)

Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA----------QHK 823
           IG G  G+V  A     G   A+K+LS       R FQ    A  RA           HK
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLS-------RPFQNVTHA-KRAYRELVLMKLVNHK 75

Query: 824 NLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD------SVLKWDVRLK 871
           N++ L      Q       D   +Y  ME   +D  L + +  D      S L + +   
Sbjct: 76  NIIGLLNVFTPQKSLEEFQD---VYLVME--LMDANLCQVIQMDLDHERMSYLLYQMLC- 129

Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
                  G+ +LH      I+HRD+K SNI++       + DFGL+R      + + T  
Sbjct: 130 -------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 177

Query: 932 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           V T  Y  PE      Y + +      D++S G ++ E++ G 
Sbjct: 178 VVTRYYRAPEVILGMGYKENV------DIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.7 bits (100), Expect = 0.001
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 36/165 (21%)

Query: 877  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGT 934
            ARG+ +L  K C    VHRD+ + N+LL +     + DFGL+R +     +V+       
Sbjct: 247  ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 994
            + ++ PE       T   DV+S+G++L E                      +F +     
Sbjct: 303  VKWMAPESIFDNLYTTLSDVWSYGILLWE----------------------IFSLGGTPY 340

Query: 995  EVEIIDASIWHKDR--------EKQLLEMLEIACKCIDQDPRRRP 1031
               I+D++ ++K +        +    E+ +I  KC + +P +RP
Sbjct: 341  PGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 40.8 bits (96), Expect = 0.002
 Identities = 58/241 (24%), Positives = 81/241 (33%), Gaps = 51/241 (21%)

Query: 407 HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG----GFES---LMVLALGNCGLKGH- 458
                 S L+   +L  L L+ N  G  IP  +     G      L  L L +  L    
Sbjct: 39  AAKALASALRPQPSLKELCLSLNETGR-IPRGLQSLLQGLTKGCGLQELDLSDNALGPDG 97

Query: 459 IPVW--LLRCKKLQVLDLSWNHFDGNIPPWIGQ-----MENLFYLDFSNNTLTGEIPKSL 511
             V   LLR   LQ L L+ N         + +        L  L    N L G    S 
Sbjct: 98  CGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA---SC 154

Query: 512 TELKSLISSNCT------SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRI 565
             L   + +N        ++N    AGI    +      GL  N        + L+NN +
Sbjct: 155 EALAKALRANRDLKELNLANNGIGDAGIRALAE------GLKANCNLEV---LDLNNNGL 205

Query: 566 N--------GTIPPEIGQLKHLHVLDLSRNNITGTI-----PSSISEIRNLEVLDLSSND 612
                     T+      LK L VL+L  NN+T         + +S   +L  L LS ND
Sbjct: 206 TDEGASALAETLA----SLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261

Query: 613 L 613
           +
Sbjct: 262 I 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.8 bits (95), Expect = 0.003
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 43/211 (20%)

Query: 775 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQH 822
           IG G  G+V   Y A L      A+K+LS       R FQ +  A         +    H
Sbjct: 25  IGSGAQGIVCAAYDAVLDR--NVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 75

Query: 823 KNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDVRLKIAQ 874
           KN++SL      Q       D  L+   M+  +L   +   +D +  S L + +      
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLC---- 130

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               G+ +LH      I+HRD+K SNI++       + DFGL+R      + + T  V T
Sbjct: 131 ----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVT 181

Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELL 965
             Y  PE    +      D++S G ++ E++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 40.6 bits (95), Expect = 0.004
 Identities = 24/71 (33%), Positives = 40/71 (56%), Gaps = 2/71 (2%)

Query: 176 FSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHVDN 234
             +L   N+S NS  G +   + S +  +++LDLS N F GS+ + L    SL+ L+++ 
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITS-LEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499

Query: 235 NLLGGDLPDSL 245
           N L G +P +L
Sbjct: 500 NSLSGRVPAAL 510

Length = 623

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.8 bits (95), Expect = 0.004
 Identities = 36/125 (28%), Positives = 45/125 (36%), Gaps = 46/125 (36%)

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDT-------HVTTD------------- 930
           +HRD+K  NIL+D      L DFGL    R  +D+       HV  D             
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 931 -------------------------LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL 965
                                    LVGT  YI PE       T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 966 TGRRP 970
            G+ P
Sbjct: 243 VGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1048
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.72
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.71
PRK10345	210	hypothetical protein; Provisional	99.71
smart00090	237	RIO RIO-like kinase.	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
PRK14879	211	serine/threonine protein kinase; Provisional	99.65
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.62
PLN03150	623	hypothetical protein; Provisional	99.61
PLN03150	623	hypothetical protein; Provisional	99.56
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.52
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.5
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.49
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.35
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.32
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.31
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.21
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.2
KOG1243	690	consensus Protein kinase [General function predict	99.16
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.16
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.15
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.11
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.11
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.09
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.06
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.04
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.04
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.03
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.03
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.02
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.02
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.01
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.97
COG4248	637	Uncharacterized protein with protein kinase and he	98.89
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.83
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.77
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.76
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.75
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.75
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.72
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.67
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.49
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.47
PRK09902	216	hypothetical protein; Provisional	98.45
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.45
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.45
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.45
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.36

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.2e-115  Score=1121.05  Aligned_cols=916  Identities=30%  Similarity=0.522  Sum_probs=772.7

Q ss_pred             CHHHHHHHHHHHhcCCC-CCCCcCcCCCCCCceeeeeeeCCCCCCCCCCcEEEEEecCCCCccccCccccCCcCCCeEec
Q 001591           35 DPSDLLALKEFAGNLTN-GSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDL  113 (1048)
Q Consensus        35 ~~~~~~aLl~~k~~~~~-~~~l~sw~~~~~~c~w~gv~C~~~~~~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L  113 (1048)
                      .++|+.||++||+++.+ .+.+.+|+..++||.|.||+|++      .++|+.|+|++++++|.+++++..+++|+.|+|
T Consensus        27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~------~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L  100 (968)
T PLN00113         27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN------SSRVVSIDLSGKNISGKISSAIFRLPYIQTINL  100 (968)
T ss_pred             CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCC------CCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence            66899999999999964 45789999888999999999963      468999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccc-CCCCccEEeccCCcccCcccccccccccccEEEecCcccCCc-cccccccCcccEEEecCccccC
Q 001591          114 SCNHLEGVVPVELS-NLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGS-LFELGEFSNLAVFNISNNSFTG  191 (1048)
Q Consensus       114 s~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~~~l~~l~~L~~L~Ls~n~l~~  191 (1048)
                      ++|++++.+|..+. .+++|++|+|++|.+++.+|.  ..+++|++|+|++|.+++. +..++.+++|++|++++|.+.+
T Consensus       101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~  178 (968)
T PLN00113        101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG  178 (968)
T ss_pred             CCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc
Confidence            99999988887755 999999999999999987765  5689999999999999864 5669999999999999999998


Q ss_pred             ccchhhhhcccccceEeccCccccc-ccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhc
Q 001591          192 KLNSRIWSASKEIQILDLSMNHFMG-SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS  270 (1048)
Q Consensus       192 ~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  270 (1048)
                      .+|.. +..+++|++|+|++|.+.+ .+..+..+++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..+.
T Consensus       179 ~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~  257 (968)
T PLN00113        179 KIPNS-LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG  257 (968)
T ss_pred             cCChh-hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh
Confidence            88765 4678999999999999976 456789999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEe
Q 001591          271 NLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTL  350 (1048)
Q Consensus       271 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  350 (1048)
                      ++++|++|+|++|++++.+|..+.++++|+.|++++|.+.+.+|..+..+++|++|++++|.+++..|..+..+++|+.|
T Consensus       258 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L  337 (968)
T PLN00113        258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVL  337 (968)
T ss_pred             CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCcCcccccccccccceEecccCc
Q 001591          351 DLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF  430 (1048)
Q Consensus       351 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~  430 (1048)
                      +|++|.+++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|++....  ...+..+++|+.|++++|.
T Consensus       338 ~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~--p~~~~~~~~L~~L~L~~n~  415 (968)
T PLN00113        338 QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI--PKSLGACRSLRRVRLQDNS  415 (968)
T ss_pred             ECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccC--CHHHhCCCCCCEEECcCCE
Confidence            99999999999999999999999999999999999999999999999999999987532  2457789999999999999


Q ss_pred             cCCCCCccccCCCcCcEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCcccccCCcc
Q 001591          431 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKS  510 (1048)
Q Consensus       431 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  510 (1048)
                      +.+..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.||+++|++++.+|..
T Consensus       416 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~  494 (968)
T PLN00113        416 FSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRK  494 (968)
T ss_pred             eeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChh
Confidence            999999999999999999999999999999999999999999999999999998866 4689999999999999999999


Q ss_pred             hhhhhhhhccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCcccccCCccccCCCCCcEEEccCceec
Q 001591          511 LTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNIT  590 (1048)
Q Consensus       511 ~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~  590 (1048)
                      +.++++|                                      ..|++++|++.+.+|..++++++|++|+|++|+++
T Consensus       495 ~~~l~~L--------------------------------------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  536 (968)
T PLN00113        495 LGSLSEL--------------------------------------MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS  536 (968)
T ss_pred             hhhhhcc--------------------------------------CEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence            8888776                                      46899999999999999999999999999999999


Q ss_pred             ccCCcccccccCccEeeCCCCccCCCCccccccccCCCeeeeccccccccCCCCCcccCCCCccccCCCCCcCCC----C
Q 001591          591 GTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEI----D  666 (1048)
Q Consensus       591 g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~----~  666 (1048)
                      |.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|++++|+++|.+|..+++.++...+|.||+++||..    .
T Consensus       537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~  616 (968)
T PLN00113        537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL  616 (968)
T ss_pred             ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999962    1


Q ss_pred             CCCCCcCCCCCCCCCCCCCCCCCCCcEEEEeeehhHHHH-HHHHhhhheeeccCCCCCCCCCccccCCcchhhHHhhccc
Q 001591          667 SPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIA-LLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSK  745 (1048)
Q Consensus       667 ~~~~~~~~~~~p~~~~~~~~~~~~~~ii~i~~~~~v~i~-~l~~~~~~~~~rr~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (1048)
                      ++|...             .+...+ .+.++++++++++ ++++++++ ++||++...........+.          ..
T Consensus       617 ~~c~~~-------------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~----------~~  671 (968)
T PLN00113        617 PPCKRV-------------RKTPSW-WFYITCTLGAFLVLALVAFGFV-FIRGRNNLELKRVENEDGT----------WE  671 (968)
T ss_pred             CCCccc-------------ccccee-eeehhHHHHHHHHHHHHHHHHH-HHHhhhccccccccccccc----------cc
Confidence            234210             011111 1112212222222 22222222 2232221111111000000          00


Q ss_pred             eeeecCCCCccccHHHHHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCc
Q 001591          746 LVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN  824 (1048)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  824 (1048)
                      ...+.......++++++.   ..|+..++||+|+||.||+|++. ++..||||++......    ...|++++++++|||
T Consensus       672 ~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~Hpn  744 (968)
T PLN00113        672 LQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPN  744 (968)
T ss_pred             ccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCC
Confidence            011111111234445543   45777889999999999999874 7899999998744322    234688999999999


Q ss_pred             eeeecceEeeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001591          825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  904 (1048)
Q Consensus       825 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~  904 (1048)
                      ||+++++|.+++..++||||+++|+|.++++.       ++|.++.+|+.|+++|++|||..+.++|+||||||+||+++
T Consensus       745 Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~  817 (968)
T PLN00113        745 IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID  817 (968)
T ss_pred             cceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC
Confidence            99999999999999999999999999999852       78999999999999999999977678999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHH
Q 001591          905 EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS  984 (1048)
Q Consensus       905 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~  984 (1048)
                      .++.+++. ||.+......     ....||+.|+|||++.+..++.++|||||||++|||+||+.||+...+ .......
T Consensus       818 ~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~  890 (968)
T PLN00113        818 GKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVE  890 (968)
T ss_pred             CCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHH
Confidence            99888875 6655433211     223688999999999999999999999999999999999999964332 2345566


Q ss_pred             HHHHhhcccccccccccccCc--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591          985 WVFQMKSEKREVEIIDASIWH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      |..............++....  ....++..++.+++.+||+.+|++||+|+||+++|+++...
T Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        891 WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             HHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            665544333333444444422  22345566889999999999999999999999999988653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.9e-59  Score=599.07  Aligned_cols=514  Identities=33%  Similarity=0.516  Sum_probs=471.6

Q ss_pred             cCCCeEecCCCCCCCCCCccccCCCCccEEeccCCcccCccccc-ccccccccEEEecCcccCCccccccccCcccEEEe
Q 001591          106 NQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGM-LAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNI  184 (1048)
Q Consensus       106 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L  184 (1048)
                      .+++.|||++|++++.+|..|..+++|++|+|++|++++.+|.. +..+.+|++|+|++|.+++... .+.+++|++|+|
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p-~~~l~~L~~L~L  147 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP-RGSIPNLETLDL  147 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccC-ccccCCCCEEEC
Confidence            47999999999999999999999999999999999999876655 4599999999999999987543 357899999999


Q ss_pred             cCccccCccchhhhhcccccceEeccCccccc-ccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCc
Q 001591          185 SNNSFTGKLNSRIWSASKEIQILDLSMNHFMG-SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG  263 (1048)
Q Consensus       185 s~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  263 (1048)
                      ++|.+++.+|.. +..+++|++|+|++|.+.+ .+..+.++++|++|+|++|.+.+.+|..++++++|++|+|++|++++
T Consensus       148 s~n~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  226 (968)
T PLN00113        148 SNNMLSGEIPND-IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG  226 (968)
T ss_pred             cCCcccccCChH-HhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence            999999888765 5678999999999999875 55678999999999999999999999999999999999999999999


Q ss_pred             chhhhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCccccc
Q 001591          264 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG  343 (1048)
Q Consensus       264 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  343 (1048)
                      .+|..+.++++|++|+|++|++++.+|..++++++|++|++++|++.+.+|..+.++++|++|++++|.+.+.+|..+.+
T Consensus       227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~  306 (968)
T PLN00113        227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ  306 (968)
T ss_pred             cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCcCcccccccccccce
Q 001591          344 LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT  423 (1048)
Q Consensus       344 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~  423 (1048)
                      +++|+.|++++|.+++.+|..+..+++|+.|++++|.+++.+|..++.+++|+.|++++|++....  ...+..+++|+.
T Consensus       307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~--p~~~~~~~~L~~  384 (968)
T PLN00113        307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI--PEGLCSSGNLFK  384 (968)
T ss_pred             CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeC--ChhHhCcCCCCE
Confidence            999999999999999999999999999999999999999999999999999999999999987532  134667889999


Q ss_pred             EecccCccCCCCCccccCCCcCcEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCcc
Q 001591          424 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTL  503 (1048)
Q Consensus       424 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  503 (1048)
                      |++++|.+.+.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|+|++|++
T Consensus       385 L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~  464 (968)
T PLN00113        385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF  464 (968)
T ss_pred             EECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCcee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCcchhhhhhhhccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCcccccCCccccCCCCCcEEE
Q 001591          504 TGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLD  583 (1048)
Q Consensus       504 ~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~~p~~~~~L~~L~~L~  583 (1048)
                      .+.+|..+. ..+|                                      +.|++++|++++.+|..++++++|+.|+
T Consensus       465 ~~~~p~~~~-~~~L--------------------------------------~~L~ls~n~l~~~~~~~~~~l~~L~~L~  505 (968)
T PLN00113        465 FGGLPDSFG-SKRL--------------------------------------ENLDLSRNQFSGAVPRKLGSLSELMQLK  505 (968)
T ss_pred             eeecCcccc-cccc--------------------------------------eEEECcCCccCCccChhhhhhhccCEEE
Confidence            998887542 1222                                      5789999999999999999999999999


Q ss_pred             ccCceecccCCcccccccCccEeeCCCCccCCCCccccccccCCCeeeeccccccccCCCCC-cccCCCCccccCCCCCc
Q 001591          584 LSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGG-QFYSFPNSSFEGNPGLC  662 (1048)
Q Consensus       584 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~~lc  662 (1048)
                      |++|+++|.+|..++++++|++|+|++|+++|.+|..|..+++|+.|+|++|+++|.+|..- .+..+....+.+|+..+
T Consensus       506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence            99999999999999999999999999999999999999999999999999999999999752 34445555677887544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=451.73  Aligned_cols=290  Identities=51%  Similarity=0.835  Sum_probs=255.0

Q ss_pred             CCccccHHHHHHhhcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceE
Q 001591          753 DCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC  832 (1048)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  832 (1048)
                      ....|+++++.+++++|...+.||+|+||.||+|...+|..||||++........++|..|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45678999999999999999999999999999999998999999988765432156699999999999999999999999


Q ss_pred             eeCC-cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEE
Q 001591          833 RHGN-DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  911 (1048)
Q Consensus       833 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  911 (1048)
                      .+.+ +.++|||||++|+|+++++.....  +++|..|++||.++|+||+|||..+.++||||||||+|||+|+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 499999999999999999975432  8899999999999999999999998889999999999999999999999


Q ss_pred             eecccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhc
Q 001591          912 ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS  991 (1048)
Q Consensus       912 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~  991 (1048)
                      +|||+|+..............||.+|+|||+...+..+.++|||||||++.|++||+.|.+.........+++|......
T Consensus       219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999976543122211111899999999999999999999999999999999999999886554555568999988888


Q ss_pred             ccccccccccccC-chhhH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          992 EKREVEIIDASIW-HKDRE-KQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       992 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      .....+++|+.+. ..+.. +....+.+++.+|++.+|++||+|.||+++|+.+.
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            8889999999987 55554 67888999999999999999999999999997765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-45  Score=379.11  Aligned_cols=253  Identities=28%  Similarity=0.444  Sum_probs=211.3

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeeecceEeeCC-cEEEEEEec
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-DRLLIYSYM  845 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  845 (1048)
                      ++..+.||+|..|+|||++++ +++.+|+|++... .....+++.+|++++++++||+||.++|.|..+. ...++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344778999999999999987 7889999999544 3566788999999999999999999999999998 499999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|++++..    .+.+++....+|+.+|++||.|||..  ++||||||||+|||+++.|++||+|||.++.+...  
T Consensus       161 DgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  161 DGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             CCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999998874    35689999999999999999999973  59999999999999999999999999999886432  


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccC--CCCchhHHHHHHHhhccccccccccccc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK--GKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                       ....++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....  .....+++.++....    .....+.  
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p----pP~lP~~--  305 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP----PPRLPEG--  305 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC----CCCCCcc--
Confidence             4566899999999999999999999999999999999999999997541  122233333332211    1111111  


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~ 1042 (1048)
                            ..+.++.+++..|+++||.+||++.|+++  ++.+
T Consensus       306 ------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  306 ------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             ------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence                  34568999999999999999999999987  5543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-44  Score=379.21  Aligned_cols=256  Identities=25%  Similarity=0.423  Sum_probs=207.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-------hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-------QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  838 (1048)
                      +.|.+.+.||+|+||.|-+|..+ +|+.||||++.+...       .....+++|+++|++++|||||+++++|..++..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45778999999999999999754 899999999975431       1223467999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC---CcEEEeecc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK---FEAHLADFG  915 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfg  915 (1048)
                      |+|||||+||+|.+++-.    ...+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|||
T Consensus       252 YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             EEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999988763    45577788899999999999999997   99999999999999755   789999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCcCCCC---chhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT---CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE  992 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  992 (1048)
                      +|+..+  ....+.+.||||.|.|||++.+..++   .++|+||+||++|-+++|.+||.....+..  +.+   ++.+.
T Consensus       325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~e---QI~~G  397 (475)
T KOG0615|consen  325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKE---QILKG  397 (475)
T ss_pred             hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHH---HHhcC
Confidence            999875  45567789999999999998765433   478999999999999999999976443331  111   11111


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          993 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      . .  .+.+    ....+..++..++|.+|+..||++|||++|+++  |+...
T Consensus       398 ~-y--~f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  398 R-Y--AFGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             c-c--cccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            1 1  1112    223345668999999999999999999999997  77643

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=396.08  Aligned_cols=254  Identities=35%  Similarity=0.497  Sum_probs=208.5

Q ss_pred             cccCeEeccCceEEEEEEECCCcEEEEEEecCCchh--hHHHHHHHHHHHHhcCCCceeeecceEeeCC-cEEEEEEecc
Q 001591          770 NQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNLVSLQGYCRHGN-DRLLIYSYME  846 (1048)
Q Consensus       770 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  846 (1048)
                      ...+.||+|+||+||+|.|.....||||++......  ..++|.+|+.++.+++|||||+++|+|.+.. ...+|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            345569999999999999984445999999865422  2568999999999999999999999999887 7899999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEcCCCCCceEECCCC-cEEEeecccccccCCCC
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-IVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~kl~Dfg~a~~~~~~~  924 (1048)
                      +|+|.++++..  ....+++..+.+||.|||+|+.|||+.   + ||||||||+|||++.++ ++||+|||+++......
T Consensus       124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99999999864  466799999999999999999999996   6 99999999999999997 99999999998754321


Q ss_pred             CceeecccccccccCccccC--cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQ--TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                       ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....   ......   .........     
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~---v~~~~~Rp~-----  266 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASA---VVVGGLRPP-----  266 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHhcCCCCC-----
Confidence             2334478999999999999  66999999999999999999999999975432   112211   111111111     


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                          .+......+..++.+||+.||++||++.+++..|+.+.
T Consensus       267 ----~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  267 ----IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             ----CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence                11124457899999999999999999999999998764

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-44  Score=392.63  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=211.0

Q ss_pred             cCCcccCeEeccCceEEEEEEE-CCCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .+|...+.||+|||++||.++. .+|+.||+|++.+..   ....+.+.+|+++.+.++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999997 789999999998632   334556889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      |+|..++|.++++    ...++++.+++.+++||+.|+.|||++   +|+|||||..|++++++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999887    356799999999999999999999997   999999999999999999999999999998864


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      + .+...+.||||.|+|||++....++..+||||+|||+|-|++|++||+...       +.......+....       
T Consensus       171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~Y-------  235 (592)
T KOG0575|consen  171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNEY-------  235 (592)
T ss_pred             c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcCc-------
Confidence            3 344556899999999999999999999999999999999999999997421       1111111111111       


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                         ..+...+.+..++|.++++++|.+|||+++|+.
T Consensus       236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               112233457899999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=368.94  Aligned_cols=200  Identities=28%  Similarity=0.499  Sum_probs=181.0

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .++|...+.||.|+||+||+|+++ ++..||||.+.+.  ..+..+....|+++++.++|||||++++++..++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457888888999999999999977 6899999999866  4566677899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC------CcEEEeeccc
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK------FEAHLADFGL  916 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~Dfg~  916 (1048)
                      |||.||+|.+|++.    .+.+++..++.++.|+|.|+++||+.   +||||||||+|||++..      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999985    34689999999999999999999985   99999999999999754      5689999999


Q ss_pred             ccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCccc
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC  974 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~  974 (1048)
                      |+.+.+  .....+.||+|.|||||+++..+|+.|+|+||+|+|+|+|++|++||+..
T Consensus       162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            998863  34445689999999999999999999999999999999999999999753

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=387.78  Aligned_cols=256  Identities=28%  Similarity=0.447  Sum_probs=214.5

Q ss_pred             CCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      .++..+.||+|.||.||.|.|....+||+|.++.. ....+.|.+|+.+|++++|++||+++|+|..++..+||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            34557789999999999999997789999999865 34456789999999999999999999999998899999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+||+..  .+..+...+.+.++.|||+|++||+++   ++|||||.++|||++++..+||+|||+|+....+.-..
T Consensus       286 GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  286 GSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             CcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            9999999872  566789999999999999999999986   99999999999999999999999999999544332222


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCch
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      .....-...|.|||.+....++.+||||||||+||||+| |+.||..+...+   .++.             ++....-+
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~~-------------le~GyRlp  424 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLEL-------------LERGYRLP  424 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHHH-------------HhccCcCC
Confidence            333334458999999999999999999999999999999 999987654222   2211             11222223


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591         1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus      1007 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                      .++.++.+++++|..||+.+|++|||++.+...|+++..
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            344566789999999999999999999999999998754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-43  Score=349.53  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=208.4

Q ss_pred             cCCcccCeEeccCceEEEEEEE-CCCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecc-eEeeCCc-EEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQG-YCRHGND-RLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  841 (1048)
                      .+|++.++||+|.||+||++.. .+|..||.|.+.-+  +.+..++...|+.++++++|||||++++ .+.++.+ .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3477888999999999999975 48999999988632  3445567889999999999999999999 4444444 7899


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCC-CeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP-HIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      |||+++|+|...++......+.+++..+++++.|+++||.++|+...+ -|+||||||.||+++.+|.||++|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999988887888999999999999999999999984323 2889999999999999999999999999987


Q ss_pred             CCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ... ......++|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.   +-.++..   .+.. .....+  
T Consensus       179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~---KI~q-gd~~~~--  248 (375)
T KOG0591|consen  179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCK---KIEQ-GDYPPL--  248 (375)
T ss_pred             cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHH---HHHc-CCCCCC--
Confidence            643 33345679999999999999999999999999999999999999999742   2222222   2221 111111  


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            ..+..+.++.++|..|+..||+.||+...++.
T Consensus       249 ------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  249 ------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             ------cHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence                  12456678999999999999999998444433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-42  Score=346.64  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=207.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ++|+....+|+|+||+|||++++ +|+.||||++...  ++...+-..+|++++++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888899999999999999987 7999999998633  34455667899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |++.--|++ ++.   ....++.+.+.++++|+++|+.|+|++   ++|||||||+|||++.+|.+|+||||+|+.+.. 
T Consensus        82 ~~dhTvL~e-Le~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   82 YCDHTVLHE-LER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             ecchHHHHH-HHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            998865544 332   233478899999999999999999997   999999999999999999999999999998874 


Q ss_pred             CCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhc-----------
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS-----------  991 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----------  991 (1048)
                      .+...++++.|.+|+|||.+.+ .+|.+++||||+||++.||++|.+-|.+..+   .+....+.....           
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD---iDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD---IDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch---HHHHHHHHHHHcccCHHHHHHhc
Confidence            4455677899999999997766 8999999999999999999999999975332   222222222111           


Q ss_pred             -ccc-----cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          992 -EKR-----EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       992 -~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       ...     .++.-+++.....-+....-+.+++.+|++.||.+|++-+|++.
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence             111     11111111112222334457899999999999999999999985

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=357.34  Aligned_cols=242  Identities=28%  Similarity=0.355  Sum_probs=202.0

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      .++|++.++||+|+||+||.++.+ +++.+|+|++++...   ...+...+|..++.+++||.||+++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            457999999999999999999865 688999999986542   2345678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      +||+.||.|..+|++    .+.+++..++-++.+|+.||.|||+.   +|||||+||+|||+|++|+++++|||+++...
T Consensus       104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999973    56799999999999999999999986   99999999999999999999999999998643


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      . .+..+..+|||+.|||||++.+..|+.++|.||+|+++|||++|.+||....      ...+........ .  .   
T Consensus       177 ~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k-~--~---  243 (357)
T KOG0598|consen  177 K-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK-L--P---  243 (357)
T ss_pred             c-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc-C--C---
Confidence            2 2334456899999999999999999999999999999999999999997422      122222222221 0  0   


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCC
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 1031 (1048)
                          ..+.-...+..+++.+.+..||++|.
T Consensus       244 ----~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  244 ----LPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ----CCCccCCHHHHHHHHHHhccCHHHhc
Confidence                01111234788999999999999995

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=9.8e-45  Score=376.64  Aligned_cols=391  Identities=26%  Similarity=0.329  Sum_probs=235.1

Q ss_pred             cCCCeEecCCCCCCCCCCccccCCCCccEEeccCCcccCcccccccccccccEEEecCcccCCccccccccCcccEEEec
Q 001591          106 NQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNIS  185 (1048)
Q Consensus       106 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls  185 (1048)
                      ..|+.|++++|.++ .+...+.++..|++|++++|+++.. |+.++.+..++.|+.++|+++..+.+++.+.+|+.++++
T Consensus        45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~l-p~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s  122 (565)
T KOG0472|consen   45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQL-PAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCS  122 (565)
T ss_pred             cchhhhhhccCchh-hccHhhhcccceeEEEeccchhhhC-CHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcc
Confidence            34556666666665 3344566666666666666666643 345566666666666666666666666666666777777


Q ss_pred             CccccCccchhhhhcccccceEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcch
Q 001591          186 NNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL  265 (1048)
Q Consensus       186 ~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  265 (1048)
                      +|.+. .++.+++ .+-.++.++..+|++.+.|+++..+.+|..|++.+|++....|..+. ++.|++||...|-++ .+
T Consensus       123 ~n~~~-el~~~i~-~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tl  198 (565)
T KOG0472|consen  123 SNELK-ELPDSIG-RLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TL  198 (565)
T ss_pred             cccee-ecCchHH-HHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cC
Confidence            66666 4444443 34456666777777777777777777777777777777754444444 777777777777776 66


Q ss_pred             hhhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCC
Q 001591          266 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLS  345 (1048)
Q Consensus       266 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~  345 (1048)
                      |..++.+.+|..|+|..|+|. ..| .|.++..|.+|+++.|+|+........++++|.+|||+.|+++ ..|..+.-+.
T Consensus       199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr  275 (565)
T KOG0472|consen  199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR  275 (565)
T ss_pred             ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence            777777777777777777777 555 6777777777777777777444444557777777888888777 4555666777


Q ss_pred             cccEeecccccccCCCCccccCCCccceeeccccccccccchhh------------------------------------
Q 001591          346 SLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESF------------------------------------  389 (1048)
Q Consensus       346 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~------------------------------------  389 (1048)
                      +|.+||+|+|.|+ .+|..++++ .|+.|-+.+|.+..+ -..+                                    
T Consensus       276 sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~  352 (565)
T KOG0472|consen  276 SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTI-RREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPS  352 (565)
T ss_pred             hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHH-HHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCC
Confidence            7777888877777 467777777 777777777776521 1111                                    


Q ss_pred             ------ccCCcCcEEeccCCcCCCCcCcccccccccccceEecccCccCCCCCccccCCCcCcEEEccCCcccCCchHhh
Q 001591          390 ------GKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWL  463 (1048)
Q Consensus       390 ------~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l  463 (1048)
                            ..+.+.+.|++++-+++.+|..+....+-.-.+..++++|++ .++|..+..++.+.+.-+..|+..+.+|..+
T Consensus       353 ~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL-~elPk~L~~lkelvT~l~lsnn~isfv~~~l  431 (565)
T KOG0472|consen  353 ESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQL-CELPKRLVELKELVTDLVLSNNKISFVPLEL  431 (565)
T ss_pred             CcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchH-hhhhhhhHHHHHHHHHHHhhcCccccchHHH
Confidence                  112234445555555555544333333333344455555554 2344444444443332222222223455555


Q ss_pred             hccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCcccccCCcch
Q 001591          464 LRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSL  511 (1048)
Q Consensus       464 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  511 (1048)
                      +.+++|..|+|++|.+. .+|..++.+-.|+.||+|.|+|. .+|..+
T Consensus       432 ~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~  477 (565)
T KOG0472|consen  432 SQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECL  477 (565)
T ss_pred             Hhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHH
Confidence            55555555555555444 45555555555555555555544 344433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=363.34  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=210.2

Q ss_pred             HHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCc
Q 001591          763 LKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       763 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  837 (1048)
                      .+...+|...+.||+|+|++||+|+.. ++++||||++.+..   ....+.+.+|-++|.++ .||.|++++..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            344567899999999999999999755 79999999997654   23345678899999999 89999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .|+|+||+++|+|.++++.    -+.+++..++.+|.+|+.||+|||++   |||||||||+|||+|+|+++||+|||.|
T Consensus       149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            9999999999999999985    46799999999999999999999996   9999999999999999999999999999


Q ss_pred             cccCCCCCc------------eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHH
Q 001591          918 RLLRPYDTH------------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW  985 (1048)
Q Consensus       918 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~  985 (1048)
                      +.+.+....            ....++||..|.+||++.....++.+|+|+||||+|+|+.|++||...   +..-..+.
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~---NeyliFqk  298 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA---NEYLIFQK  298 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc---cHHHHHHH
Confidence            987653221            113479999999999999999999999999999999999999999642   22222222


Q ss_pred             HHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          986 VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +....          -    .+++..++.+.+|+.+.+..||.+|+|..++.+
T Consensus       299 I~~l~----------y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  299 IQALD----------Y----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHhc----------c----cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            22111          1    122222347889999999999999999988876

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=357.65  Aligned_cols=261  Identities=22%  Similarity=0.300  Sum_probs=210.5

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHH-HHHHHHHHHhcC-CCceeeecceEeeCC-cEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQ-HKNLVSLQGYCRHGN-DRLLI  841 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  841 (1048)
                      .++|.+.+.||.|.||.||+|+-. +|+.||||+++......++- =.+|+..+++++ |||||++.+++.+.+ ..++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            357888999999999999999754 79999999998665444433 368999999998 999999999999888 89999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      ||||+. +|++.+.++   ++.+++..++.|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+|+.+.
T Consensus        89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            999965 899988764   77899999999999999999999997   99999999999999988899999999999875


Q ss_pred             CCCCceeecccccccccCccc-cCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ...  ..+.++.|.+|+|||+ ++.+.|+.+.|+||+|||++|+.+-++-|.+.   ...|.+..+.++.+.........
T Consensus       162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~---sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA---SEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC---cHHHHHHHHHHHhCCCccccchh
Confidence            433  3466789999999995 56778999999999999999999999988643   33344444444443222111111


Q ss_pred             ---------ccc-------CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ---------ASI-------WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ---------~~~-------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                               -.+       ....-..+..++.+++.+|+++||.+|||+.|+++
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                     000       00111235668999999999999999999999987

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.5e-44  Score=375.35  Aligned_cols=460  Identities=28%  Similarity=0.385  Sum_probs=367.2

Q ss_pred             cccCCCCccEEeccCCcccCcccccccccccccEEEecCcccCCccccccccCcccEEEecCccccCccchhhhhccccc
Q 001591          125 ELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI  204 (1048)
Q Consensus       125 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L  204 (1048)
                      .+..-..|+.|++++|.+...- .-+.++..|+.|++++|++...+.+++.+.+++.++.++|++. .+|.++. .+.++
T Consensus        40 ~wW~qv~l~~lils~N~l~~l~-~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~-s~~~l  116 (565)
T KOG0472|consen   40 NWWEQVDLQKLILSHNDLEVLR-EDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELPEQIG-SLISL  116 (565)
T ss_pred             hhhhhcchhhhhhccCchhhcc-HhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hccHHHh-hhhhh
Confidence            4555677999999999998544 4578999999999999999999999999999999999999998 7777665 45789


Q ss_pred             ceEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccCCc
Q 001591          205 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ  284 (1048)
Q Consensus       205 ~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  284 (1048)
                      ..|+.+.|.+...+++++.+..|+.|+..+|+++ ..|.+++.+.+|..|++.+|++....|..+. ++.|++||...|-
T Consensus       117 ~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~  194 (565)
T KOG0472|consen  117 VKLDCSSNELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNL  194 (565)
T ss_pred             hhhhccccceeecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhh
Confidence            9999999999999999999999999999999999 6799999999999999999999966666665 9999999999999


Q ss_pred             CCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCCCcc
Q 001591          285 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS  364 (1048)
Q Consensus       285 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  364 (1048)
                      ++ .+|+.++.+.+|+.|++..|+|. .+| .|..++.|++|+++.|++.-.+......+.++..|||.+|+++ ..|+.
T Consensus       195 L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde  270 (565)
T KOG0472|consen  195 LE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDE  270 (565)
T ss_pred             hh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchH
Confidence            98 88999999999999999999999 556 8999999999999999999655555668999999999999999 78999


Q ss_pred             ccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCcCcc--------------------------------
Q 001591          365 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL--------------------------------  412 (1048)
Q Consensus       365 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~--------------------------------  412 (1048)
                      ++-+++|..||+|+|.|+ ..|..++++ .|++|-+.+|.++++-..+                                
T Consensus       271 ~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~  348 (565)
T KOG0472|consen  271 ICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAM  348 (565)
T ss_pred             HHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccC
Confidence            999999999999999999 578899999 9999999999987752111                                


Q ss_pred             -------cccccccccceEecccCccCCCCCccccCC--CcCcEEEccCCcccCCchHhhhccCCCcE-EeCcCceeccC
Q 001591          413 -------SVLQQCKNLTTLILTKNFVGEEIPENVGGF--ESLMVLALGNCGLKGHIPVWLLRCKKLQV-LDLSWNHFDGN  482 (1048)
Q Consensus       413 -------~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~-L~Ls~N~l~~~  482 (1048)
                             .......+.+.|++++-+++....+.|..-  .-...++++.|++. ++|..+..++.+.+ +++++|.+ +-
T Consensus       349 t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sf  426 (565)
T KOG0472|consen  349 TLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SF  426 (565)
T ss_pred             CCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-cc
Confidence                   111223345555555555543222222211  12556666666666 66666666555443 33444444 36


Q ss_pred             CCcccccCCCCCeEeecCCcccccCCcchhhhhhhhccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeec
Q 001591          483 IPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSN  562 (1048)
Q Consensus       483 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~  562 (1048)
                      +|..++.+++|..|+|++|.+. .+|..++.+..|                                      +.+++|.
T Consensus       427 v~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~L--------------------------------------q~LnlS~  467 (565)
T KOG0472|consen  427 VPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRL--------------------------------------QTLNLSF  467 (565)
T ss_pred             chHHHHhhhcceeeecccchhh-hcchhhhhhhhh--------------------------------------heecccc
Confidence            6666777777777777777665 466666655554                                      4567788


Q ss_pred             CcccccCCccccCCCCCcEEEccCceecccCCcccccccCccEeeCCCCccCCCCccccccccCCCeeeecccccc
Q 001591          563 NRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ  638 (1048)
Q Consensus       563 N~l~g~~p~~~~~L~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  638 (1048)
                      |+|. .+|..+-.+..|+.+-.++||+....|+.+.+|.+|.+|||.+|.+. .||+.++++++|++|++++|++.
T Consensus       468 NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  468 NRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             cccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            8776 67777777777777777778888555666888888888888888887 78888888888888888888887

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.6e-40  Score=324.38  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=213.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .+|...+.+|+|.||.||+|++. +|+.||||+++....  .......+|++.++.++||||+.++++|.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35777889999999999999865 899999999975432  223457899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      ||+. +|+..+++   ....++..++..++.++++|++|+|+.   .|+|||+||.|+|++++|.+||+|||+|+.+.+.
T Consensus        82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9976 78888876   567799999999999999999999986   9999999999999999999999999999998765


Q ss_pred             CCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ....... +-|.+|+|||.+.+ +.|+..+|+||.|||+.||+-|.+-|.+   +.+.+....++.........++.+-.
T Consensus       155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG---~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG---DSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC---CchHHHHHHHHHHcCCCCcccCcccc
Confidence            5443333 77999999997665 5799999999999999999998887753   44556666667665543322222211


Q ss_pred             c--------------CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1003 I--------------WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1003 ~--------------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .              .......+...+.+++.+|+..+|.+|++++|+++
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            1              11122345567799999999999999999999986

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.7e-40  Score=379.09  Aligned_cols=260  Identities=30%  Similarity=0.479  Sum_probs=214.8

Q ss_pred             CCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      +....+.||+|+||+||+|+..      +..-||||.++..... ...+|++|++++..++|||||+++|.|.+++..++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            4455788999999999999854      3457999999977655 77899999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCC----------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEE
Q 001591          841 IYSYMENGSLDYWLHESVDK----------DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH  910 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  910 (1048)
                      |+|||..|+|.+||......          ..+++..+.+.||.|||.|++||-++   .+|||||..+|+|+.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEE
Confidence            99999999999999754321          23488999999999999999999987   999999999999999999999


Q ss_pred             EeecccccccCCCCCceee-cccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHH
Q 001591          911 LADFGLSRLLRPYDTHVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQ  988 (1048)
Q Consensus       911 l~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~  988 (1048)
                      |+|||+++..-..+-+... .-.-..+|||||.+..+++|.+||||||||++||+++ |+.||.+....+       +..
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe  716 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIE  716 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHH
Confidence            9999999875432222211 1123459999999999999999999999999999999 999998654433       122


Q ss_pred             hhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      ..+.+..         -+-++.++.++++||..||+..|++||+++|+-..|++..+.
T Consensus       717 ~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  717 CIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            2222222         233456677999999999999999999999999999887654

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=344.82  Aligned_cols=266  Identities=23%  Similarity=0.354  Sum_probs=212.7

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.++||.|..++||+|+.. .++.||||++.-+. ....+.+.+|+..|+.++||||++++..|..+...|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            467999999999999999999865 78999999997543 3345789999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      ||.+|++.+.+......+  +++..+..|.+++++||.|||++   |.||||||+.|||++++|.|||+|||.+..+...
T Consensus       105 fMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            999999999998775444  89999999999999999999997   9999999999999999999999999998765443


Q ss_pred             CCce---eecccccccccCccccCc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          924 DTHV---TTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       924 ~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ....   ...++||+.|||||+++.  ..|+.|+||||||++..||.+|..||....+..      ......... ....
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~-pp~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQND-PPTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCC-CCCc
Confidence            2211   145699999999998543  578999999999999999999999997543221      111111111 1111


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      .......+........+.+++..|++.||.+|||++++++  ++...
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence            1111112222334458899999999999999999999986  55443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=351.86  Aligned_cols=252  Identities=29%  Similarity=0.446  Sum_probs=204.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCC--cEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN--DRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  843 (1048)
                      .++...+.||+|+||+||++... +|+..|||..........+.+.+|+.++++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34666889999999999999876 48999999987653333566899999999999999999999855444  5889999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCcEEEeecccccccCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~a~~~~~  922 (1048)
                      |+++|+|.+++....  + .+++..+..+++||++||+|||++   +||||||||+|||++. ++.+||+|||.++....
T Consensus        97 y~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999998642  2 699999999999999999999986   9999999999999999 79999999999987663


Q ss_pred             --CCCceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          923 --YDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       923 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                        ........+.||+.|||||++..+ ...+++||||+||++.||+||++||...     .+...+++........+.  
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~--  243 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPE--  243 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCC--
Confidence              112223457899999999999853 3446999999999999999999999742     223344444443332221  


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                             .+...+.+..+++.+|+..+|++|||++++++
T Consensus       244 -------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~  275 (313)
T KOG0198|consen  244 -------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE  275 (313)
T ss_pred             -------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                   22224457899999999999999999999997

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=359.90  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=212.2

Q ss_pred             cCCcccCeEeccCceEEEEEEE-CCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ..|+....||+|+.|.||.|.. .+++.||||++.......++-+..|+.+|+..+|+|||.+++.|..+++.|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4577778899999999999974 478999999998777777777899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      +||+|.+.+..     ..+++.++..|.+++++||+|||..   +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            99999998854     4489999999999999999999986   999999999999999999999999999998765443


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       .....+|||.|||||+.....|++++||||||++++||+-|++||-....      ++.++.+...+ ..+       .
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng-~P~-------l  489 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG-TPK-------L  489 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcC-CCC-------c
Confidence             34457999999999999999999999999999999999999999963211      11122222221 111       2


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +.++..+..+.+|+.+|++.||++||++.|+++
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            334455668999999999999999999999997

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=327.20  Aligned_cols=236  Identities=24%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhh---HHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .+|+..+.||.|+||+|.+++.+ +|..+|+|++.+..-..   .+....|..+++.+.||.++++++.|.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45888999999999999999876 78999999998764332   234577999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||++||.|..+++.    .+.+++..++.+|.||+.|++|||+.   +|++||+||+|||+|++|.+||+|||+|+.+..
T Consensus       124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999984    56799999999999999999999996   999999999999999999999999999998642


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                          .+.+.||||.|+|||++....+..++|.|||||++|||+.|++||...+.   ....+.+...  .-         
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~--~v---------  258 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEG--KV---------  258 (355)
T ss_pred             ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhC--cc---------
Confidence                25678999999999999999999999999999999999999999974332   2222222111  11         


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCC
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRR 1030 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~R 1030 (1048)
                         .++.....++.+++.+.++.|-.+|
T Consensus       259 ---~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 ---KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence               1122223368899999999998888

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-40  Score=351.62  Aligned_cols=262  Identities=26%  Similarity=0.361  Sum_probs=210.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  841 (1048)
                      ..|+..+.||+|.||.||+|+.. +|+.||+|+++-+.  .....-..+|+.+|++++||||+++.+...+.  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            34677788999999999999754 89999999987554  33445578999999999999999999998876  689999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      +|||+. +|.-++..   .+..|++.++..+++|++.||+|+|+.   +|+|||||.+|||+|.+|.+||+|||+|+++.
T Consensus       197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999987 56666653   456799999999999999999999985   99999999999999999999999999999988


Q ss_pred             CCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccc-
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII-  999 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  999 (1048)
                      +......+..+-|.+|+|||++.+ ..|+.++|+||.|||+.||++|++.|.+   ....+.+..++.........-+. 
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G---~tEveQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG---RTEVEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC---ccHHHHHHHHHHHhCCCChhcccc
Confidence            777666777889999999997655 5799999999999999999999999975   34445555556555432211111 


Q ss_pred             ----cccc---Cchhh-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1000 ----DASI---WHKDR-------EKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1000 ----~~~~---~~~~~-------~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                          ....   ...+.       ........+|+..++..||.+|.|+.++++
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                0000   00111       122346789999999999999999999985

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9e-41  Score=373.42  Aligned_cols=257  Identities=28%  Similarity=0.485  Sum_probs=216.4

Q ss_pred             CCcccCeEeccCceEEEEEEEC-C---CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-N---GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ...+.++||.|.||.||+|+++ .   ...||||.++... .+...+|..|+.+|.++.||||+++.|+.......++|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3466889999999999999876 2   3579999998654 445578999999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      |||++|+|+.||+..   +..+++.+...++++||.|++||-++   ++|||||.++|||++++..+||+|||+++.+.+
T Consensus       710 EyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999874   56699999999999999999999987   999999999999999999999999999998765


Q ss_pred             CCCceeeccccc--ccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          923 YDTHVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       923 ~~~~~~~~~~gt--~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      +.....+...|.  .+|.|||.+..+++|.++||||||+++||.++ |+.||-.+..   ++.+             ..+
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdVI-------------kaI  847 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVI-------------KAI  847 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHHH-------------HHH
Confidence            543333333343  48999999999999999999999999999887 9999864432   1222             222


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      +..+.-+.+.+++..+.+||..||++|-.+||++.|++..|..+-.+
T Consensus       848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            33333445567778999999999999999999999999999876443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=359.70  Aligned_cols=365  Identities=25%  Similarity=0.198  Sum_probs=303.7

Q ss_pred             EEeccCCcccCcccccccccccccEEEecCcccCCccccccccCcccEEEecCccccCccchhhhhcccccceEeccCcc
Q 001591          134 VLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH  213 (1048)
Q Consensus       134 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~  213 (1048)
                      .||+|+|.++...+..|.++++|+++++.+|.++.+|.-.....+|+.|+|.+|.|+ .+..+-.+.++.|+.||||.|.
T Consensus        82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~  160 (873)
T KOG4194|consen   82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNL  160 (873)
T ss_pred             eeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhch
Confidence            355555555544444455555555555555555544444444455666666666666 5566667777788888888888


Q ss_pred             ccccc-CCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccCCcCCCCcccc
Q 001591          214 FMGSL-QGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV  292 (1048)
Q Consensus       214 l~~~~-~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  292 (1048)
                      ++.++ +.+..-.++++|+|++|.|+...-+.|.++.+|..|.|++|+++...+..|.+|++|+.|+|..|+|.-.---.
T Consensus       161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt  240 (873)
T KOG4194|consen  161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT  240 (873)
T ss_pred             hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence            88777 45666688999999999999888899999999999999999999888889999999999999999998554567


Q ss_pred             ccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCCCccccCCCccc
Q 001591          293 LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK  372 (1048)
Q Consensus       293 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~  372 (1048)
                      |.+|++|+.|.|..|.+.......|..+.++++|+|..|+++..-...+.+++.|+.|+||+|.|...-++....+++|+
T Consensus       241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~  320 (873)
T KOG4194|consen  241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK  320 (873)
T ss_pred             hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence            89999999999999999988888999999999999999999988888889999999999999999988889999999999


Q ss_pred             eeeccccccccccchhhccCCcCcEEeccCCcCCCCcCcccccccccccceEecccCccCCCC---CccccCCCcCcEEE
Q 001591          373 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI---PENVGGFESLMVLA  449 (1048)
Q Consensus       373 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~  449 (1048)
                      +|+|++|+|+...+..|..++.|+.|.|++|++..+.+  ..|..+++|+.|||++|.+...+   ...|.++++|+.|.
T Consensus       321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e--~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~  398 (873)
T KOG4194|consen  321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAE--GAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR  398 (873)
T ss_pred             eEeccccccccCChhHHHHHHHhhhhcccccchHHHHh--hHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence            99999999998888999999999999999999998865  46788999999999999887544   45678899999999


Q ss_pred             ccCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCc
Q 001591          450 LGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNT  502 (1048)
Q Consensus       450 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  502 (1048)
                      |.+|+|+...-.+|.+++.|++|||.+|.|...-|.+|..| .|+.|-+..-.
T Consensus       399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss  450 (873)
T KOG4194|consen  399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS  450 (873)
T ss_pred             ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence            99999997777889999999999999999998889999999 89988876544

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-39  Score=355.48  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=211.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      +-|+..+.||+|+.|.|..|++. +|+.+|||++.+..   ......+++|+-+|+-+.||||+++++++++..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            56788999999999999999875 89999999998653   222345889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|.|.+++-.    .+++++.++.+++.||+.|+.|+|..   +|+|||+||+|+|+|..+.+||+|||+|..-. 
T Consensus        92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-  163 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-  163 (786)
T ss_pred             EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence            99999999999874    56789999999999999999999998   99999999999999999999999999998643 


Q ss_pred             CCCceeecccccccccCccccCcCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTAT-CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                       ....-.+.||+|.|.|||++++..|. .++||||.|||+|.|+||+.||+   +++.+.+...+....-          
T Consensus       164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~f----------  229 (786)
T KOG0588|consen  164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGVF----------  229 (786)
T ss_pred             -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCcc----------
Confidence             23334557999999999999998885 68999999999999999999997   4454444443332111          


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~ 1042 (1048)
                          +.+...+.++.+++++|+..||++|.|+.||++  +|..
T Consensus       230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence                112233457899999999999999999999997  5544

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.4e-39  Score=346.78  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=208.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+..  .+..+.+.+|++++++++|||||.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56888899999999999999765 78899999987543  3344668999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+.| +|.+++.    .+..++++.+..|+.+++.||.|||++   +|.|||+||+|||++..+.+|++|||+|+.+.. 
T Consensus        82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9988 9999987    467799999999999999999999997   999999999999999999999999999998764 


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      .+.+.+...|||.|||||+..++.|+..+|+||+|||+||+++|++||..      ..+.+-+..+..+.        . 
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~--------v-  217 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDP--------V-  217 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCC--------C-
Confidence            45566678999999999999999999999999999999999999999963      11222222222211        1 


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        ..+......+..++...+.+||.+|.+-.+++.
T Consensus       218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             --CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence              112245567899999999999999999888775

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=354.57  Aligned_cols=252  Identities=27%  Similarity=0.391  Sum_probs=207.2

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC----ch-hhHHHHHHHHHHHHhcC-CCceeeecceEeeCCc
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD----CG-QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGND  837 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  837 (1048)
                      ..++|.+.+.||+|.||+||.|.+. +++.||+|++...    .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4568999999999999999999765 7899999977653    12 34556789999999999 9999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-CcEEEeeccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGL  916 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~  916 (1048)
                      .++||||+.||+|.+++..    ..++.+..+.++++|++.|++|+|+.   +|+||||||+||+++.+ +.+||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999975    45688899999999999999999996   99999999999999999 9999999999


Q ss_pred             ccccCCCCCceeecccccccccCccccCcCC-CC-chhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT-AT-CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      +.... .......+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.   .+...+...   ......
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~k---i~~~~~  240 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRK---IRKGEF  240 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHH---HhcCCc
Confidence            99774 2233445679999999999999877 75 789999999999999999999974   111111111   111110


Q ss_pred             cccccccccCchhhHHH-HHHHHHHHHHcccCCCCCCCCHHHHHH--HHH
Q 001591          995 EVEIIDASIWHKDREKQ-LLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1041 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~RPt~~evl~--~L~ 1041 (1048)
                          .       .+... ..++.+++.+|+..+|.+|+++.++++  |++
T Consensus       241 ----~-------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~  279 (370)
T KOG0583|consen  241 ----K-------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ  279 (370)
T ss_pred             ----c-------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence                0       01111 447899999999999999999999985  554

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.6e-39  Score=346.74  Aligned_cols=252  Identities=26%  Similarity=0.312  Sum_probs=204.9

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ..++|+..++||+|+||.||+|+.+ +|+.+|+|++++..-.   ..+.+..|-.+|.....|.||+++..|++.+..|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999865 7999999999876422   23457889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ||||++||++..+|.    ....++++.+..++.+++-|++.+|+.   |||||||||+|+|||..|++|++|||++.-+
T Consensus       219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            999999999999887    356799999999999999999999997   9999999999999999999999999998532


Q ss_pred             CC----------------------C-CCc----e-------------------eecccccccccCccccCcCCCCchhhh
Q 001591          921 RP----------------------Y-DTH----V-------------------TTDLVGTLGYIPPEYSQTLTATCRGDV  954 (1048)
Q Consensus       921 ~~----------------------~-~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv  954 (1048)
                      ..                      . ...    .                   ....+|||.|+|||++.+..|+..+|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                      0 000    0                   012389999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCcccCCC-CchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCC-
Q 001591          955 YSFGVVLLELLTGRRPVEVCKGK-NCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF- 1032 (1048)
Q Consensus       955 ~slGvil~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt- 1032 (1048)
                      ||+|||+|||+.|.+||...... ..+.++.|.........              .....+..++|.+|+. ||++|-- 
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcCc
Confidence            99999999999999999764432 23344455433222111              1122578999999999 9999975 


Q ss_pred             --HHHHHH
Q 001591         1033 --IEEVVT 1038 (1048)
Q Consensus      1033 --~~evl~ 1038 (1048)
                        +.||.+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              555544

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=351.80  Aligned_cols=262  Identities=29%  Similarity=0.465  Sum_probs=208.5

Q ss_pred             HHhhcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          763 LKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       763 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ....+++.+.+.||+|.||+||+|+|.  ..||||++..+.  ++..+.|+.|+.++++-+|.||+-+.|||..+.. .+
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            333455667889999999999999997  359999998654  4455789999999999999999999999998876 99


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      |+.||+|-+|+.++|..   +..+++.+.+.||+||++|+.|||.   ++|||||+|..||++++++.|||+|||++...
T Consensus       465 iTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence            99999999999999974   4679999999999999999999998   59999999999999999999999999999764


Q ss_pred             CCCC-CceeecccccccccCccccCc---CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          921 RPYD-THVTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       921 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      .... ......-.|...|||||+++.   ..|+..+||||||+|+|||+||..||....    .+.+   ..+...+...
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~----~dqI---ifmVGrG~l~  611 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN----RDQI---IFMVGRGYLM  611 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC----hhhe---EEEecccccC
Confidence            3321 111222357889999998764   468999999999999999999999996211    1111   1111111110


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                        .|.   ......+..++.+|+..||..++++||.+.+++..|+++..
T Consensus       612 --pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  612 --PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              111   11223455689999999999999999999999998887754

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=314.26  Aligned_cols=265  Identities=24%  Similarity=0.319  Sum_probs=216.7

Q ss_pred             hhcCCcccCeEeccCceEEEEEE-ECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCC-----cE
Q 001591          765 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----DR  838 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  838 (1048)
                      ..++|++.+.+|+|||+.||.++ ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34689999999999999999998 4478999999998777777788999999999999999999999875443     48


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      |++++|...|+|.+.++....++..+++.+.++|+.++++||++||+. .++++||||||.||++.+++.+++.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999999988877788899999999999999999999986 5679999999999999999999999999998


Q ss_pred             ccCCCCCc--------eeecccccccccCccccC---cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHH
Q 001591          919 LLRPYDTH--------VTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF  987 (1048)
Q Consensus       919 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~  987 (1048)
                      ...-....        .......|..|+|||.+.   +...++++|||||||++|+|+.|..||+....           
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----------  246 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----------  246 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence            65321111        112235789999999765   44678899999999999999999999974221           


Q ss_pred             HhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          988 QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                        ....-...+....+..+.....++.+.+++.+|++.||.+||++.+++..++++
T Consensus       247 --~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  247 --QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence              111112222333332233333667899999999999999999999999988765

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=351.89  Aligned_cols=388  Identities=23%  Similarity=0.220  Sum_probs=336.1

Q ss_pred             ceEeccCcccccccC-CCCC--CCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEcc
Q 001591          205 QILDLSMNHFMGSLQ-GLDH--SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIF  281 (1048)
Q Consensus       205 ~~L~Ls~n~l~~~~~-~l~~--~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  281 (1048)
                      ..||.+++++..+.. .+..  .+.-+.|++++|.++.+.+..|.++++|++++|.+|.++ .+|.......+|+.|+|.
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~  133 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR  133 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence            345566665544321 1111  245667999999999888888999999999999999998 778776677779999999


Q ss_pred             CCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCC
Q 001591          282 GNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPL  361 (1048)
Q Consensus       282 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  361 (1048)
                      +|.|+.+-.+.+.-++.|+.|||+.|.|+...-.+|..-.++++|+|++|+|+......|.++.+|.+|.|+.|+++...
T Consensus       134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp  213 (873)
T KOG4194|consen  134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP  213 (873)
T ss_pred             ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence            99999888888999999999999999999777778888889999999999999999999999999999999999999877


Q ss_pred             CccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCcCcccccccccccceEecccCccCCCCCccccC
Q 001591          362 PNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG  441 (1048)
Q Consensus       362 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  441 (1048)
                      +..|.++++|+.|+|..|+|.-.--..|.++++|+.|.|..|.+..+.++  .|..|.++++|+|+.|++...-..++.+
T Consensus       214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG--~Fy~l~kme~l~L~~N~l~~vn~g~lfg  291 (873)
T KOG4194|consen  214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDG--AFYGLEKMEHLNLETNRLQAVNEGWLFG  291 (873)
T ss_pred             HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCc--ceeeecccceeecccchhhhhhcccccc
Confidence            88999999999999999999844466899999999999999999998764  6889999999999999999888889999


Q ss_pred             CCcCcEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCcccccCCcchhhhhhhhccC
Q 001591          442 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSN  521 (1048)
Q Consensus       442 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~  521 (1048)
                      +.+|+.|+|++|.|...-++.+.-.++|++|||++|+++..-+..|..+..|+.|+|++|+++..--..|..+++|    
T Consensus       292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL----  367 (873)
T KOG4194|consen  292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSL----  367 (873)
T ss_pred             cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhh----
Confidence            9999999999999998888888999999999999999997778889999999999999999987766777778777    


Q ss_pred             CCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCcccccCCc---cccCCCCCcEEEccCceecccCCcccc
Q 001591          522 CTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPP---EIGQLKHLHVLDLSRNNITGTIPSSIS  598 (1048)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~~p~---~~~~L~~L~~L~Ls~N~l~g~ip~~~~  598 (1048)
                                                        ++|||++|.+++.|-+   .|.+|++|+.|+|.+|+|....-..|.
T Consensus       368 ----------------------------------~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfs  413 (873)
T KOG4194|consen  368 ----------------------------------HKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFS  413 (873)
T ss_pred             ----------------------------------hhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhc
Confidence                                              4578999999887654   477899999999999999955557899


Q ss_pred             cccCccEeeCCCCccCCCCccccccccCCCeeeecc
Q 001591          599 EIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN  634 (1048)
Q Consensus       599 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~  634 (1048)
                      .+.+|+.|||.+|.|...-|..|..+ .|+.|-+..
T Consensus       414 gl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  414 GLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             cCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            99999999999999998999999998 888887654

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=341.60  Aligned_cols=251  Identities=27%  Similarity=0.395  Sum_probs=209.0

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhh-HHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .|+..+.||+|.||.||+|... +++.||+|++.-+..+. .+++++|+.++..++++||.++++.+..+...+++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            4667789999999999999865 78999999998665433 356899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      .||++.+.+..    +..+++..+..|++++..|+.|+|.+   +.+|||||+.||++..+|.||++|||.+.++.....
T Consensus        94 ~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   94 GGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             cCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999988863    44558888889999999999999997   999999999999999999999999999988765433


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      . ..+++|||.|||||++....|+.++||||||++.+||++|.+|+....+.                ...-.+......
T Consensus       167 r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP  229 (467)
T KOG0201|consen  167 R-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPP  229 (467)
T ss_pred             c-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCC
Confidence            3 36789999999999999999999999999999999999999999653321                111111111112


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~ 1042 (1048)
                      .........+.+++..|+..+|+.||++.++++  .+..
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            222245557999999999999999999999986  4444

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.4e-38  Score=356.83  Aligned_cols=262  Identities=26%  Similarity=0.416  Sum_probs=204.7

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeeecceEeeCC-
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN-  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-  836 (1048)
                      .++|++.+.||+|+||.||+|.+.      +++.||+|++..... ...+.+.+|+++++++ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            457899999999999999999742      356899999875432 3345688999999999 8999999999887654 


Q ss_pred             cEEEEEEeccCCChhhhcccccCC--------------------------------------------------------
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDK--------------------------------------------------------  860 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------  860 (1048)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            578999999999999988643210                                                        


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce-eecccccccc
Q 001591          861 --DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGY  937 (1048)
Q Consensus       861 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y  937 (1048)
                        ..++++.++..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++......... .....+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              23588899999999999999999985   99999999999999999999999999998654322221 2233566789


Q ss_pred             cCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHH
Q 001591          938 IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML 1016 (1048)
Q Consensus       938 ~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1016 (1048)
                      +|||++.+..++.++|||||||++|||++ |+.||......  .....   ... ......         .+......+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~---~~~-~~~~~~---------~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQ---RLK-DGTRMR---------APENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHH---HHh-cCCCCC---------CCCCCCHHHH
Confidence            99999998899999999999999999997 99999743211  11111   111 111110         0112234688


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591         1017 EIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus      1017 ~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                      +++.+|++.||++|||+.|+++.|+++-.
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-39  Score=312.25  Aligned_cols=248  Identities=27%  Similarity=0.370  Sum_probs=209.5

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      .++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   ...+.++.+|+++.+.++||||+++++||.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            356999999999999999999865 78899999987553   34567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      +||..+|++...|++.  ....+++.....+..|+|.|+.|+|.   ++|+||||||+|+|++.++..|++|||.+....
T Consensus       101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999854  34568889999999999999999997   599999999999999999999999999997643


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                         .......|||..|.|||+..+..++..+|+|++|++.||++.|.+||+....   .+....+..       .++.+ 
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etYkrI~k-------~~~~~-  241 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETYKRIRK-------VDLKF-  241 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHHHHHHH-------ccccC-
Confidence               2234567999999999999999999999999999999999999999975331   122211111       11111 


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            +.....++.++|.+|+..+|.+|.+..|+++
T Consensus       242 ------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  242 ------PSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ------CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                  1233457899999999999999999999986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=343.30  Aligned_cols=238  Identities=26%  Similarity=0.424  Sum_probs=201.8

Q ss_pred             cCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCChh
Q 001591          772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD  851 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  851 (1048)
                      .+-||.|+.|.||+|+++ ++.||||+++..       -+.+++-+++++||||+.+.|+|.....++||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            567999999999999997 889999987521       245788899999999999999999999999999999999999


Q ss_pred             hhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeecc
Q 001591          852 YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL  931 (1048)
Q Consensus       852 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  931 (1048)
                      +.|+    .+.+++......|..+||.|+.|||.+   .|||||||.-||||..+..|||+|||-++.....  .....+
T Consensus       201 ~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF  271 (904)
T KOG4721|consen  201 EVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF  271 (904)
T ss_pred             HHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence            9997    466789999999999999999999997   9999999999999999999999999999876543  223457


Q ss_pred             cccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHH
Q 001591          932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1011 (1048)
Q Consensus       932 ~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      +||..|||||++.....++|+||||||||||||+||..||.....    .           ..+.-+-...+.-..+..+
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----s-----------AIIwGVGsNsL~LpvPstc  336 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----S-----------AIIWGVGSNSLHLPVPSTC  336 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----h-----------eeEEeccCCcccccCcccC
Confidence            999999999999999999999999999999999999999852110    0           0111111222333455667


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591         1012 LLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus      1012 ~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      ++.+.-+++.||+..|..||++++++.-|+
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            778999999999999999999999998664

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=314.38  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=204.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      +.|++.++||+|.|+.||++.+. +|+++|+|++...  .....+++++|+++-+.++|||||++.+.+.+....|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            46788889999999999999765 7999999987532  23456778999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC---CCCcEEEeeccccccc
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLL  920 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfg~a~~~  920 (1048)
                      +|+|++|..-+-    .+..+++..+-.+++||++|++|+|..   +|||||+||+|+++-   ....+|++|||+|..+
T Consensus        91 ~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   91 LVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             cccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999854332    224578899999999999999999986   999999999999995   3456899999999988


Q ss_pred             CCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      +  ........+|||+|||||+....+|+..+|||+.|||+|-++.|++||..   +...++.+.+....-      -++
T Consensus       164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~y------d~~  232 (355)
T KOG0033|consen  164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAY------DYP  232 (355)
T ss_pred             C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhcccc------CCC
Confidence            7  55566778999999999999999999999999999999999999999963   222233332221111      122


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +..|...    .++..+++++|+..||.+|.|+.|+++
T Consensus       233 ~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  233 SPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CcccCcC----CHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2233333    347889999999999999999999986

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-38  Score=333.68  Aligned_cols=252  Identities=24%  Similarity=0.340  Sum_probs=198.4

Q ss_pred             HhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch----------h----hHHHHHHHHHHHHhcCCCceeee
Q 001591          764 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG----------Q----MEREFQAEVEALSRAQHKNLVSL  828 (1048)
Q Consensus       764 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~----~~~~~~~E~~~l~~l~h~niv~l  828 (1048)
                      +..++|++.+.||+|.||.|-+|+.. +++.||+|++.+...          .    ..+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999876 789999999975421          0    12468899999999999999999


Q ss_pred             cceEeeC--CcEEEEEEeccCCChhhhcccccCCccc-cCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC
Q 001591          829 QGYCRHG--NDRLLIYSYMENGSLDYWLHESVDKDSV-LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE  905 (1048)
Q Consensus       829 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~  905 (1048)
                      +++..+.  +..|||+|||..|.+...=     ...+ +++.++++++.+++.||+|||.+   +||||||||+|+|+++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence            9999765  5789999999999764332     3344 99999999999999999999997   9999999999999999


Q ss_pred             CCcEEEeecccccccCCCCC----ceeecccccccccCccccCcC----CCCchhhhHHHHHHHHHHHcCCCCCcccCCC
Q 001591          906 KFEAHLADFGLSRLLRPYDT----HVTTDLVGTLGYIPPEYSQTL----TATCRGDVYSFGVVLLELLTGRRPVEVCKGK  977 (1048)
Q Consensus       906 ~~~~kl~Dfg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltg~~P~~~~~~~  977 (1048)
                      +|+|||+|||.+........    ......+|||.|+|||...++    ..+.+.||||+||++|+|+.|+.||..   +
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~  322 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---D  322 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---c
Confidence            99999999999986632211    112235899999999976653    235688999999999999999999963   2


Q ss_pred             CchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          978 NCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ...++.+.            ++...+..+..++..+.+.++|.+++.+||++|.+..+|..
T Consensus       323 ~~~~l~~K------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  323 FELELFDK------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             hHHHHHHH------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            22222221            11222222223345568999999999999999999998864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.7e-37  Score=340.36  Aligned_cols=248  Identities=22%  Similarity=0.323  Sum_probs=200.0

Q ss_pred             cCeEeccCceEEEEEEECCCcEEEEEEecCCchhh---HHHHHHHHHHHHhcCCCceeeecceEee----CCcEEEEEEe
Q 001591          772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQGYCRH----GNDRLLIYSY  844 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  844 (1048)
                      ...||+|++|.||+|.+ +|+.||||+++......   .+.+.+|+.++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            46799999999999998 58999999997653322   4667899999999999999999999876    3467899999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++|+|.+++..    ...+++..+..++.+++.|++|||+.  .+++||||||+||++++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999874    34688999999999999999999973  378899999999999999999999999998653221


Q ss_pred             CceeecccccccccCccccCc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                          ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||....   ..+....+.   ......      
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~---~~~~~~------  241 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLII---NKNNSL------  241 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH---hcCCCC------
Confidence                23468899999999876  688999999999999999999999997432   122222111   111110      


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                         ..+...+.++.+++.+||+.||++|||++|+++.|+.++.
T Consensus       242 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        242 ---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence               0111234578999999999999999999999999988753

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=345.53  Aligned_cols=242  Identities=24%  Similarity=0.324  Sum_probs=201.8

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  840 (1048)
                      .++|...++||+|.||+|++|..+ +++.+|||+++++..   ...+..+.|.+++.... ||.++.++..|++.++.|.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            467999999999999999999876 688999999998752   33455678888888775 9999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ||||+.||++..+.+     ...+++..+..+|..|+.||+|||++   +||+||||.+|||+|.+|++||+|||+++.-
T Consensus       447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999554443     45699999999999999999999986   9999999999999999999999999999974


Q ss_pred             CCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      .- ....++++||||.|||||++.+..|+.++|.|||||++|||+.|..||.+   ++.+++.+.+....          
T Consensus       519 m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g---ddEee~FdsI~~d~----------  584 (694)
T KOG0694|consen  519 MG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG---DDEEEVFDSIVNDE----------  584 (694)
T ss_pred             CC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCC----------
Confidence            32 33356779999999999999999999999999999999999999999974   33333333222111          


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1033 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 1033 (1048)
                          ..++...+.+...++++++..+|++|--+
T Consensus       585 ----~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 ----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                01233344578999999999999999865

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=375.78  Aligned_cols=260  Identities=30%  Similarity=0.454  Sum_probs=211.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC--CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT--NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  839 (1048)
                      ...+..+.||+|.||.||.|...  .|.    .||+|.++... .+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            45566889999999999999865  343    58999987654 456678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccccC---CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccc
Q 001591          840 LIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      +++|||++|+|..|+++.+.   ....++..+.+.++.|||+|+.||++.   ++|||||.++|+|+++...|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999987532   245689999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecc-cccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          917 SRLLRPYDTHVTTDL-VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      |+.+...+-+..... .-...|||||.+..+.+|.|+|||||||++||++| |..||......   +...   .....+ 
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~---~~~~gg-  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLL---DVLEGG-  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHH---HHHhCC-
Confidence            995433222222221 12248999999999999999999999999999999 99999743211   1111   111111 


Q ss_pred             cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                               .-+.+..++..++++|..||+.+|++||++..++++++.|..
T Consensus       922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                     112344556689999999999999999999999998887754

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.1e-38  Score=324.13  Aligned_cols=245  Identities=24%  Similarity=0.365  Sum_probs=206.6

Q ss_pred             cCCcccCeEeccCceEEEEEEE-CCCcEEEEEEecCCchhhHH---HHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMER---EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .+|++.+.||+|.||.|-+|+. ..|+.||||.++++..+.++   .+.+|+++|+.++||||+.++++|+..+..++||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4688889999999999999975 58999999999877655444   4689999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||..+|.|++|+.+    .+.+++.+++.+++||+.|+.|+|.+   ++||||+|.+|||+|+++++||+|||++-.+..
T Consensus       133 EYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999974    56799999999999999999999997   999999999999999999999999999987753


Q ss_pred             CCCceeecccccccccCccccCcCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTAT-CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                        .....++||+|-|.+||++.+..|. +.+|.||+||++|.|+.|..||++.      +.-..+.++... ...+   +
T Consensus       206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~------Dhk~lvrQIs~G-aYrE---P  273 (668)
T KOG0611|consen  206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR------DHKRLVRQISRG-AYRE---P  273 (668)
T ss_pred             --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc------hHHHHHHHhhcc-cccC---C
Confidence              3445678999999999999998884 7899999999999999999999752      122222222222 1111   1


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                              +.+....-+|++|+..+|++|.|+.++..
T Consensus       274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  274 --------ETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             --------CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence                    11124667899999999999999999875

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=317.62  Aligned_cols=261  Identities=26%  Similarity=0.303  Sum_probs=207.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh--hHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  841 (1048)
                      ++|+..+.|++|+||.||+|+++ +++.||+|+++-+...  ..-...+|+.++.+++|||||.+-++....  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45778899999999999999876 7899999999854321  112357899999999999999999988654  579999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      ||||+. +|...++..   .+++...++..++.|+++|++|||.+   .|+|||+|++|+|+...|.+||+|||+|+.++
T Consensus       156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999987 677777653   46789999999999999999999986   99999999999999999999999999999987


Q ss_pred             CCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccc--
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI--  998 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  998 (1048)
                      .... ..+..+-|.+|+|||.+.+ ..|+.++|+||+|||+.||+++++-|.+   ....+.++.++..........+  
T Consensus       229 sp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G---~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  229 SPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG---KSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             CCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC---CchHHHHHHHHHHhCCCccccCCC
Confidence            6533 3456788999999997655 5789999999999999999999999864   3444556666665543322111  


Q ss_pred             -cccccCc--------------hhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          999 -IDASIWH--------------KDREK-QLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       999 -~~~~~~~--------------~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       .....+.              .+... ..+.-++++..++..||.+|.|+.|.++
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             1111111              01111 2256789999999999999999999986

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.7e-37  Score=337.95  Aligned_cols=262  Identities=21%  Similarity=0.266  Sum_probs=202.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36889999999999999999986 68899999987542  2334567889999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |++++.+..+..    ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            999987765443    234588999999999999999999986   9999999999999999999999999999876443


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhc------------
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS------------  991 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------  991 (1048)
                      .........|++.|+|||++.+..++.++||||+||++|||++|++||......   +....+.....            
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI---DQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhCCCCHHHHHhhhc
Confidence            333333457999999999998888999999999999999999999999743211   11111111100            


Q ss_pred             ccccccccccccC------chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          992 EKREVEIIDASIW------HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       992 ~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .........+...      .......+..+.+++.+|++.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000000      0011123457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-36  Score=335.34  Aligned_cols=255  Identities=24%  Similarity=0.338  Sum_probs=203.0

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      |+..+.||+|+||.||+|... +|+.||+|.+....   ......+.+|++++++++|++|+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            677889999999999999865 78999999987543   22234578899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++|+|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999998877543  234589999999999999999999986   99999999999999999999999999998653221


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.   +........          
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~----------  221 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKEDQ----------  221 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhccc----------
Confidence              22345799999999999999999999999999999999999999975332111111   111111000          


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH--HHHhc
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~--~L~~i 1043 (1048)
                      ...+.....++.+++.+|++.||++||+     ++++++  +++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            0111223447889999999999999997     788886  55544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3e-36  Score=336.41  Aligned_cols=264  Identities=26%  Similarity=0.368  Sum_probs=204.6

Q ss_pred             cCCcccCeEeccCceEEEEEEECC-----------------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeee
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN-----------------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSL  828 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  828 (1048)
                      ++|++.+.||+|+||.||+|.+.+                 +..||+|++.... .....++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997542                 3369999987653 3345678999999999999999999


Q ss_pred             cceEeeCCcEEEEEEeccCCChhhhcccccC---------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 001591          829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVD---------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH  893 (1048)
Q Consensus       829 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  893 (1048)
                      ++++.+.+..++||||+++|+|.+++.....               ....+++..+.+++.|++.|++|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999998854321               123578899999999999999999986   9999


Q ss_pred             cCCCCCceEECCCCcEEEeecccccccCCCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc--CCCC
Q 001591          894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRP  970 (1048)
Q Consensus       894 ~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--g~~P  970 (1048)
                      |||||+||++++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999865433221 1223456789999999988889999999999999999986  5677


Q ss_pred             CcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          971 VEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                      |....   ..+....+............      ...+...+..+.+++.+||+.+|++|||+.|+.+.|++
T Consensus       242 ~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELT---DEQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCC---HHHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            76432   22222222221111110000      00111233478999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=323.60  Aligned_cols=262  Identities=25%  Similarity=0.371  Sum_probs=202.3

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEee-----CCc
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRH-----GND  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  837 (1048)
                      ...|...+.||+|+||.|+.|... +|++||+|++...  .....+...+|++.++.++|+||+.+.+.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345666789999999999999876 7999999998733  23445667899999999999999999998865     357


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .|+|+|+| +.+|...++    .++.++.+.+..+++|+++|+.|+|+.   +|+|||+||+|++++.+..+||+|||+|
T Consensus       101 vYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence            89999999 447777776    355599999999999999999999997   9999999999999999999999999999


Q ss_pred             cccCCC-CCceeecccccccccCcccc-CcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc
Q 001591          918 RLLRPY-DTHVTTDLVGTLGYIPPEYS-QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  995 (1048)
Q Consensus       918 ~~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1048)
                      +..... .....+.++-|.+|+|||+. ....||.+.||||.|||+.||++|++-|.+..   ..+.+..+....+....
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d---~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD---YVHQLQLILELLGTPSE  249 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc---hHHHHHHHHHhcCCCCH
Confidence            987543 23345778999999999964 56789999999999999999999999986432   11222222221111100


Q ss_pred             ---ccc--------------cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          996 ---VEI--------------IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       996 ---~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                         ..+              ..+..+....+.......+++.+|+..||.+|+|++|+++
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence               000              0000111112233457889999999999999999999986

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.7e-37  Score=333.75  Aligned_cols=255  Identities=23%  Similarity=0.406  Sum_probs=204.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC----CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++.... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56888999999999999999764    356899999886532 3345789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++|+|.+++...   ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+....
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999998652   34689999999999999999999986   99999999999999999999999999876543


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ...........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....   .+....+.   . ....    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~---~-~~~~----  227 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAVE---D-GFRL----  227 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHH---C-CCCC----
Confidence            221111122345678999999999999999999999999999775 9999964321   12222211   1 1000    


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                           ..+...+..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       228 -----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 -----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 11122344789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-37  Score=308.32  Aligned_cols=258  Identities=24%  Similarity=0.399  Sum_probs=206.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--------hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCC
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--------GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  836 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  836 (1048)
                      .+|+..+.+|+|..++|.++.++ +|.++|+|++....        ....++-.+|+++++++ .||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            45777888999999999999765 78899999886322        12233456799999998 5999999999999999


Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccc
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..++|+|.|+.|.|.+++..    ...+++...++|++|+.+|++|||..   .|||||+||+|||+|++.++||+|||+
T Consensus        97 F~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999974    45689999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccccccccCccccC------cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQ------TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      |+.+.+..  .....||||+|+|||.+.      ...|+..+|+||.|||+|.++.|.+||....     +++  +.++.
T Consensus       170 a~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Qml--MLR~I  240 (411)
T KOG0599|consen  170 ACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QML--MLRMI  240 (411)
T ss_pred             eeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHH--HHHHH
Confidence            99887543  345689999999999754      3578899999999999999999999996411     111  11222


Q ss_pred             cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCcc
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1046 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~~ 1046 (1048)
                      ..+.. + +.    .+.-.+......++|.+|++.||.+|.|++|+++  ++..+.++
T Consensus       241 meGky-q-F~----speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~  292 (411)
T KOG0599|consen  241 MEGKY-Q-FR----SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ  292 (411)
T ss_pred             Hhccc-c-cC----CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence            11111 1 11    1112234457889999999999999999999996  66555443

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=346.24  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=204.8

Q ss_pred             CcccCeEeccCceEEEEEEECC--C--cE-EEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          769 FNQANIIGCGGFGLVYKATLTN--G--TK-AAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ....+.||+|+||.||+|++..  +  .. ||||..+...   .....+|.+|+++|+.++|||||+++|++......++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3445889999999999998652  2  23 8999988532   4556789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      |||+|.||+|.++|+..   ...++..++..++.++|+||+|||+.   +++||||.++|+|++.++.+||+|||+++.-
T Consensus       239 vmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999864   33689999999999999999999986   9999999999999999999999999998864


Q ss_pred             CCCCCceeec-c-cccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccc
Q 001591          921 RPYDTHVTTD-L-VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVE  997 (1048)
Q Consensus       921 ~~~~~~~~~~-~-~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1048)
                      ..+   .... . .-...|+|||.+....++.++|||||||++||+++ |..||.+...   .+...++..   .+..  
T Consensus       313 ~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~kI~~---~~~r--  381 (474)
T KOG0194|consen  313 SQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKAKIVK---NGYR--  381 (474)
T ss_pred             cce---eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHHHHHh---cCcc--
Confidence            311   1111 1 23458999999999999999999999999999999 8999975432   233333211   1111  


Q ss_pred             ccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          998 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                             ...+...+.++..++.+||..+|++||+|.++.++++.+..
T Consensus       382 -------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  382 -------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             -------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                   11112334478889999999999999999999999988754

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-37  Score=352.98  Aligned_cols=257  Identities=23%  Similarity=0.321  Sum_probs=212.5

Q ss_pred             cCCcccCeEeccCceEEEEEEECCC-cEEEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeeecce-Eee------CCc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNG-TKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY-CRH------GND  837 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~  837 (1048)
                      .++++.++|.+|||+.||.|....+ .+||+|++........+.+.+|+++|++++ |||||.+++. ...      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4677889999999999999987755 999999988777778888999999999997 9999999993 221      135


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .++.||||+||.|-+++..+...+  |++.++++|+.++++|+++||.. .++|||||||.+|||+..++..||||||.|
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            688999999999999998765433  99999999999999999999986 788999999999999999999999999999


Q ss_pred             cccCCCC-Ccee-------ecccccccccCcccc---CcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001591          918 RLLRPYD-THVT-------TDLVGTLGYIPPEYS---QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  986 (1048)
Q Consensus       918 ~~~~~~~-~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~  986 (1048)
                      ...-... ....       ....-|+.|+|||++   .+...++|+||||+||+||-|+....||+..            
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s------------  261 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES------------  261 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC------------
Confidence            7533222 1100       112568999999964   5678899999999999999999999999742            


Q ss_pred             HHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          987 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                             ....+++..+..+..+.+...+.+||+.|++++|++||++-+|++.+.++..
T Consensus       262 -------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  262 -------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             -------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                   1223444444444445777899999999999999999999999998877643

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.2e-37  Score=349.61  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=203.6

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCc
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  837 (1048)
                      .++|++.+.||+|+||.||+|++.      ++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            346888999999999999999742      35689999987543 33445688999999999 89999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccccC----------------------------------------------------------
Q 001591          838 RLLIYSYMENGSLDYWLHESVD----------------------------------------------------------  859 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  859 (1048)
                      .++||||+++|+|.++++....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999988864221                                                          


Q ss_pred             -------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          860 -------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       860 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                                   ....+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         112578999999999999999999986   9999999999999999999999999999875433221


Q ss_pred             e-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          927 V-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       927 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      . .....++..|+|||++.+..++.++|||||||++|||++ |..||......  .....++..    .....  .    
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~----~~~~~--~----  338 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIKE----GYRML--S----  338 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHHh----CccCC--C----
Confidence            1 122345668999999999999999999999999999998 89998643211  112221111    10000  0    


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                         +...+.++.+++.+|++.||++||+++|+++.|++
T Consensus       339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               01123478999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=324.60  Aligned_cols=260  Identities=32%  Similarity=0.479  Sum_probs=198.5

Q ss_pred             CCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHh--cCCCceeeecceEeeCC----cEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR--AQHKNLVSLQGYCRHGN----DRLLI  841 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv  841 (1048)
                      ..+..++||+|+||.||||.+. ++.||||++.   .+..+.|+.|-++++.  ++|+||++++++-...+    ++++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3445678999999999999987 6999999997   3455678888888775  47999999999877665    78999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC------EPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                      +||.+.|+|.+||.     ...++|....+|+..+++||+|||+..      .++|+|||||++|||+.+|+.+.|+|||
T Consensus       287 t~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             eeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999996     456899999999999999999999753      5689999999999999999999999999


Q ss_pred             cccccCCCCCc-eeecccccccccCccccCcCC------CCchhhhHHHHHHHHHHHcCCCCC------------ccc--
Q 001591          916 LSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLT------ATCRGDVYSFGVVLLELLTGRRPV------------EVC--  974 (1048)
Q Consensus       916 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGvil~elltg~~P~------------~~~--  974 (1048)
                      +|..+.+.... .....+||.+|||||++.+.-      .-.+.||||+|.|+|||++...-+            +..  
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99988754332 223469999999999987642      224789999999999999854332            211  


Q ss_pred             CCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          975 KGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      .....+++...+.+.+...   .+.+.  |...  ..+..+.+.+..||..||+.|.|+.=|.+.+.++
T Consensus       442 ~hPt~e~mq~~VV~kK~RP---~~p~~--W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRP---KIPDA--WRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CCCCHHHHHHHHHhhccCC---CChhh--hhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            1112223333232222222   12121  2222  3345788999999999999999998777766544

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.7e-36  Score=335.44  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=199.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|++.+.||+|+||+||+|+.. ++..||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56899999999999999999876 78999999987443 22334578899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++ +|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            975 88887754   234578999999999999999999986   99999999999999999999999999997643222


Q ss_pred             CceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc---ccc--
Q 001591          925 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE---VEI--  998 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--  998 (1048)
                       .......|++.|+|||++.+ ..++.++||||+||++|||++|++||....   ..+....+.........   ..+  
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST---VKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChHHhhcccc
Confidence             12233578999999998765 568999999999999999999999996432   22222222222111100   000  


Q ss_pred             -------cccccCc----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          999 -------IDASIWH----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       999 -------~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                             ..+....    ........++.+++.+|++.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                   0000000    001122346889999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.7e-36  Score=340.55  Aligned_cols=265  Identities=26%  Similarity=0.390  Sum_probs=205.6

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.+.||+|+||.||+|++. +|..||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            357999999999999999999876 68899999987543 3345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++|+|.+++..    ...+++..+..++.|++.|++|||+.  .+|+||||||+||++++++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            9999999998864    34588999999999999999999973  36999999999999999999999999999765322


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc--cccc-----
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE--KREV-----  996 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~-----  996 (1048)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   .++..........  ....     
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA---KELEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhcccccccccCCccccCc
Confidence               22345799999999999998999999999999999999999999963221   1111110000000  0000     


Q ss_pred             ------c---------------------ccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 001591          997 ------E---------------------IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus       997 ------~---------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~ 1042 (1048)
                            .                     +...............++.+++.+|++.||++|||++|+++  ++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                  0                     00000000000123457899999999999999999999987  5543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1e-36  Score=348.75  Aligned_cols=260  Identities=27%  Similarity=0.433  Sum_probs=204.0

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCc
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  837 (1048)
                      .++|++.+.||+|+||.||+|++.      ++..||+|++.... ......+.+|+++++++ +||||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            347889999999999999999753      23579999997543 33345688999999999 89999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccccC----------------------------------------------------------
Q 001591          838 RLLIYSYMENGSLDYWLHESVD----------------------------------------------------------  859 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  859 (1048)
                      .++||||+++|+|.++++....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999998854210                                                          


Q ss_pred             --------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc-eeec
Q 001591          860 --------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD  930 (1048)
Q Consensus       860 --------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~  930 (1048)
                              ....+++.++++++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    113578899999999999999999985   9999999999999999999999999999865432221 1122


Q ss_pred             ccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhH
Q 001591          931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE 1009 (1048)
Q Consensus       931 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.......  ...    .........  ..+       .
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~~~~--~~~-------~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY----KMVKRGYQM--SRP-------D  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH----HHHHcccCc--cCC-------C
Confidence            345668999999988899999999999999999997 999996432111  111    111111000  001       1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1010 KQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1010 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ..+.++.+++.+|++.||++||++.++++.|+++
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1234789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=320.27  Aligned_cols=266  Identities=27%  Similarity=0.377  Sum_probs=206.3

Q ss_pred             HhhcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhc--CCCceeeecceEeeCC----c
Q 001591          764 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNLVSLQGYCRHGN----D  837 (1048)
Q Consensus       764 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~  837 (1048)
                      ...++..+.+.||+|.||.||+|+|+ |+.||||++..   ..++.+.+|.++++.+  +|+||+.+++.-..++    +
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34567888999999999999999998 99999999974   4567789999998875  9999999999875543    5


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEcCCCCCceEECCCCcEEEe
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV-----CEPHIVHRDVKSSNILLDEKFEAHLA  912 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~  912 (1048)
                      .|+|.+|.+.|+|+|||..     ..++.+..++++..+|.||+|||..     ..|.|+|||||+.|||+.+++.+.|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            7999999999999999964     5689999999999999999999964     36789999999999999999999999


Q ss_pred             ecccccccCCCCCce---eecccccccccCccccCcC------CCCchhhhHHHHHHHHHHHcC----------CCCCcc
Q 001591          913 DFGLSRLLRPYDTHV---TTDLVGTLGYIPPEYSQTL------TATCRGDVYSFGVVLLELLTG----------RRPVEV  973 (1048)
Q Consensus       913 Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGvil~elltg----------~~P~~~  973 (1048)
                      |+|+|..........   ....+||.+|||||++...      .....+||||||.|+||++..          ++||..
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            999998766543322   2346999999999987643      224579999999999999763          356654


Q ss_pred             cC-CCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          974 CK-GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       974 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      .. .+...+....+.-..+..+    .-+..|.  ..+....+.++|+.||..+|..|-|+-.+-+.|.++.
T Consensus       439 ~Vp~DPs~eeMrkVVCv~~~RP----~ipnrW~--s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVVCVQKLRP----NIPNRWK--SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCCCCHHHHhcceeecccCC----CCCcccc--cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            32 2222222211111111111    1111222  2356778999999999999999999999988887775

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-36  Score=329.65  Aligned_cols=251  Identities=24%  Similarity=0.447  Sum_probs=203.7

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      .+|++.+.||+|+||.||+|++.++..+|+|.+... ....+.+..|++++++++||||+++++++..++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            458888999999999999999988889999988644 2334678899999999999999999999999999999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +|+|.++++..   ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+|++|||.++........
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999988753   23588999999999999999999986   9999999999999999999999999999865432222


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||....   ..+...++..   ...   ...+.   
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~---~~~---~~~~~---  224 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISR---GFR---LYRPK---  224 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHC---CCC---CCCCC---
Confidence            2223345668999999988889999999999999999999 999986422   1222222211   111   00111   


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 1040 (1048)
                          ....++.+++.+|++.+|++||+++|+++.|
T Consensus       225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                1224689999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.3e-36  Score=327.46  Aligned_cols=256  Identities=26%  Similarity=0.404  Sum_probs=208.2

Q ss_pred             hcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            356889999999999999999988888999999875432 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.++++..  ....+++..+..++.|+++|++|||+.   +++||||||+||++++++.++++|||.+........
T Consensus        84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999998653  344688999999999999999999986   999999999999999999999999999987643222


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .......++..|+|||+.....++.++||||||+++|||++ |+.||....   ..+...++....   ..         
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~---~~---------  223 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSALQRGY---RM---------  223 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHHHcCC---CC---------
Confidence            22223346678999999988889999999999999999998 999996421   112222221111   00         


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                       +.....+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             00112234688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-37  Score=323.79  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=201.2

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCc-----EEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND-----RLLI  841 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv  841 (1048)
                      .|+..+++|.|+||.||+|... +++.||||+.-.+..    .-.+|+.+|++++|||||++..+|.....     ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4667889999999999999876 579999999875533    23568999999999999999998865432     2489


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-CcEEEeeccccccc
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGLSRLL  920 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~a~~~  920 (1048)
                      ||||+. +|.++++.....+..++...+.-+..|+++|++|||+.   +|+||||||.|+|+|.+ |.+||+|||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 89888887655677788889999999999999999996   99999999999999955 99999999999998


Q ss_pred             CCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccc-
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI-  998 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  998 (1048)
                      .+.+..  ..+..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.   ...+....+..+.+.....++ 
T Consensus       177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~---s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD---SSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC---CHHHHHHHHHHHhCCCCHHHHh
Confidence            765544  34577899999997665 57999999999999999999999999753   333333333333322111111 


Q ss_pred             ---------c----ccccCch-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          999 ---------I----DASIWHK-DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       999 ---------~----~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                               .    ....|.. .......+..+++.++++.+|.+|.++.|++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                     1    1111111 22344568899999999999999999999985

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=343.27  Aligned_cols=252  Identities=24%  Similarity=0.323  Sum_probs=203.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+..|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999876 68999999987542   223456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999864    34688999999999999999999986   999999999999999999999999999986543


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+....+......      ....
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~------~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST---PNETWENLKYWKET------LQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC---HHHHHHHHHhcccc------ccCC
Confidence                2234579999999999999899999999999999999999999996432   12222211111100      0000


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ...........++.+++.+|+..+|++||++.++++
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            000001123457889999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=333.54  Aligned_cols=244  Identities=25%  Similarity=0.288  Sum_probs=200.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999876 78999999986432   223456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999998864    34688999999999999999999986   999999999999999999999999999986542


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+.   ....  .     
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~---~~~~--~-----  216 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKIL---AGKL--E-----  216 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH---hCCc--C-----
Confidence            2    223579999999999999899999999999999999999999996422   112221111   1110  0     


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 1038 (1048)
                          .+......+.+++.+|++.||.+||+     ++|+++
T Consensus       217 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         217 ----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                01112346889999999999999995     888875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-36  Score=317.94  Aligned_cols=269  Identities=25%  Similarity=0.349  Sum_probs=208.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh--hHHHHHHHHHHHHhcCCCc-eeeecceEeeCC------
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKN-LVSLQGYCRHGN------  836 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  836 (1048)
                      ..|+..+.||+|+||+||+|+.. +|+.||+|++.-+..+  ......+|+.++++++|+| ||++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34666778999999999999865 7899999998755332  3344688999999999999 999999998877      


Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccc
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..++|+||++. +|.+++.........++...+..++.|+++|++|||++   +|+||||||+||+++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            78899999965 78888876543324577789999999999999999997   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  995 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1048)
                      |+.+.-... ..+..++|..|+|||++.+. .|+..+||||+|||++||+++++-|.+..   ..+....++...+....
T Consensus       167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s---e~~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS---EIDQLFRIFRLLGTPNE  242 (323)
T ss_pred             HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHHHcCCCCc
Confidence            997653222 24456889999999987765 78999999999999999999999887533   34555556665543221


Q ss_pred             ---cccc---cccc-Cchh------hH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhc
Q 001591          996 ---VEII---DASI-WHKD------RE---KQLLEMLEIACKCIDQDPRRRPFIEEVVTW--LDGI 1043 (1048)
Q Consensus       996 ---~~~~---~~~~-~~~~------~~---~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~i 1043 (1048)
                         +.+.   +... ....      ..   .......+++.+|++.+|.+|.|++.+++.  +..+
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence               1111   1110 0000      01   111368899999999999999999999873  5554

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-36  Score=330.96  Aligned_cols=257  Identities=31%  Similarity=0.475  Sum_probs=212.1

Q ss_pred             hhcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ...+|++.+.||.|+||.||+|.+.++..+|+|.+.........++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34578889999999999999999888999999999877665667789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+|++|||.+.......
T Consensus        84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            9999999999764  245689999999999999999999986   99999999999999999999999999998764322


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                       .......++..|+|||......++.++||||||+++|+|++ |+.||....   ..+....+..   ....        
T Consensus       159 -~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~---~~~~--------  223 (261)
T cd05148         159 -YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITA---GYRM--------  223 (261)
T ss_pred             -ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHh---CCcC--------
Confidence             11223356778999999988899999999999999999998 899996432   1222222211   1000        


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                        ..+...+..+.+++.+|++.+|++|||++++++.|+++
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              01112234788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-36  Score=327.21  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=207.2

Q ss_pred             hcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .++|++.+.||+|++|.||+|.+.+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688899999999999999998878899999987543 33567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++....  ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||+++.......
T Consensus        84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            9999999987532  45689999999999999999999985   999999999999999999999999999987653221


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ........+..|+|||+..+..++.++||||||+++|||++ |+.||....   .......+   ......         
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~---~~~~~~---------  223 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQV---DQGYRM---------  223 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH---HcCCCC---------
Confidence            11112233458999999999899999999999999999999 999986422   11111111   111000         


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                       ..+......+.+++.+|++.+|++||+++++++.|+++
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence             01112334789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.7e-36  Score=328.32  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=205.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .+|++.+.||+|+||.||+|.+. .++.||+|++..+. ....++.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999876 58899999987543 33456889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++...  ....+++..++.++.|+++|++|||+.   +++||||||+||++++++.+||+|||.+........
T Consensus        85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            999999988653  234589999999999999999999985   999999999999999999999999999987643322


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .......++..|+|||...+..++.++||||||+++|||++ |..||....   ..+.....   . .....        
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~~~~~---~-~~~~~--------  224 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELL---E-KGYRM--------  224 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH---H-CCCCC--------
Confidence            22222334668999999998999999999999999999998 999986421   11211111   1 11000        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                       ..+...+.++.+++.+|++.+|++||++.++++.|+++
T Consensus       225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             11112335789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.1e-36  Score=352.05  Aligned_cols=252  Identities=21%  Similarity=0.258  Sum_probs=206.0

Q ss_pred             CCcccCeEeccCceEEEEEEEC-C-CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-N-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .|.+.+.||+|++|.||+|... + +++||+|.+..........+.+|+.+++.++|||||++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999765 3 6788999876555555567888999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|.++++.......++++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999998876544556789999999999999999999986   999999999999999999999999999987643322


Q ss_pred             -ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 -HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...   ...+....+..   ... .        
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~---~~~~~~~~~~~---~~~-~--------  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP---SQREIMQQVLY---GKY-D--------  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CCC-C--------
Confidence             1233467999999999999999999999999999999999999999632   11222221111   110 0        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       ..+.....++.+++.+|++.+|++||++.++++
T Consensus       290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             011122347899999999999999999999875

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-35  Score=341.32  Aligned_cols=265  Identities=19%  Similarity=0.258  Sum_probs=201.8

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ..+|++.+.||+|+||.||+|... +++.||+|....      ..+.+|++++++++||||+++++++..+...++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999875 788999997532      3467899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +. ++|.+++..    ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+......
T Consensus       165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            85 678777753    34588999999999999999999986   99999999999999999999999999997543322


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCC----chhHHHHHHHhhcccccc----
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN----CRDLVSWVFQMKSEKREV----  996 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~----~~~~~~~~~~~~~~~~~~----  996 (1048)
                      .......+||+.|+|||++.+..++.++||||+||++|||++|+.||....+..    .......+.......+..    
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            223345689999999999999899999999999999999999998875322110    011111111111000000    


Q ss_pred             ------c---------ccccccC--chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591          997 ------E---------IIDASIW--HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       997 ------~---------~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                            +         ...+...  .......+.++.+++.+|++.||++|||++|+++  ++.++.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                  0         0000000  0011133457899999999999999999999996  776653

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-36  Score=340.90  Aligned_cols=267  Identities=22%  Similarity=0.332  Sum_probs=199.7

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC-----cEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----DRL  839 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  839 (1048)
                      +|++.+.||+|+||.||+|+.. +|..||+|++....  ......+.+|++++++++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4888999999999999999865 78999999987432  233456889999999999999999999886432     479


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      +||||++ ++|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 688887753    34589999999999999999999986   999999999999999999999999999986


Q ss_pred             cCCCCC--ceeecccccccccCccccCc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc
Q 001591          920 LRPYDT--HVTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  995 (1048)
Q Consensus       920 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1048)
                      ......  .......||+.|+|||++.+  ..++.++|||||||++|||++|++||.....   ......+.........
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~  229 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLITDLLGTPSP  229 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCH
Confidence            432211  12234679999999998765  6789999999999999999999999964321   1111111111110000


Q ss_pred             -----------ccc---ccccc---CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCc
Q 001591          996 -----------VEI---IDASI---WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       996 -----------~~~---~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~ 1045 (1048)
                                 .+.   .....   ...........+.+++.+|++.+|++||+++|+++  +++++..
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                       000   00000   00000112346789999999999999999999996  6666543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=315.09  Aligned_cols=247  Identities=24%  Similarity=0.378  Sum_probs=209.9

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      |++.+.||+|+||.||+|.++ +|..+|+|.+..+  ...+++..|+.+|++++.|++|+++|.|......|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            667788999999999999876 7999999998754  3457789999999999999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+..+.++-   .+.+++++++..+++..++||+|||..   .-+|||||+.|||++.+|.+|++|||.|..+... -..
T Consensus       113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK  185 (502)
T KOG0574|consen  113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK  185 (502)
T ss_pred             CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence            999998875   467899999999999999999999997   7799999999999999999999999999876432 112


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ..+++|||.|||||++..-.|..++||||+|++..||..|++||....+.      +.++.+        ...+......
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM------RAIFMI--------PT~PPPTF~K  251 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM------RAIFMI--------PTKPPPTFKK  251 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc------ceeEec--------cCCCCCCCCC
Confidence            34579999999999999999999999999999999999999999632111      001111        1122223455


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ++.++.++-++++.|+.+.|++|.|+.++++
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            7788889999999999999999999998876

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-36  Score=338.31  Aligned_cols=244  Identities=22%  Similarity=0.281  Sum_probs=199.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46889999999999999999876 68899999987532   123356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999998864    34578899999999999999999986   999999999999999999999999999986543


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......   .....  ...    
T Consensus       171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~---i~~~~--~~~----  234 (329)
T PTZ00263        171 R----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEK---ILAGR--LKF----  234 (329)
T ss_pred             C----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHH---HhcCC--cCC----
Confidence            2    223579999999999999999999999999999999999999996321   1111111   11110  000    


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 1038 (1048)
                           +.....++.+++.+|++.||++||+     ++++++
T Consensus       235 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        235 -----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             -----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 0112236789999999999999997     677764

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=322.39  Aligned_cols=255  Identities=25%  Similarity=0.372  Sum_probs=215.3

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .+-|+..+.||+|.|+.|-+|++- +|++||||++.+..  ......+..|++.|+.++|||||++|++.......|+|.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            345778889999999999999765 89999999998653  334456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-CCCcEEEeecccccccC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~a~~~~  921 (1048)
                      |.-++|+|++|+-.+   ...+.++.+.+++.||+.|+.|+|+.   ++||||+||+||.+- +-|-||++|||++-.+.
T Consensus        97 ELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            999999999999763   55689999999999999999999998   999999999999875 67899999999998877


Q ss_pred             CCCCceeecccccccccCccccCcCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTAT-CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      +..  .....||+..|-|||++.+..|+ +++||||+|||+|-|++|++||+..++.+...+               +.|
T Consensus       171 PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImD  233 (864)
T KOG4717|consen  171 PGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMD  233 (864)
T ss_pred             Ccc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhc
Confidence            543  34557999999999999988876 578999999999999999999987655442221               222


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCc
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~ 1045 (1048)
                      ..  ...+.....+..++|..|++.||++|.+.+|++.  ||+.+..
T Consensus       234 CK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  234 CK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             cc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            22  2334556678999999999999999999999986  8876643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.1e-36  Score=336.47  Aligned_cols=241  Identities=23%  Similarity=0.326  Sum_probs=195.8

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  848 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  848 (1048)
                      ++||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 78999999987542   223345778999999999999999999999999999999999999


Q ss_pred             ChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCcee
Q 001591          849 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  928 (1048)
Q Consensus       849 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  928 (1048)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~  152 (323)
T cd05571          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence            99888864    34689999999999999999999986   9999999999999999999999999999754322 1223


Q ss_pred             ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhh
Q 001591          929 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008 (1048)
Q Consensus       929 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||....   .......+.   ...  .         ..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~---~~~--~---------~~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELIL---MEE--I---------RFP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHH---cCC--C---------CCC
Confidence            34579999999999999999999999999999999999999996421   111111111   110  0         011


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1009 EKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1009 ~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                      .....++.+++.+|++.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            12334788999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=333.06  Aligned_cols=251  Identities=23%  Similarity=0.367  Sum_probs=213.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCc-EEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND-RLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  842 (1048)
                      ++|...+++|+|+||.++.++++ ++..+|+|.+....  ....+....|+.++++++|||||.+.+.|.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999999876 67899999887443  3344567899999999999999999999999988 89999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      +|++||++.+.+.+..  +..++++.+..|+.|++.|+.|||+.   +|+|||||+.||+++.++.||++|||+|+.+.+
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999987653  67799999999999999999999975   999999999999999999999999999999876


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .. .....++||+.|+.||++.+..|..|+||||+||++|||++-+++|..   .+...++..+....            
T Consensus       159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a---~~m~~Li~ki~~~~------------  222 (426)
T KOG0589|consen  159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA---SNMSELILKINRGL------------  222 (426)
T ss_pred             ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc---cchHHHHHHHhhcc------------
Confidence            54 234457999999999999999999999999999999999999999964   23333443333222            


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1039 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 1039 (1048)
                       ..+.+..++.++..++..|++.+|+.||++.+++..
T Consensus       223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             123344556689999999999999999999999874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.3e-35  Score=331.01  Aligned_cols=270  Identities=22%  Similarity=0.320  Sum_probs=203.5

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999876 789999999875432 223457789999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |++ +++.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            996 577777654   234588899999999999999999986   9999999999999999999999999998754322


Q ss_pred             CCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc-----
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE-----  997 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  997 (1048)
                      . .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+  ..+....+...........     
T Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence            1 22234578999999998765 4678999999999999999999999975321  1122222222111100000     


Q ss_pred             ---ccccccC---ch--hhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCc
Q 001591          998 ---IIDASIW---HK--DRE-----KQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       998 ---~~~~~~~---~~--~~~-----~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~ 1045 (1048)
                         ...+...   ..  ...     .....+.+++.+|++.||++|||+.|+++  ++.++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence               0000000   00  000     11246789999999999999999999997  7666543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.3e-36  Score=331.10  Aligned_cols=262  Identities=28%  Similarity=0.481  Sum_probs=210.6

Q ss_pred             cCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ++|.+.+.||+|+||.||+|++.      ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999753      345689999887666666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCc
Q 001591          841 IYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE  908 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~  908 (1048)
                      ||||+++++|.+++.....            ....+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            9999999999999865321            224589999999999999999999986   9999999999999999999


Q ss_pred             EEEeecccccccCCCCC-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHH
Q 001591          909 AHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV  986 (1048)
Q Consensus       909 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~  986 (1048)
                      ++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ....+.+
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~  238 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECI  238 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence            99999999976543221 11223456789999999998899999999999999999999 9999864221   1222211


Q ss_pred             HHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCccc
Q 001591          987 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1047 (1048)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~~ 1047 (1048)
                          .......         .....+..+.+++.+|++.+|++||++++++++|+++...+
T Consensus       239 ----~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         239 ----TQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             ----hCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence                1111111         01112346889999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.8e-36  Score=329.22  Aligned_cols=258  Identities=29%  Similarity=0.490  Sum_probs=207.2

Q ss_pred             cCCcccCeEeccCceEEEEEEECC------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  839 (1048)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... .....++.+|++.+++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998642      2579999987543 334567899999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhcccccCC------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC
Q 001591          840 LIYSYMENGSLDYWLHESVDK------------DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF  907 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  907 (1048)
                      ++|||+++|+|.+++......            ...+++..+..++.|++.|++|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999998653211            14688999999999999999999986   999999999999999999


Q ss_pred             cEEEeecccccccCCCCC-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHH
Q 001591          908 EAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSW  985 (1048)
Q Consensus       908 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~  985 (1048)
                      .++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....   .+....
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence            999999999986533222 12233467889999999988899999999999999999998 9999864322   222222


Q ss_pred             HHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          986 VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      +.    .....         ..+...+.++.+++.+||+.+|.+||+++|+++.|+++
T Consensus       239 i~----~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         239 IR----SRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HH----cCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            11    11111         11223446899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.7e-35  Score=322.39  Aligned_cols=261  Identities=22%  Similarity=0.314  Sum_probs=210.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD---CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+...   .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999865 7899999987542   2334456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++.........+++..+..++.|+++|++|||+.   +++||||||+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988865443455688999999999999999999986   999999999999999999999999999887543


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ... ......|++.|+|||...+..++.++|+||+|+++|||++|+.||.....    +...+........ ...     
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~-~~~-----  227 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCD-YPP-----  227 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCC-CCC-----
Confidence            221 12234688899999999888899999999999999999999999853211    1111111111111 000     


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                         .........+.+++.+||+.+|++||++.+|++.+++++
T Consensus       228 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 ---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence               011223457899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.8e-36  Score=324.74  Aligned_cols=252  Identities=24%  Similarity=0.411  Sum_probs=203.2

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      ++|++.+.||+|+||.||+|++.++..+|+|.+.... ....++.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4688889999999999999998877789999887543 334668999999999999999999999998888999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +|+|.+++...   ...+++..++.++.|++.|++|||+.   +++|+||||+||++++++.+||+|||.++........
T Consensus        83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999988653   23689999999999999999999985   9999999999999999999999999998865432221


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||.....   .+....+..   .... .  .     
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~---~~~~-~--~-----  222 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQ---GLRL-Y--R-----  222 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhc---CCCC-C--C-----
Confidence            1222345678999999988889999999999999999999 9999864321   122221111   1110 0  0     


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                        +......+.+++.+||+.+|.+||++.++++.|+
T Consensus       223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              0112347899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-35  Score=333.28  Aligned_cols=199  Identities=28%  Similarity=0.459  Sum_probs=174.7

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367999999999999999999877 68899999887543 3344668999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++|+|.+++..    ...+++..+..++.+++.|++|||+.  .+|+||||||+||++++++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999999864    34578899999999999999999973  37999999999999999999999999999765321


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV  973 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~  973 (1048)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence               12335789999999999988999999999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6e-36  Score=314.59  Aligned_cols=252  Identities=25%  Similarity=0.312  Sum_probs=204.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      +.|+..+.||+|.-|+||+++.. ++..+|+|++.+..-.   .....+.|-++|+.++||.++.+++.++.+...++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            34677889999999999999987 4589999999876533   3345678999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      |||+||+|....+..  .+..+++..++.+|.+|+-||+|||..   |||.|||||+|||+.++|++.++||.++.....
T Consensus       157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999888754  567899999999999999999999997   999999999999999999999999998753210


Q ss_pred             ---------------------------------C-C---------------------CceeecccccccccCccccCcCC
Q 001591          923 ---------------------------------Y-D---------------------THVTTDLVGTLGYIPPEYSQTLT  947 (1048)
Q Consensus       923 ---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~  947 (1048)
                                                       . .                     ......++||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                     00112358999999999999999


Q ss_pred             CCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCC
Q 001591          948 ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDP 1027 (1048)
Q Consensus       948 ~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P 1027 (1048)
                      .+.++|+|+|||++|||+.|+.||.+....+   -.   ..         ++......+..+..+..+.++|++.+.+||
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---Tl---~N---------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---TL---RN---------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchh---hH---HH---------HhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence            9999999999999999999999997543222   11   11         111111122222455688999999999999


Q ss_pred             CCCCC----HHHHHH
Q 001591         1028 RRRPF----IEEVVT 1038 (1048)
Q Consensus      1028 ~~RPt----~~evl~ 1038 (1048)
                      ++|.-    +.||.+
T Consensus       377 ~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhhccccchHHhhc
Confidence            99987    676654

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.1e-36  Score=342.38  Aligned_cols=261  Identities=24%  Similarity=0.362  Sum_probs=205.8

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeeecceEeeCCc
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGND  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  837 (1048)
                      .++|++.+.||+|+||.||+|.+.      .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467889999999999999999863      234799999975433 33456899999999996 9999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccccC----------------------------------------------------------
Q 001591          838 RLLIYSYMENGSLDYWLHESVD----------------------------------------------------------  859 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  859 (1048)
                      .++||||+++|+|.++++....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999988764210                                                          


Q ss_pred             ----------------------------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC
Q 001591          860 ----------------------------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE  905 (1048)
Q Consensus       860 ----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~  905 (1048)
                                                        ....+++..+..++.|+++|++|||+.   +|+||||||+||++++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                              013478899999999999999999986   9999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHH
Q 001591          906 KFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV  983 (1048)
Q Consensus       906 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~  983 (1048)
                      ++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......  ...
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence            999999999999865432221 1223456788999999988899999999999999999997 999986432111  111


Q ss_pred             HHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          984 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      .    ........         ..+...+.++.+++.+||+.+|++||++.++.++|+++-
T Consensus       351 ~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 N----KIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H----HHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1    11111000         111223457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.7e-35  Score=337.31  Aligned_cols=246  Identities=28%  Similarity=0.467  Sum_probs=193.1

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      +|+..+.||+|+||.||+|++. +++.||+|++.... ......+.+|++++++++|+||+++++++.+++..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4566788999999999999876 68999999986543 334567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|.+..        ...+..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.......
T Consensus       155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999986432        245677889999999999999986   999999999999999999999999999987543211


Q ss_pred             ceeecccccccccCccccCc-----CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          926 HVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                       ......||..|+|||++..     ...+.++|||||||++|||++|+.||..............   ..... ..    
T Consensus       224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~~-~~----  294 (353)
T PLN00034        224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA---ICMSQ-PP----  294 (353)
T ss_pred             -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---HhccC-CC----
Confidence             1234579999999998643     3345689999999999999999999973222221111111   11000 00    


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                           ........++.+++.+|++.||++||++.|+++
T Consensus       295 -----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        295 -----EAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             -----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 011123347899999999999999999999987

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=324.41  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=206.1

Q ss_pred             cCCcccCeEeccCceEEEEEEECC----CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      ++|++.+.||+|+||+||+|.+..    ...||+|+++... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568899999999999999998752    4579999987543 33456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999998653   33689999999999999999999986   99999999999999999999999999998875


Q ss_pred             CCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          922 PYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       922 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ..... ......+++.|+|||...+..++.++||||||+++|||++ |..||.....   ......+..    ....   
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~----~~~~---  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVED----GYRL---  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHc----CCCC---
Confidence            22222 2222345678999999998899999999999999999998 9999864221   122221111    1000   


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                            +.+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  00112334789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.2e-36  Score=328.89  Aligned_cols=257  Identities=28%  Similarity=0.476  Sum_probs=206.6

Q ss_pred             cCCcccCeEeccCceEEEEEEECC------CcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  839 (1048)
                      ++|.+.+.||+|+||.||+|.+.+      +..||+|.+...... ..+.+.+|++++++++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468888999999999999998643      478999998765443 4578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccccc----------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcE
Q 001591          840 LIYSYMENGSLDYWLHESV----------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  909 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  909 (1048)
                      +||||+++++|.++++...          .....+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999987532          1234588999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCC-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHH
Q 001591          910 HLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF  987 (1048)
Q Consensus       910 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~  987 (1048)
                      |++|||.++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....   ..+....+.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~---~~~~~~~~~  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEVIECIT  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH
Confidence            9999999976432221 11223356788999999999999999999999999999998 999986432   122222221


Q ss_pred             HhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          988 QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                          ......         .+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus       239 ----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         239 ----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                111100         011233478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.4e-36  Score=329.70  Aligned_cols=261  Identities=28%  Similarity=0.474  Sum_probs=208.9

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  839 (1048)
                      ..+|.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            356888999999999999999742      34568999988766666677999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccccc---------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEE
Q 001591          840 LIYSYMENGSLDYWLHESV---------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH  910 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  910 (1048)
                      +||||+++++|.+++....         .....+++..++.++.|++.||+|||+.   +++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            9999999999999886432         1223589999999999999999999986   999999999999999999999


Q ss_pred             EeecccccccCCCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHH
Q 001591          911 LADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQ  988 (1048)
Q Consensus       911 l~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~  988 (1048)
                      ++|||.++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |++||....   ..+....+. 
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~---~~~~~~~i~-  236 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECIT-  236 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH-
Confidence            9999999865432211 1122345778999999998899999999999999999998 999986432   112222111 


Q ss_pred             hhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                         .......         +...+.++.+++.+|++.+|.+|||+.|+.+.|+++..
T Consensus       237 ---~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         237 ---QGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             ---cCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence               1111000         01123468999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.9e-36  Score=330.05  Aligned_cols=261  Identities=24%  Similarity=0.313  Sum_probs=196.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC--CCcEEEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeeecceEee-----
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT--NGTKAAVKRLSGDCG--QMEREFQAEVEALSRA---QHKNLVSLQGYCRH-----  834 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  834 (1048)
                      ++|++.+.||+|+||+||+|+..  ++..||+|++.....  .....+.+|+.+++++   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  468899998874332  2234456777777766   69999999998852     


Q ss_pred             CCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       835 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                      ....++||||++ ++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            346899999996 5888888653  234589999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          915 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       915 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      |+++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|++||....   ..+....+........
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~---~~~~~~~i~~~~~~~~  229 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIGLPG  229 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC---HHHHHHHHHHHhCCCC
Confidence            999865432  22334578999999999988899999999999999999999999997432   2233333322211100


Q ss_pred             cccc----------cccccC---chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          995 EVEI----------IDASIW---HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       995 ~~~~----------~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..+.          ......   ..........+.+++.+|++.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000          000000   0011123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-35  Score=323.28  Aligned_cols=253  Identities=28%  Similarity=0.459  Sum_probs=204.1

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      ++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46888999999999999999988888999999875433 3456899999999999999999999885 456789999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +++|.++++..  ....+++.++..++.+++.|++|||+.   +++||||||+||++++++.++++|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            99999998753  234589999999999999999999986   9999999999999999999999999999865433222


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......++..|+|||...+..++.++||||||+++|||++ |++||....   ..+....+.   .. ...         
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~---~~-~~~---------  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQVE---RG-YRM---------  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH---cC-CCC---------
Confidence            2222345678999999988899999999999999999999 899986422   222222211   11 000         


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                      +.+...+..+.+++.+|+..+|++|||++++.++|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1111233478999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-35  Score=335.59  Aligned_cols=244  Identities=23%  Similarity=0.275  Sum_probs=198.5

Q ss_pred             cCCcccCeEeccCceEEEEEEECC--CcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN--GTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      ++|++.+.||+|+||.||+|.+..  +..||+|++....   ......+.+|+++++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468899999999999999998653  3689999986432   22345678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999998864    34689999999999999999999986   99999999999999999999999999998654


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ..    .....||+.|+|||++.+..++.++||||+||++|||++|++||....   .......   ......  .    
T Consensus       183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~---i~~~~~--~----  246 (340)
T PTZ00426        183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQK---ILEGII--Y----  246 (340)
T ss_pred             CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHH---HhcCCC--C----
Confidence            21    234579999999999998889999999999999999999999996421   1111111   111110  0    


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                           .+......+.+++.+|++.+|++|+     +++++++
T Consensus       247 -----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        247 -----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             -----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                 0111233678999999999999995     8888876

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-35  Score=334.80  Aligned_cols=251  Identities=26%  Similarity=0.334  Sum_probs=198.7

Q ss_pred             CCcccCeEeccCceEEEEEEEC----CCcEEEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC----GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  838 (1048)
                      +|++.+.||+|+||.||+++..    +++.||+|++.+..    ....+.+..|+.+++++ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999999753    57899999986432    22334578899999999 499999999999999999


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            999999999999998864    34588999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc
Q 001591          919 LLRPYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE  997 (1048)
Q Consensus       919 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1048)
                      .............+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.  .......    
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~~~----  227 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILKCD----  227 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhcCC----
Confidence            7544333334456899999999988765 47889999999999999999999996432222111111  1111110    


Q ss_pred             ccccccCchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591          998 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                         +..    +......+.+++.+|++.||++||     +++++++
T Consensus       228 ---~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 ---PPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---CCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               111    112234688999999999999999     6777775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.2e-36  Score=325.94  Aligned_cols=249  Identities=33%  Similarity=0.527  Sum_probs=194.0

Q ss_pred             ccCeEeccCceEEEEEEEC-----CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          771 QANIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       771 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +.+.||.|.||.||+|.+.     .+..|+||.+.... ....+++.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999877     35689999996543 33467899999999999999999999999988889999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++|+|.++++..  ....+++..+..|+.|+++||+|||+.   +++|+||+++||++++++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999864  345689999999999999999999986   99999999999999999999999999998763222


Q ss_pred             Cc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          925 TH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       925 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .. ......+...|+|||.+....++.++||||||+++||+++ |+.||...   ...+....+   ..... ..     
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~---~~~~~-~~-----  225 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKL---KQGQR-LP-----  225 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHH---HTTEE-TT-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc---ccccc-ce-----
Confidence            22 2223456779999999988889999999999999999999 78998542   222222222   11111 11     


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 1040 (1048)
                          .+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       226 ----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 ----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                1111234688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-35  Score=322.01  Aligned_cols=251  Identities=25%  Similarity=0.426  Sum_probs=201.5

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      .+|++.+.||+|+||.||+|.+.++..+|+|++..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35788899999999999999988778999999865432 34568889999999999999999999999999999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +++|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.++........
T Consensus        83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999988653   23689999999999999999999986   9999999999999999999999999999865432211


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||.....   .+....+   .....   .       
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~---~~~~~---~-------  220 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESV---SAGYR---L-------  220 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHH---HcCCc---C-------
Confidence            1112234457999999998899999999999999999999 8999864221   1111111   11100   0       


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 1040 (1048)
                      ..+...+.++.+++.+|+..+|++|||+.|++++|
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            00112344789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.3e-35  Score=331.58  Aligned_cols=241  Identities=23%  Similarity=0.305  Sum_probs=194.6

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  848 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  848 (1048)
                      +.||+|+||.||+|+.. +|..||+|++....   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999875 78999999987542   223345678999999999999999999999999999999999999


Q ss_pred             ChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCcee
Q 001591          849 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  928 (1048)
Q Consensus       849 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  928 (1048)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~  152 (323)
T cd05595          81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence            99888763    34689999999999999999999986   99999999999999999999999999987532221 222


Q ss_pred             ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhh
Q 001591          929 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008 (1048)
Q Consensus       929 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+   .....  .         .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~---~~~~~--~---------~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELI---LMEEI--R---------FP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH---hcCCC--C---------CC
Confidence            345799999999999999999999999999999999999999964221   1111111   11100  0         11


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1009 EKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1009 ~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                      .....++.+++.+|++.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            12234788999999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=331.88  Aligned_cols=239  Identities=24%  Similarity=0.288  Sum_probs=192.6

Q ss_pred             EeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      ||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999876 68899999987432   23345678899999999999999999999999999999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeec
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  930 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  930 (1048)
                      .+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~  152 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNT  152 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccc
Confidence            998864    34589999999999999999999986   9999999999999999999999999999864322 222334


Q ss_pred             ccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHH
Q 001591          931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010 (1048)
Q Consensus       931 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||....   ......   .......           ..+..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~---~~~~~~~-----------~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYR---KILQEPL-----------RFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHH---HHHcCCC-----------CCCCc
Confidence            679999999999999999999999999999999999999996421   111111   1111100           01112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 001591         1011 QLLEMLEIACKCIDQDPRRRPF---IEEVVT 1038 (1048)
Q Consensus      1011 ~~~~l~~li~~cl~~~P~~RPt---~~evl~ 1038 (1048)
                      ...++.+++.+|++.||++||+   +.|+++
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            3347889999999999999985   556554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.3e-35  Score=321.79  Aligned_cols=254  Identities=26%  Similarity=0.444  Sum_probs=203.9

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      ++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            56899999999999999999987777899999875432 34568999999999999999999998754 56799999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +|+|.+++...  ....+++..+..++.|+++||+|+|+.   +++||||||+||++++++.++|+|||.++........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            99999999753  234578999999999999999999985   9999999999999999999999999999866433322


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......++..|+|||+..+..++.++||||||+++|||++ |+.||.....   ......   .......          
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~---~~~~~~~----------  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQ---VERGYRM----------  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHH---HhcCCCC----------
Confidence            2223356778999999988899999999999999999999 8889864221   111111   1110000          


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ......+..+.+++.+|++.+|++||++.++++.|++.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            11123345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-35  Score=345.58  Aligned_cols=266  Identities=20%  Similarity=0.312  Sum_probs=198.5

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeC--------C
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--------N  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  836 (1048)
                      .++|++.+.||+|+||.||+|... +++.||||++....    ....+|+.++++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999875 68899999886432    2245799999999999999999887432        1


Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-cEEEeecc
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFG  915 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg  915 (1048)
                      ..++||||+++ ++.+++.........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence            35689999985 67777655444566789999999999999999999986   999999999999999654 79999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      +|+.+....  ......||+.|+|||++.+ ..++.++||||+||++|||++|++||.....   .+....+........
T Consensus       217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS---VDQLVRIIQVLGTPT  291 (440)
T ss_pred             cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCC
Confidence            998764322  2234578999999998765 4689999999999999999999999964321   122222221111100


Q ss_pred             c----------cc-----ccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591          995 E----------VE-----IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       995 ~----------~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                      .          .+     +....+....+...+.++.+++.+|++.||.+|||+.|+++  +++++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            0          00     00000001111223457899999999999999999999995  666553

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-35  Score=350.99  Aligned_cols=255  Identities=24%  Similarity=0.326  Sum_probs=205.2

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC-----
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----  836 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  836 (1048)
                      ..++|++.+.||+|+||+||+|+.. +|+.||+|++....  ......+.+|+..+..++|+||+++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            3568999999999999999999865 78999999986542  334456788999999999999999988775432     


Q ss_pred             ---cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEee
Q 001591          837 ---DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLAD  913 (1048)
Q Consensus       837 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  913 (1048)
                         ..++||||+++|+|.+++.........+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               25799999999999999976555566799999999999999999999986   999999999999999999999999


Q ss_pred             cccccccCCCC-CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc
Q 001591          914 FGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE  992 (1048)
Q Consensus       914 fg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  992 (1048)
                      ||+++.+.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...   ...+...   .....
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~---~~~~~~~---~~~~~  260 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---NMEEVMH---KTLAG  260 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHH---HHhcC
Confidence            99998764322 22233468999999999999999999999999999999999999999642   1111111   11111


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          993 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      . ..         ..+.....++.+++.+|++.+|++||++.++++
T Consensus       261 ~-~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        261 R-YD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             C-CC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            1 00         111223447899999999999999999999976

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.6e-35  Score=332.46  Aligned_cols=257  Identities=24%  Similarity=0.396  Sum_probs=203.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      .+|+..+.||+|+||.||+|++. +++    +||+|++.... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999864 343    48999987543 34556788999999999999999999999765 5679


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      |+||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999988753   34588999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCcee-ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          921 RPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       921 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ........ ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....   ..+....    ......  .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~~~~----~~~~~~--~  230 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSI----LEKGER--L  230 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----HhCCCC--C
Confidence            54333222 22334678999999999999999999999999999998 999986422   1111111    111100  0


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      ..       +......+.+++.+|++.+|.+||++.+++..+..+..+
T Consensus       231 ~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         231 PQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            00       111223688999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=327.54  Aligned_cols=264  Identities=27%  Similarity=0.384  Sum_probs=214.9

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhH-HHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ....+.+.||+|.||.|.++....+.+||||.++.+..... ++|.+|+++|.+++|||||+++|+|..++..++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            34566889999999999999998889999999998765554 78999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|.+|+..+....  ..-....+|+.||+.|++||.+.   ++||||+.++|+|+|.++++||+|||+++-+-..+.
T Consensus       618 EnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             hcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999998764332  45566778999999999999998   999999999999999999999999999996544333


Q ss_pred             c-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc--CCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          926 H-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       926 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      + .....+-..+|||||.+.-+++|.++|||+||+++||+++  .+.||....++   +.++......+.+....     
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~-----  764 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQV-----  764 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcce-----
Confidence            3 2334556679999999999999999999999999999765  88898754432   23332222222222111     


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                       ....+..++.++++++.+||+.+-++||+++++...|.+.+
T Consensus       765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence             11234456668999999999999999999999999887654

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.3e-35  Score=322.89  Aligned_cols=261  Identities=23%  Similarity=0.336  Sum_probs=209.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|++|.||+|... +++.||+|.+....   .....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999864 78999999876432   233457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++++|.+++.........+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998875433456789999999999999999999986   999999999999999999999999999886543


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ... ......|+..|+|||...+..++.++|+||||+++|||++|..||.....    +............      .+.
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~------~~~  227 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCD------YPP  227 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhhcCC------CCC
Confidence            222 12335788999999999888899999999999999999999999863211    1111111111000      000


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                         ........++.+++.+|++.+|++|||+.+|+++++++.
T Consensus       228 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         228 ---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence               011124457899999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=328.92  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=212.5

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  840 (1048)
                      ...|++.+.||+|.||.||+++.. +|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+.++|++.+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            356888899999999999999877 5999999999866543   3357899999999998 9999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC----CCcEEEeeccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGL  916 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~Dfg~  916 (1048)
                      |||++.||.|.+.+...     .+++..+..++.|++.|++|||+.   ||+|||+||+|+|+..    ++.+|++|||+
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999988764     389999999999999999999996   9999999999999963    35799999999


Q ss_pred             ccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      +....+  .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......   ...   .......  
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~---~~~---~i~~~~~--  255 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE---IFL---AILRGDF--  255 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH---HHH---HHHcCCC--
Confidence            998765  445667899999999999999999999999999999999999999997533211   111   1111111  


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                       .++...|    ......+.++++.|+..||.+|+|+.++++  |+.+.
T Consensus       256 -~f~~~~w----~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  256 -DFTSEPW----DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             -CCCCCCc----cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence             1222222    334558899999999999999999999997  65544

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.9e-35  Score=321.00  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=211.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|+|++++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999877 79999999886322   233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++.........+++.++..++.++++|++|||+.   +|+||||+|+||++++++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998876544556789999999999999999999986   999999999999999999999999999876543


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ... ......|++.|+|||...+..++.++|||||||++|+|++|+.||....    ....+....... ......    
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~-~~~~~~----  228 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEK-CDYPPL----  228 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhc-CCCCCC----
Confidence            221 1233468899999999988889999999999999999999999985321    111111111111 100000    


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                          ........+.+++.+|+..+|++||++.+++++|+++.
T Consensus       229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                01133457889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-35  Score=325.74  Aligned_cols=267  Identities=25%  Similarity=0.382  Sum_probs=201.7

Q ss_pred             CcccCeEeccCceEEEEEEE-----CCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEEE
Q 001591          769 FNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLL  840 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  840 (1048)
                      |+..+.||+|+||+||++..     .++..||+|.+.... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48889999999999988753     357889999987653 23456788999999999999999999988654  35789


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ||||+++++|.+++..     ..+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++++|||+++..
T Consensus        86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            9999999999998864     3489999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCce--eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          921 RPYDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       921 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      .......  .....++..|+|||......++.++||||||+++|||++|+.||...... ..+...+...........+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhh
Confidence            4322211  12234566799999998888999999999999999999999998542110 00111000000000000011


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      .+.......+...+.++.+++.+|++++|++|||+++++++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111111112233458999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.1e-35  Score=321.87  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=205.9

Q ss_pred             hcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .++|++.+.||+|+||.||+|...++++||+|.+..... ....+.+|+.++++++||||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            356888999999999999999988899999999875543 3456889999999999999999999874 45689999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++...  .+..+++.++..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999988653  345689999999999999999999986   999999999999999999999999999987653222


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .......++..|+|||+.....++.++||||||+++||+++ |++||....   ..+....+.   .... ..       
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~---~~~~-~~-------  223 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQNLE---RGYR-MP-------  223 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHH---cCCC-CC-------
Confidence            22223356778999999988889999999999999999999 999996432   122222111   1100 00       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                        .+...+.++.+++.+|++.+|++||+++++..+|+++
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         224 --RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence              1111234799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-35  Score=335.83  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=202.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36889999999999999999876 78999999987542   224456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            999999999998753   34689999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCceeecccccccccCccccC------cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQ------TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ..........||+.|+|||++.      ...++.++|||||||++|||++|+.||.....   ....   ..........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~---~~i~~~~~~~  228 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTY---NNIMNFQRFL  228 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHH---HHHHcCCCcc
Confidence            3333333457999999999876      45678999999999999999999999964221   1111   1111111111


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ...+       ......++.+++.+|++ +|++||++.++++
T Consensus       229 ~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1111       11233468899999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-35  Score=338.55  Aligned_cols=253  Identities=23%  Similarity=0.283  Sum_probs=200.7

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4567999999999999999999876 68899999986432   2233457789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++...
T Consensus       121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            9999999999998853     2478888999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCceeecccccccccCccccCcC----CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTL----TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ...........+||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....   .....   .........
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~---~i~~~~~~~  266 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYS---KIMDHKNSL  266 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHH---HHHcCCCcC
Confidence            43322223346799999999987643    478899999999999999999999964221   11111   111111111


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRR--RPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~ 1038 (1048)
                      ...+       ....+.++.+++.+|++.+|++  ||++.|+++
T Consensus       267 ~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         267 TFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            1111       1122347889999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-35  Score=325.86  Aligned_cols=263  Identities=26%  Similarity=0.393  Sum_probs=203.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-----CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRL  839 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  839 (1048)
                      .+|++.+.||+|+||+||+|...     ++..||+|++........+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888999999999999999742     5789999998876665667889999999999999999999987543  4678


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      +||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence            999999999999998642   34589999999999999999999986   999999999999999999999999999987


Q ss_pred             cCCCCCcee--ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCC-------Cc--hhHHHHHHH
Q 001591          920 LRPYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGK-------NC--RDLVSWVFQ  988 (1048)
Q Consensus       920 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~-------~~--~~~~~~~~~  988 (1048)
                      .........  ....++..|+|||...+..++.++||||||+++|||++|..|+......       ..  .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            643322211  1123345699999998889999999999999999999987775321100       00  000000000


Q ss_pred             hhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      ....         ......+...+.++.+++.+|++.+|++|||+.|+++.|++++
T Consensus       238 ~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         238 LLKN---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHhc---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            0000         0000111223457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=362.51  Aligned_cols=471  Identities=29%  Similarity=0.337  Sum_probs=273.5

Q ss_pred             cCccccCCcCCCeEecCCCCCCCCCCccccCCCCccEEeccCCcccCcccccccccccccEEEecCcccCCccccccccC
Q 001591           98 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFS  177 (1048)
Q Consensus        98 ~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~  177 (1048)
                      ||.-+..-..++.|+++.|.+-...-+.....-+|+.||||+|+++. .|-.+..+.+|+.|+++.|.+..++...+++.
T Consensus        13 ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~-fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~   91 (1081)
T KOG0618|consen   13 IPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISS-FPIQITLLSHLRQLNLSRNYIRSVPSSCSNMR   91 (1081)
T ss_pred             cchhhccHHHHHhhhccccccccCchHHhhheeeeEEeecccccccc-CCchhhhHHHHhhcccchhhHhhCchhhhhhh
Confidence            45555555557777777776653322333444447777777777763 34556677777777777777777777777777


Q ss_pred             cccEEEecCccccCccchhhhhcccccceEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcc
Q 001591          178 NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS  257 (1048)
Q Consensus       178 ~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  257 (1048)
                      +|++|+|.+|++. .+|.. +..+++|++||+|.|++...|..+..++.++++..++|.-.    ..++... ++.++|.
T Consensus        92 ~l~~lnL~~n~l~-~lP~~-~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~----~~lg~~~-ik~~~l~  164 (1081)
T KOG0618|consen   92 NLQYLNLKNNRLQ-SLPAS-ISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKI----QRLGQTS-IKKLDLR  164 (1081)
T ss_pred             cchhheeccchhh-cCchh-HHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhh----hhhcccc-chhhhhh
Confidence            7777777777766 34433 45667777777777777777777777777777777777221    1122222 6677777


Q ss_pred             cccCCcchhhhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcc
Q 001591          258 VNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPI  337 (1048)
Q Consensus       258 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  337 (1048)
                      .|.+.+.++..+..++.  .|+|.+|.++   -..+.++.+|+.+....|++....    -..++|+.|+.++|.++...
T Consensus       165 ~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~  235 (1081)
T KOG0618|consen  165 LNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLD  235 (1081)
T ss_pred             hhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeec
Confidence            77777777666666655  6777777665   223556666677777766665221    12345666666666666222


Q ss_pred             CcccccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCcCccccccc
Q 001591          338 DLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQ  417 (1048)
Q Consensus       338 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~  417 (1048)
                      + .+ .-.+|+++++++|+++ .+|++++.+.+|+.++..+|+++ .+|..+....+|++|++..|.+..+|..   +.+
T Consensus       236 ~-~p-~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~---le~  308 (1081)
T KOG0618|consen  236 V-HP-VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPF---LEG  308 (1081)
T ss_pred             c-cc-ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCc---ccc
Confidence            2 11 2345666666666666 34566666666666666666665 5666666666666666666666666542   344


Q ss_pred             ccccceEecccCccCCCCCcccc-------------------------CCCcCcEEEccCCcccCCchHhhhccCCCcEE
Q 001591          418 CKNLTTLILTKNFVGEEIPENVG-------------------------GFESLMVLALGNCGLKGHIPVWLLRCKKLQVL  472 (1048)
Q Consensus       418 l~~L~~L~L~~N~l~~~~p~~~~-------------------------~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  472 (1048)
                      ++.|++|+|..|.+....+..+.                         .++.|+.|.+.+|.++...-+.+.+.+.|+.|
T Consensus       309 ~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVL  388 (1081)
T KOG0618|consen  309 LKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVL  388 (1081)
T ss_pred             cceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeee
Confidence            56666666666666332221121                         23445555555565555554555555566666


Q ss_pred             eCcCceeccCCCc-ccccCCCCCeEeecCCcccccCCcchhhhhhhhccCCCCCCCCCCCCccceeeccccCCCcCCCCC
Q 001591          473 DLSWNHFDGNIPP-WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQA  551 (1048)
Q Consensus       473 ~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  551 (1048)
                      +|++|++. .+|. .+.++..|+.|+||+|+++ .+|..+.++..|.                                 
T Consensus       389 hLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~---------------------------------  433 (1081)
T KOG0618|consen  389 HLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH---------------------------------  433 (1081)
T ss_pred             eecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH---------------------------------
Confidence            66666555 3333 3455555666666666655 4455555555442                                 


Q ss_pred             CCCCCeeeeecCcccccCCccccCCCCCcEEEccCceeccc-CCcccccccCccEeeCCCCccCCCCccccccccCCCee
Q 001591          552 SSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGT-IPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKF  630 (1048)
Q Consensus       552 ~~~~~~l~Ls~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~g~-ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l  630 (1048)
                           +|...+|++. ..| ++.+++.|+.+|+|.|+|+-. +|.... -++|++||||+|.=.-.--+.|..++++..+
T Consensus       434 -----tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~  505 (1081)
T KOG0618|consen  434 -----TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNTRLVFDHKTLKVLKSLSQM  505 (1081)
T ss_pred             -----HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCcccccchhhhHHhhhhhhe
Confidence                 2334445554 344 555666666666666666522 222221 1566666666665222333445555555555


Q ss_pred             eeccc
Q 001591          631 SVANN  635 (1048)
Q Consensus       631 ~l~~N  635 (1048)
                      ++.-|
T Consensus       506 ~i~~~  510 (1081)
T KOG0618|consen  506 DITLN  510 (1081)
T ss_pred             ecccC
Confidence            55544

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.2e-35  Score=335.18  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=195.2

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++.+++||+|+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999876 68899999987532   223346788999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999998864    34689999999999999999999986   999999999999999999999999999876432


Q ss_pred             CCC----------------------------------ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCC
Q 001591          923 YDT----------------------------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR  968 (1048)
Q Consensus       923 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~  968 (1048)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0112357999999999999999999999999999999999999


Q ss_pred             CCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHccc--CCCCCCCCHHHHHH
Q 001591          969 RPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCID--QDPRRRPFIEEVVT 1038 (1048)
Q Consensus       969 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~RPt~~evl~ 1038 (1048)
                      .||....   ..+....+...   .....+ .+.      .....++.+++.+++.  .++..||+++|+++
T Consensus       234 ~Pf~~~~---~~~~~~~i~~~---~~~~~~-p~~------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         234 PPFCSET---PQETYKKVMNW---KETLIF-PPE------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCCCCCC---HHHHHHHHHcC---cCcccC-CCc------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            9996422   11222111111   000111 000      0122356677776443  23445789999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.4e-35  Score=324.52  Aligned_cols=259  Identities=24%  Similarity=0.408  Sum_probs=203.8

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCc
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  837 (1048)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999753      25679999986432 2344568899999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccccCC------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEE
Q 001591          838 RLLIYSYMENGSLDYWLHESVDK------DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  911 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  911 (1048)
                      .++||||+++|+|.+++......      ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999998653211      23468889999999999999999985   9999999999999999999999


Q ss_pred             eecccccccCCCCCcee-ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHh
Q 001591          912 ADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM  989 (1048)
Q Consensus       912 ~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~  989 (1048)
                      +|||+++.......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.....   ......+.  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~--  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVM--  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH--
Confidence            99999976543222111 12345778999999998899999999999999999999 7889864221   12221111  


Q ss_pred             hcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          990 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                        ......         .+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus       236 --~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 --EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             --cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence              111100         011223468999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.5e-35  Score=330.72  Aligned_cols=241  Identities=24%  Similarity=0.314  Sum_probs=195.1

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  848 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  848 (1048)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 68999999987542   223356788999999999999999999999999999999999999


Q ss_pred             ChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCcee
Q 001591          849 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  928 (1048)
Q Consensus       849 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  928 (1048)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  152 (328)
T cd05593          81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM  152 (328)
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence            99888763    34689999999999999999999986   9999999999999999999999999998754322 1222


Q ss_pred             ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhh
Q 001591          929 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008 (1048)
Q Consensus       929 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||....   ......   ......  .         ..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~~---~~~~~~--~---------~~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFE---LILMED--I---------KFP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---HHHHHH---HhccCC--c---------cCC
Confidence            34579999999999998899999999999999999999999996421   111111   111110  0         011


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1009 EKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1009 ~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                      .....++.+++.+|++.||++||     ++.|+++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            12234688999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=338.34  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=199.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36889999999999999999876 68999999997432   223345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++.+..
T Consensus        81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999998864    34589999999999999999999986   999999999999999999999999999875432


Q ss_pred             CCCc-------------------------------------eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHH
Q 001591          923 YDTH-------------------------------------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL  965 (1048)
Q Consensus       923 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ell  965 (1048)
                      ....                                     .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011246999999999999999999999999999999999


Q ss_pred             cCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 001591          966 TGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF---IEEVVT 1038 (1048)
Q Consensus       966 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~ 1038 (1048)
                      +|+.||....   .......+.   ...........       .....++.+++.+|+. +|.+|++   +.|+++
T Consensus       234 ~G~~Pf~~~~---~~~~~~~i~---~~~~~~~~~~~-------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDN---PQETYRKII---NWKETLQFPDE-------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCC---HHHHHHHHH---cCCCccCCCCC-------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999996432   111111111   11111111110       0123467889999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3e-35  Score=324.09  Aligned_cols=251  Identities=23%  Similarity=0.292  Sum_probs=198.3

Q ss_pred             EeccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      ||+|+||+||+|... +++.||+|++......   ..+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999876 7889999998754322   224567899999999999999999999999999999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeec
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  930 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  930 (1048)
                      .+++.........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||.+........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            888765444456789999999999999999999986   999999999999999999999999999976543322 2234


Q ss_pred             ccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHH
Q 001591          931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010 (1048)
Q Consensus       931 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||........  ........... .          ...+..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~-~----------~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILND-S----------VTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhccc-C----------CCCccc
Confidence            5789999999999999999999999999999999999999964221110  00000111000 0          011122


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH--HHHh
Q 001591         1011 QLLEMLEIACKCIDQDPRRRP-----FIEEVVT--WLDG 1042 (1048)
Q Consensus      1011 ~~~~l~~li~~cl~~~P~~RP-----t~~evl~--~L~~ 1042 (1048)
                      .+..+.+++.+|++.||++||     +++++++  ++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            345788999999999999999     7788875  4544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=324.32  Aligned_cols=251  Identities=26%  Similarity=0.331  Sum_probs=200.9

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .|++.++||+|+||+||++... +++.||+|++.....   .....+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999875 689999999875432   223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++|+|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999887643  234689999999999999999999986   9999999999999999999999999999865422


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      .  ......|++.|+|||++.+..++.++||||+||++|||++|+.||.......   ....+........         
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~---------  221 (285)
T cd05605         156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ---------  221 (285)
T ss_pred             C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc---------
Confidence            2  1223578999999999998899999999999999999999999997432111   1111111111000         


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                       ...+...+..+.+++.+|++.||++||     +++++++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence             011223345788999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=325.60  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=212.8

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ..+..+...||-|.||.||.|.|+ ..-.||||.++.+.. ..++|..|+.+|+.++|||+|+++|+|..+..+|||+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            345667889999999999999997 467899999986643 456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      |.+|+|.+||++.  ....++.-..+++|.||+.|++||..   +++|||||.++|.|+.++..|||+|||+++.+..+.
T Consensus       345 M~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  345 MCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             ccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9999999999875  34557788899999999999999998   499999999999999999999999999999886543


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      -..........-|.|||-+-...++.|+|||+|||++||+.| |-.||.+..-.+       ++..         +...+
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~L---------LEkgy  483 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGL---------LEKGY  483 (1157)
T ss_pred             eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHH---------Hhccc
Confidence            222223334568999999988899999999999999999999 888886432211       1222         12222


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ..+.++.+++.++++|+.||++.|.+||+++|+-+.+|.+
T Consensus       484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            2334556677899999999999999999999999988876

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.9e-35  Score=336.07  Aligned_cols=255  Identities=23%  Similarity=0.269  Sum_probs=199.6

Q ss_pred             HHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcE
Q 001591          763 LKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       763 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  838 (1048)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            334578999999999999999999876 68899999986422   22344578899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence            999999999999998853     2478899999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccccccccCccccCcC----CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          919 LLRPYDTHVTTDLVGTLGYIPPEYSQTL----TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       919 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      .............+||+.|+|||++.+.    .++.++||||+||++|||++|+.||....   ......   .......
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~---~i~~~~~  264 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYS---KIMDHKN  264 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHH---HHHhCCc
Confidence            7653332223456899999999987654    37889999999999999999999996422   111111   1111111


Q ss_pred             cccccccccCchhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR--RPFIEEVVT 1038 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~ 1038 (1048)
                      ....       +........+.+++.+|+..++.+  ||++.|+++
T Consensus       265 ~~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         265 SLNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             ccCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            1111       111122346788899999755543  899999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=338.64  Aligned_cols=251  Identities=26%  Similarity=0.345  Sum_probs=202.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++....   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999876 78999999987542   133456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999998743    5689999999999999999999986   999999999999999999999999999987643


Q ss_pred             CC----------------------------CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCccc
Q 001591          923 YD----------------------------THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC  974 (1048)
Q Consensus       923 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~  974 (1048)
                      ..                            ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                            01223457999999999999999999999999999999999999999743


Q ss_pred             CCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 001591          975 KGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF-IEEVVT 1038 (1048)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~ 1038 (1048)
                      ..   .....   .............       ......++.+++.+|+. +|.+||+ ++|+++
T Consensus       234 ~~---~~~~~---~i~~~~~~~~~p~-------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         234 TL---QETYN---KIINWKESLRFPP-------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CH---HHHHH---HHhccCCcccCCC-------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            21   11111   1111000000000       00134478899999997 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.1e-35  Score=318.75  Aligned_cols=254  Identities=27%  Similarity=0.438  Sum_probs=203.5

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      ++|++.+.||+|++|.||+|.+.++..+|+|++.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4588889999999999999998877789999887543 33456889999999999999999999875 456789999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +++|.++++..  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            99999998753  234578999999999999999999986   9999999999999999999999999999865432222


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||....   ..+...++..    ....         
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~----~~~~---------  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NREVLEQVER----GYRM---------  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHc----CCCC---------
Confidence            2222346678999999988899999999999999999999 999986422   1222222111    1000         


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ..+...+..+.+++.+|++.+|++||++++++++|++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            01112345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.6e-35  Score=336.28  Aligned_cols=251  Identities=24%  Similarity=0.299  Sum_probs=195.7

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .|+..+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999865 68899999997542   2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999998864    34588999999999999999999986   9999999999999999999999999997643110


Q ss_pred             CC----------------------------------------------ceeecccccccccCccccCcCCCCchhhhHHH
Q 001591          924 DT----------------------------------------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSF  957 (1048)
Q Consensus       924 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  957 (1048)
                      ..                                              ......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00123579999999999998899999999999


Q ss_pred             HHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHH--cccCCCCCCCCHHH
Q 001591          958 GVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACK--CIDQDPRRRPFIEE 1035 (1048)
Q Consensus       958 Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~P~~RPt~~e 1035 (1048)
                      ||++|||++|+.||......   .....+.   .........       .......++.+++.+  |...+|.+||+++|
T Consensus       235 G~il~elltG~~Pf~~~~~~---~~~~~i~---~~~~~~~~~-------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPT---ETQLKVI---NWENTLHIP-------PQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHH---HHHHHHH---ccccccCCC-------CCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            99999999999999643211   1111111   100000000       001123467788887  55666677999999


Q ss_pred             HHH
Q 001591         1036 VVT 1038 (1048)
Q Consensus      1036 vl~ 1038 (1048)
                      +++
T Consensus       302 ~l~  304 (381)
T cd05626         302 IKA  304 (381)
T ss_pred             Hhc
Confidence            986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-35  Score=333.30  Aligned_cols=262  Identities=26%  Similarity=0.394  Sum_probs=203.9

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeeecceEeeC-C
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHG-N  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  836 (1048)
                      .++|++.+.||+|+||.||+|...      +++.||+|++..... ...+.+..|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357899999999999999999642      347899999875432 2335678899999999 799999999988654 5


Q ss_pred             cEEEEEEeccCCChhhhcccccC---------------------------------------------------------
Q 001591          837 DRLLIYSYMENGSLDYWLHESVD---------------------------------------------------------  859 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  859 (1048)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999988754211                                                         


Q ss_pred             CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce-eeccccccccc
Q 001591          860 KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYI  938 (1048)
Q Consensus       860 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~  938 (1048)
                      ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||+++.+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            023689999999999999999999986   99999999999999999999999999998764332222 22345677899


Q ss_pred             CccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHH
Q 001591          939 PPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLE 1017 (1048)
Q Consensus       939 aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1017 (1048)
                      |||++.+..++.++|||||||++|||++ |+.||......+  .....    ........         .+.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~----~~~~~~~~---------~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRR----LKEGTRMR---------APEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHH----HhccCCCC---------CCccCCHHHHH
Confidence            9999999999999999999999999998 999996422111  11111    11111000         01122347899


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591         1018 IACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus      1018 li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                      ++.+|++.+|++||++.|+++.|+++-+
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999988744

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4e-35  Score=336.70  Aligned_cols=264  Identities=23%  Similarity=0.326  Sum_probs=200.4

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC-----cEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----DRL  839 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  839 (1048)
                      +|+..+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999865 78999999986532  234456889999999999999999999998776     789


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      +|+||+. ++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999997 467766642    45689999999999999999999986   999999999999999999999999999986


Q ss_pred             cCCCCCceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc-
Q 001591          920 LRPYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE-  997 (1048)
Q Consensus       920 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-  997 (1048)
                      .............+++.|+|||++.+. .++.++||||+||++|||++|+.||......   +....+..........+ 
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI---QQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCHHHH
Confidence            544333333445789999999988764 5789999999999999999999999743211   11111111111000000 


Q ss_pred             ----------c----cccc-c--CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 001591          998 ----------I----IDAS-I--WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus       998 ----------~----~~~~-~--~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~ 1042 (1048)
                                +    ..+. .  .........+++.+++.+|++.||++|||+.|+++  ++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence                      0    0000 0  00001122457889999999999999999999986  5554

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-35  Score=331.28  Aligned_cols=248  Identities=21%  Similarity=0.330  Sum_probs=195.6

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      ++||+|+||.||+|++. +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999876 68899999997542   22334578899999988 699999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++..... ...
T Consensus        81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~  152 (329)
T cd05588          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT  152 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence            999888753    34689999999999999999999986   9999999999999999999999999998753221 122


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCC--chhHHHHHHHhhcccccccccccccCc
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN--CRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+  ......+.......... .        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~--------  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R--------  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C--------
Confidence            334689999999999999999999999999999999999999996422111  11112222222211111 0        


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPF------IEEVVT 1038 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt------~~evl~ 1038 (1048)
                       .+.....++.+++.+|++.||.+||+      +.++++
T Consensus       224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             01112346889999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.5e-35  Score=317.62  Aligned_cols=247  Identities=26%  Similarity=0.365  Sum_probs=196.4

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      +.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999875 78999999876543 34456789999999999999999999999999999999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCcee-e
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-T  929 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~  929 (1048)
                      .+++..   ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||.+........... .
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            999864   234588999999999999999999986   999999999999999999999999999876432211111 1


Q ss_pred             cccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhh
Q 001591          930 DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008 (1048)
Q Consensus       930 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |..||......   .....+.   ....          ...+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~---~~~~----------~~~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIE---QGVR----------LPCP  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHH---cCCC----------CCCc
Confidence            1123457999999998899999999999999999998 99998642211   1111111   1000          0111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591         1009 EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus      1009 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      ...+..+.+++.+|++.+|++||++.|+.++|+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            223447899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.2e-35  Score=330.21  Aligned_cols=243  Identities=22%  Similarity=0.340  Sum_probs=191.3

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||.||+|+.. +++.||+|++....   ....+.+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 67899999987542   23344577888888777 799999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|..++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~  152 (329)
T cd05618          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT  152 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence            999888753    34689999999999999999999986   9999999999999999999999999999753221 122


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCC--CchhHHHHHHHhhcccccccccccccCc
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGK--NCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .......++......... .        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~--------  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R--------  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C--------
Confidence            33467999999999999999999999999999999999999999632211  111112222222111110 0        


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFI 1033 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~ 1033 (1048)
                       .+.....++.+++.+|++.||++||++
T Consensus       224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 -IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             111223468899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.1e-35  Score=323.09  Aligned_cols=257  Identities=27%  Similarity=0.426  Sum_probs=203.4

Q ss_pred             cCCcccCeEeccCceEEEEEEE-----CCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      .+|++.+.||+|+||.||+|.+     .++..||+|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3577889999999999999975     246789999987543 3344678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccC-------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC
Q 001591          841 IYSYMENGSLDYWLHESVD-------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF  907 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  907 (1048)
                      ||||+++++|.+++.....             ....+++.++..++.|++.|++|||+.   +++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999998853211             123578999999999999999999986   999999999999999999


Q ss_pred             cEEEeecccccccCCCCC-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHH
Q 001591          908 EAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSW  985 (1048)
Q Consensus       908 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~  985 (1048)
                      .+|++|||+++....... .......++..|+|||+..+..++.++||||||+++|||++ |..||....   .......
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence            999999999986543221 12223456778999999988889999999999999999998 999986422   1122211


Q ss_pred             HHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          986 VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                      +.    ......         .+.....++.+++.+|++.+|++||++.++.+.|.+
T Consensus       239 ~~----~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VR----KRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----cCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11    111110         111223478899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.3e-35  Score=316.05  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=198.6

Q ss_pred             CeEeccCceEEEEEEECCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCChh
Q 001591          773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD  851 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  851 (1048)
                      ++||+|+||.||+|...++..||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998888999999987654 334456889999999999999999999999999999999999999999


Q ss_pred             hhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeecc
Q 001591          852 YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL  931 (1048)
Q Consensus       852 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  931 (1048)
                      +++...   ...+++..+..++.|++.|+.|+|+.   +++||||||+||++++++.+|++|||++..............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            988643   34578999999999999999999986   999999999999999999999999999976433222112223


Q ss_pred             cccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHH
Q 001591          932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010 (1048)
Q Consensus       932 ~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      .+++.|+|||+..+..++.++||||||+++||+++ |..||.....   ......+   .. .....         .+..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~~~---~~-~~~~~---------~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAREQV---EK-GYRMS---------CPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHH---Hc-CCCCC---------CCCC
Confidence            44668999999998899999999999999999998 9999964321   1111111   11 11000         0112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591         1011 QLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus      1011 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      .+..+.+++.+|++.+|++||++.|++++|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2347899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-34  Score=319.34  Aligned_cols=245  Identities=24%  Similarity=0.339  Sum_probs=192.8

Q ss_pred             EeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      ||+|+||.||+++.. +|+.||+|++....   ...++.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999875 68999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeec
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  930 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  930 (1048)
                      .+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~  153 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ  153 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence            8887543  234588999999999999999999985   99999999999999999999999999998654322  2234


Q ss_pred             ccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHH
Q 001591          931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010 (1048)
Q Consensus       931 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||.........  ...........    . ..     ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~----~-~~-----~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLEDE----V-KF-----EHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhccc----c-cc-----cccc
Confidence            57899999999998888999999999999999999999999643221111  11111111100    0 00     0012


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1011 QLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1011 ~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ...++.+++.+|++.||++||+++|+++
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            2346899999999999999999976553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-35  Score=318.72  Aligned_cols=256  Identities=28%  Similarity=0.455  Sum_probs=207.7

Q ss_pred             hcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .++|++.+.||+|+||.||+|...++..||+|.+.... ...+++.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46789999999999999999998888899999987543 33466899999999999999999999999888999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++...  ....+++..+..++.+++.|++|||+.   +++|+||||+||++++++.++++|||.+........
T Consensus        84 ~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          84 SKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             CCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999998753  234689999999999999999999986   999999999999999999999999999987643221


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .......++..|+|||...+..++.++||||+|+++||+++ |+.||....   .......+.....   .         
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~~~~~---~---------  223 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQVERGYR---M---------  223 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC---C---------
Confidence            11122234568999999998889999999999999999998 999985422   2222222211100   0         


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                       ..+...+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence             00111234789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.4e-35  Score=327.66  Aligned_cols=241  Identities=25%  Similarity=0.336  Sum_probs=193.4

Q ss_pred             CeEeccCceEEEEEEEC----CCcEEEEEEecCCc----hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          773 NIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +.||+|+||.||+++..    +++.||+|++....    ......+..|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999753    57899999987532    22334577899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++|+|.+++..    ...+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999988864    34578889999999999999999986   99999999999999999999999999987543222


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   .....   ........  .       
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~---~~~~~~~~--~-------  218 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTI---DKILKGKL--N-------  218 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHH---HHHHcCCC--C-------
Confidence             22234579999999999998889999999999999999999999996422   11111   11111110  0       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                        .+......+.+++.+|++.+|++||     ++.++++
T Consensus       219 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 --LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              0111234688999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-34  Score=317.84  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=198.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|+..++||+|+||.||+|.+. ++..||+|++.... ....+++.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999864 78899999987543 34456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|..+.        .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999986542        367888999999999999999986   9999999999999999999999999999765322 


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........................      
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------  220 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL------  220 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC------
Confidence              223457899999999999989999999999999999999999999653322211111011111111100000      


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        .......++.+++.+|++.+|++||+++|+++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              01112346889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.1e-35  Score=351.73  Aligned_cols=260  Identities=24%  Similarity=0.354  Sum_probs=203.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||.||+|++. +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999876 68999999987542   234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccC-------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          843 SYMENGSLDYWLHESVD-------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                      ||++||+|.+++.....       .....++..++.++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864321       123467788899999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCC-----------------ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCC
Q 001591          916 LSRLLRPYDT-----------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN  978 (1048)
Q Consensus       916 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~  978 (1048)
                      +++.......                 ......+||+.|+|||++.+..++.++||||+||++|||+||+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9986521110                 0112347999999999999999999999999999999999999999642211 


Q ss_pred             chhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHhc
Q 001591          979 CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF-IEEVVTWLDGI 1043 (1048)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~~L~~i 1043 (1048)
                        .... ......   ....       ......+..+.+++.+|++.||++||+ ++++.+.|+..
T Consensus       238 --ki~~-~~~i~~---P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        238 --KISY-RDVILS---PIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             --hhhh-hhhccC---hhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              1110 000000   0000       001123346889999999999999965 66677777665

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.3e-35  Score=326.40  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=206.6

Q ss_pred             hcCCcccCeEeccCceEEEEEEECC------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCc
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  837 (1048)
                      .++|++.+.||+|+||.||+|.+..      ...+|+|++.... .....++.+|+++++++ +||||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            4568889999999999999998642      3679999987543 33345688999999999 79999999999999999


Q ss_pred             EEEEEEeccCCChhhhccccc------------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC
Q 001591          838 RLLIYSYMENGSLDYWLHESV------------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE  905 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~  905 (1048)
                      .++||||+++|+|.++++...            .....+++..++.++.|++.|++|||+.   +|+||||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence            999999999999999986432            2345789999999999999999999985   9999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHH
Q 001591          906 KFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV  983 (1048)
Q Consensus       906 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~  983 (1048)
                      ++.+|++|||.++.+....... .....++..|+|||+..+..++.++|||||||++|||++ |..||.....   .+..
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~  244 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EELF  244 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HHHH
Confidence            9999999999998764322211 122245678999999988899999999999999999998 9999864221   1111


Q ss_pred             HHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          984 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      .    ........         ..+......+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus       245 ~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 K----LLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1    11111110         011122347889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.7e-35  Score=323.30  Aligned_cols=258  Identities=29%  Similarity=0.421  Sum_probs=204.2

Q ss_pred             CCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      +|++.+.||+|+||.||+|...      ....+|+|.+..... .....+.+|+.++++++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999753      235788888875543 334578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccccc--------------------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCc
Q 001591          841 IYSYMENGSLDYWLHESV--------------------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN  900 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  900 (1048)
                      |+||+.+|+|.+++....                    .....+++..++.++.|++.|++|||+.   +|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            999999999999876432                    1224588999999999999999999986   99999999999


Q ss_pred             eEECCCCcEEEeecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCC
Q 001591          901 ILLDEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN  978 (1048)
Q Consensus       901 Ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~  978 (1048)
                      |++++++.+||+|||+++......... .....++..|+|||...+..++.++||||||+++|||++ |+.||....   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            999999999999999998654322221 122345678999999888889999999999999999998 999986422   


Q ss_pred             chhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          979 CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      .........    .....         ..+.....++.+++.+|++.+|++||+++|+++.|+++-
T Consensus       235 ~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         235 PERLFNLLK----TGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHHHHHh----CCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            122222111    11000         011122347889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.3e-35  Score=327.13  Aligned_cols=267  Identities=22%  Similarity=0.366  Sum_probs=202.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56889999999999999999876 678999999874432 2334577899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++ ++.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 777776542   34578999999999999999999986   99999999999999999999999999997643222


Q ss_pred             CceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc---ccc--
Q 001591          925 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE---VEI--  998 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--  998 (1048)
                      . ......+++.|+|||.+.+ ..++.++||||+|+++|||++|++||.....   .+....+.........   ..+  
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV---EDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHhhhcc
Confidence            1 2223468899999998754 5688999999999999999999999964322   1222112111110000   000  


Q ss_pred             ----cc---ccc----CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591          999 ----ID---ASI----WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       999 ----~~---~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                          .+   +..    ..........++.+++.+|++.||++|||+.|+++  +++.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                00   000    00011123457889999999999999999999997  777654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.3e-35  Score=321.38  Aligned_cols=257  Identities=23%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCc----EEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ++|++.+.||+|+||+||+|.+. +++    +|++|.+..... ....++..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46888899999999999999875 344    477887754332 234567888889999999999999998864 45788


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ++||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.++..
T Consensus        86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999999999998752   34689999999999999999999985   9999999999999999999999999999875


Q ss_pred             CCCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          921 RPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       921 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      .+.... ......++..|+|||...+..++.++||||||+++||+++ |+.||.....   ....+.+    .....  .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~----~~~~~--~  230 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDLL----EKGER--L  230 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCCCc--C
Confidence            433222 2223457779999999988899999999999999999998 9999964321   1111111    11111  0


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      ..+.       .....+.+++.+|+..+|++||++.|+++.|+.+..+
T Consensus       231 ~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         231 AQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            1111       1123578899999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.2e-35  Score=329.93  Aligned_cols=244  Identities=25%  Similarity=0.344  Sum_probs=193.0

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHH---HhcCCCceeeecceEeeCCcEEEE
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEAL---SRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      |++.+.||+|+||.||+|.+. +++.||+|+++...   ....+.+.+|++++   ++++||||+++++++..++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667889999999999999876 68999999987542   12234466666655   456799999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++|+|..+++.     ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999887753     3589999999999999999999986   99999999999999999999999999987543


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ... ......+|++.|+|||++.+..++.++|||||||++|||++|+.||....   ..+....+   ......      
T Consensus       153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i---~~~~~~------  219 (324)
T cd05589         153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSI---VNDEVR------  219 (324)
T ss_pred             CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHH---HhCCCC------
Confidence            222 22334679999999999999999999999999999999999999996422   11221111   111100      


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                           .+......+.+++.+|++.||.+||     ++.++++
T Consensus       220 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 -----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 0111234678999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.6e-35  Score=322.23  Aligned_cols=262  Identities=23%  Similarity=0.387  Sum_probs=209.2

Q ss_pred             hcCCcccCeEeccCceEEEEEEECC-----CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEee-CCcE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRH-GNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  838 (1048)
                      .++|++.+.||+|+||.||+|.+.+     +..||+|++.... ......+.+|+.++++++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678899999999999999998765     6889999887543 3345668899999999999999999998876 4678


Q ss_pred             EEEEEeccCCChhhhcccccCC----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          839 LLIYSYMENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                      ++++||+++|+|.+++......    ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|++||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            8999999999999998654322    25689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCcee-ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcc
Q 001591          915 GLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE  992 (1048)
Q Consensus       915 g~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  992 (1048)
                      |+++.+.+...... ....++..|+|||++.+..++.++||||||+++||+++ |+.||....   ..+...++..   .
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~---~  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEMAAYLKD---G  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---HHHHHHHHHc---C
Confidence            99987644332221 22345678999999988889999999999999999999 999996422   1222222111   1


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591          993 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      ....          .....+.++.+++.+|++.+|++|||+.++++.|+++...
T Consensus       236 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         236 YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            1000          0111234789999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.7e-35  Score=316.89  Aligned_cols=252  Identities=35%  Similarity=0.496  Sum_probs=201.7

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHH--HHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      |++.+.||+|+||+||+|+.. +++.||+|++.........  ...+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677889999999999999987 5678999999876543332  3356999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++.    ....+++..+..++.|+++||++||+.   +|+|+||||+||++++++.++|+|||.+.... ...
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN  152 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred             cccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence            9999999987    345689999999999999999999996   99999999999999999999999999997642 223


Q ss_pred             ceeecccccccccCccccC-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 HVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .......+++.|+|||+.. +..++.++||||+|+++|+|++|+.||....   ..+.................     .
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~-----~  224 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN---SDDQLEIIEKILKRPLPSSS-----Q  224 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS---HHHHHHHHHHHHHTHHHHHT-----T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc---chhhhhhhhhcccccccccc-----c
Confidence            3444568899999999988 8899999999999999999999999997531   11111111111111000000     0


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        .......++.+++.+|++.||++||++.++++
T Consensus       225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             --ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00001158999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.5e-35  Score=328.15  Aligned_cols=240  Identities=25%  Similarity=0.338  Sum_probs=189.5

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 67899999987542   12233455666776654 799999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            999988864    34588999999999999999999986   99999999999999999999999999997643222 22


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+   .....           ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~~i---~~~~~-----------~~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFDSI---LNDRP-----------HF  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHHHH---HcCCC-----------CC
Confidence            334679999999999999899999999999999999999999996422   11222111   11110           01


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIE-EVV 1037 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~-evl 1037 (1048)
                      +.....++.+++.+|++.+|++||++. +++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111234678999999999999999975 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-35  Score=335.92  Aligned_cols=251  Identities=24%  Similarity=0.293  Sum_probs=196.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36889999999999999999865 78999999986432   223356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999998864    34588999999999999999999986   999999999999999999999999999964321


Q ss_pred             CCCc----------------------------------------------eeecccccccccCccccCcCCCCchhhhHH
Q 001591          923 YDTH----------------------------------------------VTTDLVGTLGYIPPEYSQTLTATCRGDVYS  956 (1048)
Q Consensus       923 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s  956 (1048)
                      ....                                              .....+||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            1000                                              001247999999999999989999999999


Q ss_pred             HHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCC---CCH
Q 001591          957 FGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRR---PFI 1033 (1048)
Q Consensus       957 lGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Pt~ 1033 (1048)
                      |||++|||++|++||.....   .+....+.   .........+       ......++.+++.+|+. +|.+|   +++
T Consensus       234 lGvil~elltG~~Pf~~~~~---~~~~~~i~---~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENS---HETYRKII---NWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCH---HHHHHHHH---ccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            99999999999999964221   11111111   1111111111       01123468899999997 66665   599


Q ss_pred             HHHHH
Q 001591         1034 EEVVT 1038 (1048)
Q Consensus      1034 ~evl~ 1038 (1048)
                      .|+++
T Consensus       300 ~~~l~  304 (377)
T cd05629         300 HEIKS  304 (377)
T ss_pred             HHHhc
Confidence            99886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-35  Score=315.87  Aligned_cols=251  Identities=29%  Similarity=0.458  Sum_probs=205.8

Q ss_pred             hcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999876 88999999986644 4567899999999999999999999999889999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++.......
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          83 AKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            999999998753  223689999999999999999999986   999999999999999999999999999987632211


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                          ...++..|+|||......++.++||||||+++|||++ |+.||....   ..+....+.    ......       
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~----~~~~~~-------  219 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPHVE----KGYRME-------  219 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHh----cCCCCC-------
Confidence                2234568999999988889999999999999999997 999986421   122221111    110000       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                        .+...+.++.+++.+|+..+|++||++.|++++|+++
T Consensus       220 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 --APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              1112235789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.8e-35  Score=316.29  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=196.5

Q ss_pred             eEeccCceEEEEEEEC---CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCC
Q 001591          774 IIGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  848 (1048)
Q Consensus       774 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  848 (1048)
                      .||+|+||.||+|.++   ++..+|+|+++...  ....+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   57899999986443  334567899999999999999999999885 45678999999999


Q ss_pred             ChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCcee
Q 001591          849 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  928 (1048)
Q Consensus       849 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  928 (1048)
                      +|.+++..    ...+++..+..++.|++.|++|+|+.   +|+||||||+||++++++.+||+|||.++..........
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99998864    34588999999999999999999986   999999999999999999999999999987654332211


Q ss_pred             --ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          929 --TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       929 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                        ....+++.|+|||......++.++||||||+++|||++ |+.||.....   .+....+   . ......        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i---~-~~~~~~--------  218 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMI---E-SGERME--------  218 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---H-CCCCCC--------
Confidence              12234578999999988889999999999999999998 9999964321   1222211   1 111111        


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                       .+...+.++.+++.+|++.+|++||++++|++.|++.
T Consensus       219 -~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 -CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence             1112334788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.4e-35  Score=318.45  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=201.2

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            57899999999999999999874 78899999987655455567889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.++++.    ...+++..+..++.|++.|++|||+.   +|+|||+||+||++++++.++|+|||++........
T Consensus        89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999998863    34688999999999999999999986   999999999999999999999999999986543221


Q ss_pred             ceeecccccccccCccccC---cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          926 HVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                       ......|++.|+|||.+.   ...++.++||||+||++|||++|+.||........  .    .......    ...+.
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~----~~~~~~~----~~~~~  230 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLMSKSN----FQPPK  230 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--h----eeeecCC----CCCCC
Confidence             122356889999999874   44578899999999999999999999853221110  0    0000000    00000


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1039 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 1039 (1048)
                      .  ......+..+.+++.+|++.+|++||+++++++.
T Consensus       231 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         231 L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            0  0111234578999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.3e-35  Score=335.39  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=203.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCchh-hHHHHHHHHHHHHhcC-CCceeeecceEeeCCcE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  838 (1048)
                      ++|.+.+.||+|+||.||+|++.      .+..||+|++...... ..+.+.+|++++.++. ||||++++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            45778899999999999999864      2468999999755322 2346889999999997 99999999999999999


Q ss_pred             EEEEEeccCCChhhhcccccC-----------------------------------------------------------
Q 001591          839 LLIYSYMENGSLDYWLHESVD-----------------------------------------------------------  859 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------------  859 (1048)
                      ++||||+++|+|.++++....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999865321                                                           


Q ss_pred             -----------------------------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001591          860 -----------------------------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  904 (1048)
Q Consensus       860 -----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~  904 (1048)
                                                         ....+++..+..++.|++.||+|||+.   +++||||||+||+++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence                                               113467888999999999999999985   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCC-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhH
Q 001591          905 EKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL  982 (1048)
Q Consensus       905 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~  982 (1048)
                      +++.+|++|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |+.||.....   .+.
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~---~~~  350 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM---NEQ  350 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---hHH
Confidence            999999999999986532221 11223457789999999988889999999999999999998 8999864221   111


Q ss_pred             HHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          983 VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ..   .........         ..+.....++.+++.+||+.+|++||+++|+++.|+++
T Consensus       351 ~~---~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 FY---NAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HH---HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11   111111000         01112234789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=326.88  Aligned_cols=245  Identities=25%  Similarity=0.375  Sum_probs=204.5

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCChh
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD  851 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  851 (1048)
                      -++|+|.||+||-|++. +...+|||-+.....+..+.+.+|+...++++|.|||+++|.+.+++..-+.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            36999999999999876 45678999998776666777899999999999999999999999999889999999999999


Q ss_pred             hhcccccCCcccc--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-CCCcEEEeecccccccCCCCCcee
Q 001591          852 YWLHESVDKDSVL--KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVT  928 (1048)
Q Consensus       852 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~  928 (1048)
                      +.++....   ++  .+.+.-.+.+||++||.|||.+   .|||||||-+|||++ -.|.+||+|||-++.+.. .+..+
T Consensus       661 sLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~T  733 (1226)
T KOG4279|consen  661 SLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCT  733 (1226)
T ss_pred             HHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccc
Confidence            99987543   34  5677888999999999999986   999999999999996 678999999999998653 34456


Q ss_pred             ecccccccccCccccCcC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCch
Q 001591          929 TDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006 (1048)
Q Consensus       929 ~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      .++.||..|||||++..+  .|.+++|||||||++.||.||++||.......     ..++...-         -....+
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-----AAMFkVGm---------yKvHP~  799 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-----AAMFKVGM---------YKVHPP  799 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-----Hhhhhhcc---------eecCCC
Confidence            678999999999998764  68899999999999999999999997533221     11121111         112234


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1007 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .+++...+...+|.+|+.+||.+||++.++++
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            56677788999999999999999999999986

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.3e-35  Score=329.24  Aligned_cols=242  Identities=23%  Similarity=0.312  Sum_probs=194.4

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  848 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  848 (1048)
                      +.||+|+||.||+|+.. +|..||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 78999999987542   223345678999999999999999999999999999999999999


Q ss_pred             ChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCcee
Q 001591          849 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  928 (1048)
Q Consensus       849 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  928 (1048)
                      +|.+++..    ...+++..+..++.|++.||+|||+.  ++|+||||||+||++++++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (325)
T cd05594          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM  153 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccc
Confidence            99888763    34689999999999999999999972  499999999999999999999999999987543221 222


Q ss_pred             ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhh
Q 001591          929 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008 (1048)
Q Consensus       929 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+   ....  ..         .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i---~~~~--~~---------~p  216 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI---LMEE--IR---------FP  216 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHH---hcCC--CC---------CC
Confidence            345799999999999999999999999999999999999999964221   1111111   1000  00         01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1009 EKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1009 ~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                      .....++.+++.+|++.||++|+     ++.++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            11234688999999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=313.48  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=201.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-----hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ++|++.+.||+|++|.||+|... ++++||+|.+.....     ...+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999865 689999998864321     123468889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      |+||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||.++..
T Consensus        82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999999988864    34578999999999999999999986   9999999999999999999999999999765


Q ss_pred             CCCCCcee--ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          921 RPYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       921 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ........  ....|+..|+|||...+..++.++||||+|+++|||++|+.||....   .....   ..........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~---~~~~~~~~~~--  226 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE---AMAAI---FKIATQPTNP--  226 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc---hHHHH---HHHhccCCCC--
Confidence            43221111  23568889999999999889999999999999999999999986321   11111   1111111110  


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                             ..+......+.+++.+|++.+|++|||+.|+++
T Consensus       227 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         227 -------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             -------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence                   111223447889999999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9e-35  Score=323.77  Aligned_cols=257  Identities=27%  Similarity=0.427  Sum_probs=204.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  838 (1048)
                      ++|++.+.||+|+||.||+|...      ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            56889999999999999999742      34589999987543 33345689999999999 799999999999999999


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++|+|.++++...  ...+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.++++|||.++
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999987532  23489999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          919 LLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       919 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ........ ......++..|+|||.+.+..++.++||||+||++|||++ |+.||......+  .....    .......
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~~----~~~~~~~  263 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYKL----IKEGYRM  263 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHHH----HHcCCcC
Confidence            65433221 1222356778999999998899999999999999999998 999986432111  11111    1111000


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                               ..+.....++.+++.+|++++|++||++.|+++.|++.
T Consensus       264 ---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 ---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                     00111234789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.9e-35  Score=327.44  Aligned_cols=243  Identities=23%  Similarity=0.317  Sum_probs=192.9

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||+||+|+.. +++.||+|+++....   ...+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 678999999985432   2334578899999888 699999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|..++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  152 (327)
T cd05617          81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT  152 (327)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence            999887753    34689999999999999999999986   9999999999999999999999999998753221 122


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............+.......... .         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~---------~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-R---------I  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-C---------C
Confidence            33468999999999999999999999999999999999999999653322222222222222211111 0         0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFI 1033 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~ 1033 (1048)
                      +......+.+++.+|++.||++|+++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            11123467899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1e-34  Score=331.90  Aligned_cols=259  Identities=24%  Similarity=0.267  Sum_probs=201.3

Q ss_pred             HHHHHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEee
Q 001591          759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRH  834 (1048)
Q Consensus       759 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  834 (1048)
                      +.++....++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3444555689999999999999999999876 68899999986422   2233457889999999999999999999999


Q ss_pred             CCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       835 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                      ++..++||||+++|+|.+++..     ..++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            9999999999999999998853     2478889999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeecccccccccCccccCcC----CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001591          915 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL----TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       915 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      |+++.............+||+.|+|||++...    .++.++|||||||++|||++|+.||....   .....   ....
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~---~~i~  260 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTY---SKIM  260 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHH---HHHH
Confidence            99987653332233456899999999987653    37889999999999999999999996421   11111   1111


Q ss_pred             cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR--RPFIEEVVT 1038 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~ 1038 (1048)
                      .........+       .......+.+++.+|++.++.+  ||++.|+++
T Consensus       261 ~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         261 NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence            1111111111       1123446889999999844433  778998887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=318.62  Aligned_cols=256  Identities=27%  Similarity=0.421  Sum_probs=201.9

Q ss_pred             CcccCeEeccCceEEEEEEECC----CcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCc-----
Q 001591          769 FNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND-----  837 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  837 (1048)
                      |++.+.||+|+||.||+|.+..    +..||+|+++.+.  ......+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    3689999987543  2334578999999999999999999998876554     


Q ss_pred             -EEEEEEeccCCChhhhcccccC--CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          838 -RLLIYSYMENGSLDYWLHESVD--KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       838 -~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                       .++|+||+++|+|..++.....  ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             6899999999999988855321  234689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCcee-ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcc
Q 001591          915 GLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE  992 (1048)
Q Consensus       915 g~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  992 (1048)
                      |.++.......... ....++..|+|||...+..++.++||||||+++|||++ |.+||....   ..+...++..   .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~~---~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLRH---G  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHc---C
Confidence            99987543322211 12245678999999988899999999999999999999 899986422   1222222211   1


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          993 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                       ...         ..+.....++.+++.+|++.||++||++.|+++.|+++
T Consensus       232 -~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 -NRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -CCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             110         11122344789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-34  Score=325.41  Aligned_cols=241  Identities=24%  Similarity=0.309  Sum_probs=193.1

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCC-ceeeecceEeeCCcEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK-NLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  842 (1048)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|.+++..++|+ +|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999876 57899999987542   22345577899999999764 5888999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            99999999988864    34578999999999999999999986   999999999999999999999999999875322


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      . .......+||+.|+|||++.+..++.++||||+||++|||++|+.||....   ..+....+..   ...        
T Consensus       154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~---~~~--------  218 (324)
T cd05587         154 G-GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIME---HNV--------  218 (324)
T ss_pred             C-CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHc---CCC--------
Confidence            1 122334579999999999999999999999999999999999999996422   1222221111   100        


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1033 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 1033 (1048)
                         ..+.....++.+++.+|++.+|.+|++.
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               0111223468899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-34  Score=314.72  Aligned_cols=246  Identities=24%  Similarity=0.414  Sum_probs=195.2

Q ss_pred             EeccCceEEEEEEEC---CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          775 IGCGGFGLVYKATLT---NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      ||+|+||.||+|.+.   .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999764   35579999987553 334466899999999999999999999886 4578999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceee-
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-  929 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~-  929 (1048)
                      .+++...   ...+++..+++++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++............ 
T Consensus        82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9988642   34689999999999999999999986   9999999999999999999999999999865433222111 


Q ss_pred             -cccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          930 -DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       930 -~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                       ...++..|+|||......++.++||||||+++||+++ |+.||......   +....+   ..... .         ..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~---~~~~~-~---------~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFI---EQGKR-L---------DC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH---HCCCC-C---------CC
Confidence             1233568999999888889999999999999999996 99999643221   111111   11110 0         11


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      +.....++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            112345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.6e-35  Score=336.17  Aligned_cols=250  Identities=24%  Similarity=0.297  Sum_probs=195.9

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6899999999999999999865 68999999986432   1223557889999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|..+...
T Consensus        82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999864    34578899999999999999999986   9999999999999999999999999998533100


Q ss_pred             C------------------------------------------CceeecccccccccCccccCcCCCCchhhhHHHHHHH
Q 001591          924 D------------------------------------------THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVL  961 (1048)
Q Consensus       924 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil  961 (1048)
                      .                                          .......+||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                          0001235799999999999999999999999999999


Q ss_pred             HHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCC---CHHHHHH
Q 001591          962 LELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP---FIEEVVT 1038 (1048)
Q Consensus       962 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP---t~~evl~ 1038 (1048)
                      |||++|+.||......   +..   ..............       ......++.+++.+|+ .+|.+|+   ++.|+++
T Consensus       235 yell~G~~Pf~~~~~~---~~~---~~i~~~~~~~~~~~-------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         235 YEMLVGQPPFLADTPA---ETQ---LKVINWETTLHIPS-------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eehhhCCCCCCCCCHH---HHH---HHHhccCccccCCC-------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999999999743211   111   11111111111100       0112335677888876 5999999   8899886

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-34  Score=322.89  Aligned_cols=257  Identities=28%  Similarity=0.433  Sum_probs=201.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCc--EEEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGT--KAAVKRLSGD-CGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      ++|++.++||+|+||.||+|... ++.  .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46888999999999999999875 333  4788887743 233456789999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhcccccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcE
Q 001591          842 YSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  909 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  909 (1048)
                      +||+++|+|.++++....            ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999865321            123588999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHH
Q 001591          910 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQ  988 (1048)
Q Consensus       910 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~  988 (1048)
                      ||+|||++........  ......+..|+|||+..+..++.++|||||||++|||++ |..||....   ..+....   
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~---~~~~~~~---  230 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT---CAELYEK---  230 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH---
Confidence            9999999864321111  111233557999999988889999999999999999997 999996422   1122211   


Q ss_pred             hhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      ... ....         ..+......+.+++.+|++.+|.+||+++++++.|+++.
T Consensus       231 ~~~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         231 LPQ-GYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             Hhc-CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111 1000         011123347889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=321.53  Aligned_cols=264  Identities=24%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             cCCcccCeEeccCceEEEEEEECC---------------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN---------------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQG  830 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  830 (1048)
                      ++|++.+.||+|+||.||+|+...               ...||+|++.... ......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999997642               2358999987653 334456899999999999999999999


Q ss_pred             eEeeCCcEEEEEEeccCCChhhhcccccC--------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceE
Q 001591          831 YCRHGNDRLLIYSYMENGSLDYWLHESVD--------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNIL  902 (1048)
Q Consensus       831 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIl  902 (1048)
                      ++...+..++||||+++++|.+++.....        ....+++..++.++.|+++|++|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            99999999999999999999998864311        112478999999999999999999986   9999999999999


Q ss_pred             ECCCCcEEEeecccccccCCCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc--CCCCCcccCCCCc
Q 001591          903 LDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGKNC  979 (1048)
Q Consensus       903 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--g~~P~~~~~~~~~  979 (1048)
                      +++++.+|++|||++......... ......++..|+|||......++.++||||||+++|||++  |..||.....   
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---  238 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---  238 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence            999999999999999765432211 1122345678999999988889999999999999999988  6677764221   


Q ss_pred             hhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          980 RDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                      .+...................      .....+..+.+++.+|++.+|++||++++|++.|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            222222111111110000000      011123479999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-34  Score=315.10  Aligned_cols=249  Identities=25%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|+..+.||+|++|.||+|... +++.|++|.+...  ......++.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999876 6899999998643  234556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.++++..  ....+++..+..++.+++.|++|||+.   +++||||||+||++++++.++++|||+++......
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999998753  245689999999999999999999985   99999999999999999999999999998765432


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .. .....|++.|+|||+..+..++.++|+||||+++|||++|+.||....   .......+   .. ....        
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~---~~-~~~~--------  219 (256)
T cd08529         156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKI---IR-GVFP--------  219 (256)
T ss_pred             ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---Hc-CCCC--------
Confidence            22 233568899999999999899999999999999999999999996422   11111111   11 1110        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       .........+.+++.+|++.+|++||++.++++
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence             111123347899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-34  Score=323.81  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=206.2

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC--------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeC
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHG  835 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  835 (1048)
                      ..+|++.+.||+|+||.||+|++.        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456888999999999999999742        24579999887543 33456789999999999 899999999999999


Q ss_pred             CcEEEEEEeccCCChhhhcccccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEE
Q 001591          836 NDRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL  903 (1048)
Q Consensus       836 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll  903 (1048)
                      ...++||||+++|+|.+++.....            ....+++.++..++.|+++|++|||+.   +++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            999999999999999999875321            134588999999999999999999986   99999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchh
Q 001591          904 DEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD  981 (1048)
Q Consensus       904 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~  981 (1048)
                      ++++.+||+|||.++......... .....+++.|+|||+..+..++.++||||||+++|||++ |..||....   ..+
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE  247 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HHH
Confidence            999999999999998764332221 222346678999999988889999999999999999998 888885422   112


Q ss_pred             HHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          982 LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      ....   . .......         .+......+.+++.+|++.+|++||++.|+++.|+++.
T Consensus       248 ~~~~---~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         248 LFKL---L-KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHHH---H-HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            2211   1 1111100         01123457889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-34  Score=317.27  Aligned_cols=255  Identities=28%  Similarity=0.487  Sum_probs=203.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CC---cEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NG---TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      .+|+..+.||+|+||.||+|... ++   ..+|+|.+.... ....+.+..|++++++++||||+++++++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46788899999999999999875 33   379999887543 33456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++++|.+++..   ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||++....
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999865   235689999999999999999999986   99999999999999999999999999998664


Q ss_pred             CCCCceee--cccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          922 PYDTHVTT--DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       922 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ........  ....++.|+|||++....++.++||||||+++|||++ |+.||.....   .+....+   ......   
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i---~~~~~~---  229 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAI---NDGFRL---  229 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH---hcCCCC---
Confidence            33222111  1223457999999988889999999999999999997 9999864221   1222111   111100   


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                             +.....+.++.+++.+|++.+|++||++.++++.|+++
T Consensus       230 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 -------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   01112234789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-34  Score=325.26  Aligned_cols=236  Identities=26%  Similarity=0.336  Sum_probs=190.0

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||+||+|+.. +++.||+|++....   ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 68899999987542   22334567788888876 699999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++..... ...
T Consensus        81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~  152 (320)
T cd05590          81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT  152 (320)
T ss_pred             chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence            999988864    34588999999999999999999986   9999999999999999999999999998754321 222


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....   .......+.   ....    ..       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~---~~~~----~~-------  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAIL---NDEV----VY-------  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHh---cCCC----CC-------
Confidence            334579999999999999899999999999999999999999996422   122222211   1110    00       


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFI 1033 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~ 1033 (1048)
                      +.....++.+++.+|++.||++||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            11123468899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-34  Score=317.26  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=204.6

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-C---CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-N---GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      .+|++.+.||+|+||.||+|++. +   +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999864 2   3379999887543 33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++++|.+++...   ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+....
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999998653   34589999999999999999999986   99999999999999999999999999998765


Q ss_pred             CCCCceee--cccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          922 PYDTHVTT--DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       922 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ........  ...++..|+|||.+.+..++.++|+||||+++||+++ |+.||.....   .+....+....   ..   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~---~~---  228 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEEGY---RL---  228 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhCCC---cC---
Confidence            43322221  1233568999999998899999999999999999887 9999864321   12222221110   00   


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                             +.....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 -------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   00112234788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-34  Score=334.60  Aligned_cols=250  Identities=24%  Similarity=0.306  Sum_probs=194.5

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      +|+..+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999875 68899999987542   2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999998864    34578899999999999999999986   9999999999999999999999999997533110


Q ss_pred             C----------------------------------------------CceeecccccccccCccccCcCCCCchhhhHHH
Q 001591          924 D----------------------------------------------THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSF  957 (1048)
Q Consensus       924 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  957 (1048)
                      .                                              .......+||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000123479999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 001591          958 GVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF---IE 1034 (1048)
Q Consensus       958 Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~ 1034 (1048)
                      ||++|||++|++||.....   .+..   .............       .......++.+++.+|+ .+|++|++   +.
T Consensus       235 Gvil~elltG~~Pf~~~~~---~~~~---~~i~~~~~~~~~p-------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTP---LETQ---MKVINWQTSLHIP-------PQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCH---HHHH---HHHHccCCCcCCC-------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            9999999999999974321   1111   1111111100000       01112335677777765 59999997   88


Q ss_pred             HHHH
Q 001591         1035 EVVT 1038 (1048)
Q Consensus      1035 evl~ 1038 (1048)
                      |+++
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            8765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.5e-34  Score=319.67  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=203.2

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-----------------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeee
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-----------------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSL  828 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  828 (1048)
                      ++|++.+.||+|+||.||++.+.                 ++..||+|++.... .....++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999998643                 23468999987543 3345678999999999999999999


Q ss_pred             cceEeeCCcEEEEEEeccCCChhhhcccccCC-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCce
Q 001591          829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDK-------DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNI  901 (1048)
Q Consensus       829 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NI  901 (1048)
                      ++++..++..++||||+++|+|.+++......       ...+++.++..++.|++.|++|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999998754321       23478899999999999999999986   999999999999


Q ss_pred             EECCCCcEEEeecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc--CCCCCcccCCCC
Q 001591          902 LLDEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGKN  978 (1048)
Q Consensus       902 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--g~~P~~~~~~~~  978 (1048)
                      ++++++.++++|||+++.+....... .....+++.|+|||......++.++|||||||++|||++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence            99999999999999998654322111 122344678999998888889999999999999999998  77888643221 


Q ss_pred             chhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          979 CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                        +.+................      +.+...+..+.+++.+|++.||++||++.|+++.|++
T Consensus       241 --~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 --QVIENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             --HHHHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              1121111111110000000      0111223578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-34  Score=318.91  Aligned_cols=258  Identities=25%  Similarity=0.399  Sum_probs=204.2

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  839 (1048)
                      ..+|+..+.||+|+||+||+|++. +|+    +||+|++.... .....++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            356888999999999999999864 444    48999987543 34456788999999999999999999998754 568


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      +++||+++|+|.++++..   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            999999999999988652   34689999999999999999999986   999999999999999999999999999987


Q ss_pred             cCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccc
Q 001591          920 LRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVE  997 (1048)
Q Consensus       920 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1048)
                      ........ .....+++.|+|||...+..++.++||||||+++|||++ |..||....   ......++...   ... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~---~~~-~  231 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLLEKG---ERL-P  231 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCC---CcC-C
Confidence            65332221 112245678999999988899999999999999999998 999986322   12222222111   000 0


Q ss_pred             ccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591          998 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                               .+......+.+++.+|++.||++||++.++++.|+++...
T Consensus       232 ---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         232 ---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             ---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence                     0112234688999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.6e-35  Score=320.58  Aligned_cols=257  Identities=28%  Similarity=0.467  Sum_probs=204.8

Q ss_pred             cCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ++|+..+.||+|+||.||+|...      ++..+|+|.+..........+.+|++++++++||||+++++++.+++..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999642      356899999887666666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccC-----------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcE
Q 001591          841 IYSYMENGSLDYWLHESVD-----------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  909 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  909 (1048)
                      ||||+++|+|.+++.....           ....+++..++.++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999999875321           113588999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHH
Q 001591          910 HLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF  987 (1048)
Q Consensus       910 kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~  987 (1048)
                      ||+|||++.......... .....+++.|+|||...+..++.++|||||||++|||++ |++||.....   .+..... 
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~-  237 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECI-  237 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHH-
Confidence            999999997654322111 122345678999999998899999999999999999998 9999864221   1111111 


Q ss_pred             HhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          988 QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                        ..... ..         .+...+..+.+++.+|++.||++||++.|+.+.|++
T Consensus       238 --~~~~~-~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         238 --TQGRE-LE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             --HcCcc-CC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence              11100 00         011223468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.7e-34  Score=313.44  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=197.9

Q ss_pred             CcccCeEeccCceEEEEEEECC-Cc--EEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeC------Cc
Q 001591          769 FNQANIIGCGGFGLVYKATLTN-GT--KAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------ND  837 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  837 (1048)
                      |.+.+.||+|+||.||+|.+.+ +.  .||+|.++...  ....+.+.+|++++++++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3457889999999999998764 32  68999887542  33446788999999999999999999987532      24


Q ss_pred             EEEEEEeccCCChhhhccccc--CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          838 RLLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                      .++||||+++|+|.+++....  .....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998874322  1234589999999999999999999985   99999999999999999999999999


Q ss_pred             cccccCCCCCcee-ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccc
Q 001591          916 LSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK  993 (1048)
Q Consensus       916 ~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  993 (1048)
                      +++.+........ ....+++.|+|||...+..++.++||||||+++|||++ |+.||....   .......+   . ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~---~-~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDYL---R-QG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH---H-cC
Confidence            9987643322111 12345678999999999999999999999999999999 899986421   11222111   1 11


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          994 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ....         ........+.+++.+|++.+|++|||+.++++.|+++
T Consensus       231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1100         0112234689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1e-34  Score=324.54  Aligned_cols=260  Identities=28%  Similarity=0.409  Sum_probs=205.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC--------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCC
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  836 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  836 (1048)
                      ++|.+.+.||+|+||.||+|.+.        ++..+|+|.+.... .....++.+|+++++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            46889999999999999999753        23479999988543 33445688899999999 7999999999999999


Q ss_pred             cEEEEEEeccCCChhhhcccccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001591          837 DRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  904 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~  904 (1048)
                      ..++||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.   +++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            99999999999999999975422            124589999999999999999999986   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhH
Q 001591          905 EKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL  982 (1048)
Q Consensus       905 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~  982 (1048)
                      +++.+|++|||.++......... .....+++.|+|||...+..++.++|||||||++|||++ |+.||....   ..+.
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---~~~~  251 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEEL  251 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHH
Confidence            99999999999997654322111 112234568999999988889999999999999999998 889985321   1111


Q ss_pred             HHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          983 VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                      ..    ........         ..+.....++.+++.+|++.+|++||++.++++.|+++-+
T Consensus       252 ~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         252 FK----LLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             HH----HHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            11    11111111         1111233478899999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-34  Score=325.61  Aligned_cols=241  Identities=25%  Similarity=0.333  Sum_probs=193.2

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      ++||+|+||.||+|+.. +++.||+|++....   ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 57899999987542   22334567788888876 799999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~  152 (321)
T cd05591          81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT  152 (321)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence            999888864    34588999999999999999999986   99999999999999999999999999987543222 22


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....   ..+....+.   ....    ..       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~---~~~~----~~-------  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESIL---HDDV----LY-------  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHH---cCCC----CC-------
Confidence            334579999999999999899999999999999999999999997432   222222211   1110    00       


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRP-------FIEEVVT 1038 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RP-------t~~evl~ 1038 (1048)
                      +.....++.+++.+|++.||++||       ++.++++
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            011234688999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.7e-35  Score=326.83  Aligned_cols=241  Identities=25%  Similarity=0.302  Sum_probs=193.4

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      +|++.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+..|..++... +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999876 678999999875432   2233466788888777 5899999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            99999999888864    34588999999999999999999986   999999999999999999999999999975432


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      . .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+..   ...        
T Consensus       154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~---~~~--------  218 (323)
T cd05616         154 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIME---HNV--------  218 (323)
T ss_pred             C-CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHh---CCC--------
Confidence            2 122334679999999999999999999999999999999999999996422   1222222111   110        


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1033 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 1033 (1048)
                         ..+.....++.+++.+|++.+|++|++.
T Consensus       219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               0111223478899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-34  Score=321.91  Aligned_cols=249  Identities=22%  Similarity=0.383  Sum_probs=203.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|+..+.||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999864 68899999988665555567889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++..     ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+........
T Consensus       100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            99999998853     3478899999999999999999986   999999999999999999999999999886543222


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       ......|++.|+|||...+..++.++|||||||++|+|++|+.||.....   ..   +........ ....       
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~---~~---~~~~~~~~~-~~~~-------  236 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LR---ALYLIATNG-TPEL-------  236 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH---HH---hHHHHhcCC-CCCC-------
Confidence             12334788999999999888899999999999999999999999964221   11   111111111 0000       


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..+......+.+++.+|+..+|++||++.|+++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            111223346889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-34  Score=315.01  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=205.5

Q ss_pred             hcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .++|++.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46788999999999999999998778889999887543 234568899999999999999999999887 7789999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          83 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            999999998753  244578999999999999999999985   999999999999999999999999999976543222


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .......++..|+|||++....++.++|+||||+++|++++ |+.||....   ..+...++..    ....        
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~----~~~~--------  222 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALER----GYRM--------  222 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhC----CCCC--------
Confidence            22223345678999999998889999999999999999998 999986421   1122222111    1100        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                       ......+.++.+++.+|++.+|++||++.++.+.|++.
T Consensus       223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence             01112334788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.7e-35  Score=324.62  Aligned_cols=257  Identities=30%  Similarity=0.471  Sum_probs=201.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCc--EEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGT--KAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      ++|++.+.||+|+||.||+|.+. ++.  .+|+|.+.... ......+.+|++++.++ +||||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46888999999999999999875 454  46777776432 33456788999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhcccccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcE
Q 001591          842 YSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  909 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  909 (1048)
                      |||+++|+|.++++....            ....+++.+++.++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999999865321            123588999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHH
Q 001591          910 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQ  988 (1048)
Q Consensus       910 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~  988 (1048)
                      ||+|||++........  .....++..|+|||...+..++.++|||||||++|||+| |..||....   ..+....+  
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~--  236 (303)
T cd05088         164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKL--  236 (303)
T ss_pred             EeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC---hHHHHHHH--
Confidence            9999999864321111  111234668999999988889999999999999999998 999996422   11222111  


Q ss_pred             hhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                       . ......         .+......+.+++.+|++.+|++||++.++++.|+++-
T Consensus       237 -~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         237 -P-QGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             -h-cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             1 110000         01112346889999999999999999999999888763

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.3e-35  Score=321.84  Aligned_cols=256  Identities=24%  Similarity=0.381  Sum_probs=202.7

Q ss_pred             CCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      +|++.+.||+|+||.||+|.+.      ++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4677888999999999999864      247899999975543 334668899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccccc------------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCc
Q 001591          841 IYSYMENGSLDYWLHESV------------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE  908 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~  908 (1048)
                      ++||+++++|.+++....            .....+++..+..++.|++.||+|+|+.   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999875321            1124588999999999999999999986   9999999999999999999


Q ss_pred             EEEeecccccccCCCCC-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHH
Q 001591          909 AHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV  986 (1048)
Q Consensus       909 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~  986 (1048)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....   ..+..+.+
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~i  239 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVIEMI  239 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Confidence            99999999886543222 11223456789999999988889999999999999999998 888886422   11222211


Q ss_pred             HHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          987 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                      .   .. ...         ..+...+..+.+++.+|++.+|++||++++++..|+.
T Consensus       240 ~---~~-~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 R---NR-QVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H---cC-CcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1   11 110         1112234468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-34  Score=348.59  Aligned_cols=263  Identities=21%  Similarity=0.337  Sum_probs=203.8

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEE
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRL  839 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  839 (1048)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|++...  .......+..|+.++++++|||||+++++|.+.  ...|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999876 5778999988643  233456788999999999999999999988543  4689


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcC----CCCeEEcCCCCCceEECC----------
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC----EPHIVHRDVKSSNILLDE----------  905 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dlk~~NIll~~----------  905 (1048)
                      +||||+++|+|.+++.........+++..++.|+.||+.||+|||+..    .++||||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999999765444567999999999999999999999852    146999999999999964          


Q ss_pred             -------CCcEEEeecccccccCCCCCceeecccccccccCccccCc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Q 001591          906 -------KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKG  976 (1048)
Q Consensus       906 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~P~~~~~~  976 (1048)
                             .+.+||+|||++......  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.... 
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-  247 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence                   234899999999865432  12234579999999998754  458899999999999999999999996422 


Q ss_pred             CCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHHHhcCc
Q 001591          977 KNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV--TWLDGIGI 1045 (1048)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl--~~L~~i~~ 1045 (1048)
                       ....+   +.... .......          .....++.++|..||+.+|.+||++.|++  .++..+.+
T Consensus       248 -~~~ql---i~~lk-~~p~lpi----------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        248 -NFSQL---ISELK-RGPDLPI----------KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             -cHHHH---HHHHh-cCCCCCc----------CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence             11111   11111 1111000          01234689999999999999999999998  47766543

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-34  Score=318.41  Aligned_cols=257  Identities=27%  Similarity=0.427  Sum_probs=201.9

Q ss_pred             hcCCcccCeEeccCceEEEEEEECC------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  838 (1048)
                      .++|++.+.||+|++|.||+|.+.+      +..||+|.+.... ...+..+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999998753      5688999887543 33456789999999999999999999999998899


Q ss_pred             EEEEEeccCCChhhhcccccC---CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC---cEEEe
Q 001591          839 LLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF---EAHLA  912 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~  912 (1048)
                      ++||||+++++|.++++....   ....+++..+.+++.||+.|++|||+.   +++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            999999999999999875431   123589999999999999999999986   999999999999998654   59999


Q ss_pred             ecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhh
Q 001591          913 DFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       913 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      |||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....   ......+   .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~---~  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFV---T  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---H
Confidence            999998753221111 112233568999999998899999999999999999997 9999964321   1121111   1


Q ss_pred             cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      .... .         ..+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       236 ~~~~-~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGGR-L---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCc-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1110 0         011122347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.2e-34  Score=324.53  Aligned_cols=241  Identities=27%  Similarity=0.338  Sum_probs=191.1

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||+||+|++. +++.||+|+++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 57899999987542   12234456677787764 899999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++..    ...+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++...... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05619          81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence            999988864    34588999999999999999999986   99999999999999999999999999987532211 12


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....   ..+....+..   ....           .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i~~---~~~~-----------~  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSIRM---DNPC-----------Y  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh---CCCC-----------C
Confidence            334579999999999999899999999999999999999999996422   1222222111   1000           0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIE-EVVT 1038 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~-evl~ 1038 (1048)
                      +.....++.+++.+|++.+|++||++. ++.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111234688999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-35  Score=320.15  Aligned_cols=258  Identities=24%  Similarity=0.410  Sum_probs=205.7

Q ss_pred             hcCCcccCeEeccCceEEEEEEECC------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  838 (1048)
                      .++|++.+.||+|+||.||+|.+.+      +..||+|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578889999999999999998642      3689999987543 33445788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccccC------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEe
Q 001591          839 LLIYSYMENGSLDYWLHESVD------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLA  912 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  912 (1048)
                      ++||||+++|+|.+++.....      ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            999999999999999865432      123478999999999999999999985   99999999999999999999999


Q ss_pred             ecccccccCCCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhh
Q 001591          913 DFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       913 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      |||+++........ ......++..|+|||...+..++.++||||||+++||+++ |+.||....   ......+..   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~~---  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVLKFVI---  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHHHHHHh---
Confidence            99999865432211 1223456789999999988889999999999999999998 999986322   222222221   


Q ss_pred             cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                       .......         +...+.++.+++.+|++.+|++|||+.++++.|++
T Consensus       236 -~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 -DGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -cCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence             1111111         11124478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-34  Score=322.51  Aligned_cols=240  Identities=26%  Similarity=0.340  Sum_probs=190.9

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      ++||+|+||.||+|++. +|+.||+|+++...   ......+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999876 68899999987542   12234466777777754 899999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++..... ...
T Consensus        81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  152 (316)
T cd05620          81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence            999988864    34588999999999999999999986   9999999999999999999999999998753221 222


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||....   .......+..   ..  ..         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~~---~~--~~---------~  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIRV---DT--PH---------Y  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHh---CC--CC---------C
Confidence            345689999999999999999999999999999999999999996421   1222221111   10  00         0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIE-EVV 1037 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~-evl 1037 (1048)
                      +.....++.+++.+|++.||++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111234688999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.6e-34  Score=317.68  Aligned_cols=265  Identities=27%  Similarity=0.407  Sum_probs=206.6

Q ss_pred             hcCCcccCeEeccCceEEEEEEECC-----------------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceee
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTN-----------------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS  827 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  827 (1048)
                      .++|++.+.||+|+||.||+|....                 +..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999997642                 2458999987653 334567899999999999999999


Q ss_pred             ecceEeeCCcEEEEEEeccCCChhhhcccccC-------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCc
Q 001591          828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN  900 (1048)
Q Consensus       828 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  900 (1048)
                      +++++..++..++|+||+++++|.+++.....       ....+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999875431       123689999999999999999999986   99999999999


Q ss_pred             eEECCCCcEEEeecccccccCCCCC-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc--CCCCCcccCCC
Q 001591          901 ILLDEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGK  977 (1048)
Q Consensus       901 Ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--g~~P~~~~~~~  977 (1048)
                      |+++.++.++++|||+++....... .......+++.|+|||...+..++.++||||||+++|||++  |..||....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence            9999999999999999986543221 12233456789999999988889999999999999999998  777875322  


Q ss_pred             CchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          978 NCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                       ..+..................      ..+...+.++.+++.+|++.+|++|||+.|++++|++
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         239 -DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence             222222222221111111000      1111233579999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=320.65  Aligned_cols=256  Identities=26%  Similarity=0.387  Sum_probs=210.8

Q ss_pred             cCCcccCeEeccCceEEEEEEECC---Cc--EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN---GT--KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~---~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      +.....+.||+|-||.||+|.+.+   |+  .||||..+.++ ....+.|..|..+|+.++|||||+++|+|.+. ..|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            445567889999999999998653   33  58899888754 45567799999999999999999999999864 6899


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      |||.++-|.|..|++..   ...++......++.|+..|++|||+-   .+|||||..+|||+.+...||++|||+++.+
T Consensus       468 vmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence            99999999999999863   45688899999999999999999985   9999999999999999999999999999987


Q ss_pred             CCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ....-+..+...-..-|||||-+.-.++|.++|||.|||++||++. |..||.+.....                ..-.+
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~i  605 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHI  605 (974)
T ss_pred             cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEe
Confidence            6544333332233458999999999999999999999999999988 999997643221                11112


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                      ...-..+.++.++..++.++.+||..+|.+||.+.|+...|+++.+
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            2222334556677789999999999999999999999999987754

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-34  Score=323.82  Aligned_cols=257  Identities=23%  Similarity=0.328  Sum_probs=203.2

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-C-----CceeeecceEeeCCcEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-H-----KNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  840 (1048)
                      +|++.++||+|+||.|-+|.+. +++.||||+++.. ..-.++...|+.+|..++ |     -|+|+++++|...++.++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7999999999999999999765 7999999999865 334455678999999997 4     479999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC--CCcEEEeeccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE--KFEAHLADFGLSR  918 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfg~a~  918 (1048)
                      |+|.++. +|.+++...  ....++...++.|+.||+.||.+||..   +|||+||||+|||+.+  ...+||+|||.|.
T Consensus       266 VfELL~~-NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eehhhhh-hHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999855 899999875  455699999999999999999999987   9999999999999964  3479999999999


Q ss_pred             ccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc----
Q 001591          919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR----  994 (1048)
Q Consensus       919 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----  994 (1048)
                      +....    ...++-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+   +...+.+..+.+.....+    
T Consensus       340 ~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG---~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  340 FESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG---DNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             ccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC---CCHHHHHHHHHHHhCCCCHHHH
Confidence            75422    2256788999999999999999999999999999999999887754   333444433333222000    


Q ss_pred             -----ccccccc---------------------------------------ccCchh-hHHHHHHHHHHHHHcccCCCCC
Q 001591          995 -----EVEIIDA---------------------------------------SIWHKD-REKQLLEMLEIACKCIDQDPRR 1029 (1048)
Q Consensus       995 -----~~~~~~~---------------------------------------~~~~~~-~~~~~~~l~~li~~cl~~~P~~ 1029 (1048)
                           ....++.                                       .-+... .......+.+++++|+.+||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                 0011111                                       000001 1133457899999999999999


Q ss_pred             CCCHHHHHH
Q 001591         1030 RPFIEEVVT 1038 (1048)
Q Consensus      1030 RPt~~evl~ 1038 (1048)
                      |+|..|+++
T Consensus       493 R~tp~qal~  501 (586)
T KOG0667|consen  493 RITPAQALN  501 (586)
T ss_pred             cCCHHHHhc
Confidence            999999986

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.8e-34  Score=320.95  Aligned_cols=265  Identities=26%  Similarity=0.395  Sum_probs=203.6

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999876 68889999887543 33445688999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++..    ...+++..+..++.|+++||+|||+.  .+++||||||+||+++.++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            999999999864    34588999999999999999999972  38999999999999999999999999998764322 


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc--------
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV--------  996 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--------  996 (1048)
                        ......|++.|+|||...+..++.++||||||+++|||++|+.||.....   .....+...........        
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA---KELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch---hhHHHhhcCccccccccCCcccccC
Confidence              22345789999999998888899999999999999999999999863221   11111110000000000        


Q ss_pred             ------------c----ccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          997 ------------E----IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       997 ------------~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                                  +    ................++.+++.+|++.+|++||++.|+++  ++.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                        0    00000000000013446899999999999999999999987  55543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-34  Score=313.83  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=200.6

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEe-eCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR-HGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  845 (1048)
                      ++|++.+.||+|+||.||+|... |..||+|.+..+.  ..+.+.+|+.++++++|+|++++++++. .++..++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999876 8889999987543  3456889999999999999999999764 456789999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+++...... 
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999998753  234588999999999999999999986   99999999999999999999999999987643221 


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                         ....++..|+|||+..+..++.++||||||+++|||++ |+.||....   ..+...++.   . .....       
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~---~-~~~~~-------  219 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVE---K-GYKMD-------  219 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHh---c-CCCCC-------
Confidence               12344668999999998899999999999999999997 999986321   112222211   1 11111       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                        .....+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              1112234788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.2e-34  Score=313.06  Aligned_cols=251  Identities=24%  Similarity=0.444  Sum_probs=202.2

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      .+|++.+.||+|+||.||+|.+.++..+|+|++.... ....++.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4678889999999999999988778899999887543 234568999999999999999999999999999999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +++|.+++...   ...++++.+..++.+++.|++|||+.   +++||||||+||+++.++.++|+|||.+.........
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999988642   34578999999999999999999986   9999999999999999999999999998765432221


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......++.+|+|||...+..++.++||||+|+++|||++ |+.||....   .........    ..  .....+..  
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~----~~--~~~~~~~~--  225 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVETIN----AG--FRLYKPRL--  225 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHh----CC--CCCCCCCC--
Confidence            1222345678999999988899999999999999999998 999986321   112222111    10  01111111  


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 1040 (1048)
                           .+..+.+++.+|++.+|++||++.|++++|
T Consensus       226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 234789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=323.83  Aligned_cols=254  Identities=24%  Similarity=0.282  Sum_probs=195.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999876 68999999986421   223345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999998642   34588999999999999999999986   999999999999999999999999999976543


Q ss_pred             CCCceeecccccccccCccccCc-----CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE  997 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1048)
                      ..........||+.|+|||++..     ..++.++||||+||++|||++|+.||....   ..+...   ..........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---~~~~~~---~i~~~~~~~~  228 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYG---KIMNHKEHFQ  228 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC---HHHHHH---HHHcCCCccc
Confidence            33322333579999999998763     457889999999999999999999996421   111111   1111111111


Q ss_pred             ccccccCchhhHHHHHHHHHHHHHcccCCC--CCCCCHHHHHH
Q 001591          998 IIDASIWHKDREKQLLEMLEIACKCIDQDP--RRRPFIEEVVT 1038 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P--~~RPt~~evl~ 1038 (1048)
                      ...      .....+..+.+++.+|+..++  ..||++.++++
T Consensus       229 ~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         229 FPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             CCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            100      011133467888888775533  34789999886

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-34  Score=311.52  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=198.4

Q ss_pred             CeEeccCceEEEEEEECC----CcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLTN----GTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||.||+|.+..    +..||+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997642    26899999885543 34567899999999999999999999876 4568999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++...    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999998743    3689999999999999999999986   99999999999999999999999999998764433222


Q ss_pred             eec--ccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          928 TTD--LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       928 ~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ...  ..++..|+|||...+..++.++||||||+++|||++ |++||....+   .+...++....   . .        
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~---~-~--------  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGE---R-L--------  217 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCC---c-C--------
Confidence            211  123467999999998899999999999999999998 9999964321   22222222111   0 0        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                       ..+...+..+.+++.+|+..+|++||++.++++.|+++.
T Consensus       218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             011122347889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=351.95  Aligned_cols=466  Identities=25%  Similarity=0.295  Sum_probs=313.3

Q ss_pred             cEEEEEecCCCCccccCccccCCcCCCeEecCCCCCCCCCCccccCCCCccEEeccCCcccCcccccccccccccEEEec
Q 001591           83 RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVS  162 (1048)
Q Consensus        83 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls  162 (1048)
                      +++.|++.+|-+-...-+.+..--+|+.||||+|++. ..|..+..+.+|+.|+++.|.|...+ .....+.+|++|+|.
T Consensus        22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp-~s~~~~~~l~~lnL~   99 (1081)
T KOG0618|consen   22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVP-SSCSNMRNLQYLNLK   99 (1081)
T ss_pred             HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCc-hhhhhhhcchhheec
Confidence            3677777777654432234444455999999999987 66888889999999999999988654 677888999999999


Q ss_pred             CcccCCccccccccCcccEEEecCccccCccchhhhhcccccceEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCC
Q 001591          163 SNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLP  242 (1048)
Q Consensus       163 ~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p  242 (1048)
                      +|.+...|..+..+.+|++|++|+|++. .+|. ....++.++.++.++|....   .++.. .++.+++..|.+.+.++
T Consensus       100 ~n~l~~lP~~~~~lknl~~LdlS~N~f~-~~Pl-~i~~lt~~~~~~~s~N~~~~---~lg~~-~ik~~~l~~n~l~~~~~  173 (1081)
T KOG0618|consen  100 NNRLQSLPASISELKNLQYLDLSFNHFG-PIPL-VIEVLTAEEELAASNNEKIQ---RLGQT-SIKKLDLRLNVLGGSFL  173 (1081)
T ss_pred             cchhhcCchhHHhhhcccccccchhccC-CCch-hHHhhhHHHHHhhhcchhhh---hhccc-cchhhhhhhhhcccchh
Confidence            9999999999999999999999999987 4443 34456677778888882211   11111 16677777777777666


Q ss_pred             ccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCC
Q 001591          243 DSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK  322 (1048)
Q Consensus       243 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~  322 (1048)
                      .++..+..  .|+|++|.+.   --.+.++.+|+.|....|+++...    -.-++|+.|+.++|.+....+.  ..-.+
T Consensus       174 ~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--p~p~n  242 (1081)
T KOG0618|consen  174 IDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--PVPLN  242 (1081)
T ss_pred             cchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--ccccc
Confidence            66666555  5777777765   123445555555555555554211    1223444444444444421111  11234


Q ss_pred             CcEEEecCccccCccCcccccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccC
Q 001591          323 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN  402 (1048)
Q Consensus       323 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  402 (1048)
                      |+++++++|++++.+ ..++.+.+|+.|+..+|+|+ .+|..+...++|+.|++.+|.++ -+|.....++.|+.|+|..
T Consensus       243 l~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~  319 (1081)
T KOG0618|consen  243 LQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQS  319 (1081)
T ss_pred             ceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehh
Confidence            445555555544333 44444445555555555443 34444444444444444444444 3344444444444444444


Q ss_pred             CcCCCCcCccc-----------------------ccccccccceEecccCccCCCCCccccCCCcCcEEEccCCcccCCc
Q 001591          403 NSFNHLSGTLS-----------------------VLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHI  459 (1048)
Q Consensus       403 N~l~~l~~~~~-----------------------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~  459 (1048)
                      |++..+|..+.                       .=..++.|+.|.+.+|.+++..-..+.+++.|+.|+|++|+|....
T Consensus       320 N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fp  399 (1081)
T KOG0618|consen  320 NNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFP  399 (1081)
T ss_pred             ccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCC
Confidence            44444443110                       1123567899999999999998889999999999999999999666


Q ss_pred             hHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCcccccCCcchhhhhhhhccCCCCCCCCCCCCccceeec
Q 001591          460 PVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH  539 (1048)
Q Consensus       460 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~  539 (1048)
                      ...+.++..|++|+||+|+++ .+|..+..+..|+.|...+|.+. ..| .+..++.|                      
T Consensus       400 as~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL----------------------  454 (1081)
T KOG0618|consen  400 ASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQL----------------------  454 (1081)
T ss_pred             HHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcc----------------------
Confidence            678899999999999999999 89999999999999999999998 455 66666555                      


Q ss_pred             cccCCCcCCCCCCCCCCeeeeecCcccccCCccccCCCCCcEEEccCceecccCCcccccccCccEeeCCCC
Q 001591          540 NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN  611 (1048)
Q Consensus       540 ~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N  611 (1048)
                                      +.+|+|.|+++...-++.-.-++|++|||++|.=.-.--+.|..+.++...+++-|
T Consensus       455 ----------------~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  455 ----------------KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             ----------------eEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence                            56899999999654333333389999999999733244567788888888888877

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.8e-34  Score=314.86  Aligned_cols=257  Identities=25%  Similarity=0.352  Sum_probs=204.7

Q ss_pred             cCCcccCeEeccCceEEEEEEECC----CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      ++|.+.+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457888999999999999998653    2468999887654 4455678999999999999999999998875 457899


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++|+|.+++...   ...+++..+..++.+++.|++|||+.   +++||||||+||+++.++.++++|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999998653   33589999999999999999999986   99999999999999999999999999998654


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ...........++..|+|||.+....++.++||||||+++||+++ |+.||.....   .+...++..   ....     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~---~~~~-----  227 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIEN---GERL-----  227 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHc---CCcC-----
Confidence            332222223345568999999988889999999999999999986 9999964321   122222111   1100     


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                           ..+...+..+.+++.+|+..+|.+|||+.++++.|+++..+
T Consensus       228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                 01112234789999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.4e-34  Score=315.56  Aligned_cols=255  Identities=26%  Similarity=0.347  Sum_probs=201.6

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+....   ......+..|+.++++++|++|+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999876 68899999886432   2223457789999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++++|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++......
T Consensus        81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999888543  234588999999999999999999985   9999999999999999999999999998765322


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ..  .....|+..|+|||++.+..++.++||||+|+++|||++|+.||....................         .  
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~--  222 (285)
T cd05630         156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---------E--  222 (285)
T ss_pred             cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------h--
Confidence            21  2234789999999999999999999999999999999999999975322111111111100000         0  


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH--HHHh
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDG 1042 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~--~L~~ 1042 (1048)
                        ........++.+++.+|++.||++||+     +.|+++  ++.+
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence              011122346889999999999999999     888886  5543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.9e-34  Score=322.06  Aligned_cols=241  Identities=24%  Similarity=0.317  Sum_probs=193.6

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||+||+|++. ++..||+|+++...   ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 57899999987542   22334567888888888 699999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  152 (318)
T cd05570          81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT  152 (318)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence            999888764    34689999999999999999999986   99999999999999999999999999987532211 22


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+   .....           ..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i---~~~~~-----------~~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSI---LEDEV-----------RY  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHH---HcCCC-----------CC
Confidence            234579999999999999999999999999999999999999996422   11221111   11110           00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFI-----EEVVT 1038 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~ 1038 (1048)
                      +.....++.+++.+|++.||++||++     .++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            11223478899999999999999999     87765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-34  Score=318.57  Aligned_cols=260  Identities=23%  Similarity=0.383  Sum_probs=203.6

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCc
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  837 (1048)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567999999999999999999754      24589999876443 2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccccC------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEE
Q 001591          838 RLLIYSYMENGSLDYWLHESVD------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  911 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  911 (1048)
                      .++||||+++|+|.+++.....      .....++..+..++.|++.|++|||+.   +|+||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999975321      124467788999999999999999986   9999999999999999999999


Q ss_pred             eecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHh
Q 001591          912 ADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM  989 (1048)
Q Consensus       912 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~  989 (1048)
                      +|||+++......... .....++..|+|||...+..++.++|||||||++|||++ |..||....   ..+....+.  
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~--  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---NEQVLKFVM--  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH--
Confidence            9999998653322111 112245678999999988899999999999999999998 788986422   112222111  


Q ss_pred             hcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          990 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                       ... ...         .+......+.+++.+|++.+|++||++.++++.|++.
T Consensus       236 -~~~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         236 -DGG-YLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -cCC-CCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence             110 000         0112234799999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-34  Score=319.71  Aligned_cols=262  Identities=25%  Similarity=0.405  Sum_probs=202.8

Q ss_pred             cCCcccCeEeccCceEEEEEEE-----CCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcE
Q 001591          767 NNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDR  838 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  838 (1048)
                      +-|++.+.||+|+||.||+|.+     .++..||+|.++... ......+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478889999999999999974     257899999987543 34446789999999999999999999998775  567


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999998642   23589999999999999999999985   99999999999999999999999999998


Q ss_pred             ccCCCCCc--eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------CCchhHHHHHHH
Q 001591          919 LLRPYDTH--VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKG--------KNCRDLVSWVFQ  988 (1048)
Q Consensus       919 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~--------~~~~~~~~~~~~  988 (1048)
                      ........  ......++..|+|||+..+..++.++||||||+++|||++++.|......        ............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76433221  12234567789999998888899999999999999999998776432110        000000111111


Q ss_pred             hhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ......         ..+.....+.++.+++.+|++.+|++||++.++++.|+++
T Consensus       238 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111100         0011112345799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-35  Score=325.18  Aligned_cols=245  Identities=24%  Similarity=0.392  Sum_probs=196.2

Q ss_pred             cccCeEeccCceEEEEEEEC-CCcEEEEEEec----CCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCc--EEEEE
Q 001591          770 NQANIIGCGGFGLVYKATLT-NGTKAAVKRLS----GDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND--RLLIY  842 (1048)
Q Consensus       770 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  842 (1048)
                      +...+||+|+|-+||+|.+. +|..||--.++    ...+...+.|..|+++++.++||||++++.+|.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44668999999999999876 67777743222    1123444679999999999999999999999987765  67899


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-CCCcEEEeecccccccC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~a~~~~  921 (1048)
                      |.|..|+|..|..++    +.........|++||++||.|||++ +|+|+|||||-+||+++ ..|.|||+|+|+|....
T Consensus       123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999998754    4577889999999999999999998 89999999999999997 56899999999999875


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ....   ..++|||.|||||+.. ..|+..+||||||++++||+|+..||..|...  .++...+....+......+.| 
T Consensus       198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGiKP~sl~kV~d-  270 (632)
T KOG0584|consen  198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGIKPAALSKVKD-  270 (632)
T ss_pred             cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCCCHHHhhccCC-
Confidence            4332   2369999999999888 68999999999999999999999999765532  122222222222222222222 


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                                 .++.++|.+|+.. .++|||+.|+++
T Consensus       271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 -----------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence                       2789999999999 999999999986

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.6e-35  Score=327.05  Aligned_cols=238  Identities=25%  Similarity=0.311  Sum_probs=192.1

Q ss_pred             CeEeccCceEEEEEEE----CCCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          773 NIIGCGGFGLVYKATL----TNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999975    3678999999875432  223456789999999999999999999999999999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +|+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++...... .
T Consensus        82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~  153 (318)
T cd05582          82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K  153 (318)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence            9999988863    34689999999999999999999986   99999999999999999999999999998654322 2


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCch
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....   ..+....   ......           .
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~---i~~~~~-----------~  216 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTM---ILKAKL-----------G  216 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHH---HHcCCC-----------C
Confidence            2334679999999999998889999999999999999999999996422   1111211   111110           0


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 001591         1007 DREKQLLEMLEIACKCIDQDPRRRPFIEE 1035 (1048)
Q Consensus      1007 ~~~~~~~~l~~li~~cl~~~P~~RPt~~e 1035 (1048)
                      .+......+.+++.+|++.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            11122346889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-34  Score=321.68  Aligned_cols=268  Identities=22%  Similarity=0.342  Sum_probs=203.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56889999999999999999876 68899999987443 22334577899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      ++ ++|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 5888877642   34578999999999999999999986   99999999999999999999999999997643222


Q ss_pred             CceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc---ccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK---REVEIID 1000 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 1000 (1048)
                       .......+++.|+|||++.+ ..++.++|||||||++|||++|++||.....   .+....+.......   ......+
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCChhhchhhhc
Confidence             12223467889999998765 4578899999999999999999999964321   22222222111110   0000000


Q ss_pred             ---------cccCc----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCc
Q 001591         1001 ---------ASIWH----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus      1001 ---------~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~ 1045 (1048)
                               +....    .........+.+++.+|++.||.+|||++|+++  +++.++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                     00000    011123446889999999999999999999997  6665553

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.4e-34  Score=318.60  Aligned_cols=260  Identities=24%  Similarity=0.308  Sum_probs=194.2

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeeecceEeeC-----C
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRA---QHKNLVSLQGYCRHG-----N  836 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~  836 (1048)
                      +|++.+.||+|+||+||+|+.. +++.||+|.++....  .....+.+|+++++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788999999999999999876 688999998875321  1223456677777665   699999999988642     3


Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccc
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..++||||+++ +|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            57899999985 788877643  234589999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ++......  ......||+.|+|||++.+..++.++||||+||++|||++|++||.....   .+....+..........
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIGLPPED  229 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH---HHHHHHHHHHhCCCChh
Confidence            98654221  22345789999999999888999999999999999999999999964321   12222222211100000


Q ss_pred             c----------cccccc---CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 E----------IIDASI---WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~----------~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .          ...+..   ..........++.+++.+|++.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0          000000   00111223457889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.9e-35  Score=327.14  Aligned_cols=237  Identities=25%  Similarity=0.337  Sum_probs=187.7

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHH-HHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVE-ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||+||+|+.. +|+.||+|++.....   .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999876 789999999875321   12233444544 56789999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~  152 (323)
T cd05575          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT  152 (323)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence            999988864    34688999999999999999999986   9999999999999999999999999998753221 222


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+....   ......  .     .    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~---i~~~~~--~-----~----  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDN---ILNKPL--R-----L----  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHH---HHcCCC--C-----C----
Confidence            334579999999999999999999999999999999999999996421   1111111   111100  0     0    


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIE 1034 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~ 1034 (1048)
                      .......+.+++.+|++.||++||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            111234688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.2e-34  Score=312.58  Aligned_cols=240  Identities=24%  Similarity=0.417  Sum_probs=189.3

Q ss_pred             CeEeccCceEEEEEEECC-------------CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEE
Q 001591          773 NIIGCGGFGLVYKATLTN-------------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  839 (1048)
                      +.||+|+||.||+|++.+             ..+||+|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998542             2368999887655555567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCc-------EEEe
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-------AHLA  912 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~kl~  912 (1048)
                      +||||+++|+|..++..   ....+++..+.+++.|+++|++|||+.   +|+||||||+||+++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999888764   234589999999999999999999985   9999999999999986654       8999


Q ss_pred             ecccccccCCCCCceeecccccccccCccccC-cCCCCchhhhHHHHHHHHHHH-cCCCCCcccCCCCchhHHHHHHHhh
Q 001591          913 DFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELL-TGRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       913 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~ell-tg~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      |||.+......     ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+    ..   ...
T Consensus       155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~---~~~  222 (262)
T cd05077         155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KE---RFY  222 (262)
T ss_pred             CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HH---HHH
Confidence            99998764322     2346788999999876 567899999999999999998 5888875322111    00   011


Q ss_pred             cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      ...  ...     ..    ....++.+++.+||+.||++||++.++++.++
T Consensus       223 ~~~--~~~-----~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQ--CML-----VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcC--ccC-----CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            100  000     00    11246889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.4e-34  Score=312.44  Aligned_cols=250  Identities=22%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      +|++.+.||+|+||.||++... ++..||+|.++... ....+.+..|+.+++.++||||+++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999876 68899999986432 334566888999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|.+++...  ....+++..+..++.|++.|++|||+.   +|+|+||||+||++++++.++++|||.+...... .
T Consensus        81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~  154 (255)
T cd08219          81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-G  154 (255)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc-c
Confidence            999998887643  344578999999999999999999986   9999999999999999999999999999765432 2


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      .......|++.|+|||+..+..++.++|+||||+++|+|++|+.||....   .....   ...... ....        
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~---~~~~~~-~~~~--------  219 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLI---LKVCQG-SYKP--------  219 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHH---HHHhcC-CCCC--------
Confidence            22234578999999999999899999999999999999999999996421   11111   111111 1100        


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1039 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 1039 (1048)
                       .+......+.+++.+|++.+|++||++.|++..
T Consensus       220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             111233468899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-34  Score=315.05  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=203.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CC---cEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NG---TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      .+|++.+.||+|+||.||+|.+. ++   ..||+|++.... .....+|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35788999999999999999875 33   369999987543 33456799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++++|.+++...   ...+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999988653   34589999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCCce--eeccc--ccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          922 PYDTHV--TTDLV--GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       922 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ......  .....  .+..|+|||...+..++.++||||+|+++|||++ |..||....   ..+...++....   .. 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i~~~~---~~-  230 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAIEQDY---RL-  230 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCC---cC-
Confidence            322211  11111  2457999999999999999999999999999887 999986422   122233221110   00 


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                               +.+.+.+..+.+++.+|++.+|.+||++.+++..|+++
T Consensus       231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         231 ---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     01112334688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=292.41  Aligned_cols=270  Identities=24%  Similarity=0.382  Sum_probs=215.6

Q ss_pred             cHHHHHHhhcCCcccCeEeccCceEEEEEE-ECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeeecceEeeC
Q 001591          758 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHG  835 (1048)
Q Consensus       758 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  835 (1048)
                      ++.|+.+-+     .+.||+|+|+.|.-+. ..+|.+||||++.+..+.....+.+|++++...+ |+||++++++|+++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            466776666     4579999999999996 5689999999999988888889999999999995 99999999999999


Q ss_pred             CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC---CcEEEe
Q 001591          836 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK---FEAHLA  912 (1048)
Q Consensus       836 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~  912 (1048)
                      +.+|+|||-|.||.|..++++    ...+++.++.++.++|+.||.|||.   +||+|||+||+|||..+.   ..+||+
T Consensus       149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence            999999999999999888874    5578999999999999999999998   599999999999999654   448999


Q ss_pred             ecccccccCCCC------CceeecccccccccCccccC-----cCCCCchhhhHHHHHHHHHHHcCCCCCccc-------
Q 001591          913 DFGLSRLLRPYD------THVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVC-------  974 (1048)
Q Consensus       913 Dfg~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~P~~~~-------  974 (1048)
                      ||.++.-.....      +....+-+|+..|||||+..     ...|++++|.||+|||+|-|++|++||.+.       
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            999876532111      11122348999999999643     346889999999999999999999999753       


Q ss_pred             -CCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCc
Q 001591          975 -KGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       975 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~ 1045 (1048)
                       +++.++......+....++.. ++.|.+     -...+.+..+++...+..|+.+|-++.+++.  +...+.+
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence             234455555555555544332 222221     2244567889999999999999999999987  5555543

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.1e-34  Score=316.37  Aligned_cols=261  Identities=27%  Similarity=0.398  Sum_probs=203.1

Q ss_pred             HHHHHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEe---
Q 001591          759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCR---  833 (1048)
Q Consensus       759 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---  833 (1048)
                      ++++..+.++|++.+.||+|+||.||+|... +++.+|+|++.... ....++.+|+.+++++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4455567789999999999999999999875 68899999886532 2345678899999999 6999999999874   


Q ss_pred             --eCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEE
Q 001591          834 --HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  911 (1048)
Q Consensus       834 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  911 (1048)
                        .++..++||||+++++|.+++.........+++..+..++.|+++|+.|||+.   +++||||||+||++++++.+++
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence              34568999999999999998765443456789999999999999999999986   9999999999999999999999


Q ss_pred             eecccccccCCCCCceeecccccccccCccccC-----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001591          912 ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  986 (1048)
Q Consensus       912 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~  986 (1048)
                      +|||+++....... ......|++.|+|||++.     +..++.++||||+||++|||++|+.||......  ..    .
T Consensus       166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~----~  238 (286)
T cd06638         166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RA----L  238 (286)
T ss_pred             ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HH----H
Confidence            99999986543221 222347899999999875     345788999999999999999999998643211  11    1


Q ss_pred             HHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          987 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ...... ......++.       ....++.+++.+|++.+|++||++.|+++
T Consensus       239 ~~~~~~-~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~  282 (286)
T cd06638         239 FKIPRN-PPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQ  282 (286)
T ss_pred             hhcccc-CCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            111111 111111111       12336889999999999999999999986

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6e-34  Score=314.55  Aligned_cols=250  Identities=26%  Similarity=0.333  Sum_probs=198.1

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      |+..+.||+|+||+||+|.+. +++.||+|.+.....   .....+.+|++++++++|++|+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999875 788999999865432   2234578899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999887643  234689999999999999999999986   99999999999999999999999999997653221


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                        ......|+..|+|||++.+..++.++|+||+|+++|||++|+.||...........+  ........   .       
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~--~~~~~~~~---~-------  222 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--DRRVLETE---E-------  222 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhhhccc---c-------
Confidence              123457899999999998889999999999999999999999999643211111111  11111100   0       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 1038 (1048)
                       .........+.+++.+|++.+|++||+     ++++++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             011122346789999999999999999     667765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.6e-34  Score=318.21  Aligned_cols=258  Identities=29%  Similarity=0.464  Sum_probs=204.4

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  838 (1048)
                      .++|+..+.||+|+||.||+|...      ++..||+|++.... ....+++.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            357889999999999999999863      46789999987553 34456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccccC------------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCc
Q 001591          839 LLIYSYMENGSLDYWLHESVD------------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN  900 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  900 (1048)
                      ++||||+++|+|.+++.....                  ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            999999999999999864321                  123578899999999999999999985   99999999999


Q ss_pred             eEECCCCcEEEeecccccccCCCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCC
Q 001591          901 ILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN  978 (1048)
Q Consensus       901 Ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~  978 (1048)
                      |++++++.++++|||.+......... ......++..|+|||...+..++.++|||||||++|||++ |..||....   
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---  237 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---  237 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence            99999999999999998765322211 1122345668999999988899999999999999999998 888885322   


Q ss_pred             chhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          979 CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                      ..+....   ..... ...         .+...+.++.+++.+|++.+|++||++.|+++.|++
T Consensus       238 ~~~~~~~---~~~~~-~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 HEEVIYY---VRDGN-VLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHHH---HhcCC-CCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1122211   11111 100         011223478999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.6e-34  Score=310.77  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=192.6

Q ss_pred             CeEeccCceEEEEEEECC---CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCC
Q 001591          773 NIIGCGGFGLVYKATLTN---GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  848 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  848 (1048)
                      +.||+|+||.||+|.+.+   +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998653   4579999887554 334457889999999999999999999999999999999999999


Q ss_pred             ChhhhcccccC-CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          849 SLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       849 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      +|.++++.... .....++..+..++.|+++|++|||+.   +++||||||+||+++.++.+|++|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999875432 223567788899999999999999985   99999999999999999999999999997543222111


Q ss_pred             -eecccccccccCccccCcC-------CCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          928 -TTDLVGTLGYIPPEYSQTL-------TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       928 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||......   +.....  ..  ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~--~~--~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYT--VR--EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH--hh--cccCCC
Confidence             1234578899999987542       35789999999999999996 99999643211   111111  11  111111


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      .++....    .....+.+++.+|+ .+|++|||++||++.|+
T Consensus       231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111111    12336788999998 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-34  Score=325.42  Aligned_cols=240  Identities=25%  Similarity=0.311  Sum_probs=188.6

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHH-HHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEV-EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||+||+|++. +++.||+|++.....   .....+..|. .+++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 678899999875321   2223344444 456778999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~  152 (325)
T cd05602          81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT  152 (325)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence            999988864    34577888999999999999999986   99999999999999999999999999997543222 22


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|++||....   ..+....+..   .. .          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~---~~-~----------~~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILN---KP-L----------QL  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHh---CC-c----------CC
Confidence            334679999999999999999999999999999999999999996422   1222222211   10 0          00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl 1037 (1048)
                      .......+.+++.+|++.+|.+||++.+.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            112234688999999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.4e-34  Score=325.22  Aligned_cols=261  Identities=25%  Similarity=0.316  Sum_probs=196.6

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC------
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  836 (1048)
                      .++|++.+.||+|+||.||+|... +|..||+|++....  ......+.+|+.+++.++||||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999875 68999999987432  334456789999999999999999999986543      


Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccc
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..++||||+++ ++.+.++.      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence            46999999976 45554432      378889999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh------
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK------  990 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~------  990 (1048)
                      ++....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....   .+....+....      
T Consensus       170 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         170 ARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH---IDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             cccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCcHH
Confidence            976432  2223345789999999999999999999999999999999999999974321   11111111000      


Q ss_pred             -------------ccccc-c-----cccccccC---chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHH
Q 001591          991 -------------SEKRE-V-----EIIDASIW---HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1041 (1048)
Q Consensus       991 -------------~~~~~-~-----~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~ 1041 (1048)
                                   ..... .     +.......   .........++.+++.+|++.||++|||+.|+++  ++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence                         00000 0     00000000   0001112346889999999999999999999997  554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2e-34  Score=316.41  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=198.4

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEeeC------C
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHG------N  836 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~  836 (1048)
                      +.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888999999999999999876 68899999987543 3445688999999998 699999999998753      3


Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccc
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..++||||+++++|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence            578999999999999988753  234688999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccccccccCccccC-----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhc
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS  991 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~  991 (1048)
                      +........ ......|++.|+|||++.     +..++.++||||+||++|||++|+.||.....     .... .....
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----~~~~-~~~~~  230 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----MRAL-FLIPR  230 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----HHHH-HHHhc
Confidence            986543222 223457899999999875     34678899999999999999999999963221     1111 11111


Q ss_pred             ccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          992 EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       .......        ....+.++.+++.+|++.+|.+||++.|+++
T Consensus       231 -~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 -NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -CCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             1111111        1122346889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.4e-34  Score=321.38  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=201.9

Q ss_pred             cCCcccCeEeccCceEEEEEEE------CCCcEEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeeecceEeeC-Cc
Q 001591          767 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHG-ND  837 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  837 (1048)
                      ++|++.+.||+|+||.||+|.+      .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5789999999999999999974      2467899999975432 3345688999999999 689999999988654 45


Q ss_pred             EEEEEEeccCCChhhhcccccC----------------------------------------------------------
Q 001591          838 RLLIYSYMENGSLDYWLHESVD----------------------------------------------------------  859 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  859 (1048)
                      .++||||+++|+|.++++....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999998864210                                                          


Q ss_pred             -----CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc-eeecccc
Q 001591          860 -----KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVG  933 (1048)
Q Consensus       860 -----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g  933 (1048)
                           ....+++..+..++.|+++|++|||+.   +|+||||||+||++++++.+|++|||++......... ......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                 012478899999999999999999986   9999999999999999999999999999865332221 1122345


Q ss_pred             cccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHH
Q 001591          934 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012 (1048)
Q Consensus       934 t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      ++.|+|||...+..++.++||||||+++|||++ |..||......  .....   ... .......  +       ....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~---~~~-~~~~~~~--~-------~~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCR---RLK-EGTRMRA--P-------DYTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHH---HHh-ccCCCCC--C-------CCCC
Confidence            678999999988899999999999999999997 99998643211  11111   111 1111000  0       0112


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591         1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus      1013 ~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      .++.+++.+|++.+|++||++.|+++.|+.+-++
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            3688999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-34  Score=313.26  Aligned_cols=250  Identities=30%  Similarity=0.481  Sum_probs=195.5

Q ss_pred             CeEeccCceEEEEEEEC-CCc--EEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGT--KAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      ++||+|+||.||+|++. ++.  .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999876 343  46888887433 34456788999999999 799999999999999999999999999


Q ss_pred             CChhhhcccccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          848 GSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       848 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                      |+|.+++.....            ....+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999865321            123578999999999999999999985   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      ++........  ......+..|+|||+.....++.++||||||+++|||++ |..||....   ..+....+   .. ..
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~---~~-~~  228 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKL---PQ-GY  228 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHHHHHH---hC-CC
Confidence            9864321111  111234567999999988899999999999999999997 999996421   11222111   11 11


Q ss_pred             cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ..+         .+.....++.+++.+|++.+|.+||++.|+++.|+++
T Consensus       229 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         229 RLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            000         0111234688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.7e-34  Score=310.38  Aligned_cols=249  Identities=27%  Similarity=0.417  Sum_probs=203.7

Q ss_pred             cCCcccCeEeccCceEEEEEEECC-CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|+..+.||+|+||.||+|.+.. +..||+|.+.....  .+++.+|++++++++||||+++++++..+...++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999999874 78999999875533  567999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++..   ....+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            99999998864   245689999999999999999999986   999999999999999999999999999987643321


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......  .    ...... ....       ..
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--~----~~~~~~-~~~~-------~~  219 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--A----IFMIPN-KPPP-------TL  219 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--h----hhhhcc-CCCC-------CC
Confidence             2233468889999999998899999999999999999999999996422111  0    011100 0000       00


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..+.....++.+++.+|++.+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            112233457899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6e-34  Score=316.49  Aligned_cols=254  Identities=22%  Similarity=0.376  Sum_probs=205.8

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            67999999999999999999864 79999999997655555567889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++.+     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+........
T Consensus        99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999998853     3478899999999999999999986   999999999999999999999999999976543322


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       ......+++.|+|||...+..++.++|+|||||++|+|++|+.||.......  .    ........ ...       .
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~----~~~~~~~~-~~~-------~  235 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--A----LYLIATNG-TPE-------L  235 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--h----eeeeccCC-CCC-------C
Confidence             2233478899999999998889999999999999999999999996422111  0    00000000 000       0


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      ..+......+.+++.+|++.+|++||+++++++  +++..
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence            011223346789999999999999999999997  65543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.6e-34  Score=308.15  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=200.4

Q ss_pred             CeEeccCceEEEEEEECC--C--cEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLTN--G--TKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  3  3699999987665 566789999999999999999999999988 888999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      ++|.+++.....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++.........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999876421  4689999999999999999999985   99999999999999999999999999998765432211


Q ss_pred             --eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          928 --TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       928 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                        .....++..|+|||...+..++.++||||||+++|||++ |+.||.....   .+....+..   .....        
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~---~~~~~--------  220 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDK---EGERL--------  220 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHh---cCCcC--------
Confidence              112457789999999999899999999999999999998 9999964321   122221111   11000        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                       ..+...+..+.+++.+|++.+|++||++.++++.|.+
T Consensus       221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence             0111223478999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-34  Score=328.50  Aligned_cols=264  Identities=21%  Similarity=0.253  Sum_probs=202.3

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC---CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ..+|++.+.||+|+||.||+|...   .+.+||+|.+...     +...+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999754   3578999987643     23568999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      |++. ++|.+++.    ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++....
T Consensus       166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9986 57877773    345689999999999999999999986   999999999999999999999999999976543


Q ss_pred             CCC-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccc---
Q 001591          923 YDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI---  998 (1048)
Q Consensus       923 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  998 (1048)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..+............   
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            322 2223467999999999999999999999999999999999999999764433322222222222111100000   


Q ss_pred             --------------cccccC-chh--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 001591          999 --------------IDASIW-HKD--REKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus       999 --------------~~~~~~-~~~--~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~ 1042 (1048)
                                    ..+... ...  ......++.+++.+|++.||++||++.|++.  ++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence                          000000 000  0012346788999999999999999999987  5544

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.4e-37  Score=334.08  Aligned_cols=365  Identities=25%  Similarity=0.351  Sum_probs=244.2

Q ss_pred             CcCCCeEecCCCCCC-CCCCccccCCCCccEEeccCCcccCcccccccccccccEEEecCcccCCccccccccCcccEEE
Q 001591          105 LNQLKLLDLSCNHLE-GVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFN  183 (1048)
Q Consensus       105 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~  183 (1048)
                      |+..+-.|+|+|.++ +..|.....+++++.|.|...++. .+|..++.+.+|++|.+++|++..+-.++..++.|+.+.
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~   84 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVI   84 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHh
Confidence            334444455555554 344555555555555555555544 334455555555555555555555555566666666666


Q ss_pred             ecCcccc-CccchhhhhcccccceEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCC
Q 001591          184 ISNNSFT-GKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS  262 (1048)
Q Consensus       184 Ls~n~l~-~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  262 (1048)
                      +..|++. ..+|..+| .++.|+.||||+|+++..|.++...+++-.|+|++|+|..+.-.-|-++..|-.||||+|++.
T Consensus        85 ~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe  163 (1255)
T KOG0444|consen   85 VRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE  163 (1255)
T ss_pred             hhccccccCCCCchhc-ccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence            6666665 34666666 467888888888888888888888888888888888888554445667888888888888887


Q ss_pred             cchhhhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCccc-CCCCcccccCCCCcEEEecCccccCccCccc
Q 001591          263 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS-GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNF  341 (1048)
Q Consensus       263 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  341 (1048)
                       .+|..+..|..|++|.|++|.+...--..+..+++|+.|.+++.+=+ ..+|.++..+.+|..+|||.|.+. ..|.++
T Consensus       164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl  241 (1255)
T KOG0444|consen  164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL  241 (1255)
T ss_pred             -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence             66777888888888888888776443444555677777777775433 466777777777888888887777 566677


Q ss_pred             ccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCcCccccccccccc
Q 001591          342 SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNL  421 (1048)
Q Consensus       342 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L  421 (1048)
                      -++.+|+.|+||+|+|+ .+....+.-.+|++|+||+|+++ .+|+.+.+++.|+.|++.+|+++.              
T Consensus       242 y~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F--------------  305 (1255)
T KOG0444|consen  242 YKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF--------------  305 (1255)
T ss_pred             hhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc--------------
Confidence            77777777888888777 44445555667777777777777 677777777777777777777642              


Q ss_pred             ceEecccCccCCCCCccccCCCcCcEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCC
Q 001591          422 TTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN  501 (1048)
Q Consensus       422 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  501 (1048)
                                 +-+|+.++.+..|+.+..++|.+. .+|+.++++.+|+.|.|++|++. .+|++|.-++.|+.|||..|
T Consensus       306 -----------eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN  372 (1255)
T KOG0444|consen  306 -----------EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLREN  372 (1255)
T ss_pred             -----------cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCC
Confidence                       234555556666666666666655 55666666666666666666665 56666666666666666666


Q ss_pred             c
Q 001591          502 T  502 (1048)
Q Consensus       502 ~  502 (1048)
                      .
T Consensus       373 p  373 (1255)
T KOG0444|consen  373 P  373 (1255)
T ss_pred             c
Confidence            5

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.5e-34  Score=315.21  Aligned_cols=263  Identities=22%  Similarity=0.291  Sum_probs=197.7

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|++.+.||+|++|.||+|+.. ++..||+|++....  ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999876 68999999986432  22345688899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      ++ ++|.+++.... ....+++..+..++.|+++||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 58888876432 235689999999999999999999986   99999999999999999999999999997654322


Q ss_pred             CceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc--c-------
Q 001591          925 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK--R-------  994 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~-------  994 (1048)
                       .......+++.|+|||++.+ ..++.++||||||+++|||++|++||.....  ...............  .       
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE--IDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCChhhhhcchhh
Confidence             12223467889999998765 4578999999999999999999999964221  111111100000000  0       


Q ss_pred             --ccccccc---ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          995 --EVEIIDA---SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       995 --~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        .......   ............++.+++.+|++.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              0000000   0000001113457789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4e-34  Score=321.56  Aligned_cols=241  Identities=24%  Similarity=0.314  Sum_probs=192.8

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      +|+..+.||+|+||+||+|+.. +|+.||+|++....   ....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999876 68899999987542   223345677888888885 577888999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            99999999988863    34589999999999999999999986   999999999999999999999999999875432


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .. .......||+.|+|||++.+..++.++||||+||++|||++|+.||....   .......+..   ...        
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~---~~~--------  218 (323)
T cd05615         154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIME---HNV--------  218 (323)
T ss_pred             CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHh---CCC--------
Confidence            21 12234579999999999998899999999999999999999999996422   1222222211   100        


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1033 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 1033 (1048)
                         ..+.....++.+++.+|++.+|.+|++.
T Consensus       219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               0111223467899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-34  Score=308.98  Aligned_cols=248  Identities=27%  Similarity=0.380  Sum_probs=199.0

Q ss_pred             CeEeccCceEEEEEEECCCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCChh
Q 001591          773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD  851 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  851 (1048)
                      +.||+|+||.||+|...+++.||+|++...... ....+..|++++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999998765443 4567899999999999999999999999999999999999999999


Q ss_pred             hhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCcee-ec
Q 001591          852 YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TD  930 (1048)
Q Consensus       852 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~~  930 (1048)
                      +++...   ...+++..+..++.+++.|++|||+.   +++||||||+||+++.++.++|+|||.+........... ..
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            998653   33578999999999999999999986   999999999999999999999999999986542211111 11


Q ss_pred             ccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhH
Q 001591          931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE 1009 (1048)
Q Consensus       931 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      ..++..|+|||.+.+..++.++|+||||+++|||++ |..||.....   ......+.    ...  ..       ..+.
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~~~----~~~--~~-------~~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRERIE----SGY--RM-------PAPQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHHHh----cCC--CC-------CCCc
Confidence            234567999999988899999999999999999999 8899864321   11111111    100  00       0111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591         1010 KQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus      1010 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                      ..+.++.+++.+|++.+|++||++.|+++.|++
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            233478999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6e-34  Score=319.30  Aligned_cols=260  Identities=25%  Similarity=0.406  Sum_probs=204.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC--------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCC
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  836 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  836 (1048)
                      ++|.+.+.||+|+||.||+|+..        ....||+|++.... ......+..|+++++++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46888999999999999999752        24578999887543 33445688999999999 6999999999999988


Q ss_pred             cEEEEEEeccCCChhhhcccccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001591          837 DRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  904 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~  904 (1048)
                      ..++||||+++|+|.+++.....            ....+++.++..++.|++.|++|||+.   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            99999999999999999865321            234589999999999999999999986   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhH
Q 001591          905 EKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL  982 (1048)
Q Consensus       905 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~  982 (1048)
                      +++.+|++|||.++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....   ..+.
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~~~  245 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VEEL  245 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence            99999999999998654322111 111234567999999988899999999999999999999 899986422   1122


Q ss_pred             HHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          983 VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                      ...+    .......         .+.....++.+++.+|++.+|++||++.|+++.|+++..
T Consensus       246 ~~~~----~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         246 FKLL----REGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHH----HcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            2211    1111111         111223468899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.9e-34  Score=311.88  Aligned_cols=254  Identities=23%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             HhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          764 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       764 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .+++++.....||+|+||.||+|++. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34556666778999999999999865 67889999988766666678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCcccc--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCcEEEeecccccc
Q 001591          843 SYMENGSLDYWLHESVDKDSVL--KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRL  919 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~a~~  919 (1048)
                      ||+++++|.+++....   ..+  ++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++|+|||.+..
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          85 EQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             ecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999987532   234  7888999999999999999985   9999999999999986 67999999999876


Q ss_pred             cCCCCCceeecccccccccCccccCcC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc
Q 001591          920 LRPYDTHVTTDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE  997 (1048)
Q Consensus       920 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1048)
                      ...... ......|++.|+|||+....  .++.++||||||+++|+|++|++||.......   ...+.......  .  
T Consensus       159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~--~--  230 (268)
T cd06624         159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKI--H--  230 (268)
T ss_pred             cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhcc--C--
Confidence            543221 12234688999999987654  37889999999999999999999986422111   11111100000  0  


Q ss_pred             ccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          998 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                             ...+.....++.+++.+|++.+|++|||+.|+++
T Consensus       231 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 -------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                   0111223347889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.7e-34  Score=319.81  Aligned_cols=268  Identities=21%  Similarity=0.260  Sum_probs=198.1

Q ss_pred             ccCeEecc--CceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          771 QANIIGCG--GFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       771 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      +.++||+|  +|++||++... +|+.||+|++....  ....+.+++|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35689999  78899999865 78999999987542  334456788999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999886432  33589999999999999999999986   999999999999999999999999987544321111


Q ss_pred             c------eeecccccccccCccccCc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc-----
Q 001591          926 H------VTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE-----  992 (1048)
Q Consensus       926 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----  992 (1048)
                      .      ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  ............     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccccc
Confidence            0      0112356778999998875  468899999999999999999999996432111  011000000000     


Q ss_pred             ---------cccccccc-----------------cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591          993 ---------KREVEIID-----------------ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       993 ---------~~~~~~~~-----------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                               .......+                 ..............+.+++.+|++.||++|||++|+++  ++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                     00000000                 00000111233457899999999999999999999997  676654


Q ss_pred             c
Q 001591         1045 I 1045 (1048)
Q Consensus      1045 ~ 1045 (1048)
                      .
T Consensus       315 ~  315 (327)
T cd08227         315 R  315 (327)
T ss_pred             h
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.5e-34  Score=313.04  Aligned_cols=256  Identities=23%  Similarity=0.349  Sum_probs=202.9

Q ss_pred             CCcccCeEeccCceEEEEEEECC--CcEEEEEEecCC----------chhhHHHHHHHHHHHHh-cCCCceeeecceEee
Q 001591          768 NFNQANIIGCGGFGLVYKATLTN--GTKAAVKRLSGD----------CGQMEREFQAEVEALSR-AQHKNLVSLQGYCRH  834 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  834 (1048)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999998764  688999987532          12233456778888865 799999999999999


Q ss_pred             CCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       835 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                      ++..++||||+++++|.+++.........+++..++.++.|++.|+.|||+.  .+++|+||+|+||++++++.++++||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998865444456789999999999999999999963  48999999999999999999999999


Q ss_pred             ccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          915 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       915 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      |.+.......  ......|+..|+|||...+..++.++||||||+++|||++|++||....   .....   ....... 
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~---~~~~~---~~~~~~~-  229 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN---MLSLA---TKIVEAV-  229 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC---HHHHH---HHHhhcc-
Confidence            9998754332  3344578999999999998889999999999999999999999985321   11111   1111111 


Q ss_pred             cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                      ....        ........+.+++.+|++.||++||++.|+.+++++
T Consensus       230 ~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         230 YEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             CCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            0000        011223478899999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-33  Score=317.82  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=188.4

Q ss_pred             cCeEeccCceEEEEEEEC---CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEee--CCcEEEEEEecc
Q 001591          772 ANIIGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLLIYSYME  846 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  846 (1048)
                      .+.||+|+||+||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            467999999999999865   46789999987542  23457889999999999999999998854  345789999986


Q ss_pred             CCChhhhccccc-----CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEE----CCCCcEEEeecccc
Q 001591          847 NGSLDYWLHESV-----DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLS  917 (1048)
Q Consensus       847 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfg~a  917 (1048)
                      + +|.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 7777664321     1233589999999999999999999986   99999999999999    46678999999999


Q ss_pred             cccCCCCC--ceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCC------chhHHHHHHH
Q 001591          918 RLLRPYDT--HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN------CRDLVSWVFQ  988 (1048)
Q Consensus       918 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~------~~~~~~~~~~  988 (1048)
                      +.......  .......||+.|+|||++.+ ..++.++||||+||++|||++|++||.......      ..+....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            87643221  12234678999999998876 458999999999999999999999996432110      1112222222


Q ss_pred             hhcccccccc---------------cccccCc-----hh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          989 MKSEKREVEI---------------IDASIWH-----KD----REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       989 ~~~~~~~~~~---------------~~~~~~~-----~~----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..........               .......     ..    ......++.+++.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1110000000               0000000     00    0011235789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.3e-34  Score=327.62  Aligned_cols=251  Identities=23%  Similarity=0.301  Sum_probs=195.8

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|+..+.||+|+||+||+|... +++.||+|++....   ......+.+|+.++..++||+|+++++++.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999876 68999999987432   223456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999998864    34589999999999999999999986   999999999999999999999999999875432


Q ss_pred             CCC----------------------------------ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCC
Q 001591          923 YDT----------------------------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR  968 (1048)
Q Consensus       923 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~  968 (1048)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                  0112357999999999999999999999999999999999999


Q ss_pred             CCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 001591          969 RPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF---IEEVVT 1038 (1048)
Q Consensus       969 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~ 1038 (1048)
                      +||.....   ......+.   .......+ .+.      .....++.+++.+|+. +|++|++   +.|+++
T Consensus       234 ~Pf~~~~~---~~~~~~i~---~~~~~~~~-p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSETP---QETYRKVM---NWKETLVF-PPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCCH---HHHHHHHH---cCCCceec-CCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            99964321   11111111   10100010 000      0123367788888764 9999985   666664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.1e-34  Score=313.10  Aligned_cols=239  Identities=23%  Similarity=0.385  Sum_probs=187.7

Q ss_pred             eEeccCceEEEEEEECC-------------------------CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeee
Q 001591          774 IIGCGGFGLVYKATLTN-------------------------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL  828 (1048)
Q Consensus       774 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  828 (1048)
                      .||+|+||.||+|.+..                         ...||+|++.........++.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997521                         13588998876555555678899999999999999999


Q ss_pred             cceEeeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-
Q 001591          829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-  907 (1048)
Q Consensus       829 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-  907 (1048)
                      ++++.++...++||||+++|+|..++..   ....+++..+..++.|+++||+|||+.   +|+||||||+||++++++ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999988864   244688999999999999999999985   999999999999997543 


Q ss_pred             ------cEEEeecccccccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHH-cCCCCCcccCCCCc
Q 001591          908 ------EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELL-TGRRPVEVCKGKNC  979 (1048)
Q Consensus       908 ------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~ell-tg~~P~~~~~~~~~  979 (1048)
                            .+|++|||.+......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+ 
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                  4899999998653221     12357788999998765 56899999999999999985 6999986432211 


Q ss_pred             hhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          980 RDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                        ... ....  .....            .....++.+++.+||+.+|++||++.++++.|+
T Consensus       230 --~~~-~~~~--~~~~~------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 --KER-FYEK--KHRLP------------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHH-HHHh--ccCCC------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              111 1110  00000            011236889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.6e-34  Score=314.56  Aligned_cols=252  Identities=21%  Similarity=0.384  Sum_probs=205.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .+|++.+.||.|++|.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46899999999999999999864 78999999987655555667889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++..     ..+++.++..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999998853     3589999999999999999999986   999999999999999999999999999886543322


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.....   ..   ......... ....       
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~---~~---~~~~~~~~~-~~~~-------  235 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LR---ALYLIATNG-TPEL-------  235 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH---HHHHHHhcC-Cccc-------
Confidence             12234788999999999988899999999999999999999999964221   11   111111111 0000       


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1041 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~ 1041 (1048)
                      ..+......+.+++.+|+..+|++||++.++++  +++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence            011123346889999999999999999999986  554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.9e-34  Score=323.08  Aligned_cols=192  Identities=22%  Similarity=0.318  Sum_probs=164.4

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++..+...++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999876 5778999975432      23468999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+. ++|.+++..   ....+++..+..|+.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++.....
T Consensus       138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            995 578877754   345689999999999999999999986   9999999999999999999999999999753221


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCC
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV  971 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~  971 (1048)
                        .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1223457999999999999999999999999999999999865554

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.3e-34  Score=314.29  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=203.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC------CCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  839 (1048)
                      ++|+..+.||+|+||.||+|+.+      +...||+|.+...... ....+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999864      2467999988754433 4567899999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhcccccCC-----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          840 LIYSYMENGSLDYWLHESVDK-----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                      +||||+++|+|.+++......     ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998754321     12689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccc
Q 001591          915 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK  993 (1048)
Q Consensus       915 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  993 (1048)
                      |++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....   ....+....    ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~~~~~~----~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEVLNRLQ----AG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHHHHHHH----cC
Confidence            9987543222222233456778999999888889999999999999999998 888985322   112222111    11


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          994 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      ... ..       .....+..+.+++.+|++.+|++||++.|+++.|+
T Consensus       235 ~~~-~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLE-LP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcC-CC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            100 00       01122347899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-34  Score=326.10  Aligned_cols=239  Identities=27%  Similarity=0.361  Sum_probs=188.5

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHH-HHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVE-ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||+||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999875 78999999987542   222334555554 46778999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|..++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++..... ...
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~  152 (325)
T cd05604          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT  152 (325)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence            999888763    44689999999999999999999986   9999999999999999999999999998753221 122


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+....+   .....   ..        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~---~~~~~---~~--------  215 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNI---LHKPL---VL--------  215 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHH---HcCCc---cC--------
Confidence            334579999999999999999999999999999999999999996421   11111111   11100   00        


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIEEV 1036 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~ev 1036 (1048)
                      .......+.+++.+|++.+|.+||++++.
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            01123467899999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-34  Score=314.54  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=203.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|++.+.||+|+||+||+|.+. +|..||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46788899999999999999876 68899999876443 34557789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++..    ...+++..+..++.+++.|+.|||+.  .+++||||||+||++++++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            999999988764    34689999999999999999999973  489999999999999999999999999987542211


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCC-----CchhHHHHHHHhhccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGK-----NCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                         .....|+..|+|||++.+..++.++|||||||++|||++|+.||......     .......+.........     
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  230 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-----  230 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-----
Confidence               22357899999999988889999999999999999999999999753321     11111222222211110     


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1039 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 1039 (1048)
                       +...   ......++.+++.+|++.||++||++.|+++.
T Consensus       231 -~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         231 -PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             -CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             0000   11234578999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-33  Score=307.66  Aligned_cols=250  Identities=31%  Similarity=0.481  Sum_probs=203.8

Q ss_pred             CeEeccCceEEEEEEECC----CcEEEEEEecCCchhh-HHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLTN----GTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||.||+|....    +..||+|.+....... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998763    7899999998654433 57789999999999999999999999999999999999999


Q ss_pred             CChhhhcccccCC-----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          848 GSLDYWLHESVDK-----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       848 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ++|.+++......     ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998764222     46789999999999999999999985   999999999999999999999999999987654


Q ss_pred             CCC-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          923 YDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       923 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ... .......+++.|+|||.+....++.++||||+|+++|||++ |+.||....   ..+....+..    ....    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~----~~~~----  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEYLRK----GYRL----  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHc----CCCC----
Confidence            321 12233467889999999988899999999999999999999 699997532   1222222111    1100    


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                           ..+...+.++.+++.+|++.+|++||++.|+++.|+
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 111222457899999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.6e-34  Score=316.46  Aligned_cols=263  Identities=25%  Similarity=0.414  Sum_probs=205.8

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-----CCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecceEee--CCcE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDR  838 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  838 (1048)
                      ++|+..+.||+|+||.||+|.+.     ++..||+|++...... ..+.+.+|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45778899999999999999864     3678999999865443 46779999999999999999999999877  5578


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999998753   23589999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCce--eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCch--------hHHHHHHH
Q 001591          919 LLRPYDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR--------DLVSWVFQ  988 (1048)
Q Consensus       919 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~--------~~~~~~~~  988 (1048)
                      .........  .....++..|+|||...+..++.++||||||+++|||++|+.|+.........        ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            765332211  11234556799999998889999999999999999999999998542211100        00111111


Q ss_pred             hhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      ......         ....+...+.++.+++.+|++.+|++||++.|++++|+++.
T Consensus       238 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         238 LLKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            111100         00111223357899999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-34  Score=312.69  Aligned_cols=257  Identities=24%  Similarity=0.404  Sum_probs=204.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCc----EEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      .+|++.+.||+|+||.||+|.+. +|+    .||+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56888999999999999999865 333    589998876543 345678899999999999999999999987 78899


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ||||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.++..
T Consensus        86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999998753   34589999999999999999999985   9999999999999999999999999999876


Q ss_pred             CCCCCceee-cccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          921 RPYDTHVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       921 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ......... ...++..|+|||......++.++|+||||+++||+++ |+.||.....   .+....+.   .....   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---~~~~~---  230 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLLE---KGERL---  230 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHh---CCCCC---
Confidence            543322221 1223568999999988899999999999999999998 9999964321   12222111   11100   


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      ..       +......+.+++.+|+..+|.+||++.++++.|+++...
T Consensus       231 ~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         231 PQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            00       111223678999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.1e-34  Score=312.23  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=200.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46778889999999999999865 68899999987665555566889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++..    ...+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+....... 
T Consensus        89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            99999998863    34689999999999999999999986   99999999999999999999999999987654321 


Q ss_pred             ceeecccccccccCccccC---cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          926 HVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .......|++.|+|||++.   ...++.++||||+||++|||++|+.||......  ...    ............... 
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--~~~----~~~~~~~~~~~~~~~-  233 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RAL----FLMTKSNFQPPKLKD-  233 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--hhH----HhhhccCCCCCcccc-
Confidence            1223457899999999864   456888999999999999999999998642211  111    111111100000000 


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                           ....+..+.+++.+|++.+|++||+++++++
T Consensus       234 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         234 -----KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -----cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                 0112346889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.2e-33  Score=311.43  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=201.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      +.|++.+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999999876 58899999998776666677899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|..++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+....... 
T Consensus        92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            999998877542   34589999999999999999999986   99999999999999999999999999987543221 


Q ss_pred             ceeecccccccccCccccC-----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          926 HVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      .......+++.|+|||++.     ...++.++|||||||++|||++|++||.....      ............ .... 
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~-~~~~-  236 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP-PTLS-  236 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCCC-ccCC-
Confidence            1122346889999999874     34568899999999999999999999864221      111111111110 0100 


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            .+.....++.+++.+|++.+|++||++.|+++
T Consensus       237 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         237 ------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  11123346889999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.8e-33  Score=310.53  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=199.2

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      |++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567788999999999999876 5778899998766555566788999999999999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      ++|..++..   ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+|++|||++....... ..
T Consensus        87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~  159 (282)
T cd06643          87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  159 (282)
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence            999887764   234689999999999999999999986   99999999999999999999999999987643221 12


Q ss_pred             eecccccccccCccccC-----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          928 TTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .....|++.|+|||++.     +..++.++|||||||++|||++|++||....   ..+..   ......... ...   
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~---~~~~~~~~~-~~~---  229 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN---PMRVL---LKIAKSEPP-TLA---  229 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC---HHHHH---HHHhhcCCC-CCC---
Confidence            23357899999999873     4557789999999999999999999986422   11111   111111110 110   


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                          .+.....++.+++.+|++.+|.+||++.++++
T Consensus       230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                11122347899999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.4e-34  Score=320.39  Aligned_cols=254  Identities=24%  Similarity=0.281  Sum_probs=196.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||++++. +++.||+|++.+..   ......+.+|+.++..++|++|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999876 57889999986432   122345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999752   34588999999999999999999986   999999999999999999999999999976543


Q ss_pred             CCCceeecccccccccCccccC-----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE  997 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1048)
                      .........+||+.|+|||++.     ...++.++|||||||++|||++|+.||....   .....   ...........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~---~~~~~---~~i~~~~~~~~  228 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETY---GKIMNHKERFQ  228 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC---HHHHH---HHHhCCCcccc
Confidence            3333333457999999999875     3467899999999999999999999996421   11111   11111111000


Q ss_pred             ccccccCchhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 001591          998 IIDASIWHKDREKQLLEMLEIACKCIDQDPRR--RPFIEEVVT 1038 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~ 1038 (1048)
                      .  +    ........++.+++.+|+..++++  |+++.|+++
T Consensus       229 ~--p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         229 F--P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             C--C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            0  0    011123446888999988654444  789999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=307.91  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=205.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57889999999999999999875 67899999998665556678899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++|+|||.+....... 
T Consensus        83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            999999988652   24688999999999999999999986   99999999999999999999999999997654321 


Q ss_pred             ceeecccccccccCccccCcC---CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTL---TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .......++..|+|||...+.   .++.++||||||+++|||++|++||.......  ..    .........    ...
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~----~~~~~~~~~----~~~  225 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--AL----FLISKSNFP----PPK  225 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHHhccCC----Ccc
Confidence            122345788899999998776   88999999999999999999999996422111  11    111111000    000


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        .......+.++.+++.+|++.+|.+||++.+++.
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0112344567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=332.16  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=210.4

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .+..++||.|+||+||+|.|- .|+    +||+|++.... .+...++.+|+-+|.+++|||+++++|+|.... ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            344789999999999999874 443    78999887554 455678999999999999999999999998776 78999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      +||+.|+|.+|++..   +..+..+..+.|..|||+|+.|||.+   ++|||||.++|||+.+-..+||+|||+|+...+
T Consensus       777 q~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            999999999999874   55688899999999999999999986   999999999999999999999999999999877


Q ss_pred             CCCceeecc-cccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          923 YDTHVTTDL-VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       923 ~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      +..+..... .-.+.|||=|.+....++.++|||||||++||++| |..|+++...++..++++                
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle----------------  914 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE----------------  914 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh----------------
Confidence            665544332 22347999999999999999999999999999999 999998654333222221                


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      ....-..++-+..+++.++.+||..|+..||+++++...+.++..+
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            1111233445566899999999999999999999999988877543

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.7e-34  Score=321.43  Aligned_cols=254  Identities=24%  Similarity=0.283  Sum_probs=197.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+++.. +++.||+|++.+..   ......+.+|..++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999876 67889999986422   222345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999998752   34688999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCceeecccccccccCccccCc-----CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE  997 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1048)
                      ..........||+.|+|||++.+     ..++.++|||||||++|||++|+.||....   ..+...   ..........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~---~i~~~~~~~~  228 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYG---KIMNHEERFQ  228 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHH---HHHcCCCccc
Confidence            33323334579999999998765     467889999999999999999999996421   111111   1111110000


Q ss_pred             ccccccCchhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 001591          998 IIDASIWHKDREKQLLEMLEIACKCIDQDPRR--RPFIEEVVT 1038 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~ 1038 (1048)
                      .  +    ......+.++.+++.+|+..++++  |++++++++
T Consensus       229 ~--p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         229 F--P----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             C--C----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            0  0    001123457889999998865544  468888875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.8e-34  Score=321.72  Aligned_cols=260  Identities=27%  Similarity=0.416  Sum_probs=204.9

Q ss_pred             cCCcccCeEeccCceEEEEEEECC--------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCC
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN--------GTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  836 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  836 (1048)
                      .+|++.+.||+|+||.||+|++..        +..||+|.+.... ....+++.+|+++++++ +||||+++++++..++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468889999999999999997531        2368999887543 33456789999999999 7999999999999999


Q ss_pred             cEEEEEEeccCCChhhhcccccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001591          837 DRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  904 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~  904 (1048)
                      ..++++||+++|+|.+++.....            ....+++.++..++.|++.|++|||+.   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            99999999999999999875321            234588999999999999999999986   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhH
Q 001591          905 EKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL  982 (1048)
Q Consensus       905 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~  982 (1048)
                      +++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||....   ..+.
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~  245 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEEL  245 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHH
Confidence            99999999999998654322111 122234568999999999999999999999999999998 889986422   1121


Q ss_pred             HHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          983 VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                      ...   .. ......         .+.....++.+++.+|++.+|++||++.|+++.|+.+..
T Consensus       246 ~~~---~~-~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         246 FKL---LK-EGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHH---HH-cCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            111   11 111111         111223478899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-33  Score=312.57  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      +|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            6888999999999999999876 78999999887542 333467889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|..++.... ....+++..+..++.+++.|+.|||+.  .+|+||||||+||+++.++.++|+|||.+......  
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999998886532 234689999999999999999999963  48999999999999999999999999999765322  


Q ss_pred             ceeecccccccccCccccCcC------CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTL------TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                       ......+++.|+|||.+.+.      .++.++|+|||||++|||++|+.||......   ............ ...   
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~-~~~---  228 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVDG-DPP---  228 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhhc-CCC---
Confidence             12234688899999987554      3488999999999999999999999642211   111111111111 100   


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                            ..+.....++.+++.+|++.+|++||++.++++  ++...
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         229 ------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             ------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence                  111224457889999999999999999999987  55444

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-33  Score=326.58  Aligned_cols=259  Identities=20%  Similarity=0.243  Sum_probs=196.0

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ...|.+.+.||+|+||.||+|.+. .++.||+|....      ..+.+|++++++++|||||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            447999999999999999999876 578999996432      2356899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +. ++|.+++...   ...+++..+..|+.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            95 6888777542   34689999999999999999999986   99999999999999999999999999998654322


Q ss_pred             C-ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccC-CCC----chhHHHHHHHhhcc-ccccc
Q 001591          925 T-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK-GKN----CRDLVSWVFQMKSE-KREVE  997 (1048)
Q Consensus       925 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~-~~~----~~~~~~~~~~~~~~-~~~~~  997 (1048)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ...    ...+...+...... .....
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            1 12234579999999999999999999999999999999999887654322 111    11112111111100 00000


Q ss_pred             cc--------------------ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          998 II--------------------DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       998 ~~--------------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..                    ....|..+ ......+.+++.+|++.||++|||+.|+++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            00                    00001100 012236889999999999999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-35  Score=320.56  Aligned_cols=249  Identities=25%  Similarity=0.412  Sum_probs=207.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC--CCc--EEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT--NGT--KAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      +....+.||+|.||.|++|.|.  +|+  .||||.++.+... .-..|.+|+.+|-+++|||++++||+..+ ....+|+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            4455778999999999999987  444  6899999876543 56789999999999999999999999987 6778999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      |.++.|+|.+.|++  .....+-......++.|||.|+.||.+.   ++||||+..+|+++-....+||+|||+.+.++.
T Consensus       190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            99999999999987  3566788899999999999999999985   999999999999999999999999999998876


Q ss_pred             CCCce-ee-cccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          923 YDTHV-TT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       923 ~~~~~-~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      .+.+. +. ...-.+.|.|||.+....++.++|||+|||++|||++ |+.||-++.+..   ++             +.+
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---IL-------------~~i  328 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---IL-------------KNI  328 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---HH-------------Hhc
Confidence            54433 22 1233558999999999999999999999999999999 999997654321   11             112


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      |....-..+..+++.+++++..||...|++|||+.++.+
T Consensus       329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            222223345567789999999999999999999999974

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-33  Score=313.30  Aligned_cols=263  Identities=28%  Similarity=0.378  Sum_probs=205.4

Q ss_pred             ccHHHHHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEee
Q 001591          757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH  834 (1048)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  834 (1048)
                      +++.++.++.++|++.+.||+|+||.||+|... +++.+|+|++.... ....++.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344556667789999999999999999999875 68899999986532 2345678899999999 79999999999875


Q ss_pred             C-----CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcE
Q 001591          835 G-----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  909 (1048)
Q Consensus       835 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  909 (1048)
                      .     +..++||||+++++|.++++........+++..++.++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     357999999999999998875444456789999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeecccccccccCccccCcC-----CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHH
Q 001591          910 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL-----TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS  984 (1048)
Q Consensus       910 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~  984 (1048)
                      ||+|||.+........ ......|+..|+|||.+...     .++.++|||||||++|||++|++||......  ..   
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~---  241 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KT---  241 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HH---
Confidence            9999999986543221 12234688999999987543     3688999999999999999999998642211  11   


Q ss_pred             HHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          985 WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       +...... ......+       +......+.+++.+|++.+|++||++.|+++
T Consensus       242 -~~~~~~~-~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         242 -LFKIPRN-PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHHHhcC-CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1111111 1111111       1223346899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-33  Score=306.74  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=200.0

Q ss_pred             CCcccCeEeccCceEEEEEEECCCcEEEEEEecCCc------hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      +|+..+.||+|+||+||+|...+++.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      12234588999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      +||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +|+|+||+|+||++++++.++++|||.+....
T Consensus        81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            999999999999864    24578999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCC-----CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          922 PYD-----THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       922 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ...     ........|+..|+|||+..+..++.++||||+|+++|||++|+.||......  ..    .......... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~----~~~~~~~~~~-  226 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AA----MFYIGAHRGL-  226 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--HH----HHHhhhccCC-
Confidence            211     11123356899999999999988999999999999999999999999642211  11    1111111000 


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                         .+..    +.....++.+++.+|++.+|++||++.|+++
T Consensus       227 ---~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 ---MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               0111    1123447899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-33  Score=310.20  Aligned_cols=264  Identities=28%  Similarity=0.399  Sum_probs=206.8

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  842 (1048)
                      ++|+..+.||.|++|.||+|... +++.+|+|.+.... ......+.+|++++++++||||++++++|...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999875 68899999987543 24456789999999999999999999998654  3689999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988765444456689999999999999999999986   999999999999999999999999999876432


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--CCchhHHHHHHHhhcccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKG--KNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ..   .....++..|+|||...+..++.++||||+|+++|+|++|+.||.....  ....+...++....    .....+
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  230 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPELKD  230 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chhhcc
Confidence            21   1234678899999999988999999999999999999999999975422  11122222222111    111100


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      . .  .........+.+++.+|++.+|++|||+.|+++  ++.+.
T Consensus       231 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         231 E-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             C-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            0 0  001123457899999999999999999999997  55444

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-33  Score=311.48  Aligned_cols=261  Identities=25%  Similarity=0.329  Sum_probs=202.5

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|++.+.||+|++|.||+|.+. +|+.||+|++....  ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788999999999999999875 78999999987543  33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      + +++|.+++...   ...+++.+++.++.|+++||+|||+.   +++|+||||+||++++++.++++|||.+.......
T Consensus        81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 99999988653   35689999999999999999999986   99999999999999999999999999998765433


Q ss_pred             CceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc---c----
Q 001591          925 THVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE---V----  996 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~----  996 (1048)
                      ........|+..|+|||.+.+. .++.++||||+|+++|||++|++||....   ......++.........   .    
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN---DIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC---HHHHHHHHHHHcCCCChHHHhhccC
Confidence            2223345789999999987654 46899999999999999999988885422   11222222221111000   0    


Q ss_pred             -----cccccc----cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 -----EIIDAS----IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 -----~~~~~~----~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                           .+....    .+..........+.+++.+|++.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 000000    000111123468899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.4e-34  Score=319.48  Aligned_cols=237  Identities=25%  Similarity=0.339  Sum_probs=186.7

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHH-HHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVE-ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      ++||+|+||.||+|+.. +++.||+|++.....   .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 688999999875321   22234445544 67889999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|..++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (321)
T cd05603          81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET  152 (321)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence            999887753    34578899999999999999999986   99999999999999999999999999987532221 22


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+   ... . ..         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i---~~~-~-~~---------~  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNI---LHK-P-LQ---------L  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHH---hcC-C-CC---------C
Confidence            334579999999999998899999999999999999999999996421   11111111   111 0 00         1


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIE 1034 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~ 1034 (1048)
                      +.....++.+++.+|++.+|.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            112234688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.3e-34  Score=325.51  Aligned_cols=259  Identities=21%  Similarity=0.266  Sum_probs=195.7

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeC------
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------  835 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  835 (1048)
                      ..++|++.+.||+|+||.||+|... .++.||+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468999999999999999999865 68899999987542  23345678899999999999999999988643      


Q ss_pred             CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          836 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       836 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                      ...++||||+++ ++.+++..      .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            346899999976 55555532      378899999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh-----
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK-----  990 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~-----  990 (1048)
                      +++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   .+....+....     
T Consensus       165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~  239 (355)
T cd07874         165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence            99865322  223345789999999999998999999999999999999999999964221   11111111000     


Q ss_pred             --------------cccc-ccccc-----ccccC---chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          991 --------------SEKR-EVEII-----DASIW---HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       991 --------------~~~~-~~~~~-----~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                                    .... .....     .....   .........++.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                          0000 00000     00000   0001112346889999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-33  Score=322.89  Aligned_cols=261  Identities=20%  Similarity=0.270  Sum_probs=197.0

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeC------C
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------N  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  836 (1048)
                      .++|++.+.||+|+||.||+|... .++.||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999865 68899999987542  33345678899999999999999999987543      3


Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccc
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..++||||+++ ++.+++..      .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            57999999976 56665532      378889999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhc-----
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS-----  991 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----  991 (1048)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   .+....+.....     
T Consensus       173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHH
Confidence            9865422  223345789999999999999999999999999999999999999964321   111111111000     


Q ss_pred             --------------cccc-ccc----cccccC----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHH
Q 001591          992 --------------EKRE-VEI----IDASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1041 (1048)
Q Consensus       992 --------------~~~~-~~~----~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~ 1041 (1048)
                                    .... ...    ......    .........++.+++.+|++.||++|||+.|+++  ++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~  322 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  322 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                          0000 000    000000    0001112346889999999999999999999987  554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-33  Score=312.23  Aligned_cols=261  Identities=24%  Similarity=0.325  Sum_probs=200.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|++....  ....+.+.+|++++++++|||++++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888999999999999999876 68999999886432  2234567899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |++++.+..+...    ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999988877643    33589999999999999999999986   9999999999999999999999999999876433


Q ss_pred             CCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc----------
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----------  992 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------  992 (1048)
                      .. ......++..|+|||++.+ ..++.++||||||+++|||++|++||......+   ....+......          
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD---QLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChHHhhhcc
Confidence            21 2233467889999998765 567899999999999999999999997432211   11111110000          


Q ss_pred             -cc-c--ccccccccCc---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          993 -KR-E--VEIIDASIWH---KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       993 -~~-~--~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       .. .  ....++....   .........+.+++.+|++.+|++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             00 0  0000000000   001123457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=311.55  Aligned_cols=256  Identities=24%  Similarity=0.364  Sum_probs=204.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|++.+.||.|+||.||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46888999999999999999875 68999999998666666677899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++...   ...+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||.+........
T Consensus        85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999988652   34689999999999999999999986   999999999999999999999999999876433221


Q ss_pred             ceeecccccccccCccccC-----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          926 HVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                       ......|++.|+|||.+.     ...++.++||||||+++|||++|++||.....   ..   ......... ....  
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~---~~~~~~~~~-~~~~--  228 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MR---VLLKILKSE-PPTL--  228 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HH---HHHHHhcCC-CCCc--
Confidence             223356899999999864     34567899999999999999999999964221   11   111111111 0000  


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                           ..+.....++.+++.+|++.+|.+||++.++++  ++.+.
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         229 -----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             -----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                 011123347889999999999999999999986  55443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-34  Score=309.40  Aligned_cols=252  Identities=22%  Similarity=0.381  Sum_probs=197.3

Q ss_pred             hcCCcccCeEeccCceEEEEEEECCCcEEEEEEec--CCchhhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLS--GDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ...|++.+.||+||.+.||++...+...||+|++.  ..+.+....|..|++.|.+++ |.+||++++|-..++..|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            45788999999999999999998877888888764  334556678999999999995 999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||- ..+|..+|....  .....| .++.+..|++.|+.+.|.+   ||||.||||.|+|+-+ |.+||+|||.|..+..
T Consensus       440 E~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             ecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            975 458999997642  222234 7888999999999999998   9999999999999975 6999999999998877


Q ss_pred             CCCcee-ecccccccccCccccCcC-----------CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001591          923 YDTHVT-TDLVGTLGYIPPEYSQTL-----------TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       923 ~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      +.+... ...+||+.||+||.+...           +.++++||||+|||+|+|+.|++||...     ...+..+..+.
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl~aI~  586 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKLHAIT  586 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHHHhhc
Confidence            655433 346999999999976543           2457899999999999999999999631     11222222222


Q ss_pred             cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..+...++  +.....      .++.++++.|+.+||++||+..|+++
T Consensus       587 ~P~~~Ief--p~~~~~------~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  587 DPNHEIEF--PDIPEN------DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCCccccc--cCCCCc------hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            21111111  111111      13899999999999999999999987

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-33  Score=309.09  Aligned_cols=248  Identities=26%  Similarity=0.452  Sum_probs=199.1

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh---------hHHHHHHHHHHHHhcCCCceeeecceEeeCCc
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---------MEREFQAEVEALSRAQHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  837 (1048)
                      +|.+.+.||+|++|.||+|... +++.||+|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999865 6889999988654221         22467889999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .++|+||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            9999999999999999864    34578899999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCC-----ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc
Q 001591          918 RLLRPYDT-----HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE  992 (1048)
Q Consensus       918 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  992 (1048)
                      +.......     .......|+..|+|||...+..++.++||||+|+++|+|++|+.||.....      ...+......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~  227 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIGEN  227 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHhcc
Confidence            87642111     111234688999999999888899999999999999999999999964321      1111111110


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          993 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            ..+    ..+......+.+++.+|++++|.+||++.|+++
T Consensus       228 ------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ------ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  000    111223457889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=317.21  Aligned_cols=243  Identities=28%  Similarity=0.410  Sum_probs=199.5

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      |.-.+.||.|+||.||-|++. +.+.||||++.-..   .+.-.++..|++.+++++|||++.+-|+|..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            444567999999999999865 78899999987433   22334688899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      |-| +-.+.+.-   ...++.+.++..|..+++.||+|||++   +.||||||+.|||+++.|.||++|||.|..+.+..
T Consensus       108 ClG-SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn  180 (948)
T KOG0577|consen  108 CLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN  180 (948)
T ss_pred             Hhc-cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence            965 66666654   245688899999999999999999998   99999999999999999999999999998876543


Q ss_pred             CceeecccccccccCccccC---cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                           .++|||.|||||++.   .+.|+-++||||+|++-.|+.-.++|+..++.      ....+.+...... - +  
T Consensus       181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQNesP-t-L--  245 (948)
T KOG0577|consen  181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-T-L--  245 (948)
T ss_pred             -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhcCCC-C-C--
Confidence                 479999999999754   57899999999999999999999999865431      2222333322211 1 1  


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                           ...+++..+..++..|+++-|.+|||..++++
T Consensus       246 -----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  246 -----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                 13467778999999999999999999999886

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=310.95  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=202.6

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|++.+.||.|++|.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999876 68999999987543 33446688999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++...     .+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||.++......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999988642     689999999999999999999986   99999999999999999999999999998765432


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      . ......|++.|+|||...+..++.++||||||+++|||++|+.||.....   ...   ...... ........    
T Consensus       153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~---~~~~~~-~~~~~~~~----  220 (274)
T cd06609         153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRV---LFLIPK-NNPPSLEG----  220 (274)
T ss_pred             c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHH---HHHhhh-cCCCCCcc----
Confidence            1 22335788899999999988899999999999999999999999964221   111   111111 11111110    


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       .   ..+..+.+++.+|+..+|++||+++++++
T Consensus       221 -~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 -N---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             0   03346889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.4e-34  Score=311.85  Aligned_cols=240  Identities=24%  Similarity=0.455  Sum_probs=189.3

Q ss_pred             CeEeccCceEEEEEEECC--------CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          773 NIIGCGGFGLVYKATLTN--------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +.||+|+||.||+|....        ..+||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999997642        235888888765555566788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCc--------EEEeeccc
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE--------AHLADFGL  916 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~Dfg~  916 (1048)
                      +++|+|.++++..   ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.        ++++|||.
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999998753   33688999999999999999999985   9999999999999987665        69999999


Q ss_pred             ccccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCC-CCCcccCCCCchhHHHHHHHhhcccc
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGR-RPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      +......     ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.....   ....    ...... 
T Consensus       155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~----~~~~~~-  221 (258)
T cd05078         155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKL----QFYEDR-  221 (258)
T ss_pred             ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHH----HHHHcc-
Confidence            8754321     22467889999998876 45789999999999999999985 56542111   1101    011110 


Q ss_pred             cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                       ...         +.....++.+++.+|++.+|++|||++++++.|+
T Consensus       222 -~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 -HQL---------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -ccC---------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             000         1111246899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-34  Score=313.80  Aligned_cols=262  Identities=26%  Similarity=0.350  Sum_probs=202.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ++|++.+.||+|++|.||+|.+. +++.||+|++....  ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999876 68899999887432  2334678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |++++.+..+...    ...+++..+..++.|++.|++|||+.   +++|||++|+||++++++.+||+|||.+......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9998777665532    34589999999999999999999986   9999999999999999999999999999876554


Q ss_pred             CCceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc----------
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----------  992 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------  992 (1048)
                      .........++..|+|||++.+. .++.++||||||+++|+|++|++||.....   .+...........          
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD---IDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHhhhcc
Confidence            33233446788999999998887 889999999999999999999999964321   1111111111000          


Q ss_pred             --ccc--ccccccccCc----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          993 --KRE--VEIIDASIWH----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       993 --~~~--~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        ...  .+..+.....    ..+.....++.+++.+|++.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence              000  0000000000    011123568999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.8e-34  Score=335.86  Aligned_cols=266  Identities=19%  Similarity=0.248  Sum_probs=195.0

Q ss_pred             HHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCC------CceeeecceEeeC
Q 001591          763 LKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH------KNLVSLQGYCRHG  835 (1048)
Q Consensus       763 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~  835 (1048)
                      ....++|++.+.||+|+||+||+|.+. +++.||||+++.. ....+++..|+.++++++|      ++++++++++..+
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            345678999999999999999999875 6788999998643 2233456678888777754      4588999988765


Q ss_pred             -CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-------
Q 001591          836 -NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-------  907 (1048)
Q Consensus       836 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-------  907 (1048)
                       ...++|||++ +++|.+++..    ...+++..+..|+.||+.||+|||+.  .+||||||||+|||++.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccc
Confidence             4678888887 6788887763    34689999999999999999999972  3999999999999998765       


Q ss_pred             ---------cEEEeecccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCC
Q 001591          908 ---------EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN  978 (1048)
Q Consensus       908 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~  978 (1048)
                               .+||+|||.+....    ......+||+.|+|||++.+..++.++|||||||++|||++|++||.....  
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--  350 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN--  350 (467)
T ss_pred             ccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--
Confidence                     49999999886432    223346899999999999999999999999999999999999999975322  


Q ss_pred             chhHHHHHHHhhccc-----------ccccccc------cccCc-----------hhhHHHHHHHHHHHHHcccCCCCCC
Q 001591          979 CRDLVSWVFQMKSEK-----------REVEIID------ASIWH-----------KDREKQLLEMLEIACKCIDQDPRRR 1030 (1048)
Q Consensus       979 ~~~~~~~~~~~~~~~-----------~~~~~~~------~~~~~-----------~~~~~~~~~l~~li~~cl~~~P~~R 1030 (1048)
                       .+.+..+.......           ...++.+      +....           .........+.+|+.+|++.||++|
T Consensus       351 -~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        351 -LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             -HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence             11111111110000           0000000      00000           0000113467899999999999999


Q ss_pred             CCHHHHHH--HHHhc
Q 001591         1031 PFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1031 Pt~~evl~--~L~~i 1043 (1048)
                      ||++|+++  ++...
T Consensus       430 ~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        430 LNARQMTTHPYVLKY  444 (467)
T ss_pred             CCHHHHhcCcccccc
Confidence            99999997  66553

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1e-33  Score=308.91  Aligned_cols=250  Identities=29%  Similarity=0.420  Sum_probs=192.7

Q ss_pred             CeEeccCceEEEEEEEC----CCcEEEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeeecceEe-eCCcEEEEEEecc
Q 001591          773 NIIGCGGFGLVYKATLT----NGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQGYCR-HGNDRLLIYSYME  846 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  846 (1048)
                      +.||+|+||.||+|.+.    ++..||+|++... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999864    2357999988643 2344567889999999999999999999876 4556789999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +|+|.+++...   ....++..+..++.|+++|++|||+.   +++||||||+||++++++.+|++|||+++........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999998653   23467788899999999999999986   9999999999999999999999999999765322111


Q ss_pred             ---eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcC-CCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          927 ---VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG-RRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       927 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                         ......++..|+|||...+..++.++||||||+++|||++| .+||...   ...+....+   ......       
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~~---~~~~~~-------  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYL---LQGRRL-------  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHH---hcCCCC-------
Confidence               11223567789999999888999999999999999999995 5666432   122222221   111100       


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                         ..+...+..+.+++.+|++.+|++||++.|+++.|+++-
T Consensus       222 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 ---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence               001112346889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-33  Score=312.49  Aligned_cols=261  Identities=23%  Similarity=0.299  Sum_probs=197.5

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|+..+.||+|+||.||+|++. +|+.||+|++....  ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999876 68999999986432  22234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++ +|.+++...   ...+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||.++......
T Consensus        81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            974 777776542   34589999999999999999999986   99999999999999999999999999998654322


Q ss_pred             CceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc---------
Q 001591          925 THVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR---------  994 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---------  994 (1048)
                      . ......+++.|+|||.+.+. .++.++|||||||++|||++|+.|+....  ........+........         
T Consensus       154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            2 12334678899999987664 46899999999999999999998864322  11122222221111000         


Q ss_pred             ------cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          995 ------EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       995 ------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            .........+.........++.+++.+|++.||.+|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                  00000000011111223457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-33  Score=312.36  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=202.7

Q ss_pred             ccHHHHHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEee
Q 001591          757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH  834 (1048)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  834 (1048)
                      .++.++....+.|++.+.||+|+||.||+|.+. +++.||+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            455666667788999999999999999999875 68899999986543 2345688899999998 69999999999853


Q ss_pred             ------CCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCc
Q 001591          835 ------GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE  908 (1048)
Q Consensus       835 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~  908 (1048)
                            .+..+++|||+++|+|.+++....  ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence                  456799999999999999886532  34578889999999999999999986   9999999999999999999


Q ss_pred             EEEeecccccccCCCCCceeecccccccccCccccC-----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHH
Q 001591          909 AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV  983 (1048)
Q Consensus       909 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~  983 (1048)
                      ++|+|||++........ ......|++.|+|||.+.     ...++.++|||||||++|||++|+.||.......  .  
T Consensus       160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~--  234 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--A--  234 (282)
T ss_pred             EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--h--
Confidence            99999999876532211 122357899999999865     3567889999999999999999999996422110  0  


Q ss_pred             HHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          984 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        ....... .....        .....+.++.+++.+|++.+|.+||++.|+++
T Consensus       235 --~~~~~~~-~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 --LFLIPRN-PPPKL--------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --hhhHhhC-CCCCC--------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence              1111110 00000        01123447899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-33  Score=307.60  Aligned_cols=238  Identities=26%  Similarity=0.439  Sum_probs=189.5

Q ss_pred             CeEeccCceEEEEEEECCCc-----------EEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          773 NIIGCGGFGLVYKATLTNGT-----------KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999876432           5788877654333 6778999999999999999999999988 778999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-------cEEEeec
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-------EAHLADF  914 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl~Df  914 (1048)
                      |||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++       .+|++||
T Consensus        79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999998753   22689999999999999999999986   999999999999999887       7999999


Q ss_pred             ccccccCCCCCceeecccccccccCccccCcC--CCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhc
Q 001591          915 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKS  991 (1048)
Q Consensus       915 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  991 (1048)
                      |++.....     .....++..|+|||++.+.  .++.++||||||+++|||++ |..||......   ....+..   .
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~~~---~  221 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERFYQ---D  221 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHHHh---c
Confidence            99986543     1223567789999998776  78999999999999999999 57777543211   1111111   1


Q ss_pred             ccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          992 EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      ... ..  .+         ....+.+++.+|+..+|.+||++.|+++.|+
T Consensus       222 ~~~-~~--~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QHR-LP--MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCC-CC--CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            100 00  00         0147889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.1e-33  Score=307.33  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=190.0

Q ss_pred             eEeccCceEEEEEEECCC---cEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCC
Q 001591          774 IIGCGGFGLVYKATLTNG---TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS  849 (1048)
Q Consensus       774 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  849 (1048)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999976533   346677766443 3445678999999999999999999999999999999999999999


Q ss_pred             hhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC-Ccee
Q 001591          850 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVT  928 (1048)
Q Consensus       850 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~  928 (1048)
                      |.++++.........++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999976433344567788899999999999999986   99999999999999999999999999986432111 1112


Q ss_pred             ecccccccccCccccCc-------CCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          929 TDLVGTLGYIPPEYSQT-------LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       929 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ....++..|+|||+...       ..++.++||||||+++|||++ |..||.....   .+....+   ... ......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~---~~~-~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHV---IKD-QQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---Hhh-cccccCC
Confidence            23568889999998743       345789999999999999997 5778753221   1222211   111 1112222


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      +.....    ....+.+++..|+ .+|++||+++++++.|.
T Consensus       232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222222    2346788999999 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-33  Score=306.55  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=200.1

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeC-CcEEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-NDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  843 (1048)
                      +|++.+.||+|++|.||++... +++.||+|++....  ....+.+.+|++++++++|||++++++.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999866 67899999986432  23445688999999999999999999987644 45789999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++++|.+++...  ....+++.++..++.+++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999988753  234589999999999999999999986   9999999999999999999999999999866432


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      . .......|++.|+|||+..+..++.++||||+|+++|||++|+.||....      ........... ...       
T Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~-~~~-------  220 (257)
T cd08223         156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEG-KLP-------  220 (257)
T ss_pred             C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc-CCC-------
Confidence            2 22234578999999999999999999999999999999999999986321      11111111111 110       


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        ..+.....++.+++.+|++.+|++||++.++++
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              111233457899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-34  Score=323.02  Aligned_cols=262  Identities=24%  Similarity=0.315  Sum_probs=197.3

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeC------
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHG------  835 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  835 (1048)
                      ..++|++.+.||+|+||.||+|... ++..||+|++.....  ...+.+.+|++++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4568999999999999999999865 688999999875432  2335577899999999999999999987543      


Q ss_pred             CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          836 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       836 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                      ...++++|++ +++|.+++.     ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence            3468999987 778887764     34589999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      +++.....    .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....   ..+....+........
T Consensus       164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~  236 (343)
T cd07878         164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND---YIDQLKRIMEVVGTPS  236 (343)
T ss_pred             cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHhCCCC
Confidence            99865422    234578999999998876 568899999999999999999999996422   1111111111111000


Q ss_pred             cccccc--------------cccCc----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          995 EVEIID--------------ASIWH----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       995 ~~~~~~--------------~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                       .+...              +....    .........+.+++.+|++.||++|||+.|+++  ++...
T Consensus       237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         237 -PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             -HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence             00000              00000    000011235789999999999999999999996  56544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.8e-34  Score=315.85  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=201.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCc----EEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ++|+..+.||+|+||.||+|.+. +|.    .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56788899999999999999864 444    578898875433 3344688999999999999999999998754 4678


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence            99999999999988642   34578999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          921 RPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       921 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ....... .....++..|+|||...+..++.++||||||+++|||++ |+.||....   ..+...++.    .....  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~----~~~~~--  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLE----KGERL--  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----CCCCC--
Confidence            4332211 122345678999999998899999999999999999997 999986422   122222211    11100  


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                      ..+       ......+.+++.+|+..+|++||+++++++.|+++..
T Consensus       231 ~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 PQP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            000       1122368899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.1e-33  Score=307.77  Aligned_cols=246  Identities=25%  Similarity=0.368  Sum_probs=201.6

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .|+..+.||.|+||.||+|.+. ++..||+|++.... ......+.+|+.++++++||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4777888999999999999876 68899999987543 344567889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|.+++..     ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++|||++........
T Consensus        85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999998853     3578899999999999999999986   999999999999999999999999999976543221


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       ......++..|+|||++.+..++.++|+||||+++|||++|+.||.......   ..   ..... .         ...
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~---~~~~~-~---------~~~  219 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VL---FLIPK-N---------NPP  219 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hh---hhhhc-C---------CCC
Confidence             2223468889999999988889999999999999999999999986432111   11   11100 0         011


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ......+..+.+++.+|++.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            122345567899999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2e-33  Score=305.50  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=203.8

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|+..++||.|+||.||.++.. +++.+++|.+....  ....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788999999999999999865 68899999876442  34456688999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++....  ...+++..+..++.|+++|++|||+.   +++||||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999887532  45689999999999999999999986   99999999999999999999999999998764332


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      . ......|++.|+|||...+..++.++||||||+++|||++|+.||....   ..+..   .........         
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~---~~~~~~~~~---------  219 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLV---VKIVQGNYT---------  219 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHH---HHHHcCCCC---------
Confidence            2 2334578999999999988889999999999999999999999986421   11111   111111110         


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1039 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 1039 (1048)
                       ........++.+++.+|++.+|++||++.|+++.
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence             0112234478899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=290.98  Aligned_cols=251  Identities=23%  Similarity=0.272  Sum_probs=195.4

Q ss_pred             cCCcc-cCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEeeC----CcEE
Q 001591          767 NNFNQ-ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHG----NDRL  839 (1048)
Q Consensus       767 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~~  839 (1048)
                      ++|++ .++||-|-.|.|-.+.++ +|+++|+|++...     ...++|++..-.. .|||||+++++|...    ....
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL  135 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL  135 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence            34444 357999999999999876 8999999998632     2346777776655 599999999988642    3567


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC---CCCcEEEeeccc
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGL  916 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfg~  916 (1048)
                      +|||.|+||.|...+++.  ....+++.++..|++||+.|++|||+.   +|+||||||+|+|.+   .+..+|++|||+
T Consensus       136 iVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence            999999999999988875  466799999999999999999999997   999999999999996   466799999999


Q ss_pred             ccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      |+.-...  ....+-+-||.|.|||++...+|+..+|+||+||++|-|++|.+||....+.....-   +......+. .
T Consensus       211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg---Mk~rI~~gq-y  284 (400)
T KOG0604|consen  211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKRRIRTGQ-Y  284 (400)
T ss_pred             ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh---HHhHhhccC-c
Confidence            9875432  223345889999999999999999999999999999999999999976443221100   011111110 1


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ++.+     +.-...++...++|+.++..+|.+|.|+.|+++
T Consensus       285 ~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  285 EFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1111     112345668899999999999999999999986

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.9e-34  Score=313.36  Aligned_cols=261  Identities=25%  Similarity=0.355  Sum_probs=199.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....  ...+.+.+|++++++++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888999999999999999986 589999998764322  234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |++++++.++...    ...+++..+..++.|+++|++|||+.   +++|||++|+||++++++.++++|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999988876643    33489999999999999999999986   9999999999999999999999999999865433


Q ss_pred             CCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc--cccc---
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK--REVE---  997 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~---  997 (1048)
                      . .......++..|+|||+..+ ..++.++||||||+++|||++|++||.....   .+....+......-  ....   
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHHhc
Confidence            2 22334568899999998765 4578899999999999999999999864221   11111111100000  0000   


Q ss_pred             -------ccccccCc-----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          998 -------IIDASIWH-----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       998 -------~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                             ...+....     .........+.+++.+|++.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                   00000000     001123457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1e-33  Score=311.63  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=201.6

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566778999999999999865 67899999987443 334467899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++..     ..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++++|||++........
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999988753     4578999999999999999999985   999999999999999999999999999976543221


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......   ...   .......          ..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~---~~~~~~~----------~~  219 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVL---FLIPKNS----------PP  219 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHH---hhhhcCC----------CC
Confidence             122346888999999999989999999999999999999999998632211   111   1111100          00


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      .........+.+++.+|++.+|++||++.++++  ++...
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            111223457889999999999999999999997  55543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-33  Score=307.44  Aligned_cols=254  Identities=23%  Similarity=0.362  Sum_probs=203.7

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEee--CCcEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLLIY  842 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  842 (1048)
                      +|++.+.||.|+||.||+|... ++..||+|++....  ....+.+..|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999865 68899999886432  3344568889999999999999999998764  34578999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC--EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ||+++++|.+++.........+++..++.++.|++.|++|||..+  ..+++|+||||+||++++++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999765545677999999999999999999999322  349999999999999999999999999999876


Q ss_pred             CCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ..... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....   .......+    .....     
T Consensus       161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~----~~~~~-----  227 (265)
T cd08217         161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI----KEGKF-----  227 (265)
T ss_pred             cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHH----hcCCC-----
Confidence            54322 1234578999999999998889999999999999999999999997422   11211111    11111     


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                          ...+.....++.+++.+|++.+|++||++.++++
T Consensus       228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                1112233457899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-33  Score=305.58  Aligned_cols=252  Identities=26%  Similarity=0.434  Sum_probs=201.0

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc------hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      +|+..+.||+|++|.||+|... +++.||+|++....      ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999864 78999999987432      1234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-cEEEeecccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRL  919 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~a~~  919 (1048)
                      |+||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            9999999999998864    34688999999999999999999986   999999999999998775 599999999987


Q ss_pred             cCCCCCc---eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          920 LRPYDTH---VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       920 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      .......   ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||.......   .............. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~-  229 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASATTA-  229 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhccCCC-
Confidence            6543211   1223468899999999988889999999999999999999999996422211   11111111111110 


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                              ...+.....++.+++.+|++.+|.+||++.|+++
T Consensus       230 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         230 --------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    1122234457889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-33  Score=306.57  Aligned_cols=249  Identities=27%  Similarity=0.405  Sum_probs=194.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDR  838 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  838 (1048)
                      .+|+..+.||+|+||.||+|... ++..||+|++....     .+....+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999875 68999999886432     12334688899999999999999999988753  567


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++++||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            899999999999998864    33578999999999999999999986   99999999999999999999999999997


Q ss_pred             ccCCCCC--ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          919 LLRPYDT--HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       919 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      .......  .......++..|+|||.+.+..++.++||||+||++|||++|+.||.....      ...+........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~--  226 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT--  226 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC--
Confidence            6543211  111234688899999999988899999999999999999999999964211      111111111111  


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                         .+    ..+......+.+++ +|+..+|++||+++|+++
T Consensus       227 ---~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 ---NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               01    11122233566676 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.8e-33  Score=305.68  Aligned_cols=253  Identities=25%  Similarity=0.376  Sum_probs=189.6

Q ss_pred             eEeccCceEEEEEEECC---CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCC
Q 001591          774 IIGCGGFGLVYKATLTN---GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS  849 (1048)
Q Consensus       774 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  849 (1048)
                      .||+|+||+||+|...+   ...+|+|.+.... ......+.+|++.++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   3578888776443 3344568899999999999999999999999999999999999999


Q ss_pred             hhhhcccccCC-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce-
Q 001591          850 LDYWLHESVDK-DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-  927 (1048)
Q Consensus       850 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-  927 (1048)
                      |.+++...... ....++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99998764322 23456888899999999999999986   99999999999999999999999999987543221111 


Q ss_pred             eecccccccccCccccC-------cCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          928 TTDLVGTLGYIPPEYSQ-------TLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      .....+++.|+|||+..       ...++.++|||||||++|||++ |..||.....   .+......   .. ......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~---~~-~~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQVV---RE-QDIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHh---hc-cCccCC
Confidence            12234567899999764       3456889999999999999999 7888864321   11111111   11 111111


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      .+..    +......+.+++..|+ .||++||++++|++.|.
T Consensus       232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111    1123346677888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.8e-33  Score=302.76  Aligned_cols=247  Identities=27%  Similarity=0.429  Sum_probs=200.1

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      +|+..+.||+|++|.||+|... +++.||+|.+....     .+..+.+.+|++++++++||||+++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999876 78999999886432     23456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      +||+++++|.+++..    ...+++..+..++.|+++|++|||+.   +++|+||+|+||+++.++.+||+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999999864    34588999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCCceeecccccccccCccccCcCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLT-ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ...  ......|+..|+|||...... ++.++|+||||+++|+|++|+.||....  .    ...............   
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~----~~~~~~~~~~~~~~~---  222 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--G----VAAVFKIGRSKELPP---  222 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--H----HHHHHHHHhcccCCC---
Confidence            322  223456889999999887766 8999999999999999999999996432  1    111111111111111   


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            .+......+.+++.+|++.+|.+||++.++++
T Consensus       223 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 ------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                  11122346889999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=319.39  Aligned_cols=268  Identities=26%  Similarity=0.348  Sum_probs=203.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeC------CcEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------NDRL  839 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  839 (1048)
                      .+...+.||+|+||.||+|+++ +|+.||||.+.... ....+.+.+|++++++++|||||++++.=++.      +..+
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3455778999999999999965 89999999998654 33456689999999999999999999976544      3568


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC--CCCc--EEEeecc
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD--EKFE--AHLADFG  915 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~--~kl~Dfg  915 (1048)
                      +|||||.+|+|...+++.. ....+++.+.+.+..+++.|+.|||.+   +||||||||.||++-  ++|+  -||+|||
T Consensus        94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            9999999999999998755 345699999999999999999999986   999999999999983  4444  6999999


Q ss_pred             cccccCCCCCceeecccccccccCccccC-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      .|+.....  .....++||+.|++||+.. .+.|+..+|.|||||++|+.+||..||....+.....-+.|.....+...
T Consensus       170 ~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  170 AARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             ccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            99987643  3566789999999999988 48899999999999999999999999986554432222333322222111


Q ss_pred             ccccccccc-----Cc-------hhhHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHH
Q 001591          995 EVEIIDASI-----WH-------KDREKQLLEMLEIACKCIDQDPRRRP--FIEEVVTWLD 1041 (1048)
Q Consensus       995 ~~~~~~~~~-----~~-------~~~~~~~~~l~~li~~cl~~~P~~RP--t~~evl~~L~ 1041 (1048)
                      ..-......     |.       .........+...+..++..+|++|.  .+.+....+.
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~  308 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD  308 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence            111111111     11       11223344667788888899999998  5555544443

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-33  Score=309.35  Aligned_cols=251  Identities=29%  Similarity=0.486  Sum_probs=197.2

Q ss_pred             CeEeccCceEEEEEEECC-------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          773 NIIGCGGFGLVYKATLTN-------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +.||+|+||.||+|++.+       +..+|+|.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2578999876543 23456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccC---CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-----cEEEeeccc
Q 001591          845 MENGSLDYWLHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-----EAHLADFGL  916 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~Dfg~  916 (1048)
                      +++++|.+++.....   ....+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999875322   234578999999999999999999985   999999999999999877     899999999


Q ss_pred             ccccCCCCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          917 SRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       917 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      ++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.....   .+....+.    ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT----AGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh----cCC
Confidence            9765322211 1122345678999999999999999999999999999998 9999863221   12221111    110


Q ss_pred             cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                      ..         ......+..+.+++.+|++.+|.+||+++++++.|++
T Consensus       231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            00         1111234578899999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=5e-36  Score=325.87  Aligned_cols=370  Identities=25%  Similarity=0.399  Sum_probs=320.1

Q ss_pred             CCCCCEEEcccCCCC-CCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccCCcCCCCccccccCccccccc
Q 001591          224 SPSLKQLHVDNNLLG-GDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFF  302 (1048)
Q Consensus       224 ~~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  302 (1048)
                      +|-.+-.|+++|.++ +..|.+...+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..++.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            455677788888888 478889999999999999999888 78999999999999999999988 556678888999999


Q ss_pred             cccCCccc-CCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCCCccccCCCccceeecccccc
Q 001591          303 VAHSNSFS-GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL  381 (1048)
Q Consensus       303 ~l~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l  381 (1048)
                      .+..|++. .-+|..+..+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|..+.-..|.+++.|-.||||+|++
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence            99999886 456777888999999999999998 5677788888999999999999954445677899999999999999


Q ss_pred             ccccchhhccCCcCcEEeccCCcCCCCcCcccccccccccceEecccCcc-CCCCCccccCCCcCcEEEccCCcccCCch
Q 001591          382 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFV-GEEIPENVGGFESLMVLALGNCGLKGHIP  460 (1048)
Q Consensus       382 ~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  460 (1048)
                      . .+|..+..+..|+.|+|++|.+..+  .+..+..+++|+.|.+++.+- ...+|.++.++.+|..+||+.|++. .+|
T Consensus       163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hf--QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP  238 (1255)
T KOG0444|consen  163 E-MLPPQIRRLSMLQTLKLSNNPLNHF--QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP  238 (1255)
T ss_pred             h-hcCHHHHHHhhhhhhhcCCChhhHH--HHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence            8 6778899999999999999988764  344566678888888988654 3468999999999999999999998 899


Q ss_pred             HhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCcccccCCcchhhhhhhhccCCCCCCCCCCCCccceeecc
Q 001591          461 VWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHN  540 (1048)
Q Consensus       461 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~  540 (1048)
                      +.+-++++|+.|+||+|+|+ .+.-..+...+|+.|+||.|+++ .+|..+..|+.|..                     
T Consensus       239 ecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k---------------------  295 (1255)
T KOG0444|consen  239 ECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK---------------------  295 (1255)
T ss_pred             HHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH---------------------
Confidence            99999999999999999998 67677788889999999999999 78999998888843                     


Q ss_pred             ccCCCcCCCCCCCCCCeeeeecCccc-ccCCccccCCCCCcEEEccCceecccCCcccccccCccEeeCCCCccCCCCcc
Q 001591          541 RSTNGLPYNQASSFPPSVFLSNNRIN-GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG  619 (1048)
Q Consensus       541 ~~~~~l~~~~~~~~~~~l~Ls~N~l~-g~~p~~~~~L~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~  619 (1048)
                                       |.+.+|+++ .-||..||.|.+|+.+..++|.+. .+|..++.+..|+.|.|++|+|- .+|.
T Consensus       296 -----------------Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPe  356 (1255)
T KOG0444|consen  296 -----------------LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPE  356 (1255)
T ss_pred             -----------------HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echh
Confidence                             556677776 348999999999999999999999 99999999999999999999998 7999


Q ss_pred             ccccccCCCeeeeccccccccCC
Q 001591          620 SFEKLTFLSKFSVANNHLQGTIP  642 (1048)
Q Consensus       620 ~~~~l~~L~~l~l~~N~l~g~~p  642 (1048)
                      .+--|+.|..|||.+|.----+|
T Consensus       357 aIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  357 AIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             hhhhcCCcceeeccCCcCccCCC
Confidence            99999999999999996544444

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.5e-33  Score=302.91  Aligned_cols=251  Identities=30%  Similarity=0.481  Sum_probs=201.4

Q ss_pred             CcccCeEeccCceEEEEEEECC-----CcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          769 FNQANIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      |++.+.||.|+||.||+|.+.+     +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999998763     388999999765433 5567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++++|.+++....  ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+.....
T Consensus        81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            9999999999987532  12289999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ..........+++.|+|||...+..++.++||||+|+++|||++ |++||...   ...+..+.+....    ...    
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~~~~----~~~----  224 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEYLKKGY----RLP----  224 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCC----CCC----
Confidence            32222212346789999999988889999999999999999998 88888642   2222222221111    100    


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 1040 (1048)
                           .....+.++.+++.+|+..+|++|||+.|++++|
T Consensus       225 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 -----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 0111344789999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.6e-33  Score=311.10  Aligned_cols=257  Identities=27%  Similarity=0.405  Sum_probs=198.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHH-HHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEA-LSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++.... ...+.++..|+.. ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888999999999999999876 69999999987543 2334455566665 566789999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |++ |+|.+++.........+++..+..++.|++.|++|||+.  .+++||||||+||++++++.+||+|||.+......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 678887765444456789999999999999999999973  38999999999999999999999999999865322


Q ss_pred             CCceeecccccccccCccccCc----CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQT----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      .  ......|+..|+|||.+.+    ..++.++|+||||+++|||++|+.||....  ...+..   ....... .....
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~---~~~~~~~-~~~~~  229 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK--TPFQQL---KQVVEEP-SPQLP  229 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc--cCHHHH---HHHHhcC-CCCCC
Confidence            1  1223468889999998754    456889999999999999999999986321  111111   1111110 01110


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~ 1042 (1048)
                              ....+.++.+++.+|+..+|++||++.++++  +++.
T Consensus       230 --------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  266 (283)
T cd06617         230 --------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL  266 (283)
T ss_pred             --------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence                    0113357899999999999999999999987  4443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.9e-33  Score=302.20  Aligned_cols=255  Identities=27%  Similarity=0.456  Sum_probs=209.2

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      +|++.+.||+|++|.||+|+.. +++.||+|++..... .....+.+|++++.+++|||++++++++..++..++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6888999999999999999877 599999999876543 45677999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      ++++|.+++...    ..+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++++|||.+.......
T Consensus        82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999998643    568999999999999999999998 6   99999999999999999999999999998764332


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .. .....++..|+|||...+..++.++|+||||+++|+|++|+.||.........+...++.   .. ....       
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~-~~~~-------  222 (264)
T cd06623         155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DG-PPPS-------  222 (264)
T ss_pred             Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cC-CCCC-------
Confidence            22 223468889999999998899999999999999999999999997543222222222222   11 1100       


Q ss_pred             chhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1005 HKDREK-QLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                        .+.. .+..+.+++.+|++++|++||++.|+++  +++.+
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence              1111 3457899999999999999999999997  55544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.4e-33  Score=311.00  Aligned_cols=267  Identities=22%  Similarity=0.298  Sum_probs=203.2

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh-----hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ-----MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      +|++.+.||+|++|.||+|... +++.||+|++......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999876 6899999999755322     344567899999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+ +|+|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||+++...
T Consensus        81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 89999998653   23689999999999999999999986   99999999999999999999999999998765


Q ss_pred             CCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc----
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV----  996 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----  996 (1048)
                      .... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||....+   .+....+..........    
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD---IDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc---HHHHHHHHHHcCCCchhhhhh
Confidence            4322 1223356789999998754 4678999999999999999999888764221   11121121111100000    


Q ss_pred             -----cccccccC-----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCc
Q 001591          997 -----EIIDASIW-----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       997 -----~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~ 1045 (1048)
                           ........     ..........+.+++.+|++++|++||++.|+++  ++++-..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence                 00000000     0011223457899999999999999999999997  5665443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=314.61  Aligned_cols=249  Identities=23%  Similarity=0.380  Sum_probs=203.4

Q ss_pred             CcccCeEeccCceEEEEEEECC-CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          769 FNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      ++++..||.|+||.||+|..++ +--.|.|++........+.|.-|++++..+.||+||++++.|..++..++..|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            5556779999999999998763 445677888777677777899999999999999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |-.+..+-+   -+..+++.++..+.++++.||.|||+.   .|||||+|+.|||++-+|.++++|||.+..... ....
T Consensus       114 GAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk  186 (1187)
T KOG0579|consen  114 GAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK  186 (1187)
T ss_pred             chHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence            998887765   467899999999999999999999996   999999999999999999999999999865332 2223


Q ss_pred             eecccccccccCcccc-----CcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          928 TTDLVGTLGYIPPEYS-----QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ...++|||.|||||+.     ...+|+.++||||||+++.||..+.+|-....      ..+.+..+.+.. .+....+ 
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKiaKSe-PPTLlqP-  258 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSE-PPTLLQP-  258 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHHhhcC-CCcccCc-
Confidence            3457999999999974     46789999999999999999999999964321      122222222221 1222223 


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            ..+...+.+++.+|+..+|..||+++++++
T Consensus       259 ------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  259 ------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                  345558999999999999999999999986

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-33  Score=306.40  Aligned_cols=247  Identities=26%  Similarity=0.446  Sum_probs=197.9

Q ss_pred             cCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      ++|++.+.||+|+||.||+|.. +++.||+|.+....  ....+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999975 58889999987543  235688999999999999999999998754 4799999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+......   
T Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            99999998753  234578999999999999999999986   9999999999999999999999999998754321   


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.....   .+...   .... .....        
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~---~~~~-~~~~~--------  217 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKE---CVEK-GYRME--------  217 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHH---HHhC-CCCCC--------
Confidence             112234568999999988899999999999999999997 9999864221   11111   1111 11000        


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                       .....+..+.+++.+|++.+|++||+++++++.|++
T Consensus       218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             011233478899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.2e-33  Score=309.67  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=200.9

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      |.....||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            333466999999999999865 6889999998766555566789999999999999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      ++|.+++..     ..+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++........ .
T Consensus       104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~  174 (292)
T cd06658         104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K  174 (292)
T ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence            999988743     3478999999999999999999986   999999999999999999999999999876543222 1


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      .....|++.|+|||...+..++.++||||||+++|||++|+.||.....   .....   .... ..     .....  .
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~---~~~~-~~-----~~~~~--~  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMR---RIRD-NL-----PPRVK--D  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHh-cC-----CCccc--c
Confidence            2335789999999999888899999999999999999999999863211   11111   1110 00     00000  0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      .......+.+++.+|+..+|.+|||+.|+++  +++..
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            1122346889999999999999999999996  45433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.9e-33  Score=311.02  Aligned_cols=196  Identities=26%  Similarity=0.359  Sum_probs=159.3

Q ss_pred             cCeEeccCceEEEEEEEC---CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEee--CCcEEEEEEecc
Q 001591          772 ANIIGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLLIYSYME  846 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  846 (1048)
                      ...||+|+||+||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999865   35789999987543  23457889999999999999999998854  456789999987


Q ss_pred             CCChhhhccccc-----CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEE----CCCCcEEEeecccc
Q 001591          847 NGSLDYWLHESV-----DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLS  917 (1048)
Q Consensus       847 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfg~a  917 (1048)
                      + +|.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+||++    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 6666654221     1233588999999999999999999986   99999999999999    56679999999999


Q ss_pred             cccCCCCCc--eeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcc
Q 001591          918 RLLRPYDTH--VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEV  973 (1048)
Q Consensus       918 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~  973 (1048)
                      +........  ......||+.|+|||++.+ ..++.++||||+||++|||+||++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876433221  2234578999999998876 4579999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.6e-33  Score=304.27  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=195.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDR  838 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  838 (1048)
                      .+|++.+.||+|+||.||+|... ++..||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46889999999999999999875 68999999875322     22235678899999999999999999988764  457


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++++|.+++..    ...+++..+.+++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+.
T Consensus        82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            899999999999998864    23478899999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCC--ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          919 LLRPYDT--HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       919 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      .......  .......|+..|+|||...+..++.++||||||+++|||++|+.||.....      ...+........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~--  226 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPT--  226 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHHHHhcCCC--
Confidence            6542211  112234688999999999888899999999999999999999999963211      111111111110  


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                             ....+......+.+++.+|+. +|++||+++|+++
T Consensus       227 -------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 -------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                   011123344578889999985 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=309.14  Aligned_cols=256  Identities=28%  Similarity=0.427  Sum_probs=202.8

Q ss_pred             HhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEeeCC-----
Q 001591          764 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN-----  836 (1048)
Q Consensus       764 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  836 (1048)
                      ...++|++.+.||+|++|.||+|... +++.+|+|++..... ..+++.+|+++++++ +||||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            34678999999999999999999876 678999999876543 346789999999999 6999999999997644     


Q ss_pred             -cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          837 -DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       837 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                       ..++||||+++++|.+++.........+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             47999999999999998876543456789999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCc-----CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      .+....... .......|++.|+|||++..     ..++.++||||||+++|+|++|+.||......   .   ......
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~---~~~~~~  231 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---R---ALFKIP  231 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---H---HHHHhh
Confidence            987654322 22233568999999997643     35678999999999999999999999632111   1   111111


Q ss_pred             cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .. .....       ........++.+++.+|++.||++|||+.|+++
T Consensus       232 ~~-~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RN-PPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cc-CCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11 11111       112234557899999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=289.83  Aligned_cols=248  Identities=25%  Similarity=0.345  Sum_probs=201.8

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHH---HHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      .++|+..++||+|.||+|.+++-+ +|+.+|+|+++++.....+++   ..|-++++..+||.+..+-..|+..+..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            457888999999999999999755 799999999998765444443   5588999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+.||.|.-++..    ...+++..++.+-.+|+.||.|||+.   +||.||+|.+|.|+|+||++||+|||+++.--
T Consensus       247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999888863    56789999999999999999999985   99999999999999999999999999998643


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      . ....+..+||||.|+|||++....|..++|.|.+||++|||++|+.||.....+   .+    +...-.+   ++   
T Consensus       320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kL----FeLIl~e---d~---  385 (516)
T KOG0690|consen  320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KL----FELILME---DL---  385 (516)
T ss_pred             c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HH----HHHHHhh---hc---
Confidence            2 233456789999999999999999999999999999999999999999632111   11    1111110   11   


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                          .++.....+...++...+.+||.+|.     .+.||.+
T Consensus       386 ----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  386 ----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence                11222334677888999999999995     3555543

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.4e-33  Score=305.38  Aligned_cols=253  Identities=28%  Similarity=0.431  Sum_probs=204.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|+..+.||+|++|.||+|.+. +++.||+|++.... ....+++.+|++++++++||||+++++++..+...++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999876 68899999987653 34556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      +++++|.+++....   ..+++..+.+++.|++.|++|||+ .   +++||||||+||++++++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999987532   568899999999999999999998 5   9999999999999999999999999998765322


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ...   ...++..|+|||...+..++.++||||||+++|+|++|+.||...... .....+.+....... ....     
T Consensus       155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~-----  224 (265)
T cd06605         155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP-PPRL-----  224 (265)
T ss_pred             Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC-CCCC-----
Confidence            111   257889999999999889999999999999999999999999643211 111222221111111 0000     


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .   ......++.+++.+|+..+|++|||+.+++.
T Consensus       225 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 P---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             C---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            0   0113457899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=314.14  Aligned_cols=257  Identities=25%  Similarity=0.316  Sum_probs=204.0

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|+..+.||+|++|.||+|... +++.||+|.+......   ..+.+..|++++++++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999876 5899999998765322   3456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+.+++|.+++...  ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999988643  345689999999999999999999986   999999999999999999999999999876432


Q ss_pred             CCCc----------------------------eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCccc
Q 001591          923 YDTH----------------------------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC  974 (1048)
Q Consensus       923 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~  974 (1048)
                      ....                            ......|+..|+|||+..+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            2110                            111346889999999999889999999999999999999999999643


Q ss_pred             CCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH--HHHhc
Q 001591          975 KGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF----IEEVVT--WLDGI 1043 (1048)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt----~~evl~--~L~~i 1043 (1048)
                      ...   ....   ........         .........++.+++.+|++.+|++||+    +.|+++  +++.+
T Consensus       236 ~~~---~~~~---~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         236 NRD---ETFS---NILKKEVT---------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             chH---HHHH---HHhcCCcc---------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            211   1111   11111000         0011113457999999999999999999    777765  55443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9e-33  Score=302.30  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=204.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999865 68899999987543 33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.++++.... ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999875322 34689999999999999999999986   99999999999999999999999999998765432


Q ss_pred             Cc---eeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          925 TH---VTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       925 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ..   ......|+..|+|||++... .++.++|+||||+++|||++|+.||......  ......    ..... .. ..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~----~~~~~-~~-~~  228 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLT----LQNDP-PS-LE  228 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHH----hcCCC-CC-cC
Confidence            22   22345789999999988776 7899999999999999999999999643221  111111    11110 00 00


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..   ......+.++.+++.+|++.+|++||++.++++
T Consensus       229 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             Cc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00   001133457889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.9e-33  Score=307.85  Aligned_cols=253  Identities=22%  Similarity=0.373  Sum_probs=204.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57889999999999999999864 68899999987555555567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++..     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++....+...
T Consensus        99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            99999998853     3478899999999999999999986   999999999999999999999999999876543322


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       ......|++.|+|||......++.++||||||+++|++++|+.||.......   ..   ........ .       ..
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~---~~~~~~~~-~-------~~  235 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---AL---YLIATNGT-P-------EL  235 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---he---eehhcCCC-C-------CC
Confidence             2233468899999999888889999999999999999999999996432111   00   00000000 0       00


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~ 1042 (1048)
                      .........+.+++.+|++.+|++||++++++.  +++.
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~  274 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI  274 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            111223446889999999999999999999986  4543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.9e-33  Score=304.14  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=201.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|++.+.||+|+||.||++... +|+.||+|++...  .....+++.+|++++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4888999999999999999865 6889999998643  233445789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++...  ....+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999988643  233578999999999999999999986   99999999999999999999999999997654322


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      . ......|++.|+|||+..+..++.++|+||||+++|+|++|+.||...   +..+..   ....... ..        
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~---~~~~~~~-~~--------  219 (256)
T cd08218         156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLV---LKIIRGS-YP--------  219 (256)
T ss_pred             h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHH---HHHhcCC-CC--------
Confidence            1 122346888999999999889999999999999999999999998632   111111   1111111 00        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       ..+.....++.+++.+|++.+|.+||++++|++
T Consensus       220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             011123347899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-34  Score=301.05  Aligned_cols=248  Identities=26%  Similarity=0.322  Sum_probs=201.9

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ..+.|+.-++||+||||.||-++.+ +|+-+|.|++.+...   ..+.....|-.++.+++.+.||.+-..|+..+..++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3467888999999999999999866 799999998865432   334556789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      |+..|.||+|.-++...  ....+++..+..+|.+|+.||++||..   +||.||+||+|||+|+.|+++|+|+|+|..+
T Consensus       263 VLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999888765  346799999999999999999999986   9999999999999999999999999999987


Q ss_pred             CCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ...  ......+||.+|||||++....|+..+|.||+||++|||+.|+.||.......-.   +.+.+.....       
T Consensus       338 ~~g--~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~~-------  405 (591)
T KOG0986|consen  338 PEG--KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLED-------  405 (591)
T ss_pred             CCC--CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhcc-------
Confidence            643  3344459999999999999999999999999999999999999999642211111   0011111000       


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCC
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1032 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt 1032 (1048)
                         ..++++..+++..++.+..+..||++|--
T Consensus       406 ---~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  406 ---PEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             ---hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence               11233445567888888999999999963

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-32  Score=300.23  Aligned_cols=251  Identities=30%  Similarity=0.457  Sum_probs=201.5

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|+..+.||+|+||.||+|... ++..||+|.+.....  ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999865 789999999876544  3567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++..    ...+++..+..++.++++|++|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999998864    34578999999999999999999986   99999999999999999999999999998764432


Q ss_pred             Ccee---ecccccccccCccccCcCC---CCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          925 THVT---TDLVGTLGYIPPEYSQTLT---ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       925 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ....   ....+++.|+|||++.+..   ++.++||||||+++||+++|+.||......     ......... ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~~~  227 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GHKPPI  227 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CCCCCC
Confidence            2211   1356888999999988766   889999999999999999999999643211     111111111 111111


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .       ........+.+++.+|++.+|++||++.|++.
T Consensus       228 ~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 P-------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C-------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0       01122446789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=318.00  Aligned_cols=240  Identities=27%  Similarity=0.292  Sum_probs=185.3

Q ss_pred             EeccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhc---CCCceeeecceEeeCCcEEEEEEeccC
Q 001591          775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRA---QHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      ||+|+||+||+|+.. +++.||+|++......   ....+..|..++.+.   +||+|+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999876 6899999998643221   222345566666655   699999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~  152 (330)
T cd05586          81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT  152 (330)
T ss_pred             ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence            999888763    45689999999999999999999986   99999999999999999999999999997543222 22


Q ss_pred             eecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCch
Q 001591          928 TTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      ....+||+.|+|||++.+. .++.++||||+||++|||++|+.||....   ..+....   .....  .....      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~---i~~~~--~~~~~------  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRN---IAFGK--VRFPK------  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHH---HHcCC--CCCCC------
Confidence            3346799999999988654 57899999999999999999999996421   1111111   11110  01100      


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 001591         1007 DREKQLLEMLEIACKCIDQDPRRRP----FIEEVVT 1038 (1048)
Q Consensus      1007 ~~~~~~~~l~~li~~cl~~~P~~RP----t~~evl~ 1038 (1048)
                        .....++.+++.+|++.||++||    ++.++++
T Consensus       219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              01234678999999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.1e-33  Score=304.10  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=198.0

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch----------hhHHHHHHHHHHHHhcCCCceeeecceEeeCC
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG----------QMEREFQAEVEALSRAQHKNLVSLQGYCRHGN  836 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  836 (1048)
                      +|...+.||+|+||.||+|... +|+.||+|.++....          ...+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999765 689999998763211          11245788999999999999999999999999


Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccc
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..++||||+++++|.++++..    ..+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999988753    4689999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCC-ceeecccccccccCccccCcCC--CCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc
Q 001591          917 SRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLT--ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  993 (1048)
Q Consensus       917 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  993 (1048)
                      ++....... .......|+..|+|||......  ++.++|+||+|+++||+++|+.||.....      ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~  228 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKR  228 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccc
Confidence            976532211 1123356889999999877654  78999999999999999999999853211      11111111111


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          994 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .... +...    ........+.+++.+|+.++|++||++.++++
T Consensus       229 ~~~~-~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 SAPP-IPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCc-CCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111 1111    11123457899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-32  Score=305.86  Aligned_cols=264  Identities=22%  Similarity=0.275  Sum_probs=196.0

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+++++.++|+||+++++++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3567999999999999999999865 689999999875432 22345778999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+. +++.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 6776665432   34577888999999999999999986   999999999999999999999999999976432


Q ss_pred             CCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc--------
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK--------  993 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--------  993 (1048)
                      .. .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......  .+....+.......        
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         156 PS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence            21 11223467899999998765 45788999999999999999999999743221  11111111100000        


Q ss_pred             -----ccccccccccCchh-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          994 -----REVEIIDASIWHKD-----REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       994 -----~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                           ...+..........     ......++.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                 00000000000000     0011347889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.2e-33  Score=306.10  Aligned_cols=260  Identities=23%  Similarity=0.315  Sum_probs=196.9

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|+..+.||.|++|.||+|+.. +|..||+|++....  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999876 68999999887543  22335688999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +. ++|.+++...  ....+++..+..++.|+++|++|||+.   +++||||+|+||++++++.+|++|||++.......
T Consensus        81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 5788887643  245689999999999999999999986   99999999999999999999999999987654322


Q ss_pred             CceeecccccccccCccccCcCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc---------
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLT-ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR---------  994 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---------  994 (1048)
                      . ......+++.|+|||...+.. ++.++||||||+++|||+||+.||....  ......+. ........         
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRI-FRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH-HHHhCCCChhhhhhhhH
Confidence            2 122345788999999876544 6889999999999999999999996422  11111111 11110000         


Q ss_pred             -------cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          995 -------EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       995 -------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                             ........ ..........++.+++.+|++.||++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQD-FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccC-HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                   00000000 00001122346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-33  Score=311.67  Aligned_cols=267  Identities=24%  Similarity=0.302  Sum_probs=197.2

Q ss_pred             CCcccCeEeccCceEEEEEEEC---CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT---NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRL  839 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  839 (1048)
                      +|++.+.||+|+||.||+|...   ++..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999875   47899999998633   33345678899999999999999999999988  7899


Q ss_pred             EEEEeccCCChhhhcccccCC-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC----CCcEEEeec
Q 001591          840 LIYSYMENGSLDYWLHESVDK-DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADF  914 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~Df  914 (1048)
                      +||||+++ ++.+++...... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 566655443322 34789999999999999999999986   9999999999999999    999999999


Q ss_pred             ccccccCCCCC--ceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCC------chhHHHH
Q 001591          915 GLSRLLRPYDT--HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN------CRDLVSW  985 (1048)
Q Consensus       915 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~------~~~~~~~  985 (1048)
                      |++........  .......+++.|+|||++.+ ..++.++||||||+++|||++|++||.......      .......
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987543222  11223578899999997765 457899999999999999999999997543221      0011111


Q ss_pred             HHHhhcccc------------ccc---c-----cc-cccCchhhH--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          986 VFQMKSEKR------------EVE---I-----ID-ASIWHKDRE--KQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       986 ~~~~~~~~~------------~~~---~-----~~-~~~~~~~~~--~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +........            ...   .     .. .........  ....++.+++.+|+++||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111110000            000   0     00 000000000  23347899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-33  Score=331.06  Aligned_cols=266  Identities=20%  Similarity=0.255  Sum_probs=189.7

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC--CCcEEEEE------------------EecCCchhhHHHHHHHHHHHHhcCCCce
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT--NGTKAAVK------------------RLSGDCGQMEREFQAEVEALSRAQHKNL  825 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ni  825 (1048)
                      .++|++.+.||+|+||+||+|.++  ++..+++|                  .+. ........+.+|++++++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            468999999999999999998754  22222222                  111 112234568899999999999999


Q ss_pred             eeecceEeeCCcEEEEEEeccCCChhhhccccc-CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001591          826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV-DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  904 (1048)
Q Consensus       826 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~  904 (1048)
                      +++++++...+..|+|+|++.+ ++.+++.... ..........+..|+.|++.||+|||+.   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            9999999999999999999854 6666654321 1122334667889999999999999986   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCC-CcccCCCCchhHH
Q 001591          905 EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLV  983 (1048)
Q Consensus       905 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P-~~~~~~~~~~~~~  983 (1048)
                      .++.+||+|||+++.+...........+||+.|+|||++.+..++.++|||||||++|||++|..+ +..........+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987654433334456899999999999999999999999999999999998754 4332222222222


Q ss_pred             HHHHHhhccccccccccc----------c----cCchhh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          984 SWVFQMKSEKREVEIIDA----------S----IWHKDR-----EKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~----------~----~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..+......  ..++.+.          .    .....+     ......+.+++.+|++.||++|||+.|+++
T Consensus       382 ~~~~~~~~~--~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        382 KIIDSLSVC--DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHhcccC--hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            211111000  0000000          0    000000     011235678899999999999999999986

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-33  Score=308.61  Aligned_cols=262  Identities=23%  Similarity=0.359  Sum_probs=196.3

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57889999999999999999876 689999999875432 2234567899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++ +|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||.++......
T Consensus        85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            985 898887643   34688999999999999999999986   99999999999999999999999999987543211


Q ss_pred             CceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc---cc--
Q 001591          925 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV---EI--  998 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--  998 (1048)
                       .......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.....  ..+....+..........   ..  
T Consensus       158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence             11122356889999998765 4578999999999999999999999964321  111111111111100000   00  


Q ss_pred             ----ccc--ccC--c---hhhHHH--HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          999 ----IDA--SIW--H---KDREKQ--LLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       999 ----~~~--~~~--~---~~~~~~--~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                          ...  ...  .   ......  ..++.+++.+|++++|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                000  000  0   000011  156789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.4e-33  Score=302.05  Aligned_cols=248  Identities=23%  Similarity=0.408  Sum_probs=200.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|+..+.||+|+||.||+|... +++.+|+|++....  ......+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788999999999999999875 68899999986542  33456788999999999999999999999989999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-CcEEEeecccccccCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~a~~~~~~  923 (1048)
                      +++++|.+++...  ....+++..+.+++.++++|++|||+.   +++||||||+||+++++ +.+|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999998753  244589999999999999999999986   99999999999999854 46899999999876432


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      .  ......|+..|+|||...+..++.++||||||+++|+|++|+.||....   .......+.   ... ....     
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~~---~~~-~~~~-----  221 (256)
T cd08220         156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVLKIM---SGT-FAPI-----  221 (256)
T ss_pred             c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc---hHHHHHHHH---hcC-CCCC-----
Confidence            2  1223568899999999998889999999999999999999999986422   111221111   111 0011     


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                          +.....++.+++.+|++.+|++|||+.|+++
T Consensus       222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                1123347889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8e-33  Score=307.32  Aligned_cols=247  Identities=22%  Similarity=0.341  Sum_probs=198.3

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      |+....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334557999999999999875 6899999998755444556788999999999999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      ++|.+++..     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++....... ..
T Consensus       103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~  173 (297)
T cd06659         103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK  173 (297)
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence            999887643     3578999999999999999999986   99999999999999999999999999987654322 12


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      .....|++.|+|||++.+..++.++||||||+++|||++|+.||....   ......   ....... ...       ..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~~~~---~~~~~~~-~~~-------~~  239 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMK---RLRDSPP-PKL-------KN  239 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHhccCC-CCc-------cc
Confidence            233578999999999998889999999999999999999999996321   111111   1111110 000       00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .......+.+++.+|++.+|++||++.++++
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            1112346889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-32  Score=307.89  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=198.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999876 67899999987543   223356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++....
T Consensus        81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999999864    34589999999999999999999986   999999999999999999999999999874211


Q ss_pred             CC--------------CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHH
Q 001591          923 YD--------------THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ  988 (1048)
Q Consensus       923 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~  988 (1048)
                      ..              ........|+..|+|||.+....++.++|+||||+++|||++|+.||....   ..+..   ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~---~~  227 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELF---GQ  227 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH---HH
Confidence            00              001112467889999999988889999999999999999999999996321   11111   11


Q ss_pred             hhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      ..... .   ..+..    ....+.++.+++.+|++.+|++||++.++.+.|+
T Consensus       228 ~~~~~-~---~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         228 VISDD-I---EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHhcc-c---CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            11110 0   00000    0123346899999999999999999765655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-32  Score=302.00  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=199.0

Q ss_pred             CcccCeEeccCceEEEEEEEC----CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC------
Q 001591          769 FNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  836 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  836 (1048)
                      |++.++||+|+||.||+|.+.    ++..||+|++....  ....+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999754    36889999987543  334566889999999999999999999886542      


Q ss_pred             cEEEEEEeccCCChhhhccccc--CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          837 DRLLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                      ..++++||+++|+|.+++....  .....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988875332  1223578999999999999999999985   9999999999999999999999999


Q ss_pred             ccccccCCCCCce-eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcc
Q 001591          915 GLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE  992 (1048)
Q Consensus       915 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  992 (1048)
                      |.++......... .....+++.|++||......++.++||||||+++|||++ |++||....   ..+...++..   .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~---~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLIK---G  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHHHHc---C
Confidence            9998754322211 122345678999999988889999999999999999999 889986321   1222222111   1


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          993 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ....          ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus       232 ~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1100          0012234789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-33  Score=304.18  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=201.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcC---CCceeeecceEeeCCcEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQ---HKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.... .....++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777889999999999999874 78999999987543 334456889999999997   999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++++|.+++..     ..+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            99999999988753     2689999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ... ......|+..|+|||...+ ..++.++|+||||+++|+|++|+.||.....      ..+...... .....    
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~~~~~-~~~~~----  221 (277)
T cd06917         154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMMLIPK-SKPPR----  221 (277)
T ss_pred             Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhhcccc-CCCCC----
Confidence            332 2234578999999998765 4568899999999999999999999964221      111111111 00011    


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                       ....   ....++.+++.+|++.+|++||++.|+++  ++++..
T Consensus       222 -~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         222 -LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             -CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence             1000   13347889999999999999999999986  555543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-32  Score=303.52  Aligned_cols=244  Identities=23%  Similarity=0.302  Sum_probs=199.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|++|.||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999999876 68999999986432   223456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999998864    35689999999999999999999986   999999999999999999999999999987543


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .    .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||....   .......+.   ... .       
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~---~~~-~-------  215 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKIL---EGK-V-------  215 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHh---cCC-c-------
Confidence            3    234578999999999888888999999999999999999999996422   111111111   110 0       


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                         ..+......+.+++.+|++.+|.+||     +++|+++
T Consensus       216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               00111234788999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.5e-32  Score=302.39  Aligned_cols=246  Identities=25%  Similarity=0.381  Sum_probs=199.5

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      -|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+..+++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3677889999999999999865 68899999886433 334467889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++++|.+++..     ..+++..+..++.+++.|++|||+.   +++|+||+|+||+++.++.++++|||++........
T Consensus        85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            99999998853     3578999999999999999999985   999999999999999999999999999876543221


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       ......|+..|+|||...+..++.++|+|||||++|+|++|+.||.....   ....   ....... ..         
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~---~~~~~~~-~~---------  219 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVL---FLIPKNN-PP---------  219 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHH---HHHhcCC-CC---------
Confidence             12234688899999999888899999999999999999999999863221   1111   1111111 00         


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ........++.+++.+|++.+|.+||++.++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            111223447889999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.8e-33  Score=306.87  Aligned_cols=264  Identities=21%  Similarity=0.254  Sum_probs=196.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcC-CCceeeecceEeeCCc-----
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGND-----  837 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  837 (1048)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....  .....+.+|++++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999876 689999998765432  22356788999999995 6999999999987665     


Q ss_pred             EEEEEEeccCCChhhhcccccCC-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCcEEEeecc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDK-DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFG  915 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg  915 (1048)
                      .|+||||+++ ++.+++...... ...+++..++.++.||+.||+|||+.   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 788887654322 45689999999999999999999986   9999999999999998 8999999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      .++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||.....   ......+........
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE---LQQLLHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHhCCCC
Confidence            99865332211 122357889999997754 4578999999999999999999999964221   111111111110000


Q ss_pred             c---ccccc-------cccC----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          995 E---VEIID-------ASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       995 ~---~~~~~-------~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .   .....       +...    ....+....++.+++.+|++.+|.+||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   00000       0000    0001123457899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-32  Score=306.92  Aligned_cols=245  Identities=27%  Similarity=0.386  Sum_probs=195.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      +.|+..+.||+|+||.||+|... +++.||+|++....   ....+++.+|++++++++||||+++++++.+++..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999875 68999999886432   233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||++ |++.+++...   ...+++..+..++.|++.|+.|||+.   +|+||||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 5666665432   34589999999999999999999986   999999999999999999999999999876543


Q ss_pred             CCCceeecccccccccCccccC---cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      .     ....|++.|+|||++.   ...++.++||||||+++|||++|++||.....   ..   ......... ...  
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~---~~~~~~~~~-~~~--  233 (307)
T cd06607         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MS---ALYHIAQND-SPT--  233 (307)
T ss_pred             C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HH---HHHHHhcCC-CCC--
Confidence            2     2346788999999874   45688999999999999999999999863211   11   111111111 000  


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            ........++.+++.+||+.+|++||++.+++.
T Consensus       234 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         234 ------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             ------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  011224457899999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.5e-32  Score=293.76  Aligned_cols=249  Identities=28%  Similarity=0.474  Sum_probs=204.8

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      +|+..+.||+|++|.||+|... ++..+++|++........+.+.+|++++++++||+++++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999886 788999999987655566789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +++|.+++...   ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999988653   25689999999999999999999985   999999999999999999999999999987654332 


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCch
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                       .....++..|+|||...+..++.++||||||+++|+|++|+.||.....      ......... .........     
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~~-----  220 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIAT-NGPPGLRNP-----  220 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHh-cCCCCcCcc-----
Confidence             2345788999999999888899999999999999999999999864221      111111111 111111111     


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1007 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        ......+.+++.+|++.+|++|||+.|+++
T Consensus       221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             --cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              112347899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-32  Score=302.89  Aligned_cols=252  Identities=22%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      |+..+.||+|++|.||+|... +++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            455678999999999999865 7889999998755555556788999999999999999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      ++|.+++..     ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+........ .
T Consensus       101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~  171 (285)
T cd06648         101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R  171 (285)
T ss_pred             CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence            999998864     3578999999999999999999986   999999999999999999999999998876543221 2


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      .....|++.|+|||...+..++.++||||||+++|||++|+.||....   ....   ....... ......       .
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~---~~~~---~~~~~~~-~~~~~~-------~  237 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP---PLQA---MKRIRDN-LPPKLK-------N  237 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC---HHHH---HHHHHhc-CCCCCc-------c
Confidence            233568999999999988889999999999999999999999986321   1111   1111111 000000       0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      .......+.+++.+|++.+|++||++.++++  +++..
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA  275 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence            1113347899999999999999999999986  44443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.3e-32  Score=302.08  Aligned_cols=262  Identities=22%  Similarity=0.329  Sum_probs=199.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      +|+..+.||.|++|.||+|+.. +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999986 689999999875532 23455778999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++ +|.+++.... ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+........
T Consensus        81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 7888776432 234689999999999999999999986   999999999999999999999999999976543221


Q ss_pred             ceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc---ccccc--
Q 001591          926 HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR---EVEII--  999 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--  999 (1048)
                       ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|++||.....   .+....+........   .....  
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN---EDQLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhHHHHhcC
Confidence             1223467889999998755 4578899999999999999999999974322   122211111110000   00000  


Q ss_pred             ---cc-------ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1000 ---DA-------SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1000 ---~~-------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                         ..       .......+.....+.+++.+|++.+|.+||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               00       0001111233457889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.8e-33  Score=300.78  Aligned_cols=247  Identities=26%  Similarity=0.326  Sum_probs=201.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      +|++.+.||.|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999876 68999999987543   2345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++++|.+++..    ...+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++++|||.+......
T Consensus        81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            9999999998864    24688999999999999999999986   9999999999999999999999999999875432


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      .  ......|+..|+|||...+..++.++|+||+|+++|+|++|+.||.......    ..+....... ...       
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~~~-------  219 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET-ADV-------  219 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-ccc-------
Confidence            2  2234568889999999988889999999999999999999999997543221    1111111111 000       


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFI--EEVV 1037 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~--~evl 1037 (1048)
                        ..+...+..+.+++.+|++.||.+||++  +|++
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              1111233578899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-32  Score=306.04  Aligned_cols=261  Identities=23%  Similarity=0.287  Sum_probs=197.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  841 (1048)
                      ++|++.+.||.|+||.||+|.+. +++.+|+|.++....  .....+.+|++++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999886 688999999874432  2234567899999999999999999999877  789999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++ +|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||.+....
T Consensus        85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999975 888887653   23689999999999999999999986   99999999999999999999999999998765


Q ss_pred             CCCCceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc-------
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK-------  993 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-------  993 (1048)
                      .... ......+++.|+|||.+.+. .++.++|+||+|+++|||++|++||......   +....+.......       
T Consensus       158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHHHHH
Confidence            4321 12234678899999987654 4688999999999999999999999743221   1111111111000       


Q ss_pred             ----------ccccccccccCchhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          994 ----------REVEIIDASIWHKDREK-QLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       994 ----------~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                                ..............+.. ....+.+++.+|++.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                      00000000000111111 2457889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-33  Score=313.11  Aligned_cols=266  Identities=26%  Similarity=0.389  Sum_probs=198.0

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC-----cE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----DR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  838 (1048)
                      +++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.++++++||||+++++++...+     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 78999999986432 234456788999999999999999999876543     47


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++|+||+++ ++.+++.     ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            999999975 7776664     34589999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCc--eeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc
Q 001591          919 LLRPYDTH--VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  995 (1048)
Q Consensus       919 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1048)
                      ........  ......|++.|+|||.+.+ ..++.++||||+||++|+|++|++||....   .......+.........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~---~~~~~~~~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YLHQLNLILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCH
Confidence            65432211  1233578999999997654 568999999999999999999999996421   11111111111111000


Q ss_pred             c---cccc-----------ccc---CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          996 V---EIID-----------ASI---WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       996 ~---~~~~-----------~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      .   .+.+           ...   +....+....++.+++.+|++.+|++||++.|+++  +++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            0   0000           000   00011123457899999999999999999999987  45443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-32  Score=308.06  Aligned_cols=267  Identities=26%  Similarity=0.327  Sum_probs=199.5

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLL  840 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  840 (1048)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++....  .....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457999999999999999999875 689999999874432  2223466899999999999999999998765  46899


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ||||+++ +|.+++...   ...+++.++..++.|+++|++|||+.   +++||||||+||++++++.+||+|||.+...
T Consensus        86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999975 787777642   25689999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc---
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV---  996 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---  996 (1048)
                      ..... ......+++.|+|||.+.+ ..++.++||||+|+++|||++|++||....   ..+....+..........   
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~---~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS---EIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCChhhch
Confidence            53321 1223356788999998765 567899999999999999999999996432   222222222211110000   


Q ss_pred             ---------cc-cccccCc---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          997 ---------EI-IDASIWH---KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       997 ---------~~-~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                               .. .......   .........+.+++.+|++.||++|||+.|+++  ++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                     00 0000000   000112457789999999999999999999986  55543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-32  Score=305.93  Aligned_cols=264  Identities=27%  Similarity=0.346  Sum_probs=198.2

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC-----
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----  836 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  836 (1048)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|+++...  ......+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567999999999999999999986 68899999987543  223346788999999999999999999987654     


Q ss_pred             -----cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEE
Q 001591          837 -----DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  911 (1048)
Q Consensus       837 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  911 (1048)
                           ..++|+||+++ ++.+.+...   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence                 78999999986 666665532   34689999999999999999999986   9999999999999999999999


Q ss_pred             eecccccccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001591          912 ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       912 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      +|||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|++||....   ..+....+....
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~---~~~~~~~~~~~~  234 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ---ELAQLELISRLC  234 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHh
Confidence            9999998765433222223356788999997754 457899999999999999999999996422   222222222221


Q ss_pred             ccccc---cccccccc-------------CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          991 SEKRE---VEIIDASI-------------WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       991 ~~~~~---~~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .....   ..+.....             ........+..+.+++.+|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11100   00000000             00011122457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=302.71  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=198.8

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEEEEEE
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLIYS  843 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  843 (1048)
                      |++.+.||.|++|.||+|+.. +++.+|+|++....  ......+.+|++++++++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999877 58899999998653  33345688899999999999999999999988  78999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++ +|.+++...   ...+++..++.++.|+++|++|||+.   +++|+||||+||++++++.++++|||.+......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 788777542   24689999999999999999999986   9999999999999999999999999999876544


Q ss_pred             CCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc---cc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE---II  999 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  999 (1048)
                      .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....   ......+...........   ..
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---LEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchhhccccc
Confidence            3222334467889999997654 4678999999999999999999999964332   122222222111100000   00


Q ss_pred             c----------cccC---chhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1000 D----------ASIW---HKDREK-QLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1000 ~----------~~~~---~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +          ....   ...... ....+.+++.+|++.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0          0000   000011 2557899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-32  Score=296.56  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=200.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|+..+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|+.++++++|+||+++++++..++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999876 68899999986532  23345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-cEEEeecccccccCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPY  923 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~a~~~~~~  923 (1048)
                      +++++|.+++...  ....+++..+..++.|+++|++|||+.   +++|+||||+||++++++ .+|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999988653  234579999999999999999999986   999999999999999875 4699999999876432


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      .. ......|++.|+|||+..+..++.++|+||||+++|||++|+.||....      ...++....... ...      
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~------  221 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGY-FAP------  221 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhccc-CCC------
Confidence            22 2223468899999999988889999999999999999999999986321      112222222111 100      


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                         .......++.+++.+|++.+|++|||+.|+++
T Consensus       222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               11122346889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=302.26  Aligned_cols=260  Identities=23%  Similarity=0.304  Sum_probs=195.8

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      |++.+.||.|++|.||+|.+. +|..||+|++....  ......+.+|++++++++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999875 79999999987543  223356788999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      + ++|.+++....  ...+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++|||.+........
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 68988886532  24689999999999999999999986   999999999999999999999999999976543221


Q ss_pred             ceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc---------c
Q 001591          926 HVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR---------E  995 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---------~  995 (1048)
                       ......+++.|+|||++.+. .++.++||||||+++|||++|++||.....  ...... +........         .
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFR-IFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHHHhCCCChHHhhhhhhc
Confidence             11223568899999987654 578899999999999999999999964221  111111 111100000         0


Q ss_pred             cc----ccc--cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          996 VE----IID--ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       996 ~~----~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .+    ...  ..............+.+++.+|++.+|++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00    000  00000111122357889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.7e-33  Score=325.99  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=188.4

Q ss_pred             HhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeecceEeeC------
Q 001591          764 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------  835 (1048)
Q Consensus       764 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  835 (1048)
                      +...+|+..++||+||||.||+++.+ ||+.||||++.... ......+.+|+..+++++|||||+++..|.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888999999999999999988 99999999998653 33445688999999999999999998521000      


Q ss_pred             --------------------------------------------------------------------------------
Q 001591          836 --------------------------------------------------------------------------------  835 (1048)
Q Consensus       836 --------------------------------------------------------------------------------  835 (1048)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHH
Q 001591          836 ---------------------------------NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY  882 (1048)
Q Consensus       836 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~  882 (1048)
                                                       ...|+-||||+..++.+++++.....   .....++++++|++||+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence                                             01367788888877777776432111   467889999999999999


Q ss_pred             HHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC----------C-------CCCceeecccccccccCccccCc
Q 001591          883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR----------P-------YDTHVTTDLVGTLGYIPPEYSQT  945 (1048)
Q Consensus       883 LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~----------~-------~~~~~~~~~~gt~~y~aPE~~~~  945 (1048)
                      +|++   |||||||||.||++|+++.|||+|||+|+...          .       ......+..+||.-|+|||++.+
T Consensus       713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            9986   99999999999999999999999999998721          0       00112345689999999998776


Q ss_pred             C---CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHc
Q 001591          946 L---TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKC 1022 (1048)
Q Consensus       946 ~---~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 1022 (1048)
                      .   .|+.|+|+||+|||++||+.   ||..     ..+.+..+.... .+..+..  +.++.    .....=.++|++|
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa~iL~~LR-~g~iP~~--~~f~~----~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERASILTNLR-KGSIPEP--ADFFD----PEHPEEASLIRWL  854 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCc-----hHHHHHHHHhcc-cCCCCCC--ccccc----ccchHHHHHHHHH
Confidence            5   49999999999999999995   5642     122222222222 2222211  11111    1222446899999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 001591         1023 IDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1023 l~~~P~~RPt~~evl~ 1038 (1048)
                      ++.||.+|||+.|+++
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999986

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.5e-32  Score=300.26  Aligned_cols=257  Identities=22%  Similarity=0.216  Sum_probs=193.7

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCceeeecceEeeC--CcEEEEEE
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHG--NDRLLIYS  843 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  843 (1048)
                      |++.+.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |||++++++++.++  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999865 68999999987542 222234457888898885 99999999999987  88999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++ ++.+++...   ...+++.++..++.|++.||+|||+.   +++||||||+||++++ +.+||+|||.++.....
T Consensus        81 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMDM-NLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCCc-cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            9974 777776542   34689999999999999999999986   9999999999999999 99999999999875432


Q ss_pred             CCceeecccccccccCccccC-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc--------
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR--------  994 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------  994 (1048)
                      ..  .....++..|+|||... +..++.++||||+||++|||++|++||....   ..+.+.+.........        
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN---ELDQIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC---HHHHHHHHHHHcCCCCHHHHHhhc
Confidence            21  22346789999999654 4567889999999999999999999996432   2222222222111100        


Q ss_pred             ---cccccccccC----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          995 ---EVEIIDASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       995 ---~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                         ......+...    .......+.++.+++.+|++++|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence               0000000000    0011234568999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.6e-33  Score=307.29  Aligned_cols=247  Identities=24%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh--hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .+.|.+.+.||+|.|+.|.+|++. ++..||+|.+.+....  ....+.+|+++|+.++|||||+++.+.......|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467889999999999999999876 7999999999876532  2345889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+.+|.+++|+..    ........+..++.|+.+|++|+|+.   .|||||||++||+++.+.++||+|||++..+..
T Consensus       135 eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999975    33455588999999999999999985   999999999999999999999999999998763


Q ss_pred             CCCceeecccccccccCccccCcCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                        .......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.+-++               +++-.
T Consensus       208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~g  270 (596)
T KOG0586|consen  208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRG  270 (596)
T ss_pred             --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheee
Confidence              334456799999999999998776 579999999999999999999998532111000               00111


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .+  ..+.....+..+++++++..+|.+|++++++.+
T Consensus       271 k~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  271 KY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            11  111122336779999999999999999999986

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=337.61  Aligned_cols=251  Identities=28%  Similarity=0.394  Sum_probs=203.3

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      +-+++....||.|.||.||-|... +|+-.|+|-+....  ....+.+.+|+.++..++|||+|+++|+-.+.+..++.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            346677889999999999999854 79999999876543  333456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      |||++|+|.+.++.    ++..++.....+..|++.|++|||++   |||||||||+||+++.+|.+|.+|||.|..+..
T Consensus      1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999998873    55577788888999999999999998   999999999999999999999999999998764


Q ss_pred             CCCce---eecccccccccCccccCcC---CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          923 YDTHV---TTDLVGTLGYIPPEYSQTL---TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       923 ~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      .....   -....||+.|||||++.+.   ....++||||+|||+.||+||+.||....     .-++.++... .+.. 
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-----ne~aIMy~V~-~gh~- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-----NEWAIMYHVA-AGHK- 1459 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-----chhHHHhHHh-ccCC-
Confidence            42111   2246899999999998764   45678999999999999999999996422     1122222222 1111 


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                              .+.++....+-.+++..|++.||++|+++.|+++
T Consensus      1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                    1233445667889999999999999999998876

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.1e-32  Score=297.50  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=206.5

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|++.+.||+|+||.||+|.+. ++.+||+|++.....  ...+.+.+|+++++.++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999876 689999999876533  4556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++.........+++..+..++.+++.|++|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999876544457799999999999999999999986   99999999999999999999999999998765432


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                       .......|++.|+|||...+..++.++|+||+|+++|+|++|+.||....   ......   ..... ....       
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~---~~~~~-~~~~-------  222 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL---KILKG-QYPP-------  222 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHH---HHhcC-CCCC-------
Confidence             23334578999999999888889999999999999999999999986422   111111   11111 1100       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        .+......+.+++.+|+..+|++||++.|+++
T Consensus       223 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 --IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              11122347889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-32  Score=311.43  Aligned_cols=270  Identities=24%  Similarity=0.368  Sum_probs=202.5

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEee----CCcE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH----GNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  838 (1048)
                      .++|++.+.||+|++|.||+|... +|..||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367999999999999999999865 69999999987543  2334567789999999999999999998763    3467


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+. |+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999996 588888753    34589999999999999999999986   99999999999999999999999999997


Q ss_pred             ccCCCCC---ceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          919 LLRPYDT---HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       919 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      .......   .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......   .....+........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~---~~~~~~~~~~g~~~  232 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV---HQLKLILSVLGSPS  232 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH---HHHHHHHHHhCCCh
Confidence            6543221   11234578999999998755 56889999999999999999999999643211   11111111111000


Q ss_pred             -----------cccc---cc---cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCcc
Q 001591          995 -----------EVEI---ID---ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1046 (1048)
Q Consensus       995 -----------~~~~---~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~~ 1046 (1048)
                                 ..+.   ..   ...+.........++.+++.+|++.+|++||+++++++  ++++.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                       0000   00   00001111233567999999999999999999999987  77665443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.7e-32  Score=298.08  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=204.0

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|++.+.||+|+||.||++... +++.+|+|.+....  .....++.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999765 78899999987542  23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++.........+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+|++|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999876444456789999999999999999999986   9999999999999999999999999999876543 


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                        ......+++.|+|||...+..++.++|+||+|+++|||++|+.||.....   ......+    .....         
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~----~~~~~---------  218 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKV----QRGKY---------  218 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----hcCCC---------
Confidence              22234688899999999998999999999999999999999999964221   1111111    11111         


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .........++.+++.+|++.+|++||++.|+++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1112234457899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.5e-32  Score=300.02  Aligned_cols=256  Identities=26%  Similarity=0.406  Sum_probs=206.0

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ..+.|+..+.||+|++|.||+|.+. ++..||+|++..... ....+.+|++++++++|+|++++++++...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3456888889999999999999887 789999999986544 45678899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++++|.+++....   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999997532   3689999999999999999999985   9999999999999999999999999998765432


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      .. ......++..|+|||...+..++.++|+||||+++|+|++|+.||......   ..   ....... ......    
T Consensus       170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~---~~~~~~~-~~~~~~----  237 (286)
T cd06614         170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RA---LFLITTK-GIPPLK----  237 (286)
T ss_pred             hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhc-CCCCCc----
Confidence            21 122345788999999998888999999999999999999999998632111   11   1111111 111100    


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~ 1042 (1048)
                         ........+.+++.+|++.+|.+||++.++++  +++.
T Consensus       238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         238 ---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             ---chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence               11113457899999999999999999999986  5544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.7e-32  Score=303.68  Aligned_cols=260  Identities=26%  Similarity=0.377  Sum_probs=197.4

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999876 68999999987543 334567889999999996 99999999999999999999999


Q ss_pred             ccCCChhhhcccc-cCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          845 MENGSLDYWLHES-VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       845 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      +.. ++.++.... ......+++..+..++.+++.|++|||+.  .+++||||||+||++++++.++|+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 554433211 11235689999999999999999999973  48999999999999999999999999999765432


Q ss_pred             CCceeecccccccccCccccCcC---CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTL---TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ..  .....|++.|+|||++.+.   .++.++||||+||++|||++|+.||....     .....+........      
T Consensus       162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~------  228 (288)
T cd06616         162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDP------  228 (288)
T ss_pred             Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCC------
Confidence            21  1233688999999988765   68999999999999999999999996432     11111111111110      


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      +..........+.++.+++.+|++.+|++||++.++++  +++..
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            01111111234457899999999999999999999987  55443

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-33  Score=275.57  Aligned_cols=250  Identities=25%  Similarity=0.416  Sum_probs=195.6

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +.+....||.|..|.||+++++ +|...|||.+..... +..+.+...++++.+-+ .|+||+.+|||..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3445677999999999999877 689999999986543 33355777788777665 89999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      |.. .+++.+...   ..++++..+-++...+++||.||...  .+|+|||+||+|||+|+.|++|++|||.+.++-.. 
T Consensus       173 Ms~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-  245 (391)
T KOG0983|consen  173 MST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-  245 (391)
T ss_pred             HHH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc-
Confidence            865 355555542   44588999999999999999999874  59999999999999999999999999999876533 


Q ss_pred             CceeecccccccccCccccCc---CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                       ...+...|-+.|||||.+..   ..|+.++||||||+.++||.||+.||..+.  ...+....+..   .++  ..++.
T Consensus       246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln---~eP--P~L~~  317 (391)
T KOG0983|consen  246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLN---EEP--PLLPG  317 (391)
T ss_pred             -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHh---cCC--CCCCc
Confidence             23344589999999997764   478899999999999999999999998643  22333333332   111  11111


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .      ...+..+.+++..|+++|+.+||...++++
T Consensus       318 ~------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  318 H------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             c------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            1      113457899999999999999999998875

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-32  Score=310.46  Aligned_cols=266  Identities=23%  Similarity=0.322  Sum_probs=199.9

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeC-----Cc
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-----ND  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  837 (1048)
                      .++|++.+.||+|+||+||+|+.. +++.||+|.+...  .......+.+|+.++++++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999999865 6899999998753  223345677899999999999999999988654     24


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .++|+||+. ++|.+++..    ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 678777753    34689999999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc--
Q 001591          918 RLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR--  994 (1048)
Q Consensus       918 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--  994 (1048)
                      +...... .......++..|+|||.+.. ..++.++||||||+++|+|++|++||.....   ......+........  
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY---VHQLKLITELLGSPSEE  231 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCChH
Confidence            8754322 22234568899999997754 4688999999999999999999999964321   111111111110000  


Q ss_pred             -c--------ccc-------cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591          995 -E--------VEI-------IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       995 -~--------~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                       .        ...       ..... .........++.+++.+|++.+|++||+++|+++  +++.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence             0        000       00000 0011234457899999999999999999999996  566543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-32  Score=309.65  Aligned_cols=268  Identities=25%  Similarity=0.340  Sum_probs=206.4

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC-----cEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----DRL  839 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  839 (1048)
                      +|++.+.||.|++|.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999876 58999999987643  334567899999999999999999999988775     789


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      +||||+++ +|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||.+..
T Consensus        81 lv~e~~~~-~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999984 78887763    33789999999999999999999986   999999999999999999999999999987


Q ss_pred             cCCCCC--ceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc-
Q 001591          920 LRPYDT--HVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE-  995 (1048)
Q Consensus       920 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-  995 (1048)
                      ......  .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|++||.....   .+....+......... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY---IDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHhcCCCChh
Confidence            654321  123345688999999998887 889999999999999999999999964321   1111111111110000 


Q ss_pred             ----------ccccc------cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCcc
Q 001591          996 ----------VEIID------ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1046 (1048)
Q Consensus       996 ----------~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~~ 1046 (1048)
                                ...+.      ...+..........+.+++.+|++++|++||++.++++  ++++++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                      00000      00000011123457899999999999999999999998  77776543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.9e-32  Score=307.69  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=198.2

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeC------
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------  835 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  835 (1048)
                      ..++|+..+.||+|+||.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3578999999999999999999875 78999999986432  23345677899999999999999999988643      


Q ss_pred             CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          836 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       836 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                      ...++||||+.+ +|.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            346999999965 77776642      278899999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc---
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE---  992 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---  992 (1048)
                      .++.....  .......+++.|+|||.+.+..++.++||||+||++|+|++|+.||.....   .+....+......   
T Consensus       164 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~  238 (353)
T cd07850         164 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGTPSD  238 (353)
T ss_pred             cceeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence            99875432  122345688999999999999999999999999999999999999964221   1111111100000   


Q ss_pred             ----------------cc------cccccccccC----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHH
Q 001591          993 ----------------KR------EVEIIDASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1041 (1048)
Q Consensus       993 ----------------~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~ 1041 (1048)
                                      ..      ..+.......    .........++.+++.+|++.||++|||+.|+++  +++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                            00      0000000000    0001123456889999999999999999999996  554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-32  Score=299.61  Aligned_cols=259  Identities=24%  Similarity=0.316  Sum_probs=199.7

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      |++.+.||.|++|.||+|... +++.+|+|++.....  .....+.+|++++++++||||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999875 788999999875432  24567888999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++ ++.+++...   ...+++..+..++.|++.|++|||+.   +|+|+||||+||++++++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 787777642   35689999999999999999999986   99999999999999999999999999998765433 


Q ss_pred             ceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc---cccc----
Q 001591          926 HVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK---REVE----  997 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~----  997 (1048)
                      .......++..|+|||...+. .++.++|+||+|+++|+|++|+.||.....   .+....+.......   ....    
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE---IDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCchHhcccchhh
Confidence            122334678899999988776 789999999999999999999999964221   11111111110000   0000    


Q ss_pred             -------ccccc--cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          998 -------IIDAS--IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       998 -------~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                             .....  ...........++.+++.+|+++||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                   00000  001112234568999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=324.42  Aligned_cols=259  Identities=26%  Similarity=0.275  Sum_probs=209.1

Q ss_pred             HHHHHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEee
Q 001591          759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRH  834 (1048)
Q Consensus       759 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  834 (1048)
                      +.++.-..++|++.++||+|+||.|..++++ +++.||.|++.+..   .....-|..|-++|...+.+-|++++..|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3455556789999999999999999999876 68899999987632   2233458889999999999999999999999


Q ss_pred             CCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       835 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                      +...|+|||||+||+|-..+..+   + ++++..++.++..|+-||.-+|+.   |+|||||||+|||+|..|++|++||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            99999999999999999988753   2 799999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeecccccccccCccccC----c-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHh
Q 001591          915 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ----T-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM  989 (1048)
Q Consensus       915 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~  989 (1048)
                      |.+..+..+..-.....+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||..      +.++.-...+
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KI  293 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKI  293 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHH
Confidence            999888766555556679999999999764    2 5789999999999999999999999963      2233222222


Q ss_pred             hcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 001591          990 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF---IEEVVT 1038 (1048)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~ 1038 (1048)
                      ........++       ...+++++..++|.+.+. +|+.|..   +.++..
T Consensus       294 m~hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  294 MNHKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hchhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            2222222221       112356678888888776 6777776   776654

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=9e-33  Score=278.84  Aligned_cols=268  Identities=24%  Similarity=0.297  Sum_probs=202.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC---C--CcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEee-CCcE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT---N--GTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH-GNDR  838 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  838 (1048)
                      ..|+.+..||+|.||.||+|.-.   +  ...+|+|+++...  ........+|+..++.++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46889999999999999999543   2  2368999998552  1223446889999999999999999999877 6788


Q ss_pred             EEEEEeccCCChhhhcccccC-CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC----CcEEEee
Q 001591          839 LLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK----FEAHLAD  913 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~D  913 (1048)
                      ++++||.+. +|...++..+. ....++...+..|+.||+.|+.|||++   -|+|||+||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 67766654432 345789999999999999999999986   89999999999999876    9999999


Q ss_pred             cccccccCCCCCc--eeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCC------CCchhHHH
Q 001591          914 FGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKG------KNCRDLVS  984 (1048)
Q Consensus       914 fg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~------~~~~~~~~  984 (1048)
                      ||+|+.+...-..  ....++-|..|+|||.+.+ ..||++.||||.|||+.||+|-++-|.+...      .-..+.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999987644322  2335678999999997665 5689999999999999999999988864321      11234455


Q ss_pred             HHHHhhcccccccccccccCchh-------h-----H----H-------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          985 WVFQMKSEKREVEIIDASIWHKD-------R-----E----K-------QLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~-------~-----~----~-------~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .++.........+..+-....++       +     .    .       .....++++.+++..||.+|.|+.++++
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            56655544333222221111111       0     0    0       0113679999999999999999999986

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.5e-32  Score=299.53  Aligned_cols=268  Identities=23%  Similarity=0.311  Sum_probs=198.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ++|++.+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999876 78899999886442  2233568889999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCcEEEeecccccccCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~a~~~~~  922 (1048)
                      |++ +++.+++...  ....+++..+..++.|++.||+|||+.   +++||||+|+||++++ ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 4777766432  233467888999999999999999985   9999999999999985 56799999999976543


Q ss_pred             CCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc----
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE----  997 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~----  997 (1048)
                      ... ......+++.|+|||++.+ ..++.++||||+|+++|+|++|++||....   ..+....+...........    
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS---EIDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChhhcccc
Confidence            211 1223467889999998765 457899999999999999999999996422   1111111111111100000    


Q ss_pred             --ccc-----cccC----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591          998 --IID-----ASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       998 --~~~-----~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                        ..+     +...    .........++.+++.+|++.+|++||++.++++  ++++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence              000     0000    0001123456889999999999999999999986  666554

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-31  Score=293.16  Aligned_cols=251  Identities=22%  Similarity=0.252  Sum_probs=193.1

Q ss_pred             cHHHHHHhhcCCcccCeE--eccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEe
Q 001591          758 TVSDLLKSTNNFNQANII--GCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCR  833 (1048)
Q Consensus       758 ~~~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  833 (1048)
                      +..+.....++|++.+.+  |.|+||.||++... ++..+|+|.+.......     .|+.....+ +||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe
Confidence            344555556677777777  99999999999865 68889999986432111     122222222 6999999999999


Q ss_pred             eCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-cEEEe
Q 001591          834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLA  912 (1048)
Q Consensus       834 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~  912 (1048)
                      .++..++||||+++++|.+++...    ..+++.++..++.|+++|++|||+.   +++||||||+||+++.++ .++|+
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence            999999999999999999998642    3789999999999999999999986   999999999999999888 99999


Q ss_pred             ecccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc
Q 001591          913 DFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE  992 (1048)
Q Consensus       913 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  992 (1048)
                      |||.+......     ....|+..|+|||++.+..++.++||||+|+++|||++|+.||....... .+...+.... . 
T Consensus       153 dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~-  224 (267)
T PHA03390        153 DYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-Q-  224 (267)
T ss_pred             cCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-c-
Confidence            99998765422     12468899999999999899999999999999999999999997432211 1111111111 1 


Q ss_pred             cccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 001591          993 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF-IEEVVT 1038 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~ 1038 (1048)
                      ...          .........+.+++.+|++.+|.+||+ ++|+++
T Consensus       225 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 KKL----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ccC----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            000          001123447899999999999999996 688874

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.9e-32  Score=303.46  Aligned_cols=244  Identities=27%  Similarity=0.401  Sum_probs=193.8

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      |+..+.||+|+||.||+|+.. ++..||+|++....   ......+..|++++++++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667888999999999999865 68899999986432   23345688899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +.+ ++.+++..   ....+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++...... 
T Consensus       107 ~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         107 CLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            975 77666643   244589999999999999999999986   9999999999999999999999999998754321 


Q ss_pred             CceeecccccccccCccccC---cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                          ....|++.|+|||++.   ...++.++|||||||++|||++|+.||....   ....   .......... .    
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~---~~~~~~~~~~-~----  243 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSA---LYHIAQNESP-T----  243 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHH---HHHHHhccCC-C----
Confidence                2346888999999863   4568899999999999999999999986421   1111   1111111100 0    


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1039 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 1039 (1048)
                          .........+.+++.+|++.+|.+||++.++++.
T Consensus       244 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         244 ----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             ----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence                0111233468999999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.5e-32  Score=304.72  Aligned_cols=266  Identities=24%  Similarity=0.303  Sum_probs=193.6

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC------
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  836 (1048)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999876 68999999886432  222334678999999999999999999987654      


Q ss_pred             --cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          837 --DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       837 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                        ..++||||+.+ ++.+++..   ....+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence              34999999975 77776653   234689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCc---eeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001591          915 GLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       915 g~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      |.+.........   ......++..|+|||.+.+. .++.++||||||+++|||++|++||...........+..+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999865432211   12234678899999987654 47889999999999999999999996432221111111111000


Q ss_pred             cccccccc-----cc----cc-cCchhhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          991 SEKREVEI-----ID----AS-IWHKDRE-----KQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       991 ~~~~~~~~-----~~----~~-~~~~~~~-----~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ........     .+    +. .......     .....+.+++.+|++.+|++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000000     00    00 0000000     01235679999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.1e-32  Score=297.47  Aligned_cols=241  Identities=28%  Similarity=0.334  Sum_probs=186.2

Q ss_pred             eEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHh---cCCCceeeecceEeeCCcEEEEEEecc
Q 001591          774 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSR---AQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       774 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      +||+|+||.||+|... +++.+|+|.+.....   .....+.+|..+++.   .+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 688999998865321   222334445444443   479999999999999999999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +|+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++.......  
T Consensus        81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            9999988864    34589999999999999999999986   99999999999999999999999999987553221  


Q ss_pred             eeecccccccccCccccC-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       .....|++.|+|||... +..++.++||||+||++|||++|+.||.......... .   ...... .     ..    
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~---~~~~~~-~-----~~----  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I---DRMTLT-V-----NV----  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-H---HHHhhc-C-----Cc----
Confidence             12346899999999876 4568899999999999999999999996432221111 1   111100 0     00    


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                      ..+...+.++.+++.+|++.||++||     +++|+++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            11222345789999999999999999     5999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-31  Score=290.93  Aligned_cols=250  Identities=30%  Similarity=0.430  Sum_probs=204.2

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLIY  842 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  842 (1048)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999877 789999999876542  4456789999999999999999999999988  8899999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++++|.+++...    ..+++..+..++.|+++|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999998753    2789999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCc-eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          923 YDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       923 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      .... ......++..|+|||...+...+.++||||||+++|+|++|+.||....     +...............     
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-----  223 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP-----  223 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc-----
Confidence            3221 1233578899999999988889999999999999999999999997432     1111111111111111     


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                          ..+......+.+++.+|++.+|++||++.|+++
T Consensus       224 ----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         224 ----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                112222457999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=4.5e-32  Score=300.40  Aligned_cols=249  Identities=23%  Similarity=0.325  Sum_probs=199.2

Q ss_pred             cCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          772 ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      ...||+|+||.||+|... +++.||+|++..........+.+|+.++++++|+||+++++++..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            356999999999999875 7899999998755555566789999999999999999999999999999999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeec
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  930 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  930 (1048)
                      .+++..     ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||.+........ ....
T Consensus       105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~  175 (292)
T cd06657         105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS  175 (292)
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence            987743     3478999999999999999999986   999999999999999999999999999876543221 2233


Q ss_pred             ccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHH
Q 001591          931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010 (1048)
Q Consensus       931 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ..|++.|+|||...+..++.++|+||+|+++|||++|+.||....   .......+......    ..       .....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~---~~~~~~~~~~~~~~----~~-------~~~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPP----KL-------KNLHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhCCc----cc-------CCccc
Confidence            578999999999888888999999999999999999999986421   11111111111100    00       00011


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591         1011 QLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus      1011 ~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      ....+.+++.+|++.+|.+||++.++++  ++...
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence            2336789999999999999999999987  55443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=1.2e-31  Score=302.42  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=195.5

Q ss_pred             eEecc--CceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCC
Q 001591          774 IIGCG--GFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  848 (1048)
Q Consensus       774 ~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  848 (1048)
                      .||+|  +||+||+|.+. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999875 79999999987432  233467889999999999999999999999999999999999999


Q ss_pred             ChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce-
Q 001591          849 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-  927 (1048)
Q Consensus       849 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-  927 (1048)
                      ++.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+.......... 
T Consensus        85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999887542  23588999999999999999999985   99999999999999999999999998654322111100 


Q ss_pred             -----eecccccccccCccccCc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh----------
Q 001591          928 -----TTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK----------  990 (1048)
Q Consensus       928 -----~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~----------  990 (1048)
                           .....++..|+|||++.+  ..++.++||||+||++|||++|+.||......  ...........          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence                 001234567999998866  35789999999999999999999999643211  11111100000          


Q ss_pred             ----------------------cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCc
Q 001591          991 ----------------------SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       991 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~ 1045 (1048)
                                            .........+..............+.+++++|++.||++|||++|+++  ++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                  000000011111112223345678999999999999999999999986  7766543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.98  E-value=1.1e-31  Score=293.00  Aligned_cols=247  Identities=23%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             EeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      ||+|++|.||+|+.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999876 58999999987543   23446789999999999999999999999999999999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeec
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  930 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  930 (1048)
                      .+++..    ...+++..+..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||.+.......  ....
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            999864    23488999999999999999999986   99999999999999999999999999998764322  2233


Q ss_pred             ccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHH
Q 001591          931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010 (1048)
Q Consensus       931 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ..|++.|+|||...+..++.++|+||+|+++|+|++|+.||.....+    ..............         ...+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~---------~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGK---------LEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCC---------CCCCcc
Confidence            57889999999988888999999999999999999999999753321    11111111110110         011111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHH--HHHhc
Q 001591         1011 QLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDGI 1043 (1048)
Q Consensus      1011 ~~~~l~~li~~cl~~~P~~RPt-----~~evl~--~L~~i 1043 (1048)
                      ...++.+++.+|++.+|++||+     ++|+++  ++.+.
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence            2457899999999999999999     788776  55543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=3.5e-32  Score=308.25  Aligned_cols=268  Identities=25%  Similarity=0.340  Sum_probs=199.6

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhc-CCCceeeecceEeeC--CcEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHG--NDRL  839 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~  839 (1048)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467888999999999999999876 68899999886432  22334577899999999 999999999998654  3579


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      +||||++ ++|..++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+..
T Consensus        86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 488887753     2678999999999999999999986   999999999999999999999999999986


Q ss_pred             cCCCCC----ceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          920 LRPYDT----HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       920 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      ......    .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......   +....+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~  233 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL---NQLEKIIEVIGPPS  233 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC
Confidence            543322    12334578999999997654 56788999999999999999999999643211   11111111100000


Q ss_pred             -----------cccccc----ccc--CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCc
Q 001591          995 -----------EVEIID----ASI--WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       995 -----------~~~~~~----~~~--~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~ 1045 (1048)
                                 .....+    ...  ..........++.+++.+|++.+|++|||+.++++  +++.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                       000000    000  00001113457899999999999999999999997  5666543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.7e-32  Score=294.40  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=196.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeeecceEeeC--CcE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-----CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDR  838 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  838 (1048)
                      .+|++.+.||+|+||.||+|... ++..||+|++...     .......+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999865 6899999987532     123345788999999999999999999998764  457


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++|+||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.++
T Consensus        82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            899999999999988864    23478899999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCC--CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          919 LLRPYD--THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       919 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ......  ........|+..|+|||...+..++.++|+|||||++|||++|+.||....   ...   .+......... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~---~~~~~~~~~~~-  227 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE---AMA---AIFKIATQPTK-  227 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC---HHH---HHHHHHcCCCC-
Confidence            653211  111223568999999999988889999999999999999999999996321   111   11111111110 


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                              ...+.....++.+++.+|++ +|.+||++.+++.
T Consensus       228 --------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 --------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                    11122344578999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=9e-32  Score=296.08  Aligned_cols=244  Identities=26%  Similarity=0.342  Sum_probs=192.5

Q ss_pred             EeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      ||+|+||+||+|... +|+.||+|.+....   ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999765 68999999986432   12234567899999999999999999999999999999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeec
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  930 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  930 (1048)
                      .+++....  ...+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||.+......  .....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG  153 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence            99887532  24689999999999999999999986   9999999999999999999999999998765432  12233


Q ss_pred             ccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHH
Q 001591          931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010 (1048)
Q Consensus       931 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ..++..|+|||...+..++.++||||+|+++|+|++|+.||............   .......      .    ...+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~------~----~~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRTLEM------A----VEYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhccccc------c----ccCCcc
Confidence            46788999999988888999999999999999999999999643321111111   0000000      0    011112


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591         1011 QLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus      1011 ~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                      ....+.+++.+|++.+|++||     ++.++++
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            244788999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=1.4e-31  Score=297.00  Aligned_cols=256  Identities=18%  Similarity=0.236  Sum_probs=182.1

Q ss_pred             hcCCcccCeEeccCceEEEEEEECC----CcEEEEEEecCCchhh--H---------HHHHHHHHHHHhcCCCceeeecc
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDCGQM--E---------REFQAEVEALSRAQHKNLVSLQG  830 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l~~  830 (1048)
                      .++|++.+.||+|+||+||+|.+.+    +..+|+|+........  +         .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3579999999999999999998764    3466666543222111  1         11223334455668999999999


Q ss_pred             eEeeCC----cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC
Q 001591          831 YCRHGN----DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK  906 (1048)
Q Consensus       831 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~  906 (1048)
                      ++....    ..++++|++.. ++.+.+..    ....++..+..++.|+++|++|||+.   +|+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            776543    23566776643 44444432    22356788999999999999999986   99999999999999999


Q ss_pred             CcEEEeecccccccCCCCCc------eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCch
Q 001591          907 FEAHLADFGLSRLLRPYDTH------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR  980 (1048)
Q Consensus       907 ~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~  980 (1048)
                      +.++|+|||+|+.+......      ......||+.|+|||+..+..++.++|||||||++|||++|+.||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999876432211      112347999999999999999999999999999999999999999754221110


Q ss_pred             -hH--HHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          981 -DL--VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       981 -~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                       ..  .++.........         .   .......+.+++..|+..+|++||++.++.+.++
T Consensus       243 ~~~~~~~~~~~~~~~~~---------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLHEGKI---------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhhhhhh---------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence             00  011111111100         0   0112357899999999999999999999998763

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.1e-31  Score=289.01  Aligned_cols=247  Identities=28%  Similarity=0.447  Sum_probs=201.9

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|++.+.||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++|||++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999876 678999999876543  3456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++++|.+++...    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999988642    5689999999999999999999986   99999999999999999999999999998765433


Q ss_pred             CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccC
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .. .....++..|+|||...+..++.++||||+|+++|+|++|+.||....   .....   ...... ...        
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---~~~~~---~~~~~~-~~~--------  217 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN---PMAAL---FRIVQD-DHP--------  217 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc---HHHHH---HHHhcc-CCC--------
Confidence            21 233568899999999888888999999999999999999999986322   11111   111111 000        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                       ..+......+.+++.+|++.+|++||++.+++.
T Consensus       218 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 -PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             011122347889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=1.8e-31  Score=299.43  Aligned_cols=265  Identities=19%  Similarity=0.200  Sum_probs=194.0

Q ss_pred             cCeEeccCceEEEEEEECCCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCC
Q 001591          772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS  849 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  849 (1048)
                      .+.+|.|+++.||++.. +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            33344555555555544 6999999998754  34455679999999999999999999999999999999999999999


Q ss_pred             hhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC----
Q 001591          850 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT----  925 (1048)
Q Consensus       850 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~----  925 (1048)
                      +.+++....  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+|++|||.+........    
T Consensus        86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999987542  33578899999999999999999986   999999999999999999999999999875532111    


Q ss_pred             --ceeecccccccccCccccCc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc----cc---
Q 001591          926 --HVTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----KR---  994 (1048)
Q Consensus       926 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----~~---  994 (1048)
                        .......++..|+|||++..  ..++.++|||||||++|||++|+.||.....  .....+........    ..   
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCchhh
Confidence              11123457789999998765  3588999999999999999999999964221  11111111100000    00   


Q ss_pred             ----ccc----ccccc----cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591          995 ----EVE----IIDAS----IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       995 ----~~~----~~~~~----~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                          ...    ..+..    ...........++.+++.+||+.+|++|||++++++  ++..+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                000    00000    001112233457889999999999999999999997  666654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=5.9e-32  Score=306.66  Aligned_cols=262  Identities=24%  Similarity=0.334  Sum_probs=195.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC------c
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------D  837 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  837 (1048)
                      .+|...+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++....      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            68999999999999999999865 68999999987532  223355788999999999999999999987543      4


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .++|+||+.. ++..+.      +..+++..+..++.|+++|++|||+.   +++||||||+||+++.++.+|++|||++
T Consensus        95 ~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             EEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            6899999964 665543      23578999999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc--
Q 001591          918 RLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR--  994 (1048)
Q Consensus       918 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--  994 (1048)
                      +.....    .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....   .......+....+...  
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~  237 (342)
T cd07879         165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPGPE  237 (342)
T ss_pred             cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCHH
Confidence            764321    223467889999998766 468899999999999999999999996421   1111111111100000  


Q ss_pred             ---------cccccc--cccC----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCc
Q 001591          995 ---------EVEIID--ASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       995 ---------~~~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~ 1045 (1048)
                               ......  +...    ....+.....+.+++.+|++.||++||+++|+++  +++.++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                     000000  0000    0000122346889999999999999999999994  6777654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=3.1e-31  Score=293.48  Aligned_cols=259  Identities=24%  Similarity=0.328  Sum_probs=195.9

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeeecceEeeCCc-----
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRA---QHKNLVSLQGYCRHGND-----  837 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  837 (1048)
                      |++.+.||+|+||.||+|+++ ++.+||+|++.....  .....+.+|+++++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999987 589999999974322  2234566788877766   59999999999988776     


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .+++|||+.+ +|.+++....  ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||.+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999975 7888876432  23589999999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc--
Q 001591          918 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE--  995 (1048)
Q Consensus       918 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--  995 (1048)
                      ........  .....++..|+|||++.+..++.++|+||||+++|||++|++||.....   .+....+.........  
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE---ADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh---HHHHHHHHHHcCCCChHh
Confidence            77643221  2234578899999999988999999999999999999999999874322   1222222211110000  


Q ss_pred             --------cccccccc---CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          996 --------VEIIDASI---WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       996 --------~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                              ........   ...........+.+++.+|++.||++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                    00000000   01111234467889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=1.6e-31  Score=295.97  Aligned_cols=255  Identities=24%  Similarity=0.301  Sum_probs=198.5

Q ss_pred             CCcccCeEeccCceEEEEEEEC----CCcEEEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC----GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  838 (1048)
                      +|++.+.||+|++|.||+|+..    +++.||+|+++...    ....+.+..|+.+++++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999753    57889999987432    22335678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++|+|.+++..    ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++++|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            999999999999988863    34588999999999999999999985   99999999999999999999999999988


Q ss_pred             ccCCCCCceeecccccccccCccccCcCC--CCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLT--ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       919 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ..............|+..|+|||...+..  .+.++||||||+++|||++|+.||.......  .............   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~---  228 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK---  228 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC---
Confidence            75443322233456899999999877654  7889999999999999999999985321111  1111111111110   


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 1042 (1048)
                          .    ..+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       229 ----~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 ----P----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----C----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                0    0111123468899999999999999998888776643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=1.2e-31  Score=292.89  Aligned_cols=244  Identities=26%  Similarity=0.320  Sum_probs=193.9

Q ss_pred             EeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      ||+|+||.||+|++. +|+.||+|++.....   ...+.+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            589999999999987 599999999875543   3456688999999999999999999999999999999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC-----
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT-----  925 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~-----  925 (1048)
                      .+++...    ..+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9988642    3689999999999999999999986   999999999999999999999999999876432211     


Q ss_pred             --ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          926 --HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       926 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                        .......++..|+|||......++.++||||||+++||+++|+.||....   .......   ..... . ..     
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~---~~~~~-~-~~-----  220 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQN---ILNGK-I-EW-----  220 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHH---HhcCC-c-CC-----
Confidence              12234568889999999888889999999999999999999999996422   1111111   11100 0 00     


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 1040 (1048)
                        .........+.+++.+|++.+|++|||+.++.+.|
T Consensus       221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         221 --PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence              00001245789999999999999999994444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=1.6e-31  Score=296.25  Aligned_cols=251  Identities=25%  Similarity=0.329  Sum_probs=196.0

Q ss_pred             CCcccCeEeccCceEEEEEEEC----CCcEEEEEEecCCch----hhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDCG----QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  838 (1048)
                      +|++.+.||+|+||.||+|+..    +|..||+|++.....    ...+.+.+|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999863    688999999875322    2345678899999999 599999999999998899


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++++|.+++..    ...+++..+..++.|+++||+|||+.   +++||||+|+||++++++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            999999999999998864    34578999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccccccccCccccCcC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          919 LLRPYDTHVTTDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       919 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ..............|+..|+|||.....  .++.++||||||+++|+|++|+.||.......  ..............  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~--  229 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP--  229 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccCC--
Confidence            7644332233345789999999987653  46789999999999999999999996322111  11111111111110  


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 1038 (1048)
                               ..+......+.+++.+|++.+|++||     ++.++++
T Consensus       230 ---------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 ---------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                     01112234688999999999999997     6676665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.1e-31  Score=304.63  Aligned_cols=270  Identities=23%  Similarity=0.310  Sum_probs=200.5

Q ss_pred             cHHHHHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEee
Q 001591          758 TVSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH  834 (1048)
Q Consensus       758 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  834 (1048)
                      ...++....++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34566667889999999999999999999764 78999999987542  2234567889999999999999999998864


Q ss_pred             C------CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCc
Q 001591          835 G------NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE  908 (1048)
Q Consensus       835 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~  908 (1048)
                      .      ...+++++++ +++|.+++..     ..+++..+..++.|+++|++|||+.   +|+||||||+||++++++.
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            3      3467788876 7788877753     3488999999999999999999986   9999999999999999999


Q ss_pred             EEEeecccccccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHH
Q 001591          909 AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF  987 (1048)
Q Consensus       909 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~  987 (1048)
                      +||+|||++......    .....|+..|+|||...+ ..++.++|||||||++|||++|+.||......   .....+.
T Consensus       159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~  231 (345)
T cd07877         159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLIL  231 (345)
T ss_pred             EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence            999999998764321    233568899999998765 56888999999999999999999999642211   1111111


Q ss_pred             Hhhccc---cccccccc----------cc----CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          988 QMKSEK---REVEIIDA----------SI----WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       988 ~~~~~~---~~~~~~~~----------~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      ......   ....+.+.          ..    ..........++.+++.+|++.||.+||++.++++  ++.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence            110000   00000000          00    00000012346889999999999999999999986  55544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=294.50  Aligned_cols=259  Identities=24%  Similarity=0.336  Sum_probs=195.8

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEEEEec
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      |++.+.||+|++|+||+|... +++.||+|++..... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999986 578999999875432 22334567999999999 999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                       +|++.+++....  ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             788988876532  34689999999999999999999986   999999999999999999999999999986543221


Q ss_pred             ceeecccccccccCccccC-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc-----------
Q 001591          926 HVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK-----------  993 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-----------  993 (1048)
                        .....++..|+|||+.. ...++.++|+||||+++|||++|++||.....   .+....+.......           
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE---IDQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh---HHHHHHHHHhcCCCChhhhhhHhhh
Confidence              23356888999999764 45678999999999999999999999864321   11111111110000           


Q ss_pred             --ccccccc---cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          994 --REVEIID---ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       994 --~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        .......   ..............+.+++.+|++.+|++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence              0000000   00000111112357899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1.5e-31  Score=299.69  Aligned_cols=263  Identities=25%  Similarity=0.313  Sum_probs=193.3

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh--hHHHHHHHHHHHHhcCCCceeeecceEeeCC------
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  836 (1048)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++......  ....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999876 6899999988643221  2345678999999999999999999875433      


Q ss_pred             --cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeec
Q 001591          837 --DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       837 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                        ..++|+||+++ ++...+..   ....+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              46899999975 56655543   234689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCc----------eeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHH
Q 001591          915 GLSRLLRPYDTH----------VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV  983 (1048)
Q Consensus       915 g~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~  983 (1048)
                      |+++........          ......+++.|+|||...+ ..++.++||||||+++|||++|++||......   ...
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~---~~~  236 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI---DQL  236 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence            999865432211          1123467889999997654 45789999999999999999999999643221   111


Q ss_pred             HHHHHhhcccc---------ccccc----ccccCc---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          984 SWVFQMKSEKR---------EVEII----DASIWH---KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       984 ~~~~~~~~~~~---------~~~~~----~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +.+........         .....    ......   .........+.+++.+|++.+|++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            11111111000         00000    000000   000122257889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=2.9e-31  Score=294.98  Aligned_cols=251  Identities=27%  Similarity=0.428  Sum_probs=192.6

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ++|++.+.||+|+||.||+|.+. +++.||||++.... .....++.+|++++.+.. ||||+++++++.++...++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            56888999999999999999987 48999999987543 233445667777777775 9999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++ ++.++....   ...+++..+..++.|+++|++|||+.  ++|+||||+|+||++++++.+||+|||.+......
T Consensus        95 ~~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9854 666665432   34689999999999999999999973  48999999999999999999999999999765432


Q ss_pred             CCceeecccccccccCccccCcCC----CCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLT----ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ..  .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.....  ..+....+   .... .....
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~---~~~~-~~~~~  240 (296)
T cd06618         169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKI---LQEE-PPSLP  240 (296)
T ss_pred             Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHH---hcCC-CCCCC
Confidence            21  12235788999999876543    78899999999999999999999964211  11111111   1111 00000


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .       ......++.+++.+|++.+|++||++.++++
T Consensus       241 ~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         241 P-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             C-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0       0012347899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-31  Score=287.93  Aligned_cols=240  Identities=24%  Similarity=0.284  Sum_probs=185.3

Q ss_pred             CeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHH-HhcCCCceeeecceEeeCCcEEEEEEeccC
Q 001591          773 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEAL-SRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||.||+|... +|+.||+|++.....   .....+..|..++ ...+|||++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999875 689999999875432   1222344554444 345899999999999999999999999999


Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      ++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++++|||++.....     
T Consensus        82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            999998864    34588999999999999999999986   999999999999999999999999999875432     


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      .....|++.|+|||...+..++.++||||+|+++|||++|..||....   .......   ........   .    ...
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~---~~~~~~~~---~----~~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET---PDAVFDN---ILSRRINW---P----EEV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHH---HHhcccCC---C----Ccc
Confidence            223468889999999888888999999999999999999999996422   1111111   11110000   0    001


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 001591         1008 REKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037 (1048)
Q Consensus      1008 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl 1037 (1048)
                      ......++.+++.+|++.+|++||++.++.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~  246 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQ  246 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHH
Confidence            112345789999999999999999765333

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.2e-31  Score=295.47  Aligned_cols=248  Identities=24%  Similarity=0.364  Sum_probs=200.9

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  841 (1048)
                      ++|++.+.||+|+||.||+|... +|..||+|++....   ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888999999999999999876 78999999987532   233467889999999998 99999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999998864    33699999999999999999999986   99999999999999999999999999998654


Q ss_pred             CCCC-------------------ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhH
Q 001591          922 PYDT-------------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDL  982 (1048)
Q Consensus       922 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~  982 (1048)
                      ....                   .......|+..|+|||......++.++|+||+|++++++++|+.||....   ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~  230 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLT  230 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHH
Confidence            3221                   11223467899999999888889999999999999999999999996422   1111


Q ss_pred             HHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 001591          983 VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFI----EEVVT 1038 (1048)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~----~evl~ 1038 (1048)
                      ...+.   ....           ..+......+.+++.+|++.+|++||++    .++++
T Consensus       231 ~~~~~---~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 FQKIL---KLEY-----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHH---hcCC-----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11111   1000           1111224478999999999999999999    76653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=2e-31  Score=301.90  Aligned_cols=261  Identities=22%  Similarity=0.231  Sum_probs=195.3

Q ss_pred             cCCc-ccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhh--------------HHHHHHHHHHHHhcCCCceeeecc
Q 001591          767 NNFN-QANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--------------EREFQAEVEALSRAQHKNLVSLQG  830 (1048)
Q Consensus       767 ~~~~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  830 (1048)
                      ++|. +.+.||.|+||+||+|... +++.||+|++.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3554 3577999999999999865 78999999986442211              124678999999999999999999


Q ss_pred             eEeeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEE
Q 001591          831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH  910 (1048)
Q Consensus       831 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  910 (1048)
                      ++..++..++||||++ |+|.+++..    ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999997 588888753    34588999999999999999999986   999999999999999999999


Q ss_pred             EeecccccccCCC-------------CCceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCC
Q 001591          911 LADFGLSRLLRPY-------------DTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKG  976 (1048)
Q Consensus       911 l~Dfg~a~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~  976 (1048)
                      ++|||.+......             .........+++.|+|||.+.+. .++.++||||+|+++|||++|++||.... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~-  238 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN-  238 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence            9999999765411             01111223568899999987664 46899999999999999999999996432 


Q ss_pred             CCchhHHHHHHHhhcccccc---ccc--------cccc---CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          977 KNCRDLVSWVFQMKSEKREV---EII--------DASI---WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        ..+....+..........   +..        ....   ..........++.+++.+|++.+|++||+++|++.
T Consensus       239 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        239 --EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             --HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence              222222222222111100   000        0000   00001122457889999999999999999999986

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=8.9e-31  Score=293.25  Aligned_cols=243  Identities=28%  Similarity=0.402  Sum_probs=191.5

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      |...+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++++++|||++++++++.+++..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555677999999999999875 68899999986432   22335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +. |++.+++..   ....+++.++..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||++.....  
T Consensus       103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 567666653   234689999999999999999999986   999999999999999999999999999865322  


Q ss_pred             CceeecccccccccCccccC---cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                         .....|+..|+|||++.   ...++.++||||||+++|||++|++||....   .....   ........ ....  
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~---~~~~~---~~~~~~~~-~~~~--  241 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSAL---YHIAQNDS-PTLQ--  241 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHH---HHHHhcCC-CCCC--
Confidence               12356889999999874   4568889999999999999999999986422   11111   11111111 1110  


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            .......+.+++.+|++.+|.+||++.+++.
T Consensus       242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  1112236889999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=2.1e-31  Score=297.65  Aligned_cols=244  Identities=27%  Similarity=0.407  Sum_probs=192.5

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD---CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .|+..+.||+|+||.||+|+.. ++..+|+|.+...   .....+++.+|+++++.++|+|++++++++..+...++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999875 6789999988642   22334567889999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+. |++.+++..   ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++......
T Consensus        96 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          96 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             ccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            996 577776643   234588999999999999999999986   9999999999999999999999999998765432


Q ss_pred             CCceeecccccccccCccccC---cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                           ....|++.|+|||.+.   ...++.++|||||||++|||++|+.||.....      ........... ....  
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~~--  234 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-SPAL--  234 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhhcC-CCCc--
Confidence                 2346888999999864   35678899999999999999999999864211      11111111111 0000  


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            ........+.+++.+|++.+|++||++.++++
T Consensus       235 ------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~  266 (308)
T cd06634         235 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (308)
T ss_pred             ------CcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence                  01123346889999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=3.1e-31  Score=289.00  Aligned_cols=250  Identities=24%  Similarity=0.318  Sum_probs=196.3

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-----CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      +|.+.+.||+|+||.||+|.+. .+..+++|..+..     ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999875 3445555555421     122334577899999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++++|.+++.........+++..++.++.|+++|++|||+.   +++|+||||+||++++ +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998876544556799999999999999999999986   9999999999999975 569999999997754


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ... .......|++.|+|||...+..++.++|+||||+++|+|++|..||....      ............ ..     
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~~-~~-----  223 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEGP-TP-----  223 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCC-CC-----
Confidence            322 22234568889999999888888999999999999999999999985311      111111111111 00     


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                          ..+.....++.+++.+|++.+|++||++.|+++
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                112234457899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.5e-31  Score=301.16  Aligned_cols=266  Identities=24%  Similarity=0.359  Sum_probs=198.8

Q ss_pred             HHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEee-CCc
Q 001591          762 LLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH-GND  837 (1048)
Q Consensus       762 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  837 (1048)
                      +...+++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999866 78999999886432  2234567889999999999999999998865 457


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .++|+||+ +++|.+++..     ..+++..+..++.|+++|++|||+.   +|+||||+|+||++++++.++++|||.+
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            88999998 5688877752     3478888999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcc----
Q 001591          918 RLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----  992 (1048)
Q Consensus       918 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----  992 (1048)
                      ......    .....++..|+|||.+.+ ..++.++||||||+++|||++|++||.......   ....+......    
T Consensus       156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~  228 (328)
T cd07856         156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN---QFSIITDLLGTPPDD  228 (328)
T ss_pred             cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence            754321    123467889999998765 578999999999999999999999996432111   11100110000    


Q ss_pred             -------cccccccc-cccCc-----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          993 -------KREVEIID-ASIWH-----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       993 -------~~~~~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                             ....++.. .....     ........++.+++.+|++.+|++||++.+++.  +++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence                   00000000 00000     001122357899999999999999999999986  45433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=4.4e-31  Score=290.57  Aligned_cols=245  Identities=27%  Similarity=0.339  Sum_probs=187.4

Q ss_pred             eEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHH---HHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          774 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVE---ALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       774 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      +||+|+||.||+|... +++.||+|.+.....   .....+..|..   .++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 688999998875421   11222334433   3444579999999999999999999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +|+|.+++..    ...+++..+..++.|+++|++|||+.   +|+||||||+||++++++.++|+|||++.......  
T Consensus        81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            9999988753    34689999999999999999999986   99999999999999999999999999987653222  


Q ss_pred             eeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          927 VTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       .....|+..|+|||...++ .++.++||||+|+++|||++|+.||.......... .   .......      ....  
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~---~~~~~~~------~~~~--  218 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I---DRMTLTM------AVEL--  218 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-H---HHHhhcc------CCCC--
Confidence             2234789999999988754 68899999999999999999999997432211111 1   1100000      0111  


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH--HHHh
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT--WLDG 1042 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~--~L~~ 1042 (1048)
                        +...+.++.+++.+|+..+|.+||     ++.++++  ++++
T Consensus       219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence              111234789999999999999999     9999985  4443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=3.2e-31  Score=292.60  Aligned_cols=259  Identities=26%  Similarity=0.336  Sum_probs=198.8

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      |+..+.||+|++|.||+|+.. +++.||+|++....  ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999876 58999999988653  333456788999999999999999999999999999999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCC
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      + ++|.+++...   ...+++..+..++.+++.|++|||+.   +|+||||+|+||++++++.++|+|||.+........
T Consensus        81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            8 5899988753   24689999999999999999999986   999999999999999999999999999987643322


Q ss_pred             ceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc---------
Q 001591          926 HVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE---------  995 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------  995 (1048)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|++||....   ..+....+.........         
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS---EIDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHHHhCCCcHHHHHhhccc
Confidence             22234567889999987766 78999999999999999999999996422   11222222211110000         


Q ss_pred             ------ccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          996 ------VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       996 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                            .............+.....+.+++.+|++.+|++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                  0000000000111122457999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1.3e-31  Score=304.00  Aligned_cols=266  Identities=22%  Similarity=0.328  Sum_probs=195.8

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeC---------
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG---------  835 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  835 (1048)
                      ..+|++.+.||.|+||.||+|... +|..||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367999999999999999999875 6899999998765555556788999999999999999999876543         


Q ss_pred             -----CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-CCCcE
Q 001591          836 -----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA  909 (1048)
Q Consensus       836 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~  909 (1048)
                           ...++||||++ ++|.+++..     ..+++..+..++.|++.|++|||+.   +|+||||||+||+++ +++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 34789999997 588777742     3588999999999999999999986   999999999999998 45678


Q ss_pred             EEeecccccccCCCCCc--eeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001591          910 HLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  986 (1048)
Q Consensus       910 kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~  986 (1048)
                      |++|||.++........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.......   .....
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~~  231 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE---QMQLI  231 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence            99999999765432111  1122367889999997544 567889999999999999999999996432111   11100


Q ss_pred             HHhhcccc---cccc--------c--cccc---CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          987 FQMKSEKR---EVEI--------I--DASI---WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       987 ~~~~~~~~---~~~~--------~--~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                      ........   ..+.        .  ....   ..........++.+++.+|++.||++||++.|+++  +++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            00000000   0000        0  0000   00001123357889999999999999999999985  66644

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.9e-31  Score=301.05  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=197.9

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCC-----
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----  836 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  836 (1048)
                      ..++|++.+.||+|+||.||+|... ++..||+|++....  ......+.+|++++++++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3568999999999999999999865 78999999986432  223456789999999999999999999887553     


Q ss_pred             -cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          837 -DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       837 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                       ..++||||+ +++|.+++..     ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++++|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             358999998 6788877742     3588999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      ++......    .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||.....   ...............
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~  236 (343)
T cd07880         164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH---LDQLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCC
Confidence            99865322    223467889999998765 4688999999999999999999999964221   111111111000000


Q ss_pred             -----------cccccc--ccc----CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591          995 -----------EVEIID--ASI----WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       995 -----------~~~~~~--~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                                 ......  +..    ...........+.+++.+|++.||++|||+.++++  +++.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                       000000  000    00001123346889999999999999999999994  666553

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=319.88  Aligned_cols=259  Identities=28%  Similarity=0.443  Sum_probs=207.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC----C----CcEEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeeecceEeeCC
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT----N----GTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  836 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  836 (1048)
                      ++..+.+.+|+|.||.||+|...    .    ...||||.++.... ...+.+..|+++|+.+ +||||+.++|+|.+.+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            44456669999999999999743    1    45799999885543 3456789999999999 5999999999999999


Q ss_pred             cEEEEEEeccCCChhhhccccc---C-------Cc--cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001591          837 DRLLIYSYMENGSLDYWLHESV---D-------KD--SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  904 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~  904 (1048)
                      ..++|+||+..|+|.++++..+   .       ..  ..++..+.+.++.|||.|++||++.   ++||||+.++|||++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence            9999999999999999998765   0       01  2489999999999999999999985   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeecccc--cccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchh
Q 001591          905 EKFEAHLADFGLSRLLRPYDTHVTTDLVG--TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD  981 (1048)
Q Consensus       905 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~  981 (1048)
                      ++..+||+|||+|+.......+....-.|  ...|||||.+....++.++|||||||++||+++ |..||.....  ..+
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~  530 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEE  530 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHH
Confidence            99999999999999765444433222233  235999999999999999999999999999999 9999964221  222


Q ss_pred             HHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          982 LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      +.+++....+             .+.+..+..+++++|+.||+.+|++||++.++.+.++..
T Consensus       531 l~~~l~~G~r-------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  531 LLEFLKEGNR-------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHhcCCC-------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            3332222111             122334456899999999999999999999999988763

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=272.22  Aligned_cols=252  Identities=26%  Similarity=0.359  Sum_probs=195.8

Q ss_pred             cCeEeccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEeccCC
Q 001591          772 ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMENG  848 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  848 (1048)
                      ...||.|+||+|+|-.++ +|+..|||+++.... ...+++..|.++..+- +.||||+++|.+..++..|+.||.|+- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            557999999999999876 799999999986654 5566788888876655 699999999999999999999999954 


Q ss_pred             Chhhhcccc-cCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          849 SLDYWLHES-VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       849 ~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      +++.+.... .-....+++.-.-+|+...+.||.||...  -.|||||+||+|||+|..|.+|++|||.+..+...  ..
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iA  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IA  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--HH
Confidence            554433211 12455688888999999999999999874  68999999999999999999999999999876432  22


Q ss_pred             eecccccccccCccccCc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          928 TTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      .+.-+|-..|||||.+..  ..|+.++||||+|+++||+.||+.|+.+.     .+..+.+.+.....+..-..+     
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----~svfeql~~Vv~gdpp~l~~~-----  293 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----DSVFEQLCQVVIGDPPILLFD-----  293 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----HHHHHHHHHHHcCCCCeecCc-----
Confidence            233478889999997754  35899999999999999999999999642     334444444433322211111     


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .........+.+++.-|+.+|-..||.+.++.+
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            112334557999999999999999999999876

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.5e-31  Score=300.49  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=199.2

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCc----
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND----  837 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  837 (1048)
                      ..++|++.+.||+|++|.||+|+.. ++..||+|++....  ......+.+|+.++++++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567999999999999999999876 68899999987532  2233557789999999999999999998876554    


Q ss_pred             --EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          838 --RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       838 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                        .++|+||+ +++|.+++..     ..+++..+..++.|+++|++|||+.   +|+||||||+||++++++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 5688888753     4589999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      ++......    .....++..|+|||...+ ..++.++||||+|+++|||++|+.||....   ..+.+..+....+...
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~---~~~~~~~i~~~~~~~~  236 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD---HIDQLKRIMNLVGTPD  236 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCC
Confidence            99865432    233467889999998754 467899999999999999999999996422   1111222111111000


Q ss_pred             cccccc---------------cc---cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhc
Q 001591          995 EVEIID---------------AS---IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043 (1048)
Q Consensus       995 ~~~~~~---------------~~---~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i 1043 (1048)
                       .....               ..   ...........++.+++.+|++.+|++|||+.|+++  +++..
T Consensus       237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         237 -EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             -HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence             00000               00   000001122457899999999999999999999986  55544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=292.72  Aligned_cols=244  Identities=23%  Similarity=0.375  Sum_probs=198.8

Q ss_pred             cCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCC
Q 001591          772 ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  848 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  848 (1048)
                      .++||.|.||+||-|+++ +|+.||||++.+..  .+.+.+++.|+.+++.++||.||.+.-.|+..+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            578999999999999876 89999999998653  445678999999999999999999999999999999999999776


Q ss_pred             ChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC---CcEEEeecccccccCCCCC
Q 001591          849 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK---FEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       849 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      -|+-.+..   ....+++.....+..||+.||.|||..   +|||+|+||+|||+.+.   -++|++|||+|+.+++  .
T Consensus       649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--k  720 (888)
T KOG4236|consen  649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--K  720 (888)
T ss_pred             HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--h
Confidence            55555543   455688999999999999999999975   99999999999999643   5699999999999863  3


Q ss_pred             ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCc
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      .....++|||.|+|||++..+.|...-|+||.|||+|--+.|..||..  +++..+.++....+.         .+..|.
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMy---------Pp~PW~  789 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMY---------PPNPWS  789 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhcccccc---------CCCchh
Confidence            445568999999999999999999999999999999999999999963  222222222211111         222233


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +    ...+..++|...++..-++|-+.++.+.
T Consensus       790 e----is~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  790 E----ISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             h----cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            3    3347789999999999999999888765

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4.3e-31  Score=298.59  Aligned_cols=266  Identities=23%  Similarity=0.291  Sum_probs=194.7

Q ss_pred             CCcccCeEeccCceEEEEEEEC-C--CcEEEEEEecCCc--hhhHHHHHHHHHHHHhc-CCCceeeecceEeeC----Cc
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-N--GTKAAVKRLSGDC--GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHG----ND  837 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  837 (1048)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++....  ....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999876 4  7799999987432  22345678899999999 599999999875432    45


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .++++||+. ++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            688888886 588887753    45689999999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCCc---eeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc
Q 001591          918 RLLRPYDTH---VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  993 (1048)
Q Consensus       918 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  993 (1048)
                      +........   ......|++.|+|||...+ ..++.++||||+||++|+|++|++||.....   ......+.......
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~  229 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY---VDQLNQILQVLGTP  229 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---HHHHHHHHHHhCCC
Confidence            865432211   1233578999999997655 5689999999999999999999999864221   11111111111000


Q ss_pred             cc---ccc-----------c---ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcC
Q 001591          994 RE---VEI-----------I---DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       994 ~~---~~~-----------~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~ 1044 (1048)
                      ..   ...           .   ...............+.+++.+|++.+|++|||+.|+++  ++....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence            00   000           0   000000000112347889999999999999999999986  665443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-32  Score=280.43  Aligned_cols=240  Identities=26%  Similarity=0.365  Sum_probs=192.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHH---HHHHHHHHHhc-CCCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMERE---FQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  841 (1048)
                      .+|....+||+|+||.|-+|..+ +.+.+|||+++++.....+.   -..|-+++... +-|.+++++.+|+.-+..|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46888999999999999999766 56789999998775322211   23455666554 468899999999999999999


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+.||+|-.+++.    -..+.+..+..+|.+||-||-+||+.   ||+.||+|..|||+|.+|++||+|||+++.--
T Consensus       429 MEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence            999999999888764    45577888999999999999999985   99999999999999999999999999998632


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                       .....+.+++|||.|+|||++...+|+.++|.|||||++|||+.|++||++   +...++.+.+....           
T Consensus       502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG---eDE~elF~aI~ehn-----------  566 (683)
T KOG0696|consen  502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQAIMEHN-----------  566 (683)
T ss_pred             -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHcc-----------
Confidence             233345678999999999999999999999999999999999999999975   23333433332211           


Q ss_pred             ccCchhhHHHHHHHHHHHHHcccCCCCCCC
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 1031 (1048)
                         -.++...+.+...+....+.+.|.+|.
T Consensus       567 ---vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 ---VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ---CcCcccccHHHHHHHHHHhhcCCcccc
Confidence               122333445778888888999999984

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=247.67  Aligned_cols=260  Identities=23%  Similarity=0.327  Sum_probs=199.1

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|+..+.||+|.||+||+|+.. +++.||+|+++-+.  ........+|+-+++.++|.|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4666788999999999999855 78999999887443  22334568899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      |.. +|.+|...   -.+.++.+.++.++.|+++|+.++|++   ++.|||+||.|.+++.+|+.|++|||+|+.++-..
T Consensus        83 cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            965 67776654   355689999999999999999999997   99999999999999999999999999999876543


Q ss_pred             CceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhccccc------c
Q 001591          925 THVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE------V  996 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~------~  996 (1048)
                      .. ....+-|..|++|.++.+. -|+...|+||-|||+.|+.. |++-|.+   ....+....++........      .
T Consensus       156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg---~dvddqlkrif~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIFRLLGTPTEDQWPSMT  231 (292)
T ss_pred             Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC---CcHHHHHHHHHHHhCCCccccCCccc
Confidence            33 3345679999999987775 57889999999999999998 5555542   3334444445544432221      1


Q ss_pred             cccccccCchhhH---------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDRE---------KQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ...|-....-++.         .-...=.+++.+.+.-+|.+|.+++++++
T Consensus       232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2222222221211         11123467888889999999999998875

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=299.91  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=210.5

Q ss_pred             HHHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEee----
Q 001591          761 DLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH----  834 (1048)
Q Consensus       761 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----  834 (1048)
                      .+...++.|++.++||+|.+|.||+++.. +++.+|+|+...+. ...++++.|.++++.. .|||++.++|++..    
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            33344567889999999999999999854 78999999887653 3445688899999887 59999999999864    


Q ss_pred             -CCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEee
Q 001591          835 -GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLAD  913 (1048)
Q Consensus       835 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  913 (1048)
                       +++.|+|||||.+|+..+++....  +..+.|+.+..|.+.+++|+.+||.+   .++|||||-.|||++.++.||+.|
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence             568999999999999999998775  77899999999999999999999986   999999999999999999999999


Q ss_pred             cccccccCCCCCceeecccccccccCccccCc-----CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHH
Q 001591          914 FGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ  988 (1048)
Q Consensus       914 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~  988 (1048)
                      ||.+..+.... ....+.+|||.|||||++..     ..|+.++|+||+|++..||.-|.+|+..+.+      +..++.
T Consensus       167 FGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mraLF~  239 (953)
T KOG0587|consen  167 FGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MRALFL  239 (953)
T ss_pred             eeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hhhhcc
Confidence            99998875432 23445799999999998653     4567899999999999999999999864332      122233


Q ss_pred             hhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..+.        +......+..+.+++-++|..|+.+|-++||++.++++
T Consensus       240 IpRN--------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 IPRN--------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCC--------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            2222        22222345677789999999999999999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.1e-30  Score=316.34  Aligned_cols=145  Identities=30%  Similarity=0.422  Sum_probs=130.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||.||+|.+. +++.||+|+++...   ......+..|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999877 78999999987542   233466889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ||+.+++|.+++..    ...+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999998864    33578899999999999999999986   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-30  Score=277.98  Aligned_cols=236  Identities=26%  Similarity=0.319  Sum_probs=191.6

Q ss_pred             EeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCCh
Q 001591          775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      ||+|+||.||++... +++.||+|++.....   .....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999876 589999999875432   2345788999999999999999999999999999999999999999


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeec
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  930 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  930 (1048)
                      .+++..    ...+++..+..++.|+++|+.|+|+.   +++|+||+|+||+++.++.++++|||.+....... .....
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            998864    23589999999999999999999985   99999999999999999999999999998754322 12334


Q ss_pred             ccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHH
Q 001591          931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010 (1048)
Q Consensus       931 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ..++..|+|||...+...+.++|+||||+++||+++|+.||.....   ......+..   ...           ..+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~---~~~-----------~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK---DPL-----------RFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc---CCC-----------CCCCC
Confidence            5788899999999888899999999999999999999999963211   111211111   100           01111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHH
Q 001591         1011 QLLEMLEIACKCIDQDPRRRPFIEE 1035 (1048)
Q Consensus      1011 ~~~~l~~li~~cl~~~P~~RPt~~e 1035 (1048)
                      ....+.+++.+|+..||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1347889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-31  Score=293.39  Aligned_cols=239  Identities=24%  Similarity=0.286  Sum_probs=191.7

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ...|+....+|.|+|+.|-.+... ++...+||++.+..    .+-.+|+.++.+. +||||+++.+.+.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            456777778999999999999765 78899999998652    2234567666655 69999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEE-CCCCcEEEeecccccccCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL-DEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      .+.|+.+.+.+..    ...+. ..+..|+.+++.|+.|||.+   |+||||+||+|||+ ++.++++|+|||.++...+
T Consensus       397 ~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  397 LLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999988766643    22233 77888999999999999986   99999999999999 5999999999999998754


Q ss_pred             CCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccc
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .    ...-+-|..|.|||+.....|++++|+||||+++|+|++|+.||....++  .++    .......         
T Consensus       469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~~~---------  529 (612)
T KOG0603|consen  469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQMP---------  529 (612)
T ss_pred             h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhcCC---------
Confidence            3    22235688999999999999999999999999999999999999743222  111    1111111         


Q ss_pred             cCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                         ++....+.++.+++.+|++.||.+||+|+++..
T Consensus       530 ---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 ---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ---ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence               112445568899999999999999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=277.84  Aligned_cols=262  Identities=19%  Similarity=0.298  Sum_probs=199.3

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcC--CC----ceeeecceEeeCCcE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ--HK----NLVSLQGYCRHGNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~l~~~~~~~~~~  838 (1048)
                      +++|.+...+|+|.||.|-.+.++ .+..||+|+++.- ....+...-|+++++++.  .|    -+|.+.+||...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            578999999999999999999765 5789999998743 344455677999999994  23    388999999999999


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-------------
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-------------  905 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------------  905 (1048)
                      ++|+|.+ |-++.+++...  ...+++...++.|+.|++++++|||+.   +++|.|+||+||++.+             
T Consensus       167 Civfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999988 66899999764  456789999999999999999999997   9999999999999932             


Q ss_pred             -------CCcEEEeecccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCC
Q 001591          906 -------KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN  978 (1048)
Q Consensus       906 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~  978 (1048)
                             +..+||+|||.|+.....    ....+.|..|+|||++.+-.++.++||||+|||++|+.||..-|+.-.+.+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                   245899999999875433    345678999999999999999999999999999999999999987533222


Q ss_pred             chhHHHHHHHhhcccccccc----------cc---------------ccc-Cc---hhhHHHHHHHHHHHHHcccCCCCC
Q 001591          979 CRDLVSWVFQMKSEKREVEI----------ID---------------ASI-WH---KDREKQLLEMLEIACKCIDQDPRR 1029 (1048)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~----------~~---------------~~~-~~---~~~~~~~~~l~~li~~cl~~~P~~ 1029 (1048)
                      ...+.+.+....+.......          +|               .-. ..   .....+..++.+++++|+..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            22222222111000000000          00               000 00   001233447999999999999999


Q ss_pred             CCCHHHHHH
Q 001591         1030 RPFIEEVVT 1038 (1048)
Q Consensus      1030 RPt~~evl~ 1038 (1048)
                      |+|++|++.
T Consensus       397 RiTl~EAL~  405 (415)
T KOG0671|consen  397 RITLREALS  405 (415)
T ss_pred             cccHHHHhc
Confidence            999999986

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-31  Score=272.60  Aligned_cols=269  Identities=22%  Similarity=0.307  Sum_probs=210.8

Q ss_pred             cHHHHHHhhcCCcccCeEeccCceEEEEEEECC------CcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecc
Q 001591          758 TVSDLLKSTNNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQG  830 (1048)
Q Consensus       758 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~  830 (1048)
                      ...++.....+++...++.+|.||.||+|.|.+      .+.|.+|.++....+ ....+..|--.+..+.|||+.++.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            345666667789999999999999999997763      345667776644333 2345677888888889999999999


Q ss_pred             eEeeC-CcEEEEEEeccCCChhhhccccc----CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC
Q 001591          831 YCRHG-NDRLLIYSYMENGSLDYWLHESV----DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE  905 (1048)
Q Consensus       831 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~  905 (1048)
                      ++.++ +..+++|.++.-|+|..|+..-+    ...+.++-.+...+|.|++.|++|||++   +|||.||.++|.++|+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            98654 56788999999999999998221    2345577888999999999999999997   9999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeec-ccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHH
Q 001591          906 KFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV  983 (1048)
Q Consensus       906 ~~~~kl~Dfg~a~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~  983 (1048)
                      ..++|++|=.+++.+-+.+-+.-.+ .-....||+||.+....|+.++|||||||++|||+| |+.|+....+   .++.
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---fEm~  508 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---FEME  508 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---HHHH
Confidence            9999999999999876654433322 223458999999999999999999999999999999 9999864221   1122


Q ss_pred             HHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCc
Q 001591          984 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~ 1045 (1048)
                      .++.   ++.+          -..+..++.+++.++.-||..+|++||+++|++..|.++..
T Consensus       509 ~ylk---dGyR----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  509 HYLK---DGYR----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             HHHh---ccce----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            1111   1111          12234566789999999999999999999999999988753

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=278.09  Aligned_cols=257  Identities=25%  Similarity=0.382  Sum_probs=196.7

Q ss_pred             hcCCcccCeEeccCceEEEEEEE-CCCcEEEEEEec--CCchhhH-----HHHHHHHHHHHhcCCCceeeecceEeeC-C
Q 001591          766 TNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLS--GDCGQME-----REFQAEVEALSRAQHKNLVSLQGYCRHG-N  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~-~  836 (1048)
                      .++|-+..+||+|||+.||+|.+ ...+.||||+-.  +.+....     +...+|.++.+.+.||.||++++|+.-+ +
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            45677889999999999999964 457789999754  3332221     2357899999999999999999999754 5


Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC---CCCcEEEee
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLAD  913 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~D  913 (1048)
                      .++-|.|||+|.+|+-|+..    ...+++.+++.|+.||+.||.||... .++|||-|+||.|||+.   .-|.+||+|
T Consensus       542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            78899999999999988874    45689999999999999999999986 78999999999999995   458899999


Q ss_pred             cccccccCCCCC------ceeecccccccccCccccC----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHH
Q 001591          914 FGLSRLLRPYDT------HVTTDLVGTLGYIPPEYSQ----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV  983 (1048)
Q Consensus       914 fg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~  983 (1048)
                      ||+++.+..+..      ..+....||.+|++||.+.    ..+.+.++||||+|||+|+.+.|+.||+..  ....+++
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn--qsQQdIL  694 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN--QSQQDIL  694 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc--hhHHHHH
Confidence            999998864321      1234568999999999654    235688999999999999999999999742  2222333


Q ss_pred             HHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          984 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +.-.-.. . ....+       +..+.+..+...+|++|++..-++|..+.++..
T Consensus       695 qeNTIlk-A-tEVqF-------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  695 QENTILK-A-TEVQF-------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhhchhc-c-eeccC-------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            2211111 0 11111       112233447889999999999999998887753

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.8e-32  Score=264.68  Aligned_cols=262  Identities=24%  Similarity=0.365  Sum_probs=192.5

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeC--------
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--------  835 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  835 (1048)
                      ..|+....||+|.||.||+|+.+ +|++||+|+.--+  .........+|++++..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666778999999999999865 6888898865321  111123357899999999999999999988543        


Q ss_pred             CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecc
Q 001591          836 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       836 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                      ...|+||++|+. +|.-.+..   ....++..++.+++.++..||.|+|..   .|+|||+||.|+||+.++.+|++|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            247999999987 56666643   345689999999999999999999997   99999999999999999999999999


Q ss_pred             cccccCCCCCc---eeecccccccccCccccC-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhc
Q 001591          916 LSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS  991 (1048)
Q Consensus       916 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~  991 (1048)
                      +++.+......   ..+..+-|..|++||.+. ...|+++.|||+-|||+.||+||.+-+++..   ....+..+.....
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt---eqqql~~Is~LcG  246 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT---EQQQLHLISQLCG  246 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh---HHHHHHHHHHHhc
Confidence            99776443322   233456799999999655 5679999999999999999999999886432   2233333333222


Q ss_pred             c---cccccccccccCc----------hh--hHHHH------HHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          992 E---KREVEIIDASIWH----------KD--REKQL------LEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       992 ~---~~~~~~~~~~~~~----------~~--~~~~~------~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      .   +..+.+..-.++.          .+  -++..      .+..+++.+++..||.+|+++++++.
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            1   1111111111110          11  01111      26789999999999999999999985

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4.6e-30  Score=275.30  Aligned_cols=220  Identities=22%  Similarity=0.209  Sum_probs=175.9

Q ss_pred             cCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCChhhhccc
Q 001591          778 GGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE  856 (1048)
Q Consensus       778 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  856 (1048)
                      |.+|.||+++.. +++.||+|++....     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999875 78999999987542     234455555566799999999999999999999999999999998864


Q ss_pred             ccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeeccccccc
Q 001591          857 SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG  936 (1048)
Q Consensus       857 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~  936 (1048)
                      .    ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++++|||.+......    .....++..
T Consensus        79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~  147 (237)
T cd05576          79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM  147 (237)
T ss_pred             h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence            2    3589999999999999999999985   9999999999999999999999999988665432    122356778


Q ss_pred             ccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHH
Q 001591          937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML 1016 (1048)
Q Consensus       937 y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1016 (1048)
                      |+|||...+..++.++||||+|+++|||++|+.|+......           .. .  ....       ..+......+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~~-~--~~~~-------~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------IN-T--HTTL-------NIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------cc-c--cccc-------CCcccCCHHHH
Confidence            99999998888999999999999999999999987531100           00 0  0000       01112234688


Q ss_pred             HHHHHcccCCCCCCCCHH
Q 001591         1017 EIACKCIDQDPRRRPFIE 1034 (1048)
Q Consensus      1017 ~li~~cl~~~P~~RPt~~ 1034 (1048)
                      +++.+|++.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            999999999999999974

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=285.17  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=202.9

Q ss_pred             CCcccCeEeccCceEEEEEEECCCc-EEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLTNGT-KAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      +++....||.|+||.|-++..++.. .+|+|++++..   ...++.+..|-.+|...+.|.||++|-.|.+....|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4555778999999999999876433 48888887543   3344557889999999999999999999999999999999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      -|-||.+...+++    ++.++...+..++..+++|++|||+.   +||.||+||+|.++|.+|.+|+.|||+|+.+...
T Consensus       501 aClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  501 ACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999974    56688899999999999999999986   9999999999999999999999999999988643


Q ss_pred             CCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                        ..+-++||||.|.|||++.....+.++|.||+|+++|||++|.+||.+........++      .+.-...       
T Consensus       574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkGid~i-------  638 (732)
T KOG0614|consen  574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKGIDKI-------  638 (732)
T ss_pred             --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhhhhhh-------
Confidence              3455689999999999999999999999999999999999999999753322221111      1111111       


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH--HHHhc
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDGI 1043 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~--~L~~i 1043 (1048)
                        .++........+++++.+..+|.+|--     +.++-+  |++++
T Consensus       639 --~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  639 --EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             --hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence              112233446789999999999999974     555543  55544

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.5e-29  Score=300.71  Aligned_cols=261  Identities=21%  Similarity=0.250  Sum_probs=170.8

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-C----CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecce------Ee
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-N----GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY------CR  833 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  833 (1048)
                      ..++|++.+.||+|+||.||+|++. +    +..||+|++..... .+. +..|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~-~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEI-WMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHH-HHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3568999999999999999999876 4    68999998764321 111 1111  1222223333322222      24


Q ss_pred             eCCcEEEEEEeccCCChhhhcccccC----------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 001591          834 HGNDRLLIYSYMENGSLDYWLHESVD----------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVK  897 (1048)
Q Consensus       834 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  897 (1048)
                      .+...++||||+++++|.++++....                .........+..++.|++.||+|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            55678999999999999998864310                011122345678999999999999986   99999999


Q ss_pred             CCceEECC-CCcEEEeecccccccCCCCCceeecccccccccCccccCcC----------------------CCCchhhh
Q 001591          898 SSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL----------------------TATCRGDV  954 (1048)
Q Consensus       898 ~~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv  954 (1048)
                      |+|||+++ ++.+||+|||+|+.+............+|+.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999985 68999999999987654444444567899999999954321                      23456799


Q ss_pred             HHHHHHHHHHHcCCCCCcccC-------CCCchhHHHHHHHhhcccccccccccccCc--hhhHHHHHHHHHHHHHcccC
Q 001591          955 YSFGVVLLELLTGRRPVEVCK-------GKNCRDLVSWVFQMKSEKREVEIIDASIWH--KDREKQLLEMLEIACKCIDQ 1025 (1048)
Q Consensus       955 ~slGvil~elltg~~P~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~ 1025 (1048)
                      ||+||++|||+++..|++...       .....+...|.......      .......  +..........+++.+|++.
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence            999999999999777653210       00001111111111100      0000000  00001122456899999999


Q ss_pred             CCCCCCCHHHHHH
Q 001591         1026 DPRRRPFIEEVVT 1038 (1048)
Q Consensus      1026 ~P~~RPt~~evl~ 1038 (1048)
                      ||++|||++|+++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999987

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.5e-29  Score=289.23  Aligned_cols=261  Identities=20%  Similarity=0.314  Sum_probs=182.5

Q ss_pred             hhcCCcccCeEeccCceEEEEEEE-----------------CCCcEEEEEEecCCchhhHHH--------------HHHH
Q 001591          765 STNNFNQANIIGCGGFGLVYKATL-----------------TNGTKAAVKRLSGDCGQMERE--------------FQAE  813 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  813 (1048)
                      ..++|++.++||+|+||+||+|.+                 ..++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999964                 235689999987543322222              3346


Q ss_pred             HHHHHhcCCCce-----eeecceEee--------CCcEEEEEEeccCCChhhhcccccC--------------------C
Q 001591          814 VEALSRAQHKNL-----VSLQGYCRH--------GNDRLLIYSYMENGSLDYWLHESVD--------------------K  860 (1048)
Q Consensus       814 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~  860 (1048)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776654     677887753        3568999999999999998874321                    1


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeecccccccccCc
Q 001591          861 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP  940 (1048)
Q Consensus       861 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP  940 (1048)
                      ...+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||++...............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12357788999999999999999986   999999999999999999999999999976543222222223458899999


Q ss_pred             cccCcCCC----------------------CchhhhHHHHHHHHHHHcCCC-CCcccCC--CC----chhHHHHHHHhhc
Q 001591          941 EYSQTLTA----------------------TCRGDVYSFGVVLLELLTGRR-PVEVCKG--KN----CRDLVSWVFQMKS  991 (1048)
Q Consensus       941 E~~~~~~~----------------------~~~~Dv~slGvil~elltg~~-P~~~~~~--~~----~~~~~~~~~~~~~  991 (1048)
                      |.+.....                      ..+.||||+||++|+|++|.. ||.....  .+    ..+...|...  .
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence            97653221                      124799999999999999875 6643210  00    1111122111  0


Q ss_pred             ccccccccccccCchhhHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 001591          992 EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDP---RRRPFIEEVVT 1038 (1048)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~RPt~~evl~ 1038 (1048)
                      ..    ..+...+    ........+++.+|+..+|   .+|+|++|+++
T Consensus       458 ~~----~~~~~~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        458 GQ----KYDFSLL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cc----CCCcccc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            00    0111111    1233478899999999766   68999999985

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.7e-30  Score=259.16  Aligned_cols=248  Identities=21%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ..+|+..++||+|+|++|..+++. +.+.+|+|+++++.   .+..+-++.|-.+..+. +||.+|-+..+|..+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467999999999999999999876 67889999987643   23334467777777776 69999999999999999999


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      |.||++||+|--+++    ..+.++++.++.+..+|.-||.|||+.   ||+.||+|..|||+|.+|++|++|||+++.-
T Consensus       329 vieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999866665    356699999999999999999999985   9999999999999999999999999999863


Q ss_pred             CCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCC-CchhHHHHHHHhhccccccccc
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGK-NCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      - .....+.+++|||.|+|||++.+..|...+|.|++||+++||+.|+.||+...-+ .....-++.++..-+....   
T Consensus       402 l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---  477 (593)
T KOG0695|consen  402 L-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---  477 (593)
T ss_pred             C-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---
Confidence            2 2233456789999999999999999999999999999999999999999853211 1222223334433222110   


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCC
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 1031 (1048)
                             .+...+.....+++.-+.+||.+|.
T Consensus       478 -------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 -------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -------ccceeehhhHHHHHHhhcCCcHHhc
Confidence                   0111122456777888899999984

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=241.97  Aligned_cols=201  Identities=28%  Similarity=0.408  Sum_probs=169.5

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +......||+|++|.|-+.++. +|...|+|++.... .+..+...+|+++..+. .+|.+|.++|.+......++.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            3444567999999999888765 79999999998554 34445677788876554 699999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      |+. +|+.+..+....+..+++...-+||..+++|+.|||+.  -.++|||+||+|||++.+|++|++|||.+..+....
T Consensus       127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            965 88888877777889999999999999999999999995  689999999999999999999999999998764322


Q ss_pred             CceeecccccccccCccccC----cCCCCchhhhHHHHHHHHHHHcCCCCCcc
Q 001591          925 THVTTDLVGTLGYIPPEYSQ----TLTATCRGDVYSFGVVLLELLTGRRPVEV  973 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slGvil~elltg~~P~~~  973 (1048)
                      .  .+...|-..|||||.+.    ...|+.++||||+|+.+.||.+++.||+.
T Consensus       204 A--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  204 A--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             H--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            1  12246788999999765    34789999999999999999999999974

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.3e-29  Score=275.00  Aligned_cols=202  Identities=27%  Similarity=0.358  Sum_probs=171.7

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      .-|..++.||-|+||+|.+++.. +...||.|.+++.+--   ....++.|-++|.....+-||+++..|.+++..|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            45778899999999999999644 5667899998865422   2234688999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC-
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-  921 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~-  921 (1048)
                      ||++||++-.+|..    -..|.++.++.++.++..|+++.|..   |+|||||||+|||||.+|++|++|||++.-+. 
T Consensus       709 dYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             eccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence            99999999887763    45688999999999999999999997   99999999999999999999999999985321 


Q ss_pred             --------CCCC-----------------c---------------eeecccccccccCccccCcCCCCchhhhHHHHHHH
Q 001591          922 --------PYDT-----------------H---------------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVL  961 (1048)
Q Consensus       922 --------~~~~-----------------~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil  961 (1048)
                              ..+.                 .               .....+||+.|+|||++....++..+|.||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence                    0000                 0               00123799999999999999999999999999999


Q ss_pred             HHHHcCCCCCcccC
Q 001591          962 LELLTGRRPVEVCK  975 (1048)
Q Consensus       962 ~elltg~~P~~~~~  975 (1048)
                      |||+.|++||-...
T Consensus       862 ~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADT  875 (1034)
T ss_pred             HHHhhCCCCccCCC
Confidence            99999999997544

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.9e-28  Score=263.51  Aligned_cols=238  Identities=31%  Similarity=0.388  Sum_probs=192.7

Q ss_pred             CceEEEEEEEC-CCcEEEEEEecCCchhh-HHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCChhhhccc
Q 001591          779 GFGLVYKATLT-NGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE  856 (1048)
Q Consensus       779 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  856 (1048)
                      +||.||+|.+. +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 58999999998655443 67899999999999999999999999999999999999999999998864


Q ss_pred             ccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeeccccccc
Q 001591          857 SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG  936 (1048)
Q Consensus       857 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~  936 (1048)
                      .    ..+++..+..++.+++++++|||+.   +++|+||+|+||++++++.++++|||.+.......  ......++..
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            3    2288999999999999999999986   99999999999999999999999999998765432  2334578889


Q ss_pred             ccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHH
Q 001591          937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML 1016 (1048)
Q Consensus       937 y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1016 (1048)
                      |+|||......++.++||||+|+++|++++|..||...  .......++..    ...... ...      ......++.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~~~----~~~~~~-~~~------~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKKIG----KPKPPF-PPP------EWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHh----ccCCCC-ccc------cccCCHHHH
Confidence            99999998888999999999999999999999998642  11112222111    111000 000      000334789


Q ss_pred             HHHHHcccCCCCCCCCHHHHHH
Q 001591         1017 EIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1017 ~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=3e-29  Score=242.86  Aligned_cols=256  Identities=20%  Similarity=0.290  Sum_probs=195.0

Q ss_pred             hcCCcccCeEeccCceEEEEEEE-CCCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeeecceEeeCC--cEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGN--DRLLI  841 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv  841 (1048)
                      .++|++.+.+|+|.|+.||.|.. .+.++++||+++   +...+.+.+|+.+++.++ ||||+++++...++.  ...+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46789999999999999999974 478899999998   345567899999999997 999999999998764  46799


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCcEEEeeccccccc
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLL  920 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~a~~~  920 (1048)
                      +||+.+.+.....       +.++...++.++.++++||.|+|+.   ||+|||+||+|+++|. ...++++|+|+|.++
T Consensus       114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence            9999998765543       2467788899999999999999997   9999999999999994 567999999999998


Q ss_pred             CCCCCceeecccccccccCccccCc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccc----
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE----  995 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~----  995 (1048)
                      .+.....  -.+.+..|.-||.+-. ..|+.+-|+|||||++..|+..+.||....+ +.++++.. ....+....    
T Consensus       184 Hp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkI-akVLGt~el~~Yl  259 (338)
T KOG0668|consen  184 HPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKI-AKVLGTDELYAYL  259 (338)
T ss_pred             CCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHH-HHHhChHHHHHHH
Confidence            7654432  2356778899997655 5678899999999999999999999975332 22233321 111110000    


Q ss_pred             ---ccccccc-----------cCchh-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          996 ---VEIIDAS-----------IWHKD-----REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       996 ---~~~~~~~-----------~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                         .-.+|+.           .|..+     ..-...++.+++.+.+..|..+|+|++|++.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence               0001111           11111     1112357889999999999999999999986

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-30  Score=257.03  Aligned_cols=261  Identities=24%  Similarity=0.327  Sum_probs=194.5

Q ss_pred             cccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeecceEeeC-----CcEEEE
Q 001591          770 NQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHG-----NDRLLI  841 (1048)
Q Consensus       770 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  841 (1048)
                      +-.+.||.|+||.||.+.+. +|+.||.|++..-..  ...+.+.+|.+++..++|.|++..++...-.     ++.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            33678999999999999865 899999999875432  3446788999999999999999998876533     356788


Q ss_pred             EEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      +|.|.. +|.+.+-    ..+.++.+.+.-+.+||++||+|||+.   +|.||||||.|.|++++...||+|||+|+...
T Consensus       136 TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  136 TELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence            888855 5555443    567789999999999999999999997   99999999999999999999999999999876


Q ss_pred             CCCCceeecccccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhc---------
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS---------  991 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------  991 (1048)
                      .++...++..+-|..|+|||++++. .|+.++||||.|||+.|++..+.-|+...+-+..+++........         
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            6665556666789999999988775 689999999999999999998888865443333233221111000         


Q ss_pred             cc------ccccccccccCch--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          992 EK------REVEIIDASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       992 ~~------~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..      ......+-.....  .+...-.+...+..+++.+||.+|.+..+.+.
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence            00      0000001000000  01122235678888999999999999988875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=287.44  Aligned_cols=246  Identities=25%  Similarity=0.354  Sum_probs=187.6

Q ss_pred             CcccCeEeccCceE-EEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecceEeeCCcEEEEEEecc
Q 001591          769 FNQANIIGCGGFGL-VYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      |.-.+++|.|+.|+ ||+|... |+.||||++-.+   ...-..+|+..++.- +|||||++++.-.+.+..|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            33456789998884 6999886 899999998643   334567899999988 59999999999888889999999995


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC---C--CcEEEeecccccccC
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE---K--FEAHLADFGLSRLLR  921 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~Dfg~a~~~~  921 (1048)
                       .+|++++...............+.+..|+++||++||+.   +|||||+||.||||+.   +  .+++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             589999976411111122245678889999999999997   9999999999999975   2  579999999999987


Q ss_pred             CCCCce--eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccc
Q 001591          922 PYDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       922 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ......  ..+..||.+|+|||++....-+.++||||+||++|+.++ |..||+.....        ...+.........
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--------~~NIl~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--------QANILTGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--------hhhhhcCccceee
Confidence            655433  335689999999999999988999999999999999998 59999742111        0111111111110


Q ss_pred             cccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +.+      ..++  +..++|.+|++++|..||++.+|+.
T Consensus       735 L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 LEP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ecc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            100      0111  7889999999999999999999975

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-27  Score=250.40  Aligned_cols=143  Identities=24%  Similarity=0.389  Sum_probs=114.5

Q ss_pred             CccccHHHHHHhhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-----C---Cc
Q 001591          754 CKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-----H---KN  824 (1048)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~n  824 (1048)
                      ...+.+.|... .++|.+.++||.|.|++||+|.+. ..+.||+|+.+.. ..-.+....|++++++++     |   ..
T Consensus        66 YHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   66 YHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             Cceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            33344444433 367999999999999999999765 5678999998754 333445678999999984     3   36


Q ss_pred             eeeecceEee----CCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCc
Q 001591          825 LVSLQGYCRH----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN  900 (1048)
Q Consensus       825 iv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  900 (1048)
                      ||+++++|..    +.+.+||+|++ |.+|..++...  .-+.++...+.+|++||+.||.|||..|  +|||.||||+|
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPEN  218 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPEN  218 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcce
Confidence            9999999975    45789999998 66788888754  3345888999999999999999999975  99999999999


Q ss_pred             eEE
Q 001591          901 ILL  903 (1048)
Q Consensus       901 Ill  903 (1048)
                      ||+
T Consensus       219 vLl  221 (590)
T KOG1290|consen  219 VLL  221 (590)
T ss_pred             eee
Confidence            999

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=3.4e-28  Score=268.85  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=206.9

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ..+|+....+|.|.||.||||++. +++.+|+|+++-.......-++.|+-+++..+|||||.++|.|...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            357888999999999999999865 7999999999987777777788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +.+|+|++.-+    ...++++.++..+.++..+|++|||+.   +=+|||||-.||++++.|.+|++|||.+..+....
T Consensus        94 cgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             cCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999988766    466799999999999999999999996   88999999999999999999999999998776433


Q ss_pred             CceeecccccccccCccc---cCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHh-hcccccccccc
Q 001591          925 THVTTDLVGTLGYIPPEY---SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM-KSEKREVEIID 1000 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~---~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 1000 (1048)
                      .. ...+.||+.|||||+   -..+.|...+|||+.|+...|+-.-++|.....      -.+..+-+ .+.-.....-|
T Consensus       167 ~K-rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh------pmr~l~LmTkS~~qpp~lkD  239 (829)
T KOG0576|consen  167 AK-RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH------PMRALFLMTKSGFQPPTLKD  239 (829)
T ss_pred             hh-hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc------hHHHHHHhhccCCCCCcccC
Confidence            22 335799999999995   456788999999999999999998888854211      11111111 22222233334


Q ss_pred             cccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +..|       .+-+-++++.|+..+|++||++..++.
T Consensus       240 k~kw-------s~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 KTKW-------SEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             Cccc-------hHHHHHHHHHHhcCCCccCCChhhhee
Confidence            4444       336789999999999999999987764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=260.59  Aligned_cols=197  Identities=20%  Similarity=0.278  Sum_probs=167.5

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhh--------HHHHHHHHHHHHhcC---CCceeeecceEe
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--------EREFQAEVEALSRAQ---HKNLVSLQGYCR  833 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---h~niv~l~~~~~  833 (1048)
                      ..+|...+.+|+|+||.|+.|.++ +...|++|.+.+...-.        .-.+..|+.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            446888999999999999999887 45678889887553110        112456999999997   999999999999


Q ss_pred             eCCcEEEEEEecc-CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEe
Q 001591          834 HGNDRLLIYSYME-NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLA  912 (1048)
Q Consensus       834 ~~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  912 (1048)
                      +++.+|++||... +-+|.+++..    ...+++.++..|++||+.|+++||++   +|||||||-+||.++.+|-+|++
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence            9999999999764 4588888864    45689999999999999999999997   99999999999999999999999


Q ss_pred             ecccccccCCCCCceeecccccccccCccccCcCCC-CchhhhHHHHHHHHHHHcCCCCCc
Q 001591          913 DFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVE  972 (1048)
Q Consensus       913 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~P~~  972 (1048)
                      |||.|......   ....++||..|.|||++.+..| .+.-|||++|+++|.++....||.
T Consensus       713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999865432   2345689999999999999877 467899999999999999988874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=242.34  Aligned_cols=254  Identities=22%  Similarity=0.259  Sum_probs=191.4

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeecceEeeC------Cc
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------ND  837 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  837 (1048)
                      .+|...+.+|.|.- .|..|.+. .++.||+|+.....  ....+...+|...+..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666788999988 66666544 68899999876442  23345678899999999999999999988533      45


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .|+|||+|.. +|...++.      .++.++...|..|++.|++|||+.   +|+||||||+||++..++.+||.|||+|
T Consensus        96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence            7999999954 67766652      367788999999999999999997   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc---
Q 001591          918 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR---  994 (1048)
Q Consensus       918 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---  994 (1048)
                      +..+..  ...++++.|..|+|||++-+..+.+.+||||+||++.||++|+.-|.+.     +.+-+|.......+.   
T Consensus       166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-----d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-----DHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-----hHHHHHHHHHHHhcCCCH
Confidence            865433  4567889999999999999888999999999999999999999988631     111122111110000   


Q ss_pred             ------------------------ccc-ccccccCch--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          995 ------------------------EVE-IIDASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       995 ------------------------~~~-~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                                              ..+ +.|......  ........+.+++.+|+..+|++|-+++++++
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                    000 111111000  01122335789999999999999999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=9.8e-26  Score=236.47  Aligned_cols=210  Identities=37%  Similarity=0.579  Sum_probs=183.2

Q ss_pred             EeccCceEEEEEEEC-CCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCChhh
Q 001591          775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY  852 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  852 (1048)
                      ||+|.+|.||++... +++++++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999886 4899999999865432 34678999999999999999999999999999999999999999999


Q ss_pred             hcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCcEEEeecccccccCCCCCceeecc
Q 001591          853 WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDL  931 (1048)
Q Consensus       853 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~  931 (1048)
                      ++....   ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++++|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            886431   4688999999999999999999986   9999999999999999 89999999999987643321 12234


Q ss_pred             cccccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHH
Q 001591          932 VGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010 (1048)
Q Consensus       932 ~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      .+...|++||..... .++.++|+|++|++++++                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            678899999998877 888999999999999999                                              


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001591         1011 QLLEMLEIACKCIDQDPRRRPFIEEVVTW 1039 (1048)
Q Consensus      1011 ~~~~l~~li~~cl~~~P~~RPt~~evl~~ 1039 (1048)
                        ..+.+++.+|++.+|++||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              368899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=7.6e-28  Score=251.25  Aligned_cols=418  Identities=23%  Similarity=0.256  Sum_probs=306.6

Q ss_pred             eEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccC-Cc
Q 001591          206 ILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFG-NQ  284 (1048)
Q Consensus       206 ~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~  284 (1048)
                      ..|-++-.++.+|..+  .+.-..++|..|+|+.+.|.+|+.+++|+.|||++|+|+.+.|++|.++.+|..|-+.+ |+
T Consensus        50 ~VdCr~~GL~eVP~~L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk  127 (498)
T KOG4237|consen   50 IVDCRGKGLTEVPANL--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK  127 (498)
T ss_pred             eEEccCCCcccCcccC--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence            3455555666677665  56788999999999999999999999999999999999999999999999998887777 99


Q ss_pred             CCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeeccccccc------
Q 001591          285 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFS------  358 (1048)
Q Consensus       285 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~------  358 (1048)
                      |+...-..|++|..|+.|.+.-|++.-.....|..+++|..|.+..|.+..+....|..+.+++.+.+..|.+-      
T Consensus       128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~  207 (498)
T KOG4237|consen  128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP  207 (498)
T ss_pred             hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence            99777788999999999999999999888899999999999999999999777778999999999999998732      


Q ss_pred             ------CCCCccccCCCccceeeccccccccccchhhccCCcCcEE--eccCCcCCCCcCcccccccccccceEecccCc
Q 001591          359 ------GPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFL--SLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF  430 (1048)
Q Consensus       359 ------~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L--~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~  430 (1048)
                            ...|..++...-..-..+.++++..+.+..|...  ++.+  .++.+.+-..+.....|.++++|+.|+|++|.
T Consensus       208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~--~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~  285 (498)
T KOG4237|consen  208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS--LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK  285 (498)
T ss_pred             hhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh--HHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence                  2344455555556666677777765555555432  2222  22333322333344568999999999999999


Q ss_pred             cCCCCCccccCCCcCcEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCcccccC-Cc
Q 001591          431 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEI-PK  509 (1048)
Q Consensus       431 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~  509 (1048)
                      ++.+-+.+|.++..++.|.|..|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+..|..|+|-.|.+--.- -.
T Consensus       286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~  365 (498)
T KOG4237|consen  286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA  365 (498)
T ss_pred             cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence            99999999999999999999999998666778999999999999999999888999999999999999999875210 01


Q ss_pred             chhhhhhhhccC----CCCCCCCCCCCccce-eeccccCCC----cCCCCCCCCC------CeeeeecCcccccCCcccc
Q 001591          510 SLTELKSLISSN----CTSSNPTASAGIPLY-VKHNRSTNG----LPYNQASSFP------PSVFLSNNRINGTIPPEIG  574 (1048)
Q Consensus       510 ~~~~l~~L~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~----l~~~~~~~~~------~~l~Ls~N~l~g~~p~~~~  574 (1048)
                      +++  ..|....    -....|....++++. +.+...+-+    ..-.....-|      .++.=..|+....+|.-+-
T Consensus       366 wl~--~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP  443 (498)
T KOG4237|consen  366 WLG--EWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP  443 (498)
T ss_pred             HHH--HHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC
Confidence            111  1222111    111112222222221 111111100    0000000011      1122233444446665543


Q ss_pred             CCCCCcEEEccCceecccCCcccccccCccEeeCCCCccCCCCccccccccCCCeeeeccc
Q 001591          575 QLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN  635 (1048)
Q Consensus       575 ~L~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N  635 (1048)
                        ..-.+|+|.+|+++ .+|.+  .+.+| .+|||+|+++..--..|.+++.|.+|-+|+|
T Consensus       444 --~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  444 --VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             --chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence              35678999999999 88988  78889 9999999999777788999999999999987

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-26  Score=228.60  Aligned_cols=250  Identities=19%  Similarity=0.275  Sum_probs=188.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecce-EeeCCcEEEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGY-CRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e  843 (1048)
                      +.|++.+.+|+|.||.+-+++++ +.+.+|+|.+... ....++|.+|..---.+ .|.||+.-++. |+..+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            35888899999999999999987 5678899988755 44567788887654444 48999998875 556677789999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC--CCCcEEEeecccccccC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD--EKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~Dfg~a~~~~  921 (1048)
                      |++.|+|..-+..     ..+.+....+++.|++.|+.|||+.   ++||||||.+|||+-  +..++|++|||..+..+
T Consensus       103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999876643     4477888999999999999999985   999999999999993  44579999999998754


Q ss_pred             CCCCceeecccccccccCccccCc-----CCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccc
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      .....    .--+..|.|||....     ....+.+|+|.||+++|.++||++||+. ....+..+++|.....+...  
T Consensus       175 ~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk~~--  247 (378)
T KOG1345|consen  175 TTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRKNP--  247 (378)
T ss_pred             ceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhcccCc--
Confidence            32221    123557999996443     3457789999999999999999999984 33445567777665554432  


Q ss_pred             cccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ...+      ......+.+.++.++-+.++|++|-...++.+
T Consensus       248 ~~P~------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  248 ALPK------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             cCch------hhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            1111      11122346788899999999999955444444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=2.9e-25  Score=235.93  Aligned_cols=198  Identities=32%  Similarity=0.443  Sum_probs=172.6

Q ss_pred             CcccCeEeccCceEEEEEEECC-CcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          769 FNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      |+..+.||.|++|.||+|...+ ++++|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667889999999999998874 899999999876554 56788999999999999999999999999899999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +++|.+++....   ..+++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++++|||.+.........
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            999999887532   1178999999999999999999986   9999999999999999999999999999876543211


Q ss_pred             eeecccccccccCcccc-CcCCCCchhhhHHHHHHHHHHHcCCCCCc
Q 001591          927 VTTDLVGTLGYIPPEYS-QTLTATCRGDVYSFGVVLLELLTGRRPVE  972 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltg~~P~~  972 (1048)
                      ......++..|++||.. ....++.++|+|+||++++||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22345678899999988 67778889999999999999999999995

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=2.2e-26  Score=247.15  Aligned_cols=261  Identities=21%  Similarity=0.259  Sum_probs=200.9

Q ss_pred             hcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcC------CCceeeecceEeeCCcE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ------HKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~  838 (1048)
                      ..+|.+....|+|-|++|.+|... -|..||||++... ....+.=..|+++|++++      --++++++-.|...++.
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            467999999999999999999865 5789999999865 334455578999999995      34789999999999999


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-CcEEEeecccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGLS  917 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~a  917 (1048)
                      ++|+|-+ .-+|.+.+... .....+....+..++.|+.-||..|...   +|+|.||||.|||+++. ..+||||||.|
T Consensus       510 ClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  510 CLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             EEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccc
Confidence            9999977 44788888764 3455688899999999999999999997   99999999999999864 56899999999


Q ss_pred             cccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc---
Q 001591          918 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR---  994 (1048)
Q Consensus       918 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---  994 (1048)
                      ......   ..+++.-+..|.|||++.+..|+...|+||+||+|||+.||+.-|.+...   .+++.........-+   
T Consensus       585 ~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN---N~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  585 SFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN---NQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             cccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc---HHHHHHHHHhcCCCcHHH
Confidence            876532   23445567789999999999999999999999999999999999865322   222222221111000   


Q ss_pred             --------------------------------ccccccc-----------ccCchhhHHHHHHHHHHHHHcccCCCCCCC
Q 001591          995 --------------------------------EVEIIDA-----------SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031 (1048)
Q Consensus       995 --------------------------------~~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 1031 (1048)
                                                      .+..+.+           .-...........+.+|+.+|+..||++|.
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence                                            0000000           001112335566899999999999999999


Q ss_pred             CHHHHHH
Q 001591         1032 FIEEVVT 1038 (1048)
Q Consensus      1032 t~~evl~ 1038 (1048)
                      |..++++
T Consensus       739 t~nqAL~  745 (752)
T KOG0670|consen  739 TVNQALK  745 (752)
T ss_pred             CHHHHhc
Confidence            9999875

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=7.1e-27  Score=244.03  Aligned_cols=288  Identities=20%  Similarity=0.217  Sum_probs=200.2

Q ss_pred             eeeeCCCCCC----CCCCcEEEEEecCCCCccccCccccCCcCCCeEecCCCCCCCCCCccccCCCCccEEeccC-Cccc
Q 001591           69 GVVCGHGSTG----SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSH-NMLS  143 (1048)
Q Consensus        69 gv~C~~~~~~----~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~  143 (1048)
                      -|.|+..+..    ..+...+.|+|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|.+|..+.+|..|-+-+ |+|+
T Consensus        50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~  129 (498)
T KOG4237|consen   50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT  129 (498)
T ss_pred             eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence            3778755442    4677899999999999999999999999999999999999999999999999988776655 9999


Q ss_pred             CcccccccccccccEEEecCcccCCcc-ccccccCcccEEEecCccccCccchhhhhcccccceEeccCccccc------
Q 001591          144 GPVSGMLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG------  216 (1048)
Q Consensus       144 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~------  216 (1048)
                      ..+.+.|++|..|+.|.+.-|++.... ..+..+++|..|.+..|.+. .++...|..+..++.+.+..|.+.-      
T Consensus       130 ~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~w  208 (498)
T KOG4237|consen  130 DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPW  208 (498)
T ss_pred             hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccch
Confidence            999999999999999999999998765 44677788888888888777 6677777777777777777776321      


Q ss_pred             -------ccCCCCCCCCCCEEEcccCCCCCCCCccccCC-CCCcEEEcccccCCcchh-hhhcCCCCCcEEEccCCcCCC
Q 001591          217 -------SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSM-SSLQHVSLSVNNFSGQLS-EKISNLTSLRHLIIFGNQFSG  287 (1048)
Q Consensus       217 -------~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~  287 (1048)
                             .+..+++..-.....+.++++..+.+..|... ..+..=..+.+...++.| ..|..|++|+.|+|++|+|++
T Consensus       209 la~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~  288 (498)
T KOG4237|consen  209 LADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR  288 (498)
T ss_pred             hhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch
Confidence                   11223333334444444555544444433321 111111111222222333 456677777777777777776


Q ss_pred             CccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccc
Q 001591          288 KLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF  357 (1048)
Q Consensus       288 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  357 (1048)
                      +-+.+|..+..+++|+|..|+|...-...|.++..|+.|+|++|+|+...|.+|..+.+|.+|+|-.|.+
T Consensus       289 i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~  358 (498)
T KOG4237|consen  289 IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF  358 (498)
T ss_pred             hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence            6677777777777777777776655555666666777777777777666666666666666666666644

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=3.5e-25  Score=235.19  Aligned_cols=203  Identities=31%  Similarity=0.409  Sum_probs=167.3

Q ss_pred             HHHHhhcCCcccCeEeccCceEEEEEEEC----CCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeeecceEeeC
Q 001591          761 DLLKSTNNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHG  835 (1048)
Q Consensus       761 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  835 (1048)
                      ++....+.|...+.||+|.|++||+|...    ..+.||+|.+....  ....+..|++++..+. +.||+++.+++...
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            34445678999999999999999999754    46789999887543  2345889999999995 99999999999999


Q ss_pred             CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-CCCcEEEeec
Q 001591          836 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADF  914 (1048)
Q Consensus       836 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Df  914 (1048)
                      +...+|+||++.....++...       ++..++..+++.+..||+++|+.   |||||||||+|++.+ ..+.-.|.||
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence            999999999999988887754       66889999999999999999986   999999999999998 5677899999


Q ss_pred             ccccccCCCC---------------------------------Cc----------eeecccccccccCccccCc-CCCCc
Q 001591          915 GLSRLLRPYD---------------------------------TH----------VTTDLVGTLGYIPPEYSQT-LTATC  950 (1048)
Q Consensus       915 g~a~~~~~~~---------------------------------~~----------~~~~~~gt~~y~aPE~~~~-~~~~~  950 (1048)
                      |+|.....+.                                 .+          ......||+||+|||++.. ..-+.
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9997211000                                 00          0112379999999998665 45688


Q ss_pred             hhhhHHHHHHHHHHHcCCCCCcccC
Q 001591          951 RGDVYSFGVVLLELLTGRRPVEVCK  975 (1048)
Q Consensus       951 ~~Dv~slGvil~elltg~~P~~~~~  975 (1048)
                      ++||||.|||+.-+++++.||....
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAK  282 (418)
T ss_pred             ccceeeccceeehhhccccccccCc
Confidence            9999999999999999999997543

>PLN03210 Resistant to P

Probab=99.91  E-value=2.1e-23  Score=269.21  Aligned_cols=240  Identities=21%  Similarity=0.207  Sum_probs=116.8

Q ss_pred             CcEEEcccccCCcchhhhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecC
Q 001591          251 LQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRN  330 (1048)
Q Consensus       251 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~  330 (1048)
                      |+.|++.++.+. .+|..| ...+|++|+|.+|++. .++..+..+++|+.|+++++.....+|. ++.+++|+.|+|++
T Consensus       591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~  666 (1153)
T PLN03210        591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD  666 (1153)
T ss_pred             cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence            444444444443 333333 2344444444444444 3333444444444444444332223332 44445555555555


Q ss_pred             ccccCccCcccccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCcC
Q 001591          331 NSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSG  410 (1048)
Q Consensus       331 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~  410 (1048)
                      |.....+|..+..+++|+.|++++|.....+|..+ ++++|+.|++++|...+.+|..   .++|+.|++++|.+..+|.
T Consensus       667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~  742 (1153)
T PLN03210        667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPS  742 (1153)
T ss_pred             CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccc
Confidence            44333444445555555555555543222444333 4555555555555433333322   2345555555555555543


Q ss_pred             cccccccccccceEecccCccC-------CCCCccccCCCcCcEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCC
Q 001591          411 TLSVLQQCKNLTTLILTKNFVG-------EEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNI  483 (1048)
Q Consensus       411 ~~~~l~~l~~L~~L~L~~N~l~-------~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  483 (1048)
                      .+    .+++|++|.+.++...       ...+......++|+.|+|++|...+.+|..++++++|+.|++++|...+.+
T Consensus       743 ~~----~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~L  818 (1153)
T PLN03210        743 NL----RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETL  818 (1153)
T ss_pred             cc----cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCee
Confidence            22    3445555555442211       111112223456667777776666666766777777777777766544456


Q ss_pred             CcccccCCCCCeEeecCCcc
Q 001591          484 PPWIGQMENLFYLDFSNNTL  503 (1048)
Q Consensus       484 p~~~~~l~~L~~L~Ls~N~l  503 (1048)
                      |..+ ++++|+.|+|++|..
T Consensus       819 P~~~-~L~sL~~L~Ls~c~~  837 (1153)
T PLN03210        819 PTGI-NLESLESLDLSGCSR  837 (1153)
T ss_pred             CCCC-CccccCEEECCCCCc
Confidence            6554 566677777766643

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=5.6e-23  Score=265.32  Aligned_cols=337  Identities=18%  Similarity=0.205  Sum_probs=223.4

Q ss_pred             ccccccccccEEEecCcccCC-------cccccccc-CcccEEEecCccccCccchhhhhcccccceEeccCcccccccC
Q 001591          148 GMLAGLNLIQSLNVSSNSFNG-------SLFELGEF-SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQ  219 (1048)
Q Consensus       148 ~~l~~l~~L~~L~Ls~N~l~~-------~~~~l~~l-~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~  219 (1048)
                      ..|.++.+|+.|.+.++....       .+..+..+ .+|+.|++.++.+. .+|..+  ...+|+.|++++|++..++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLEKLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccccccc
Confidence            345555555555555443211       11223333 24666666666655 444443  34667777777777766666


Q ss_pred             CCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccCCcCCCCccccccCcccc
Q 001591          220 GLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL  299 (1048)
Q Consensus       220 ~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  299 (1048)
                      ++..+++|+.|+|++|.....+| .+..+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            66677777777777665444555 36667777777777766555677777777777777777765444566544 67777


Q ss_pred             ccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccc-------cCCCCccccCCCccc
Q 001591          300 EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF-------SGPLPNSLSDCHDLK  372 (1048)
Q Consensus       300 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-------~~~~p~~l~~l~~L~  372 (1048)
                      +.|++++|.....+|..   .++|++|++++|.+.. +|..+ .+++|++|.+.++..       ....|..+...++|+
T Consensus       707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~  781 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT  781 (1153)
T ss_pred             CEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence            77777777554444432   3567777787777764 33333 466777777766432       111222233356788


Q ss_pred             eeeccccccccccchhhccCCcCcEEeccCC-cCCCCcCcccccccccccceEecccCccCCCCCccccCCCcCcEEEcc
Q 001591          373 ILSLAKNELSGQVPESFGKLTSLLFLSLSNN-SFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALG  451 (1048)
Q Consensus       373 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  451 (1048)
                      .|+|++|...+.+|.+++++++|+.|++++| .+..+|...    .+++|+.|++++|.....+|..   ..+|+.|+|+
T Consensus       782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~----~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls  854 (1153)
T PLN03210        782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI----NLESLESLDLSGCSRLRTFPDI---STNISDLNLS  854 (1153)
T ss_pred             heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC----CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence            8888888777778888888888888888876 466665432    5788888888887665555553   3578889999


Q ss_pred             CCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCc
Q 001591          452 NCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNT  502 (1048)
Q Consensus       452 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  502 (1048)
                      +|.++ .+|.++..+++|++|+|++|+--..+|..+..++.|+.+++++|.
T Consensus       855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence            99887 688889999999999998854333678888889999999998885

syringae 6; Provisional

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=2e-24  Score=270.97  Aligned_cols=194  Identities=18%  Similarity=0.223  Sum_probs=138.6

Q ss_pred             cCC-CceeeecceE-------eeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 001591          820 AQH-KNLVSLQGYC-------RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI  891 (1048)
Q Consensus       820 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  891 (1048)
                      ++| +||++++++|       .+++.++.++||+ +++|.+++..   ....+++.+++.++.||++||+|||+.   +|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            455 5888888887       2334567788887 5699999964   245689999999999999999999986   99


Q ss_pred             EEcCCCCCceEECC-------------------CCcEEEeecccccccCCCC---------------Cceeecccccccc
Q 001591          892 VHRDVKSSNILLDE-------------------KFEAHLADFGLSRLLRPYD---------------THVTTDLVGTLGY  937 (1048)
Q Consensus       892 vH~Dlk~~NIll~~-------------------~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~gt~~y  937 (1048)
                      +||||||+|||++.                   ++.+|++|||+++......               .......+||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   4456666666665421100               0001124689999


Q ss_pred             cCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHH
Q 001591          938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLE 1017 (1048)
Q Consensus       938 ~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1017 (1048)
                      +|||++.+..++.++|||||||++|||++|.+|+...     .....   .....     ...+.     ......+..+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~---~~~~~-----~~~~~-----~~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMS---SLRHR-----VLPPQ-----ILLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHH---HHHHh-----hcChh-----hhhcCHHHHH
Confidence            9999999999999999999999999999999886421     01111   11000     00000     0111224567


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 001591         1018 IACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1018 li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ++.+|++++|.+||++.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            888999999999999999986

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-24  Score=214.87  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=193.2

Q ss_pred             CcccCeEeccCceEEEEEEECCCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEecc
Q 001591          769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      ......|.+...|..|+|+|+ |..+++|++...  .....+.|..|.-.++.+.||||+.++|.|..+....++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            334556889999999999998 566666776533  24455779999999999999999999999999999999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      .|+|+..+++.  .....+..++.++|.++|+|++|||+. ++-|.---+.++.|++|++.+++|+- +-+++.     .
T Consensus       271 ~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs-----f  341 (448)
T KOG0195|consen  271 FGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----F  341 (448)
T ss_pred             chHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee-----e
Confidence            99999999975  455678889999999999999999997 44444556899999999999988751 111110     0


Q ss_pred             eeecccccccccCccccCcCCCC---chhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccccccc
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTAT---CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ......-.|.||+||.++..+.+   .++|+|||++++||+.|.+.||....+.++.               +.+.-+.+
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialegl  406 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGL  406 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccc
Confidence            01122346789999988876543   5799999999999999999999754433321               11111222


Q ss_pred             CchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      ....++.....+.+++.-|+..||.+||.++.++-.||.+.
T Consensus       407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            23344555667899999999999999999999999998764

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=2.7e-23  Score=248.05  Aligned_cols=77  Identities=25%  Similarity=0.336  Sum_probs=45.3

Q ss_pred             eeeecCcccccCCccccCCCCCcEEEccCceecccCCcccccccCccEeeCCCCccCCCCccccccccCCCeeeeccccc
Q 001591          558 VFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL  637 (1048)
Q Consensus       558 l~Ls~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l  637 (1048)
                      |++++|+|++ +|...   ++|+.|++++|+|+ .+|...   .+|+.|+|++|+|+ .+|..+.++++|..|+|++|+|
T Consensus       387 LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~L  457 (788)
T PRK15387        387 LIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL  457 (788)
T ss_pred             EEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCC
Confidence            4445555542 33322   35666666666666 355432   34566666766666 5666666666677777777776


Q ss_pred             cccCCC
Q 001591          638 QGTIPT  643 (1048)
Q Consensus       638 ~g~~p~  643 (1048)
                      +|.+|.
T Consensus       458 s~~~~~  463 (788)
T PRK15387        458 SERTLQ  463 (788)
T ss_pred             CchHHH
Confidence            666654

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=7.6e-23  Score=244.18  Aligned_cols=267  Identities=24%  Similarity=0.314  Sum_probs=158.3

Q ss_pred             eEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccCCcC
Q 001591          206 ILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF  285 (1048)
Q Consensus       206 ~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  285 (1048)
                      .|+|+.|.++.+|..+.  ++|+.|++.+|+|+. +|.   .+++|++|+|++|+|+. +|..   .++|+.|+|++|.+
T Consensus       205 ~LdLs~~~LtsLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L  274 (788)
T PRK15387        205 VLNVGESGLTTLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPL  274 (788)
T ss_pred             EEEcCCCCCCcCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCch
Confidence            44444444444444332  244555555555542 232   12455555555555552 2321   23455555555555


Q ss_pred             CCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCCCccc
Q 001591          286 SGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL  365 (1048)
Q Consensus       286 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l  365 (1048)
                      + .+|..+   ++|+.|++++|+++. +|.   ..++|+.|++++|++++..+ .   ..+|+.|++++|+|++ +|.. 
T Consensus       275 ~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~L~~-LP~l-  340 (788)
T PRK15387        275 T-HLPALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQLTS-LPTL-  340 (788)
T ss_pred             h-hhhhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCccccCCC-C---cccccccccccCcccc-cccc-
Confidence            4 233222   334455555555552 232   12456666666666664322 1   2345666666666663 4431 


Q ss_pred             cCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCcCcccccccccccceEecccCccCCCCCccccCCCcC
Q 001591          366 SDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESL  445 (1048)
Q Consensus       366 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  445 (1048)
                        ..+|+.|+|++|+|++ +|..   .++|+.|++++|++..+|..      ..+|+.|++++|.+.. +|..   .++|
T Consensus       341 --p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~l------~~~L~~LdLs~N~Lt~-LP~l---~s~L  404 (788)
T PRK15387        341 --PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL------PSGLKELIVSGNRLTS-LPVL---PSEL  404 (788)
T ss_pred             --ccccceEecCCCccCC-CCCC---CcccceehhhccccccCccc------ccccceEEecCCcccC-CCCc---ccCC
Confidence              1356677777777763 3432   23566667777777666542      2457777777777753 4433   2578


Q ss_pred             cEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCcccccCCcchhhhhhh
Q 001591          446 MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL  517 (1048)
Q Consensus       446 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  517 (1048)
                      +.|++++|++++ +|...   .+|+.|+|++|+|+ .+|..++++++|+.|+|++|+|++.+|..+..+.+.
T Consensus       405 ~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~s~  471 (788)
T PRK15387        405 KELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA  471 (788)
T ss_pred             CEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHhcC
Confidence            889999999884 66533   46889999999998 799999999999999999999999888877666544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=5.4e-23  Score=209.54  Aligned_cols=168  Identities=21%  Similarity=0.200  Sum_probs=126.1

Q ss_pred             CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCce
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.++++.   .+..+++.+++.|+.|+++||+|||+.   +      ||+||+++.++.+|+  ||.++......   
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            678888864   245699999999999999999999986   4      999999999999999  99998754321   


Q ss_pred             eecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchh
Q 001591          928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007 (1048)
Q Consensus       928 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                         ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....  .......+.........   .+    ...
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~---~~----~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPADDP---RD----RSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccCCc---cc----ccc
Confidence               2689999999999999999999999999999999999999964221  11111111111111000   00    011


Q ss_pred             hHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591         1008 REKQLL--EMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1008 ~~~~~~--~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      ......  ++.+++.+|++.+|++||++.|+++.+..+.
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            122222  6899999999999999999999999776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=2.2e-22  Score=197.14  Aligned_cols=258  Identities=20%  Similarity=0.261  Sum_probs=201.2

Q ss_pred             hcCCcccCeEeccCceEEEEEE-ECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCC-CceeeecceEeeCCcEEEEEE
Q 001591          766 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH-KNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.+.||.|+||.+|.|. ..+|++||+|+-+.....  .++..|.++.+.+++ ..|..+..|..+...-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4689999999999999999997 458999999987755432  346788999999974 788888888888888899999


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC---CCcEEEeeccccccc
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE---KFEAHLADFGLSRLL  920 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~a~~~  920 (1048)
                      .. |.+|++.+.-   ....++..+++-.|-|++.-++|+|..   +++||||||+|+|+.-   -..+.++|||+|+.+
T Consensus        92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            88 7899987764   456789999999999999999999985   9999999999999963   356899999999987


Q ss_pred             CCCCCcee------ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          921 RPYDTHVT------TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       921 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      ....+...      ....||..|.+-...-+..-+.+.|+-|+|.++.+.--|..||++.......+..+.+.+.+-...
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            65443322      345899999998888887888899999999999999999999997665544444444433332211


Q ss_pred             cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                       .+.        .+...+.++.-.+..|-..--++-|....+-+.++
T Consensus       245 -ie~--------LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  245 -IEV--------LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             -HHH--------HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence             111        12233446777788888888888888776665443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=2.8e-22  Score=241.33  Aligned_cols=316  Identities=22%  Similarity=0.290  Sum_probs=169.3

Q ss_pred             CCCCCHHHHHHHHHHHhcCCCCCCCcC----cCCCCCCceeee----------------eeeCCCCCCCCCCcEEEEEec
Q 001591           31 FQSCDPSDLLALKEFAGNLTNGSIITS----WSNESMCCQWDG----------------VVCGHGSTGSNAGRVTMLILP   90 (1048)
Q Consensus        31 ~~~~~~~~~~aLl~~k~~~~~~~~l~s----w~~~~~~c~w~g----------------v~C~~~~~~~~~~~v~~l~L~   90 (1048)
                      .....++|-+++++..+.+.-++++.+    |.+.++.|.=..                |.|.       .+.|+.+..-
T Consensus        57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~-------~~~vt~l~~~  129 (754)
T PRK15370         57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG-------GKSVTYTRVT  129 (754)
T ss_pred             CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecC-------CCcccccccc
Confidence            345678899999999999988877777    999999996543                6774       3445555443


Q ss_pred             CCCCccccCccccCCcCCCeEecC-----CCCCCCCCC---ccc-----cCCCCccEEeccCCcccCccccccccccccc
Q 001591           91 RKGLKGIIPRSLGHLNQLKLLDLS-----CNHLEGVVP---VEL-----SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ  157 (1048)
Q Consensus        91 ~~~l~g~~~~~l~~l~~L~~L~Ls-----~n~l~~~~p---~~~-----~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~  157 (1048)
                      +.........+    ..-..-+..     .+.-.+..+   .++     +-..+...|+++++.++..+. .+.  .+|+
T Consensus       130 g~~~~~~~~~~----~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~-~Ip--~~L~  202 (754)
T PRK15370        130 ESEQASSASGS----KDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPA-CIP--EQIT  202 (754)
T ss_pred             cccccccCCCC----CChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCc-ccc--cCCc
Confidence            32211111000    000000000     000000000   001     112456778888888776443 232  4678


Q ss_pred             EEEecCcccCCccccccccCcccEEEecCccccCccchhhhhcccccceEeccCcccccccCCCCCCCCCCEEEcccCCC
Q 001591          158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLL  237 (1048)
Q Consensus       158 ~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l  237 (1048)
                      .|+|++|+++.++..+.  ++|+.|++++|+|+ .+|..+.   .+|+.|+|++|++..+                    
T Consensus       203 ~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~~L--------------------  256 (754)
T PRK15370        203 TLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMELSINRITEL--------------------  256 (754)
T ss_pred             EEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEECcCCccCcC--------------------
Confidence            88888888877665443  46777777777666 3343322   2344444444444433                    


Q ss_pred             CCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCccc
Q 001591          238 GGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL  317 (1048)
Q Consensus       238 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l  317 (1048)
                          |..+.  ++|+.|+|++|+++ .+|..+.  ++|+.|+|++|+|++ +|..+.  ++|+.|++++|+++. +|..+
T Consensus       257 ----P~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l  323 (754)
T PRK15370        257 ----PERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETL  323 (754)
T ss_pred             ----ChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCccc
Confidence                33332  34555555555555 2343332  356666666666653 333322  346666666666653 33222


Q ss_pred             ccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcE
Q 001591          318 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLF  397 (1048)
Q Consensus       318 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  397 (1048)
                        .++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+++ .+|..+.  ..|+.
T Consensus       324 --~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~  392 (754)
T PRK15370        324 --PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQI  392 (754)
T ss_pred             --cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHH
Confidence              2456667777776664 333332  46666777776666 3454442  46666777777666 3444443  24666


Q ss_pred             EeccCCcCCCCcC
Q 001591          398 LSLSNNSFNHLSG  410 (1048)
Q Consensus       398 L~L~~N~l~~l~~  410 (1048)
                      |++++|++..+|.
T Consensus       393 LdLs~N~L~~LP~  405 (754)
T PRK15370        393 MQASRNNLVRLPE  405 (754)
T ss_pred             HhhccCCcccCch
Confidence            6666666665553

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=9.3e-22  Score=201.50  Aligned_cols=257  Identities=18%  Similarity=0.220  Sum_probs=203.9

Q ss_pred             cCCcccCeEeccCceEEEEEEE-CCCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEEEEe
Q 001591          767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      -.|++.+.||+|.||..+.|+. -+++.||||.-....  ...++..|.+.++.+. .++|...+.|..++-.-.+|+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            4699999999999999999974 479999999765432  2345788999999885 78999998888888888899998


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-----CCcEEEeecccccc
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-----KFEAHLADFGLSRL  919 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~Dfg~a~~  919 (1048)
                      + |.+|++.+.-   .++.|+..++..||.|++.-++|+|+.   ..|.|||||+|+||..     ...+.++|||+|+.
T Consensus       106 L-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  106 L-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             h-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            8 7788887643   567899999999999999999999985   9999999999999963     34589999999999


Q ss_pred             cCCCCCcee------ecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccc
Q 001591          920 LRPYDTHVT------TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  993 (1048)
Q Consensus       920 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  993 (1048)
                      +....+...      ....||.+||+-....+..-+.+.|+-|+|-++++.+-|..||++...++..+..+.+-..++..
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            876655433      23579999999999999999999999999999999999999999876665555444443333322


Q ss_pred             ccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 001591          994 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 1041 (1048)
                      ...         ..++..++++..-+...-+.+-.+-|+.+.+...+.
T Consensus       259 ~i~---------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~  297 (449)
T KOG1165|consen  259 PIE---------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD  297 (449)
T ss_pred             CHH---------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            211         123334557777777777888899999887765443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=5.6e-22  Score=219.90  Aligned_cols=164  Identities=21%  Similarity=0.219  Sum_probs=128.0

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC--CCcEEEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeeecceEeeCCc
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT--NGTKAAVKRLSGD-----CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  837 (1048)
                      ..++|++.+.||+|+||+||+|++.  +++.||||++...     .....+.+.+|++++++++|+|+++.+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            3467999999999999999999865  5778899987533     12235568999999999999999853322   245


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCceEECCCCcEEEeeccc
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV-KSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~Dfg~  916 (1048)
                      .++||||++|++|... .    ...      ...++.++++||+|||+.   ||+|||| ||+||+++.++.+||+|||+
T Consensus        93 ~~LVmE~~~G~~L~~~-~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-R----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             cEEEEEccCCCCHHHh-C----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            7999999999998632 1    111      146788999999999986   9999999 99999999999999999999


Q ss_pred             ccccCCCCCce-------eecccccccccCccccCc
Q 001591          917 SRLLRPYDTHV-------TTDLVGTLGYIPPEYSQT  945 (1048)
Q Consensus       917 a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  945 (1048)
                      |+.+.......       .....+++.|+|||++..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99765432111       134578889999998664

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.6e-21  Score=218.09  Aligned_cols=258  Identities=22%  Similarity=0.247  Sum_probs=192.5

Q ss_pred             CCcccCeEeccCceEEEEEEECCC--cEEEEEEecCCchhhHHHHHHHHHHHHhcCC----CceeeecceE-eeCCcEEE
Q 001591          768 NFNQANIIGCGGFGLVYKATLTNG--TKAAVKRLSGDCGQMEREFQAEVEALSRAQH----KNLVSLQGYC-RHGNDRLL  840 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  840 (1048)
                      +|.+.+.||+|+||.||+|.....  ..+|+|............+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999987643  4788888765433322267888999888873    6888888888 46777899


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-----CcEEEeecc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-----FEAHLADFG  915 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~Dfg  915 (1048)
                      ||+.+ |.+|.++.....  ...++..++.+|+.|++.+|+++|+.   |++||||||.|+++...     ..+.+.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99977 779998765432  56799999999999999999999986   99999999999999754     469999999


Q ss_pred             cccccC--CCCC-------ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001591          916 LSRLLR--PYDT-------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  986 (1048)
Q Consensus       916 ~a~~~~--~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~  986 (1048)
                      +|+.+.  ....       .......||..|.+++...+...+.+.|+||++.++.|+..|..||.........   ..+
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~  249 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKF  249 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHH
Confidence            999322  1111       1123456999999999999999999999999999999999999999654322211   111


Q ss_pred             HHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhc
Q 001591          987 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i 1043 (1048)
                      ...........         .....+.++.++...+-..+..++|....+.+.+++.
T Consensus       250 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  250 EKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            11111111100         0111123566666666678999999999998887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=3.1e-22  Score=236.90  Aligned_cols=260  Identities=21%  Similarity=0.236  Sum_probs=193.2

Q ss_pred             ccCeEeccCceEEEEEEEC-CCcEEEEEEec----CC-chhh-HHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEE
Q 001591          771 QANIIGCGGFGLVYKATLT-NGTKAAVKRLS----GD-CGQM-EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       771 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  843 (1048)
                      ..+++|.|++|.|+.+... ..+.++.|.++    .. .... ...+..|+.+-..++|||++..+..+.+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4678999999988887644 34445555443    11 1111 1125667777788899999999998888777777799


Q ss_pred             eccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCC
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++ +|...+..    ...++..++..+++|+..|++|+|++   ||.|||+|++|++++.+|.+||+|||.+....-.
T Consensus       402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            9999 99888864    24688899999999999999999997   9999999999999999999999999999876433


Q ss_pred             CC---ceeecccccccccCccccCcCCCCc-hhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccccc
Q 001591          924 DT---HVTTDLVGTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       924 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ..   ......+|+..|+|||+..+..|.+ ..||||.|+++..|++|+.||.........-     .......   +..
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~---~~~  545 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSD---QRN  545 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccc---ccc
Confidence            22   4556789999999999999999876 5799999999999999999997543221110     0001000   000


Q ss_pred             ccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhcCcc
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1046 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~i~~~ 1046 (1048)
                      ...-....-...+.+-..++.+|++++|.+|.|+.++++  |++.|...
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence            000011112233446788999999999999999999996  88887654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=1e-20  Score=227.87  Aligned_cols=245  Identities=22%  Similarity=0.336  Sum_probs=124.1

Q ss_pred             cceEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccCC
Q 001591          204 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN  283 (1048)
Q Consensus       204 L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  283 (1048)
                      .+.|++++++++.+|..+  .++|+.|+|++|+|+ .+|..+.  .+|++|++++|+|+ .+|..+.  .+|+.|+|++|
T Consensus       180 ~~~L~L~~~~LtsLP~~I--p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N  251 (754)
T PRK15370        180 KTELRLKILGLTTIPACI--PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSIN  251 (754)
T ss_pred             ceEEEeCCCCcCcCCccc--ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCC
Confidence            455666666666555444  245666666666666 3344433  36666666666665 3344332  35666666666


Q ss_pred             cCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCCCc
Q 001591          284 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN  363 (1048)
Q Consensus       284 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  363 (1048)
                      +++ .+|..+.  ++|+.|++++|+++ .+|..+.                          ++|+.|+|++|+|++ +|.
T Consensus       252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--------------------------~sL~~L~Ls~N~Lt~-LP~  300 (754)
T PRK15370        252 RIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--------------------------EELRYLSVYDNSIRT-LPA  300 (754)
T ss_pred             ccC-cCChhHh--CCCCEEECcCCccC-ccccccC--------------------------CCCcEEECCCCcccc-Ccc
Confidence            665 3443332  23444444444444 2232221                          244555555555442 333


Q ss_pred             cccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCcCcccccccccccceEecccCccCCCCCccccCCC
Q 001591          364 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFE  443 (1048)
Q Consensus       364 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  443 (1048)
                      .+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|.++.+|..+     .++|+.|++++|.+. .+|..+  .+
T Consensus       301 ~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l-----~~sL~~L~Ls~N~L~-~LP~~l--p~  367 (754)
T PRK15370        301 HLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSLPASL-----PPELQVLDVSKNQIT-VLPETL--PP  367 (754)
T ss_pred             cch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccCChhh-----cCcccEEECCCCCCC-cCChhh--cC
Confidence            222  245555555555552 333222  35556666666655554322     134455555555443 233332  13


Q ss_pred             cCcEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCCCccc----ccCCCCCeEeecCCccc
Q 001591          444 SLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI----GQMENLFYLDFSNNTLT  504 (1048)
Q Consensus       444 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~  504 (1048)
                      +|+.|+|++|+|+ .+|..+.  ..|+.|++++|+++ .+|..+    +.++.+..|++.+|.++
T Consensus       368 ~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        368 TITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            5666666666666 3444433  24666677777766 444433    33456667777777665

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=2e-19  Score=203.42  Aligned_cols=259  Identities=28%  Similarity=0.406  Sum_probs=197.1

Q ss_pred             CcccCeEeccCceEEEEEEECCCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCC-ceeeecceEeeCCcEEEEEEe
Q 001591          769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHK-NLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      |+..+.||.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999877  88899988755432   367789999999999988 799999999777778999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-cEEEeecccccccCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPY  923 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~a~~~~~~  923 (1048)
                      +.++++.+++...... ..++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++.....
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999666542211 3688999999999999999999986   899999999999999888 7999999999865443


Q ss_pred             CCc-----eeecccccccccCccccCc---CCCCchhhhHHHHHHHHHHHcCCCCCcccCCC-CchhHHHHHHHhhcccc
Q 001591          924 DTH-----VTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGK-NCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       924 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~  994 (1048)
                      ...     ......||..|+|||...+   ..+....|+||+|++++++++|..||...... ........+...... .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-S  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-c
Confidence            322     2356789999999999887   67889999999999999999999997643221 011222222211111 0


Q ss_pred             cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..    ..............+.+++.+|+..+|..|.++.+...
T Consensus       235 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         235 LA----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             cc----cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            00    00000000222346889999999999999999887765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=3.8e-21  Score=224.31  Aligned_cols=253  Identities=22%  Similarity=0.233  Sum_probs=184.2

Q ss_pred             CCcccCeEeccCceEEEEEEECCCcEEEEEEecCCc-hhhHHHHHHHHHH--HHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC-GQMEREFQAEVEA--LSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +|...+.+|.+.|=+|.+|+++.|. |+||++-+.. .-..+.|.++++.  ...++|||.+++..+-..+...|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677889999999999999998777 8889886554 3334445444443  3445899999999988888888899999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc--CC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RP  922 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~--~~  922 (1048)
                      +.. +|+|.+.    .+..+...+..+||.|++.|+..+|..   ||+|||||.+|||+++-.-+.++||..-+..  .+
T Consensus       103 vkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            865 6666664    566788899999999999999999986   9999999999999999999999999876542  22


Q ss_pred             CCCceee----cccccccccCccccCcC-----------CCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHH
Q 001591          923 YDTHVTT----DLVGTLGYIPPEYSQTL-----------TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV  986 (1048)
Q Consensus       923 ~~~~~~~----~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~  986 (1048)
                      ++....+    +...-..|+|||.+...           ..+++.||||+||+++|+++ |++||+-.      +    .
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------Q----L  244 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------Q----L  244 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------H----H
Confidence            2221111    11223379999965431           15678999999999999999 89998621      1    1


Q ss_pred             HHhhccc-ccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcCcc
Q 001591          987 FQMKSEK-REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       987 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      +.....+ ...+..-..+       +...+..++..|++.||++|-+++++++.-+++...
T Consensus       245 ~aYr~~~~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP  298 (1431)
T KOG1240|consen  245 LAYRSGNADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP  298 (1431)
T ss_pred             HhHhccCccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence            1111111 0011111111       111578999999999999999999999987776543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=4.4e-20  Score=189.87  Aligned_cols=170  Identities=14%  Similarity=0.157  Sum_probs=133.3

Q ss_pred             hcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHH---------HHHHHHHHHHhcCCCceeeecceEeeC-
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER---------EFQAEVEALSRAQHKNLVSLQGYCRHG-  835 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~-  835 (1048)
                      .++|+..+++|.|+||.||.+.. ++..+|+|.+.......+.         .+++|+..+.++.||+|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            57899999999999999999766 5779999999755433332         268899999999999999999886543 


Q ss_pred             -------CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCc
Q 001591          836 -------NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE  908 (1048)
Q Consensus       836 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~  908 (1048)
                             ...++||||++|.+|.++..        ++.    ....+++.+++.+|+.   |++|||+||+||+++.++ 
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence                   35789999999999977632        222    2456899999999986   999999999999999988 


Q ss_pred             EEEeecccccccCCCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHH
Q 001591          909 AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL  965 (1048)
Q Consensus       909 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ell  965 (1048)
                      ++++|||...........             ..+.....+..++|+|+||+++....
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999998765321110             11333445667899999999987765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=2.3e-19  Score=183.38  Aligned_cols=140  Identities=18%  Similarity=0.147  Sum_probs=108.9

Q ss_pred             cCeEeccCceEEEEEEECCCcEEEEEEecCCchh--h------------------------HHHHHHHHHHHHhcCCCce
Q 001591          772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ--M------------------------EREFQAEVEALSRAQHKNL  825 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  825 (1048)
                      ...||+|++|.||+|...+|+.||+|+++.....  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998754211  0                        1122459999999988877


Q ss_pred             eeecceEeeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCCceEEC
Q 001591          826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLD  904 (1048)
Q Consensus       826 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlk~~NIll~  904 (1048)
                      .....+..  ...++||||++++++.....    ....+++..+..++.|++.+++|+ |+.   +|+||||||+||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            54433322  23489999999987654422    234688999999999999999999 665   999999999999998


Q ss_pred             CCCcEEEeecccccccC
Q 001591          905 EKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       905 ~~~~~kl~Dfg~a~~~~  921 (1048)
                       ++.++++|||+|....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=4.1e-19  Score=188.27  Aligned_cols=234  Identities=23%  Similarity=0.314  Sum_probs=148.6

Q ss_pred             CCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcC----------CCceeeecceEe
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQ----------HKNLVSLQGYCR  833 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~  833 (1048)
                      .+...+.||.|+++.||.+++. +++++|+|++....   ....+++++|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3556788999999999999987 68999999875332   223345666654444422          222333333221


Q ss_pred             ---------eCC--------cEEEEEEeccCCChhhhcc---cccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 001591          834 ---------HGN--------DRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH  893 (1048)
Q Consensus       834 ---------~~~--------~~~lv~e~~~~g~L~~~l~---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  893 (1048)
                               ...        ..+++|+-+ -++|.+++.   ........+....++.+..|+++.+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                     111        125667766 457766643   2222234466777888889999999999997   9999


Q ss_pred             cCCCCCceEECCCCcEEEeecccccccCCCCCceeecccccccccCccccCc--------CCCCchhhhHHHHHHHHHHH
Q 001591          894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT--------LTATCRGDVYSFGVVLLELL  965 (1048)
Q Consensus       894 ~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slGvil~ell  965 (1048)
                      +||+|+|++++++|.+.++||+.....+..    ......+..|.+||....        ..++.+.|.|++|+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999988764321    111345578999996533        35788999999999999999


Q ss_pred             cCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCC
Q 001591          966 TGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRR 1030 (1048)
Q Consensus       966 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 1030 (1048)
                      +|+.||+........+.                    .. ..+.+.++.+.++|..+++++|++|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f-~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DF-SRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GG-TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cc-hhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999975322211110                    11 1122566689999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.7e-18  Score=172.41  Aligned_cols=185  Identities=19%  Similarity=0.121  Sum_probs=139.4

Q ss_pred             cccCeEeccCceEEEEEEECCCcEEEEEEecCCchh----hHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEEEEe
Q 001591          770 NQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ----MEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       770 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-    ....+.+|+++++++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999998865 5888888877754321    1225789999999995 5889999886    346999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCceEECCCCcEEEeecccccccCCC
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV-KSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      ++|.+|......           ....++.|++++++++|+.   ||+|||| ||+||++++++.++|+|||+|....+.
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999988654311           1135778999999999986   9999999 799999999999999999999865432


Q ss_pred             CCc----e--------eecccccccccCccccCc--CCCCchhhhHHHHHHHHHHHcCCCCCcc
Q 001591          924 DTH----V--------TTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEV  973 (1048)
Q Consensus       924 ~~~----~--------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~P~~~  973 (1048)
                      ...    .        ..-...++.|++|+...-  ..--.+.+.++-|.-+|.++|+..|...
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            210    0        011235778888874322  2223577999999999999999998643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=2.3e-18  Score=177.02  Aligned_cols=139  Identities=18%  Similarity=0.159  Sum_probs=111.2

Q ss_pred             cCeEeccCceEEEEEEECCCcEEEEEEecCCchh--------------------------hHHHHHHHHHHHHhcCCCce
Q 001591          772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ--------------------------MEREFQAEVEALSRAQHKNL  825 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  825 (1048)
                      .+.||+|++|.||+|...+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754211                          01123678999999999987


Q ss_pred             eeecceEeeCCcEEEEEEeccCCChhhh-cccccCCccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCceEE
Q 001591          826 VSLQGYCRHGNDRLLIYSYMENGSLDYW-LHESVDKDSVLKWDVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILL  903 (1048)
Q Consensus       826 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~NIll  903 (1048)
                      .....+...  ..++||||++++++... +.     ...++...+..++.+++.++.++|+ .   ||+||||||+||++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            555544433  24899999998855332 32     2346788999999999999999998 5   99999999999999


Q ss_pred             CCCCcEEEeecccccccC
Q 001591          904 DEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       904 ~~~~~~kl~Dfg~a~~~~  921 (1048)
                      + ++.++++|||++....
T Consensus       152 ~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         152 H-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             E-CCCEEEEEcccceecC
Confidence            9 8899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=1.1e-19  Score=204.52  Aligned_cols=273  Identities=23%  Similarity=0.237  Sum_probs=115.9

Q ss_pred             EEcccCCCC-CCCCccccCCCCCcEEEcccccCCcc----hhhhhcCCCCCcEEEccCCcCCC------CccccccCccc
Q 001591          230 LHVDNNLLG-GDLPDSLYSMSSLQHVSLSVNNFSGQ----LSEKISNLTSLRHLIIFGNQFSG------KLPNVLGNLTQ  298 (1048)
Q Consensus       230 L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~  298 (1048)
                      |+|.++.++ ......+..+.+|++|+++++.++..    ++..+...++|++|+++++.+.+      .++..+.++++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            344444443 22233334444455555555554322    33334444455555555554441      11223333444


Q ss_pred             cccccccCCcccCCCCcccccCCC---CcEEEecCccccC----ccCcccccC-CcccEeecccccccCC----CCcccc
Q 001591          299 LEFFVAHSNSFSGPLPLSLSLCSK---LHVLDLRNNSLTG----PIDLNFSGL-SSLCTLDLATNHFSGP----LPNSLS  366 (1048)
Q Consensus       299 L~~L~l~~n~l~~~~~~~l~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~Ls~N~l~~~----~p~~l~  366 (1048)
                      |+.|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++.    ++..+.
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~  162 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR  162 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence            444444444444333333333332   5555555555542    111122333 4555555555555521    222344


Q ss_pred             CCCccceeeccccccccc----cchhhccCCcCcEEeccCCcCCCCcC--cccccccccccceEecccCccCCCCCcccc
Q 001591          367 DCHDLKILSLAKNELSGQ----VPESFGKLTSLLFLSLSNNSFNHLSG--TLSVLQQCKNLTTLILTKNFVGEEIPENVG  440 (1048)
Q Consensus       367 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~l~~--~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~  440 (1048)
                      .+++|++|++++|.+++.    ++..+..+++|+.|++++|.+.....  ....+..+++|++|++++|.+.+.....+.
T Consensus       163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~  242 (319)
T cd00116         163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA  242 (319)
T ss_pred             hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence            444555555555555521    22223334455555555555443211  011223344444444444444332111111


Q ss_pred             -----CCCcCcEEEccCCcccC----CchHhhhccCCCcEEeCcCceeccC----CCcccccC-CCCCeEeecCCc
Q 001591          441 -----GFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDLSWNHFDGN----IPPWIGQM-ENLFYLDFSNNT  502 (1048)
Q Consensus       441 -----~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~  502 (1048)
                           ..+.|+.|++++|.++.    .+...+..+++|+++++++|.++..    +...+-.. +.|++||+.+|.
T Consensus       243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence                 12455555555555541    1223344445555555555555532    22222222 455555555554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=7.8e-20  Score=205.62  Aligned_cols=263  Identities=26%  Similarity=0.303  Sum_probs=123.4

Q ss_pred             hhhhcccccceEeccCccccc-----ccCCCCCCCCCCEEEcccCCCCC------CCCccccCCCCCcEEEcccccCCcc
Q 001591          196 RIWSASKEIQILDLSMNHFMG-----SLQGLDHSPSLKQLHVDNNLLGG------DLPDSLYSMSSLQHVSLSVNNFSGQ  264 (1048)
Q Consensus       196 ~~~~~~~~L~~L~Ls~n~l~~-----~~~~l~~~~~L~~L~L~~N~l~~------~~p~~l~~l~~L~~L~L~~N~l~~~  264 (1048)
                      ..+..+..|+.|+++++.++.     ++..+...+++++|+++++.+.+      .++..+..+++|++|++++|.+.+.
T Consensus        17 ~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~   96 (319)
T cd00116          17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPD   96 (319)
T ss_pred             HHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChh
Confidence            334444444444444444421     22233444556666666655542      1233455566666666666666554


Q ss_pred             hhhhhcCCCC---CcEEEccCCcCCCC----ccccccCc-cccccccccCCcccCC----CCcccccCCCCcEEEecCcc
Q 001591          265 LSEKISNLTS---LRHLIIFGNQFSGK----LPNVLGNL-TQLEFFVAHSNSFSGP----LPLSLSLCSKLHVLDLRNNS  332 (1048)
Q Consensus       265 ~~~~~~~l~~---L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~N~  332 (1048)
                      .+..+..+.+   |++|++++|++++.    +...+..+ ++|+.|++++|.+++.    ++..+..+++|++|++++|.
T Consensus        97 ~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~  176 (319)
T cd00116          97 GCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNG  176 (319)
T ss_pred             HHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCC
Confidence            5554444444   66666666665521    11222333 4444444444444421    12223333445555555554


Q ss_pred             ccCccCcccccCCcccEeecccccccCCCCccccCCCccceeeccccccccc----cchhhccCCcCcEEeccCCcCCCC
Q 001591          333 LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ----VPESFGKLTSLLFLSLSNNSFNHL  408 (1048)
Q Consensus       333 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~l  408 (1048)
                      +++....                    .++..+..+++|++|++++|.+++.    ++..+..+++|++|++++|.++..
T Consensus       177 l~~~~~~--------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~  236 (319)
T cd00116         177 IGDAGIR--------------------ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA  236 (319)
T ss_pred             CchHHHH--------------------HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence            4421100                    1112222333444444444444322    122233344455555555544321


Q ss_pred             cCcccccc----cccccceEecccCccCC----CCCccccCCCcCcEEEccCCcccCC----chHhhhcc-CCCcEEeCc
Q 001591          409 SGTLSVLQ----QCKNLTTLILTKNFVGE----EIPENVGGFESLMVLALGNCGLKGH----IPVWLLRC-KKLQVLDLS  475 (1048)
Q Consensus       409 ~~~~~~l~----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l-~~L~~L~Ls  475 (1048)
                      . ......    ..+.|++|++++|.++.    .+...+..+++|+.+++++|.++..    ....+... +.|+.|++.
T Consensus       237 ~-~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~  315 (319)
T cd00116         237 G-AAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVK  315 (319)
T ss_pred             H-HHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccC
Confidence            0 000001    12455555555555542    2234455557788888888888754    33444444 688888888


Q ss_pred             Ccee
Q 001591          476 WNHF  479 (1048)
Q Consensus       476 ~N~l  479 (1048)
                      +|.+
T Consensus       316 ~~~~  319 (319)
T cd00116         316 DDSF  319 (319)
T ss_pred             CCCC
Confidence            8764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2.7e-19  Score=200.27  Aligned_cols=225  Identities=25%  Similarity=0.261  Sum_probs=176.2

Q ss_pred             eEeccCceEEEEEEE----CCCcEEEEEEecCCchh--hHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEEEEecc
Q 001591          774 IIGCGGFGLVYKATL----TNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       774 ~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  846 (1048)
                      ++|+|.||.|++++.    ..|.-+|.|+.++....  .......|..++..++ ||.+|++...++.+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998752    24677888887654321  1113456778888887 9999999999999999999999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCc
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +|.+...+..    ...++......+...++-|++++|+.   +|+|||+|++||+++.+|++++.|||.++..-.... 
T Consensus        81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            9998877763    44567777888888999999999997   999999999999999999999999999987543222 


Q ss_pred             eeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCch
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                          .|||..|||||++.  ....++|.||||++++||+||..||..       +.   +..+.+.+           ..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~---~~~Il~~~-----------~~  205 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DT---MKRILKAE-----------LE  205 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HH---HHHHhhhc-----------cC
Confidence                18999999999988  678899999999999999999999974       11   11222211           12


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001591         1007 DREKQLLEMLEIACKCIDQDPRRRPFI 1033 (1048)
Q Consensus      1007 ~~~~~~~~l~~li~~cl~~~P~~RPt~ 1033 (1048)
                      .+......+.+++..+...+|..|--.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            233444567788888888888888644

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=5.7e-18  Score=190.67  Aligned_cols=215  Identities=28%  Similarity=0.444  Sum_probs=163.4

Q ss_pred             HhcCCCceeeecceEeeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 001591          818 SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVK  897 (1048)
Q Consensus       818 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  897 (1048)
                      +.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..   ....++|.....+.++++.|++|+|+.  +-..|+.++
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~   76 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK   76 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence            567899999999999999999999999999999999976   456789999999999999999999985  334999999


Q ss_pred             CCceEECCCCcEEEeecccccccCCC-CCceeecccccccccCccccCcC-------CCCchhhhHHHHHHHHHHHcCCC
Q 001591          898 SSNILLDEKFEAHLADFGLSRLLRPY-DTHVTTDLVGTLGYIPPEYSQTL-------TATCRGDVYSFGVVLLELLTGRR  969 (1048)
Q Consensus       898 ~~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slGvil~elltg~~  969 (1048)
                      +.|.++|....+|++|||+....... .........-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998876421 11111112234579999987663       24678999999999999999999


Q ss_pred             CCcccCCCCc-hhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhcC
Q 001591          970 PVEVCKGKNC-RDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       970 P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      ||........ .+.+.++..   .  ....+-+.++...  +...++..++..||..+|++||+++++-..++.+-
T Consensus       157 ~~~~~~~~~~~~eii~~~~~---~--~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK---G--GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             ccccccccCChHHHHHHHHh---c--CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9986432222 334443333   1  1111222222111  33337889999999999999999999988877653

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=8.1e-18  Score=202.11  Aligned_cols=199  Identities=22%  Similarity=0.251  Sum_probs=162.9

Q ss_pred             HHHHhhcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcC---CCceeeecceEeeCCc
Q 001591          761 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ---HKNLVSLQGYCRHGND  837 (1048)
Q Consensus       761 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  837 (1048)
                      +.....+.|.+.+.||+|+||+||+|...+|+.||+|+-+....   -+|.--..++.+++   -+.|..+...+.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            44455678999999999999999999988899999998764421   22333344555555   3456666666667788


Q ss_pred             EEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-------CCCcEE
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-------EKFEAH  910 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~-------~~~~~k  910 (1048)
                      -++|+||.+.|+|.+++.    ....++|..++.++.|+++.+++||.+   +|||+||||+|+|+.       ....++
T Consensus       769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            899999999999999987    466789999999999999999999997   999999999999994       234589


Q ss_pred             EeecccccccCCCC-CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCC
Q 001591          911 LADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRR  969 (1048)
Q Consensus       911 l~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~  969 (1048)
                      |+|||.+-.+.-.. .......++|-.+-.+|+..++.+++++|.|.++-+++-|+.|+.
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999997765432 224456789999999999999999999999999999999998876

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=1.6e-19  Score=168.05  Aligned_cols=166  Identities=27%  Similarity=0.542  Sum_probs=120.4

Q ss_pred             cccccccceEecccCccCCCCCccccCCCcCcEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCC
Q 001591          415 LQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLF  494 (1048)
Q Consensus       415 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  494 (1048)
                      +-.+.+.+.|.|++|.++ .+|..+..+.+|+.|++.+|++. .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            334556666777777764 45667778888888888888888 78888888999999999988887 7888899999999


Q ss_pred             eEeecCCcccc-cCCcchhhhhhhhccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCcccccCCccc
Q 001591          495 YLDFSNNTLTG-EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEI  573 (1048)
Q Consensus       495 ~L~Ls~N~l~~-~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~~p~~~  573 (1048)
                      .|||++|++.. .+|..|-.++.|.                                      .|+|++|.+. .+|+++
T Consensus       106 vldltynnl~e~~lpgnff~m~tlr--------------------------------------alyl~dndfe-~lp~dv  146 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLR--------------------------------------ALYLGDNDFE-ILPPDV  146 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHH--------------------------------------HHHhcCCCcc-cCChhh
Confidence            99999888764 4566555555542                                      2456666665 566677


Q ss_pred             cCCCCCcEEEccCceecccCCcccccccCccEeeCCCCccCCCCccccccc
Q 001591          574 GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKL  624 (1048)
Q Consensus       574 ~~L~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l  624 (1048)
                      |+|++||.|.+.+|.+- .+|.+++.+++|++|.+.+|+++ .+|++++++
T Consensus       147 g~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l  195 (264)
T KOG0617|consen  147 GKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL  195 (264)
T ss_pred             hhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence            77777777777777766 66777777777777777777776 566655554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.3e-17  Score=174.75  Aligned_cols=195  Identities=21%  Similarity=0.256  Sum_probs=133.3

Q ss_pred             CCCceeeecceEeeC---------------------------CcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHH
Q 001591          821 QHKNLVSLQGYCRHG---------------------------NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA  873 (1048)
Q Consensus       821 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~  873 (1048)
                      +|||||+++++|.+.                           ...|+||.-.+. +|.+++..     ...+...+.-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence            599999999876432                           235777776543 67777743     335667778889


Q ss_pred             HHHHHHHHHHHhcCCCCeEEcCCCCCceEE--CCCC--cEEEeecccccccCCCC-----CceeecccccccccCccccC
Q 001591          874 QGAARGLAYLHKVCEPHIVHRDVKSSNILL--DEKF--EAHLADFGLSRLLRPYD-----THVTTDLVGTLGYIPPEYSQ  944 (1048)
Q Consensus       874 ~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll--~~~~--~~kl~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~  944 (1048)
                      .|+++|+.|||++   ||+|||+|++|||+  |+|+  ...|+|||++---....     .....+..|...-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999998   99999999999999  3443  46889999985321100     01112345777899999876


Q ss_pred             cCC------CCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHH
Q 001591          945 TLT------ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1018 (1048)
Q Consensus       945 ~~~------~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 1018 (1048)
                      ...      ...|+|.|+.|.+.||+++...||.. +++...+...     .++..         ....+..++..+.++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~L~~r~-----Yqe~q---------LPalp~~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEMLLDTRT-----YQESQ---------LPALPSRVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchheechhh-----hhhhh---------CCCCcccCChHHHHH
Confidence            532      23589999999999999999999975 2221111111     01111         112233444578899


Q ss_pred             HHHcccCCCCCCCCHHHHHHH
Q 001591         1019 ACKCIDQDPRRRPFIEEVVTW 1039 (1048)
Q Consensus      1019 i~~cl~~~P~~RPt~~evl~~ 1039 (1048)
                      +...++.||.+|++..-....
T Consensus       490 V~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHHHhcCCccccCCccHHHhH
Confidence            999999999999986654443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.71  E-value=1.3e-19  Score=168.69  Aligned_cols=164  Identities=31%  Similarity=0.463  Sum_probs=109.1

Q ss_pred             CCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEE
Q 001591          247 SMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL  326 (1048)
Q Consensus       247 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L  326 (1048)
                      .+++++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|++|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            3445555555555555 44445555555555556555555 55555666666666666666655 556666666666666


Q ss_pred             EecCccccC-ccCcccccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcC
Q 001591          327 DLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF  405 (1048)
Q Consensus       327 ~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  405 (1048)
                      ||+.|++.. ..|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|++.+|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            666666653 45666777777777777777777 67777788888888888888776 6777888888888888888887


Q ss_pred             CCCcCccccc
Q 001591          406 NHLSGTLSVL  415 (1048)
Q Consensus       406 ~~l~~~~~~l  415 (1048)
                      +-+|..+..+
T Consensus       186 ~vlppel~~l  195 (264)
T KOG0617|consen  186 TVLPPELANL  195 (264)
T ss_pred             eecChhhhhh
Confidence            7777554433

>PRK10345 hypothetical protein; Provisional

Probab=99.71  E-value=7.1e-17  Score=166.24  Aligned_cols=137  Identities=15%  Similarity=0.180  Sum_probs=106.3

Q ss_pred             CcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-----CCCceeeecceEeeCC---cEE
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-----QHKNLVSLQGYCRHGN---DRL  839 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~  839 (1048)
                      +...+.||+|+||.||.  +. ++.+ +||++........+.+.+|+++++.+     .||||++++|+++++.   ..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34467899999999996  43 4444 68988765444567799999999999     5799999999998874   333


Q ss_pred             -EEEEe--ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEcCCCCCceEECC----CCcEEE
Q 001591          840 -LIYSY--MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL-AYLHKVCEPHIVHRDVKSSNILLDE----KFEAHL  911 (1048)
Q Consensus       840 -lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl  911 (1048)
                       +|+||  +.+|+|.+++.+.     .+++.  ..++.+++.++ +|||++   +|+||||||+||+++.    ++.++|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence             78999  5579999999642     24444  35677888777 999997   9999999999999974    347999


Q ss_pred             eeccccc
Q 001591          912 ADFGLSR  918 (1048)
Q Consensus       912 ~Dfg~a~  918 (1048)
                      +||+-+.
T Consensus       151 iDg~G~~  157 (210)
T PRK10345        151 CDNIGES  157 (210)
T ss_pred             EECCCCc
Confidence            9954443

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=2.3e-16  Score=166.96  Aligned_cols=147  Identities=18%  Similarity=0.143  Sum_probs=113.6

Q ss_pred             HHhhcCCcccCeEeccCceEEEEEE--ECCCcEEEEEEecCCchh------------------------hHHHHHHHHHH
Q 001591          763 LKSTNNFNQANIIGCGGFGLVYKAT--LTNGTKAAVKRLSGDCGQ------------------------MEREFQAEVEA  816 (1048)
Q Consensus       763 ~~~~~~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~  816 (1048)
                      .+...-|++.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+.+|++.
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            3344468899999999999999998  458999999998743210                        11335789999


Q ss_pred             HHhcCCCc--eeeecceEeeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCC-eEE
Q 001591          817 LSRAQHKN--LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-IVH  893 (1048)
Q Consensus       817 l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH  893 (1048)
                      +.++.+..  +.+++++    ...++||||++++++..+...    .......+...++.|++.++++||+.   + |+|
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH  172 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVH  172 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEe
Confidence            99997533  3344432    235899999999888765422    23355667789999999999999986   8 999


Q ss_pred             cCCCCCceEECCCCcEEEeecccccccC
Q 001591          894 RDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       894 ~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||||+||+++ ++.++++|||.+....
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999999 8899999999987543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=5.7e-17  Score=190.05  Aligned_cols=207  Identities=26%  Similarity=0.332  Sum_probs=142.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .+|+.++.|-.|+||.||.++++ +.+.+|.| +.++..     +.+-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-------------------
Confidence            57889999999999999999887 46778874 332211     1111  22223333333                   


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCC-
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-  924 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~-  924 (1048)
                        |+-.+.+..    -.+++.+        ++.+++|+|+-   +|+|||+||+|.+|+.-|++|++|||+++...... 
T Consensus       136 --gDc~tllk~----~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 --GDCATLLKN----IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             --chhhhhccc----CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence              332333321    1223322        27789999985   99999999999999999999999999987532110 


Q ss_pred             -----C--------ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhc
Q 001591          925 -----T--------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS  991 (1048)
Q Consensus       925 -----~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~  991 (1048)
                           .        -....++||+.|+|||++..+.|.+.+|+|++|+|+||.+.|+.||.+...   .+++..+.... 
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~-  274 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDD-  274 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhh-
Confidence                 0        012245999999999999999999999999999999999999999975332   23332221111 


Q ss_pred             ccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCC
Q 001591          992 EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031 (1048)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 1031 (1048)
                                -.|.+.++....++.+++.+.++.+|.+|-
T Consensus       275 ----------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  275 ----------IEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ----------ccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                      112222333445788999999999999995

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.65  E-value=7.5e-16  Score=161.88  Aligned_cols=134  Identities=22%  Similarity=0.333  Sum_probs=113.5

Q ss_pred             CeEeccCceEEEEEEECCCcEEEEEEecCCchh--------hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ--------MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      +.||+|++|.||+|.+ .|..|++|+.......        ....+.+|++++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 5788999986543211        123578899999999999998888888777888999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      ++|++|.+++...       .+ .+..++.+++.+++++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887532       12 7889999999999999986   999999999999999 78999999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=1e-15  Score=158.70  Aligned_cols=144  Identities=19%  Similarity=0.120  Sum_probs=112.0

Q ss_pred             HHHHhhcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCchh----------------------hHHHHHHHHHHHH
Q 001591          761 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ----------------------MEREFQAEVEALS  818 (1048)
Q Consensus       761 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  818 (1048)
                      ++......|.+.+.||+|+||.||+|...+|+.||||++......                      .......|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            344444457888999999999999999888999999987643210                      1123577889999


Q ss_pred             hcCCCc--eeeecceEeeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 001591          819 RAQHKN--LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV  896 (1048)
Q Consensus       819 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  896 (1048)
                      ++.|++  +.+.++    ....++||||+++++|......          .....++.+++.++.++|+.   +|+||||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            988774  344433    2445899999999998765321          23467889999999999986   9999999


Q ss_pred             CCCceEECCCCcEEEeecccccccC
Q 001591          897 KSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       897 k~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      ||+||++++++.++|+|||.+....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=4.7e-17  Score=179.01  Aligned_cols=174  Identities=24%  Similarity=0.360  Sum_probs=130.6

Q ss_pred             cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccc
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..|+.|++++..+|.+|+.... .....++.....++.|++.|++|      ++.+|||+||.||.+..+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            4679999999999999997544 34557888999999999999999      2999999999999999999999999999


Q ss_pred             ccccCCCC-----CceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhh
Q 001591          917 SRLLRPYD-----THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       917 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      ........     ....+..+||..||+||.+.+..|+.++||||+|++++|++. =..+++.         .. .....
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------~~-t~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------IA-TLTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---------HH-hhhhh
Confidence            98765443     224455689999999999999999999999999999999996 2222211         00 01111


Q ss_pred             cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev 1036 (1048)
                      +.+.    +++..+..++     +=+.++.+++.+.|.+||++.++
T Consensus       473 r~g~----ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  473 RDGI----IPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hcCC----CChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence            1111    1111122222     34578999999999999954443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=8.7e-16  Score=159.74  Aligned_cols=131  Identities=25%  Similarity=0.356  Sum_probs=107.1

Q ss_pred             eEeccCceEEEEEEECCCcEEEEEEecCCch--------hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEec
Q 001591          774 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCG--------QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       774 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  845 (1048)
                      .||+|+||.||+|.+ +|..|++|+......        .....+.+|++++++++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 478899998653211        11245778999999999988766666666677789999999


Q ss_pred             cCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      +|++|.+++...    ..       .++.+++++++++|+.   +++|||++|+||+++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998876531    10       7899999999999986   999999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.62  E-value=1.7e-15  Score=181.19  Aligned_cols=139  Identities=21%  Similarity=0.252  Sum_probs=112.1

Q ss_pred             hcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCc-------hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcE
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC-------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  838 (1048)
                      ...|...+.||+|+||+||+|.+.+...++.++..+..       ....+.+.+|++++++++|++++....++.+....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34456688999999999999988644433333332211       11234578999999999999999888888877788


Q ss_pred             EEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccc
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++++|.+++.            .+..++.+++++++|||+.   +++|||+||+||++ +++.++|+|||+++
T Consensus       412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999988774            3567899999999999986   99999999999999 67899999999997


Q ss_pred             cc
Q 001591          919 LL  920 (1048)
Q Consensus       919 ~~  920 (1048)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>PLN03150 hypothetical protein; Provisional

Probab=99.61  E-value=1.1e-15  Score=184.39  Aligned_cols=116  Identities=39%  Similarity=0.634  Sum_probs=103.6

Q ss_pred             CCeeeeecCcccccCCccccCCCCCcEEEccCceecccCCcccccccCccEeeCCCCccCCCCccccccccCCCeeeecc
Q 001591          555 PPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN  634 (1048)
Q Consensus       555 ~~~l~Ls~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~  634 (1048)
                      ...|+|++|.+.|.+|.+++.|++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|..++++++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            46789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCc--ccCCCCccccCCCCCcCCC-CCCCC
Q 001591          635 NHLQGTIPTGGQ--FYSFPNSSFEGNPGLCGEI-DSPCD  670 (1048)
Q Consensus       635 N~l~g~~p~~~~--~~~~~~~~~~~n~~lcg~~-~~~~~  670 (1048)
                      |+|+|.+|..-.  +.......+.||+++||.+ ...|.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~  538 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG  538 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence            999999997522  2233456789999999963 34564

>PLN03150 hypothetical protein; Provisional

Probab=99.56  E-value=1.6e-14  Score=174.33  Aligned_cols=134  Identities=31%  Similarity=0.524  Sum_probs=109.3

Q ss_pred             CCCCHHHHHHHHHHHhcCCCCCCCcCcCCCCCCc----eeeeeeeCCCCCCCCCCcEEEEEecCCCCccccCccccCCcC
Q 001591           32 QSCDPSDLLALKEFAGNLTNGSIITSWSNESMCC----QWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQ  107 (1048)
Q Consensus        32 ~~~~~~~~~aLl~~k~~~~~~~~l~sw~~~~~~c----~w~gv~C~~~~~~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~  107 (1048)
                      .++.++|.+||+++|+.+.... ..+|.+ ++||    .|.||.|+.... .....|+.|+|+++++.|.+|.+++.+++
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~-~~~W~g-~~C~p~~~~w~Gv~C~~~~~-~~~~~v~~L~L~~n~L~g~ip~~i~~L~~  443 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPL-RFGWNG-DPCVPQQHPWSGADCQFDST-KGKWFIDGLGLDNQGLRGFIPNDISKLRH  443 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCcc-cCCCCC-CCCCCcccccccceeeccCC-CCceEEEEEECCCCCccccCCHHHhCCCC
Confidence            3577889999999999986543 258964 4553    799999953211 11236999999999999999999999999


Q ss_pred             CCeEecCCCCCCCCCCccccCCCCccEEeccCCcccCcccccccccccccEEEecCcccCC
Q 001591          108 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNG  168 (1048)
Q Consensus       108 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  168 (1048)
                      |+.|+|++|++.|.+|..++.+++|+.|||++|++++.+|..++.+++|++|+|++|.+++
T Consensus       444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g  504 (623)
T PLN03150        444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG  504 (623)
T ss_pred             CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc
Confidence            9999999999999999999999999999999999999988887777666666666665553

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.55  E-value=3.9e-14  Score=140.10  Aligned_cols=134  Identities=19%  Similarity=0.160  Sum_probs=114.7

Q ss_pred             cCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCC--CceeeecceEeeCCcEEEEEEeccCCC
Q 001591          772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH--KNLVSLQGYCRHGNDRLLIYSYMENGS  849 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  849 (1048)
                      .+.||+|.++.||++... +..+++|.......  ...+.+|+.+++.++|  ..+++++++...++..+++|||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            567999999999999986 47899999875533  4568899999999976  589999998888888999999999887


Q ss_pred             hhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          850 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       850 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      +..+           +......++.+++++++++|....++++|+|++|+||++++.+.++++|||.++.
T Consensus        80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            6543           4567788899999999999986556899999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.52  E-value=6.5e-14  Score=144.08  Aligned_cols=137  Identities=20%  Similarity=0.193  Sum_probs=98.4

Q ss_pred             cCeEeccCceEEEEEEECCCcEEEEEEecCCchhh---HHH---------------------HHHHHHHHHhcCCCc--e
Q 001591          772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM---ERE---------------------FQAEVEALSRAQHKN--L  825 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~---------------------~~~E~~~l~~l~h~n--i  825 (1048)
                      .+.||+|+||+||+|...+|+.||||++.......   ...                     ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999987542211   111                     134566666654433  3


Q ss_pred             eeecceEeeCCcEEEEEEeccCCChhhh-cccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001591          826 VSLQGYCRHGNDRLLIYSYMENGSLDYW-LHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  904 (1048)
Q Consensus       826 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~  904 (1048)
                      .+.+++    ...++||||++++.+... +...     ... ..+..++.+++.++.++|..  .+|+||||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE
Confidence            333332    245899999999654321 2111     011 66788999999999999982  3999999999999999


Q ss_pred             CCCcEEEeecccccccC
Q 001591          905 EKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       905 ~~~~~kl~Dfg~a~~~~  921 (1048)
                       ++.++++|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=2.5e-15  Score=178.36  Aligned_cols=254  Identities=26%  Similarity=0.324  Sum_probs=189.1

Q ss_pred             cCCcccCeEeccCceEEEEEEEC--CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEEEE
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT--NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  841 (1048)
                      ..|+..+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-+.+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            34677788999999999888654  34566667665442  223344556888878887 99999999999999999999


Q ss_pred             EEeccCCChhhhc-ccccCCccccCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEcCCCCCceEECCCC-cEEEeeccccc
Q 001591          842 YSYMENGSLDYWL-HESVDKDSVLKWDVRLKIAQGAARGLAYLH-KVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSR  918 (1048)
Q Consensus       842 ~e~~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~a~  918 (1048)
                      .+|..++++.+-+ +.   .....+...+..++.|+..++.|+| .   .++.|||+||+|.+++..+ ..+++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999988777 32   2224666778889999999999999 5   4999999999999999999 99999999998


Q ss_pred             ccCC--CCCceeecccc-cccccCccccCcC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhcccc
Q 001591          919 LLRP--YDTHVTTDLVG-TLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       919 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      .+..  .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+...... ..+..|....     
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~-----  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK-----  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc-----
Confidence            8765  22333445688 9999999988874 55678999999999999999999997533222 1222221111     


Q ss_pred             cccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                        .......|...    .....++..+++..+|..|.+.+++..
T Consensus       248 --~~~~~~~~~~~----~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 --GRFTQLPWNSI----SDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --cccccCccccC----ChhhhhcccccccCCchhccccccccc
Confidence              00011112222    235678888999999999999887754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.49  E-value=2.2e-13  Score=144.56  Aligned_cols=136  Identities=21%  Similarity=0.223  Sum_probs=105.3

Q ss_pred             cCeEe-ccCceEEEEEEECCCcEEEEEEecCCc-------------hhhHHHHHHHHHHHHhcCCCce--eeecceEeeC
Q 001591          772 ANIIG-CGGFGLVYKATLTNGTKAAVKRLSGDC-------------GQMEREFQAEVEALSRAQHKNL--VSLQGYCRHG  835 (1048)
Q Consensus       772 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  835 (1048)
                      ..+|| .||.|+||.+... +..+|+|++....             ......+.+|++++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45788 8999999999875 7889999885321             1223457889999999998875  6777765433


Q ss_pred             C----cEEEEEEeccC-CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEE
Q 001591          836 N----DRLLIYSYMEN-GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH  910 (1048)
Q Consensus       836 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  910 (1048)
                      .    ..++|+||++| .+|.+++..     ..++..    .+.+++.++++||+.   ||+||||||+|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2    23599999997 688888753     234433    356889999999986   999999999999999989999


Q ss_pred             Eeeccccccc
Q 001591          911 LADFGLSRLL  920 (1048)
Q Consensus       911 l~Dfg~a~~~  920 (1048)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999998753

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.43  E-value=6.6e-15  Score=161.73  Aligned_cols=158  Identities=32%  Similarity=0.493  Sum_probs=76.2

Q ss_pred             CccccCCCcCcEEEccCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCcccccCCcchhhhh
Q 001591          436 PENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELK  515 (1048)
Q Consensus       436 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  515 (1048)
                      |..+..+..|+.+.|.+|.+. .+|..++++..|.+|||+.|+++ .+|..++.++ |+.|-+++|+++ .+|..++.+.
T Consensus        91 p~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~  166 (722)
T KOG0532|consen   91 PEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLP  166 (722)
T ss_pred             chHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccch
Confidence            333333444444444444444 44444455555555555555554 4444444443 455555555544 3343333322


Q ss_pred             hhhccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCcccccCCccccCCCCCcEEEccCceecccCCc
Q 001591          516 SLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPS  595 (1048)
Q Consensus       516 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~g~ip~  595 (1048)
                      .|.                                      .+|.+.|.+. .+|..+++|.+|+.|++..|++. .+|.
T Consensus       167 tl~--------------------------------------~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~  206 (722)
T KOG0532|consen  167 TLA--------------------------------------HLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE  206 (722)
T ss_pred             hHH--------------------------------------Hhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence            221                                      2334444444 44555555555555555555555 4455


Q ss_pred             ccccccCccEeeCCCCccCCCCccccccccCCCeeeeccccccc
Q 001591          596 SISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQG  639 (1048)
Q Consensus       596 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g  639 (1048)
                      +++.| .|..||+|.|+++ .||-.|.+|..|++|-|.+|.|+.
T Consensus       207 El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  207 ELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             HHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence            55522 4555555555555 455555555555555555555553

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.35  E-value=3.8e-12  Score=146.94  Aligned_cols=142  Identities=20%  Similarity=0.222  Sum_probs=100.6

Q ss_pred             cCeEeccCceEEEEEEECCCcEEEEEEecCCchhh----------------------------------------HHHHH
Q 001591          772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM----------------------------------------EREFQ  811 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  811 (1048)
                      .+.||.|++|.||+|++++|+.||||+.+....+.                                        +-.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986542110                                        01244


Q ss_pred             HHHHHHHhcC----CCceeeecceE-eeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHH-HHHHHHh
Q 001591          812 AEVEALSRAQ----HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR-GLAYLHK  885 (1048)
Q Consensus       812 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~  885 (1048)
                      +|++.+.+++    |.+-+.+-..+ ...+..++||||++|+++.++.....   ...   .+..++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence            5666555552    33333333333 23456799999999999988764311   111   23456666665 4677887


Q ss_pred             cCCCCeEEcCCCCCceEECCCCcEEEeecccccccCC
Q 001591          886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       886 ~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      .   |++|+|+||.||++++++.++++|||++..+.+
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            5   999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=1e-12  Score=135.52  Aligned_cols=203  Identities=20%  Similarity=0.298  Sum_probs=142.4

Q ss_pred             HHHhcCCCceeeecceEeeCC-----cEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 001591          816 ALSRAQHKNLVSLQGYCRHGN-----DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH  890 (1048)
Q Consensus       816 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  890 (1048)
                      -+-.+.|-|||+++.|+.+..     +..++.|||..|++..+|++.......+....-.+|..||..||.|||+. .++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            344457999999999987543     46789999999999999998776777788888899999999999999995 999


Q ss_pred             eEEcCCCCCceEECCCCcEEEeecccccccC---CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcC
Q 001591          891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLR---PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG  967 (1048)
Q Consensus       891 ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg  967 (1048)
                      |+|+++.-+-|++..++-+|+.----.....   ...........+-++|.|||.-.....+.++|||+||+...||..|
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999988874211111000   0001111123567899999988888888899999999999999987


Q ss_pred             CCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          968 RRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       968 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      ..--..  +.. ....+        ......+-. ....       .=.+++.+|++..|..||+|++++.
T Consensus       279 Eiq~tn--seS-~~~~e--------e~ia~~i~~-len~-------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTN--SES-KVEVE--------ENIANVIIG-LENG-------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCC--Ccc-eeehh--------hhhhhheee-ccCc-------cccCcCcccccCCCCCCcchhhhhc
Confidence            653211  000 00000        000000000 0000       1136788999999999999998764

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.32  E-value=5e-14  Score=154.93  Aligned_cols=178  Identities=28%  Similarity=0.438  Sum_probs=112.2

Q ss_pred             cccceEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEcc
Q 001591          202 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIF  281 (1048)
Q Consensus       202 ~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  281 (1048)
                      ..-...||+.|++..+|.....+..|+.+.|..|.+. .+|.++.++..|++|||+.|+++ ..|..++.|+ |+.|-++
T Consensus        75 tdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s  151 (722)
T KOG0532|consen   75 TDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS  151 (722)
T ss_pred             cchhhhhccccccccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence            3445667777777777776666677777777777776 56777777777777777777776 5666666666 7777777


Q ss_pred             CCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCC
Q 001591          282 GNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPL  361 (1048)
Q Consensus       282 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  361 (1048)
                      +|+++ .+|+.++.+..|..|+.+.|.+. .+|..+..+.+|+.|.++.|++...++ .+..| .|..||+|.|+++ .+
T Consensus       152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~-El~~L-pLi~lDfScNkis-~i  226 (722)
T KOG0532|consen  152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPE-ELCSL-PLIRLDFSCNKIS-YL  226 (722)
T ss_pred             cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCH-HHhCC-ceeeeecccCcee-ec
Confidence            77776 56666666666666666666666 445555666666666666666553332 22322 3555555555555 45


Q ss_pred             CccccCCCccceeeccccccccccchh
Q 001591          362 PNSLSDCHDLKILSLAKNELSGQVPES  388 (1048)
Q Consensus       362 p~~l~~l~~L~~L~L~~N~l~~~~p~~  388 (1048)
                      |-.|.+|+.|++|-|.+|.++ ..|..
T Consensus       227 Pv~fr~m~~Lq~l~LenNPLq-SPPAq  252 (722)
T KOG0532|consen  227 PVDFRKMRHLQVLQLENNPLQ-SPPAQ  252 (722)
T ss_pred             chhhhhhhhheeeeeccCCCC-CChHH
Confidence            555555555555555555555 34443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.31  E-value=2.3e-12  Score=149.29  Aligned_cols=178  Identities=35%  Similarity=0.451  Sum_probs=76.8

Q ss_pred             CCCcEEEcccccCCcchhhhhcCCC-CCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEE
Q 001591          249 SSLQHVSLSVNNFSGQLSEKISNLT-SLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLD  327 (1048)
Q Consensus       249 ~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  327 (1048)
                      +.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|......+.|+.|+
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~  192 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD  192 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence            34444444444444 2222233332 4444444444444 23333444444444444444444 2222222344444444


Q ss_pred             ecCccccCccCcccccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCC
Q 001591          328 LRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNH  407 (1048)
Q Consensus       328 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  407 (1048)
                      +++|+++...+ .......|++|.+++|++. ..+..+..+.++..+.+.+|++. ..+..++.++++++|++++|.++.
T Consensus       193 ls~N~i~~l~~-~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~  269 (394)
T COG4886         193 LSGNKISDLPP-EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS  269 (394)
T ss_pred             ccCCccccCch-hhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccc
Confidence            44444442221 2222333555555555322 23444455555555555555554 224445555555555555555554


Q ss_pred             CcCcccccccccccceEecccCccCCCCC
Q 001591          408 LSGTLSVLQQCKNLTTLILTKNFVGEEIP  436 (1048)
Q Consensus       408 l~~~~~~l~~l~~L~~L~L~~N~l~~~~p  436 (1048)
                      ++.    +..+.+++.|++++|.+....|
T Consensus       270 i~~----~~~~~~l~~L~~s~n~~~~~~~  294 (394)
T COG4886         270 ISS----LGSLTNLRELDLSGNSLSNALP  294 (394)
T ss_pred             ccc----ccccCccCEEeccCccccccch
Confidence            432    3344445555555544444333

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.29  E-value=3.1e-12  Score=148.16  Aligned_cols=196  Identities=31%  Similarity=0.459  Sum_probs=95.8

Q ss_pred             EEEecCccccCccchhhhhcccccceEeccCcccccccCCCCCCC-CCCEEEcccCCCCCCCCccccCCCCCcEEEcccc
Q 001591          181 VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN  259 (1048)
Q Consensus       181 ~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  259 (1048)
                      .++++.|.+...+.  .....+.++.|++.+|.++.++......+ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccccCch--hhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            45566665531111  11222445555555555555554444442 5555555555554 23344455555555555555


Q ss_pred             cCCcchhhhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCc
Q 001591          260 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL  339 (1048)
Q Consensus       260 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  339 (1048)
                      +++ .+|.....++.|+.|++++|+++ .+|......                        ..|++|.+++|.+. ..+.
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~------------------------~~L~~l~~~~N~~~-~~~~  226 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL------------------------SALEELDLSNNSII-ELLS  226 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhh------------------------hhhhhhhhcCCcce-ecch
Confidence            554 33333334445555555555554 333333333                        34555555555322 2233


Q ss_pred             ccccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcCCCCc
Q 001591          340 NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLS  409 (1048)
Q Consensus       340 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~  409 (1048)
                      .+.++.++..|.+.+|++. .++..++.+++++.|++++|.++.. +. ++.+.+++.|++++|.+...+
T Consensus       227 ~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~  293 (394)
T COG4886         227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNAL  293 (394)
T ss_pred             hhhhcccccccccCCceee-eccchhccccccceecccccccccc-cc-ccccCccCEEeccCccccccc
Confidence            3445555555555555554 2245555556666666666666632 22 566666666666666655543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=7e-12  Score=141.67  Aligned_cols=247  Identities=23%  Similarity=0.238  Sum_probs=179.7

Q ss_pred             CCcccCeEec--cCceEEEEEEE--C-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcC-CCceeeecceEeeCCcEE
Q 001591          768 NFNQANIIGC--GGFGLVYKATL--T-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       768 ~~~~~~~lG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  839 (1048)
                      .|...+.+|.  |.+|.||.+..  . ++..+|+|+-+...  +.....-.+|+....+++ |++.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4666788999  99999999986  3 78899999844322  233333456777777775 999999999999999999


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEcCCCCCceEECCC-CcEEEeec
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR----GLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADF  914 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Df  914 (1048)
                      +-+|++. .++..+.+..   ...++....+.+..+..+    |+.++|+.   +++|-|+||.||...++ ...+.+||
T Consensus       195 iqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999885 6777776642   333666777788888888    99999986   99999999999999999 88999999


Q ss_pred             ccccccCCCCC----ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001591          915 GLSRLLRPYDT----HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       915 g~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      |+...+....-    .......|...|++||...+ .++..+|+|++|.++.+..+|..+........+...        
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--------  338 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--------  338 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--------
Confidence            99988765431    11122257778999998776 678899999999999999988766532111111110        


Q ss_pred             cccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 1038 (1048)
                      +...        +..++...-..++...+..|++.+|..|++.+.+..
T Consensus       339 r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  339 RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0000        111222222335556888999999999999887764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.21  E-value=2.2e-11  Score=141.76  Aligned_cols=145  Identities=15%  Similarity=0.171  Sum_probs=94.5

Q ss_pred             cCCcccCeEeccCceEEEEEEECC-CcEEEEEEecCCchh----------------------------------hHH---
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQ----------------------------------MER---  808 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~---  808 (1048)
                      ..|+. +.||.|++|.||+|++++ |+.||||+.++....                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35776 789999999999999987 999999999754210                                  011   


Q ss_pred             ---HHHHHHHHHHhcC----CCceeeecceEee-CCcEEEEEEeccCCChhhhc--ccccCCccccCHHHHHHHHHHHHH
Q 001591          809 ---EFQAEVEALSRAQ----HKNLVSLQGYCRH-GNDRLLIYSYMENGSLDYWL--HESVDKDSVLKWDVRLKIAQGAAR  878 (1048)
Q Consensus       809 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~~i~~  878 (1048)
                         ++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.++-  .........+....+..++.|+. 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence               1334444444442    3333443343332 35678999999999987642  11100111233333333333333 


Q ss_pred             HHHHHHhcCCCCeEEcCCCCCceEECCCC----cEEEeecccccccCC
Q 001591          879 GLAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRP  922 (1048)
Q Consensus       879 ~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg~a~~~~~  922 (1048)
                            .   .|++|+|+||.||+++.++    .+++.|||++..+.+
T Consensus       278 ------~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 ------R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  2   3999999999999999888    999999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.20  E-value=5.2e-11  Score=120.34  Aligned_cols=131  Identities=18%  Similarity=0.127  Sum_probs=96.8

Q ss_pred             cCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCcee-eecceEeeCCcEEEEEEeccCCCh
Q 001591          772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV-SLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      .+.++.|.++.||+++.. +..|++|+...... ....+..|+++++.+.+.+++ +++.+.  .+..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356899999999999876 78899999765432 223467899999988765544 344332  3345899999999886


Q ss_pred             hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC--EPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      .+..            .....++.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430            111345678999999999862  12369999999999999 66899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.16  E-value=7.6e-10  Score=126.14  Aligned_cols=168  Identities=18%  Similarity=0.204  Sum_probs=127.7

Q ss_pred             EECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEeccCCChhhhcccccCCccccCH
Q 001591          787 TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW  866 (1048)
Q Consensus       787 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~  866 (1048)
                      +..++.+|.|..++...........+-++.++.++||||+++++.++.++..|+|+|-+.-  |..++.+       ++.
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~-------l~~  103 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE-------LGK  103 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH-------hHH
Confidence            3447888999888766554455677888999999999999999999999999999998753  4444543       335


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCceeecccccccccCccccCcC
Q 001591          867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL  946 (1048)
Q Consensus       867 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  946 (1048)
                      ......+.||+.||.|||+.  .+++|++|.-..|++++.|..||++|.++........ ......--..|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence            66777889999999999973  6999999999999999999999999998865432221 11111222356677654432


Q ss_pred             CCCchhhhHHHHHHHHHHHcCC
Q 001591          947 TATCRGDVYSFGVVLLELLTGR  968 (1048)
Q Consensus       947 ~~~~~~Dv~slGvil~elltg~  968 (1048)
                      .  -..|.|.||++++|++.|.
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcc
Confidence            2  3569999999999999993

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.16  E-value=4.5e-12  Score=132.59  Aligned_cols=138  Identities=22%  Similarity=0.345  Sum_probs=107.3

Q ss_pred             CCCccceeecccccccccc----chhhccCCcCcEEeccCCcCCCCc--CcccccccccccceEecccCccCCC----CC
Q 001591          367 DCHDLKILSLAKNELSGQV----PESFGKLTSLLFLSLSNNSFNHLS--GTLSVLQQCKNLTTLILTKNFVGEE----IP  436 (1048)
Q Consensus       367 ~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~l~--~~~~~l~~l~~L~~L~L~~N~l~~~----~p  436 (1048)
                      .-++|+++..++|++....    ...|...+.|+.+.++.|.|..-.  .....+..|++|+.|||++|.++..    +.
T Consensus       155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La  234 (382)
T KOG1909|consen  155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA  234 (382)
T ss_pred             CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence            4468999999999987432    345677789999999999886421  1235678899999999999998764    44


Q ss_pred             ccccCCCcCcEEEccCCcccCCchHhhh-----ccCCCcEEeCcCceeccC----CCcccccCCCCCeEeecCCccc
Q 001591          437 ENVGGFESLMVLALGNCGLKGHIPVWLL-----RCKKLQVLDLSWNHFDGN----IPPWIGQMENLFYLDFSNNTLT  504 (1048)
Q Consensus       437 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  504 (1048)
                      +.+..++.|+.|++++|.++......+.     ..++|++|.|.+|.++..    +-..+...+.|..|+|++|++.
T Consensus       235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            6778889999999999999876554443     368999999999999632    3345667899999999999994

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.15  E-value=4.1e-10  Score=113.79  Aligned_cols=138  Identities=17%  Similarity=0.156  Sum_probs=99.7

Q ss_pred             cCeEeccCceEEEEEEECC-------CcEEEEEEecCCc----------------------hhhHHHH----HHHHHHHH
Q 001591          772 ANIIGCGGFGLVYKATLTN-------GTKAAVKRLSGDC----------------------GQMEREF----QAEVEALS  818 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~  818 (1048)
                      ...||.|.-+.||.|...+       +..+|||+++...                      ....+.+    ++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997553       4799999875211                      0112223    37999999


Q ss_pred             hcCC--CceeeecceEeeCCcEEEEEEeccCCChhh-hcccccCCccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEc
Q 001591          819 RAQH--KNLVSLQGYCRHGNDRLLIYSYMENGSLDY-WLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHR  894 (1048)
Q Consensus       819 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~  894 (1048)
                      ++..  -++.+++++    ...++||||+.++.+.. .+.     +..++..+...+..+++.++..| |..   ++||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            9863  455556654    45689999998754421 222     22344556677889999999999 765   99999


Q ss_pred             CCCCCceEECCCCcEEEeecccccccCC
Q 001591          895 DVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       895 Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      |+++.||+++ ++.+.++|||.+....+
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999999997 46899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.11  E-value=1.5e-11  Score=125.03  Aligned_cols=104  Identities=29%  Similarity=0.314  Sum_probs=48.3

Q ss_pred             CCCCcEEEecCccccCccCcccccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEe
Q 001591          320 CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLS  399 (1048)
Q Consensus       320 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  399 (1048)
                      .+.|++||||+|.|+ .++.+..-++.++.|++|+|.|...  ..+..+++|+.||||+|.++ .+..|-.++-+.+.|.
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            344555555555554 2333334444555555555555421  12444555555555555554 3333444444555555


Q ss_pred             ccCCcCCCCcCcccccccccccceEecccCcc
Q 001591          400 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNFV  431 (1048)
Q Consensus       400 L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l  431 (1048)
                      |++|.|.++.    .+.++.+|..||+++|+|
T Consensus       359 La~N~iE~LS----GL~KLYSLvnLDl~~N~I  386 (490)
T KOG1259|consen  359 LAQNKIETLS----GLRKLYSLVNLDLSSNQI  386 (490)
T ss_pred             hhhhhHhhhh----hhHhhhhheeccccccch
Confidence            5555544332    234444444444444444

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.11  E-value=1.4e-11  Score=132.15  Aligned_cols=208  Identities=22%  Similarity=0.257  Sum_probs=109.6

Q ss_pred             CCCCCCCEEEcccCCCCCCCC-ccccCCCCCcEEEcccccCCcchh--hhhcCCCCCcEEEccCCcCCCCccccc-cCcc
Q 001591          222 DHSPSLKQLHVDNNLLGGDLP-DSLYSMSSLQHVSLSVNNFSGQLS--EKISNLTSLRHLIIFGNQFSGKLPNVL-GNLT  297 (1048)
Q Consensus       222 ~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~  297 (1048)
                      +++.+|+...|.++.+..... .....|++++.|||++|-+....+  .-...|++|+.|+|+.|++.-...... ..++
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            345567777777776653211 355667778888888877764332  345567778888888777652221111 2345


Q ss_pred             ccccccccCCcccC-CCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCCC--ccccCCCcccee
Q 001591          298 QLEFFVAHSNSFSG-PLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLP--NSLSDCHDLKIL  374 (1048)
Q Consensus       298 ~L~~L~l~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L  374 (1048)
                      .|+.|.++.|.++- .+...+..+++|+.|+|..|............+..|+.|||++|++-. .+  ...+.++.|+.|
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~L  276 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQL  276 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhh
Confidence            55556666655542 111223345666666666664222223333445566666666666542 22  344556666666


Q ss_pred             eccccccccc-cchh-----hccCCcCcEEeccCCcCCCCcCcccccccccccceEecccCcc
Q 001591          375 SLAKNELSGQ-VPES-----FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFV  431 (1048)
Q Consensus       375 ~L~~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l  431 (1048)
                      +++.+.++.. .|+.     ...+++|++|++..|++..++. +..+..+++|+.|.+..|.+
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~s-l~~l~~l~nlk~l~~~~n~l  338 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRS-LNHLRTLENLKHLRITLNYL  338 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCccccccc-cchhhccchhhhhhcccccc
Confidence            6666655532 1211     2344566666666666655432 23333344444444444444

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.09  E-value=7.1e-12  Score=131.09  Aligned_cols=246  Identities=23%  Similarity=0.269  Sum_probs=109.9

Q ss_pred             CcEEEEEecCCCCccc----cCccccCCcCCCeEecCCC---CCCCCCCcc-------ccCCCCccEEeccCCcccCccc
Q 001591           82 GRVTMLILPRKGLKGI----IPRSLGHLNQLKLLDLSCN---HLEGVVPVE-------LSNLKQLEVLDLSHNMLSGPVS  147 (1048)
Q Consensus        82 ~~v~~l~L~~~~l~g~----~~~~l~~l~~L~~L~Ls~n---~l~~~~p~~-------~~~l~~L~~L~Ls~N~l~~~~~  147 (1048)
                      ..++.|+|++|.+.-.    +.+.+.+.++|+.-++|+-   +....+|..       +...++|++||||+|.|....+
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~  109 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI  109 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence            4577777777776544    4455666777777777653   222233332       3344566677777776654333


Q ss_pred             ccccccccccEEEecCcccCCccccccccCcccEEEecCccccCccchhhhhcccccceEeccCcccccccCCCCCCCCC
Q 001591          148 GMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSL  227 (1048)
Q Consensus       148 ~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L  227 (1048)
                      ..|..+                   +..+++|++|.|.+|-+.-..-..+...+..   |-  .|+      .....+.|
T Consensus       110 ~~l~~l-------------------l~s~~~L~eL~L~N~Glg~~ag~~l~~al~~---l~--~~k------k~~~~~~L  159 (382)
T KOG1909|consen  110 RGLEEL-------------------LSSCTDLEELYLNNCGLGPEAGGRLGRALFE---LA--VNK------KAASKPKL  159 (382)
T ss_pred             HHHHHH-------------------HHhccCHHHHhhhcCCCChhHHHHHHHHHHH---HH--HHh------ccCCCcce
Confidence            222211                   3334445555555554431111111110000   00  000      11222344


Q ss_pred             CEEEcccCCCCCC----CCccccCCCCCcEEEcccccCCc----chhhhhcCCCCCcEEEccCCcCCCCc----cccccC
Q 001591          228 KQLHVDNNLLGGD----LPDSLYSMSSLQHVSLSVNNFSG----QLSEKISNLTSLRHLIIFGNQFSGKL----PNVLGN  295 (1048)
Q Consensus       228 ~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~  295 (1048)
                      +.+...+|++...    +...|...+.|+.+.++.|.|..    .+...|..+++|+.|||.+|-++...    ...+..
T Consensus       160 rv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s  239 (382)
T KOG1909|consen  160 RVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSS  239 (382)
T ss_pred             EEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcc
Confidence            4444444444321    11123333444444444444321    12233444444444444444443221    122334


Q ss_pred             ccccccccccCCcccCCCCccc-----ccCCCCcEEEecCccccC----ccCcccccCCcccEeecccccc
Q 001591          296 LTQLEFFVAHSNSFSGPLPLSL-----SLCSKLHVLDLRNNSLTG----PIDLNFSGLSSLCTLDLATNHF  357 (1048)
Q Consensus       296 l~~L~~L~l~~n~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l  357 (1048)
                      +++|++|++++|.++..-..+|     ...++|++|.+.+|.++.    .+..++...+.|..|+|++|.+
T Consensus       240 ~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  240 WPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             cchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            4444555555544442222111     124567777777776653    2223344566777777777777

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.06  E-value=3.4e-11  Score=129.31  Aligned_cols=135  Identities=18%  Similarity=0.133  Sum_probs=68.9

Q ss_pred             CCCCcEEEcccccCCcchh-hhhcCCCCCcEEEccCCcCCCCccccccCccccccccccCCcccCCC-CcccccCCCCcE
Q 001591          248 MSSLQHVSLSVNNFSGQLS-EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL-PLSLSLCSKLHV  325 (1048)
Q Consensus       248 l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~  325 (1048)
                      ++.|+.|.|+.|.++...- ......++|+.|+|..|.....-......+..|++|+|++|++-... -...+.++.|+.
T Consensus       196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence            4455555555555542221 12233455555555555322222223334455555666655554211 133455666666


Q ss_pred             EEecCccccCccCcc------cccCCcccEeecccccccCC-CCccccCCCccceeeccccccc
Q 001591          326 LDLRNNSLTGPIDLN------FSGLSSLCTLDLATNHFSGP-LPNSLSDCHDLKILSLAKNELS  382 (1048)
Q Consensus       326 L~L~~N~l~~~~~~~------~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~  382 (1048)
                      |+++.+.++.+--..      ...+++|++|+++.|++..- .-..+..+.+|+.|....|.++
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            666666665432111      23456777777777776421 1134445567777777777776

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=1.6e-09  Score=104.94  Aligned_cols=131  Identities=26%  Similarity=0.384  Sum_probs=102.4

Q ss_pred             CeEeccCceEEEEEEECCCcEEEEEE-ecCCc--hh-----hHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEEEe
Q 001591          773 NIIGCGGFGLVYKATLTNGTKAAVKR-LSGDC--GQ-----MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~--~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  844 (1048)
                      ..+++|+-+.+|.+.+. |.++++|. +++..  +.     ....-.+|++++.+++--.|...+=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999886 44455553 33322  11     113457799999999877777777777788888999999


Q ss_pred             ccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      ++|..|.+.+...           ...++..+-+-+.-||..   +|||+|+.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999988888642           256777888889999986   999999999999998765 99999999975

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.04  E-value=4.9e-11  Score=121.40  Aligned_cols=179  Identities=21%  Similarity=0.166  Sum_probs=118.9

Q ss_pred             CCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchhhhhcCCCCCcEEEccC-CcCCCCccccccCcccccc
Q 001591          223 HSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFG-NQFSGKLPNVLGNLTQLEF  301 (1048)
Q Consensus       223 ~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~  301 (1048)
                      -+.+|+.+.++.+.-..+ -+-...-+.|+++...+..++.. | .+-..+.+..+.-+. .-.+|..-..+.....|++
T Consensus       212 ~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~~-~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~Lte  288 (490)
T KOG1259|consen  212 AFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQDV-P-SLLPETILADPSGSEPSTSNGSALVSADTWQELTE  288 (490)
T ss_pred             Hhhhhheeeeeccchhhe-eceeecCchhheeeeeccccccc-c-cccchhhhcCccCCCCCccCCceEEecchHhhhhh
Confidence            345566666665543311 11122235666666665544311 1 111112222221111 1223444445566778999


Q ss_pred             ccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCCCCccccCCCccceeecccccc
Q 001591          302 FVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL  381 (1048)
Q Consensus       302 L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l  381 (1048)
                      ++|++|.|+ .+..+..-.++++.|++|+|.++....  +..+++|+.||||+|.++ .+-.+-..+-+++.|.|+.|.|
T Consensus       289 lDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~i  364 (490)
T KOG1259|consen  289 LDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKI  364 (490)
T ss_pred             ccccccchh-hhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhH
Confidence            999999988 566778888999999999999985443  778899999999999998 5556666788999999999998


Q ss_pred             ccccchhhccCCcCcEEeccCCcCCCCcC
Q 001591          382 SGQVPESFGKLTSLLFLSLSNNSFNHLSG  410 (1048)
Q Consensus       382 ~~~~p~~~~~l~~L~~L~L~~N~l~~l~~  410 (1048)
                      ...  ..++++-+|..||+++|+|..+..
T Consensus       365 E~L--SGL~KLYSLvnLDl~~N~Ie~lde  391 (490)
T KOG1259|consen  365 ETL--SGLRKLYSLVNLDLSSNQIEELDE  391 (490)
T ss_pred             hhh--hhhHhhhhheeccccccchhhHHH
Confidence            732  457788899999999999987653

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.03  E-value=2e-09  Score=114.07  Aligned_cols=142  Identities=20%  Similarity=0.266  Sum_probs=110.6

Q ss_pred             CeEeccCceEEEEEEECCCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCC--ceeeecceEeeCC---cEEEEEEecc
Q 001591          773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHK--NLVSLQGYCRHGN---DRLLIYSYME  846 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~~  846 (1048)
                      +.|+.|.++.||+++..+|+.+++|+...... .....+..|+++++.+++.  .+.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887778999998765432 1345688999999999763  4566777766542   5689999999


Q ss_pred             CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC---------------------------------------  887 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  887 (1048)
                      |.++.+.+..     ..++..++..++.++++++++||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9988765531     24677788888899999999998531                                       


Q ss_pred             --------------CCCeEEcCCCCCceEECC--CCcEEEeecccccc
Q 001591          888 --------------EPHIVHRDVKSSNILLDE--KFEAHLADFGLSRL  919 (1048)
Q Consensus       888 --------------~~~ivH~Dlk~~NIll~~--~~~~kl~Dfg~a~~  919 (1048)
                                    ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245799999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.03  E-value=3.5e-11  Score=139.43  Aligned_cols=148  Identities=29%  Similarity=0.321  Sum_probs=64.7

Q ss_pred             CCCcEEEcccccCCcchhhhhcCCCCCcEEEccCCcCCCCcc-ccccCccccccccccCCcccCCCCcccccCCCCcEEE
Q 001591          249 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLP-NVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLD  327 (1048)
Q Consensus       249 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  327 (1048)
                      +.|+.|++++|.++..  ..+..++.|+.+++++|++...-+ . ...+.+++.+++..|.+...  ..+..+..+..++
T Consensus       140 ~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~  214 (414)
T KOG0531|consen  140 TLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLS  214 (414)
T ss_pred             cchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhh
Confidence            3344444444444311  223334444455555554442222 1 34444555555555554421  1223333444445


Q ss_pred             ecCccccCccCcccccCC--cccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEeccCCcC
Q 001591          328 LRNNSLTGPIDLNFSGLS--SLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF  405 (1048)
Q Consensus       328 L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  405 (1048)
                      +..|.++..-+.  ..+.  .|+.+++++|.+. ..+..+..+..+..|++.+|++...  ..+...+.+..+....|.+
T Consensus       215 l~~n~i~~~~~l--~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~  289 (414)
T KOG0531|consen  215 LLDNKISKLEGL--NELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKL  289 (414)
T ss_pred             cccccceeccCc--ccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchh
Confidence            555555532221  1112  2555566666555 2224444555566666666655532  1233334444445555544


Q ss_pred             C
Q 001591          406 N  406 (1048)
Q Consensus       406 ~  406 (1048)
                      .
T Consensus       290 ~  290 (414)
T KOG0531|consen  290 A  290 (414)
T ss_pred             c
Confidence            3

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.02  E-value=1.5e-10  Score=114.59  Aligned_cols=83  Identities=31%  Similarity=0.439  Sum_probs=15.6

Q ss_pred             CCcCCCeEecCCCCCCCCCCcccc-CCCCccEEeccCCcccCcccccccccccccEEEecCcccCCccccc-cccCcccE
Q 001591          104 HLNQLKLLDLSCNHLEGVVPVELS-NLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFEL-GEFSNLAV  181 (1048)
Q Consensus       104 ~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l-~~l~~L~~  181 (1048)
                      +...+++|+|++|.|+.+  +.++ .+.+|+.||||+|.|+...  .+..++.|++|++++|+|+.....+ ..+++|+.
T Consensus        17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE   92 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred             cccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence            334455556666655532  1233 3455555666666555432  2444455555555555554432222 23444444


Q ss_pred             EEecCcccc
Q 001591          182 FNISNNSFT  190 (1048)
Q Consensus       182 L~Ls~n~l~  190 (1048)
                      |++++|+|.
T Consensus        93 L~L~~N~I~  101 (175)
T PF14580_consen   93 LYLSNNKIS  101 (175)
T ss_dssp             EE-TTS---
T ss_pred             EECcCCcCC
Confidence            444444443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.02  E-value=3.1e-10  Score=112.40  Aligned_cols=109  Identities=33%  Similarity=0.383  Sum_probs=36.2

Q ss_pred             ccCCCCcEEEecCccccCccCcccc-cCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhh-ccCCcC
Q 001591          318 SLCSKLHVLDLRNNSLTGPIDLNFS-GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESF-GKLTSL  395 (1048)
Q Consensus       318 ~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L  395 (1048)
                      .+..++++|+|++|.|+.+.  .++ .+.+|+.|+|++|.|+.. + .+..+++|++|++++|+|+. +++.+ ..+++|
T Consensus        16 ~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L   90 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNL   90 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred             cccccccccccccccccccc--chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCCcC
Confidence            34456777777777777432  233 467778888888887743 2 46677888888888888884 33334 457888


Q ss_pred             cEEeccCCcCCCCcCcccccccccccceEecccCccC
Q 001591          396 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVG  432 (1048)
Q Consensus       396 ~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~  432 (1048)
                      +.|++++|+|..+.. +..+..+++|+.|++.+|++.
T Consensus        91 ~~L~L~~N~I~~l~~-l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   91 QELYLSNNKISDLNE-LEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -EEE-TTS---SCCC-CGGGGG-TT--EEE-TT-GGG
T ss_pred             CEEECcCCcCCChHH-hHHHHcCCCcceeeccCCccc
Confidence            888888888877643 455566666666666666653

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.01  E-value=4.7e-11  Score=138.41  Aligned_cols=243  Identities=28%  Similarity=0.321  Sum_probs=136.6

Q ss_pred             CCCCccEEeccCCcccCcccccccccccccEEEecCcccCCccccccccCcccEEEecCccccCccchhhhhcccccceE
Q 001591          128 NLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQIL  207 (1048)
Q Consensus       128 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L  207 (1048)
                      .+..++.+++..|.|.. +-..+..+.+|..|++.+|+|......+..+++|++|++++|+|+.                
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~----------------  132 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITK----------------  132 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheecccccccc----------------
Confidence            34445555555555543 2223444445555555555554433334445555555555555442                


Q ss_pred             eccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcccccCCcchh-hhhcCCCCCcEEEccCCcCC
Q 001591          208 DLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS-EKISNLTSLRHLIIFGNQFS  286 (1048)
Q Consensus       208 ~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  286 (1048)
                                ..++..++.|+.|++++|.|+.  ...+..+.+|+.+++++|.+....+ . ...+.+|+.+++.+|.+.
T Consensus       133 ----------i~~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  133 ----------LEGLSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR  199 (414)
T ss_pred             ----------ccchhhccchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence                      1233444556666666666663  2344556777777777777764443 2 466777777777777775


Q ss_pred             CCccccccCccccccccccCCcccCCCCcccccCC--CCcEEEecCccccCccCcccccCCcccEeecccccccCCCCcc
Q 001591          287 GKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCS--KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS  364 (1048)
Q Consensus       287 ~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  364 (1048)
                      ..  ..+..+..+..+++..|.++..-+  +..+.  .|+.+++++|++.... ..+..+.++..|++.+|++...  ..
T Consensus       200 ~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~--~~  272 (414)
T KOG0531|consen  200 EI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNL--EG  272 (414)
T ss_pred             cc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccccc--cc
Confidence            32  223444455555777777663322  11222  3788888888877432 4556677888888888887743  23


Q ss_pred             ccCCCccceeeccccccccc---cchh-hccCCcCcEEeccCCcCCC
Q 001591          365 LSDCHDLKILSLAKNELSGQ---VPES-FGKLTSLLFLSLSNNSFNH  407 (1048)
Q Consensus       365 l~~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~L~L~~N~l~~  407 (1048)
                      +.....+..+.+..|.+...   .... ....+.++...+.+|.+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
T KOG0531|consen  273 LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRK  319 (414)
T ss_pred             ccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccc
Confidence            44556677777777776522   1111 3445566666666665544

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=3.2e-10  Score=128.35  Aligned_cols=246  Identities=22%  Similarity=0.228  Sum_probs=174.1

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC--CCcEEEEEEecCCchhhHHH--HHHHHHHHHhc-CCCceeeecceEeeCCcEE
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT--NGTKAAVKRLSGDCGQMERE--FQAEVEALSRA-QHKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  839 (1048)
                      ...+|..+..||.|.|+.|++...+  ++..|++|...........+  -..|+-+...+ .|.++++....+...+..|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3567899999999999999998654  67889999876543322222  23455555555 4899999988888888888


Q ss_pred             EEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-CcEEEeeccccc
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGLSR  918 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~a~  918 (1048)
                      +--||+++++......    ....++...++++..|++.++.++|+   +.++|+|+||+||++..+ +.-++.|||.+.
T Consensus       343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccc
Confidence            9999999998776552    34457788899999999999999997   499999999999999876 788999999987


Q ss_pred             ccCCCCCceeecccccccc-cCccccCcCCCCchhhhHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhccccccc
Q 001591          919 LLRPYDTHVTTDLVGTLGY-IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE  997 (1048)
Q Consensus       919 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1048)
                      .+.-..   ....-++..| .+|+......+..++|+||||.-+.|.++|.+--..  .      ..|..  ...+....
T Consensus       416 ~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--~------~~~~~--i~~~~~p~  482 (524)
T KOG0601|consen  416 RLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--G------VQSLT--IRSGDTPN  482 (524)
T ss_pred             ccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcc--c------cccee--eecccccC
Confidence            532111   1111222334 356666777888999999999999999998764221  0      01100  00010100


Q ss_pred             ccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001591          998 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 1040 (1048)
                                ......++..+...+..+++..||.+.+.....
T Consensus       483 ----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  483 ----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             ----------CCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence                      011114677888889999999999998876533

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.97  E-value=5.6e-09  Score=100.36  Aligned_cols=143  Identities=19%  Similarity=0.278  Sum_probs=106.7

Q ss_pred             ccCeEeccCceEEEEEEECCCcEEEEE-EecCCc-------hhhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEEEE
Q 001591          771 QANIIGCGGFGLVYKATLTNGTKAAVK-RLSGDC-------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       771 ~~~~lG~G~~g~Vy~~~~~~~~~vavK-~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  842 (1048)
                      ...++-+|+-+.|+++.+. |+...|| ++.+..       .-..+...+|++.+.+++--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678899999999999987 7776665 343322       122345678999999998667666666676777778999


Q ss_pred             EeccC-CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC---cEEEeeccccc
Q 001591          843 SYMEN-GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF---EAHLADFGLSR  918 (1048)
Q Consensus       843 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfg~a~  918 (1048)
                      ||++| .++.+++.....  .....+....++..|.+.+.-||..   +|+|+|+..+||++..++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 467777765432  2223333478899999999999986   999999999999996544   35899999986


Q ss_pred             c
Q 001591          919 L  919 (1048)
Q Consensus       919 ~  919 (1048)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.89  E-value=4.8e-08  Score=104.98  Aligned_cols=262  Identities=17%  Similarity=0.180  Sum_probs=156.8

Q ss_pred             ccCeEeccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeecce----Ee--eC-CcEEEEE
Q 001591          771 QANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGY----CR--HG-NDRLLIY  842 (1048)
Q Consensus       771 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~~--~~-~~~~lv~  842 (1048)
                      ..+.||+|+.+.+|-.--- +..| .|++.........+.   ++.|.+. .||-+-.=+.|    ..  +. ....+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hchh-heeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4677999999999976321 2334 477776554433322   2333333 46643331211    11  11 2256777


Q ss_pred             EeccCCCh-hhhccc--ccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccc
Q 001591          843 SYMENGSL-DYWLHE--SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       843 e~~~~g~L-~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      ..+.+-.- ..++..  .+.......|...+++++.++.+.+.||.+   |.+-+|+.++|+|+.+++.+.+.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence            77766422 111111  122344578999999999999999999997   999999999999999999999988543322


Q ss_pred             cCCCCCceeecccccccccCccccC-----cCCCCchhhhHHHHHHHHHHHcC-CCCCcccC--C---CCch-hHHHHHH
Q 001591          920 LRPYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTG-RRPVEVCK--G---KNCR-DLVSWVF  987 (1048)
Q Consensus       920 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg-~~P~~~~~--~---~~~~-~~~~~~~  987 (1048)
                      .  ........-+|...|.+||.-.     +...+...|.|.+||++++++.| +.||.+..  .   .... ++....+
T Consensus       167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            1  2333444568999999999643     55667889999999999999885 99997532  1   1111 1111111


Q ss_pred             HhhcccccccccccccCchhhHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHhcC
Q 001591          988 QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQ--DPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~P~~RPt~~evl~~L~~i~ 1044 (1048)
                      ...+.........+.-+ + ...-...+..+..+|+..  .+.-||+++..+..|.++.
T Consensus       245 ~ya~~~~~g~~p~P~~~-P-~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         245 AYASDQRRGLKPPPRSI-P-LSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             eechhccCCCCCCCCCC-C-hhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            11111110000011000 0 011122456666777754  3668999998887765543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.89  E-value=4.2e-08  Score=108.37  Aligned_cols=170  Identities=22%  Similarity=0.275  Sum_probs=129.4

Q ss_pred             CceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeecceEe----eCCcEEEEEEeccC-CChhh
Q 001591          779 GFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR----HGNDRLLIYSYMEN-GSLDY  852 (1048)
Q Consensus       779 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~  852 (1048)
                      -..+.||+... ||..|++|++.++..........-+++++++.|+|+|++.+++.    .+...++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34578999754 89999999996654443333455688999999999999999886    34567899999986 46655


Q ss_pred             hccccc-----------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          853 WLHESV-----------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       853 ~l~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      +-....           ..+...+++..|.++.|+..||.++|+.   |.+-+-+.+++|+++.+.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            433211           1234577899999999999999999997   99999999999999998899999888776654


Q ss_pred             CCCCceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCC
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRR  969 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~  969 (1048)
                      .+..               |.+.   --.+-|.-.||.+++.|.||..
T Consensus       445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            3321               1111   1236799999999999999854

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.83  E-value=6.7e-10  Score=131.66  Aligned_cols=249  Identities=20%  Similarity=0.241  Sum_probs=169.8

Q ss_pred             hhcCCcccCeEeccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeecceEeeCCcEEE
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  840 (1048)
                      ..+.+.+.+.+-.|.++.++-+.-. .|...+.|+......   ...+....+-.+.-..++|-+++....+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456777888999999999988644 454455554332211   111112222222222456777777766666677899


Q ss_pred             EEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeeccccccc
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      |++|..+++|...++..    ...+.+.++.....+..+.+|||+.   .+.|||++|.|.+...++..+++|||.....
T Consensus       882 ~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            99999999998888753    2455556667777888999999985   6899999999999999999999999843321


Q ss_pred             CC---------------------CC-----C----ceeecccccccccCccccCcCCCCchhhhHHHHHHHHHHHcCCCC
Q 001591          921 RP---------------------YD-----T----HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP  970 (1048)
Q Consensus       921 ~~---------------------~~-----~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~P  970 (1048)
                      .-                     ..     .    .......||+.|.|||...+......+|+|+.|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            10                     00     0    012234799999999999999999999999999999999999999


Q ss_pred             CcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 001591          971 VEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIE 1034 (1048)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 1034 (1048)
                      |.......       +++-......       .|...+.....+..+++...+..+|.+|-.+.
T Consensus      1035 ~na~tpq~-------~f~ni~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQ-------IFENILNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhh-------hhhccccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            96433211       1111111111       12222334445678888888899999997765

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.77  E-value=4.9e-09  Score=129.41  Aligned_cols=179  Identities=23%  Similarity=0.286  Sum_probs=79.8

Q ss_pred             CCcEEEecCcc--ccCccCcccccCCcccEeecccccccCCCCccccCCCccceeeccccccccccchhhccCCcCcEEe
Q 001591          322 KLHVLDLRNNS--LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLS  399 (1048)
Q Consensus       322 ~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  399 (1048)
                      +|++|-+..|.  +.......|..++.|+.|||++|.=-+.+|..++++-+|++|+|++..++ .+|..++++..|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            44444444443  33233333444445555555544433345555555555555555555554 4445555555555555


Q ss_pred             ccCCcCCCCcCcccccccccccceEecccCc--cCCCCCccccCCCcCcEEEccCCcccCCchHhhhccCCCc----EEe
Q 001591          400 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNF--VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQ----VLD  473 (1048)
Q Consensus       400 L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~  473 (1048)
                      +..+......  ......+.+|++|.+....  .+...-..+..+..|+.+.......  .+-..+..+.+|.    .+.
T Consensus       625 l~~~~~l~~~--~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~  700 (889)
T KOG4658|consen  625 LEVTGRLESI--PGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS  700 (889)
T ss_pred             cccccccccc--cchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence            5444322111  1222334445544444332  1111222333444444444433322  1111122222222    333


Q ss_pred             CcCceeccCCCcccccCCCCCeEeecCCccccc
Q 001591          474 LSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGE  506 (1048)
Q Consensus       474 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  506 (1048)
                      +.++... ..+..++.+.+|+.|.+.++.++..
T Consensus       701 ~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~  732 (889)
T KOG4658|consen  701 IEGCSKR-TLISSLGSLGNLEELSILDCGISEI  732 (889)
T ss_pred             hcccccc-eeecccccccCcceEEEEcCCCchh
Confidence            3333333 4556677888888888888887643

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.76  E-value=4.6e-09  Score=85.48  Aligned_cols=61  Identities=43%  Similarity=0.612  Sum_probs=47.6

Q ss_pred             CCCcEEEccCceecccCCcccccccCccEeeCCCCccCCCCccccccccCCCeeeeccccc
Q 001591          577 KHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL  637 (1048)
Q Consensus       577 ~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l  637 (1048)
                      ++|++|++++|+|+...+..|..+++|++||+++|+++...|..|..+++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3677888888888865567778888888888888888766667788888888888888865

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=1.1e-07  Score=102.04  Aligned_cols=141  Identities=13%  Similarity=0.105  Sum_probs=101.8

Q ss_pred             CeEeccCceEEEEEEECCCcEEEEEEecCCchh-----------hHHHHHHHHHHHHhcCCCce--eeecceEee-----
Q 001591          773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ-----------MEREFQAEVEALSRAQHKNL--VSLQGYCRH-----  834 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----  834 (1048)
                      +++-......|+++.+ +|+.|.||+.......           ....+.+|...+.++...+|  .+++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455445556777766 4789999987543211           11147789999988854443  344555543     


Q ss_pred             CCcEEEEEEeccCC-ChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-------C
Q 001591          835 GNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-------K  906 (1048)
Q Consensus       835 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------~  906 (1048)
                      ....++|+|++++. +|.+++....  ....+...+..++.+++..++-||..   ||+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23468999999986 7888875321  23345677889999999999999986   9999999999999975       4


Q ss_pred             CcEEEeecccccc
Q 001591          907 FEAHLADFGLSRL  919 (1048)
Q Consensus       907 ~~~kl~Dfg~a~~  919 (1048)
                      ..+.++||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6899999998864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=6.4e-08  Score=97.67  Aligned_cols=126  Identities=21%  Similarity=0.237  Sum_probs=82.5

Q ss_pred             EEEEEEECCCcEEEEEEecCCc--------------------------hhhHHHHHHHHHHHHhcCCCc--eeeecceEe
Q 001591          782 LVYKATLTNGTKAAVKRLSGDC--------------------------GQMEREFQAEVEALSRAQHKN--LVSLQGYCR  833 (1048)
Q Consensus       782 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~  833 (1048)
                      .||.|...+|..+|+|+.+...                          .......++|++.|.++...+  +.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999885321                          001234578999999998664  55555442 


Q ss_pred             eCCcEEEEEEecc--CCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCCceEECCCCcEE
Q 001591          834 HGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAH  910 (1048)
Q Consensus       834 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlk~~NIll~~~~~~k  910 (1048)
                         ..++||||++  |..+..+...      .++.+....++.+++..+..+ |..   ||+|+|+.+.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999999  5444332221      111344566777888866664 665   99999999999999987 999


Q ss_pred             EeecccccccC
Q 001591          911 LADFGLSRLLR  921 (1048)
Q Consensus       911 l~Dfg~a~~~~  921 (1048)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999987644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.75  E-value=7.1e-09  Score=128.03  Aligned_cols=284  Identities=26%  Similarity=0.260  Sum_probs=123.8

Q ss_pred             CCCCEEEcccCCCCCCCCccccCCCCCcEEEccccc--CCcchhhhhcCCCCCcEEEccCCcCCCCccccccCccccccc
Q 001591          225 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNN--FSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFF  302 (1048)
Q Consensus       225 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  302 (1048)
                      ...+...+-+|.+. .++.... .++|++|-+..|.  +.......|..++.|+.|||++|.=-+.+|..+++|-+|++|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            34444444444443 1222221 2245555555553  332333334445555555555554444555555555555555


Q ss_pred             cccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecccccc--cCCCCccccCCCccceeeccccc
Q 001591          303 VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF--SGPLPNSLSDCHDLKILSLAKNE  380 (1048)
Q Consensus       303 ~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l--~~~~p~~l~~l~~L~~L~L~~N~  380 (1048)
                      ++++..++ .+|..+.++..|.+|++..+.-...++.....+.+|++|.+..-..  +...-..+..+.+|+.+......
T Consensus       601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s  679 (889)
T KOG4658|consen  601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISS  679 (889)
T ss_pred             cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecch
Confidence            55555555 4455555555555555555444333344444455555555543321  11111222333334433332222


Q ss_pred             cccccchhhccCCcCc----EEeccCCcCCCCcCcccccccccccceEecccCccCCCCCccccC------CCcCcEEEc
Q 001591          381 LSGQVPESFGKLTSLL----FLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG------FESLMVLAL  450 (1048)
Q Consensus       381 l~~~~p~~~~~l~~L~----~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~L  450 (1048)
                      .  .+-..+..+..|.    .+.+.++..   ......+..+.+|+.|.+.++.+.+........      ++++..+..
T Consensus       680 ~--~~~e~l~~~~~L~~~~~~l~~~~~~~---~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~  754 (889)
T KOG4658|consen  680 V--LLLEDLLGMTRLRSLLQSLSIEGCSK---RTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSI  754 (889)
T ss_pred             h--HhHhhhhhhHHHHHHhHhhhhccccc---ceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHh
Confidence            1  0111112222221    222222221   222234455556666666665554322222111      222333333


Q ss_pred             cCCcccCCchHhhhccCCCcEEeCcCceeccCCCcccccCCCCCeEeecCCccccc-CCcchhhhhhh
Q 001591          451 GNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGE-IPKSLTELKSL  517 (1048)
Q Consensus       451 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L  517 (1048)
                      .++..- ..+.+.--.++|+.|.+.++.....+.+....+..+..+-+..+.+.+. .-...+.++++
T Consensus       755 ~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i  821 (889)
T KOG4658|consen  755 LNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQL  821 (889)
T ss_pred             hccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCcee
Confidence            333221 2334444556777777777666555555555566666555666666554 23333344443

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=1.1e-07  Score=97.90  Aligned_cols=149  Identities=23%  Similarity=0.172  Sum_probs=104.6

Q ss_pred             ccHHHHHHhhcCCcccCeEeccCceEEEEEEECCCcEEEEEEecCCc----------------------hhhHHHHHHHH
Q 001591          757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC----------------------GQMEREFQAEV  814 (1048)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~  814 (1048)
                      +.+..+.+...-..+...||.|.-+.||.|....|.++|||.-+...                      .......++|.
T Consensus        81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf  160 (304)
T COG0478          81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF  160 (304)
T ss_pred             HHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence            33444444444456688999999999999999999999999543211                      01223457899


Q ss_pred             HHHHhcCCC--ceeeecceEeeCCcEEEEEEeccCCChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 001591          815 EALSRAQHK--NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV  892 (1048)
Q Consensus       815 ~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  892 (1048)
                      ++|.++.-.  .+.+.+++    +...+||||++|-.|...-         ++.+....++..|++-+...-..   |||
T Consensus       161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiV  224 (304)
T COG0478         161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIV  224 (304)
T ss_pred             HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---Ccc
Confidence            999998654  67777765    4568999999997654321         12233334444444444444343   999


Q ss_pred             EcCCCCCceEECCCCcEEEeecccccccC
Q 001591          893 HRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       893 H~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |+|+.+-||++++||.+.++||-.+....
T Consensus       225 HGDlSefNIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         225 HGDLSEFNILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             ccCCchheEEEecCCCEEEEeCcccccCC
Confidence            99999999999999999999999886543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.72  E-value=8.4e-09  Score=83.94  Aligned_cols=61  Identities=38%  Similarity=0.505  Sum_probs=49.5

Q ss_pred             cCCCeEecCCCCCCCCCCccccCCCCccEEeccCCcccCcccccccccccccEEEecCccc
Q 001591          106 NQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSF  166 (1048)
Q Consensus       106 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  166 (1048)
                      ++|++|+|++|+|+.+.+..|..+++|++|++++|.++...++.|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4678888888888877777888888888888888888888888888888888888887764

...

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.67  E-value=1.7e-08  Score=75.00  Aligned_cols=38  Identities=37%  Similarity=0.755  Sum_probs=30.1

Q ss_pred             HHHHHHHHHHHhcCCC-C-CCCcCcCCC--CCCceeeeeeeC
Q 001591           36 PSDLLALKEFAGNLTN-G-SIITSWSNE--SMCCQWDGVVCG   73 (1048)
Q Consensus        36 ~~~~~aLl~~k~~~~~-~-~~l~sw~~~--~~~c~w~gv~C~   73 (1048)
                      ++|++||++||+++.. + +.+.+|+..  .+||.|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            5899999999999974 3 789999987  799999999994

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.49  E-value=2.6e-08  Score=102.03  Aligned_cols=115  Identities=23%  Similarity=0.312  Sum_probs=70.5

Q ss_pred             CccccCCcCCCeEecCCCCCCCCCCc-cc-cCCCCccEEeccCCcccC--cccccccccccccEEEecCcccCCccccc-
Q 001591           99 PRSLGHLNQLKLLDLSCNHLEGVVPV-EL-SNLKQLEVLDLSHNMLSG--PVSGMLAGLNLIQSLNVSSNSFNGSLFEL-  173 (1048)
Q Consensus        99 ~~~l~~l~~L~~L~Ls~n~l~~~~p~-~~-~~l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l-  173 (1048)
                      +-.++.+..+..|.+.++.|...... .| ...+.++.|||.+|.|+.  .+...+..++.|+.|+|++|++...+..+ 
T Consensus        38 ~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp  117 (418)
T KOG2982|consen   38 YLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP  117 (418)
T ss_pred             eeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc
Confidence            33344445555666666666432221 12 235667778888887774  45556677777888888888777666555 


Q ss_pred             cccCcccEEEecCccccCccchhhhhcccccceEeccCcc
Q 001591          174 GEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH  213 (1048)
Q Consensus       174 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~  213 (1048)
                      ....+|+.|-|.+..+.-.-.......++.++.|.+|.|+
T Consensus       118 ~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~  157 (418)
T KOG2982|consen  118 LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNS  157 (418)
T ss_pred             ccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccch
Confidence            3566777777777776644444555555555555555553

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.47  E-value=3.8e-08  Score=113.00  Aligned_cols=150  Identities=22%  Similarity=0.295  Sum_probs=103.9

Q ss_pred             HHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCcEEEeecccccccCCCCCcee--------ecccccccccCccccCc
Q 001591          874 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--------TDLVGTLGYIPPEYSQT  945 (1048)
Q Consensus       874 ~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~  945 (1048)
                      .+++.|+.|+|..  .++||++|.|++|.++..+..|++.|+++...........        .-..-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455899999985  8999999999999999999999999999876544222111        11234568999999999


Q ss_pred             CCCCchhhhHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhcccccccccccccCchhhHHHHHHHHHHHHHccc
Q 001591          946 LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCID 1024 (1048)
Q Consensus       946 ~~~~~~~Dv~slGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 1024 (1048)
                      ...+.++|+||+|+.+|.+.. |+.-+..........     +....        +......+....+.++.+=+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----~~~~~--------~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----FSRNL--------LNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----hhhcc--------cccccccccccCcHHHHHHHHHHhc
Confidence            889999999999999999994 555443221111111     00000        0000111223445578888999999


Q ss_pred             CCCCCCCCHHHHHH
Q 001591         1025 QDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1025 ~~P~~RPt~~evl~ 1038 (1048)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999997776654

>PRK09902 hypothetical protein; Provisional

Probab=98.45  E-value=1.9e-06  Score=87.27  Aligned_cols=138  Identities=19%  Similarity=0.166  Sum_probs=102.6

Q ss_pred             EeccCceEEEEEEECCCcEEEEEEecCCc------hhhHHHHHHHHHHHHhcCCCc--eeeecceEe-eC----CcEEEE
Q 001591          775 IGCGGFGLVYKATLTNGTKAAVKRLSGDC------GQMEREFQAEVEALSRAQHKN--LVSLQGYCR-HG----NDRLLI  841 (1048)
Q Consensus       775 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~~----~~~~lv  841 (1048)
                      -|+||-+.|+..... |..+-+|+-....      +-.+..|.+|+..+.++...+  +.++. ++. ..    -..++|
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            367888889998776 5578888765111      335677999999999985322  44444 332 11    235799


Q ss_pred             EEeccC-CChhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCc--EEEeeccccc
Q 001591          842 YSYMEN-GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE--AHLADFGLSR  918 (1048)
Q Consensus       842 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~Dfg~a~  918 (1048)
                      +|-+++ -+|.+++.+.  .-.+.+...+..+..++++.++-||+.   |+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997764 4888887543  223457778899999999999999996   9999999999999986666  9999999876


Q ss_pred             c
Q 001591          919 L  919 (1048)
Q Consensus       919 ~  919 (1048)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.45  E-value=5.6e-08  Score=99.66  Aligned_cols=183  Identities=21%  Similarity=0.147  Sum_probs=87.5

Q ss_pred             cccCCCCcEEEecCccccCccCcccccCCcccEeecccccccCC-CCccccCCCccceeecccccccc--ccchhhccC-
Q 001591          317 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP-LPNSLSDCHDLKILSLAKNELSG--QVPESFGKL-  392 (1048)
Q Consensus       317 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l-  392 (1048)
                      +.+++.|++|+|+.|.+...+...-..+.+|++|.|.+..+... ....+..++.++.|+++.|.+..  ...+..... 
T Consensus        93 le~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s  172 (418)
T KOG2982|consen   93 LEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWS  172 (418)
T ss_pred             HhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccc
Confidence            34455555555555555433322112344555555555544422 22334445555566665553321  111111111 


Q ss_pred             CcCcEEeccCCcCCCCcCcccccccccccceEecccCccCCCCC-ccccCCCcCcEEEccCCcccCCc-hHhhhccCCCc
Q 001591          393 TSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIP-ENVGGFESLMVLALGNCGLKGHI-PVWLLRCKKLQ  470 (1048)
Q Consensus       393 ~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~  470 (1048)
                      +.++.|++-.|...........-..++++..+.+..|++..... +....++.+-.|+|+.|+|...- -+.+.++++|.
T Consensus       173 ~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~  252 (418)
T KOG2982|consen  173 TEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLV  252 (418)
T ss_pred             hhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhh
Confidence            13333333333222111111112234566666666666644332 34455666667777777776332 24566777777


Q ss_pred             EEeCcCceeccCCCc------ccccCCCCCeEeec
Q 001591          471 VLDLSWNHFDGNIPP------WIGQMENLFYLDFS  499 (1048)
Q Consensus       471 ~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls  499 (1048)
                      .|.+++|.+...+-.      -++.+++++.|+=+
T Consensus       253 dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLNGs  287 (418)
T KOG2982|consen  253 DLRVSENPLSDPLRGGERRFLLIARLTKVQVLNGS  287 (418)
T ss_pred             eeeccCCcccccccCCcceEEEEeeccceEEecCc
Confidence            788887776533221      24566666666543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.45  E-value=4.4e-09  Score=119.33  Aligned_cols=128  Identities=27%  Similarity=0.262  Sum_probs=74.8

Q ss_pred             CCcEEEccCCcCCCCccccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCccCcccccCCcccEeecc
Q 001591          274 SLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLA  353 (1048)
Q Consensus       274 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  353 (1048)
                      .|...+.+.|.+. .....+.-++.|+.|+|++|++....  .+..+++|++|||+.|.++..+.....++. |+.|.|+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            4555666666665 44555566666666667666666432  566666666666666666654443333433 6666666


Q ss_pred             cccccCCCCccccCCCccceeeccccccccccc-hhhccCCcCcEEeccCCcCCC
Q 001591          354 TNHFSGPLPNSLSDCHDLKILSLAKNELSGQVP-ESFGKLTSLLFLSLSNNSFNH  407 (1048)
Q Consensus       354 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~  407 (1048)
                      +|.++..  ..+.++++|+.||++.|-|.+.-. ..++.|..|+.|+|.+|.+-.
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            6666532  345566666666666666654211 234455566666666666543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.45  E-value=1.1e-08  Score=116.19  Aligned_cols=127  Identities=27%  Similarity=0.238  Sum_probs=82.2

Q ss_pred             cccEEEecCccccCccchhhhhcccccceEeccCcccccccCCCCCCCCCCEEEcccCCCCCCCCccccCCCCCcEEEcc
Q 001591          178 NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS  257 (1048)
Q Consensus       178 ~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  257 (1048)
                      .|...+.++|++.  ......+.++.|+.||||+|+++... .+..++.|++|||++|.+....--....+. |+.|.|+
T Consensus       165 ~L~~a~fsyN~L~--~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV--LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH--hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            3666677777765  33444566677777777777776655 666777777777777777632211222333 7888888


Q ss_pred             cccCCcchhhhhcCCCCCcEEEccCCcCCCCcc-ccccCccccccccccCCccc
Q 001591          258 VNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLP-NVLGNLTQLEFFVAHSNSFS  310 (1048)
Q Consensus       258 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~  310 (1048)
                      +|.++..  ..+.+|.+|+.||+++|-|.+.-. ..++.|..|+.|+|.+|.+.
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            8877632  356777888888888887764321 22456677777777777764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.36  E-value=7.5e-06  Score=83.90  Aligned_cols=154  Identities=19%  Similarity=0.210  Sum_probs=104.1

Q ss_pred             cccHHHHHHhhcCCcccCeE---eccCceEEEEEEECCCcEEEEEEecCCchhhH------------------------H
Q 001591          756 DLTVSDLLKSTNNFNQANII---GCGGFGLVYKATLTNGTKAAVKRLSGDCGQME------------------------R  808 (1048)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~l---G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~  808 (1048)
                      ..+.+.+.....+..+....   ..|.-+.||+|.-.++..+|||+++.......                        .
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            34555566655555555554   46777789999888899999999874431111                        1


Q ss_pred             HHHHHHHHHHhcC--CCceeeecceEeeCCcEEEEEEeccCCCh-hhhcccccCCccccCHHHHHHHHHHHHHHHHHHHh
Q 001591          809 EFQAEVEALSRAQ--HKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK  885 (1048)
Q Consensus       809 ~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  885 (1048)
                      -..+|+.-|+++.  +-.+.+.+++.    .-.+||||+..... .-.|     .+..+..++...+..++++.+.-|-.
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence            1245777777764  33344445443    24799999976521 1122     22334444677778888888888876


Q ss_pred             cCCCCeEEcCCCCCceEECCCCcEEEeecccccccC
Q 001591          886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       886 ~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      .  .++||+|+..-|||+. ++.+.|+|||.|....
T Consensus       185 ~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 E--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             h--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            2  4999999999999999 8899999999997654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1048
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-65
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-63
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-60
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-60
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-48
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-37
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-21
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		6e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		1e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		3e-04
2z7x_B	520	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		3e-04
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		4e-04
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		4e-04
3soa_A	444	Full-Length Human Camkii Length = 444		4e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		4e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  246 bits (628), Expect = 5e-65,   Method: Composition-based stats.
 Identities = 125/294 (42%), Positives = 189/294 (64%), Gaps = 3/294 (1%)
Query: 755  KDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAE 813
            K  ++ +L  +++NF+  NI+G GGFG VYK  L +GT  AVKRL  +  Q  E +FQ E
Sbjct: 26   KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 814  VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA 873
            VE +S A H+NL+ L+G+C    +RLL+Y YM NGS+   L E  +    L W  R +IA
Sbjct: 86   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 874  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 933
             G+ARGLAYLH  C+P I+HRDVK++NILLDE+FEA + DFGL++L+   D HV   + G
Sbjct: 146  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 205
Query: 934  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKS 991
            T+G+I PEY  T  ++ + DV+ +GV+LLEL+TG+R  ++ +  N  D  L+ WV  +  
Sbjct: 206  TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045
            EK+   ++D  +    +++++ +++++A  C    P  RP + EVV  L+G G+
Sbjct: 266  EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 319

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  241 bits (614), Expect = 2e-63,   Method: Composition-based stats.
 Identities = 123/294 (41%), Positives = 186/294 (63%), Gaps = 3/294 (1%)
Query: 755  KDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAE 813
            K  ++ +L  +++NF   NI+G GGFG VYK  L +G   AVKRL  +  Q  E +FQ E
Sbjct: 18   KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 814  VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA 873
            VE +S A H+NL+ L+G+C    +RLL+Y YM NGS+   L E  +    L W  R +IA
Sbjct: 78   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 874  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 933
             G+ARGLAYLH  C+P I+HRDVK++NILLDE+FEA + DFGL++L+   D HV   + G
Sbjct: 138  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 197
Query: 934  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKS 991
             +G+I PEY  T  ++ + DV+ +GV+LLEL+TG+R  ++ +  N  D  L+ WV  +  
Sbjct: 198  XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045
            EK+   ++D  +    +++++ +++++A  C    P  RP + EVV  L+G G+
Sbjct: 258  EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  231 bits (590), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 194/603 (32%), Positives = 284/603 (47%), Gaps = 85/603 (14%)
Query: 107 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSF 166
            L+ LD+S N+    +P  L +   L+ LD+S N LSG  S  ++    ++ LN+SSN F
Sbjct: 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 167 NGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSP 225
            G +  L    +L   +++ N FTG++   +  A   +  LDLS NHF G++        
Sbjct: 260 VGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318
Query: 226 SLKQLHVDNNLLGGDLP-DSLYSMSSLQHVSLSVNNFSGQLSEKISNLT-SLRHLIIFGN 283
            L+ L + +N   G+LP D+L  M  L+ + LS N FSG+L E ++NL+ SL  L +  N
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 284 QFSGKLPNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSG 343
            FSG    +L NL Q                           L L+NN  TG I    S 
Sbjct: 379 NFSGP---ILPNLCQ-------------------NPKNTLQELYLQNNGFTGKIPPTLSN 416
Query: 344 LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXX 403
            S L +L L+ N+ SG +P+SL     L+ L L  N L G++P+                
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE--------------- 461
Query: 404 XXXXXXGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWL 463
                      L   K L TLIL  N +  EIP  +    +L  ++L N  L G IP W+
Sbjct: 462 -----------LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 464 LRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCT 523
            R + L +L LS N F GNIP  +G   +L +LD + N   G IP ++ +    I++N  
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570
Query: 524 SSNPTA------------SAGIPLYVKHNRST--NGLPYNQASSFPPSVF---------- 559
           +                  AG  L  +  RS   N L      +    V+          
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 560 --------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 611
                   +S N ++G IP EIG + +L +L+L  N+I+G+IP  + ++R L +LDLSSN
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 612 DLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDS 671
            L G IP +   LT L++  ++NN+L G IP  GQF +FP + F  NPGLCG     CD 
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750
Query: 672 MHA 674
            +A
Sbjct: 751 SNA 753

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  231 bits (589), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 194/603 (32%), Positives = 284/603 (47%), Gaps = 85/603 (14%)
Query: 107 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSF 166
            L+ LD+S N+    +P  L +   L+ LD+S N LSG  S  ++    ++ LN+SSN F
Sbjct: 198 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 256
Query: 167 NGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSP 225
            G +  L    +L   +++ N FTG++   +  A   +  LDLS NHF G++        
Sbjct: 257 VGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 315
Query: 226 SLKQLHVDNNLLGGDLP-DSLYSMSSLQHVSLSVNNFSGQLSEKISNLT-SLRHLIIFGN 283
            L+ L + +N   G+LP D+L  M  L+ + LS N FSG+L E ++NL+ SL  L +  N
Sbjct: 316 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 375
Query: 284 QFSGKLPNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSG 343
            FSG    +L NL Q                           L L+NN  TG I    S 
Sbjct: 376 NFSGP---ILPNLCQ-------------------NPKNTLQELYLQNNGFTGKIPPTLSN 413
Query: 344 LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXX 403
            S L +L L+ N+ SG +P+SL     L+ L L  N L G++P+                
Sbjct: 414 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE--------------- 458
Query: 404 XXXXXXGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWL 463
                      L   K L TLIL  N +  EIP  +    +L  ++L N  L G IP W+
Sbjct: 459 -----------LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 507
Query: 464 LRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCT 523
            R + L +L LS N F GNIP  +G   +L +LD + N   G IP ++ +    I++N  
Sbjct: 508 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 567
Query: 524 SSNPTA------------SAGIPLYVKHNRST--NGLPYNQASSFPPSVF---------- 559
           +                  AG  L  +  RS   N L      +    V+          
Sbjct: 568 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 627
Query: 560 --------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 611
                   +S N ++G IP EIG + +L +L+L  N+I+G+IP  + ++R L +LDLSSN
Sbjct: 628 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 687
Query: 612 DLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDS 671
            L G IP +   LT L++  ++NN+L G IP  GQF +FP + F  NPGLCG     CD 
Sbjct: 688 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 747
Query: 672 MHA 674
            +A
Sbjct: 748 SNA 750

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  191 bits (484), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 123/306 (40%), Positives = 177/306 (57%), Gaps = 7/306 (2%)
Query: 737  LSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAV 796
            +++AL+SS LV F++     + + DL ++TNNF+   +IG G FG VYK  L +G K A+
Sbjct: 12   INDALSSSYLVPFESYR---VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVAL 68
Query: 797  KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE 856
            KR + +  Q   EF+ E+E LS  +H +LVSL G+C   N+ +LIY YMENG+L   L+ 
Sbjct: 69   KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
Query: 857  SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL 916
            S      + W+ RL+I  GAARGL YLH      I+HRDVKS NILLDE F   + DFG+
Sbjct: 129  SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185
Query: 917  SRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK 975
            S+     D TH+   + GTLGYI PEY      T + DVYSFGVVL E+L  R  +    
Sbjct: 186  SKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 976  GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
             +   +L  W  +  +  +  +I+D ++  K R + L +  + A KC+      RP + +
Sbjct: 246  PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 1036 VVTWLD 1041
            V+  L+
Sbjct: 306  VLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  188 bits (478), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 122/306 (39%), Positives = 176/306 (57%), Gaps = 7/306 (2%)
Query: 737  LSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAV 796
            +++AL+SS LV F++     + + DL ++TNNF+   +IG G FG VYK  L +G K A+
Sbjct: 12   INDALSSSYLVPFESYR---VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVAL 68
Query: 797  KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE 856
            KR + +  Q   EF+ E+E LS  +H +LVSL G+C   N+ +LIY YMENG+L   L+ 
Sbjct: 69   KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
Query: 857  SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL 916
            S      + W+ RL+I  GAARGL YLH      I+HRDVKS NILLDE F   + DFG+
Sbjct: 129  SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185
Query: 917  SRLLRPY-DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK 975
            S+       TH+   + GTLGYI PEY      T + DVYSFGVVL E+L  R  +    
Sbjct: 186  SKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 976  GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
             +   +L  W  +  +  +  +I+D ++  K R + L +  + A KC+      RP + +
Sbjct: 246  PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 1036 VVTWLD 1041
            V+  L+
Sbjct: 306  VLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (418), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 163/291 (56%), Gaps = 19/291 (6%)
Query: 761  DLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSG----DCGQMEREF 810
            +L   TNNF++       N +G GGFG+VYK  + N T  AVK+L+        +++++F
Sbjct: 19   ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 77
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E++ +++ QH+NLV L G+   G+D  L+Y YM NGSL   L   +D    L W +R 
Sbjct: 78   DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRC 136
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY-DTHVTT 929
            KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R    +  T + +
Sbjct: 137  KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS 193
Query: 930  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
             +VGT  Y+ PE  +    T + D+YSFGVVLLE++TG   V+  +      L       
Sbjct: 194  RIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIE 251
Query: 990  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
              EK   + ID  +   D    +  M  +A +C+ +   +RP I++V   L
Sbjct: 252  DEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (415), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 162/291 (55%), Gaps = 19/291 (6%)
Query: 761  DLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSG----DCGQMEREF 810
            +L   TNNF++       N +G GGFG+VYK  + N T  AVK+L+        +++++F
Sbjct: 19   ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 77
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E++ +++ QH+NLV L G+   G+D  L+Y YM NGSL   L   +D    L W +R 
Sbjct: 78   DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRC 136
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY-DTHVTT 929
            KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R    +  T +  
Sbjct: 137  KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXX 193
Query: 930  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
             +VGT  Y+ PE  +    T + D+YSFGVVLLE++TG   V+  +      L       
Sbjct: 194  RIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIE 251
Query: 990  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
              EK   + ID  +   D    +  M  +A +C+ +   +RP I++V   L
Sbjct: 252  DEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  164 bits (414), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 161/291 (55%), Gaps = 19/291 (6%)
Query: 761  DLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSG----DCGQMEREF 810
            +L   TNNF++       N +G GGFG+VYK  + N T  AVK+L+        +++++F
Sbjct: 13   ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 71
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E++ +++ QH+NLV L G+   G+D  L+Y YM NGSL   L   +D    L W +R 
Sbjct: 72   DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRC 130
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TT 929
            KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R    +   V   
Sbjct: 131  KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXX 187
Query: 930  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
             +VGT  Y+ PE  +    T + D+YSFGVVLLE++TG   V+  +      L       
Sbjct: 188  RIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIE 245
Query: 990  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
              EK   + ID  +   D    +  M  +A +C+ +   +RP I++V   L
Sbjct: 246  DEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  154 bits (388), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 107/291 (36%), Positives = 155/291 (53%), Gaps = 19/291 (6%)
Query: 761  DLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSG----DCGQMEREF 810
            +L   TNNF++       N  G GGFG+VYK  + N T  AVK+L+        +++++F
Sbjct: 10   ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 68
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E++  ++ QH+NLV L G+   G+D  L+Y Y  NGSL   L   +D    L W  R 
Sbjct: 69   DQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPLSWHXRC 127
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TT 929
            KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R    +   V  +
Sbjct: 128  KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXS 184
Query: 930  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
             +VGT  Y  PE  +    T + D+YSFGVVLLE++TG   V+  +      L       
Sbjct: 185  RIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIE 242
Query: 990  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
              EK   + ID      D    +     +A +C+ +   +RP I++V   L
Sbjct: 243  DEEKTIEDYIDKKXNDAD-STSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 6/205 (2%)
Query: 768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNL 825
           + N    IG G FG V++A   +G+  AVK L       ER  EF  EV  + R +H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           V   G      +  ++  Y+  GSL   LH+S  ++  L    RL +A   A+G+ YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN 155
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
              P IVHRD+KS N+L+D+K+   + DFGLSR L+      +    GT  ++ PE  + 
Sbjct: 156 R-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 946 LTATCRGDVYSFGVVLLELLTGRRP 970
             +  + DVYSFGV+L EL T ++P
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 109/205 (53%), Gaps = 6/205 (2%)
Query: 768 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNL 825
           + N    IG G FG V++A   +G+  AVK L       ER  EF  EV  + R +H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           V   G      +  ++  Y+  GSL   LH+S  ++  L    RL +A   A+G+ YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN 155
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
              P IVHR++KS N+L+D+K+   + DFGLSR L+      +    GT  ++ PE  + 
Sbjct: 156 R-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 946 LTATCRGDVYSFGVVLLELLTGRRP 970
             +  + DVYSFGV+L EL T ++P
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP 238

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 137/292 (46%), Gaps = 40/292 (13%)
Query: 765  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRL-----SGDCGQMER--EFQAEVEA 816
            + N       IG GGFGLV+K  L  + +  A+K L      G+   +E+  EFQ EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 817  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
            +S   H N+V L G     N   ++  ++  G L    H  +DK   +KW V+L++    
Sbjct: 77   MSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDI 131
Query: 877  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRPYDTHVTTDL 931
            A G+ Y+     P IVHRD++S NI L    E     A +ADFGLS+       H  + L
Sbjct: 132  ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGL 186
Query: 932  VGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRPV-EVCKGKNCRDLVSWVFQ 988
            +G   ++ PE   ++  + T + D YSF ++L  +LTG  P  E   GK     + ++  
Sbjct: 187  LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINM 241
Query: 989  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            ++ E     I +      D   +L  ++E+   C   DP++RP    +V  L
Sbjct: 242  IREEGLRPTIPE------DCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 136/283 (48%), Gaps = 31/283 (10%)
Query: 770  NQANIIGCGGFGLVYKATL--TNGTK---AAVKRLSGDCGQMER-EFQAEVEALSRAQHK 823
             +  +IG G FG VYK  L  ++G K    A+K L     + +R +F  E   + +  H 
Sbjct: 47   TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 824  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
            N++ L+G        ++I  YMENG+LD +L E   + SVL+    + + +G A G+ YL
Sbjct: 107  NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL---VGMLRGIAAGMKYL 163
Query: 884  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPE 941
              +   + VHRD+ + NIL++      ++DFGLSR+L   P  T+ T+     + +  PE
Sbjct: 164  ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 942  YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
                   T   DV+SFG+V+ E++T G RP            ++  F++ +       +D
Sbjct: 221  AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP------MD 274
Query: 1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                          + ++  +C  Q+  RRP   ++V+ LD +
Sbjct: 275  CP----------SAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 773 NIIGCGGFGLVYKATLTN---GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
            IIG GGFG VY+A         KAA      D  Q     + E +  +  +H N+++L+
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           G C    +  L+  +   G L+  L  + +  D ++ W V++      ARG+ YLH    
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDEAI 126
Query: 889 PHIVHRDVKSSNILLDEKFE--------AHLADFGLSRLLRPYDTHVTTDL--VGTLGYI 938
             I+HRD+KSSNIL+ +K E          + DFGL+R     + H TT +   G   ++
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWM 181
Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKG 976
            PE  +    +   DV+S+GV+L ELLTG  P     G
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 136/292 (46%), Gaps = 40/292 (13%)
Query: 765  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRL-----SGDCGQMER--EFQAEVEA 816
            + N       IG GGFGLV+K  L  + +  A+K L      G+   +E+  EFQ EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 817  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
            +S   H N+V L G     N   ++  ++  G L    H  +DK   +KW V+L++    
Sbjct: 77   MSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDI 131
Query: 877  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRPYDTHVTTDL 931
            A G+ Y+     P IVHRD++S NI L    E     A +ADFG S+       H  + L
Sbjct: 132  ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGL 186
Query: 932  VGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRPV-EVCKGKNCRDLVSWVFQ 988
            +G   ++ PE   ++  + T + D YSF ++L  +LTG  P  E   GK     + ++  
Sbjct: 187  LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINM 241
Query: 989  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            ++ E     I +      D   +L  ++E+   C   DP++RP    +V  L
Sbjct: 242  IREEGLRPTIPE------DCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 136/292 (46%), Gaps = 40/292 (13%)
Query: 765  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRL-----SGDCGQMER--EFQAEVEA 816
            + N       IG GGFGLV+K  L  + +  A+K L      G+   +E+  EFQ EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 817  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
            +S   H N+V L G     N   ++  ++  G L    H  +DK   +KW V+L++    
Sbjct: 77   MSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDI 131
Query: 877  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRPYDTHVTTDL 931
            A G+ Y+     P IVHRD++S NI L    E     A +ADF LS+       H  + L
Sbjct: 132  ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGL 186
Query: 932  VGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRPV-EVCKGKNCRDLVSWVFQ 988
            +G   ++ PE   ++  + T + D YSF ++L  +LTG  P  E   GK     + ++  
Sbjct: 187  LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINM 241
Query: 989  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            ++ E     I +      D   +L  ++E+   C   DP++RP    +V  L
Sbjct: 242  IREEGLRPTIPE------DCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 109/241 (45%), Gaps = 16/241 (6%)
Query: 429 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 488
           N VG  IP  +     L  L + +  + G IP +L + K L  LD S+N   G +PP I 
Sbjct: 88  NLVGP-IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 489 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 548
            + NL  + F  N ++G IP S      L +S              + +  NR T  +P 
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTS--------------MTISRNRLTGKIPP 192
Query: 549 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 608
             A+     V LS N + G      G  K+   + L++N++   +   +   +NL  LDL
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDL 251
Query: 609 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSP 668
            +N ++G++P    +L FL   +V+ N+L G IP GG    F  S++  N  LCG     
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
Query: 669 C 669
           C
Sbjct: 312 C 312

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH S  K  + K    + IA+  ARG+ YLH      I+HR
Sbjct: 80  PQ-LAIVTQWCEGSSLYHHLHASETKFEMKKL---IDIARQTARGMDYLHAKS---IIHR 132
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +   +   + 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 193 QSDVYAFGIVLYELMTGQLP 212

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 79/294 (26%), Positives = 135/294 (45%), Gaps = 47/294 (15%)
Query: 775  IGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G G FG V+ A   N +        AVK L        ++FQ E E L+  QH+++V  
Sbjct: 23   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR-------------LKIAQG 875
             G C  G+  ++++ YM++G L+ +L      D+++  D +             L IA  
Sbjct: 83   YGVCGDGDPLIMVFEYMKHGDLNKFLRAH-GPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 876  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGT 934
             A G+ YL      H VHRD+ + N L+       + DFG+SR +   D + V    +  
Sbjct: 142  IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 993
            + ++PPE       T   DV+SFGV+L E+ T G++P              W FQ+ +  
Sbjct: 199  IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------W-FQLSN-- 241
Query: 994  REVEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044
               E+I+     +  E+  +   E+ ++   C  ++P++R  I+E+   L  +G
Sbjct: 242  --TEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH S  K  + K    + IA+  ARG+ YLH      I+HR
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKL---IDIARQTARGMDYLHAKS---IIHR 144
Query: 895 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +   +   + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH S  K  + K    + IA+  ARG+ YLH      I+HR
Sbjct: 92  PQ-LAIVTQWCEGSSLYHHLHASETKFEMKKL---IDIARQTARGMDYLHAKS---IIHR 144
Query: 895 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +   +   + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---IIHR 128
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 773 NIIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVS 827
            +IG G FG V    L    K     A+K L SG   +  R+F +E   + +  H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L+G        ++I  +MENGSLD +L ++  + +V++    + + +G A G+ YL    
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL---A 152
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEY 942
           + + VHRD+ + NIL++      ++DFGLSR L   DT   T      G IP     PE 
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED-DTSDPTYTSALGGKIPIRWTAPEA 211
Query: 943 SQTLTATCRGDVYSFGVVLLELLT-GRRP 970
            Q    T   DV+S+G+V+ E+++ G RP
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +G G FG V+ A   N          AVK L        ++F  E E L+  QH+++V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD----------VRLKIAQGAAR 878
            G C  G+  ++++ YM++G L+ +L  +   D+VL  +            L IAQ  A 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFL-RAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGY 937
           G+ YL      H VHRD+ + N L+ E     + DFG+SR +   D + V    +  + +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
           +PPE       T   DV+S GVVL E+ T G++P
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 78  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 130
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 191 QSDVYAFGIVLYELMTGQLP 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 81  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 133
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 76  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---IIHR 128
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 81  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 133
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 103 PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 155
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 216 QSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 104 PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 156
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 76  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---IIHR 128
Query: 895 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +       + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LV 150
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 73/252 (28%), Positives = 121/252 (48%), Gaps = 23/252 (9%)
Query: 774  IIGCGGFGLVYKATL----TNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            IIG G  G V    L          A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 56   IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            +G    G   +++  YMENGSLD +L     + ++++    + + +G   G+ YL  +  
Sbjct: 116  EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYLSDL-- 170
Query: 889  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 946
               VHRD+ + N+L+D      ++DFGLSR+L   P   + TT     + +  PE     
Sbjct: 171  -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 947  TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV---FQMKSE---KREVEII 999
            T +   DV+SFGVV+ E+L  G RP         RD++S V   +++ +       +  +
Sbjct: 230  TFSSASDVWSFGVVMWEVLAYGERPYW---NMTNRDVISSVEEGYRLPAPMGCPHALHQL 286
Query: 1000 DASIWHKDREKQ 1011
                WHKDR ++
Sbjct: 287  MLDCWHKDRAQR 298

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 96  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 148
Query: 895 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +       + 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 209 QSDVYAFGIVLYELMTGQLP 228

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 32/294 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 22   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 81
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 82   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LV 138
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 139  GMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 195
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 196  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 239
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD
Sbjct: 240  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 293

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 ++I  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   EEPIYIVI-EYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 104 PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 156
Query: 895 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 950
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +       + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 951 RGDVYSFGVVLLELLTGRRP 970
           + DVY+FG+VL EL+TG+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 5    TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 65   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LV 121
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 122  GMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 179  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 222
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 223  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 ++I  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   EEPIYIVI-EYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LV 150
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LV 150
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 37/271 (13%)
Query: 774  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            ++G G FG+V KA        A+K++  +  +  + F  E+  LSR  H N+V L G C 
Sbjct: 16   VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 834  HGNDRLLIYSYMENGSLDYWLHES-----VDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
              N   L+  Y E GSL   LH +           + W ++       ++G+AYLH +  
Sbjct: 73   --NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ------CSQGVAYLHSMQP 124
Query: 889  PHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 947
              ++HRD+K  N+LL        + DFG +  ++   TH+T +  G+  ++ PE  +   
Sbjct: 125  KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGSN 180
Query: 948  ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007
             + + DV+S+G++L E++T R+P +   G   R  + W     +    +           
Sbjct: 181  YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHNGTRPPLI----------- 227
Query: 1008 REKQLLEMLE-IACKCIDQDPRRRPFIEEVV 1037
              K L + +E +  +C  +DP +RP +EE+V
Sbjct: 228  --KNLPKPIESLMTRCWSKDPSQRPSMEEIV 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 37/271 (13%)
Query: 774  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            ++G G FG+V KA        A+K++  +  +  + F  E+  LSR  H N+V L G C 
Sbjct: 15   VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 834  HGNDRLLIYSYMENGSLDYWLHES-----VDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
              N   L+  Y E GSL   LH +           + W ++       ++G+AYLH +  
Sbjct: 72   --NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ------CSQGVAYLHSMQP 123
Query: 889  PHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 947
              ++HRD+K  N+LL        + DFG +  ++   TH+T +  G+  ++ PE  +   
Sbjct: 124  KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGSN 179
Query: 948  ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007
             + + DV+S+G++L E++T R+P +   G   R  + W     +    +           
Sbjct: 180  YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHNGTRPPLI----------- 226
Query: 1008 REKQLLEMLE-IACKCIDQDPRRRPFIEEVV 1037
              K L + +E +  +C  +DP +RP +EE+V
Sbjct: 227  --KNLPKPIESLMTRCWSKDPSQRPSMEEIV 255

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LV 150
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 15   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 73   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 126
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 127  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 187  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 231
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 232  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 17   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 75   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 128
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 129  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 189  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 233
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 234  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 52   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 108
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 109  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 165
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 937
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 166  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 223  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 280
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 281  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 32   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 91
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 92   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LV 148
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 149  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 205
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 206  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 249
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 250  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 51   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 107
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 108  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 164
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 937
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 165  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 222  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 279
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 280  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 73/252 (28%), Positives = 120/252 (47%), Gaps = 23/252 (9%)
Query: 774  IIGCGGFGLVYKATL----TNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            IIG G  G V    L          A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 56   IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            +G    G   +++  YMENGSLD +L     + ++++    + + +G   G+ YL  +  
Sbjct: 116  EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYLSDL-- 170
Query: 889  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 946
               VHRD+ + N+L+D      ++DFGLSR+L   P     TT     + +  PE     
Sbjct: 171  -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 947  TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV---FQMKSE---KREVEII 999
            T +   DV+SFGVV+ E+L  G RP         RD++S V   +++ +       +  +
Sbjct: 230  TFSSASDVWSFGVVMWEVLAYGERPYW---NMTNRDVISSVEEGYRLPAPMGCPHALHQL 286
Query: 1000 DASIWHKDREKQ 1011
                WHKDR ++
Sbjct: 287  MLDCWHKDRAQR 298

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 774 IIGCGGFGLVYKATLT----NGTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +IG G FG V    L          A+K L  G   +  R+F  E   + +  H N+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           +G    G   +++  +MENG+LD +L +   + +V++    + + +G A G+ YL    +
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL---VGMLRGIAAGMRYL---AD 163
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 946
              VHRD+ + NIL++      ++DFGLSR++   P   + TT     + +  PE  Q  
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             T   DV+S+G+V+ E+++ G RP
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 775  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V  
Sbjct: 26   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW--DVR---------LKIAQGAA 877
             G C  G   L+++ YM +G L+ +L        +L    DV          L +A   A
Sbjct: 86   FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLG 936
             G+ YL  +   H VHRD+ + N L+ +     + DFG+SR +   D + V    +  + 
Sbjct: 146  AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 937  YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
            ++PPE       T   DV+SFGVVL E+ T G++P              W +Q+ +    
Sbjct: 203  WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------W-YQLSN---- 243
Query: 996  VEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEV 1036
             E ID     ++ E+      E+  I   C  ++P++R  I++V
Sbjct: 244  TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 775  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V  
Sbjct: 20   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW--DVR---------LKIAQGAA 877
             G C  G   L+++ YM +G L+ +L        +L    DV          L +A   A
Sbjct: 80   FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLG 936
             G+ YL  +   H VHRD+ + N L+ +     + DFG+SR +   D + V    +  + 
Sbjct: 140  AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 937  YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
            ++PPE       T   DV+SFGVVL E+ T G++P              W +Q+ +    
Sbjct: 197  WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------W-YQLSN---- 237
Query: 996  VEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEV 1036
             E ID     ++ E+      E+  I   C  ++P++R  I++V
Sbjct: 238  TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 775  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V  
Sbjct: 49   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW--DVR---------LKIAQGAA 877
             G C  G   L+++ YM +G L+ +L        +L    DV          L +A   A
Sbjct: 109  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLG 936
             G+ YL  +   H VHRD+ + N L+ +     + DFG+SR +   D + V    +  + 
Sbjct: 169  AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 937  YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
            ++PPE       T   DV+SFGVVL E+ T G++P              W +Q+ +    
Sbjct: 226  WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------W-YQLSN---- 266
Query: 996  VEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEV 1036
             E ID     ++ E+      E+  I   C  ++P++R  I++V
Sbjct: 267  TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVCEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGL+R+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT 207
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 773 NIIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVS 827
            +IG G FG V    L    K     A+K L SG   +  R+F +E   + +  H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L+G        ++I  +MENGSLD +L ++  + +V++    + + +G A G+ YL    
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL---A 126
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEY 942
           + + VHR + + NIL++      ++DFGLSR L   DT   T      G IP     PE 
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLED-DTSDPTYTSALGGKIPIRWTAPEA 185
Query: 943 SQTLTATCRGDVYSFGVVLLELLT-GRRP 970
            Q    T   DV+S+G+V+ E+++ G RP
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 25   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 81
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 82   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 138
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 937
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 139  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 196  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 253
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 254  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 33   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 89
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 90   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 146
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 937
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 147  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 204  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 261
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 262  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 31   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 87
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 88   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 144
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 937
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 145  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 202  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 259
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 260  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 33   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 89
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 90   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 146
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 937
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 147  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 204  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 261
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 262  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 30   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 86
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 87   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 143
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 937
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 144  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 201  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 259  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 32   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 88
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 89   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 145
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 937
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 146  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 203  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 260
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 261  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGL R+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 28   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 84
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 85   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 141
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 937
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 142  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 199  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 256
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 257  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 131
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 87  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 139
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 200 DVWSFGILLTEIVTHGRIP 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 85  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 137
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 198 DVWSFGILLTEIVTHGRIP 216

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 80  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 132
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 193 DVWSFGILLTEIVTHGRIP 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 81  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 133
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 194 DVWSFGILLTEIVTHGRIP 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 131
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 88  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 140
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 201 DVWSFGILLTEIVTHGRIP 219

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD+ ++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    TK A+K L    G M  E F  E + + + +H  LV L     
Sbjct: 17   LGNGQFGEVWMGTWNGNTKVAIKTLKP--GTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L +   +   LK    + +A   A G+AY+ ++   + +H
Sbjct: 75   E-EPIYIVTEYMNKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIH 128
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++S+NIL+       +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 129  RDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL+T GR P     G N R+++    Q++   R     D  I         
Sbjct: 189  VWSFGILLTELVTKGRVPY---PGMNNREVLE---QVERGYRMPCPQDCPI--------- 233
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + E+   C  +DP  RP  E + ++L+
Sbjct: 234  -SLHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 773 NIIGCGGFGLVYKATLTNGTK----AAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            +IG G FG V +  L    K     A+K L G   + +R EF +E   + + +H N++ 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L+G   +    +++  +MENG+LD +L  +  + +V++    + + +G A G+ YL    
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ---LVGMLRGIASGMRYL---A 133
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGT--LGYIPPEYS 943
           E   VHRD+ + NIL++      ++DFGLSR L     D   T+ L G   + +  PE  
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 944 QTLTATCRGDVYSFGVVLLELLT-GRRP 970
                T   D +S+G+V+ E+++ G RP
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 193  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 251  E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 304
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL RL+   +          + +  PE +     T + D
Sbjct: 305  RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E +             
Sbjct: 365  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------------ 412
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                ++ C+C  +DP  RP  E +  +L+
Sbjct: 413  ----DLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 85  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 137
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 198 DVWSFGILLTEIVTHGRIP 216

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 89  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 141
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 202 DVWSFGILLTEIVTHGRIP 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 131
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 74  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 126
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 187 DVWSFGILLTEIVTHGRIP 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 84  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 136
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 197 DVWSFGILLTEIVTHGRIP 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 773 NIIGCGGFGLVYKATLTNGTK----AAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            +IG G FG V +  L    K     A+K L G   + +R EF +E   + + +H N++ 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L+G   +    +++  +MENG+LD +L  +  + +V++    + + +G A G+ YL    
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL---VGMLRGIASGMRYL---A 135
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGT--LGYIPPEYS 943
           E   VHRD+ + NIL++      ++DFGLSR L     D   T+ L G   + +  PE  
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 944 QTLTATCRGDVYSFGVVLLELLT-GRRP 970
                T   D +S+G+V+ E+++ G RP
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 16   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 74   E-EPIXIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 127
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 128  RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 188  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 232
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  ++P  RP  E +  +L+
Sbjct: 233  -SLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  G L  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVMEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  G L  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVTEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 19   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 77   E-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 130
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 131  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 191  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 235
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  ++P  RP  E +  +L+
Sbjct: 236  -SLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 275  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 333  E-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 387  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E +             
Sbjct: 447  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------------ 494
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                ++ C+C  ++P  RP  E +  +L+
Sbjct: 495  ----DLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 34   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 90
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 91   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 147
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR--LLRPYDT-HVTTDLVGTLGY 937
             +L        VHRD+ + N +LDEKF   +ADFGL+R  L + +D+ H  T     + +
Sbjct: 148  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKW 204
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 205  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 262
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 263  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 129/288 (44%), Gaps = 38/288 (13%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 32   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 88
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 89   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 145
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-----THVTTDLVGTL 935
             YL        VHRD+ + N +LDEKF   +ADFGL+R +  YD      H  T     +
Sbjct: 146  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEXXSVHNKTGAKLPV 200
Query: 936  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
             ++  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   + 
Sbjct: 201  KWMALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQP 258
Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                D              + E+  KC       RP   E+V+ +  I
Sbjct: 259  EYCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++   MENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 92   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 148
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 149  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 205
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 937
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 206  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 263  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 320
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 321  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 5    TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++   MENGSLD +L +   + +V++    +
Sbjct: 65   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LV 121
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 122  GMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 179  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 222
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 223  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 774 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +IG G FG V    L    K     A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           +G        ++I  YMENGSLD +L ++  + +V++    + + +G   G+ YL  +  
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYLSDMSA 152
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 946
              VHRD+ + NIL++      ++DFG+SR+L   P   + T      + +  PE     
Sbjct: 153 ---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 209
Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             T   DV+S+G+V+ E+++ G RP
Sbjct: 210 KFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 38   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 94
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 95   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 151
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 937
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 152  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 208
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 209  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 266
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 267  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 774 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +IG G FG V    L    K     A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           +G        ++I  YMENGSLD +L ++  + +V++    + + +G   G+ YL  +  
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYLSDM-- 129
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 946
              VHRD+ + NIL++      ++DFG+SR+L   P   + T      + +  PE     
Sbjct: 130 -SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             T   DV+S+G+V+ E+++ G RP
Sbjct: 189 KFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 774 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +IG G FG V    L    K     A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           +G        ++I  YMENGSLD +L ++  + +V++    + + +G   G+ YL  +  
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYLSDM-- 135
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 946
              VHRD+ + NIL++      ++DFG+SR+L   P   + T      + +  PE     
Sbjct: 136 -SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             T   DV+S+G+V+ E+++ G RP
Sbjct: 195 KFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 32/296 (10%)
Query: 758  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 810
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
              E   + +  H N++ L+G        +++   MENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LV 150
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 928
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 987
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 22/268 (8%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            IG G FG VYK          + ++     +  + F+ EV  L + +H N++   GY   
Sbjct: 44   IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 835  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
             N   ++  + E  SL   LH    K  + +    + IA+  A+G+ YLH     +I+HR
Sbjct: 104  DN-LAIVTQWCEGSSLYKHLHVQETKFQMFQL---IDIARQTAQGMDYLH---AKNIIHR 156
Query: 895  DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 950
            D+KS+NI L E     + DFGL+ +   +  +       G++ ++ PE  +       + 
Sbjct: 157  DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 951  RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010
            + DVYS+G+VL EL+TG  P       N RD +  +F +    R     D S  +K+  K
Sbjct: 217  QSDVYSYGIVLYELMTGELPYSHI---NNRDQI--IFMV---GRGYASPDLSKLYKNCPK 268
Query: 1011 QLLEMLEIACKCIDQDPRRRPFIEEVVT 1038
                M  +   C+ +    RP   ++++
Sbjct: 269  ---AMKRLVADCVKKVKEERPLFPQILS 293

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 34   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 90
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 91   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 147
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 937
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 148  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 204
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 205  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 262
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 263  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 250  E-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 304  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E +             
Sbjct: 364  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------------ 411
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                ++ C+C  ++P  RP  E +  +L+
Sbjct: 412  ----DLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L     K   L+    + ++   A G+AY+ ++   + VH
Sbjct: 81   E-EPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERM---NYVH 134
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 135  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 195  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 239
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  ++P  RP  E +  +L+
Sbjct: 240  -SLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 33   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 89
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 90   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 146
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 937
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 147  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 204  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 261
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 262  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 33   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 89
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 90   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 146
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 937
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 147  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 204  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 261
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 262  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 250  E-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 304  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E +             
Sbjct: 364  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------------ 411
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                ++ C+C  ++P  RP  E +  +L+
Sbjct: 412  ----DLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 75  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 127
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HR+++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 188 DVWSFGILLTEIVTHGRIP 206

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 768  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 821
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 31   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 87
Query: 822  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 88   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 144
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 937
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 145  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 201
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 202  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 259
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 260  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  ++  YM  GSL  +L     K   L+    + ++   A G+AY+ ++   + VH
Sbjct: 81   E-EPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERM---NYVH 134
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 135  RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 195  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 239
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + ++ C+C  ++P  RP  E +  +L+
Sbjct: 240  -SLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 28/270 (10%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L  Y  
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 834  HGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
               + + I   YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + V
Sbjct: 248  VSEEPIYIVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 893  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
            HRD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + 
Sbjct: 303  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 953  DVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1011
            DV+SFG++L EL T GR P      +   D V   ++M       E +            
Sbjct: 363  DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----------- 411
Query: 1012 LLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                 ++ C+C  ++P  RP  E +  +L+
Sbjct: 412  -----DLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                L++ +ME+G L  +L     +  +   +  L +      G+AYL + C   ++HR
Sbjct: 72  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 954
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 955 YSFGVVLLELLT-GRRPVE 972
           +SFGV++ E+ + G+ P E
Sbjct: 186 WSFGVLMWEVFSEGKIPYE 204

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                L++ +ME+G L  +L     +  +   +  L +      G+AYL + C   ++HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 954
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 955 YSFGVVLLELLT-GRRPVE 972
           +SFGV++ E+ + G+ P E
Sbjct: 188 WSFGVLMWEVFSEGKIPYE 206

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
           +G G  G V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 131
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 953 DVYSFGVVLLELLT-GRRP 970
           DV+SFG++L E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 774 IIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +IG G FG V    L    K     A+K L  G   +  R+F  E   + +  H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           +G        +++  YMENGSLD +L ++  + +V++    + + +G + G+ YL  +  
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQL---VGMLRGISAGMKYLSDM-- 143
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 946
              VHRD+ + NIL++      ++DFGLSR+L   P   + T      + +  PE     
Sbjct: 144 -GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             T   DV+S+G+V+ E+++ G RP
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                L++ +ME+G L  +L     +  +   +  L +      G+AYL + C   ++HR
Sbjct: 77  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 954
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 955 YSFGVVLLELLT-GRRPVE 972
           +SFGV++ E+ + G+ P E
Sbjct: 191 WSFGVLMWEVFSEGKIPYE 209

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 756 DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           DL   +L   +       +   G FG V+KA L N   A       D    + E+  EV 
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY--EVY 70
Query: 816 ALSRAQHKNLVSLQGYCRHGN----DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
           +L   +H+N++   G  + G     D  LI ++ E GSL  +L     K +V+ W+    
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCH 125
Query: 872 IAQGAARGLAYLHKVC-------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--- 921
           IA+  ARGLAYLH+         +P I HRD+KS N+LL     A +ADFGL+       
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 922 -PYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLT 966
              DTH     VGT  Y+ PE  +        A  R D+Y+ G+VL EL +
Sbjct: 186 SAGDTHGQ---VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 10/200 (5%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G FGLV+     N  K A+K +    G M E +F  E E + +  H  LV L G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKE--GSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 L++ +ME+G L  +L     +  +   +  L +      G+AYL + C   ++H
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N L+ E     ++DFG++R +       +T     + +  PE       + + D
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 954 VYSFGVVLLELLT-GRRPVE 972
           V+SFGV++ E+ + G+ P E
Sbjct: 207 VWSFGVLMWEVFSEGKIPYE 226

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 13/216 (6%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 823
           +F   N++G G F  VY+A ++  G + A+K +         M +  Q EV+   + +H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           +++ L  Y    N   L+     NG ++ +L   V   S  + + R  + Q    G+ YL
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS--ENEARHFMHQ-IITGMLYL 128
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDLVGTLGYIPPEY 942
           H      I+HRD+  SN+LL       +ADFGL+  L+ P++ H T  L GT  YI PE 
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 943 SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
           +         DV+S G +   LL GR P +    KN
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 8/199 (4%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                L+  +ME+G L  +L     +  +   +  L +      G+AYL + C   ++HR
Sbjct: 75  QAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 954
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 955 YSFGVVLLELLT-GRRPVE 972
           +SFGV++ E+ + G+ P E
Sbjct: 189 WSFGVLMWEVFSEGKIPYE 207

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 8/199 (4%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                L++ +ME+G L  +L     +  +   +  L +      G+AYL    E  ++HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHR 127
Query: 895 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 954
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 955 YSFGVVLLELLT-GRRPVE 972
           +SFGV++ E+ + G+ P E
Sbjct: 188 WSFGVLMWEVFSEGKIPYE 206

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 122/290 (42%), Gaps = 45/290 (15%)
Query: 767  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKN 824
            +++    +IG G   +V  A       K A+KR++ + C     E   E++A+S+  H N
Sbjct: 15   DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 825  LVSLQGYCRHGNDRLLIYSYMENGS-LDYWLH---ESVDKDSVLKWDVRLKIAQGAARGL 880
            +VS        ++  L+   +  GS LD   H   +   K  VL       I +    GL
Sbjct: 75   IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP----YDTHVTTDLVGTLG 936
             YLHK  +   +HRDVK+ NILL E     +ADFG+S  L          V    VGT  
Sbjct: 135  EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 937  YIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPV------------------------ 971
            ++ PE   Q      + D++SFG+  +EL TG  P                         
Sbjct: 192  WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251
Query: 972  ---EVCK--GKNCRDLVSWVFQMKSEKR--EVEIIDASIWHKDREKQLLE 1014
               E+ K  GK+ R ++S   Q   EKR    E++    + K + K+ L+
Sbjct: 252  QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQ 301

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 121/282 (42%), Gaps = 21/282 (7%)
Query: 767  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKN 824
            +++    +IG G   +V  A       K A+KR++ + C     E   E++A+S+  H N
Sbjct: 10   DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 825  LVSLQGYCRHGNDRLLIYSYMENGS-LDYWLH---ESVDKDSVLKWDVRLKIAQGAARGL 880
            +VS        ++  L+   +  GS LD   H   +   K  VL       I +    GL
Sbjct: 70   IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP----YDTHVTTDLVGTLG 936
             YLHK  +   +HRDVK+ NILL E     +ADFG+S  L          V    VGT  
Sbjct: 130  EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 937  YIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
            ++ PE   Q      + D++SFG+  +EL TG  P           L     Q      E
Sbjct: 187  WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---TLQNDPPSLE 243
Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
              + D  +  K   K   +M+ +   C+ +DP +RP   E++
Sbjct: 244  TGVQDKEML-KKYGKSFRKMISL---CLQKDPEKRPTAAELL 281

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNLVSLQG 830
            I   G FG V+KA L N    AVK       Q ++ +Q+E E  S    +H+NL+    
Sbjct: 21  EIKARGRFGCVWKAQLMNDF-VAVKIFPL---QDKQSWQSEREIFSTPGMKHENLLQFIA 76
Query: 831 YCRHGN----DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
             + G+    +  LI ++ + GSL  +L     K +++ W+    +A+  +RGL+YLH+ 
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHED 131
Query: 887 C--------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR----PYDTHVTTDLVGT 934
                    +P I HRD KS N+LL     A LADFGL+        P DTH     VGT
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH---GQVGT 188
Query: 935 LGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLT 966
             Y+ PE  +        A  R D+Y+ G+VL EL++
Sbjct: 189 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 49/298 (16%)
Query: 767  NNFNQANIIGCGGFGLVYKATLTNG---TKAAVKRLSGDCGQME-REFQAEVEALSR-AQ 821
            N+    ++IG G FG V KA +        AA+KR+     + + R+F  E+E L +   
Sbjct: 25   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVR 869
            H N+++L G C H     L   Y  +G+L  +L +S  ++ D          S L     
Sbjct: 85   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 870  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
            L  A   ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 145  LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------ 195
Query: 930  DLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 983
             +  T+G +P  +    +      T   DV+S+GV+L E+++ G  P   C G  C +L 
Sbjct: 196  -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC-GMTCAELY 251
Query: 984  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + Q    ++ +   D             E+ ++  +C  + P  RP   +++  L+
Sbjct: 252  EKLPQGYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLN 296

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 49/298 (16%)
Query: 767  NNFNQANIIGCGGFGLVYKATLTNG---TKAAVKRLSGDCGQME-REFQAEVEALSR-AQ 821
            N+    ++IG G FG V KA +        AA+KR+     + + R+F  E+E L +   
Sbjct: 15   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVR 869
            H N+++L G C H     L   Y  +G+L  +L +S  ++ D          S L     
Sbjct: 75   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 870  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
            L  A   ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 135  LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------ 185
Query: 930  DLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 983
             +  T+G +P  +    +      T   DV+S+GV+L E+++ G  P   C G  C +L 
Sbjct: 186  -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC-GMTCAELY 241
Query: 984  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + Q    ++ +   D             E+ ++  +C  + P  RP   +++  L+
Sbjct: 242  EKLPQGYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLN 286

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 30/271 (11%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+ AT    TK AVK +    G M  E F AE   +   QH  LV L     
Sbjct: 23   LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 834  HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKW-DVRLKIAQGAARGLAYLHKVCEPHI 891
                  +I  +M  GSL D+   +   K  + K  D   +IA+G    +A++    + + 
Sbjct: 81   K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG----MAFIE---QRNY 132
Query: 892  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
            +HRD++++NIL+       +ADFGL+R++   +          + +  PE     + T +
Sbjct: 133  IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 952  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010
             DV+SFG++L+E++T GR P                +   S    +  ++        E 
Sbjct: 193  SDVWSFGILLMEIVTYGRIP----------------YPGMSNPEVIRALERGYRMPRPEN 236
Query: 1011 QLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
               E+  I  +C    P  RP  E + + LD
Sbjct: 237  CPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 775 IGCGGFGLVYKA--TLTNGTKAAVKRLSGDCGQME---REFQAEVEALSRAQHKNLVSLQ 829
           +G GG   VY A  T+ N  K A+K +     + E   + F+ EV   S+  H+N+VS+ 
Sbjct: 19  LGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
                 +   L+  Y+E  +L     E ++    L  D  +        G+ + H +   
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLS----EYIESHGPLSVDTAINFTNQILDGIKHAHDM--- 130
Query: 890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            IVHRD+K  NIL+D      + DFG+++ L       T  ++GT+ Y  PE ++     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 950 CRGDVYSFGVVLLELLTGRRP 970
              D+YS G+VL E+L G  P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 149
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 48/299 (16%)
Query: 771  QANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
               ++G G FG   K T    G    +K L     + +R F  EV+ +   +H N++   
Sbjct: 14   HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 830  GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
            G          I  Y++ G+L   +      DS   W  R+  A+  A G+AYLH +   
Sbjct: 74   GVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM--- 127
Query: 890  HIVHRDVKSSNILLDEKFEAHLADFGLSRL-------------LRPYDTHVTTDLVGTLG 936
            +I+HRD+ S N L+ E     +ADFGL+RL             L+  D      +VG   
Sbjct: 128  NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 937  YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRR-------PVEVCKGKNCRDLVSWVFQM 989
            ++ PE     +   + DV+SFG+VL E++ GR        P  +  G N R  +      
Sbjct: 188  WMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 990  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1048
                                        I  +C D DP +RP   ++  WL+ + +  A
Sbjct: 247  NCPP--------------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 134
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 131
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 136
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 149
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 131
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 135
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 131
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 130
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 71/235 (30%), Positives = 105/235 (44%), Gaps = 36/235 (15%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSR 819
           NN      IG G FG V++A           T  AVK L  +    M+ +FQ E   ++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV---------------- 863
             + N+V L G C  G    L++ YM  G L+ +L  S+   +V                
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-RSMSPHTVCSLSHSDLSTRARVSS 165
Query: 864 -----LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 918
                L    +L IA+  A G+AYL    E   VHRD+ + N L+ E     +ADFGLSR
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 919 LLRPYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
            +   D +     D +  + ++PPE       T   DV+++GVVL E+ + G +P
Sbjct: 223 NIYSADYYKADGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 162
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 134/298 (44%), Gaps = 49/298 (16%)
Query: 767  NNFNQANIIGCGGFGLVYKATLTNG---TKAAVKRLSGDCGQME-REFQAEVEALSR-AQ 821
            N+    ++IG G FG V KA +        AA+KR+     + + R+F  E+E L +   
Sbjct: 22   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVR 869
            H N+++L G C H     L   Y  +G+L  +L +S  ++ D          S L     
Sbjct: 82   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 870  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
            L  A   ARG+ YL    +   +HR++ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 142  LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVY------ 192
Query: 930  DLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 983
             +  T+G +P  +    +      T   DV+S+GV+L E+++ G  P   C G  C +L 
Sbjct: 193  -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC-GMTCAELY 248
Query: 984  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
              + Q    ++ +   D             E+ ++  +C  + P  RP   +++  L+
Sbjct: 249  EKLPQGYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLN 293

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 137
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L    ++   +K    L+      +G+ YL    
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL---LQYTSQICKGMEYL---G 134
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 129
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 138
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 9/198 (4%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V+     N TK AVK L    G M  + F  E   +   QH  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  YM  GSL  +L    D+   +     +  +   A G+AY+ +    + +H
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 133
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD++++N+L+ E     +ADFGL+R++   +          + +  PE       T + D
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 954 VYSFGVVLLELLT-GRRP 970
           V+SFG++L E++T G+ P
Sbjct: 194 VWSFGILLYEIVTYGKIP 211

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 26/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            +G G FG V+ AT    TK AVK +      +E  F AE   +   QH  LV L      
Sbjct: 196  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 835  GNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  GSL D+   +   K  + K    +  +   A G+A++    + + +H
Sbjct: 255  -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIE---QRNYIH 307
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+       +ADFGL+R++   +          + +  PE     + T + D
Sbjct: 308  RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L+E++T GR P            +   ++M   +   E               
Sbjct: 368  VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE--------------- 412
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
             E+  I  +C    P  RP  E + + LD
Sbjct: 413  -ELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  ++  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 134
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 820 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVR--LKI 872
             QH+N+V+L G C HG   L+I  Y   G L  +L       +DK+     ++R  L  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDL 931
           +   A+G+A+L      + +HRDV + N+LL     A + DFGL+R ++   +  V  + 
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+S+G++L E+ +
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 824
           ++F + + +G G  G+V K     +G   A K +  +     R +   E++ L       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V   G      +  +   +M+ GSLD  L E+      +  ++  K++    RGLAYL 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLR 131
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
           +  +  I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  Q
Sbjct: 132 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMAPERLQ 186
Query: 945 TLTATCRGDVYSFGVVLLELLTGRRPV 971
               + + D++S G+ L+EL  GR P+
Sbjct: 187 GTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 128/304 (42%), Gaps = 58/304 (19%)
Query: 767  NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQME-REFQAEVEALSR 819
             N      +G G FG V KAT          T  AVK L  +    E R+  +E   L +
Sbjct: 23   KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV--------------------- 858
              H +++ L G C      LLI  Y + GSL  +L ES                      
Sbjct: 83   VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 859  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 918
            D+ ++   D+ +  A   ++G+ YL    E  +VHRD+ + NIL+ E  +  ++DFGLSR
Sbjct: 143  DERALTMGDL-ISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 919  LLRPYDTHVTTDLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVE 972
             +   D++V      + G IP ++    +      T + DV+SFGV+L E++T G  P  
Sbjct: 199  DVYEEDSYVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 973  VCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1032
                +   +L+    +M+      E                EM  +  +C  Q+P +RP 
Sbjct: 255  GIPPERLFNLLKTGHRMERPDNCSE----------------EMYRLMLQCWKQEPDKRPV 298
Query: 1033 IEEV 1036
              ++
Sbjct: 299  FADI 302

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 122
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   TDL GTL Y+PPE
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTDLCGTLDYLPPE 176
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 830 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 132
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 944
               +HR++ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
               +   DV+SFGVVL EL T
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 71
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 127
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   TDL GTL Y+PPE
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTDLCGTLDYLPPE 181
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 823
           N+     +G G FG V  A   T G K A+K ++        M+   + E+  L   +H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           +++ L    +  ++ +++  Y  N   DY     V +D + + + R +  Q     + Y 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYI----VQRDKMSEQEAR-RFFQQIISAVEYC 129
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY- 942
           H+     IVHRD+K  N+LLDE     +ADFGLS ++   D +      G+  Y  PE  
Sbjct: 130 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVI 184
Query: 943 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           S  L A    DV+S GV+L  +L  R P +
Sbjct: 185 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 67
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   TDL GTL Y+PPE
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTDLCGTLDYLPPE 177
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 823
           N+     +G G FG V  A   T G K A+K ++        M+   + E+  L   +H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           +++ L    +  ++ +++  Y  N   DY     V +D + + + R +  Q     + Y 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYI----VQRDKMSEQEAR-RFFQQIISAVEYC 128
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY- 942
           H+     IVHRD+K  N+LLDE     +ADFGLS ++   D +      G+  Y  PE  
Sbjct: 129 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVI 183
Query: 943 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           S  L A    DV+S GV+L  +L  R P +
Sbjct: 184 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 823
           N+     +G G FG V  A   T G K A+K ++        M+   + E+  L   +H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           +++ L    +  ++ +++  Y  N   DY     V +D + + + R +  Q     + Y 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYI----VQRDKMSEQEAR-RFFQQIISAVEYC 119
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY- 942
           H+     IVHRD+K  N+LLDE     +ADFGLS ++   D +      G+  Y  PE  
Sbjct: 120 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVI 174
Query: 943 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           S  L A    DV+S GV+L  +L  R P +
Sbjct: 175 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 122
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   TDL GTL Y+PPE
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTDLCGTLDYLPPE 176
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 823
           N+     +G G FG V  A   T G K A+K ++        M+   + E+  L   +H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           +++ L    +  ++ +++  Y  N   DY     V +D + + + R +  Q     + Y 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYI----VQRDKMSEQEAR-RFFQQIISAVEYC 123
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY- 942
           H+     IVHRD+K  N+LLDE     +ADFGLS ++   D +      G+  Y  PE  
Sbjct: 124 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVI 178
Query: 943 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           S  L A    DV+S GV+L  +L  R P +
Sbjct: 179 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 767 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 820 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR-------LK 871
             QH+N+V+L G C HG   L+I  Y   G L  +L    + D + K D R       L 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAD-LDKEDGRPLELRDLLH 164
Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 930
            +   A+G+A+L      + +HRDV + N+LL     A + DFGL+R ++   +  V  +
Sbjct: 165 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
               + ++ PE       T + DV+S+G++L E+ +
Sbjct: 222 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 775 IGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G +G VY     K +LT     AVK L  D  ++E EF  E   +   +H NLV L 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLT----VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 94
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
           G C       ++  YM  G+L  +L E  +++ V    V L +A   +  + YL K    
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAV-VLLYMATQISSAMEYLEK---K 149
Query: 890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLT 947
           + +HRD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE     T
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNT 207
Query: 948 ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMK 990
            + + DV++FGV+L E+ T G  P          DL+   ++M+
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRME 251

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 58/304 (19%)
Query: 767  NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQME-REFQAEVEALSR 819
             N      +G G FG V KAT          T  AVK L  +    E R+  +E   L +
Sbjct: 23   KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV--------------------- 858
              H +++ L G C      LLI  Y + GSL  +L ES                      
Sbjct: 83   VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 859  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 918
            D+ ++   D+ +  A   ++G+ YL    E  +VHRD+ + NIL+ E  +  ++DFGLSR
Sbjct: 143  DERALTMGDL-ISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 919  LLRPYDTHVTTDLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVE 972
             +   D+ V      + G IP ++    +      T + DV+SFGV+L E++T G  P  
Sbjct: 199  DVYEEDSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 973  VCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1032
                +   +L+    +M+      E                EM  +  +C  Q+P +RP 
Sbjct: 255  GIPPERLFNLLKTGHRMERPDNCSE----------------EMYRLMLQCWKQEPDKRPV 298
Query: 1033 IEEV 1036
              ++
Sbjct: 299  FADI 302

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 58/304 (19%)
Query: 767  NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQME-REFQAEVEALSR 819
             N      +G G FG V KAT          T  AVK L  +    E R+  +E   L +
Sbjct: 23   KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV--------------------- 858
              H +++ L G C      LLI  Y + GSL  +L ES                      
Sbjct: 83   VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 859  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 918
            D+ ++   D+ +  A   ++G+ YL    E  +VHRD+ + NIL+ E  +  ++DFGLSR
Sbjct: 143  DERALTMGDL-ISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 919  LLRPYDTHVTTDLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVE 972
             +   D+ V      + G IP ++    +      T + DV+SFGV+L E++T G  P  
Sbjct: 199  DVYEEDSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 973  VCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1032
                +   +L+    +M+      E                EM  +  +C  Q+P +RP 
Sbjct: 255  GIPPERLFNLLKTGHRMERPDNCSE----------------EMYRLMLQCWKQEPDKRPV 298
Query: 1033 IEEV 1036
              ++
Sbjct: 299  FADI 302

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 55/293 (18%)
Query: 768  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
            +F +  +IG GGFG V+KA    +G    +KR+  +  + ERE    V+AL++  H N+V
Sbjct: 12   DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 827  SLQGYCRHGNDR-----------------LLIYSYMENGSLDYWLHESVDK--DSVLKWD 867
               G C  G D                   +   + + G+L+ W+ +   +  D VL   
Sbjct: 68   HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA-- 124
Query: 868  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 927
              L++ +   +G+ Y+H      +++RD+K SNI L +  +  + DFGL   L+      
Sbjct: 125  --LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX 179
Query: 928  TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 987
             +   GTL Y+ PE   +       D+Y+ G++L ELL       VC      D      
Sbjct: 180  RSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELL------HVC------DTAFETS 225
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            +  ++ R+  I D  I+ K +EK LL+      K + + P  RP   E++  L
Sbjct: 226  KFFTDLRDGIISD--IFDK-KEKTLLQ------KLLSKKPEDRPNTSEILRTL 269

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 775 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
           +G G FG V  Y    TN   G   AVK L  DCG   R  ++ E++ L    H++++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 829 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           +G C    ++   L+  Y+  GSL DY    S+    +L +      AQ    G+AYLH 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLH- 134
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 943
               H +HR++ + N+LLD      + DFGL++ +     +  V  D    + +  PE  
Sbjct: 135 --SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 944 QTLTATCRGDVYSFGVVLLELLT 966
           +        DV+SFGV L ELLT
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 69/269 (25%), Positives = 116/269 (43%), Gaps = 25/269 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG V+     N TK AVK L    G M  + F  E   +   QH  LV L     
Sbjct: 20   LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  +I  +M  GSL  +L    D+   +     +  +   A G+AY+ +    + +H
Sbjct: 78   KEEPIYIITEFMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 132
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++N+L+ E     +ADFGL+R++   +          + +  PE       T + +
Sbjct: 133  RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L E++T G+ P     G+   D++S + Q     R     D            
Sbjct: 193  VWSFGILLYEIVTYGKIPY---PGRTNADVMSALSQGYRMPRMENCPD------------ 237
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
             E+ +I   C  +    RP  + + + LD
Sbjct: 238  -ELYDIMKMCWKEKAEERPTFDYLQSVLD 265

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 775 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
           +G G FG V  Y    TN   G   AVK L  DCG   R  ++ E++ L    H++++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 829 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           +G C    ++   L+  Y+  GSL DY    S+    +L +      AQ    G+AYLH 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLHA 135
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 943
               H +HR++ + N+LLD      + DFGL++ +     +  V  D    + +  PE  
Sbjct: 136 ---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 944 QTLTATCRGDVYSFGVVLLELLT 966
           +        DV+SFGV L ELLT
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 95/231 (41%), Gaps = 28/231 (12%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 92
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 879
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 146
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGTL 935
           L+Y H      ++HRD+K  N+LL    E  +ADFG S        H  +    DL GTL
Sbjct: 147 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTL 196
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
            Y+PPE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 767 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 820 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG--- 875
             QH+N+V+L G C HG   L+I  Y   G L  +L     K  VL+ D    IA     
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR---KSRVLETDPAFAIANSTLS 162
Query: 876 ----------AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYD 924
                      A+G+A+L      + +HRDV + N+LL     A + DFGL+R ++   +
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
             V  +    + ++ PE       T + DV+S+G++L E+ +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 122
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   T+L GTL Y+PPE
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTELCGTLDYLPPE 176
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 767 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 820 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA- 877
             QH+N+V+L G C HG   L+I  Y   G L  +L     K  VL+ D    IA   A 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR---KSRVLETDPAFAIANSTAS 162
Query: 878 ------------RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYD 924
                       +G+A+L      + +HRDV + N+LL     A + DFGL+R ++   +
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
             V  +    + ++ PE       T + DV+S+G++L E+ +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 824
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 885 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRPV 971
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 71
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G +    ++ + K S              A  L+
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANALS 127
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPPE 181
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 768 NFNQANI---IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRA 820
           NF+   I   IG G FG V      +  K    +       +ER        E++ +   
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           +H  LV+L    +   D  ++   +  G L Y L ++V      +  V+L I +     L
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICE-LVMAL 128
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            YL       I+HRD+K  NILLDE    H+ DF ++ +L P +T +TT + GT  Y+ P
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT-MAGTKPYMAP 183
Query: 941 EYSQTLTATCRGDVYSF-------GVVLLELLTGRRPVEVCKGKNCRDLV 983
           E    + ++ +G  YSF       GV   ELL GRRP  +    + +++V
Sbjct: 184 E----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 824
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 885 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRPV 971
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 92
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 879
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 146
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+P
Sbjct: 147 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLP 200
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 20/232 (8%)
Query: 756 DLTVSDL-LKSTNNFNQANIIGCGGFG--LVYKATLTNGTKAAVKRL--SGDCGQMEREF 810
           DL   +L  +S   + +   IG G FG  ++ K+T  +G +  +K +  S    +   E 
Sbjct: 12  DLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSSKEREES 70
Query: 811 QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKW 866
           + EV  L+  +H N+V  +          ++  Y E G L   ++        +D +L W
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 926
            V++ +A         L  V +  I+HRD+KS NI L +     L DFG++R+L      
Sbjct: 131 FVQICLA---------LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVE 180
Query: 927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
           +    +GT  Y+ PE  +      + D+++ G VL EL T +   E    KN
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 824
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 885 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 184 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 237
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRPV 971
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 93/229 (40%), Gaps = 24/229 (10%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 69
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 125
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGTLGY 937
           Y H      ++HRD+K  N+LL    E  +ADFG S        H  +    DL GTL Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDY 175
Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           +PPE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 824
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 885 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRPV 971
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 824
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 885 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRPV 971
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 824
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 885 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRPV 971
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 767 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 820 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-----------------ESVDKD 861
             QH+N+V+L G C HG   L+I  Y   G L  +L                  E +DK+
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 862 SVLKWDVR--LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR- 918
                ++R  L  +   A+G+A+L      + +HRDV + N+LL     A + DFGL+R 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           ++   +  V  +    + ++ PE       T + DV+S+G++L E+ +
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 824
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V   G      +  +   +M+ GSLD    + + K   +   +  K++    +GL YL 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 885 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              E H I+HRDVK SNIL++ + E  L DFG+S  L      +  + VGT  Y+ PE  
Sbjct: 125 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DEMANEFVGTRSYMSPERL 178
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           Q    + + D++S G+ L+E+  GR P
Sbjct: 179 QGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 27/254 (10%)
Query: 721 GCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGF 780
           G  +++L+ D  + +RL   L   + V     + KD          ++F + + +G G  
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKV----GELKD----------DDFEKISELGAGNG 46
Query: 781 GLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCRHGNDR 838
           G+V+K +   +G   A K +  +     R +   E++ L       +V   G      + 
Sbjct: 47  GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106
Query: 839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-IVHRDVK 897
            +   +M+ GSLD  L     K   +   +  K++    +GL YL    E H I+HRDVK
Sbjct: 107 SICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVK 159
Query: 898 SSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSF 957
            SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  Q    + + D++S 
Sbjct: 160 PSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 958 GVVLLELLTGRRPV 971
           G+ L+E+  GR P+
Sbjct: 217 GLSLVEMAVGRYPI 230

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 36/269 (13%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            +G G FG V+ AT    TK AVK +      +E  F AE   +   QH  LV L      
Sbjct: 190  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 835  GNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  GSL D+   +   K  + K    +  +   A G+A++    + + +H
Sbjct: 249  -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIE---QRNYIH 301
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD++++NIL+       +ADFGL+R+   +           + +  PE     + T + D
Sbjct: 302  RDLRAANILVSASLVCKIADFGLARVGAKF----------PIKWTAPEAINFGSFTIKSD 351
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            V+SFG++L+E++T GR P            +   ++M   +   E               
Sbjct: 352  VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE--------------- 396
Query: 1013 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
             E+  I  +C    P  RP  E + + LD
Sbjct: 397  -ELYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 25  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 83
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 879
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 84  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 137
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+P
Sbjct: 138 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLP 191
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 238

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 768 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 72
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 880
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 126
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PP
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPP 180
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           E  +      + D++S GV+  E L G+ P E
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 768 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 8   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 66
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 880
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 120
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PP
Sbjct: 121 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPP 174
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           E  +      + D++S GV+  E L G+ P E
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 768 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 70
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 880
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 124
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PP
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPP 178
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           E  +      + D++S GV+  E L G+ P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 147
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 205
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 206 SDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 138
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 196
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 197 SDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 136
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 194
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 136
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 194
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 122
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPPE 176
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 13/208 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 824
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           +V   G      +  +   +M+ GSLD    + + K   +   +  K++    +GL YL 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 885 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 141 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 194
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRPV 971
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 69
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 879
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 123
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+P
Sbjct: 124 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLP 177
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 22/233 (9%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDCG-QMEREFQAEVE 815
           +LK T    +  ++G G FG VYK        T     A+K L+   G +   EF  E  
Sbjct: 34  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 92
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   H +LV L G C     +L +   M +G L  ++HE  D      +L W V++  
Sbjct: 93  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI-- 149
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
               A+G+ YL    E  +VHRD+ + N+L+       + DFGL+RLL   +     D  
Sbjct: 150 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 202
Query: 933 GT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 983
              + ++  E       T + DV+S+GV + EL+T G +P +    +   DL+
Sbjct: 203 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 22/233 (9%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDCG-QMEREFQAEVE 815
           +LK T    +  ++G G FG VYK        T     A+K L+   G +   EF  E  
Sbjct: 11  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   H +LV L G C     +L +   M +G L  ++HE  D      +L W V++  
Sbjct: 70  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI-- 126
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
               A+G+ YL    E  +VHRD+ + N+L+       + DFGL+RLL   +     D  
Sbjct: 127 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179
Query: 933 GT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 983
              + ++  E       T + DV+S+GV + EL+T G +P +    +   DL+
Sbjct: 180 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 71
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 879
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 125
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+P
Sbjct: 126 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLP 179
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A   N       K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 122
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P        L GTL Y+PPE
Sbjct: 123 YCHS---KKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA--LCGTLDYLPPE 176
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    ++    +S V
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV 221

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 768 NFNQANIIGCGGFGLVYKA-----TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           +F     +G G FG VY A           K   K      G +E + + EVE  S  +H
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 64
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 880
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 118
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PP
Sbjct: 119 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPP 172
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           E  +      + D++S GV+  E L G+ P E
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 768 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 67
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 880
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 121
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   T L GTL Y+PP
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTXLCGTLDYLPP 175
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           E  +      + D++S GV+  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 12  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 70
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 126
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPPE 180
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 225

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 80/306 (26%), Positives = 133/306 (43%), Gaps = 68/306 (22%)
Query: 768  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
            +F +  +IG GGFG V+KA    +G    ++R+  +  + ERE    V+AL++  H N+V
Sbjct: 13   DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 827  SLQGYCRHGNDR------------------------------LLIYSYMENGSLDYWLHE 856
               G C  G D                                +   + + G+L+ W+ +
Sbjct: 69   HYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 857  SVDK--DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 914
               +  D VL     L++ +   +G+ Y+H      ++HRD+K SNI L +  +  + DF
Sbjct: 128  RRGEKLDKVLA----LELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 915  GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC 974
            GL   L+  +    T   GTL Y+ PE   +       D+Y+ G++L ELL       VC
Sbjct: 181  GLVTSLK--NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL------HVC 232
Query: 975  KGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIE 1034
                  D      +  ++ R+  I D  I+ K +EK LL+      K + + P  RP   
Sbjct: 233  ------DTAFETSKFFTDLRDGIISD--IFDK-KEKTLLQ------KLLSKKPEDRPNTS 277
Query: 1035 EVVTWL 1040
            E++  L
Sbjct: 278  EILRTL 283

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 132
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 954 VYSFGVVLLELLT 966
           V++FGV+L E+ T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSGDCGQMEREFQAEVE--ALSRA 820
           + F    ++G G FG V+     +G+ A    A+K L     ++    + ++E   L   
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H  +V L    +      LI  ++  G L   L + V      + DV+  +A+  A  L
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALAL 140
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            +LH +    I++RD+K  NILLDE+    L DFGLS+    ++    +   GT+ Y+ P
Sbjct: 141 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 196
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           E       T   D +SFGV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAK 243

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSGDCGQMEREFQAEVE--ALSRA 820
           + F    ++G G FG V+     +G+ A    A+K L     ++    + ++E   L   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H  +V L    +      LI  ++  G L   L + V      + DV+  +A+  A  L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALAL 139
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            +LH +    I++RD+K  NILLDE+    L DFGLS+    ++    +   GT+ Y+ P
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 195
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           E       T   D +SFGV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAK 242

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSGDCGQMEREFQAEVE--ALSRA 820
           + F    ++G G FG V+     +G+ A    A+K L     ++    + ++E   L   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H  +V L    +      LI  ++  G L   L + V      + DV+  +A+  A  L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALAL 139
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            +LH +    I++RD+K  NILLDE+    L DFGLS+    ++    +   GT+ Y+ P
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 195
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           E       T   D +SFGV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAK 242

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 767 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 820 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKW 866
             QH+N+V+L G C HG   L+I  Y   G L            +Y  + S + +  L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDT 925
              L  +   A+G+A+L      + +HRDV + N+LL     A + DFGL+R ++   + 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
            V  +    + ++ PE       T + DV+S+G++L E+ +
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 92/229 (40%), Gaps = 24/229 (10%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 71
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G +    ++ + K S              A  L+
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANALS 127
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTLGY 937
           Y H      ++HRD+K  N+LL    E  +ADFG S        H  +     L GTL Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDY 177
Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           +PPE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 22/227 (9%)
Query: 755 KDLTVSDLLKSTNN---FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREF 810
           KD  V++L    +    F+    IG G FG VY A  + N    A+K++S    Q   ++
Sbjct: 39  KDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 98
Query: 811 Q---AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD 867
           Q    EV  L + +H N +  +G     +   L+  Y    + D      V K  + + +
Sbjct: 99  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVE 155
Query: 868 VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 927
           +   +  GA +GLAYLH     +++HRDVK+ NILL E     L DFG + ++ P     
Sbjct: 156 I-AAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206
Query: 928 TTDLVGTLGYIPPEYSQTLTA---TCRGDVYSFGVVLLELLTGRRPV 971
               VGT  ++ PE    +       + DV+S G+  +EL   + P+
Sbjct: 207 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 819
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 23   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 820  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 870
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 83   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 871  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 143  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 925  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 982
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 200  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 249
Query: 983  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 250  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 132
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           RD+ + N L+ E     +ADFGLSRL+    +  H        + +  PE       + +
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPESLAYNKFSIK 190
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 67
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDT--LCGTLDYLPPE 177
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 775 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSL 828
           +G G FG V  Y    TN   G   AVK L   CG Q+   +Q E+E L    H+++V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 829 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           +G C    ++   L+  Y+  GSL DY     V    +L +      AQ    G+AYLH 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLF------AQQICEGMAYLHA 129
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 943
               H +HR + + N+LLD      + DFGL++ +     +  V  D    + +  PE  
Sbjct: 130 ---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 944 QTLTATCRGDVYSFGVVLLELLT 966
           +        DV+SFGV L ELLT
Sbjct: 187 KECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 775 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSL 828
           +G G FG V  Y    TN   G   AVK L   CG Q+   +Q E+E L    H+++V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 829 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           +G C    ++   L+  Y+  GSL DY     V    +L +      AQ    G+AYLH 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLF------AQQICEGMAYLHA 130
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 943
               H +HR + + N+LLD      + DFGL++ +     +  V  D    + +  PE  
Sbjct: 131 ---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 944 QTLTATCRGDVYSFGVVLLELLT 966
           +        DV+SFGV L ELLT
Sbjct: 188 KECKFYYASDVWSFGVTLYELLT 210

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 94/227 (41%), Gaps = 20/227 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 67
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 879
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 121
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L+Y H      ++HRD+K  N+LL    E  +ADFG S    P     T  L GTL Y+P
Sbjct: 122 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTT--LSGTLDYLP 175
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F+    +G G FG VY     ++      K   K      G +E + + EVE  S  +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG-VEHQLRREVEIQSHLR 70
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALS 126
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPPE 180
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G  P E    +     +S V
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV 225

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 135
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 954 VYSFGVVLLELLT 966
           V++FGV+L E+ T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 132
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 954 VYSFGVVLLELLT 966
           V++FGV+L E+ T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 819
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 46   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 820  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 870
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 106  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 871  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 166  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 925  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 982
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 223  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 272
Query: 983  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 273  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 954 VYSFGVVLLELLT 966
           V++FGV+L E+ T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 768 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 67
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 880
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 121
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P        L GTL Y+PP
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA--LCGTLDYLPP 175
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           E  +      + D++S GV+  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 769 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHKN 824
           F+    IG G FG VY A  + N    A+K++S    Q   ++Q    EV  L + +H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
            +  +G     +   L+  Y    + D      V K  + + ++   +  GA +GLAYLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEI-AAVTHGALQGLAYLH 132
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
                +++HRDVK+ NILL E     L DFG + ++ P         VGT  ++ PE   
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVIL 184
Query: 945 TLTA---TCRGDVYSFGVVLLELLTGRRPV 971
            +       + DV+S G+  +EL   + P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 94/227 (41%), Gaps = 20/227 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 69
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 879
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 123
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P        L GTL Y+P
Sbjct: 124 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA--LCGTLDYLP 177
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 819
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 39   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 820  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 870
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 99   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 871  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 159  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 925  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 982
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 216  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 265
Query: 983  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 266  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 135
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 954 VYSFGVVLLELLT 966
           V++FGV+L E+ T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 136
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 954 VYSFGVVLLELLT 966
           V++FGV+L E+ T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 768 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 67
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 880
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 121
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTLG 936
           +Y H      ++HRD+K  N+LL    E  +ADFG S        H  +     L GTL 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLD 171
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           Y+PPE  +      + D++S GV+  E L G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 768 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 70
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 880
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 124
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTLG 936
           +Y H      ++HRD+K  N+LL    E  +ADFG S        H  +     L GTL 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLD 174
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           Y+PPE  +      + D++S GV+  E L G+ P E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 93/225 (41%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 69
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 125
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +A+FG S +  P     T  L GTL Y+PPE
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTT--LCGTLDYLPPE 179
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 68
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 879
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 122
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L+Y H      ++HRD+K  N+LL    E  +A+FG S +  P     T  L GTL Y+P
Sbjct: 123 LSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTT--LCGTLDYLP 176
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 29/236 (12%)
Query: 767 NNFNQANIIGCGGFG---LVYKATLTNG---------TKAAVKRLSGDCGQMEREFQAEV 814
           ++F    ++G G FG   LV K T  +           KA +K       +MER+  A+V
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
                  H  +V L    +      LI  ++  G L   L + V      + DV+  +A+
Sbjct: 88  ------NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE 138
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
             A GL +LH +    I++RD+K  NILLDE+    L DFGLS+    ++    +   GT
Sbjct: 139 -LALGLDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGT 193
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           + Y+ PE       +   D +S+GV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQ---GKDRKETMTLILKAK 246

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 94/231 (40%), Gaps = 28/231 (12%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 68
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 879
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 122
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTL 935
           L+Y H      ++HRD+K  N+LL    E  +ADFG S        H  +     L GTL
Sbjct: 123 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTL 172
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
            Y+PPE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 223

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTNGT-KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+      +   AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 341
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           R++ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 399
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 400 SDVWAFGVLLWEIAT 414

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 819
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 46   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 820  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 870
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 106  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 871  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 166  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 925  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 982
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 223  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 272
Query: 983  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 273  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 819
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 41   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 820  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 870
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 101  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 871  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 161  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 925  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 982
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 218  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 267
Query: 983  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 268  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 765 STNNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 823
           + N+F+   IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIML 243
Query: 824 NLVSL--------QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
           +LVS           Y  H  D+L  I   M  G L Y L +        + D+R   A+
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAE 300
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               GL ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT
Sbjct: 301 -IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGT 353
Query: 935 LGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 992
            GY+ PE  Q   A     D +S G +L +LL G  P    K K+  ++      M  E
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 765 STNNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 823
           + N+F+   IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIML 243
Query: 824 NLVSL--------QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
           +LVS           Y  H  D+L  I   M  G L Y L +        + D+R   A+
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAE 300
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               GL ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT
Sbjct: 301 -IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGT 353
Query: 935 LGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 992
            GY+ PE  Q   A     D +S G +L +LL G  P    K K+  ++      M  E
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 775 IGCGGFGLVYKATLTNGT-KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G +G VY+      +   AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 380
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
           R++ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 438
Query: 952 GDVYSFGVVLLELLT 966
            DV++FGV+L E+ T
Sbjct: 439 SDVWAFGVLLWEIAT 453

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 765 STNNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 823
           + N+F+   IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIML 242
Query: 824 NLVSL--------QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
           +LVS           Y  H  D+L  I   M  G L Y L +        + D+R   A+
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAE 299
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               GL ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT
Sbjct: 300 -IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGT 352
Query: 935 LGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 992
            GY+ PE  Q   A     D +S G +L +LL G  P    K K+  ++      M  E
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 411

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 765 STNNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 823
           + N+F+   IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIML 243
Query: 824 NLVSL--------QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
           +LVS           Y  H  D+L  I   M  G L Y L +        + D+R   A+
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAE 300
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               GL ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT
Sbjct: 301 -IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGT 353
Query: 935 LGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 992
            GY+ PE  Q   A     D +S G +L +LL G  P    K K+  ++      M  E
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 769 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 827
           F+    +G G +G VYKA     G   A+K++  +     +E   E+  + +    ++V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVK 88
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
             G      D  ++  Y   GS+   +     ++  L  D    I Q   +GL YLH + 
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTL 946
           +   +HRD+K+ NILL+ +  A LADFG++  L   D     + ++GT  ++ PE  Q +
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 947 TATCRGDVYSFGVVLLELLTGRRP 970
              C  D++S G+  +E+  G+ P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 775 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
           +G G FG V  Y    TN   G   AVK L  D G   R  ++ E++ L    H++++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 829 QGYCRH-GNDRL-LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           +G C   G   L L+  Y+  GSL DY    S+    +L +      AQ    G+AYLH 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLHA 152
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTH-VTTDLVGTLGYIPPEYS 943
               H +HRD+ + N+LLD      + DFGL++ +   ++ + V  D    + +  PE  
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 944 QTLTATCRGDVYSFGVVLLELLT 966
           +        DV+SFGV L ELLT
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 16/225 (7%)
Query: 767 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            +F+    +G G FG VY     ++      K   K      G +E + + EVE  S  +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG-VEHQLRREVEIQSHLR 70
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALS 126
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDT--LCGTLDYLPPE 180
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
             +      + D++S GV+  E L G  P E    +     +S V
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV 225

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKN 824
             + +   +G G +G+VYKA  + G   A+KR+  D     +      E+  L    H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA-QGAARGLAYL 883
           +VSL           L++ +ME       L + +D++     D ++KI      RG+A+ 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKD-----LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 939
           H   +  I+HRD+K  N+L++      LADFGL+R     +R Y     T  V TL Y  
Sbjct: 136 H---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-----THEVVTLWYRA 187
Query: 940 PEY---SQTLTATCRGDVYSFGVVLLELLTGR 968
           P+    S+  + +   D++S G +  E++TG+
Sbjct: 188 PDVLMGSKKYSTSV--DIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKN 824
             + +   +G G +G+VYKA  + G   A+KR+  D     +      E+  L    H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA-QGAARGLAYL 883
           +VSL           L++ +ME       L + +D++     D ++KI      RG+A+ 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKD-----LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 939
           H   +  I+HRD+K  N+L++      LADFGL+R     +R Y     T  V TL Y  
Sbjct: 136 H---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-----THEVVTLWYRA 187
Query: 940 PEY---SQTLTATCRGDVYSFGVVLLELLTGR 968
           P+    S+  + +   D++S G +  E++TG+
Sbjct: 188 PDVLMGSKKYSTSV--DIWSIGCIFAEMITGK 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 766 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 820
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 938
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 174
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSL 828
           +G G FG V    Y     N G + AVK L  + G     + + E+E L    H+N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 829 QGYCRH--GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           +G C    GN   LI  ++ +GSL  +L ++ +K ++ +   +LK A    +G+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGMDYLGSR 145
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT--DLVGTLGYIPPEYSQ 944
                VHRD+ + N+L++ + +  + DFGL++ +       T   D    + +  PE   
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
                   DV+SFGV L ELLT
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSL 828
           +G G FG V    Y     N G + AVK L  + G     + + E+E L    H+N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 829 QGYCRH--GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           +G C    GN   LI  ++ +GSL  +L ++ +K ++ +   +LK A    +G+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGMDYLGSR 133
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT--DLVGTLGYIPPEYSQ 944
                VHRD+ + N+L++ + +  + DFGL++ +       T   D    + +  PE   
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 945 TLTATCRGDVYSFGVVLLELLT 966
                   DV+SFGV L ELLT
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 127/269 (47%), Gaps = 27/269 (10%)
Query: 775  IGCGGFGLVY-KATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 832
            +G G FG V+     ++G +  +K ++ D  Q+  E  +AE+E L    H N++ +    
Sbjct: 30   LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 833  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
               ++  ++    E G L   +  +  +   L      ++ +     LAY H     H+V
Sbjct: 90   EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVV 146
Query: 893  HRDVKSSNILLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQTLTA 948
            H+D+K  NIL  +        + DFGL+ L +  D H +T+  GT  Y+ PE + + +T 
Sbjct: 147  HKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEH-STNAAGTALYMAPEVFKRDVTF 204
Query: 949  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008
             C  D++S GVV+  LLTG  P     G +  ++     Q K+  +E    + ++  +  
Sbjct: 205  KC--DIWSAGVVMYFLLTGCLPF---TGTSLEEV-----QQKATYKEP---NYAVECRPL 251
Query: 1009 EKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
              Q +++L+   + + +DP RRP   +V+
Sbjct: 252  TPQAVDLLK---QMLTKDPERRPSAAQVL 277

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 23   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 835  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 82   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 135
Query: 895  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATCR 951
            D+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + +
Sbjct: 136  DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSSK 192
Query: 952  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWH 1005
             D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH
Sbjct: 193  SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWH 250
Query: 1006 KDREKQ 1011
            +  +++
Sbjct: 251  EKADER 256

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 16   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 835  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 75   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 128
Query: 895  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATCR 951
            D+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + +
Sbjct: 129  DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSSK 185
Query: 952  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWH 1005
             D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH
Sbjct: 186  SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWH 243
Query: 1006 KDREKQ 1011
            +  +++
Sbjct: 244  EKADER 249

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 17   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 835  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 76   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 895  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATCR 951
            D+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + +
Sbjct: 130  DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSSK 186
Query: 952  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWH 1005
             D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH
Sbjct: 187  SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWH 244
Query: 1006 KDREKQ 1011
            +  +++
Sbjct: 245  EKADER 250

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 835  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 71   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 895  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATCR 951
            D+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + +
Sbjct: 125  DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSSK 181
Query: 952  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWH 1005
             D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH
Sbjct: 182  SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWH 239
Query: 1006 KDREKQ 1011
            +  +++
Sbjct: 240  EKADER 245

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 144 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 196
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 197 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 140 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 192
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 175 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 227
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 198
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 198
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 205
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 199
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 763 LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRA 820
           + S++ F Q   +G G +  VYK    T G   A+K +  D  +        E+  +   
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV-DKDSVLKWDVRLKIAQGAARG 879
           +H+N+V L       N   L++ +M+N    Y    +V +    L+ ++         +G
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDLVGTLGYI 938
           LA+ H   E  I+HRD+K  N+L++++ +  L DFGL+R    P +T  +   V TL Y 
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VVTLWYR 175
Query: 939 PPEY---SQTLTATCRGDVYSFGVVLLELLTGR 968
            P+    S+T + +   D++S G +L E++TG+
Sbjct: 176 APDVLMGSRTYSTSI--DIWSCGCILAEMITGK 206

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 42/283 (14%)
Query: 775  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 18   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
            L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 78   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 882  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
            YL+       VHRD+ + N ++ E F   + DFG++R +   D        G  G +P  
Sbjct: 138  YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 190
Query: 940  ---PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
               PE  +    T   DV+SFGVVL E+ T   +P +   G +   ++ +V        E
Sbjct: 191  WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GLSNEQVLRFVM-------E 240
Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038
              ++D      +    LLE++ +   C   +P+ RP   E+++
Sbjct: 241  GGLLDKP---DNCPDMLLELMRM---CWQYNPKMRPSFLEIIS 277

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 766 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 820
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 938
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 173
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 825
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 826 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
               G    G+   +I  Y+  GS LD       D+  +        + +   +GL YLH
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLH 137
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 943
              +   +HRD+K++N+LL E+ +  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 138 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 192
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           Q      + D++S G+  +EL  G  P
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 23/247 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG+V           A+K +    G M E EF  E + +    H+ LV L G C 
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  +I  YM NG L  +L E   +    +    L++ +     + YL        +H
Sbjct: 90   KQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 950
            RD+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + 
Sbjct: 144  RDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSS 200
Query: 951  RGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIW 1004
            + D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S W
Sbjct: 201  KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCW 258
Query: 1005 HKDREKQ 1011
            H+  +++
Sbjct: 259  HEKADER 265

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 756 DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           ++ +S L      F    ++G G +G VYK       + A  ++    G  E E + E+ 
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN 72
Query: 816 ALSR-AQHKNLVSLQGYCRHGN-----DRL-LIYSYMENGSLDYWLHESVDKDSVLKWDV 868
            L + + H+N+ +  G     N     D+L L+  +   GS+   +  +  K + LK + 
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEW 130
Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 928
              I +   RGL++LH   +  ++HRD+K  N+LL E  E  L DFG+S  L        
Sbjct: 131 IAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 929 TDLVGTLGYIPPEY-----SQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           T  +GT  ++ PE      +   T   + D++S G+  +E+  G  P+
Sbjct: 188 T-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 108/244 (44%), Gaps = 17/244 (6%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG+V           A+K +    G M E EF  E + +    H+ LV L G C 
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
                  +I  YM NG L  +L E   +    +    L++ +     + YL        +H
Sbjct: 90   KQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD+ + N L++++    ++DFGLSR +   +   +      + + PPE       + + D
Sbjct: 144  RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 954  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWHKD 1007
            +++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH+ 
Sbjct: 204  IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWHEK 261
Query: 1008 REKQ 1011
             +++
Sbjct: 262  ADER 265

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 825
           ++++    +G G FG+V++ T    G   A K +       +   + E++ +S  +H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           V+L       N+ ++IY +M  G L     +  D+ + +  D  ++  +   +GL ++H 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 272
Query: 886 VCEPHIVHRDVKSSNILLDEKF--EAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEY 942
             E + VH D+K  NI+   K   E  L DFGL+  L P  +  VTT   GT  +  PE 
Sbjct: 273 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 327
Query: 943 SQTLTATCRGDVYSFGVVLLELLTGRRP 970
           ++        D++S GV+   LL+G  P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D        G  G +P  
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 199
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQ--- 829
           +G GGFG V +    + G + A+K+   +     RE +  E++ + +  H N+VS +   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 830 -GYCRHG-ND-RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            G  +   ND  LL   Y E G L  +L++  +   + +  +R  ++  ++  L YLH  
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-ALRYLH-- 138
Query: 887 CEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
            E  I+HRD+K  NI+L    ++    + D G ++ L      + T+ VGTL Y+ PE  
Sbjct: 139 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLAPELL 195
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           +    T   D +SFG +  E +TG RP
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 766 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 820
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 938
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 174
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 766 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 820
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 938
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 174
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 766 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 820
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 938
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 174
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQ--- 829
           +G GGFG V +    + G + A+K+   +     RE +  E++ + +  H N+VS +   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 830 -GYCRHG-ND-RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            G  +   ND  LL   Y E G L  +L++  +   + +  +R  ++  ++  L YLH  
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-ALRYLH-- 139
Query: 887 CEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
            E  I+HRD+K  NI+L    ++    + D G ++ L      + T+ VGTL Y+ PE  
Sbjct: 140 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLAPELL 196
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           +    T   D +SFG +  E +TG RP
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 15/187 (8%)
Query: 802 DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD 861
           DC +     + E+       H+N+V   G+ R GN + L   Y   G L     + ++ D
Sbjct: 46  DCPE---NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPD 98
Query: 862 SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 921
             +      +       G+ YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R
Sbjct: 99  IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 922 PYDT--HVTTDLVGTLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 978
            Y+    +   + GTL Y+ PE  +         DV+S G+VL  +L G  P +     +
Sbjct: 156 -YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDS 213
Query: 979 CRDLVSW 985
           C++   W
Sbjct: 214 CQEYSDW 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 15/187 (8%)
Query: 802 DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD 861
           DC +     + E+       H+N+V   G+ R GN + L   Y   G L     + ++ D
Sbjct: 46  DCPE---NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPD 98
Query: 862 SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 921
             +      +       G+ YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R
Sbjct: 99  IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 922 PYDT--HVTTDLVGTLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 978
            Y+    +   + GTL Y+ PE  +         DV+S G+VL  +L G  P +     +
Sbjct: 156 -YNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDS 213
Query: 979 CRDLVSW 985
           C++   W
Sbjct: 214 CQEYSDW 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 15/187 (8%)
Query: 802 DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD 861
           DC +     + E+       H+N+V   G+ R GN + L   Y   G L     + ++ D
Sbjct: 47  DCPE---NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPD 99
Query: 862 SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 921
             +      +       G+ YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 922 PYDT--HVTTDLVGTLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 978
            Y+    +   + GTL Y+ PE  +         DV+S G+VL  +L G  P +     +
Sbjct: 157 -YNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDS 214
Query: 979 CRDLVSW 985
           C++   W
Sbjct: 215 CQEYSDW 221

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G    
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 835 GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
               L I + YM  GSL  +L       SVL  D  LK +      + YL      + VH
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 131
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + D
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREAAFSTKSD 187
Query: 954 VYSFGVVLLELLT-GRRP 970
           V+SFG++L E+ + GR P
Sbjct: 188 VWSFGILLWEIYSFGRVP 205

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 825
           ++++    +G G FG+V++ T    G   A K +       +   + E++ +S  +H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           V+L       N+ ++IY +M  G L     +  D+ + +  D  ++  +   +GL ++H 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 166
Query: 886 VCEPHIVHRDVKSSNILLDEKF--EAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEY 942
             E + VH D+K  NI+   K   E  L DFGL+  L P  +  VTT   GT  +  PE 
Sbjct: 167 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 221
Query: 943 SQTLTATCRGDVYSFGVVLLELLTGRRP 970
           ++        D++S GV+   LL+G  P
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 117
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 118 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 173
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 219

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 175
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 175
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 175
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L     ++  + VL      K+ Q A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 205
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
           L G    G   L+I   M  G L  +L     ++  + VL      K+ Q A   A G+A
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 143 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 195
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLELLT 966
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 42/283 (14%)
Query: 775  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 20   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 881
            L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 80   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 882  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
            YL+       VHRD+ + N  + E F   + DFG++R +   D +      G  G +P  
Sbjct: 140  YLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 192
Query: 940  ---PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
               PE  +    T   DV+SFGVVL E+ T   +P +   G +   ++ +V        E
Sbjct: 193  WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GLSNEQVLRFVM-------E 242
Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038
              ++D      +    LLE++ +   C   +P+ RP   E+++
Sbjct: 243  GGLLDKP---DNCPDMLLELMRM---CWQYNPKMRPSFLEIIS 279

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMXGTLPYVA 174
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMXGTLPYVA 174
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 775 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 872
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 873 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 930
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 197 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 23/250 (9%)
Query: 736 RLSEALASSKLVLFQNSDC---KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT-- 789
           +LS+   S+ +  +  + C   K  ++SDL +    N      +G G FG VY+  ++  
Sbjct: 12  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 71
Query: 790 ----NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 844
               +  + AVK L   C  Q E +F  E   +S+  H+N+V   G       R ++   
Sbjct: 72  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 131
Query: 845 MENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
           M  G L  +L E+  +     S+   D+ L +A+  A G  YL    E H +HRD+ + N
Sbjct: 132 MAGGDLKSFLRETRPRPSQPSSLAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARN 187
Query: 901 ILLD---EKFEAHLADFGLSR-LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
            LL        A + DFG++R + R          +  + ++PPE       T + D +S
Sbjct: 188 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 247
Query: 957 FGVVLLELLT 966
           FGV+L E+ +
Sbjct: 248 FGVLLWEIFS 257

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 20/191 (10%)
Query: 792 TKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGS 849
           TK AVK L  D  + +  +  +E+E +    +HKN+++L G C       +I  Y   G+
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 850 L------------DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDV 896
           L            +Y  + S + +  L     +  A   ARG+ YL  K C    +HRD+
Sbjct: 121 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDL 176
Query: 897 KSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVY 955
            + N+L+ E     +ADFGL+R +   D +  TT+    + ++ PE       T + DV+
Sbjct: 177 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 236
Query: 956 SFGVVLLELLT 966
           SFGV+L E+ T
Sbjct: 237 SFGVLLWEIFT 247

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKN 824
            + Q   IG G +G+V  A      T+ A+K++S    Q   +R  + E++ L R +H+N
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHEN 102
Query: 825 LVSLQGYCRHG-----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
           ++ ++   R        D  ++   ME         + +  D +  +  ++       RG
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQI------LRG 156
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGY 937
           L Y+H     +++HRD+K SN+L++   +  + DFGL+R+  P   H    T+ V T  Y
Sbjct: 157 LKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 938 IPPEY---SQTLTATCRGDVYSFGVVLLELLTGR 968
             PE    S+  T +   D++S G +L E+L+ R
Sbjct: 214 RAPEIMLNSKGYTKSI--DIWSVGCILAEMLSNR 245

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 15/243 (6%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 17   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 835  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 76   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 895  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 954
            D+ + N L++++    ++DFGLSR +   +   +      + + PPE       + + D+
Sbjct: 130  DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 955  YSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWHKDR 1008
            ++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH+  
Sbjct: 190  WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWHEKA 247
Query: 1009 EKQ 1011
            +++
Sbjct: 248  DER 250

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 113/272 (41%), Gaps = 28/272 (10%)
Query: 775  IGCGGFGLVYKATLTNGTKAAV-KRLSGDCGQM-EREFQ---AEVEALSRAQHKNLVSLQ 829
            IG G +G   K    +  K  V K L  D G M E E Q   +EV  L   +H N+V   
Sbjct: 14   IGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 830  GYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
                 R      ++  Y E G L   + +   +   L  +  L++       L   H+  
Sbjct: 72   DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 888  EP--HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
            +    ++HRD+K +N+ LD K    L DFGL+R+L  +DT      VGT  Y+ PE    
Sbjct: 132  DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTFVGTPYYMSPEQMNR 190
Query: 946  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005
            ++   + D++S G +L EL     P      K          ++  + RE +       +
Sbjct: 191  MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----------ELAGKIREGKFRRIPYRY 240
Query: 1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             D      E+ EI  + ++     RP +EE++
Sbjct: 241  SD------ELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 775 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 872
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 873 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 930
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 141 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 775 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 872
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 873 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 930
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 156 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 113/272 (41%), Gaps = 28/272 (10%)
Query: 775  IGCGGFGLVYKATLTNGTKAAV-KRLSGDCGQM-EREFQ---AEVEALSRAQHKNLVSLQ 829
            IG G +G   K    +  K  V K L  D G M E E Q   +EV  L   +H N+V   
Sbjct: 14   IGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 830  GYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
                 R      ++  Y E G L   + +   +   L  +  L++       L   H+  
Sbjct: 72   DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 888  EP--HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
            +    ++HRD+K +N+ LD K    L DFGL+R+L  +DT      VGT  Y+ PE    
Sbjct: 132  DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMSPEQMNR 190
Query: 946  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005
            ++   + D++S G +L EL     P      K          ++  + RE +       +
Sbjct: 191  MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----------ELAGKIREGKFRRIPYRY 240
Query: 1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             D      E+ EI  + ++     RP +EE++
Sbjct: 241  SD------ELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 9   KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 68
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 129 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 184
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 185 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 775 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 872
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 873 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 930
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 149 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 23/250 (9%)
Query: 736 RLSEALASSKLVLFQNSDC---KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT-- 789
           +LS+   S+ +  +  + C   K  ++SDL +    N      +G G FG VY+  ++  
Sbjct: 36  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 95
Query: 790 ----NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 844
               +  + AVK L   C  Q E +F  E   +S+  H+N+V   G       R ++   
Sbjct: 96  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155
Query: 845 MENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
           M  G L  +L E+  +     S+   D+ L +A+  A G  YL    E H +HRD+ + N
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARN 211
Query: 901 ILLD---EKFEAHLADFGLSR-LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
            LL        A + DFG++R + R          +  + ++PPE       T + D +S
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271
Query: 957 FGVVLLELLT 966
           FGV+L E+ +
Sbjct: 272 FGVLLWEIFS 281

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 775 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 872
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 873 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 930
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 156 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 775 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE------------SVDKDSVLKWDVRLKI 872
           +++L G C       +I  Y   G+L  +L              S + +  L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 873 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTD 930
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D    TT+
Sbjct: 156 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 137 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 152 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 775 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 872
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 873 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 930
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 148 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 775 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 872
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 873 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 930
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 145 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 23/250 (9%)
Query: 736 RLSEALASSKLVLFQNSDC---KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT-- 789
           +LS+   S+ +  +  + C   K  ++SDL +    N      +G G FG VY+  ++  
Sbjct: 13  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 72
Query: 790 ----NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 844
               +  + AVK L   C  Q E +F  E   +S+  H+N+V   G       R ++   
Sbjct: 73  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 132
Query: 845 MENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
           M  G L  +L E+  +     S+   D+ L +A+  A G  YL    E H +HRD+ + N
Sbjct: 133 MAGGDLKSFLRETRPRPSQPSSLAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARN 188
Query: 901 ILLD---EKFEAHLADFGLSR-LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
            LL        A + DFG++R + R          +  + ++PPE       T + D +S
Sbjct: 189 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 248
Query: 957 FGVVLLELLT 966
           FGV+L E+ +
Sbjct: 249 FGVLLWEIFS 258

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 137 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 76/274 (27%), Positives = 117/274 (42%), Gaps = 33/274 (12%)
Query: 769  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 825
            F + + IG G FG VYK  + N TK  V     D  + E E    Q E+  LS+     +
Sbjct: 21   FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 826  VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                G         +I  Y+  GS LD        K   L+      I +   +GL YLH
Sbjct: 80   TRYFGSYLKSTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLH 133
Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 943
                   +HRD+K++N+LL E+ +  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 134  ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 188
Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
            +      + D++S G+  +EL  G  P          DL          K     ++   
Sbjct: 189  KQSAYDFKADIWSLGITAIELAKGEPPNS--------DLHPMRVLFLIPKNSPPTLEGQ- 239
Query: 1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             H    K+ +E       C+++DPR RP  +E++
Sbjct: 240  -HSKPFKEFVE------ACLNKDPRFRPTAKELL 266

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G    
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 835 GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
               L I + YM  GSL  +L       SVL  D  LK +      + YL      + VH
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 125
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 954 VYSFGVVLLELLT-GRRP 970
           V+SFG++L E+ + GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 152 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G    
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 835 GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
               L I + YM  GSL  +L       SVL  D  LK +      + YL      + VH
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 196
Query: 954 VYSFGVVLLELLT-GRRP 970
           V+SFG++L E+ + GR P
Sbjct: 197 VWSFGILLWEIYSFGRVP 214

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 939
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMXGTLPYVA 174
Query: 940 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRP 970
           PE  +         DV+S G+VL  +L G  P
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQHKNLVS 827
           +G G +G+V+K+     G   AVK++      S D  +  RE     E    + H+N+V+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL---SGHENIVN 73
Query: 828 LQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           L    R  NDR   L++ YME       LH +V + ++L+   +  +     + + YLH 
Sbjct: 74  LLNVLRADNDRDVYLVFDYMETD-----LH-AVIRANILEPVHKQYVVYQLIKVIKYLH- 126
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY--------------------DT 925
                ++HRD+K SNILL+ +    +ADFGLSR                         D 
Sbjct: 127 --SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 926 HVTTDLVGTLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            + TD V T  Y  PE     T   +G D++S G +L E+L G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 138 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 193
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 138 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 193
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 78/283 (27%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 773  NIIGCGGFGLVYKATLTNGTK------AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
            +++G G F  V  A      K       A K L G  G ME E    +  L + +H N+V
Sbjct: 24   DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE----IAVLHKIKHPNIV 79
Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            +L      G    LI   +  G L       V+K    + D    I Q     + YLH +
Sbjct: 80   ALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDASRLIFQ-VLDAVKYLHDL 135
Query: 887  CEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
                IVHRD+K  N+L   LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 136  ---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 190
Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
                 +   D +S GV+   LL G  P      +N   L   + + + E       D+  
Sbjct: 191  AQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDAKLFEQILKAEYE------FDSPY 241
Query: 1004 WH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042
            W    D  K  +  L      +++DP +R   E+ +   W+ G
Sbjct: 242  WDDISDSAKDFIRHL------MEKDPEKRFTCEQALQHPWIAG 278

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 24  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 83
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 144 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 199
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 200 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 70/209 (33%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 774 IIGCGGFGLVYKATL----TNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
           +IG G FG+VY         N  + A+K LS      + E F  E   +    H N+++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 829 QGYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            G      G   +L+  YM +G L  ++  S  ++  +K D+ +      ARG+ YL   
Sbjct: 88  IGIMLPPEGLPHVLL-PYMCHGDLLQFI-RSPQRNPTVK-DL-ISFGLQVARGMEYL--- 140
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSR--LLRPY---DTHVTTDLVGTLGYIPPE 941
            E   VHRD+ + N +LDE F   +ADFGL+R  L R Y     H    L   + +   E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVKWTALE 198
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             QT   T + DV+SFGV+L ELLT   P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 747 VLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM 806
           + FQ+ D ++L           F +   IG G FG V+K  + N T+  V     D  + 
Sbjct: 18  LYFQSMDPEEL-----------FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEA 65
Query: 807 EREF---QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDS 862
           E E    Q E+  LS+     +    G         +I  Y+  GS LD      +D+  
Sbjct: 66  EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ 125
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP 922
           +        I +   +GL YLH   +   +HRD+K++N+LL E  E  LADFG++  L  
Sbjct: 126 IAT------ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT- 175
Query: 923 YDTHVTTD-LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            DT +  +  VGT  ++ PE  +      + D++S G+  +EL  G  P
Sbjct: 176 -DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 824 NLVSLQGYCRHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
             V L  +C   +++L    SY +NG L  ++ +    D       R   A+     L Y
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALEY 152
Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE 941
           LH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ PE
Sbjct: 153 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                +A    D+++ G ++ +L+ G  P
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 28/272 (10%)
Query: 775  IGCGGFGLVYKATLTNGTKAAV-KRLSGDCGQM-EREFQ---AEVEALSRAQHKNLVSLQ 829
            IG G +G   K    +  K  V K L  D G M E E Q   +EV  L   +H N+V   
Sbjct: 14   IGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 830  GYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
                 R      ++  Y E G L   + +   +   L  +  L++       L   H+  
Sbjct: 72   DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 888  EP--HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
            +    ++HRD+K +N+ LD K    L DFGL+R+L  +D     + VGT  Y+ PE    
Sbjct: 132  DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDEDFAKEFVGTPYYMSPEQMNR 190
Query: 946  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005
            ++   + D++S G +L EL     P      K          ++  + RE +       +
Sbjct: 191  MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----------ELAGKIREGKFRRIPYRY 240
Query: 1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             D      E+ EI  + ++     RP +EE++
Sbjct: 241  SD------ELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 56/299 (18%)
Query: 775  IGCGGFGLVYKATL------TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 827
            +G   FG VYK  L            A+K L     G +  EF+ E    +R QH N+V 
Sbjct: 34   LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWL-----HESV---DKDSVLKW-----DVRLKIAQ 874
            L G         +I+SY  +G L  +L     H  V   D D  +K      D    +AQ
Sbjct: 94   LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 875  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
             AA G+ YL      H+VH+D+ + N+L+ +K    ++D GL R +   D +    L+G 
Sbjct: 154  IAA-GMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY---KLLGN 206
Query: 935  ----LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM 989
                + ++ PE       +   D++S+GVVL E+ + G +P   C G + +D+V  +   
Sbjct: 207  SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YC-GYSNQDVVEMI--- 260
Query: 990  KSEKREVEII----DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044
                R  +++    D   W          +  +  +C ++ P RRP  +++ + L   G
Sbjct: 261  ----RNRQVLPCPDDCPAW----------VYALMIECWNEFPSRRPRFKDIHSRLRAWG 305

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 44  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 103
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 164 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 219
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 220 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 766 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 821
           ++ +    I+G GG   V+ A  L +    AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 822 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTL 935
           + L + H   +  I+HRDVK +NIL+       + DFG++R +      V  T  ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +    +IG G FG+V++A L    + A+K++  D     RE Q     +   +H N+V L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNVVDL 97
Query: 829 QGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
           + +     D+       L+  Y+         H +  K ++    ++L + Q   R LAY
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAY 156
Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           +H +    I HRD+K  N+LLD       L DFG +++L   + +V+   + +  Y  PE
Sbjct: 157 IHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX--ICSRYYRAPE 211
Query: 942 YSQTLT-ATCRGDVYSFGVVLLELLTGR 968
                T  T   D++S G V+ EL+ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 114/255 (44%), Gaps = 20/255 (7%)
Query: 730 DMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANI-IGCGGFGLVYKATL 788
           D  RP  +  ++  S       SD ++L    L    +N   A+I +GCG FG V +   
Sbjct: 303 DKPRPMPMDTSVFESPF-----SDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVY 357
Query: 789 TNGTK---AAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 844
               K    A+K L     + +  E   E + + +  +  +V L G C+     +L+   
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEM 416
Query: 845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD 904
              G L  +L   V K   +      ++    + G+ YL    E + VHR++ + N+LL 
Sbjct: 417 AGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLV 470
Query: 905 EKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLL 962
            +  A ++DFGLS+ L   D++ T    G   L +  PE       + R DV+S+GV + 
Sbjct: 471 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 963 ELLT-GRRPVEVCKG 976
           E L+ G++P +  KG
Sbjct: 531 EALSYGQKPYKKMKG 545

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 773 NIIGCGGFGLVY--KATLTNGTKAAVKRLSGD-------CGQMEREFQAEVEALSRAQHK 823
           + +G G FG V   K  LT G K AVK L+          G++ RE Q     L   +H 
Sbjct: 22  DTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQN----LKLFRHP 76
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
           +++ L       +D  ++  Y+  G L DY     + K+  L      ++ Q    G+ Y
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDY-----ICKNGRLDEKESRRLFQQILSGVDY 131
Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
            H+     +VHRD+K  N+LLD    A +ADFGLS ++   D        G+  Y  PE 
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRXSCGSPNYAAPEV 186
Query: 943 -SQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
            S  L A    D++S GV+L  LL G  P +
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 765 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDC----GQMEREFQAEVEALSR 819
           S  +F     +G G FG V+   +  NG   A+K L  +      Q+E     E   LS 
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSI 62
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAAR 878
             H  ++ + G  +      +I  Y+E G L   L +S    + V K+      A     
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-----YAAEVCL 117
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
            L YLH      I++RD+K  NILLD+     + DFG ++    Y   VT  L GT  YI
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYXLCGTPDYI 170
Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            PE   T       D +SFG+++ E+L G  P
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  AT  + G + AVK++     Q       EV  +    H N+V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
            G++  ++  ++E G+L D   H  ++++ +        +     R L+YLH      ++
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHNQG---VI 163
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L      
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 953 DVYSFGVVLLELLTGRRP 970
           D++S G++++E++ G  P
Sbjct: 223 DIWSLGIMVIEMIDGEPP 240

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 825
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 826 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
               G         +I  Y+  GS LD      +D+  +        I +   +GL YLH
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLH 136
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 943
              +   +HRD+K++N+LL E  E  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 137 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 191
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           +      + D++S G+  +EL  G  P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 27/274 (9%)
Query: 708 LAVTLLKMSRRDSGCPIDDLDEDMGRPQR----LSEALASSKLVLFQNSDCKDLTVS--D 761
           ++VT     RRDS  P     ++ G P++     S      ++   Q      L V   D
Sbjct: 89  MSVTRSNSLRRDSPPPPARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGD 148
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRA 820
                +NF +   IG G  G+V  AT+ ++G   AVK++     Q       EV  +   
Sbjct: 149 PRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARG 879
           QH+N+V +      G++  ++  ++E G+L D   H  ++++ +            AA  
Sbjct: 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVC 253
Query: 880 LAYLHKVCEPH---IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
           LA L  +   H   ++HRD+KS +ILL       L+DFG    +   +      LVGT  
Sbjct: 254 LAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPY 312
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           ++ PE    L      D++S G++++E++ G  P
Sbjct: 313 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G    
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 835 GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
               L I + YM  GSL  +L       SVL  D  LK +      + YL      + VH
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312
Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 368
Query: 954 VYSFGVVLLELLT-GRRP 970
           V+SFG++L E+ + GR P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSR 819
           K   +F    I+G G F  V  A  L    + A+K L       E +      E + +SR
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 820 AQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
             H   V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+   
Sbjct: 64  LDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IV 117
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLG 936
             L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  
Sbjct: 118 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSR 819
           K   +F    I+G G F  V  A  L    + A+K L       E +      E + +SR
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 820 AQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
             H   V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+   
Sbjct: 66  LDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IV 119
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLG 936
             L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  
Sbjct: 120 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSR 819
           K   +F    I+G G F  V  A  L    + A+K L       E +      E + +SR
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 820 AQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
             H   V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+   
Sbjct: 67  LDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IV 120
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLG 936
             L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  
Sbjct: 121 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSR 819
           K   +F    I+G G F  V  A  L    + A+K L       E +      E + +SR
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 820 AQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
             H   V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+   
Sbjct: 65  LDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IV 118
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLG 936
             L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-- 890
            G++  ++  ++E G+L D   H  ++++ +            AA  LA L  +   H  
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVCLAVLQALSVLHAQ 139
Query: 891 -IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L   
Sbjct: 140 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 950 CRGDVYSFGVVLLELLTGRRP 970
              D++S G++++E++ G  P
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPP 219

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 56/299 (18%)
Query: 775  IGCGGFGLVYKATL------TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 827
            +G   FG VYK  L            A+K L     G +  EF+ E    +R QH N+V 
Sbjct: 17   LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWL-----HESV---DKDSVLKW-----DVRLKIAQ 874
            L G         +I+SY  +G L  +L     H  V   D D  +K      D    +AQ
Sbjct: 77   LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 875  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
             AA G+ YL      H+VH+D+ + N+L+ +K    ++D GL R +   D +    L+G 
Sbjct: 137  IAA-GMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY---KLLGN 189
Query: 935  ----LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM 989
                + ++ PE       +   D++S+GVVL E+ + G +P   C G + +D+V  +   
Sbjct: 190  SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YC-GYSNQDVVEMI--- 243
Query: 990  KSEKREVEII----DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044
                R  +++    D   W          +  +  +C ++ P RRP  +++ + L   G
Sbjct: 244  ----RNRQVLPCPDDCPAW----------VYALMIECWNEFPSRRPRFKDIHSRLRAWG 288

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-- 890
            G++  ++  ++E G+L D   H  ++++ +            AA  LA L  +   H  
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVCLAVLQALSVLHAQ 135
Query: 891 -IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L   
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 950 CRGDVYSFGVVLLELLTGRRP 970
              D++S G++++E++ G  P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 766 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 821
           ++ +    I+G GG   V+ A  L +    AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 822 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 935
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 766 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 821
           ++ +    I+G GG   V+ A  L +    AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 822 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 935
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 773  NIIGCGGFGLVYKATLTNGTK------AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
            +++G G F  V  A      K       A + L G  G ME E    +  L + +H N+V
Sbjct: 24   DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE----IAVLHKIKHPNIV 79
Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            +L      G    LI   +  G L       V+K    + D    I Q     + YLH +
Sbjct: 80   ALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDASRLIFQ-VLDAVKYLHDL 135
Query: 887  CEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
                IVHRD+K  N+L   LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 136  ---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 190
Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
                 +   D +S GV+   LL G  P      +N   L   + + + E       D+  
Sbjct: 191  AQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDAKLFEQILKAEYE------FDSPY 241
Query: 1004 WH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042
            W    D  K  +  L      +++DP +R   E+ +   W+ G
Sbjct: 242  WDDISDSAKDFIRHL------MEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 773  NIIGCGGFGLVYKATLTNGTK------AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
            +++G G F  V  A      K       A + L G  G ME E    +  L + +H N+V
Sbjct: 24   DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE----IAVLHKIKHPNIV 79
Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            +L      G    LI   +  G L       V+K    + D    I Q     + YLH +
Sbjct: 80   ALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDASRLIFQ-VLDAVKYLHDL 135
Query: 887  CEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
                IVHRD+K  N+L   LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 136  ---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 190
Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
                 +   D +S GV+   LL G  P      +N   L   + + + E       D+  
Sbjct: 191  AQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDAKLFEQILKAEYE------FDSPY 241
Query: 1004 WH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042
            W    D  K  +  L      +++DP +R   E+ +   W+ G
Sbjct: 242  WDDISDSAKDFIRHL------MEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 773  NIIGCGGFGLVYKATLTNGTK------AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
            +++G G F  V  A      K       A + L G  G ME E    +  L + +H N+V
Sbjct: 24   DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE----IAVLHKIKHPNIV 79
Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            +L      G    LI   +  G L       V+K    + D    I Q     + YLH +
Sbjct: 80   ALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDASRLIFQ-VLDAVKYLHDL 135
Query: 887  CEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
                IVHRD+K  N+L   LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 136  ---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 190
Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
                 +   D +S GV+   LL G  P      +N   L   + + + E       D+  
Sbjct: 191  AQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDAKLFEQILKAEYE------FDSPY 241
Query: 1004 WH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042
            W    D  K  +  L      +++DP +R   E+ +   W+ G
Sbjct: 242  WDDISDSAKDFIRHL------MEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A+   D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 74/278 (26%), Positives = 119/278 (42%), Gaps = 38/278 (13%)
Query: 768  NFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR- 819
            N     ++G G FG V  AT    +K       AVK L       ERE   +E++ +++ 
Sbjct: 46   NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS----------------- 862
              H+N+V+L G C       LI+ Y   G L  +L    +K S                 
Sbjct: 106  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 863  --VLKWDVRLKIAQGAARGLAYLH-KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR- 918
              VL ++  L  A   A+G+ +L  K C    VHRD+ + N+L+       + DFGL+R 
Sbjct: 166  LNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 919  LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE-VCKG 976
            ++   +  V  +    + ++ PE       T + DV+S+G++L E+ + G  P   +   
Sbjct: 222  IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 977  KNCRDLVSWVFQMKS---EKREVEIIDASIWHKDREKQ 1011
             N   L+   F+M        E+ II  S W  D  K+
Sbjct: 282  ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 319

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC-GQMEREFQAEVE-ALSRAQHKNLVSLQGY 831
            +G G +G+V K   + +G   AVKR+      Q ++    +++ ++        V+  G 
Sbjct: 59   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                 D  +    M+  SLD +  + +DK   +  D+  KIA    + L +LH      +
Sbjct: 119  LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 892  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS----QTLT 947
            +HRDVK SN+L++   +  + DFG+S  L   D+   T   G   Y+ PE          
Sbjct: 176  IHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 948  ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1007
             + + D++S G+ ++EL   R P +           SW    +  K+ VE     +    
Sbjct: 234  YSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQL---P 279
Query: 1008 REKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             +K   E ++   +C+ ++ + RP   E++
Sbjct: 280  ADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG+++ 
Sbjct: 138 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQD 193
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 13  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 874
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 123
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
              + L +LH      ++HRD+KS NILL       L DFG    + P  +  +T +VGT
Sbjct: 124 ECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGT 179
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 775 IGCGGFGLVYKATLTNGTK---AAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQG 830
           +GCG FG V +       K    A+K L     + +  E   E + + +  +  +V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
            C+     +L+      G L  +L   V K   +      ++    + G+ YL    E +
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLE---EKN 130
Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLTA 948
            VHRD+ + N+LL  +  A ++DFGLS+ L   D++ T    G   L +  PE       
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 949 TCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
           + R DV+S+GV + E L+ G++P +  KG
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENI 87
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 765 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-----FQAEVEALS 818
           + ++F+    +G G FG VY A    N    A+K L     Q+E+E      + E+E  S
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVEHQLRREIEIQS 70
Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
             +H N++ +  Y    +DR  IY  +E       L++ + K             +  A 
Sbjct: 71  HLRHPNILRMYNYF---HDRKRIYLMLEFAPRGE-LYKELQKHGRFDEQRSATFMEELAD 126
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGT 934
            L Y H   E  ++HRD+K  N+L+  K E  +ADFG S        H  +     + GT
Sbjct: 127 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGT 176
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           L Y+PPE  +  T   + D++  GV+  E L G  P +
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 85
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 139
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 140 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 24/256 (9%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            +G G FG+V           AVK +  +    E EF  E + + +  H  LV   G C  
Sbjct: 16   LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 835  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-IVH 893
                 ++  Y+ NG L  +L         L+    L++      G+A+L    E H  +H
Sbjct: 75   EYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFL----ESHQFIH 127
Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 950
            RD+ + N L+D      ++DFG++R +   D +V++  VGT   + +  PE       + 
Sbjct: 128  RDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSS--VGTKFPVKWSAPEVFHYFKYSS 184
Query: 951  RGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSW---VFQMKSEKREVEIIDASIWHK 1006
            + DV++FG+++ E+ + G+ P ++         VS    +++       +  I  S WH+
Sbjct: 185  KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHE 244
Query: 1007 DREK-----QLLEMLE 1017
              EK     QLL  +E
Sbjct: 245  LPEKRPTFQQLLSSIE 260

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 139/316 (43%), Gaps = 50/316 (15%)
Query: 750  QNSDCKDLTVSDLLKSTNNFNQA-----------NIIGCGGFGLVYKATLTNGTKAAVK- 797
            Q+ D  DL   D  K++++ N+              IG GG   V++         A+K 
Sbjct: 28   QHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 87
Query: 798  -RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY--WL 854
              L     Q    ++ E+  L++ Q  +   ++ Y     D+  IY  ME G++D   WL
Sbjct: 88   VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWL 146
Query: 855  HESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 914
             +   K S+  W+ +          L  +H + +  IVH D+K +N L+ +     L DF
Sbjct: 147  KK---KKSIDPWERK----SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDF 198
Query: 915  GLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTATCRG-----------DVYSFGVVLL 962
            G++  ++P  T V  D  VGT+ Y+PPE  + ++++              DV+S G +L 
Sbjct: 199  GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 963  ELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKC 1022
             +  G+ P +        + +S +  +     E+E  D        EK L ++L+  C C
Sbjct: 259  YMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIP------EKDLQDVLK--C-C 304
Query: 1023 IDQDPRRRPFIEEVVT 1038
            + +DP++R  I E++ 
Sbjct: 305  LKRDPKQRISIPELLA 320

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 77/315 (24%), Positives = 138/315 (43%), Gaps = 50/315 (15%)
Query: 750  QNSDCKDLTVSDLLKSTNNFNQA-----------NIIGCGGFGLVYKATLTNGTKAAVK- 797
            Q+ D  DL   D  K++++ N+              IG GG   V++         A+K 
Sbjct: 28   QHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 87
Query: 798  -RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY--WL 854
              L     Q    ++ E+  L++ Q  +   ++ Y     D+  IY  ME G++D   WL
Sbjct: 88   VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWL 146
Query: 855  HESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 914
             +   K S+  W+ +          L  +H + +  IVH D+K +N L+ +     L DF
Sbjct: 147  KK---KKSIDPWERK----SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDF 198
Query: 915  GLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTATCRG-----------DVYSFGVVLL 962
            G++  ++P  T V  D  VGT+ Y+PPE  + ++++              DV+S G +L 
Sbjct: 199  GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 963  ELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKC 1022
             +  G+ P +        + +S +  +     E+E  D        EK L ++L+    C
Sbjct: 259  YMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIP------EKDLQDVLKC---C 304
Query: 1023 IDQDPRRRPFIEEVV 1037
            + +DP++R  I E++
Sbjct: 305  LKRDPKQRISIPELL 319

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 144
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 144
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 75  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 128
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 129 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 96  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 149
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 150 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 90  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 143
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 144 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 90  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 143
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 144 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 144
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 94  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 147
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 148 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 823
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 824 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 94  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 147
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 940
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 148 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 91
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 145
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 146 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 202
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 103
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 157
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 158 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-- 890
            G++  ++  ++E G+L D   H  ++++ +            AA  LA L  +   H  
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVCLAVLQALSVLHAQ 189
Query: 891 -IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L   
Sbjct: 190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYG 248
Query: 950 CRGDVYSFGVVLLELLTGRRP 970
              D++S G++++E++ G  P
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPP 269

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-- 890
            G++  ++  ++E G+L D   H  ++++ +            AA  LA L  +   H  
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVCLAVLQALSVLHAQ 144
Query: 891 -IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L   
Sbjct: 145 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYG 203
Query: 950 CRGDVYSFGVVLLELLTGRRP 970
              D++S G++++E++ G  P
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-- 890
            G++  ++  ++E G+L D   H  ++++ +            AA  LA L  +   H  
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVCLAVLQALSVLHAQ 146
Query: 891 -IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L   
Sbjct: 147 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYG 205
Query: 950 CRGDVYSFGVVLLELLTGRRP 970
              D++S G++++E++ G  P
Sbjct: 206 PEVDIWSLGIMVIEMVDGEPP 226

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 765 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-----FQAEVEALS 818
           + ++F+    +G G FG VY A    N    A+K L     Q+E+E      + E+E  S
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVEHQLRREIEIQS 69
Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
             +H N++ +  Y    +DR  IY  +E       L++ + K             +  A 
Sbjct: 70  HLRHPNILRMYNYF---HDRKRIYLMLEFAPRGE-LYKELQKHGRFDEQRSATFMEELAD 125
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGT 934
            L Y H   E  ++HRD+K  N+L+  K E  +ADFG S        H  +     + GT
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGT 175
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           L Y+PPE  +  T   + D++  GV+  E L G  P +
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 81
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 135
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 136 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 88
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 142
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 143 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 199
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 89
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 143
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 144 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 200
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 80
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 134
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 135 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 191
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 13  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 874
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 123
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
              + L +LH      ++HRD+KS NILL       L DFG    + P  +   +++VGT
Sbjct: 124 ECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSEMVGT 179
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 81
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 135
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 136 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 112/262 (42%), Gaps = 40/262 (15%)
Query: 775  IGCGGFGLVYKATLTNG-TKAAVK----------RLSGDCGQMER---EFQAEVEALSRA 820
            +G G +G V      NG ++ A+K          R S D   +E+   E   E+  L   
Sbjct: 44   LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 821  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
             H N++ L           L+  + E G L     + +++    + D    I +    G+
Sbjct: 104  DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---FEQIINRHKFDECDA-ANIMKQILSGI 159
Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEK---FEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
             YLHK    +IVHRD+K  NILL+ K       + DFGLS        +   D +GT  Y
Sbjct: 160  CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAYY 214
Query: 938  IPPEY-SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
            I PE   +     C  DV+S GV++  LL G  P     G+N +D++  V + K      
Sbjct: 215  IAPEVLKKKYNEKC--DVWSCGVIMYILLCGYPPF---GGQNDQDIIKKVEKGKY----- 264
Query: 997  EIIDASIWHK--DREKQLLEML 1016
               D + W    D  K+L++++
Sbjct: 265  -YFDFNDWKNISDEAKELIKLM 285

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNL---VSLQ 829
           +G G +G V++ +   G   AVK  S    + E+ +  E E  +    +H+N+   ++  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 830 GYCRHGNDRL-LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH--- 884
              RH + +L LI  Y E GSL DY    ++D  S L+      I    A GLA+LH   
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR------IVLSIASGLAHLHIEI 154
Query: 885 --KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD---LVGTLGYIP 939
                +P I HRD+KS NIL+ +  +  +AD GL+ +       +       VGT  Y+ 
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 940 PEY-SQTLTATC-----RGDVYSFGVVLLELLTGRRPV 971
           PE   +T+   C     R D+++FG+VL E+   RR V
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 250

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 42/294 (14%)
Query: 763  LKSTN---NFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQAEVEAL 817
            +++TN    F    ++G G F  V+  K  LT G   A+K +       +   + E+  L
Sbjct: 2    MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 818  SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESV--DKDSVLKWDVRLKIAQ 874
             + +H+N+V+L+          L+   +  G L D  L   V  +KD+ L       + Q
Sbjct: 61   KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQ 113
Query: 875  GAARGLAYLHKVCEPHIVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHVTTDL 931
                 + YLH   E  IVHRD+K  N+L    +E  +  + DFGLS++ +     + +  
Sbjct: 114  QVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTA 167
Query: 932  VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVSWVFQMK 990
             GT GY+ PE       +   D +S GV+   LL G  P  E  + K    +    ++ +
Sbjct: 168  CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE 227
Query: 991  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042
            S            W    E       +  C  +++DP  R   E+ ++  W+DG
Sbjct: 228  S----------PFWDDISES----AKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 73/313 (23%), Positives = 135/313 (43%), Gaps = 51/313 (16%)
Query: 756  DLTVSDL-LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQ 811
            DL   +L  +S   +    ++G G +G+V K      G   A+K+   S D   +++   
Sbjct: 13   DLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM 72
Query: 812  AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD--YWLHESVDKDSVLKWDVR 869
             E++ L + +H+NLV+L   C+      L++ ++++  LD        +D   V K+  +
Sbjct: 73   REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 870  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
            +        G+ + H     +I+HRD+K  NIL+ +     L DFG +R L      V  
Sbjct: 133  I------INGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYD 182
Query: 930  DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR------------RP 970
            D V T  Y  PE       Y + +      DV++ G ++ E+  G               
Sbjct: 183  DEVATRWYRAPELLVGDVKYGKAV------DVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236
Query: 971  VEVCKGKNCRDLVSWVFQMKSEK------REVEIIDASIWHKDREKQLLEMLEIACKCID 1024
            + +C G    +L+    ++ ++       R  EI +     +   K    ++++A KC+ 
Sbjct: 237  IMMCLG----NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLH 292
Query: 1025 QDPRRRPFIEEVV 1037
             DP +RPF  E++
Sbjct: 293  IDPDKRPFCAELL 305

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQH 822
           +NF    ++G G FG V  A +   G   AVK L  D    + + +    E   LS A++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 823 KNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
              ++    C    DRL  +  ++  G L + + +S   D       R   A+     L 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAE-IISALM 138
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGTLGYIPP 940
           +LH   +  I++RD+K  N+LLD +    LADFG+ +        VTT    GT  YI P
Sbjct: 139 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV 973
           E  Q +      D ++ GV+L E+L G  P E 
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 825
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 826 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
               G         +I  Y+  GS LD      +D+  +        I +   +GL YLH
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLH 121
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 943
                  +HRD+K++N+LL E  E  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 122 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 176
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           +      + D++S G+  +EL  G  P
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 769 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 825
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 826 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
               G         +I  Y+  GS LD      +D+  +        I +   +GL YLH
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLH 121
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 943
                  +HRD+K++N+LL E  E  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 122 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 176
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           +      + D++S G+  +EL  G  P
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQI------LRGL 141
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 41/222 (18%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNL---VSLQ 829
           +G G +G V++ +   G   AVK  S    + E+ +  E E  +    +H+N+   ++  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 830 GYCRHGNDRL-LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH--- 884
              RH + +L LI  Y E GSL DY    ++D  S L+      I    A GLA+LH   
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR------IVLSIASGLAHLHIEI 125
Query: 885 --KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-------VGTL 935
                +P I HRD+KS NIL+ +  +  +AD GL+ +     +  T  L       VGT 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGNNPRVGTK 181
Query: 936 GYIPPEY-SQTLTATC-----RGDVYSFGVVLLELLTGRRPV 971
            Y+ PE   +T+   C     R D+++FG+VL E+   RR V
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR------ 819
             ++  ++IG G   +V +      G + AVK +     ++  E   EV   +R      
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 820 ---AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
              A H ++++L       +   L++  M  G L  +L E V     L       I +  
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSL 209
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              +++LH     +IVHRD+K  NILLD+  +  L+DFG S  L P +     +L GT G
Sbjct: 210 LEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPG 264
Query: 937 YIPPEYSQ-TLTATCRG-----DVYSFGVVLLELLTGRRP 970
           Y+ PE  + ++  T  G     D+++ GV+L  LL G  P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 12/161 (7%)
Query: 813 EVEALSRAQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRL 870
           E + +SR  H   V L  Y    +D  L +  SY +NG L  ++ +    D       R 
Sbjct: 80  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRF 134
Query: 871 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 930
             A+     L YLH      I+HRD+K  NILL+E     + DFG +++L P       +
Sbjct: 135 YTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 931 -LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             VGT  Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 41/222 (18%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNL---VSLQ 829
           +G G +G V++ +   G   AVK  S    + E+ +  E E  +    +H+N+   ++  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 830 GYCRHGNDRL-LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH--- 884
              RH + +L LI  Y E GSL DY    ++D  S L+      I    A GLA+LH   
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR------IVLSIASGLAHLHIEI 125
Query: 885 --KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-------VGTL 935
                +P I HRD+KS NIL+ +  +  +AD GL+ +     +  T  L       VGT 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGNNPRVGTK 181
Query: 936 GYIPPEY-SQTLTATC-----RGDVYSFGVVLLELLTGRRPV 971
            Y+ PE   +T+   C     R D+++FG+VL E+   RR V
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQG 830
           +G G FG V  AT      K A+K +S        M    + E+  L   +H +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                 D +++  Y      DY     V+K  + + + R +  Q     + Y H+     
Sbjct: 77  VITTPTDIVMVIEYAGGELFDY----IVEKKRMTEDEGR-RFFQQIICAIEYCHR---HK 128
Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY-SQTLTAT 949
           IVHRD+K  N+LLD+     +ADFGLS ++   D +      G+  Y  PE  +  L A 
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 950 CRGDVYSFGVVLLELLTGRRPVE 972
              DV+S G+VL  +L GR P +
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 765 STNNFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQ---AEVEALSRA 820
              +F    ++G G FG V+ A      +  A+K L  D   M+ + +    E   LS A
Sbjct: 16  KIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 821 -QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA-- 877
            +H  L  +    +   +   +  Y+  G L Y +       S  K+D+       A   
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ------SCHKFDLSRATFYAAEII 129
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            GL +LH      IV+RD+K  NILLD+     +ADFG+ +     D   T +  GT  Y
Sbjct: 130 LGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGTPDY 185
Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           I PE           D +SFGV+L E+L G+ P
Sbjct: 186 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 19/215 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQH 822
            +F    +IG G FG V    L N  K    ++      ++R     F+ E + L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
           K + +L    +  N+  L+  Y   G L   L  S  +D + +   R  +A+     +  
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVI-AIDS 190
Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
           +H++   H VHRD+K  NIL+D      LADFG    L    T  ++  VGT  YI PE 
Sbjct: 191 VHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 943 SQTLTA-------TCRGDVYSFGVVLLELLTGRRP 970
            Q +          C  D +S GV + E+L G  P
Sbjct: 248 LQAMEGGKGRYGPEC--DWWSLGVCMYEMLYGETP 280

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 823
           ++   + +   +G GGF   Y+ T  +  +    ++      + +  Q E  +   A HK
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK-SMLLKPHQKEKMSTEIAIHK 97
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR---- 878
           +L +      HG        + E+    Y + E   + S+L+   R K + +  AR    
Sbjct: 98  SLDNPHVVGFHG--------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 879 ----GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               G+ YLH      ++HRD+K  N+ L++  +  + DFGL+  +  +D     DL GT
Sbjct: 150 QTIQGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKDLCGT 205
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             YI PE       +   D++S G +L  LL G+ P E
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 823
           ++   + +   +G GGF   Y+ T  +  +    ++      + +  Q E  +   A HK
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK-SMLLKPHQKEKMSTEIAIHK 81
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR---- 878
           +L +      HG        + E+    Y + E   + S+L+   R K + +  AR    
Sbjct: 82  SLDNPHVVGFHG--------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 133
Query: 879 ----GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               G+ YLH      ++HRD+K  N+ L++  +  + DFGL+  +  +D     DL GT
Sbjct: 134 QTIQGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKDLCGT 189
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             YI PE       +   D++S G +L  LL G+ P E
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A++++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 772 ANIIGCGGFGLVY--KATLTNGTKAAVKRLSGD-------CGQMEREFQAEVEALSRAQH 822
            + +G G FG V   +  LT G K AVK L+          G+++RE Q     L   +H
Sbjct: 16  GDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQN----LKLFRH 70
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            +++ L        D  ++  Y+  G L DY          V + + R ++ Q     + 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG----RVEEMEAR-RLFQQILSAVD 125
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H+     +VHRD+K  N+LLD    A +ADFGLS ++   D     D  G+  Y  PE
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRDSCGSPNYAAPE 180
Query: 942 Y-SQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             S  L A    D++S GV+L  LL G  P +
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 766 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 821
           ++ +    I+G GG   V+ A  L      AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 822 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 935
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 766 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 821
           ++ +    I+G GG   V+ A  L      AVK L  D  +       F+ E +  +   
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 822 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 143
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 935
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 144 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 766 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 821
           ++ +    I+G GG   V+ A  L      AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 822 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 935
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/111 (38%), Positives = 56/111 (50%), Gaps = 11/111 (9%)
Query: 871 KIAQGAARGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
           K+     + L YL    E H ++HRDVK SNILLDE+ +  L DFG+S  L   D     
Sbjct: 128 KMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKD 182
Query: 930 DLVGTLGYIPPEYSQTLTAT-----CRGDVYSFGVVLLELLTGRRPVEVCK 975
              G   Y+ PE       T      R DV+S G+ L+EL TG+ P + CK
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 38/239 (15%)
Query: 750 QNSDCKDLTVSDLLKSTNNFNQAN---IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ 805
           +  DC+    SDLL+    +++     ++G G +G+VY    L+N  + A+K +     +
Sbjct: 6   EEGDCE----SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR 61
Query: 806 MEREFQAEVEALSRAQHKNLVSLQG-YCRHGNDRLLIYSYMEN---GSLDYWLHES---- 857
             +    E+      +HKN+V   G +  +G     I  +ME    GSL   L       
Sbjct: 62  YSQPLHEEIALHKHLKHKNIVQYLGSFSENG----FIKIFMEQVPGGSLSALLRSKWGPL 117
Query: 858 VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGL 916
            D +  + +  +  +      GL YLH   +  IVHRD+K  N+L++       ++DFG 
Sbjct: 118 KDNEQTIGFYTKQIL-----EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGT 169
Query: 917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 970
           S+ L   +   T    GTL Y+ PE    +    RG     D++S G  ++E+ TG+ P
Sbjct: 170 SKRLAGINP-CTETFTGTLQYMAPE---IIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 14  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 70
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 874
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 124
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
              + L +LH      ++HRD+KS NILL       L DFG    + P  +   + +VGT
Sbjct: 125 ECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSXMVGT 180
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 14  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 70
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 874
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 124
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
              + L +LH      ++HR++KS NILL       L DFG    + P  +  +T +VGT
Sbjct: 125 ECLQALEFLHS---NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGT 180
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 757 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 815
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 13  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 874
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 123
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
              + L +LH      ++HRD+KS NILL       L DFG    + P  +   + +VGT
Sbjct: 124 ECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSXMVGT 179
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKN 824
           +N     +IG G +G VYK +L +    AVK  S    Q    F  +  +  +   +H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDN 68
Query: 825 LVS-LQGYCRHGND----RLLIYSYMENGSLDYWL--HESVDKDSVLKWDVRLKIAQGAA 877
           +   + G  R   D     LL+  Y  NGSL  +L  H S        W    ++A    
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-------DWVSSCRLAHSVT 121
Query: 878 RGLAYLHKVC------EPHIVHRDVKSSNILLDEKFEAHLADFGLS------RLLRP-YD 924
           RGLAYLH         +P I HRD+ S N+L+       ++DFGLS      RL+RP  +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 925 THVTTDLVGTLGYIPPEYSQTL-------TATCRGDVYSFGVVLLELL 965
            +     VGT+ Y+ PE  +         +A  + D+Y+ G++  E+ 
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 16   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 833  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 76   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 127
Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 949
            IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+PPE  + ++++
Sbjct: 128  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 186
Query: 950  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 187  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 241
Query: 999  IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 242  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 271

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I +Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 27/234 (11%)
Query: 769 FNQANIIGCGGFGLVYKATLTNGT------------KAAVKRLSGDCGQMEREFQAEVEA 816
           F    ++G GG+G V++     G             KA + R + D        +AE   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT----KAERNI 74
Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
           L   +H  +V L    + G    LI  Y+  G L   L    +++ +   D         
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEI 130
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
           +  L +LH   +  I++RD+K  NI+L+ +    L DFGL +    +D  VT    GT+ 
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIE 186
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           Y+ PE           D +S G ++ ++LTG  P     G+N +  +  + + K
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILKCK 237

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 767 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA- 820
            +F+   +IG G +  V      K       K   K L  D   ++   Q E     +A 
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 63
Query: 821 QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
            H  LV L   C     RL  +  Y+  G L + +     +  + +   R   A+  +  
Sbjct: 64  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAE-ISLA 118
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 938
           L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT  T+   GT  YI
Sbjct: 119 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 173
Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKSEKR 994
            PE  +        D ++ GV++ E++ GR P ++    +  D     ++FQ+  EK+
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 231

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 27/234 (11%)
Query: 769 FNQANIIGCGGFGLVYKATLTNGT------------KAAVKRLSGDCGQMEREFQAEVEA 816
           F    ++G GG+G V++     G             KA + R + D        +AE   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT----KAERNI 74
Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
           L   +H  +V L    + G    LI  Y+  G L   L    +++ +   D         
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEI 130
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
           +  L +LH   +  I++RD+K  NI+L+ +    L DFGL +    +D  VT    GT+ 
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIE 186
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           Y+ PE           D +S G ++ ++LTG  P     G+N +  +  + + K
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILKCK 237

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 138/316 (43%), Gaps = 50/316 (15%)
Query: 750  QNSDCKDLTVSDLLKSTNNFNQA-----------NIIGCGGFGLVYKATLTNGTKAAVK- 797
            Q+ D  DL   D  K++++ N+              IG GG   V++         A+K 
Sbjct: 28   QHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 87
Query: 798  -RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY--WL 854
              L     Q    ++ E+  L++ Q  +   ++ Y     D+  IY  ME G++D   WL
Sbjct: 88   VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWL 146
Query: 855  HESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 914
             +   K S+  W+ +          L  +H + +  IVH D+K +N L+ +     L DF
Sbjct: 147  KK---KKSIDPWERK----SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDF 198
Query: 915  GLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTATCRG-----------DVYSFGVVLL 962
            G++  ++P  T V  D  VG + Y+PPE  + ++++              DV+S G +L 
Sbjct: 199  GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 963  ELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKC 1022
             +  G+ P +        + +S +  +     E+E  D        EK L ++L+  C C
Sbjct: 259  YMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIP------EKDLQDVLK--C-C 304
Query: 1023 IDQDPRRRPFIEEVVT 1038
            + +DP++R  I E++ 
Sbjct: 305  LKRDPKQRISIPELLA 320

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 36   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 833  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 96   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 147
Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 949
            IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+PPE  + ++++
Sbjct: 148  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 950  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 207  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 261
Query: 999  IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 262  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 291

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 774  IIGCGGFGLVYKATLTN--GTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
            I+G G FG VY+   TN  G K   AVK    DC    +E F +E   +    H ++V L
Sbjct: 31   ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 829  QGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAYLHK 885
             G        ++  +Y Y   G L ++L  + +   VL   +  L+I     + +AYL  
Sbjct: 91   IGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES 143
Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
            +   + VHRD+   NIL+       L DFGLSR +   D +  +     + ++ PE    
Sbjct: 144  I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 946  LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004
               T   DV+ F V + E+L+ G++P    + K+    V  V +      + ++    ++
Sbjct: 201  RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEKGDRLPKPDLCPPVLY 256
Query: 1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                         +  +C D DP  RP   E+V  L  +
Sbjct: 257  ------------TLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 774  IIGCGGFGLVYKATLTN--GTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
            I+G G FG VY+   TN  G K   AVK    DC    +E F +E   +    H ++V L
Sbjct: 15   ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 829  QGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAYLHK 885
             G        ++  +Y Y   G L ++L  + +   VL   +  L+I     + +AYL  
Sbjct: 75   IGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES 127
Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
            +   + VHRD+   NIL+       L DFGLSR +   D +  +     + ++ PE    
Sbjct: 128  I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 946  LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004
               T   DV+ F V + E+L+ G++P    + K+    V  V +      + ++    ++
Sbjct: 185  RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEKGDRLPKPDLCPPVLY 240
Query: 1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                         +  +C D DP  RP   E+V  L  +
Sbjct: 241  ------------TLMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 774  IIGCGGFGLVYKATLTN--GTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
            I+G G FG VY+   TN  G K   AVK    DC    +E F +E   +    H ++V L
Sbjct: 19   ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 829  QGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAYLHK 885
             G        ++  +Y Y   G L ++L  + +   VL   +  L+I     + +AYL  
Sbjct: 79   IGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES 131
Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
            +   + VHRD+   NIL+       L DFGLSR +   D +  +     + ++ PE    
Sbjct: 132  I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 946  LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004
               T   DV+ F V + E+L+ G++P    + K+    V  V +      + ++    ++
Sbjct: 189  RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEKGDRLPKPDLCPPVLY 244
Query: 1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                         +  +C D DP  RP   E+V  L  +
Sbjct: 245  ------------TLMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 767 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA- 820
            +F+   +IG G +  V      K       K   K L  D   ++   Q E     +A 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 67
Query: 821 QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
            H  LV L   C     RL  +  Y+  G L + +     +  + +   R   A+  +  
Sbjct: 68  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAE-ISLA 122
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 938
           L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT  T+   GT  YI
Sbjct: 123 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 177
Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKSEKR 994
            PE  +        D ++ GV++ E++ GR P ++    +  D     ++FQ+  EK+
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 103
Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           + +    R      +   Y+    +   L++ + K   L  D          RGL Y+H 
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYIPPEYS 943
               +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y  PE  
Sbjct: 163 A---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 944 QTLTATCRG-DVYSFGVVLLELLTGR 968
                  +  D++S G +L E+L+ R
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 20   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 833  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 80   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 131
Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 949
            IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+PPE  + ++++
Sbjct: 132  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 190
Query: 950  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 191  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 245
Query: 999  IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 246  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 275

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 755 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 806
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L      Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQD 91
Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 862
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 918
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 152 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG VYKA        AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
           + N+  ++  +   G++D  + E   +  + +  +++ + +     L YLH   +  I+H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQV-VCKQTLDALNYLH---DNKIIH 158
Query: 894 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
           RD+K+ NIL     +  LADFG+S    R ++  D+      +GT  ++ PE     T+ 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYWMAPEVVMCETSK 213
Query: 950 CR-----GDVYSFGVVLLELLTGRRP 970
            R      DV+S G+ L+E+     P
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLT--------NGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A                AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGA------- 876
           +++L G C       +I  Y   G+L  +L           +D+ R+   Q         
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 877 ----ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG VYKA        AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
           + N+  ++  +   G++D  + E   +  + +  +++ + +     L YLH   +  I+H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQV-VCKQTLDALNYLH---DNKIIH 158
Query: 894 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
           RD+K+ NIL     +  LADFG+S    R ++  D+      +GT  ++ PE     T+ 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS-----FIGTPYWMAPEVVMCETSK 213
Query: 950 CR-----GDVYSFGVVLLELLTGRRP 970
            R      DV+S G+ L+E+     P
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 17   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 833  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 77   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 128
Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 949
            IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+PPE  + ++++
Sbjct: 129  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 950  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 188  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 242
Query: 999  IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 243  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 272

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 11/203 (5%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQH-KNLVSLQGY 831
           IG G +G V K     +G   AVKR+     + E ++   +++ + R+     +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                D  +    M      ++ +     D V+  ++  KI     + L +L +  +  I
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--I 147
Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT-- 949
           +HRD+K SNILLD      L DFG+S  L   D+   T   G   Y+ PE      +   
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 950 --CRGDVYSFGVVLLELLTGRRP 970
              R DV+S G+ L EL TGR P
Sbjct: 206 YDVRSDVWSLGITLYELATGRFP 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H     + V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 198
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 88
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 142
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H     + V T  Y 
Sbjct: 143 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 199
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 767 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA- 820
            +F+   +IG G +  V      K       K   K L  D   ++   Q E     +A 
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 78
Query: 821 QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
            H  LV L   C     RL  +  Y+  G L + +     +  + +   R   A+  +  
Sbjct: 79  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAE-ISLA 133
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 938
           L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT  T+   GT  YI
Sbjct: 134 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 188
Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKSEKR 994
            PE  +        D ++ GV++ E++ GR P ++    +  D     ++FQ+  EK+
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 246

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L   +H+N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENI 85
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 139
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 140 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 77
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 136
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 137 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 191
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWL--------HESVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D    TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 44/223 (19%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVKRLSGDCGQMEREFQA-------EVE 815
           S + + +   +G G +G VYKA  T+TN T  A+KR+     ++E E +        EV 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNET-VAIKRI-----RLEHEEEGVPGTAIREVS 85
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
            L   QH+N++ L+    H +   LI+ Y EN      L + +DK+  +   V       
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-----LKKYMDKNPDVSMRVIKSFLYQ 140
Query: 876 AARGLAYLH-KVCEPHIVHRDVKSSNILL-----DEKFEAHLADFGLSRLLRPYDTHVTT 929
              G+ + H + C    +HRD+K  N+LL      E     + DFGL+R         T 
Sbjct: 141 LINGVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 930 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELL 965
           +++ TL Y PPE       YS ++      D++S   +  E+L
Sbjct: 197 EII-TLWYRPPEILLGSRHYSTSV------DIWSIACIWAEML 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 76
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 190
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 21/200 (10%)
Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG VYKA     G  AA K +     +   ++  E+E L+   H  +V L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
           H     ++  +   G++D  + E +D+  + +  +++ + +     L +LH      I+H
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLE-LDR-GLTEPQIQV-VCRQMLEALNFLH---SKRIIH 132
Query: 894 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPE--YSQTLT 947
           RD+K+ N+L+  + +  LADFG+S    + L+  D+      +GT  ++ PE    +T+ 
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-----FIGTPYWMAPEVVMCETMK 187
Query: 948 AT---CRGDVYSFGVVLLEL 964
            T    + D++S G+ L+E+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 21/200 (10%)
Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG VYKA     G  AA K +     +   ++  E+E L+   H  +V L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
           H     ++  +   G++D  + E +D+  + +  +++ + +     L +LH      I+H
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLE-LDR-GLTEPQIQV-VCRQMLEALNFLH---SKRIIH 140
Query: 894 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPE--YSQTLT 947
           RD+K+ N+L+  + +  LADFG+S    + L+  D+      +GT  ++ PE    +T+ 
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-----FIGTPYWMAPEVVMCETMK 195
Query: 948 AT---CRGDVYSFGVVLLEL 964
            T    + D++S G+ L+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D    TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 69/237 (29%), Positives = 106/237 (44%), Gaps = 40/237 (16%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L       +R+FQ E++ L +A H + +   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKY 76
Query: 830 GYCRHGNDRL---LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
               +G  R    L+  Y+ +G L         +D + +   RL     A+R L Y  ++
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCL---------RDFLQRHRARLD----ASRLLLYSSQI 123
Query: 887 CE-------PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLG 936
           C+          VHRD+ + NIL++ +    +ADFGL++LL P D     V       + 
Sbjct: 124 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIF 182
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 993
           +  PE       + + DV+SFGVVL EL T       C  K+C     ++  M SE+
Sbjct: 183 WYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCD-KSCSPSAEFLRMMGSER 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 88
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 147
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 148 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 202
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 111/229 (48%), Gaps = 20/229 (8%)
Query: 767 NNFNQANIIGCGGFGLVYK--ATLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
             + + + +G G +  VYK  + LT+   A  + RL  + G      + EV  L   +H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 60
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLA 881
           N+V+L           L++ Y     LD  L + +D   + +   +V+L + Q   RGLA
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQ-LLRGLA 114
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H+     ++HRD+K  N+L++E+ E  LADFGL+R  +   T    + V TL Y PP+
Sbjct: 115 YCHR---QKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPD 170
Query: 942 YSQTLT-ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
                T  + + D++  G +  E+ TGR    +  G    + + ++F++
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR---PLFPGSTVEEQLHFIFRI 216

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 80
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 139
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 140 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 194
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 76
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 190
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           ++ L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 769 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 825
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L   +H+N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENI 85
Query: 826 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 139
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 938
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 140 KYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 939 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 968
            PE         +  D++S G +L E+L+ R
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 95
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 154
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 155 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 209
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 767 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA- 820
            +F+   +IG G +  V      K       +   K L  D   ++   Q E     +A 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDW-VQTEKHVFEQAS 110
Query: 821 QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
            H  LV L   C     RL  +  Y+  G L + +     +  + +   R   A+  +  
Sbjct: 111 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAE-ISLA 165
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 938
           L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT  T+   GT  YI
Sbjct: 166 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYI 220
Query: 939 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKSEKR 994
            PE  +        D ++ GV++ E++ GR P ++    +  D     ++FQ+  EK+
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 76
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 190
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 155
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 214
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 215 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 269
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 270 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 89
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 148
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 149 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 203
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 204 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 88
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 147
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 148 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 202
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 81
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 140
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 141 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 195
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 196 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 107/257 (41%), Gaps = 43/257 (16%)
Query: 757 LTVSDLLKSTN-----------NFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSG 801
           LTV   L++ N           NF    ++G G +G V+     +G       A+K L  
Sbjct: 33  LTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK 92
Query: 802 DC----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE 856
                  +     + E + L   +    +    Y      +L LI  Y+  G L  + H 
Sbjct: 93  ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHL 150
Query: 857 SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL 916
           S  ++   + +V++ + +     L +LHK+    I++RD+K  NILLD      L DFGL
Sbjct: 151 S-QRERFTEHEVQIYVGE-IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG---------DVYSFGVVLLELLTG 967
           S+     +T    D  GT+ Y+ P+         RG         D +S GV++ ELLTG
Sbjct: 206 SKEFVADETERAYDFCGTIEYMAPD-------IVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 968 RRPVEVCKGKNCRDLVS 984
             P  V   KN +  +S
Sbjct: 259 ASPFTVDGEKNSQAEIS 275

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 84
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 143
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 144 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 198
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC-GQMEREFQAEVE-ALSRAQHKNLVSLQGY 831
            +G G +G+V K   + +G   AVKR+      Q ++    +++ ++        V+  G 
Sbjct: 15   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                 D  +    M+  SLD +  + +DK   +  D+  KIA    + L +LH   +  +
Sbjct: 75   LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSV 131
Query: 892  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-VGTLGYIPPEYS----QTL 946
            +HRDVK SN+L++   +  + DFG+S  L      V  D+  G   Y+ PE         
Sbjct: 132  IHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 947  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
              + + D++S G+ ++EL   R P +           SW    +  K+ VE     +   
Sbjct: 189  GYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQL--- 234
Query: 1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
              +K   E ++   +C+ ++ + RP   E++
Sbjct: 235  PADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 104
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 163
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 164 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 218
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 219 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 110
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 169
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 224
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 110
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 169
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 224
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 765 STNNFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQA--EVEALSRA 820
           + N F Q  ++G GGFG V   +   T    A  K       + + E  A  E + L + 
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 821 QHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA--- 876
             + +VSL  Y     D L L+ + M  G L + ++                + Q     
Sbjct: 242 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH---------------MGQAGFPE 285
Query: 877 ARGLAYLHKVC-------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
           AR + Y  ++C          IV+RD+K  NILLD+     ++D GL+  +   +     
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK 343
Query: 930 DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
             VGT+GY+ PE  +    T   D ++ G +L E++ G+ P +  K K  R+ V 
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQ-----MEREFQAEVEALSRAQHKNLVSL 828
           IG G FG V+   L  + T  AVK     C +     ++ +F  E   L +  H N+V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            G C       ++   ++ G    +L     + + L+    L++   AA G+ YL   C 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 943
              +HRD+ + N L+ EK    ++DFG+SR     +        G L  +P     PE  
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 944 QTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 984
                +   DV+SFG++L E  + G  P      +  R+ V 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 112
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 171
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 172 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 226
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 227 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 114
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 173
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 174 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 228
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 229 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 24/217 (11%)
Query: 765 STNNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR 819
           + ++F     +G G FG VY     K+      K   K      G +E + + E+E  + 
Sbjct: 21  TIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG-VEHQLRREIEIQAH 79
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
             H N++ L  Y        LI  Y   G L    ++ + K           I +  A  
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFDEQRTATIMEELADA 135
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGTL 935
           L Y H      ++HRD+K  N+LL  K E  +ADFG S        H  +     + GTL
Sbjct: 136 LMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWS-------VHAPSLRRKTMCGTL 185
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
            Y+PPE  +      + D++  GV+  ELL G  P E
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L       +R+FQ E++ L +A H + +   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKY 73
Query: 830 GYCRHGNDR---LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
               +G  R    L+  Y+ +G L         +D + +   RL     A+R L Y  ++
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCL---------RDFLQRHRARLD----ASRLLLYSSQI 120
Query: 887 CE-------PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           C+          VHRD+ + NIL++ +    +ADFGL++LL P D      +V   G  P
Sbjct: 121 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDXX--VVREPGQSP 177
Query: 940 -----PEYSQTLTATCRGDVYSFGVVLLELLT 966
                PE       + + DV+SFGVVL EL T
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 31/243 (12%)
Query: 807  EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW 866
            E   + E+  L + +H+N+V+L+      N   L+   +  G L       V+K    + 
Sbjct: 64   ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL---FDRIVEKGFYTEK 120
Query: 867  DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPY 923
            D    I Q     + YLH++    IVHRD+K  N+L    DE+ +  ++DFGLS++    
Sbjct: 121  DASTLIRQ-VLDAVYYLHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG 176
Query: 924  DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 983
            D  V +   GT GY+ PE       +   D +S GV+   LL G  P      +N   L 
Sbjct: 177  D--VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDSKLF 231
Query: 984  SWVFQMKSEKREVEIIDASIWH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVV--TW 1039
              + + + E       D+  W    D  K  +  L      +++DP +R   E+     W
Sbjct: 232  EQILKAEYE------FDSPYWDDISDSAKDFIRNL------MEKDPNKRYTCEQAARHPW 279
Query: 1040 LDG 1042
            + G
Sbjct: 280  IAG 282

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 114/246 (46%), Gaps = 26/246 (10%)
Query: 752 SDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA-----AVKRLSGDCGQM 806
           S+  +  ++ + K T    +  ++G G FG V+K       ++      +K +    G+ 
Sbjct: 17  SEKANKVLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR- 74
Query: 807 EREFQAEVE---ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDK 860
            + FQA  +   A+    H ++V L G C  G+   L+  Y+  GSL   + +   ++  
Sbjct: 75  -QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGP 132
Query: 861 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL 920
             +L W V++      A+G+ YL    E  +VHR++ + N+LL    +  +ADFG++ LL
Sbjct: 133 QLLLNWGVQI------AKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 183
Query: 921 RPYDTHVTTDLVGT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
            P D  +      T + ++  E       T + DV+S+GV + EL+T G  P    +   
Sbjct: 184 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 243
Query: 979 CRDLVS 984
             DL+ 
Sbjct: 244 VPDLLE 249

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G +G V+      G K AVK   + +     RE +     L R  H+N++       
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMR--HENILGFIAADI 101
Query: 834 HGN----DRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC- 887
            G        LI  Y ENGSL DY    ++D  S+LK      +A  +  GL +LH    
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLK------LAYSSVSGLCHLHTEIF 155
Query: 888 ----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT---TDLVGTLGYIPP 940
               +P I HRD+KS NIL+ +     +AD GL+         V       VGT  Y+PP
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 941 EY------SQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           E            +    D+YSFG++L E+   RR V
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCV 250

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 775 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 824
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 872
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 931
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L       +R+FQ E++ L +A H + +   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKY 89
Query: 830 GYCRHGNDRL---LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
               +G  R    L+  Y+ +G L         +D + +   RL     A+R L Y  ++
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCL---------RDFLQRHRARLD----ASRLLLYSSQI 136
Query: 887 CE-------PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLG 936
           C+          VHRD+ + NIL++ +    +ADFGL++LL P D     V       + 
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIF 195
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           +  PE       + + DV+SFGVVL EL T
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 765 STNNFNQANIIGCGGFGLVYKATL--TNGTKAAVKRLSGDCGQMEREFQA--EVEALSRA 820
           + N F Q  ++G GGFG V    +  T    A  K       + + E  A  E + L + 
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 821 QHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA--- 876
             + +VSL  Y     D L L+ + M  G L + ++                + Q     
Sbjct: 242 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH---------------MGQAGFPE 285
Query: 877 ARGLAYLHKVC-------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
           AR + Y  ++C          IV+RD+K  NILLD+     ++D GL+  +   +     
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK 343
Query: 930 DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
             VGT+GY+ PE  +    T   D ++ G +L E++ G+ P +  K K  R+ V 
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 775 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V    Y     N G   AVK+L       +R+FQ E++ L +A H + +   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKY 77
Query: 830 GYCRHGNDRL---LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
               +G  R    L+  Y+ +G L         +D + +   RL     A+R L Y  ++
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCL---------RDFLQRHRARLD----ASRLLLYSSQI 124
Query: 887 CE-------PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLG 936
           C+          VHRD+ + NIL++ +    +ADFGL++LL P D     V       + 
Sbjct: 125 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIF 183
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
           +  PE       + + DV+SFGVVL EL T
Sbjct: 184 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++   F   + DFG++R +   D +      G  G +P  
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 197
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLEL 964
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKXQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 832
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 833 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 159
Query: 888 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 937
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 217
Query: 938 IPPEY------SQTLTATCRGDVYSFGVVLLEL 964
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 766 TNNFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 820
           ++ +    ++G G FG V   K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++ L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDA-ARIIRQVLSGI 139
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            Y+HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYY 194
Query: 938 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 985
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 195 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQ-----MEREFQAEVEALSRAQHKNLVSL 828
           IG G FG V+   L  + T  AVK     C +     ++ +F  E   L +  H N+V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            G C       ++   ++ G    +L     + + L+    L++   AA G+ YL   C 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 943
              +HRD+ + N L+ EK    ++DFG+SR     +        G L  +P     PE  
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 944 QTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 984
                +   DV+SFG++L E  + G  P      +  R+ V 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++   F   + DFG++R +   D        G  G +P  
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 197
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLEL 964
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 32/287 (11%)
Query: 759  VSDLLKSTNNFNQANIIGCGGFGLVYKATLT--NGT--KAAVKRLSGD-CGQME-REFQA 812
            + D++   N      I+G G FG V +  L   +GT  K AVK +  D   Q E  EF +
Sbjct: 26   LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 813  EVEALSRAQHKNLVSLQGYCRHGNDR-----LLIYSYMENGSL-DYWLHESVDKDSV-LK 865
            E   +    H N++ L G C   + +     ++I  +M+ G L  Y L+  ++     + 
Sbjct: 86   EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 866  WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 925
                LK     A G+ YL      + +HRD+ + N +L +     +ADFGLS+ +   D 
Sbjct: 146  LQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 926  HVTTDLVGT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
            +    +    + +I  E       T + DV++FGV + E+ T  R +    G    ++  
Sbjct: 203  YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYD 260
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031
            ++      K+  + +D             E+ EI   C   DP  RP
Sbjct: 261  YLLHGHRLKQPEDCLD-------------ELYEIMYSCWRTDPLDRP 294

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++   F   + DFG++R +   D        G  G +P  
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 197
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLEL 964
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 39/279 (13%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 36   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 833  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 96   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 147
Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 949
            IVH D+K +N L+ +     L DFG++  ++P    V  D  VGT+ Y+PPE  + ++++
Sbjct: 148  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 950  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 207  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 261
Query: 999  IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 262  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 291

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 26/240 (10%)
Query: 758 TVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA-----AVKRLSGDCGQMEREFQA 812
            ++ + K T    +  ++G G FG V+K       ++      +K +    G+  + FQA
Sbjct: 5   VLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQA 61
Query: 813 EVE---ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKW 866
             +   A+    H ++V L G C  G+   L+  Y+  GSL   + +   ++    +L W
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 926
            V++      A+G+ YL    E  +VHR++ + N+LL    +  +ADFG++ LL P D  
Sbjct: 121 GVQI------AKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 927 VTTDLVGT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 984
           +      T + ++  E       T + DV+S+GV + EL+T G  P    +     DL+ 
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 832
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 833 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 146
Query: 888 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 937
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 204
Query: 938 IPPEY------SQTLTATCRGDVYSFGVVLLEL 964
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++   F   + DFG++R +   D        G  G +P  
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 194
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLEL 964
              PE  +    T   D++SFGVVL E+
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 61/242 (25%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 824
           +G G +G V  A    +G K A+K+LS       R FQ+E+ A         L   QH+N
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYW-LHESVDKDSVLKWDVRLKIAQGAA 877
           ++ L          R+  D  L+  +M+        L  S +K   L + +         
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM--------L 136
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---T 934
           +GL Y+H      +VHRD+K  N+ ++E  E  + DFGL+R       H   ++ G   T
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVT 186
Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 987
             Y  PE       Y+QT+      D++S G ++ E+LTG+    + KGK+  D ++ + 
Sbjct: 187 RWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK---TLFKGKDYLDQLTQIL 237
Query: 988 QM 989
           ++
Sbjct: 238 KV 239

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 61/242 (25%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 824
           +G G +G V  A    +G K A+K+LS       R FQ+E+ A         L   QH+N
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHE-SVDKDSVLKWDVRLKIAQGAA 877
           ++ L          R+  D  L+  +M+         E S +K   L + +         
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQM--------L 154
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---T 934
           +GL Y+H      +VHRD+K  N+ ++E  E  + DFGL+R       H   ++ G   T
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVT 204
Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 987
             Y  PE       Y+QT+      D++S G ++ E+LTG+    + KGK+  D ++ + 
Sbjct: 205 RWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK---TLFKGKDYLDQLTQIL 255
Query: 988 QM 989
           ++
Sbjct: 256 KV 257

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 864
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 107
Query: 865 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 108 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 159
Query: 925 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 160 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 214

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 864
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 119
Query: 865 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 120 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
Query: 925 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 864
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 865 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 130 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181
Query: 925 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 236

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 864
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 865 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 130 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181
Query: 925 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 236

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 864
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 109
Query: 865 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 110 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161
Query: 925 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 864
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 865 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 114 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165
Query: 925 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 166 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 220

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 767 NNFNQANIIGCGGFGLVYK-ATLTNGTKAAVKRLSGDCGQME--REFQAEVEALSRAQHK 823
             +N   ++G G FG V K        + AVK ++    + +       EVE L +  H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           N++ L       +   ++      G L     E + +    + D   +I +    G+ Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDA-ARIIKQVFSGITYM 137
Query: 884 HKVCEPHIVHRDVKSSNILLDEKF---EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           HK    +IVHRD+K  NILL+ K    +  + DFGLS   +        D +GT  YI P
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAP 192
Query: 941 EYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
           E  + T    C  DV+S GV+L  LL+G  P     GKN  D++  V
Sbjct: 193 EVLRGTYDEKC--DVWSAGVILYILLSGTPPF---YGKNEYDILKRV 234

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 864
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 69  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 127
Query: 865 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 128 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 179
Query: 925 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 180 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 234

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 774 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 884
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 87  HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 138
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 139 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTPNYIAPEVLS 194
Query: 945 TLTATCRGDVYSFGVVLLELLTGRRPVE 972
               +   DV+S G ++  LL G+ P E
Sbjct: 195 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 823
           ++   + +   +G GGF   Y+ T  +  +    ++      + +  Q E  +   A HK
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK-SMLLKPHQKEKMSTEIAIHK 97
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR---- 878
           +L +      HG        + E+    Y + E   + S+L+   R K + +  AR    
Sbjct: 98  SLDNPHVVGFHG--------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 879 ----GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               G+ YLH      ++HRD+K  N+ L++  +  + DFGL+  +  +D      L GT
Sbjct: 150 QTIQGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKTLCGT 205
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             YI PE       +   D++S G +L  LL G+ P E
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG VYKA        AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
           + N+  ++  +   G++D  + E     +  +  V   + +     L YLH   +  I+H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQV---VCKQTLDALNYLH---DNKIIH 158
Query: 894 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
           RD+K+ NIL     +  LADFG+S    R ++  D       +GT  ++ PE     T+ 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDX-----FIGTPYWMAPEVVMCETSK 213
Query: 950 CR-----GDVYSFGVVLLEL 964
            R      DV+S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++   F   + DFG++R +   D +      G  G +P  
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 196
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLEL 964
              PE  +    T   D++SFGVVL E+
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 774 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 884
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 83  HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 134
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 135 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTPNYIAPEVLS 190
Query: 945 TLTATCRGDVYSFGVVLLELLTGRRPVE 972
               +   DV+S G ++  LL G+ P E
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 774 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 884
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 83  HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 134
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 135 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTPNYIAPEVLS 190
Query: 945 TLTATCRGDVYSFGVVLLELLTGRRPVE 972
               +   DV+S G ++  LL G+ P E
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V 
Sbjct: 113 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV 166
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 823
           ++   + +   +G GGF   Y+ T  +  +    ++      + +  Q E  +   A HK
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK-SMLLKPHQKEKMSTEIAIHK 97
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR---- 878
           +L +      HG        + E+    Y + E   + S+L+   R K + +  AR    
Sbjct: 98  SLDNPHVVGFHG--------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 879 ----GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               G+ YLH      ++HRD+K  N+ L++  +  + DFGL+  +  +D      L GT
Sbjct: 150 QTIQGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKXLCGT 205
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             YI PE       +   D++S G +L  LL G+ P E
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 772 ANIIGCGGFGLVY--KATLTNGTKAAVKRLSGD-------CGQMEREFQAEVEALSRAQH 822
            + +G G FG V   +  LT G K AVK L+          G+++RE Q     L   +H
Sbjct: 16  GDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQN----LKLFRH 70
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            +++ L        D  ++  Y+  G L DY          V + + R ++ Q     + 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG----RVEEMEAR-RLFQQILSAVD 125
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H+     +VHRD+K  N+LLD    A +ADFGLS ++   D        G+  Y  PE
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPNYAAPE 180
Query: 942 Y-SQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             S  L A    D++S GV+L  LL G  P +
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           IG G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 147
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 200
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 NWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKXQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL----- 828
           +GCGG GLV+ A   +   + A+K++     Q  +    E++ + R  H N+V +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 829 ---------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
                     G     N   ++  YME       L   +++  +L+   RL + Q   RG
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQ-LLRG 132
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDT---HVTTDLVGTL 935
           L Y+H     +++HRD+K +N+ ++ E     + DFGL+R++ P+ +   H++  LV   
Sbjct: 133 LKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR 968
              P         T   D+++ G +  E+LTG+
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 775 IGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V K               + +   +   ++ E  AE   + +  +  +V + 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           G C      +L+    E G L+ +L ++   KD  +     +++    + G+ YL    E
Sbjct: 437 GICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE---E 487
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTL 946
            + VHRD+ + N+LL  +  A ++DFGLS+ LR  + +      G   + +  PE     
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
             + + DV+SFGV++ E  + G++P    KG
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 766 TNNFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 820
           ++ +    ++G G FG V   K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++ L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDA-ARIIRQVLSGI 162
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            Y+HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 163 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYY 217
Query: 938 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 985
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 218 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 274

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHRD+ + N ++   F   + DFG++R +  Y+T       G  G +P  
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETAYYRK--GGKGLLPVR 197
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLEL 964
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQHK 823
           + +     IG G +G+V  A     G + A+K++    D     +    E++ L   +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 824 NLVSLQGYCR----HGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGA 876
           N+++++   R    +G  +   ++   ME+      LH+ +     L  + VR  + Q  
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESD-----LHQIIHSSQPLTLEHVRYFLYQ-L 168
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYD-THVTTDLVG 933
            RGL Y+H      ++HRD+K SN+L++E  E  + DFG++R L   P +  +  T+ V 
Sbjct: 169 LRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 934 TLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 978
           T  Y  PE   +L    +  D++S G +  E+L  R   ++  GKN
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR---QLFPGKN 268

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 766 TNNFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 820
           ++ +    ++G G FG V   K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++ L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDA-ARIIRQVLSGI 163
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            Y+HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 164 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYY 218
Query: 938 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 985
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 219 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 275

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 775 IGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G G FG V K               + +   +   ++ E  AE   + +  +  +V + 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
           G C      +L+    E G L+ +L ++   KD  +     +++    + G+ YL    E
Sbjct: 438 GICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE---E 488
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTL 946
            + VHRD+ + N+LL  +  A ++DFGLS+ LR  + +      G   + +  PE     
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
             + + DV+SFGV++ E  + G++P    KG
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 579

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 18/181 (9%)
Query: 787 TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME 846
           T +N  K ++K    D       F+ E++ ++  +++  ++ +G   + ++  +IY YME
Sbjct: 74  TKSNNDKISIKSKYDD-------FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYME 126
Query: 847 NGSL----DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNIL 902
           N S+    +Y+     +    +   V   I +      +Y+H   E +I HRDVK SNIL
Sbjct: 127 NDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184
Query: 903 LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY--SQTLTATCRGDVYSFGVV 960
           +D+     L+DFG S  +   D  +     GT  ++PPE+  +++     + D++S G+ 
Sbjct: 185 MDKNGRVKLSDFGESEYM--VDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 961 L 961
           L
Sbjct: 242 L 242

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 774 IIGCGGFGLVYKATLTN-----GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G GGF   ++ +  +       K   K L     Q E+    E+       H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            G+    +   ++       SL   LH+   + ++ + + R  + Q    G  YLH+   
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSL-LELHKR--RKALTEPEARYYLRQ-IVLGCQYLHRN-- 160
Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA 948
             ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE       
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 949 TCRGDVYSFGVVLLELLTGRRPVE 972
           +   DV+S G ++  LL G+ P E
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 832
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 833 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 121
Query: 888 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 937
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 179
Query: 938 IPPEY------SQTLTATCRGDVYSFGVVLLEL 964
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 832
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 833 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 120
Query: 888 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 937
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 178
Query: 938 IPPEY------SQTLTATCRGDVYSFGVVLLEL 964
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 832
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 833 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 126
Query: 888 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 937
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 184
Query: 938 IPPEY------SQTLTATCRGDVYSFGVVLLEL 964
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 832
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 833 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 123
Query: 888 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 937
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 181
Query: 938 IPPEY------SQTLTATCRGDVYSFGVVLLEL 964
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 147
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 148 GLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYR 200
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 231

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 167
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 166
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 143
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYR 196
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 197 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 147
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 200
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 NWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 107/268 (39%), Gaps = 37/268 (13%)
Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            ++G G +G+VY    L+N  + A+K +     +  +    E+      +HKN+V   G  
Sbjct: 15   VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 833  RHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
                   +    +  GSL   L        D +  + +  +  +      GL YLH   +
Sbjct: 75   SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLH---D 126
Query: 889  PHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 947
              IVHRD+K  N+L++       ++DFG S+ L   +   T    GTL Y+ PE    + 
Sbjct: 127  NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPE---IID 182
Query: 948  ATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002
               RG     D++S G  ++E+ TG+ P               +F++  E  E    +A 
Sbjct: 183  KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 242
Query: 1003 IWHKDREKQLLEMLEIACKCIDQDPRRR 1030
             +                KC + DP +R
Sbjct: 243  AF--------------ILKCFEPDPDKR 256

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 17/210 (8%)
Query: 768 NFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQ---AEVEALSRA-QH 822
           +F    ++G G FG V+ A      +  A+K L  D   M+ + +    E   LS A +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA--RGL 880
             L  +    +   +   +  Y+  G L Y +       S  K+D+       A    GL
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ------SCHKFDLSRATFYAAEIILGL 131
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            +LH      IV+RD+K  NILLD+     +ADFG+ +     D   T    GT  YI P
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYIAP 187
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E           D +SFGV+L E+L G+ P
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 143
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYR 196
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 197 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 763 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 819
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA 877
             H N+V L       N   L++ +         LH+ + K  D+     + L + +   
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 878 ----RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDL 931
               +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     
Sbjct: 114 FQLLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-- 167
Query: 932 VGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           V TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 205

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 828
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 829 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 154
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 155 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 207
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 208 NWMHYNQTV------DIWSVGCIMAELLTGR 232

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 828
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 829 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 149
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIML 202
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 203 NWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 763 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 819
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA 877
             H N+V L       N   L++ +         LH+ + K  D+     + L + +   
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 878 ----RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDL 931
               +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     
Sbjct: 113 FQLLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-- 166
Query: 932 VGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           V TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++        RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIV 76
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 190
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 774 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 884
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 105 HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 156
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 157 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEVLS 212
Query: 945 TLTATCRGDVYSFGVVLLELLTGRRPVE 972
               +   DV+S G ++  LL G+ P E
Sbjct: 213 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++  D    +R    E++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 190
Query: 940 PEYSQTLTA-TCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 763 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 819
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAA 877
             H N+V L       N   L++ ++   S+D  L + +D  ++    + L  +      
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL---SMD--LKDFMDASALTGIPLPLIKSYLFQLL 115
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 116 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 169
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 170 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 203

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQHK 823
           + +     IG G +G+V  A     G + A+K++    D     +    E++ L   +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 824 NLVSLQGYCR----HGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGA 876
           N+++++   R    +G  +   ++   ME+      LH+ +     L  + VR  + Q  
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESD-----LHQIIHSSQPLTLEHVRYFLYQ-L 167
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYD-THVTTDLVG 933
            RGL Y+H      ++HRD+K SN+L++E  E  + DFG++R L   P +  +  T+ V 
Sbjct: 168 LRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 934 TLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 978
           T  Y  PE   +L    +  D++S G +  E+L  R   ++  GKN
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR---QLFPGKN 267

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 94/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKSQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 763 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 819
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAA 877
             H N+V L       N   L++ ++   S+D  L + +D  ++    + L  +      
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMD--LKDFMDASALTGIPLPLIKSYLFQLL 116
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 117 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 170
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 171 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 138
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 139 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 191
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 13/175 (7%)
Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 864
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 865 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 114 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165
Query: 925 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 976
                   G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 166 NXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++        RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIV 76
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 190
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 763 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 819
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAA 877
             H N+V L       N   L++ ++   S+D  L + +D  ++    + L  +      
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMD--LKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 117 QGLAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 170
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 171 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 138
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 139 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 191
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 147
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 200
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 NWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 70  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 121 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 174
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 175 WYRAPEILLGXKYYSTAV------DIWSLGCIFAEMVTRR 208

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 148
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 149 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 201
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 202 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 139
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 140 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 192
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 193 NWMHYNQTV------DIWSVGCIMAELLTGR 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRWYRAPEIML 195
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 140
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 141 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 193
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 194 NWMHYNQTV------DIWSVGCIMAELLTGR 218

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 148
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 149 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 201
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 202 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 138
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 139 GLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYR 191
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 70  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 121 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 174
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 175 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 208

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 147
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 148 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 200
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 156
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 157 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 209
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 210 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 159
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 160 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 212
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 213 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 155
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 156 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 208
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 209 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 139
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 140 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 192
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 193 NWMHYNQTV------DIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 138
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 191
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 NWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 769 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME--REFQAEVEALSRAQHKNL 825
           +N   ++G G FG V K        + AVK ++    + +       EVE L +  H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           + L       +   ++      G L     E + +    + D   +I +    G+ Y+HK
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK 139
Query: 886 VCEPHIVHRDVKSSNILLDEK---FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
               +IVHRD+K  NILL+ K    +  + DFGLS   +        D +GT  YI PE 
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEV 194
Query: 943 SQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
            + T    C  DV+S GV+L  LL+G  P     GKN  D++  V
Sbjct: 195 LRGTYDEKC--DVWSAGVILYILLSGTPPF---YGKNEYDILKRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 769 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME--REFQAEVEALSRAQHKNL 825
           +N   ++G G FG V K        + AVK ++    + +       EVE L +  H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           + L       +   ++      G L     E + +    + D   +I +    G+ Y+HK
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK 139
Query: 886 VCEPHIVHRDVKSSNILLDEK---FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
               +IVHRD+K  NILL+ K    +  + DFGLS   +        D +GT  YI PE 
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEV 194
Query: 943 SQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
            + T    C  DV+S GV+L  LL+G  P     GKN  D++  V
Sbjct: 195 LRGTYDEKC--DVWSAGVILYILLSGTPPF---YGKNEYDILKRV 234

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 143
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 196
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 197 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 167
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 142
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 143 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 195
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 166
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 138
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 139 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 191
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 156
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 157 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 209
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 210 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA---- 877
           H N+V L       N   L++ ++     D+        D+     + L + +       
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDF-------MDASALTGIPLPLIKSYLFQLL 113
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 167
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNAMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 141
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 142 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 194
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 195 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 81
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 82  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 135
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 136 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 188
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 189 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 142
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 143 GLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYR 195
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 167
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 155
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 156 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 208
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 209 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 768 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           ++    +IG G FG+VY+A L + G   A+K++        RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIV 76
Query: 827 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 190
Query: 940 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 968
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 138
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 191
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 NWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 167
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGXKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 114 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 167
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 203

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 166
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSR-AQ 821
           ++F+   +IG G FG V  A         AVK L        + E+   +E   L +  +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H  LV L    +  +    +  Y+  G L Y L     +   L+   R   A+ A+  L 
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIAS-ALG 153
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           YLH +   +IV+RD+K  NILLD +    L DFGL +    +++  T+   GT  Y+ PE
Sbjct: 154 YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPE 209
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                      D +  G VL E+L G  P
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHR++ + N ++   F   + DFG++R +   D +      G  G +P  
Sbjct: 146 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 198
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLEL 964
              PE  +    T   D++SFGVVL E+
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 31/239 (12%)
Query: 766 TNNFNQANIIGCGGFG--LVYKATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 820
           ++ +    ++G G FG  ++ K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N++ L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAA-RIIRQVLSGI 145
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            Y+HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 146 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYY 200
Query: 938 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 985
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 201 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 257

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 774 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 884
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 81  HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 133 R---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEVLS 188
Query: 945 TLTATCRGDVYSFGVVLLELLTGRRPVE 972
               +   DV+S G ++  LL G+ P E
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 763 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 819
           L    NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA 877
             H N+V L       N   L++ +         LH+ + K  D+     + L + +   
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 878 ----RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDL 931
               +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  
Sbjct: 114 FQLLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THE 167
Query: 932 VGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           V TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 205

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 114 LLQGLAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 167
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 203

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 16/216 (7%)
Query: 765 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA--EVEALSRAQ 821
           +T+ +     IG G +G VYKA    +G   A+K +    G+         EV  L R +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 822 ---HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIAQGA 876
              H N+V L   C        I   +    +D  L   +DK     L  +    + +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTL 935
            RGL +LH  C   IVHRD+K  NIL+       LADFGL+R+   Y   +  D +V TL
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVTL 175
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
            Y  PE     T     D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 114 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 167
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 203

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 775 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 939
           YL+       VHR++ + N ++   F   + DFG++R +   D +      G  G +P  
Sbjct: 145 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 197
Query: 940 ---PEYSQTLTATCRGDVYSFGVVLLEL 964
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 112 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 165
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 115 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 168
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 169 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 112 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 165
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 131 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 184 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAARG 879
           H N+V L       N   L++ ++   S+D  L + +D  ++    + L  +      +G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMD--LKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 880 LAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGY 937
           LA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL Y
Sbjct: 117 LAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 170
Query: 938 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
             PE       YS  +      D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 113 LLQGLAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 166
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 112 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 165
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 92
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 93  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 146
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 147 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 199
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 200 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 230

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 113/245 (46%), Gaps = 25/245 (10%)
Query: 741 LASSKLVLFQNS-DCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA---- 794
           + +++ + FQ S +  +  +  +LK T  F +  ++G G FG VYK   +  G K     
Sbjct: 14  IPTTENLYFQGSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV 72
Query: 795 AVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYW 853
           A+K L      +  +E   E   ++   + ++  L G C     +L I   M  G L  +
Sbjct: 73  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDY 131
Query: 854 LHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH 910
           + E  D      +L W V++      A+G+ YL    +  +VHRD+ + N+L+       
Sbjct: 132 VREHKDNIGSQYLLNWCVQI------AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVK 182
Query: 911 LADFGLSRLL--RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-G 967
           + DFGL++LL     + H     V  + ++  E       T + DV+S+GV + EL+T G
Sbjct: 183 ITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 241
Query: 968 RRPVE 972
            +P +
Sbjct: 242 SKPYD 246

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 32/272 (11%)
Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNL-VSLQGY 831
            +G G +G+V K   + +G   AVKR+      Q ++    +++   R       V+  G 
Sbjct: 42   LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 832  C-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
              R G+  + I   + + SLD +  + +DK   +  D+  KIA    + L +LH   +  
Sbjct: 102  LFREGD--VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 157
Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-VGTLGY-----IPPEYSQ 944
            ++HRDVK SN+L++   +    DFG+S  L      V  D+  G   Y     I PE +Q
Sbjct: 158  VIHRDVKPSNVLINALGQVKXCDFGISGYLV---DDVAKDIDAGCKPYXAPERINPELNQ 214
Query: 945  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004
                + + D++S G+  +EL   R P +           SW    +  K+ VE     + 
Sbjct: 215  K-GYSVKSDIWSLGITXIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQL- 261
Query: 1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                +K   E ++   +C+ ++ + RP   E+
Sbjct: 262  --PADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  A    +G + AVK +     Q       EV  +   QH N+V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 834 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
            G +  ++  +++ G+L D      ++++ +        + +   + LAYLH      ++
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT------VCEAVLQALAYLHA---QGVI 163
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY-SQTLTATCR 951
           HRD+KS +ILL       L+DFG    +   D      LVGT  ++ PE  S++L AT  
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKXLVGTPYWMAPEVISRSLYAT-E 221
Query: 952 GDVYSFGVVLLELLTGRRP 970
            D++S G++++E++ G  P
Sbjct: 222 VDIWSLGIMVIEMVDGEPP 240

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 16/218 (7%)
Query: 761 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMEREFQ---AEVE 815
           D +K T+ FN   ++G G FG V  A    GT+   A+K L  D    + + +    E  
Sbjct: 14  DRVKLTD-FNFLMVLGKGSFGKVMLAD-RKGTEELYAIKILKKDVVIQDDDVECTMVEKR 71
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
            L+       ++    C    DRL  +  Y+  G L Y + +        K    +  A 
Sbjct: 72  VLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAA 127
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
             + GL +LHK     I++RD+K  N++LD +    +ADFG+ +     D   T +  GT
Sbjct: 128 EISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMMDGVTTREFCGT 183
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             YI PE           D +++GV+L E+L G+ P +
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLA 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +     L 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 882 YLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGYIP 939
                C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL Y  
Sbjct: 114 QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRA 171
Query: 940 PE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           PE       YS  +      D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 113 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 166
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 828
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 829 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 148
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 149 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 201
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 202 NWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 24/232 (10%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTK-AAVKR--LSGDCGQMEREFQAEVEALSRAQHK 823
             + +   IG G +G V+KA      +  A+KR  L  D   +      E+  L   +HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           N+V L           L++ + +     Y+   + D D  +      ++     +GL + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL----KGLGFC 117
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 939
           H     +++HRD+K  N+L++   E  LADFGL+R     +R Y   V      TL Y P
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRP 169
Query: 940 PE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
           P+  +   L +T   D++S G +  EL    RP  +  G +  D +  +F++
Sbjct: 170 PDVLFGAKLYSTS-IDMWSAGCIFAELANAARP--LFPGNDVDDQLKRIFRL 218

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 128 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 181 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 877
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 878 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 933
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 112 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 165
Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 130 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 183 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 128 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 181 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLAYL 883
                      ND  L+ +++    L+     ++ K + L  D V+  I Q   RGL Y+
Sbjct: 85  VFTPARSLEEFNDVYLV-THLMGADLN-----NIVKCAKLTDDHVQFLIYQ-ILRGLKYI 137
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 941
           H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE  
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 942 -----YSQTLTATCRGDVYSFGVVLLELLTGR 968
                Y+QT+      D++S G ++ ELLTGR
Sbjct: 191 LNWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 142
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 143 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 195
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 761 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTK-AAVKRL-----SGDCGQMEREFQAEV 814
           D+      + + + +G G F  VYKA   N  +  A+K++     S     + R    E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
           + L    H N++ L     H ++  L++ +ME       L   +  +S++     +K   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-----LEVIIKDNSLVLTPSHIKAYM 118
Query: 875 -GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL----RPYDTHVTT 929
               +GL YLH+     I+HRD+K +N+LLDE     LADFGL++      R Y   V T
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVT 175
Query: 930 DLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELL 965
                  Y  PE      A   G   D+++ G +L ELL
Sbjct: 176 RW-----YRAPEL--LFGARMYGVGVDMWAVGCILAELL 207

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 132
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 133 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 186 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 41/295 (13%)
Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRL-------SGDCGQMEREFQAEVEALSR 819
            +  N    +G G FG V +A      K A  R         G      R   +E++ L  
Sbjct: 27   DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 820  -AQHKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLH----ESVDKDSVLKWDVRLK-- 871
               H N+V+L G C + G   ++I  + + G+L  +L     E V    + K  + L+  
Sbjct: 87   IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 872  --IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVT 928
               +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D    
Sbjct: 147  ICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSW 985
             D    L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L   
Sbjct: 204  GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--- 260
Query: 986  VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                  E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 261  -----KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 136
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 137 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 190 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 130 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 183 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 134 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 187 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 120
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 121 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 174 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 130 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 183 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 130 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 183 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/280 (22%), Positives = 107/280 (38%), Gaps = 35/280 (12%)
Query: 768  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----------GDCGQMEREFQAEVEA 816
            NF     IG G F  VY+A  L +G   A+K++            DC +       E++ 
Sbjct: 33   NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-------EIDL 85
Query: 817  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
            L +  H N++         N+  ++    + G L   +     +  ++      K     
Sbjct: 86   LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 877  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
               L ++H      ++HRD+K +N+ +       L D GL R      T     LVGT  
Sbjct: 146  CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPY 201
Query: 937  YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
            Y+ PE         + D++S G +L E+   + P    K             + S  +++
Sbjct: 202  YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLYSLCKKI 250
Query: 997  EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            E  D      D   +  E+ ++   CI+ DP +RP +  V
Sbjct: 251  EQCDYPPLPSDHYSE--ELRQLVNMCINPDPEKRPDVTYV 288

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 766 TNNFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 820
           ++ +    ++G G FG V   K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 821 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H N+  L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDA-ARIIRQVLSGI 139
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            Y HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 140 TYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKXKDKIGTAYY 194
Query: 938 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 985
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 195 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRL-------SGDCGQMEREFQAEVEALSR 819
           +  N    +G G FG V +A      K A  R         G      R   +E++ L  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 820 -AQHKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWL---------HESVDKDSVLKWDV 868
              H N+V+L G C + G   ++I  + + G+L  +L         ++ + KD  L  + 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD-FLTLEH 145
Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHV 927
            +  +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D   
Sbjct: 146 LIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR 202
Query: 928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 966
             D    L ++ PE       T + DV+SFGV+L E+ +
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 15/221 (6%)
Query: 759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 814
           V ++     +F    +IG G FG V    + N  +    ++      ++R     F+ E 
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 125
Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
           + L     + + +L    +  N   L+  Y   G L   L +  DK   L  D+      
Sbjct: 126 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK---LPEDMARFYIG 182
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
                +  +H++   H VHRD+K  N+LLD      LADFG    +    T  ++  VGT
Sbjct: 183 EMVLAIDSIHQL---HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGT 239
Query: 935 LGYIPPEYSQTLTATC-----RGDVYSFGVVLLELLTGRRP 970
             YI PE  Q +           D +S GV + E+L G  P
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + D+GL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 17/222 (7%)
Query: 759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 814
           V ++     +F    +IG G FG V    + N  +    ++      ++R     F+ E 
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 141
Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIA 873
           + L     + + +L    +  N   L+  Y   G L   L +  DK   L  D+ R  I 
Sbjct: 142 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK---LPEDMARFYIG 198
Query: 874 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 933
           +     +  +H++   H VHRD+K  N+LLD      LADFG    +    T  ++  VG
Sbjct: 199 E-MVLAIDSIHQL---HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVG 254
Query: 934 TLGYIPPEYSQTLTATC-----RGDVYSFGVVLLELLTGRRP 970
           T  YI PE  Q +           D +S GV + E+L G  P
Sbjct: 255 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---TL 935
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R       H   ++ G   T 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATR 186
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 187 WYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 118/290 (40%), Gaps = 45/290 (15%)
Query: 775  IGCGGFGLVYKATLTNGTKAAVKRL-------SGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A      K A  R         G      R   +E++ L     H N+V
Sbjct: 37   LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-----------ESVDKDSVLKWDVRLKIAQ 874
            +L G C + G   ++I  + + G+L  +L            E + KD  L  +  +  + 
Sbjct: 97   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD-FLTLEHLIXYSF 155
Query: 875  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVG 933
              A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D     D   
Sbjct: 156  QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 934  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMK 990
             L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L        
Sbjct: 213  PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------- 264
Query: 991  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
             E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 265  KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---TL 935
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R       H   ++ G   T 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATR 186
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 187 WYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 773 NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSL 828
            ++G GGFG V+   +   G   A K+L+    +  + +Q    E + L++   + +VSL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKV 886
                   D  L+ + M  G + Y ++ +VD+D+    + R     AQ    GL +LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQ-IVSGLEHLH-- 306
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
            + +I++RD+K  N+LLD+     ++D GL+  L+   T  T    GT G++ PE     
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 947 TATCRGDVYSFGVVLLELLTGRRPVEV 973
                 D ++ GV L E++  R P   
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 43/214 (20%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 138
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---TLGYIPPE 941
                 I+HRD+K SN+ ++E  E  + DFGL+R       H   ++ G   T  Y  PE
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPE 188
Query: 942 -------YSQTLTATCRGDVYSFGVVLLELLTGR 968
                  Y+QT+      D++S G ++ ELLTGR
Sbjct: 189 IMLNWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 159
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL---VGTL 935
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R       H   ++   V T 
Sbjct: 160 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATR 209
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 210 WYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 243

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 773 NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSL 828
            ++G GGFG V+   +   G   A K+L+    +  + +Q    E + L++   + +VSL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKV 886
                   D  L+ + M  G + Y ++ +VD+D+    + R     AQ    GL +LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQ-IVSGLEHLH-- 306
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
            + +I++RD+K  N+LLD+     ++D GL+  L+   T  T    GT G++ PE     
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 947 TATCRGDVYSFGVVLLELLTGRRPVEV 973
                 D ++ GV L E++  R P   
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 108/256 (42%), Gaps = 41/256 (16%)
Query: 769 FNQANIIGCGGFG--LVYKATLTNGTKA-AVKRLSGDCGQMEREFQAEVEALSRAQHKNL 825
           + +   +G G +G  L+ +  +T+  +A  + R +        +   EV  L    H N+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           + L  +     +  L+    + G L     E + +    + D  + I Q    G+ YLHK
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGEL---FDEIIHRMKFNEVDAAVIIKQ-VLSGVTYLHK 154
Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
               +IVHRD+K  N+LL+ K +  L    DFGLS +    +     + +GT  YI PE 
Sbjct: 155 ---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEV 209
Query: 943 -SQTLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGK-------------N 978
             +     C  DV+S GV+L  LL G  P           +V KGK              
Sbjct: 210 LRKKYDEKC--DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267
Query: 979 CRDLVSWVFQMKSEKR 994
            +DL+  + Q  S++R
Sbjct: 268 AKDLIKQMLQFDSQRR 283

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 773 NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSL 828
            ++G GGFG V+   +   G   A K+L+    +  + +Q    E + L++   + +VSL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKV 886
                   D  L+ + M  G + Y ++ +VD+D+    + R     AQ    GL +LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQ-IVSGLEHLH-- 306
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
            + +I++RD+K  N+LLD+     ++D GL+  L+   T  T    GT G++ PE     
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 947 TATCRGDVYSFGVVLLELLTGRRPVEV 973
                 D ++ GV L E++  R P   
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 37/209 (17%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLVS 827
           IG G +G+VYKA    G   A+K++     ++E+E +        E+  L   +H N+V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L          +L++ +++   L   L       ESV   S L     L++  G    +A
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-----LQLLNG----IA 114
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H   +  ++HRD+K  N+L++ + E  +ADFGL+R         T ++V TL Y  P+
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
Query: 942 Y---SQTLTATCRGDVYSFGVVLLELLTG 967
               S+  + T   D++S G +  E++ G
Sbjct: 171 VLMGSKKYSTTI--DIWSVGCIFAEMVNG 197

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTK-AAVKRLSGDCGQ------MEREFQAE 813
           L ++   +     IG G +G V+KA  L NG +  A+KR+    G+        RE  A 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AV 64
Query: 814 VEALSRAQHKNLVSLQGYCR-HGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDV 868
           +  L   +H N+V L   C     DR     L++ +++     Y   + V +  V    +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETI 122
Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 928
           +  + Q   RGL +LH      +VHRD+K  NIL+    +  LADFGL+R+   Y   + 
Sbjct: 123 KDMMFQ-LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMA 175
Query: 929 -TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
            T +V TL Y  PE     +     D++S G +  E+   R+P+
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 773 NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSL 828
            ++G GGFG V+   +   G   A K+L+    +  + +Q    E + L++   + +VSL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKV 886
                   D  L+ + M  G + Y ++ +VD+D+    + R     AQ    GL +LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQ-IVSGLEHLH-- 306
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
            + +I++RD+K  N+LLD+     ++D GL+  L+   T  T    GT G++ PE     
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 947 TATCRGDVYSFGVVLLELLTGRRPVEV 973
                 D ++ GV L E++  R P   
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 166
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 45/213 (21%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLVS 827
           IG G +G+VYKA    G   A+K++     ++E+E +        E+  L   +H N+V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L          +L++ +++   L   L       ESV   S L     L++  G    +A
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-----LQLLNG----IA 114
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGY 937
           Y H   +  ++HRD+K  N+L++ + E  +ADFGL+R     +R Y     T  V TL Y
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-----THEVVTLWY 166
Query: 938 IPPEY---SQTLTATCRGDVYSFGVVLLELLTG 967
             P+    S+  + T   D++S G +  E++ G
Sbjct: 167 RAPDVLMGSKKYSTTI--DIWSVGCIFAEMVNG 197

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 166
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 32/207 (15%)
Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           IG G +G+V+K      G   A+K+   S D   +++    E+  L + +H NLV+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
            R      L++ Y ++  L    HE       +   +   I     + + + HK    + 
Sbjct: 71  FRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNC 123
Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRP----YDTHVTTD-------LVGTLGYIPP 940
           +HRDVK  NIL+ +     L DFG +RLL      YD  V T        LVG   Y PP
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTG 967
                       DV++ G V  ELL+G
Sbjct: 184 V-----------DVWAIGCVFAELLSG 199

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 45/213 (21%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLVS 827
           IG G +G+VYKA    G   A+K++     ++E+E +        E+  L   +H N+V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 881
           L          +L++ +++   L   L       ESV   S L     L++  G    +A
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-----LQLLNG----IA 114
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGY 937
           Y H   +  ++HRD+K  N+L++ + E  +ADFGL+R     +R Y     T  V TL Y
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-----THEVVTLWY 166
Query: 938 IPPEY---SQTLTATCRGDVYSFGVVLLELLTG 967
             P+    S+  + T   D++S G +  E++ G
Sbjct: 167 RAPDVLMGSKKYSTTI--DIWSVGCIFAEMVNG 197

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 156
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL---VGTL 935
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R       H   ++   V T 
Sbjct: 157 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATR 206
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 207 WYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 240

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAA-----VKRLSG-DCGQMEREFQAEVEA 816
           K ++N++    +G G F +V +    T G + A      K+LS  D  ++ERE       
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 58
Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q  
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-I 114
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVG 933
              +AY H      IVHR++K  N+LL  K +     LADFGL+  +   D+       G
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 169
Query: 934 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T GY+ PE  +    +   D+++ GV+L  LL G  P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAA-----VKRLSG-DCGQMEREFQAEVEA 816
           K ++N++    +G G F +V +    T G + A      K+LS  D  ++ERE       
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 57
Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q  
Sbjct: 58  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-I 113
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVG 933
              +AY H      IVHR++K  N+LL  K +     LADFGL+  +   D+       G
Sbjct: 114 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 168
Query: 934 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T GY+ PE  +    +   D+++ GV+L  LL G  P
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAA-----VKRLSG-DCGQMEREFQAEVEA 816
           K ++N++    +G G F +V +    T G + A      K+LS  D  ++ERE       
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 58
Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q  
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-I 114
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVG 933
              +AY H      IVHR++K  N+LL  K +     LADFGL+  +   D+       G
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 169
Query: 934 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T GY+ PE  +    +   D+++ GV+L  LL G  P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAARG 879
           H N+V L       N   L++ +++       L + +D  ++    + L  +      +G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-----LKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 880 LAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGY 937
           LA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL Y
Sbjct: 119 LAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 172
Query: 938 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
             PE       YS  +      D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK-----RLSG-DCGQMEREFQAEVEA 816
           K ++N++    +G G F +V +    T G + A K     +LS  D  ++ERE       
Sbjct: 26  KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 81
Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q  
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-I 137
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVG 933
              +AY H      IVHR++K  N+LL  K +     LADFGL+  +   D+       G
Sbjct: 138 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 192
Query: 934 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T GY+ PE  +    +   D+++ GV+L  LL G  P
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 102/239 (42%), Gaps = 20/239 (8%)
Query: 758 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAE 813
           T +D      N+     IG G F  V  A  +  G + AVK   +   +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-E 63
Query: 814 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 872
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   + T   
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FC 173
Query: 933 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 123
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 124 ----AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 177 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 877
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 878 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 935
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 115 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 168
Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 169 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 102/239 (42%), Gaps = 20/239 (8%)
Query: 758 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAE 813
           T +D      N+     IG G F  V  A  +  G + AVK   +   +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-E 63
Query: 814 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 872
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   + T   
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FC 173
Query: 933 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 128/302 (42%), Gaps = 60/302 (19%)
Query: 763  LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            L+  ++F +  ++G G FG V KA    +    A+K++     ++     +EV  L+   
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLN 60
Query: 822  H-------------KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWD 867
            H             +N V      +  +   +   Y ENG+L   +H E++++     W 
Sbjct: 61   HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 868  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-------LL 920
            +  +I +     L+Y+H      I+HRD+K  NI +DE     + DFGL++       +L
Sbjct: 121  LFRQILEA----LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 921  R------PYDTHVTTDLVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELL----TGRR 969
            +      P  +   T  +GT  Y+  E    T     + D+YS G++  E++    TG  
Sbjct: 174  KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 970  PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1029
             V + K       VS  F    +  ++++          EK+++ +L      ID DP +
Sbjct: 234  RVNILKKLRS---VSIEFPPDFDDNKMKV----------EKKIIRLL------IDHDPNK 274
Query: 1030 RP 1031
            RP
Sbjct: 275  RP 276

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 113/254 (44%), Gaps = 26/254 (10%)
Query: 733 RPQRLSEALASSKLV--LFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LT 789
           R + L   L   +LV  L  + +  +  +  +LK T  F +  ++G G FG VYK   + 
Sbjct: 14  RKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIP 72
Query: 790 NGTK-----AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 844
            G K     A ++       +  +E   E   ++   + ++  L G C     +L I   
Sbjct: 73  EGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQL 131
Query: 845 MENGSLDYWLHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNI 901
           M  G L  ++ E  D      +L W V++      A+G+ YL    +  +VHRD+ + N+
Sbjct: 132 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE---DRRLVHRDLAARNV 182
Query: 902 LLDEKFEAHLADFGLSRLL--RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGV 959
           L+       + DFGL++LL     + H     V  + ++  E       T + DV+S+GV
Sbjct: 183 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGV 241
Query: 960 VLLELLT-GRRPVE 972
            + EL+T G +P +
Sbjct: 242 TVWELMTFGSKPYD 255

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 765 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 821
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAARG 879
           H N+V L       N   L++ ++        L   +D  ++    + L  +      +G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKTFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 880 LAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGY 937
           LA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL Y
Sbjct: 119 LAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 172
Query: 938 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
             PE       YS  +      D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 123/293 (41%), Gaps = 43/293 (14%)
Query: 759  VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNG----TKAAVKRLSGD--CGQMEREFQA 812
            + D+L     F    ++G G FG V +A L        K AVK L  D        EF  
Sbjct: 15   LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 813  EVEALSRAQHKNLVSLQGYCRHGNDR------LLIYSYMENGSLDYWLHESVDKDSVLKW 866
            E   +    H ++  L G       +      ++I  +M++G L  +L  S   ++    
Sbjct: 75   EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 867  DVR--LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
             ++  ++     A G+ YL      + +HRD+ + N +L E     +ADFGLSR +   D
Sbjct: 135  PLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 925  THVTTDLVGTLGYIPPEY--SQTLT---ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             +      G    +P ++   ++L     T   DV++FGV + E++T G+ P     G  
Sbjct: 192  YYRQ----GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY---AGIE 244
Query: 979  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031
              ++ +++      K+  E ++             E+ ++  +C   DP++RP
Sbjct: 245  NAEIYNYLIGGNRLKQPPECME-------------EVYDLMYQCWSADPKQRP 284

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 813 EVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
           EV+ L +   H N++ L+          L++  M+ G L  +L E V     L      K
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRK 115
Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
           I +     +  LHK+   +IVHRD+K  NILLD+     L DFG S  L P +     ++
Sbjct: 116 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 170
Query: 932 VGTLGYIPPEYSQ-TLTATCRG-----DVYSFGVVLLELLTGRRP 970
            GT  Y+ PE  + ++     G     D++S GV++  LL G  P
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 772 ANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQ 829
           + ++G G +  V  A +L NG + AVK +    G        EVE L + Q +KN++ L 
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
            +        L++  ++ GS+       + K          ++ +  A  L +LH     
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSI----LAHIQKQKHFNEREASRVVRDVAAALDFLHT---K 130
Query: 890 HIVHRDVKSSNILLD--EKFE-AHLADFGLSRLLR------PYDTHVTTDLVGTLGYIPP 940
            I HRD+K  NIL +  EK     + DF L   ++      P  T   T   G+  Y+ P
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 941 EYSQTLTATC-----RGDVYSFGVVLLELLTGRRPVEVCKGKNC 979
           E  +  T        R D++S GVVL  +L+G  P     G +C
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADC 234

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNL---VSLQ 829
           +G G +G V++  L +G   AVK  S    + E+ +  E E  +    +H N+   ++  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSS---RDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 830 GYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC- 887
              R+ + +L LI  Y E+GSL  +L         L+  + L++A  AA GLA+LH    
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT-----LEPHLALRLAVSAACGLAHLHVEIF 126
Query: 888 ----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGTLGYIPP 940
               +P I HRD KS N+L+    +  +AD GL+ +      ++       VGT  Y+ P
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 941 EY-SQTLTATC-----RGDVYSFGVVLLELLTGRRPV 971
           E   + +   C       D+++FG+VL E+   RR +
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 775 IGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYC 832
           +G G F +  K       +A AVK +S    +ME   Q E+ AL   + H N+V L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 833 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                  L+   +  G L     E + K           I +     ++++H V    +V
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VV 128
Query: 893 HRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
           HRD+K  N+L    ++  E  + DFG +RL +P D         TL Y  PE        
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPCFTLHYAAPELLNQNGYD 187
Query: 950 CRGDVYSFGVVLLELLTGRRPVE 972
              D++S GV+L  +L+G+ P +
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 123/300 (41%), Gaps = 48/300 (16%)
Query: 767  NNFNQANIIGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR 819
            +  N    +G G FG V +A       T T  T A      G      R   +E++ L  
Sbjct: 28   DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 820  -AQHKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLH------------ESVDKDSVLK 865
               H N+V+L G C + G   ++I  + + G+L  +L             E + KD  L 
Sbjct: 88   IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKD-FLT 146
Query: 866  WDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPY 923
             +  +  +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  
Sbjct: 147  LEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 924  DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCR 980
            D     D    L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR
Sbjct: 203  DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 981  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
             L         E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 263  RL--------KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 30/234 (12%)
Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAEVEALSRAQHK 823
           N+     IG G F  V  A  +  G + AVK +     +   +++ F+ EV  +    H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSL-DY-----WLHESVDKDSVLKWDVRLKIAQGAA 877
           N+V L           L+  Y   G + DY     W+ E          + R K  Q  +
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK---------EARAKFRQIVS 117
Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
             + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   + T   G+  Y
Sbjct: 118 -AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FCGSPPY 171
Query: 938 IPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
             PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 172 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 813 EVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
           EV+ L +   H N++ L+          L++  M+ G L  +L E V     L      K
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRK 128
Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
           I +     +  LHK+   +IVHRD+K  NILLD+     L DFG S  L P +     ++
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 183
Query: 932 VGTLGYIPPEYSQ-TLTATCRG-----DVYSFGVVLLELLTGRRP 970
            GT  Y+ PE  + ++     G     D++S GV++  LL G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 102/239 (42%), Gaps = 20/239 (8%)
Query: 758 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAE 813
           T +D      N+     IG G F  V  A  +  G + AV+   +   +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-E 63
Query: 814 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 872
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   + T   
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FC 173
Query: 933 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 767 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAARGLA 881
           N+V L       N   L++ ++        L   +D  ++    + L  +      +GLA
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD-----LKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 882 YLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGYIP 939
           +    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL Y  
Sbjct: 117 F----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRA 170
Query: 940 PE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           PE       YS  +      D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 765 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA--EVEALSRAQ 821
           +T+ +     IG G +G VYKA    +G   A+K +    G+         EV  L R +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 822 ---HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIAQGA 876
              H N+V L   C        I   +    +D  L   +DK     L  +    + +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTL 935
            RGL +LH  C   IVHRD+K  NIL+       LADFGL+R+   Y   +    +V TL
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVTL 175
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
            Y  PE     T     D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 115/266 (43%), Gaps = 34/266 (12%)
Query: 767  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQAEVEAL---- 817
            + +    ++G GGFG VY    +++    A+K +      D G++    +  +E +    
Sbjct: 8    SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 818  SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
              +    ++ L  +    +  +LI   ME       L + + +   L+ ++         
Sbjct: 68   VSSGFSGVIRLLDWFERPDSFVLILERMEPVQD---LFDFITERGALQEELARSFFWQVL 124
Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              + + H      ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  
Sbjct: 125  EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRV 178
Query: 937  YIPPEYSQTLTATCR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDL 982
            Y PPE+ +      R   V+S G++L +++ G  P     E+ +G+          C+ L
Sbjct: 179  YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHL 238
Query: 983  VSWVFQMK-SEKREVEIIDASIWHKD 1007
            + W   ++ S++   E I    W +D
Sbjct: 239  IRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 775 IGCGGFGLVYKA-TLTNGTK-AAVKRLSGDCGQ------MEREFQAEVEALSRAQHKNLV 826
           IG G +G V+KA  L NG +  A+KR+    G+        RE  A +  L   +H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 77
Query: 827 SLQGYCR-HGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            L   C     DR     L++ +++     Y   + V +  V    ++  + Q   RGL 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQ-LLRGLD 134
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPP 940
           +LH      +VHRD+K  NIL+    +  LADFGL+R+   Y   +  T +V TL Y  P
Sbjct: 135 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAP 188
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           E     +     D++S G +  E+   R+P+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 775 IGCGGFGLVYKA-TLTNGTK-AAVKRLSGDCGQ------MEREFQAEVEALSRAQHKNLV 826
           IG G +G V+KA  L NG +  A+KR+    G+        RE  A +  L   +H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 77
Query: 827 SLQGYCR-HGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            L   C     DR     L++ +++     Y   + V +  V    ++  + Q   RGL 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQ-LLRGLD 134
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPP 940
           +LH      +VHRD+K  NIL+    +  LADFGL+R+   Y   +  T +V TL Y  P
Sbjct: 135 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAP 188
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
           E     +     D++S G +  E+   R+P+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  +  + +G K AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 111
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 165
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 166 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 218
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+ T+      D++S G ++ ELLTGR
Sbjct: 219 APEIMLNWMHYNMTV------DIWSVGCIMAELLTGR 249

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 16/218 (7%)
Query: 761 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMEREFQ---AEVE 815
           D +K T+ FN   ++G G FG V  +    GT    AVK L  D    + + +    E  
Sbjct: 15  DRMKLTD-FNFLMVLGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
            L+       ++    C    DRL  +  Y+  G L Y + +        K    +  A 
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAA 128
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
             A GL +L       I++RD+K  N++LD +    +ADFG+ +    +D   T    GT
Sbjct: 129 EIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGT 184
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             YI PE           D ++FGV+L E+L G+ P E
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 24/232 (10%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTK-AAVKR--LSGDCGQMEREFQAEVEALSRAQHK 823
             + +   IG G +G V+KA      +  A+KR  L  D   +      E+  L   +HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           N+V L           L++ + +     Y+   + D D  +      ++     +GL + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL----KGLGFC 117
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 939
           H     +++HRD+K  N+L++   E  LA+FGL+R     +R Y   V      TL Y P
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRP 169
Query: 940 PE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
           P+  +   L +T   D++S G +  EL    RP  +  G +  D +  +F++
Sbjct: 170 PDVLFGAKLYSTS-IDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRL 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++  G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 134 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 187 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  +  FGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 29   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 88
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 89   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 145
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 146  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 202
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 203  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 259
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 260  IPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 312

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 131 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 184 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRLSGDCG-QMEREFQAEVE 815
           +LK T    +  ++G G FG VYK   + +G       A+K L  +   +  +E   E  
Sbjct: 13  ILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++      +  L G C     +L +   M  G L   + E+  +     +L W +++  
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI-- 128
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
               A+G++YL  V    +VHRD+ + N+L+       + DFGL+RLL   +T    D  
Sbjct: 129 ----AKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-- 179
Query: 933 GTLGYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 984
              G +P ++    +      T + DV+S+GV + EL+T G +P +    +   DL+ 
Sbjct: 180 --GGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 235

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 830
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 831 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
                 I+HRD+K SN+ ++E  E  + DF L+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGR 968
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 134  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 190
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 191  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 250
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 251  TFEEIQNHPWMQD 263

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 16/218 (7%)
Query: 761 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMEREFQ---AEVE 815
           D +K T+ FN   ++G G FG V   +   GT    AVK L  D    + + +    E  
Sbjct: 336 DRMKLTD-FNFLMVLGKGSFGKVM-LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
            L+       ++    C    DRL  +  Y+  G L Y + +        K    +  A 
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAA 449
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
             A GL +L       I++RD+K  N++LD +    +ADFG+ +    +D   T    GT
Sbjct: 450 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGT 505
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
             YI PE           D ++FGV+L E+L G+ P E
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 765 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA--EVEALSRAQ 821
           +T+ +     IG G +G VYKA    +G   A+K +    G+         EV  L R +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 822 ---HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIAQGA 876
              H N+V L   C        I   +    +D  L   +DK     L  +    + +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGTL 935
            RGL +LH  C   IVHRD+K  NIL+       LADFGL+R+   Y   +    +V TL
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVTL 175
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
            Y  PE     T     D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 131  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 187
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 188  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRP 247
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 248  TFEEIQNHPWMQD 260

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + D GL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 65/239 (27%), Positives = 101/239 (42%), Gaps = 20/239 (8%)
Query: 758 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAE 813
           + +D      N+     IG G F  V  A  +  G + AVK   +   +   +++ F+ E
Sbjct: 6   SATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-E 64
Query: 814 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 872
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 120
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            Q     + Y H   + +IVHRD+K+ N+LLD      +ADFG S      +   T    
Sbjct: 121 RQ-IVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FC 174
Query: 933 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 230

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++  G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 134 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 187 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++  G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 124/286 (43%), Gaps = 39/286 (13%)
Query: 747  VLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----G 801
            VLFQ    K+    + L+S   +    ++G GGFG VY    +++    A+K +      
Sbjct: 16   VLFQGPHMKE---KEPLES--QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 70
Query: 802  DCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES 857
            D G++    +  +E +      +    ++ L  +    +  +LI   +E       L + 
Sbjct: 71   DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDF 127
Query: 858  VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGL 916
            + +   L+ ++           + + H      ++HRD+K  NIL+D  + E  L DFG 
Sbjct: 128  ITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 184
Query: 917  SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGRRPV---- 971
              LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G  P     
Sbjct: 185  GALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 241
Query: 972  EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
            E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 242  EIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 287

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 24   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 83
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 84   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 140
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 141  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 197
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 198  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 255  IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 134 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 187 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 815
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 872
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 930
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 972
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 9    LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 68
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 69   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 125
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 126  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 182
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 183  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 240  IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 813 EVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
           EV+ L +   H N++ L+          L++  M+ G L  +L E V     L      K
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRK 128
Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
           I +     +  LHK+   +IVHRD+K  NILLD+     L DFG S  L P +      +
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRSV 183
Query: 932 VGTLGYIPPEYSQ-TLTATCRG-----DVYSFGVVLLELLTGRRP 970
            GT  Y+ PE  + ++     G     D++S GV++  LL G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 24   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 83
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 84   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 140
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 141  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 197
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 198  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 255  IPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + D GL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 101/239 (42%), Gaps = 20/239 (8%)
Query: 758 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAE 813
           T +D      N+     IG G F  V  A  +  G + AV+ +     +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-E 63
Query: 814 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 872
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S        +   +  
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF--GNKLDEFC 173
Query: 933 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 775 IGCGGFGLVYKATLTNGTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLV----S 827
           IG G F  VYK   T  T   A  +       + ER+ F+ E E L   QH N+V    S
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHE-SVDKDSVLK-WDVRLKIAQGAARGLAYLHK 885
            +   +     +L+     +G+L  +L    V K  VL+ W       +   +GL +LH 
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQFLHT 147
Query: 886 VCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YS 943
              P I+HRD+K  NI +        + D GL+ L R         ++GT  +  PE Y 
Sbjct: 148 RTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFXAPEXYE 203
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRPVEVCK 975
           +    +   DVY+FG   LE  T   P   C+
Sbjct: 204 EKYDESV--DVYAFGXCXLEXATSEYPYSECQ 233

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 16/207 (7%)
Query: 769 FNQANIIGCGGFGLVYKATLTNGTK--AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           +   N IG G +G V K  +  GT+   A K++     +    F+ E+E +    H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            L        D  L+      G     L E V    V +     +I +     +AY HK+
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 887 CEPHIVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              ++ HRD+K  N L           L DFGL+   +P     T   VGT  Y+ P+  
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVL 180
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           + L      D +S GV++  LL G  P
Sbjct: 181 EGLYGP-ECDEWSAGVMMYVLLCGYPP 206

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 28/219 (12%)
Query: 772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
             +IG G FG VY           +  +  D     + F+ EV A  + +H+N+V   G 
Sbjct: 38  GELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKVCEP 889
           C       +I S  +  +L      SV +D+ +  DV    +IAQ   +G+ YLH     
Sbjct: 98  CMSPPHLAIITSLCKGRTL-----YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 890 HIVHRDVKSSNILLDEKFEAHLADFGLS---------------RLLRPYDTHVTTDLVGT 934
            I+H+D+KS N+  D   +  + DFGL                R+   +  H+  +++  
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV 973
           L   P      L  +   DV++ G +  EL     P + 
Sbjct: 209 LS--PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 120/285 (42%), Gaps = 40/285 (14%)
Query: 754  CKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----GD 802
            C DL  + L          + +    ++G GGFG VY    +++    A+K +      D
Sbjct: 24   CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 83
Query: 803  CGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV 858
             G++    +  +E +      +    ++ L  +    +  +LI   +E       L + +
Sbjct: 84   WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFI 140
Query: 859  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLS 917
             +   L+ ++           + + H      ++HRD+K  NIL+D  + E  L DFG  
Sbjct: 141  TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 197
Query: 918  RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGRRPV----E 972
             LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G  P     E
Sbjct: 198  ALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254
Query: 973  VCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
            + +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 255  IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 769 FNQANIIGCGGFGLVYKATLTNGTK--AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
           +   N IG G +G V K  +  GT+   A K++     +    F+ E+E +    H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            L        D  L+      G     L E V    V +     +I +     +AY HK+
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 142
Query: 887 CEPHIVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              ++ HRD+K  N L           L DFGL+   +P     T   VGT  Y+ P+  
Sbjct: 143 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVL 197
Query: 944 QTLTA-TCRGDVYSFGVVLLELLTGRRP 970
           + L    C  D +S GV++  LL G  P
Sbjct: 198 EGLYGPEC--DEWSAGVMMYVLLCGYPP 223

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 136  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 192
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 193  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 252
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 253  TFEEIQNHPWMQD 265

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 129/302 (42%), Gaps = 67/302 (22%)
Query: 769  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER-----------------EFQ 811
            FN++  +G G F  ++K          V+R  GD GQ+                    F 
Sbjct: 12   FNES--LGQGTFTKIFKG---------VRREVGDYGQLHETEVLLKVLDKAHRNYSESFF 60
Query: 812  AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
                 +S+  HK+LV   G C  G++ +L+  +++ GSLD +L ++ +  ++L W  +L+
Sbjct: 61   EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLE 117
Query: 872  IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA--------HLADFGLSRLLRPY 923
            +A+  A  + +L    E  ++H +V + NILL  + +          L+D G+S  + P 
Sbjct: 118  VAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 924  DTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD 981
            D      L   + ++PPE            D +SFG  L E+ + G +P+     +  R 
Sbjct: 175  DI-----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RK 227
Query: 982  LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
            L     Q   ++ ++    A+           E+  +   C+D +P  RP    ++  L+
Sbjct: 228  L-----QFYEDRHQLPAPKAA-----------ELANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 1042 GI 1043
             +
Sbjct: 272  SL 273

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 178  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 234
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 235  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 294
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 295  TFEEIQNHPWMQD 307

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 71/290 (24%), Positives = 125/290 (43%), Gaps = 35/290 (12%)
Query: 767  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVK-----RLSGDCGQMERE-FQAEVEALSR 819
            +++     +G G F +V K      G + A K     RLS     + RE  + EV  L  
Sbjct: 5    DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
             +H N+++L     +  D +LI   +  G L  +L E   K+S+ + D   +  +    G
Sbjct: 65   IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTE-DEATQFLKQILDG 120
Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTL 935
            + YLH      I H D+K  NI+L +K        L DFG++  +   +     ++ GT 
Sbjct: 121  VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTP 175
Query: 936  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
             ++ PE           D++S GV+   LL+G  P     G+  ++ ++ +  +  +  E
Sbjct: 176  EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGETKQETLTNISAVNYDFDE 232
Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV--TWLDGI 1043
                + S   KD  ++LL           +DP+RR  I + +  +W+  I
Sbjct: 233  EYFSNTSELAKDFIRRLLV----------KDPKRRMTIAQSLEHSWIKAI 272

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 151  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 207
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 208  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 267
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 268  TFEEIQNHPWMQD 280

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 57/221 (25%)
Query: 775 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQH 822
           +G G +G V   Y A L    K AVK+LS       R FQ+         E+  L   +H
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLS-------RPFQSLIHARRTYRELRLLKHLKH 78
Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWD------VRLKIAQ 874
           +N++ L        D     + +E+ S  Y +      D ++++K        V+  + Q
Sbjct: 79  ENVIGLL-------DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQ 131
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
              RGL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R          T  V T
Sbjct: 132 -LLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVAT 183
Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
             Y  PE       Y+QT+      D++S G ++ ELL G+
Sbjct: 184 RWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLQGK 218

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 150  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 206
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 207  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 266
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 267  TFEEIQNHPWMQD 279

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 151  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 207
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 208  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRP 267
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 268  TFEEIQNHPWMQD 280

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + D GL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRWYR 189
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 150  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 206
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 207  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRP 266
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 267  TFEEIQNHPWMQD 279

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 20/239 (8%)
Query: 758 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAE 813
           T +D      N+     IG G F  V  A  +  G + AVK +     +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-E 63
Query: 814 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 872
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   +     
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDA-FC 173
Query: 933 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           G   Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 775  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 72   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 872
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 132  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 190
Query: 873  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 930
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 191  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 987
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 247  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 301
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 302  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 26/240 (10%)
Query: 760 SDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVE 815
           SD      N+     IG G F  V  A  +  G + A+K   +   +   +++ F+ EV 
Sbjct: 5   SDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVR 63
Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQ 874
            +    H N+V L           LI  Y   G + DY +     K+     + R K  Q
Sbjct: 64  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQ 119
Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR---PYDTHVTTDL 931
             +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S         DT      
Sbjct: 120 IVS-AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-----F 170
Query: 932 VGTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
            G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 171 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 227

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 775  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 872
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 153
Query: 873  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 930
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 154  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 987
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 210  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 264
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 265  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 136  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 192
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 193  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 252
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 253  TFEEIQNHPWMQD 265

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 775  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 872
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 153
Query: 873  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 930
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 154  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 987
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 210  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 264
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 265  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 766 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG-DCGQMEREFQAEVEALSRAQHK 823
           +++F   +++G G +G+V  AT    G   A+K++   D          E++ L   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           N++++    R  +       Y+    +   LH  +    +    ++  I Q   R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-TLRAVKVL 128
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--------RPYDTHV-TTDLVGT 934
           H     +++HRD+K SN+L++   +  + DFGL+R++         P       T+ V T
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 935 LGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 987
             Y  PE   T     R  DV+S G +L EL   RRP  +  G++ R  +  +F
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP--IFPGRDYRHQLLLIF 236

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 129/302 (42%), Gaps = 67/302 (22%)
Query: 769  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER-----------------EFQ 811
            FN++  +G G F  ++K          V+R  GD GQ+                    F 
Sbjct: 12   FNES--LGQGTFTKIFKG---------VRREVGDYGQLHETEVLLKVLDKAHRNYSESFF 60
Query: 812  AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
                 +S+  HK+LV   G C  G++ +L+  +++ GSLD +L ++ +  ++L W  +L+
Sbjct: 61   EAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLE 117
Query: 872  IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA--------HLADFGLSRLLRPY 923
            +A+  A  + +L    E  ++H +V + NILL  + +          L+D G+S  + P 
Sbjct: 118  VAKQLAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 924  DTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD 981
            D      L   + ++PPE            D +SFG  L E+ + G +P+     +  R 
Sbjct: 175  DI-----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RK 227
Query: 982  LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
            L     Q   ++ ++    A+           E+  +   C+D +P  RP    ++  L+
Sbjct: 228  L-----QFYEDRHQLPAPKAA-----------ELANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 1042 GI 1043
             +
Sbjct: 272  SL 273

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 35/290 (12%)
Query: 767  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVK-----RL-SGDCGQMEREFQAEVEALSR 819
            +++     +G G F +V K      G + A K     RL S   G    E + EV  L  
Sbjct: 26   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
             +H N+++L     +  D +LI   +  G L  +L E   K+S+ + D   +  +    G
Sbjct: 86   IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTE-DEATQFLKQILDG 141
Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTL 935
            + YLH      I H D+K  NI+L +K        L DFG++  +   +     ++ GT 
Sbjct: 142  VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTP 196
Query: 936  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
             ++ PE           D++S GV+   LL+G  P     G+  ++ ++ +  +  +  E
Sbjct: 197  EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGETKQETLTNISAVNYDFDE 253
Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV--TWLDGI 1043
                + S   KD  ++LL           +DP+RR  I + +  +W+  I
Sbjct: 254  EYFSNTSELAKDFIRRLLV----------KDPKRRMXIAQSLEHSWIKAI 293

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 766 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG-DCGQMEREFQAEVEALSRAQHK 823
           +++F   +++G G +G+V  AT    G   A+K++   D          E++ L   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           N++++    R  +       Y+    +   LH  +    +    ++  I Q   R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-TLRAVKVL 128
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--------RPYDTHV-TTDLVGT 934
           H     +++HRD+K SN+L++   +  + DFGL+R++         P       T+ V T
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 935 LGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 987
             Y  PE   T     R  DV+S G +L EL   RRP  +  G++ R  +  +F
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP--IFPGRDYRHQLLLIF 236

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 775  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 37   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 872
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 97   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD-FLTLEHLICY 155
Query: 873  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 930
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 156  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 987
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 212  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 266
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 267  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N F    ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             ++H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   D         
Sbjct: 65  QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEI 119
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH   E ++V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 120 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPE 176
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N F    ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 62
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             ++H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   D         
Sbjct: 63  QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEI 117
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH   E ++V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 118 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPE 174
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 175 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N F    ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 63
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             ++H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   D         
Sbjct: 64  QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEI 118
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH   E ++V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 119 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPE 175
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 55/243 (22%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLS-----------------------GD 802
           N +   + IG G +G+V  A   N  T  A+K LS                       G 
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 803 C----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV 858
           C    G +E+ +Q E+  L +  H N+V L       N+  L           Y + E V
Sbjct: 73  CIQPRGPIEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHL-----------YMVFELV 120
Query: 859 DKDSVLKWDVRLKIAQGAAR--------GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH 910
           ++  V++      +++  AR        G+ YLH      I+HRD+K SN+L+ E     
Sbjct: 121 NQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIK 177
Query: 911 LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTG 967
           +ADFG+S   +  D  + ++ VGT  ++ PE          G   DV++ GV L   + G
Sbjct: 178 IADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 968 RRP 970
           + P
Sbjct: 237 QCP 239

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 136  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 192
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 193  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 252
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 253  TFEEIQNHPWMQD 265

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 131  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 187
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 188  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 247
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 248  TFEEIQNHPWMQD 260

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 135  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 191
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 192  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 251
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 252  TFEEIQNHPWMQD 264

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 10   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 69
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 70   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 126
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 127  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 183
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 184  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 241  IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 151  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 207
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMKSEKRE 995
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++   R 
Sbjct: 208  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPXDRP 267
Query: 996  V-EIIDASIWHKD 1007
              E I    W +D
Sbjct: 268  TFEEIQNHPWMQD 280

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 775  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 872
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 153
Query: 873  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 930
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 154  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 987
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 210  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 264
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 265  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 119/292 (40%), Gaps = 47/292 (16%)
Query: 775  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 872
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 86   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 144
Query: 873  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDL 931
            +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D     D 
Sbjct: 145  SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 932  VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQ 988
               L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L      
Sbjct: 202  RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 255
Query: 989  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
               E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 256  --KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 65/239 (27%), Positives = 98/239 (41%), Gaps = 20/239 (8%)
Query: 758 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAE 813
           T +D      N+     IG G F  V  A  +  G + AVK   +   +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-E 63
Query: 814 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 872
           V       H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK----EARAKF 119
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
            Q     + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   +     
Sbjct: 120 RQ-IVSAVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDA-FC 173
Query: 933 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           G   Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 10   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 69
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 70   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 126
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 127  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 183
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 184  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 241  IPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 9    LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 68
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 69   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 125
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 126  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 182
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 183  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 240  IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 127/302 (42%), Gaps = 60/302 (19%)
Query: 763  LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            L+  ++F +  ++G G FG V KA    +    A+K++     ++     +EV  L+   
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLN 60
Query: 822  H-------------KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWD 867
            H             +N V      +  +   +   Y EN +L   +H E++++     W 
Sbjct: 61   HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 868  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-------LL 920
            +  +I +     L+Y+H      I+HRD+K  NI +DE     + DFGL++       +L
Sbjct: 121  LFRQILEA----LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 921  R------PYDTHVTTDLVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELL----TGRR 969
            +      P  +   T  +GT  Y+  E    T     + D+YS G++  E++    TG  
Sbjct: 174  KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 970  PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1029
             V + K       VS  F    +  ++++          EK+++ +L      ID DP +
Sbjct: 234  RVNILKKLRS---VSIEFPPDFDDNKMKV----------EKKIIRLL------IDHDPNK 274
Query: 1030 RP 1031
            RP
Sbjct: 275  RP 276

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 9    LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 68
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 69   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 125
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 126  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 182
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 183  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 240  IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 9    LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 68
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 69   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 125
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 126  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 182
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 183  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 240  IPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 10   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 69
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 70   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 126
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 127  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 183
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 184  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 241  IPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 746  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 798
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 10   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 69
Query: 799  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 850
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 70   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 126
Query: 851  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 909
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 127  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 183
Query: 910  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 968
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 184  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 969  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1007
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 241  IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 775  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 872
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 86   NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 144
Query: 873  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 930
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 145  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 987
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 201  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 255
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 256  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 25/233 (10%)
Query: 751 NSDCKDLTVSDLLK-----STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSG 801
           NS  +++ VS L K     + N F    ++G G FG V     KAT   G   A+K L  
Sbjct: 128 NSGAEEMEVS-LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKK 183
Query: 802 DCGQMEREFQ---AEVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHES 857
           +    + E      E   L  ++H  L +L+ Y    +DRL  +  Y   G L + L   
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL--- 239
Query: 858 VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS 917
             ++ V   D            L YLH   E ++V+RD+K  N++LD+     + DFGL 
Sbjct: 240 -SRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
Query: 918 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           +     D        GT  Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 297 K-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 32/80 (40%), Positives = 40/80 (50%)
Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRDVK  NIL+     A+L DFG++            + VGTL Y  PE      AT R 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 953 DVYSFGVVLLELLTGRRPVE 972
           D+Y+   VL E LTG  P +
Sbjct: 217 DIYALTCVLYECLTGSPPYQ 236

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 25/233 (10%)
Query: 751 NSDCKDLTVSDLLK-----STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSG 801
           NS  +++ VS L K     + N F    ++G G FG V     KAT   G   A+K L  
Sbjct: 131 NSGAEEMEVS-LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKK 186
Query: 802 DCGQMEREFQ---AEVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHES 857
           +    + E      E   L  ++H  L +L+ Y    +DRL  +  Y   G L + L   
Sbjct: 187 EVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL--- 242
Query: 858 VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS 917
             ++ V   D            L YLH   E ++V+RD+K  N++LD+     + DFGL 
Sbjct: 243 -SRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 299
Query: 918 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           +     D        GT  Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 300 K-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 70/287 (24%), Positives = 124/287 (43%), Gaps = 35/287 (12%)
Query: 767  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVK-----RLSGDCGQMERE-FQAEVEALSR 819
            +++     +G G F +V K      G + A K     RLS     + RE  + EV  L  
Sbjct: 12   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
             +H N+++L     +  D +LI   +  G L  +L E   K+S+ + D   +  +    G
Sbjct: 72   IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTE-DEATQFLKQILDG 127
Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTL 935
            + YLH      I H D+K  NI+L +K        L DFG++  +   +     ++ GT 
Sbjct: 128  VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTP 182
Query: 936  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
             ++ PE           D++S GV+   LL+G  P     G+  ++ ++ +  +  +  E
Sbjct: 183  EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGETKQETLTNISAVNYDFDE 239
Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV--TWL 1040
                + S   KD  ++LL           +DP+RR  I + +  +W+
Sbjct: 240  EYFSNTSELAKDFIRRLLV----------KDPKRRMXIAQSLEHSWI 276

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 19/219 (8%)
Query: 765 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL-----SGDCGQMEREFQAEVEALS 818
           +T+ +     IG G +G VYKA    +G   A+K +      G  G +      EV  L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 819 RAQ---HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIA 873
           R +   H N+V L   C        I   +    +D  L   +DK     L  +    + 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 874 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLV 932
           +   RGL +LH  C   IVHRD+K  NIL+       LADFGL+R+   Y   +  T +V
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVV 180
Query: 933 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 971
            TL Y  PE     T     D++S G +  E+   R+P+
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 766 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG-DCGQMEREFQAEVEALSRAQHK 823
           +++F   +++G G +G+V  AT    G   A+K++   D          E++ L   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           N++++    R  +       Y+    +   LH  +    +    ++  I Q   R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-TLRAVKVL 128
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTT-------DLVGT 934
           H     +++HRD+K SN+L++   +  + DFGL+R++     D    T       + V T
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 935 LGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 987
             Y  PE   T     R  DV+S G +L EL   RRP  +  G++ R  +  +F
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP--IFPGRDYRHQLLLIF 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 775  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 872
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 86   NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 144
Query: 873  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 930
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 145  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 987
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 201  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 255
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 256  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 775  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 826
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 827  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 872
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 86   NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 144
Query: 873  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 930
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 145  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 931  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 987
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 201  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 255
Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 256  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 102/249 (40%), Gaps = 30/249 (12%)
Query: 766 TNNFNQANIIGCGGFG--LVYKATLTNGTKAA--VKRLSGDCGQMEREFQAEVEALSRAQ 821
           ++ + +   +G G +G  L+ K  LT   +A   +K+ S            EV  L +  
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L  +     +  L+      G L     E + +    + D  + I +    G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL---FDEIILRQKFSEVDAAV-IMKQVLSGTT 135
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           YLHK    +IVHRD+K  N+LL+ K    L    DFGLS            + +GT  YI
Sbjct: 136 YLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV--GGKMKERLGTAYYI 190
Query: 939 PPEY-SQTLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSWVF 987
            PE   +     C  DV+S GV+L  LL G  P            V KGK   D   W  
Sbjct: 191 APEVLRKKYDEKC--DVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWT- 247
Query: 988 QMKSEKREV 996
           Q+  E +++
Sbjct: 248 QVSDEAKQL 256

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           +G G +G V   Y A L    K AVK+LS       R FQ+ + A  R  ++ L  L+ +
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLS-------RPFQSLIHA--RRTYRELRLLK-H 83
Query: 832 CRHGN-----DRLLIYSYMENGSLDYW--------LHESVDKDSVLKWDVRLKIAQGAAR 878
            +H N     D     + +E+ S  Y         L+  V   ++    V+  + Q   R
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQ-LLR 142
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R          T  V T  Y 
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQA----DEEMTGYVATRWYR 195
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELL G+
Sbjct: 196 APEIMLNWMHYNQTV------DIWSVGCIMAELLQGK 226

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 22/230 (9%)
Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAEVEALSRAQHK 823
           N+     IG G F  V  A  +  G + A+K +     +   +++ F+ EV  +    H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
           N+V L           LI  Y   G + DY +     K+     + R K  Q  +  + Y
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQIVS-AVQY 129
Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE 941
            H   +  IVHRD+K+ N+LLD      +ADFG S     +      D   G   Y  PE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPYAAPE 183
Query: 942 YSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
             Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 230

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 66/133 (49%), Gaps = 19/133 (14%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 131  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 187
Query: 950  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 994
             R   V+S G++L +++ G  P     E+  G+          C+ L+ W   ++ S++ 
Sbjct: 188  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRP 247
Query: 995  EVEIIDASIWHKD 1007
              E I    W +D
Sbjct: 248  TFEEIQNHPWMQD 260

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 768 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNL 825
           +F     +G GGFG+V++A    +    A+KR+     ++ RE    EV+AL++ +H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 826 VS-LQGYCRHGNDRLL------IYSYME-----NGSLDYWLHESVDKDSVLKWDVRLKIA 873
           V     +        L      +Y Y++       +L  W++     +   +  V L I 
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER-SVCLHIF 124
Query: 874 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL----------SRLLRPY 923
              A  + +LH      ++HRD+K SNI         + DFGL            +L P 
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 924 DTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL 965
             +   T  VGT  Y+ PE     + + + D++S G++L ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 766 TNNFNQANIIGCGGFG--LVYKATLTNGTKAA--VKRLSGDCGQMEREFQAEVEALSRAQ 821
           ++ + +   +G G +G  L+ K  LT   +A   +K+ S            EV  L +  
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N++ L  +     +  L+      G L     E + +    + D  + I +    G  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL---FDEIILRQKFSEVDAAV-IMKQVLSGTT 118
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           YLHK    +IVHRD+K  N+LL+ K    L    DFGLS            + +GT  YI
Sbjct: 119 YLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV--GGKMKERLGTAYYI 173
Query: 939 PPEY-SQTLTATCRGDVYSFGVVLLELLTGRRP 970
            PE   +     C  DV+S GV+L  LL G  P
Sbjct: 174 APEVLRKKYDEKC--DVWSCGVILYILLCGYPP 204

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           +G G +G V   Y A L    K AVK+LS       R FQ+ + A  R  ++ L  L+ +
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLS-------RPFQSLIHA--RRTYRELRLLK-H 83
Query: 832 CRHGN-----DRLLIYSYMENGSLDYWLHE--SVDKDSVLKWD------VRLKIAQGAAR 878
            +H N     D     + +E+ S  Y +      D ++++K        V+  + Q   R
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQ-LLR 142
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R          T  V T  Y 
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQA----DEEMTGYVATRWYR 195
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ ELL G+
Sbjct: 196 APEIMLNWMHYNQTV------DIWSVGCIMAELLQGK 226

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 775  IGCGGFGLV-YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G GGF  V     L +G   A+KR+     Q   E Q E +      H N++ L  YC 
Sbjct: 37   LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 834  H----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
                  ++  L+  + + G+L   +    DK + L  D  L +  G  RGL  +H     
Sbjct: 97   RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---K 153
Query: 890  HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--------TDLVG---TLGYI 938
               HRD+K +NILL ++ +  L D G    +     HV          D      T+ Y 
Sbjct: 154  GYAHRDLKPTNILLGDEGQPVLMDLG---SMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 939  PPEYSQTLTATC----RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 994
             PE   ++ + C    R DV+S G VL  ++ G  P ++   K   D V+   Q +    
Sbjct: 211  APELF-SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--DSVALAVQNQLSIP 267
Query: 995  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            +     +++W      QLL  +      +  DP +RP I  +++ L+ +
Sbjct: 268  QSPRHSSALW------QLLNSM------MTVDPHQRPHIPLLLSQLEAL 304

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 90/224 (40%), Gaps = 24/224 (10%)
Query: 759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 814
           + DL     ++    +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           + ++ A    +V L  +    +DR L  +  YM  G L   ++   + D   KW  R   
Sbjct: 126 DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYT 179
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
           A+     L  +H +     +HRDVK  N+LLD+     LADFG    +           V
Sbjct: 180 AE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 933 GTLGYIPPEYSQT------LTATCRGDVYSFGVVLLELLTGRRP 970
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 90/224 (40%), Gaps = 24/224 (10%)
Query: 759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 814
           + DL     ++    +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           + ++ A    +V L  +    +DR L  +  YM  G L   ++   + D   KW  R   
Sbjct: 121 DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYT 174
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
           A+     L  +H +     +HRDVK  N+LLD+     LADFG    +           V
Sbjct: 175 AE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 933 GTLGYIPPEYSQT------LTATCRGDVYSFGVVLLELLTGRRP 970
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 272

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 60/302 (19%)
Query: 763  LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            L+  ++F +  ++G G FG V KA    +    A+K++     ++     +EV  L+   
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVXLLASLN 60
Query: 822  H-------------KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWD 867
            H             +N V      +  +   +   Y EN +L   +H E++++     W 
Sbjct: 61   HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 868  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-------LL 920
            +  +I +     L+Y+H      I+HR++K  NI +DE     + DFGL++       +L
Sbjct: 121  LFRQILEA----LSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 921  R------PYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELL----TGRR 969
            +      P  +   T  +GT  Y+  E    T     + D YS G++  E +    TG  
Sbjct: 174  KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXE 233
Query: 970  PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1029
             V + K       VS  F    +  + ++          EK+++ +L      ID DP +
Sbjct: 234  RVNILKKLRS---VSIEFPPDFDDNKXKV----------EKKIIRLL------IDHDPNK 274
Query: 1030 RP 1031
            RP
Sbjct: 275  RP 276

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 90/224 (40%), Gaps = 24/224 (10%)
Query: 759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 814
           + DL     ++    +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           + ++ A    +V L  +    +DR L  +  YM  G L   ++   + D   KW  R   
Sbjct: 126 DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYT 179
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
           A+     L  +H +     +HRDVK  N+LLD+     LADFG    +           V
Sbjct: 180 AE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 933 GTLGYIPPEYSQT------LTATCRGDVYSFGVVLLELLTGRRP 970
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 277

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 24/224 (10%)
Query: 759 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 814
           +  L     +++   +IG G FG V         K    +L      ++R     F  E 
Sbjct: 67  IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
           + ++ A    +V L  +C   +D+ L  +  YM  G L   ++   + D   KW  +   
Sbjct: 127 DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL---VNLMSNYDVPEKW-AKFYT 180
Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
           A+     L  +H +    ++HRDVK  N+LLD+     LADFG    +           V
Sbjct: 181 AE-VVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV 236
Query: 933 GTLGYIPPEYSQT------LTATCRGDVYSFGVVLLELLTGRRP 970
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLFEMLVGDTP 278

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 49/217 (22%)
Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 824
           +G G +G V  A     G K A+K+L        R FQ+E+ A         L   +H+N
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           ++ L              D  L+  +M         HE + +D +     +  + Q   +
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI-----QFLVYQ-MLK 139
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL Y+H      I+HRD+K  N+ ++E  E  + DFGL+R     D+ +   +V T  Y 
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMXGXVV-TRWYR 192
Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+QT+      D++S G ++ E++TG+
Sbjct: 193 APEVILNWMRYTQTV------DIWSVGCIMAEMITGK 223

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 23/225 (10%)
Query: 771 QANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSL 828
           Q +++G G    V     L    + AVK +    G +      EVE L + Q H+N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
             +    +   L++  M  GS+   +H+    +  L+  V   + Q  A  L +LH    
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASV---VVQDVASALDFLHN--- 129
Query: 889 PHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLR------PYDTHVTTDLVGTLGYIP 939
             I HRD+K  NIL +   +     + DFGL   ++      P  T       G+  Y+ 
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 940 PEYSQTLTATC-----RGDVYSFGVVLLELLTGRRPVEVCKGKNC 979
           PE  +  +        R D++S GV+L  LL+G  P     G +C
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 12   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 72   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 127
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 128  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 182
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 183  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 239
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 240  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 267

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 12   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 72   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 127
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 128  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 182
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 183  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 239
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 240  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 267

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 772 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           A  +G G FG+V++   T+  K  + +     G  +   + E+  L+ A+H+N++ L   
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP-- 889
                + ++I+ ++    LD  + E ++  S  + + R  ++        Y+H+VCE   
Sbjct: 70  FESMEELVMIFEFIS--GLD--IFERINT-SAFELNEREIVS--------YVHQVCEALQ 116
Query: 890 -----HIVHRDVKSSNILLDEKFEA--HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
                +I H D++  NI+   +  +   + +FG +R L+P D      L     Y  PE 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEV 174
Query: 943 SQTLTATCRGDVYSFGVVLLELLTGRRP 970
            Q    +   D++S G ++  LL+G  P
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 35/228 (15%)
Query: 765 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEA 816
             + + +   IG G FG V+KA     G K A+K++      ME E +        E++ 
Sbjct: 16  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKI 70
Query: 817 LSRAQHKNLVSLQGYCRHGN---DRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVR-- 869
           L   +H+N+V+L   CR      +R     Y+     D+  H+   +  + ++K+ +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYL---VFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 870 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---LLRPYDTH 926
            ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R   L +    +
Sbjct: 128 KRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 927 VTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPV 971
              + V TL Y PPE    L     G   D++  G ++ E+ T R P+
Sbjct: 185 RYXNRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V++      G + AVK++     ++E     E+ A +      +V L G  R
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-----RLEVFRAEELMACAGLTSPRIVPLYGAVR 155
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G    +    +E GSL     + V +   L  D  L     A  GL YLH      I+H
Sbjct: 156 EGPWVNIFMELLEGGSLG----QLVKEQGCLPEDRALYYLGQALEGLEYLHSR---RILH 208
Query: 894 RDVKSSNILL-DEKFEAHLADFGLSRLLRP---YDTHVTTDLV-GTLGYIPPEYSQTLTA 948
            DVK+ N+LL  +   A L DFG +  L+P     + +T D + GT  ++ PE     + 
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 949 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 984
             + DV+S   ++L +L G  P  +  +G  C  + S
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIAS 305

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 781 GLVYKATLTNGTKAAVKRLSGDCGQME----------REFQAEVEALSR-AQHKNLVSLQ 829
           G V K T+  G+ +  KR       ME          R+   E+E L R  QH N+++L+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 830 GYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
                G    L+   M  G L D  L +    +    +     +     + + YLH    
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLHS--- 139
Query: 889 PHIVHRDVKSSNIL-LDEKFEA---HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
             +VHRD+K SNIL +DE        + DFG ++ LR  +  + T    T  ++ PE  +
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLK 198
Query: 945 TLTATCRGDVYSFGVVLLELLTGRRP 970
                   D++S G++L  +L G  P
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 38/224 (16%)
Query: 763 LKSTNNFNQANIIGCGGFGL----VYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALS 818
           ++ T+ +     IG G + +    ++KAT     + AVK +     + +R+   E+E L 
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIID----KSKRDPTEEIEILL 70
Query: 819 R-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
           R  QH N+++L+     G    ++   M+ G L          D +L+     +    A 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---------LDKILRQKFFSEREASAV 121
Query: 878 -----RGLAYLHKVCEPHIVHRDVKSSNIL-LDEK---FEAHLADFGLSRLLRPYDTHVT 928
                + + YLH      +VHRD+K SNIL +DE        + DFG ++ LR  +  + 
Sbjct: 122 LFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 929 TDLVGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T    T  ++ PE    Q   A C  D++S GV+L  +LTG  P
Sbjct: 179 TPCY-TANFVAPEVLERQGYDAAC--DIWSLGVLLYTMLTGYTP 219

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 769 FNQANIIGCGGFGLVYK-ATLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
           ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882 YLHKVCEPHIVHRDVKSSNI-LLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
           YLH +    I H D+K  NI LLD    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPAF 183
Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           + PE           D++S GV+   LL+G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 781 GLVYKATLTNGTKAAVKRLSGDCGQME----------REFQAEVEALSR-AQHKNLVSLQ 829
           G V K T+  G+ +  KR       ME          R+   E+E L R  QH N+++L+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 830 GYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
                G    L+   M  G L D  L +    +    +     +     + + YLH    
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLH---S 139
Query: 889 PHIVHRDVKSSNIL-LDEKFEA---HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
             +VHRD+K SNIL +DE        + DFG ++ LR  +  + T    T  ++ PE  +
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLK 198
Query: 945 TLTATCRGDVYSFGVVLLELLTGRRP 970
                   D++S G++L  +L G  P
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 43/246 (17%)
Query: 808  REFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLLIYSYMENGSLDYWLHESVDKDSVLK 865
            R+F  E   L    H N++ + G C+        LI  +M  GSL   LHE  +   V+ 
Sbjct: 52   RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVD 109
Query: 866  WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLS-----R 918
                +K A   ARG+A+LH + EP I    + S ++++DE   A   +AD   S     R
Sbjct: 110  QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR 168
Query: 919  LLRPYDTHVTTDLVGTLGYIPPEYSQTL---TATCRGDVYSFGVVLLELLTGRRPVEVCK 975
            +  P              ++ PE  Q     T     D++SF V+L EL+T   P     
Sbjct: 169  MYAP-------------AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA--- 212
Query: 976  GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
                 DL +    MK     +E +  +I        + ++++I   C+++DP +RP  + 
Sbjct: 213  -----DLSNMEIGMKV---ALEGLRPTI-PPGISPHVSKLMKI---CMNEDPAKRPKFDM 260
Query: 1036 VVTWLD 1041
            +V  L+
Sbjct: 261  IVPILE 266

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 63  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 117
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 118 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 173
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 769  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILIGELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V++      G + AVK++  +  ++E     E+ A +      +V L G  R
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G    +    +E GSL     + + +   L  D  L     A  GL YLH      I+H
Sbjct: 121 EGPWVNIFMELLEGGSLG----QLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILH 173
Query: 894 RDVKSSNILL-DEKFEAHLADFGLSRLLRP---YDTHVTTDLV-GTLGYIPPEYSQTLTA 948
            DVK+ N+LL  +   A L DFG +  L+P     + +T D + GT  ++ PE       
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 949 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 984
             + D++S   ++L +L G  P  +  +G  C  + S
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 65  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 119
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 120 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 175
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 769 FNQANIIGCGGFGLVYK-ATLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
           ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882 YLHKVCEPHIVHRDVKSSNI-LLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
           YLH +    I H D+K  NI LLD    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           + PE           D++S GV+   LL+G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 781 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 840
           GL Y A      ++   R     G    E + EV  L +  H N+++L     +  D +L
Sbjct: 37  GLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
           I   +  G L  +L +   K+S+ + +    I Q    G+ YLH      I H D+K  N
Sbjct: 93  ILELVSGGELFDFLAQ---KESLSEEEATSFIKQ-ILDGVNYLHT---KKIAHFDLKPEN 145
Query: 901 ILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
           I+L +K        L DFGL+  +   D     ++ GT  ++ PE           D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 957 FGVVLLELLTGRRP 970
            GV+   LL+G  P
Sbjct: 204 IGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 781 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 840
           GL Y A      ++   R     G    E + EV  L +  H N+++L     +  D +L
Sbjct: 37  GLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
           I   +  G L  +L +   K+S+ + +    I Q    G+ YLH      I H D+K  N
Sbjct: 93  ILELVSGGELFDFLAQ---KESLSEEEATSFIKQ-ILDGVNYLHT---KKIAHFDLKPEN 145
Query: 901 ILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
           I+L +K        L DFGL+  +   D     ++ GT  ++ PE           D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 957 FGVVLLELLTGRRP 970
            GV+   LL+G  P
Sbjct: 204 IGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 781 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 840
           GL Y A      ++   R     G    E + EV  L +  H N+++L     +  D +L
Sbjct: 37  GLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
           I   +  G L  +L +   K+S+ + +    I Q    G+ YLH      I H D+K  N
Sbjct: 93  ILELVSGGELFDFLAQ---KESLSEEEATSFIKQ-ILDGVNYLHT---KKIAHFDLKPEN 145
Query: 901 ILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
           I+L +K        L DFGL+  +   D     ++ GT  ++ PE           D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 957 FGVVLLELLTGRRP 970
            GV+   LL+G  P
Sbjct: 204 IGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 781 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 840
           GL Y A      ++   R     G    E + EV  L +  H N+++L     +  D +L
Sbjct: 37  GLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
           I   +  G L  +L +   K+S+ + +    I Q    G+ YLH      I H D+K  N
Sbjct: 93  ILELVSGGELFDFLAQ---KESLSEEEATSFIKQ-ILDGVNYLHT---KKIAHFDLKPEN 145
Query: 901 ILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 956
           I+L +K        L DFGL+  +   D     ++ GT  ++ PE           D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 957 FGVVLLELLTGRRP 970
            GV+   LL+G  P
Sbjct: 204 IGVITYILLSGASP 217

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 37/229 (16%)
Query: 765 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEA 816
             + + +   IG G FG V+KA     G K A+K++      ME E +        E++ 
Sbjct: 16  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKI 70
Query: 817 LSRAQHKNLVSLQGYCRHGNDRL--------LIYSYMENGSLDYWLHESVDKDSVLKWDV 868
           L   +H+N+V+L   CR              L++ + E+  L   L   + K ++ +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK- 128
Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---LLRPYDT 925
             ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R   L +    
Sbjct: 129 --RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 926 HVTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPV 971
           +   + V TL Y PPE    L     G   D++  G ++ E+ T R P+
Sbjct: 184 NRYXNRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 37/229 (16%)
Query: 765 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEA 816
             + + +   IG G FG V+KA     G K A+K++      ME E +        E++ 
Sbjct: 16  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKI 70
Query: 817 LSRAQHKNLVSLQGYCRHGNDRL--------LIYSYMENGSLDYWLHESVDKDSVLKWDV 868
           L   +H+N+V+L   CR              L++ + E+  L   L   + K ++ +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK- 128
Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---LLRPYDT 925
             ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R   L +    
Sbjct: 129 --RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 926 HVTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPV 971
           +   + V TL Y PPE    L     G   D++  G ++ E+ T R P+
Sbjct: 184 NRYXNRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 769 FNQANIIGCGGFGLVYK-ATLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 821
           ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 882 YLHKVCEPHIVHRDVKSSNI-LLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
           YLH +    I H D+K  NI LLD    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 938 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           + PE           D++S GV+   LL+G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 19/217 (8%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V++      G + AVK++  +  + E     E+ A +      +V L G  R
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGAVR 136
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G    +    +E GSL     + V +   L  D  L     A  GL YLH      I+H
Sbjct: 137 EGPWVNIFMELLEGGSLG----QLVKEQGCLPEDRALYYLGQALEGLEYLHSR---RILH 189
Query: 894 RDVKSSNILL-DEKFEAHLADFGLSRLLRP----YDTHVTTDLVGTLGYIPPEYSQTLTA 948
            DVK+ N+LL  +   A L DFG +  L+P     D      + GT  ++ PE     + 
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 949 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 984
             + DV+S   ++L +L G  P  +  +G  C  + S
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIAS 286

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 37/229 (16%)
Query: 765 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEA 816
             + + +   IG G FG V+KA     G K A+K++      ME E +        E++ 
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKI 69
Query: 817 LSRAQHKNLVSLQGYCRHGNDRL--------LIYSYMENGSLDYWLHESVDKDSVLKWDV 868
           L   +H+N+V+L   CR              L++ + E+  L   L   + K ++ +   
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK- 127
Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---LLRPYDT 925
             ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R   L +    
Sbjct: 128 --RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 926 HVTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPV 971
           +   + V TL Y PPE    L     G   D++  G ++ E+ T R P+
Sbjct: 183 NRYXNRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 52/307 (16%)
Query: 751  NSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-ERE 809
              D  D   S ++    +F   +++G G  G +    + +    AVKR+  +C    +RE
Sbjct: 8    EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE 67
Query: 810  FQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR 869
             Q   E+    +H N++    +C    DR   Y  +E  +    L E V++       + 
Sbjct: 68   VQLLRES---DEHPNVIRY--FCTE-KDRQFQYIAIELCAAT--LQEYVEQKDFAHLGLE 119
Query: 870  -LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-----KFEAHLADFGLSRLLR-- 921
             + + Q    GLA+LH +   +IVHRD+K  NIL+       K +A ++DFGL + L   
Sbjct: 120  PITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 922  PYDTHVTTDLVGTLGYIPPEYSQTLTATCRG------DVYSFGVVLLELLT-GRRPVEVC 974
             +     + + GT G+I PE    L+  C+       D++S G V   +++ G  P    
Sbjct: 177  RHSFSRRSGVPGTEGWIAPE---MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF--- 230
Query: 975  KGKNCRDLVSWVFQMKSEKREVEII----DASIWHKDREKQLLEMLEIACKCIDQDPRRR 1030
                           KS +R+  I+         H ++ + ++   E+  K I  DP++R
Sbjct: 231  --------------GKSLQRQANILLGACSLDCLHPEKHEDVIAR-ELIEKMIAMDPQKR 275
Query: 1031 PFIEEVV 1037
            P  + V+
Sbjct: 276  PSAKHVL 282

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 46/239 (19%)
Query: 766 TNNFNQANIIGCGGFGLVYKAT--LTNG--TKAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
           +N F   + IG G F  VY AT  L  G   K A+K L      +     AE++ L+ A 
Sbjct: 20  SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR--IAAELQCLTVAG 77
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQGAARGL 880
            ++ V    YC   ND ++I       ++ Y  HES +D  + L +    +      + L
Sbjct: 78  GQDNVMGVKYCFRKNDHVVI-------AMPYLEHESFLDILNSLSFQEVREYMLNLFKAL 130
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAH-LADFGLSR--------LLRPYDTHVTTD- 930
             +H+     IVHRDVK SN L + + + + L DFGL++        LL+   +    + 
Sbjct: 131 KRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQER 187
Query: 931 ------------------LVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELLTGRRP 970
                               GT G+  PE  ++    T   D++S GV+ L LL+GR P
Sbjct: 188 CSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 32/151 (21%)
Query: 891  IVHRDVKSSNILLD-EKFEAHLADFGLSRLL--RPYDTHVTTDLVGTLGYIPPEY-SQTL 946
            +VHRD+K  NIL+D  +  A L DFG   LL   PY     TD  GT  Y PPE+ S+  
Sbjct: 160  VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-----TDFDGTRVYSPPEWISRHQ 214
Query: 947  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
                   V+S G++L +++ G  P E                     R+ EI++A +   
Sbjct: 215  YHALPATVWSLGILLYDMVCGDIPFE---------------------RDQEILEAELHFP 253
Query: 1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
                   +   +  +C+   P  RP +EE++
Sbjct: 254  AHVSP--DCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 775 IGCGGFGLVYK-ATLTNGTKAAVKRLSGDCGQMER------EFQAEVEALSRAQHKNLVS 827
           +G G F +V K    + G + A K +     +  R      E + EV  L +  H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L     +  D +LI   +  G L  +L     K+S+ + +    I Q    G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHT-- 133
Query: 888 EPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              I H D+K  NI+L +K        L DFGL+  +   D     ++ GT  ++ PE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIV 190
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
                    D++S GV+   LL+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V++      G + AVK++  +  ++E     E+ A +      +V L G  R
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 136
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G    +    +E GSL     + + +   L  D  L     A  GL YLH      I+H
Sbjct: 137 EGPWVNIFMELLEGGSLG----QLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILH 189
Query: 894 RDVKSSNILL-DEKFEAHLADFGLSRLLRP---YDTHVTTDLV-GTLGYIPPEYSQTLTA 948
            DVK+ N+LL  +   A L DFG +  L+P     + +T D + GT  ++ PE       
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 949 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 984
             + D++S   ++L +L G  P  +  +G  C  + S
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 286

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 57/206 (27%), Positives = 82/206 (39%), Gaps = 17/206 (8%)
Query: 775 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC-GQMER--EFQAEVEALSRAQHKNLVS 827
           +G G FG+V    + A        AVK L  D   Q E   +F  EV A+    H+NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 76  LYGVVLTPPMKMV----TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--- 128
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQT 945
               +HRD+ + N+LL  +    + DFGL R L   D H  +         +  PE  +T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
            T +   D + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG V++      G + AVK++  +  ++E     E+ A +      +V L G  R
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 134
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G    +    +E GSL     + + +   L  D  L     A  GL YLH      I+H
Sbjct: 135 EGPWVNIFMELLEGGSLG----QLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILH 187
Query: 894 RDVKSSNILL-DEKFEAHLADFGLSRLLRP---YDTHVTTDLV-GTLGYIPPEYSQTLTA 948
            DVK+ N+LL  +   A L DFG +  L+P     + +T D + GT  ++ PE       
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 949 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 984
             + D++S   ++L +L G  P  +  +G  C  + S
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 284

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 129/297 (43%), Gaps = 55/297 (18%)
Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 831
             I+G G  G V       G   AVKR+  D   +      E++ L+ +  H N++  + Y
Sbjct: 21   KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVI--RYY 75
Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-------IAQGAARGLAYLH 884
            C    DR L Y  +E  +L+  L + V+  +V   +++L+       + +  A G+A+LH
Sbjct: 76   CSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 885  KVCEPHIVHRDVKSSNILLD-------------EKFEAHLADFGLSRLLRPYDTHVTTDL 931
             +    I+HRD+K  NIL+              E     ++DFGL + L    +   T+L
Sbjct: 133  SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 932  ---VGTLGYIPPEY------SQTLTATCRG-DVYSFGVVLLELLT-GRRPVEVCKGKNCR 980
                GT G+  PE        QT     R  D++S G V   +L+ G+ P      +   
Sbjct: 190  NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248
Query: 981  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
            +++  +F +   K    + D S+        + E  ++  + ID DP +RP   +V+
Sbjct: 249  NIIRGIFSLDEMK---CLHDRSL--------IAEATDLISQMIDHDPLKRPTAMKVL 294

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 775 IGCGGFGLVYK-ATLTNGTKAAVKRLSGDCGQMER------EFQAEVEALSRAQHKNLVS 827
           +G G F +V K    + G + A K +     +  R      E + EV  L +  H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L     +  D +LI   +  G L  +L     K+S+ + +    I Q    G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHT-- 133
Query: 888 EPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              I H D+K  NI+L +K        L DFGL+  +   D     ++ GT  ++ PE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIV 190
Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
                    D++S GV+   LL+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 773 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQG 830
            ++  GGF  VY+A  + +G + A+KRL  +  +  R    EV  + + + H N+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 831 YCRHGNDR-------LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
               G +         L+ + +  G L  +L + ++    L  D  LKI     R + ++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY 923
           H+  +P I+HRD+K  N+LL  +    L DFG +  +  Y
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 23/225 (10%)
Query: 771 QANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSL 828
           Q +++G G    V     L    + AVK +    G +      EVE L + Q H+N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
             +    +   L++  M  GS+   +H+    +  L+  V   + Q  A  L +LH    
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASV---VVQDVASALDFLHN--- 129
Query: 889 PHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLR------PYDTHVTTDLVGTLGYIP 939
             I HRD+K  NIL +   +     + DF L   ++      P  T       G+  Y+ 
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 940 PEYSQTLTATC-----RGDVYSFGVVLLELLTGRRPVEVCKGKNC 979
           PE  +  +        R D++S GV+L  LL+G  P     G +C
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 17/206 (8%)
Query: 775 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVS 827
           +G G FG+V    + A        AVK L  D     +   +F  EV A+    H+NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQT 945
               +HRD+ + N+LL  +    + DFGL R L   D H  +         +  PE  +T
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
            T +   D + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 69   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 124
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 927
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 125  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 178
Query: 928  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 179  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 233
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1040
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 234  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 82/206 (39%), Gaps = 17/206 (8%)
Query: 775 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC-GQMER--EFQAEVEALSRAQHKNLVS 827
           +G G FG+V    + A        AVK L  D   Q E   +F  EV A+    H+NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 80  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 133
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL--GYIPPEYSQT 945
               +HRD+ + N+LL  +    + DFGL R L   D H        +   +  PE  +T
Sbjct: 134 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
            T +   D + FGV L E+ T G+ P
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 202  ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 257
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 927
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 258  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 311
Query: 928  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 312  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 366
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1040
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 367  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 17/206 (8%)
Query: 775 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVS 827
           +G G FG+V    + A        AVK L  D     +   +F  EV A+    H+NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 86  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQT 945
               +HRD+ + N+LL  +    + DFGL R L   D H  +         +  PE  +T
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
            T +   D + FGV L E+ T G+ P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 38/224 (16%)
Query: 763 LKSTNNFNQANIIGCGGFGL----VYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALS 818
           ++ T+ +     IG G + +    ++KAT     + AVK +     + +R+   E+E L 
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKAT---NXEFAVKIID----KSKRDPTEEIEILL 70
Query: 819 R-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA- 876
           R  QH N+++L+     G    ++    + G L          D +L+     +    A 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELXKGGEL---------LDKILRQKFFSEREASAV 121
Query: 877 ----ARGLAYLHKVCEPHIVHRDVKSSNIL-LDEKFEAH---LADFGLSRLLRPYDTHVT 928
                + + YLH      +VHRD+K SNIL +DE        + DFG ++ LR  +  + 
Sbjct: 122 LFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLX 178
Query: 929 TDLVGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T    T  ++ PE    Q   A C  D++S GV+L   LTG  P
Sbjct: 179 TPCY-TANFVAPEVLERQGYDAAC--DIWSLGVLLYTXLTGYTP 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 82/206 (39%), Gaps = 17/206 (8%)
Query: 775 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC-GQMER--EFQAEVEALSRAQHKNLVS 827
           +G G FG+V    + A        AVK L  D   Q E   +F  EV A+    H+NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 80  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 133
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL--GYIPPEYSQT 945
               +HRD+ + N+LL  +    + DFGL R L   D H        +   +  PE  +T
Sbjct: 134 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
            T +   D + FGV L E+ T G+ P
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 80/206 (38%), Gaps = 17/206 (8%)
Query: 775 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVS 827
           +G G FG+V    + A        AVK L  D     +   +F  EV A+    H+NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQT 945
               +HRD+ + N+LL  +    + DFGL R L   D H            +  PE  +T
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
            T +   D + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 80/206 (38%), Gaps = 17/206 (8%)
Query: 775 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVS 827
           +G G FG+V    + A        AVK L  D     +   +F  EV A+    H+NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 86  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQT 945
               +HRD+ + N+LL  +    + DFGL R L   D H            +  PE  +T
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
            T +   D + FGV L E+ T G+ P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 63   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 118
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 927
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 119  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 928  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 173  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 227
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1040
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 228  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 157
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 158 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 215
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 216 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 248

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 188  ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 243
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 927
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 244  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 297
Query: 928  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 298  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 352
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1040
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 353  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 44/240 (18%)
Query: 756 DLTVSDL-LKSTNNFNQANII-----GCGGFGLVYKA-TLTNGTKAAVK-----RLSGDC 803
           DL   +L  +S  NFN   I+     G G F +V +  + + G + A K     R   DC
Sbjct: 12  DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC 71
Query: 804 GQMEREFQAEVEALSRAQH-KNLVSLQGYCRHGNDRLLIYSYMENGSLDYW----LHESV 858
                E   E+  L  A+    +++L     + ++ +LI  Y   G +       L E V
Sbjct: 72  ---RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128
Query: 859 DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF---EAHLADFG 915
            ++ V++      + +    G+ YLH+    +IVH D+K  NILL   +   +  + DFG
Sbjct: 129 SENDVIR------LIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 916 LSRLLRPYDTHVTT--DLVGTLGYIPPE---YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           +SR +     H     +++GT  Y+ PE   Y    TAT   D+++ G++   LLT   P
Sbjct: 180 MSRKI----GHACELREIMGTPEYLAPEILNYDPITTAT---DMWNIGIIAYMLLTHTSP 232

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 134
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 135 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 129
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 63   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 118
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 927
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 119  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 928  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 173  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 227
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1040
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 228  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 51/225 (22%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEA--------- 816
             + Q   IG G  G+V  A  T  G   AVK+LS       R FQ +  A         
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYRELVL 76
Query: 817 LSRAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDV 868
           L    HKN++SL      Q       D  L+   M + +L   +H  +D +  S L + +
Sbjct: 77  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQM 135
Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR------LLRP 922
                     G+ +LH      I+HRD+K SNI++       + DFGL+R      ++ P
Sbjct: 136 LC--------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 184
Query: 923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 967
           Y        V T  Y  PE    +      D++S G ++ EL+ G
Sbjct: 185 Y--------VVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 62   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 117
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 927
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 118  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 171
Query: 928  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 172  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 226
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1040
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 227  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 63   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 118
Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 927
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 119  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 928  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 173  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 227
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1040
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 228  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 31/198 (15%)
Query: 747 VLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTK-AAVKRLSG---- 801
           + FQ +  K++ V D      N+   ++IG G +G VY A   N  K  A+K+++     
Sbjct: 14  LYFQGAIIKNVKVPD------NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFED 67
Query: 802 --DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD 859
             DC ++ RE    +  L+R +   ++ L        D ++    ++   L Y + E  D
Sbjct: 68  LIDCKRILRE----ITILNRLKSDYIIRLH-------DLIIPEDLLKFDEL-YIVLEIAD 115
Query: 860 KDSVLKWDVRLKIAQGAARGLAY-----LHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 914
            D    +   + + +   + + Y        + E  I+HRD+K +N LL++     + DF
Sbjct: 116 SDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDF 175
Query: 915 GLSRLLRP-YDTHVTTDL 931
           GL+R +    D H+  DL
Sbjct: 176 GLARTINSDKDIHIVNDL 193

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 766 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAA-----VKRLSG-DCGQMEREFQAEVEALS 818
           T+ +     IG G F +V +   L  G + A      K+LS  D  ++ERE  A +  L 
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLERE--ARICRL- 59
Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
             +H N+V L           L++  +  G L     + V ++   + D    I Q    
Sbjct: 60  -LKHSNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQ-ILE 114
Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVGTL 935
            + + H++    +VHRD+K  N+LL  K +     LADFGL+  ++  D        GT 
Sbjct: 115 AVLHCHQM---GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG-DQQAWFGFAGTP 170
Query: 936 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 15/209 (7%)
Query: 766 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQAEVEALSRAQHKN 824
           ++ F   + +G G   +VY+       K  A+K L     +  +  + E+  L R  H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
           ++ L+       +  L+   +  G L       V+K    + D    + Q     +AYLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL---FDRIVEKGYYSERDAADAVKQ-ILEAVAYLH 165
Query: 885 KVCEPHIVHRDVKSSNILLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
              E  IVHRD+K  N+L           +ADFGLS+++      +   + GT GY  PE
Sbjct: 166 ---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPE 220
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             +        D++S G++   LL G  P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 129
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA------LAYLES- 129
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 130 --KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 132
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 133 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 190
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 191 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 16/244 (6%)
Query: 756 DLTVSDLLKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK-----RLSGDCGQMERE 809
           D+   D+L   + +    +IG G F +V +      G + AVK     + +   G    +
Sbjct: 14  DMADDDVL-FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 810 FQAEVEALSRAQHKNLVSL-QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV 868
            + E       +H ++V L + Y   G    +++ +M+   L + + +  D   V    V
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDT 925
                +     L Y H   + +I+HRDVK  N+LL  K  +    L DFG++  L     
Sbjct: 132 ASHYMRQILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL 188
Query: 926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
            V    VGT  ++ PE  +        DV+  GV+L  LL+G  P    K +    ++  
Sbjct: 189 -VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKG 247
Query: 986 VFQM 989
            ++M
Sbjct: 248 KYKM 251

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 126
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 131
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 132 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 189
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 190 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 222

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 27/179 (15%)
Query: 807 EREFQAEVEALSRAQHKNLVSLQG--YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVL 864
           E   + E++ L R +HKN++ L    Y        ++  Y   G     + E +D     
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-----MQEMLDSVP-- 102
Query: 865 KWDVRLKIAQGAAR------GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 918
             + R  + Q          GL YLH      IVH+D+K  N+LL       ++  G++ 
Sbjct: 103 --EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157
Query: 919 LLRPY---DTHVTTDLVGTLGYIPPEYSQTLT--ATCRGDVYSFGVVLLELLTGRRPVE 972
            L P+   DT  T+   G+  + PPE +  L   +  + D++S GV L  + TG  P E
Sbjct: 158 ALHPFAADDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA------LAYLES- 129
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +        +     + ++ PE     
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFR 187
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 51/293 (17%)
Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 831
             I+G G  G V       G   AVKR+  D   +      E++ L+ +  H N++  + Y
Sbjct: 39   KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVI--RYY 93
Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-------IAQGAARGLAYLH 884
            C    DR L Y  +E  +L+  L + V+  +V   +++L+       + +  A G+A+LH
Sbjct: 94   CSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 885  KVCEPHIVHRDVKSSNILLD-------------EKFEAHLADFGLSRLLRPYDTHVTTDL 931
             +    I+HRD+K  NIL+              E     ++DFGL + L         +L
Sbjct: 151  SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 932  ---VGTLGYIPPEYSQTLTA---TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 984
                GT G+  PE  +  T    T   D++S G V   +L+ G+ P      +   +++ 
Sbjct: 208  NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-NIIR 266
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             +F +   K    + D S+        + E  ++  + ID DP +RP   +V+
Sbjct: 267  GIFSLDEMK---CLHDRSL--------IAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATL---TNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA------LAYLES- 509
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 31/233 (13%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
           IG GGFGL+Y A  TN  +   + +     Q      +E++   R   K+ +  +   R 
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK-KWIERK 103
Query: 835 GNDRLLI---------------YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
             D L I               Y +M    L   L +   ++   K    L++       
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKF--EAHLADFGLSRLLRP------YDTHVTTDL 931
           L Y+H   E   VH D+K++N+LL  K   + +LAD+GLS    P      Y  +     
Sbjct: 164 LEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
            GT+ +   +  + +  + R DV   G  +L  L G+ P E    +N +D V+
Sbjct: 221 NGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE----QNLKDPVA 269

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 51/293 (17%)
Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 831
             I+G G  G V       G   AVKR+  D   +      E++ L+ +  H N++  + Y
Sbjct: 39   KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVI--RYY 93
Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-------IAQGAARGLAYLH 884
            C    DR L Y  +E  +L+  L + V+  +V   +++L+       + +  A G+A+LH
Sbjct: 94   CSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 885  KVCEPHIVHRDVKSSNILLD-------------EKFEAHLADFGLSRLLRPYDTHVTTDL 931
             +    I+HRD+K  NIL+              E     ++DFGL + L         +L
Sbjct: 151  SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 932  ---VGTLGYIPPEYSQTLTA---TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 984
                GT G+  PE  +  T    T   D++S G V   +L+ G+ P      +   +++ 
Sbjct: 208  NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-NIIR 266
Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
             +F +   K    + D S+        + E  ++  + ID DP +RP   +V+
Sbjct: 267  GIFSLDEMK---CLHDRSL--------IAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 877  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGT 934
            A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D    
Sbjct: 210  AKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMKS 991
            L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L         
Sbjct: 266  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--------K 317
Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 318  EGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 877  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGT 934
            A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D    
Sbjct: 208  AKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMKS 991
            L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L         
Sbjct: 264  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--------K 315
Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 316  EGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 775 IGCGGFGLVYKATL---TNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 829
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 830 GYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA------LAYLES- 509
Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 510 --KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 947 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 877  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGT 934
            A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D    
Sbjct: 201  AKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMKS 991
            L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L         
Sbjct: 257  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--------K 308
Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 309  EGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 93/249 (37%), Gaps = 25/249 (10%)
Query: 738 SEALASSKLV--LFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAA 795
           +  LA  K V    Q ++   + + ++    ++F    +IG G F  V    +    +  
Sbjct: 30  ASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVY 89
Query: 796 VKRLSGDCGQMERE----FQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD 851
             ++      ++R     F+ E + L     + +  L    +  N   L+  Y   G L 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 852 YWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE 908
             L    E +  +    +   + +A  +   L Y         VHRD+K  NILLD    
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY---------VHRDIKPDNILLDRCGH 200
Query: 909 AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG-------DVYSFGVVL 961
             LADFG    LR   T  +   VGT  Y+ PE  Q +             D ++ GV  
Sbjct: 201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 962 LELLTGRRP 970
            E+  G+ P
Sbjct: 261 YEMFYGQTP 269

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 877  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGT 934
            A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D    
Sbjct: 203  AKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMKS 991
            L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L         
Sbjct: 259  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--------K 310
Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 311  EGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEA--------- 816
             + Q   IG G  G+V  A  T  G   AVK+LS       R FQ +  A         
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYRELVL 74
Query: 817 LSRAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDV 868
           L    HKN++SL      Q       D  L+   M + +L   +H  +D +  S L + +
Sbjct: 75  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQM 133
Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 928
                     G+ +LH      I+HRD+K SNI++       + DFGL+R        + 
Sbjct: 134 LC--------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAS--TNFMM 180
Query: 929 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 967
           T  V T  Y  PE    +      D++S G ++ EL+ G
Sbjct: 181 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLV---YKATLTNGTKAAV---KRLSG-DCGQMEREFQAEVEA 816
           + T+++     +G G F +V    K T T    A +   K+LS  D  ++ERE  A +  
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLERE--ARICR 85
Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
           L +  H N+V L           L++  +  G L     + V ++   + D    I Q  
Sbjct: 86  LLK--HPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIHQI- 139
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVG 933
              L  ++ + +  IVHRD+K  N+LL  K +     LADFGL+  ++  +        G
Sbjct: 140 ---LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG-EQQAWFGFAG 195
Query: 934 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 55/297 (18%)
Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 831
             I+G G  G V       G   AVKR+  D   +      E++ L+ +  H N++  + Y
Sbjct: 21   KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVI--RYY 75
Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-------IAQGAARGLAYLH 884
            C    DR L Y  +E  +L+  L + V+  +V   +++L+       + +  A G+A+LH
Sbjct: 76   CSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 885  KVCEPHIVHRDVKSSNILLD-------------EKFEAHLADFGLSRLLRPYDTHVTTDL 931
             +    I+HRD+K  NIL+              E     ++DFGL + L         +L
Sbjct: 133  SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 932  ---VGTLGYIPPEY------SQTLTATCRG-DVYSFGVVLLELLT-GRRPVEVCKGKNCR 980
                GT G+  PE        QT     R  D++S G V   +L+ G+ P      +   
Sbjct: 190  NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248
Query: 981  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
            +++  +F +   K    + D S+        + E  ++  + ID DP +RP   +V+
Sbjct: 249  NIIRGIFSLDEMK---CLHDRSL--------IAEATDLISQMIDHDPLKRPTAMKVL 294

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 877  ARGLAYLH-KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGT 934
            ARG+ +L  + C    +HRD+ + NILL E     + DFGL+R +     +V   D    
Sbjct: 209  ARGMEFLSSRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 993
            L ++ PE       + + DV+S+GV+L E+ + G  P    +     D  S +       
Sbjct: 265  LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE--DFCSRL------- 315
Query: 994  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            RE   + A       E    E+ +I   C  +DP+ RP   E+V  L
Sbjct: 316  REGMRMRAP------EYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 18/217 (8%)
Query: 762 LLKSTNNFNQANIIGCGGFGL--VYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR 819
           ++  ++ ++    IG G FG+  + +  LT     AVK +      ++   Q E+     
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIERGAA-IDENVQREIINHRS 72
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
            +H N+V  +          +I  Y   G L    +E +        D      Q    G
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSG 128
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLA--DFGLSRLLRPYDTHVTTDLVGTLGY 937
           ++Y H +    I HRD+K  N LLD      L   DFG S+    +    +T  VGT  Y
Sbjct: 129 VSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAY 183
Query: 938 IPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRPVE 972
           I PE    Q        DV+S GV L  +L G  P E
Sbjct: 184 IAPEVLLRQEYDGKI-ADVWSCGVTLYVMLVGAYPFE 219

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAV------KRLSGDCGQMEREF---QAEVEA 816
           +  ++  + +G G FG V+ A      K  V      +++  DC   + +      E+  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 817 LSRAQHKNLVS-LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
           LSR +H N++  L  +   G  +L++  +     LD  L   +D+   L   +   I + 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH--GSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
               + YL       I+HRD+K  NI++ E F   L DFG +  L       T    GT+
Sbjct: 139 LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTI 193
Query: 936 GYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRP 970
            Y  PE    +    RG   +++S GV L  L+    P
Sbjct: 194 EYCAPEV--LMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 775 IGCGGFGLVYKATLTNGTKA---AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG- 830
           +G G +G VYKA   +G      A+K++ G    M      E+  L   +H N++SLQ  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 86
Query: 831 YCRHGNDRL-LIYSYMENGSLDYW----LHESVDKDSVLKWDVRLKIAQGAARGLAY--- 882
           +  H + ++ L++ Y E+   D W     H +   +        +++ +G  + L Y   
Sbjct: 87  FLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKK-----PVQLPRGMVKSLLYQIL 138
Query: 883 --LHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLSRLLR-PYDTHVTTD-LVGT 934
             +H +    ++HRD+K +NIL+     E+    +AD G +RL   P       D +V T
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 935 LGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCR 980
             Y  PE         +  D+++ G +  ELLT   P+  C+ ++ +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIK 244

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 13/200 (6%)
Query: 775 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG+V++       +  V +       +++   + E+  +++  H  L++L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
              + +LI  ++  G L         +D  +     +   + A  GL ++H   E  IVH
Sbjct: 119 DKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVH 172
Query: 894 RDVKSSNILLDEKFEA--HLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTATC 950
            D+K  NI+ + K  +   + DFGL+  L P +   VTT    T  +  PE         
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGF 229
Query: 951 RGDVYSFGVVLLELLTGRRP 970
             D+++ GV+   LL+G  P
Sbjct: 230 YTDMWAIGVLGYVLLSGLSP 249

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 53/193 (27%), Positives = 84/193 (43%), Gaps = 19/193 (9%)
Query: 781 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 840
           G  Y A + N  K + +    D  ++ERE  A +  L   +H N+V L           L
Sbjct: 47  GQEYAAKIINTKKLSAR----DHQKLERE--ARICRL--LKHPNIVRLHDSISEEGHHYL 98
Query: 841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
           I+  +  G L     + V ++   + D    I Q     + + H++    +VHRD+K  N
Sbjct: 99  IFDLVTGGEL---FEDIVAREYYSEADASHCIQQ-ILEAVLHCHQM---GVVHRDLKPEN 151
Query: 901 ILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSF 957
           +LL  K +     LADFGL+  +   +        GT GY+ PE  +        D+++ 
Sbjct: 152 LLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 210
Query: 958 GVVLLELLTGRRP 970
           GV+L  LL G  P
Sbjct: 211 GVILYILLVGYPP 223

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD----CGQMEREFQAEVEALSRAQ 821
           + F +   IG G FG V     +  G   A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWDVRLKIAQGAARGL 880
              LV L+   +  ++  ++  YM  G  D + H   + + S  +   R   AQ      
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFS--EPHARFYAAQ-IVLTF 154
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            YLH +    +++RD+K  N+L+D++    +ADFG ++ ++      T  L GT  Y+ P
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAP 207
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E   +       D ++ GV++ E+  G  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 766 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK-----RLSG-DCGQMEREFQAEVEALS 818
           T+ +     +G G F +V +   +  G + A K     +LS  D  ++ERE  A +  L 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLERE--ARICRL- 59
Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
             +H N+V L           L++  +  G L     + V ++   + D    I Q    
Sbjct: 60  -LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQ---- 111
Query: 879 GLAYLHKVCEPH---IVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLV 932
               L  V   H   IVHRD+K  N+LL  K +     LADFGL+  ++  D        
Sbjct: 112 ---ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG-DQQAWFGFA 167
Query: 933 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           GT GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD----CGQMEREFQAEVEALSRAQ 821
           + F +   IG G FG V     +  G   A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWDVRLKIAQGAARGL 880
              LV L+   +  ++  ++  YM  G  D + H   + + S  +   R   AQ      
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFS--EPHARFYAAQ-IVLTF 154
Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            YLH +    +++RD+K  N+L+D++    +ADFG ++ ++      T  L GT  Y+ P
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAP 207
Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           E   +       D ++ GV++ E+  G  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 766 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK-----RLSG-DCGQMEREFQAEVEALS 818
           T+ +     +G G F +V +   +  G + A K     +LS  D  ++ERE  A +  L 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLERE--ARICRLL 60
Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           +  H N+V L           L++  +  G L     + V ++   + D    I Q    
Sbjct: 61  K--HPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQ---- 111
Query: 879 GLAYLHKVCEPH---IVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLV 932
               L  V   H   IVHRD+K  N+LL  K +     LADFGL+  ++  D        
Sbjct: 112 ---ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG-DQQAWFGFA 167
Query: 933 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           GT GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 764 KSTNNFNQANIIGCGGFGLVY-KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           K  + F    + G G FG V      + G   A+K++  D     RE Q  ++ L+   H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHH 78
Query: 823 KNLVSLQGYCRH--GNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQ-GA 876
            N+V LQ Y       DR  IY  +    +   LH    +  +  V    + +K+     
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTL 935
            R +  LH +   ++ HRD+K  N+L++E      L DFG ++ L P + +V    + + 
Sbjct: 139 IRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA--YICSR 195
Query: 936 GYIPPEY---SQTLTATCRGDVYSFGVVLLELLTG 967
            Y  PE    +Q  T     D++S G +  E++ G
Sbjct: 196 YYRAPELIFGNQHYTTAV--DIWSVGCIFAEMMLG 228

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 68/151 (45%), Gaps = 16/151 (10%)
Query: 847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL--D 904
           NGS+ +   ES+D   V +  +   I +     L YLH      I HRD+K  N L   +
Sbjct: 151 NGSI-HGFRESLD--FVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTN 204
Query: 905 EKFEAHLADFGLSR---LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC--RGDVYSFGV 959
           + FE  L DFGLS+    L   + +  T   GT  ++ PE   T   +   + D +S GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 960 VLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
           +L  LL G  P     G N  D +S V   K
Sbjct: 265 LLHLLLMGAVPF---PGVNDADTISQVLNKK 292

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 25/178 (14%)
Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTK-AAVKRLSG------DCGQMEREFQAEVEALSR 819
           +N+   ++IG G +G VY A   N  K  A+K+++       DC ++ RE    +  L+R
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILNR 81
Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
            +   ++ L  Y     D LL +  +      Y + E  D D    +   + + +   + 
Sbjct: 82  LKSDYIIRL--YDLIIPDDLLKFDEL------YIVLEIADSDLKKLFKTPIFLTEEHIKT 133
Query: 880 LAY-----LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDL 931
           + Y      + + E  I+HRD+K +N LL++     + DFGL+R +    DT++  DL
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 749 FQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQ 805
           F + +  D T + +LK   N      IG G  G+V   Y A L      A+K+LS     
Sbjct: 10  FYSVEIGDSTFT-VLKRYQNLKP---IGSGAQGIVVAAYDAILERNV--AIKKLS----- 58
Query: 806 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD-----YWLHESVDK 860
             R FQ +  A  +  ++ LV L     H N   L+  +    SL+     Y + E +D 
Sbjct: 59  --RPFQNQTHA--KRAYRELV-LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA 113
Query: 861 DSVLKWDVRLKIAQGAARGLAYLHKVCEPH-----IVHRDVKSSNILLDEKFEAHLADFG 915
           +  L   +++++       L Y   V   H     I+HRD+K SNI++       + DFG
Sbjct: 114 N--LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG 171
Query: 916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 967
           L+R      + + T  V T  Y  PE    +      D++S GV++ E++ G
Sbjct: 172 LARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 775 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           IG G  G+V   Y A L      A+K+LS       R FQ +  A  +  ++ LV L   
Sbjct: 32  IGSGAQGIVCAAYDAILERNV--AIKKLS-------RPFQNQTHA--KRAYRELV-LMKV 79
Query: 832 CRHGNDRLLIYSYMENGSLD-----YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
             H N   L+  +    SL+     Y + E +D +  L   +++++       L Y   V
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV 137
Query: 887 CEPH-----IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
              H     I+HRD+K SNI++       + DFGL+R      + + T  V T  Y  PE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 195
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTG 967
               +      D++S GV++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 33/157 (21%)
Query: 108 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
           +K  DLS + +  ++    S+   LE L L+ N ++        GL  +  LN+S N   
Sbjct: 277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN--- 333
Query: 168 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG----SLQGLDH 223
                                F G ++SR++    ++++LDLS NH       S  GL  
Sbjct: 334 ---------------------FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL-- 370
Query: 224 SPSLKQLHVDNNLLGGDLPDSLYS-MSSLQHVSLSVN 259
            P+LK+L +D N L   +PD ++  ++SLQ + L  N
Sbjct: 371 -PNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405

>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 24/167 (14%)
Query: 493 LFYLDFSNNTLTGEIPKS---LTELKSLISSNCTSSNPTASAGIPLYVKH----NRSTNG 545
             +LDFSNN LT  + ++   LTEL++LI         +  A +   +K     + S N 
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385
Query: 546 LPYNQAS---SFPPSVF---LSNNRINGTI----PPEIGQLKHLHVLDLSRNNITGTIPS 595
           + Y++     S+  S+    +S+N +  TI    PP I       VLDL  N I  +IP 
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK------VLDLHSNKI-KSIPK 438
Query: 596 SISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 642
            + ++  L+ L+++SN L     G F++LT L K  +  N    + P
Sbjct: 439 QVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 110 LLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGS 169
           LLDL  N +  +   +  NLK L  L L +N +S    G  A L  ++ L +S N     
Sbjct: 56  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ---- 111
Query: 170 LFELGEF--SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM------GSLQGL 221
           L EL E     L    +  N  T K+   +++   ++ +++L  N         G+ QG+
Sbjct: 112 LKELPEKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 222 DH------------------SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 263
                                PSL +LH+D N +      SL  +++L  + LS N+ S 
Sbjct: 171 KKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230
Query: 264 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 305
             +  ++N   LR L +  N+   K+P  L +   ++    H
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 110 LLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGS 169
           LLDL  N +  +   +  NLK L  L L +N +S    G  A L  ++ L +S N     
Sbjct: 56  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ---- 111
Query: 170 LFELGEF--SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM------GSLQGL 221
           L EL E     L    +  N  T K+   +++   ++ +++L  N         G+ QG+
Sbjct: 112 LKELPEKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 222 DH------------------SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 263
                                PSL +LH+D N +      SL  +++L  + LS N+ S 
Sbjct: 171 KKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230
Query: 264 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 305
             +  ++N   LR L +  N+   K+P  L +   ++    H
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 764 KSTNNFNQANIIGCGGFGLVYK--ATLTNGTKAAV----KRLSG-DCGQMEREFQAEVEA 816
           + T  +     +G G F +V +    L     AA+    K+LS  D  ++ERE  A +  
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE--ARICR 65
Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
           L   +H N+V L           LI+  +  G L     + V ++   + D    I Q  
Sbjct: 66  L--LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQ-I 119
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVG 933
              + + H++    +VHR++K  N+LL  K +     LADFGL+  +   +        G
Sbjct: 120 LEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAG 175
Query: 934 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 23/229 (10%)
Query: 419 KNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL--KGHIPVWLLRCKKLQVLDLSW 476
           K+L  L  T N  G    E      SL  L L   GL  KG           L+ LDLS+
Sbjct: 325 KSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 477 NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLY 536
           N        ++G +E L +LDF ++ L     K ++E    +S             I L 
Sbjct: 383 NGVITMSSNFLG-LEQLEHLDFQHSNL-----KQMSEFSVFLS---------LRNLIYLD 427
Query: 537 VKHNRST---NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTI 593
           + H  +    NG+ +N  SS        N+     +P    +L++L  LDLS+  +    
Sbjct: 428 ISHTHTRVAFNGI-FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 594 PSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 642
           P++ + + +L+VL+++SN L     G F++LT L K  +  N    + P
Sbjct: 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 17/209 (8%)
Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD----CGQMEREFQAEVEALSRAQ 821
           + F +   IG G FG V     +  G   A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
              LV L+   +  ++  ++  Y+  G +   L   + + S  +   R   AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR-IGRFS--EPHARFYAAQ-IVLTFE 155
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           YLH +    +++RD+K  N+L+D++    +ADFG ++ ++      T  L GT  Y+ PE
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLAPE 208
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
              +       D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/91 (28%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
             YLH +    +++RD+K  N+L+D++    +ADFG ++ ++      T  L GT  Y+ 
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLA 207
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE   +       D ++ GV++ E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
             YLH +    +++RD+K  N+L+D++    + DFG ++ ++      T  L GT  Y+ 
Sbjct: 175 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTLCGTPEYLA 227
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE   +       D ++ GV++ E+  G  P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           YLH +    +++RD+K  N+L+DE+    + DFG ++ ++      T  L GT  Y+ PE
Sbjct: 143 YLHSL---DLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 195
Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
              +       D ++ GV++ E+  G  P
Sbjct: 196 IILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
             YLH +    +++RD+K  N+L+D++    + DFG ++ ++      T  L GT  Y+ 
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLAGTPEYLA 206
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE   +       D ++ GV++ E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 13/233 (5%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
           ++  ++ +     IG G FG+          +    +      +++   + E+      +
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 72
Query: 822 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
           H N+V  +          ++  Y   G L     E +        D      Q    G++
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVS 128
Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLA--DFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           Y H +    + HRD+K  N LLD      L   DFG S+    +    +T  VGT  YI 
Sbjct: 129 YCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 183
Query: 940 PEYSQTLTATCR-GDVYSFGVVLLELLTGRRPVEVCKG-KNCRDLVSWVFQMK 990
           PE         +  DV+S GV L  +L G  P E  +  KN R  +  +  ++
Sbjct: 184 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 236

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 22/219 (10%)
Query: 762 LLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLS-GDCGQMEREFQAEVEA 816
           ++  ++ +     IG G FG+   A L    +A    AVK +  G+  +++   + E+  
Sbjct: 14  IMHDSDRYELVKDIGAGNFGV---ARLMRDKQANELVAVKYIERGE--KIDENVKREIIN 68
Query: 817 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
               +H N+V  +          ++  Y   G L     E +        D      Q  
Sbjct: 69  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQL 124
Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGT 934
             G++Y H +    + HRD+K  N LLD      L  ADFG S+    +    +   VGT
Sbjct: 125 ISGVSYAHAM---QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA--VGT 179
Query: 935 LGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGRRPVE 972
             YI PE         +  DV+S GV L  +L G  P E
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
             YLH +    +++RD+K  N+++D++    + DFGL++ ++      T  L GT  Y+ 
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG----RTWXLCGTPEYLA 206
Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE   +       D ++ GV++ E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1048
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-154
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-143
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-141
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-63
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-124
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-114
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-92
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-81
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-70
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-47
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-89
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-62
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-45
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-33
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-83
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-71
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-58
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-35
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-78
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-58
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-77
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-73
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-66
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-55
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-52
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-42
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-11
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-72
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-53
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-68
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-61
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-56
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-41
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-39
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-52
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-51
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-29
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-27
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-51
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-49
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-33
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-29
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-49
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-42
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-26
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-21
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-32
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-32
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-34
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-26
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-07
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-31
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-34
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-34
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-07
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-33
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-29
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-32
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-32
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-27
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-04
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-30
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-30
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-10
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-23
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-11
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-10
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-22
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-19
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-07
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-06
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-07
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-10
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-06
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-12
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-12
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	8e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  460 bits (1185), Expect = e-154
 Identities = 128/294 (43%), Positives = 192/294 (65%), Gaps = 3/294 (1%)

Query: 755  KDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAE 813
            K  ++ +L  +++NF+  NI+G GGFG VYK  L +GT  AVKRL  +  Q  E +FQ E
Sbjct: 18   KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 814  VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA 873
            VE +S A H+NL+ L+G+C    +RLL+Y YM NGS+   L E  +    L W  R +IA
Sbjct: 78   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 874  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 933
             G+ARGLAYLH  C+P I+HRDVK++NILLDE+FEA + DFGL++L+   DTHVTT + G
Sbjct: 138  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197

Query: 934  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKS 991
            T+G+I PEY  T  ++ + DV+ +GV+LLEL+TG+R  ++ +  N  D  L+ WV  +  
Sbjct: 198  TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045
            EK+   ++D  +    +++++ +++++A  C    P  RP + EVV  L+G G+
Sbjct: 258  EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  447 bits (1153), Expect = e-143
 Identities = 162/595 (27%), Positives = 262/595 (44%), Gaps = 78/595 (13%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
             L +    L G   R++    +LKLL++S N   G +P     LK L+ L L+ N  +G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTG 283

Query: 145 PVSGMLAG-LNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASK 202
            +   L+G  + +  L++S N F G++    G  S L    +S+N+F+G+L        +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343

Query: 203 EIQILDLSMNHFMGSLQG--LDHSPSLKQLHVDNNLLGGDLPDSL--YSMSSLQHVSLSV 258
            +++LDLS N F G L     + S SL  L + +N   G +  +L     ++LQ + L  
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403

Query: 259 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 318
           N F+G++   +SN + L  L +  N  SG +P+ LG+L++L       N   G +P  L 
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463

Query: 319 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
               L  L L  N LTG I    S  ++L  + L+ N  +G +P  +    +L IL L+ 
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 438
           N  SG +P   G   SL++L L+ N F   +GT                       IP  
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLF---NGT-----------------------IPAA 557

Query: 439 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWN--HFDGNIPPWIGQMENLFYL 496
           +      +        + G   V++      +    + N   F G     + ++      
Sbjct: 558 MFKQSGKIAANF----IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613

Query: 497 DFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP 556
           + ++    G    +     S++  +                                   
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLD----------------------------------- 638

Query: 557 SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 616
              +S N ++G IP EIG + +L +L+L  N+I+G+IP  + ++R L +LDLSSN L G 
Sbjct: 639 ---MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR 695

Query: 617 IPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDS 671
           IP +   LT L++  ++NN+L G IP  GQF +FP + F  NPGLCG     CD 
Sbjct: 696 IPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  440 bits (1135), Expect = e-141
 Identities = 181/625 (28%), Positives = 259/625 (41%), Gaps = 88/625 (14%)

Query: 33  SCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRK 92
                ++  L  F   L + +++  WS+    C +DGV C          +VT + L  K
Sbjct: 8   QSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTC-------RDDKVTSIDLSSK 60

Query: 93  GLKGI---IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGM 149
            L      +  SL  L  L+ L LS +H+ G V         L  LDLS N LSGPV+  
Sbjct: 61  PLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVT-- 117

Query: 150 LAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDL 209
                              +L  LG  S L   N+S+N+               +++LDL
Sbjct: 118 -------------------TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158

Query: 210 SMNHFMG----SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL 265
           S N   G         D    LK L +  N + GD+   +    +L+ + +S NNFS  +
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216

Query: 266 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 325
              + + ++L+HL I GN+ SG     +   T+L+     SN F GP+P        L  
Sbjct: 217 PF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQY 273

Query: 326 LDLRNNSLTGPIDLNFSG-LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ 384
           L L  N  TG I    SG   +L  LDL+ NHF G +P     C  L+ L+L+ N  SG+
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333

Query: 385 VP-ESFGKLTSLLFLSLSNNSFNHLSGTL--SVLQQCKNLTTLILTKNFVGEEIPENVGG 441
           +P ++  K+  L  L LS    N  SG L  S+     +L TL L+ N     I  N+  
Sbjct: 334 LPMDTLLKMRGLKVLDLSF---NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 390

Query: 442 F--ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFS 499
               +L  L L N G  G IP  L  C +L  L LS+N+  G IP  +G +  L  L   
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450

Query: 500 NNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF 559
            N L GEIP+ L  +K+L                                       ++ 
Sbjct: 451 LNMLEGEIPQELMYVKTLE--------------------------------------TLI 472

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
           L  N + G IP  +    +L+ + LS N +TG IP  I  + NL +L LS+N   G+IP 
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532

Query: 620 SFEKLTFLSKFSVANNHLQGTIPTG 644
                  L    +  N   GTIP  
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  229 bits (587), Expect = 1e-63
 Identities = 92/331 (27%), Positives = 150/331 (45%), Gaps = 12/331 (3%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 138
           SN   +  L L    L G IP SLG L++L+ L L  N LEG +P EL  +K LE L L 
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474

Query: 139 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRI 197
            N L+G +   L+    +  +++S+N   G +   +G   NLA+  +SNNSF+G + + +
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534

Query: 198 WSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVD--NNLLGGDLPDSLYSMSSLQHVS 255
                 +  LDL+ N F G++       ++ +       N + G     + +    +   
Sbjct: 535 GDCRS-LIWLDLNTNLFNGTI-----PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588

Query: 256 LSVN--NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 313
            + N   F G  SE+++ L++     I    + G       N   + F     N  SG +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648

Query: 314 PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 373
           P  +     L +L+L +N ++G I      L  L  LDL++N   G +P ++S    L  
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708

Query: 374 LSLAKNELSGQVPESFGKLTSLLFLSLSNNS 404
           + L+ N LSG +PE  G+  +       NN 
Sbjct: 709 IDLSNNNLSGPIPEM-GQFETFPPAKFLNNP 738

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  106 bits (268), Expect = 1e-23
 Identities = 35/166 (21%), Positives = 67/166 (40%), Gaps = 8/166 (4%)

Query: 36  PSDLLAL-KEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGS------NAGRVTMLI 88
           P+ +     + A N   G       N+ M  +  G        G                
Sbjct: 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 614

Query: 89  LPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSG 148
           +  +   G    +  +   +  LD+S N L G +P E+ ++  L +L+L HN +SG +  
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674

Query: 149 MLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKL 193
            +  L  +  L++SSN  +G +   +   + L   ++SNN+ +G +
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 59.9 bits (146), Expect = 3e-09
 Identities = 19/78 (24%), Positives = 35/78 (44%), Gaps = 4/78 (5%)

Query: 578 HLHVLDLSRNNIT---GTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN 634
            +  +DLS   +      + SS+  +  LE L LS++ ++GS+   F+    L+   ++ 
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSR 109

Query: 635 NHLQGTIPTGGQFYSFPN 652
           N L G + T     S   
Sbjct: 110 NSLSGPVTTLTSLGSCSG 127

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  380 bits (977), Expect = e-124
 Identities = 116/294 (39%), Positives = 166/294 (56%), Gaps = 4/294 (1%)

Query: 751  NSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF 810
              +   + + DL ++TNNF+   +IG G FG VYK  L +G K A+KR + +  Q   EF
Sbjct: 23   PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82

Query: 811  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 870
            + E+E LS  +H +LVSL G+C   N+ +LIY YMENG+L   L+ S      + W+ RL
Sbjct: 83   ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTT 929
            +I  GAARGL YLH      I+HRDVKS NILLDE F   + DFG+S+       TH++T
Sbjct: 143  EICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199

Query: 930  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
             + GTLGYI PEY      T + DVYSFGVVL E+L  R  +     +   +L  W  + 
Sbjct: 200  VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259

Query: 990  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
             +  +  +I+D ++  K R + L +  + A KC+      RP + +V+  L+  
Sbjct: 260  HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  354 bits (910), Expect = e-114
 Identities = 110/308 (35%), Positives = 175/308 (56%), Gaps = 23/308 (7%)

Query: 749  FQNSDCKDLTVSDLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSGD 802
              ++     +  +L   TNNF++       N +G GGFG+VYK  + N T  AVK+L+  
Sbjct: 7    VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65

Query: 803  C----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV 858
                  +++++F  E++ +++ QH+NLV L G+   G+D  L+Y YM NGSL   L    
Sbjct: 66   VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL- 124

Query: 859  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 918
            D    L W +R KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R
Sbjct: 125  DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 919  LLRPYD-THVTTDLVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKG 976
                +  T +T+ +VGT  Y+ PE     +T   + D+YSFGVVLLE++TG   V+  + 
Sbjct: 182  ASEKFAQTVMTSRIVGTTAYMAPEALRGEITP--KSDIYSFGVVLLEIITGLPAVD--EH 237

Query: 977  KNCRDLVSWVFQMKSEKREVE-IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
            +  + L+    +++ E++ +E  ID  +   D    +  M  +A +C+ +   +RP I++
Sbjct: 238  REPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 1036 VVTWLDGI 1043
            V   L  +
Sbjct: 297  VQQLLQEM 304

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  308 bits (792), Expect = 2e-92
 Identities = 128/607 (21%), Positives = 213/607 (35%), Gaps = 53/607 (8%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           +  + P     L  LK+L+L  N L  +     +    L  L L  N +    +      
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 154 NLIQSLNVSSNSFNG-SLFELGEFSNLAVFNISNNSFTG-KLNSRIWSASKEIQILDLSM 211
             + +L++S N  +   L    +  NL    +SNN     K       A+  ++ L+LS 
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 212 NHFMGSLQG-LDHSPSLKQLHVDNNLLGGDLPDSL---YSMSSLQHVSLSVNNFSGQLSE 267
           N       G       L  L ++N  LG  L + L    + +S++++SLS +  S   + 
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 268 KISNL--TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 325
               L  T+L  L +  N  +    +    L QLE+F    N+       SL     +  
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 326 LDLRNN---------SLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 376
           L+L+ +         SL    D +F  L  L  L++  N   G   N  +   +LK LSL
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360

Query: 377 AKNELSGQV--PESFGKL--TSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVG 432
           + +  S +    E+F  L  + L  L+L+ N  + +           +L  L L  N +G
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES--DAFSWLGHLEVLDLGLNEIG 418

Query: 433 EEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG--NIPPWIGQ 489
           +E+      G E++  + L                  LQ L L         + P     
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478

Query: 490 MENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYN 549
           + NL  LD SNN +       L  L+ L                 L ++HN     L  +
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEI---------------LDLQHNNLAR-LWKH 522

Query: 550 QASSFPPSVF----------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 599
                P              L +N  +         L  L ++DL  NN+     S  + 
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582

Query: 600 IRNLEVLDLSSNDLHGSIPGSFEK-LTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGN 658
             +L+ L+L  N +       F      L++  +  N    T  +   F ++ N +    
Sbjct: 583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNI 642

Query: 659 PGLCGEI 665
           P L    
Sbjct: 643 PELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  278 bits (713), Expect = 2e-81
 Identities = 111/588 (18%), Positives = 194/588 (32%), Gaps = 96/588 (16%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           +P  L     + +L+L+ N L  +     +   QL  LD+  N +S     +   L +++
Sbjct: 19  VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
            LN+  N  +                +S+ +F              +  L L  N     
Sbjct: 77  VLNLQHNELSQ---------------LSDKTFAF---------CTNLTELHLMSNSIQKI 112

Query: 218 LQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS--NLTS 274
                    +L  L + +N L      +   + +LQ + LS N      SE++     +S
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172

Query: 275 LRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL---CSKLHVLDLRNN 331
           L+ L +  NQ     P     + +L     ++      L   L L    + +  L L N+
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232

Query: 332 SLTGPIDLNFSGL--SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESF 389
            L+   +  F GL  ++L  LDL+ N+ +    +S +    L+   L  N +      S 
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292

Query: 390 GKLTSLLFLSLSNN------SFNHLSG-TLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 442
             L ++ +L+L  +      S   L        Q  K L  L +  N +         G 
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352

Query: 443 ESLMVLALGNCGLKGHIPV----WLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 498
            +L  L+L N               L    L +L+L+ N            + +L  LD 
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412

Query: 499 SNNTLTGEIPKS----LTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF 554
             N +  E+       L  +  +                            L YN+    
Sbjct: 413 GLNEIGQELTGQEWRGLENIFEIY---------------------------LSYNKYLQL 445

Query: 555 PPSVF----------LSNNRING--TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 602
             + F          L    +    + P     L++L +LDLS NNI       +  +  
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505

Query: 603 LEVLDLSSNDLH--------GSIPGSFEKLTFLSKFSVANNHLQGTIP 642
           LE+LDL  N+L         G      + L+ L   ++ +N       
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  248 bits (635), Expect = 1e-70
 Identities = 98/496 (19%), Positives = 162/496 (32%), Gaps = 40/496 (8%)

Query: 178 NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNNL 236
           +  V + S+     KL          I +L+L+ N               L  L V  N 
Sbjct: 5   SHEVADCSHL----KLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 237 LGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNL 296
           +    P+    +  L+ ++L  N  S    +  +  T+L  L +  N       N     
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 297 TQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG--PIDLNFSGLSSLCTLDLAT 354
             L       N  S     +      L  L L NN +      +L+    SSL  L+L++
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 355 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFG---KLTSLLFLSLSNNSFNHLSGT 411
           N      P        L  L L   +L   + E        TS+  LSLSN+  +  S T
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 412 LSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 471
             +  +  NLT L L+ N +     ++      L    L    ++      L     ++ 
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 472 LDLSWNHFDGNI---------PPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNC 522
           L+L  +    +I               ++ L +L+  +N + G      T L +L     
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY--- 357

Query: 523 TSSNPTASAGIPLYVKHNR-STNGLPYNQASSFPPS----VFLSNNRINGTIPPEIGQLK 577
                       L + ++  S   L      S   S    + L+ N+I+         L 
Sbjct: 358 ------------LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405

Query: 578 HLHVLDLSRNNITGTIP-SSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNH 636
           HL VLDL  N I   +       + N+  + LS N        SF  +  L +  +    
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465

Query: 637 LQGTIPTGGQFYSFPN 652
           L+    +   F    N
Sbjct: 466 LKNVDSSPSPFQPLRN 481

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  180 bits (460), Expect = 1e-47
 Identities = 69/334 (20%), Positives = 122/334 (36%), Gaps = 33/334 (9%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
           T   +    L  I   S   L  L+ L++  N + G+     + L  L+ L LS++  S 
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367

Query: 145 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI 204
                               +     F     S L + N++ N  +  + S  +S    +
Sbjct: 368 -------------------RTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSWLGHL 407

Query: 205 QILDLSMNHFMGSLQG--LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 262
           ++LDL +N     L G       ++ ++++  N       +S   + SLQ + L      
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467

Query: 263 G--QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS--------GP 312
                      L +L  L +  N  +    ++L  L +LE      N+ +        G 
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527

Query: 313 LPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 372
               L   S LH+L+L +N         F  L  L  +DL  N+ +    +  ++   LK
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587

Query: 373 ILSLAKNELSGQVPESFGK-LTSLLFLSLSNNSF 405
            L+L KN ++    + FG    +L  L +  N F
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.5 bits (194), Expect = 6e-15
 Identities = 27/113 (23%), Positives = 47/113 (41%), Gaps = 4/113 (3%)

Query: 89  LPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSG 148
           L +    G     L  L+ L +L+L  N  + +      +L +L+++DL  N L+   + 
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578

Query: 149 MLAGLNLIQSLNVSSN---SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 198
           +      ++SLN+  N   S    +F    F NL   ++  N F     S  W
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPA-FRNLTELDMRFNPFDCTCESIAW 630

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 68.5 bits (168), Expect = 8e-12
 Identities = 21/101 (20%), Positives = 41/101 (40%), Gaps = 1/101 (0%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 138
                + +L L   G   I       L +LK++DL  N+L  +     +N   L+ L+L 
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592

Query: 139 HNMLSGPVSGMLA-GLNLIQSLNVSSNSFNGSLFELGEFSN 178
            N+++     +       +  L++  N F+ +   +  F N
Sbjct: 593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 48.5 bits (116), Expect = 1e-05
 Identities = 13/79 (16%), Positives = 24/79 (30%), Gaps = 1/79 (1%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELS-NLKQLEVLDLSHNMLSGPVSGMLAG 152
           L  +      +   LK L+L  N +  V         + L  LD+  N        +   
Sbjct: 572 LNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 631

Query: 153 LNLIQSLNVSSNSFNGSLF 171
           +N I   + +    +    
Sbjct: 632 VNWINETHTNIPELSSHYL 650

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  299 bits (767), Expect = 2e-89
 Identities = 92/630 (14%), Positives = 190/630 (30%), Gaps = 78/630 (12%)

Query: 40  LALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIP 99
           L  K ++          +W+       W       G + ++ GRVT L L   G  G +P
Sbjct: 42  LNGKNWSQQGFGTQPGANWNFNKELDMWGAQP---GVSLNSNGRVTGLSLEGFGASGRVP 98

Query: 100 RSLGHLNQLKLLDLSCNHLEG----VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNL 155
            ++G L +L++L L  +  +       P  +S     E                    + 
Sbjct: 99  DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDF 158

Query: 156 --IQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 212
             +    ++S+    S+                +N+ T  ++  +   +K ++   +  +
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTK-LRQFYMGNS 216

Query: 213 HFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNL 272
            F+          + +  + +             ++  L  V +       +L   +  L
Sbjct: 217 PFVAEN----ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272

Query: 273 TSLRHLIIFGNQF--------SGKLPNVLGNLTQLEFFVAHSNSF-SGPLPLSLSLCSKL 323
             ++ + +  N+           +         +++      N+  + P+  SL    KL
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332

Query: 324 HVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 383
            +L+   N L G +   F     L +L+LA N  +    N       ++ LS A N+L  
Sbjct: 333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391

Query: 384 QVPESF--GKLTSLLFLSLSNNSF-----NHLSGTLSVLQQCKNLTTLILTKNFVGEEIP 436
            +P  F    ++ +  +  S N        +         +  N++++ L+ N + +   
Sbjct: 392 -IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450

Query: 437 ENVGGFESLMVLALGNCGLKG-------HIPVWLLRCKKLQVLDLSWNHFDGNIPPW-IG 488
           E       L  + L    L                    L  +DL +N        +   
Sbjct: 451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRAT 510

Query: 489 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 548
            +  L  +D S N+ +   P       +L                   +++ R       
Sbjct: 511 TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG---------------FGIRNQRD------ 548

Query: 549 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 608
                         NR     P  I     L  L +  N+I   +   I+   N+ VLD+
Sbjct: 549 -----------AQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP--NISVLDI 594

Query: 609 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 638
             N                  + +  +  Q
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  222 bits (568), Expect = 4e-62
 Identities = 65/464 (14%), Positives = 144/464 (31%), Gaps = 58/464 (12%)

Query: 221 LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ----LSEKISNLTSLR 276
           L+ +  +  L ++     G +PD++  ++ L+ ++L  +           + IS   S  
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 277 HLIIFGNQFSGKLPNVLG--NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLT 334
                   +     +     + + L     +S+     +  S  +  K   +   +N++T
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 335 GPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTS 394
             +      L+ L    +  + F              +  +    +        +  L  
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEA-----WENENSEYAQQYKTEDLKWDNLKD 250

Query: 395 LLFLSLSNNSFNHLSGTL-SVLQQCKNLTTLILTKN--------FVGEEIPENVGGFESL 445
           L  + + N         L + L+    +  + +  N            +   +    E +
Sbjct: 251 LTDVEVYNCP---NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307

Query: 446 MVLALGNCGLK-GHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLT 504
            ++ +G   LK   +   L + KKL +L+  +N  +G   P  G    L  L+ + N +T
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQIT 366

Query: 505 GEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP--SVFLSN 562
                     + + +               L   HN+         A S     ++  S 
Sbjct: 367 EIPANFCGFTEQVEN---------------LSFAHNKLKYIPNIFDAKSVSVMSAIDFSY 411

Query: 563 NRING-------TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG 615
           N I          + P   +  ++  ++LS N I+       S    L  ++L  N L  
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

Query: 616 -------SIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 652
                      +F+    L+   +  N L   +    +  + P 
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPY 514

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  172 bits (437), Expect = 5e-45
 Identities = 51/336 (15%), Positives = 109/336 (32%), Gaps = 40/336 (11%)

Query: 96  GIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNL 155
             +  SL  + +L +L+   N LEG +P    +  +L  L+L++N ++   +        
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378

Query: 156 IQSLNVSSNSFNG--SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 213
           +++L+ + N      ++F+    S ++  + S N                     +   +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS-----------------VDGKN 421

Query: 214 FMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG-------QLS 266
           F           ++  +++ NN +     +   + S L  ++L  N  +          +
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481

Query: 267 EKISNLTSLRHLIIFGNQFSGKLPN--VLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLH 324
           E   N   L  + +  N+ +  L +      L  L       NSFS   P      S L 
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK 539

Query: 325 VLDLRN------NSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
              +RN      N          +   SL  L + +N     +   +    ++ +L +  
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKD 596

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSV 414
           N                    L  +    + G  ++
Sbjct: 597 NPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDAL 632

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  135 bits (343), Expect = 3e-33
 Identities = 38/332 (11%), Positives = 89/332 (26%), Gaps = 81/332 (24%)

Query: 349 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF--N 406
             +   + +      SL+    +  LSL     SG+VP++ G+LT L  L+L ++    N
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 407 HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG--FESLMVLALGNCGLKGHIPVWLL 464
                   +    +       +    +   +      F  L+   + +   +  I     
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 465 RCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTS 524
              K   +    N+    +   + ++  L      N+    E      E ++        
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS------- 232

Query: 525 SNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDL 584
                                                  +   T   +   LK L  +++
Sbjct: 233 ------------------------------------EYAQQYKTEDLKWDNLKDLTDVEV 256

Query: 585 SRNNITGTIPSSISEIRNLEVLDLSSNDL------------------------------- 613
                   +P+ +  +  +++++++ N                                 
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316

Query: 614 --HGSIPGSFEKLTFLSKFSVANNHLQGTIPT 643
                +  S +K+  L       N L+G +P 
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  281 bits (721), Expect = 2e-83
 Identities = 111/568 (19%), Positives = 184/568 (32%), Gaps = 66/568 (11%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           L+ +   S     +L++LDLS   ++ +      +L  L  L L+ N +     G  +GL
Sbjct: 40  LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99

Query: 154 NLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 212
           + +Q L     +      F +G    L   N+++N          +S    ++ LDLS N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 213 HFMG----SLQGLDHSPSLK-QLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE 267
                    L+ L   P L   L +  N +   +    +    L  ++L  N  S  + +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218

Query: 268 K-ISNLTSLRHLIIFGNQFSGKL------PNVLGNLTQLEFFV---AHSNSFSGPLPLSL 317
             I  L  L    +   +F  +        + L  L  L       A+ + +   +    
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278

Query: 318 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 377
           +  + +    L + ++    D  FS       L+L    F       L     L   S  
Sbjct: 279 NCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336

Query: 378 KNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPE 437
                     S   L SL FL LS N  +             +L  L L+ N V   +  
Sbjct: 337 GGNAF-----SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSS 390

Query: 438 NVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 496
           N  G E L  L   +  LK      +    + L  LD+S  H           + +L  L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450

Query: 497 DFSNNTLTGEI-PKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFP 555
             + N+      P   TEL++L                 L                    
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTF---------------LD------------------- 476

Query: 556 PSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG 615
               LS  ++    P     L  L VL++S NN           + +L+VLD S N +  
Sbjct: 477 ----LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532

Query: 616 SIPGSFEKL-TFLSKFSVANNHLQGTIP 642
           S     +   + L+  ++  N    T  
Sbjct: 533 SKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  249 bits (637), Expect = 1e-71
 Identities = 109/546 (19%), Positives = 183/546 (33%), Gaps = 71/546 (13%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGV-VPVELSNLKQLEVLDLSHNMLS 143
             L+     L  +    +GHL  LK L+++ N ++   +P   SNL  LE LDLS N + 
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 144 GPVSGMLAGL----NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWS 199
                 L  L     L  SL++S N  N       +   L    + NN  +  +      
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222

Query: 200 ASKEIQILDLSMNHFMGSLQGLDHSPS----LKQLHVDNN------LLGGDLPDSLYSMS 249
               +++  L +  F           S    L  L ++            D+ D    ++
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282

Query: 250 SLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 309
           ++   SL          +  S     +HL +   +F       L +L +L F      S 
Sbjct: 283 NVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSN 335

Query: 310 SGPLPLSLSLCSKLHVLDLRNNSLT--GPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 367
            G    S      L  LDL  N L+  G    +  G +SL  LDL+ N     + ++   
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG 394

Query: 368 CHDLKILSLAKNELSGQVPES-FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 426
              L+ L    + L      S F  L +L++L +S+           +     +L  L +
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN--GIFNGLSSLEVLKM 452

Query: 427 TKN-FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP 485
             N F    +P+      +L  L L  C L+   P        LQVL++S N+F      
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512

Query: 486 WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNG 545
               + +L  LD+S N +     + L    S ++                          
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF------------------------- 547

Query: 546 LPYNQASSFPPSVFLSNNRINGTIPPE--IGQLKHLHVLDLSRNNITGTIPSSISEIRNL 603
                       + L+ N    T   +  +  +K    L +    +    PS     + +
Sbjct: 548 ------------LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD---KQGM 592

Query: 604 EVLDLS 609
            VL L+
Sbjct: 593 PVLSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  209 bits (535), Expect = 6e-58
 Identities = 83/442 (18%), Positives = 145/442 (32%), Gaps = 35/442 (7%)

Query: 225 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 284
           P++    ++ N     +PD+L    S +++ LS N      S    +   L+ L +   +
Sbjct: 8   PNITYQCMELNFY--KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63

Query: 285 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGL 344
                     +L+ L   +   N        + S  S L  L     +L    +     L
Sbjct: 64  IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

Query: 345 SSLCTLDLATNHF-SGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNN 403
            +L  L++A N   S  LP   S+  +L+ L L+ N++          L  +  L+LS +
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 404 -SFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPV 461
            S N ++       +   L  L L  NF    + +    G   L V  L     +    +
Sbjct: 184 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 462 W------LLRCKKLQVLDLSWNHFD---GNIPPWIGQMENLFYLDFSNNTLTGEIPKS-L 511
                  L     L + +    + D    +I      + N+      + T+      S  
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303

Query: 512 TELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF--------LSNN 563
              + L   NC           P     +        N+  +    V         LS N
Sbjct: 304 FGWQHLELVNCKFG------QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357

Query: 564 RIN--GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGS- 620
            ++  G           L  LDLS N +  T+ S+   +  LE LD   ++L      S 
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

Query: 621 FEKLTFLSKFSVANNHLQGTIP 642
           F  L  L    +++ H +    
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFN 438

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  155 bits (394), Expect = 1e-39
 Identities = 57/375 (15%), Positives = 100/375 (26%), Gaps = 36/375 (9%)

Query: 290 PNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCT 349
            N+  +   L+      N        S     +L VLDL    +    D  +  LS L T
Sbjct: 24  DNLPFSTKNLDL---SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80

Query: 350 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLS 409
           L L  N        + S    L+ L   +  L+       G L +L  L++++N      
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 410 GTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESL----MVLALGNCGLKGHIPVWLLR 465
                     NL  L L+ N +      ++     +    + L L    +   I     +
Sbjct: 141 -LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFK 198

Query: 466 CKKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTS 524
             +L  L L  N    N+    I  +  L            E    L +          +
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN--LEKFDKSALEGLCN 256

Query: 525 SNPTASAGIPLYVKHNR-STNGLPYNQASSFPP------SVFLSNNRINGTIPPEIGQLK 577
                     L ++  R +      +             S  L +  I      +     
Sbjct: 257 ----------LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNF 304

Query: 578 HLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 637
               L+L               ++   +  L+     G    S   L  L    ++ N L
Sbjct: 305 GWQHLELVNCKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL 359

Query: 638 QGTIPTGGQFYSFPN 652
                     +   +
Sbjct: 360 SFKGCCSQSDFGTTS 374

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  142 bits (361), Expect = 2e-35
 Identities = 58/306 (18%), Positives = 96/306 (31%), Gaps = 15/306 (4%)

Query: 78  GSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDL 137
            S       L L            L  L +L        +          +L  LE LDL
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS-----EVDLPSLEFLDL 354

Query: 138 SHNMLS--GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNS 195
           S N LS  G  S    G   ++ L++S N              L   +  +++       
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEF 414

Query: 196 RIWSASKEIQILDLSMNHFMGSLQG-LDHSPSLKQLHV-DNNLLGGDLPDSLYSMSSLQH 253
            ++ + + +  LD+S  H   +  G  +   SL+ L +  N+     LPD    + +L  
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474

Query: 254 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 313
           + LS            ++L+SL+ L +  N F          L  L+      N      
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534

Query: 314 PLSL-SLCSKLHVLDLRNNSLTGPIDLN--FSGLSSLCTLDLATNHFSGPLPNSLSDCHD 370
              L    S L  L+L  N      +       +     L +         P+       
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK---QG 591

Query: 371 LKILSL 376
           + +LSL
Sbjct: 592 MPVLSL 597

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  272 bits (698), Expect = 7e-78
 Identities = 99/631 (15%), Positives = 197/631 (31%), Gaps = 88/631 (13%)

Query: 37  SDLLALKEF------------AGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRV 84
            D  ALK              +G + N     +W+       W       G    N GRV
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQ---PGVDLDNNGRV 325

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
           T L L   G KG +P ++G L +LK+L    +       +        ++ +   + +  
Sbjct: 326 TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385

Query: 145 PVSGM-LAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 203
               M L     +   ++  ++ N +  E+      +  ++ +      L +RI   SK 
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINRNP-EMKPIKKDSRISLKDTQIGN-LTNRITFISKA 443

Query: 204 I------QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS 257
           I      QI+  + +         + +   +  + D      +   S  ++  L  V L 
Sbjct: 444 IQRLTKLQIIYFANSP----FTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499

Query: 258 VNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL 317
                 QL + + +L  L+ L I  N+       +  + T+L                  
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTRL--------------ADDE 544

Query: 318 SLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 376
               K+ +  +  N+L   P   +   +  L  LD   N        +      L  L L
Sbjct: 545 DTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKL 602

Query: 377 AKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIP 436
             N++     +       +  L  S+N   ++    +  +    + ++  + N +     
Sbjct: 603 DYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFN-AKSVYVMGSVDFSYNKI-GSEG 660

Query: 437 ENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 496
            N+                         +      + LS+N               +  +
Sbjct: 661 RNISCSMDD------------------YKGINASTVTLSYNEIQKFPTELFATGSPISTI 702

Query: 497 DFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP 556
             SNN +T  IP++  + K     N             + ++ N+ T  L  +  ++  P
Sbjct: 703 ILSNNLMT-SIPENSLKPKDGNYKNTYLLTT-------IDLRFNKLT-SLSDDFRATTLP 753

Query: 557 S---VFLSNNRINGTIPPEIGQLKHLHVLDLSR------NNITGTIPSSISEIRNLEVLD 607
               + +S N  + + P +      L    +        N I    P+ I+   +L  L 
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812

Query: 608 LSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 638
           + SND+   +         L    +A+N   
Sbjct: 813 IGSNDI-RKVDEKL--TPQLYILDIADNPNI 840

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  214 bits (546), Expect = 9e-58
 Identities = 73/546 (13%), Positives = 159/546 (29%), Gaps = 100/546 (18%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           +K I   S   L   ++ +L+ N +  +    +  L +L+++  +++  +   +  +   
Sbjct: 414 MKPIKKDSRISLKDTQIGNLT-NRITFI-SKAIQRLTKLQIIYFANSPFTY-DNIAVDWE 470

Query: 154 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 213
           +          +   S   L    +L    + N     +L   ++   + +Q L+++ N 
Sbjct: 471 DANSDYAKQYENEELSWSNL---KDLTDVELYNCPNMTQLPDFLYDLPE-LQSLNIACNR 526

Query: 214 FMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG-QLSEKISNL 272
            + + Q       L               D   +   +Q   +  NN      S  +  +
Sbjct: 527 GISAAQLKADWTRL--------------ADDEDTGPKIQIFYMGYNNLEEFPASASLQKM 572

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL-SLCSKLHVLDLRNN 331
             L  L    N+         G   +L       N     +P    +   ++  L   +N
Sbjct: 573 VKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHN 629

Query: 332 SLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD-----CHDLKILSLAKNELSGQV 385
            L   P   N   +  + ++D + N       N           +   ++L+ NE+    
Sbjct: 630 KLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFP 689

Query: 386 PESFGKLTSLLFLSLSNNSF-----NHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN-- 438
            E F   + +  + LSNN       N L       +    LTT+ L  N +   + ++  
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFR 748

Query: 439 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 498
                 L  + +         P   L   +L+   +                      D 
Sbjct: 749 ATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ------------------RDA 789

Query: 499 SNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSV 558
             N +  + P  +T   SLI                                       +
Sbjct: 790 EGNRILRQWPTGITTCPSLIQ--------------------------------------L 811

Query: 559 FLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 618
            + +N I   +  ++     L++LD++ N       +S+       +  L  +       
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRG 868

Query: 619 GSFEKL 624
                +
Sbjct: 869 CDALGI 874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  124 bits (312), Expect = 5e-29
 Identities = 54/454 (11%), Positives = 122/454 (26%), Gaps = 78/454 (17%)

Query: 226 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 285
            LK + V       +  +   +      + ++  + +  L      + +      +    
Sbjct: 172 ELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYT---TYSQSG 228

Query: 286 SGKLPNVLGNLTQLEFFVA------------HSNSFSGPLPLSLSLCSKLHVLDLRNNSL 333
             +      ++    F V                  +  +    +L +    LD +N   
Sbjct: 229 IKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRY 288

Query: 334 TGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLT 393
                +N +  S     +   + +       L +   +  LSLA     G+VP++ G+LT
Sbjct: 289 YSGT-INNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLT 347

Query: 394 SLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNC 453
            L  LS   +S   +SG L   ++     +               +   + L +  L   
Sbjct: 348 ELKVLSFGTHSE-TVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406

Query: 454 GLKGHIPVWLLRCKKLQVLDLSWNHFDGN------IPPWIGQMENLFYLDFSNNTLTGEI 507
            +  +  +  +  KK   + L              I   I ++  L  + F+N+  T + 
Sbjct: 407 AINRNPEMKPI--KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDN 464

Query: 508 PKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRING 567
                E  +                                               +   
Sbjct: 465 IAVDWEDANS-------------------------------------------DYAKQYE 481

Query: 568 TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG---------SIP 618
                   LK L  ++L        +P  + ++  L+ L+++ N              + 
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 619 GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 652
              +    +  F +  N+L+   P          
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVK 574

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  109 bits (273), Expect = 3e-24
 Identities = 32/237 (13%), Positives = 68/237 (28%), Gaps = 38/237 (16%)

Query: 453 CGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLT 512
                   V L    ++  L L+     G +P  IGQ+  L  L F  ++ T    +   
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-SGRLFG 367

Query: 513 ELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLP--------YNQASSFPPSVFLS--- 561
           + +     +    +        +++ +++  N             +         +S   
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427

Query: 562 ------NNRINGTIPPEIGQLKHLHVLDLSRNNITG-------------------TIPSS 596
                  NRI   I   I +L  L ++  + +  T                        S
Sbjct: 428 TQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS 486

Query: 597 ISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNS 653
            S +++L  ++L +      +P     L  L   ++A N           +    + 
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  254 bits (650), Expect = 9e-77
 Identities = 83/307 (27%), Positives = 123/307 (40%), Gaps = 34/307 (11%)

Query: 756  DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE 815
            DL   +L   +       +   G FG V+KA L      AVK       Q   + + EV 
Sbjct: 13   DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVY 70

Query: 816  ALSRAQHKNLVSLQGYCRHGND----RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
            +L   +H+N++   G  + G        LI ++ E GSL  +L  +V     + W+    
Sbjct: 71   SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCH 125

Query: 872  IAQGAARGLAYLH-------KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
            IA+  ARGLAYLH          +P I HRD+KS N+LL     A +ADFGL+       
Sbjct: 126  IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 925  THV-TTDLVGTLGYIPPEY-----SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
            +   T   VGT  Y+ PE      +    A  R D+Y+ G+VL EL +     +    + 
Sbjct: 186  SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 979  CRDLVSWVFQMKSEKREVEIIDA--------SIWHKDREKQLLEMLEIACKCIDQDPRRR 1030
                   + Q  S +   E++            W K     +  + E   +C D D   R
Sbjct: 246  MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH--AGMAMLCETIEECWDHDAEAR 303

Query: 1031 PFIEEVV 1037
                 V 
Sbjct: 304  LSAGCVG 310

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  254 bits (650), Expect = 2e-73
 Identities = 113/566 (19%), Positives = 201/566 (35%), Gaps = 53/566 (9%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           IP +L   N  + L+ S N L  +     S L  L  LDL+   +           + + 
Sbjct: 27  IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 158 SLNVSSNSFNG-SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 216
           +L +++N     +   L     L          +  ++       K ++ L L  NH   
Sbjct: 85  TLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISS 143

Query: 217 -SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN-NFSGQLSEKISNLTS 274
             L     +  LK L   NN +     + + S+    ++SL++N N    +     +   
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203

Query: 275 LRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLT 334
            + L   G Q    +   L N T                         L +    +    
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNST----------------------IQSLWLGTFEDMDDE 241

Query: 335 GPIDLNFSGLS--SLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL 392
                 F GL   S+ +++L  ++F     N+      L+ L L    LS ++P     L
Sbjct: 242 DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300

Query: 393 TSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALG 451
           ++L  L LS N F +L           +LT L +  N    E+        E+L  L L 
Sbjct: 301 STLKKLVLSANKFENLCQ--ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358

Query: 452 NCGLK--GHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPK 509
           +  ++      + L     LQ L+LS+N           +   L  LD +   L  +  +
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418

Query: 510 S----LTELKSL-ISSNC-TSSNPTASAGIP----LYVKHNRSTNGLPYNQASSFPP--- 556
           S    L  LK L +S +    S+     G+P    L ++ N         + +S      
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP-KGNIQKTNSLQTLGR 477

Query: 557 --SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 614
              + LS   ++         LK ++ +DLS N +T +   ++S ++ +  L+L+SN + 
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536

Query: 615 GSIPGSFEKLTFLSKFSVANNHLQGT 640
             +P     L+     ++  N L  T
Sbjct: 537 IILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  232 bits (594), Expect = 9e-66
 Identities = 99/534 (18%), Positives = 170/534 (31%), Gaps = 75/534 (14%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           L  +   +L     LK L      +  +  + L N K LE L L  N +S          
Sbjct: 93  LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152

Query: 154 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 213
             ++ L+  +N+ +                +S    +    +   S       L+L+ N 
Sbjct: 153 EKLKVLDFQNNAIH---------------YLSKEDMSSLQQATNLS-------LNLNGND 190

Query: 214 FMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSL--YSMSSLQHVSLSVNNFSGQLSEKISN 271
             G   G   S   + L+         +   L   ++ SL   +    +           
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 272 L--TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLR 329
           L   S+  + +  + F     N     + L+     +   S  LP  L   S L  L L 
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLS 309

Query: 330 NNSLTGPIDLNFSGLSSLCTLDLATNHFSGPL-PNSLSDCHDLKILSLAKNEL--SGQVP 386
            N       ++ S   SL  L +  N     L    L +  +L+ L L+ +++  S    
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369

Query: 387 ESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESL 445
                L+ L  L+LS N    L       ++C  L  L L    +  +  ++       L
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKT--EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427

Query: 446 MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNI---PPWIGQMENLFYLDFSNNT 502
            VL L +  L             LQ L+L  NHF          +  +  L  L  S   
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

Query: 503 LTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSN 562
           L+     + T LK +                                        V LS+
Sbjct: 488 LSSIDQHAFTSLKMMN--------------------------------------HVDLSH 509

Query: 563 NRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 616
           NR+  +    +  LK +  L+L+ N+I+  +PS +  +     ++L  N L  +
Sbjct: 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  202 bits (517), Expect = 1e-55
 Identities = 89/453 (19%), Positives = 152/453 (33%), Gaps = 35/453 (7%)

Query: 204 IQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
            + L+ S N        +   L    +L  L +    +     D+  S   L  + L+ N
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRL---INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 260 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL 319
                    +S   +L+HL       S      L N   LE     SN  S         
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 320 CSKLHVLDLRNNSLTGPIDLNFSGLSSL--CTLDLATNHFSGPLPNSLSDCHDLKILSLA 377
             KL VLD +NN++      + S L      +L+L  N  +G +     D    + L+  
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210

Query: 378 KNELSGQVPE--SFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 435
             +    + +      + SL   +  +     +S  +       ++ ++ L K++     
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270

Query: 436 PENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFY 495
                 F  L  L L    L   +P  L+    L+ L LS N F+           +L +
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329

Query: 496 LDFSNNTLTGEIP----KSLTELKSL-ISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 550
           L    NT   E+     ++L  L+ L +S +   ++             N     L + Q
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC----------CNLQLRNLSHLQ 379

Query: 551 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIP-SSISEIRNLEVLDLS 609
                 S+ LS N           +   L +LDL+   +      S    +  L+VL+LS
Sbjct: 380 ------SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433

Query: 610 SNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 642
            + L  S    F+ L  L   ++  NH      
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  193 bits (493), Expect = 2e-52
 Identities = 75/455 (16%), Positives = 126/455 (27%), Gaps = 52/455 (11%)

Query: 224 SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 283
             S + L    N+L      +   + +L  + L+         +   +   L  L++  N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 284 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG 343
                    L     L+         S    + L     L  L L +N ++         
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 344 LSSLCTLDLATNHFSGPLPNSLSDCHDLKI--LSLAKNELSGQVPESFGKLTSLLFLSLS 401
              L  LD   N         +S         L+L  N+++G +            L+  
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210

Query: 402 NNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFE--SLMVLALGNCGLKGHI 459
                 +          ++L           +  P    G    S+  + L         
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270

Query: 460 PVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLIS 519
                    LQ LDL+  H    +P  +  +  L  L  S N        S +   SL  
Sbjct: 271 SNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329

Query: 520 SNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRIN--G 567
                          L +K N         +                   LS++ I    
Sbjct: 330 ---------------LSIKGN--------TKRLELGTGCLENLENLRELDLSHDDIETSD 366

Query: 568 TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGS-FEKLTF 626
               ++  L HL  L+LS N        +  E   LE+LDL+   L      S F+ L  
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426

Query: 627 LSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 661
           L   +++++ L                 F+G P L
Sbjct: 427 LKVLNLSHSLLD----------ISSEQLFDGLPAL 451

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  189 bits (482), Expect = 6e-51
 Identities = 71/439 (16%), Positives = 137/439 (31%), Gaps = 52/439 (11%)

Query: 233 DNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV 292
           +  L   ++P +L   +S + +  S N      +   S L +L  L +   Q      + 
Sbjct: 21  NLGL--NEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 293 LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDL 352
             +  +L+  V  +N        +LS    L  L      ++    +      +L +L L
Sbjct: 77  FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136

Query: 353 ATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL--LFLSLSNNSFNHLSG 410
            +NH S            LK+L    N +     E    L     L L+L+ N    +  
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP 196

Query: 411 TLSVLQQCKNLTTLILTKNFVGEEIPENVGG--FESLMVLALGNCGLKGHIPVWLLRCKK 468
                       +L          I + +     +SL +    +   +   P       +
Sbjct: 197 GAF---DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253

Query: 469 --LQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSN 526
             ++ ++L  ++F             L  LD +   L+ E+P  L  L +L         
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKK------- 305

Query: 527 PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPE-IGQ 575
                   L          L  N+  +                +  N     +    +  
Sbjct: 306 --------LV---------LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348

Query: 576 LKHLHVLDLSRNNIT--GTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVA 633
           L++L  LDLS ++I         +  + +L+ L+LS N+       +F++   L    +A
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408

Query: 634 NNHLQGTIPTGGQFYSFPN 652
              L+        F +   
Sbjct: 409 FTRLKV-KDAQSPFQNLHL 426

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  164 bits (417), Expect = 1e-42
 Identities = 64/331 (19%), Positives = 115/331 (34%), Gaps = 32/331 (9%)

Query: 83  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 142
            V  + L +     I   +    + L+ LDL+  HL   +P  L  L  L+ L LS N  
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKF 313

Query: 143 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 202
                   +    +  L++  N+    L   G   NL                      +
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGT-GCLENL----------------------E 350

Query: 203 EIQILDLSMNHFMGS---LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
            ++ LDLS +    S      L +   L+ L++  N       ++      L+ + L+  
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410

Query: 260 NFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPL--- 315
               + ++    NL  L+ L +  +        +   L  L+      N F         
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470

Query: 316 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 375
           SL    +L +L L    L+      F+ L  +  +DL+ N  +     +LS    +  L+
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLN 529

Query: 376 LAKNELSGQVPESFGKLTSLLFLSLSNNSFN 406
           LA N +S  +P     L+    ++L  N  +
Sbjct: 530 LASNHISIILPSLLPILSQQRTINLRQNPLD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  128 bits (324), Expect = 8e-31
 Identities = 55/256 (21%), Positives = 103/256 (40%), Gaps = 13/256 (5%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEG-VVPVELSNLKQLEVLDLSHNML--SGPVSGML 150
            + +   S  +   L  L +  N     +    L NL+ L  LDLSH+ +  S   +  L
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372

Query: 151 AGLNLIQSLNVSSNSFNGSLFELGEFSNLA---VFNISNNSFTGKLNSRIWSASKEIQIL 207
             L+ +QSLN+S N       +   F       + +++      K     +     +++L
Sbjct: 373 RNLSHLQSLNLSYNEPLS--LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430

Query: 208 DLSMNHFMGSLQG-LDHSPSLKQLHVDNNLLGG---DLPDSLYSMSSLQHVSLSVNNFSG 263
           +LS +    S +   D  P+L+ L++  N          +SL ++  L+ + LS  + S 
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

Query: 264 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKL 323
                 ++L  + H+ +  N+ +      L +L  +   +A  N  S  LP  L + S+ 
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLAS-NHISIILPSLLPILSQQ 549

Query: 324 HVLDLRNNSLTGPIDL 339
             ++LR N L      
Sbjct: 550 RTINLRQNPLDCTCSN 565

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 65.8 bits (161), Expect = 5e-11
 Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 2/101 (1%)

Query: 92  KGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLA 151
                    SL  L +L++L LS   L  +     ++LK +  +DLSHN L+      L+
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521

Query: 152 GLNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTG 191
            L  I  LN++SN  +  L   L   S     N+  N    
Sbjct: 522 HLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  242 bits (621), Expect = 1e-72
 Identities = 89/333 (26%), Positives = 138/333 (41%), Gaps = 43/333 (12%)

Query: 340 NFSGLSS-LCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ--VPESFGKLTSLL 396
           N + LSS L T D     + G L ++ +  + +  L L+   L     +P S   L  L 
Sbjct: 20  NPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79

Query: 397 FLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLK 456
           FL +     N+L G                        IP  +     L  L + +  + 
Sbjct: 80  FLYIGGI--NNLVGP-----------------------IPPAIAKLTQLHYLYITHTNVS 114

Query: 457 GHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKS 516
           G IP +L + K L  LD S+N   G +PP I  + NL  + F  N ++G IP S      
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 517 LISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQL 576
           L +S              + +  NR T  +P   A+     V LS N + G      G  
Sbjct: 175 LFTS--------------MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220

Query: 577 KHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNH 636
           K+   + L++N++   +   +   +NL  LDL +N ++G++P    +L FL   +V+ N+
Sbjct: 221 KNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279

Query: 637 LQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPC 669
           L G IP GG    F  S++  N  LCG     C
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  215 bits (549), Expect = 7e-63
 Identities = 81/368 (22%), Positives = 142/368 (38%), Gaps = 95/368 (25%)

Query: 255 SLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSG--KLPNVLGNLTQLEF-FVAHSNSFSG 311
                 + G L +  +    + +L + G        +P+ L NL  L F ++   N+  G
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91

Query: 312 PLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDL 371
           P+P +++  ++LH L + + +++G I    S + +L TLD + N  SG LP S+S   +L
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151

Query: 372 KILSLAKNELSGQVPESFGKLTSLL-FLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 430
             ++   N +SG +P+S+G  + L   +++S    N L+G                    
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISR---NRLTG-------------------- 188

Query: 431 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM 490
              +IP               N                L  +DLS N  +G+     G  
Sbjct: 189 ---KIPP-----------TFANL--------------NLAFVDLSRNMLEGDASVLFGSD 220

Query: 491 ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 550
           +N   +  + N+L  ++   +   K+L                                 
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLN-------------------------------- 247

Query: 551 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSS 610
                  + L NNRI GT+P  + QLK LH L++S NN+ G IP     ++  +V   ++
Sbjct: 248 ------GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYAN 300

Query: 611 NDLHGSIP 618
           N      P
Sbjct: 301 NKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  189 bits (482), Expect = 1e-53
 Identities = 82/332 (24%), Positives = 128/332 (38%), Gaps = 61/332 (18%)

Query: 32  QSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQ--WDGVVCGHGSTGSNAGRVTMLIL 89
           + C+P D  AL +   +L N + ++SW   + CC   W GV+C    T +   RV  L L
Sbjct: 1   ELCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLC---DTDTQTYRVNNLDL 57

Query: 90  PRKGLK---------------------------GIIPRSLGHLNQLKLLDLSCNHLEGVV 122
               L                            G IP ++  L QL  L ++  ++ G +
Sbjct: 58  SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117

Query: 123 PVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAV 181
           P  LS +K L  LD S+N LSG +   ++ L  +  +    N  +G++    G FS L  
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177

Query: 182 F-NISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGD 240
              IS N  TGK+     + +  +  +DLS N                        L GD
Sbjct: 178 SMTISRNRLTGKIPPTFANLN--LAFVDLSRNM-----------------------LEGD 212

Query: 241 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 300
                 S  + Q + L+ N+ +  L + +    +L  L +  N+  G LP  L  L  L 
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 301 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 332
                 N+  G +P   +L  +  V    NN 
Sbjct: 272 SLNVSFNNLCGEIPQGGNL-QRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  186 bits (475), Expect = 9e-53
 Identities = 76/331 (22%), Positives = 126/331 (38%), Gaps = 59/331 (17%)

Query: 183 NISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQ---GLDHSPSLKQLHV-DNNLLG 238
           +  N ++ G L     + +  +  LDLS  +          L + P L  L++   N L 
Sbjct: 32  DCCNRTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 239 GDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQ 298
           G +P ++  ++ L ++ ++  N SG + + +S + +L  L    N  SG LP  + +L  
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 299 LEFFVAHSNSFSGPLPLSLSLCSKLH-VLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF 357
           L       N  SG +P S    SKL   + +  N LTG I   F+ L +L  +DL+ N  
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209

Query: 358 SGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQ 417
            G          + + + LAKN L+  +    G   +L  L L N   N + GT      
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRN---NRIYGT------ 259

Query: 418 CKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWN 477
                                                    +P  L + K L  L++S+N
Sbjct: 260 -----------------------------------------LPQGLTQLKFLHSLNVSFN 278

Query: 478 HFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 508
           +  G IP   G ++      ++NN      P
Sbjct: 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  240 bits (614), Expect = 2e-68
 Identities = 108/565 (19%), Positives = 191/565 (33%), Gaps = 72/565 (12%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           LK +   S  + ++L+ LDLS   +E +       L  L  L L+ N +     G  +GL
Sbjct: 44  LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103

Query: 154 NLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 212
             +++L              +G+   L   N+++N          +S    +  +DLS N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163

Query: 213 HFMG----SLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE 267
           +        LQ L  +P     L +  N +   + D  +    L  ++L  N  S  + +
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMK 222

Query: 268 K-ISNLTSLRHLIIFGNQFSG---------KLPNVLGNLTQLEFFVAHSNSFSGPLPLSL 317
             + NL  L    +   +F            +   L ++T  EF + ++N FS    +  
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD-IVKF 281

Query: 318 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 377
              + +  + L   S+    D+         +L +            L     LK L+L 
Sbjct: 282 HCLANVSAMSLAGVSIKYLEDVPK--HFKWQSLSIIRCQLKQFPTLDLP---FLKSLTLT 336

Query: 378 KNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPE 437
            N+ S  +      L SL +L LS N+ +             +L  L L+ N     +  
Sbjct: 337 MNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA-IIMSA 393

Query: 438 NVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 496
           N  G E L  L   +  LK           +KL  LD+S+ +   +       + +L  L
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453

Query: 497 DFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQAS 552
             + N+           + T L  L                                   
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFL----------------------------------- 478

Query: 553 SFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSND 612
                  LS  ++          L  L +L++S NN+     S  +++ +L  LD S N 
Sbjct: 479 ------DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532

Query: 613 LHGSIPGSFEKLTFLSKFSVANNHL 637
           +  S          L+ F++ NN +
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  218 bits (557), Expect = 9e-61
 Identities = 98/579 (16%), Positives = 176/579 (30%), Gaps = 72/579 (12%)

Query: 96  GIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNL 155
           G +   +  +  +         L  V P ++ +    + +DLS N L    S   +  + 
Sbjct: 2   GSLNPCIEVVPNITY-QCMDQKLSKV-PDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 156 IQSLNVSSNSFNGSLFELGEFSNLA---VFNISNNSFTGKLNSRIWSASKEIQILDLSMN 212
           +Q L++S         E   +  L       ++ N      +   +S    ++ L     
Sbjct: 58  LQWLDLSRCEIET--IEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVET 114

Query: 213 HFMGSLQG-LDHSPSLKQLHVDNNLLGG-DLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS 270
                    +    +LK+L+V +N +    LP    ++++L HV LS N         + 
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 271 NLTSLR----HLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL 326
            L         L +  N            +   E  +  + + S  +   L   + LHV 
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234

Query: 327 DLRNNSLTGPIDLN------FSGLSSLCT--LDLATNHFSGPLPNSLSDCHDLKILSLAK 378
            L         +L         GL  +      L   +             ++  +SLA 
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 438
             +     E   K      LS+                    L +L LT N     I   
Sbjct: 295 VSIKY--LEDVPKHFKWQSLSIIRCQLKQFPT-----LDLPFLKSLTLTMNKG--SISFK 345

Query: 439 VGGFESLMVLALGNCGLK--GHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 496
                SL  L L    L   G      L    L+ LDLS+N     +      +E L +L
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHL 404

Query: 497 DFSNNTLTGEIPKS-LTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFP 555
           DF ++TL      S    L+ L+  +                        + Y       
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLD------------------------ISYTNTKIDF 440

Query: 556 PSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNLE 604
             +F          ++ N         +     +L  LDLS+  +          +  L+
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500

Query: 605 VLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPT 643
           +L++S N+L       + +L  LS    + N ++ +   
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  206 bits (526), Expect = 1e-56
 Identities = 92/531 (17%), Positives = 154/531 (29%), Gaps = 96/531 (18%)

Query: 93  GLKGIIPRSLGHLNQLKLLDLSCNHLEGV-VPVELSNLKQLEVLDLSHNMLSGPVSGMLA 151
            L  +    +G L  LK L+++ N +    +P   SNL  L  +DLS+N +       L 
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 152 GL----NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQIL 207
            L     +  SL++S N  +    +  +   L    +  N  +  +          + + 
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234

Query: 208 DLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE 267
            L +  F             + L +    +   L D      ++    L+  N       
Sbjct: 235 RLILGEF----------KDERNLEIFEPSIMEGLCD-----VTIDEFRLTYTNDFSDDIV 279

Query: 268 KISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLD 327
           K   L ++  + + G            ++  LE                +    K   L 
Sbjct: 280 KFHCLANVSAMSLAGV-----------SIKYLE---------------DVPKHFKWQSLS 313

Query: 328 LRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPE 387
           +    L          L  L +L L  N  S  +         L  L L++N LS     
Sbjct: 314 IIRCQLK---QFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCC 368

Query: 388 SF--GKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFES 444
           S+      SL  L LS N    +S         + L  L    + +      +     E 
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAIIMSANFM---GLEELQHLDFQHSTLKRVTEFSAFLSLEK 425

Query: 445 LMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSNNTL 503
           L+ L +     K       L    L  L ++ N F  N          NL +LD S   L
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485

Query: 504 TGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNN 563
                     L  L                                        + +S+N
Sbjct: 486 EQISWGVFDTLHRLQ--------------------------------------LLNMSHN 507

Query: 564 RINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 614
            +         QL  L  LD S N I  +        ++L   +L++N + 
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  160 bits (406), Expect = 4e-41
 Identities = 81/467 (17%), Positives = 138/467 (29%), Gaps = 76/467 (16%)

Query: 224 SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 283
             S K + +  N L      S  + S LQ + LS         +    L  L +LI+ GN
Sbjct: 31  PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90

Query: 284 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNFS 342
                 P     LT LE  VA     +      +     L  L++ +N +    +   FS
Sbjct: 91  PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 343 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKI----LSLAKNELSGQVPESFGKLTSLLFL 398
            L++L  +DL+ N+      N L    +       L ++ N +   + +   +   L  L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHEL 209

Query: 399 SLSNNSFN-----HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMV--LALG 451
           +L  N  +          L+ L   + +      +  +    P  + G   + +    L 
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 452 NCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSL 511
                    V       +  + L+           + +      L      L       L
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327

Query: 512 TELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPP 571
             LKSL                                          L+ N+   +I  
Sbjct: 328 PFLKSLT-----------------------------------------LTMNKG--SISF 344

Query: 572 EIGQLKHLHVLDLSRNNITGTIPSSISEI--RNLEVLDLSSNDLHGSIPGSFEKLTFLSK 629
           +   L  L  LDLSRN ++ +   S S++   +L  LDLS N     +  +F  L  L  
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH 403

Query: 630 FSVANNHLQGTIPTGG---------------QFYSFPNSSFEGNPGL 661
               ++ L+                            +  F G   L
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  154 bits (391), Expect = 3e-39
 Identities = 76/420 (18%), Positives = 137/420 (32%), Gaps = 49/420 (11%)

Query: 87  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG-VVPVELSNLKQLEVLDLSHNMLSGP 145
           L +    +  I  ++   +  L  L L  N     ++   L NL  L V  L        
Sbjct: 186 LDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD- 243

Query: 146 VSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQ 205
                      ++L +   S    L ++     +  F ++  +     +   +     + 
Sbjct: 244 ----------ERNLEIFEPSIMEGLCDV----TIDEFRLTYTNDFS-DDIVKFHCLANVS 288

Query: 206 ILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL 265
            + L+       L+ +      + L +    L       L     L+ ++L++N  S  +
Sbjct: 289 AMSLAGVSI-KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGS--I 342

Query: 266 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 325
           S K   L SL +L +  N  S        +L                        + L  
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLG----------------------TNSLRH 380

Query: 326 LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS-LSDCHDLKILSLAKNELSGQ 384
           LDL  N     +  NF GL  L  LD   +        S       L  L ++       
Sbjct: 381 LDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439

Query: 385 VPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFES 444
               F  LTSL  L ++ NSF   + + +V     NLT L L+K  + +           
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLS-NVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498

Query: 445 LMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLT 504
           L +L + +  L         +   L  LD S+N  + +        ++L + + +NN++ 
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  144 bits (365), Expect = 5e-36
 Identities = 63/382 (16%), Positives = 108/382 (28%), Gaps = 51/382 (13%)

Query: 290 PNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCT 349
            ++  +   ++      N        S S  S+L  LDL    +    D  + GL  L  
Sbjct: 28  DDIPSSTKNIDL---SFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84

Query: 350 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLS 409
           L L  N      P S S    L+ L   + +L+       G+L +L  L++++N  +   
Sbjct: 85  LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144

Query: 410 GTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKL 469
              +      NL  + L+ N++      ++        +                     
Sbjct: 145 -LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV--------------------N 183

Query: 470 QVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKS----LTELKSLISSNCTSS 525
             LD+S N     I     Q   L  L    N  +  I K+    L  L           
Sbjct: 184 LSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242

Query: 526 NPTASAGIPLYV-----KHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIP 570
           +          +             L Y    S     F          L+   I     
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYL 300

Query: 571 PEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKF 630
            ++ +      L + R  +       +     L+ L L+ N   GSI      L  LS  
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQFPTLDLP---FLKSLTLTMN--KGSISFKKVALPSLSYL 355

Query: 631 SVANNHLQGTIPTGGQFYSFPN 652
            ++ N L  +           +
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNS 377

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  203 bits (519), Expect = 7e-59
 Identities = 83/273 (30%), Positives = 133/273 (48%), Gaps = 21/273 (7%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQG 830
              IG G FG V++A   +G+  AVK L       +   EF  EV  + R +H N+V   G
Sbjct: 43   EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 831  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                  +  ++  Y+  GSL   LH+S  ++  L    RL +A   A+G+ YLH    P 
Sbjct: 102  AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC 950
            IVHR++KS N+L+D+K+   + DFGLSR L+      +    GT  ++ PE  +   +  
Sbjct: 160  IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 951  RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010
            + DVYSFGV+L EL T ++P       N   +V+ V     + + +EI       ++   
Sbjct: 219  KSDVYSFGVILWELATLQQPWG---NLNPAQVVAAVGF---KCKRLEIP------RNLNP 266

Query: 1011 QLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            Q+  ++E    C   +P +RP    ++  L  +
Sbjct: 267  QVAAIIE---GCWTNEPWKRPSFATIMDLLRPL 296

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  203 bits (519), Expect = 2e-58
 Identities = 70/326 (21%), Positives = 120/326 (36%), Gaps = 49/326 (15%)

Query: 756  DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE 815
            +   S+     +N     +IG G +G VYK +L +    AVK  S       + F  E  
Sbjct: 2    EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKN 57

Query: 816  --ALSRAQHKNLVSLQGYCRHGNDR-----LLIYSYMENGSLDYWLHESVDKDSVLKWDV 868
               +   +H N+                  LL+  Y  NGSL  +L           W  
Sbjct: 58   IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112

Query: 869  RLKIAQGAARGLAYLH------KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP 922
              ++A    RGLAYLH         +P I HRD+ S N+L+       ++DFGLS  L  
Sbjct: 113  SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 923  -------YDTHVTTDLVGTLGYIPPEY-------SQTLTATCRGDVYSFGVVLLELLTGR 968
                    + +     VGT+ Y+ PE            +A  + D+Y+ G++  E+    
Sbjct: 173  NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-- 230

Query: 969  RPVEVCKGKNCRDL-VSWVFQMKSEKREVEIIDASIWHKDR----------EKQLLEMLE 1017
            R  ++  G++  +  +++  ++ +     ++       K R             +  + E
Sbjct: 231  RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 1018 IACKCIDQDPRRRPFIEEVVTWLDGI 1043
                C DQD   R   +     +  +
Sbjct: 291  TIEDCWDQDAEARLTAQXAEERMAEL 316

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  199 bits (508), Expect = 1e-57
 Identities = 81/286 (28%), Positives = 131/286 (45%), Gaps = 38/286 (13%)

Query: 773  NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ-------MEREFQAEVEALSRAQHKN 824
              IG GGFGLV+K   + + +  A+K L     +         +EFQ EV  +S   H N
Sbjct: 25   KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 825  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
            +V L G     N   ++  ++  G L + L    DK   +KW V+L++    A G+ Y+ 
Sbjct: 85   IVKLYGLMH--NPPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 885  KVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
                P IVHRD++S NI L    E     A +ADFGLS+       H  + L+G   ++ 
Sbjct: 140  N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMA 194

Query: 940  PE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            PE   ++  + T + D YSF ++L  +LTG  P +     +    + ++  ++ E     
Sbjct: 195  PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGK-IKFINMIREEGLRPT 250

Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            I       +D   +L  ++E    C   DP++RP    +V  L  +
Sbjct: 251  IP------EDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  198 bits (506), Expect = 4e-57
 Identities = 68/276 (24%), Positives = 124/276 (44%), Gaps = 33/276 (11%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
             ++G G FG+V KA        A+K++  +     + F  E+  LSR  H N+V L G C
Sbjct: 14   EVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 833  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
               N   L+  Y E GSL   LH + +          +      ++G+AYLH +    ++
Sbjct: 71   L--NPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 893  HRDVKSSNILLDEKFE-AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
            HRD+K  N+LL        + DFG +  +        T+  G+  ++ PE  +    + +
Sbjct: 128  HRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYSEK 183

Query: 952  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR--- 1008
             DV+S+G++L E++T R+P +        ++    F+          I  ++ +  R   
Sbjct: 184  CDVFSWGIILWEVITRRKPFD--------EIGGPAFR----------IMWAVHNGTRPPL 225

Query: 1009 -EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
             +     +  +  +C  +DP +RP +EE+V  +  +
Sbjct: 226  IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  194 bits (496), Expect = 4e-56
 Identities = 63/283 (22%), Positives = 109/283 (38%), Gaps = 42/283 (14%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQG 830
              +     G ++K     G    VK L       +  R+F  E   L    H N++ + G
Sbjct: 16   TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 831  YCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
             C+         I  +M  GSL   LHE    + V+     +K A   ARG+A+LH   E
Sbjct: 75   ACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LE 131

Query: 889  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE---YSQT 945
            P I    + S ++++DE   A ++   +           +   +    ++ PE       
Sbjct: 132  PLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKPE 185

Query: 946  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDL--VSWVFQMKSEKREVEI---ID 1000
             T     D++SF V+L EL+T   P          DL  +    ++  E     I   I 
Sbjct: 186  DTNRRSADMWSFAVLLWELVTREVPFA--------DLSNMEIGMKVALEGLRPTIPPGIS 237

Query: 1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              +       +L++       C+++DP +RP  + +V  L+ +
Sbjct: 238  PHV------SKLMK------ICMNEDPAKRPKFDMIVPILEKM 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  194 bits (494), Expect = 1e-55
 Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 26/275 (9%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            IG G FG VYK    +G   AVK L+      Q  + F+ EV  L + +H N++   GY 
Sbjct: 32   IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 833  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                   ++  + E  SL + LH     ++  +    + IA+  ARG+ YLH      I+
Sbjct: 90   TAPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSII 142

Query: 893  HRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGYIPPE---YSQTLTA 948
            HRD+KS+NI L E     + DFGL+    R   +H    L G++ ++ PE      +   
Sbjct: 143  HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 949  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008
            + + DVY+FG+VL EL+TG+ P       N RD +  +    S   ++  + ++      
Sbjct: 203  SFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMVGRGSLSPDLSKVRSNC----- 254

Query: 1009 EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
             K++  ++    +C+ +    RP    ++  ++ +
Sbjct: 255  PKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 286

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  192 bits (490), Expect = 2e-55
 Identities = 78/283 (27%), Positives = 119/283 (42%), Gaps = 36/283 (12%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRL----SGDCGQMEREFQAEVEALSRAQHKNLVSL 828
             IIG GGFG VY+A    G + AVK        D  Q     + E +  +  +H N+++L
Sbjct: 13   EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            +G C    +  L+  +   G L+  L         +  D+ +  A   ARG+ YLH    
Sbjct: 72   RGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 889  PHIVHRDVKSSNILLDEKFEAH--------LADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
              I+HRD+KSSNIL+ +K E          + DFGL+R    + T   +   G   ++ P
Sbjct: 127  VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSA-AGAYAWMAP 183

Query: 941  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
            E  +    +   DV+S+GV+L ELLTG  P     G +   +   V      K  + I  
Sbjct: 184  EVIRASMFSKGSDVWSYGVLLWELLTGEVPFR---GIDGLAVAYGVAM---NKLALPIPS 237

Query: 1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                            ++   C + DP  RP    ++  L  I
Sbjct: 238  TC---------PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  187 bits (477), Expect = 3e-53
 Identities = 71/300 (23%), Positives = 117/300 (39%), Gaps = 42/300 (14%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE--ALSRAQHKNLVSLQG 830
              +G G +G V++ +   G   AVK  S    + E+ +  E E       +H+N++    
Sbjct: 14   ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 831  YCRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-- 884
                         LI  Y E GSL  +L       + L     L+I    A GLA+LH  
Sbjct: 70   SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 885  ---KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGTLGYI 938
                  +P I HRD+KS NIL+ +  +  +AD GL+ +       +       VGT  Y+
Sbjct: 125  IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 939  PPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC--RDLVSW---VF 987
             PE            +  R D+++FG+VL E+        + +       D+V       
Sbjct: 185  APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 988  QMKS----EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
             M+     +++   I +   W  D    L  + ++  +C  Q+P  R     +   L  I
Sbjct: 245  DMRKVVCVDQQRPNIPNR--WFSD--PTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  187 bits (477), Expect = 8e-53
 Identities = 72/300 (24%), Positives = 113/300 (37%), Gaps = 42/300 (14%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE--ALSRAQHKNLVSLQG 830
              IG G +G V+      G K AVK         E  +  E E       +H+N++    
Sbjct: 43   KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98

Query: 831  YCRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-- 884
                G        LI  Y ENGSL  +L       + L     LK+A  +  GL +LH  
Sbjct: 99   ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 885  ---KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGTLGYI 938
                  +P I HRD+KS NIL+ +     +AD GL+         V       VGT  Y+
Sbjct: 154  IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 939  PPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 992
            PPE            +    D+YSFG++L E+        + +       + +   + S+
Sbjct: 214  PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ----LPYHDLVPSD 269

Query: 993  KREVEIIDASIWHKDR---------EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                ++ +     K R         ++ L +M ++  +C   +P  R     V   L  +
Sbjct: 270  PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  185 bits (472), Expect = 4e-52
 Identities = 78/361 (21%), Positives = 133/361 (36%), Gaps = 57/361 (15%)

Query: 711  TLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFN 770
              L       G  + DL  DM      +    S   +L Q +  + + +           
Sbjct: 3    PSLDRPFISEGTTLKDLIYDMT-----TSGSGSGLPLLVQRTIARTIVLQ---------- 47

Query: 771  QANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE--ALSRAQHKNLVSL 828
                IG G FG V++     G + AVK  S    + ER +  E E       +H+N++  
Sbjct: 48   --ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101

Query: 829  QGYCRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                   N       L+  Y E+GSL  +L+        +  +  +K+A   A GLA+LH
Sbjct: 102  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLH 156

Query: 885  -----KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL---VGTLG 936
                    +P I HRD+KS NIL+ +     +AD GL+         +       VGT  
Sbjct: 157  MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 937  YIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC--RDLVSW--- 985
            Y+ PE        +   +  R D+Y+ G+V  E+        + +       DLV     
Sbjct: 217  YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 986  VFQMKS---EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1042
            V +M+    E++    I       +  + + +++    +C   +   R     +   L  
Sbjct: 277  VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLSQ 333

Query: 1043 I 1043
            +
Sbjct: 334  L 334

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  184 bits (468), Expect = 9e-52
 Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 39/286 (13%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
             +IG G FG VY     +G   A++ +    D     + F+ EV A  + +H+N+V   G
Sbjct: 39   ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 831  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
             C       +I S  +  +L   +    D   VL  +   +IAQ   +G+ YLH      
Sbjct: 97   ACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150

Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLR----PYDTHVTTDLVGTLGYIPPEYSQTL 946
            I+H+D+KS N+  D   +  + DFGL  +                 G L ++ PE  + L
Sbjct: 151  ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 947  TATCRG---------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            +              DV++ G +  EL     P +    +    ++  +      K  + 
Sbjct: 210  SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK---TQPAEAIIWQM--GTGMKPNLS 264

Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
             I          K++ ++L     C   +   RP   +++  L+ +
Sbjct: 265  QIGMG-------KEISDILL---FCWAFEQEERPTFTKLMDMLEKL 300

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  195 bits (497), Expect = 1e-51
 Identities = 130/653 (19%), Positives = 224/653 (34%), Gaps = 72/653 (11%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV-SGMLAGLNLI 156
           +P+    LN  + L LS N++  V       L+QL++L+L        +       L  +
Sbjct: 19  VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75

Query: 157 QSLNVSSNSFNGSLFELGEF---SNLAVFNISNNSFTGK-LNSRIWSASKEIQILDLSMN 212
           + L++ S+           F    +L    +     +   L    +   K +  LDLS N
Sbjct: 76  RILDLGSSKI--YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133

Query: 213 HF--MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYS--MSSLQHVSLSVNNFSGQLSEK 268
               +          SLK +   +N +       L      +L   SL+ N+   ++S  
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193

Query: 269 ISNL------TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 322
                       L  L + GN ++  +                SN+ S     SL L   
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNF------------SNAISKSQAFSLILAHH 241

Query: 323 LHVLDLRNNSLTGPIDLNFSGL--SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNE 380
           +       +++  P    F+GL  SS+  LDL+                DLK+L+LA N+
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301

Query: 381 LSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG 440
           ++    E+F  L +L  L+LS N    L    S       +  + L KN +     +   
Sbjct: 302 INKIADEAFYGLDNLQVLNLSYNLLGELYS--SNFYGLPKVAYIDLQKNHIAIIQDQTFK 359

Query: 441 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 500
             E L  L L +  L       +     +  + LS N     +P           +  S 
Sbjct: 360 FLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKL-VTLPK---INLTANLIHLSE 410

Query: 501 NTLT----GEIPKSLTELKSL-ISSNC-TSSNPTASAGIPLYVKH-NRSTNGLPYNQASS 553
           N L           +  L+ L ++ N  +S +   +      ++      N L     + 
Sbjct: 411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470

Query: 554 FPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRN 602
               VF          L++N +N ++PP +   L  L  L L+ N +T    + +    N
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527

Query: 603 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 662
           LE+LD+S N L    P  F     LS   + +N           F ++ N +     G  
Sbjct: 528 LEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECEL-STFINWLNHTNVTIAGPP 583

Query: 663 GEI--DSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLL 713
            +I    P       L  +   G + +    S+    F +      L  +T+L
Sbjct: 584 ADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTIL 636

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  123 bits (311), Expect = 7e-29
 Identities = 74/330 (22%), Positives = 128/330 (38%), Gaps = 44/330 (13%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
           V  L L    +  +  R    L  LK+L+L+ N +  +       L  L+VL+LS+N+L 
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 203
                            + S++F G          +A  ++  N     +  + +   ++
Sbjct: 328 ----------------ELYSSNFYG-------LPKVAYIDLQKNHIA-IIQDQTFKFLEK 363

Query: 204 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 263
           +Q LDL  N    +L  +   PS+  + +  N L      +L    +   + LS N    
Sbjct: 364 LQTLDLRDN----ALTTIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLEN 415

Query: 264 -QLSEKISNLTSLRHLIIFGNQFSGKLPNVL-GNLTQLEFFVAHSNSFSGPLPLSLSL-- 319
             +   +  +  L+ LI+  N+FS    +        LE      N         L    
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475

Query: 320 ---CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 376
               S L VL L +N L       FS L++L  L L +N  +    N L    +L+IL +
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDI 533

Query: 377 AKNELSGQVPESFGKLTSLLFLSLSNNSFN 406
           ++N+L    P+ F  L+ L    +++N F 
Sbjct: 534 SRNQLLAPNPDVFVSLSVLD---ITHNKFI 560

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  118 bits (297), Expect = 3e-27
 Identities = 68/361 (18%), Positives = 126/361 (34%), Gaps = 30/361 (8%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 138
                + +L L    +  I   +   L+ L++L+LS N L  +       L ++  +DL 
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346

Query: 139 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 198
            N ++         L  +Q+L++  N+       +    ++    +S N         + 
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLV-----TLP 397

Query: 199 SASKEIQILDLSMNHF--MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYS-MSSLQHVS 255
             +    ++ LS N    +  L  L   P L+ L ++ N       D   S   SL+ + 
Sbjct: 398 KINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457

Query: 256 LSVNNFSGQLSEKI-----SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS 310
           L  N        ++       L+ L+ L +  N  +   P V  +LT L     +SN  +
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

Query: 311 GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN----SLS 366
             L  +  L + L +LD+  N L      N     SL  LD+  N F          +  
Sbjct: 518 V-LSHN-DLPANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKFICECELSTFINWL 572

Query: 367 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 426
           +  ++ I     +             + +   SLS    +      S+      + T+ L
Sbjct: 573 NHTNVTIAGPPAD----IYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTL 628

Query: 427 T 427
           T
Sbjct: 629 T 629

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  182 bits (464), Expect = 2e-51
 Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 36/286 (12%)

Query: 773  NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
             ++G G FG   K T    G    +K L     + +R F  EV+ +   +H N++   G 
Sbjct: 16   EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                     I  Y++ G+L   +      DS   W  R+  A+  A G+AYLH     +I
Sbjct: 76   LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 892  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-------------TDLVGTLGYI 938
            +HRD+ S N L+ E     +ADFGL+RL+    T                  +VG   ++
Sbjct: 130  IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 939  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
             PE     +   + DV+SFG+VL E++                             +  +
Sbjct: 190  APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP---------------DYLPRTMDFGL 234

Query: 999  IDASIWHKDREKQLLEML-EIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                   +            I  +C D DP +RP   ++  WL+ +
Sbjct: 235  NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  184 bits (470), Expect = 2e-50
 Identities = 102/482 (21%), Positives = 171/482 (35%), Gaps = 51/482 (10%)

Query: 101 SLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLN 160
           +   L +     L   ++   V    ++L Q+  L      +       +  LN +  +N
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQIN 74

Query: 161 VSSNSFNGSLFELGEFSNLAVFNISNNSFT-----GKLNSRIWSASKEIQILDLSMNHFM 215
            S+N     +  L   + L    ++NN          L +        +  L L  N   
Sbjct: 75  FSNNQLT-DITPLKNLTKLVDILMNNNQIADITPLANLTN--------LTGLTLFNNQIT 125

Query: 216 GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 275
             +  L +  +L +L + +N +      +L  ++SLQ +S   N  +    + ++NLT+L
Sbjct: 126 -DIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTD--LKPLANLTTL 179

Query: 276 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 335
             L I  N+ S    +VL  LT LE  +A +N  S   P  L + + L  L L  N L  
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235

Query: 336 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 395
                 + L++L  LDLA N  S   P  LS    L  L L  N++S         LT+L
Sbjct: 236 IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTAL 289

Query: 396 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 455
             L L+ N    +S     +   KNLT L L  N + +  P  V     L  L   N  +
Sbjct: 290 TNLELNENQLEDISP----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343

Query: 456 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELK 515
                  L     +  L    N      P  +  +  +  L  ++   T         + 
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399

Query: 516 SLISS---NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF----PPSVFLSNNRINGT 568
              +          P   +    Y + + + N   Y    S+    P ++       +GT
Sbjct: 400 IPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGT 459

Query: 569 IP 570
           + 
Sbjct: 460 VT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  182 bits (464), Expect = 1e-49
 Identities = 102/510 (20%), Positives = 173/510 (33%), Gaps = 53/510 (10%)

Query: 109 KLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNG 168
                    +  +     + L +     L    ++  VS     L+ + +L         
Sbjct: 5   SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 59

Query: 169 SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLK 228
           S+  +   +NL   N SNN  T            ++  + ++ N     +  L +  +L 
Sbjct: 60  SIDGVEYLNNLTQINFSNNQLTDITPL---KNLTKLVDILMNNNQIA-DITPLANLTNLT 115

Query: 229 QLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGK 288
            L + NN +     D L ++++L  + LS N  S      +S LTSL+ L   GNQ +  
Sbjct: 116 GLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDL 170

Query: 289 LPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLC 348
            P  L NLT LE     SN  S      L+  + L  L   NN ++         L++L 
Sbjct: 171 KP--LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDIT--PLGILTNLD 224

Query: 349 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL 408
            L L  N        +L+   +L  L LA N++S         LT L  L L  N  +++
Sbjct: 225 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNI 280

Query: 409 SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKK 468
           S     L     LT L L +N + +     +   ++L  L L    +    P  +    K
Sbjct: 281 SP----LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTK 332

Query: 469 LQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPT 528
           LQ L    N         +  + N+ +L   +N ++   P  L  L  +           
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQ--------- 379

Query: 529 ASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNN 588
                 L +     TN  P N  ++      + N       P  I         D++ N 
Sbjct: 380 ------LGLNDQAWTN-APVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNL 432

Query: 589 ITGTIPSSISEIRNLEVLDLSSNDLHGSIP 618
            +               +   +    G++ 
Sbjct: 433 PSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  134 bits (340), Expect = 1e-33
 Identities = 68/354 (19%), Positives = 120/354 (33%), Gaps = 67/354 (18%)

Query: 293 LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDL 352
              L +    V    + +  +  +     ++  L      +          L++L  ++ 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVSQTD--LDQVTTLQADRLGIKSID--GVEYLNNLTQINF 75

Query: 353 ATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL 412
           + N  +   P  L +   L  + +  N+++         LT+L  L+L NN    +    
Sbjct: 76  SNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP-- 129

Query: 413 SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVL 472
             L+   NL  L L+ N + +     + G  SL  L+ GN  +    P  L     L+ L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ-VTDLKP--LANLTTLERL 182

Query: 473 DLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSNCTSSNPTASA 531
           D+S N         + ++ NL  L  +NN ++   P   LT L  L              
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDEL-------------- 226

Query: 532 GIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITG 591
                                       L+ N++       +  L +L  LDL+ N I+ 
Sbjct: 227 ---------------------------SLNGNQL--KDIGTLASLTNLTDLDLANNQISN 257

Query: 592 TIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGG 645
             P  +S +  L  L L +N +    P     LT L+   +  N L+   P   
Sbjct: 258 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISN 307

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  114 bits (288), Expect = 7e-27
 Identities = 54/315 (17%), Positives = 106/315 (33%), Gaps = 63/315 (20%)

Query: 328 LRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPE 387
            ++  +        + L+      L   + +  +    +D   +  L   +  +     +
Sbjct: 9   TQDTPINQIF--TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--ID 62

Query: 388 SFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMV 447
               L +L  ++ SNN    ++     L+    L  +++  N +       +    +L  
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP----LKNLTKLVDILMNNNQI--ADITPLANLTNLTG 116

Query: 448 LALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEI 507
           L L N  +    P  L     L  L+LS N    +I   +  + +L  L F N     + 
Sbjct: 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTI-SDISA-LSGLTSLQQLSFGNQVTDLKP 172

Query: 508 PKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRING 567
             +LT L+ L                                          +S+N++  
Sbjct: 173 LANLTTLERL-----------------------------------------DISSNKV-- 189

Query: 568 TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFL 627
           +    + +L +L  L  + N I+   P  +  + NL+ L L+ N L     G+   LT L
Sbjct: 190 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIGTLASLTNL 245

Query: 628 SKFSVANNHLQGTIP 642
           +   +ANN +    P
Sbjct: 246 TDLDLANNQISNLAP 260

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  186 bits (474), Expect = 2e-50
 Identities = 88/538 (16%), Positives = 175/538 (32%), Gaps = 82/538 (15%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           +  I    L     L++L L  + +  +      +L  LE LDLS N LS   S     L
Sbjct: 38  ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL 97

Query: 154 NLIQSLNVSSNSFNGSLFELGEFSNLA---VFNISNNSFTGKLNSRIWSASKEIQILDLS 210
           + ++ LN+  N +  +L     F NL       I N     ++    ++    +  L++ 
Sbjct: 98  SSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156

Query: 211 MNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS 266
                     SL+ +     +  L +  +     L      +SS++++ L   N +    
Sbjct: 157 ALSLRNYQSQSLKSI---RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213

Query: 267 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL 326
             +        +     + S         L +L  ++   +       +    C+   + 
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE------VEFDDCTLNGLG 267

Query: 327 DLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVP 386
           D   +      +L      ++  L +   +    L    S    +K +++  +++     
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327

Query: 387 ESFGKLTSLLFLSLSNNSFNHLS-GTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESL 445
                L SL FL LS N          +      +L TL+L++N +   + +      +L
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL-RSMQKTGEILLTL 386

Query: 446 MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLT- 504
                                K L  LD+S N F   +P      E + +L+ S+  +  
Sbjct: 387 ---------------------KNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRV 424

Query: 505 --GEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPS----- 557
               IP++L  L                               +  N   SF        
Sbjct: 425 VKTCIPQTLEVLD------------------------------VSNNNLDSFSLFLPRLQ 454

Query: 558 -VFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 614
            +++S N++     P+      L V+ +SRN +          + +L+ + L +N   
Sbjct: 455 ELYISRNKL--KTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  153 bits (389), Expect = 2e-39
 Identities = 101/585 (17%), Positives = 192/585 (32%), Gaps = 126/585 (21%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           IP  L     +K LDLS N +  +   +L     L+VL L  + ++         L  ++
Sbjct: 20  IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
            L++S N  +               ++S++ F                            
Sbjct: 78  HLDLSDNHLS---------------SLSSSWF---------------------------- 94

Query: 218 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYS-MSSLQHVSLSVNNFSGQLSEK-ISNLTSL 275
                   SLK L++  N        SL+  +++LQ + +       ++     + LTSL
Sbjct: 95  ----GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150

Query: 276 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 335
             L I            L ++                          +H L L  +    
Sbjct: 151 NELEIKALSLRNYQSQSLKSIR------------------------DIHHLTLHLSESAF 186

Query: 336 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 395
            +++    LSS+  L+L   + +    + L        +       S    ESF +L  L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246

Query: 396 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 455
           L   L  +       TL+ L       + ++++    E +        ++  L +    L
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV--------TIRRLHIPQFYL 298

Query: 456 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ-MENLFYLDFSNNTLTGEIPKSLTEL 514
              +       +K++ + +  +     +P    Q +++L +LD S N +  E  K+    
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357

Query: 515 KSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP-----SVFLSNNRINGTI 569
            +  S               L +  N   + +               S+ +S N  +  +
Sbjct: 358 GAWPSLQ------------TLVLSQNHLRS-MQ-KTGEILLTLKNLTSLDISRNTFH-PM 402

Query: 570 PPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSK 629
           P      + +  L+LS   I   + + I   + LEVLD+S+N+L  S      +L  L  
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL-DSFSLFLPRLQEL-- 456

Query: 630 FSVANNHLQGTIPTGG-------------QFYSFPNSSFEGNPGL 661
             ++ N L+ T+P                Q  S P+  F+    L
Sbjct: 457 -YISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  124 bits (313), Expect = 1e-29
 Identities = 63/353 (17%), Positives = 114/353 (32%), Gaps = 31/353 (8%)

Query: 320 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
           C    V D R+ S T  P  L     +++ +LDL+ N  +      L  C +L++L L  
Sbjct: 4   CDASGVCDGRSRSFTSIPSGL----TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN-FVGEEIPE 437
           + ++    ++F  L SL  L LS+N  + LS   S      +L  L L  N +    +  
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS--SWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 438 NVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 496
                 +L  L +GN      I          L  L++            +  + ++ +L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 497 DFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP 556
               +     +      L S+       +N       PL V    S       + S    
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 557 SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIR--------NLEVLDL 608
             F    +    +   I +L  +   D + N +    PS    +          +  L +
Sbjct: 238 ESFNELLK----LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293

Query: 609 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 661
               L   +   +  L  + + +V N+ +             P S  +    L
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVF----------LVPCSFSQHLKSL 336

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  119 bits (299), Expect = 5e-28
 Identities = 59/354 (16%), Positives = 117/354 (33%), Gaps = 30/354 (8%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
             L L       ++      L+ ++ L+L   +L       L   +    +       S 
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234

Query: 145 PVSGMLAGLNLIQSLNVSSNSF---NGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSAS 201
                   L  +    +  +     + +L  LG+F+      +S       +        
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT------- 287

Query: 202 KEIQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNN 260
             I+ L +   +    L         +K++ V+N+ +          + SL+ + LS N 
Sbjct: 288 --IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENL 345

Query: 261 FS---GQLSEKISNLTSLRHLIIFGNQFS--GKLPNVLGNLTQLEFFVAHSNSFSGPLPL 315
                 + S       SL+ L++  N      K   +L  L  L       N+F  P+P 
Sbjct: 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404

Query: 316 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 375
           S     K+  L+L +  +     +      +L  LD++ N+        L     L+ L 
Sbjct: 405 SCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLDS-FSLFL---PRLQELY 457

Query: 376 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
           +++N+L      S      LL + +S N    +     +  +  +L  + L  N
Sbjct: 458 ISRNKLKTLPDASL--FPVLLVMKISRNQLKSVP--DGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  101 bits (253), Expect = 2e-22
 Identities = 64/307 (20%), Positives = 106/307 (34%), Gaps = 35/307 (11%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLK--------QLEVLDLSHNMLSGPVSGM 149
           + R +  L++++  D + N L    P E   +          +  L +    L   +S +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305

Query: 150 LAGLNLIQSLNVSSNSFNGSLFELGEFS---NLAVFNISNNSFT--GKLNSRIWSASKEI 204
            + L  ++ + V ++     L          +L   ++S N        NS    A   +
Sbjct: 306 YSLLEKVKRITVENSKV--FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 205 QILDLSMNHF--MGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
           Q L LS NH   M     +     +L  L +  N     +PDS      ++ ++LS    
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGI 422

Query: 262 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCS 321
              +   I    +L  L +  N         L  L +L       N     LP   SL  
Sbjct: 423 R-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELYI---SRNKLKT-LP-DASLFP 473

Query: 322 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 381
            L V+ +  N L    D  F  L+SL  + L TN +          C  +  LS   N+ 
Sbjct: 474 VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC-------SCPRIDYLSRWLNKN 526

Query: 382 SGQVPES 388
           S +   S
Sbjct: 527 SQKEQGS 533

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 84.4 bits (209), Expect = 7e-17
 Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 14/212 (6%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVV---PVELSNLKQLEVL 135
           S   +V  + +    +  +      HL  L+ LDLS N +                L+ L
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

Query: 136 DLSHNMLS--GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKL 193
            LS N L        +L  L  + SL++S N+F+           +   N+S+      +
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST----GI 422

Query: 194 NSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 253
                   + +++LD+S N+       L   P L++L++  N L   LPD+      L  
Sbjct: 423 RVVKTCIPQTLEVLDVSNNNLDSFSLFL---PRLQELYISRNKL-KTLPDAS-LFPVLLV 477

Query: 254 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 285
           + +S N            LTSL+ + +  N +
Sbjct: 478 MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  183 bits (466), Expect = 3e-49
 Identities = 106/557 (19%), Positives = 178/557 (31%), Gaps = 73/557 (13%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
              L L    L+ +   S     +L++LDLS   ++ +      +L  L  L L+ N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNG-SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 202
               G  +GL+ +Q L     +      F +G    L   N+++N          +S   
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 203 EIQILDLSMNHFM----GSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS 257
            ++ LDLS N         L+ L   P     L +  N +   +    +    L  ++L 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208

Query: 258 VNNFSGQLSEK-ISNLTSLRHLIIFGNQFSG---------KLPNVLGNLTQLEFFVAHSN 307
            N  S  + +  I  L  L    +   +F                L NLT  EF +A+ +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 308 SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 367
            +   +    +  + +    L + ++      +FS       L+L    F       L  
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKL-- 324

Query: 368 CHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 427
              LK L+   N+       S   L SL FL LS N  +             +L  L L+
Sbjct: 325 -KSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 428 KNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPW 486
            N V   +  N  G E L  L   +  LK      +    + L  LD+S  H        
Sbjct: 382 FNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440

Query: 487 IGQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 542
              + +L  L  + N+            L  L  L                         
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD------------------------ 476

Query: 543 TNGLPYNQASSFPPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIR 601
                            LS  ++   + P     L  L VL+++ N +          + 
Sbjct: 477 -----------------LSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518

Query: 602 NLEVLDLSSNDLHGSIP 618
           +L+ + L +N    S P
Sbjct: 519 SLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  174 bits (444), Expect = 3e-46
 Identities = 110/569 (19%), Positives = 194/569 (34%), Gaps = 99/569 (17%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
            +L L R  ++ I   +   L+ L  L L+ N ++ +     S L  L+ L      L+ 
Sbjct: 55  QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114

Query: 145 PVSGMLAGLNLIQSLNVSSNSFN----GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSA 200
             +  +  L  ++ LNV+ N          F     +NL   ++S+N       + +   
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYF--SNLTNLEHLDLSSNKIQSIYCTDLRVL 172

Query: 201 SK---EIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPD-SLYSMSSLQHVSL 256
            +       LDLS+N       G      L +L + NN    ++    +  ++ L+   L
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232

Query: 257 SVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLS 316
            +  F  +      NL          +   G     L NLT  EF +A+ + +   +   
Sbjct: 233 VLGEFRNE-----GNLEKFDK-----SALEG-----LCNLTIEEFRLAYLDYYLDDIIDL 277

Query: 317 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 376
            +  + +    L + ++      +FS       L+L    F       L     LK L+ 
Sbjct: 278 FNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTF 332

Query: 377 AKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIP 436
             N+       S   L SL FL LS N  +             +L  L L+ N V     
Sbjct: 333 TSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI---- 386

Query: 437 ENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI--GQMENLF 494
                                 +    L  ++L+ LD   ++    +  +     + NL 
Sbjct: 387 ---------------------TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 424

Query: 495 YLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF 554
           YLD S+             L SL                 L                   
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEV---------------LK------------------ 451

Query: 555 PPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 613
                ++ N       P+I  +L++L  LDLS+  +    P++ + + +L+VL+++SN L
Sbjct: 452 -----MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506

Query: 614 HGSIPGSFEKLTFLSKFSVANNHLQGTIP 642
                G F++LT L K  +  N    + P
Sbjct: 507 KSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  162 bits (411), Expect = 5e-42
 Identities = 93/462 (20%), Positives = 160/462 (34%), Gaps = 48/462 (10%)

Query: 204 IQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
            + LDLS N        S       P L+ L +    +      +  S+S L  + L+ N
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSF---PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 260 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF-SGPLPLSLS 318
                     S L+SL+ L+      +      +G+L  L+      N   S  LP   S
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 319 LCSKLHVLDLRNNSLTGPIDLNFSGLSSL----CTLDLATNHFSGPLPNSLSDCHDLKIL 374
             + L  LDL +N +      +   L  +     +LDL+ N  +   P +  +   L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKL 205

Query: 375 SLAKNELSGQVPE-SFGKLTSLLFLSLSNNSFNHL----SGTLSVLQQCKNLTTLILTKN 429
           +L  N  S  V +     L  L    L    F +         S L+   NLT       
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 430 ---FVGEEIPENVGGFESLMVLALGNCGLKGHIP-VWLLRCKKLQVLDLSWNHFDGNIPP 485
              +  ++I +      ++   +L +  ++      +    + L++++  +  F      
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL--- 322

Query: 486 WIGQMENLFYLDFSNNTLTGEIP-KSLTELKSL-ISSNCTSSNPTASAGIPLYVKHNRST 543
              ++++L  L F++N          L  L+ L +S N  S     S           S 
Sbjct: 323 ---KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ----------SD 369

Query: 544 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRN 602
            G    +       + LS N +  T+      L+ L  LD   +N+      S+   +RN
Sbjct: 370 FGTTSLK------YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422

Query: 603 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTG 644
           L  LD+S      +  G F  L+ L    +A N  Q      
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  156 bits (395), Expect = 5e-40
 Identities = 85/431 (19%), Positives = 144/431 (33%), Gaps = 49/431 (11%)

Query: 241 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 300
           +PD+L    S +++ LS N      S    +   L+ L +   +          +L+ L 
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 301 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF-SG 359
             +   N        + S  S L  L     +L    +     L +L  L++A N   S 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 360 PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL----LFLSLSNNSFNHLS-GTLSV 414
            LP   S+  +L+ L L+ N++          L  +    L L LS N  N +  G    
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199

Query: 415 LQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPV------WLLRCK 467
           +     L  L L  NF    + +    G   L V  L     +    +       L    
Sbjct: 200 I----RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255

Query: 468 KLQVLDLSWNHFDGNIPPWIG---QMENLFYLDFSNNTLTGEIPKS-LTELKSLISSNCT 523
            L + +    + D  +   I     + N+      + T+      S     + L   NC 
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC- 314

Query: 524 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLD 583
                                  P  +  S    +  ++N+       E+  L  L  LD
Sbjct: 315 ------------------KFGQFPTLKLKSL-KRLTFTSNKGG-NAFSEVD-LPSLEFLD 353

Query: 584 LSRNNIT--GTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTI 641
           LSRN ++  G    S     +L+ LDLS N +  ++  +F  L  L      +++L+  +
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QM 411

Query: 642 PTGGQFYSFPN 652
                F S  N
Sbjct: 412 SEFSVFLSLRN 422

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 73.6 bits (181), Expect = 1e-13
 Identities = 34/156 (21%), Positives = 68/156 (43%), Gaps = 11/156 (7%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVE-LSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 156
           +  +   L QL+ LD   ++L+ +       +L+ L  LD+SH       +G+  GL+ +
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 157 QSLNVSSNSFNGSLFE--LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF 214
           + L ++ NSF  +       E  NL   ++S      +L+   +++   +Q+L+++ N  
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQL 506

Query: 215 ----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLY 246
                G    L    SL+++ +  N      P   Y
Sbjct: 507 KSVPDGIFDRL---TSLQKIWLHTNPWDCSCPRIDY 539

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 57.8 bits (140), Expect = 1e-08
 Identities = 22/82 (26%), Positives = 38/82 (46%)

Query: 97  IIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 156
            +P     L  L  LDLS   LE + P   ++L  L+VL+++ N L     G+   L  +
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520

Query: 157 QSLNVSSNSFNGSLFELGEFSN 178
           Q + + +N ++ S   +   S 
Sbjct: 521 QKIWLHTNPWDCSCPRIDYLSR 542

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  163 bits (416), Expect = 2e-44
 Identities = 68/412 (16%), Positives = 138/412 (33%), Gaps = 67/412 (16%)

Query: 227 LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFS 286
              L      +    PD+   ++      L   + +         L S+  L++ G + +
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 287 GKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSS 346
             +   +  LT LE+   + N  +   PLS     KL  L +  N +T         L++
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISPLSN--LVKLTNLYIGTNKITDIS--ALQNLTN 111

Query: 347 LCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFN 406
           L  L L  ++ S   P  L++   +  L+L  N            +T L +L+++ +   
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168

Query: 407 HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRC 466
            ++     +    +L +L L  N + +     +    SL         +    P  +   
Sbjct: 169 DVTP----IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANM 220

Query: 467 KKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSN 526
            +L  L +  N    ++ P +  +  L +L+   N ++     ++ +L  L         
Sbjct: 221 TRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISD--INAVKDLTKLKM------- 269

Query: 527 PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR 586
                                          + + +N+I  +    +  L  L+ L L+ 
Sbjct: 270 -------------------------------LNVGSNQI--SDISVLNNLSQLNSLFLNN 296

Query: 587 NNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 638
           N +       I  + NL  L LS N +    P     L+ +     AN  ++
Sbjct: 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  159 bits (405), Expect = 5e-43
 Identities = 74/394 (18%), Positives = 144/394 (36%), Gaps = 52/394 (13%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
             L      +  I P     L +     L    +  VV      L+ +  L ++   ++ 
Sbjct: 3   ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58

Query: 145 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI 204
            + G +  L  ++ LN++ N     +  L     L    I  N  T              
Sbjct: 59  -IQG-IEYLTNLEYLNLNGNQIT-DISPLSNLVKLTNLYIGTNKIT-------------- 101

Query: 205 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ 264
                        +  L +  +L++L+++ + +       L +++ +  ++L  N+    
Sbjct: 102 ------------DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD 147

Query: 265 LSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLH 324
           LS  +SN+T L +L +  ++    +   + NLT L     + N      P  L+  + LH
Sbjct: 148 LSP-LSNMTGLNYLTVTESKVK-DVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLH 202

Query: 325 VLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ 384
                 N +T       + ++ L +L +  N  +    + L++   L  L +  N++S  
Sbjct: 203 YFTAYVNQITDIT--PVANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD- 257

Query: 385 VPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFES 444
              +   LT L  L++ +N  + +S     L     L +L L  N +G E  E +GG  +
Sbjct: 258 -INAVKDLTKLKMLNVGSNQISDISV----LNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312

Query: 445 LMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH 478
           L  L L    +    P  L    K+   D +   
Sbjct: 313 LTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  151 bits (385), Expect = 2e-40
 Identities = 69/377 (18%), Positives = 124/377 (32%), Gaps = 65/377 (17%)

Query: 267 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL 326
              ++L      ++     +  +      L  +   V      +    +     + L  L
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQGIEY--LTNLEYL 71

Query: 327 DLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVP 386
           +L  N +T       S L  L  L + TN  +    ++L +  +L+ L L ++ +S    
Sbjct: 72  NLNGNQITDIS--PLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISD--I 125

Query: 387 ESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLM 446
                LT +  L+L     NH    LS L     L  L +T++ V +     +     L 
Sbjct: 126 SPLANLTKMYSLNLG---ANHNLSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLY 180

Query: 447 VLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGE 506
            L+L    ++   P+  L    L       N      P  +  M  L  L   NN +T  
Sbjct: 181 SLSLNYNQIEDISPLASL--TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236

Query: 507 IP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRI 565
            P  +L++L  L                                          +  N+I
Sbjct: 237 SPLANLSQLTWL-----------------------------------------EIGTNQI 255

Query: 566 NGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLT 625
             +    +  L  L +L++  N I+    S ++ +  L  L L++N L          LT
Sbjct: 256 --SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311

Query: 626 FLSKFSVANNHLQGTIP 642
            L+   ++ NH+    P
Sbjct: 312 NLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  111 bits (280), Expect = 1e-26
 Identities = 49/305 (16%), Positives = 97/305 (31%), Gaps = 66/305 (21%)

Query: 343 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN 402
           G ++L TL    N          +D  +     L K  ++     +  +L S+  L ++ 
Sbjct: 1   GAATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAG 53

Query: 403 NSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVW 462
                + G    ++   NL  L L  N + +  P  +     L  L +G   +   I   
Sbjct: 54  EKVASIQG----IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISA- 105

Query: 463 LLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP--KSLTELKSLISS 520
           L     L+ L L+ ++    I P +  +  ++ L+   N    ++    ++T L  L   
Sbjct: 106 LQNLTNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYL--- 160

Query: 521 NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLH 580
                                                  ++ +++       I  L  L+
Sbjct: 161 --------------------------------------TVTESKVKD--VTPIANLTDLY 180

Query: 581 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGT 640
            L L+ N I    P  ++ + +L       N +    P     +T L+   + NN +   
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236

Query: 641 IPTGG 645
            P   
Sbjct: 237 SPLAN 241

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 96.5 bits (241), Expect = 1e-21
 Identities = 38/193 (19%), Positives = 82/193 (42%), Gaps = 13/193 (6%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           +K + P  + +L  L  L L+ N +E + P  L++L  L       N ++      +A +
Sbjct: 167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220

Query: 154 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 213
             + SL + +N     L  L   S L    I  N  +  +N+       ++++L++  N 
Sbjct: 221 TRLNSLKIGNNKIT-DLSPLANLSQLTWLEIGTNQIS-DINA--VKDLTKLKMLNVGSNQ 276

Query: 214 FMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLT 273
               +  L++   L  L ++NN LG +  + +  +++L  + LS N+ +      +++L+
Sbjct: 277 I-SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLS 333

Query: 274 SLRHLIIFGNQFS 286
            +           
Sbjct: 334 KMDSADFANQVIK 346

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  165 bits (421), Expect = 4e-44
 Identities = 103/547 (18%), Positives = 178/547 (32%), Gaps = 103/547 (18%)

Query: 97  IIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 156
           I PR++     L+      ++L   +PVE  N+K       + +               +
Sbjct: 3   INPRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60

Query: 157 QSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 216
               +                      ++N   +      +      ++ L  S N    
Sbjct: 61  AVSRLRDCLDR----------QAHELELNNLGLS-----SLPELPPHLESLVASCNS--- 102

Query: 217 SLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 275
            L  L   P SLK L VDNN L   L D       L+++ +S N    +L E + N + L
Sbjct: 103 -LTELPELPQSLKSLLVDNNNLK-ALSDLP---PLLEYLGVSNNQLE-KLPE-LQNSSFL 155

Query: 276 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 335
           + + +  N    KLP++  +L  +    A +N     LP  L     L  +   NNSL  
Sbjct: 156 KIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK 209

Query: 336 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 395
             DL      SL ++    N         L +   L  +    N L   +P+    L +L
Sbjct: 210 LPDL----PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL 262

Query: 396 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 455
              ++ +N    L           +LT L +++N     + E      +L  L   +  +
Sbjct: 263 ---NVRDNYLTDLPELPQ------SLTFLDVSENIF-SGLSEL---PPNLYYLNASSNEI 309

Query: 456 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELK 515
           +  +         L+ L++S N     +P    ++E L     S N L  E+P+    LK
Sbjct: 310 R-SLCDLP---PSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQNLK 360

Query: 516 SLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF-----LSNNRINGTIP 570
            L                            + YN    FP           N+ +   +P
Sbjct: 361 QLH---------------------------VEYNPLREFPDIPESVEDLRMNSHLA-EVP 392

Query: 571 PEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKF 630
                LK L    +  N +    P       ++E L ++S  +      + E    L   
Sbjct: 393 ELPQNLKQL---HVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDD 445

Query: 631 SVANNHL 637
              ++H 
Sbjct: 446 VFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  164 bits (417), Expect = 1e-43
 Identities = 102/517 (19%), Positives = 169/517 (32%), Gaps = 89/517 (17%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           +P    ++        + +  E   P      +++ V  L   +                
Sbjct: 26  MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-----------AH 74

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
            L +++   + SL E     +L     S NS T +L     S  K + + + ++      
Sbjct: 75  ELELNNLGLS-SLPE--LPPHLESLVASCNSLT-ELPELPQSL-KSLLVDNNNLKALSDL 129

Query: 218 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRH 277
                  P L+ L V NN L   LP+ L + S L+ + +  N     L +      SL  
Sbjct: 130 P------PLLEYLGVSNNQL-EKLPE-LQNSSFLKIIDVDNN----SLKKLPDLPPSLEF 177

Query: 278 LIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPI 337
           +    NQ   +LP  L NL  L    A +NS    LP        L  +   NN L    
Sbjct: 178 IAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILEELP 231

Query: 338 DLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLF 397
           +L    L  L T+    N     LP+       L+ L++  N L+  +PE    LT    
Sbjct: 232 EL--QNLPFLTTIYADNNLLKT-LPDLPP---SLEALNVRDNYLT-DLPELPQSLTF--- 281

Query: 398 LSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKG 457
           L +S N F+ LS          NL  L  + N +   + +      SL  L + N  L  
Sbjct: 282 LDVSENIFSGLSELP------PNLYYLNASSNEI-RSLCDL---PPSLEELNVSNNKLI- 330

Query: 458 HIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL 517
            +P       +L+ L  S+NH    +P       NL  L    N L  E P     ++ L
Sbjct: 331 ELPALP---PRLERLIASFNHL-AEVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDL 382

Query: 518 ISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLK 577
             ++  +  P     +                        + +  N +    P     ++
Sbjct: 383 RMNSHLAEVPELPQNL----------------------KQLHVETNPLR-EFPDIPESVE 419

Query: 578 HLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 614
               L ++   +      +      LE      +  H
Sbjct: 420 D---LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  155 bits (395), Expect = 8e-41
 Identities = 92/444 (20%), Positives = 156/444 (35%), Gaps = 61/444 (13%)

Query: 83  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 142
           +   L L   GL   +P    HL  L     SCN L   +P    +LK L V + +   L
Sbjct: 72  QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126

Query: 143 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 202
           S           L++ L VS+N     L EL   S L + ++ NNS       ++     
Sbjct: 127 SDL-------PPLLEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLK-----KLPDLPP 173

Query: 203 EIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 262
            ++ +    N     L  L + P L  ++ DNN L   LPD      SL+ +    N   
Sbjct: 174 SLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLK-KLPDLP---LSLESIVAGNNILE 228

Query: 263 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 322
            +L E + NL  L  +    N     LP++  +L  L       N  +  LP      + 
Sbjct: 229 -ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEALNV---RDNYLTD-LPELPQSLTF 281

Query: 323 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 382
           L V +   + L+           +L  L+ ++N     L +       L+ L+++ N+L 
Sbjct: 282 LDVSENIFSGLS-------ELPPNLYYLNASSNEIRS-LCDLPPS---LEELNVSNNKLI 330

Query: 383 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 442
            ++P    +L  L     S N    +           NL  L +  N +  E P+     
Sbjct: 331 -ELPALPPRLERL---IASFNHLAEVPELPQ------NLKQLHVEYNPL-REFPDIPESV 379

Query: 443 ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNT 502
           E L +           +P      + L+ L +  N      P     +E+L         
Sbjct: 380 EDLRM-----NSHLAEVPEL---PQNLKQLHVETNPLR-EFPDIPESVEDLRMNSERVVD 430

Query: 503 LTGEIPKSLTELKSLISSNCTSSN 526
                 ++  +L+  +  +    +
Sbjct: 431 PYEFAHETTDKLEDDVFEHHHHHH 454

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  130 bits (328), Expect = 4e-32
 Identities = 70/396 (17%), Positives = 128/396 (32%), Gaps = 107/396 (27%)

Query: 247 SMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHS 306
           S + LQ      +N + ++  +  N+ S        +++    P   G   ++       
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV----- 62

Query: 307 NSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLS 366
                   L   L  + H L+L N  L+                          LP    
Sbjct: 63  ------SRLRDCLDRQAHELELNNLGLS-------------------------SLPELPP 91

Query: 367 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 426
               L+ L  + N L+ ++PE    L SLL  + +  + + L            L  L +
Sbjct: 92  ---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL---------PPLLEYLGV 138

Query: 427 TKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPW 486
           + N + E++PE +     L ++ + N  LK  +P        L+ +    N  +  +P  
Sbjct: 139 SNNQL-EKLPE-LQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLE-ELPE- 190

Query: 487 IGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGL 546
           +  +  L  +   NN+L  ++P     L+S++                            
Sbjct: 191 LQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---------------------------- 221

Query: 547 PYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVL 606
                          NN +     PE+  L  L  +    N +  T+P       +LE L
Sbjct: 222 -------------AGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEAL 262

Query: 607 DLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 642
           ++  N L   +P   + LTFL       + L    P
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.7 bits (127), Expect = 5e-07
 Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 18/105 (17%)

Query: 547 PYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE------- 599
           P N +++F       ++ +   +P E   +K       + +      P    E       
Sbjct: 5   PRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63

Query: 600 ------IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 638
                  R    L+L++  L  S+P     L  L     + N L 
Sbjct: 64  RLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT 104

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  159 bits (403), Expect = 1e-41
 Identities = 69/426 (16%), Positives = 144/426 (33%), Gaps = 47/426 (11%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           I     + N+ K+  ++ + L+  +     +   ++ LDLS N LS   +  LA    ++
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
            LN+SSN     L+E  +  +L                        ++ LDL+ N+    
Sbjct: 62  LLNLSSN----VLYETLDLESL----------------------STLRTLDLNNNY---- 91

Query: 218 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRH 277
           +Q L   PS++ LH  NN +   +  S       +++ L+ N  +          + +++
Sbjct: 92  VQELLVGPSIETLHAANNNI-SRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148

Query: 278 LIIFGNQFSG-KLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 336
           L +  N+        +  +   LE      N     +   +   +KL  LDL +N L   
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVF-AKLKTLDLSSNKLAF- 205

Query: 337 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS-GQVPESFGKLTSL 395
           +   F   + +  + L  N     +  +L    +L+   L  N    G + + F K   +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 396 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 455
              +++  +   L+G     ++C   T          +          +L          
Sbjct: 265 --QTVAKQTVKKLTG--QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG 320

Query: 456 KG----HIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSL 511
           +G     +        + + +D     +   I     + +    L+     L  ++    
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380

Query: 512 TELKSL 517
                L
Sbjct: 381 RAHAEL 386

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  146 bits (369), Expect = 3e-37
 Identities = 69/411 (16%), Positives = 126/411 (30%), Gaps = 52/411 (12%)

Query: 241 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 300
           + +   + +  +   ++ ++    L+    +  +++ L + GN  S      L   T+LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 301 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 360
                SN     L L  SL S L  LDL NN +            S+ TL  A N+ S  
Sbjct: 62  LLNLSSNVLYETLDLE-SL-STLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114

Query: 361 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 420
             +        K + LA N+++       G  + + +L L  N  + ++    +      
Sbjct: 115 SCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN-FAELAASSDT 170

Query: 421 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD 480
           L  L L  NF+  ++   V                            KL+ LDLS N   
Sbjct: 171 LEHLNLQYNFI-YDVKGQVV-------------------------FAKLKTLDLSSNKLA 204

Query: 481 GNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL----ISSN---CTSSNPTASAGI 533
             + P       + ++   NN L   I K+L   ++L    +  N   C +     S   
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

Query: 534 PLYVKHNRSTNGLPYN--QASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLS----RN 587
            +     ++   L     +  + P               P   +L  L   + +    + 
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322

Query: 588 NITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 638
           + T  +            +D         I     +             L 
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  129 bits (327), Expect = 8e-32
 Identities = 76/436 (17%), Positives = 143/436 (32%), Gaps = 25/436 (5%)

Query: 76  STGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVL 135
           S   +A  V  L L    L  I    L    +L+LL+LS N L   +   L +L  L  L
Sbjct: 28  SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTL 85

Query: 136 DLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNS 195
           DL++N +       L     I++L+ ++N+   S              ++NN  T  L  
Sbjct: 86  DLNNNYVQ-----ELLVGPSIETLHAANNNI--SRVSCSRGQGKKNIYLANNKIT-MLRD 137

Query: 196 RIWSASKEIQILDLSMNHFMG--SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 253
                   +Q LDL +N        +    S +L+ L++  N +  D+   +   + L+ 
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQV-VFAKLKT 195

Query: 254 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS-GP 312
           + LS N  +  +  +  +   +  + +  N+    +   L     LE F    N F  G 
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253

Query: 313 LPLSLSLCSKLHVLDLR-NNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLS--DCH 369
           L    S   ++  +  +    LTG  +   +  +              P  + L      
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRK 313

Query: 370 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
           +  +LS   +E    +            +      +  +     V  + +   TL   K 
Sbjct: 314 EHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQ--VTLRKQAKITLEQKKK 370

Query: 430 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD-GNIPPWIG 488
            + E++         L        G +  +         LQ+L      ++   +     
Sbjct: 371 ALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSV 429

Query: 489 QMENLFYLDFSNNTLT 504
           Q   +   D   +  T
Sbjct: 430 QNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 72.6 bits (178), Expect = 2e-13
 Identities = 25/193 (12%), Positives = 54/193 (27%), Gaps = 41/193 (21%)

Query: 468 KLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNP 527
           + ++  ++ +     +        N+  LD S N L+      L     L          
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL-------- 62

Query: 528 TASAGIPLYVKHNRSTNGLPYNQASSFPP--------SVFLSNNRINGTIPPEIGQLKHL 579
                  L          L  N               ++ L+NN +      E+     +
Sbjct: 63  -------LN---------LSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSI 101

Query: 580 HVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQG 639
             L  + NNI+  +  S    +  + + L++N +           + +    +  N +  
Sbjct: 102 ETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID- 157

Query: 640 TIPTGGQFYSFPN 652
           T+       S   
Sbjct: 158 TVNFAELAASSDT 170

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 13/70 (18%), Positives = 27/70 (38%)

Query: 573 IGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSV 632
                   +  ++ +++   + S      N++ LDLS N L           T L   ++
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 633 ANNHLQGTIP 642
           ++N L  T+ 
Sbjct: 66  SSNVLYETLD 75

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  147 bits (372), Expect = 7e-39
 Identities = 57/376 (15%), Positives = 104/376 (27%), Gaps = 65/376 (17%)

Query: 263 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 322
           G       + +   +L   G+       +VL    +      +    +     S    + 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NN 57

Query: 323 LHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 381
             +      +L      L  +       L+L +       P+       L+ +++    L
Sbjct: 58  PQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGL 116

Query: 382 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG 441
             ++P++  +   L  L+L+ N    L  +++       L  L +       E+PE +  
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLRALPASIA---SLNRLRELSIRACPELTELPEPLA- 171

Query: 442 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 501
                                      LQ L L W     ++P  I  ++NL  L   N+
Sbjct: 172 --------------STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216

Query: 502 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLS 561
            L+  +  ++  L  L                 L                        L 
Sbjct: 217 PLS-ALGPAIHHLPKLEE---------------LD-----------------------LR 237

Query: 562 NNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSF 621
                   PP  G    L  L L   +   T+P  I  +  LE LDL        +P   
Sbjct: 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297

Query: 622 EKLTFLSKFSVANNHL 637
            +L       V  +  
Sbjct: 298 AQLPANCIILVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  141 bits (357), Expect = 7e-37
 Identities = 59/377 (15%), Positives = 111/377 (29%), Gaps = 67/377 (17%)

Query: 239 GDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQ 298
           G      +  S  +++    +       + +S      +        + +      N   
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 299 LEFFVAHSNSFSGPLPLSLSLCS--KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNH 356
            +       +        L   +      L+LR+  L          LS L  + +    
Sbjct: 58  PQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAG 115

Query: 357 FSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQ 416
               LP+++     L+ L+LA+N L   +P S   L  L  LS+                
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA-------------- 159

Query: 417 QCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSW 476
            C  LT   L +     +      G  +L  L L   G++  +P  +   + L+ L +  
Sbjct: 160 -CPELTE--LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215

Query: 477 NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLY 536
           +     + P I  +  L  LD    T     P        L                 L 
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR---------------LI 259

Query: 537 VKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSS 596
           +K                        + +  T+P +I +L  L  LDL        +PS 
Sbjct: 260 LKD----------------------CSNL-LTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296

Query: 597 ISEIRNLEVLDLSSNDL 613
           I+++    ++ +  +  
Sbjct: 297 IAQLPANCIILVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  131 bits (333), Expect = 9e-34
 Identities = 53/340 (15%), Positives = 99/340 (29%), Gaps = 29/340 (8%)

Query: 177 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNL 236
           S         ++     +  +     + Q    +  +   S     +S + +        
Sbjct: 12  SGRENLYFQGSTALRPYHDVL----SQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRA 67

Query: 237 LGGDLPDSLY--SMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLG 294
           L     D L   +      + L       Q  ++   L+ L+H+ I       +LP+ + 
Sbjct: 68  LK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124

Query: 295 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLAT 354
               LE      N     LP S++  ++L  L +R       +    +            
Sbjct: 125 QFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTD--------- 174

Query: 355 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSV 414
                          +L+ L L    +   +P S   L +L  L + N+  + L   +  
Sbjct: 175 ------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIH- 226

Query: 415 LQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDL 474
                 L  L L         P   GG   L  L L +C     +P+ + R  +L+ LDL
Sbjct: 227 --HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284

Query: 475 SWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTEL 514
                   +P  I Q+     +    +             
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  129 bits (326), Expect = 7e-33
 Identities = 48/308 (15%), Positives = 86/308 (27%), Gaps = 33/308 (10%)

Query: 344 LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNN 403
            S    L    +    P  + LS           +               +    + +  
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 404 SFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWL 463
           +    +  L    Q      L L    +  + P+       L  + +   GL   +P  +
Sbjct: 67  ALKATADLLEDATQ-PGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123

Query: 464 LRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCT 523
            +   L+ L L+ N     +P  I  +  L  L         E+P+ L    +       
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182

Query: 524 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF---------LSNNRINGTIPPEIG 574
            +  +      L          L +    S P S+          + N+ ++  + P I 
Sbjct: 183 VNLQS------LR---------LEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226

Query: 575 QLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN 634
            L  L  LDL         P        L+ L L       ++P    +LT L K  +  
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286

Query: 635 NHLQGTIP 642
                 +P
Sbjct: 287 CVNLSRLP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  126 bits (319), Expect = 6e-32
 Identities = 54/332 (16%), Positives = 102/332 (30%), Gaps = 34/332 (10%)

Query: 99  PRSLGHLNQLKLLDLS-CNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
                H +  + L       L       LS  ++    D +    +       A  N  Q
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPY-HDVLSQWQRHYNADRNRWHSAW----RQANSNNPQ 59

Query: 158 SLNVSSNSFNGSLFELGEFS--NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF- 214
               +  +   +   L + +        + +     +   + +  S  +Q + +      
Sbjct: 60  IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGLM 117

Query: 215 -----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNN--------- 260
                M           L+ L +  N L   LP S+ S++ L+ +S+             
Sbjct: 118 ELPDTMQQFA------GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170

Query: 261 FSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLC 320
            S   S +   L +L+ L +        LP  + NL  L+     ++  S  L  ++   
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHL 228

Query: 321 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNE 380
            KL  LDLR  +        F G + L  L L        LP  +     L+ L L    
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288

Query: 381 LSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL 412
              ++P    +L +   + +  +    L    
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  113 bits (284), Expect = 2e-27
 Identities = 43/268 (16%), Positives = 87/268 (32%), Gaps = 46/268 (17%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
            P     L+ L+ + +    L   +P  +     LE L L+ N L               
Sbjct: 96  FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-------------- 140

Query: 158 SLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 216
                      +L   +   + L   +I       +L   + S     +   L       
Sbjct: 141 -----------ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV------ 183

Query: 217 SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLR 276
                    +L+ L ++   +   LP S+ ++ +L+ + +  +  S  L   I +L  L 
Sbjct: 184 ---------NLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232

Query: 277 HLIIFGNQFSGKLPNVLGNLTQL-EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 335
            L + G       P + G    L    +   ++    LPL +   ++L  LDLR      
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLS 291

Query: 336 PIDLNFSGLSSLCTLDLATNHFSGPLPN 363
            +    + L + C + +  +  +    +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 66.5 bits (163), Expect = 1e-11
 Identities = 26/211 (12%), Positives = 63/211 (29%), Gaps = 53/211 (25%)

Query: 89  LPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG-PVS 147
           LP              L  L+ L L    +   +P  ++NL+ L+ L + ++ LS    +
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPA 224

Query: 148 GMLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQI 206
             +  L  ++ L++   +   +     G  + L    + +                    
Sbjct: 225 --IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC------------------- 263

Query: 207 LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS 266
                                      +NL    LP  ++ ++ L+ + L       +L 
Sbjct: 264 ---------------------------SNL--LTLPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 267 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLT 297
             I+ L +   +++  +  +    +      
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  138 bits (351), Expect = 3e-36
 Identities = 64/345 (18%), Positives = 128/345 (37%), Gaps = 44/345 (12%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           I     + N+ K+  ++ + L+  +     +   ++ LDLS N LS   +  LA    ++
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
            LN+SSN     L+E  +  +L                        ++ LDL+ N+    
Sbjct: 62  LLNLSSN----VLYETLDLESL----------------------STLRTLDLNNNY---- 91

Query: 218 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRH 277
           +Q L   PS++ LH  NN +   +  S       +++ L+ N  +          + +++
Sbjct: 92  VQELLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQY 148

Query: 278 LIIFGNQFSG-KLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 336
           L +  N+        +  +   LE      N     +   +   +KL  LDL +N L   
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVF-AKLKTLDLSSNKLAF- 205

Query: 337 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS-GQVPESFGKLTSL 395
           +   F   + +  + L  N     +  +L    +L+   L  N    G + + F K   +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 396 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG 440
              +++  +   L+G          + TL     +  E++P    
Sbjct: 265 --QTVAKQTVKKLTGQNEEE---CTVPTLGHYGAYCCEDLPAPFA 304

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  136 bits (345), Expect = 2e-35
 Identities = 62/352 (17%), Positives = 121/352 (34%), Gaps = 63/352 (17%)

Query: 321 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNE 380
           ++  +  + ++SL   +        ++  LDL+ N  S      L+    L++L+L+ N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 381 LSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG 440
           L          L++L  L L+NN        +  L    ++ TL    N +   +  +  
Sbjct: 70  LYE--TLDLESLSTLRTLDLNNNY-------VQELLVGPSIETLHAANNNI-SRVSCSR- 118

Query: 441 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG-NIPPWIGQMENLFYLDFS 499
             +    + L N  +     +      ++Q LDL  N  D  N        + L +L+  
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 500 NNTLTGEIPKS--LTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPS 557
            N +  ++       +LK+L                                        
Sbjct: 178 YNFIY-DVKGQVVFAKLKTL---------------------------------------- 196

Query: 558 VFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH-GS 616
             LS+N++   + PE      +  + L  N +   I  ++   +NLE  DL  N  H G+
Sbjct: 197 -DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253

Query: 617 IPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSP 668
           +   F K   +   +VA   ++       +  + P     G    C ++ +P
Sbjct: 254 LRDFFSKNQRVQ--TVAKQTVKKLTGQNEEECTVPTLGHYGA-YCCEDLPAP 302

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  110 bits (276), Expect = 2e-26
 Identities = 61/291 (20%), Positives = 108/291 (37%), Gaps = 23/291 (7%)

Query: 76  STGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVL 135
           S   +A  V  L L    L  I    L    +L+LL+LS N L   +   L +L  L  L
Sbjct: 28  SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTL 85

Query: 136 DLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNS 195
           DL++N +       L     I++L+ ++N+   S              ++NN  T  L  
Sbjct: 86  DLNNNYVQ-----ELLVGPSIETLHAANNNI--SRVSCSRGQGKKNIYLANNKIT-MLRD 137

Query: 196 RIWSASKEIQILDLSMNHF--MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 253
                   +Q LDL +N    +   +    S +L+ L++  N +  D+   +   + L+ 
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQV-VFAKLKT 195

Query: 254 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS-GP 312
           + LS N  +  +  +  +   +  + +  N+    +   L     LE F    N F  G 
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253

Query: 313 LPLSLSLCSKLHVLDLRNNS-LTGPIDLNFSG-----LSSLCTLDLATNHF 357
           L    S   ++  +  +    LTG  +   +        + C  DL     
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 44/261 (16%), Positives = 76/261 (29%), Gaps = 67/261 (25%)

Query: 386 PESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESL 445
            E            ++++S        S+ Q   N+  L L+ N +  +I          
Sbjct: 3   HEIKQNGNRYKIEKVTDSSLKQALA--SLRQSAWNVKELDLSGNPL-SQISAAD--LAPF 57

Query: 446 MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG 505
                                 KL++L+LS N         +  +  L  LD +NN +  
Sbjct: 58  ---------------------TKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ- 93

Query: 506 EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF------ 559
           E+      +++L                               N  S    S        
Sbjct: 94  ELL-VGPSIETLH---------------------------AANNNISRVSCSRGQGKKNI 125

Query: 560 -LSNNRINGTIPPEIGQLKHLHVLDLSRNNITG-TIPSSISEIRNLEVLDLSSNDLHGSI 617
            L+NN+I      + G    +  LDL  N I         +    LE L+L  N ++  +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DV 184

Query: 618 PGSFEKLTFLSKFSVANNHLQ 638
            G       L    +++N L 
Sbjct: 185 KGQV-VFAKLKTLDLSSNKLA 204

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 13/70 (18%), Positives = 26/70 (37%)

Query: 569 IPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLS 628
           I           +  ++ +++   + S      N++ LDLS N L           T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 629 KFSVANNHLQ 638
             ++++N L 
Sbjct: 62  LLNLSSNVLY 71

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  138 bits (350), Expect = 2e-35
 Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 18/204 (8%)

Query: 775 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYC 832
           IG G FG V+   L  + T  AVK          + +F  E   L +  H N+V L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 833 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                  ++   ++ G    +L     + + L+    L++   AA G+ YL        +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235

Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTLT 947
           HRD+ + N L+ EK    ++DFG+SR     D        G L  +P     PE      
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE--ADGVYAAS--GGLRQVPVKWTAPEALNYGR 291

Query: 948 ATCRGDVYSFGVVLLELLT-GRRP 970
            +   DV+SFG++L E  + G  P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  140 bits (355), Expect = 2e-35
 Identities = 60/328 (18%), Positives = 115/328 (35%), Gaps = 31/328 (9%)

Query: 83  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 142
              +L L +  +K +          L+ L+L+ N +  V P   +NL  L  L L  N L
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92

Query: 143 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 202
                G+  GL+ +  L++S N                   + +  F   L +       
Sbjct: 93  KLIPLGVFTGLSNLTKLDISENKIV---------------ILLDYMFQD-LYN------- 129

Query: 203 EIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 258
            ++ L++  N  +     +  GL    SL+QL ++   L     ++L  +  L  + L  
Sbjct: 130 -LKSLEVGDNDLVYISHRAFSGL---NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185

Query: 259 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 318
            N +         L  L+ L I    +   +         L        + +    L++ 
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245

Query: 319 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
               L  L+L  N ++         L  L  + L     +   P +    + L++L+++ 
Sbjct: 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFN 406
           N+L+      F  + +L  L L +N   
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  127 bits (321), Expect = 4e-31
 Identities = 64/386 (16%), Positives = 131/386 (33%), Gaps = 66/386 (17%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           +P  +    + +LLDL  N ++ +   E ++   LE L+L+ N++S              
Sbjct: 26  VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-------------- 69

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
              V   +FN          NL    + +N                 ++  + +  F   
Sbjct: 70  --AVEPGAFNN-------LFNLRTLGLRSN-----------------RLKLIPLGVF--- 100

Query: 218 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNLTSLR 276
             GL    +L +L +  N +   L      + +L+ + +  N+    +S +  S L SL 
Sbjct: 101 -TGL---SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLE 155

Query: 277 HLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 336
            L +     +      L +L  L        + +     S     +L VL++ +      
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215

Query: 337 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLL 396
           +  N     +L +L +   + +     ++     L+ L+L+ N +S        +L  L 
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275

Query: 397 FLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALG---- 451
            + L       +       +    L  L ++ N +   + E+V     +L  L L     
Sbjct: 276 EIQLVGGQLAVVEP--YAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETLILDSNPL 332

Query: 452 --NCGLKGHIPVWLLRCKKLQVLDLS 475
             +C L      W+ R +     +  
Sbjct: 333 ACDCRLL-----WVFRRRWRLNFNRQ 353

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  124 bits (312), Expect = 5e-30
 Identities = 72/347 (20%), Positives = 120/347 (34%), Gaps = 58/347 (16%)

Query: 319 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
           + ++  +LDL  N +       F+    L  L+L  N  S   P + ++  +L+ L L  
Sbjct: 30  IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 438
           N L       F  L++L  L +S N    L   +   Q   NL +L +  N +   I   
Sbjct: 90  NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYM--FQDLYNLKSLEVGDNDL-VYISHR 146

Query: 439 V-GGFESLMVLALGNCGLKGHIPV-WLLRCKKLQVLDLSWNHFDGNIPPWI-GQMENLFY 495
              G  SL  L L  C L   IP   L     L VL L   + +  I  +   ++  L  
Sbjct: 147 AFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKV 204

Query: 496 LDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFP 555
           L+ S+      +  +     +L S                                    
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTS------------------------------------ 228

Query: 556 PSVFLSNNRINGTIPPE-IGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 614
             + +++  +   +P   +  L +L  L+LS N I+    S + E+  L+ + L    L 
Sbjct: 229 --LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285

Query: 615 GSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 661
              P +F  L +L   +V+ N L           +   S F     L
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLT----------TLEESVFHSVGNL 322

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (346), Expect = 7e-35
 Identities = 69/380 (18%), Positives = 125/380 (32%), Gaps = 46/380 (12%)

Query: 241 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 300
           +  +L        V + +         +   L + + +    +        +L +  Q+E
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 301 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 360
               +          + +    +  L +  N++       F  +  L  L L  N  S  
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132

Query: 361 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 420
                 +   L  LS++ N L     ++F   TSL  L LS+N   H+      L    +
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-----LSLIPS 187

Query: 421 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD 480
           L    ++ N +   +   +    ++  L   +  +   +   +    +L +L L  N+  
Sbjct: 188 LFHANVSYNLL-STLAIPI----AVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT 239

Query: 481 GNIPPWIGQMENLFYLDFSNNTLTGEIPK----SLTELKSL-ISSNCTSSNPTASAGIP- 534
                W+     L  +D S N L  +I       +  L+ L IS+N   +       IP 
Sbjct: 240 D--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPT 296

Query: 535 LYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIP 594
           L V                    + LS+N +   +     Q   L  L L  N+I  T+ 
Sbjct: 297 LKV--------------------LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK 334

Query: 595 SSISEIRNLEVLDLSSNDLH 614
            S      L+ L LS ND  
Sbjct: 335 LST--HHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (346), Expect = 7e-35
 Identities = 72/389 (18%), Positives = 135/389 (34%), Gaps = 51/389 (13%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           I  +L +      + +     +     E   L   +++   ++ +    + +L     ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM-- 215
            LN++                     I   +F           +  IQ L +  N     
Sbjct: 73  LLNLNDLQIE---------------EIDTYAFAY---------AHTIQKLYMGFNAIRYL 108

Query: 216 --GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLT 273
                Q +   P L  L ++ N L        ++   L  +S+S NN      +     T
Sbjct: 109 PPHVFQNV---PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165

Query: 274 SLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSL 333
           SL++L +  N+ +    +++ +L          N  S     +L++   +  LD  +NS+
Sbjct: 166 SLQNLQLSSNRLTHVDLSLIPSLFHANV---SYNLLS-----TLAIPIAVEELDASHNSI 217

Query: 334 TGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLT 393
                +       L  L L  N+ +      L +   L  + L+ NEL   +   F K+ 
Sbjct: 218 N---VVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272

Query: 394 SLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNC 453
            L  L +SNN    L+      Q    L  L L+ N +   +  N   F+ L  L L + 
Sbjct: 273 RLERLYISNNRLVALNLYG---QPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHN 328

Query: 454 GLKGHIPVWLLRCKKLQVLDLSWNHFDGN 482
            +   + +       L+ L LS N +D N
Sbjct: 329 SIV-TLKLSTH--HTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  134 bits (339), Expect = 5e-34
 Identities = 66/360 (18%), Positives = 121/360 (33%), Gaps = 51/360 (14%)

Query: 74  HGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLE 133
            G          ++      ++ +    L    Q++LL+L+   +E +     +    ++
Sbjct: 37  FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQ 96

Query: 134 VLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKL 193
            L +  N +      +   + L+  L +  N  +               ++    F    
Sbjct: 97  KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS---------------SLPRGIFHN-- 139

Query: 194 NSRIWSASKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMS 249
                  + ++  L +S N+       + Q      SL+ L + +N L   +  SL  + 
Sbjct: 140 -------TPKLTTLSMSNNNLERIEDDTFQAT---TSLQNLQLSSNRL-THVDLSL--IP 186

Query: 250 SLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 309
           SL H ++S N  S      ++   ++  L    N  +     V   LT L+      N+ 
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKL---QHNNL 238

Query: 310 SGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH 369
           +      L     L  +DL  N L   +   F  +  L  L ++ N     L        
Sbjct: 239 T-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 295

Query: 370 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
            LK+L L+ N L   V  +  +   L  L L +NS   L      L     L  L L+ N
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK-----LSTHHTLKNLTLSHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  125 bits (315), Expect = 6e-31
 Identities = 63/369 (17%), Positives = 127/369 (34%), Gaps = 33/369 (8%)

Query: 303 VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLP 362
           V         +  +L      + + +   +           L++   +    +       
Sbjct: 3   VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 62

Query: 363 NSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLT 422
             L     +++L+L   ++      +F    ++  L +  N+  +L     V Q    LT
Sbjct: 63  ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP--HVFQNVPLLT 120

Query: 423 TLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFD 480
            L+L +N +   +P  +      L  L++ N  L+  I     +    LQ L LS N   
Sbjct: 121 VLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178

Query: 481 GNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL-ISSNCTSSNPTASAGIPLYVKH 539
            ++      + +LF+ + S N L+  +      ++ L  S N  +        +   V  
Sbjct: 179 -HVDL--SLIPSLFHANVSYNLLS-TLAI-PIAVEELDASHNSINV-------VRGPVNV 226

Query: 540 NRSTNGLPYNQASSFPP--------SVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNIT 590
             +   L +N  +             V LS N +   I      +++ L  L +S N + 
Sbjct: 227 ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 285

Query: 591 GTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSF 650
             +      I  L+VLDLS N L   +  +  +   L    + +N +  T+      ++ 
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST-HHTL 341

Query: 651 PNSSFEGNP 659
            N +   N 
Sbjct: 342 KNLTLSHND 350

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (338), Expect = 9e-35
 Identities = 62/267 (23%), Positives = 104/267 (38%), Gaps = 33/267 (12%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
             IG G F  VYK        + A    +         + F+ E E L   QH N+V    
Sbjct: 33   EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 831  YCRH---GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
                   G   +++ +  M +G+L       + +  V+K  V     +   +GL +LH  
Sbjct: 93   SWESTVKGKKCIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 887  CEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
              P I+HRD+K  NI +        + D GL+ L R         ++GT  ++ PE  + 
Sbjct: 148  RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYEE 204

Query: 946  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005
                   DVY+FG+ +LE+ T   P   C+        + +++  +   +    D     
Sbjct: 205  -KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFDK---V 254

Query: 1006 KDRE-KQLLEMLEIACKCIDQDPRRRP 1031
               E K+++E       CI Q+   R 
Sbjct: 255  AIPEVKEIIE------GCIRQNKDERY 275

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  134 bits (338), Expect = 4e-34
 Identities = 36/315 (11%), Positives = 72/315 (22%), Gaps = 51/315 (16%)

Query: 758  TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD---CGQMEREFQAE 813
              S L +          +  G   +V+    +      A+K  +                
Sbjct: 53   VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112

Query: 814  VEALSRAQHKNLVSLQGYCR-----------------------HGNDRLLIYSYME---- 846
              A +R   ++    +   R                                  M     
Sbjct: 113  TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV 172

Query: 847  -NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE 905
                L   L                 +     R  A L       +VH      N+ +  
Sbjct: 173  DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMP 229

Query: 906  KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLE 963
                 L D                     + Y P E+  + T T T   + +  G+ +  
Sbjct: 230  DGRLMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285

Query: 964  LLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML-EIACKC 1022
            +     P           LV+   +   ++  + +             L + +  +  + 
Sbjct: 286  VWCLFLPF---------GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336

Query: 1023 IDQDPRRRPFIEEVV 1037
            ++ D RRR    E +
Sbjct: 337  LNFDRRRRLLPLEAM 351

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  136 bits (345), Expect = 6e-34
 Identities = 96/462 (20%), Positives = 178/462 (38%), Gaps = 39/462 (8%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
            T+L + +  +  +    +  L++L++L +S N ++ +        ++LE LDLSHN L 
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA---VFNISNNSFTGKLNSRIWSA 200
                    L   + L++S N+F+ +L    EF N++      +S           I   
Sbjct: 83  KISCHPTVNL---KHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138

Query: 201 SKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 256
           +    +L L   +        LQ  +   SL  +   N      L  S+ ++++L+  ++
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTE-SLHIVFPTNKEFHFILDVSVKTVANLELSNI 197

Query: 257 SVNNFSGQLSEKISNLT-----------SLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 305
                  + S  +S L            +L ++    N F   L  V    T + +F   
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV--WHTTVWYFSIS 255

Query: 306 SNSFSGPLPLSLSLCS-----KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 360
           +    G L       S      L +  + ++    P    +   S++   +   +     
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 361 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 420
                S       L  + N L+  V E+ G LT L  L L  N    LS    +  Q K+
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375

Query: 421 LTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 479
           L  L +++N V  +  +      +SL+ L + +  L   I   L    +++VLDL  N  
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKI 433

Query: 480 DGNIPPWIGQMENLFYLDFSNNTLTGEIPK----SLTELKSL 517
             +IP  + ++E L  L+ ++N L   +P      LT L+ +
Sbjct: 434 K-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKI 473

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  101 bits (253), Expect = 2e-22
 Identities = 82/412 (19%), Positives = 128/412 (31%), Gaps = 42/412 (10%)

Query: 249 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNS 308
                +++S N  S   +  I +L+ LR LII  N+      +V     +LE+     N 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 309 FSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 367
                 +S      L  LDL  N+    PI   F  +S L  L L+T H        ++ 
Sbjct: 81  LVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137

Query: 368 CHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 427
            +  K+L +          E    L      SL      +       +      T   L 
Sbjct: 138 LNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTN--KEFHFILDVSVKTVANLE 193

Query: 428 KNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI 487
            +                 VL    C     I   L    KL  L L+      N    I
Sbjct: 194 LS-------------NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240

Query: 488 GQM---ENLFYLDFSNNTLTG-----EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 539
            Q+     ++Y   SN  L G     +   S T LK+L      S            +  
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300

Query: 540 NRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPEIGQLKHLHVLDLSRNNI 589
           N +      +                     SNN +  T+    G L  L  L L  N +
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

Query: 590 T--GTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQ 638
                I    +++++L+ LD+S N +      G       L   ++++N L 
Sbjct: 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 99.2 bits (247), Expect = 1e-21
 Identities = 55/360 (15%), Positives = 108/360 (30%), Gaps = 25/360 (6%)

Query: 305 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS 364
             N  S      +   SKL +L + +N +       F     L  LDL+ N       + 
Sbjct: 29  SQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHP 88

Query: 365 LSDCHDLKILSLAKNEL-SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 423
             +   LK L L+ N   +  + + FG ++ L FL LS         ++  +        
Sbjct: 89  TVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE--KSSVLPIAHLNISKV 143

Query: 424 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGN- 482
           L++     GE+      G +     +L           ++L      V +L  ++     
Sbjct: 144 LLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVL 201

Query: 483 ----------IPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAG 532
                     I   +     L  L  +N   T      + +L    +    S +     G
Sbjct: 202 EDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQG 261

Query: 533 IPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGT 592
              +   + S   L             + ++              ++++ + + +     
Sbjct: 262 QLDFRDFDYSGTSLKALSIHQ------VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 593 IPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 652
                S+I     LD S+N L  ++  +   LT L    +  N L+             +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 4/93 (4%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
           +S N I+     +I  L  L +L +S N I     S     + LE LDLS N L   I  
Sbjct: 28  ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS- 85

Query: 620 SFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 652
                  L    ++ N     +P   +F +   
Sbjct: 86  -CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQ 116

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 18/82 (21%), Positives = 36/82 (43%), Gaps = 3/82 (3%)

Query: 557 SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 616
            V  S N +   +P ++   +   +L++S+N I+    S I  +  L +L +S N +   
Sbjct: 4   LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60

Query: 617 IPGSFEKLTFLSKFSVANNHLQ 638
               F+    L    +++N L 
Sbjct: 61  DISVFKFNQELEYLDLSHNKLV 82

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  130 bits (328), Expect = 2e-33
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK----RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G GG   VY A       K A+K            ++R F+ EV   S+  H+N+VS+ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77

Query: 830 GYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
                  +    Y  ME   G     L E ++    L  D  +        G+ + H + 
Sbjct: 78  DV---DEEDDCYYLVMEYIEGPT---LSEYIESHGPLSVDTAINFTNQILDGIKHAHDM- 130

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQT 945
              IVHRD+K  NIL+D      + DFG+++ L   +T +T    ++GT+ Y  PE ++ 
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 946 LTATCRGDVYSFGVVLLELLTGRRP 970
                  D+YS G+VL E+L G  P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (329), Expect = 2e-33
 Identities = 61/278 (21%), Positives = 103/278 (37%), Gaps = 23/278 (8%)

Query: 764  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREF-QAEVEALSR 819
             +  NF     IG G F  VY+A  L +G   A+K  ++        R     E++ L +
Sbjct: 29   NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88

Query: 820  AQHKNLVSLQGYCRHGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
              H N++         ++ L I     + G L   +     +  ++      K       
Sbjct: 89   LNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147

Query: 879  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
             L ++H      ++HRD+K +N+ +       L D GL R      T   + LVGT  Y+
Sbjct: 148  ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYM 203

Query: 939  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
             PE         + D++S G +L E+   + P       N   L   + Q        + 
Sbjct: 204  SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY-GDKMNLYSLCKKIEQCDYPPLPSDH 262

Query: 999  IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                +      +QL+        CI+ DP +RP +  V
Sbjct: 263  YSEEL------RQLVN------MCINPDPEKRPDVTYV 288

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (329), Expect = 2e-33
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL- 828
           +G GG   V+ A  L +    AVK     L+ D     R F+ E +  +   H  +V++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78

Query: 829 -QGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
             G         L Y  ME  +G     L + V  +  +     +++   A + L + H+
Sbjct: 79  DTG-EAETPAGPLPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 134

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYS 943
                I+HRDVK +NI++       + DFG++R +      VT    ++GT  Y+ PE +
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
           +  +   R DVYS G VL E+LTG  P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  130 bits (328), Expect = 3e-33
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 39/292 (13%)

Query: 773  NIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 826
              +G G FG V            G + AVK L  + G     + + E+E L    H+N+V
Sbjct: 27   RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 827  SLQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
              +G C         LI  ++ +GSL  +L ++ +K   +    +LK A    +G+ YL 
Sbjct: 87   KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLG 143

Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP----- 939
                   VHRD+ + N+L++ + +  + DFGL++ +   D    T  V      P     
Sbjct: 144  ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYT--VKDDRDSPVFWYA 197

Query: 940  PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 999
            PE           DV+SFGV L ELLT             + +     QM        ++
Sbjct: 198  PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT----RLV 253

Query: 1000 DASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            +       +E + L        E+ ++  KC +  P  R   + ++   + +
Sbjct: 254  N-----TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  128 bits (324), Expect = 4e-33
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 20/205 (9%)

Query: 773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 831
             IG G FGLV+     N  K A+K +      M  E F  E E + +  H  LV L G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
           C       L+  +ME+G L  +L        +   +  L +      G+AYL    E  +
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYL---EEACV 125

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 946
           +HRD+ + N L+ E     ++DFG++R +   D   T+   GT    P     PE     
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSS-TGTK--FPVKWASPEVFSFS 180

Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             + + DV+SFGV++ E+ + G+ P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  128 bits (324), Expect = 4e-33
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)

Query: 773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
             IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 833 RHGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                 L I + YM  GSL  +L       SVL  D  LK +      + YL      + 
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 946
           VHRD+ + N+L+ E   A ++DFGL++     +   T       G +P     PE  +  
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQ----DTGKLPVKWTAPEALREK 189

Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             + + DV+SFG++L E+ + GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  128 bits (325), Expect = 5e-33
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 773 NIIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            +IG G FG VY  TL +        AVK L+      E  +F  E   +    H N++S
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 828 LQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           L G C R     L++  YM++G L  ++       +V      +      A+G+ YL   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLA-- 145

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 941
                VHRD+ + N +LDEKF   +ADFGL+R +  YD    +    T   +P      E
Sbjct: 146 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALE 202

Query: 942 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
             QT   T + DV+SFGV+L EL+T G  P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  128 bits (324), Expect = 5e-33
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 20/205 (9%)

Query: 773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 831
             +G G FG+V           A+K +      M  + F  E + +    H+ LV L G 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
           C       +I  YM NG L  +L E        +    L++ +     + YL        
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QF 141

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 946
           +HRD+ + N L++++    ++DFGLSR +   D   T+  VG+    P     PE     
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSK--FPVRWSPPEVLMYS 196

Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             + + D+++FGV++ E+ + G+ P
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMP 221

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  134 bits (339), Expect = 7e-33
 Identities = 84/520 (16%), Positives = 160/520 (30%), Gaps = 79/520 (15%)

Query: 74  HGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLE 133
            G          ++      ++ +    L    Q++LL+L+   +E +     +    ++
Sbjct: 43  FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQ 102

Query: 134 VLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKL 193
            L +  N +      +   + L+  L +  N  +               ++    F    
Sbjct: 103 KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS---------------SLPRGIFHN-- 145

Query: 194 NSRIWSASKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMS 249
                  + ++  L +S N+       + Q      SL+ L + +N L   +  SL  + 
Sbjct: 146 -------TPKLTTLSMSNNNLERIEDDTFQAT---TSLQNLQLSSNRL-THVDLSL--IP 192

Query: 250 SLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 309
           SL H ++S N  S      ++   ++  L    N  +     V   LT L+      N+ 
Sbjct: 193 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKL---QHNNL 244

Query: 310 SGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH 369
           +      L     L  +DL  N L   +   F  +  L  L ++ N     L        
Sbjct: 245 T-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 301

Query: 370 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
            LK+L L+ N L   V  +  +   L  L L +NS   L      L     L  L L+ N
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK-----LSTHHTLKNLTLSHN 355

Query: 430 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWN-HFDGNIPPWIG 488
                                 +C     +   + R     V D   +   D  +   + 
Sbjct: 356 DW--------------------DCNSLRALFRNVAR---PAVDDADQHCKIDYQLEHGLC 392

Query: 489 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 548
             E+     + +  L      S+ E        C++++   S  +     +     G+P 
Sbjct: 393 CKESD--KPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINS--VQSLSHYITQQGGVPL 448

Query: 549 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNN 588
                    V      +      +I Q + L  L    + 
Sbjct: 449 QGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDT 488

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  132 bits (333), Expect = 4e-32
 Identities = 67/425 (15%), Positives = 126/425 (29%), Gaps = 87/425 (20%)

Query: 241 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 300
           +  +L        V + +         +   L + + +    +        +L +  Q+E
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 301 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 360
                                   +L+L +  +       F+   ++  L +  N     
Sbjct: 79  ------------------------LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL 114

Query: 361 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 420
            P+   +   L +L L +N+LS      F     L  LS+SNN+   +       Q   +
Sbjct: 115 PPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED--DTFQATTS 172

Query: 421 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD 480
           L  L L+ N +   +        SL    +    L       L     ++ LD S N  +
Sbjct: 173 LQNLQLSSNRL-THVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224

Query: 481 GNIPPWIGQMENLFYLDFSNNTLTGEIP--KSLTELKSLISSNCTSSNPTASAGIPLYVK 538
             +         L  L   +N LT +     +   L  +                     
Sbjct: 225 -VVRG--PVNVELTILKLQHNNLT-DTAWLLNYPGLVEV--------------------- 259

Query: 539 HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI 597
                                LS N +   I      +++ L  L +S N +   +    
Sbjct: 260 --------------------DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297

Query: 598 SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEG 657
             I  L+VLDLS N L   +  +  +   L    + +N +  T+      ++  N +   
Sbjct: 298 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKNLTLSH 354

Query: 658 NPGLC 662
           N   C
Sbjct: 355 NDWDC 359

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (323), Expect = 9e-33
 Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 20/210 (9%)

Query: 773 NIIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            +IG G FG+VY     +      + A+K LS      +   F  E   +    H N+++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 828 LQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           L G          ++  YM +G L  ++               +      ARG+ YL   
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLA-- 141

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 941
            E   VHRD+ + N +LDE F   +ADFGL+R +   D    +        +P      E
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKWTALE 198

Query: 942 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
             QT   T + DV+SFGV+L ELLT G  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  132 bits (334), Expect = 1e-32
 Identities = 65/258 (25%), Positives = 109/258 (42%), Gaps = 22/258 (8%)

Query: 773  NIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQG 830
            + +G G +G VY+          AVK L  D   ME E F  E   +   +H NLV L G
Sbjct: 226  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 831  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
             C       +I  +M  G+L  +L E       +   V L +A   +  + YL    + +
Sbjct: 284  VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKN 338

Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTA 948
             +HR++ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       
Sbjct: 339  FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 396

Query: 949  TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK---REVEIIDASIW 1004
            + + DV++FGV+L E+ T G  P          +L+   ++M+  +    +V  +  + W
Sbjct: 397  SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 456

Query: 1005 HKDREK-----QLLEMLE 1017
              +        ++ +  E
Sbjct: 457  QWNPSDRPSFAEIHQAFE 474

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  127 bits (321), Expect = 1e-32
 Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 20/204 (9%)

Query: 774 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 832
            +G G FG+V           AVK +      M  + F  E + + +  H  LV   G C
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 833 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                  ++  Y+ NG L  +L         L+    L++      G+A+L        +
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126

Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTLT 947
           HRD+ + N L+D      ++DFG++R +   D    +  VGT    P     PE      
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSS-VGTK--FPVKWSAPEVFHYFK 181

Query: 948 ATCRGDVYSFGVVLLELLT-GRRP 970
            + + DV++FG+++ E+ + G+ P
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP 205

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  126 bits (320), Expect = 1e-32
 Identities = 69/279 (24%), Positives = 111/279 (39%), Gaps = 28/279 (10%)

Query: 767  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQM---EREF-QAEVEALSRAQ 821
             ++     IG G +G   K    ++G     K L  D G M   E++   +EV  L   +
Sbjct: 6    EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELK 63

Query: 822  HKNLVSLQG-YCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
            H N+V          N  L I   Y E G L   + +   +   L  +  L++       
Sbjct: 64   HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 880  LAYLH--KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            L   H        ++HRD+K +N+ LD K    L DFGL+R+L   DT      VGT  Y
Sbjct: 124  LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVGTPYY 182

Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
            + PE    ++   + D++S G +L EL     P       + ++L       K  + +  
Sbjct: 183  MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELA-----GKIREGKFR 234

Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
             I    +         E+ EI  + ++     RP +EE+
Sbjct: 235  RIP-YRYSD-------ELNEIITRMLNLKDYHRPSVEEI 265

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  127 bits (320), Expect = 2e-32
 Identities = 66/268 (24%), Positives = 110/268 (41%), Gaps = 53/268 (19%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQ 821
           +   +F +  +IG GGFG V+KA    +G    +KR+     +   E  + EV+AL++  
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLD 62

Query: 822 HKNLVSLQGY---------------CRHGNDRLLIY-SYMENGSLDYWLH----ESVDKD 861
           H N+V   G                 R     L I   + + G+L+ W+     E +DK 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 862 SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 921
             L+        Q   +G+ Y+H      +++RD+K SNI L +  +  + DFGL   L+
Sbjct: 123 LALEL-----FEQ-ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173

Query: 922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP--------VEV 973
                  +   GTL Y+ PE   +       D+Y+ G++L ELL              ++
Sbjct: 174 NDGKRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231

Query: 974 CKGK-------NCRDLVSWVFQMKSEKR 994
             G          + L+  +   K E R
Sbjct: 232 RDGIISDIFDKKEKTLLQKLLSKKPEDR 259

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  127 bits (322), Expect = 2e-32
 Identities = 62/205 (30%), Positives = 83/205 (40%), Gaps = 21/205 (10%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK----RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
           +G GG G VY+A         A+K     LS D     R  Q E     R Q  ++V + 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVVPIH 100

Query: 830 GYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
            +   G     +Y  M   NG     L   + +   L     + I +     L   H   
Sbjct: 101 DF---GEIDGQLYVDMRLINGVD---LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT--DLVGTLGYIPPEYSQT 945
                HRDVK  NIL+     A+L DFG++      D  +T   + VGTL Y+ PE    
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSE 209

Query: 946 LTATCRGDVYSFGVVLLELLTGRRP 970
             AT R D+Y+   VL E LTG  P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  127 bits (322), Expect = 2e-32
 Identities = 65/283 (22%), Positives = 104/283 (36%), Gaps = 43/283 (15%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME--REFQAEVEALSRAQHKNLVSLQGY 831
            +G GGF  V     L +G   A+KR+   C + +   E Q E +      H N++ L  Y
Sbjct: 37   LGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 832  CRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
            C           L+  + + G+L   +    DK + L  D  L +  G  RGL  +H   
Sbjct: 95   CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152

Query: 888  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL--------VGTLGYIP 939
                 HRD+K +NILL ++ +  L D G       +       L          T+ Y  
Sbjct: 153  -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 940  PE----YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
            PE     S       R DV+S G VL  ++ G  P                + M  +K +
Sbjct: 212  PELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGP----------------YDMVFQKGD 254

Query: 996  VE--IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                 +   +      +    + ++    +  DP +RP I  +
Sbjct: 255  SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  127 bits (322), Expect = 3e-32
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 23/210 (10%)

Query: 773 NIIGCGGFGLVYKATLTNGTKA-----AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 826
            ++G G FG VYK       +      A+K L          E   E   ++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            L G C   +   LI   M  G L  ++ E  D    +     L      A+G+ YL   
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE-- 134

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 941
            +  +VHRD+ + N+L+       + DFGL++LL   +           G +P      E
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALE 189

Query: 942 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                  T + DV+S+GV + EL+T G +P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (319), Expect = 3e-32
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 20/206 (9%)

Query: 775 IGCGGFGLVYKATLTNGTKA---AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 830
           +GCG FG V +       K    A+K L     + +  E   E + + +  +  +V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
            C+     +L+      G L  +L     K   +      ++    + G+ YL    E +
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQT 945
            VHRD+ + N+LL  +  A ++DFGLS+ L   D++ T     + G  P     PE    
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA---RSAGKWPLKWYAPECINF 187

Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
              + R DV+S+GV + E L+ G++P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  133 bits (335), Expect = 3e-32
 Identities = 62/365 (16%), Positives = 114/365 (31%), Gaps = 87/365 (23%)

Query: 249 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNS 308
           +    +++  +  +  L + +     +  L+I  N  +  LP +   L  LE      N 
Sbjct: 40  NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLEV---SGNQ 92

Query: 309 FSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC 368
            +  LP+      +L +       L        +  S LC L +  N  +  LP      
Sbjct: 93  LTS-LPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTS-LPVLPPG- 142

Query: 369 HDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK 428
             L+ LS++ N+L+  +P    +L  L      NN    L    S       L  L ++ 
Sbjct: 143 --LQELSVSDNQLA-SLPALPSELCKL---WAYNNQLTSLPMLPS------GLQELSVSD 190

Query: 429 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 488
           N +   +P        L      N  L   +P        L+ L +S N    ++P    
Sbjct: 191 NQL-ASLPTLPSELYKLWAY---NNRLT-SLPALP---SGLKELIVSGNRL-TSLPVLPS 241

Query: 489 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 548
           +++ L     S N LT  +P   + L SL                               
Sbjct: 242 ELKEL---MVSGNRLT-SLPMLPSGLLSL------------------------------- 266

Query: 549 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 608
                      +  N++   +P  +  L     ++L  N ++         +R +     
Sbjct: 267 ----------SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQA--LREITSAPG 312

Query: 609 SSNDL 613
            S  +
Sbjct: 313 YSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (331), Expect = 1e-31
 Identities = 71/351 (20%), Positives = 124/351 (35%), Gaps = 74/351 (21%)

Query: 315 LSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKIL 374
           +   L +   VL++  + LT    L     + + TL +  N+ +  LP       +L+ L
Sbjct: 34  MRACLNNGNAVLNVGESGLT---TLPDCLPAHITTLVIPDNNLTS-LPALPP---ELRTL 86

Query: 375 SLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEE 434
            ++ N+L+  +P     L     LS+ +N   HL    S       L  L +  N +   
Sbjct: 87  EVSGNQLT-SLPVLPPGLLE---LSIFSNPLTHLPALPS------GLCKLWIFGNQL-TS 135

Query: 435 IPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLF 494
           +P        L  L++ +  L   +P       +L  L    N    ++P        L 
Sbjct: 136 LPVL---PPGLQELSVSDNQLA-SLPALP---SELCKLWAYNNQLT-SLPMLPS---GLQ 184

Query: 495 YLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF 554
            L  S+N L   +P   +EL  L + N                           N+ +S 
Sbjct: 185 ELSVSDNQLA-SLPTLPSELYKLWAYN---------------------------NRLTSL 216

Query: 555 PPSV------FLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 608
           P          +S NR+  ++P    +LK    L +S N +T ++P   S    L  L +
Sbjct: 217 PALPSGLKELIVSGNRLT-SLPVLPSELKE---LMVSGNRLT-SLPMLPS---GLLSLSV 268

Query: 609 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNP 659
             N L   +P S   L+  +  ++  N L  +  T        ++     P
Sbjct: 269 YRNQLT-RLPESLIHLSSETTVNLEGNPL--SERTLQALREITSAPGYSGP 316

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  125 bits (314), Expect = 1e-29
 Identities = 75/327 (22%), Positives = 124/327 (37%), Gaps = 52/327 (15%)

Query: 105 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 164
            N   +L++  + L   +P  L     +  L +  N L+  +  +   L   ++L VS N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALPPEL---RTLEVSGN 91

Query: 165 SFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH 223
               SL         L++F+          +         +  L +  N     L  L  
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPSG--------LCKLWIFGNQ----LTSLPV 138

Query: 224 S-PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFG 282
             P L++L V +N L   LP      S L  +    N  +  L    S L  L    +  
Sbjct: 139 LPPGLQELSVSDNQL-ASLPALP---SELCKLWAYNNQLT-SLPMLPSGLQELS---VSD 190

Query: 283 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFS 342
           NQ +  LP +   L +L    A++N  +  LP   +L S L  L +  N LT    L   
Sbjct: 191 NQLA-SLPTLPSELYKLW---AYNNRLT-SLP---ALPSGLKELIVSGNRLTSLPVL--- 239

Query: 343 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN 402
             S L  L ++ N  +  LP   S    L  LS+ +N+L+ ++PES   L+S   ++L  
Sbjct: 240 -PSELKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293

Query: 403 NSFNHLSGTLSVLQQCKNLTTLILTKN 429
           N  +  +      Q  + +T+      
Sbjct: 294 NPLSERTL-----QALREITSAPGYSG 315

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  120 bits (303), Expect = 3e-28
 Identities = 82/356 (23%), Positives = 124/356 (34%), Gaps = 50/356 (14%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
            +L +   GL   +P  L     +  L +  N+L   +P     L+    L++S N L+ 
Sbjct: 43  AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TLEVSGNQLTS 95

Query: 145 -PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 203
            PV     GL  +   +                S L    I  N  T      +      
Sbjct: 96  LPVL--PPGLLELSIFSNPLTHLPALP------SGLCKLWIFGNQLT-----SLPVLPPG 142

Query: 204 IQILDLSMNHFMGSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 262
           +Q L +S N     L  L   P  L +L   NN L   LP      S LQ +S+S N  +
Sbjct: 143 LQELSVSDNQ----LASLPALPSELCKLWAYNNQLT-SLPMLP---SGLQELSVSDNQLA 194

Query: 263 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 322
             L    S L  L     + N+ +  LP +   L +L       N  +  LP+  S   +
Sbjct: 195 -SLPTLPSELYKLW---AYNNRLT-SLPALPSGLKELI---VSGNRLTS-LPVLPS---E 242

Query: 323 LHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 381
           L  L +  N LT  P        S L +L +  N  +  LP SL        ++L  N L
Sbjct: 243 LKELMVSGNRLTSLP-----MLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPL 296

Query: 382 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQC-KNLTTLILTKNFVGEEIP 436
           S +  ++  ++TS    S     F+    +     +         L     GE  P
Sbjct: 297 SERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  113 bits (285), Expect = 4e-26
 Identities = 73/347 (21%), Positives = 117/347 (33%), Gaps = 50/347 (14%)

Query: 177 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPS-LKQLHVDNN 235
           +  AV N+  +  T  L   +      I  L +  N    +L  L   P  L+ L V  N
Sbjct: 40  NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDN----NLTSLPALPPELRTLEVSGN 91

Query: 236 LLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGN 295
            L   LP     +  L   S  + +         +  + L  L IFGNQ +  LP +   
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVLPPG 142

Query: 296 LTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLAT 354
           L +L       N  +  LP   S   +L  L   NN LT  P        S L  L ++ 
Sbjct: 143 LQELSV---SDNQLAS-LPALPS---ELCKLWAYNNQLTSLP-----MLPSGLQELSVSD 190

Query: 355 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSV 414
           N  +  LP   S+   L  L    N L+  +P     L  L    +S N    L    S 
Sbjct: 191 NQLAS-LPTLPSE---LYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRLTSLPVLPS- 241

Query: 415 LQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDL 474
                 L  L+++ N +   +P        L+ L++    L   +P  L+       ++L
Sbjct: 242 -----ELKELMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291

Query: 475 SWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSN 521
             N         + ++ +                 +  E ++L  + 
Sbjct: 292 EGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA 338

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  130 bits (328), Expect = 4e-32
 Identities = 85/473 (17%), Positives = 165/473 (34%), Gaps = 58/473 (12%)

Query: 105 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 164
                         +    +    L  L  LD  ++ ++  ++G +  L  +  L  +SN
Sbjct: 20  FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTSN 74

Query: 165 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 224
           +      +L + +NL      +N    KL +   +   ++  L+   N     L  LD S
Sbjct: 75  NITT--LDLSQNTNLTYLACDSN----KLTNLDVTPLTKLTYLNCDTNK----LTKLDVS 124

Query: 225 --PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFG 282
             P L  L+   N L  ++  S    + L  +   +N    +L   ++  T L  L    
Sbjct: 125 QNPLLTYLNCARNTL-TEIDVS--HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179

Query: 283 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFS 342
           N+ + +L   +     L      +N+ +    L L+   +L  LD  +N LT   +++ +
Sbjct: 180 NKIT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT---EIDVT 230

Query: 343 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN 402
            L+ L   D + N  +  L   +S    L  L   + +L           T L++     
Sbjct: 231 PLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEG 284

Query: 403 NSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVW 462
                       +     L  L      +  E+   +     L+ L L N  L   +   
Sbjct: 285 CRKI----KELDVTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT-ELD-- 334

Query: 463 LLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNC 522
           +    KL+ L     H   +    +G++  L     +       +PK      SL  +  
Sbjct: 335 VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSL--TIA 389

Query: 523 TSSNPTASAGIPLYVK------HNRSTNGLPYNQASSFPPSVFLSNNRINGTI 569
            S +     G P+ ++      ++++TN + +   S+  P+V  +    NG I
Sbjct: 390 VSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAI 442

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  129 bits (325), Expect = 1e-31
 Identities = 78/408 (19%), Positives = 134/408 (32%), Gaps = 56/408 (13%)

Query: 251 LQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS 310
                 +        +     L +L  L    +  +  +   +  LT L   +  SN+ +
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77

Query: 311 GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHD 370
               L LS  + L  L   +N LT   +L+ + L+ L  L+  TN  +      +S    
Sbjct: 78  T---LDLSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLT---KLDVSQNPL 128

Query: 371 LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 430
           L  L+ A+N L+          T L  L    N       T   +     LTTL  + N 
Sbjct: 129 LTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKI----TKLDVTPQTQLTTLDCSFNK 181

Query: 431 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM 490
           +  E+   V   + L  L      +   +   L +  +L  LD S N     I   +  +
Sbjct: 182 I-TELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPL 232

Query: 491 ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 550
             L Y D S N LT     +L++L +L                            L    
Sbjct: 233 TQLTYFDCSVNPLTELDVSTLSKLTTLHCIQ----------------------TDLLEID 270

Query: 551 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSS 610
            +     ++            ++     L++LD     IT  +   +S+   L  L L++
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNN 327

Query: 611 NDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGN 658
            +L   +       T L   S  N H+Q    + G+  +  N+     
Sbjct: 328 TELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEG 371

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  128 bits (323), Expect = 2e-31
 Identities = 76/452 (16%), Positives = 149/452 (32%), Gaps = 47/452 (10%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 138
                +T L      +  +    +  L  L  L  + N++     ++LS    L  L   
Sbjct: 39  EQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACD 93

Query: 139 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 198
            N L+   +  +  L  +  LN  +N       ++ +   L   N + N     L     
Sbjct: 94  SNKLT---NLDVTPLTKLTYLNCDTNKLTK--LDVSQNPLLTYLNCARN----TLTEIDV 144

Query: 199 SASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 258
           S + ++  LD  +N  +  L  +     L  L    N +  +L   +     L  ++   
Sbjct: 145 SHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFNKI-TELD--VSQNKLLNRLNCDT 200

Query: 259 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 318
           NN +      ++    L  L    N+ + ++   +  LTQL +F    N  +    L +S
Sbjct: 201 NNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVS 251

Query: 319 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
             SKL  L      L    +++ +  + L             L   ++    L +L    
Sbjct: 252 TLSKLTTLHCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQA 306

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 438
             ++        +   L++L L+N     L      +     L +L      + ++    
Sbjct: 307 AGIT---ELDLSQNPKLVYLYLNNTELTELD-----VSHNTKLKSLSCVNAHI-QDFSS- 356

Query: 439 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 498
           VG   +L             +P   L    L  + +S +  D    P   +  +    D 
Sbjct: 357 VGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQ 414

Query: 499 SNNTLTGEIPKSLTELKSLISSNCTSSNPTAS 530
           + NT+T    ++L+     ++   TS N    
Sbjct: 415 ATNTIT---WENLSTDNPAVTYTFTSENGAIV 443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  125 bits (317), Expect = 9e-31
 Identities = 72/479 (15%), Positives = 147/479 (30%), Gaps = 77/479 (16%)

Query: 202 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
             +  LD   +     + G++    L +L   +N +   L  S    ++L +++   N  
Sbjct: 42  ATLTSLDCHNSSI-TDMTGIEKLTGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKL 97

Query: 262 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCS 321
           +   +  ++ LT L +L    N+ + KL   +     L +     N+ +    + +S  +
Sbjct: 98  T---NLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNT 148

Query: 322 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 381
           +L  LD   N     +D   +  + L TLD + N  +      +S    L  L+   N +
Sbjct: 149 QLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI 203

Query: 382 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG 441
           +        +   L FL  S+N    +      +     LT    + N +  E+   V  
Sbjct: 204 TKL---DLNQNIQLTFLDCSSNKLTEID-----VTPLTQLTYFDCSVNPL-TELD--VST 252

Query: 442 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 501
              L  L      L   I   L    +L             +   +     L+ LD    
Sbjct: 253 LSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAA 307

Query: 502 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPS---- 557
            +T        +L  L  +N                            + +    S    
Sbjct: 308 GITELDLSQNPKLVYLYLNN---------------------------TELTELDVSHNTK 340

Query: 558 ---VFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIR-----NLEVLDLS 609
              +   N  I       +G++  L+    +          +++        + ++LD  
Sbjct: 341 LKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398

Query: 610 SNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSP 668
            N +  +I      +   +  ++   +L    P     ++  N +  G      E   P
Sbjct: 399 GNPM--NIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEAPQP 455

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  127 bits (320), Expect = 4e-32
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 26/217 (11%)

Query: 773 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 825
             +G G FG VY+  ++         + AVK L   C + +  +F  E   +S+  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGLAY 882
           V   G       R ++   M  G L  +L E+     + S L     L +A+  A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L    E H +HRD+ + N LL       +    DFG++R +  Y         G    +P
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYR--KGGCAMLP 208

Query: 940 -----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                PE       T + D +SFGV+L E+ + G  P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  128 bits (323), Expect = 5e-32
 Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 773 NIIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            +IG G FG VY  TL +        AVK L+      E  +F  E   +    H N++S
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 828 LQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           L G C R     L++  YM++G L  ++       +V      +      A+G+ +L   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLA-- 209

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 941
                VHRD+ + N +LDEKF   +ADFGL+R +  YD    +    T   +P      E
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTGAKLPVKWMALE 266

Query: 942 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
             QT   T + DV+SFGV+L EL+T G  P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  129 bits (325), Expect = 8e-32
 Identities = 72/257 (28%), Positives = 112/257 (43%), Gaps = 22/257 (8%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 831
              +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L   
Sbjct: 190  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                    ++  YM  GSL  +L         L+    + +A   A G+AY+ ++   + 
Sbjct: 248  V-SEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 301

Query: 892  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY--IPPEYSQTLTAT 949
            VHRD++++NIL+ E     +ADFGL+RL+   D   T             PE +     T
Sbjct: 302  VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 950  CRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK---REVEIIDASIWH 1005
             + DV+SFG++L EL T GR P      +   D V   ++M         +  +    W 
Sbjct: 360  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 419

Query: 1006 KDREK-----QLLEMLE 1017
            K+ E+      L   LE
Sbjct: 420  KEPEERPTFEYLQAFLE 436

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  127 bits (321), Expect = 8e-32
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 24/211 (11%)

Query: 773 NIIGCGGFGLVYKATLTNGTKA----AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            ++G G FG V    L   +K     A+K L     + +R +F  E   + +  H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L+G        +++  YMENGSLD +L +    D+       + + +G A G+ YL    
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLS--- 164

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIP-----P 940
           +   VHRD+ + NIL++      ++DFGL R+L   P   + T       G IP     P
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG-----GKIPIRWTSP 219

Query: 941 EYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
           E       T   DV+S+G+VL E+++ G RP
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  126 bits (318), Expect = 9e-32
 Identities = 69/292 (23%), Positives = 108/292 (36%), Gaps = 40/292 (13%)

Query: 773  NIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 827
            + +G G FG V            G   AVK+L       +R+FQ E++ L       +V 
Sbjct: 29   SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 828  LQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
             +G       +   L+  Y+ +G L  +L     +   L     L  +    +G+ YL  
Sbjct: 89   YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLG- 144

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----P 940
                  VHRD+ + NIL++ +    +ADFGL++LL     +     V   G  P     P
Sbjct: 145  --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV---VREPGQSPIFWYAP 199

Query: 941  EYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 999
            E       + + DV+SFGVVL EL T   +    C        +    +       +   
Sbjct: 200  ESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---CSPSAEFLRMMGCERDVPALSRL--- 253

Query: 1000 DASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                     E Q L        E+ E+   C    P+ RP    +   LD +
Sbjct: 254  ----LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (324), Expect = 1e-31
 Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 24/205 (11%)

Query: 773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
             IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 833 RHGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                 L I + YM  GSL  +L       SVL  D  LK +      + YL      + 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 946
           VHRD+ + N+L+ E   A ++DFGL++         ++        +P     PE  +  
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGK--LPVKWTAPEALREK 361

Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
             + + DV+SFG++L E+ + GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  124 bits (314), Expect = 2e-31
 Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 43/226 (19%)

Query: 775 IGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           +G G FG V+ A   N +        AVK L        ++FQ E E L+  QH+++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWL------------HESVDKDSVLKWDVRLKIAQGA 876
            G C  G+  ++++ YM++G L+ +L             +       L     L IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
           A G+ YL      H VHRD+ + N L+       + DFG+SR +  Y T      VG   
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYR--VGGHT 195

Query: 937 YIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
            +P     PE      +      T   DV+SFGV+L E+ T G++P
Sbjct: 196 MLPIRWMPPESIMYRKF------TTESDVWSFGVILWEIFTYGKQP 235

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  126 bits (318), Expect = 2e-31
 Identities = 46/308 (14%), Positives = 85/308 (27%), Gaps = 73/308 (23%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLS-------GDCGQMERE---------------- 809
            ++G        +AT    G    V               QM+ E                
Sbjct: 80   VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 810  -----FQAEVEALSRAQHKNLVSLQGYCRHGN--DRLLIYSYMENGSLDY--WLHESVDK 860
                 F    + +   Q K ++ ++   R      R  +Y  M++    +   L      
Sbjct: 140  KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 861  DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL 920
               L    RL++     R LA LH      +VH  ++  +I+LD++    L  F      
Sbjct: 200  HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 921  RPYDTHVTTDLVGTLGYIPPEY-----------SQTLTATCRGDVYSFGVVLLELLTGRR 969
                         + G+ PPE             +    T   D ++ G+V+  +     
Sbjct: 257  -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 970  PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1029
            P+             W+F+          I   +      + LL         +      
Sbjct: 312  PIT---KDAALGGSEWIFRSCKN------IPQPV------RALL------EGFLRYPKED 350

Query: 1030 RPFIEEVV 1037
            R    + +
Sbjct: 351  RLLPLQAM 358

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  125 bits (315), Expect = 2e-31
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 23/210 (10%)

Query: 773 NIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 826
            ++G G FG V+K        +      +K +    G+         + A+    H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            L G C  G+   L+  Y+  GSL   + +       L   + L      A+G+ YL   
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLE-- 132

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 941
            E  +VHR++ + N+LL    +  +ADFG++ LL P D  +      +    P      E
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY----SEAKTPIKWMALE 187

Query: 942 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                  T + DV+S+GV + EL+T G  P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  126 bits (317), Expect = 2e-31
 Identities = 77/346 (22%), Positives = 131/346 (37%), Gaps = 64/346 (18%)

Query: 721  GCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGF 780
            G  +++L+ D  + +RL          L Q     +L   D  K        + +G G  
Sbjct: 1    GKKLEELELDEQQRKRLEA-------FLTQKQKVGELKDDDFEK-------ISELGAGNG 46

Query: 781  GLVYKATLT-NGTKAAVKRLSGDCGQMEREF-QAEVEALSRAQHKNLVSLQGYCRHGNDR 838
            G+V+K +   +G   A K +  +     R     E++ L       +V   G      + 
Sbjct: 47   GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106

Query: 839  LLIYSYMENGSLDYWLHESVDKDSVLKWDVRL------KIAQGAARGLAYLHKVCEPHIV 892
             +   +M+ GSLD           VLK   R+      K++    +GL YL +  +  I+
Sbjct: 107  SICMEHMDGGSLD----------QVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 154

Query: 893  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
            HRDVK SNIL++ + E  L DFG+S  L   D+   +  VGT  Y+ PE  Q    + + 
Sbjct: 155  HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGTHYSVQS 211

Query: 953  DVYSFGVVLLELLTGRRPVEVCKGKN------CRDLVSWVFQMKSEKREVEIIDASIWHK 1006
            D++S G+ L+E+  GR P+     K       C+            +     ++      
Sbjct: 212  DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271

Query: 1007 DREKQLLEMLEIACK---------------------CIDQDPRRRP 1031
                 + E+L+                         C+ ++P  R 
Sbjct: 272  RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  124 bits (313), Expect = 2e-31
 Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 37/291 (12%)

Query: 773  NIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 827
              +G G FG V            G   AVK+L     +  R+F+ E+E L   QH N+V 
Sbjct: 16   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 828  LQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
             +G C     R   LI  Y+  GSL  +L +  ++   +     L+      +G+ YL  
Sbjct: 76   YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 131

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----P 940
                  +HRD+ + NIL++ +    + DFGL+++L P D       V   G  P     P
Sbjct: 132  --TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFK--VKEPGESPIFWYAP 186

Query: 941  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
            E       +   DV+SFGVVL EL T     +    +  R + +           +E++ 
Sbjct: 187  ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL- 245

Query: 1001 ASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                   +    L        E+  I  +C + +  +RP   ++   +D I
Sbjct: 246  -------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (311), Expect = 2e-31
 Identities = 68/205 (33%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 831
             +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                   +I  YMENGSL  +L         L  +  L +A   A G+A++    E + 
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 946
           +HRD++++NIL+ +     +ADFGL+RL+   D   T          P     PE     
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAK---FPIKWTAPEAINYG 185

Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
           T T + DV+SFG++L E++T GR P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  124 bits (314), Expect = 3e-31
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 773 NIIGCGGFGLVYKATLT----NGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
            IIG G  G V    L          A+K L     + +R +F +E   + +  H N++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L+G    G   +++  YMENGSLD +L     +         + + +G   G+ YL    
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLS--- 168

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIP-----P 940
           +   VHRD+ + N+L+D      ++DFGLSR+L   P   + TT      G IP     P
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG-----GKIPIRWTAP 223

Query: 941 EYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
           E     T +   DV+SFGVV+ E+L  G RP
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (315), Expect = 3e-31
 Identities = 64/282 (22%), Positives = 113/282 (40%), Gaps = 37/282 (13%)

Query: 764  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQM---EREF-QAEVEALS 818
            +S   + +   IG G FG         +G +  +K +  +  +M   ERE  + EV  L+
Sbjct: 21   QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLA 78

Query: 819  RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWL----HESVDKDSVLKWDVRLKIAQ 874
              +H N+V  +          ++  Y E G L   +         +D +L W       Q
Sbjct: 79   NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-----FVQ 133

Query: 875  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
                 L ++H   +  I+HRD+KS NI L +     L DFG++R+L      +    +GT
Sbjct: 134  -ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGT 188

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 994
              Y+ PE  +      + D+++ G VL EL T +   E     + ++LV     +K    
Sbjct: 189  PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLV-----LKIISG 240

Query: 995  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                +            L  ++    +   ++PR RP +  +
Sbjct: 241  SFPPVSLHY-----SYDLRSLVS---QLFKRNPRDRPSVNSI 274

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  124 bits (313), Expect = 4e-31
 Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 42/227 (18%)

Query: 773 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
             +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWL-----------HESVDKDSVLKWDVRLKIAQG 875
              G C  G   L+++ YM +G L+ +L                    L     L +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
            A G+ YL      H VHRD+ + N L+ +     + DFG+SR +  Y T      VG  
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYR--VGGR 219

Query: 936 GYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
             +P     PE      ++   T +   DV+SFGVVL E+ T G++P
Sbjct: 220 TMLPIRWMPPESILYRKFT---TES---DVWSFGVVLWEIFTYGKQP 260

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  124 bits (313), Expect = 4e-31
 Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 37/291 (12%)

Query: 773  NIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 827
              +G G FG V            G   AVK+L     +  R+F+ E+E L   QH N+V 
Sbjct: 47   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 828  LQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
             +G C     R   LI  Y+  GSL  +L +  ++   +     L+      +G+ YL  
Sbjct: 107  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 162

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----P 940
                  +HRD+ + NIL++ +    + DFGL+++L P D       V   G  P     P
Sbjct: 163  --TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYK--VKEPGESPIFWYAP 217

Query: 941  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
            E       +   DV+SFGVVL EL T     +    +  R + +           +E++ 
Sbjct: 218  ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL- 276

Query: 1001 ASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                   +    L        E+  I  +C + +  +RP   ++   +D I
Sbjct: 277  -------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  125 bits (315), Expect = 4e-31
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 38/223 (17%)

Query: 773 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 825
             +G G FG VY+  ++         + AVK L   C + +  +F  E   +S+  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGLAY 882
           V   G       R ++   M  G L  +L E+     + S L     L +A+  A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           L    E H +HRD+ + N LL       +    DFG++R +  Y         G    +P
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYR--KGGCAMLP 249

Query: 940 -----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                PE      ++   + T   D +SFGV+L E+ + G  P
Sbjct: 250 VKWMPPEAFMEGIFT---SKT---DTWSFGVLLWEIFSLGYMP 286

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  123 bits (310), Expect = 5e-31
 Identities = 61/304 (20%), Positives = 105/304 (34%), Gaps = 65/304 (21%)

Query: 767  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQH 822
             +F     +G GGFG+V++A    +    A+KR+       E   +    EV+AL++ +H
Sbjct: 5    TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEH 62

Query: 823  KNLVSL-------QGYCRHGNDRLLIYSY--ME---NGSLDYWLHESVDKDSVLKWDVRL 870
              +V             +       +Y Y  M+     +L  W++         +  V L
Sbjct: 63   PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCL 121

Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---------- 920
             I    A  + +LH      ++HRD+K SNI         + DFGL   +          
Sbjct: 122  HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 921  -RPYDTHVTTDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEV 973
                     T  VGT  Y+ PE      YS       + D++S G++L ELL        
Sbjct: 179  TPMPAYARHTGQVGTKLYMSPEQIHGNSYSH------KVDIFSLGLILFELL-------- 224

Query: 974  CKGKNCRDLVSWVFQMKSEKREV-EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1032
                       + F  + E+      +    +     ++      +    +   P  RP 
Sbjct: 225  -----------YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE 273

Query: 1033 IEEV 1036
               +
Sbjct: 274  AINI 277

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  122 bits (309), Expect = 5e-31
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 32/223 (14%)

Query: 773 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 825
             +G   FG VYK  L            A+K L        R EF+ E    +R QH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWL------------HESVDKDSVLKWDVRLKIA 873
           V L G         +I+SY  +G L  +L             +     S L+    + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 874 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 933
              A G+ YL      H+VH+D+ + N+L+ +K    ++D GL R +  Y        + 
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYK--LL 187

Query: 934 TLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
               +P     PE       +   D++S+GVVL E+ + G +P
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (312), Expect = 6e-31
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 25/211 (11%)

Query: 774 IIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 827
           +IG G FG VYK  L   +       A+K L     + +R +F  E   + +  H N++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L+G        ++I  YMENG+LD +L E   +         + + +G A G+ YL    
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLA--- 164

Query: 888 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIP-----P 940
             + VHRD+ + NIL++      ++DFGLSR+L   P  T+ T+      G IP     P
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG-----GKIPIRWTAP 219

Query: 941 EYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
           E       T   DV+SFG+V+ E++T G RP
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  122 bits (308), Expect = 7e-31
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 20/206 (9%)

Query: 773 NIIGCGGFGLVYKATLTNG-TKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQG 830
           + +G G +G VY+          AVK L      ME E F  E   +   +H NLV L G
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
            C       +I  +M  G+L  +L E       +   V L +A   +  + YL K    +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---N 131

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQT 945
            +HRD+ + N L+ E     +ADFGLSRL         T   G     P     PE    
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAK--FPIKWTAPESLAY 186

Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
              + + DV++FGV+L E+ T G  P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  123 bits (311), Expect = 7e-31
 Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 26/217 (11%)

Query: 773 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 825
             +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL------KIAQGAARG 879
           V L G    G   L+I   M  G L  +L       +              ++A   A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           +AYL+       VHRD+ + N ++ E F   + DFG++R +  Y+T       G  G +P
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYR--KGGKGLLP 203

Query: 940 -----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                PE  +    T   DV+SFGVVL E+ T   +P
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  125 bits (315), Expect = 8e-31
 Identities = 36/302 (11%), Positives = 67/302 (22%), Gaps = 62/302 (20%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLS-------GDCGQMERE------FQAEVEALSR 819
            ++G        +AT    G    V               QM+ E       +        
Sbjct: 85   VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 820  AQHKNLVSLQGYCRHGNDRLLI-------------------YSYMENGSLDYWLHESVDK 860
              H   +      +    + +I                          +    L      
Sbjct: 145  KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 861  DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL 920
               L    RL++     R LA LH      +VH  ++  +I+LD++    L  F      
Sbjct: 205  HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 921  RPYDTHVTTDLVGTLGYIPPE-----YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK 975
                                             T   D ++ G+ +  +     P     
Sbjct: 262  GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT--- 318

Query: 976  GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035
                     W+F+           +     +     LLE        +      R    +
Sbjct: 319  DDAALGGSEWIFR--------SCKNIPQPVRA----LLE------GFLRYPKEDRLLPLQ 360

Query: 1036 VV 1037
             +
Sbjct: 361  AM 362

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (324), Expect = 1e-30
 Identities = 53/209 (25%), Positives = 73/209 (34%), Gaps = 34/209 (16%)

Query: 775 IGCGGFGLVYKA--TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
           I  GG G +Y A     NG    +K    SGD         AE + L+   H ++V +  
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVVHPSIVQIFN 146

Query: 831 YCRHGNDRLLIYSY--ME--NG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           +  H +       Y  ME   G SL     +       L     +         L+YLH 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLH- 199

Query: 886 VCEPHIVHRDVKSSNILLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
                +V+ D+K  NI+L E   K    L D G    +          L GT G+  PE 
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQLK----LIDLGAVSRI----NS-FGYLYGTPGFQAPE- 247

Query: 943 SQTLT-ATCRGDVYSFGVVLLELLTGRRP 970
               T  T   D+Y+ G  L  L      
Sbjct: 248 -IVRTGPTVATDIYTVGRTLAALTLDLPT 275

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  123 bits (310), Expect = 1e-30
 Identities = 78/308 (25%), Positives = 127/308 (41%), Gaps = 77/308 (25%)

Query: 773  NIIGCGGFGLVYKATLTNG---TKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKNLVS 827
            ++IG G FG V KA +        AA+KR+     + +  +F  E+E L +   H N+++
Sbjct: 31   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHES------------VDKDSVLKWDVRLKIAQG 875
            L G C H     L   Y  +G+L  +L +S                S L     L  A  
Sbjct: 91   LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 876  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
             ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y       +  T+
Sbjct: 151  VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------VKKTM 200

Query: 936  GYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 983
            G +P      E      Y+   T +   DV+S+GV+L E+++ G  P     G  C +L 
Sbjct: 201  GRLPVRWMAIESLNYSVYT---TNS---DVWSYGVLLWEIVSLGGTPYC---GMTCAELY 251

Query: 984  SWVFQMKSEKREVEIIDASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEE 1035
              +                      +   L        E+ ++  +C  + P  RP   +
Sbjct: 252  EKL---------------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 290

Query: 1036 VVTWLDGI 1043
            ++  L+ +
Sbjct: 291  ILVSLNRM 298

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  122 bits (308), Expect = 1e-30
 Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 60/304 (19%)

Query: 766  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN 824
             ++F +  ++G G FG V KA    +    A+K++     +      +EV  L+   H+ 
Sbjct: 5    ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQY 63

Query: 825  LVSLQG-YCRHGNDRLLIYS------------YMENGSLDYWLHE---SVDKDSVLKWDV 868
            +V     +    N    + +            Y ENG+L   +H    +  +D   +   
Sbjct: 64   VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-- 121

Query: 869  RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL-------- 920
                 Q     L+Y+H      I+HRD+K  NI +DE     + DFGL++ +        
Sbjct: 122  ---FRQ-ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 921  -----RPYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC 974
                  P  +   T  +GT  Y+  E    T     + D+YS G++  E++         
Sbjct: 175  LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST---- 230

Query: 975  KGKNCRDLVSWVFQMKSEKREVEIIDASIWHK--DREKQLLEMLEIACKCIDQDPRRRPF 1032
             G    ++      +K  +                 EK+++         ID DP +RP 
Sbjct: 231  -GMERVNI------LKKLRSVSIEFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPG 277

Query: 1033 IEEV 1036
               +
Sbjct: 278  ARTL 281

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  127 bits (320), Expect = 1e-30
 Identities = 72/257 (28%), Positives = 112/257 (43%), Gaps = 22/257 (8%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 831
              +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L   
Sbjct: 273  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                    ++  YM  GSL  +L         L+    + +A   A G+AY+ ++   + 
Sbjct: 331  V-SEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 384

Query: 892  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY--IPPEYSQTLTAT 949
            VHRD++++NIL+ E     +ADFGL+RL+   D   T             PE +     T
Sbjct: 385  VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 950  CRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK---REVEIIDASIWH 1005
             + DV+SFG++L EL T GR P      +   D V   ++M         +  +    W 
Sbjct: 443  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 502

Query: 1006 KDREK-----QLLEMLE 1017
            K+ E+      L   LE
Sbjct: 503  KEPEERPTFEYLQAFLE 519

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  122 bits (308), Expect = 1e-30
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 773 NIIGCGGFGLVYKATLTNG----TKAAVKRL-SGDCGQMER-EFQAEVEALSRAQHKNLV 826
            I+G G FG V +  L        K AVK +   +  Q E  EF +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 827 SLQGYC-----RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARG 879
            L G C     +     ++I  +M+ G L  +L  S  +       ++  LK     A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
           + YL      + +HRD+ + N +L +     +ADFGLS+ +   D +      G +  +P
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAKMP 212

Query: 940 -----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                 E       T + DV++FGV + E+ T G  P
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  124 bits (314), Expect = 2e-30
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 20/205 (9%)

Query: 773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGY 831
             +G G FG V+ AT    TK AVK +    G M    F AE   +   QH  LV L   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                   +I  +M  GSL  +L    D+ S       +  +   A G+A++    + + 
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 946
           +HRD++++NIL+       +ADFGL+R++   D   T          P     PE     
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAR---EGAKFPIKWTAPEAINFG 360

Query: 947 TATCRGDVYSFGVVLLELLT-GRRP 970
           + T + DV+SFG++L+E++T GR P
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP 385

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  124 bits (314), Expect = 2e-30
 Identities = 79/391 (20%), Positives = 130/391 (33%), Gaps = 50/391 (12%)

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPL-SLSLCSKLHVLDLRNN 331
             + ++ +  N  +         L  L+F      +    +   +    S L +L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 332 SLTG-PIDLNFSGLSSLCTLDLATNHF-SGPLP-NSLSDCHDLKILSLAKNELSGQVPES 388
                     F+GL++L  L L   +     L  N       L++L L  N +    P S
Sbjct: 90  QFLQLETGA-FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 389 -FGKLTSLLFLSLSNNSFNHL-SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLM 446
            F  +     L L+ N    +    L   Q  K+ T L L+                   
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQG-KHFTLLRLSSI----------------T 191

Query: 447 VLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGE 506
           +  +    L         +   +  LDLS N F  ++            +     + +  
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251

Query: 507 IPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF------- 559
           +  S          N T     AS               L  ++  +   SVF       
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCD---------LSKSKIFALLKSVFSHFTDLE 302

Query: 560 ---LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLH 614
              L+ N IN  I       L HL  L+LS+N +  +I S +   +  LEVLDLS N + 
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360

Query: 615 GSIP-GSFEKLTFLSKFSVANNHLQGTIPTG 644
            ++   SF  L  L + ++  N L+ ++P G
Sbjct: 361 -ALGDQSFLGLPNLKELALDTNQLK-SVPDG 389

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  120 bits (303), Expect = 5e-29
 Identities = 82/418 (19%), Positives = 145/418 (34%), Gaps = 62/418 (14%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL-SNLKQLEVLDLSHNML 142
           V  + L    +  +   S   L  L+ L +       V+       L  L +L L +N  
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 143 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 202
               +G   GL  ++ L ++  + +G++     F  L                       
Sbjct: 92  LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL----------------------T 129

Query: 203 EIQILDLSMNHFMGSLQGL------DHSPSLKQLHVDNNLLGGDLPDSLYSMSSL----- 251
            +++L L  N+    ++ +       +      L +  N +     + L +         
Sbjct: 130 SLEMLVLRDNN----IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185

Query: 252 -----QHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHS 306
                    ++      +        TS+  L + GN F   +           FF A +
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR--------FFDAIA 237

Query: 307 NSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGL--SSLCTLDLATNHFSGPLPNS 364
            +    L LS    S        + +   P +  F GL  S + T DL+ +     L + 
Sbjct: 238 GTKIQSLILS---NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSV 294

Query: 365 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 424
            S   DL+ L+LA+NE++     +F  LT LL L+LS N    +     + +    L  L
Sbjct: 295 FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS--RMFENLDKLEVL 352

Query: 425 ILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLL-RCKKLQVLDLSWNHFD 480
            L+ N +   + +    G  +L  LAL    LK  +P  +  R   LQ + L  N +D
Sbjct: 353 DLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  114 bits (286), Expect = 9e-27
 Identities = 82/383 (21%), Positives = 136/383 (35%), Gaps = 44/383 (11%)

Query: 289 LPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLN-FSGLSSL 347
           +P +  ++  ++      NS +     S S    L  L +   +    I  N F GLSSL
Sbjct: 25  VPELPAHVNYVDL---SLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 348 CTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQV--PESFGKLTSLLFLSLSNNSF 405
             L L  N F      + +   +L++L+L +  L G V     F  LTSL  L L +N+ 
Sbjct: 82  IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 406 NHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLR 465
             +    S     +    L LT N V + I E      +                  LLR
Sbjct: 142 KKIQPA-SFFLNMRRFHVLDLTFNKV-KSICEED--LLNFQGKHFT-----------LLR 186

Query: 466 CKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL--ISSNCT 523
              + + D++             +  ++  LD S N     + K   +  +   I S   
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246

Query: 524 SSNPTASAGIP---LYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEI-GQLKHL 579
           S++    +           N +  GL  +   +      LS ++I   +   +      L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKT----CDLSKSKIF-ALLKSVFSHFTDL 301

Query: 580 HVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 638
             L L++N I   I  +    + +L  L+LS N L       FE L  L    ++ NH++
Sbjct: 302 EQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360

Query: 639 GTIPTGGQFYSFPNSSFEGNPGL 661
                     +  + SF G P L
Sbjct: 361 ----------ALGDQSFLGLPNL 373

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 40/233 (17%), Positives = 77/233 (33%), Gaps = 38/233 (16%)

Query: 6   FVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALK-EFAGNLTNGSIITSWSNESMC 64
               T +  L L+         +  F +   + + +L    + N+ +    T++ +    
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267

Query: 65  CQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPV 124
                        G  A  V    L +  +  ++     H   L+ L L+ N +  +   
Sbjct: 268 TFK----------GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN 317

Query: 125 ELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNI 184
               L  L  L+LS N L    S M   L+ ++ L++S N                   +
Sbjct: 318 AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR---------------AL 362

Query: 185 SNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG--LDHSPSLKQLHVDNN 235
            + SF   L +        ++ L L  N    S+     D   SL+++ +  N
Sbjct: 363 GDQSFL-GLPN--------LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 23/88 (26%), Positives = 40/88 (45%)

Query: 80  NAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSH 139
               +  L L +  L  I  R   +L++L++LDLS NH+  +       L  L+ L L  
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380

Query: 140 NMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
           N L     G+   L  +Q + + +N ++
Sbjct: 381 NQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  120 bits (304), Expect = 2e-30
 Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 23/208 (11%)

Query: 774 IIGCGGFGLVYKATLTNG----TKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           I+G G FG VY+   TN        AVK          + +F +E   +    H ++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            G         +I      G L ++L       + LK    +  +    + +AYL     
Sbjct: 79  IGIIE-EEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLE---S 131

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 943
            + VHRD+   NIL+       L DFGLSR +   D         ++  +P     PE  
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYK---ASVTRLPIKWMSPESI 186

Query: 944 QTLTATCRGDVYSFGVVLLELLT-GRRP 970
                T   DV+ F V + E+L+ G++P
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP 214

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  121 bits (306), Expect = 2e-30
 Identities = 69/293 (23%), Positives = 107/293 (36%), Gaps = 43/293 (14%)

Query: 773  NIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 826
              +G G FG V            G   AVK L  D G   R  ++ E++ L    H++++
Sbjct: 37   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 827  SLQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
              +G C         L+  Y+  GSL  +L         +     L  AQ    G+AYLH
Sbjct: 97   KYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP----- 939
                 H +HRD+ + N+LLD      + DFGL++ +     +     V   G  P     
Sbjct: 152  ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR---VREDGDSPVFWYA 205

Query: 940  PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
            PE  +        DV+SFGV L ELLT                 ++   QM        +
Sbjct: 206  PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTVL----RL 260

Query: 999  IDASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
             +          + L        E+  +   C + +   RP  E ++  L  +
Sbjct: 261  TE-----LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  122 bits (307), Expect = 3e-30
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 23/210 (10%)

Query: 773 NIIGCGGFGLVYKATLTNGTKA-----AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 826
            ++G G FG VYK       +      A+K L          E   E   ++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            L G C   +   LI   M  G L  ++ E  D    +     L      A+G+ YL   
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE-- 134

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 941
            +  +VHRD+ + N+L+       + DFGL++LL   +           G +P      E
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALE 189

Query: 942 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                  T + DV+S+GV + EL+T G +P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  120 bits (303), Expect = 3e-30
 Identities = 54/208 (25%), Positives = 80/208 (38%), Gaps = 23/208 (11%)

Query: 774 IIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSL 828
            IG G FG V++    +        A+K          R +F  E   + +  H ++V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            G     N   +I      G L  +L     +   L     +  A   +  LAYL     
Sbjct: 82  IGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE---S 134

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 943
              VHRD+ + N+L+       L DFGLSR +   D+        + G +P     PE  
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYK---ASKGKLPIKWMAPESI 189

Query: 944 QTLTATCRGDVYSFGVVLLELLT-GRRP 970
                T   DV+ FGV + E+L  G +P
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKP 217

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  122 bits (307), Expect = 3e-30
 Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 22/246 (8%)

Query: 732 GRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTN 790
            + QRL      ++ VL            +  +  +       +G G FG V++      
Sbjct: 25  AKLQRLGPETEDNEGVLLTEKL--KPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82

Query: 791 GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY-SYMENGS 849
           G + AVK++     ++E     E+ A +      +V L G  R G   + I+   +E GS
Sbjct: 83  GFQCAVKKV-----RLEVFRVEELVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEGGS 136

Query: 850 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FE 908
           L     + + +   L  D  L     A  GL YLH      I+H DVK+ N+LL      
Sbjct: 137 L----GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSR 189

Query: 909 AHLADFGLSRLLRPYDTHVTT----DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLEL 964
           A L DFG +  L+P     +      + GT  ++ PE         + D++S   ++L +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 965 LTGRRP 970
           L G  P
Sbjct: 250 LNGCHP 255

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  126 bits (318), Expect = 3e-30
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 20/206 (9%)

Query: 775 IGCGGFGLVYKATLTNGTKA---AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 830
           +GCG FG V +       K    A+K L     + +  E   E + + +  +  +V L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 831 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
            C+     +L+      G L  +L     K   +      ++    + G+ YL    E +
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQT 945
            VHR++ + N+LL  +  A ++DFGLS+ L   D++ T     + G  P     PE    
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPLKWYAPECINF 513

Query: 946 LTATCRGDVYSFGVVLLELLT-GRRP 970
              + R DV+S+GV + E L+ G++P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 4e-30
 Identities = 62/286 (21%), Positives = 108/286 (37%), Gaps = 44/286 (15%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQGYC 832
            +  GGF  VY+A  + +G + A+KRL  +  +  R    EV  + + + H N+V      
Sbjct: 36   LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 833  -------RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
                     G    L+ + +  G L  +L +   +   L  D  LKI     R + ++H+
Sbjct: 96   SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHR 154

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----------VGT 934
              +P I+HRD+K  N+LL  +    L DFG +  +  Y  +  +               T
Sbjct: 155  -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 935  LGYIPPE---YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS 991
              Y  PE            + D+++ G +L  L   + P                F+  +
Sbjct: 214  PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----------------FEDGA 257

Query: 992  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
            + R   I++        + Q      +    +  +P  R  I EVV
Sbjct: 258  KLR---IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (302), Expect = 4e-30
 Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 43/222 (19%)

Query: 774 IIGCGGFGLVYKATL--------TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 825
            +G G F  ++K            + T+  +K L          F      +S+  HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 826 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
           V   G C  G++ +L+  +++ GSLD +L +     + +    +L++A+  A  + +L  
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLE- 130

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAH--------LADFGLSRLLRPYDTHVTTDLVGTLGY 937
             E  ++H +V + NILL  + +          L+D G+S  + P D             
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI----------LQ 178

Query: 938 IP-----PE---YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                  PE     + L      D +SFG  L E+ + G +P
Sbjct: 179 ERIPWVPPECIENPKNLNLAT--DKWSFGTTLWEICSGGDKP 218

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (303), Expect = 4e-30
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 11/210 (5%)

Query: 766 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN 824
            +      ++G G +G+VY    L+N  + A+K +     +  +    E+      +HKN
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 825 LVSLQGYCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           +V   G        + I+   +  GSL   L          +  +     Q    GL YL
Sbjct: 81  IVQYLGSFSEN-GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-ILEGLKYL 138

Query: 884 HKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE- 941
           H   +  IVHRD+K  N+L++       ++DFG S+ L   +    T   GTL Y+ PE 
Sbjct: 139 H---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEI 194

Query: 942 -YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                       D++S G  ++E+ TG+ P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  120 bits (302), Expect = 9e-30
 Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 59/299 (19%)

Query: 773  NIIGCGGFGLVYKATLTNG----TKAAVKRL-SGDCGQMERE-FQAEVEALSRAQHKNLV 826
             ++G G FG V +A L        K AVK L +      + E F  E   +    H ++ 
Sbjct: 29   RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 827  SLQGYC------RHGNDRLLIYSYMENGSLDYWL--HESVDKDSVLKWDVRLKIAQGAAR 878
             L G              ++I  +M++G L  +L      +    L     ++     A 
Sbjct: 89   KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 879  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
            G+ YL      + +HRD+ + N +L E     +ADFGLSR +   D +      G    +
Sbjct: 149  GMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASKL 201

Query: 939  P-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE 992
            P      E       T   DV++FGV + E++T G+ P     G    ++ +++      
Sbjct: 202  PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA---GIENAEIYNYL------ 252

Query: 993  KREVEIIDASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                                L        E+ ++  +C   DP++RP    +   L+ I
Sbjct: 253  ---------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  119 bits (300), Expect = 1e-29
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 774 IIGCGGFGLVYKATLTNG---TKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSL 828
            +G G FG V K            AVK L  +     ++ E  AE   + +  +  +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            G C      +L+    E G L+ +L     ++  +K    +++    + G+ YL    E
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE---E 135

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 943
            + VHRD+ + N+LL  +  A ++DFGLS+ LR  + +       T G  P     PE  
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ---THGKWPVKWYAPECI 192

Query: 944 QTLTATCRGDVYSFGVVLLELLT-GRRP 970
                + + DV+SFGV++ E  + G++P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  119 bits (300), Expect = 1e-29
 Identities = 73/308 (23%), Positives = 126/308 (40%), Gaps = 54/308 (17%)

Query: 750  QNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKR--LSGDCGQME 807
            +N   + ++V         ++    IG GG   V++         A+K   L     Q  
Sbjct: 16   ENLYFQSMSVKG-----RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 70

Query: 808  REFQAEVEALSRAQHKNL--VSLQGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSV 863
              ++ E+  L++ Q  +   + L  Y         IY  ME  N  L+ WL +   K S+
Sbjct: 71   DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKK---KKSI 124

Query: 864  LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE---KFEAHLADFGLSRLL 920
              W+ +          +  +H   +  IVH D+K +N L+ +   K    L DFG++  +
Sbjct: 125  DPWERKSYWKN-MLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK----LIDFGIANQM 176

Query: 921  RPYDTHVTTD-LVGTLGYIPPE------YSQTLTATCRG-----DVYSFGVVLLELLTGR 968
            +P  T V  D  VGT+ Y+PPE       S+    +        DV+S G +L  +  G+
Sbjct: 177  QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

Query: 969  RPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPR 1028
             P +        + +S +  +     E+E  D        EK L ++L     C+ +DP+
Sbjct: 237  TPFQ-----QIINQISKLHAIIDPNHEIEFPD------IPEKDLQDVL---KCCLKRDPK 282

Query: 1029 RRPFIEEV 1036
            +R  I E+
Sbjct: 283  QRISIPEL 290

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  118 bits (299), Expect = 1e-29
 Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 23/210 (10%)

Query: 774 IIGCGGFGLVYKATLT----NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLV 826
            +G G FG+V +             AVK L  D     +   +F  EV A+    H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
            L G         ++      GSL   L +              + A   A G+ YL   
Sbjct: 85  RLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE-- 138

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 941
                +HRD+ + N+LL  +    + DFGL R L   D H           +P     PE
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM---QEHRKVPFAWCAPE 194

Query: 942 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
             +T T +   D + FGV L E+ T G+ P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  124 bits (313), Expect = 2e-29
 Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 38/298 (12%)

Query: 764  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQ 821
            ++   +     +G GGFG V +      G + A+K+   +     RE +  E++ + +  
Sbjct: 11   QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 822  HKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
            H N+VS              +  LL   Y E G L  +L++  +    LK      +   
Sbjct: 71   HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSD 129

Query: 876  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLV 932
             +  L YLH   E  I+HRD+K  NI+L    +     + D G ++ L       T   V
Sbjct: 130  ISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTE-FV 184

Query: 933  GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC----------KGKNCRDL 982
            GTL Y+ PE  +    T   D +SFG +  E +TG RP              + K+   +
Sbjct: 185  GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244

Query: 983  VSWVFQMKSEKREVEIID----ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            V +     + K    +      + I     E+ L  ML           R+R    + 
Sbjct: 245  VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW-------HQRQRGTDPQN 295

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (305), Expect = 2e-29
 Identities = 69/309 (22%), Positives = 117/309 (37%), Gaps = 58/309 (18%)

Query: 751  NSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF 810
              D  D   S ++    +F   +++G G  G +    + +    AVKR+  +C       
Sbjct: 8    EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFA 64

Query: 811  QAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWD 867
              EV+ L    +H N++      +   DR   Y  +E    +L  ++     KD      
Sbjct: 65   DREVQLLRESDEHPNVIRYFCTEK---DRQFQYIAIELCAATLQEYV---EQKDFAHLGL 118

Query: 868  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRP 922
              + + Q    GLA+LH +   +IVHRD+K  NIL+          A ++DFGL + L  
Sbjct: 119  EPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175

Query: 923  --YDTHVTTDLVGTLGYIPPEY---SQTLTATCRGDVYSFGVVLLELLTGRRP------- 970
              +     + + GT G+I PE          T   D++S G V   +++           
Sbjct: 176  GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235

Query: 971  --VEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE-KQLLEMLEIACKCIDQDP 1027
                +  G    D +                     H+D   ++L+E      K I  DP
Sbjct: 236  RQANILLGACSLDCLHPE-----------------KHEDVIARELIE------KMIAMDP 272

Query: 1028 RRRPFIEEV 1036
            ++RP  + V
Sbjct: 273  QKRPSAKHV 281

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  123 bits (310), Expect = 4e-29
 Identities = 54/208 (25%), Positives = 80/208 (38%), Gaps = 23/208 (11%)

Query: 774 IIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSL 828
            IG G FG V++    +        A+K          R +F  E   + +  H ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
            G     N   +I      G L  +L     +   L     +  A   +  LAYL     
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLE---S 509

Query: 889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 943
              VHRD+ + N+L+       L DFGLSR +   D+        + G +P     PE  
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYK---ASKGKLPIKWMAPESI 564

Query: 944 QTLTATCRGDVYSFGVVLLELLT-GRRP 970
                T   DV+ FGV + E+L  G +P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  117 bits (295), Expect = 4e-29
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 12/203 (5%)

Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMERE-FQAEVEALSRA-QHKNLVSLQGY 831
           +G G +G+V K     +G   AVKR+       E++    +++   R       V+  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                D  +    M + SLD +  + +DK   +  D+  KIA    + L +LH   +  +
Sbjct: 75  LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE----YSQTLT 947
           +HRDVK SN+L++   +  + DFG+S  L   D        G   Y+ PE          
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQKG 189

Query: 948 ATCRGDVYSFGVVLLELLTGRRP 970
            + + D++S G+ ++EL   R P
Sbjct: 190 YSVKSDIWSLGITMIELAILRFP 212

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  118 bits (297), Expect = 6e-29
 Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 45/289 (15%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKR--LSGDCGQMEREFQAEVEALSRAQHKN 824
              ++    IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +
Sbjct: 9    RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 825  L--VSLQGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
               + L  Y         IY  ME  N  L+ WL +   K S+  W+ +          +
Sbjct: 69   DKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKK---KKSIDPWERKSYWKN-MLEAV 121

Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIP 939
              +H   +  IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+P
Sbjct: 122  HTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 940  PE------YSQTLTATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 988
            PE       S+    +        DV+S G +L  +  G+ P +        + +S +  
Sbjct: 178  PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHA 232

Query: 989  MKSEKREVEIID-ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            +     E+E  D      +D    +L        C+ +DP++R  I E+
Sbjct: 233  IIDPNHEIEFPDIPEKDLQD----VL------KCCLKRDPKQRISIPEL 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  119 bits (299), Expect = 7e-29
 Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 43/282 (15%)

Query: 773  NIIGCGGFGLVYKATLTNGTKAAVKR--LSGDCGQMEREFQAEVEALSRAQHKNL--VSL 828
              IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   + L
Sbjct: 62   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 829  QGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
              Y         IY  ME  N  L+ WL +   K S+  W+ +          +  +H  
Sbjct: 122  YDYEITDQY---IYMVMECGNIDLNSWLKK---KKSIDPWERKSYWKN-MLEAVHTIH-- 172

Query: 887  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE---- 941
             +  IVH D+K +N L+ +     L DFG++  ++P  T V  D  VG + Y+PPE    
Sbjct: 173  -QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 942  -------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 994
                          + + DV+S G +L  +  G+ P +        + +S +  +     
Sbjct: 231  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNH 285

Query: 995  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            E+E  D        EK L ++L+    C+ +DP++R  I E+
Sbjct: 286  EIEFPD------IPEKDLQDVLK---CCLKRDPKQRISIPEL 318

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (296), Expect = 8e-29
 Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 47/232 (20%)

Query: 773 NIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQH 822
             +G G FG V  A                AVK L  D  + +  +  +E+E +    +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRL 870
           KN+++L G C       +I  Y   G+L            +Y    +   +  + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 871 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 930
                 ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +    
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK--- 214

Query: 931 LVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
              T G +P     PE      Y      T + DV+SFGV++ E+ T G  P
Sbjct: 215 -KTTNGRLPVKWMAPEALFDRVY------THQSDVWSFGVLMWEIFTLGGSP 259

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  117 bits (294), Expect = 2e-28
 Identities = 71/313 (22%), Positives = 116/313 (37%), Gaps = 79/313 (25%)

Query: 773  NIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQH 822
              +G G FG V  A                AVK L  D  + +  +  +E+E +    +H
Sbjct: 87   KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 823  KNLVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRL 870
            KN+++L G C       +I  Y   G+L            +Y    +   +  + +   +
Sbjct: 147  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 871  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 930
                  ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +    
Sbjct: 207  SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK--- 260

Query: 931  LVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
               T G +P     PE      Y      T + DV+SFGV++ E+ T G  P     G  
Sbjct: 261  -KTTNGRLPVKWMAPEALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP---GIP 310

Query: 979  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLL--------EMLEIACKCIDQDPRRR 1030
              +L   +                     +E   +        E+  +   C    P +R
Sbjct: 311  VEELFKLL---------------------KEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349

Query: 1031 PFIEEVVTWLDGI 1043
            P  +++V  LD I
Sbjct: 350  PTFKQLVEDLDRI 362

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  114 bits (287), Expect = 7e-28
 Identities = 63/232 (27%), Positives = 91/232 (39%), Gaps = 47/232 (20%)

Query: 773 NIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 824
             +G G FG V +AT             AVK L       ER    +E++ LS    H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--------------VDKDSVLKWDVRL 870
           +V+L G C  G   L+I  Y   G L  +L                  D +  L  +  L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 871 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 930
             +   A+G+A+L      + +HRD+ + NILL       + DFGL+R +   +      
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDSNYV- 202

Query: 931 LVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
            V     +P     PE      Y      T   DV+S+G+ L EL + G  P
Sbjct: 203 -VKGNARLPVKWMAPESIFNCVY------TFESDVWSYGIFLWELFSLGSSP 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  114 bits (288), Expect = 9e-28
 Identities = 75/318 (23%), Positives = 113/318 (35%), Gaps = 84/318 (26%)

Query: 773  NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 825
              IG G FG V++A           T  AVK L  +     + +FQ E   ++   + N+
Sbjct: 53   RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 826  VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR---------------- 869
            V L G C  G    L++ YM  G L+ +L                               
Sbjct: 113  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 870  ----LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 925
                L IA+  A G+AYL    E   VHRD+ + N L+ E     +ADFGLSR +   D 
Sbjct: 173  CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 926  HVTTDLVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEV 973
            +           IP     PE      Y      T   DV+++GVVL E+ + G +P   
Sbjct: 230  YK----ADGNDAIPIRWMPPESIFYNRY------TTESDVWAYGVVLWEIFSYGLQPYY- 278

Query: 974  CKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLE--------MLEIACKCIDQ 1025
              G    +++ +V                     R+  +L         +  +   C  +
Sbjct: 279  --GMAHEEVIYYV---------------------RDGNILACPENCPLELYNLMRLCWSK 315

Query: 1026 DPRRRPFIEEVVTWLDGI 1043
             P  RP    +   L  +
Sbjct: 316  LPADRPSFCSIHRILQRM 333

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  114 bits (288), Expect = 9e-28
 Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 43/228 (18%)

Query: 773 NIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 824
             +G G FG V +AT           K AVK L       E+    +E++ +S   QH+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWL----------HESVDKDSVLKWDVRLKIAQ 874
           +V+L G C HG   L+I  Y   G L  +L                +S       L  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
             A+G+A+L      + +HRDV + N+LL     A + DFGL+R +     ++    V  
Sbjct: 172 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI----VKG 224

Query: 935 LGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
              +P     PE      Y      T + DV+S+G++L E+ + G  P
Sbjct: 225 NARLPVKWMAPESIFDCVY------TVQSDVWSYGILLWEIFSLGLNP 266

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  115 bits (289), Expect = 1e-27
 Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 47/230 (20%)

Query: 775 IGCGGFGLVYKATLTN--------GTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 824
           +G G FG V  A             TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 872
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
           A   ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +      
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK----K 249

Query: 933 GTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
            T G +P     PE      Y      T + DV+SFGV+L E+ T G  P
Sbjct: 250 TTNGRLPVKWMAPEALFDRIY------THQSDVWSFGVLLWEIFTLGGSP 293

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  117 bits (295), Expect = 1e-27
 Identities = 93/470 (19%), Positives = 170/470 (36%), Gaps = 46/470 (9%)

Query: 204 IQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLY-SMSSLQHVSLSV 258
            + L LS N      M  +  L     L+ L + +N +   L   ++     L+++ +S 
Sbjct: 54  TKALSLSQNSISELRMPDISFL---SELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSH 109

Query: 259 NNFSGQLSE-KISNLTSLRHLIIFGNQF-SGKLPNVLGNLTQLEFFVAHSNSF-SGPLPL 315
           N    +L       + SLRHL +  N F    +    GNLT+L F    +  F    L  
Sbjct: 110 N----RLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLP 165

Query: 316 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 375
              L     +LDL +  + G    +    ++   L L  +  S          + L  L 
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTT-VLHLVFHPNSLFSVQVNMSVNALGHLQ 224

Query: 376 LAKNELSGQVPESFGKLTSLLF--LSLSNNSFNHLSGTLSVLQQCK-----------NLT 422
           L+  +L+ +  +      S L    +L N +  H+  T     +             N+ 
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284

Query: 423 TLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGN 482
            L +T+    EE   +    +SLM+  + N               ++ +  LS +     
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344

Query: 483 IPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 542
                    +  +L+F+ N  T  + +  + LK L +      N   +      +  N S
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL-QRNGLKNFFKVALMTKNMS 403

Query: 543 TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 602
           +        +S     +                 + + VL+LS N +TG++   +     
Sbjct: 404 SLETLDVSLNSLNSHAYDRT----------CAWAESILVLNLSSNMLTGSVFRCLPP--K 451

Query: 603 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 652
           ++VLDL +N +  SIP     L  L + +VA+N L+ ++P  G F    +
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDRLTS 498

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  113 bits (284), Expect = 4e-26
 Identities = 82/441 (18%), Positives = 154/441 (34%), Gaps = 25/441 (5%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML-S 143
            +L L    ++ +          L+ LD+S N L+    +    +  L  LDLS N    
Sbjct: 79  RVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDV 135

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 203
            PV      L  +  L +S+  F           +L+   +   S+  K           
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195

Query: 204 IQILDLSMN-HFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 262
             +L L  + + + S+Q      +L  L + N  L  +    L +  S      ++ N +
Sbjct: 196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255

Query: 263 GQLSEKISNLTSLRHLIIFGNQFSGKLPNV-LGNLTQLEFFVAHSNSFSGPLPLSLSLCS 321
            Q        T    + +F   +   +  + + NLT  E               S +   
Sbjct: 256 LQ----HIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE------RIDREEFTYSETALK 305

Query: 322 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 381
            L +  ++N       +  +S  + +    L+ +                  L+  +N  
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365

Query: 382 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN-VG 440
           +  V +    L  L  L L  N   +      + +   +L TL ++ N +     +    
Sbjct: 366 TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA 425

Query: 441 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 500
             ES++VL L +  L G +   L    K++VLDL  N    +IP  +  ++ L  L+ ++
Sbjct: 426 WAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS 482

Query: 501 NTLTGEIPK----SLTELKSL 517
           N L   +P      LT L+ +
Sbjct: 483 NQLK-SVPDGVFDRLTSLQYI 502

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 92.6 bits (230), Expect = 2e-19
 Identities = 71/337 (21%), Positives = 131/337 (38%), Gaps = 25/337 (7%)

Query: 89  LPRKGLKGIIPRSLGHLN--QLKLLDLSCNHLEGVVPVELSNLKQLEVLDL-----SHNM 141
           L    +KG    SL   N   L L+    +     V + ++ L  L++ ++     +   
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237

Query: 142 LSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEF---SNLAVFNISNNSFTGKLNSRIW 198
           L   +S +  G  L+        +      +L +F     +   NI N + T +++   +
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297

Query: 199 SAS----KEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 253
           + S    K + I  +    F+ S + L      +    +  +           S SS   
Sbjct: 298 TYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTF 357

Query: 254 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV---LGNLTQLEFFVAHSNSF- 309
           ++ + N F+  + +  S L  L+ LI+  N        V     N++ LE      NS  
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLN 416

Query: 310 SGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGL-SSLCTLDLATNHFSGPLPNSLSDC 368
           S     + +    + VL+L +N LTG +   F  L   +  LDL  N     +P  ++  
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIMS-IPKDVTHL 472

Query: 369 HDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF 405
             L+ L++A N+L       F +LTSL ++ L +N +
Sbjct: 473 QALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 88.4 bits (219), Expect = 4e-18
 Identities = 57/378 (15%), Positives = 103/378 (27%), Gaps = 51/378 (13%)

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 332
              + L +  N  S      +  L++L       N               L  LD+ +N 
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111

Query: 333 LTGPIDLNFSGLSSLCTLDLATNHF-SGPLPNSLSDCHDLKILSLAKNELSGQVPESFGK 391
           L     ++   ++SL  LDL+ N F   P+     +   L  L L+  +           
Sbjct: 112 LQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLP 165

Query: 392 LTSL-LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLAL 450
           +  L L   L +    H+ G  +   Q  N T L L  +       +      +L  L L
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225

Query: 451 GN-------CGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ---MENLFYLDFSN 500
            N       C         L R   L  + L            + Q      + YL+  N
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285

Query: 501 NTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFL 560
            T+T  I +           +    +                   +          +++ 
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEH-------------------VKNQVFLFSKEALYS 326

Query: 561 SNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGS 620
                             +++  LS ++             +   L+ + N    S+   
Sbjct: 327 V--------------FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372

Query: 621 FEKLTFLSKFSVANNHLQ 638
              L  L    +  N L+
Sbjct: 373 CSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 63.7 bits (155), Expect = 2e-10
 Identities = 38/227 (16%), Positives = 79/227 (34%), Gaps = 7/227 (3%)

Query: 87  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 146
           L +  +  +     S   L  L +  +             S   ++ +  LS +      
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345

Query: 147 SGMLAGLNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTG-KLNSRIWSASKEI 204
                  +    LN + N F  S+F+       L    +  N        + +      +
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL 405

Query: 205 QILDLSMNHFM-GSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 262
           + LD+S+N     +         S+  L++ +N+L G +   L     ++ + L  N   
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM 463

Query: 263 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 309
             + + +++L +L+ L +  NQ       V   LT L++   H N +
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  112 bits (282), Expect = 2e-27
 Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 16/209 (7%)

Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQH 822
            +F     +G G FG VY A    +    A+K L         +E + + EVE  S  +H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 823 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            N++ L GY  H   R+ LI  Y   G++    +  + K S              A  L+
Sbjct: 69  PNILRLYGYF-HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H      ++HRD+K  N+LL    E  +ADFG S    P        L GTL Y+PPE
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTD--LCGTLDYLPPE 177

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             +      + D++S GV+  E L G+ P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (285), Expect = 2e-27
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 13/204 (6%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRA-QHKNLVSLQGY 831
           IG G +G V K     +G   AVKR+     + E++    +++ + R+     +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                D  +    M + S D +        D V+  ++  KI     + L +L +     
Sbjct: 90  LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146

Query: 891 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE----YSQTL 946
           I+HRD+K SNILLD      L DFG+S  L   D+   T   G   Y+ PE     +   
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSASRQ 204

Query: 947 TATCRGDVYSFGVVLLELLTGRRP 970
               R DV+S G+ L EL TGR P
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFP 228

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  113 bits (284), Expect = 2e-27
 Identities = 65/237 (27%), Positives = 96/237 (40%), Gaps = 52/237 (21%)

Query: 773 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 825
             +G G FG V KAT  +       T  AVK L  +    E  +  +E   L +  H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 826 VSLQGYCRHGNDRLLIYSYMENGSL-DY-------------------WLHESVDKDSVLK 865
           + L G C      LLI  Y + GSL  +                           +  L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 866 WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 925
               +  A   ++G+ YL    E  +VHRD+ + NIL+ E  +  ++DFGLSR +  Y+ 
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV--YEE 203

Query: 926 HVTTDLVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                   + G IP      E      Y      T + DV+SFGV+L E++T G  P
Sbjct: 204 DSYV--KRSQGRIPVKWMAIESLFDHIY------TTQSDVWSFGVLLWEIVTLGGNP 252

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  113 bits (284), Expect = 2e-27
 Identities = 59/303 (19%), Positives = 102/303 (33%), Gaps = 36/303 (11%)

Query: 764  KSTNN--FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQAEVEALSR 819
            +ST+N  +  ++I+G G    V++      G   A+K  +     +       E E L +
Sbjct: 4    QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 820  AQHKNLVSLQGYCRHGNDRL--LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
              HKN+V L         R   LI  +   GSL   L E       L     L + +   
Sbjct: 64   LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVV 122

Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVG 933
             G+ +L +     IVHR++K  NI+     +      L DFG +R L   D    + L G
Sbjct: 123  GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS-LYG 177

Query: 934  TLGYIPPEYSQTLTATCRG--------DVYSFGVVLLELLTGRRP-VEVCKGKNCRDL-- 982
            T  Y+ P+  +                D++S GV      TG  P       +  +++  
Sbjct: 178  TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 983  ---------VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1033
                          Q           D  +         + +  +    ++ D  +    
Sbjct: 238  KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 1034 EEV 1036
            ++ 
Sbjct: 298  DQF 300

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  113 bits (284), Expect = 2e-27
 Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 46/231 (19%)

Query: 773 NIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 824
             +G G FG V +A              AVK L       E     +E++ L     H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 825 LVSLQGYC-RHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLK 871
           +V+L G C + G   ++I  + + G+L             Y +         L  +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 931
            +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R +  Y        
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYV-- 205

Query: 932 VGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                 +P     PE      Y      T + DV+SFGV+L E+ + G  P
Sbjct: 206 RKGDARLPLKWMAPETIFDRVY------TIQSDVWSFGVLLWEIFSLGASP 250

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (284), Expect = 3e-27
 Identities = 58/287 (20%), Positives = 106/287 (36%), Gaps = 26/287 (9%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
             +L L    +  I      +L  L  L L  N +  + P   + L +LE L LS N L 
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFN----GSLFELGEFSNLAVFNISNNSFT-GKLNSRIW 198
                M   L   Q L V  N            L   + + V  +  N      + +  +
Sbjct: 114 ELPEKMPKTL---QELRVHENEITKVRKSVFNGL---NQMIVVELGTNPLKSSGIENGAF 167

Query: 199 SASKEIQILDLSMNHFMGSLQGLDHS--PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 256
              K++  + ++  +    +  +     PSL +LH+D N +      SL  +++L  + L
Sbjct: 168 QGMKKLSYIRIADTN----ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 223

Query: 257 SVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSG----- 311
           S N+ S   +  ++N   LR L +  N+   K+P  L +   ++    H+N+ S      
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282

Query: 312 -PLPLSLSLCSKLHVLDLRNNSLT-GPIDLN-FSGLSSLCTLDLATN 355
              P   +  +    + L +N +    I  + F  +     + L   
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  106 bits (266), Expect = 5e-25
 Identities = 74/343 (21%), Positives = 124/343 (36%), Gaps = 71/343 (20%)

Query: 320 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
           C  L V+   +  L   P DL          LDL  N  +        +  +L  L L  
Sbjct: 31  CH-LRVVQCSDLGLEKVPKDL----PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 438
           N++S   P +F  L  L  L LS N    L   +      K L  L + +N +  ++ ++
Sbjct: 86  NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP-----KTLQELRVHENEI-TKVRKS 139

Query: 439 V-GGFESLMVLALGNCGLK-GHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFY 495
           V  G   ++V+ LG   LK   I     +  KKL  + ++  +    IP   G   +L  
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTE 196

Query: 496 LDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQA 551
           L    N +T ++     K L  L  L                           GL +N  
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKL---------------------------GLSFNSI 228

Query: 552 SSFPPSVF----------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSS----- 596
           S+                L+NN++   +P  +   K++ V+ L  NNI+  I S+     
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPP 286

Query: 597 --ISEIRNLEVLDLSSNDL-HGSI-PGSFEKLTFLSKFSVANN 635
              ++  +   + L SN + +  I P +F  +   +   + N 
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  100 bits (251), Expect = 5e-23
 Identities = 60/310 (19%), Positives = 102/310 (32%), Gaps = 40/310 (12%)

Query: 201 SKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 256
             +  +LDL  N       G  + L    +L  L + NN +    P +   +  L+ + L
Sbjct: 51  PPDTALLDLQNNKITEIKDGDFKNL---KNLHTLILINNKISKISPGAFAPLVKLERLYL 107

Query: 257 SVNNFSGQLSEKISNL-TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL-- 313
           S N    QL E    +  +L+ L +  N+ +    +V   L Q+      +N        
Sbjct: 108 SKN----QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 163

Query: 314 PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 373
             +     KL  + + + ++T    +      SL  L L  N  +     SL   ++L  
Sbjct: 164 NGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAK 220

Query: 374 LSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE 433
           L L+ N +S     S      L  L L+NN    + G L+     K +  + L  N +  
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH---KYIQVVYLHNNNI-S 276

Query: 434 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF-DGNIPPWI-GQME 491
            I  N   F                 P +  +      + L  N      I P     + 
Sbjct: 277 AIGSND--FCP---------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319

Query: 492 NLFYLDFSNN 501
               +   N 
Sbjct: 320 VRAAVQLGNY 329

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  112 bits (281), Expect = 5e-27
 Identities = 67/316 (21%), Positives = 111/316 (35%), Gaps = 52/316 (16%)

Query: 733  RPQRLSEALASSKLVL---FQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-L 788
            +P+R+S    +S+ +    +  S  +             F + + +G G +G V+K    
Sbjct: 27   QPRRVSFRGEASETLQSPGYDPSRPESFFQQS-------FQRLSRLGHGSYGEVFKVRSK 79

Query: 789  TNGTKAAVKRL-SGDCGQMERE-FQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYM 845
             +G   AVKR  S   G  +R    AEV +  +  QH   V L+         L +    
Sbjct: 80   EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQ--T 136

Query: 846  E--NGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 900
            E    SL         S+ +  V  +     +       LA+LH      +VH DVK +N
Sbjct: 137  ELCGPSLQQHCEAWGASLPEAQVWGY-----LRD-TLLALAHLH---SQGLVHLDVKPAN 187

Query: 901  ILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVV 960
            I L  +    L DFGL   L            G   Y+ PE  Q  +     DV+S G+ 
Sbjct: 188  IFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQG-SYGTAADVFSLGLT 244

Query: 961  LLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIAC 1020
            +LE+                         +  ++  +      +      +L  +L    
Sbjct: 245  ILEVACNMEL---------------PHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV--- 286

Query: 1021 KCIDQDPRRRPFIEEV 1036
              ++ DP+ R   E +
Sbjct: 287  MMLEPDPKLRATAEAL 302

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  114 bits (287), Expect = 5e-27
 Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 55/302 (18%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNL 825
            N      I+G G  G V       G   AVKR+  D          E++ L+    H N+
Sbjct: 15   NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 826  VSLQGYCRHGNDRLLIYSYME--NGSLDYWL---HESVDKDSVLKWDVRLKIAQGAARGL 880
            +    YC        +Y  +E  N +L   +   + S +   + K    + + +  A G+
Sbjct: 72   IRY--YCSE-TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAH-------------LADFGLSRLLRPYDTHV 927
            A+LH +    I+HRD+K  NIL+                    ++DFGL + L    +  
Sbjct: 129  AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 928  TTDL---VGTLGYIPPEYSQTLTATCRG-------DVYSFGVVLLELLT-GRRPVEVCKG 976
             T+L    GT G+  PE  +               D++S G V   +L+ G+ P      
Sbjct: 186  RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG---D 242

Query: 977  KNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE--KQLLEMLEIACKCIDQDPRRRPFIE 1034
            K  R+       +      ++ +              L+       + ID DP +RP   
Sbjct: 243  KYSRE-----SNIIRGIFSLDEMKCLHDRSLIAEATDLIS------QMIDHDPLKRPTAM 291

Query: 1035 EV 1036
            +V
Sbjct: 292  KV 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (283), Expect = 1e-26
 Identities = 59/304 (19%), Positives = 99/304 (32%), Gaps = 46/304 (15%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVS 827
            I+G G    V++      G   A+K               RE     E L +  HKN+V 
Sbjct: 16   ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE----FEVLKKLNHKNIVK 71

Query: 828  LQGYCRHGNDRL--LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
            L         R   LI  +   GSL   L E  +   + + +  + +      G+ +L +
Sbjct: 72   LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG-GMNHLRE 130

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
                 IVHR++K  NI+     +      L DFG +R L   D    + L GT  Y+ P+
Sbjct: 131  N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS-LYGTEEYLHPD 185

Query: 942  YSQTLTATCRG--------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 993
              +                D++S GV      TG  P    +G   R     ++++ + K
Sbjct: 186  MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKIITGK 243

Query: 994  REVEIIDASIWHKDREKQLLEML--------------EIACKCIDQDPRRRPFIEEVVTW 1039
                I               +M                +    ++ D  +    ++    
Sbjct: 244  PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

Query: 1040 LDGI 1043
               I
Sbjct: 304  TSDI 307

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (278), Expect = 2e-26
 Identities = 55/263 (20%), Positives = 97/263 (36%), Gaps = 49/263 (18%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVEALSR 819
           +S   + +   +G GGF   ++ +        A K   +          +   E+     
Sbjct: 38  RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97

Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             H+++V   G+     D   ++  +E     SL   L     + ++ + + R  + Q  
Sbjct: 98  LAHQHVVGFHGFFE---DNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQ-I 150

Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
             G  YLH+     ++HRD+K  N+ L+E  E  + DFGL+  +          L GT  
Sbjct: 151 VLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPN 206

Query: 937 YIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK--- 977
           YI PE      +S  +      DV+S G ++  LL G+ P E          + K +   
Sbjct: 207 YIAPEVLSKKGHSFEV------DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 260

Query: 978 ------NCRDLVSWVFQMKSEKR 994
                     L+  + Q     R
Sbjct: 261 PKHINPVAASLIQKMLQTDPTAR 283

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (274), Expect = 2e-26
 Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 20/204 (9%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
           +G GGF   ++ +        A K   +          +   E+       H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 831 YCRHGNDRLLIYSYME---NGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           +     D   ++  +E     SL +        + ++ + + R  + Q    G  YLH+ 
Sbjct: 83  FFE---DNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQ-IVLGCQYLHRN 134

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
               ++HRD+K  N+ L+E  E  + DFGL+  +          L GT  YI PE     
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKK 190

Query: 947 TATCRGDVYSFGVVLLELLTGRRP 970
             +   DV+S G ++  LL G+ P
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPP 214

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  108 bits (273), Expect = 3e-26
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 27/219 (12%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD---CGQMEREFQAEVEALSR 819
           +   +F   N++G G F  VY+A  +  G + A+K +         M +  Q EV+   +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67

Query: 820 AQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQGAA 877
            +H +++ L  Y    ++ + L+     NG +        ++       + R  + Q   
Sbjct: 68  LKHPSILELYNYF-EDSNYVYLVLEMCHNGEM---NRYLKNRVKPFSENEARHFMHQ-II 122

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
            G+ YLH      I+HRD+  SN+LL       +ADFGL+  L+       T L GT  Y
Sbjct: 123 TGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNY 178

Query: 938 IPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           I PE      +          DV+S G +   LL GR P
Sbjct: 179 ISPEIATRSAHGLES------DVWSLGCMFYTLLIGRPP 211

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  109 bits (275), Expect = 5e-26
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 52/237 (21%)

Query: 773 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 824
            ++G G FG V  AT           + AVK L       ER    +E++ +++   H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--------------- 869
           +V+L G C       LI+ Y   G L  +L    +K S  + +                 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 870 ----LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 925
               L  A   A+G+ +L        VHRD+ + N+L+       + DFGL+R +     
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI--MSD 225

Query: 926 HVTTDLVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                 V     +P     PE      Y      T + DV+S+G++L E+ + G  P
Sbjct: 226 SNYV--VRGNARLPVKWMAPESLFEGIY------TIKSDVWSYGILLWEIFSLGVNP 274

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (275), Expect = 5e-26
 Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 31/231 (13%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLS-----------------GDCGQM 806
           K  N++     +  G F  +      +    A+K+                         
Sbjct: 28  KYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86

Query: 807 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLK 865
             +F+ E++ ++  +++  ++ +G      D + +IY YMEN S+  +       D    
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 866 W----DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 921
                 V   I +      +Y+H   E +I HRDVK SNIL+D+     L+DFG S  + 
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 922 PYDTHVTTDLVGTLGYIPPE--YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             D  +     GT  ++PPE   +++     + D++S G+ L  +     P
Sbjct: 204 --DKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (268), Expect = 1e-25
 Identities = 61/304 (20%), Positives = 100/304 (32%), Gaps = 69/304 (22%)

Query: 766  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQ-AEVEALSR-AQ 821
            T  F++   IG G FG V+K     +G   A+KR      G ++ +    EV A +   Q
Sbjct: 10   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 822  HKNLVSLQGYCRHGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            H ++V         +D +LI + Y   GSL   + E+    S  K      +     RGL
Sbjct: 70   HSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 881  AYLHKVCEPHIVHRDVKSSNILLDE-------------------KFEAHLADFGLSRLLR 921
             Y+H      +VH D+K SNI +                     K    + D G    + 
Sbjct: 129  RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 922  PYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR 980
                       G   ++  E   +  T   + D+++  + ++                  
Sbjct: 186  SPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR-------- 232

Query: 981  DLVSWVFQMKSEKREVEIIDASIWHKDREKQL--------LEMLEIACKCIDQDPRRRPF 1032
                               +   WH+ R+ +L         E  E+    I  DP RRP 
Sbjct: 233  -------------------NGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPS 273

Query: 1033 IEEV 1036
               +
Sbjct: 274  AMAL 277

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  107 bits (268), Expect = 2e-25
 Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 10/197 (5%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G VY A  +  G + A+++++      +     E+  +   ++ N+V+      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G++  ++  Y+  GSL       V  ++ +       + +   + L +LH      ++H
Sbjct: 88  VGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+KS NILL       L DFG    + P  +  +T +VGT  ++ PE         + D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 198

Query: 954 VYSFGVVLLELLTGRRP 970
           ++S G++ +E++ G  P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (266), Expect = 3e-25
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 27/215 (12%)

Query: 769 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 827
           +     +G G FG VYKA     G  AA K +     +   ++  E+E L+   H  +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK------IAQGAARGLA 881
           L G   H     ++  +   G++D           +L+ D  L       + +     L 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVD---------AIMLELDRGLTEPQIQVVCRQMLEALN 131

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY---- 937
           +LH      I+HRD+K+ N+L+  + +  LADFG+S           +  +GT  Y    
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTP-YWMAP 186

Query: 938 --IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             +  E  +      + D++S G+ L+E+     P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (266), Expect = 3e-25
 Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 11/198 (5%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 832
           IG G FG V+K          A+K +  +  + E E  Q E+  LS+     +    G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 833 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                  +I  Y+  GS        + +   L       I +   +GL YLH       +
Sbjct: 90  LKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE---KKI 141

Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           HRD+K++N+LL E  E  LADFG++  L        T  VGT  ++ PE  +      + 
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKA 200

Query: 953 DVYSFGVVLLELLTGRRP 970
           D++S G+  +EL  G  P
Sbjct: 201 DIWSLGITAIELARGEPP 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (267), Expect = 4e-25
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 10/197 (5%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           IG G  G+V  A    +G + AVK +     Q       EV  +   QH N+V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            G +  ++  +++ G+L       +     L  +    + +   + LAYLH      ++H
Sbjct: 113 VGEELWVLMEFLQGGALT-----DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIH 164

Query: 894 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
           RD+KS +ILL       L+DFG    +        + LVGT  ++ PE           D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLYATEVD 223

Query: 954 VYSFGVVLLELLTGRRP 970
           ++S G++++E++ G  P
Sbjct: 224 IWSLGIMVIEMVDGEPP 240

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (263), Expect = 6e-25
 Identities = 61/252 (24%), Positives = 103/252 (40%), Gaps = 35/252 (13%)

Query: 767 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGD---CGQMEREFQAEVEALSRAQH 822
           ++F+    +G G FG VY A    N    A+K L         +E + + E+E  S  +H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 823 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            N++ +  Y  H   R+ L+  +   G L    ++ + K             +  A  L 
Sbjct: 74  PNILRMYNYF-HDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALH 128

Query: 882 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
           Y H+     ++HRD+K  N+L+  K E  +ADFG S       +     + GTL Y+PPE
Sbjct: 129 YCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLDYLPPE 182

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDL 982
             +  T   + D++  GV+  E L G  P +          +               +DL
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242

Query: 983 VSWVFQMKSEKR 994
           +S + +    +R
Sbjct: 243 ISKLLRYHPPQR 254

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  105 bits (265), Expect = 6e-25
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 16/204 (7%)

Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMERE-FQAEVEALSRA-QHKNLVSLQGY 831
           +G G  G V+K      G   AVK++     + E +    +++ + ++     +V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                D  +    M   +              +   +  K+     + L YL +  +  +
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE--KHGV 146

Query: 892 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA--- 948
           +HRDVK SNILLDE+ +  L DFG+S  L   D        G   Y+ PE          
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKP 204

Query: 949 --TCRGDVYSFGVVLLELLTGRRP 970
               R DV+S G+ L+EL TG+ P
Sbjct: 205 DYDIRADVWSLGISLVELATGQFP 228

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  105 bits (264), Expect = 7e-25
 Identities = 62/239 (25%), Positives = 102/239 (42%), Gaps = 26/239 (10%)

Query: 743 SSKLVLFQNSDCKDLTVSDLLKSTNN----FNQANIIGCGGFGLVYKAT-LTNGTKAAVK 797
           S + V  +N   + L   D    T      F+    +G G +G VYKA     G   A+K
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 798 RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES 857
           ++        +E   E+  + +    ++V   G      D  ++  Y   GS+       
Sbjct: 61  QV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS------ 112

Query: 858 VDKDSVLKWDVRLK------IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL 911
              D +   +  L       I Q   +GL YLH +     +HRD+K+ NILL+ +  A L
Sbjct: 113 ---DIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKL 166

Query: 912 ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           ADFG++  L        T ++GT  ++ PE  Q +   C  D++S G+  +E+  G+ P
Sbjct: 167 ADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (263), Expect = 9e-25
 Identities = 67/315 (21%), Positives = 120/315 (38%), Gaps = 63/315 (20%)

Query: 764  KSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS---------GDCGQMERE 809
             ST+ F +      I+G G   +V +        + AVK +           +  ++   
Sbjct: 10   HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 810  FQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV 868
               EV+ L + + H N++ L+          L++  M+ G L        +K ++ + + 
Sbjct: 70   TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL---FDYLTEKVTLSEKET 126

Query: 869  RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 928
            R  +       +  LHK+   +IVHRD+K  NILLD+     L DFG S  L P      
Sbjct: 127  RKIMRA-LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKL 180

Query: 929  TDLVGTLGYIPPE-YSQTLTATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRDL 982
             ++ GT  Y+ PE    ++     G     D++S GV++  LL G  P            
Sbjct: 181  REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------------ 228

Query: 983  VSWVFQMKSEKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFI 1033
                F  + +   + +I        +  W    D  K L+       + +   P++R   
Sbjct: 229  ----FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV------SRFLVVQPQKRYTA 278

Query: 1034 EEVVT--WLDGIGID 1046
            EE +   +     ++
Sbjct: 279  EEALAHPFFQQYVVE 293

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (263), Expect = 1e-24
 Identities = 60/334 (17%), Positives = 99/334 (29%), Gaps = 73/334 (21%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
            T+L L    +  +       L  L  L L  N +  +     S L++L+ L +S N L 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 203
                + + L     L +  N                   +    F+G  N         
Sbjct: 116 EIPPNLPSSL---VELRIHDNRIR---------------KVPKGVFSGLRN--------- 148

Query: 204 IQILDLSMNHFM------GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS 257
           +  +++  N         G+  GL     L  L +    L   +P  L    +L  + L 
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGL----KLNYLRISEAKL-TGIPKDL--PETLNELHLD 201

Query: 258 VNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL 317
            N       E +   + L  L +  NQ           +  +      + S S       
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQ-----------IRMI-----ENGSLSF------ 239

Query: 318 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHD------L 371
                L  L L NN L+  +      L  L  + L TN+ +    N              
Sbjct: 240 --LPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYY 296

Query: 372 KILSLAKNELSGQV--PESFGKLTSLLFLSLSNN 403
             +SL  N +      P +F  +T  L +   N 
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  101 bits (253), Expect = 3e-23
 Identities = 57/308 (18%), Positives = 97/308 (31%), Gaps = 37/308 (12%)

Query: 201 SKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 256
           S +  +LDL  N          +GL     L  L + NN +      +   +  LQ + +
Sbjct: 53  SPDTTLLDLQNNDISELRKDDFKGL---QHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109

Query: 257 SVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF-SGPLPL 315
           S N+   ++   +   +SL  L I  N+       V   L  +       N   +     
Sbjct: 110 SKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166

Query: 316 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 375
                 KL+ L +    LT    +      +L  L L  N         L     L  L 
Sbjct: 167 GAFDGLKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLG 223

Query: 376 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 435
           L  N++      S   L +L  L L NN  + +   L  L   K L  + L  N +  ++
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDL---KLLQVVYLHTNNI-TKV 279

Query: 436 PENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD-GNIPPWIGQ-MENL 493
             N   F  +                + ++      + L  N      + P   + + + 
Sbjct: 280 GVND--FCPV---------------GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR 322

Query: 494 FYLDFSNN 501
             + F N 
Sbjct: 323 LAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 64/365 (17%), Positives = 119/365 (32%), Gaps = 98/365 (26%)

Query: 320 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
           C  L V+   +  L   P +++         LDL  N  S    +       L  L L  
Sbjct: 33  CH-LRVVQCSDLGLKAVPKEIS----PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 438
           N++S    ++F  L  L  L +S N    +   L       +L  L +  N +  ++P+ 
Sbjct: 88  NKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP-----SSLVELRIHDNRI-RKVPKG 141

Query: 439 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF-DGNIPPWIGQMENLFYLD 497
           V  F  L                     + +  +++  N   +    P       L YL 
Sbjct: 142 V--FSGL---------------------RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLR 178

Query: 498 FSNNTLTG---EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF 554
            S   LTG   ++P++L EL                               L +N+  + 
Sbjct: 179 ISEAKLTGIPKDLPETLNELH------------------------------LDHNKIQAI 208

Query: 555 PPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNL 603
                          L +N+I   I       L  L  L L  N ++  +P+ + +++ L
Sbjct: 209 ELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL 266

Query: 604 EVLDLSSNDLHGSIP-------GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFE 656
           +V+ L +N++   +        G   K  + +  S+ NN +         ++    ++F 
Sbjct: 267 QVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPV--------PYWEVQPATFR 317

Query: 657 GNPGL 661
                
Sbjct: 318 CVTDR 322

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 96.2 bits (240), Expect = 2e-21
 Identities = 54/302 (17%), Positives = 94/302 (31%), Gaps = 40/302 (13%)

Query: 323 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 382
             +LDL+NN ++     +F GL  L  L L  N  S     + S    L+ L ++KN L 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

Query: 383 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEE-IPENVGG 441
              P     L  L    + +N    +     V    +N+  + +  N +           
Sbjct: 116 EIPPNLPSSLVEL---RIHDNRIRKVPK--GVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 442 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSN 500
              L  L +    L   IP  L     L  L L  N     I      +   L+ L   +
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226

Query: 501 NTLTGEIP----KSLTELKSL-ISSNCTSSNPTASAGIP----LYVKHNRSTNGLPYNQA 551
           N +   I       L  L+ L + +N  S  P     +     +Y         L  N  
Sbjct: 227 NQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVY---------LHTNNI 276

Query: 552 SSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTI--PSSISEIRNLEVLDLS 609
           +    + F               +  + + + L  N +      P++   + +   +   
Sbjct: 277 TKVGVNDFCPVGFGV--------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328

Query: 610 SN 611
           + 
Sbjct: 329 NY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 68/323 (21%), Positives = 108/323 (33%), Gaps = 78/323 (24%)

Query: 341 FSGLSSLCTLDLATNHFSGPLPNSLSDCH-DLKILSLAKNELSGQVPESFGKLTSLLFLS 399
            SG+  L +L      +S   P     CH  L+++  +   L   VP+          L 
Sbjct: 10  TSGIPDLDSLPPT---YSAMCP---FGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLD 60

Query: 400 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHI 459
           L NN  + L       +  ++L  L+L  N +  +I E    F  L              
Sbjct: 61  LQNNDISELRK--DDFKGLQHLYALVLVNNKI-SKIHEKA--FSPL-------------- 101

Query: 460 PVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPK-SLTELKSLI 518
                  +KLQ L +S NH    IPP      +L  L   +N +  ++PK   + L+++ 
Sbjct: 102 -------RKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMN 150

Query: 519 SSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF---------LSNNRINGTI 569
                           + +  N   N       S F P  F         +S  ++   I
Sbjct: 151 C---------------IEMGGNPLEN-------SGFEPGAFDGLKLNYLRISEAKLT-GI 187

Query: 570 PPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSK 629
           P ++   + L+ L L  N I       +     L  L L  N +     GS   L  L +
Sbjct: 188 PKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245

Query: 630 FSVANNHLQGTIPTGGQFYSFPN 652
             + NN L   +P G        
Sbjct: 246 LHLDNNKLS-RVPAG--LPDLKL 265

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 2e-24
 Identities = 46/206 (22%), Positives = 76/206 (36%), Gaps = 16/206 (7%)

Query: 776 GCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNLVSLQGYC 832
           G      V  A     G    V+R++ +    E     Q E+       H N+V  +   
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 833 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
              N+  ++ S+M  GS    +         +       I QG  + L Y+H +     V
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHM---GYV 150

Query: 893 HRDVKSSNILLDEKFEAHLADFGLSRLL------RPYDTHVTTDLVGTLGYIPPE-YSQT 945
           HR VK+S+IL+    + +L+    +  +      +          V  L ++ PE   Q 
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210

Query: 946 LTA-TCRGDVYSFGVVLLELLTGRRP 970
           L     + D+YS G+   EL  G  P
Sbjct: 211 LQGYDAKSDIYSVGITACELANGHVP 236

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (257), Expect = 5e-24
 Identities = 69/271 (25%), Positives = 111/271 (40%), Gaps = 27/271 (9%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 832
            IG G   +V  A       K A+KR++ +  Q   +    E++A+S+  H N+VS     
Sbjct: 23   IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 833  RHGNDRLLIYSYMENGSL----DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
               ++  L+   +  GS+     + + +   K  VL       I +    GL YLHK   
Sbjct: 83   VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140

Query: 889  PHIVHRDVKSSNILLDEKFEAHLADFG----LSRLLRPYDTHVTTDLVGTLGYIPPE-YS 943
               +HRDVK+ NILL E     +ADFG    L+         V    VGT  ++ PE   
Sbjct: 141  -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199

Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
            Q      + D++SFG+  +EL TG  P         +     V  +  +     +     
Sbjct: 200  QVRGYDFKADIWSFGITAIELATGAAP-------YHKYPPMKVLMLTLQNDPPSLETGVQ 252

Query: 1004 WHKDREK---QLLEMLEIACKCIDQDPRRRP 1031
              +  +K      +M+     C+ +DP +RP
Sbjct: 253  DKEMLKKYGKSFRKMIS---LCLQKDPEKRP 280

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  105 bits (263), Expect = 1e-23
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 35/286 (12%)

Query: 762  LLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRL--SGDCGQMEREFQAEV 814
            +     + ++       +G G +G V          + A+K +  +        +   EV
Sbjct: 28   ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 815  EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
              L    H N++ L  +     +  L+    + G L     E + +    + D    I +
Sbjct: 88   AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---FDEIIHRMKFNEVDAA-VIIK 143

Query: 875  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDL 931
                G+ YLHK    +IVHRD+K  N+LL+ K +     + DFGLS +          + 
Sbjct: 144  QVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKER 198

Query: 932  VGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
            +GT  YI PE   +     C  DV+S GV+L  LL G  P     G+  ++++  V + K
Sbjct: 199  LGTAYYIAPEVLRKKYDEKC--DVWSIGVILFILLAGYPP---FGGQTDQEILRKVEKGK 253

Query: 991  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                  E  + S   KD  KQ+L+           D +RR   ++ 
Sbjct: 254  YTFDSPEWKNVSEGAKDLIKQMLQF----------DSQRRISAQQA 289

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  105 bits (263), Expect = 1e-23
 Identities = 55/330 (16%), Positives = 99/330 (30%), Gaps = 69/330 (20%)

Query: 329 RNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPES 388
            NN+ +   +  ++ +S                 ++        +    +NE    + E 
Sbjct: 7   INNNFSLSQNSFYNTISGTYAD----------YFSAWDKWEKQALPGENRNEAVSLLKEC 56

Query: 389 FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVL 448
              +     L L+  + + L   L        +T L +T+N +   +PE      SL  L
Sbjct: 57  L--INQFSELQLNRLNLSSLPDNL-----PPQITVLEITQNAL-ISLPELPA---SLEYL 105

Query: 449 ALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 508
              +  L   +P      K L   D+  N     +P        L Y++  NN LT  +P
Sbjct: 106 DACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPA---LLEYINADNNQLT-MLP 156

Query: 509 KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSV------FLSN 562
           +  T L+ L                            +  NQ +  P          +S 
Sbjct: 157 ELPTSLEVLS---------------------------VRNNQLTFLPELPESLEALDVST 189

Query: 563 NRINGTIPPEIGQLKHL----HVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 618
           N +  ++P    +  H            N IT  IP +I  +     + L  N L   I 
Sbjct: 190 NLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247

Query: 619 GSFEKLTFLSKFSVANNHLQGTIPTGGQFY 648
            S  + T    +     +   +       +
Sbjct: 248 ESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  103 bits (258), Expect = 6e-23
 Identities = 55/298 (18%), Positives = 108/298 (36%), Gaps = 32/298 (10%)

Query: 122 VPVELSNLKQLEV-LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGE--FSN 178
           + + L       +  +  +N +SG  +   +  +  +   +   + N ++  L E   + 
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60

Query: 179 LAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSP-SLKQLHVDNNLL 237
            +   ++  + +  L   +     +I +L+++ N     L  L   P SL+ L   +N L
Sbjct: 61  FSELQLNRLNLS-SLPDNL---PPQITVLEITQNA----LISLPELPASLEYLDACDNRL 112

Query: 238 GGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLT 297
              LP+     +SL+H+ +  N  +  L E  + L  +       NQ +  LP +  +L 
Sbjct: 113 S-TLPELP---ASLKHLDVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPTSLE 163

Query: 298 QLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG-P--IDLNFSGLSSLCTLDLAT 354
            L      +N  +  LP        L  LD+  N L   P     N     +        
Sbjct: 164 VLS---VRNNQLTF-LPELPE---SLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRE 216

Query: 355 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL 412
           N  +  +P ++        + L  N LS ++ ES  + T+          F+   G  
Sbjct: 217 NRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  101 bits (252), Expect = 3e-22
 Identities = 63/338 (18%), Positives = 112/338 (33%), Gaps = 35/338 (10%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPV-ELSNLKQLEVLDLSHNMLSG-PVSGMLA 151
           + G         ++ +   L   +    V + +   + Q   L L+   LS  P +    
Sbjct: 22  ISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSLPDN---- 77

Query: 152 GLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSM 211
               I  L ++ N+   SL E    ++L   +  +N  +  L     S    ++ LD+  
Sbjct: 78  LPPQITVLEITQNAL-ISLPE--LPASLEYLDACDNRLS-TLPELPAS----LKHLDVDN 129

Query: 212 NHFMGSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS 270
           N     L  L   P  L+ ++ DNN L   LP+     +SL+ +S+  N    QL+    
Sbjct: 130 NQ----LTMLPELPALLEYINADNNQL-TMLPELP---TSLEVLSVRNN----QLTFLPE 177

Query: 271 NLTSLRHLIIFGNQFSGKLPNVLGNLTQLE----FFVAHSNSFSGPLPLSLSLCSKLHVL 326
              SL  L +  N     LP V       E    FF    N  +  +P ++        +
Sbjct: 178 LPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTI 235

Query: 327 DLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVP 386
            L +N L+  I  + S  ++         +FS       +    L               
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT--AWFPENKQ 293

Query: 387 ESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 424
               ++          N+F+     LS     +N +  
Sbjct: 294 SDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGF 331

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 90.4 bits (224), Expect = 8e-19
 Identities = 60/364 (16%), Positives = 107/364 (29%), Gaps = 96/364 (26%)

Query: 248 MSSLQHVSLSVNNFSGQLS----EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFV 303
           +    + SLS N+F   +S    +  S         + G                L    
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGEN--------RNEAVSL---- 52

Query: 304 AHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN 363
                      L   L ++   L L   +L+    L  +    +  L++  N     LP 
Sbjct: 53  -----------LKECLINQFSELQLNRLNLS---SLPDNLPPQITVLEITQNALI-SLPE 97

Query: 364 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 423
             +    L+ L    N LS  +PE    L  L    + NN    L    +       L  
Sbjct: 98  LPAS---LEYLDACDNRLS-TLPELPASLKHL---DVDNNQLTMLPELPA------LLEY 144

Query: 424 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNI 483
           +    N +   +PE      SL VL++ N  L   +P      + L+ LD+S N  + ++
Sbjct: 145 INADNNQL-TMLPELPT---SLEVLSVRNNQLT-FLPELP---ESLEALDVSTNLLE-SL 195

Query: 484 PPWIGQMENL----FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 539
           P    +  +      +     N +T  IP+++  L    +                    
Sbjct: 196 PAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT-------------------- 234

Query: 540 NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 599
                             + L +N ++  I   + Q          R   + +     + 
Sbjct: 235 ------------------IILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276

Query: 600 IRNL 603
            R L
Sbjct: 277 HRPL 280

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 29/213 (13%), Positives = 58/213 (27%), Gaps = 20/213 (9%)

Query: 98  IPRSLGHLNQLK----LLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           +P      +  +          N +   +P  + +L     + L  N LS  +   L+  
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253

Query: 154 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNN--SFTGKLNSRIWSASKEIQILDLSM 211
                 +     F+ S  +           ++           S+IW A +     +   
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEH----EEHA 309

Query: 212 NHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISN 271
           N F   L  L  + S +            +   L  +S+   +       +   +E   +
Sbjct: 310 NTFSAFLDRLSDTVSARNTS----GFREQVAAWLEKLSASAELRQQSFAVAADATESCED 365

Query: 272 LTSLRHLIIFGNQF-----SGKLPNVLGNLTQL 299
             +L    +           G   N  G L  L
Sbjct: 366 RVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (256), Expect = 1e-23
 Identities = 62/338 (18%), Positives = 114/338 (33%), Gaps = 48/338 (14%)

Query: 308 SFSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLS 366
           S       +   C +  +    + SL   P  L      ++ +LDL+ N  +    + L 
Sbjct: 18  SKEESSNQASLSCDRNGICKGSSGSLNSIPSGLT----EAVKSLDLSNNRITYISNSDLQ 73

Query: 367 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 426
            C +L+ L L  N ++    +SF  L SL  L LS N  ++LS   S  +   +LT L L
Sbjct: 74  RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSS--SWFKPLSSLTFLNL 131

Query: 427 TKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPV-WLLRCKKLQVLDLSWNHFDGNIP 484
             N        ++      L +L +GN      I          L+ L++  +      P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191

Query: 485 PWIGQMENLFYLDFSNNTLT---GEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNR 541
             +  ++N+ +L                  + ++ L   +                    
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD-------------------- 231

Query: 542 STNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIR 601
               L     S        S           + +      + ++  ++   +   +++I 
Sbjct: 232 --TDLDTFHFSELSTGETNS-----------LIKKFTFRNVKITDESLF-QVMKLLNQIS 277

Query: 602 NLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQ 638
            L  L+ S N L  S+P G F++LT L K  +  N   
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  101 bits (254), Expect = 2e-23
 Identities = 71/313 (22%), Positives = 108/313 (34%), Gaps = 37/313 (11%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
           V  L L    +  I    L     L+ L L+ N +  +     S+L  LE LDLS+N LS
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 203
              S     L+ +  LN+  N +  +L E   FS+L            KL          
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHL-----------TKLQILRVGNMDT 161

Query: 204 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 263
              +            GL     L++L +D + L    P SL S+ ++ H+ L +     
Sbjct: 162 FTKIQR------KDFAGL---TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212

Query: 264 QLSEKISNLTSLRHLIIFGNQFSG----KLP----NVLGNLTQLEFFVAHSNSFSGPLPL 315
            L   +   +S+  L +           +L     N L              S    + L
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL 272

Query: 316 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 375
              + S L  L+   N L    D  F  L+SL  + L TN +          C  +  LS
Sbjct: 273 LNQI-SGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYLS 324

Query: 376 LAKNELSGQVPES 388
              N+ S +   S
Sbjct: 325 RWLNKNSQKEQGS 337

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 57/267 (21%), Positives = 103/267 (38%), Gaps = 13/267 (4%)

Query: 224 SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFG 282
           + ++K L + NN +       L    +LQ + L+ N  +  + E   S+L SL HL +  
Sbjct: 51  TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSY 109

Query: 283 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL-SLCSKLHVLDLRNNSLTGPIDLN- 340
           N  S    +    L+ L F     N +      SL S  +KL +L + N      I    
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 341 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSL 400
           F+GL+ L  L++  +      P SL    ++  L L   +    +       +S+  L L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229

Query: 401 SNNSFNHL------SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCG 454
            +   +        +G  + L +      + +T   +  ++ + +     L+ L      
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQ 288

Query: 455 LKGHIPVWLL-RCKKLQVLDLSWNHFD 480
           LK  +P  +  R   LQ + L  N +D
Sbjct: 289 LKS-VPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.0 bits (156), Expect = 8e-11
 Identities = 53/321 (16%), Positives = 94/321 (29%), Gaps = 82/321 (25%)

Query: 347 LCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFN 406
                + +         +   C    I   +   L+  +P       ++  L LSNN   
Sbjct: 9   WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT 65

Query: 407 HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRC 466
           ++S   S LQ+C NL  L+LT N +   I E+   F SL                     
Sbjct: 66  YISN--SDLQRCVNLQALVLTSNGI-NTIEEDS--FSSL--------------------- 99

Query: 467 KKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSNNTLT----GEIPKSLTELKSLISSN 521
             L+ LDLS+N+   N+   W   + +L +L+   N         +   LT+L+ L   N
Sbjct: 100 GSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158

Query: 522 CTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHV 581
                                      +  +      F                L  L  
Sbjct: 159 M--------------------------DTFTKIQRKDFAG--------------LTFLEE 178

Query: 582 LDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGT 640
           L++  +++    P S+  I+N+  L L        +     +  + +    + +  L   
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237

Query: 641 IPTGGQFYSFPNSSFEGNPGL 661
                 F              
Sbjct: 238 -----HFSELSTGETNSLIKK 253

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (260), Expect = 1e-23
 Identities = 46/232 (19%), Positives = 86/232 (37%), Gaps = 12/232 (5%)

Query: 203 EIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 258
             ++L+L  N        S + L     L+ L +  N +      +   +++L  + L  
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHL---RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121

Query: 259 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEF-FVAHSNSFSGPLPLSL 317
           N  +   +     L+ L+ L +  N            +  L    +      S     + 
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181

Query: 318 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 377
              S L  L+L   +L   I  N + L  L  LDL+ NH S   P S      L+ L + 
Sbjct: 182 EGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239

Query: 378 KNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
           ++++      +F  L SL+ ++L++N+   L     +     +L  + L  N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH--DLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  100 bits (252), Expect = 2e-22
 Identities = 65/326 (19%), Positives = 114/326 (34%), Gaps = 77/326 (23%)

Query: 82  GRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNM 141
            + + +I  RK L+ + P  +      +LL+L  N ++ +      +L+ LE+L LS N 
Sbjct: 43  NQFSKVICVRKNLREV-PDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 142 LSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSAS 201
           +     G   GL  + +L +  N                +  I N +F            
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNR---------------LTTIPNGAFVY---------- 134

Query: 202 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
                                    LK+L + NN +      +   + SL+ + L     
Sbjct: 135 ----------------------LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172

Query: 262 SGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLC 320
              +SE     L++LR+L +       ++PN L  L +L+                    
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDE------------------- 211

Query: 321 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNE 380
                LDL  N L+     +F GL  L  L +  +       N+  +   L  ++LA N 
Sbjct: 212 -----LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266

Query: 381 LSGQVPESFGKLTSLLFLSLSNNSFN 406
           L+    + F  L  L  + L +N +N
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 97.9 bits (244), Expect = 2e-21
 Identities = 63/294 (21%), Positives = 98/294 (33%), Gaps = 69/294 (23%)

Query: 323 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 382
             +L+L  N +      +F  L  L  L L+ NH       + +   +L  L L  N L+
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125

Query: 383 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GG 441
                +F  L+ L  L L NN    +        +  +L  L L +      I E    G
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIESIPS--YAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 442 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 501
             +L  L L  C L+  IP  L    KL  LDLS NH    I P        F       
Sbjct: 184 LSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRP------GSF------- 227

Query: 502 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLS 561
                  + L  L+ L                            +  +Q      + F +
Sbjct: 228 -------QGLMHLQKL---------------------------WMIQSQIQVIERNAFDN 253

Query: 562 NNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLH 614
                         L+ L  ++L+ NN+T  +P  + + + +LE + L  N  +
Sbjct: 254 --------------LQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 83.6 bits (207), Expect = 7e-17
 Identities = 63/327 (19%), Positives = 109/327 (33%), Gaps = 85/327 (25%)

Query: 345 SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNS 404
           +    +     +    +P+ +S   + ++L+L +N++      SF  L  L  L LS N 
Sbjct: 43  NQFSKVICVRKNLRE-VPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 405 FNHL-SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWL 463
              +  G  + L    NL TL L  N +   IP     F  L                  
Sbjct: 100 IRTIEIGAFNGL---ANLNTLELFDNRL-TTIPNGA--FVYL------------------ 135

Query: 464 LRCKKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSNNTLTGEIP----KSLTELKSLI 518
               KL+ L L  N  + +IP     ++ +L  LD         I     + L+ L+ L 
Sbjct: 136 ---SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191

Query: 519 SSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKH 578
                                                    L+   +     P +  L  
Sbjct: 192 -----------------------------------------LAMCNL--REIPNLTPLIK 208

Query: 579 LHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 638
           L  LDLS N+++   P S   + +L+ L +  + +      +F+ L  L + ++A+N+L 
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268

Query: 639 GTIPTGGQFYSFPNS---SFEGNPGLC 662
             +P    F    +        NP  C
Sbjct: 269 -LLP-HDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 19/89 (21%), Positives = 41/89 (46%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 138
           +   ++  L L    L  I P S   L  L+ L +  + ++ +      NL+ L  ++L+
Sbjct: 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263

Query: 139 HNMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
           HN L+     +   L+ ++ +++  N +N
Sbjct: 264 HNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 2e-23
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 20/229 (8%)

Query: 755 KDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAE 813
            ++ +S L      F    ++G G +G VYK   +  G  AA+K +    G  E E + E
Sbjct: 12  DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQE 70

Query: 814 VEALSRA-QHKNLVS-----LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKW 866
           +  L +   H+N+ +     ++      +D+L L+  +   GS+   +  +      LK 
Sbjct: 71  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--TLKE 128

Query: 867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 926
           +    I +   RGL++LH+     ++HRD+K  N+LL E  E  L DFG+S  L      
Sbjct: 129 EWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185

Query: 927 VTTDLVGTLGYIPPEYSQTLTAT-----CRGDVYSFGVVLLELLTGRRP 970
             T  +GT  ++ PE              + D++S G+  +E+  G  P
Sbjct: 186 RNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (251), Expect = 2e-23
 Identities = 45/211 (21%), Positives = 75/211 (35%), Gaps = 8/211 (3%)

Query: 201 SKEIQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 256
               Q + L  N        S +      +L  L + +N+L      +   ++ L+ + L
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRAC---RNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87

Query: 257 SVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPL 315
           S N     +       L  L  L +         P +   L  L++     N+       
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 316 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 375
           +      L  L L  N ++   +  F GL SL  L L  N  +   P++  D   L  L 
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 376 LAKNELSGQVPESFGKLTSLLFLSLSNNSFN 406
           L  N LS    E+   L +L +L L++N + 
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 48/264 (18%), Positives = 93/264 (35%), Gaps = 60/264 (22%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           +P  +      + + L  N +  V        + L +L L  N+L+              
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-------------- 69

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM-- 215
              + + +F G        + L   ++S+N+    ++   +     +  L L        
Sbjct: 70  --RIDAAAFTG-------LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120

Query: 216 --GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNL 272
             G  +GL    +L+ L++ +N L     D+   + +L H+ L  N  S  + E+    L
Sbjct: 121 GPGLFRGL---AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGL 176

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 332
            SL  L++  N+ +   P+   +L +L                          L L  N+
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLM------------------------TLYLFANN 212

Query: 333 LTG-PIDLNFSGLSSLCTLDLATN 355
           L+  P +   + L +L  L L  N
Sbjct: 213 LSALPTEA-LAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 47/207 (22%), Positives = 71/207 (34%), Gaps = 7/207 (3%)

Query: 249 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNS 308
           ++ Q + L  N  S   +       +L  L +  N  +         L  LE      N+
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 309 FSGPLPLS-LSLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLS 366
               +  +      +LH L L    L      L F GL++L  L L  N       ++  
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL-FRGLAALQYLYLQDNALQALPDDTFR 150

Query: 367 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 426
           D  +L  L L  N +S     +F  L SL  L L  N   H+       +    L TL L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP--HAFRDLGRLMTLYL 208

Query: 427 TKNFVGEEIPENV-GGFESLMVLALGN 452
             N +   +P        +L  L L +
Sbjct: 209 FANNL-SALPTEALAPLRALQYLRLND 234

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 42/248 (16%), Positives = 71/248 (28%), Gaps = 52/248 (20%)

Query: 434 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP-WIGQMEN 492
            +P  +    +   + L    +          C+ L +L L  N     I       +  
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLAL 81

Query: 493 LFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 548
           L  LD S+N     +       L  L +L                            L  
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLH---------------------------LDR 114

Query: 549 NQASSFPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI 597
                  P +F          L +N +   +P +    L +L  L L  N I+     + 
Sbjct: 115 CGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173

Query: 598 SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSF-- 655
             + +L+ L L  N +    P +F  L  L    +  N+L   +P            +  
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALP-TEALAPLRALQYLR 231

Query: 656 -EGNPGLC 662
              NP +C
Sbjct: 232 LNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 54/289 (18%), Positives = 87/289 (30%), Gaps = 84/289 (29%)

Query: 367 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 426
            C    + +         VP       +   + L  N  +H+    +  + C+NLT L L
Sbjct: 17  SCPQQGLQA---------VPVGI--PAASQRIFLHGNRISHVPA--ASFRACRNLTILWL 63

Query: 427 TKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP- 485
             N +   I      F  L                       L+ LDLS N    ++ P 
Sbjct: 64  HSNVL-ARIDA--AAFTGL---------------------ALLEQLDLSDNAQLRSVDPA 99

Query: 486 WIGQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNR 541
               +  L  L      L  E+     + L  L+ L                        
Sbjct: 100 TFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY----------------------- 135

Query: 542 STNGLPYNQASSFPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNIT 590
               L  N   + P   F          L  NRI+ ++P      L  L  L L +N + 
Sbjct: 136 ----LQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA 190

Query: 591 GTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQ 638
              P +  ++  L  L L +N+L  ++P  +   L  L    + +N   
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 48/212 (22%), Positives = 78/212 (36%), Gaps = 32/212 (15%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCN-HLEGVVPVELSNLKQLEVLDL 137
                +T+L L    L  I   +   L  L+ LDLS N  L  V P     L +L  L L
Sbjct: 53  RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112

Query: 138 SHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRI 197
               L     G+  GL  +Q L +  N+                  + +++F    N   
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQ---------------ALPDDTFRDLGN--- 154

Query: 198 WSASKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 253
                 +  L L  N        + +GL    SL +L +  N +    P +   +  L  
Sbjct: 155 ------LTHLFLHGNRISSVPERAFRGL---HSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 254 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 285
           + L  NN S   +E ++ L +L++L +  N +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 25/89 (28%), Positives = 39/89 (43%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 138
            + G +T L L    +  +  R+   L+ L  L L  N +  V P    +L +L  L L 
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209

Query: 139 HNMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
            N LS   +  LA L  +Q L ++ N + 
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWV 238

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (255), Expect = 3e-23
 Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 32/278 (11%)

Query: 716 SRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLL---KSTNNFNQA 772
            RR     + D           ++ L  ++    +N   + +   D L    +   F Q 
Sbjct: 36  QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK 95

Query: 773 ----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS--------GDCGQMEREFQAEVEALSR 819
               ++IG G   +V +      G + AVK +             ++    + E   L +
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 820 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
            A H ++++L       +   L++  M  G L        +K ++ + + R  +      
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGEL---FDYLTEKVALSEKETRSIMRS-LLE 211

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
            +++LH     +IVHRD+K  NILLD+  +  L+DFG S  L P       +L GT GY+
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELCGTPGYL 266

Query: 939 PPE-YSQTLTATCRG-----DVYSFGVVLLELLTGRRP 970
            PE    ++  T  G     D+++ GV+L  LL G  P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  100 bits (250), Expect = 4e-23
 Identities = 59/311 (18%), Positives = 102/311 (32%), Gaps = 73/311 (23%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           +P  +   +    L+L  N L+ +       L QL  L LS N LS              
Sbjct: 22  VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-------------- 65

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
                S S  G        ++L   ++S N                  ++ +S       
Sbjct: 66  FKGCCSQSDFG-------TTSLKYLDLSFN-----------------GVITMS------- 94

Query: 218 LQGLDHSPSLKQLHVDNNLLGGDLPDSL-YSMSSLQHVSLSVNNFSGQLSEKISNLTSLR 276
                    L+ L   ++ L      S+  S+ +L ++ +S  +     +   + L+SL 
Sbjct: 95  -SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 153

Query: 277 HLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 336
            L + GN F                     + F+            L  LDL    L   
Sbjct: 154 VLKMAGNSFQENFL---------------PDIFTE--------LRNLTFLDLSQCQLEQL 190

Query: 337 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL-TSL 395
               F+ LSSL  L+++ N+F           + L++L  + N +     +      +SL
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 250

Query: 396 LFLSLSNNSFN 406
            FL+L+ N F 
Sbjct: 251 AFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 51/238 (21%), Positives = 82/238 (34%), Gaps = 15/238 (6%)

Query: 201 SKEIQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLL--GGDLPDSLYSMSSLQHV 254
                 L+L  N       G    L     L +L + +N L   G    S +  +SL+++
Sbjct: 27  PSSATRLELESNKLQSLPHGVFDKL---TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83

Query: 255 SLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLP-NVLGNLTQLEFFVAHSNSFSGPL 313
            LS N     +S     L  L HL    +        +V  +L  L +            
Sbjct: 84  DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 142

Query: 314 PLSLSLCSKLHVLDL-RNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 372
               +  S L VL +  N+     +   F+ L +L  LDL+        P + +    L+
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202

Query: 373 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLS-GTLSVLQQCKNLTTLILTKN 429
           +L+++ N         +  L SL  L  S N         L       +L  L LT+N
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP--SSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 55/279 (19%), Positives = 87/279 (31%), Gaps = 51/279 (18%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLE--GVVPVELSNLKQLEVLDLSHNM 141
            T L L    L+ +       L QL  L LS N L   G           L+ LDLS N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 142 LSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSAS 201
           +   +S    GL  ++ L+   ++    + E   F +L                      
Sbjct: 90  VIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL---------------------- 125

Query: 202 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
                                   +L  L + +             +SSL+ + ++ N+F
Sbjct: 126 -----------------------RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162

Query: 262 SGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLC 320
                  I + L +L  L +   Q     P    +L+ L+      N+F           
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222

Query: 321 SKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFS 358
           + L VLD   N +            SSL  L+L  N F+
Sbjct: 223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 87.8 bits (218), Expect = 7e-19
 Identities = 61/299 (20%), Positives = 97/299 (32%), Gaps = 71/299 (23%)

Query: 370 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
               L L  N+L       F KLT L  LSLS+N  +             +L  L L+ N
Sbjct: 29  SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 430 FVGEEIPENVGGFESLMVLALGNCGLKGHIPV-WLLRCKKLQVLDLSWNHFDGNIPPWIG 488
            V   +  N  G E L  L   +  LK        L  + L  LD+S  H          
Sbjct: 89  GV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFN--- 143

Query: 489 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 548
               +F                L+ L+ L                               
Sbjct: 144 ---GIF--------------NGLSSLEVL------------------------------- 155

Query: 549 NQASSFPPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLD 607
                      ++ N       P+I  +L++L  LDLS+  +    P++ + + +L+VL+
Sbjct: 156 ----------KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205

Query: 608 LSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNS----SFEGNPGLC 662
           +S N+        ++ L  L     + NH+  T     +   FP+S    +   N   C
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSK-KQELQHFPSSLAFLNLTQNDFAC 262

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  101 bits (252), Expect = 4e-23
 Identities = 51/248 (20%), Positives = 76/248 (30%), Gaps = 58/248 (23%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           IG G +G+V  A         A+K     ++     +     + EV  + +  H N+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 829 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG------------- 875
                      L+      G L   L+  +D  +       +K                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 876 ----------------AAR-------GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL- 911
                            +         L YLH      I HRD+K  N L        + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 912 -ADFGLSRLL---RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLL 962
             DFGLS+        + +  T   GT  ++ PE    L  T        D +S GV+L 
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE---VLNTTNESYGPKCDAWSAGVLLH 267

Query: 963 ELLTGRRP 970
            LL G  P
Sbjct: 268 LLLMGAVP 275

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  103 bits (258), Expect = 4e-23
 Identities = 73/296 (24%), Positives = 113/296 (38%), Gaps = 54/296 (18%)

Query: 762  LLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS---GDCGQMEREFQAE 813
            +  ST  F+       ++G G FG V        G + AVK +S         +     E
Sbjct: 17   VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 814  VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA 873
            V+ L +  H N++ L  +        L+      G L     E + +    + D   +I 
Sbjct: 77   VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAA-RII 132

Query: 874  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-AHL--ADFGLSRLLRPYDTHVTTD 930
            +    G+ Y+HK     IVHRD+K  N+LL+ K + A++   DFGLS       +    D
Sbjct: 133  RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKD 187

Query: 931  LVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
             +GT  YI PE    T    C  DV+S GV+L  LL+G  P                F  
Sbjct: 188  KIGTAYYIAPEVLHGTYDEKC--DVWSTGVILYILLSGCPP----------------FNG 229

Query: 990  KSEKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
             +E   ++ +       +   W K  +  K L+       K +   P  R    + 
Sbjct: 230  ANEYDILKKVEKGKYTFELPQWKKVSESAKDLI------RKMLTYVPSMRISARDA 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  102 bits (255), Expect = 8e-23
 Identities = 60/326 (18%), Positives = 107/326 (32%), Gaps = 77/326 (23%)

Query: 82  GRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNM 141
            + + ++  R+GL  + P+ +   +  + L+L  N+++ +      +L  LEVL L  N 
Sbjct: 54  NQFSKVVCTRRGLSEV-PQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 142 LSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSAS 201
           +     G   GL  + +L +  N              L    I + +F            
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDN-------------WLT--VIPSGAFEY---------- 145

Query: 202 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
                                    L++L + NN +      +   + SL  + L     
Sbjct: 146 ----------------------LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183

Query: 262 SGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLC 320
              +SE     L +L++L +                           + +          
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK------------------DMPNLTP--------L 217

Query: 321 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNE 380
             L  L++  N        +F GLSSL  L +  +  S    N+      L  L+LA N 
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277

Query: 381 LSGQVPESFGKLTSLLFLSLSNNSFN 406
           LS    + F  L  L+ L L +N +N
Sbjct: 278 LSSLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 96.4 bits (240), Expect = 5e-21
 Identities = 64/294 (21%), Positives = 96/294 (32%), Gaps = 69/294 (23%)

Query: 323 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 382
              L+L  N++       F  L  L  L L  N        + +    L  L L  N L+
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136

Query: 383 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GG 441
                +F  L+ L  L L NN    +        +  +L  L L +    E I E    G
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIESIPS--YAFNRVPSLMRLDLGELKKLEYISEGAFEG 194

Query: 442 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 501
             +L  L LG C +K  +P  L     L+ L++S NHF   I P        F       
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRP------GSF------- 238

Query: 502 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLS 561
                    L+ LK L                            +  +Q S    + F  
Sbjct: 239 -------HGLSSLKKL---------------------------WVMNSQVSLIERNAFDG 264

Query: 562 NNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLH 614
                         L  L  L+L+ NN++ ++P  + + +R L  L L  N  +
Sbjct: 265 --------------LASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 88.7 bits (220), Expect = 2e-18
 Identities = 49/231 (21%), Positives = 83/231 (35%), Gaps = 24/231 (10%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 138
            +   + +L L R  ++ I   +   L  L  L+L  N L  +       L +L  L L 
Sbjct: 96  RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155

Query: 139 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 198
           +N +    S     +  +  L            +LGE   L    IS  +F G L +   
Sbjct: 156 NNPIESIPSYAFNRVPSLMRL------------DLGELKKLE--YISEGAFEG-LFN--- 197

Query: 199 SASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 258
                ++ L+L M +    +  L     L++L +  N      P S + +SSL+ + +  
Sbjct: 198 -----LKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 259 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 309
           +  S         L SL  L +  N  S    ++   L  L     H N +
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 84.0 bits (208), Expect = 5e-17
 Identities = 59/323 (18%), Positives = 101/323 (31%), Gaps = 77/323 (23%)

Query: 345 SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNS 404
           +    +       S  +P  +    + + L+L +N +     ++F  L  L  L L  NS
Sbjct: 54  NQFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 405 FNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLL 464
              +           +L TL L  N++   IP     FE L                   
Sbjct: 111 IRQIEV--GAFNGLASLNTLELFDNWL-TVIPSGA--FEYL------------------- 146

Query: 465 RCKKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSN-NTLTGEIPKSLTELKSLISSNC 522
              KL+ L L  N    +IP     ++ +L  LD      L      +   L +L     
Sbjct: 147 --SKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY--- 200

Query: 523 TSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVL 582
                       L                        L    I     P +  L  L  L
Sbjct: 201 ------------LN-----------------------LGMCNI--KDMPNLTPLVGLEEL 223

Query: 583 DLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 642
           ++S N+     P S   + +L+ L + ++ +      +F+ L  L + ++A+N+L  ++P
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLP 282

Query: 643 TGGQFYSFPNS---SFEGNPGLC 662
               F             NP  C
Sbjct: 283 -HDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 20/89 (22%), Positives = 35/89 (39%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 138
           +    +  L +       I P S   L+ LK L +  + +  +       L  L  L+L+
Sbjct: 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274

Query: 139 HNMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
           HN LS     +   L  +  L++  N +N
Sbjct: 275 HNNLSSLPHDLFTPLRYLVELHLHHNPWN 303

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  102 bits (255), Expect = 1e-22
 Identities = 67/306 (21%), Positives = 113/306 (36%), Gaps = 64/306 (20%)

Query: 762  LLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS-------------GDC 803
            + K      ++      +G G +G V         ++ A+K +               + 
Sbjct: 27   VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 804  GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV 863
             +   E   E+  L    H N++ L           L+  + E G L     + +++   
Sbjct: 87   EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---FEQIINRHKF 143

Query: 864  LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-AHL--ADFGLSRLL 920
             + D    I +    G+ YLHK    +IVHRD+K  NILL+ K    ++   DFGLS   
Sbjct: 144  DECDAA-NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 921  RPYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC 979
                 +   D +GT  YI PE   +     C  DV+S GV++  LL G  P         
Sbjct: 200  SK--DYKLRDRLGTAYYIAPEVLKKKYNEKC--DVWSCGVIMYILLCGYPP--------- 246

Query: 980  RDLVSWVFQMKSEKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRR 1030
                   F  ++++  ++ +       D + W    D  K+L+         +  D  +R
Sbjct: 247  -------FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELI------KLMLTYDYNKR 293

Query: 1031 PFIEEV 1036
               EE 
Sbjct: 294  CTAEEA 299

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  100 bits (249), Expect = 1e-22
 Identities = 40/256 (15%), Positives = 76/256 (29%), Gaps = 23/256 (8%)

Query: 735 QRLSEALASSKLVLFQNSDCKDLTV-SDLLKSTNNFNQANIIGCGGFGLVYKAT------ 787
             LS+ ++S             +   ++    +      +++G G F  VY+AT      
Sbjct: 32  SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91

Query: 788 LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN 847
             N  K  +K                +E L  +     +         N  +L+      
Sbjct: 92  AKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151

Query: 848 GSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK 906
           G+L +         + V+   + +  A      +  +H      I+H D+K  N +L   
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNG 208

Query: 907 FEAH-----------LADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDV 954
           F              L D G S  ++ +      T    T G+   E         + D 
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268

Query: 955 YSFGVVLLELLTGRRP 970
           +     +  +L G   
Sbjct: 269 FGVAATVYCMLFGTYM 284

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 53/281 (18%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G G FG V+     ++G +  +K     R      Q+E E    +E L    H N++ +
Sbjct: 30   LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE----IEVLKSLDHPNIIKI 85

Query: 829  QGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
                   ++  ++    E G L +  +       ++ +  V   + Q     LAY H   
Sbjct: 86   FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ-MMNALAYFHSQ- 143

Query: 888  EPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YS 943
              H+VH+D+K  NIL  +        + DFGL+ L +      +T+  GT  Y+ PE + 
Sbjct: 144  --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYMAPEVFK 199

Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
            + +T  C  D++S GVV+  LLTG  P                F   S +   +      
Sbjct: 200  RDVTFKC--DIWSAGVVMYFLLTGCLP----------------FTGTSLEEVQQKATYKE 241

Query: 1004 WHKDRE--------KQLLEMLEIACKCIDQDPRRRPFIEEV 1036
             +   E          LL       + + +DP RRP   +V
Sbjct: 242  PNYAVECRPLTPQAVDLL------KQMLTKDPERRPSAAQV 276

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 22/231 (9%)

Query: 750 QNSDCKDLTVSDLLKSTN---NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ 805
           +    KD  V++L    +    F+    IG G FG VY A  + N    A+K++S    Q
Sbjct: 34  RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93

Query: 806 MEREF---QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS 862
              ++     EV  L + +H N +  +G     +   L+  Y    + D  L E   K  
Sbjct: 94  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK-- 149

Query: 863 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP 922
            L+      +  GA +GLAYLH     +++HRDVK+ NILL E     L DFG + ++ P
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206

Query: 923 YDTHVTTDLVGTLGYIPPE---YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            ++      VGT  ++ PE            + DV+S G+  +EL   + P
Sbjct: 207 ANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.9 bits (247), Expect = 3e-22
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 24/228 (10%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLS-GDCGQME--REFQAEVEALSRAQ 821
           ++F     IG G FG V      N TK   A+K ++   C +    R    E++ +   +
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQK-NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 822 HKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAAR 878
           H  LV+L  Y     + + ++   +  G L Y L ++V   ++      V+L I +    
Sbjct: 74  HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-----TVKLFICE-LVM 126

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
            L YL       I+HRD+K  NILLDE    H+ DF ++ +L       T  + GT  Y+
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181

Query: 939 PPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 983
            PE   +          D +S GV   ELL GRRP  +    + +++V
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.4 bits (248), Expect = 7e-22
 Identities = 73/294 (24%), Positives = 110/294 (37%), Gaps = 53/294 (18%)

Query: 763  LKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD--CGQMEREFQAEVE 815
            L     F +      ++G G FG V K        + AVK ++      +       EVE
Sbjct: 14   LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73

Query: 816  ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
             L +  H N++ L       +   ++      G L     E + +    + D   +I + 
Sbjct: 74   LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAA-RIIKQ 129

Query: 876  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-AHL--ADFGLSRLLRPYDTHVTTDLV 932
               G+ Y+HK    +IVHRD+K  NILL+ K +   +   DFGLS   +        D +
Sbjct: 130  VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI 184

Query: 933  GTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS 991
            GT  YI PE    T    C  DV+S GV+L  LL+G  P                F  K+
Sbjct: 185  GTAYYIAPEVLRGTYDEKC--DVWSAGVILYILLSGTPP----------------FYGKN 226

Query: 992  EKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            E   ++ +       D   W    D  K L+       K +   P  R    + 
Sbjct: 227  EYDILKRVETGKYAFDLPQWRTISDDAKDLI------RKMLTFHPSLRITATQC 274

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 8e-22
 Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 61/290 (21%)

Query: 765  STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
              + F    ++G GGFG V+    KAT   G   A K+L+    +  + +Q    E + L
Sbjct: 183  GEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239

Query: 818  SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQG 875
            ++   + +VSL  Y       L L+ + M  G + Y ++   + +   +        AQ 
Sbjct: 240  AKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ- 297

Query: 876  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
               GL +LH+    +I++RD+K  N+LLD+     ++D GL+  L+   T       GT 
Sbjct: 298  IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTP 353

Query: 936  GYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
            G++ PE      Y  ++      D ++ GV L E++  R P                F+ 
Sbjct: 354  GFMAPELLLGEEYDFSV------DYFALGVTLYEMIAARGP----------------FRA 391

Query: 990  KSEKREVEIIDASIWHKDRE---------KQLLEMLEIACKCIDQDPRRR 1030
            + EK E + +   +  +            K   E L      + +DP +R
Sbjct: 392  RGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL------LQKDPEKR 435

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 96.5 bits (241), Expect = 9e-22
 Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 48/230 (20%)

Query: 763 LKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE----FQA--EVE 815
           + S++ F Q   +G G +  VYK    T G   A+K +     +++ E      A  E+ 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIREIS 55

Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
            +   +H+N+V L       N   L++ +M+    D  L + +D  +V      L++   
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFMD---ND--LKKYMDSRTVGNTPRGLELNLV 110

Query: 876 AA------RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDT 925
                   +GLA+ H+     I+HRD+K  N+L++++ +  L DFGL+R     +  + +
Sbjct: 111 KYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-S 166

Query: 926 HVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
                 V TL Y  P+       YS   T+    D++S G +L E++TG+
Sbjct: 167 S----EVVTLWYRAPDVLMGSRTYS---TSI---DIWSCGCILAEMITGK 206

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.6 bits (241), Expect = 9e-22
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 32/214 (14%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMERE-FQAEVEALSRAQHKNLV 826
            +G G F +V K    + G + A K     +       + RE  + EV  L +  H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
           +L     +  D +LI   +  G L         K+S+ + +    I Q    G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL---FDFLAQKESLSEEEATSFIKQ-ILDGVNYLHTK 134

Query: 887 CEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE- 941
               I H D+K  NI+L +K        L DFGL+  +         ++ GT  ++ PE 
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAPEI 189

Query: 942 -----YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                           D++S GV+   LL+G  P
Sbjct: 190 VNYEPLG---LEA---DMWSIGVITYILLSGASP 217

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-----FQA--EVEALS 818
             + +   IG G +G V+KA         A+KR+     +++ +       A  E+  L 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLK 56

Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
             +HKN+V L           L++ + +   L  +         +    V+  + Q   +
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQ-LLK 112

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGT 934
           GL + H     +++HRD+K  N+L++   E  LA+FGL+R     +R Y +      V T
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SA----EVVT 164

Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           L Y PP+       YS ++      D++S G +  EL    RP
Sbjct: 165 LWYRPPDVLFGAKLYSTSI------DMWSAGCIFAELANAGRP 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.2 bits (245), Expect = 1e-21
 Identities = 59/239 (24%), Positives = 93/239 (38%), Gaps = 37/239 (15%)

Query: 755 KDLTVSDLLKSTNNFNQ----ANIIGCGGFGLVYKAT-LTNGTKAAVKRLS--------G 801
            DLTV D              +  +G G  G V  A       K A++ +S         
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178

Query: 802 DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDK 860
                    + E+E L +  H  ++ ++ +     D  ++   ME G L D      V  
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDK----VVGN 233

Query: 861 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLS 917
             + +   +L   Q     + YLH+     I+HRD+K  N+LL  + E     + DFG S
Sbjct: 234 KRLKEATCKLYFYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289

Query: 918 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG------DVYSFGVVLLELLTGRRP 970
           ++L   +T +   L GT  Y+ PE    L +          D +S GV+L   L+G  P
Sbjct: 290 KILG--ETSLMRTLCGTPTYLAPE---VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.5 bits (240), Expect = 1e-21
 Identities = 45/290 (15%), Positives = 87/290 (30%), Gaps = 38/290 (13%)

Query: 762  LLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
             L    +                K              +           A    + R  
Sbjct: 57   ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116

Query: 822  HKNLVSLQGYCRHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
              +  +  G  +  + ++ +Y  M+     +L  W++     +   +  V L I    A 
Sbjct: 117  PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED-REHGVCLHIFIQIAE 175

Query: 879  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL-----------RPYDTHV 927
             + +LH      ++HRD+K SNI         + DFGL   +                  
Sbjct: 176  AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232

Query: 928  TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 987
             T  VGT  Y+ PE       + + D++S G++L ELL                     F
Sbjct: 233  HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-------------------F 273

Query: 988  QMKSEKREV-EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
              + E+  +   +    +     ++  +   +    +   P  RP   ++
Sbjct: 274  STQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 32/213 (15%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMERE-FQAEVEALSRAQHKNLVS 827
           +G G F +V K      G + A K     RLS     + RE  + EV  L   +H N+++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L     +  D +LI   +  G L        +K+S+ + +    + Q    G+ YLH   
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL---FDFLAEKESLTEDEATQFLKQ-ILDGVHYLHSK- 127

Query: 888 EPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 941
              I H D+K  NI+L +K   +    L DFG++  +     +   ++ GT  ++ PE  
Sbjct: 128 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTPEFVAPEIV 183

Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                          D++S GV+   LL+G  P
Sbjct: 184 NYEPLG---LEA---DMWSIGVITYILLSGASP 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 96.2 bits (240), Expect = 2e-21
 Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 27/213 (12%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVS 827
           +IG G F +V +      G + AVK     + +   G    + + E       +H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW----DVRLKIAQGAARGLAYL 883
           L           +++ +M+   L     E V +               + Q     L Y 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQ-ILEALRYC 146

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           H   + +I+HRDVK   +LL  K  +    L  FG++  L      V    VGT  ++ P
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTPHFMAP 202

Query: 941 EYSQTLTATCRG---DVYSFGVVLLELLTGRRP 970
           E    +     G   DV+  GV+L  LL+G  P
Sbjct: 203 E---VVKREPYGKPVDVWGCGVILFILLSGCLP 232

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 95.3 bits (238), Expect = 2e-21
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 41/220 (18%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-----FQA--EVEALSR 819
             + +   +G G +G+VYKA  + G   A+KR+     +++ E       A  E+  L  
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-----RLDAEDEGIPSTAIREISLLKE 75

Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
             H N+VSL           L++ +ME   L   L E+  K  +    +++ + Q   RG
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQ-LLRG 131

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTL 935
           +A+ H+     I+HRD+K  N+L++      LADFGL+R     +R Y TH     V TL
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-TH----EVVTL 183

Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  P+       YS ++      D++S G +  E++TG+
Sbjct: 184 WYRAPDVLMGSKKYSTSV------DIWSIGCIFAEMITGK 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 60/295 (20%), Positives = 100/295 (33%), Gaps = 59/295 (20%)

Query: 764  KSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALS 818
             +  + NQ     N IG G +G V  A       + A K++     +    F+ E+E + 
Sbjct: 2    STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 819  RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
               H N++ L        D  L+      G L       V K    + D    +      
Sbjct: 62   SLDHPNIIRLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESDAARIMKD-VLS 117

Query: 879  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTL 935
             +AY HK+   ++ HRD+K  N L           L DFGL+   +P    +    VGT 
Sbjct: 118  AVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTP 172

Query: 936  GYIPPE-----YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
             Y+ P+     Y          D +S GV++  LL G  P                F   
Sbjct: 173  YYVSPQVLEGLYGP------ECDEWSAGVMMYVLLCGYPP----------------FSAP 210

Query: 991  SEKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            ++   +  I           W     + + L+       + + + P++R    + 
Sbjct: 211  TDSEVMLKIREGTFTFPEKDWLNVSPQAESLI------RRLLTKSPKQRITSLQA 259

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 96.3 bits (240), Expect = 3e-21
 Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 31/209 (14%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG+V++      G     K ++      +   + E+  +++  H  L++L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 834 HGNDRLLIYSYMENGSL-------DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
              + +LI  ++  G L       DY + E+         +V   + Q A  GL ++H+ 
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEA---------EVINYMRQ-ACEGLKHMHEH 168

Query: 887 CEPHIVHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 941
               IVH D+K  NI+ + K  + +   DFGL+  L P    +      T  +  PE   
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVD 223

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                  T   D+++ GV+   LL+G  P
Sbjct: 224 REPVGFYT---DMWAIGVLGYVLLSGLSP 249

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 43/207 (20%), Positives = 85/207 (41%), Gaps = 28/207 (13%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 832
           +G G FG+V++    ++      K +       ++   + E+  L+ A+H+N++ L    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 833 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQGAARGLAYLHKVCEPHI 891
               + ++I+ ++    +             L   ++   + Q     L +LH     +I
Sbjct: 71  ESMEELVMIFEFISGLDI---FERINTSAFELNEREIVSYVHQ-VCEALQFLHSH---NI 123

Query: 892 VHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE------YS 943
            H D++  NI+   +  + +   +FG +R L+P        L     Y  PE       S
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 944 QTLTATCRGDVYSFGVVLLELLTGRRP 970
              TAT   D++S G ++  LL+G  P
Sbjct: 182 ---TAT---DMWSLGTLVYVLLSGINP 202

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 54/253 (21%), Positives = 87/253 (34%), Gaps = 49/253 (19%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLS----------GDCGQMEREFQAEVEALSRAQHK 823
           +G GGFG V+    LT+  + A+K +            D      E     +  +   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 824 NLVSLQGYCRHGNDRLLIYSYMENGS--LDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            ++ L  +       +L+           DY     + +   L               + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDY-----ITEKGPLGEGPSRCFFGQVVAAIQ 153

Query: 882 YLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           + H      +VHRD+K  NIL+D  +  A L DFG   LL   D   T    GT  Y PP
Sbjct: 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTD-FDGTRVYSPP 207

Query: 941 EYSQTLTATCRG------DVYSFGVVLLELLTGRRPVE----VCKGK---------NCRD 981
           E+                 V+S G++L +++ G  P E    + + +         +C  
Sbjct: 208 EWISR-----HQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA 262

Query: 982 LVSWVFQMKSEKR 994
           L+      K   R
Sbjct: 263 LIRRCLAPKPSSR 275

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.5 bits (238), Expect = 5e-21
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 768 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
             ++  I+G G FG V+K      G K A K +     + + E + E+  +++  H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 827 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQGAARGLAYLHK 885
            L       ND +L+  Y++ G L       +D+   L   D  L + Q    G+ ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL---FDRIIDESYNLTELDTILFMKQ-ICEGIRHMHQ 205

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 941
           +   +I+H D+K  NIL   +    +   DFGL+R  +P          GT  ++ PE  
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVNFGTPEFLAPEVV 260

Query: 942 -YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            Y      T   D++S GV+   LL+G  P
Sbjct: 261 NYDFVSFPT---DMWSVGVIAYMLLSGLSP 287

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 93.9 bits (234), Expect = 7e-21
 Identities = 58/251 (23%), Positives = 102/251 (40%), Gaps = 47/251 (18%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQA--EVEALSRAQHK--NL 825
           +G GGFG VY    +++    A+K +      D G++    +   EV  L +       +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 826 VSLQGYCRHGNDRLLIYSYMEN-GSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           + L  +    +  +LI    E    L D+     + +   L+ ++           + + 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDF-----ITERGALQEELARSFFWQVLEAVRHC 165

Query: 884 HKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
           H      ++HRD+K  NIL+D  + E  L DFG   LL+  DT  T    GT  Y PPE+
Sbjct: 166 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTD-FDGTRVYSPPEW 219

Query: 943 SQTLTATCRG------DVYSFGVVLLELLTGRRP----VEVCKGK---------NCRDLV 983
            +               V+S G++L +++ G  P     E+ +G+          C+ L+
Sbjct: 220 IR-----YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274

Query: 984 SWVFQMKSEKR 994
            W   ++   R
Sbjct: 275 RWCLALRPSDR 285

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.2 bits (235), Expect = 7e-21
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 46/223 (20%)

Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-----FQA--EVEALS 818
             +    ++G G +G+V K      G   A+K+          +       A  E++ L 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMREIKLLK 79

Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD--KDSVLKWDVRLKIAQGA 876
           + +H+NLV+L   C+      L++ ++++      + + ++   + +    V+  + Q  
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDH---T--ILDDLELFPNGLDYQVVQKYLFQ-I 133

Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL----RPYDTHVTTDLV 932
             G+ + H     +I+HRD+K  NIL+ +     L DFG +R L      Y      D V
Sbjct: 134 INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-----DDEV 185

Query: 933 GTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            T  Y  PE       Y     A    DV++ G ++ E+  G 
Sbjct: 186 ATRWYRAPELLVGDVKYG---KAV---DVWAIGCLVTEMFMGE 222

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 94.7 bits (236), Expect = 7e-21
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 45/230 (19%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
           K  + F    + G G FG V        G   A+K++  D     RE Q  ++ L+   H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH 78

Query: 823 KNLVSLQGYCRHGNDR-------LLIYSYMENGSLDYWLHESVDKDSVLKWD-----VRL 870
            N+V LQ Y     +R        ++  Y+        LH         +       +++
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DT--LHRCCRNYYRRQVAPPPILIKV 133

Query: 871 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-----KFEAHLADFGLSRLLRPYDT 925
            + Q   R +  LH     ++ HRD+K  N+L++E     K    L DFG ++ L P + 
Sbjct: 134 FLFQ-LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK----LCDFGSAKKLSPSEP 187

Query: 926 HVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           +     + +  Y  PE       Y+  +      D++S G +  E++ G 
Sbjct: 188 N--VAYICSRYYRAPELIFGNQHYTTAV------DIWSVGCIFAEMMLGE 229

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.3 bits (235), Expect = 8e-21
 Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 60/302 (19%)

Query: 759  VSDLLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAE 813
            V  L +++  F         IG G + +  +        + AVK +     + +R+   E
Sbjct: 10   VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEE 65

Query: 814  VEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
            +E L R  QH N+++L+     G    ++   M+ G L   L + + +    + +    +
Sbjct: 66   IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---LDKILRQKFFSEREAS-AV 121

Query: 873  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVT 928
                 + + YLH      +VHRD+K SNIL  ++        + DFG ++ LR  +  + 
Sbjct: 122  LFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLL 177

Query: 929  TDLVGTLGYIPPE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 986
                 T  ++ PE    Q   A C  D++S GV+L  +LTG  P                
Sbjct: 178  MTPCYTANFVAPEVLERQGYDAAC--DIWSLGVLLYTMLTGYTP---------------- 219

Query: 987  FQMKSEKREVEIIDA----------SIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIE 1034
            F    +    EI+              W+   D  K L+       K +  DP +R    
Sbjct: 220  FANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLV------SKMLHVDPHQRLTAA 273

Query: 1035 EV 1036
             V
Sbjct: 274  LV 275

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 93.6 bits (233), Expect = 8e-21
 Identities = 58/290 (20%), Positives = 106/290 (36%), Gaps = 46/290 (15%)

Query: 245 LYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 304
             ++++   ++   +N +   +   ++L  +  L  FG   +  +   +  L  L     
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70

Query: 305 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATNHFSGPLPN 363
             N  +   PL     +K+  L+L  N L    ++   +GL S+ TLDL +   +     
Sbjct: 71  KDNQITDLAPLKN--LTKITELELSGNPLK---NVSAIAGLQSIKTLDLTSTQITDV--T 123

Query: 364 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 423
            L+   +L++L L  N+++         LT+L +LS+ N   + L+     L     LTT
Sbjct: 124 PLAGLSNLQVLYLDLNQIT--NISPLAGLTNLQYLSIGNAQVSDLTP----LANLSKLTT 177

Query: 424 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNI 483
           L    N +      ++    SL                       L  + L  N    ++
Sbjct: 178 LKADDNKI-----SDISPLASL---------------------PNLIEVHLKNNQIS-DV 210

Query: 484 PPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGI 533
            P +    NLF +  +N T+T +       L         S  P A A I
Sbjct: 211 SP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATI 259

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 88.2 bits (219), Expect = 6e-19
 Identities = 54/286 (18%), Positives = 109/286 (38%), Gaps = 33/286 (11%)

Query: 88  ILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVS 147
           I     +  I P     L     +    +++   V    ++L  +  L      ++  + 
Sbjct: 3   ITQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE 57

Query: 148 GMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFT-----GKLNSRIWSASK 202
           G +  LN +  L +  N     L  L   + +    +S N          L        +
Sbjct: 58  G-VQYLNNLIGLELKDNQIT-DLAPLKNLTKITELELSGNPLKNVSAIAGL--------Q 107

Query: 203 EIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 262
            I+ LDL+    +  +  L    +L+ L++D N +  ++   L  +++LQ++S+     S
Sbjct: 108 SIKTLDLTSTQ-ITDVTPLAGLSNLQVLYLDLNQI-TNIS-PLAGLTNLQYLSIGNAQVS 164

Query: 263 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 322
                 ++NL+ L  L    N+ S  +   L +L  L      +N  S   P  L+  S 
Sbjct: 165 D--LTPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSN 218

Query: 323 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPL-PNSLSD 367
           L ++ L N ++T   +      ++L   ++       P+ P ++SD
Sbjct: 219 LFIVTLTNQTIT---NQPVFYNNNLVVPNVVKGPSGAPIAPATISD 261

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 43/275 (15%), Positives = 87/275 (31%), Gaps = 60/275 (21%)

Query: 365 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 424
                +   ++  K+ ++     +   L  +  LS        + G    +Q   NL  L
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG----VQYLNNLIGL 68

Query: 425 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 484
            L  N +  ++   +     +  L L    LK      +   + ++ LDL+      ++ 
Sbjct: 69  ELKDNQI-TDL-APLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQI-TDVT 123

Query: 485 PWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRST 543
           P +  + NL  L    N +T   P   LT L+ L                          
Sbjct: 124 P-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYL-------------------------- 156

Query: 544 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNL 603
                           + N +++  + P +  L  L  L    N I+    S ++ + NL
Sbjct: 157 ---------------SIGNAQVS-DLTP-LANLSKLTTLKADDNKISDI--SPLASLPNL 197

Query: 604 EVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 638
             + L +N +   +       + L   ++ N  + 
Sbjct: 198 IEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTIT 230

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 78.6 bits (194), Expect = 8e-16
 Identities = 48/296 (16%), Positives = 97/296 (32%), Gaps = 63/296 (21%)

Query: 317 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 376
               +    +    +++T  +    + L  + TL       +  +   +   ++L  L L
Sbjct: 15  DPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLEL 70

Query: 377 AKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIP 436
             N+++         LT +  L LS N   ++S     +   +++ TL LT   + +   
Sbjct: 71  KDNQIT--DLAPLKNLTKITELELSGNPLKNVSA----IAGLQSIKTLDLTSTQITD--V 122

Query: 437 ENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 496
             + G  +L VL L    +  +I   L     LQ L +       ++ P +  +  L  L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178

Query: 497 DFSNNTLTG-EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFP 555
              +N ++      SL  L  +                                      
Sbjct: 179 KADDNKISDISPLASLPNLIEV-------------------------------------- 200

Query: 556 PSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 611
               L NN+I+  + P +    +L ++ L+   IT      +    NL V ++   
Sbjct: 201 ---HLKNNQIS-DVSP-LANTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKG 248

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 37/239 (15%), Positives = 74/239 (30%), Gaps = 58/239 (24%)

Query: 400 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHI 459
               + N +           N   +   K+ V +         + +  L+    G+   I
Sbjct: 4   TQPTAINVIFP----DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI 56

Query: 460 PVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG-EIPKSLTELKSLI 518
              +     L  L+L  N    ++ P +  +  +  L+ S N L        L  +K+L 
Sbjct: 57  EG-VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTL- 112

Query: 519 SSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKH 578
                                                    L++ +I   + P +  L +
Sbjct: 113 ----------------------------------------DLTSTQIT-DVTP-LAGLSN 130

Query: 579 LHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 637
           L VL L  N IT    S ++ + NL+ L + +  +   +      L+ L+     +N +
Sbjct: 131 LQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKI 185

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.4 bits (232), Expect = 1e-20
 Identities = 60/304 (19%), Positives = 101/304 (33%), Gaps = 45/304 (14%)

Query: 120 GVVPVEL-SNLKQLEVLDLSHNMLSGPV--SGMLAGLNLIQSLNVSSNSFNGSLF----E 172
           G   VEL    + LE L    +  +     + ++  L+L + L V +      +      
Sbjct: 32  GAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSL-KRLTVRAARIPSRILFGALR 90

Query: 173 LGEFSNLAVFNISNNSFTGKLNSRIWSAS-KEIQILDLSMNHFMGSLQGLDH-----SPS 226
           +   S L    + N   TG     +  A+  ++ IL+L    +      L        P 
Sbjct: 91  VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150

Query: 227 LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS----NLTSLRHLIIFG 282
           LK L +          + +    +L  + LS N   G+     +       +L+ L +  
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210

Query: 283 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNF 341
                                    + SG      +   +L  LDL +NSL       + 
Sbjct: 211 AGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249

Query: 342 SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLS 401
              S L +L+L+       +P  L     L +L L+ N L    P S  +L  +  LSL 
Sbjct: 250 DWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLK 304

Query: 402 NNSF 405
            N F
Sbjct: 305 GNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.9 bits (228), Expect = 3e-20
 Identities = 64/340 (18%), Positives = 100/340 (29%), Gaps = 64/340 (18%)

Query: 295 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLAT 354
           +  + ++  A +   +  + L     S  ++L   +         +     SL  L +  
Sbjct: 18  SDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRA 77

Query: 355 NHFSGPLPNSLSDCHD---LKILSLAKNELSGQVPESFGKLT--SLLFLSLSNNSFNHLS 409
                 +            L+ L+L   E++G  P    + T   L  L+L N S+    
Sbjct: 78  ARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRD 137

Query: 410 GTLSVLQQC--KNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRC- 466
             L+ LQQ     L  L + +        E V  F +L  L L +    G   +    C 
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197

Query: 467 ---KKLQVLDLSWNHF---DGNIPPWIGQMENLFYLDFSNNTLTGEIPKS----LTELKS 516
                LQVL L         G           L  LD S+N+L            ++L S
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257

Query: 517 LISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQL 576
           L                                          LS   +   +P  +   
Sbjct: 258 LN-----------------------------------------LSFTGLK-QVPKGLPA- 274

Query: 577 KHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 616
             L VLDLS N +      S  E+  +  L L  N    S
Sbjct: 275 -KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 87.3 bits (216), Expect = 1e-18
 Identities = 60/304 (19%), Positives = 100/304 (32%), Gaps = 47/304 (15%)

Query: 218 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE---KISNLTS 274
           L G   S       VD     G   D + S+S L+ +++       ++     ++  ++ 
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLS-LKRLTVRAARIPSRILFGALRVLGISG 96

Query: 275 LRHLIIFGNQFSGKLPNVLGNLT--QLEFFVAHSNSFSGPLPLSLSLCSKLH----VLDL 328
           L+ L +   + +G  P  L   T   L      + S++        L   L     VL +
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156

Query: 329 RNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC----HDLKILSLAKNE---L 381
                            +L TLDL+ N   G      + C      L++L+L        
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216

Query: 382 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG 441
           SG           L  L LS+NS    +G  S       L +L L+   + +++P+ +  
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPS-CDWPSQLNSLNLSFTGL-KQVPKGLP- 273

Query: 442 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 501
                                     KL VLDLS+N  D N  P   ++  +  L    N
Sbjct: 274 -------------------------AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGN 306

Query: 502 TLTG 505
               
Sbjct: 307 PFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.1 bits (213), Expect = 3e-18
 Identities = 44/249 (17%), Positives = 78/249 (31%), Gaps = 24/249 (9%)

Query: 105 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG--PVSGMLAGLNLIQSLNVS 162
           L +L +             + +  +  L+ L L +  ++G  P   + A    +  LN+ 
Sbjct: 70  LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129

Query: 163 SNSFNGSLFELGEFSN-----LAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
           + S+      L E        L V +I+        +         +  LDLS N  +G 
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN-FSCEQVRVFPALSTLDLSDNPELGE 188

Query: 218 LQGLDHS------PSLKQLHVDNNL---LGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEK 268
             GL  +      P+L+ L + N       G       +   LQ + LS N+        
Sbjct: 189 R-GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247

Query: 269 I-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLD 327
                + L  L +           +   L+ L+      N      P    L  ++  L 
Sbjct: 248 SCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDL---SYNRLDR-NPSPDEL-PQVGNLS 302

Query: 328 LRNNSLTGP 336
           L+ N     
Sbjct: 303 LKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 46/217 (21%), Positives = 71/217 (32%), Gaps = 28/217 (12%)

Query: 443 ESLMVLALGNCGLKGHIPVWLLR---CKKLQVLDLSWNHFDGNIPPWIGQ--MENLFYLD 497
            SL  L +    +   I    LR      LQ L L      G  PP + +    +L  L+
Sbjct: 68  LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127

Query: 498 FSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPS 557
             N +        L EL+  +                L +    S N     Q   FP  
Sbjct: 128 LRNVSWAT-RDAWLAELQQWLKPGLKV----------LSIAQAHSLN-FSCEQVRVFPAL 175

Query: 558 VFL--SNNRINGTIPPEI----GQLKHLHVLDLSRNNIT---GTIPSSISEIRNLEVLDL 608
             L  S+N   G           +   L VL L    +    G   +  +    L+ LDL
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235

Query: 609 SSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIPTG 644
           S N L  +    S +  + L+  +++   L+  +P G
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 34/164 (20%), Positives = 56/164 (34%), Gaps = 14/164 (8%)

Query: 83  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG-------VVPVELSNLKQLEVL 135
            + +L + +          +     L  LDLS N   G       + P++   L+ L + 
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209

Query: 136 DLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELG--EFSNLAVFNISNNSFTGKL 193
           +      SG  S + A    +Q L++S NS   +         S L   N+S       L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT----GL 265

Query: 194 NSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLL 237
                    ++ +LDLS N         D  P +  L +  N  
Sbjct: 266 KQVPKGLPAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 24/99 (24%), Positives = 34/99 (34%), Gaps = 5/99 (5%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL-SNLKQLEVLDLSHNMLSGPVSGMLAG 152
             G+         QL+ LDLS N L             QL  L+LS   L     G+ A 
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK 275

Query: 153 LNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTG 191
           L     L++S N  +       E   +   ++  N F  
Sbjct: 276 L---SVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLD 310

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 25/218 (11%)

Query: 766 TNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRL--SGDCGQMEREFQAEVEALS 818
           +  F+        +G G F +V +    T G + A K +       +  ++ + E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q    
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-ILE 116

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTL 935
            +AY H      IVHR++K  N+LL  K +     LADFGL+  +    +       GT 
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTP 171

Query: 936 GYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRP 970
           GY+ PE    L         D+++ GV+L  LL G  P
Sbjct: 172 GYLSPE---VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 60/245 (24%), Positives = 93/245 (37%), Gaps = 36/245 (14%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
           IG G F  V  A  +  G + A+K   +   +   +++ F+ EV  +    H N+V L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81

Query: 831 YCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
                    LI  Y   G + DY +         +K        +     + Y H+    
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLV-----AHGRMKEKEARSKFRQIVSAVQYCHQK--- 133

Query: 890 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQTLTA 948
            IVHRD+K+ N+LLD      +ADFG S         +     G   Y  PE +      
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDA-FCGAPPYAAPELFQGKKYD 191

Query: 949 TCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDLVSWVFQM 989
               DV+S GV+L  L++G  P +          V +GK         +C +L+     +
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251

Query: 990 KSEKR 994
              KR
Sbjct: 252 NPIKR 256

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 50/230 (21%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-----FQA--EVE 815
            S + + +   +G G +G VYKA         A+KR+     ++E E       A  EV 
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIREVS 85

Query: 816 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQ 874
            L   QH+N++ L+    H +   LI+ Y E    D  L + +DK+  +    ++  + Q
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAE---ND--LKKYMDKNPDVSMRVIKSFLYQ 140

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH-----LADFGLSRL----LRPYDT 925
               G+ + H       +HRD+K  N+LL     +      + DFGL+R     +R +  
Sbjct: 141 -LINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-- 194

Query: 926 HVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
              T  + TL Y PPE       YS ++      D++S   +  E+L   
Sbjct: 195 ---THEIITLWYRPPEILLGSRHYSTSV------DIWSIACIWAEMLMKT 235

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.4 bits (240), Expect = 1e-20
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 25/206 (12%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
           +G G FG+V++ T    G   A K +       +   + E++ +S  +H  LV+L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 834 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQGAARGLAYLHKVCEPHIV 892
             N+ ++IY +M  G L     +  D+ + +   +    + Q   +GL ++H+    + V
Sbjct: 225 DDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQ-VCKGLCHMHEN---NYV 277

Query: 893 HRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE------YSQ 944
           H D+K  NI+   K    L   DFGL+  L P          GT  +  PE         
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEGKPVG- 334

Query: 945 TLTATCRGDVYSFGVVLLELLTGRRP 970
               T   D++S GV+   LL+G  P
Sbjct: 335 --YYT---DMWSVGVLSYILLSGLSP 355

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 62/299 (20%), Positives = 107/299 (35%), Gaps = 47/299 (15%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 831
            ++G G    V     L    + AVK +    G +      EVE L + Q H+N++ L  +
Sbjct: 20   VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                +   L++  M  GS+   L     +    + +    + Q  A  L +LH      I
Sbjct: 80   FEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEAS-VVVQDVASALDFLH---NKGI 132

Query: 892  VHRDVKSSNILLDEKFEAH---LADFGLSRLLRP------YDTHVTTDLVGTLGYIPPEY 942
             HRD+K  NIL +   +     + DF L   ++         T       G+  Y+ PE 
Sbjct: 133  AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192

Query: 943  SQTLTATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
             +  +          D++S GV+L  LL+G  P        C     W         +  
Sbjct: 193  VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV----GRCGSDCGWDRGEACPACQNM 248

Query: 998  IIDA----------SIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042
            + ++            W       K L+       K + +D ++R    +V+   W+ G
Sbjct: 249  LFESIQEGKYEFPDKDWAHISCAAKDLI------SKLLVRDAKQRLSAAQVLQHPWVQG 301

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 66/287 (22%), Positives = 114/287 (39%), Gaps = 53/287 (18%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            ++G G F  V+       G   A+K +       +   + E+  L + +H+N+V+L+   
Sbjct: 16   VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 833  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
                   L+   +  G L       +++    + D  L I Q     + YLH+     IV
Sbjct: 76   ESTTHYYLVMQLVSGGEL---FDRILERGVYTEKDASLVIQQ-VLSAVKYLHEN---GIV 128

Query: 893  HRDVKSSNILLDEKFE-AHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 949
            HRD+K  N+L     E + +   DFGLS++ +     + +   GT GY+ PE    L   
Sbjct: 129  HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEV---LAQK 182

Query: 950  CRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII------- 999
                  D +S GV+   LL G  P                F  ++E +  E I       
Sbjct: 183  PYSKAVDCWSIGVITYILLCGYPP----------------FYEETESKLFEKIKEGYYEF 226

Query: 1000 DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042
            ++  W    +  K  +      C  +++DP  R   E+ ++  W+DG
Sbjct: 227  ESPFWDDISESAKDFI------CHLLEKDPNERYTCEKALSHPWIDG 267

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 32/213 (15%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMERE-FQAEVEALSRAQHKNLVS 827
           +G G F +V K    + G + A K     +       + RE  + EV  L +  H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 828 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
           L     +  D +LI   +  G L         K+S+ + +    I Q    G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL---FDFLAQKESLSEEEATSFIKQ-ILDGVNYLHTK- 134

Query: 888 EPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 941
              I H D+K  NI+L +K        L DFGL+  +         ++ GT  ++ PE  
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAPEIV 190

Query: 942 ----YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                          D++S GV+   LL+G  P
Sbjct: 191 NYEPLG---LEA---DMWSIGVITYILLSGASP 217

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 93.4 bits (233), Expect = 1e-20
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 41/228 (17%)

Query: 761 DLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE---FQA--EV 814
           D+      + + + +G G F  VYKA         A+K++        ++     A  E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 815 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW---DVRLK 871
           + L    H N++ L     H ++  L++ +ME    D  L E + KD+ L      ++  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFME---TD--L-EVIIKDNSLVLTPSHIKAY 117

Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHV 927
           +     +GL YLH+     I+HRD+K +N+LLDE     LADFGL++      R Y TH 
Sbjct: 118 MLM-TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-TH- 171

Query: 928 TTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
               V T  Y  PE       Y          D+++ G +L ELL   
Sbjct: 172 ---QVVTRWYRAPELLFGARMYG---VGV---DMWAVGCILAELLLRV 210

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 71/283 (25%), Positives = 107/283 (37%), Gaps = 57/283 (20%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQG 830
            ++G G FG V K        + AVK ++      +       EVE L +  H N++ L  
Sbjct: 29   MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 831  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                 +   ++      G L     E + +    + D    I Q    G+ Y+HK    +
Sbjct: 89   ILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIKQ-VFSGITYMHKH---N 141

Query: 891  IVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-----Y 942
            IVHRD+K  NILL+ K +     + DFGLS   +        D +GT  YI PE     Y
Sbjct: 142  IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPEVLRGTY 199

Query: 943  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII--- 999
             +      + DV+S GV+L  LL+G  P                F  K+E   ++ +   
Sbjct: 200  DE------KCDVWSAGVILYILLSGTPP----------------FYGKNEYDILKRVETG 237

Query: 1000 ----DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                D   W    D  K L+       K +   P  R    + 
Sbjct: 238  KYAFDLPQWRTISDDAKDLI------RKMLTFHPSLRITATQC 274

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.6 bits (238), Expect = 2e-20
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 66/291 (22%)

Query: 765  STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 817
            + N F Q  ++G GGFG V     +AT   G   A K+L     +  +       E + L
Sbjct: 182  TKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQIL 238

Query: 818  SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             +   + +VSL  Y     D L L+ + M  G L + ++  + +    +       A+  
Sbjct: 239  EKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARAVFYAAE-I 295

Query: 877  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGT 934
              GL  LH+     IV+RD+K  NILLD+    H  ++D GL+  +    T      VGT
Sbjct: 296  CCGLEDLHRE---RIVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQT--IKGRVGT 348

Query: 935  LGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 988
            +GY+ PE      Y+ +       D ++ G +L E++ G+ P                FQ
Sbjct: 349  VGYMAPEVVKNERYTFSP------DWWALGCLLYEMIAGQSP----------------FQ 386

Query: 989  MKSEKREVEIIDASIWHKDRE---------KQLLEMLEIACKCIDQDPRRR 1030
             + +K + E ++  +     E         + L   L      + +DP  R
Sbjct: 387  QRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL------LCKDPAER 431

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.8 bits (229), Expect = 2e-20
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-----FQA--EVEALSR 819
             ++    IG G +G+VYKA    G   A+K++     ++E+E          E+  L  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKE 56

Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
            +H N+V L          +L++ +++   L   L     +  +     +  + Q    G
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQ-LLNG 112

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTL 935
           +AY H      ++HRD+K  N+L++ + E  +ADFGL+R     +R Y TH     + TL
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-TH----EIVTL 164

Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  P+       YS T+      D++S G +  E++ G 
Sbjct: 165 WYRAPDVLMGSKKYSTTI------DIWSVGCIFAEMVNGT 198

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.3 bits (230), Expect = 3e-20
 Identities = 63/302 (20%), Positives = 116/302 (38%), Gaps = 65/302 (21%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMERE-FQAEVEALSRAQHKNLVS 827
            +G G F +V K    + G + A K     R       + RE  + EV  L   QH N+++
Sbjct: 19   LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
            L     +  D +LI   +  G L        +K+S+ + +    + Q    G+ YLH + 
Sbjct: 79   LHEVYENKTDVILILELVAGGEL---FDFLAEKESLTEEEATEFLKQ-ILNGVYYLHSL- 133

Query: 888  EPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 941
               I H D+K  NI+L ++        + DFGL+  +     +   ++ GT  ++ PE  
Sbjct: 134  --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPEIV 189

Query: 942  ----YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
                           D++S GV+   LL+G  P                F   +++  + 
Sbjct: 190  NYEPLG---LEA---DMWSIGVITYILLSGASP----------------FLGDTKQETLA 227

Query: 998  IIDASIWHKDRE---------KQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1046
             + A  +  + E         K  +       + + +DP++R  I++ +   W+      
Sbjct: 228  NVSAVNYEFEDEYFSNTSALAKDFI------RRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

Query: 1047 AA 1048
             A
Sbjct: 282  QA 283

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 33/216 (15%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVKRLS--------GDCGQMEREFQAEVEALSRAQHKN 824
            +G G  G V  A       K A+K +S                  + E+E L +  H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 825 LVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
           ++ ++ +     D  ++   ME G L D      V    + +   +L   Q     + YL
Sbjct: 77  IIKIKNFF-DAEDYYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQ-MLLAVQYL 130

Query: 884 HKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
           H+     I+HRD+K  N+LL  + E     + DFG S++L   +T +   L GT  Y+ P
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 185

Query: 941 EYSQTLTATCRG------DVYSFGVVLLELLTGRRP 970
           E    L +          D +S GV+L   L+G  P
Sbjct: 186 E---VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.5 bits (228), Expect = 4e-20
 Identities = 56/221 (25%), Positives = 84/221 (38%), Gaps = 42/221 (19%)

Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEALS 818
             + +   IG G +G+V+K      G   A+K+          +          E+  L 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLK 57

Query: 819 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
           + +H NLV+L    R      L++ Y ++  L             L   V+    Q   +
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL---VKSITWQ-TLQ 113

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL----RPYDTHVTTDLVGT 934
            + + HK    + +HRDVK  NIL+ +     L DFG +RLL      Y      D V T
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-----DDEVAT 165

Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
             Y  PE       Y          DV++ G V  ELL+G 
Sbjct: 166 RWYRSPELLVGDTQYG---PPV---DVWAIGCVFAELLSGV 200

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 34/261 (13%), Positives = 71/261 (27%), Gaps = 51/261 (19%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQG 830
             G       ++A       + A+  +         + +E  +    LSR     +  +  
Sbjct: 39   HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98

Query: 831  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
                    L++  ++  GSL      S      ++        Q  A      H+     
Sbjct: 99   VVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAHRA---G 149

Query: 891  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC 950
            +       S + +    +  LA                         +P        A  
Sbjct: 150  VALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPD-------ANP 181

Query: 951  RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1010
            + D+   G  L  LL  R P+        R  ++   +  +     + I+ +   +D   
Sbjct: 182  QDDIRGIGASLYALLVNRWPLP---EAGVRSGLAPAERDTAG----QPIEPADIDRDIPF 234

Query: 1011 QLLEMLEIACKCIDQDPRRRP 1031
            Q+     +A + +  D   R 
Sbjct: 235  QI---SAVAARSVQGDGGIRS 252

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.5 bits (228), Expect = 4e-20
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 45/222 (20%)

Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE----FQA--EVEALSR 819
             + + + +G G +  VYK          A+K +     ++E E      A  EV  L  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKD 56

Query: 820 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVL--KWDVRLKIAQGAA 877
            +H N+V+L           L++ Y++    D  L + +D    +    +V+L + Q   
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLD---KD--LKQYLDDCGNIINMHNVKLFLFQ-LL 110

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVG 933
           RGLAY H      ++HRD+K  N+L++E+ E  LADFGL+R      + Y  +     V 
Sbjct: 111 RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DN----EVV 162

Query: 934 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           TL Y PP+       YS  +      D++  G +  E+ TGR
Sbjct: 163 TLWYRPPDILLGSTDYSTQI------DMWGVGCIFYEMATGR 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 92.8 bits (231), Expect = 4e-20
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 30/217 (13%)

Query: 766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 825
              +    +IG G FG+V++A L    + A+K++  D      + + E++ +   +H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD---KRFKNR-ELQIMRIVKHPNV 94

Query: 826 VSLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
           V L+ +     D+       L+  Y+         H +  K ++    ++L + Q   R 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRS 153

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           LAY+H +    I HRD+K  N+LLD       L DFG +++L   + +     + +  Y 
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VSYICSRYYR 208

Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       Y+  +      D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNI------DIWSTGCVMAELMQGQ 239

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 93.5 bits (233), Expect = 4e-20
 Identities = 90/470 (19%), Positives = 132/470 (28%), Gaps = 96/470 (20%)

Query: 102 LGHLNQLKLLDLSCNHL--EGVVPV--ELSNLKQLEVLDLSHNMLSGP----VSGMLAGL 153
           L  L Q +++ L    L       +   L     L  L+L  N L       V   L   
Sbjct: 24  LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83

Query: 154 NL-IQSLNVSSNSFN----GSLFE-LGEFSNLAVFNISNNSFTGK----LNSRIWSASKE 203
           +  IQ L++ +        G L   L     L   ++S+N         L   +      
Sbjct: 84  SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143

Query: 204 IQILDLSMNHF----MGSL-QGLDHSPSLKQLHVDNNLLGGD----LPDSL-YSMSSLQH 253
           ++ L L            L   L   P  K+L V NN +       L   L  S   L+ 
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203

Query: 254 VSLSVNNFSGQ----LSEKISNLTSLRHLIIFGNQFSGK-----LPNVLGNLTQLEFFVA 304
           + L     +      L   +++  SLR L +  N+          P +L   ++L     
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 305 HSNSFSGP----LPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 360
                +      L   L     L  L L  N L         G   LC   L        
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGD------EGARLLCET-LLEPGCQ-- 314

Query: 361 LPNSLSDCHDLKILSLAKNELSGQVPESFGKL----TSLLFLSLSNNSF-----NHLSGT 411
                     L+ L +     +      F  +      LL L +SNN         L   
Sbjct: 315 ----------LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364

Query: 412 LSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 471
           L   Q    L  L L    V +          S   LA             LL    L+ 
Sbjct: 365 LG--QPGSVLRVLWLADCDVSDS---------SCSSLAAT-----------LLANHSLRE 402

Query: 472 LDLSWNHFDGNIPPWIGQM-----ENLFYLDFSNNTLTGEIPKSLTELKS 516
           LDLS N         + +        L  L   +   + E+   L  L+ 
Sbjct: 403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 452

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 89.3 bits (222), Expect = 1e-18
 Identities = 83/479 (17%), Positives = 159/479 (33%), Gaps = 113/479 (23%)

Query: 177 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF----MGSL-QGLDHSPSLKQLH 231
            ++   +I     +    + +    ++ Q++ L            +   L  +P+L +L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 232 VDNNLLGGD----LPDSLYSMS-SLQHVSLSVNNFSGQ----LSEKISNLTSLRHLIIFG 282
           + +N LG      +   L + S  +Q +SL     +G     LS  +  L +L+ L +  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 283 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFS 342
           N        +L                       L    +L  L L   SL+       +
Sbjct: 123 NLLGDAGLQLLCEGL-------------------LDPQCRLEKLQLEYCSLSA------A 157

Query: 343 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL-----TSLLF 397
               L ++              L    D K L+++ N+++        +        L  
Sbjct: 158 SCEPLASV--------------LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203

Query: 398 LSLSNNSFNHLSGTL--SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 455
           L L +      +      ++    +L  L L  N                    LG+ G+
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSN-------------------KLGDVGM 244

Query: 456 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM----ENLFYLDFSNNTLTGEIPKSL 511
               P  L    +L+ L +            + ++    E+L  L  + N L  E  + L
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304

Query: 512 TELKSLISSNCTSSNPTASAGIPLYVKHNRST--------NGLPYNQASSFPPSVFLSNN 563
            E  +L+   C   +        L+VK    T        + L  N+       + +SNN
Sbjct: 305 CE--TLLEPGCQLES--------LWVKSCSFTAACCSHFSSVLAQNRFLL---ELQISNN 351

Query: 564 RINGTIPPEIGQ-LKH----LHVLDLSRNNIT----GTIPSSISEIRNLEVLDLSSNDL 613
           R+      E+ Q L      L VL L+  +++     ++ +++    +L  LDLS+N L
Sbjct: 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 72.3 bits (178), Expect = 3e-13
 Identities = 75/379 (19%), Positives = 120/379 (31%), Gaps = 83/379 (21%)

Query: 98  IPRSLGHLNQLKLLDLSCNHL--EGVVPV---ELSNLKQLEVLDLSHNMLS----GPVSG 148
           +  +L  L  L+ L LS N L   G+  +    L    +LE L L +  LS     P++ 
Sbjct: 105 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 164

Query: 149 MLAGLNLIQSLNVSSNSFNGS-LFELGEF-----SNLAVFNISNNSFTGKLNSRIWSA-- 200
           +L      + L VS+N  N + +  L +        L    + +   T      +     
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224

Query: 201 -SKEIQILDLSMNHFMG------SLQGLDHSPSLKQLHVDNNLLGGD----LPDSLYSMS 249
               ++ L L  N              L  S  L+ L +    +       L   L +  
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284

Query: 250 SLQHVSLSVNNFSG----QLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 304
           SL+ +SL+ N         L E +      L  L +    F+    +   ++        
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV-------- 336

Query: 305 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS 364
                       L+    L  L + NN L        +G+  LC   L            
Sbjct: 337 ------------LAQNRFLLELQISNNRLED------AGVRELCQG-LGQPGSV------ 371

Query: 365 LSDCHDLKILSLAKNELSGQVPESFGKL----TSLLFLSLSNNSF-----NHLSGTLSVL 415
                 L++L LA  ++S     S         SL  L LSNN         L  ++   
Sbjct: 372 ------LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR-- 423

Query: 416 QQCKNLTTLILTKNFVGEE 434
           Q    L  L+L   +  EE
Sbjct: 424 QPGCLLEQLVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.1 bits (123), Expect = 1e-06
 Identities = 53/272 (19%), Positives = 80/272 (29%), Gaps = 58/272 (21%)

Query: 370 DLKILSLAKNELSGQVPESFGK-LTSLLFLSLSNNSFN--HLSGTLSVLQQCKNLTTLIL 426
           D++ L +   ELS          L     + L +            S L+    L  L L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 427 TKNFVGEEIPENVGGFESL-MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD----G 481
             N +G+       G   +   L   +C              K+Q L L          G
Sbjct: 64  RSNELGDV------GVHCVLQGLQTPSC--------------KIQKLSLQNCCLTGAGCG 103

Query: 482 NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTE--------LKSLISSNCTSSNPTASAGI 533
            +   +  +  L  L  S+N L     + L E        L+ L    C+ S  +    +
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP-L 162

Query: 534 PLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQ-LKH----LHVLDLSRNN 588
              ++       L             +SNN IN      + Q LK     L  L L    
Sbjct: 163 ASVLRAKPDFKEL------------TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG 210

Query: 589 ITGTIPSSISEI----RNLEVLDLSSNDLHGS 616
           +T      +  I     +L  L L SN L   
Sbjct: 211 VTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 49.2 bits (118), Expect = 5e-06
 Identities = 47/219 (21%), Positives = 81/219 (36%), Gaps = 32/219 (14%)

Query: 92  KGLKGIIPRSLGHLNQLKLLDLSCNHL--EGVVPV--ELSNLKQLEVLDLSHNMLSGP-- 145
            G+  + P  L   ++L+ L +    +  +G   +   L   + L+ L L+ N L     
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301

Query: 146 ---VSGMLAGLNLIQSLNVSSNSFNGSLFE-----LGEFSNLAVFNISNNSFTGK----L 193
                 +L     ++SL V S SF  +        L +   L    ISNN         L
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361

Query: 194 NSRIWSASKEIQILDLSMNHF----MGSL-QGLDHSPSLKQLHVDNNLLGGD----LPDS 244
              +      +++L L+          SL   L  + SL++L + NN LG      L +S
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421

Query: 245 LYSM-SSLQHVSLSVNNFSGQ----LSEKISNLTSLRHL 278
           +      L+ + L    +S +    L     +  SLR +
Sbjct: 422 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.3 bits (225), Expect = 6e-20
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 53/280 (18%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G G +G V  A         AVK     R       +++E    +       H+N+V  
Sbjct: 15   LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70

Query: 829  QGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAAR--------G 879
             G+ R GN + L   Y   G L D            ++ D+ +      A+        G
Sbjct: 71   YGHRREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPD--AQRFFHQLMAG 117

Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGTLGY 937
            + YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R    +  +   + GTL Y
Sbjct: 118  VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPY 173

Query: 938  IPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
            + PE   +        DV+S G+VL  +L G  P +     +C++   W       +++ 
Sbjct: 174  VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWK------EKKT 226

Query: 997  EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
             +             L ++L         +P  R  I ++
Sbjct: 227  YLNPWKKIDSAPLALLHKILVE-------NPSARITIPDI 259

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 62/289 (21%), Positives = 101/289 (34%), Gaps = 46/289 (15%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 831
             +G G F +  K     +    AVK +S    +ME   Q E+ AL   + H N+V L   
Sbjct: 18   PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                    L+   +  G L         K    + +    I +     ++++H V    +
Sbjct: 75   FHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEAS-YIMRKLVSAVSHMHDV---GV 127

Query: 892  VHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA 948
            VHRD+K  N+L  ++ +     + DFG +RL  P D         TL Y  PE    L  
Sbjct: 128  VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLHYAAPE---LLNQ 183

Query: 949  TCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI-- 1003
                   D++S GV+L  +L+G+ P +             + +         I       
Sbjct: 184  NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK--------IKKGDFSF 235

Query: 1004 ----WHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044
                W       K L+         +  DP +R  +  +    WL    
Sbjct: 236  EGEAWKNVSQEAKDLI------QGLLTVDPNKRLKMSGLRYNEWLQDGS 278

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 94.0 bits (233), Expect = 7e-20
 Identities = 47/288 (16%), Positives = 88/288 (30%), Gaps = 52/288 (18%)

Query: 227 LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFS 286
           + +    +  +    PD   + +     +L   + +   +   + L S+  +I   +   
Sbjct: 1   MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK 56

Query: 287 GKLPNVLGNLTQLEFFVAHSN---SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFS 342
             +   +  L  +     + N            L+    L  L L  N +    DL +  
Sbjct: 57  -SVQG-IQYLPNVTKLFLNGNKLTDIKP-----LTNLKNLGWLFLDENKIK---DLSSLK 106

Query: 343 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN 402
            L  L +L L  N  S  +   L     L+ L L  N+++        +LT L  LSL +
Sbjct: 107 DLKKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLED 162

Query: 403 NSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVW 462
           N  + +      L     L  L L+KN +      ++     L                 
Sbjct: 163 NQISDIVP----LAGLTKLQNLYLSKNHI-----SDLRALAGL----------------- 196

Query: 463 LLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKS 510
               K L VL+L               +     +  ++ +L      S
Sbjct: 197 ----KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.8 bits (222), Expect = 1e-18
 Identities = 55/276 (19%), Positives = 101/276 (36%), Gaps = 60/276 (21%)

Query: 365 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 424
                +    +L K  ++     +  +L S+  +  +N+    + G    +Q   N+T L
Sbjct: 17  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG----IQYLPNVTKL 70

Query: 425 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 484
            L  N +  +I + +   ++L  L L    +K  +   L   KKL+ L L  N    +I 
Sbjct: 71  FLNGNKL-TDI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN 125

Query: 485 PWIGQMENLFYLDFSNNTLTGEIP--KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 542
             +  +  L  L   NN +T +I     LT+L +L                         
Sbjct: 126 G-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTL------------------------- 158

Query: 543 TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 602
                            L +N+I+  I P +  L  L  L LS+N+I+     +++ ++N
Sbjct: 159 ----------------SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKN 198

Query: 603 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 638
           L+VL+L S +           L   +     +  L 
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.0 bits (220), Expect = 2e-18
 Identities = 52/285 (18%), Positives = 95/285 (33%), Gaps = 29/285 (10%)

Query: 87  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 146
            I     +K I P       +    +L    +   V    + L  ++ +  +++ +   V
Sbjct: 4   TITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-V 58

Query: 147 SGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFT-----GKLNSRIWSAS 201
            G +  L  +  L ++ N     +  L    NL    +  N          L        
Sbjct: 59  QG-IQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIKDLSSLKDLKK------ 110

Query: 202 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
             ++ L L  N     + GL H P L+ L++ NN +  D+   L  ++ L  +SL  N  
Sbjct: 111 --LKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKI-TDI-TVLSRLTKLDTLSLEDNQI 165

Query: 262 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCS 321
           S  +   ++ LT L++L +  N  S  L   L  L  L+     S           S   
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 322 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLS 366
             + +   + SL  P  +  S        ++  +        S  
Sbjct: 222 VPNTVKNTDGSLVTPEII--SDDGDYEKPNVKWHLPEFTNEVSFI 264

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 87.1 bits (215), Expect = 1e-17
 Identities = 48/272 (17%), Positives = 98/272 (36%), Gaps = 22/272 (8%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
                L +K +   +      LN +  +  + + ++ V    +  L  +  L L+ N L+
Sbjct: 23  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 78

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 203
             +   L  L  +  L +  N     L  L +   L   ++ +N  +  +N        +
Sbjct: 79  D-IKP-LTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGIS-DING--LVHLPQ 132

Query: 204 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 263
           ++ L L  N  +  +  L     L  L +++N +  D+   L  ++ LQ++ LS N+ S 
Sbjct: 133 LESLYLGNNK-ITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS- 188

Query: 264 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKL 323
            L   ++ L +L  L +F  +   K  N   NL           S   P  +S       
Sbjct: 189 DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS------- 240

Query: 324 HVLDLRNNSLTGPIDLNFSGLSSLCTLDLATN 355
              D    ++   +    + +S +    +   
Sbjct: 241 DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 272

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 92.5 bits (230), Expect = 8e-20
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 31/220 (14%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
               ++    +IG G FG+VY+A L  +G   A+K++  D      + + E++ + +  H
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNR-ELQIMRKLDH 106

Query: 823 KNLVSLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
            N+V L+ +     ++       L+  Y+         H S  K ++    V+L + Q  
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-L 165

Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
            R LAY+H      I HRD+K  N+LLD +     L DFG ++ L           + + 
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 220

Query: 936 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            Y  PE       Y+ ++      DV+S G VL ELL G+
Sbjct: 221 YYRAPELIFGATDYTSSI------DVWSAGCVLAELLLGQ 254

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 90.4 bits (225), Expect = 8e-20
 Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 20/216 (9%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQ-----AEVEAL 817
           K   +F    I+G G F  V  A       + A+K L      + +E +      E + +
Sbjct: 27  KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVM 84

Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQG 875
           SR  H   V L  +    +++L    SY +NG L  ++     K         R   A+ 
Sbjct: 85  SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE- 138

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGT 934
               L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT
Sbjct: 139 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 935 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 90.6 bits (225), Expect = 1e-19
 Identities = 60/256 (23%), Positives = 93/256 (36%), Gaps = 57/256 (22%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQA---EVEALSRAQHKNL 825
           +G G FG V+ A       +  VK     ++  DC   + +      E+  LSR +H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 826 VSLQGYCRHGNDRLLIYSYMEN----GSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
           + +        ++      ME       L  +     +D+   L   +   I +     +
Sbjct: 92  IKVLDIFE---NQGFFQLVMEKHGSGLDLFAF-----IDRHPRLDEPLASYIFRQLVSAV 143

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            YL       I+HRD+K  NI++ E F   L DFG +  L        T   GT+ Y  P
Sbjct: 144 GYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYT-FCGTIEYCAP 198

Query: 941 E------YSQTLTATCRG---DVYSFGVVLLELLTGRRP----VEVCKGK---------N 978
           E      Y        RG   +++S GV L  L+    P     E  +            
Sbjct: 199 EVLMGNPY--------RGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250

Query: 979 CRDLVSWVFQMKSEKR 994
              LVS + Q   E+R
Sbjct: 251 LMSLVSGLLQPVPERR 266

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 90.8 bits (226), Expect = 2e-19
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 31/225 (13%)

Query: 762 LLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQ 811
           ++ ++  F+        +G G F +V +    T G + A K     +LS    Q     +
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LE 76

Query: 812 AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 871
            E     + QH N+V L    +  +   L++  +  G L     + V ++   + D    
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHC 133

Query: 872 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVT 928
           I Q     +AY H      IVHR++K  N+LL  K +     LADFGL+  +    +   
Sbjct: 134 IQQ-ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAW 187

Query: 929 TDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRP 970
               GT GY+ PE    L         D+++ GV+L  LL G  P
Sbjct: 188 HGFAGTPGYLSPE---VLKKDPYSKPVDIWACGVILYILLVGYPP 229

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 49/232 (21%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLS--------------------------GDCGQME 807
           IG G +G+V  A    + T  A+K LS                                 
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 808 REFQAEVEALSRAQHKNLVSL-QGYCRHGNDRL-LIYSYMENGSL-DYWLHESVDKDSVL 864
            +   E+  L +  H N+V L +       D L +++  +  G + +            L
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV------PTLKPL 134

Query: 865 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
             D      Q   +G+ YLH      I+HRD+K SN+L+ E     +ADFG+S   +  D
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 925 THVTTDLVGTLGYIPPEYSQTLTATCRG------DVYSFGVVLLELLTGRRP 970
             ++   VGT  ++ PE   +L+ T +       DV++ GV L   + G+ P
Sbjct: 192 ALLSN-TVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 91.0 bits (226), Expect = 2e-19
 Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 27/219 (12%)

Query: 767 NNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMERE---FQAEVEALSR 819
            +F    +IG G FG V     K         A+K L+        E   F+ E + L  
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVN 130

Query: 820 AQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
              K + +L  Y    ++ L L+  Y   G L   L  S  +D + +   R  +A+    
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAE-MVI 186

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLG 936
            +  +H++   H VHRD+K  NIL+D     H  LADFG    L    T  ++  VGT  
Sbjct: 187 AIDSVHQL---HYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 937 YIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 970
           YI PE  Q +           D +S GV + E+L G  P
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 53/280 (18%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +G G +G V  A         AVK     R       +++E    +       H+N+V  
Sbjct: 15   LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70

Query: 829  QGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAAR--------G 879
             G+ R GN + L   Y   G L D            ++ D+ +      A+        G
Sbjct: 71   YGHRREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPD--AQRFFHQLMAG 117

Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGTLGY 937
            + YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R    +  +   + GTL Y
Sbjct: 118  VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPY 173

Query: 938  IPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
            + PE   +        DV+S G+VL  +L G  P +     +C++   W       +++ 
Sbjct: 174  VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWK------EKKT 226

Query: 997  EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
             +             L ++L         +P  R  I ++
Sbjct: 227  YLNPWKKIDSAPLALLHKILVE-------NPSARITIPDI 259

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 89.2 bits (222), Expect = 3e-19
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 39/231 (16%)

Query: 762 LLKSTNNFNQ-----ANIIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREF 810
             +S  NFN      +  +G G F +V +    + G + A K     R   DC     E 
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC---RAEI 75

Query: 811 QAEVEALSRAQH-KNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDV 868
             E+  L  A+    +++L     + ++ +LI  Y   G +    L E  +  S  + DV
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS--ENDV 133

Query: 869 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDT 925
              I Q    G+ YLH+    +IVH D+K  NILL   +      + DFG+SR +     
Sbjct: 134 IRLIKQ-ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--A 187

Query: 926 HVTTDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
               +++GT  Y+ PE       +   TAT   D+++ G++   LLT   P
Sbjct: 188 CELREIMGTPEYLAPEILNYDPIT---TAT---DMWNIGIIAYMLLTHTSP 232

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.6 bits (223), Expect = 3e-19
 Identities = 61/243 (25%), Positives = 95/243 (39%), Gaps = 70/243 (28%)

Query: 765 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-----FQA--EVEA 816
             + + +   IG G FG V+KA     G K A+K++      ME E       A  E++ 
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKI 69

Query: 817 LSRAQHKNLVSLQGYC-----RHGNDRLLIY-----------SYMENGSLDYWLHESVDK 860
           L   +H+N+V+L   C      +   +  IY             + N  +      S  K
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIK 127

Query: 861 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL- 919
                     ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R  
Sbjct: 128 ----------RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174

Query: 920 -------LRPYDTHVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELL 965
                     Y     T+ V TL Y PPE       Y          D++  G ++ E+ 
Sbjct: 175 SLAKNSQPNRY-----TNRVVTLWYRPPELLLGERDYG---PPI---DLWGAGCIMAEMW 223

Query: 966 TGR 968
           T  
Sbjct: 224 TRS 226

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.5 bits (225), Expect = 3e-19
 Identities = 61/265 (23%), Positives = 104/265 (39%), Gaps = 40/265 (15%)

Query: 725 DDLDED-MGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLV 783
            +L    + + + +++ L  ++ ++ +  + + L   D       F    +IG G F  V
Sbjct: 26  QELGASELAQDKYVADFLQWAEPIVVRLKEVR-LQRDD-------FEILKVIGRGAFSEV 77

Query: 784 Y----KATLTNGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG 835
                K T   G   A+K ++       G++   F+ E + L     + +  L  +    
Sbjct: 78  AVVKMKQT---GQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLH-FAFQD 132

Query: 836 NDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 894
            + L L+  Y   G L   L +  ++        R  +A+     +  +H++     VHR
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAE--MARFYLAE-IVMAIDSVHRL---GYVHR 186

Query: 895 DVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 952
           D+K  NILLD     H  LADFG    LR   T  +   VGT  Y+ PE  Q +      
Sbjct: 187 DIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244

Query: 953 DVY-------SFGVVLLELLTGRRP 970
             Y       + GV   E+  G+ P
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTP 269

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 57/234 (24%), Positives = 87/234 (37%), Gaps = 51/234 (21%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQAEVEALSRAQHKNLVSL- 828
           +G G +G V +        + AVK L           E   + E++ L R +HKN++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 829 QGYCRHGNDRL-LIYSYMENGS---LDYWLHESVDKDSVLKWDVRLKIAQGAAR------ 878
                    ++ ++  Y   G    LD    +            R  + Q  A       
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK------------RFPVCQ--AHGYFCQL 118

Query: 879 --GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY--DTHVTTDLVGT 934
             GL YLH      IVH+D+K  N+LL       ++  G++  L P+  D    T   G+
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGS 174

Query: 935 LGYIPPEYSQTLTATCRG------DVYSFGVVLLELLTGRRPVEVCKGKNCRDL 982
             + PPE    +            D++S GV L  + TG  P E   G N   L
Sbjct: 175 PAFQPPE----IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE---GDNIYKL 221

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 43/249 (17%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLS-------GDCGQMEREFQAEVEALSRAQHKNLV 826
           +G G FG V        G K AVK L+          G+++RE    ++ L   +H +++
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHPHII 74

Query: 827 SLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
            L        D  ++  Y+  G L DY     + K   ++     ++ Q     + Y H+
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDY-----ICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQ 944
                +VHRD+K  N+LLD    A +ADFGLS ++   +   T+   G+  Y  PE  S 
Sbjct: 130 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISG 184

Query: 945 TLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDLVSW 985
            L A    D++S GV+L  LL G  P +          +  G          +   L+  
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMH 244

Query: 986 VFQMKSEKR 994
           + Q+   KR
Sbjct: 245 MLQVDPLKR 253

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 89.7 bits (223), Expect = 7e-19
 Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 55/294 (18%)

Query: 765  STNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMERE-FQAEVEAL 817
            +   F +       +G G F +V +   +  G + A   ++       + +  + E    
Sbjct: 5    TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64

Query: 818  SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
               +H N+V L           LI+  +  G L     + V ++   + D    I Q   
Sbjct: 65   RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQ-IL 120

Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGT 934
              + + H   +  +VHR++K  N+LL  K +     LADFGL+  +   +        GT
Sbjct: 121  EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGT 176

Query: 935  LGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS 991
             GY+ PE    L     G   D+++ GV+L  LL G  P                F  + 
Sbjct: 177  PGYLSPE---VLRKDPYGKPVDLWACGVILYILLVGYPP----------------FWDED 217

Query: 992  EKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
            + R  + I        +  W       K L+       K +  +P +R    E 
Sbjct: 218  QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI------NKMLTINPSKRITAAEA 265

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 89.1 bits (221), Expect = 8e-19
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 43/221 (19%)

Query: 775 IGCGGFGLVYKA---TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 831
           +G G +G VYKA      +    A+K++ G    +      E+  L   +H N++SLQ  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKV 86

Query: 832 CR-HGNDRL-LIYSYMENGSLDYW-LHESVDKDSVLKWDVRLKIAQGAA------RGLAY 882
              H + ++ L++ Y E    D W + +        K  V+L      +       G+ Y
Sbjct: 87  FLSHADRKVWLLFDYAE---HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRL----LRPYDTHVTTDLVGT 934
           LH      ++HRD+K +NIL+  +        +AD G +RL    L+P    +   +V T
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVV-T 198

Query: 935 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
             Y  PE       Y+    A    D+++ G +  ELLT  
Sbjct: 199 FWYRAPELLLGARHYT---KAI---DIWAIGCIFAELLTSE 233

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 86.9 bits (216), Expect = 2e-18
 Identities = 70/285 (24%), Positives = 109/285 (38%), Gaps = 50/285 (17%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRL-------SGDCGQMEREFQAEVEALSRAQHKNLV 826
            +G G FG V  AT      K A+K +       S    ++ERE    +  L   +H +++
Sbjct: 17   LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHII 72

Query: 827  SLQGYCRHGNDRLLIYSYME--NGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
             L        D   I   +E   G L DY     + +   +  D   +  Q     + Y 
Sbjct: 73   KLYDVITTPTD---IVMVIEYAGGELFDY-----IVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 884  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-Y 942
            H+     IVHRD+K  N+LLD+     +ADFGLS ++      + T   G+  Y  PE  
Sbjct: 125  HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKT-SCGSPNYAAPEVI 179

Query: 943  SQTLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDLV 983
            +  L A    DV+S G+VL  +L GR P +          V               + L+
Sbjct: 180  NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239

Query: 984  SWVFQMKSEKR-EVEIIDASIW-HKDREKQLLEMLEIACKCIDQD 1026
              +      +R  ++ I    W + +    L  M E+     D  
Sbjct: 240  RRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSR 284

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 61/299 (20%), Positives = 106/299 (35%), Gaps = 67/299 (22%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQGY 831
            ++G G  G V +      G K A+K L  D  +  +E    V+   + +   ++V +   
Sbjct: 36   VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQE----VDHHWQASGGPHIVCILDV 90

Query: 832  C---RHGNDRL-LIYSYMENGSLDYWLHESVDKDSVL--KWDVRLKIAQGAARGLAYLHK 885
                 HG   L +I   ME G L        ++      + +   +I +     + +LH 
Sbjct: 91   YENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHS 146

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE- 941
                +I HRDVK  N+L   K +     L DFG +   +    +       T  Y+ PE 
Sbjct: 147  H---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA---KETTQNALQTPCYTPYYVAPEV 200

Query: 942  -YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
               +    +C  D++S GV++  LL G  P                F   + +     + 
Sbjct: 201  LGPEKYDKSC--DMWSLGVIMYILLCGFPP----------------FYSNTGQAISPGMK 242

Query: 1001 ASI-----------WHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044
              I           W +  +  KQL+         +  DP  R  I + +   W++   
Sbjct: 243  RRIRLGQYGFPNPEWSEVSEDAKQLI------RLLLKTDPTERLTITQFMNHPWINQSM 295

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 52/230 (22%), Positives = 86/230 (37%), Gaps = 57/230 (24%)

Query: 766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA-------- 816
              +     IG G  G+V  A         A+K+LS       R FQ +  A        
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76

Query: 817 -LSRAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK---W 866
            +    HKN++ L      Q       D  ++   M+            +   V++    
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----------ANLCQVIQMELD 125

Query: 867 DVRLK--IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
             R+   + Q    G+ +LH      I+HRD+K SNI++       + DFGL+R      
Sbjct: 126 HERMSYLLYQ-MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 179

Query: 925 THVTTDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           + + T  V T  Y  PE      Y + +      D++S G ++ E++ G 
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENV------DIWSVGCIMGEMIKGG 223

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 85.3 bits (212), Expect = 4e-18
 Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 42/229 (18%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEV-------- 814
            +T+ +     IG G +G VYKA    +G   A+K +              +        
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREV 62

Query: 815 ---EALSRAQHKNLVSL----QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKW 866
                L   +H N+V L             ++ L++ +++   L  +L +      +   
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAE 120

Query: 867 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 926
            ++  + Q   RGL +LH      IVHRD+K  NIL+       LADFGL+   R Y   
Sbjct: 121 TIKDLMRQ-FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA---RIYSYQ 173

Query: 927 VT-TDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           +  T +V TL Y  PE      Y+   T     D++S G +  E+   +
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYA---TPV---DMWSVGCIFAEMFRRK 216

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 86.2 bits (214), Expect = 4e-18
 Identities = 43/217 (19%), Positives = 79/217 (36%), Gaps = 36/217 (16%)

Query: 774 IIGCGGFGLVYKATLTNGTKAAVKRLS--GDCGQMEREFQAEVEA---------LSRAQH 822
            I  G +G V     + G   A+KR+      G+                    L+   H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 823 KNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLK--IAQGAAR 878
            N++ L+    H  +  +  +Y   E   +   L + +    ++     ++  +      
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTE--LMRTDLAQVIHDQRIVISPQHIQYFMYH-ILL 145

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 938
           GL  LH+     +VHRD+   NILL +  +  + DF L+R          T  V    Y 
Sbjct: 146 GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA--DANKTHYVTHRWYR 200

Query: 939 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            PE       +++ +      D++S G V+ E+   +
Sbjct: 201 APELVMQFKGFTKLV------DMWSAGCVMAEMFNRK 231

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 85.3 bits (212), Expect = 5e-18
 Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 50/232 (21%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVKRLSGDCGQMERE-----FQA--EV 814
           ++   +     IG G +G V+KA      G   A+KR+     +++            EV
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-----RVQTGEEGMPLSTIREV 62

Query: 815 EAL---SRAQHKNLVSL----QGYCRHGNDRL-LIYSYMEN---GSLDYWLHESVDKDSV 863
             L      +H N+V L             +L L++ +++      LD      V  +++
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 864 LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY 923
                +L       RGL +LH      +VHRD+K  NIL+    +  LADFGL+   R Y
Sbjct: 123 KDMMFQL------LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA---RIY 170

Query: 924 DTHVT-TDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 968
              +  T +V TL Y  PE      Y+   T     D++S G +  E+   +
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYA---TPV---DLWSVGCIFAEMFRRK 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.0 bits (218), Expect = 6e-18
 Identities = 69/237 (29%), Positives = 98/237 (41%), Gaps = 40/237 (16%)

Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLS-GDCGQMEREFQAEVE---- 815
           + N+F+   IIG GGFG VY      T   G   A+K L        + E  A  E    
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIML 243

Query: 816 -ALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKI 872
             +S      +V +  Y  H  D+L  I   M  G L Y L     +  V     +R   
Sbjct: 244 SLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYA 298

Query: 873 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
           A+    GL ++H      +V+RD+K +NILLDE     ++D GL+        H     V
Sbjct: 299 AE-IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SV 351

Query: 933 GTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDL 982
           GT GY+ PE       Y  +       D +S G +L +LL G  P    K K+  ++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSA------DWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 86.8 bits (215), Expect = 7e-18
 Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 35/212 (16%)

Query: 773 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQH 822
             IG G  G+V  A         A+K+LS       R FQ +  A         +    H
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 120

Query: 823 KNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
           KN++SL      Q       D  L+   M+    +  L + V +  +    +   + Q  
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA---N--LCQ-VIQMELDHERMSYLLYQ-M 173

Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
             G+ +LH      I+HRD+K SNI++       + DFGL+R      + + T  V T  
Sbjct: 174 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 228

Query: 937 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGR 968
           Y  PE    +      D++S G ++ E++  +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 65/275 (23%), Positives = 91/275 (33%), Gaps = 59/275 (21%)

Query: 722 CPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFG 781
             + DLD    R  +  +   S             +   D       +    +IG G FG
Sbjct: 31  ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAED-------YEVVKVIGRGAFG 83

Query: 782 LVY----KATLTNGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            V     K+T       A+K LS             F  E + ++ A    +V L  Y  
Sbjct: 84  EVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQLF-YAF 138

Query: 834 HGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR--------GLAYLH 884
             +  L ++  YM  G L   +                 + +  AR         L  +H
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMS-------------NYDVPEKWARFYTAEVVLALDAIH 185

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
            +     +HRDVK  N+LLD+    H  LADFG    +           VGT  YI PE 
Sbjct: 186 SM---GFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE- 239

Query: 943 SQTLTATCRGDVY-------SFGVVLLELLTGRRP 970
              L +      Y       S GV L E+L G  P
Sbjct: 240 --VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.4 bits (214), Expect = 1e-17
 Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 44/283 (15%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLS-------GDCGQMEREFQAEVEALSRAQHKNLV 826
            +G G FG V        G K AVK L+          G++ RE    ++ L   +H +++
Sbjct: 24   LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRHPHII 79

Query: 827  SLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
             L       +D  ++  Y+  G L DY     + K+  L      ++ Q    G+ Y H+
Sbjct: 80   KLYQVISTPSDIFMVMEYVSGGELFDY-----ICKNGRLDEKESRRLFQQILSGVDYCHR 134

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQ 944
                 +VHRD+K  N+LLD    A +ADFGLS ++   +   T+   G+  Y  PE  S 
Sbjct: 135  H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISG 189

Query: 945  TLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDLVSW 985
             L A    D++S GV+L  LL G  P +          +C G          +   L+  
Sbjct: 190  RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKH 249

Query: 986  VFQMKSEKR-EVEIIDASIWHKDREKQLLEMLEIACKCIDQDP 1027
            + Q+   KR  ++ I    W K    + L   + +      D 
Sbjct: 250  MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDD 292

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 45/206 (21%), Positives = 87/206 (42%), Gaps = 29/206 (14%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQGYC 832
           +G G +  V++A  +TN  K  VK L       +++ + E++ L       N+++L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIV 100

Query: 833 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 892
           +    R     +    + D    +     +   +D+R  + +   + L Y H +    I+
Sbjct: 101 KDPVSRTPALVFEHVNNTD--FKQLYQTLT--DYDIRFYMYE-ILKALDYCHSM---GIM 152

Query: 893 HRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-------YSQ 944
           HRDVK  N+++D E  +  L D+GL+    P   +     V +  +  PE       Y  
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDY 210

Query: 945 TLTATCRGDVYSFGVVLLELLTGRRP 970
           +L      D++S G +L  ++  + P
Sbjct: 211 SL------DMWSLGCMLASMIFRKEP 230

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 63/306 (20%), Positives = 105/306 (34%), Gaps = 80/306 (26%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 831
            ++G G  G V +        K A+K L  DC +  RE    VE   RA    ++V +   
Sbjct: 69   VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIVDV 123

Query: 832  CRHGNDR----LLIYSYMENGSLDYWLHESVDKDS----------VLKWDVRLKIAQGAA 877
              +        L++   ++ G L        D+            ++K      I +   
Sbjct: 124  YENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMK-----SIGEA-- 173

Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGT 934
              + YLH +   +I HRDVK  N+L   K       L DFG ++       +  T    T
Sbjct: 174  --IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYT 226

Query: 935  LGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 988
              Y+ PE      Y +    +C  D++S GV++  LL G  P       +   +   +  
Sbjct: 227  PYYVAPEVLGPEKYDK----SC--DMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKT 277

Query: 989  MKSEKREVEIIDASI------WHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT-- 1038
                     I           W +  +  K L+         +  +P +R  I E +   
Sbjct: 278  --------RIRMGQYEFPNPEWSEVSEEVKMLI------RNLLKTEPTQRMTITEFMNHP 323

Query: 1039 WLDGIG 1044
            W+    
Sbjct: 324  WIMQST 329

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.8 bits (205), Expect = 5e-17
 Identities = 57/207 (27%), Positives = 84/207 (40%), Gaps = 27/207 (13%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            +G G   +VY+          A+K L       ++  + E+  L R  H N++ L+   
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 833 RHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
                   I   +E    G L       V+K    + D    + Q     +AYLH   E 
Sbjct: 118 ---ETPTEISLVLELVTGGEL---FDRIVEKGYYSERDAADAVKQ-ILEAVAYLH---EN 167

Query: 890 HIVHRDVKSSNILLDEKFE-AHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
            IVHRD+K  N+L       A L  ADFGLS+++      +   + GT GY  PE    L
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPE---IL 222

Query: 947 TATCRG---DVYSFGVVLLELLTGRRP 970
                G   D++S G++   LL G  P
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEP 249

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 7e-17
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 60/231 (25%)

Query: 766 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA-------- 816
              +     +G G +G V  A    +G K A+K+LS       R FQ+E+ A        
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75

Query: 817 -LSRAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-- 867
            L   QH+N++ L          R+  D  L+  +M+            D   ++     
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----------TDLQKIMGLKFS 124

Query: 868 ---VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
              ++  + Q   +GL Y+H      +VHRD+K  N+ ++E  E  + DFGL+R      
Sbjct: 125 EEKIQYLVYQ-MLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179

Query: 925 THVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
               T  V T  Y  PE       Y+QT+      D++S G ++ E+LTG+
Sbjct: 180 ---MTGYVVTRWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK 221

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.4 bits (204), Expect = 8e-17
 Identities = 54/204 (26%), Positives = 75/204 (36%), Gaps = 22/204 (10%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
           IG G FG+             AVK   R +     ++RE    +      +H N+V  + 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83

Query: 831 YCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
                    +I  Y   G L +      +        D      Q    G++Y H +   
Sbjct: 84  VILTPTHLAIIMEYASGGELYER-----ICNAGRFSEDEARFFFQQLLSGVSYCHSM--- 135

Query: 890 HIVHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQTL 946
            I HRD+K  N LLD      L   DFG S+    +    +T  VGT  YI PE   +  
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQE 193

Query: 947 TATCRGDVYSFGVVLLELLTGRRP 970
                 DV+S GV L  +L G  P
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYP 217

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 51/218 (23%)

Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 824
           +G G +G V  A     G K A+K+L        R FQ+E+ A         L   +H+N
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELRLLKHMRHEN 85

Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAA 877
           ++ L              D  L+  +M     D  L + + K   L  D ++  + Q   
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGT---D--LGK-LMKHEKLGEDRIQFLVYQ-ML 138

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
           +GL Y+H      I+HRD+K  N+ ++E  E  + DFGL+R          T  V T  Y
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWY 191

Query: 938 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
             PE       Y+QT+      D++S G ++ E++TG+
Sbjct: 192 RAPEVILNWMRYTQTV------DIWSVGCIMAEMITGK 223

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 33/238 (13%), Positives = 69/238 (28%), Gaps = 17/238 (7%)

Query: 201 SKEIQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGDLP-DSLYSMSSLQHVS 255
            +    L   +        G+  G      L+++ +  N +   +  D   ++  L  + 
Sbjct: 29  PRNAIELRFVLTKLRVIQKGAFSGF---GDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85

Query: 256 LSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLP 314
           +   N    ++ +   NL +L++L+I              +  Q        N     + 
Sbjct: 86  IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145

Query: 315 LSL--SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 372
            +    L  +  +L L  N +    +  F+G           N+      +         
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205

Query: 373 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 430
           IL +++  +          L  L   S  N         L  L++   L    LT   
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARSTYNLK------KLPTLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 47/283 (16%), Positives = 97/283 (34%), Gaps = 25/283 (8%)

Query: 108 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHN-MLSGPVSGMLAGLNLIQSLNVSSN-- 164
              L      L  +     S    LE +++S N +L    + + + L  +  + +     
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91

Query: 165 --SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG-- 220
               N   F+     NL    ISN      L       S +  +LD+  N  + +++   
Sbjct: 92  LLYINPEAFQ--NLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148

Query: 221 -LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNLTSLRHL 278
            +  S     L ++ N +  ++ +S ++ + L  ++LS NN   +L   +    +    L
Sbjct: 149 FVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207

Query: 279 IIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS------ 332
            I   +        L NL +L     ++      LP +L     L    L   S      
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRARSTYNLKK---LP-TLEKLVALMEASLTYPSHCCAFA 263

Query: 333 --LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 373
                  +L+     S+   ++     +    +SL++ ++   
Sbjct: 264 NWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSY 306

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 41/291 (14%), Positives = 76/291 (26%), Gaps = 63/291 (21%)

Query: 367 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL-SGTLSVLQQCKNLTTLI 425
            C + K+           +P       + + L         +  G  S      +L  + 
Sbjct: 15  LCQESKVTE---------IPSDL--PRNAIELRFVLTKLRVIQKGAFSGF---GDLEKIE 60

Query: 426 LTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNI 483
           +++N V E I  +V      L  + +       +I     +    LQ L +S      ++
Sbjct: 61  ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHL 119

Query: 484 PPWIGQ-MENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 542
           P            LD  +N        ++  ++       +                   
Sbjct: 120 PDVHKIHSLQKVLLDIQDNI-------NIHTIERNSFVGLSF---------------ESV 157

Query: 543 TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 602
              L  N       S F                 +   +     NN+             
Sbjct: 158 ILWLNKNGIQEIHNSAF--------------NGTQLDELNLSDNNNLEELPNDVFHGASG 203

Query: 603 LEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 652
             +LD+S   +H S+P    E L  L   S    +L+  +PT         
Sbjct: 204 PVILDISRTRIH-SLPSYGLENLKKLRARS--TYNLK-KLPT---LEKLVA 247

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 37/173 (21%), Positives = 67/173 (38%), Gaps = 15/173 (8%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNM-LSGPVSGMLAG 152
           L  I P +  +L  L+ L +S   ++ +  V   +  Q  +LD+  N+ +         G
Sbjct: 92  LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151

Query: 153 L-NLIQSLNVSSN---SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILD 208
           L      L ++ N     + S F         +    NN+   +L + ++  +    ILD
Sbjct: 152 LSFESVILWLNKNGIQEIHNSAFNG--TQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 208

Query: 209 LSMNHFMGSLQ--GLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
           +S      SL   GL++   L+     N      LP +L  + +L   SL+  
Sbjct: 209 ISRTRIH-SLPSYGLENLKKLRARSTYNL---KKLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 3/102 (2%)

Query: 87  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 146
           L L + G++ I   +       +L     N+LE +            +LD+S   +    
Sbjct: 159 LWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 218

Query: 147 SGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNS 188
           S  L  L  +++ +  +      L  L +   L   +++  S
Sbjct: 219 SYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYPS 257

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 57/311 (18%), Positives = 107/311 (34%), Gaps = 45/311 (14%)

Query: 87  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 146
            I     +K I         +    +L    +   V    + L  ++ +  +++ +   V
Sbjct: 7   TITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-V 61

Query: 147 SGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQI 206
            G +  L  +  L ++ N     +  L    NL    +  N                 ++
Sbjct: 62  QG-IQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDEN-----------------KV 102

Query: 207 LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS 266
            DLS          L     LK L +++N +  D+ + L  +  L+ + L  N  +    
Sbjct: 103 KDLS---------SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--I 149

Query: 267 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL 326
             +S LT L  L +  NQ S  +   L  LT+L+      N  S    L+      L VL
Sbjct: 150 TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRALAG--LKNLDVL 205

Query: 327 DLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKN--ELSGQ 384
           +L +         + S L    T+           P  +SD  D +  ++  +  E + +
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNE 263

Query: 385 VPESFGKLTSL 395
           V   F +  ++
Sbjct: 264 VSFIFYQPVTI 274

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 54/274 (19%), Positives = 100/274 (36%), Gaps = 58/274 (21%)

Query: 365 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 424
                +    +L K  ++     +  +L S+  +  +N+    + G    +Q   N+T L
Sbjct: 20  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG----IQYLPNVTKL 73

Query: 425 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 484
            L  N +  +I + +   ++L  L L    +K  +   L   KKL+ L L  N    +I 
Sbjct: 74  FLNGNKL-TDI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN 128

Query: 485 PWIGQMENLFYLDFSNNTLTG-EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRST 543
             +  +  L  L   NN +T   +   LT+L +L                          
Sbjct: 129 G-LVHLPQLESLYLGNNKITDITVLSRLTKLDTL-------------------------- 161

Query: 544 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNL 603
                           L +N+I+  I P +  L  L  L LS+N+I+     +++ ++NL
Sbjct: 162 ---------------SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNL 202

Query: 604 EVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 637
           +VL+L S +           L   +     +  L
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 52/266 (19%), Positives = 86/266 (32%), Gaps = 28/266 (10%)

Query: 267 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSN---SFSGPLPLSLSLCSKL 323
                        +     +  +      L  ++  +A+++   S  G     +     +
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG-----IQYLPNV 70

Query: 324 HVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 382
             L L  N LT   D+   + L +L  L L  N       +SL D   LK LSL  N +S
Sbjct: 71  TKLFLNGNKLT---DIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS 125

Query: 383 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 442
                    L  L  L L NN    ++     L +   L TL L  N +  +I   + G 
Sbjct: 126 --DINGLVHLPQLESLYLGNNKITDITV----LSRLTKLDTLSLEDNQI-SDI-VPLAGL 177

Query: 443 ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNT 502
             L  L L    +   +   L   K L VL+L               +     +  ++ +
Sbjct: 178 TKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 503 LTGEIPKSLTELKSLISSNCTSSNPT 528
           L    P+ +++       N     P 
Sbjct: 236 LVT--PEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 37/233 (15%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
           +  +I     +K +    + +L  +  L L+ N L  + P  L+NLK L  L L  N + 
Sbjct: 48  IDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK 103

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 203
             +S  L  L  ++SL++  N  +  +  L     L    + NN                
Sbjct: 104 D-LSS-LKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNN---------------- 144

Query: 204 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 263
            +I D++          L     L  L +++N +  D+   L  ++ LQ++ LS N+ S 
Sbjct: 145 -KITDIT---------VLSRLTKLDTLSLEDNQI-SDIV-PLAGLTKLQNLYLSKNHIS- 191

Query: 264 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLS 316
            L   ++ L +L  L +F  +   K  N   NL           S   P  +S
Sbjct: 192 DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 34/163 (20%), Positives = 65/163 (39%), Gaps = 8/163 (4%)

Query: 102 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 161
           L HL QL+ L L  N +  +    LS L +L+ L L  N +S  +   LAGL  +Q+L +
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYL 185

Query: 162 SSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL 221
           S N  +  L  L    NL V  + +     K  +   +      + +   +  + + + +
Sbjct: 186 SKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS--LVTPEII 242

Query: 222 DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ 264
                 ++ +V  +L      +  +       +  +   F G+
Sbjct: 243 SDDGDYEKPNVKWHLP-EFTNEVSFIFYQPVTIGKAKARFHGR 284

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.2 bits (198), Expect = 6e-16
 Identities = 45/252 (17%), Positives = 85/252 (33%), Gaps = 63/252 (25%)

Query: 764 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 822
            S+  ++    +G G FG+V +     +G + A+K++  D     RE       +    H
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDI----MKVLDH 59

Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD--------------- 867
            N++ L  Y     D         +         +   +                     
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 868 -----------------------VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD 904
                                  + + I Q   R + ++H +    I HRD+K  N+L++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHSL---GICHRDIKPQNLLVN 175

Query: 905 -EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYS 956
            +     L DFG ++ L P +       + +  Y  PE       Y+ ++      D++S
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSI------DLWS 227

Query: 957 FGVVLLELLTGR 968
            G V  EL+ G+
Sbjct: 228 IGCVFGELILGK 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.6 bits (197), Expect = 6e-16
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 49/228 (21%)

Query: 766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA-------- 816
              +   + IG G +G+V  A    N  + A+K++S         F+ +           
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--------PFEHQTYCQRTLREIK 77

Query: 817 -LSRAQHKNLVSLQ-----GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VR 869
            L R +H+N++ +             D  ++   ME    D  L++ + K   L  D + 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET---D--LYK-LLKTQHLSNDHIC 131

Query: 870 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT- 928
             + Q   RGL Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H   
Sbjct: 132 YFLYQ-ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 929 -TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            T+ V T  Y  PE       Y++++      D++S G +L E+L+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSI------DIWSVGCILAEMLSNR 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 79.7 bits (197), Expect = 7e-16
 Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 51/218 (23%)

Query: 775 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 824
           +G G +G V  A  T  G + AVK+LS       R FQ+ + A         L   +H+N
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 89

Query: 825 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAA 877
           ++ L             ND  L+   M     D  L+  + K   L  D V+  I Q   
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNN-IVKCQKLTDDHVQFLIYQ-IL 142

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
           RGL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R          T  V T  Y
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWY 195

Query: 938 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
             PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 48/224 (21%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQAEVEALSRAQHKNLVSL 828
            +GCGG GLV+ A       + A+K++            RE    ++ + R  H N+V +
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHDNIVKV 73

Query: 829 --------------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
                          G     N   ++  YME    D  L   +++  +L+   RL + Q
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---D--LANVLEQGPLLEEHARLFMYQ 128

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVT--TDL 931
              RGL Y+H     +++HRD+K +N+ ++ E     + DFGL+R++ P+ +H    ++ 
Sbjct: 129 -LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 932 VGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           + T  Y  P        Y++ +      D+++ G +  E+LTG+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAI------DMWAAGCIFAEMLTGK 222

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.7 bits (187), Expect = 8e-15
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 36/223 (16%)

Query: 765 STNNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSGDC--GQMEREFQAEVEALS 818
             + F    ++G G FG V+     +G+ A    A+K L       +     + E + L 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81

Query: 819 RAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQG 875
              H  +V L  Y      +L LI  ++  G L   L + V   ++     DV+  +A+ 
Sbjct: 82  EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLAE- 134

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVG 933
            A  L +LH +    I++RD+K  NILLDE  E H  L DFGLS+    ++    +   G
Sbjct: 135 LALALDHLHSL---GIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKAYS-FCG 188

Query: 934 TLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T+ Y+ PE      ++Q+       D +SFGV++ E+LTG  P
Sbjct: 189 TVEYMAPEVVNRRGHTQSA------DWWSFGVLMFEMLTGTLP 225

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 31/241 (12%), Positives = 66/241 (27%), Gaps = 74/241 (30%)

Query: 371 LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 430
                L ++  +     +  ++ SL +++L+N +   L+G    ++   N+  L +    
Sbjct: 25  YLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG----IEYAHNIKDLTINNIH 77

Query: 431 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM 490
                  N      L                       L+ L +       +  P +  +
Sbjct: 78  A-----TNYNPISGL---------------------SNLERLRIMGKDVTSDKIPNLSGL 111

Query: 491 ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 550
            +L  LD S++     I   +  L  + S               + + +N          
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNS---------------IDLSYN---------- 146

Query: 551 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSS 610
                         I  T    +  L  L  L++  + +       I +   L  L   S
Sbjct: 147 ------------GAI--TDIMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFS 190

Query: 611 N 611
            
Sbjct: 191 Q 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 27/160 (16%), Positives = 60/160 (37%), Gaps = 9/160 (5%)

Query: 364 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 423
           + +  + L  ++LA   ++           ++  L+++N    + +     +    NL  
Sbjct: 39  TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNP----ISGLSNLER 92

Query: 424 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNI 483
           L +    V  +   N+ G  SL +L + +      I   +    K+  +DLS+N    +I
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

Query: 484 PPWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSL-ISSN 521
            P +  +  L  L+   + +      +   +L  L   S 
Sbjct: 153 MP-LKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 31/211 (14%), Positives = 79/211 (37%), Gaps = 35/211 (16%)

Query: 297 TQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATN 355
           +  + ++      S    ++ +  + L  + L N ++T   DL       ++  L +   
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT---DLTGIEYAHNIKDLTINNI 76

Query: 356 HFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVL 415
           H +   P  +S   +L+ L +   +++     +   LTSL  L +S+++ +     L+ +
Sbjct: 77  HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI--LTKI 132

Query: 416 QQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLS 475
                + ++ L+ N     I  ++   ++L                      +L+ L++ 
Sbjct: 133 NTLPKVNSIDLSYN---GAI-TDIMPLKTL---------------------PELKSLNIQ 167

Query: 476 WNHFDGNIPPWIGQMENLFYLDFSNNTLTGE 506
           ++    +    I     L  L   + T+ G+
Sbjct: 168 FDGVH-DYRG-IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 28/184 (15%), Positives = 62/184 (33%), Gaps = 14/184 (7%)

Query: 270 SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLR 329
           S   +  + ++  +  +      + +LT +     +    +G     +     +  L + 
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTIN 74

Query: 330 NNSLTGPIDL-NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPES 388
           N   T   +    SGLS+L  L +     +     +LS    L +L ++ +     +   
Sbjct: 75  NIHAT---NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 389 FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVL 448
              L  +  + LS N        +  L+    L +L +  + V +     +  F  L  L
Sbjct: 132 INTLPKVNSIDLSYNG---AITDIMPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQL 186

Query: 449 ALGN 452
              +
Sbjct: 187 YAFS 190

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 29/196 (14%), Positives = 72/196 (36%), Gaps = 32/196 (16%)

Query: 93  GLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAG 152
           G       +   +N L  + L+  ++  +    +     ++ L +++   +      ++G
Sbjct: 31  GQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISG 86

Query: 153 LNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSM 211
           L+ ++ L +            L   ++L + +IS+++    + ++I +   ++  +DLS 
Sbjct: 87  LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI-NTLPKVNSIDLSY 145

Query: 212 NHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISN 271
           N  +  +  L   P LK L++  +                      V+++ G     I +
Sbjct: 146 NGAITDIMPLKTLPELKSLNIQFD---------------------GVHDYRG-----IED 179

Query: 272 LTSLRHLIIFGNQFSG 287
              L  L  F     G
Sbjct: 180 FPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 27/209 (12%), Positives = 69/209 (33%), Gaps = 33/209 (15%)

Query: 127 SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISN 186
           S  K      L  +  +  ++   A +N +  + +++ +    L  +    N+    I+N
Sbjct: 20  STFKAYLNGLLGQSSTA-NIT--EAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINN 75

Query: 187 NSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLY 246
                                + +          +    +L++L +    +  D   +L 
Sbjct: 76  I-----------------HATNYN---------PISGLSNLERLRIMGKDVTSDKIPNLS 109

Query: 247 SMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHS 306
            ++SL  + +S +     +  KI+ L  +  + +  N     +   L  L +L+      
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQF 168

Query: 307 NSFSGPLPLSLSLCSKLHVLDLRNNSLTG 335
           +       +      KL+ L   + ++ G
Sbjct: 169 DGVHDYRGIE-DF-PKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 26/172 (15%), Positives = 52/172 (30%), Gaps = 45/172 (26%)

Query: 467 KKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSNCTSS 525
             L  + L+  +   ++   I    N+  L  +N   T   P   L+ L+ L        
Sbjct: 44  NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNPISGLSNLERL-------- 93

Query: 526 NPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLS 585
                                             +    +     P +  L  L +LD+S
Sbjct: 94  ---------------------------------RIMGKDVTSDKIPNLSGLTSLTLLDIS 120

Query: 586 RNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 637
            +    +I + I+ +  +  +DLS N     I    + L  L   ++  + +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 29/179 (16%), Positives = 62/179 (34%), Gaps = 31/179 (17%)

Query: 225 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 284
            SL  + + N  +  DL   +    +++ ++++  + +      IS L++L  L I G  
Sbjct: 44  NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKD 99

Query: 285 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGL 344
            +      L  LT L                         +LD+ +++    I    + L
Sbjct: 100 VTSDKIPNLSGLTSLT------------------------LLDISHSAHDDSILTKINTL 135

Query: 345 SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNN 403
             + ++DL+ N     +   L    +LK L++  + +             L  L   + 
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 17/82 (20%), Positives = 34/82 (41%), Gaps = 2/82 (2%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
           ++N       P  I  L +L  L +   ++T     ++S + +L +LD+S +    SI  
Sbjct: 73  INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 620 SFEKLTFLSKFSVANNHLQGTI 641
               L  ++   ++ N     I
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI 152

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 17/85 (20%), Positives = 35/85 (41%), Gaps = 4/85 (4%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
           L+N  +       I    ++  L ++  + T    + IS + NLE L +   D+      
Sbjct: 51  LANINVTDLTG--IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIP 106

Query: 620 SFEKLTFLSKFSVANNHLQGTIPTG 644
           +   LT L+   ++++    +I T 
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTK 131

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 52/211 (24%), Positives = 81/211 (38%), Gaps = 17/211 (8%)

Query: 204 IQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYS-MSSLQHVSLSV 258
            + LDLS N        S       P L+ L +    +   + D  Y  +S L  + L+ 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSF---PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85

Query: 259 NNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF-SGPLPLS 316
           N     L+    S L+SL+ L+      +      +G+L  L+      N   S  LP  
Sbjct: 86  NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 317 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL----CTLDLATNHFSGPLPNSLSDCHDLK 372
            S  + L  LDL +N +      +   L  +     +LDL+ N  +  +         LK
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLK 203

Query: 373 ILSLAKNELSGQVPESFGKLTSLLFLSLSNN 403
            L+L  N+L       F +LTSL  + L  N
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 47/245 (19%), Positives = 70/245 (28%), Gaps = 46/245 (18%)

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 332
            S ++L +  N           +  +L+                         LDL    
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQV------------------------LDLSRCE 63

Query: 333 LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL 392
           +    D  +  LS L TL L  N        + S    L+ L   +  L+       G L
Sbjct: 64  IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

Query: 393 TSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGN 452
            +L  L++++N                NL  L L+ N + + I         L  + L N
Sbjct: 124 KTLKELNVAHNLIQSFK-LPEYFSNLTNLEHLDLSSNKI-QSIYCTD--LRVLHQMPLLN 179

Query: 453 CGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLT 512
                              LDLS N  +  I P   +   L  L    N L         
Sbjct: 180 -----------------LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFD 221

Query: 513 ELKSL 517
            L SL
Sbjct: 222 RLTSL 226

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 57/254 (22%), Positives = 92/254 (36%), Gaps = 55/254 (21%)

Query: 108 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
            K LDLS N L  +      +  +L+VLDLS   +     G    L+ + +L ++ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN--- 86

Query: 168 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG--LDHSP 225
                      +   +++  +F+G            +Q L     +   SL+   + H  
Sbjct: 87  ----------PIQ--SLALGAFSG---------LSSLQKLVAVETNLA-SLENFPIGHLK 124

Query: 226 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 285
           +LK+L+V +NL+            S +        F        SNLT+L HL +  N+ 
Sbjct: 125 TLKELNVAHNLI-----------QSFK----LPEYF--------SNLTNLEHLDLSSNKI 161

Query: 286 SGKLPNVLGNLTQLEFFVA----HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNF 341
                  L  L Q+           N  +  +        +L  L L  N L    D  F
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIF 220

Query: 342 SGLSSLCTLDLATN 355
             L+SL  + L TN
Sbjct: 221 DRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 63.5 bits (155), Expect = 7e-11
 Identities = 55/273 (20%), Positives = 87/273 (31%), Gaps = 74/273 (27%)

Query: 370 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
             K L L+ N L      SF     L  L LS      +       Q   +L+TLILT N
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED--GAYQSLSHLSTLILTGN 86

Query: 430 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI-G 488
            + + +      F  L                       LQ L     +   ++  +  G
Sbjct: 87  PI-QSLALGA--FSGL---------------------SSLQKLVAVETNLA-SLENFPIG 121

Query: 489 QMENLFYLDFSNNTLTGEIPK-----SLTELKSLISSNCTSSNPTASAGIPLYVKHNRST 543
            ++ L  L+ ++N +           +LT L+ L                          
Sbjct: 122 HLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHL-------------------------- 154

Query: 544 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHV-LDLSRNNITGTIPSSISEIRN 602
             L  N+  S   +               + Q+  L++ LDLS N +   I     +   
Sbjct: 155 -DLSSNKIQSIYCTDLRV-----------LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR 201

Query: 603 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 635
           L+ L L +N L     G F++LT L K  +  N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 9/182 (4%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
            +L L R  ++ I   +   L+ L  L L+ N ++ +     S L  L+ L      L+ 
Sbjct: 55  QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114

Query: 145 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFS---NLAVFNISNNSFTGKLNSRIWSAS 201
             +  +  L  ++ LNV+ N    S      FS   NL   ++S+N     +        
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172

Query: 202 KEIQI----LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS 257
            ++ +    LDLS+N       G      LK+L +D N L          ++SLQ + L 
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 232

Query: 258 VN 259
            N
Sbjct: 233 TN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 19/113 (16%), Positives = 40/113 (35%), Gaps = 18/113 (15%)

Query: 546 LPYNQASSFPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIP 594
           L   +  +     +          L+ N I  ++       L  L  L     N+  ++ 
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLE 116

Query: 595 SSISEI-RNLEVLDLSSNDLHGSIP--GSFEKLTFLSKFSVANNHLQGTIPTG 644
           +      + L+ L+++ N +  S      F  LT L    +++N +Q +I   
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCT 167

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 20/65 (30%), Positives = 33/65 (50%), Gaps = 3/65 (4%)

Query: 581 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQG 639
            LDLS N +      S      L+VLDLS  ++  +I  G+++ L+ LS   +  N +Q 
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ- 89

Query: 640 TIPTG 644
           ++  G
Sbjct: 90  SLALG 94

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 56/227 (24%)

Query: 774 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHK 823
           ++G G +G+V  AT    G   A+K++          F   + A         L   +H+
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIKILKHFKHE 69

Query: 824 NLVSLQ-----GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAA 877
           N++++          + N+  +I   M+    D  LH  V    +L  D ++  I Q   
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQT---D--LHR-VISTQMLSDDHIQYFIYQ-TL 122

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--------- 928
           R +  LH     +++HRD+K SN+L++   +  + DFGL+R++       +         
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 929 TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
            + V T  Y  PE       YS+ +      DV+S G +L EL   R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAM------DVWSCGCILAELFLRR 220

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.2 bits (185), Expect = 4e-14
 Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 37/223 (16%)

Query: 765 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREF---QAEVEAL 817
           + N F    ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 202

Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQG 875
             ++H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   D  R   A+ 
Sbjct: 203 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEI 257

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVG 933
            +  L YLH   E ++V+RD+K  N++LD+  + H  + DFGL +        + T   G
Sbjct: 258 VS-ALDYLHS--EKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGATMKT-FCG 311

Query: 934 TLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T  Y+ PE      Y + +      D +  GVV+ E++ GR P
Sbjct: 312 TPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 348

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.3 bits (181), Expect = 5e-14
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 38/223 (17%)

Query: 767 NNFNQANIIGCGGFGLVY--KATLTNGTKA--AVKRLS-----GDCGQMEREFQAEVEAL 817
             F    ++G GG+G V+  +      T    A+K L       +        +AE   L
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNIL 75

Query: 818 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQG 875
              +H  +V L  Y      +L LI  Y+  G L   L     ++ +   D     +A+ 
Sbjct: 76  EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE----REGIFMEDTACFYLAE- 129

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVG 933
            +  L +LH+     I++RD+K  NI+L+   + H  L DFGL +    +D  VT    G
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNH--QGHVKLTDFGLCK-ESIHDGTVTHTFCG 183

Query: 934 TLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           T+ Y+ PE      +++ +      D +S G ++ ++LTG  P
Sbjct: 184 TIEYMAPEILMRSGHNRAV------DWWSLGALMYDMLTGAPP 220

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 74.0 bits (182), Expect = 5e-14
 Identities = 53/244 (21%), Positives = 89/244 (36%), Gaps = 32/244 (13%)

Query: 775 IGCGGFGLVYKATLTNGT------KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 828
           IG GGFG +Y A + +           VK    D G +  E +    A    Q +  +  
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 829 QGYCRHGNDRLLIYSYMENGSLDY-------------WLHESVDKDSVLKWDVRLKIAQG 875
           +     G  +       +     Y              ++E+  K    K  V L+++  
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRK-TV-LQLSLR 160

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE--AHLADFGLSRLLRPYDTHV------ 927
               L Y+H   E   VH D+K+SN+LL+ K     +L D+GL+    P   H       
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217

Query: 928 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 987
                GT+ +   +    +  + RGD+   G  +++ LTG  P E           S + 
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR 277

Query: 988 QMKS 991
             ++
Sbjct: 278 YREN 281

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 74.0 bits (182), Expect = 6e-14
 Identities = 66/347 (19%), Positives = 113/347 (32%), Gaps = 78/347 (22%)

Query: 132 LEVLDLSHNMLSG----PVSGMLAGLNLIQSLNVSSNSFNG----SLFE-LGEFSNLAVF 182
           +E   L  + ++      V  +L   + ++ + +S N+        L E +    +L + 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 183 NISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGD-- 240
             S+  FTG++   I  A + +             LQ L   P L  + + +N  G    
Sbjct: 66  EFSDI-FTGRVKDEIPEALRLL-------------LQALLKCPKLHTVRLSDNAFGPTAQ 111

Query: 241 --LPDSLYSMSSLQHVSLSVNNFS-------------GQLSEKISNLTSLRHLIIFGNQF 285
             L D L   + L+H+ L  N                  +++K  N   LR +I   N+ 
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

Query: 286 SGK----LPNVLGNLTQLEFFVAHSNSF-----SGPLPLSLSLCSKLHVLDLRNNSLTGP 336
                        +   L       N          L   L+ C +L VLDL++N+ T  
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH- 230

Query: 337 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL---- 392
                 G S+L                +L    +L+ L L    LS +   +        
Sbjct: 231 -----LGSSALA--------------IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271

Query: 393 --TSLLFLSLSNNSFNHLSGTL---SVLQQCKNLTTLILTKNFVGEE 434
               L  L L  N     +       + ++  +L  L L  N   EE
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 71.7 bits (176), Expect = 4e-13
 Identities = 51/315 (16%), Positives = 91/315 (28%), Gaps = 63/315 (20%)

Query: 226 SLKQLHVDNNLLGGD----LPDSLYSMSSLQHVSLSVNNFSGQ----LSEKISNLTSLRH 277
           S++   +  + +  +    +   L    S++ + LS N    +    LSE I++   L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 278 LIIFGNQFSGK----------LPNVLGNLTQLEFFVAHSNSFS--GPLPLS--LSLCSKL 323
                                L   L    +L       N+F      PL   LS  + L
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 324 HVLDLRNNSLT-------------GPIDLNFSGLSSLCTLDLATNHFSGP----LPNSLS 366
             L L NN L                ++        L ++    N            +  
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184

Query: 367 DCHDLKILSLAKNELSGQ-----VPESFGKLTSLLFLSLSNNSF-----NHLSGTLSVLQ 416
               L  + + +N +  +     + E       L  L L +N+F     + L+     L+
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA---IALK 241

Query: 417 QCKNLTTLILTKNFVGEE----IPE--NVGGFESLMVLALGNCGLKGHIPVWLLR----- 465
              NL  L L    +       + +  +      L  L L    ++      L       
Sbjct: 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 301

Query: 466 CKKLQVLDLSWNHFD 480
              L  L+L+ N F 
Sbjct: 302 MPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 59/407 (14%), Positives = 110/407 (27%), Gaps = 109/407 (26%)

Query: 250 SLQHVSLSVNNFSGQ----LSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 305
           S++  SL ++  + +    +   +    S++ +++ GN    +    L            
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN--------- 55

Query: 306 SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL 365
                      ++    L + +  +       D     L  L                +L
Sbjct: 56  -----------IASKKDLEIAEFSDIFTGRVKDEIPEALRLLL--------------QAL 90

Query: 366 SDCHDLKILSLAKNELSGQVPESFGKL----TSLLFLSLSNNSF-----NHLSGTL---- 412
             C  L  + L+ N       E         T L  L L NN         ++  L    
Sbjct: 91  LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELA 150

Query: 413 --SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQ 470
                +    L ++I  +N +            S+   A                 + L 
Sbjct: 151 VNKKAKNAPPLRSIICGRNRLENG---------SMKEWAKT-----------FQSHRLLH 190

Query: 471 VLDLSWNHF-DGNIPPWIGQ----MENLFYLDFSNNTLT-------GEIPKSLTELKSLI 518
            + +  N      I   + +     + L  LD  +NT T           KS   L+ L 
Sbjct: 191 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250

Query: 519 SSNCTSSNPTASA-GIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQ-- 575
            ++C  S   A+A         N     L             L  N I       +    
Sbjct: 251 LNDCLLSARGAAAVVDAFSKLENIGLQTL------------RLQYNEIELDAVRTLKTVI 298

Query: 576 ---LKHLHVLDLSRNNIT--GTIPSSISEI----RNLEVLDLSSNDL 613
              +  L  L+L+ N  +    +   I E+       E+ +L   + 
Sbjct: 299 DEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEE 345

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 26/131 (19%), Positives = 48/131 (36%), Gaps = 25/131 (19%)

Query: 92  KGLKGIIPRSLGHLNQLKLLDLSCNHL--EGVVPV--ELSNLKQLEVLDLSHNMLSGPVS 147
           +G++ ++   L +  +LK+LDL  N     G   +   L +   L  L L+  +LS    
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA--R 259

Query: 148 GMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGK----LNSRIWSASKE 203
           G  A   ++ + +   N              L    +  N         L + I     +
Sbjct: 260 GAAA---VVDAFSKLEN------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304

Query: 204 IQILDLSMNHF 214
           +  L+L+ N F
Sbjct: 305 LLFLELNGNRF 315

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.1 bits (180), Expect = 9e-14
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 44/228 (19%)

Query: 767 NNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLS----------GDCGQMEREFQA 812
            NF    ++G G +G V+     +G       A+K L            +  + ER+   
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 813 EVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESV--DKDSVLKWDVR 869
            +      Q   LV+L  Y      +L LI  Y+  G L   L +     +      +V+
Sbjct: 114 HIR-----QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQ 162

Query: 870 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHV 927
           + + +     L +LHK+    I++RD+K  NILLD     H  L DFGLS+     +T  
Sbjct: 163 IYVGE-IVLALEHLHKL---GIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETER 216

Query: 928 TTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 970
             D  GT+ Y+ P+    +     G     D +S GV++ ELLTG  P
Sbjct: 217 AYDFCGTIEYMAPD---IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 49/238 (20%), Positives = 91/238 (38%), Gaps = 34/238 (14%)

Query: 317 LSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 375
               +     +L   S+T   DL +   LS +   +   ++        +    +LK L 
Sbjct: 15  DPGLANAVKQNLGKQSVT---DLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELH 69

Query: 376 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 435
           L+ N++S         LT L  LS++ N   +L+G          L+ L L  N +    
Sbjct: 70  LSHNQIS--DLSPLKDLTKLEELSVNRNRLKNLNGI-----PSACLSRLFLDNNEL--RD 120

Query: 436 PENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFY 495
            +++   ++L +L++ N  LK  I + L    KL+VLDL  N    N    + +++ + +
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNW 176

Query: 496 LDFSNNTLTGEIPKSLTELKSL---------------ISSNCTSSNPTASAGIPLYVK 538
           +D +      E  K   EL                  IS+  +  +      +P+Y  
Sbjct: 177 IDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTD 234

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 33/198 (16%), Positives = 71/198 (35%), Gaps = 14/198 (7%)

Query: 102 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 161
              L      +L    +  +V      L  ++  +  ++ +   ++G +     ++ L++
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS-LAG-MQFFTNLKELHL 70

Query: 162 SSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL 221
           S N  +  L  L + + L   +++ N     LN      S  +  L L  N        L
Sbjct: 71  SHNQIS-DLSPLKDLTKLEELSVNRNRLK-NLNG---IPSACLSRLFLDNNELR-DTDSL 124

Query: 222 DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIF 281
            H  +L+ L + NN L   +   L  +S L+ + L  N  +      ++ L  +  + + 
Sbjct: 125 IHLKNLEILSIRNNKL-KSI-VMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLT 180

Query: 282 GNQFSGKLPNVLGNLTQL 299
           G +   +       L   
Sbjct: 181 GQKCVNEPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 44/264 (16%), Positives = 79/264 (29%), Gaps = 81/264 (30%)

Query: 365 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 424
                +    +L K  ++     S  +L+ +   +  N++   L+G    +Q   NL  L
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAG----MQFFTNLKEL 68

Query: 425 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 484
            L+ N    +I  ++   + L                      KL+ L ++ N    N+ 
Sbjct: 69  HLSHN----QI-SDLSPLKDL---------------------TKLEELSVNRNRLK-NLN 101

Query: 485 PWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRST 543
                   L  L   NN L        L  L+ L                          
Sbjct: 102 G--IPSACLSRLFLDNNELRDTDSLIHLKNLEIL-------------------------- 133

Query: 544 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNL 603
                           + NN++  +I   +G L  L VLDL  N IT      ++ ++ +
Sbjct: 134 ---------------SIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN--TGGLTRLKKV 174

Query: 604 EVLDLSSNDLHGSIPGSFEKLTFL 627
             +DL+             +L   
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 33/176 (18%), Positives = 64/176 (36%), Gaps = 38/176 (21%)

Query: 102 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 161
           L  L +L+ L ++ N L+ +  +  + L +   L L +N L    S  L  L  ++ L++
Sbjct: 81  LKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNELRDTDS--LIHLKNLEILSI 135

Query: 162 SSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL 221
            +N    S+  LG  S L V ++  N                 +I +           GL
Sbjct: 136 RNNKLK-SIVMLGFLSKLEVLDLHGN-----------------EITNTG---------GL 168

Query: 222 DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE--KISNLTSL 275
                +  + +        + + +     L  ++ +V +  G+      ISN  S 
Sbjct: 169 TRLKKVNWIDLTGQKC---VNEPVKYQPELY-ITNTVKDPDGRWISPYYISNGGSY 220

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 28/194 (14%), Positives = 56/194 (28%), Gaps = 69/194 (35%)

Query: 466 CKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP--KSLTELKSLISSNCT 523
                  +L       ++     ++  +   +  N+ +   +   +  T LK L      
Sbjct: 18  LANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKEL------ 68

Query: 524 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLD 583
                                               LS+N+I+  + P +  L  L  L 
Sbjct: 69  -----------------------------------HLSHNQIS-DLSP-LKDLTKLEELS 91

Query: 584 LSRNNITG-------------------TIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKL 624
           ++RN +                         S+  ++NLE+L + +N L  SI      L
Sbjct: 92  VNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFL 149

Query: 625 TFLSKFSVANNHLQ 638
           + L    +  N + 
Sbjct: 150 SKLEVLDLHGNEIT 163

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 34/219 (15%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQH 822
           N+F+   ++G G FG V        G   A+K L  +    + E      E   L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 823 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGL 880
             L +L+ Y    +DRL  +  Y   G L + L     ++ V   +  R   A+     L
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAE-IVSAL 118

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDLVGTLGY 937
            YLH      +V+RD+K  N++LD+  + H  + DFGL +  +    T       GT  Y
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171

Query: 938 IPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           + PE      Y + +      D +  GVV+ E++ GR P
Sbjct: 172 LAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.1 bits (179), Expect = 3e-13
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 45/225 (20%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD---------CGQMEREFQAEVEA 816
            +FN   ++G G FG V  +         AVK L  D         C  +E+   A    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-- 398

Query: 817 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 874
               +   L  L   C    DRL  +  Y+  G L Y +     +    K        A+
Sbjct: 399 ---GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAE 450

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 931
             A GL +L       I++RD+K  N++LD   E H  +ADFG+ +  +    T  T   
Sbjct: 451 -IAIGLFFLQ---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVT--TKTF 502

Query: 932 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            GT  YI PE      Y +++      D ++FGV+L E+L G+ P
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAP 541

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 50/220 (22%), Positives = 78/220 (35%), Gaps = 29/220 (13%)

Query: 775 IGCGGFGLVYKAT--LTNGTKA--AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 830
           IG GGFGL+Y A         A   VK    + G +  E +       +   K  +  + 
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 831 YCRHGNDRLLIYSYMENGSLDYW------LHESVDKDSVLKWDVR------LKIAQGAAR 878
               G          E     Y       L   + K  +   +        L++      
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK--ISGQNGTFKKSTVLQLGIRMLD 162

Query: 879 GLAYLHKVCEPHIVHRDVKSSNILLDEKFE--AHLADFGLSRLLRPYDTHV------TTD 930
            L Y+H+      VH D+K++N+LL  K     +LAD+GLS    P   H          
Sbjct: 163 VLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219

Query: 931 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
             GT+ +   +  + +  + R DV   G  +L  L G+ P
Sbjct: 220 HNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.2 bits (177), Expect = 3e-13
 Identities = 49/265 (18%), Positives = 91/265 (34%), Gaps = 83/265 (31%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHK 823
           +IG G +G V +A         A+K++        R F+  ++          L+R  H 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHD 112

Query: 824 NLVSLQ-----GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAA 877
           ++V +            ++  ++    +    D    +       L    ++  +     
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD---SD--FKKLFRTPVYLTELHIKTLLYN-LL 166

Query: 878 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--------- 928
            G+ Y+H      I+HRD+K +N L+++     + DFGL+R +   +   +         
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 929 -----------------TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLEL 964
                            T  V T  Y  PE       Y++ +      DV+S G +  EL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI------DVWSIGCIFAEL 277

Query: 965 LT----------GRRPVEVCKGKNC 979
           L            R P  +  G +C
Sbjct: 278 LNMIKENVAYHADRGP--LFPGSSC 300

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.3 bits (175), Expect = 5e-13
 Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 60/238 (25%)

Query: 774 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHK 823
           +IG G +G VY A         A+K+++       R F+  ++          L+R +  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREITILNRLKSD 85

Query: 824 NLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGL 880
            ++ L       +      +Y  +E    D  L +       L  + ++  +      G 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLE--IADSDLKKLFKTPIFLTEEHIKTILYN-LLLGE 142

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT------------ 928
            ++H+     I+HRD+K +N LL++     + DFGL+R +                    
Sbjct: 143 NFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199

Query: 929 ---------TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                    T  V T  Y  PE       Y++++      D++S G +  ELL   + 
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI------DIWSTGCIFAELLNMLQS 251

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.7 bits (174), Expect = 6e-13
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 45/225 (20%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD---------CGQMEREFQAEVEA 816
            +FN   ++G G FG V  +         AVK L  D         C  +E+   A    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-- 77

Query: 817 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 874
               +   L  L   C    DRL  +  Y+  G L Y +     +    K        A+
Sbjct: 78  ---GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAE 129

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 931
             A GL +L       I++RD+K  N++LD   E H  +ADFG+ +  +    T  T   
Sbjct: 130 -IAIGLFFLQ---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVT--TKTF 181

Query: 932 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            GT  YI PE      Y +++      D ++FGV+L E+L G+ P
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAP 220

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.3 bits (174), Expect = 8e-13
 Identities = 42/241 (17%), Positives = 90/241 (37%), Gaps = 31/241 (12%)

Query: 99  PRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQS 158
            R      QL   +LS      V+  EL + K+L+ L+  +      +  ++  L+ +  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 159 LNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL 218
              +   F+    +  +    A  +   + F  + +        ++++L L+       L
Sbjct: 401 EKETLQYFST--LKAVDPMRAAYLDDLRSKFLLENSVLKME-YADVRVLHLAHKDLT-VL 456

Query: 219 QGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHL 278
             L+    +  L + +N L   LP +L ++  L+ +  S N     +   ++NL  L+ L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQEL 513

Query: 279 IIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID 338
           ++  N+        L     ++                L  C +L +L+L+ NSL     
Sbjct: 514 LLCNNR--------LQQSAAIQ---------------PLVSCPRLVLLNLQGNSLCQEEG 550

Query: 339 L 339
           +
Sbjct: 551 I 551

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.5 bits (164), Expect = 1e-11
 Identities = 46/318 (14%), Positives = 95/318 (29%), Gaps = 20/318 (6%)

Query: 169 SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLK 228
              E  +       +      +   +  +   S+   +L +     +          +  
Sbjct: 237 GRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRP 296

Query: 229 QLHVDNNLLGGDLPDSLYSMSSLQHV--------SLSVNNFSGQLSEKISNLTSLRHLII 280
                 +L    L D L   +              + + +         +    L    +
Sbjct: 297 SHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCEL 356

Query: 281 FGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLN 340
              + S  L + L +  +L+     +      + L +     L          +    ++
Sbjct: 357 SVEK-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVD 415

Query: 341 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSL 400
               + L  L    + F         +  D+++L LA  +L+  V     +L  +  L L
Sbjct: 416 PMRAAYLDDLR---SKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDL 470

Query: 401 SNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 460
           S+N    L   L+     + L  L  + N + E +   V     L  L L N  L+    
Sbjct: 471 SHNRLRALPPALA---ALRCLEVLQASDNAL-ENVD-GVANLPRLQELLLCNNRLQQSAA 525

Query: 461 VWLLR-CKKLQVLDLSWN 477
           +  L  C +L +L+L  N
Sbjct: 526 IQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.9 bits (160), Expect = 4e-11
 Identities = 56/394 (14%), Positives = 110/394 (27%), Gaps = 26/394 (6%)

Query: 14  WLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCG 73
           W + +  +                + + LKE    L   +  T  +++S       ++  
Sbjct: 181 WHYRSCLLPQLHPQPDSGPQGRLPENVLLKEL--ELVQNAFFTDPNDQSAWFYHRWLLGR 238

Query: 74  HGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSN----- 128
                 +      +      L     R L   +++  L L  +     V     +     
Sbjct: 239 AEPH--DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRP 296

Query: 129 ----LKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNI 184
               L  L    L+  +       +  G +  +   +  +       +      L    +
Sbjct: 297 SHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCEL 356

Query: 185 SNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDS 244
           S      K            ++ +L   +    L  +    +L  L  +   L       
Sbjct: 357 SVE----KSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK 412

Query: 245 LYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 304
                   ++    + F  + S        +R L +     +  L + L  L  +     
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDL 470

Query: 305 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATNHFSG-PLP 362
             N     LP +L+    L VL   +N+L    ++   + L  L  L L  N        
Sbjct: 471 SHNRLRA-LPPALAALRCLEVLQASDNALE---NVDGVANLPRLQELLLCNNRLQQSAAI 526

Query: 363 NSLSDCHDLKILSLAKNELSGQVPESFGKLTSLL 396
             L  C  L +L+L  N L  Q      +L  +L
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEML 559

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.4 bits (156), Expect = 1e-10
 Identities = 55/335 (16%), Positives = 101/335 (30%), Gaps = 54/335 (16%)

Query: 309 FSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC 368
           FS PL +   + + L ++D    S+        +  S +   DL     +  LP      
Sbjct: 261 FSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRV 320

Query: 369 HDLKILSLAKNELSGQVPESFGK-LTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 427
                 S  +  L    PE + +   +   L     S    +   S L+ CK L  L   
Sbjct: 321 IWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPE 380

Query: 428 KNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI 487
             +    +   +    +L  L      L+    +  +   +   LD   + F        
Sbjct: 381 NKW---CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLK 437

Query: 488 GQMENLFYLDFSNNTLTGEIP--KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNG 545
            +  ++  L  ++  LT  +   + L  +  L                            
Sbjct: 438 MEYADVRVLHLAHKDLT-VLCHLEQLLLVTHL---------------------------- 468

Query: 546 LPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEV 605
                         LS+NR+   +PP +  L+ L VL  S N +   +   ++ +  L+ 
Sbjct: 469 -------------DLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQE 512

Query: 606 LDLSSNDLHGSIPG--SFEKLTFLSKFSVANNHLQ 638
           L L +N L               L   ++  N L 
Sbjct: 513 LLLCNNRL-QQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.0 bits (169), Expect = 9e-13
 Identities = 47/184 (25%), Positives = 68/184 (36%), Gaps = 14/184 (7%)

Query: 225 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS--EKISNLTSLRHLIIFG 282
                LH+  NLL      +L   + L  ++L       +L+  +    L  L  L +  
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA----ELTKLQVDGTLPVLGTLDLSH 86

Query: 283 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL--SLCSKLHVLDLRNNSLTG-PIDL 339
           NQ    LP +   L  L       N  +  LPL     L  +L  L L+ N L   P  L
Sbjct: 87  NQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGL-GELQELYLKGNELKTLPPGL 143

Query: 340 NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLS 399
             +    L  L LA N+ +      L+   +L  L L +N L   +P+ F     L F  
Sbjct: 144 -LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAF 201

Query: 400 LSNN 403
           L  N
Sbjct: 202 LHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 48/205 (23%), Positives = 71/205 (34%), Gaps = 39/205 (19%)

Query: 469 LQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLTGEIP--KSLTELKSL-ISSNCTS 524
             +L LS N                L  L+     LT ++    +L  L +L +S N   
Sbjct: 33  TTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQ 90

Query: 525 SNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDL 584
           S P     +P       +   + +N+ +S P                    L  L  L L
Sbjct: 91  SLPLLGQTLP-----ALTVLDVSFNRLTSLPLGAL--------------RGLGELQELYL 131

Query: 585 SRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIP 642
             N +  T+P  + +    LE L L++N+L   +P G    L  L    +  N L  TIP
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 643 TGGQFYSFPNSSFE-----GNPGLC 662
            G     F +         GNP LC
Sbjct: 189 KG----FFGSHLLPFAFLHGNPWLC 209

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 43/204 (21%), Positives = 65/204 (31%), Gaps = 48/204 (23%)

Query: 323 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG-PLPNSLSDCHDLKILSLAKNEL 381
             +L L  N L           + L  L+L     +   +  +L     L  L L+ N+L
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP---VLGTLDLSHNQL 89

Query: 382 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG 441
              +P     L +L  L +S N    L   L  L+    L  L L  N + + +P  +  
Sbjct: 90  Q-SLPLLGQTLPALTVLDVSFNRLTSLP--LGALRGLGELQELYLKGNEL-KTLPPGL-- 143

Query: 442 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH--------FDGNIPPWIGQMENL 493
                                     KL+ L L+ N+         +G        +ENL
Sbjct: 144 LTPT---------------------PKLEKLSLANNNLTELPAGLLNG--------LENL 174

Query: 494 FYLDFSNNTLTGEIPKSLTELKSL 517
             L    N+L   IPK       L
Sbjct: 175 DTLLLQENSLYT-IPKGFFGSHLL 197

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 52/276 (18%), Positives = 82/276 (29%), Gaps = 81/276 (29%)

Query: 341 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSL 400
            S ++S   ++    + +  LP  L    D  IL L++N L      +    T L  L+L
Sbjct: 6   VSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 401 SNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 460
                      L V      L TL L+ N + + +P      ++L               
Sbjct: 63  DRAELT----KLQVDGTLPVLGTLDLSHNQL-QSLP---LLGQTL--------------- 99

Query: 461 VWLLRCKKLQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLTGEIP----KSLTELK 515
                   L VLD+S+N    ++P      +  L  L    N L   +P        +L+
Sbjct: 100 ------PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLE 151

Query: 516 SLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQ 575
            L                            L  N  +  P  +                 
Sbjct: 152 KL---------------------------SLANNNLTELPAGLL--------------NG 170

Query: 576 LKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 611
           L++L  L L  N++  TIP        L    L  N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 43/202 (21%), Positives = 61/202 (30%), Gaps = 31/202 (15%)

Query: 132 LEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTG 191
             +L LS N+L       L     +  LN+        L +L     L            
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE----LTKLQVDGTL------------ 76

Query: 192 KLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSS 250
                       +  LDLS N    SL  L    P+L  L V  N L      +L  +  
Sbjct: 77  ----------PVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125

Query: 251 LQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 309
           LQ + L  N     L   + +    L  L +  N  +     +L  L  L+  +   NS 
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 310 SGPLPLSLSLCSKLHVLDLRNN 331
              +P        L    L  N
Sbjct: 185 YT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 31/175 (17%), Positives = 52/175 (29%), Gaps = 49/175 (28%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
             L L    L+ + P     L  L +LD+S N L  +    L  L +L+ L L  N L  
Sbjct: 80  GTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 145 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI 204
              G+L     ++ L++++N                                        
Sbjct: 139 LPPGLLTPTPKLEKLSLANN---------------------------------------- 158

Query: 205 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
            + +L            +   +L  L +  N L   +P   +    L    L  N
Sbjct: 159 NLTELPAGLL-------NGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.1 bits (172), Expect = 1e-12
 Identities = 64/239 (26%), Positives = 101/239 (42%), Gaps = 68/239 (28%)

Query: 773 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA----------- 820
             +G G +G+V+K+     G   AVK++          FQ   +A  R            
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQ-RTFREIMILTELS 66

Query: 821 QHKNLVSLQGYCR--HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK--IAQGA 876
            H+N+V+L    R  +  D  L++ YME    D  LH +V + ++L+  V  +  + Q  
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMET---D--LH-AVIRANILE-PVHKQYVVYQ-L 118

Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-------- 928
            + + YLH      ++HRD+K SNILL+ +    +ADFGLSR                  
Sbjct: 119 IKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 929 ------------TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 968
                       TD V T  Y  PE       Y++ +      D++S G +L E+L G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI------DMWSLGCILGEILCGK 228

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 21/211 (9%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQ 821
           + F++   +G G FG V       +G   A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVN 99

Query: 822 HKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARG 879
              LV L+ +    N  L ++  Y+  G +   L     +         R   AQ     
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQ-IVLT 153

Query: 880 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
             YLH +    +++RD+K  N+L+D++    + DFG ++         T  L GT   + 
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALA 206

Query: 940 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           PE   +       D ++ GV++ E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 34/161 (21%), Positives = 59/161 (36%), Gaps = 20/161 (12%)

Query: 313 LPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 372
           +  +LS       L L  N++   I  + SG+ +L  L L  N     + N  +    L+
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLE 96

Query: 373 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVG 432
            L ++ N+++        KL +L  L +SNN   +    +  L     L  L+L  N + 
Sbjct: 97  ELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGE-IDKLAALDKLEDLLLAGNPLY 153

Query: 433 EEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLD 473
            +  E              N     +    + R   L+ LD
Sbjct: 154 NDYKE--------------NNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 31/138 (22%), Positives = 55/138 (39%), Gaps = 27/138 (19%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           +  +L  L   K L LS N++E +    LS ++ L +L L  N++   +  + A  + ++
Sbjct: 40  MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIKK-IENLDAVADTLE 96

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
            L +S N    SL  + +  NL V  +SNN                 +I +         
Sbjct: 97  ELWISYNQIA-SLSGIEKLVNLRVLYMSNN-----------------KITNWG------E 132

Query: 218 LQGLDHSPSLKQLHVDNN 235
           +  L     L+ L +  N
Sbjct: 133 IDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 21/79 (26%), Positives = 31/79 (39%), Gaps = 4/79 (5%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
                I   +   +  LK    L LS NNI   I SS+S + NL +L L  N +   I  
Sbjct: 32  GMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIEN 87

Query: 620 SFEKLTFLSKFSVANNHLQ 638
                  L +  ++ N + 
Sbjct: 88  LDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 30/155 (19%), Positives = 53/155 (34%), Gaps = 40/155 (25%)

Query: 361 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 420
           +  +LS     K L+L+ N +      S   + +L  LSL  N    +    +V      
Sbjct: 40  MDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRNLIKKIENLDAV---ADT 94

Query: 421 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD 480
           L  L ++ N +      ++ G E L                       L+VL +S N   
Sbjct: 95  LEELWISYNQI-----ASLSGIEKL---------------------VNLRVLYMSNN--- 125

Query: 481 GNIPPW-----IGQMENLFYLDFSNNTLTGEIPKS 510
             I  W     +  ++ L  L  + N L  +  ++
Sbjct: 126 -KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 45/225 (20%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLS---------GDCGQMEREFQAEVEA 816
            +F+   +IG G +  V    L       A+K +           D  Q E+    +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-- 66

Query: 817 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 874
              + H  LV L   C     RL  +  Y+  G L + +     +   L  +  R   A+
Sbjct: 67  ---SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAE 118

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 931
             +  L YLH   E  I++RD+K  N+LLD   E H  L D+G+ +  LRP DT  T+  
Sbjct: 119 -ISLALNYLH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDT--TSTF 170

Query: 932 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            GT  YI PE      Y  ++      D ++ GV++ E++ GR P
Sbjct: 171 CGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 209

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 69.2 bits (170), Expect = 2e-12
 Identities = 73/263 (27%), Positives = 103/263 (39%), Gaps = 42/263 (15%)

Query: 724 IDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLV 783
           I    E        +   A S+ +    S       SD       F+   +IG G FG V
Sbjct: 2   ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGKV 54

Query: 784 YKATL-TNGTKAAVKRLSGDCGQMEREF---QAEVEALSRA-QHKNLVSLQGYCRHGNDR 838
             A         AVK L       ++E     +E   L +  +H  LV L  +     D+
Sbjct: 55  LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADK 113

Query: 839 L-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLAYLHKVCEPHIVHRDV 896
           L  +  Y+  G L Y L     ++        R   A+  A  L YLH +   +IV+RD+
Sbjct: 114 LYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAE-IASALGYLHSL---NIVYRDL 165

Query: 897 KSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDLVGTLGYIPPE------YSQTLT 947
           K  NILLD   + H  L DFGL +  +    T  T+   GT  Y+ PE      Y +T+ 
Sbjct: 166 KPENILLDS--QGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTV- 220

Query: 948 ATCRGDVYSFGVVLLELLTGRRP 970
                D +  G VL E+L G  P
Sbjct: 221 -----DWWCLGAVLYEMLYGLPP 238

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 51/283 (18%), Positives = 93/283 (32%), Gaps = 57/283 (20%)

Query: 775  IGCGGFGLVYKAT---------LTNGTKAAVK------RLSGDCGQMEREFQA-EVEALS 818
                  G++Y+A               K ++K      RL  +    +R  +  +V    
Sbjct: 50   QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 819  RAQHKNLV---SLQGYCRHGND-RLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIA 873
            +     L+   +  G+  H +  R L+   +  G SL   L  S       +  V L++A
Sbjct: 110  KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER-SV-LQVA 165

Query: 874  QGAARGLAYLHKVCEPHIVHRDVKSSNILL--DEKFEAHLADFGLSRLLRPYDTHV---- 927
                  L +LH   E   VH +V + NI +  +++ +  LA +G +    P   HV    
Sbjct: 166  CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 928  --TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 985
               +   G L +I  +  +    + R D+ S G  +L+ L G  P   C           
Sbjct: 223  GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT------- 275

Query: 986  VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPR 1028
                +   ++          K +           C    +   
Sbjct: 276  ----EDIMKQ----------KQKFVDKPGPFVGPCGHWIRPSE 304

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 70.3 bits (171), Expect = 3e-12
 Identities = 81/482 (16%), Positives = 160/482 (33%), Gaps = 126/482 (26%)

Query: 205 QILDLSMNHFMGSLQGLDHSPSLK-QLHVD--NNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
           ++L ++    M  ++     PS+  +++++  + L   +   + Y++S LQ         
Sbjct: 85  EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL------ 138

Query: 262 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCS 321
             +L + +  L   ++++I G   SGK    +     L + V     F     L+L  C+
Sbjct: 139 --KLRQALLELRPAKNVLIDGVLGSGK--TWVALDVCLSYKVQCKMDF-KIFWLNLKNCN 193

Query: 322 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 381
               +      L   ID N++  S         +  +  L       H +      + EL
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSD--------HSSNIKLR-----IHSI------QAEL 234

Query: 382 SGQVPESFGKLTSLLFLS-LSN----NSFNHLSGTLSVLQQCKNLTTLILTKN-----FV 431
              +     +   LL L  + N    N+FN           CK    L+ T+      F+
Sbjct: 235 RRLLKSKPYE-NCLLVLLNVQNAKAWNAFNL---------SCK---ILLTTRFKQVTDFL 281

Query: 432 GEEIPENV------GGF---ESLMVLALGNCGLKGHIPVWL-LRCKKL--QVLD---LSW 476
                 ++            E   +L             +L  R + L  +VL       
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLK-----------YLDCRPQDLPREVLTTNPRRL 330

Query: 477 NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLY 536
           +    +I   +   +N  +   + + LT  I  SL  L+                  P  
Sbjct: 331 SIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVLE------------------PAE 370

Query: 537 VKHNRSTNGLPYNQASSFPPSVFLSNNRI----NGTIPPEIGQ-LKHLH---VLDLSRNN 588
            +         +++ S FPPS  +    +       I  ++   +  LH   +++     
Sbjct: 371 YRKM-------FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423

Query: 589 ITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFY 648
            T +IPS   E++ +++ +  +  LH SI    +       F   ++ L         FY
Sbjct: 424 STISIPSIYLELK-VKLENEYA--LHRSI---VDHYNIPKTFD--SDDL-IPPYLDQYFY 474

Query: 649 SF 650
           S 
Sbjct: 475 SH 476

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.6 bits (151), Expect = 6e-10
 Identities = 61/397 (15%), Positives = 119/397 (29%), Gaps = 119/397 (29%)

Query: 726  DLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANI----IGCGGFG 781
            ++D  +     +S  L     +L +  +     V ++L+    F  + I           
Sbjct: 50   EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109

Query: 782  LVYKAT---LTNG----TKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG---- 830
             +Y      L N      K  V RL     Q   + +   +AL   +    V + G    
Sbjct: 110  RMYIEQRDRLYNDNQVFAKYNVSRL-----QPYLKLR---QALLELRPAKNVLIDGVLGS 161

Query: 831  --------YCRHGNDRLLIYSYMENGSLDYWLH--ESVDKDSVLK--------------- 865
                     C   + ++     M+     +WL+       ++VL+               
Sbjct: 162  GKTWVALDVCL--SYKVQ--CKMDFKI--FWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215

Query: 866  -----WDVRLKI--AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 918
                  +++L+I   Q   R L          +V  +V+++       F     +    +
Sbjct: 216  RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF-----NLS-CK 267

Query: 919  LL---RPYDTHVTTDLVGTLGYIPP--EYSQTLTATCRGDVYSFGVVL--LELLTGRRPV 971
            +L   R     VT  L            +S TLT           ++L  L+      P 
Sbjct: 268  ILLTTR--FKQVTDFLSAATTTHISLDHHSMTLTPD-----EVKSLLLKYLDCRPQDLPR 320

Query: 972  EVCK---------GKNCRDLVS-WVF--QMKSEKREVEIIDASIWHKDRE--KQLLEMLE 1017
            EV            ++ RD ++ W     +  +K    II++S+   +    +++ + L 
Sbjct: 321  EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT-TIIESSLNVLEPAEYRKMFDRLS 379

Query: 1018 IACKCIDQDPRRRPFIEEV--------VTWLDGIGID 1046
            +             F            + W D I  D
Sbjct: 380  V-------------FPPSAHIPTILLSLIWFDVIKSD 403

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.9 bits (144), Expect = 5e-09
 Identities = 106/712 (14%), Positives = 183/712 (25%), Gaps = 269/712 (37%)

Query: 400  LSNNSFNHLSGTLSVLQQCKNLTTLILTKN------FVGEEIPENVGGFESLM------- 446
            LS    +H+  +   +     L   +L+K       FV E +  N   ++ LM       
Sbjct: 46   LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN---YKFLMSPIKTEQ 102

Query: 447  -------------VLALGNCG---LKGHI----PVWLLRCKKLQVLDL------------ 474
                            L N      K ++    P   LR + L  L              
Sbjct: 103  RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR-QALLELRPAKNVLIDGVLGS 161

Query: 475  --SW------------NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISS 520
              +W               D  I          F+L+  N      + + L +L   I  
Sbjct: 162  GKTWVALDVCLSYKVQCKMDFKI----------FWLNLKNCNSPETVLEMLQKLLYQIDP 211

Query: 521  NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRING-TIPPEIGQLKHL 579
            N T S    S+ I            L  +   +    +  S    N   +   +   K  
Sbjct: 212  NWT-SRSDHSSNIK-----------LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259

Query: 580  HVLDLS-RNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP-----GSF---EKLTFLSKF 630
            +  +LS +  +T T        R  +V D  S      I       +    E  + L K+
Sbjct: 260  NAFNLSCKILLT-T--------RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310

Query: 631  SVANNHLQGTIPTGGQFYSFPNSSFEGNP---GLCGE--IDSPC------DSMHAKLKPV 679
                           +    P      NP    +  E   D              KL  +
Sbjct: 311  ------------LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358

Query: 680  IPSGSNSKFGPGSI------IAITFSIGVGI-ALLLAVTLLKMSRRDSGCPIDDLDEDMG 732
            I   S +   P         +++ F     I  +LL++    + + D    +  +++   
Sbjct: 359  I-ESSLNVLEPAEYRKMFDRLSV-FPPSAHIPTILLSLIWFDVIKSD---VMVVVNK--- 410

Query: 733  RPQRLSEALASSKLVLFQNSDCKDLTVS--DLLKSTNNFNQANIIGCGGFGLVYKATLTN 790
                    L    LV       K+ T+S   +                   L  K  L N
Sbjct: 411  --------LHKYSLV---EKQPKESTISIPSIY------------------LELKVKLEN 441

Query: 791  GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS----LQGYCRHGNDRLLIYSYME 846
                                         A H+++V      + +    +D +  Y    
Sbjct: 442  ---------------------------EYALHRSIVDHYNIPKTFD--SDDLIPPY---- 468

Query: 847  NGSLD-YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-KVCEPHIVHRDVKSSNILLD 904
               LD Y+                          + + H K  E     R      + LD
Sbjct: 469  ---LDQYFYSH-----------------------IGH-HLKNIEHP--ERMTLFRMVFLD 499

Query: 905  EKF-EAHLADFGLSRLLRPYDTHVTTDLVGTLGYI---PPEYSQTLTATCRGDVYSFGVV 960
             +F E  +     +        +    L     YI    P+Y + + A            
Sbjct: 500  FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA------------ 547

Query: 961  LLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1012
            +L+ L   +  E        DL+      + E     I +      +  KQ+
Sbjct: 548  ILDFL--PKIEENLICSKYTDLLRIALMAEDE----AIFE------EAHKQV 587

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 7e-05
 Identities = 59/364 (16%), Positives = 114/364 (31%), Gaps = 98/364 (26%)

Query: 727  LDEDMGRPQRLSEALASSKLVLF-QNSDCKD--------LT---VSDLLKSTNNFNQANI 774
            +D + G  Q   + + S     F  N DCKD        L+   +  ++ S +  +    
Sbjct: 7    MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            +    F  +    L+   +  V++   +  ++  +F                 ++   R 
Sbjct: 67   L----FWTL----LSKQEEM-VQKFVEEVLRINYKFLMS-------------PIKTEQRQ 104

Query: 835  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAYLHKVCEPH--- 890
             +    +Y    +      L+   D     K++V RL+      + L  L     P    
Sbjct: 105  PSMMTRMYIEQRDR-----LYN--DNQVFAKYNVSRLQPYLKLRQALLEL----RPAKNV 153

Query: 891  IVHRDV---KSS---NILLDEKFEAHLADFG-----LSRLLRPYDTHVTTDLVGTLGYIP 939
            ++   +   K+    ++ L  K +  + DF      L     P    V   L   L  I 
Sbjct: 154  LIDGVLGSGKTWVALDVCLSYKVQCKM-DFKIFWLNLKNCNSPET--VLEMLQKLLYQID 210

Query: 940  PEYSQTLTATCRG--DVYSFGVVLLELLTGRRPVE-------VCKGK-------NCRDLV 983
            P ++     +      ++S    L  LL  +           V   K       +C+ L+
Sbjct: 211  PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL 270

Query: 984  SWVFQMKSEKREVEIIDA-------SIWHKDREKQLL--EMLEIACKCIDQDPRRRPFIE 1034
            +         R  ++ D         I        L   E+  +  K +D  P+  P   
Sbjct: 271  T--------TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP--R 320

Query: 1035 EVVT 1038
            EV+T
Sbjct: 321  EVLT 324

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 68.4 bits (168), Expect = 3e-12
 Identities = 57/218 (26%), Positives = 85/218 (38%), Gaps = 31/218 (14%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD---------CGQMEREFQAEVEA 816
            +F    ++G G FG V+ A         A+K L  D         C  +E+   +    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-- 74

Query: 817 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
               +H  L  +        + L  +  Y+  G L Y +                  A+ 
Sbjct: 75  ---WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAE- 126

Query: 876 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDLV 932
              GL +LH      IV+RD+K  NILLD+  + H  +ADFG+ +  +       T    
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAK--TNTFC 179

Query: 933 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
           GT  YI PE           D +SFGV+L E+L G+ P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.5 bits (168), Expect = 3e-12
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 45/225 (20%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLS---------GDCGQMEREFQAEVEA 816
            +F+   +IG G +  V    L       A++ +           D  Q E+    +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-- 109

Query: 817 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 874
              + H  LV L   C     RL  +  Y+  G L + +     +   L  +  R   A+
Sbjct: 110 ---SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAE 161

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 931
             +  L YLH   E  I++RD+K  N+LLD   E H  L D+G+ +  LRP DT  T+  
Sbjct: 162 -ISLALNYLH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDT--TSTF 213

Query: 932 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            GT  YI PE      Y  ++      D ++ GV++ E++ GR P
Sbjct: 214 CGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 252

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.4 bits (168), Expect = 3e-12
 Identities = 63/225 (28%), Positives = 89/225 (39%), Gaps = 45/225 (20%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD---------CGQMEREFQAEVEA 816
           +NF    ++G G FG V  A +   G   AVK L  D         C   E+   +    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-- 80

Query: 817 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 874
                H  L  L   C    DRL  +  ++  G L + +     K         R   A+
Sbjct: 81  ---RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAE 132

Query: 875 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 931
                L +LH   +  I++RD+K  N+LLD   E H  LADFG+ +  +    T  T   
Sbjct: 133 -IISALMFLH---DKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGVT--TATF 184

Query: 932 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            GT  YI PE      Y   +      D ++ GV+L E+L G  P
Sbjct: 185 CGTPDYIAPEILQEMLYGPAV------DWWAMGVLLYEMLCGHAP 223

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 35/218 (16%)

Query: 767 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQH 822
            +F     +G G FG V+      NG   A+K L  +     ++ +    E   LS   H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 823 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGL 880
             ++ +         ++ +I  Y+E G L   L     K       V +   A+     L
Sbjct: 66  PFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAE-VCLAL 119

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYI 938
            YLH      I++RD+K  NILLD+    H  + DFG ++    Y   VT  L GT  YI
Sbjct: 120 EYLHSK---DIIYRDLKPENILLDK--NGHIKITDFGFAK----YVPDVTYTLCGTPDYI 170

Query: 939 PPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
            PE      Y++++      D +SFG+++ E+L G  P
Sbjct: 171 APEVVSTKPYNKSI------DWWSFGILIYEMLAGYTP 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 24/229 (10%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGY 831
           IG G FG +Y  T +  G + A+K         Q+  E +   + +       + +++  
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG--IPTIRWC 73

Query: 832 CRHGNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 890
              G+  +++   +  G SL+  L     +   LK    L +A      + Y+H     +
Sbjct: 74  GAEGDYNVMVMELL--GPSLED-LFNFCSRKFSLK--TVLLLADQMISRIEYIHSK---N 125

Query: 891 IVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHV------TTDLVGTLGYIPPE 941
            +HRDVK  N L+    +    ++ DFGL++  R   TH         +L GT  Y    
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
               +  + R D+ S G VL+    G  P +  K    R     + + K
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 63.9 bits (156), Expect = 8e-12
 Identities = 28/114 (24%), Positives = 41/114 (35%), Gaps = 4/114 (3%)

Query: 316 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 375
             +   +   LDLR   +    +L  + L     +D + N     L         LK L 
Sbjct: 14  QYTNAVRDRELDLRGYKIPVIENLG-ATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLL 70

Query: 376 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
           +  N +          L  L  L L+NNS   L   L  L   K+LT L + +N
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELG-DLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 31/162 (19%), Positives = 52/162 (32%), Gaps = 31/162 (19%)

Query: 266 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 325
           + + +N    R L + G +    + N+   L Q +                         
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFD------------------------A 46

Query: 326 LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS--G 383
           +D  +N +   +D  F  L  L TL +  N              DL  L L  N L   G
Sbjct: 47  IDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104

Query: 384 QVPESFGKLTSLLFLSLSNNSFNHLSG-TLSVLQQCKNLTTL 424
            + +    L SL +L +  N   +     L V+ +   +  L
Sbjct: 105 DL-DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 23/106 (21%), Positives = 44/106 (41%), Gaps = 9/106 (8%)

Query: 202 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
            +   +D S N  +  L G      LK L V+NN +         ++  L  + L+ N+ 
Sbjct: 42  DQFDAIDFSDNE-IRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100

Query: 262 SGQLSE--KISNLTSLRHLIIFGNQFSGKLPN----VLGNLTQLEF 301
             +L +   +++L SL +L I  N  +    +    V+  + Q+  
Sbjct: 101 V-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV 144

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 26/144 (18%), Positives = 53/144 (36%), Gaps = 33/144 (22%)

Query: 97  IIPRSLGHLNQLKL--LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLN 154
           +I ++  + N ++   LDL    +  +  +  + L Q + +D S N +   + G    L 
Sbjct: 8   LIEQAAQYTNAVRDRELDLRGYKIPVIENLG-ATLDQFDAIDFSDNEIR-KLDG-FPLLR 64

Query: 155 LIQSLNVSSN---SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSM 211
            +++L V++N        L +     +L    ++NN                  +++L  
Sbjct: 65  RLKTLLVNNNRICRIGEGLDQ--ALPDLTELILTNN-----------------SLVELG- 104

Query: 212 NHFMGSLQGLDHSPSLKQLHVDNN 235
                 L  L    SL  L +  N
Sbjct: 105 -----DLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 18/80 (22%), Positives = 31/80 (38%), Gaps = 3/80 (3%)

Query: 559 FLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 618
            L   +I   I      L     +D S N I   +      +R L+ L +++N +     
Sbjct: 25  DLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGE 81

Query: 619 GSFEKLTFLSKFSVANNHLQ 638
           G  + L  L++  + NN L 
Sbjct: 82  GLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 15/71 (21%), Positives = 25/71 (35%), Gaps = 7/71 (9%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
            S+N I   +      L+ L  L ++ N I          + +L  L L++N L      
Sbjct: 49  FSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----- 101

Query: 620 SFEKLTFLSKF 630
               L  L+  
Sbjct: 102 ELGDLDPLASL 112

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.4 bits (95), Expect = 9e-04
 Identities = 17/79 (21%), Positives = 28/79 (35%), Gaps = 5/79 (6%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
           L+   I      +         LDL    I   I +  + +   + +D S N++   + G
Sbjct: 4   LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG 59

Query: 620 SFEKLTFLSKFSVANNHLQ 638
            F  L  L    V NN + 
Sbjct: 60  -FPLLRRLKTLLVNNNRIC 77

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 40/176 (22%), Positives = 71/176 (40%), Gaps = 18/176 (10%)

Query: 801 GDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK 860
           G   +  +++   +    + +  ++ S Q     G       S +E       L++    
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF-- 189

Query: 861 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL 920
              L  +  +  +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R +
Sbjct: 190 ---LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 921 RPYDTHVTTDLVGTLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 970
                +V          +P     PE       T + DV+SFGV+L E+ + G  P
Sbjct: 244 YKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 9/94 (9%)

Query: 773 NIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRA-QHKN 824
             +G G FG V +A              AVK L       E     +E++ L     H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 825 LVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHES 857
           +V+L G C + G   ++I  + + G+L  +L   
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 47/210 (22%), Positives = 75/210 (35%), Gaps = 50/210 (23%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQGY 831
           ++G G  G V +        K A+K L  DC +  RE    VE   R +Q  ++V +   
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIVDV 79

Query: 832 CRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVL--KWDVRLKIAQGAARGLAYLHK 885
             +        L++   ++ G L        D+      + +    +       + YLH 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKS-IGEAIQYLHS 135

Query: 886 VCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSR--LLRPYDTHVTTDLVGTLGYIPP 940
           +   +I HRDVK  N+L   K       L DFG ++      YD                
Sbjct: 136 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSC------------- 179

Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                       D++S GV++  LL G  P
Sbjct: 180 ------------DMWSLGVIMYILLCGYPP 197

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.2 bits (161), Expect = 3e-11
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 26/230 (11%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLV-SLQG 830
           IG G FG +Y  T +    + A+K  +      Q+  E +         Q    + +++ 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI----YRILQGGTGIPNVRW 70

Query: 831 YCRHGNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 889
           +   G+  +L+   +  G SL+  L     +   LK    L +A      + ++H     
Sbjct: 71  FGVEGDYNVLVMDLL--GPSLED-LFNFCSRKLSLK--TVLMLADQMINRVEFVHSK--- 122

Query: 890 HIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHV------TTDLVGTLGYIPP 940
             +HRD+K  N L+     A+   + DFGL++  R   TH         +L GT  Y   
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182

Query: 941 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
                +  + R D+ S G VL+  L G  P +  K    +     + + K
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 42/253 (16%), Positives = 77/253 (30%), Gaps = 52/253 (20%)

Query: 108 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
            + L L   HL  +     SNL  +  + +S +               +Q L   S+SF 
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSID-------------VTLQQL--ESHSFY 77

Query: 168 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF--MGSLQGLDHSP 225
                    S +    I N      ++         ++ L +          L  +  + 
Sbjct: 78  N-------LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTD 130

Query: 226 SLKQLHV-DNNLLGGDLPDSLYSMSS-LQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 283
               L + DN  +     ++   + +    + L  N F+  +     N T L  + +  N
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189

Query: 284 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG 343
           +           LT +       ++F G       + S   +LD+   S+T    L   G
Sbjct: 190 K----------YLTVI-----DKDAFGG-------VYSGPSLLDVSQTSVT---ALPSKG 224

Query: 344 LSSLCTLDLATNH 356
           L  L  L      
Sbjct: 225 LEHLKELIARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 45/233 (19%), Positives = 75/233 (32%), Gaps = 38/233 (16%)

Query: 320 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
           C +     +    +   P     S   S  TL L   H      ++ S+  ++  + ++ 
Sbjct: 10  CHQEEDFRVTCKDIQRIP-----SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64

Query: 379 N-ELSGQVPESFGKLTSLLFLSLSNN---------SFNHLSG---------------TLS 413
           +  L      SF  L+ +  + + N          +   L                  L+
Sbjct: 65  DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLT 124

Query: 414 VLQQCKNLTTLILTKNFVGEEIPENV--GGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 471
            +        L +T N     IP N   G     + L L N G    +  +     KL  
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183

Query: 472 LDLSWNHFDGNIPPWI--GQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSN 521
           + L+ N +   I      G       LD S  ++T  +P K L  LK LI+ N
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 34/268 (12%), Positives = 77/268 (28%), Gaps = 52/268 (19%)

Query: 367 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 426
           +CH  +   +   ++  ++P       S   L L       +           N++ + +
Sbjct: 9   ECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPS--HAFSNLPNISRIYV 62

Query: 427 TKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIP 484
           + +   +++  +       +  + + N     +I    L+    L+ L +         P
Sbjct: 63  SIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFP 121

Query: 485 P--WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 542
               +   +  F L+ ++N     IP                                 +
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIP-------------------------------VNA 150

Query: 543 TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI--SEI 600
             GL     +     + L NN    ++         L  + L++N     I         
Sbjct: 151 FQGLCNETLT-----LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204

Query: 601 RNLEVLDLSSNDLHGSIP-GSFEKLTFL 627
               +LD+S   +  ++P    E L  L
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKGLEHLKEL 231

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 19/106 (17%), Positives = 38/106 (35%), Gaps = 8/106 (7%)

Query: 553 SFPPSV---FLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLD 607
           S PPS     L    +  TIP      L ++  + +S +     + S     +  +  ++
Sbjct: 28  SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86

Query: 608 LSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 652
           + +      I   + ++L  L    + N  L+   P   + YS   
Sbjct: 87  IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDI 131

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 66.1 bits (161), Expect = 4e-11
 Identities = 68/446 (15%), Positives = 149/446 (33%), Gaps = 41/446 (9%)

Query: 100 RSLGHLNQLKLLDLSC-NHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLA-GLNLIQ 157
           +   H     L+      ++   +    S+   LE + L   +++     ++A      +
Sbjct: 74  KGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFK 133

Query: 158 SLNVSSNSF--NGSLFELGE-FSNLAVFNISNNSF---TGKLNSRIWSASKEIQILDLSM 211
            L +SS        L  +     NL   ++  +     +G   S        +  L++S 
Sbjct: 134 VLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC 193

Query: 212 NHFMGSLQGL----DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV------NNF 261
                S   L       P+LK L ++  +    L   L     L+ +           + 
Sbjct: 194 LASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDV 253

Query: 262 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGP-LPLSLSLC 320
              LS  +S    LR L  F +     LP V    ++L        +     L   L  C
Sbjct: 254 YSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQC 313

Query: 321 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLA-TNHFSGPLPNSLSD---------CHD 370
            KL  L + +      +++  S    L  L +  +  F      +L++         C  
Sbjct: 314 PKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPK 373

Query: 371 LKILSLAKNELSGQ----VPESFGKLTSLLFLSLSNNSFNHLS------GTLSVLQQCKN 420
           L+ +     +++      +  +   +T      +   + ++L+      G  ++++ CK+
Sbjct: 374 LESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKD 433

Query: 421 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSW-NH 478
           L  L L+     +         + + +L++   G        +L  C  L+ L++     
Sbjct: 434 LRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493

Query: 479 FDGNIPPWIGQMENLFYLDFSNNTLT 504
            D  +     ++E +  L  S+ +++
Sbjct: 494 GDKALLANASKLETMRSLWMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 64/455 (14%), Positives = 120/455 (26%), Gaps = 74/455 (16%)

Query: 193 LNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDS-----LYS 247
           L  +   A   +         +            L+++     L    + D        S
Sbjct: 73  LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEI----RLKRMVVTDDCLELIAKS 128

Query: 248 MSSLQHVSLS-VNNFSGQ-LSEKISNLTSLRHLIIFGNQFSGK-------LPNVLGNLTQ 298
             + + + LS    FS   L+   +   +L+ L +  +             P+   +L  
Sbjct: 129 FKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188

Query: 299 LEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNN-SLTGPIDLNFSGLSSLCTLDLA---- 353
           L      S      L   ++ C  L  L L     L     L       L  L       
Sbjct: 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATL-LQRAPQLEELGTGGYTA 247

Query: 354 --TNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGT 411
                    L  +LS C +L+ LS   + +   +P  +   + L  L+LS  +       
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDL- 306

Query: 412 LSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 471
           + +L QC  L  L +                  L VLA                CK L+ 
Sbjct: 307 VKLLCQCPKLQRLWVLDYI----------EDAGLEVLAST--------------CKDLRE 342

Query: 472 LDLS-WNHFDGNIPPWIGQ---------MENLFYLDFSNNTLTGE----IPKSLTELKSL 517
           L +     F       + +            L  + +    +T      I ++   +   
Sbjct: 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRF 402

Query: 518 ISSNCTSSNPTASAGIPLYVKHNRSTNGLPY-NQASSFPPSVFLSNNRINGTIPPEIGQL 576
                    P        Y+       G     +       + LS    +          
Sbjct: 403 RLCIIEPKAPD-------YLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYA 455

Query: 577 KHLHVLDLSRNNITGTIPSSISE-IRNLEVLDLSS 610
           K + +L ++    +      +     +L  L++  
Sbjct: 456 KKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD 490

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 52/314 (16%), Positives = 93/314 (29%), Gaps = 38/314 (12%)

Query: 244 SLYSMSSLQHVSLSVNNFSGQLSEKI----SNLTSLRHLIIFGNQFS----GKLPNVLGN 295
            L         +L  + + G +   I    S+ T L  + +     +      +     N
Sbjct: 72  ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKN 131

Query: 296 LTQLEFFVAHSNSFSGP-LPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCT----L 350
              L   ++    FS   L    + C  L  LDLR + +        S      T    L
Sbjct: 132 FKVLV--LSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189

Query: 351 DLATNHFS---GPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNH 407
           +++          L   ++ C +LK L L +     ++     +   L  L     +   
Sbjct: 190 NISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEV 249

Query: 408 ----LSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL--KGHIPV 461
                SG    L  CK L  L    + V   +P        L  L L    +     + +
Sbjct: 250 RPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKL 309

Query: 462 WLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGE-------------IP 508
            L +C KLQ L +     D  +       ++L  L    +                  + 
Sbjct: 310 -LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS 368

Query: 509 KSLTELKSLISSNC 522
               +L+S++    
Sbjct: 369 MGCPKLESVLYFCR 382

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 46/326 (14%), Positives = 97/326 (29%), Gaps = 52/326 (15%)

Query: 295 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLAT 354
              + + F+ +  + S      +    K+  ++L+        +L   G        +  
Sbjct: 42  RWCRRKVFIGNCYAVS--PATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA 99

Query: 355 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGK-LTSLLFLSLSNNSFNHLSGTLS 413
                      S    L+ + L +  ++    E   K   +   L LS+       G  +
Sbjct: 100 ---------MSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA 150

Query: 414 VLQQCKNLTTLILTKNFVGEEIPENVGGFE----SLMVLALGNCGLK---GHIPVWLLRC 466
           +   C+NL  L L ++ V +     +  F     SL+ L +     +     +   + RC
Sbjct: 151 IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRC 210

Query: 467 KKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSN 526
             L+ L L+       +   + +   L   +      T E+   +    S+  S C    
Sbjct: 211 PNLKSLKLNRAVPLEKLATLLQRAPQL--EELGTGGYTAEVRPDVYSGLSVALSGC---- 264

Query: 527 PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR 586
                      K  R  +G                 + +   +P        L  L+LS 
Sbjct: 265 -----------KELRCLSGF---------------WDAVPAYLPAVYSVCSRLTTLNLSY 298

Query: 587 NNITGT-IPSSISEIRNLEVLDLSSN 611
             +    +   + +   L+ L +   
Sbjct: 299 ATVQSYDLVKLLCQCPKLQRLWVLDY 324

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 43.0 bits (101), Expect = 5e-04
 Identities = 39/273 (14%), Positives = 84/273 (30%), Gaps = 43/273 (15%)

Query: 364 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLF----------LSLSNNSFNHLSGTLS 413
            + +C+ +   ++ +          F K+ S+            L              +
Sbjct: 49  FIGNCYAVSPATVIRR---------FPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA 99

Query: 414 VLQQCKNLTTLILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLL--RCKKLQ 470
           +      L  + L +  V ++  E +   F++  VL L +C       +  +   C+ L+
Sbjct: 100 MSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLK 159

Query: 471 VLDLSWNHFDGNIPPWIGQME----NLFYLDFSN--NTLTGE----IPKSLTELKSLISS 520
            LDL  +  D     W+        +L  L+ S   + ++      +      LKSL  +
Sbjct: 160 ELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLN 219

Query: 521 NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLH 580
                       +   ++       L     ++       S       +   +   K L 
Sbjct: 220 RAVPLE-----KLATLLQRAPQLEELGTGGYTAEVRPDVYSG------LSVALSGCKELR 268

Query: 581 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 613
            L    + +   +P+  S    L  L+LS   +
Sbjct: 269 CLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATV 301

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 49/239 (20%), Positives = 90/239 (37%), Gaps = 42/239 (17%)

Query: 775 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQG- 830
           IG G FG++++ T L N  + A+K         Q+  E++          +K L    G 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---------YKLLAGCTGI 68

Query: 831 -----YCRHGNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
                + + G   +L+   +  G SL+  L +   +   +K       A+     +  +H
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL--GPSLED-LLDLCGRKFSVK--TVAMAAKQMLARVQSIH 123

Query: 885 KVCEPHIVHRDVKSSNILLDEKFEA-----HLADFGLSRLLR--------PYDTHVTTDL 931
           +     +V+RD+K  N L+           ++ DFG+ +  R        PY      +L
Sbjct: 124 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK--KNL 178

Query: 932 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
            GT  Y+          + R D+ + G V +  L G  P +  K    +     + + K
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 47/182 (25%), Positives = 68/182 (37%), Gaps = 8/182 (4%)

Query: 226 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFGNQ 284
             K+L + +N L      + + ++ L+ + L+ N     L   I   L +L  L +  N+
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96

Query: 285 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL--SLCSKLHVLDLRNNSLTG-PIDLNF 341
                  V   L  L       N     LP  +  SL +KL  L L  N L   P  + F
Sbjct: 97  LQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSL-TKLTYLSLGYNELQSLPKGV-F 153

Query: 342 SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLS 401
             L+SL  L L  N        +     +LK L L  N+L      +F  L  L  L L 
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213

Query: 402 NN 403
            N
Sbjct: 214 EN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 49/193 (25%)

Query: 469 LQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLT---GEIPKSLTELKSLISSNCTS 524
            + LDL  N    ++P     ++  L  L  ++N L      I K L  L++L       
Sbjct: 39  TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETL------- 90

Query: 525 SNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPEI- 573
                                +  N+  + P  VF          L  N++  ++PP + 
Sbjct: 91  --------------------WVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF 129

Query: 574 GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFS 631
             L  L  L L  N +  ++P  +  ++ +L+ L L +N L   +P G+F+KLT L    
Sbjct: 130 DSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLK 187

Query: 632 VANNHLQGTIPTG 644
           + NN L+  +P G
Sbjct: 188 LDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 53.8 bits (130), Expect = 9e-08
 Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 14/187 (7%)

Query: 176 FSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-----DHSPSLKQL 230
            ++    ++ +N  +  L S+ +    ++++L L+ N     LQ L         +L+ L
Sbjct: 36  PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNK----LQTLPAGIFKELKNLETL 90

Query: 231 HVDNNLLGGDLPDSLY-SMSSLQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGK 288
            V +N L   LP  ++  + +L  + L  N     L  ++  +LT L +L +  N+    
Sbjct: 91  WVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSL 148

Query: 289 LPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLC 348
              V   LT L+    ++N        +    ++L  L L NN L    +  F  L  L 
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLK 208

Query: 349 TLDLATN 355
            L L  N
Sbjct: 209 MLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 52/204 (25%), Positives = 80/204 (39%), Gaps = 24/204 (11%)

Query: 91  RKGLKGI---IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVS 147
            K L  I   IP         K LDL  N L  +       L +L +L L+ N L    +
Sbjct: 25  SKKLTAIPSNIPADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78

Query: 148 GMLAGLNLIQSLNVSSNSFNGSLFELGEF---SNLAVFNISNNSFTGKLNSRIWSASKEI 204
           G+   L  +++L V+ N    +L  +G F    NLA   +  N     L  R++ +  ++
Sbjct: 79  GIFKELKNLETLWVTDNKLQ-AL-PIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKL 135

Query: 205 QILDLSMNHFMGSLQGL-----DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
             L L  N     LQ L     D   SLK+L + NN L      +   ++ L+ + L  N
Sbjct: 136 TYLSLGYNE----LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191

Query: 260 NFSGQLSEKISNLTSLRHLIIFGN 283
                      +L  L+ L +  N
Sbjct: 192 QLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 42/184 (22%), Positives = 66/184 (35%), Gaps = 46/184 (25%)

Query: 468 KLQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLT---GEIPKSLTELKSLISSNCT 523
           KL++L L+ N     +P  I  +++NL  L  ++N L      +   L  L  L      
Sbjct: 62  KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAEL------ 114

Query: 524 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPEI 573
                                 L  NQ  S PP VF          L  N +  ++P  +
Sbjct: 115 ---------------------RLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152

Query: 574 -GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFS 631
             +L  L  L L  N +   +P     ++  L+ L L +N L     G+F+ L  L    
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211

Query: 632 VANN 635
           +  N
Sbjct: 212 LQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 45/174 (25%), Positives = 71/174 (40%), Gaps = 14/174 (8%)

Query: 350 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL- 408
           LDL +N  S     +      L++L L  N+L       F +L +L  L +++N    L 
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALP 101

Query: 409 SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLM---VLALGNCGLKGHIPVWLL- 464
            G    L    NL  L L +N + + +P  V  F+SL     L+LG   L+  +P  +  
Sbjct: 102 IGVFDQL---VNLAELRLDRNQL-KSLPPRV--FDSLTKLTYLSLGYNELQ-SLPKGVFD 154

Query: 465 RCKKLQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLTGEIPKSLTELKSL 517
           +   L+ L L  N     +P     ++  L  L   NN L      +   L+ L
Sbjct: 155 KLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL 207

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 36/176 (20%), Positives = 58/176 (32%), Gaps = 25/176 (14%)

Query: 85  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 144
            +L L    L+ +       L  L+ L ++ N L+ +       L  L  L L  N L  
Sbjct: 64  RLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS 123

Query: 145 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI 204
               +   L  +  L++  N                  ++    F  KL          +
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQ---------------SLPKGVFD-KL--------TSL 159

Query: 205 QILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
           + L L  N      +G  D    LK L +DNN L      +  S+  L+ + L  N
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 55/247 (22%), Positives = 90/247 (36%), Gaps = 42/247 (17%)

Query: 767 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHK 823
            NF     IGCG FG +     L      A+K   +     Q+  E++          +K
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF---------YK 59

Query: 824 NLVSLQG------YCRHGNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGA 876
            L S  G      +   G    ++   +  G SL+  L +  D+   LK    L IA   
Sbjct: 60  QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLED-LFDLCDRTFSLK--TVLMIAIQL 114

Query: 877 ARGLAYLHKVCEPHIVHRDVKSSNILL-----DEKFEAHLADFGLSRLLR--------PY 923
              + Y+H     ++++RDVK  N L+       +   H+ DF L++           PY
Sbjct: 115 ISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPY 171

Query: 924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 983
             H    L GT  Y+          + R D+ + G + +  L G  P +  K    ++  
Sbjct: 172 REH--KSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229

Query: 984 SWVFQMK 990
             +   K
Sbjct: 230 QKIGDTK 236

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 49/186 (26%), Positives = 69/186 (37%), Gaps = 30/186 (16%)

Query: 249 SSLQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSN 307
           S    + LS NN S   +E   + LT+L  L++  N            L  +      S 
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-----------LNFI-----SSE 82

Query: 308 SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 367
           +F             L  LDL +N L    +  FS L +L  L L  NH      N+  D
Sbjct: 83  AFVP--------VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134

Query: 368 CHDLKILSLAKNELSGQVPE----SFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 423
              L+ L L++N++S + P        KL  L+ L LS+N    L  T            
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193

Query: 424 LILTKN 429
           L L  N
Sbjct: 194 LYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 33/164 (20%), Positives = 57/164 (34%), Gaps = 28/164 (17%)

Query: 101 SLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLN 160
           +   L  L  L LS NHL  +       +  L  LDLS N L      + + L  ++ L 
Sbjct: 59  TPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118

Query: 161 VSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM----G 216
           + +N     + +   F ++A                      ++Q L LS N        
Sbjct: 119 LYNNHI--VVVDRNAFEDMA----------------------QLQKLYLSQNQISRFPVE 154

Query: 217 SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNN 260
            ++  +  P L  L + +N L       L  + +     L ++N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 41/167 (24%)

Query: 519 SSNCTSSNPTAS----------AGIPLYVKHNRSTNGLPYNQASSFPPSVF--------- 559
            +NC  ++   S            +P Y         L +N  S                
Sbjct: 13  PANCLCASNILSCSKQQLPNVPQSLPSYTALLD----LSHNNLSRLRAEWTPTRLTNLHS 68

Query: 560 --LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHG 615
             LS+N +N  I  E    + +L  LDLS N++  T+   + S+++ LEVL L +N +  
Sbjct: 69  LLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV- 125

Query: 616 SIP-GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 661
            +   +FE +  L K  ++ N +            FP    +    L
Sbjct: 126 VVDRNAFEDMAQLQKLYLSQNQIS----------RFPVELIKDGNKL 162

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 42/193 (21%), Positives = 63/193 (32%), Gaps = 54/193 (27%)

Query: 469 LQVLDLSWNHFDGNIPPWI--GQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNC 522
             +LDLS N+    +       ++ NL  L  S+N L   I       +  L+ L     
Sbjct: 41  TALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL----- 93

Query: 523 TSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPE 572
                                  L  N   +    +F          L NN I   +   
Sbjct: 94  ----------------------DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRN 130

Query: 573 I-GQLKHLHVLDLSRNNITGTIP----SSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFL 627
               +  L  L LS+N I+   P       +++  L +LDLSSN L        +KL   
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189

Query: 628 SKFSVA--NNHLQ 638
            K  +   NN L+
Sbjct: 190 VKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 42/187 (22%), Positives = 63/187 (33%), Gaps = 37/187 (19%)

Query: 122 VPVELSNLKQLEVLDLSHNMLSG-PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 180
           VP  L +     +LDLSHN LS          L  + SL +S N    +      F  + 
Sbjct: 33  VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL--NFISSEAFVPV- 87

Query: 181 VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNL 236
                                  ++ LDLS NH           L    +L+ L + NN 
Sbjct: 88  ---------------------PNLRYLDLSSNHLHTLDEFLFSDL---QALEVLLLYNNH 123

Query: 237 LGGDLPDSLYSMSSLQHVSLSVNN---FSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVL 293
           +     ++   M+ LQ + LS N    F  +L +  + L  L  L +  N+        L
Sbjct: 124 IVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183

Query: 294 GNLTQLE 300
             L    
Sbjct: 184 QKLPAWV 190

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 41/211 (19%), Positives = 63/211 (29%), Gaps = 64/211 (30%)

Query: 420 NLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWN 477
               L L+ N +     E       +L  L L +  L   I          L+ LDLS N
Sbjct: 40  YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98

Query: 478 H--------FDGNIPPWIGQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSS 525
           H        F          ++ L  L   NN +   +     + + +L+ L        
Sbjct: 99  HLHTLDEFLFSD--------LQALEVLLLYNNHIV-VVDRNAFEDMAQLQKL-------- 141

Query: 526 NPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLS 585
                               L  NQ S FP  +    N+           L  L +LDLS
Sbjct: 142 -------------------YLSQNQISRFPVELIKDGNK-----------LPKLMLLDLS 171

Query: 586 RNNITGTIPSSISEIRNL--EVLDLSSNDLH 614
            N +     + + ++       L L +N L 
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 36/133 (27%), Positives = 55/133 (41%), Gaps = 8/133 (6%)

Query: 295 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLA 353
           ++ +L    + SN   G L        +L  L   N  LT    + N   L+ L  L+L+
Sbjct: 18  DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT---SIANLPKLNKLKKLELS 72

Query: 354 TNHFSGPLPNSLSDCHDLKILSLAKNELSG-QVPESFGKLTSLLFLSLSNNSFNHLSG-T 411
            N  SG L      C +L  L+L+ N++      E   KL +L  L L N    +L+   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132

Query: 412 LSVLQQCKNLTTL 424
            +V +    LT L
Sbjct: 133 ENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 25/113 (22%), Positives = 41/113 (36%), Gaps = 6/113 (5%)

Query: 367 DCHDLKILSLAKNELS-GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLI 425
              D+K L L  +  + G++     +   L FLS  N     ++     L +   L  L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN----LPKLNKLKKLE 70

Query: 426 LTKNFVGEEIPENVGGFESLMVLALGNCGLKG-HIPVWLLRCKKLQVLDLSWN 477
           L+ N V   +        +L  L L    +K       L + + L+ LDL   
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 19/80 (23%), Positives = 40/80 (50%), Gaps = 3/80 (3%)

Query: 560 LSNNRIN-GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 618
           L N+R N G +     + + L  L      +T +I +++ ++  L+ L+LS N + G + 
Sbjct: 24  LDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLE 81

Query: 619 GSFEKLTFLSKFSVANNHLQ 638
              EK   L+  +++ N ++
Sbjct: 82  VLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 25/105 (23%), Positives = 46/105 (43%), Gaps = 7/105 (6%)

Query: 202 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
           +E++ L       + S+  L     LK+L + +N + G L        +L H++LS N  
Sbjct: 42  EELEFLSTINVG-LTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100

Query: 262 SGQLS-EKISNLTSLRHLIIFGNQFSGKLPN----VLGNLTQLEF 301
               + E +  L +L+ L +F  + +  L +    V   L QL +
Sbjct: 101 KDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTY 144

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 4/111 (3%)

Query: 247 SMSSLQHVSLSVNNFS-GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 305
           + S ++ + L  +  + G+L         L  L       +  + N L  L +L+     
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 306 SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATN 355
            N  SG L +    C  L  L+L  N +     +     L +L +LDL   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 9e-05
 Identities = 20/64 (31%), Positives = 32/64 (50%), Gaps = 1/64 (1%)

Query: 102 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVS-GMLAGLNLIQSLN 160
           L  LN+LK L+LS N + G + V       L  L+LS N +    +   L  L  ++SL+
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 161 VSSN 164
           + + 
Sbjct: 120 LFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 26/104 (25%), Positives = 46/104 (44%), Gaps = 4/104 (3%)

Query: 416 QQCKNLTTLILTKN-FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDL 474
           +   ++  L+L  +     ++      FE L  L+  N GL   I   L +  KL+ L+L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLEL 71

Query: 475 SWNHFDGNIPPWIGQMENLFYLDFSNNTLTG-EIPKSLTELKSL 517
           S N   G +     +  NL +L+ S N +      + L +L++L
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENL 115

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 22/141 (15%), Positives = 48/141 (34%), Gaps = 30/141 (21%)

Query: 97  IIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 156
           +  R+   + +L L +   N  +  +       ++LE L   +  L+             
Sbjct: 11  LRNRTPSDVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLT------------- 55

Query: 157 QSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF-- 214
                       S+  L + + L    +S+N  +      +      +  L+LS N    
Sbjct: 56  ------------SIANLPKLNKLKKLELSDNRVS-GGLEVLAEKCPNLTHLNLSGNKIKD 102

Query: 215 MGSLQGLDHSPSLKQLHVDNN 235
           + +++ L    +LK L + N 
Sbjct: 103 LSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 16/53 (30%), Positives = 29/53 (54%), Gaps = 1/53 (1%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITG-TIPSSISEIRNLEVLDLSSN 611
           LS+NR++G +     +  +L  L+LS N I   +    + ++ NL+ LDL + 
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 17/71 (23%), Positives = 29/71 (40%), Gaps = 7/71 (9%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
             N  +  +I   + +L  L  L+LS N ++G +     +  NL  L+LS N +      
Sbjct: 49  TINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK----- 101

Query: 620 SFEKLTFLSKF 630
               +  L K 
Sbjct: 102 DLSTIEPLKKL 112

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 30/129 (23%), Positives = 47/129 (36%), Gaps = 25/129 (19%)

Query: 206 ILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL 265
           +LD S ++        D    L+ L   N  L   + + L  ++ L+ + LS N  SG L
Sbjct: 23  VLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELSDNRVSGGL 80

Query: 266 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 325
                   +L HL + GN+          +L+ +E                L     L  
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIK--------DLSTIE---------------PLKKLENLKS 117

Query: 326 LDLRNNSLT 334
           LDL N  +T
Sbjct: 118 LDLFNCEVT 126

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 62/377 (16%), Positives = 108/377 (28%), Gaps = 81/377 (21%)

Query: 102 LGHLNQLKLLDLSCNHL-----EGVVPVELSNLKQLEVLDLSHNMLSGP----VSGMLAG 152
               + +  LDLS N+L       ++    +    +  L+LS N L       +  +LA 
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 153 LNL-IQSLNVSSNSF-NGSLFELGEF-----SNLAVFNISNNSFTGK----LNSRIWSAS 201
           +   + SLN+S N     S  EL +        + V ++  N F+ K          +  
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 202 KEIQILDLSMNHF----MGSL-QGLDHSP-SLKQLHVDNNLLG----GDLPDSLYSM-SS 250
             I  L+L  N         L Q L   P ++  L++  N L      +L   L S+ +S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 251 LQHVSLSVNNFSGQLSEKI-----SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 305
           +  + LS N    +   ++     S    +  L +  N   G     L  L         
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL--------- 248

Query: 306 SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL 365
                            L  + L  + +          L +                 + 
Sbjct: 249 -----------KDSLKHLQTVYLDYDIVKNMSKEQCKALGA-----------------AF 280

Query: 366 SDCHDLKILSLAKNELSGQVPESFGKL-----TSLLFLSLSNNSFNHLSG---TLSVLQQ 417
            +   + ++     E+          L           SL N            +  L  
Sbjct: 281 PNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNI 340

Query: 418 CKNLTTLILTKNFVGEE 434
              L   I T   + E 
Sbjct: 341 PDELRESIQTCKPLLEH 357

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 49/331 (14%), Positives = 95/331 (28%), Gaps = 84/331 (25%)

Query: 317 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 376
            S+   +  LDL  N+L             L     A    S            +  L+L
Sbjct: 18  TSIPHGVTSLDLSLNNLYS------ISTVELIQA-FANTPAS------------VTSLNL 58

Query: 377 AKNELSGQVPESFGKL-----TSLLFLSLSNNSFNHLSGTL--SVLQQCK-NLTTLILTK 428
           + N L  +  +   ++      ++  L+LS N  ++ S       L      +T L L  
Sbjct: 59  SGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118

Query: 429 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 488
           N    +        E     +     +                L+L  N         + 
Sbjct: 119 NDFSSK-----SSSEFKQAFSNLPASIT--------------SLNLRGNDLGIKSSDELI 159

Query: 489 QM-----ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCT------SSNPTASAGIPL-- 535
           Q+      N+  L+   N L  +    L +   L S   +      S+N           
Sbjct: 160 QILAAIPANVNSLNLRGNNLASKNCAELAK--FLASIPASVTSLDLSANLLGLKSYAELA 217

Query: 536 -YVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQL----KHLHVLDLSRNNIT 590
                  +              S+ L  N ++G     +  L    KHL  + L  + + 
Sbjct: 218 YIFSSIPNHVV-----------SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266

Query: 591 GT-------IPSSISEIRNLEVLDLSSNDLH 614
                    + ++   I+ + ++D +  ++H
Sbjct: 267 NMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 46/309 (14%), Positives = 99/309 (32%), Gaps = 50/309 (16%)

Query: 265 LSEKISNLTSLRHLIIFGNQFSGK-----LPNVLGNLTQLEFFVAHSNSFS--GPLPLSL 317
           + E  S    +  L +  N          +         +       NS        L  
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 318 SL---CSKLHVLDLRNNSLTGP-IDLNFSGL----SSLCTLDLATNHFSG----PLPNSL 365
            L    + +  L+L  N L+    D     L     ++  LDL  N FS         + 
Sbjct: 74  ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133

Query: 366 SDCH-DLKILSLAKNELSGQVPESFGKL-----TSLLFLSLSNNSFN-----HLSGTLSV 414
           S+    +  L+L  N+L  +  +   ++      ++  L+L  N+        L+  L+ 
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA- 192

Query: 415 LQQCKNLTTLILTKNFVGEEIPENVGGF-----ESLMVLALGNCGLKG----HIPVWLLR 465
                ++T+L L+ N +G +    +          ++ L L    L G    ++ +    
Sbjct: 193 -SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251

Query: 466 CKKLQVLDLSWNHFDG-------NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLI 518
            K LQ + L ++            +      ++ +  +D +   +       ++ L  + 
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNL--IR 309

Query: 519 SSNCTSSNP 527
             +  +  P
Sbjct: 310 ELSGKADVP 318

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 53/301 (17%), Positives = 92/301 (30%), Gaps = 81/301 (26%)

Query: 365 LSDCHDLKILSLAKNELSGQVPESFGKL-----TSLLFLSLSNNSFNHLSGTL--SVLQQ 417
            S  H +  L L+ N L         +       S+  L+LS NS    +      +L  
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 418 CK-NLTTLILTKNFVGEEIPENVGGFESLM-VLALGNCGLKGHIPVWLLRCKKLQVLDLS 475
              N+T+L L+ NF+  +        + L+  LA                   + VLDL 
Sbjct: 78  IPANVTSLNLSGNFLSYK------SSDELVKTLAAIPF--------------TITVLDLG 117

Query: 476 WNHFDGNIPPWIGQM-----ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTAS 530
           WN F         Q       ++  L+   N L  +    L +   L +     +     
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ--ILAAIPANVN----- 170

Query: 531 AGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQL-----KHLHVLDLS 585
                                     S+ L  N +      E+ +        +  LDLS
Sbjct: 171 --------------------------SLNLRGNNLASKNCAELAKFLASIPASVTSLDLS 204

Query: 586 RNNITGTIPSSISEI-----RNLEVLDLSSNDLHGS----IPGSFEKLTFLSKFSVANNH 636
            N +     + ++ I      ++  L+L  N LHG     +    + L  L    +  + 
Sbjct: 205 ANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDI 264

Query: 637 L 637
           +
Sbjct: 265 V 265

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 4e-09
 Identities = 32/216 (14%), Positives = 56/216 (25%), Gaps = 53/216 (24%)

Query: 763 LKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRL--------SGDCGQMEREFQAEV 814
              T    +   IG G FG V++    + T  A+K +        +G   +   E   E+
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 815 EAL---------SRAQHKNLVSLQGYC-----------------------------RHGN 836
                          + +  + L                                    +
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV 896
           D+L I    E G +D  L +   K  +        I       LA           HRD+
Sbjct: 135 DQLFIVLEFEFGGID--LEQMRTK--LSSLATAKSILHQLTASLAVAEA--SLRFEHRDL 188

Query: 897 KSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 932
              N+LL +     L      +        +   ++
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 31/111 (27%), Positives = 43/111 (38%), Gaps = 6/111 (5%)

Query: 317 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 376
            +    L  L L N  L   +  N   L  L  L+L+ N   G L        +L  L+L
Sbjct: 45  TAEFVNLEFLSLINVGLIS-VS-NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102

Query: 377 AKNELS--GQVPESFGKLTSLLFLSLSNNSFNHLSG-TLSVLQQCKNLTTL 424
           + N+L     + E   KL  L  L L N    +L+    SV +    LT L
Sbjct: 103 SGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 34/152 (22%), Positives = 57/152 (37%), Gaps = 10/152 (6%)

Query: 326 LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQV 385
           +D++        +   + +  L  LD   ++  G +    ++  +L+ LSL    L    
Sbjct: 8   MDMKRRIHLELRNRTPAAVREL-VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI--S 63

Query: 386 PESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE-EIPENVGGFES 444
             +  KL  L  L LS N        L+  ++  NLT L L+ N + +    E +   E 
Sbjct: 64  VSNLPKLPKLKKLELSENRIFGGLDMLA--EKLPNLTHLNLSGNKLKDISTLEPLKKLEC 121

Query: 445 LMVLALGN---CGLKGHIPVWLLRCKKLQVLD 473
           L  L L N     L  +         +L  LD
Sbjct: 122 LKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 26/105 (24%), Positives = 45/105 (42%), Gaps = 7/105 (6%)

Query: 202 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 261
             ++ L L     + S+  L   P LK+L +  N + G L      + +L H++LS N  
Sbjct: 49  VNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107

Query: 262 SGQLS-EKISNLTSLRHLIIFGNQFSGKLPN----VLGNLTQLEF 301
               + E +  L  L+ L +F  + +  L +    V   L QL +
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTY 151

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 29/139 (20%), Positives = 52/139 (37%), Gaps = 11/139 (7%)

Query: 370 DLKILSLAKNELS-GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK 428
            ++ L L   + + G++     +  +L FLSL N     +S     L +   L  L L++
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN----LPKLPKLKKLELSE 80

Query: 429 NFVGEEIPENVGGFESLMVLALGNCGLK--GHIPVWLLRCKKLQVLDLSWN---HFDGNI 483
           N +   +        +L  L L    LK    +   L + + L+ LDL      + +   
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDYR 139

Query: 484 PPWIGQMENLFYLDFSNNT 502
                 +  L YLD  +  
Sbjct: 140 ESVFKLLPQLTYLDGYDRE 158

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 21/81 (25%), Positives = 40/81 (49%), Gaps = 3/81 (3%)

Query: 559 FLSNNRIN-GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSI 617
            L N + N G I     +  +L  L L    +  ++ S++ ++  L+ L+LS N + G +
Sbjct: 30  VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGL 87

Query: 618 PGSFEKLTFLSKFSVANNHLQ 638
               EKL  L+  +++ N L+
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 21/98 (21%), Positives = 33/98 (33%), Gaps = 3/98 (3%)

Query: 259 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 318
            +  G++    +   +L  L +        + N L  L +L+      N   G L +   
Sbjct: 35  KSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAE 92

Query: 319 LCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATN 355
               L  L+L  N L     L     L  L +LDL   
Sbjct: 93  KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 20/64 (31%), Positives = 32/64 (50%), Gaps = 1/64 (1%)

Query: 102 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVS-GMLAGLNLIQSLN 160
           L  L +LK L+LS N + G + +    L  L  L+LS N L    +   L  L  ++SL+
Sbjct: 67  LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126

Query: 161 VSSN 164
           + + 
Sbjct: 127 LFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 27/110 (24%), Positives = 38/110 (34%), Gaps = 4/110 (3%)

Query: 105 LNQLKLLDLSCNHLEGVVPVEL-SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSS 163
              ++ L L            L +    LE L L +  L   VS  L  L  ++ L +S 
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSE 80

Query: 164 NSFNGSLFELGE-FSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 212
           N   G L  L E   NL   N+S N              + ++ LDL   
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 26/128 (20%), Positives = 49/128 (38%), Gaps = 22/128 (17%)

Query: 531 AGIPLYVKHNRSTNGLPYNQASSFPPS-VF----------LSNNRINGTIPPEI-GQLKH 578
             IP Y    R    L  N+ +    + +F           SNN+I   I          
Sbjct: 28  EHIPQYTAELR----LNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 579 LHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNH 636
           ++ + L+ N +   +   +   + +L+ L L SN +   +   SF  L+ +   S+ +N 
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140

Query: 637 LQGTIPTG 644
           +  T+  G
Sbjct: 141 IT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 26/123 (21%), Positives = 44/123 (35%), Gaps = 8/123 (6%)

Query: 325 VLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 383
            L L NN  T       F  L  L  ++ + N  +     +      +  + L  N L  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95

Query: 384 QVPESFGKLTSLLFLSLSNNSFNHL-SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 442
              + F  L SL  L L +N    + + +   L    ++  L L  N +   +    G F
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLS---SVRLLSLYDNQI-TTVAP--GAF 149

Query: 443 ESL 445
           ++L
Sbjct: 150 DTL 152

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 31/173 (17%), Positives = 58/173 (33%), Gaps = 51/173 (29%)

Query: 470 QVLDLSWNHFDGNIPPWIG--QMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCT 523
             L L+ N F   +       ++  L  ++FSNN +T +I     +  + +  +      
Sbjct: 35  AELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEI------ 86

Query: 524 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLD 583
                                 L  N+  +    +F                L+ L  L 
Sbjct: 87  ---------------------LLTSNRLENVQHKMFKG--------------LESLKTLM 111

Query: 584 LSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANN 635
           L  N IT     S   + ++ +L L  N +  ++  G+F+ L  LS  ++  N
Sbjct: 112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 21/85 (24%), Positives = 36/85 (42%)

Query: 83  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 142
            V  ++L    L+ +  +    L  LK L L  N +  V       L  + +L L  N +
Sbjct: 82  GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141

Query: 143 SGPVSGMLAGLNLIQSLNVSSNSFN 167
           +    G    L+ + +LN+ +N FN
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 32/158 (20%), Positives = 56/158 (35%), Gaps = 32/158 (20%)

Query: 205 QILDLSMNHF-----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
             L L+ N F      G  + L   P L++++  NN +      +    S +  + L+ N
Sbjct: 35  AELRLNNNEFTVLEATGIFKKL---PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 260 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL 319
                  +    L SL+ L++  N+ +    +    L+ +                    
Sbjct: 92  RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR------------------- 132

Query: 320 CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF 357
                +L L +N +T      F  L SL TL+L  N F
Sbjct: 133 -----LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 16/82 (19%), Positives = 30/82 (36%), Gaps = 1/82 (1%)

Query: 84  VTMLILPRKGLKGIIPRSL-GHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 142
              L L       +    +   L QL+ ++ S N +  +          +  + L+ N L
Sbjct: 34  TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93

Query: 143 SGPVSGMLAGLNLIQSLNVSSN 164
                 M  GL  +++L + SN
Sbjct: 94  ENVQHKMFKGLESLKTLMLRSN 115

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 58.0 bits (140), Expect = 1e-08
 Identities = 60/444 (13%), Positives = 134/444 (30%), Gaps = 50/444 (11%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSL----GHLNQLKLLDLSCNHL--EGVVPVELSNLKQL 132
               R  M  L  +   G +   +     +L QLK +      +    +  +  +    L
Sbjct: 81  KGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDL 140

Query: 133 EVLDLSH--NMLSGPVSGMLAGLNLIQSLNVSSNSF----NGSLFELGE-FSNLAVFNIS 185
           E L L       +  +  ++     I++L +  +SF       L EL +  ++L V N  
Sbjct: 141 ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY 200

Query: 186 NNSFTGKLNS---RIWSASKEIQILDLSMNHFM---GSLQGLDHSPSLKQLHVDNNLLGG 239
              F          I    + +  + +     +   G  +   +        ++ ++   
Sbjct: 201 MTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMP 260

Query: 240 DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLII-FGNQFSGKLPNVLGNLTQ 298
           +   +L     L  + LS    +  +         +R L + +    +     ++     
Sbjct: 261 EKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319

Query: 299 LEFF-VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLS------------ 345
           LE     +     G L +    C +L  L +   +    ++     +S            
Sbjct: 320 LEVLETRNVIGDRG-LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQ 378

Query: 346 SLCTLDLATNHFS----GPLPNSLSDCHDLKILSLAKNELSGQVPESFG------KLTSL 395
            L  + +  +  +      +   L +  D +++ L + E    +P   G          L
Sbjct: 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL 438

Query: 396 LFLSLSNNSFNHLS--GTLSVLQQCKNLTTLILTKNFVGEE-IPENVGGFESLMVLALGN 452
              +        L+  G   + Q   N+  ++L      +E + E   G  +L  L +  
Sbjct: 439 RRFAFYLRQ-GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG 497

Query: 453 CGLKGHIPVWLLR-CKKLQVLDLS 475
           C          +     L+ L + 
Sbjct: 498 CCFSERAIAAAVTKLPSLRYLWVQ 521

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 57/424 (13%), Positives = 127/424 (29%), Gaps = 74/424 (17%)

Query: 223 HSPSLKQLHVDNNLLG--GDLPDSLYSMSSLQHVSLS-VNNFSGQ-LSEKISNLTSLRHL 278
           +   LK +H    ++        +      L+ + L   + F+   L   +++   ++ L
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTL 169

Query: 279 IIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID 338
           ++  + FS K    L  L                        + L VL+     +T    
Sbjct: 170 LMEESSFSEKDGKWLHEL--------------------AQHNTSLEVLNF---YMTEFAK 206

Query: 339 LNFSGL-------SSLCTLDLATNHFSGP--LPNSLSDCHDLKILSLAKNELSGQVPESF 389
           ++   L        SL ++ +             + ++  +    SL ++    +   + 
Sbjct: 207 ISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL 266

Query: 390 GKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK-NFVGEEIPENVGGFESLMVL 448
                L  L LS    N +     +      +  L L       E+    +    +L VL
Sbjct: 267 VFPRKLCRLGLSYMGPNEMP---ILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVL 323

Query: 449 ALGNC-GLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQME------------NLFY 495
              N  G +G   +    CK+L+ L +     +  +    G +              L Y
Sbjct: 324 ETRNVIGDRGLEVL-AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY 382

Query: 496 LDFSNNTLT-------GEIPKSLTELKSLISSNCTS-SNPTASAGIPLYVKHNRSTNGLP 547
           +    + +T       G   K+L + + ++       ++     G+   +   +      
Sbjct: 383 MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRF- 441

Query: 548 YNQASSFPPSVFLSNNRINGTIPPEIGQL-KHLHVLDLSRNNITGTIPSSISEI-RNLEV 605
                    + +L    +       IGQ   ++  + L     +       S    NL+ 
Sbjct: 442 ---------AFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQK 492

Query: 606 LDLS 609
           L++ 
Sbjct: 493 LEMR 496

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 45/399 (11%), Positives = 122/399 (30%), Gaps = 41/399 (10%)

Query: 62  SMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHL----NQLKLLDLS-CN 116
                 +           +   + +L         I P+ L  +      L  + +    
Sbjct: 172 EESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE 231

Query: 117 HLEGV-VPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGE 175
            LE V      +NL++     L+ ++        L     +  L +S    N        
Sbjct: 232 ILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPF 291

Query: 176 FSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDN 234
            + +   ++       + +  +      +++L+         L+ L  +   LK+L ++ 
Sbjct: 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351

Query: 235 NLLGGDLPDSLYSMS------------SLQHVSLSVNNFSGQ----LSEKISNLTSLRHL 278
                 + D    +S             L+++++ V++ + +    +   + NL   R +
Sbjct: 352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411

Query: 279 IIFGNQFSGKLPN------VLGNLTQLEFFVAHSNSF----SGPLPLSLSLCSKLHVLDL 328
           ++   +    LP       +L    +L  F  +         G   +       +  + L
Sbjct: 412 LLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIG-QYSPNVRWMLL 470

Query: 329 RNNSLT--GPIDLNFSGLSSLCTLDLATNHFSGP-LPNSLSDCHDLKILSLAKNELSGQV 385
                +  G ++    G  +L  L++    FS   +  +++    L+ L +     S   
Sbjct: 471 GYVGESDEGLMEF-SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTG 529

Query: 386 PESFGK---LTSLLFLSLSNNSFNHLSGTLSVLQQCKNL 421
            +         ++  +        +  G +  ++   ++
Sbjct: 530 QDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHI 568

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 47.6 bits (113), Expect = 2e-05
 Identities = 42/343 (12%), Positives = 92/343 (26%), Gaps = 37/343 (10%)

Query: 306 SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL 365
           +  ++            L  L L+        +L         T  +     +       
Sbjct: 58  ALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNN------- 110

Query: 366 SDCHDLKILSLAKNELS--GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 423
                LK +   +  +S       +  +   L  L L   S     G LS++  C+ + T
Sbjct: 111 --LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKT 168

Query: 424 LILTKNFVGEEIPENVG----GFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDLS 475
           L++ ++   E+  + +        SL VL              +      C+ L  + + 
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG 228

Query: 476 WNHF--DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGI 533
                           +E       + +    E   +L   + L     +   P     +
Sbjct: 229 DFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPIL 288

Query: 534 PLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTI 593
             +    R  +               L            I +  +L VL+  RN I    
Sbjct: 289 FPFAAQIRKLD--------------LLYALLETEDHCTLIQKCPNLEVLET-RNVIGDRG 333

Query: 594 PSSISEI-RNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 635
              +++  + L+ L +        +      ++     ++A  
Sbjct: 334 LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG 376

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 33/138 (23%), Positives = 58/138 (42%), Gaps = 22/138 (15%)

Query: 521 NCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTI 569
           +C   +  +  +GIP     +     L     ++   + F          L  N++  T+
Sbjct: 20  DCQGKSLDSVPSGIPA----DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTL 74

Query: 570 PPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTF 626
              +   L  L  L L+ N +  ++P  +   +  L+ L L  N L  S+P G F++LT 
Sbjct: 75  SAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK 132

Query: 627 LSKFSVANNHLQGTIPTG 644
           L +  +  N LQ +IP G
Sbjct: 133 LKELRLNTNQLQ-SIPAG 149

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 23/151 (15%)

Query: 507 IPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF------- 559
           IP    +L  L S+   + +     G+        +   L YNQ  +    VF       
Sbjct: 33  IPADTEKLD-LQSTGLATLSDATFRGLT-----KLTWLNLDYNQLQTLSAGVFDDLTELG 86

Query: 560 ---LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLH 614
              L+NN++  ++P  +   L  L  L L  N +  ++PS +   +  L+ L L++N L 
Sbjct: 87  TLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144

Query: 615 GSIP-GSFEKLTFLSKFSVANNHLQGTIPTG 644
            SIP G+F+KLT L   S++ N LQ ++P G
Sbjct: 145 -SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 41/151 (27%), Positives = 60/151 (39%), Gaps = 6/151 (3%)

Query: 256 LSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPL 315
           L     +         LT L  L +  NQ       V  +LT+L      +N  +  LPL
Sbjct: 42  LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-LPL 100

Query: 316 SL--SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLK 372
            +   L ++L  L L  N L       F  L+ L  L L TN     +P    D   +L+
Sbjct: 101 GVFDHL-TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQ 158

Query: 373 ILSLAKNELSGQVPESFGKLTSLLFLSLSNN 403
            LSL+ N+L      +F +L  L  ++L  N
Sbjct: 159 TLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 43/167 (25%), Positives = 58/167 (34%), Gaps = 22/167 (13%)

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 332
                L +     +         LT+L +     N             ++L  L L NN 
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94

Query: 333 LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLKILSLAKNELSGQVPES-FG 390
           L       F  L+ L  L L  N     LP+ + D    LK L L  N+L   +P   F 
Sbjct: 95  LASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152

Query: 391 KLTSLLFLSLSNN--------SFNHLSGTLSVLQQCKNLTTLILTKN 429
           KLT+L  LSLS N        +F+ L            L T+ L  N
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRL----------GKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 18/154 (11%)

Query: 496 LDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSF 554
           LD  +  L      +   L  L   N   +     SAG+   +     T GL  NQ +S 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT-ELGTLGLANNQLASL 98

Query: 555 PPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRN 602
           P  VF          L  N++  ++P  +  +L  L  L L+ N +  +IP+    ++ N
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156

Query: 603 LEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANN 635
           L+ L LS+N L  S+P G+F++L  L   ++  N
Sbjct: 157 LQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 22/138 (15%)

Query: 521 NCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTI 569
            C S   T+   GIP       +   L  N   S P  VF          L  N++  ++
Sbjct: 13  ECYSQGRTSVPTGIPA----QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SL 67

Query: 570 PPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTF 626
           P  +  +L  L  L+LS N +  ++P+ +  ++  L+ L L++N L  S+P G F+KLT 
Sbjct: 68  PNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ 125

Query: 627 LSKFSVANNHLQGTIPTG 644
           L    +  N L+ ++P G
Sbjct: 126 LKDLRLYQNQLK-SVPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 39/130 (30%), Positives = 56/130 (43%), Gaps = 23/130 (17%)

Query: 325 VLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLKILSLAKNELSG 383
            LDL  NSL    +  F  L+SL  L L  N     LPN + +    L  L+L+ N+L  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 384 QVPESFGKLTSLLFLSLSNN--------SFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 435
                F KLT L  L+L+ N         F+ L+           L  L L +N + + +
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT----------QLKDLRLYQNQL-KSV 139

Query: 436 PENVGGFESL 445
           P+  G F+ L
Sbjct: 140 PD--GVFDRL 147

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 17/103 (16%), Positives = 34/103 (33%), Gaps = 3/103 (2%)

Query: 562 NNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPS-SISEIRNLEVLDLSSNDLHGSIPGS 620
                      +   ++L  L +        +    +  +  L  L +  + L    P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 621 FEKLTFLSKFSVANNHLQGTIPTGG-QFYSFPNSSFEGNPGLC 662
           F     LS+ +++ N L+ ++     Q  S       GNP  C
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 22/94 (23%), Positives = 34/94 (36%), Gaps = 2/94 (2%)

Query: 314 PLSLSLCSKLHVLDLRNNSLTGPIDLN-FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 372
              L     L  L + N      ++L    GL  L  L +  +      P++      L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 373 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFN 406
            L+L+ N L     ++   L SL  L LS N  +
Sbjct: 84  RLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.3 bits (122), Expect = 1e-06
 Identities = 28/112 (25%), Positives = 45/112 (40%), Gaps = 9/112 (8%)

Query: 64  CCQWD-GVVCGHGSTGSN------AGRVTMLILPR-KGLKGIIPRSLGHLNQLKLLDLSC 115
           C     G+ C       +      A  +T L +   + L+ +  R L  L +L+ L +  
Sbjct: 6   CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 116 NHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
           + L  V P       +L  L+LS N L       + GL+L Q L +S N  +
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL-QELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 7/112 (6%)

Query: 320 CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN-SLSDCHDLKILSLAK 378
                 L    +     +  +  G  +L  L +        L    L    +L+ L++ K
Sbjct: 7   PHGSSGLRCTRDGALDSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLS-GTLSVLQQCKNLTTLILTKN 429
           + L    P++F     L  L+LS N+   LS  T+  L    +L  L+L+ N
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL----SLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 6e-06
 Identities = 15/80 (18%), Positives = 31/80 (38%), Gaps = 2/80 (2%)

Query: 560 LSNNRINGTIPPE-IGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 618
           + N +    +    +  L  L  L + ++ +    P +      L  L+LS N L     
Sbjct: 38  IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSW 97

Query: 619 GSFEKLTFLSKFSVANNHLQ 638
            + + L+ L +  ++ N L 
Sbjct: 98  KTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 6e-06
 Identities = 18/96 (18%), Positives = 27/96 (28%), Gaps = 2/96 (2%)

Query: 240 DLPDSLYSMSSLQHVSLSVNNFSGQL-SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQ 298
           D    L    +L  + +        L    +  L  LR+L I  +      P+      +
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 299 LEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLT 334
           L       N+    L         L  L L  N L 
Sbjct: 82  LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 21/90 (23%), Positives = 30/90 (33%), Gaps = 2/90 (2%)

Query: 269 ISNLTSLRHLIIFGNQFSGKLPN-VLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLD 327
           +    +L  L I   Q    L    L  L +L       +      P +     +L  L+
Sbjct: 27  LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86

Query: 328 LRNNSLTGPIDLNFSGLSSLCTLDLATNHF 357
           L  N+L         GL SL  L L+ N  
Sbjct: 87  LSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 22/138 (15%), Positives = 40/138 (28%), Gaps = 48/138 (34%)

Query: 482 NIPPWIGQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYV 537
           +    +   ENL  L   N      +     + L EL++L                    
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL-------------------- 61

Query: 538 KHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQ-LKHLHVLDLSRNNITGTIPSS 596
                                 +  + +   + P+       L  L+LS N +  ++   
Sbjct: 62  ---------------------TIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWK 98

Query: 597 ISEIRNLEVLDLSSNDLH 614
             +  +L+ L LS N LH
Sbjct: 99  TVQGLSLQELVLSGNPLH 116

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 40/137 (29%), Positives = 63/137 (45%), Gaps = 21/137 (15%)

Query: 521 NCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTI 569
           +C S    +  AGIP     N     L  NQ +   P VF          L +N++   +
Sbjct: 25  DCRSKRHASVPAGIPT----NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-AL 79

Query: 570 PPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIPGSFEKLTFL 627
           P  +   L  L VLDL  N +T  +PS++   + +L+ L +  N L   +P   E+LT L
Sbjct: 80  PVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHL 137

Query: 628 SKFSVANNHLQGTIPTG 644
           +  ++  N L+ +IP G
Sbjct: 138 THLALDQNQLK-SIPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 39/169 (23%), Positives = 58/169 (34%), Gaps = 45/169 (26%)

Query: 470 QVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN---TLTGEIPKSLTELKSLISSNCTSSN 526
           Q+L L  N      P     + NL  L   +N    L   +  SLT+L  L         
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL--------- 93

Query: 527 PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR 586
                              L  NQ +  P +VF               +L HL  L +  
Sbjct: 94  ------------------DLGTNQLTVLPSAVF--------------DRLVHLKELFMCC 121

Query: 587 NNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 635
           N +T  +P  I  + +L  L L  N L     G+F++L+ L+   +  N
Sbjct: 122 NKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 35/122 (28%), Positives = 52/122 (42%), Gaps = 8/122 (6%)

Query: 325 VLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLKILSLAKNELSG 383
           +L L +N +T      F  L +L  L L +N     LP  + D    L +L L  N+L+ 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 384 QVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFE 443
                F +L  L  L +  N    L   +  L    +LT L L +N + + IP   G F+
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTELPRGIERL---THLTHLALDQNQL-KSIPH--GAFD 156

Query: 444 SL 445
            L
Sbjct: 157 RL 158

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 34/135 (25%), Positives = 54/135 (40%), Gaps = 2/135 (1%)

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 332
            ++  + +  N      P       +L      +N  S   P +      L+ L L  N 
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91

Query: 333 LTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGK 391
           +T  P  L F GL SL  L L  N  +    ++  D H+L +LSL  N+L      +F  
Sbjct: 92  ITELPKSL-FEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150

Query: 392 LTSLLFLSLSNNSFN 406
           L ++  + L+ N F 
Sbjct: 151 LRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 23/101 (22%), Positives = 33/101 (32%), Gaps = 19/101 (18%)

Query: 546 LPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLE 604
           L  N     PP  F                 K L  +DLS N I+  +       +R+L 
Sbjct: 39  LEQNTIKVIPPGAFSP--------------YKKLRRIDLSNNQIS-ELAPDAFQGLRSLN 83

Query: 605 VLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIPTG 644
            L L  N +   +P   FE L  L    +  N +   +   
Sbjct: 84  SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVD 122

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 37/172 (21%), Positives = 55/172 (31%), Gaps = 50/172 (29%)

Query: 470 QVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLTGEIPK----SLTELKSLISSNCTS 524
             + L  N     IPP      + L  +D SNN ++ E+       L  L SL       
Sbjct: 35  TEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSL------- 85

Query: 525 SNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDL 584
                                L  N+ +  P S+F                L  L +L L
Sbjct: 86  --------------------VLYGNKITELPKSLF--------------EGLFSLQLLLL 111

Query: 585 SRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 635
           + N I   +      ++ NL +L L  N L     G+F  L  +    +A N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 31/153 (20%), Positives = 59/153 (38%), Gaps = 25/153 (16%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
           +T + L +  +K I P +     +L+ +DLS N +  + P     L+ L  L L  N ++
Sbjct: 34  ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 203
                +  GL  +Q L +++N  N  L  +  F +L                        
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN-CL-RVDAFQDL----------------------HN 129

Query: 204 IQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNN 235
           + +L L  N      +G      +++ +H+  N
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 18/74 (24%), Positives = 32/74 (43%)

Query: 94  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           +  +       L  L+LL L+ N +  +      +L  L +L L  N L     G  + L
Sbjct: 92  ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151

Query: 154 NLIQSLNVSSNSFN 167
             IQ+++++ N F 
Sbjct: 152 RAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 30/133 (22%), Positives = 55/133 (41%), Gaps = 4/133 (3%)

Query: 349 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL 408
            + L  N      P + S    L+ + L+ N++S   P++F  L SL  L L  N    L
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITEL 95

Query: 409 SGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCK 467
               S+ +   +L  L+L  N +   +  +      +L +L+L +  L+          +
Sbjct: 96  PK--SLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 468 KLQVLDLSWNHFD 480
            +Q + L+ N F 
Sbjct: 153 AIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 32/149 (21%), Positives = 59/149 (39%), Gaps = 28/149 (18%)

Query: 370 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
            +  + L +N +    P +F     L  + LSNN  + L+      Q  ++L +L+L  N
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAP--DAFQGLRSLNSLVLYGN 90

Query: 430 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ 489
            +  E+P+++  FE L                       LQ+L L+ N     +     Q
Sbjct: 91  KI-TELPKSL--FEGL---------------------FSLQLLLLNANKI-NCLRVDAFQ 125

Query: 490 -MENLFYLDFSNNTLTGEIPKSLTELKSL 517
            + NL  L   +N L      + + L+++
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 32/175 (18%), Positives = 59/175 (33%), Gaps = 47/175 (26%)

Query: 111 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL 170
           + L  N ++ + P   S  K+L  +DLS+N +S        GL  + SL +  N      
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN------ 90

Query: 171 FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQL 230
                                             +I +L  + F       +   SL+ L
Sbjct: 91  ----------------------------------KITELPKSLF-------EGLFSLQLL 109

Query: 231 HVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 285
            ++ N +     D+   + +L  +SL  N          S L +++ + +  N F
Sbjct: 110 LLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 54.7 bits (132), Expect = 8e-08
 Identities = 46/220 (20%), Positives = 84/220 (38%), Gaps = 38/220 (17%)

Query: 774 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 832
            +G G F  V+ A  + N T  A+K + GD        + E++ L R    +        
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 833 RHGNDRLLIYSYMENGSLDY------WLHESVD------KDSVLKWDVRLKIAQGAARGL 880
            +   +LL +   +  +  +       L E++       +   +      +I++    GL
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144

Query: 881 AYLHKVCEPHIVHRDVKSSNILLDEKFEAH------LADFGLSRLLRPYDTHVTTDLVGT 934
            Y+H+ C   I+H D+K  N+L++            +AD G +      D H T  +  T
Sbjct: 145 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYTNSIQ-T 198

Query: 935 LGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 968
             Y  PE      +          D++S   ++ EL+TG 
Sbjct: 199 REYRSPEVLLGAPWGCGA------DIWSTACLIFELITGD 232

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 4/86 (4%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP- 618
           L  N+    +P E+   KHL ++DLS N I+     S S +  L  L LS N L   IP 
Sbjct: 38  LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPP 95

Query: 619 GSFEKLTFLSKFSVANNHLQGTIPTG 644
            +F+ L  L   S+  N +   +P G
Sbjct: 96  RTFDGLKSLRLLSLHGNDIS-VVPEG 120

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 30/131 (22%), Positives = 51/131 (38%), Gaps = 25/131 (19%)

Query: 507 IPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRIN 566
           IP+ +TEL   +  N  +  P   +        + +   L  N+ S+     F       
Sbjct: 29  IPRDVTELY--LDGNQFTLVPKELSNY-----KHLTLIDLSNNRISTLSNQSF------- 74

Query: 567 GTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKL 624
                    +  L  L LS N +   IP      +++L +L L  ND+   +P G+F  L
Sbjct: 75  -------SNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL 125

Query: 625 TFLSKFSVANN 635
           + LS  ++  N
Sbjct: 126 SALSHLAIGAN 136

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 45/277 (16%), Positives = 82/277 (29%), Gaps = 50/277 (18%)

Query: 108 LKLLDLSCNHL-----EGVVPVELSNLKQLEVLDLSHNMLSGP-VSGMLAGLNLIQSLNV 161
           L+ L+L+   +       V  V  S    L+ ++L+   L    +  +L      + L +
Sbjct: 74  LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGL 133

Query: 162 SSNSF-NGSLFELGEF-----SNLAVFNISNNSFT---GKLNSRIWSASKEIQILDLSMN 212
             NS    +  +L +        +    +SNN  T     +     + +  +  L L   
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHT 193

Query: 213 HF----MGSL-QGLDHSPSLKQLHVDNNLLGG----DLPDSLYSMSSLQHVSLSVNNFS- 262
                 +  L   LD +  L++L+V  N  G      L  +     SL+ + L  N  S 
Sbjct: 194 GLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253

Query: 263 ------GQLSEKISNLTSLRHLIIFGNQFS----GKLPNVLGNLTQLEFFVAHSNSFSGP 312
                   L         +   +  G   S      L  V  NL   +      +     
Sbjct: 254 EGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLL 313

Query: 313 LPLS---------------LSLCSKLHVLDLRNNSLT 334
             L                L +  ++  L  +  S  
Sbjct: 314 RDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 51.3 bits (123), Expect = 8e-07
 Identities = 56/362 (15%), Positives = 98/362 (27%), Gaps = 67/362 (18%)

Query: 95  KGIIPRSLGHLNQLKLLDLSCNHLE-GVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 153
           K +       L   +LLD    H E          L  L  L+L+   ++          
Sbjct: 36  KKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMT--PVKCTV-- 91

Query: 154 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 213
            +   L                   L   N+++          +       + L L +N 
Sbjct: 92  -VAAVLGSGR-------------HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNS 137

Query: 214 F----MGSL-QGLDHSPS-LKQLHVDNNLLGGD----LPDSLYSMSSLQHVSLSVNNFSG 263
                   L   L H    +  L + NN L       L + L   +S+ H+SL       
Sbjct: 138 LGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197

Query: 264 Q----LSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL 319
           +    L+ ++     L+ L +  N         L                      +   
Sbjct: 198 EGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR--------------------AARE 237

Query: 320 CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDL-----KIL 374
              L +L L  N L+        G   L  L          +  SL++   +      IL
Sbjct: 238 HPSLELLHLYFNELSS------EGRQVLRDL-GGAAEGGARVVVSLTEGTAVSEYWSVIL 290

Query: 375 SLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL--SVLQQCKNLTTLILTKNFVG 432
           S  +  L+        +   LL   L ++    L+      +L+    +  L+      G
Sbjct: 291 SEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350

Query: 433 EE 434
             
Sbjct: 351 SP 352

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 27/128 (21%), Positives = 44/128 (34%), Gaps = 25/128 (19%)

Query: 521 NCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSFPPS-VFLSNNRINGTIPPEIGQLKH 578
           +CT          IPL+         L  N+        +F              G+L H
Sbjct: 14  DCTGRGLKEIPRDIPLHTTELL----LNDNELGRISSDGLF--------------GRLPH 55

Query: 579 LHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNH 636
           L  L+L RN +T  I  +      +++ L L  N +   I    F  L  L   ++ +N 
Sbjct: 56  LVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQ 113

Query: 637 LQGTIPTG 644
           +   +  G
Sbjct: 114 IS-CVMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 30/115 (26%), Positives = 46/115 (40%), Gaps = 21/115 (18%)

Query: 325 VLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLKILSLAKNELS 382
            L L +N L     D  F  L  L  L+L  N  +G +  +  +    ++ L L +N++ 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK 91

Query: 383 GQVPESFGKLTSLLFLSLSNN--------SFNHLSGTLSVLQQCKNLTTLILTKN 429
               + F  L  L  L+L +N        SF HL           +LT+L L  N
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL----------NSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 32/87 (36%), Positives = 43/87 (49%), Gaps = 4/87 (4%)

Query: 322 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD-CHDLKILSLAKNE 380
            L  L+L+ N LTG     F G S +  L L  N     + N +    H LK L+L  N+
Sbjct: 55  HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQ 113

Query: 381 LSGQVPE-SFGKLTSLLFLSLSNNSFN 406
           +S  V   SF  L SL  L+L++N FN
Sbjct: 114 ISC-VMPGSFEHLNSLTSLNLASNPFN 139

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 39/183 (21%)

Query: 495 YLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIP-------LYVKHNRSTN--- 544
             +    ++T  + ++  EL S+      +S+  +  GI        L +  N+  +   
Sbjct: 23  KANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISA 80

Query: 545 ----------GLPYNQASSFPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLD 583
                      L  NQ  S P  VF          L  N++  ++P  +  +L +L  L+
Sbjct: 81  LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLN 139

Query: 584 LSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTI 641
           L+ N +  ++P  +  ++ NL  LDLS N L  S+P G F+KLT L    +  N L+ ++
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SV 196

Query: 642 PTG 644
           P G
Sbjct: 197 PDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.4 bits (108), Expect = 5e-05
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 205 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ 264
              +L            +   S+ Q+  +N+ +   +   +  + ++++++L  N    +
Sbjct: 22  IKANLKKKSV-TDAVTQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVRYLALGGN----K 74

Query: 265 LSEKIS---NLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF-SGPLPLSLSLC 320
           L   IS    LT+L +LI+ GNQ       V   LT L+  V   N   S P  +   L 
Sbjct: 75  LH-DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL- 132

Query: 321 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD-CHDLKILSLAKN 379
           + L  L+L +N L       F  L++L  LDL+ N     LP  + D    LK L L +N
Sbjct: 133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQN 191

Query: 380 ELSGQVPE-SFGKLTSLLFLSLSNN 403
           +L   VP+  F +LTSL ++ L +N
Sbjct: 192 QLKS-VPDGVFDRLTSLQYIWLHDN 215

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 49.2 bits (118), Expect = 9e-07
 Identities = 38/138 (27%), Positives = 58/138 (42%), Gaps = 33/138 (23%)

Query: 519 SSNCTSSNPT--------AS--AGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGT 568
            S C+ S            S   GIP     + +   L  N+  S P  VF         
Sbjct: 2   PSRCSCSGTEIRCNSKGLTSVPTGIPS----SATRLELESNKLQSLPHGVF--------- 48

Query: 569 IPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTF 626
                 +L  L  L LS+N I  ++P  +  ++  L +L L  N L  S+P G F+KLT 
Sbjct: 49  -----DKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQ 101

Query: 627 LSKFSVANNHLQGTIPTG 644
           L + ++  N L+ ++P G
Sbjct: 102 LKELALDTNQLK-SVPDG 118

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.6 bits (117), Expect = 4e-06
 Identities = 30/171 (17%), Positives = 56/171 (32%), Gaps = 21/171 (12%)

Query: 239 GDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLG---- 294
            DL   L +M  L ++ +   N    LS       +L+ L I        +   +     
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 295 -NLTQLEFFVAHSNSFSGPLP------LSLSLCSKLHVLDLRNNSLTGPI---DLNFSGL 344
            NL +L  +V   +              S      L  L + +      +    L    L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 345 SSLCTLDLATNHFSG----PLPNSLSDCHDLKILSLAKNELSGQVPESFGK 391
             L T+D++    +      L + +     LK +++  N LS ++ +   K
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.2 bits (116), Expect = 4e-06
 Identities = 25/166 (15%), Positives = 50/166 (30%), Gaps = 26/166 (15%)

Query: 473 DLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASA- 531
           ++SW     ++ P +  M  L  L            K    LKSL   +    +      
Sbjct: 155 EISW-IEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDI 213

Query: 532 ---------------GIPLYVKHNRSTNGLPYNQASSFPP--SVFLSNNRINGTIPPEIG 574
                          G+  Y          P      FP    + + +      +     
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273

Query: 575 Q---LKHLHVLDLSRNNITGT----IPSSISEIRNLEVLDLSSNDL 613
           +   L  L  +D+S   +T      +   + +I++L+ +++  N L
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 9e-06
 Identities = 29/164 (17%), Positives = 52/164 (31%), Gaps = 19/164 (11%)

Query: 287 GKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLT--GPIDLNFSGL 344
             L  VL  +  L          +  L +       L  L++ +  L      D+  S L
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 345 SSLCTLDLATNHFSGPLPNSLSD---------CHDLKILSLAKNELSGQVPESFGK---L 392
            +L  L L            ++            +LK L +   E    V E F +   L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 393 TSLLFLSLSNNSFNHLSGT--LSVLQQCKNLTTLILTKNFVGEE 434
             L  + +S            L  + + K+L  + +  N++ +E
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 1e-05
 Identities = 23/154 (14%), Positives = 48/154 (31%), Gaps = 29/154 (18%)

Query: 104 HLNQLKLLDLSCNH-----LEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQS 158
               LK L++         +E ++  +L NL++L +     +        +         
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR------- 243

Query: 159 LNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSAS--KEIQILDLSMNHFMG 216
                      LF    F NL    I +      +      +    +++ +D+S      
Sbjct: 244 ----------PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293

Query: 217 S-----LQGLDHSPSLKQLHVDNNLLGGDLPDSL 245
                 L  +D    LK +++  N L  ++   L
Sbjct: 294 EGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 41.9 bits (97), Expect = 8e-04
 Identities = 15/86 (17%), Positives = 35/86 (40%), Gaps = 8/86 (9%)

Query: 83  RVTMLILPRKGLKGIIPRSLGH---LNQLKLLDLSCNHL--EGVVPV--ELSNLKQLEVL 135
            +  L +     + ++         L QL+ +D+S   L  EG   +   +  +K L+ +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312

Query: 136 DLSHNMLSGP-VSGMLAGLNLIQSLN 160
           ++ +N LS      +   L +   ++
Sbjct: 313 NMKYNYLSDEMKKELQKSLPMKIDVS 338

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 43/226 (19%), Positives = 70/226 (30%), Gaps = 35/226 (15%)

Query: 388 SFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMV 447
                  +  + LSN+     S    +L QC  L  L L    + + I   +    +L+ 
Sbjct: 88  EHFSPFRVQHMDLSNSVIEV-STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 146

Query: 448 LALGNC-GLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG 505
           L L  C G        LL  C +L  L+LSW                    DF+   +  
Sbjct: 147 LNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF------------------DFTEKHVQV 188

Query: 506 EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRI 565
            +      +  L  S    +     + +   V+   +   L               +  +
Sbjct: 189 AVAHVSETITQLNLSGYRKN--LQKSDLSTLVRRCPNLVHL-----------DLSDSVML 235

Query: 566 NGTIPPEIGQLKHLHVLDLSR-NNITGTIPSSISEIRNLEVLDLSS 610
                 E  QL +L  L LSR  +I       + EI  L+ L +  
Sbjct: 236 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 50/232 (21%), Positives = 82/232 (35%), Gaps = 44/232 (18%)

Query: 317 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH---DLKI 373
           LS CSKL  L L    L+ PI    +  S+L  L+             LS C    +  +
Sbjct: 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN-------------LSGCSGFSEFAL 160

Query: 374 LSLAKNELSGQVPESFGKLTSLLFLSLSN-NSFNHLSGTLSVLQQCKNLTTLIL---TKN 429
            +L  +             + L  L+LS    F      ++V    + +T L L    KN
Sbjct: 161 QTLLSS------------CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 208

Query: 430 FVGEEIPENVGGFESLMVLALGNC-GLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP--- 485
               ++   V    +L+ L L +   LK        +   LQ L LS  +   +I P   
Sbjct: 209 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY---DIIPETL 265

Query: 486 -WIGQMENLFYLDFSNNTLTG---EIPKSLTELKSLISSNCTSSNPTASAGI 533
             +G++  L  L        G    + ++L  L+ +  S+ T+         
Sbjct: 266 LELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-INCSHFTTIARPTIGNK 316

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.1 bits (109), Expect = 5e-05
 Identities = 32/149 (21%), Positives = 44/149 (29%), Gaps = 55/149 (36%)

Query: 871 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL--------------------------- 903
           KI Q   +GL YLH  C   I+H D+K  NILL                           
Sbjct: 150 KIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 904 ----------------------DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
                                  EK +  +AD G +  +  + T      + T  Y   E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE----DIQTRQYRSLE 263

Query: 942 YSQTLTATCRGDVYSFGVVLLELLTGRRP 970
                      D++S   +  EL TG   
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYL 292

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 33/106 (31%), Positives = 45/106 (42%), Gaps = 21/106 (19%)

Query: 871 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE--KFEAHLADFGLSRLLRPYDTHVT 928
           K A    + L  LHK     I+H D+K  NILL +  +    + DFG S         V 
Sbjct: 204 KFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVY 257

Query: 929 TDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 968
           T +  +  Y  PE      Y   +      D++S G +L ELLTG 
Sbjct: 258 TYIQ-SRFYRAPEVILGARYGMPI------DMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 30/109 (27%), Positives = 44/109 (40%), Gaps = 20/109 (18%)

Query: 868 VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL--DEKFEAHLADFGLSRLLRPYDT 925
            R K AQ     L +L    E  I+H D+K  NILL   ++    + DFG S        
Sbjct: 159 TR-KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC----QLG 212

Query: 926 HVTTDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 968
                 + +  Y  PE      Y   +      D++S G +L+E+ TG 
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAI------DMWSLGCILVEMHTGE 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1048
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-64
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-58
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-28
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-23
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-05
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-11
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-08
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.004
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 2e-66
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 22/281 (7%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
                    IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
               GY        ++  + E  SL + LH     ++  +    + IA+  A+G+ YLH  
Sbjct: 68   LFMGYS-TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHA- 122

Query: 887  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQT 945
                I+HRD+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  + 
Sbjct: 123  --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 946  LTA---TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002
                  + + DVY+FG+VL EL+TG+ P       N RD + ++        ++  + ++
Sbjct: 181  QDKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                        M  +  +C+ +    RP   +++  ++ +
Sbjct: 238  CPK--------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 7e-64
 Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 22/277 (7%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
                    +G G FG V+       TK AVK L          F AE   + + QH+ LV
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
             L           +I  YMENGSL  +L         L  +  L +A   A G+A++   
Sbjct: 72   RLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE-- 126

Query: 887  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
             E + +HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     
Sbjct: 127  -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 947  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
            T T + DV+SFG++L E++T  R                 +   +    ++ ++      
Sbjct: 186  TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 230

Query: 1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
              +    E+ ++   C  + P  RP  + + + L+  
Sbjct: 231  RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 3e-62
 Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 22/277 (7%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
            +       IG G FGLV+     N  K A+K +       E +F  E E + +  H  LV
Sbjct: 5    SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63

Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
             L G C       L++ +ME+G L  +L       +    +  L +      G+AYL   
Sbjct: 64   QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYL--- 117

Query: 887  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
             E  ++HRD+ + N L+ E     ++DFG++R +       +T     + +  PE     
Sbjct: 118  EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 947  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
              + + DV+SFGV++ E+ +  +     + ++  ++V  +           +    +   
Sbjct: 178  RYSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDI------STGFRLYKPRLAST 229

Query: 1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                    + +I   C  + P  RP    ++  L  I
Sbjct: 230  -------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 2e-61
 Identities = 63/275 (22%), Positives = 116/275 (42%), Gaps = 22/275 (8%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
             +      +G G FG V+  T    T+ A+K L          F  E + + + +H+ LV
Sbjct: 17   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
             L           ++  YM  GSL  +L    +    L+    + +A   A G+AY+ + 
Sbjct: 76   QLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER- 131

Query: 887  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
               + VHRD++++NIL+ E     +ADFGL+RL+   +          + +  PE +   
Sbjct: 132  --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 947  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
              T + DV+SFG++L EL T  R                 +     +  ++ ++      
Sbjct: 190  RFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMP 234

Query: 1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
               +    + ++ C+C  ++P  RP  E +  +L+
Sbjct: 235  CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (521), Expect = 8e-60
 Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 41/305 (13%)

Query: 758  TVSDLLKSTNNFNQA---------NIIGCGGFGLVYKATLTNGTK----AAVKRL-SGDC 803
            T  D  ++   F +           +IG G FG V    L    K     A+K L SG  
Sbjct: 8    TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 804  GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV 863
             +  R+F +E   + +  H N++ L+G        ++I  +MENGSLD +L ++  + + 
Sbjct: 68   EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT- 126

Query: 864  LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY 923
                  + + +G A G+ YL      + VHRD+ + NIL++      ++DFGLSR L   
Sbjct: 127  --VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 924  DTHVTT----DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 978
             +  T          + +  PE  Q    T   DV+S+G+V+ E+++ G RP        
Sbjct: 182  TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW---DMT 238

Query: 979  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038
             +D+++ + Q       ++                 + ++   C  +D   RP   ++V 
Sbjct: 239  NQDVINAIEQDYRLPPPMDCPS-------------ALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 1039 WLDGI 1043
             LD +
Sbjct: 286  TLDKM 290

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 1e-59
 Identities = 52/274 (18%), Positives = 104/274 (37%), Gaps = 22/274 (8%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
             +      +G G FG+V           A+K +       E EF  E + +    H+ LV
Sbjct: 4    KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62

Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
             L G C       +I  YM NG L  +L    +     +    L++ +     + YL   
Sbjct: 63   QLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES- 118

Query: 887  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
                 +HRD+ + N L++++    ++DFGLSR +   +   +      + + PPE     
Sbjct: 119  --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 947  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1006
              + + D+++FGV++ E+ +  +                 ++  +     E I   +   
Sbjct: 177  KFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLY 221

Query: 1007 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                   ++  I   C  +    RP  + +++ +
Sbjct: 222  RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-59
 Identities = 66/300 (22%), Positives = 118/300 (39%), Gaps = 38/300 (12%)

Query: 766  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHK 823
             ++F + + +G G  G+V+K +   +G   A K +  +    +  +   E++ L      
Sbjct: 5    DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 824  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
             +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL
Sbjct: 65   YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 884  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
             +     I+HRDVK SNIL++ + E  L DFG+S  L      +    VGT  Y+ PE  
Sbjct: 121  REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERL 175

Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRP--------------------------VEVCKGK 977
            Q    + + D++S G+ L+E+  GR P                               G+
Sbjct: 176  QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 978  NCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL-LEMLEIACKCIDQDPRRRPFIEEV 1036
                         +    ++ I      K       LE  +   KC+ ++P  R  ++++
Sbjct: 236  PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (515), Expect = 4e-59
 Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 22/278 (7%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 825
             +    + +G G +G VY+          AVK L  D  ++E EF  E   +   +H NL
Sbjct: 17   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75

Query: 826  VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
            V L G C       +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K
Sbjct: 76   VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK 133

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
                + +HRD+ + N L+ E     +ADFGLSRL+              + +  PE    
Sbjct: 134  ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 946  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005
               + + DV++FGV+L E+ T                    +      +  E+++     
Sbjct: 191  NKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLEKDYRM 235

Query: 1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            +  E    ++ E+   C   +P  RP   E+    + +
Sbjct: 236  ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-58
 Identities = 68/278 (24%), Positives = 106/278 (38%), Gaps = 28/278 (10%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
                    IG G FG V       G K AVK +  D     + F AE   +++ +H NLV
Sbjct: 7    KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLV 63

Query: 827  SLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
             L G        L ++  YM  GSL  +L       SVL  D  LK +      + YL  
Sbjct: 64   QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 945
                + VHRD+ + N+L+ E   A ++DFGL++                + +  PE  + 
Sbjct: 122  ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALRE 174

Query: 946  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005
               + + DV+SFG++L E+ +  R          +D+V  V +                 
Sbjct: 175  KKFSTKSDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPRVEKGYKMDAPDGCPP----- 227

Query: 1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                     + E+   C   D   RP   ++   L+ I
Sbjct: 228  --------AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 5e-58
 Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 30/292 (10%)

Query: 775  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 834
            IG G FG V++     G + AVK  S    +     +AE+      +H+N++        
Sbjct: 11   IGKGRFGEVWRGKWR-GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 835  GNDRL----LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC--- 887
             N       L+  Y E+GSL  +L+        +  +  +K+A   A GLA+LH      
Sbjct: 69   DNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 888  --EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGTLGYIPPEY 942
              +P I HRD+KS NIL+ +     +AD GL+         +       VGT  Y+ PE 
Sbjct: 124  QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 943  ------SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC----RDLVSWVFQMKSE 992
                   +   +  R D+Y+ G+V  E+        + +                +   +
Sbjct: 184  LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 993  KREVEIIDASIWHKDREKQLL-EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                + +  +I ++ +  + L  M +I  +C   +   R     +   L  +
Sbjct: 244  VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (507), Expect = 5e-58
 Identities = 75/305 (24%), Positives = 115/305 (37%), Gaps = 46/305 (15%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSR 819
            NN      IG G FG V++A           T  AVK L  +    M+ +FQ E   ++ 
Sbjct: 13   NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------------------SVD 859
              + N+V L G C  G    L++ YM  G L+ +L                      S  
Sbjct: 73   FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 860  KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL 919
                L    +L IA+  A G+AYL    E   VHRD+ + N L+ E     +ADFGLSR 
Sbjct: 133  GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 920  LRPYD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
            +   D      +    + ++PPE       T   DV+++GVVL E+ +            
Sbjct: 190  IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-------- 241

Query: 979  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038
                    +   + +  +  +         E   LE+  +   C  + P  RP    +  
Sbjct: 242  -------PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 1039 WLDGI 1043
             L  +
Sbjct: 295  ILQRM 299

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 3e-57
 Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 40/300 (13%)

Query: 767  NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
            N  +    +G G FG V +AT             AVK L       ERE   +E++ LS 
Sbjct: 23   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 820  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--------------VDKDSVL 864
               H N+V+L G C  G   L+I  Y   G L  +L                  D +  L
Sbjct: 83   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 865  KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
              +  L  +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 143  DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 925  TH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 983
             + V  +    + ++ PE       T   DV+S+G+ L EL +                 
Sbjct: 200  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 984  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                 M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++  
Sbjct: 247  -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-56
 Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 26/282 (9%)

Query: 768  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKN 824
            ++     IG G +G   K    ++G     K L         ++   +EV  L   +H N
Sbjct: 5    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 825  LVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
            +V          +  L  +  Y E G L   + +   +   L  +  L++       L  
Sbjct: 65   IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 883  LHK--VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
             H+       ++HRD+K +N+ LD K    L DFGL+R+L   DT      VGT  Y+ P
Sbjct: 125  CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSP 183

Query: 941  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
            E    ++   + D++S G +L EL     P                F   S+K     I 
Sbjct: 184  EQMNRMSYNEKSDIWSLGCLLYELCALMPP----------------FTAFSQKELAGKIR 227

Query: 1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1040
               + +   +   E+ EI  + ++     RP +EE++    +
Sbjct: 228  EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-56
 Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 29/287 (10%)

Query: 765  STNNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMER-EFQAEVEALS 818
              +   +  +IG G FG VYK  L   +       A+K L     + +R +F  E   + 
Sbjct: 5    HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 819  RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 878
            +  H N++ L+G        ++I  YMENG+LD +L E   KD        + + +G A 
Sbjct: 65   QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAA 121

Query: 879  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLG 936
            G+ YL      + VHRD+ + NIL++      ++DFGLSR+L   P  T+ T+     + 
Sbjct: 122  GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 937  YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
            +  PE       T   DV+SFG+V+ E++T                    +   S    +
Sbjct: 179  WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEVM 223

Query: 997  EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            + I+              + ++  +C  Q+  RRP   ++V+ LD +
Sbjct: 224  KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-55
 Identities = 64/288 (22%), Positives = 115/288 (39%), Gaps = 31/288 (10%)

Query: 761  DLLKSTNNFNQANI-IGCGGFGLVYKATL---TNGTKAAVKRLSGDCGQMERE-FQAEVE 815
             L    +N   A+I +GCG FG V +            A+K L     + + E    E +
Sbjct: 2    KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 816  ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
             + +  +  +V L G C      +L+      G L  +L     K   +      ++   
Sbjct: 62   IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQ 117

Query: 876  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVG 933
             + G+ YL +    + VHRD+ + N+LL  +  A ++DFGLS+ L   D++ T  +    
Sbjct: 118  VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 934  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE 992
             L +  PE       + R DV+S+GV + E L+ G++P +        ++++++ Q K  
Sbjct: 175  PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---KMKGPEVMAFIEQGKRM 231

Query: 993  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
            +   E                E+  +   C       RP    V   +
Sbjct: 232  ECPPECPP-------------ELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 4e-55
 Identities = 75/294 (25%), Positives = 124/294 (42%), Gaps = 37/294 (12%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNG---TKAAVKRLSGD-CGQMEREFQAEVEALSR-AQ 821
            N+    ++IG G FG V KA +        AA+KR+         R+F  E+E L +   
Sbjct: 10   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD------------SVLKWDVR 869
            H N+++L G C H     L   Y  +G+L  +L +S   +            S L     
Sbjct: 70   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 870  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 929
            L  A   ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 130  LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 930  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 989
                 + ++  E       T   DV+S+GV+L E+++         G  C +L   + Q 
Sbjct: 187  --RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQG 242

Query: 990  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               ++ +   D             E+ ++  +C  + P  RP   +++  L+ +
Sbjct: 243  YRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (485), Expect = 1e-54
 Identities = 67/276 (24%), Positives = 109/276 (39%), Gaps = 34/276 (12%)

Query: 769  FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKN 824
            F+    IG G FG VY A  + N    A+K++S    Q     ++   EV  L + +H N
Sbjct: 17   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 825  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
             +  +G     +   L+  Y    + D            L+      +  GA +GLAYLH
Sbjct: 77   TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
                 +++HRDVK+ NILL E     L DFG + ++ P         VGT  ++ PE   
Sbjct: 133  ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184

Query: 945  TLT---ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001
             +       + DV+S G+  +EL   + P+      N    +  + Q +S   +      
Sbjct: 185  AMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHWSE 241

Query: 1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
                                C+ + P+ RP  E ++
Sbjct: 242  ------------YFRNFVDSCLQKIPQDRPTSEVLL 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 1e-54
 Identities = 67/304 (22%), Positives = 116/304 (38%), Gaps = 47/304 (15%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMERE-FQAEVEALSR 819
             N     ++G G FG V  AT           + AVK L       ERE   +E++ +++
Sbjct: 37   ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 820  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS---------------- 862
               H+N+V+L G C       LI+ Y   G L  +L    +K S                
Sbjct: 97   LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 863  ---VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL 919
               VL ++  L  A   A+G+ +L        VHRD+ + N+L+       + DFGL+R 
Sbjct: 157  DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 920  LRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 978
            +     +V   +    + ++ PE       T + DV+S+G++L E+ +            
Sbjct: 214  IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-------- 265

Query: 979  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLL-EMLEIACKCIDQDPRRRPFIEEVV 1037
                    +           +  + +  D+      E+  I   C   D R+RP    + 
Sbjct: 266  -------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 1038 TWLD 1041
            ++L 
Sbjct: 319  SFLG 322

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-54
 Identities = 76/285 (26%), Positives = 119/285 (41%), Gaps = 32/285 (11%)

Query: 768  NFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDCGQME-REFQAEVEALSRAQH 822
            +FN   +IG G FG VY  TL +        AVK L+      E  +F  E   +    H
Sbjct: 30   HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 823  KNLVSLQGYCRHGNDR-LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
             N++SL G C       L++  YM++G L  ++    ++         +      A+G+ 
Sbjct: 88   PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGM- 143

Query: 882  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP---YDTHVTTDLVGTLGYI 938
                +     VHRD+ + N +LDEKF   +ADFGL+R +        H  T     + ++
Sbjct: 144  --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 939  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
              E  QT   T + DV+SFGV+L EL+T   P       N  D+  ++ Q +   +    
Sbjct: 202  ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYLLQGRRLLQPEYC 259

Query: 999  IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
             D              + E+  KC       RP   E+V+ +  I
Sbjct: 260  PD-------------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-54
 Identities = 59/276 (21%), Positives = 109/276 (39%), Gaps = 32/276 (11%)

Query: 773  NIIGCGGFGLVYKATLTN---GTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVS 827
              +G G FG V K            AVK L  +     ++ E  AE   + +  +  +V 
Sbjct: 13   KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 828  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
            + G C   +  +L+    E G L+ +L     ++  +K    +++    + G+ YL +  
Sbjct: 73   MIGICEAES-WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-- 125

Query: 888  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQT 945
              + VHRD+ + N+LL  +  A ++DFGLS+ LR  + +          + +  PE    
Sbjct: 126  -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 946  LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004
               + + DV+SFGV++ E  + G++P                ++         +++    
Sbjct: 185  YKFSSKSDVWSFGVLMWEAFSYGQKP----------------YRGMKGSEVTAMLEKGER 228

Query: 1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
                     EM ++   C   D   RP    V   L
Sbjct: 229  MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-54
 Identities = 57/270 (21%), Positives = 104/270 (38%), Gaps = 31/270 (11%)

Query: 775  IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG VYKA        AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 20   LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
            + N+  ++  +   G++D  +    + +  L       + +     L YLH   +  I+H
Sbjct: 80   YENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKIIH 133

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA----- 948
            RD+K+ NIL     +  LADFG+S           +  +GT  ++ PE     T+     
Sbjct: 134  RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPY 192

Query: 949  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008
              + DV+S G+ L+E+     P                    +  R +  I  S      
Sbjct: 193  DYKADVWSLGITLIEMAEIEPP----------------HHELNPMRVLLKIAKSEPPTLA 236

Query: 1009 EKQLL--EMLEIACKCIDQDPRRRPFIEEV 1036
            +         +   KC++++   R    ++
Sbjct: 237  QPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 66/273 (24%), Positives = 106/273 (38%), Gaps = 31/273 (11%)

Query: 773  NIIGCGGFGLVYKATLT-NGTKAAVKRLS--GDCGQMEREFQAEVEALSRAQHKNLVSLQ 829
              IG G F  VYK   T    + A   L          + F+ E E L   QH N+V   
Sbjct: 15   IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 830  GYC----RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
                   +     +L+   M +G+L  +L     +  V+K  V     +   +GL +LH 
Sbjct: 75   DSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 886  VCEPHIVHRDVKSSNILL-DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
               P I+HRD+K  NI +        + D GL+ L R         ++GT  ++ PE  +
Sbjct: 131  -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186

Query: 945  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004
                    DVY+FG+ +LE+ T   P    + +N   +   V          ++      
Sbjct: 187  E-KYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAIP--- 240

Query: 1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
                     E+ EI   CI Q+   R  I++++
Sbjct: 241  ---------EVKEIIEGCIRQNKDERYSIKDLL 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-53
 Identities = 69/277 (24%), Positives = 111/277 (40%), Gaps = 31/277 (11%)

Query: 765  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLS---GDCGQMEREFQAEVEALSRA 820
            +  +F     +G G FG VY A    +    A+K L     +   +E + + EVE  S  
Sbjct: 4    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 821  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            +H N++ L GY        LI  Y   G++   L     K S              A  L
Sbjct: 64   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANAL 119

Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            +Y H      ++HRD+K  N+LL    E  +ADFG S       +   T L GTL Y+PP
Sbjct: 120  SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPP 173

Query: 941  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
            E  +      + D++S GV+  E L G+ P E       ++    +   + E    + + 
Sbjct: 174  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRI--SRVEFTFPDFVT 228

Query: 1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037
                            ++  + +  +P +RP + EV+
Sbjct: 229  E------------GARDLISRLLKHNPSQRPMLREVL 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-52
 Identities = 62/292 (21%), Positives = 107/292 (36%), Gaps = 30/292 (10%)

Query: 762  LLKSTNNFNQANIIGCGGFGLVYKATLTN-----GTKAAVKRLS-GDCGQMEREFQAEVE 815
            +LK T  F +  ++G G FG VYK              A+K L      +  +E   E  
Sbjct: 5    ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 816  ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
             ++   + ++  L G C     +L I   M  G L  ++ E  D          L     
Sbjct: 64   VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQ 119

Query: 876  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT-HVTTDLVGT 934
             A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL   +  +        
Sbjct: 120  IAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 994
            + ++  E       T + DV+S+GV + EL+T                    +       
Sbjct: 177  IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASE 221

Query: 995  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046
               I++            +++  I  KC   D   RP   E++     +  D
Sbjct: 222  ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 5e-52
 Identities = 55/265 (20%), Positives = 112/265 (42%), Gaps = 28/265 (10%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            IG G  G VY A  +  G + A+++++      +     E+  +   ++ N+V+      
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
             G++  ++  Y+  GSL   + E+              + +   + L +LH      ++H
Sbjct: 88   VGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 894  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 953
            RD+KS NILL       L DFG    + P  +  +T +VGT  ++ PE         + D
Sbjct: 140  RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 198

Query: 954  VYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLL 1013
            ++S G++ +E++ G  P                +  ++  R + +I  +   + +  + L
Sbjct: 199  IWSLGIMAIEMIEGEPP----------------YLNENPLRALYLIATNGTPELQNPEKL 242

Query: 1014 --EMLEIACKCIDQDPRRRPFIEEV 1036
                 +   +C+D D  +R   +E+
Sbjct: 243  SAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  184 bits (467), Expect = 8e-52
 Identities = 63/273 (23%), Positives = 113/273 (41%), Gaps = 24/273 (8%)

Query: 767  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 825
            ++++    +G G FG+V++ T    G   A K +       +   + E++ +S  +H  L
Sbjct: 26   DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 826  VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 885
            V+L       N+ ++IY +M  G L   +    D+ + +  D  ++  +   +GL ++H 
Sbjct: 86   VNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMH- 141

Query: 886  VCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
              E + VH D+K  NI+   K      L DFGL+  L P  +   T   GT  +  PE +
Sbjct: 142  --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVA 197

Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
            +        D++S GV+   LL+G  P     G+N  + +  V        +      S 
Sbjct: 198  EGKPVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWNMDDSAFSGIS- 253

Query: 1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                      +  +   K +  DP  R  I + 
Sbjct: 254  ---------EDGKDFIRKLLLADPNTRMTIHQA 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-51
 Identities = 62/275 (22%), Positives = 104/275 (37%), Gaps = 27/275 (9%)

Query: 767  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKN 824
             +++    +G G +G V  A         AVK +            + E+       H+N
Sbjct: 5    EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 825  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
            +V   G+ R GN + L   Y   G L   +      D  +      +       G+ YLH
Sbjct: 65   VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYS 943
                  I HRD+K  N+LLDE+    ++DFGL+ + R  +   +   + GTL Y+ PE  
Sbjct: 121  ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 944  QTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002
            +         DV+S G+VL  +L G                    Q     +E       
Sbjct: 178  KRREFHAEPVDVWSCGIVLTAMLAGEL---------------PWDQPSDSCQEYSDWKEK 222

Query: 1003 IWHKDREKQL-LEMLEIACKCIDQDPRRRPFIEEV 1036
              + +  K++    L +  K + ++P  R  I ++
Sbjct: 223  KTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 6e-51
 Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 32/291 (10%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSR 819
                 +  +G G FG+VY+            T+ A+K ++      ER EF  E   +  
Sbjct: 20   EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIA 873
                ++V L G    G   L+I   M  G L  +L        +    +       +++A
Sbjct: 80   FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 874  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLV 932
               A G+AYL        VHRD+ + N ++ E F   + DFG++R +   D        +
Sbjct: 140  GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 933  GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 992
              + ++ PE  +    T   DV+SFGVVL E+ T                    +Q  S 
Sbjct: 197  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---------------PYQGLSN 241

Query: 993  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
            ++ +  +         +     + E+   C   +P+ RP   E+++ +   
Sbjct: 242  EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 7e-51
 Identities = 62/275 (22%), Positives = 95/275 (34%), Gaps = 27/275 (9%)

Query: 774  IIGCGGFGLVYKATLTN----GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 828
             IG G FG V++    +        A+K          RE F  E   + +  H ++V L
Sbjct: 14   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 829  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 888
             G     N   +I      G L  +L         L     +  A   +  LAYL     
Sbjct: 74   IGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE---S 126

Query: 889  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA 948
               VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE       
Sbjct: 127  KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 949  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1008
            T   DV+ FGV + E+L         +G    D++  +   +                  
Sbjct: 187  TSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPMPPNCPP-------- 236

Query: 1009 EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
                  +  +  KC   DP RRP   E+   L  I
Sbjct: 237  -----TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 6e-50
 Identities = 61/284 (21%), Positives = 99/284 (34%), Gaps = 32/284 (11%)

Query: 767  NNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC---GQMEREFQAEVEALSR 819
             +      +G G FG+V +             AVK L  D     +   +F  EV A+  
Sbjct: 8    KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
              H+NL+ L G       ++ +      GSL   L                + A   A G
Sbjct: 68   LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEG 123

Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGY 937
            + YL        +HRD+ + N+LL  +    + DFGL R L   D H  +         +
Sbjct: 124  MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 997
              PE  +T T +   D + FGV L E+ T  +                 +   +  + + 
Sbjct: 181  CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILH 225

Query: 998  IIDASIWHKDREKQL-LEMLEIACKCIDQDPRRRPFIEEVVTWL 1040
             ID       R +    ++  +  +C    P  RP    +  +L
Sbjct: 226  KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (448), Expect = 2e-49
 Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 26/273 (9%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG+V++      G     K ++      +   + E+  +++  H  L++L     
Sbjct: 37   LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
               + +LI  ++  G L   +     +D  +     +   + A  GL ++H   E  IVH
Sbjct: 97   DKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSIVH 150

Query: 894  RDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
             D+K  NI+ + K  +   + DFGL+  L P +    T    T  +  PE          
Sbjct: 151  LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVGFY 208

Query: 952  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1011
             D+++ GV+   LL+G  P     G++  + +  V +   E  E      S         
Sbjct: 209  TDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVKRCDWEFDEDAFSSVS--------- 256

Query: 1012 LLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042
              E  +     + ++PR+R  + + +   WL G
Sbjct: 257  -PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 9e-49
 Identities = 69/300 (23%), Positives = 115/300 (38%), Gaps = 41/300 (13%)

Query: 767  NNFNQANIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDCGQME-REFQAEVEAL 817
            +       +G G FG V  A             TK AVK L  D  + +  +  +E+E +
Sbjct: 13   DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 818  SR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH------------ESVDKDSVL 864
                +HKN+++L G C       +I  Y   G+L  +L              S + +  L
Sbjct: 73   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 865  KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 924
                 +  A   ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D
Sbjct: 133  SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 925  THVTTDL-VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 983
             +  T      + ++ PE       T + DV+SFGV+L E+ T                 
Sbjct: 190  YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236

Query: 984  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               +     +   +++              E+  +   C    P +RP  +++V  LD I
Sbjct: 237  --PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 4e-48
 Identities = 63/283 (22%), Positives = 103/283 (36%), Gaps = 29/283 (10%)

Query: 764  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG---QMEREFQAEVEALSR 819
            K   +F    I+G G F  V  A  L    + A+K L                E + +SR
Sbjct: 5    KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 820  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 879
              H   V L    +         SY +NG L  ++     K                   
Sbjct: 65   LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSA 120

Query: 880  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYI 938
            L YLH      I+HRD+K  NILL+E     + DFG +++L P          VGT  Y+
Sbjct: 121  LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 939  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
             PE     +A    D+++ G ++ +L+ G  P       N   +   + +++ +      
Sbjct: 178  SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEYLIFQKIIKLEYD------ 228

Query: 999  IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
                 +   + + L+E      K +  D  +R   EE+  +  
Sbjct: 229  FPEKFF--PKARDLVE------KLLVLDATKRLGCEEMEGYGP 263

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-46
 Identities = 67/299 (22%), Positives = 110/299 (36%), Gaps = 39/299 (13%)

Query: 767  NNFNQANIIGCGGFGLVYKAT------LTNGTKAAVKRLSGDCGQME-REFQAEVEALSR 819
            +       +G G FG V +A              AVK L       E R   +E++ L  
Sbjct: 13   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 820  -AQHKNLVSLQGYCRHGNDRLLI-YSYMENGSLDYWLH------------ESVDKDSVLK 865
               H N+V+L G C      L++   + + G+L  +L                     L 
Sbjct: 73   IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 866  WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 925
             +  +  +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R +     
Sbjct: 133  LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 926  HV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 984
            +V   D    L ++ PE       T + DV+SFGV+L E+ +               +  
Sbjct: 190  YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDE 244

Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043
               +   E   +   D +           EM +    C   +P +RP   E+V  L  +
Sbjct: 245  EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (418), Expect = 3e-46
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 30/276 (10%)

Query: 766  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 821
            ++ +    I+G GG   V+ A  L      AVK L  D  +       F+ E +  +   
Sbjct: 6    SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 822  HKNLVSLQGYCRH----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
            H  +V++          G    ++  Y++  +L   +H     +  +     +++   A 
Sbjct: 66   HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121

Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTL 935
            + L +     +  I+HRDVK +NI++       + DFG++R +      V  T  ++GT 
Sbjct: 122  QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 936  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 995
             Y+ PE ++  +   R DVYS G VL E+LTG  P     G +   +     +       
Sbjct: 179  QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAYQHVRE------ 229

Query: 996  VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031
             + I  S  H+     L  ++    K + ++P  R 
Sbjct: 230  -DPIPPSARHEGLSADLDAVVL---KALAKNPENRY 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 6e-46
 Identities = 47/265 (17%), Positives = 104/265 (39%), Gaps = 25/265 (9%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G FG+V++    ++      K +    G  +   + E+  L+ A+H+N++ L     
Sbjct: 13   LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 834  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 893
               + ++I+ ++    +   ++ S  +   L     +         L +LH     +I H
Sbjct: 72   SMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLH---SHNIGH 125

Query: 894  RDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
             D++  NI+   +  +   + +FG +R L+P D            Y  PE  Q    +  
Sbjct: 126  FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTA 183

Query: 952  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1011
             D++S G ++  LL+G  P      +  + ++  +   +    E    + SI        
Sbjct: 184  TDMWSLGTLVYVLLSGINPFL---AETNQQIIENIMNAEYTFDEEAFKEISI-------- 232

Query: 1012 LLEMLEIACKCIDQDPRRRPFIEEV 1036
              E ++   + + ++ + R    E 
Sbjct: 233  --EAMDFVDRLLVKERKSRMTASEA 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 8e-46
 Identities = 56/273 (20%), Positives = 100/273 (36%), Gaps = 21/273 (7%)

Query: 766  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHK 823
             + ++  +++G G F  V  A         A+K ++    +  E   + E+  L + +H 
Sbjct: 8    RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 824  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
            N+V+L      G    LI   +  G L   +     +          ++       + YL
Sbjct: 68   NIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYL 123

Query: 884  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
            H +   H   +        LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 124  HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 181

Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
                 +   D +S GV+   LL G  P      +N   L   + + + E       D S 
Sbjct: 182  AQKPYSKAVDCWSIGVIAYILLCGYPPFY---DENDAKLFEQILKAEYEFDSPYWDDIS- 237

Query: 1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                         +     +++DP +R   E+ 
Sbjct: 238  ---------DSAKDFIRHLMEKDPEKRFTCEQA 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  163 bits (414), Expect = 1e-44
 Identities = 67/277 (24%), Positives = 102/277 (36%), Gaps = 36/277 (12%)

Query: 765  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQME------REFQAEVEAL 817
            + N+F+   IIG GGFG VY       G   A+K L     +M+         +  +  +
Sbjct: 2    TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 818  SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
            S      +V +       +    I   M  G L Y L     +  V         A    
Sbjct: 62   STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEII 117

Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
             GL ++H      +V+RD+K +NILLDE     ++D GL+        H +    GT GY
Sbjct: 118  LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGY 171

Query: 938  IPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 996
            + PE  Q   A     D +S G +L +LL G  P                F+    K + 
Sbjct: 172  MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----------------FRQHKTKDKH 215

Query: 997  EIIDASIWHKDREKQLL--EMLEIACKCIDQDPRRRP 1031
            EI   ++            E+  +    + +D  RR 
Sbjct: 216  EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 252

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  160 bits (406), Expect = 1e-44
 Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 39/286 (13%)

Query: 768  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG---------QMEREFQAEVEAL 817
            N+    I+G G   +V +        + AVK +    G         ++      EV+ L
Sbjct: 4    NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 818  SRAQ-HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 876
             +   H N++ L+          L++  M+ G L  +L     +   L      KI +  
Sbjct: 64   RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119

Query: 877  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 936
               +  LH   + +IVHRD+K  NILLD+     L DFG S  L P       ++ GT  
Sbjct: 120  LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPS 174

Query: 937  YIPPEYSQTLTA------TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 990
            Y+ PE  +              D++S GV++  LL G  P      +    ++  +    
Sbjct: 175  YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---FWHRKQMLMLRMIMSGN 231

Query: 991  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
             +    E  D S            + ++  + +   P++R   EE 
Sbjct: 232  YQFGSPEWDDYS----------DTVKDLVSRFLVVQPQKRYTAEEA 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 4e-44
 Identities = 60/301 (19%), Positives = 106/301 (35%), Gaps = 26/301 (8%)

Query: 764  KSTNNFNQANIIGCGGFGLVYKAT--LTNGTKAAVKRLSGDCGQ--MEREFQAEVE---A 816
            ++   +     IG G +G V+KA      G   A+KR+    G+  M      EV     
Sbjct: 4    RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 817  LSRAQHKNLVSLQGYCRHG--NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 874
            L   +H N+V L   C     +    +    E+   D   +     +  +  +    +  
Sbjct: 64   LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 875  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 934
               RGL +LH      +VHRD+K  NIL+    +  LADFGL+R+        +   V T
Sbjct: 124  QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VVT 178

Query: 935  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP----------VEVCKGKNCRDLVS 984
            L Y  PE     +     D++S G +  E+   +             ++           
Sbjct: 179  LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 985  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042
            W   +   ++      A    K          ++  KC+  +P +R      ++  +   
Sbjct: 239  WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

Query: 1043 I 1043
            +
Sbjct: 299  L 299

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 9e-44
 Identities = 68/285 (23%), Positives = 103/285 (36%), Gaps = 33/285 (11%)

Query: 767  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMERE---FQAEVEALSRA-Q 821
             +F    ++G G FG V+ A         A+K L  D   M+ +      E   LS A +
Sbjct: 2    EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            H  L  +    +   +   +  Y+  G L Y +                  A     GL 
Sbjct: 62   HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQ 117

Query: 882  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 941
            +L       IV+RD+K  NILLD+     +ADFG+ +     D    T   GT  YI PE
Sbjct: 118  FL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173

Query: 942  YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001
                       D +SFGV+L E+L G+ P     G++  +L   +               
Sbjct: 174  ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMDNPFYPR------ 224

Query: 1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT---WLDGI 1043
              W +   K LL       K   ++P +R  +   +        I
Sbjct: 225  --WLEKEAKDLLV------KLFVREPEKRLGVRGDIRQHPLFREI 261

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-43
 Identities = 63/290 (21%), Positives = 119/290 (41%), Gaps = 23/290 (7%)

Query: 766  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHK 823
               +   + IG G +G+V  A    N  + A+K++S    Q   +    E++ L R +H+
Sbjct: 7    GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 824  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
            N++ +    R      +   Y+    +   L++ + K   L  D          RGL Y+
Sbjct: 67   NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 884  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGYIPPE 941
            H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y  PE
Sbjct: 126  H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 942  YSQTLTATCR-GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
                     +  D++S G +L E+L+ R         +  + +  +    S++    II+
Sbjct: 183  IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 1001 ASIWHKDREKQLL--------------EMLEIACKCIDQDPRRRPFIEEV 1036
                +                      + L++  K +  +P +R  +E+ 
Sbjct: 243  LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 4e-43
 Identities = 57/293 (19%), Positives = 105/293 (35%), Gaps = 23/293 (7%)

Query: 768  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKN 824
            NF +   IG G +G+VYKA     G   A+K++  D     +      E+  L    H N
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 825  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
            +V L       N   L++ ++      +    ++     +   +         +GLA+  
Sbjct: 63   IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC- 118

Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
                  ++HRD+K  N+L++ +    LADFGL+R         T ++V      P     
Sbjct: 119  --HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 945  TLTATCRGDVYSFGVVLLELLTGRRP----------VEVCKGKNCRDLVSW--VFQMKSE 992
                +   D++S G +  E++T R              + +     D V W  V  M   
Sbjct: 177  CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 993  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043
            K          + K       +   +  + +  DP +R   +  +   +   +
Sbjct: 237  KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 5e-43
 Identities = 57/289 (19%), Positives = 94/289 (32%), Gaps = 27/289 (9%)

Query: 763  LKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 821
            L+  N +     IG G FG +Y  T +  G + A+K           +   E +     Q
Sbjct: 3    LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQ 60

Query: 822  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
                +    +C    D  ++   +   SL+   +    K         L +A      + 
Sbjct: 61   GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIE 117

Query: 882  YLHKVCEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHV------TTDLV 932
            Y+H     + +HRDVK  N L     +    ++ DFGL++  R   TH         +L 
Sbjct: 118  YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 933  GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 992
            GT  Y        +  + R D+ S G VL+    G  P +  K           ++  SE
Sbjct: 175  GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISE 230

Query: 993  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
            K+    I+             E       C       +P    +     
Sbjct: 231  KKMSTPIEVLCKGYPS-----EFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (395), Expect = 9e-43
 Identities = 67/290 (23%), Positives = 108/290 (37%), Gaps = 39/290 (13%)

Query: 765  STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRA 820
            S  +F     +G G FG V+      NG   A+K L  +     +       E   LS  
Sbjct: 2    SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 821  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
             H  ++ + G  +      +I  Y+E G L   L +S    + +      ++        
Sbjct: 62   THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------- 114

Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
              L  +    I++RD+K  NILLD+     + DFG ++ +      VT  L GT  YI P
Sbjct: 115  LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAP 170

Query: 941  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
            E   T       D +SFG+++ E+L G  P       N       +  + +E R     +
Sbjct: 171  EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY---DSNTMKTYEKI--LNAELRFPPFFN 225

Query: 1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRR-----PFIEEVVT--WLDGI 1043
              +      K LL       + I +D  +R        E+V    W   +
Sbjct: 226  EDV------KDLLS------RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 2e-42
 Identities = 65/285 (22%), Positives = 106/285 (37%), Gaps = 32/285 (11%)

Query: 773  NIIGCGGFGLVYKATLTN-GTKAAVKRL-----SGDCGQMEREFQAEVEALSRAQHKNLV 826
            + +G G F  VYKA   N     A+K++     S     + R    E++ L    H N++
Sbjct: 4    DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 827  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 886
             L     H ++  L++ +ME            D   VL             +GL YLH  
Sbjct: 64   GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117

Query: 887  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 946
             +  I+HRD+K +N+LLDE     LADFGL++          T  V T  Y  PE     
Sbjct: 118  -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGA 175

Query: 947  TA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005
                   D+++ G +L ELL     +    G +  D ++ +F+      E +  D     
Sbjct: 176  RMYGVGVDMWAVGCILAELLLRVPFL---PGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 1006 KDREKQLL--------------EMLEIACKCIDQDPRRRPFIEEV 1036
                 +                ++L++       +P  R    + 
Sbjct: 233  DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  154 bits (390), Expect = 2e-42
 Identities = 53/284 (18%), Positives = 108/284 (38%), Gaps = 21/284 (7%)

Query: 767  NNFNQANIIGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKN 824
              ++    IG G +G+VYKA    G   A+K  RL  +   +      E+  L   +H N
Sbjct: 2    EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 825  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
            +V L          +L++ +++              +  L+             G+AY H
Sbjct: 62   IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
               +  ++HRD+K  N+L++ + E  +ADFGL+R         T ++V      P     
Sbjct: 118  ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 945  TLTATCRGDVYSFGVVLLELLTGRRP----------VEVCKGKNCRDLVSW--VFQMKSE 992
            +   +   D++S G +  E++ G             + + +     +  +W  V ++   
Sbjct: 175  SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 993  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
                 + +   W    +      +++  K +  DP +R   ++ 
Sbjct: 235  DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 6e-42
 Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 31/298 (10%)

Query: 768  NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 826
            ++    +IG G FG+VY+A L  +G   A+K++  D    +R    E++ + +  H N+V
Sbjct: 21   SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76

Query: 827  SLQGYCRHGNDR------LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
             L+ +     ++       L+  Y+         H S  K + L             R L
Sbjct: 77   RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRSL 135

Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAH-LADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
            AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+  +       P
Sbjct: 136  AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191

Query: 940  PEYSQTLTATCRGDVYSFGVVLLELLTGRRP------------VEVCKGKNCRDLVSWVF 987
                     T   DV+S G VL ELL G+              +    G   R+ +  + 
Sbjct: 192  ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 988  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043
               +E +  +I         R +   E + +  + ++  P  R    E     + D +
Sbjct: 252  PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-41
 Identities = 62/297 (20%), Positives = 116/297 (39%), Gaps = 44/297 (14%)

Query: 769  FNQANI---------IGCGGFGLVYKAT-LTNGTKAAVKRL------SGDCGQMEREFQA 812
            F Q N+         +G G F +V K    + G + A K +      S   G    + + 
Sbjct: 3    FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 813  EVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
            EV  L   QH N+++L     +  D +LI   +  G     L + + +   L  +   + 
Sbjct: 63   EVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEF 118

Query: 873  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVT 928
             +    G+   + +    I H D+K  NI+L +    K    + DFGL+  +     +  
Sbjct: 119  LKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEF 173

Query: 929  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 988
             ++ GT  ++ PE           D++S GV+   LL+G  P     G   ++ ++ V  
Sbjct: 174  KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSA 230

Query: 989  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043
            +  E  +    + S   KD             + + +DP++R  I++ +   W+   
Sbjct: 231  VNYEFEDEYFSNTSALAKD----------FIRRLLVKDPKKRMTIQDSLQHPWIKPK 277

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (378), Expect = 1e-40
 Identities = 43/288 (14%), Positives = 89/288 (30%), Gaps = 31/288 (10%)

Query: 767  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH-KN 824
             ++     IG G FG++++ T L N  + A+K           + + E            
Sbjct: 5    VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62

Query: 825  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
            + ++  + + G   +L+   +     D                     A+     +  +H
Sbjct: 63   IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 885  KVCEPHIVHRDVKSSNILLDEKFEAH-----LADFGLSRLLRPYDTHV------TTDLVG 933
               E  +V+RD+K  N L+      +     + DFG+ +  R   T          +L G
Sbjct: 119  ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 934  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 993
            T  Y+          + R D+ + G V +  L G  P    +G           ++  +K
Sbjct: 176  TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP---WQGLKAATNKQKYERIGEKK 232

Query: 994  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041
            +   +       +       E  +      +      P  + +     
Sbjct: 233  QSTPL------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 7e-40
 Identities = 60/283 (21%), Positives = 103/283 (36%), Gaps = 45/283 (15%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE------FQAEVEALSRAQ--HKN 824
            ++G GGFG VY    +++    A+K +  D      E         EV  L +       
Sbjct: 11   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 825  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 884
            ++ L  +    +  +LI    E     +     + +   L+ ++           + +  
Sbjct: 71   VIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVLEAVRHC- 126

Query: 885  KVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
                  ++HRD+K  NIL+D  + E  L DFG   LL+     V TD  GT  Y PPE+ 
Sbjct: 127  --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWI 181

Query: 944  QTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002
            +      R   V+S G++L +++ G  P                F+   E    ++    
Sbjct: 182  RYHRYHGRSAAVWSLGILLYDMVCGDIP----------------FEHDEEIIRGQVFFRQ 225

Query: 1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043
                       E   +   C+   P  RP  EE+    W+  +
Sbjct: 226  RVSS-------ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 4e-39
 Identities = 57/272 (20%), Positives = 103/272 (37%), Gaps = 30/272 (11%)

Query: 774  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGY 831
            ++G G  G V +        K A+K L     Q   + + EVE   RA Q  ++V +   
Sbjct: 19   VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 832  CRH----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 887
              +        L++   ++ G L   + +    D         +I +     + YLH + 
Sbjct: 74   YENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI- 130

Query: 888  EPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 944
              +I HRDVK  N+L   K       L DFG ++    +++  T     T  Y+ PE   
Sbjct: 131  --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLG 186

Query: 945  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004
                    D++S GV++  LL G  P            ++    MK+  R  +    +  
Sbjct: 187  PEKYDKSCDMWSLGVIMYILLCGYPPFY------SNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
              +  +++  ++      +  +P +R  I E 
Sbjct: 241  WSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-37
 Identities = 54/288 (18%), Positives = 103/288 (35%), Gaps = 27/288 (9%)

Query: 767  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHK 823
              + +   IG G +G V+KA         A+K  RL  D   +      E+  L   +HK
Sbjct: 2    QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 824  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 883
            N+V L           L++ + +              +  L  ++         +GL + 
Sbjct: 62   NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 884  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 943
            H     +++HRD+K  N+L++   E  LA+FGL+R         + ++V      P    
Sbjct: 118  HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 944  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003
                 +   D++S G +  EL    RP+    G +  D +  +F++     E +    + 
Sbjct: 175  GAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 1004 WHKDREKQLL---------------EMLEIACKCIDQDPRRRPFIEEV 1036
                +   +                   ++    +  +P +R   EE 
Sbjct: 233  LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 1e-37
 Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 37/303 (12%)

Query: 764  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRA 820
               + + +   IG G FG V+KA     G K A+K++    +          E++ L   
Sbjct: 7    DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 821  QHKNLVSLQGYC--------RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 872
            +H+N+V+L   C        R      L++ + E+       +  V            ++
Sbjct: 67   KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRV 122

Query: 873  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT---HVTT 929
             Q    GL Y+       I+HRD+K++N+L+       LADFGL+R          +  T
Sbjct: 123  MQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 930  DLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVE--------VCKGKNCR 980
            + V TL Y PPE            D++  G ++ E+ T    ++            + C 
Sbjct: 180  NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 981  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLL-------EMLEIACKCIDQDPRRRPFI 1033
             +   V+         E ++     K + K  L         L++  K +  DP +R   
Sbjct: 240  SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 1034 EEV 1036
            ++ 
Sbjct: 300  DDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-37
 Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 33/273 (12%)

Query: 765  STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE---FQAEVEALSRA 820
            + N+F+   ++G G FG V        G   A+K L  +    + E      E   L   
Sbjct: 3    TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 821  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
            +H  L +L+   +  +    +  Y   G L + L     ++ V   +         A  +
Sbjct: 63   RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYG---AEIV 115

Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 940
            + L  +    +V+RD+K  N++LD+     + DFGL +              GT  Y+ P
Sbjct: 116  SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAP 174

Query: 941  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000
            E  +        D +  GVV+ E++ GR P                F  +  +R  E+I 
Sbjct: 175  EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELIL 218

Query: 1001 ASIWHKDRE--KQLLEMLEIACKCIDQDPRRRP 1031
                   R    +   +L      + +DP++R 
Sbjct: 219  MEEIRFPRTLSPEAKSLLA---GLLKKDPKQRL 248

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-37
 Identities = 56/291 (19%), Positives = 108/291 (37%), Gaps = 31/291 (10%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGY 831
            +G G +G V  A     G K A+K+L          +    E+  L   +H+N++ L   
Sbjct: 26   VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85

Query: 832  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 891
                        +             + K   L  D    +     +GL Y+H      I
Sbjct: 86   FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGI 142

Query: 892  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 951
            +HRD+K  N+ ++E  E  + DFGL+R     D+ +T  +V      P      +  T  
Sbjct: 143  IHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYTQT 199

Query: 952  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ------------MKSEKREVEII 999
             D++S G ++ E++TG+      KG +  D +  + +            ++S++ +  + 
Sbjct: 200  VDIWSVGCIMAEMITGKTL---FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 1000 DASIWHKDREKQLL-----EMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1043
                  K     +L       + +  K +  D  +R    E +   + + +
Sbjct: 257  GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (339), Expect = 5e-35
 Identities = 45/279 (16%), Positives = 96/279 (34%), Gaps = 28/279 (10%)

Query: 767  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE---FQAEVEALSRAQH 822
            + F++   +G G FG V       +G   A+K L        ++      E   L     
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 823  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
              LV L+   +  ++  ++  Y+  G +   L     +            A        Y
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEY 156

Query: 883  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
            LH +    +++RD+K  N+L+D++    + DFG ++ ++     +     GT   + PE 
Sbjct: 157  LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEI 209

Query: 943  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK-----REVE 997
              +       D ++ GV++ E+  G  P           +   +   K         +++
Sbjct: 210  ILSKGYNKAVDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 998  IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1036
             +  ++   D  K+   +          D +   +    
Sbjct: 267  DLLRNLLQVDLTKRFGNLKNGV-----NDIKNHKWFATT 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  131 bits (331), Expect = 4e-34
 Identities = 53/301 (17%), Positives = 106/301 (35%), Gaps = 46/301 (15%)

Query: 765  STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQH 822
            + +++     +G G +  V++A  +TN  K  VK L       +++ + E++ L      
Sbjct: 33   NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGG 89

Query: 823  KNLVSLQGYCRHGNDRL--LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 880
             N+++L    +    R   L++ ++ N                L             + L
Sbjct: 90   PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKAL 142

Query: 881  AYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 939
             Y H +    I+HRDVK  N+++D +  +  L D+GL+    P   +     V +  +  
Sbjct: 143  DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKG 197

Query: 940  PEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 998
            PE            D++S G +L  ++  + P     G +  D +  + ++   +   + 
Sbjct: 198  PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDY 255

Query: 999  IDASIWHKDREKQLL-----------------------EMLEIACKCIDQDPRRRPFIEE 1035
            ID      D     +                       E L+   K +  D + R    E
Sbjct: 256  IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315

Query: 1036 V 1036
             
Sbjct: 316  A 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 6e-34
 Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 31/278 (11%)

Query: 765  STNNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLS----GDCGQMEREFQAEVEA 816
               NF    ++G G +G V+          G   A+K L         +     + E + 
Sbjct: 22   GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81

Query: 817  LSRAQHK-NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 875
            L   +    LV+L    +      LI  Y+  G L   L +   ++   + +V++ + + 
Sbjct: 82   LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEI 138

Query: 876  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 935
                +  L  + +  I++RD+K  NILLD      L DFGLS+     +T    D  GT+
Sbjct: 139  ----VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 936  GYIPPE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 993
             Y+ P+             D +S GV++ ELLTG  P         ++  + + +   + 
Sbjct: 195  EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRRILKS 251

Query: 994  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1031
                  + S              ++  + + +DP++R 
Sbjct: 252  EPPYPQEMS----------ALAKDLIQRLLMKDPKKRL 279

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 1e-32
 Identities = 60/291 (20%), Positives = 103/291 (35%), Gaps = 29/291 (9%)

Query: 766  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQH 822
               +   + +G G +G V  A     G + AVK+LS         +    E+  L   +H
Sbjct: 17   PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 823  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
            +N++ L                     L      ++ K   L  D    +     RGL Y
Sbjct: 77   ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 883  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 942
            +H      I+HRD+K SN+ ++E  E  + DFGL+   R  D  +T  +       P   
Sbjct: 137  IH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 190

Query: 943  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ------------MK 990
               +      D++S G ++ ELLTGR       G +  D +  + +            + 
Sbjct: 191  LNWMHYNQTVDIWSVGCIMAELLTGRTL---FPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 991  SEKREVEIIDASIWHKDREKQLL-----EMLEIACKCIDQDPRRRPFIEEV 1036
            SE     I   +   K     +        +++  K +  D  +R    + 
Sbjct: 248  SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-29
 Identities = 57/304 (18%), Positives = 103/304 (33%), Gaps = 46/304 (15%)

Query: 767  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHK 823
              +     IG G  G+V  A         A+K+LS         +    E+  +    HK
Sbjct: 17   KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 824  NLVSLQGYCRH------GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 877
            N++SL              D  L+   M+         E          +    +     
Sbjct: 77   NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQML 129

Query: 878  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 937
             G+ +LH      I+HRD+K SNI++       + DFGL+R      + + T  V T  Y
Sbjct: 130  CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 184

Query: 938  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSWVF 987
              PE    +      D++S G ++ E++  +             +V +            
Sbjct: 185  RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 988  QMKSEKREVE------------IIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPF 1032
               + +  VE            +   S++  D E   L   +  ++  K +  DP +R  
Sbjct: 245  LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 1033 IEEV 1036
            +++ 
Sbjct: 305  VDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (285), Expect = 6e-28
 Identities = 55/311 (17%), Positives = 100/311 (32%), Gaps = 55/311 (17%)

Query: 775  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 833
            +G G F  V+ A  + N T  A+K + GD    E   + E++ L R    +         
Sbjct: 21   LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMGA 79

Query: 834  HGNDRLLIYSY------------MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 881
            +   +LL +               E    +        +   +      +I++    GL 
Sbjct: 80   NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 882  YLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLV-GTLGYIP 939
            Y+H      I+H D+K  N+L++      +L    ++ L               T  Y  
Sbjct: 140  YMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 940  PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM---------- 989
            PE        C  D++S   ++ EL+TG    E  +G +       + Q+          
Sbjct: 198  PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257

Query: 990  ------------------------KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQ 1025
                                    K    E  + +   + KD  K++ + L      +  
Sbjct: 258  LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS---PMLQL 314

Query: 1026 DPRRRPFIEEV 1036
            DPR+R     +
Sbjct: 315  DPRKRADAGGL 325

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  100 bits (249), Expect = 1e-23
 Identities = 75/312 (24%), Positives = 121/312 (38%), Gaps = 12/312 (3%)

Query: 32  QSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQ--WDGVVCGHGSTGSNAGRVTMLIL 89
           + C+P D  AL +   +L N + ++SW   + CC   W GV+C    T +   RV  L L
Sbjct: 1   ELCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLC---DTDTQTYRVNNLDL 57

Query: 90  PRKGLKGI--IPRSLGHLNQLKLLDLS-CNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 146
               L     IP SL +L  L  L +   N+L G +P  ++ L QL  L ++H  +SG +
Sbjct: 58  SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117

Query: 147 SGMLAGLNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQ 205
              L+ +  + +L+ S N+ +G+L   +    NL       N  +G +     S SK   
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177

Query: 206 ILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL 265
            + +S N   G +     + +       +  +       L+             N     
Sbjct: 178 SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 266 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 325
             K+    +L  L +  N+  G LP  L  L  L       N+  G +P       +  V
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDV 295

Query: 326 LDLRNNS-LTGP 336
               NN  L G 
Sbjct: 296 SAYANNKCLCGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 89.0 bits (219), Expect = 1e-19
 Identities = 65/281 (23%), Positives = 102/281 (36%), Gaps = 16/281 (5%)

Query: 390 GKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN-FVGEEIPENVGGFESLMVL 448
            +   +  L LS  +        S L     L  L +     +   IP  +     L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 449 ALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 508
            + +  + G IP +L + K L  LD S+N   G +PP I  + NL  + F  N ++G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 509 KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGT 568
            S      L +S   S N                  G      ++   +    +  +   
Sbjct: 167 DSYGSFSKLFTSMTISRN---------------RLTGKIPPTFANLNLAFVDLSRNMLEG 211

Query: 569 IPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLS 628
               +              N        +   +NL  LDL +N ++G++P    +L FL 
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 629 KFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPC 669
             +V+ N+L G IP GG    F  S++  N  LCG     C
Sbjct: 272 SLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 58.2 bits (139), Expect = 1e-09
 Identities = 56/253 (22%), Positives = 91/253 (35%), Gaps = 30/253 (11%)

Query: 204 IQILDLSMNHFMGSLQGLDHSPSLKQLHV----DNNLLGGDLPDSLYSMSSLQHVSLSVN 259
           +  LDLS  +            +L  L+       N L G +P ++  ++ L ++ ++  
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 260 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL 319
           N SG + + +S + +L  L    N  SG LP  + +L  L       N  SG +P S   
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 320 CSKLHV-LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI----- 373
            SKL   + +  N LTG I   F+ L+                    SD +  KI     
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231

Query: 374 -----------------LSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQ 416
                            L L  N + G +P+   +L  L  L++S    N+L G +    
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF---NNLCGEIPQGG 288

Query: 417 QCKNLTTLILTKN 429
             +         N
Sbjct: 289 NLQRFDVSAYANN 301

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 55.1 bits (131), Expect = 2e-08
 Identities = 55/265 (20%), Positives = 95/265 (35%), Gaps = 7/265 (2%)

Query: 223 HSPSLKQLHVDNNLLGGD--LPDSLYSMSSLQHVSLSVN-NFSGQLSEKISNLTSLRHLI 279
            +  +  L +    L     +P SL ++  L  + +    N  G +   I+ LT L +L 
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107

Query: 280 IFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL 339
           I     SG +P+ L  +  L       N+ SG LP S+S    L  +    N ++G I  
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 340 NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLS 399
           ++   S L T   +       L   +        L+      +    ++     S     
Sbjct: 168 SYGSFSKLFT---SMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 400 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHI 459
             + + N L+  L  +   KNL  L L  N +   +P+ +   + L  L +    L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 460 PVWLLRCKKLQVLDLSWNHFDGNIP 484
           P      ++  V   + N      P
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.5 bits (236), Expect = 2e-21
 Identities = 70/382 (18%), Positives = 124/382 (32%), Gaps = 33/382 (8%)

Query: 270 SNLTSLRHLIIFGNQFSGKLP-NVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDL 328
           + L      ++     +  +    L  +T L+       S  G     +   + L  ++ 
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73

Query: 329 RNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN----SLSDCHDLKILSLAKNELSGQ 384
            NN LT         L+ L  + +  N  +   P     +L+            + L   
Sbjct: 74  SNNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 385 VPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV----- 439
              +  +L+S     +S  S       LS   Q  +L  L         +I  N      
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 440 --GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLD 497
                 +L  L   N  +    P+ +     L  L L+ N         +  + NL  LD
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 498 FSNNTLTGEIP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP 556
            +NN ++   P   LT+L  L       SN +  AG+        + N L      S   
Sbjct: 248 LANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 557 ---SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 613
               + L  N I+   P  +  L  L  L  + N ++    SS++ + N+  L    N +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363

Query: 614 HGSIPGSFEKLTFLSKFSVANN 635
               P     LT +++  + + 
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.4 bits (223), Expect = 1e-19
 Identities = 74/373 (19%), Positives = 128/373 (34%), Gaps = 48/373 (12%)

Query: 77  TGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLD 136
           + ++  +VT L   R G+K I    + +LN L  ++ S N L  + P  L NL +L  + 
Sbjct: 39  SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94

Query: 137 LSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSR 196
           +++N ++                N++  +   +     +              +  ++  
Sbjct: 95  MNNNQIADITPLA-------NLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI 147

Query: 197 IWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 256
              +           N         + +   +     N +    +   L ++ SL   + 
Sbjct: 148 SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATN- 206

Query: 257 SVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLS 316
             N  S      I   T+L  L + GNQ        L +LT L      +N  S   PLS
Sbjct: 207 --NQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 260

Query: 317 LSLCSKLHVLDLRNNSLTGPIDLN--------------------FSGLSSLCTLDLATNH 356
               +KL  L L  N ++    L                      S L +L  L L  N+
Sbjct: 261 G--LTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318

Query: 357 FSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQ 416
            S   P  +S    L+ L  A N++S     S   LT++ +LS  +N  + L+     L 
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP----LA 370

Query: 417 QCKNLTTLILTKN 429
               +T L L   
Sbjct: 371 NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.1 bits (222), Expect = 1e-19
 Identities = 80/423 (18%), Positives = 136/423 (32%), Gaps = 58/423 (13%)

Query: 79  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 138
           +        +L +  +   + ++   L+Q+  L      ++ +    +  L  L  ++ S
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFS 74

Query: 139 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 198
           +N L+                             +    NL        +     +    
Sbjct: 75  NNQLTD----------------------------ITPLKNLTKLVDILMNNNQIADITPL 106

Query: 199 SASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 258
           +    +  L L  N         + +   +     N +        + ++S L  +    
Sbjct: 107 ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTI------SDISALSGLTSLQQLS 160

Query: 259 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 318
                   + ++NLT+L  L I  N+ S         LT LE  +A +N  S   P  L 
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITP--LG 216

Query: 319 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
           + + L  L L  N L        + L++L  LDLA N  S   P  LS    L  L L  
Sbjct: 217 ILTNLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 438
           N++S   P     LT+L  L L+ N    +S         KNLT L L  N + +  P  
Sbjct: 273 NQISNISP--LAGLTALTNLELNENQLEDISPI----SNLKNLTYLTLYFNNISDISP-- 324

Query: 439 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 498
           V     L  L   N  +       L     +  L    N      P  +  +  +  L  
Sbjct: 325 VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380

Query: 499 SNN 501
           ++ 
Sbjct: 381 NDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 85.8 bits (211), Expect = 3e-18
 Identities = 82/457 (17%), Positives = 154/457 (33%), Gaps = 75/457 (16%)

Query: 156 IQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM 215
           + S  ++ ++    +F     +      +   + T  ++    +   ++  L       +
Sbjct: 1   LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQ---TDLDQVTTLQADRLG-I 56

Query: 216 GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 275
            S+ G+++  +L Q++  NN L    P  L +++ L  + ++ N  +           + 
Sbjct: 57  KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTG 114

Query: 276 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 335
             L          L N+    T L      SN+ S      +S  S L  L   +     
Sbjct: 115 LTLFNNQITDIDPLKNL----TNLNRLELSSNTIS-----DISALSGLTSLQQLSFGNQV 165

Query: 336 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 395
                 + L++L  LD+++N  S       +   +L+ L    N++S   P      T+L
Sbjct: 166 TDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGIL--TNL 221

Query: 396 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 455
             LSL+ N    +      L    NLT L L  N +    P  + G   L  L LG   +
Sbjct: 222 DELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 275

Query: 456 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP-KSLTEL 514
               P+  L            N         I  ++NL YL    N ++   P  SLT+L
Sbjct: 276 SNISPLAGLTALTNL----ELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKL 331

Query: 515 KSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIG 574
           + L                                         F +NN++  +    + 
Sbjct: 332 QRL-----------------------------------------FFANNKV--SDVSSLA 348

Query: 575 QLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 611
            L +++ L    N I+   P  ++ +  +  L L+  
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 75.8 bits (185), Expect = 5e-15
 Identities = 43/227 (18%), Positives = 80/227 (35%), Gaps = 15/227 (6%)

Query: 57  SWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCN 116
           +                  S  +    +  LI     +  I P     L  L  L L+ N
Sbjct: 172 ANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGN 229

Query: 117 HLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEF 176
            L+      L++L  L  LDL++N +S      L+GL  +  L + +N  +     +   
Sbjct: 230 QLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN----ISPL 281

Query: 177 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNL 236
           + L        +     +    S  K +  L L  N+    +  +     L++L   NN 
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFFANNK 340

Query: 237 LGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 283
           +      SL +++++  +S   N  S      ++NLT +  L +   
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.2 bits (134), Expect = 1e-08
 Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 6/114 (5%)

Query: 51  NGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKL 110
           +     +        + +       S  SN   +T L L    +  I P  +  L +L+ 
Sbjct: 276 SNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 333

Query: 111 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 164
           L  + N +       L+NL  +  L   HN +S      LA L  I  L ++  
Sbjct: 334 LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 55.0 bits (131), Expect = 3e-08
 Identities = 42/285 (14%), Positives = 90/285 (31%), Gaps = 17/285 (5%)

Query: 336 PIDLNF--SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLT 393
           PI+  F  + L+      L   + +  +  S +D   +  L   +  +     +    L 
Sbjct: 11  PINQIFTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLN 66

Query: 394 SLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNC 453
           +L  ++ SNN    ++         KNLT L+       +          + +       
Sbjct: 67  NLTQINFSNNQLTDITP-------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119

Query: 454 GLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTE 513
                I          ++   S    D +    +  ++ L + +   +        +L  
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 514 LKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEI 573
           L    +     S       +   +  N   + +      +    + L+ N++       +
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTL 237

Query: 574 GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 618
             L +L  LDL+ N I+   P  +S +  L  L L +N +    P
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.1 bits (108), Expect = 2e-05
 Identities = 46/250 (18%), Positives = 79/250 (31%), Gaps = 53/250 (21%)

Query: 441 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 500
                M   LG   +   +    L   ++  L         +I   +  + NL  ++FSN
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDL--DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75

Query: 501 NTLTGEIP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF 559
           N LT   P K+LT+L  ++ +N   ++ T  A +          N +          ++ 
Sbjct: 76  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 560 LSNNRIN--------------------------------------------GTIPPEIGQ 575
                 N                                             +    + +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 576 LKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 635
           L +L  L  + N I+   P  I  + NL+ L L+ N L     G+   LT L+   +ANN
Sbjct: 196 LTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251

Query: 636 HLQGTIPTGG 645
            +    P  G
Sbjct: 252 QISNLAPLSG 261

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 93.2 bits (230), Expect = 4e-21
 Identities = 55/288 (19%), Positives = 93/288 (32%), Gaps = 17/288 (5%)

Query: 323 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 382
             +LDL+NN +T   D +F  L +L TL L  N  S   P + +    L+ L L+KN+L 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 383 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 442
               +    L  L       N    +  ++        +  L                G 
Sbjct: 93  ELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 443 ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNT 502
           + L  + + +  +   IP  L     L  L L  N         +  + NL  L  S N+
Sbjct: 150 KKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 503 LTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSN 562
           ++     SL     L   +  ++      G     K+ +    L  N  S+   + F   
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVY-LHNNNISAIGSNDFCP- 264

Query: 563 NRINGTIPPEIGQLKHLHVLDLSRNNITGT--IPSSISEIRNLEVLDL 608
                  P    +      + L  N +      PS+   +     + L
Sbjct: 265 -------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.4 bits (215), Expect = 3e-19
 Identities = 49/268 (18%), Positives = 88/268 (32%), Gaps = 14/268 (5%)

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 332
                L +  N+ +        NL  L   +  +N  S   P + +   KL  L L  N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 333 LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL 392
           L    +     L  L   +         + N L+    +  L     + SG    +F  +
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGM 149

Query: 393 TSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGN 452
             L ++ +++ +   +   L       +LT L L  N + +    ++ G  +L  L L  
Sbjct: 150 KKLSYIRIADTNITTIPQGL-----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204

Query: 453 CGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG------E 506
             +       L     L+ L L+ N     +P  +   + +  +   NN ++        
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263

Query: 507 IPKSLTELKSLISSNCTSSNPTASAGIP 534
            P   T+  S  S     SNP     I 
Sbjct: 264 PPGYNTKKASY-SGVSLFSNPVQYWEIQ 290

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.6 bits (213), Expect = 6e-19
 Identities = 58/301 (19%), Positives = 103/301 (34%), Gaps = 18/301 (5%)

Query: 65  CQWDGVVCGHGSTGS----NAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 120
           C    V C                 +L L    +  I      +L  L  L L  N +  
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 121 VVPVELSNLKQLEVLDLSHNMLSG-PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNL 179
           + P   + L +LE L LS N L   P         L    N  +         L +   +
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129

Query: 180 AVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGG 239
            +      S   +  +  +   K++  + ++  +     QGL   PSL +LH+D N +  
Sbjct: 130 ELGTNPLKSSGIENGA--FQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITK 185

Query: 240 DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 299
               SL  +++L  + LS N+ S   +  ++N   LR L +  N+     P  L +   +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYI 244

Query: 300 EFFVAHSNSFSG------PLPLSLSLCSKLHVLDLRNNSLT--GPIDLNFSGLSSLCTLD 351
           +    H+N+ S         P   +  +    + L +N +         F  +     + 
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304

Query: 352 L 352
           L
Sbjct: 305 L 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.5 bits (197), Expect = 7e-17
 Identities = 48/258 (18%), Positives = 91/258 (35%), Gaps = 11/258 (4%)

Query: 177 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNN 235
            + A+ ++ NN  T  +    +   K +  L L  N       G       L++L++  N
Sbjct: 31  PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89

Query: 236 LLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGN 295
            L  +LP+ +        V  +      +      N   +  L     + SG        
Sbjct: 90  QLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148

Query: 296 LTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATN 355
           + +L +      + +    +   L   L  L L  N +T     +  GL++L  L L+ N
Sbjct: 149 MKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 356 HFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGT---- 411
             S     SL++   L+ L L  N+L  +VP        +  + L NN+ + +       
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 412 LSVLQQCKNLTTLILTKN 429
                +  + + + L  N
Sbjct: 265 PGYNTKKASYSGVSLFSN 282

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 75.1 bits (183), Expect = 5e-15
 Identities = 60/326 (18%), Positives = 100/326 (30%), Gaps = 57/326 (17%)

Query: 320 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
           C    V    +  L   P DL          LDL  N  +        +  +L  L L  
Sbjct: 10  CHLRVV-QCSDLGLEKVPKDLP----PDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 64

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 438
           N++S   P +F  L  L  L LS N    L   +   +  + L         V + +   
Sbjct: 65  NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNG 122

Query: 439 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 498
           +     +  L        G         KKL  + ++  +    IP  +    +L  L  
Sbjct: 123 LNQMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHL 178

Query: 499 SNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSV 558
             N +T     SL  L +L                                         
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGL------------------------------------ 202

Query: 559 FLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG--- 615
             S N I+      +    HL  L L+ N +   +P  +++ + ++V+ L +N++     
Sbjct: 203 --SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 259

Query: 616 ---SIPGSFEKLTFLSKFSVANNHLQ 638
                PG   K    S  S+ +N +Q
Sbjct: 260 NDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 73.5 bits (179), Expect = 2e-14
 Identities = 39/240 (16%), Positives = 68/240 (28%), Gaps = 20/240 (8%)

Query: 434 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 493
           ++P+++       +L L N  +           K L  L L  N      P     +  L
Sbjct: 24  KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 494 FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASS 553
             L  S N L     K    L+ L                    +  +    +       
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHEN---------------EITKVRKSVFNGLNQM 126

Query: 554 FPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 613
               +  +  + +G        +K L  + ++  NIT TIP  +    +L  L L  N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKI 183

Query: 614 HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMH 673
                 S + L  L+K  ++ N +                    N  L        D  +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.4 bits (132), Expect = 1e-08
 Identities = 22/117 (18%), Positives = 42/117 (35%), Gaps = 3/117 (2%)

Query: 557 SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 616
            V  S+  +   +P ++       +LDL  N IT         ++NL  L L +N +   
Sbjct: 14  VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70

Query: 617 IPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMH 673
            PG+F  L  L +  ++ N L+       +              +   + +  + M 
Sbjct: 71  SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.8 bits (107), Expect = 2e-05
 Identities = 44/253 (17%), Positives = 76/253 (30%), Gaps = 24/253 (9%)

Query: 6   FVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCC 65
           F P+  L+ L+L+      L    P +       L + E        S+    +   +  
Sbjct: 75  FAPLVKLERLYLSKNQLKEL----PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 66  QWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVE 125
                +   G        +  L   R     I     G    L  L L  N +  V    
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAAS 190

Query: 126 LSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNIS 185
           L  L  L  L LS N +S   +G LA    ++ L++++N        L +   + V  + 
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250

Query: 186 NNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLL--GGDLPD 243
           NN+ +                  +  N F           S   + + +N +      P 
Sbjct: 251 NNNISA-----------------IGSNDFCP-PGYNTKKASYSGVSLFSNPVQYWEIQPS 292

Query: 244 SLYSMSSLQHVSL 256
           +   +     V L
Sbjct: 293 TFRCVYVRAAVQL 305

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.6 bits (211), Expect = 1e-19
 Identities = 25/156 (16%), Positives = 46/156 (29%), Gaps = 21/156 (13%)

Query: 773 NIIGCGGFGLVYKATLTNGTKAAVKRLSGD----------CGQMEREFQAEVEALSRAQH 822
            ++G G    V+        +  VK                   +  F       +R + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 823 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 882
           + L  LQG           Y++  N  L   +         ++     ++       +A 
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVEN--PDEVLDMILEEVAK 118

Query: 883 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 918
            +      IVH D+   N+L+ E     + DF  S 
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (189), Expect = 6e-16
 Identities = 48/287 (16%), Positives = 91/287 (31%), Gaps = 30/287 (10%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           +P  +      + + L  N +  V        + L +L L  N                 
Sbjct: 26  VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSN----------------- 66

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
                              + L   ++S+N+    ++   +     +  L L        
Sbjct: 67  ------VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120

Query: 218 LQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLR 276
             G      +L+ L++ +N L     D+   + +L H+ L  N  S         L SL 
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180

Query: 277 HLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 336
            L++  N+ +   P+   +L +L      +N+ S     +L+    L  L L +N     
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240

Query: 337 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 383
                   + L     +++     LP  L       +  LA N+L G
Sbjct: 241 CRAR-PLWAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.6 bits (158), Expect = 4e-12
 Identities = 51/257 (19%), Positives = 86/257 (33%), Gaps = 7/257 (2%)

Query: 201 SKEIQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
               Q + L  N              +L  L + +N+L      +   ++ L+ + LS N
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 260 NFSGQL-SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 318
                +       L  L  L +         P +   L  L++     N+       +  
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 319 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
               L  L L  N ++   +  F GL SL  L L  N  +   P++  D   L  L L  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 438
           N LS    E+   L +L +L L++N +               L     + + V   +P+ 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWV---CDCRARPLWAWLQKFRGSSSEVPCSLPQR 267

Query: 439 VGG--FESLMVLALGNC 453
           + G   + L    L  C
Sbjct: 268 LAGRDLKRLAANDLQGC 284

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.2 bits (157), Expect = 6e-12
 Identities = 52/292 (17%), Positives = 85/292 (29%), Gaps = 43/292 (14%)

Query: 369 HDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK 428
              + + L  N +S     SF    +L  L L +N    +               L    
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS-DN 90

Query: 429 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 488
             +    P    G   L  L L  CGL+   P        LQ L L  N           
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 489 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 548
            + NL +L    N ++    ++   L SL                               
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL--------------------------- 183

Query: 549 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 608
                      L  NR+    P     L  L  L L  NN++     +++ +R L+ L L
Sbjct: 184 -----------LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232

Query: 609 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP---TGGQFYSFPNSSFEG 657
           + N        +     +L KF  +++ +  ++P    G        +  +G
Sbjct: 233 NDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (144), Expect = 3e-10
 Identities = 53/269 (19%), Positives = 80/269 (29%), Gaps = 33/269 (12%)

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 332
            + + + + GN+ S            L     HSN  +     + +  + L  LDL +N+
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 333 LTGPI-DLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGK 391
               +    F GL  L TL L         P        L+ L L  N L     ++F  
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 392 LTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALG 451
           L +L  L L  N  + +                                G  SL  L L 
Sbjct: 152 LGNLTHLFLHGNRISSV--------------------------PERAFRGLHSLDRLLLH 185

Query: 452 NCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP--- 508
              +    P       +L  L L  N+        +  +  L YL  ++N    +     
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP 245

Query: 509 --KSLTELKSLISSNCTSSNPTASAGIPL 535
               L +     SS    S P   AG  L
Sbjct: 246 LWAWLQKF-RGSSSEVPCSLPQRLAGRDL 273

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.8 bits (130), Expect = 2e-08
 Identities = 37/206 (17%), Positives = 68/206 (33%), Gaps = 3/206 (1%)

Query: 58  WSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNH 117
              +        +     +T    GR+  L L R GL+ + P     L  L+ L L  N 
Sbjct: 81  LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140

Query: 118 LEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFS 177
           L+ +      +L  L  L L  N +S        GL+ +  L +  N             
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 178 NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLL 237
              +      +    L +   +  + +Q L L+ N ++   +       L++    ++ +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEV 260

Query: 238 GGDLPDSLYSMSSLQHVSLSVNNFSG 263
              LP  L          L+ N+  G
Sbjct: 261 PCSLPQRLAGRDLK---RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.2 bits (118), Expect = 5e-07
 Identities = 37/169 (21%), Positives = 63/169 (37%), Gaps = 4/169 (2%)

Query: 48  NLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQ 107
            L  G      + + +  Q + +      T  + G +T L L    +  +  R+   L+ 
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178

Query: 108 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 167
           L  L L  N +  V P    +L +L  L L  N LS   +  LA L  +Q L ++ N + 
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

Query: 168 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 216
                   ++ L  F  S++     L  R+        +  L+ N   G
Sbjct: 239 CDCRARPLWAWLQKFRGSSSEVPCSLPQRL----AGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.4 bits (116), Expect = 1e-06
 Identities = 38/231 (16%), Positives = 63/231 (27%), Gaps = 18/231 (7%)

Query: 434 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 493
            +P  +    +   + L    +          C+ L +L L  N            +  L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 494 FYLDFSNNTLTGEI-PKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQAS 552
             LD S+N     + P +   L  L + +                        L  N   
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 553 SFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSND 612
           + P   F                  +L  L L  N I+     +   + +L+ L L  N 
Sbjct: 143 ALPDDTFRDLG--------------NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188

Query: 613 LHGSIPGSFEKLTFLSKFSV-ANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 662
           +    P +F  L  L    + ANN             +        NP +C
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 0.002
 Identities = 11/97 (11%), Positives = 24/97 (24%), Gaps = 3/97 (3%)

Query: 581 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGT 640
                +  +   +P  I      + + L  N +      SF     L+   + +N L   
Sbjct: 15  TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 641 IPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLK 677
                   +        +      +D        +L 
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.7 bits (148), Expect = 9e-11
 Identities = 45/295 (15%), Positives = 85/295 (28%), Gaps = 36/295 (12%)

Query: 349 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL 408
           TLDL   +    +   L     +      ++ +   + E F     +  + LSN+    +
Sbjct: 4   TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIE-V 60

Query: 409 SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKK 468
           S    +L QC  L  L L    + + I   +    +L+ L L  C       +  L    
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 469 LQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPT 528
            ++ +L+ +         +           +   L+G                       
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG----------------------- 157

Query: 529 ASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR-N 587
                       +S       +  +        +  +      E  QL +L  L LSR  
Sbjct: 158 ------YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211

Query: 588 NITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 642
           +I       + EI  L+ L +      G++    E L  L    +  +H      
Sbjct: 212 DIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIAR 263

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 3e-08
 Identities = 57/298 (19%), Positives = 91/298 (30%), Gaps = 49/298 (16%)

Query: 289 LPNVLGNLTQLEFFVAH-SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL 347
            P+V G L            SF            ++  +DL N+ +              
Sbjct: 13  HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV------------ 60

Query: 348 CTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNH 407
                        L   LS C  L+ LSL    LS  +  +  K ++L+ L+LS  S   
Sbjct: 61  -----------STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109

Query: 408 LSGTLSVLQQCKNLTTLIL------TKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPV 461
                ++L  C  L  L L      T+  V   +         L +        K  +  
Sbjct: 110 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 169

Query: 462 WLLRCKKLQVLDLSWNH-FDGNIPPWIGQMENLFYLDFSN-NTLTGEIPKSLTELKSLIS 519
            + RC  L  LDLS +     +      Q+  L +L  S    +  E    L E+ +L +
Sbjct: 170 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229

Query: 520 SNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLK 577
                          L V        L   + +   P + ++ +       P IG  K
Sbjct: 230 ---------------LQVFGIVPDGTLQLLKEAL--PHLQINCSHFTTIARPTIGNKK 270

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 7e-08
 Identities = 46/287 (16%), Positives = 84/287 (29%), Gaps = 23/287 (8%)

Query: 205 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG- 263
           Q LDL+  +    + G   S  +       + +   L +   S   +QH+ LS +     
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVS 61

Query: 264 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKL 323
            L   +S  + L++L + G + S  + N L   + L        S      L   L    
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS--- 118

Query: 324 HVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 383
                  + L           +         +        +LS        S        
Sbjct: 119 -----SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS-------- 165

Query: 384 QVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK-NFVGEEIPENVGGF 442
               +  +    L     ++S    +       Q   L  L L++   +  E    +G  
Sbjct: 166 -DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224

Query: 443 ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ 489
            +L  L +      G + +       LQ+   + +HF     P IG 
Sbjct: 225 PTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (122), Expect = 2e-07
 Identities = 38/278 (13%), Positives = 86/278 (30%), Gaps = 17/278 (6%)

Query: 111 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL 170
           LDL+  +L   V   L +   +       + +  P++   +   + Q +++S++    S 
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRV-QHMDLSNSVIEVST 62

Query: 171 FE--LGEFSNLAVFNISNNSFTGKL--------NSRIWSASKEIQILDLSMNHFMGSLQG 220
               L + S L   ++     +  +        N    + S      + ++   + S   
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 221 LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLII 280
           LD              +   +     +++ L       N     LS  +    +L HL +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 281 FGN-QFSGKLPNVLGNLTQLEFF-VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID 338
             +             L  L+   ++          L L     L  L +      G + 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 339 LNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 376
           L    L     L +  +HF+     ++ +  + +I  +
Sbjct: 243 LLKEALPH---LQINCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.9 bits (120), Expect = 3e-07
 Identities = 39/267 (14%), Positives = 76/267 (28%), Gaps = 15/267 (5%)

Query: 135 LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLN 194
           LDL+   L   V+G L    +I +     +  +  L E      +   ++SN+       
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63

Query: 195 SRIWSASKEIQILDLSMNHFMGS-LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 253
             I S   ++Q L L         +  L  + +L +L++       +        S  + 
Sbjct: 64  HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123

Query: 254 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA--------- 304
             L+++       + +    +     I     SG   N+  +                  
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183

Query: 305 HSNSFSGPLPLSLSLCSKLHVLDLRN-NSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN 363
            S              + L  L L     +     L    + +L TL +      G L  
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243

Query: 364 SLSDCHDLKILSLAKNELSGQVPESFG 390
                  L+I     +  +     + G
Sbjct: 244 LKEALPHLQINC---SHFTTIARPTIG 267

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.7 bits (117), Expect = 7e-07
 Identities = 45/258 (17%), Positives = 94/258 (36%), Gaps = 16/258 (6%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGV-VPVELSNLKQLEVLDLSHNML 142
           V     PR  +   +        +++ +DLS + +E   +   LS   +L+ L L    L
Sbjct: 25  VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83

Query: 143 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 202
           S P+   LA  + +  LN+S  S           S+ +  +  N S+      +    + 
Sbjct: 84  SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143

Query: 203 EIQILDLSMNHFMGSLQGLDHSPSLKQ----------LHVDNNLLGGDLPDSLYSMSSLQ 252
                 ++  +  G  + L  S                  D+ +L  D     + ++ LQ
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203

Query: 253 HVSLS-VNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSG 311
           H+SLS   +   +   ++  + +L+ L +FG    G L  +   L  L+    + + F+ 
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTT 260

Query: 312 PLPLSLSLCSKLHVLDLR 329
               ++       +  ++
Sbjct: 261 IARPTIGNKKNQEIWGIK 278

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 3e-05
 Identities = 38/279 (13%), Positives = 87/279 (31%), Gaps = 25/279 (8%)

Query: 155 LIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF 214
           L Q+L+++  + +  +        +  F    +     L      +   +Q +DLS +  
Sbjct: 1   LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVI 58

Query: 215 MGS--LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNL 272
             S     L     L+ L ++   L   + ++L   S+L  ++LS  +   + + +    
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 332
           +  R   +  +         +              + SG                  N  
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK---------------NLQ 163

Query: 333 LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK-NELSGQVPESFGK 391
            +    L     + +      +              + L+ LSL++  ++  +     G+
Sbjct: 164 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223

Query: 392 LTSLLFLSLSNN----SFNHLSGTLSVLQ-QCKNLTTLI 425
           + +L  L +       +   L   L  LQ  C + TT+ 
Sbjct: 224 IPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIA 262

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 58.7 bits (140), Expect = 1e-09
 Identities = 52/324 (16%), Positives = 86/324 (26%), Gaps = 24/324 (7%)

Query: 319 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 378
           L  + H L+L N  L+   +L       L +L  + N  +  LP            SL  
Sbjct: 36  LDRQAHELELNNLGLSSLPEL----PPHLESLVASCNSLT-ELPELPQ--------SLKS 82

Query: 379 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL--ILTKNFVGEEIP 436
             +     ++   L  LL     +N+       L      K +      L K        
Sbjct: 83  LLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142

Query: 437 ENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 496
           E +    + +        L     ++       ++ DL  +         I +       
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202

Query: 497 DFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAG-IPLYVKHNRSTNGLPYNQASSFP 555
                T+  +     T      S    +           L                 S  
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262

Query: 556 PSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG 615
           P      N  +  I         L  L++S N +   +P+       LE L  S N L  
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-A 317

Query: 616 SIPGSFEKLTFLSKFSVANNHLQG 639
            +P   + L  L    V  N L+ 
Sbjct: 318 EVPELPQNLKQL---HVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 6e-06
 Identities = 55/366 (15%), Positives = 92/366 (25%), Gaps = 61/366 (16%)

Query: 249 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNS 308
                + L+       LS        L  L+   N  + +LP +  +L  L     +  +
Sbjct: 38  RQAHELELNNLG----LSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 309 FSGPLP-LSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 367
            S   P L     S   +  L     +  + +     +SL  L             +   
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 368 CHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 427
               ++ +L           S  KL  L     S  + N++   L  LQ    LTT+   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 428 KNFVGEEIPENVGGFESLMVLAL--------GNCGLKGHIPVWLLRCKKLQVLDLSWNHF 479
            N +              +             +               +L       N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 480 DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 539
              I        +L  L+ SNN L  E+P     L+ LI                     
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI--------------------- 310

Query: 540 NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 599
                                S N +   +P     LK    L +  N +    P     
Sbjct: 311 --------------------ASFNHLA-EVPELPQNLKQ---LHVEYNPLR-EFPDIPES 345

Query: 600 IRNLEV 605
           + +L +
Sbjct: 346 VEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 3e-05
 Identities = 44/322 (13%), Positives = 89/322 (27%), Gaps = 23/322 (7%)

Query: 106 NQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS------GPVSGMLAGLNLIQSL 159
            Q   L+L+   L  +          LE L  S N L+        +  +L   N +++L
Sbjct: 38  RQAHELELNNLGLSSLPE----LPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKAL 93

Query: 160 NVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQ 219
           +              +   L     S+      +++       ++      +      L+
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 220 GLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLI 279
            L    +L  L                 +S    V+ +         + +  LT++    
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 280 IFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL-----DLRNNSLT 334
                     P++     +  +             L +S      +          N+ +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 335 GPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTS 394
             I        SL  L+++ N     LP        L+ L  + N L+ +VPE    L  
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLA-EVPELPQNLKQ 328

Query: 395 LLFLSLSNNSFNHLSGTLSVLQ 416
              L +  N           ++
Sbjct: 329 ---LHVEYNPLREFPDIPESVE 347

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 3e-04
 Identities = 51/324 (15%), Positives = 99/324 (30%), Gaps = 26/324 (8%)

Query: 84  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 143
              L L   GL  + P    HL   + L  SCN L   +P    +LK L V + +   LS
Sbjct: 40  AHELELNNLGLSSL-PELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94

Query: 144 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGK----LNSRIWS 199
                +         L       N S  ++ +  N ++  + +   + +     N+++  
Sbjct: 95  DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154

Query: 200 ASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 259
             +   +  L+  +   +         L    +       +    L ++  L  +    N
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214

Query: 260 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH--------SNSFSG 311
                     S            +           ++++  F             N+ S 
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274

Query: 312 PLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDL 371
            +     L   L  L++ NN L   +    +    L  L  + NH +  +P       +L
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHLAE-VPELPQ---NL 326

Query: 372 KILSLAKNELSGQVPESFGKLTSL 395
           K L +  N L  + P+    +  L
Sbjct: 327 KQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.0 bits (94), Expect = 5e-04
 Identities = 20/123 (16%), Positives = 37/123 (30%), Gaps = 8/123 (6%)

Query: 57  SWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCN 116
             ++     Q    +    +  S    +   +         I         L+ L++S N
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 294

Query: 117 HLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEF 176
            L  +     +   +LE L  S N L+  V  +   L   + L+V  N            
Sbjct: 295 KLIEL----PALPPRLERLIASFNHLAE-VPELPQNL---KQLHVEYNPLREFPDIPESV 346

Query: 177 SNL 179
            +L
Sbjct: 347 EDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 54/342 (15%), Positives = 100/342 (29%), Gaps = 28/342 (8%)

Query: 130 KQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSF 189
           +Q   L+L++  LS  +  +   L   +SL  S NS    L EL    +L    + NN+ 
Sbjct: 38  RQAHELELNNLGLSS-LPELPPHL---ESLVASCNSLT-ELPEL--PQSLKSLLVDNNNL 90

Query: 190 TGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMS 249
                  +      ++ L +S N                      ++    L        
Sbjct: 91  KA-----LSDLPPLLEYLGVSNNQLEK-----LPELQNSSFLKIIDVDNNSLKKLPDLPP 140

Query: 250 SLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 309
           SL+ ++   N        +     +  +      +    LP  L ++      +      
Sbjct: 141 SLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPEL 200

Query: 310 SGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH 369
                L+        +  L +   +           +       +  F     N  S   
Sbjct: 201 QNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 260

Query: 370 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 429
           +L       N  S ++        SL  L++SNN    L            L  LI + N
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPP------RLERLIASFN 314

Query: 430 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 471
            +  E+PE      +L  L +    L+   P      + L++
Sbjct: 315 HL-AEVPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLRM 351

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 52.8 bits (126), Expect = 6e-09
 Identities = 21/135 (15%), Positives = 45/135 (33%), Gaps = 21/135 (15%)

Query: 470 QVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTA 529
           +VL L+       +   + Q+  + +LD S+N L    P +L  L+ L            
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQA------- 50

Query: 530 SAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPE-IGQLKHLHVLDLSRNN 588
                     + +   +           + L NNR+  +   + +     L +L+L  N+
Sbjct: 51  ---------SDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 101

Query: 589 ITGTIPSSISEIRNL 603
           +          +  +
Sbjct: 102 LCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 2e-06
 Identities = 24/130 (18%), Positives = 43/130 (33%), Gaps = 16/130 (12%)

Query: 398 LSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKG 457
           L L++     L      L+Q   +T L L+ N     +        +L  L +       
Sbjct: 3   LHLAHKDLTVLCH----LEQLLLVTHLDLSHN----RLRALPPALAALRCLEVLQASDNA 54

Query: 458 HIPVW-LLRCKKLQVLDLSWNHF-DGNIPPWIGQMENLFYLDFSNNTLTGE------IPK 509
              V  +    +LQ L L  N          +     L  L+   N+L  E      + +
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

Query: 510 SLTELKSLIS 519
            L  + S+++
Sbjct: 115 MLPSVSSILT 124

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 6e-06
 Identities = 22/123 (17%), Positives = 45/123 (36%), Gaps = 7/123 (5%)

Query: 372 KILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFV 431
           ++L LA  +L+  V     +L  +  L LS+N    L   L+ L+  +    ++   +  
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLE----VLQASDNA 54

Query: 432 GEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQME 491
            E +           +L   N   +      L+ C +L +L+L  N           ++ 
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLA 113

Query: 492 NLF 494
            + 
Sbjct: 114 EML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 7e-06
 Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 8/126 (6%)

Query: 109 KLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNG 168
           ++L L+   L   V   L  L  +  LDLSHN L      + A   L       +   N 
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN- 57

Query: 169 SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS----LQGLDHS 224
            +  +     L    + NN        +   +   + +L+L  N          +  +  
Sbjct: 58  -VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 225 PSLKQL 230
           PS+  +
Sbjct: 117 PSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.9 bits (103), Expect = 8e-06
 Identities = 27/106 (25%), Positives = 39/106 (36%), Gaps = 7/106 (6%)

Query: 134 VLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKL 193
           VL L+H  L+      L  L L+  L++S N        L     L V   S+N+     
Sbjct: 2   VLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 194 NSRIWSASKEIQILDLSMNHF--MGSLQGLDHSPSLKQLHVDNNLL 237
                     +Q L L  N      ++Q L   P L  L++  N L
Sbjct: 60  GVANL---PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 21/123 (17%), Positives = 44/123 (35%), Gaps = 4/123 (3%)

Query: 228 KQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSG 287
           + LH+ +  L   +   L  +  + H+ LS N         ++ L  L  ++   +    
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCL-EVLQASDNALE 56

Query: 288 KLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL 347
            +  V       E  + ++          L  C +L +L+L+ NSL     +       L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 348 CTL 350
            ++
Sbjct: 117 PSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 18/102 (17%), Positives = 34/102 (33%), Gaps = 24/102 (23%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPS---------------------SIS 598
           L++  +  T+   + QL  +  LDLS N +    P+                      ++
Sbjct: 5   LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62

Query: 599 EIRNLEVLDLSSNDL-HGSIPGSFEKLTFLSKFSVANNHLQG 639
            +  L+ L L +N L   +          L   ++  N L  
Sbjct: 63  NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 1e-04
 Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 5/101 (4%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           +   L  L  +  LDLS N L  + P  L+ L+ LEVL  S N L          L  +Q
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVA--NLPRLQ 68

Query: 158 SLNVSSNSFNG--SLFELGEFSNLAVFNISNNSFTGKLNSR 196
            L + +N      ++  L     L + N+  NS   +   +
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 26/142 (18%), Positives = 41/142 (28%), Gaps = 29/142 (20%)

Query: 255 SLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLP 314
            L+  + +      +  L  + HL +  N+     P  L  L  LE   A  N+      
Sbjct: 4   HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60

Query: 315 LSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKIL 374
           ++     +   L L NN L                               L  C  L +L
Sbjct: 61  VANLPRLQ--ELLLCNNRLQ-----------------------QSAAIQPLVSCPRLVLL 95

Query: 375 SLAKNELSGQVPESFGKLTSLL 396
           +L  N L         +L  +L
Sbjct: 96  NLQGNSLCQ-EEGIQERLAEML 116

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 55.0 bits (131), Expect = 8e-09
 Identities = 34/239 (14%), Positives = 61/239 (25%), Gaps = 34/239 (14%)

Query: 371 LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 430
              ++  K+ ++  V ++   L  +  LS        + G    +Q   NL  L L  N 
Sbjct: 21  AIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEG----VQYLNNLIGLELKDNQ 74

Query: 431 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM 490
           + +  P             L            L     +  L         +        
Sbjct: 75  ITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124

Query: 491 ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 550
                          +I               +  N   S   PL      +T     N+
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 551 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLS 609
            S   P                +  L +L  + L  N I+   P  ++   NL ++ L+
Sbjct: 185 ISDISP----------------LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 3e-08
 Identities = 34/225 (15%), Positives = 67/225 (29%), Gaps = 17/225 (7%)

Query: 128 NLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNN 187
            L     +    + ++  V+   A L+ I +L+        ++  +   +NL    + +N
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73

Query: 188 SFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYS 247
             T   +        +I  L+LS N                       +        L +
Sbjct: 74  QIT---DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 248 MSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSN 307
           +  L            Q++             +            L NL++L    A  N
Sbjct: 131 LQVLYL-------DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 308 SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDL 352
             S   PL+      L  + L+NN ++       +  S+L  + L
Sbjct: 184 KISDISPLAS--LPNLIEVHLKNNQISDVS--PLANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.6 bits (117), Expect = 5e-07
 Identities = 31/216 (14%), Positives = 64/216 (29%), Gaps = 8/216 (3%)

Query: 419 KNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH 478
            N   +   K+ V + + +     + +  L+    G+   I   +     L  L+L  N 
Sbjct: 19  ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74

Query: 479 FDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK 538
                P           L  +       I    +     ++S   +     +    L V 
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 539 HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSIS 598
           +         +  +      +LS      +    +  L  L  L    N I+   P  ++
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192

Query: 599 EIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN 634
            + NL  + L +N +    P      + L   ++ N
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.6 bits (117), Expect = 5e-07
 Identities = 42/226 (18%), Positives = 77/226 (34%), Gaps = 17/226 (7%)

Query: 105 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 164
           L     +    +++   V    ++L  +  L      ++      + G+  + +L     
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-----IEGVQYLNNLIGLEL 70

Query: 165 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 224
             N  + +L    NL        S     N    +  + I+ LDL+          L   
Sbjct: 71  KDN-QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV-TPLAGL 128

Query: 225 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 284
            +L+ L++D N     + +            LS+ N        ++NL+ L  L    N+
Sbjct: 129 SNLQVLYLDLN----QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 285 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRN 330
            S   P  L +L  L      +N  S   P  L+  S L ++ L N
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 16/82 (19%), Positives = 28/82 (34%), Gaps = 4/82 (4%)

Query: 58  WSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNH 117
                             +  +N  ++T L      +  I P  L  L  L  + L  N 
Sbjct: 149 GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206

Query: 118 LEGVVPVELSNLKQLEVLDLSH 139
           +  V P  L+N   L ++ L++
Sbjct: 207 ISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 32/222 (14%), Positives = 71/222 (31%), Gaps = 22/222 (9%)

Query: 169 SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLK 228
            +F     +N        ++ T  +     +    I  L         +++G+ +  +L 
Sbjct: 11  VIFPDPALANAIKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVT-TIEGVQYLNNLI 66

Query: 229 QLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGK 288
            L + +N +    P    +  +   +S +       ++   S  T         +     
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 289 LPNVLGNLTQLEFFVAHSNSFSGPL--------------PLSLSLCSKLHVLDLRNNSLT 334
             + L  L      + + +  +G                   L+  SKL  L   +N ++
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186

Query: 335 GPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 376
                  + L +L  + L  N  S   P  L++  +L I++L
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 31/219 (14%), Positives = 61/219 (27%), Gaps = 25/219 (11%)

Query: 225 PSLKQLHVDNNLLGGDLPD--SLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFG 282
           P+L    +       ++ D  +   +  +  +S      +    E +  L +L  L +  
Sbjct: 16  PALANA-IKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 283 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFS 342
           NQ +   P              +       +    S+ +         +        N  
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 343 GLSSLCTLDLATNHFSGPL--------------PNSLSDCHDLKILSLAKNELSGQVPES 388
            L          +  +G                   L++   L  L    N++S      
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISP 190

Query: 389 FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 427
              L +L+ + L NN  + +S     L    NL  + LT
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP----LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 14/61 (22%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 102 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 161
           L +L++L  L    N +  + P  L++L  L  + L +N +S      LA  + +  + +
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 162 S 162
           +
Sbjct: 225 T 225

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 55.3 bits (131), Expect = 2e-08
 Identities = 42/323 (13%), Positives = 88/323 (27%), Gaps = 40/323 (12%)

Query: 341 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ----VPESFGKLTSLL 396
           FS       LD  T      +   L +   +K + L+ N +  +    + E+      L 
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 397 FLSLSNNSFNHLSGTL--------SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVL 448
               S+     +   +          L +C  L T+ L+ N  G    E +  F S    
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122

Query: 449 ALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 508
                     +           + +L+ N    N PP    +     L+  +     +  
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182

Query: 509 KSLTELKSLISSNCTSSNPTASAGIPL----------------YVKHNRSTNGLPYNQAS 552
           +S   L ++               +                     H  S+      ++ 
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242

Query: 553 SFPPSVFLSNNRINGTIPPEIGQ------LKHLHVLDLSRNNITGTIPSSISEI-----R 601
                + L++  ++      +           L  L L  N I      ++  +      
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302

Query: 602 NLEVLDLSSNDLHGSIPGSFEKL 624
           +L  L+L+ N          +++
Sbjct: 303 DLLFLELNGNRF-SEEDDVVDEI 324

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.5 bits (116), Expect = 1e-06
 Identities = 41/340 (12%), Positives = 96/340 (28%), Gaps = 34/340 (10%)

Query: 201 SKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGD----LPDSLYSMSSLQHVSL 256
            K +++  ++          L    S+K++ +  N +G +    L +++ S   L+    
Sbjct: 7   GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 257 SVN---NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 313
           S         ++ E +  L          +              +        ++    L
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 314 PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFS-GPLPNSLSDCHDLK 372
            L  +         +        ++        L ++    N    G +          +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 373 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVG 432
           +L   K   +G  PE                    L G     +            +   
Sbjct: 187 LLHTVKMVQNGIRPE--------------GIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 232

Query: 433 EEIPENVGGFESLMVLALGNCGLKGHIPVWLLRC------KKLQVLDLSWNHFDGNIPPW 486
             +   +  + +L  L L +C L       ++          LQ L L +N  + +    
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292

Query: 487 I-----GQMENLFYLDFSNNTLTGEIPKSLTELKSLISSN 521
           +      +M +L +L+ + N    E    + E++ + S+ 
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTR 331

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.0 bits (107), Expect = 2e-05
 Identities = 43/329 (13%), Positives = 96/329 (29%), Gaps = 23/329 (6%)

Query: 108 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGP----VSGMLAGLNLIQSLNVSS 163
           LKL  ++    + V    L     ++ + LS N +       +S  +A    ++    S 
Sbjct: 10  LKLDAITTEDEKSVFA-VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 164 NSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH 223
                   E+ E   L +  +       KL++   S +         +  F+     L+H
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCP---KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125

Query: 224 SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 283
                                  +++     +  + +    +    + L +         
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS----IICGRNRLENGSMKEWAKT 181

Query: 284 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG 343
             S +L + +  +          +     L     L       +   +  +  + +    
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 344 LSSLCTLDLATNHFSGPLPNSLSDCHD------LKILSLAKNELSGQVPES-----FGKL 392
             +L  L L     S     ++ D         L+ L L  NE+      +       K+
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 393 TSLLFLSLSNNSFNHLSGTLSVLQQCKNL 421
             LLFL L+ N F+     +  +++  + 
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFST 330

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (126), Expect = 5e-08
 Identities = 35/184 (19%), Positives = 47/184 (25%), Gaps = 6/184 (3%)

Query: 318 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 377
            L     +L L  N L           + L  L+L            L     L +L   
Sbjct: 28  DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL-----DRAELTKLQVDGTLPVLGTL 82

Query: 378 KNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPE 437
               +          T      L  +     S  L  L+    L  L L  N +    P 
Sbjct: 83  DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142

Query: 438 NVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLD 497
            +     L  L+L N  L       L   + L  L L  N     IP        L +  
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201

Query: 498 FSNN 501
              N
Sbjct: 202 LHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 7e-08
 Identities = 37/207 (17%), Positives = 66/207 (31%), Gaps = 11/207 (5%)

Query: 439 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 498
           V    S + +      L   +P  L   K   +L LS N         +     L  L+ 
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 499 SN-NTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNR------STNGLPYNQA 551
                   ++  +L  L +L  S+    +          +          ++  L   + 
Sbjct: 63  DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 552 SSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 611
                 ++L  N +    P  +     L  L L+ NN+T      ++ + NL+ L L  N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 612 DLHGSIPGSFEKLTFLSKFSVANNHLQ 638
            L+ +IP  F     L    +  N   
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 7e-08
 Identities = 35/188 (18%), Positives = 63/188 (33%), Gaps = 5/188 (2%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           +P  L       +L LS N L       L    +L  L+L    L+         L ++ 
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLG 80

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
           +L++S N              L V ++S N  T      +    +  ++           
Sbjct: 81  TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140

Query: 218 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRH 277
              L  +P L++L + NN L       L  + +L  + L  N+    + +       L  
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199

Query: 278 LIIFGNQF 285
             + GN +
Sbjct: 200 AFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 1e-05
 Identities = 48/247 (19%), Positives = 69/247 (27%), Gaps = 47/247 (19%)

Query: 341 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSL 400
            S ++S   ++    + +  LP  L    D  IL L++N L      +    T L  L+L
Sbjct: 6   VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 401 SNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 460
                  L            L TL L+ N +               VL +    L     
Sbjct: 63  DRAELTKLQVD----GTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPL 117

Query: 461 VWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISS 520
             L    +LQ L L  N      P  +     L  L  +NN LT      L  L++L   
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL--- 174

Query: 521 NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLH 580
                                               ++ L  N +  TIP        L 
Sbjct: 175 -----------------------------------DTLLLQENSLY-TIPKGFFGSHLLP 198

Query: 581 VLDLSRN 587
              L  N
Sbjct: 199 FAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 1e-05
 Identities = 40/205 (19%), Positives = 66/205 (32%), Gaps = 10/205 (4%)

Query: 465 RCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTS 524
           +      ++    +    +PP + +  +   L  S N L      +L     L   N   
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 525 SNPTASAGIP-------LYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLK 577
           +  T             L + HN+  +     Q       + +S NR+       +  L 
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 578 HLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 637
            L  L L  N +    P  ++    LE L L++N+L     G    L  L    +  N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 638 QGTIPTGGQFYSFPNSSFEGNPGLC 662
                     +  P +   GNP LC
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 2e-04
 Identities = 11/65 (16%), Positives = 29/65 (44%), Gaps = 3/65 (4%)

Query: 572 EIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFS 631
           E+ ++     ++  + N+T  +P  +   ++  +L LS N L+     +    T L++ +
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 632 VANNH 636
           +    
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 4e-04
 Identities = 44/202 (21%), Positives = 59/202 (29%), Gaps = 27/202 (13%)

Query: 249 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE-------- 300
           +S   V+    N +  L   +        L +  N         L   T+L         
Sbjct: 10  ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

Query: 301 -------------FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL 347
                          +  S++    LPL       L VLD+  N LT        GL  L
Sbjct: 67  LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126

Query: 348 CTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNH 407
             L L  N      P  L+    L+ LSLA N L+         L +L  L L  NS   
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT 186

Query: 408 LSGTLSVLQQCKNLTTLILTKN 429
           +            L    L  N
Sbjct: 187 IPKGFF---GSHLLPFAFLHGN 205

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 1e-07
 Identities = 28/194 (14%), Positives = 58/194 (29%), Gaps = 30/194 (15%)

Query: 441 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 500
            F   +   L    +   +    L    +  +  + +         I  + N+  L  + 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 501 NTLTGEIPKSLTELKSLISSNCTSS------------------NPTASAGIPLYVKHNRS 542
           N LT   P +  +    +  +                      +   S    L       
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 543 TNGLPYNQASSFPPSVFLSNNRINGTI------PPEIGQLKHLHVLDLSRNNITGTIPSS 596
           +  L  N+ +       L+                 +  L  L  L LS+N+I+     +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRA 195

Query: 597 ISEIRNLEVLDLSS 610
           ++ ++NL+VL+L S
Sbjct: 196 LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 1e-05
 Identities = 31/196 (15%), Positives = 68/196 (34%), Gaps = 15/196 (7%)

Query: 87  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 146
             L +K +   + ++   LN +  +  + + ++ V    +  L  +  L L+ N L+   
Sbjct: 29  DNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDI- 83

Query: 147 SGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQI 206
                    + +L      F          S   +  + + S      S I       Q+
Sbjct: 84  -------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136

Query: 207 LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS 266
             L + +   +   +    +        +    D+   L  ++ LQ++ LS N+ S  L 
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR 194

Query: 267 EKISNLTSLRHLIIFG 282
             ++ L +L  L +F 
Sbjct: 195 A-LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 3e-05
 Identities = 24/197 (12%), Positives = 59/197 (29%), Gaps = 15/197 (7%)

Query: 105 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 164
             +    +L    +   V    + L  ++ +  +++ +       +  L  +  L ++ N
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 165 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 224
                       +NL              +       K+++ L L  N        +   
Sbjct: 79  KLTDIKP----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134

Query: 225 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 284
                   +N +    +   L  + +L      +++        ++ LT L++L +  N 
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-----LAGLTKLQNLYLSKNH 189

Query: 285 FSGKLPNVLGNLTQLEF 301
            S      L  L  L+ 
Sbjct: 190 ISD--LRALAGLKNLDV 204

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 9e-05
 Identities = 29/209 (13%), Positives = 76/209 (36%), Gaps = 16/209 (7%)

Query: 168 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSL 227
             +F    F+     N+   S T  +     +    I  +  + +  + S+QG+ + P++
Sbjct: 15  KQIFSDDAFAETIKDNLKKKSVTDAVTQ---NELNSIDQIIANNSD-IKSVQGIQYLPNV 70

Query: 228 KQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSG 287
            +L ++ N L          +++L+++     + +                +   +    
Sbjct: 71  TKLFLNGNKLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125

Query: 288 KLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL 347
            +  ++        ++ ++      +   L+    L + D + + +        +GL+ L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-----PLAGLTKL 180

Query: 348 CTLDLATNHFSGPLPNSLSDCHDLKILSL 376
             L L+ NH S     +L+   +L +L L
Sbjct: 181 QNLYLSKNHISD--LRALAGLKNLDVLEL 207

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 29/188 (15%), Positives = 56/188 (29%), Gaps = 6/188 (3%)

Query: 419 KNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH 478
                 +L K  V + + +     + +  L     G+K    V  L    L  ++ S N 
Sbjct: 18  AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEYL--NNLTQINFSNNQ 73

Query: 479 FDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK 538
                P           ++ +       +          + +N  +          L   
Sbjct: 74  LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 133

Query: 539 HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSIS 598
              S      +  S       L+ +    T    +  L  L  LD+S N ++    S ++
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLA 191

Query: 599 EIRNLEVL 606
           ++ NLE L
Sbjct: 192 KLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 37/196 (18%), Positives = 64/196 (32%), Gaps = 15/196 (7%)

Query: 105 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 164
           L +     L   ++   V    ++L Q+  L      +   + G +  LN +  +N S+N
Sbjct: 17  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNN 72

Query: 165 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 224
                        NL        +     +    +    +  L L  N         + +
Sbjct: 73  QLTDITP----LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128

Query: 225 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 284
              +     N +        L S+  L   S  V +        ++NLT+L  L I  N+
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP-----LANLTTLERLDISSNK 183

Query: 285 FSGKLPNVLGNLTQLE 300
            S    +VL  LT LE
Sbjct: 184 VSD--ISVLAKLTNLE 197

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 31/188 (16%), Positives = 54/188 (28%), Gaps = 5/188 (2%)

Query: 441 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 500
                M   LG   +   +        ++  L         +I   +  + NL  ++FSN
Sbjct: 16  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71

Query: 501 NTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFL 560
           N LT   P         I  N               +      N    +       +   
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 561 SNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG-SIPG 619
                + TI           +  L+ ++   T    ++ +  LE LD+SSN +   S+  
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLA 191

Query: 620 SFEKLTFL 627
               L  L
Sbjct: 192 KLTNLESL 199

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (106), Expect = 7e-06
 Identities = 23/143 (16%), Positives = 40/143 (27%), Gaps = 9/143 (6%)

Query: 364 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 423
             ++    + L L   ++   +      L     +  S+N    L G        + L T
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF----PLLRRLKT 67

Query: 424 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDLSWNHF 479
           L++  N +             L  L L N  L           L     L +L     + 
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 480 DGNIPPWIGQMENLFYLDFSNNT 502
                  I ++  +  LDF    
Sbjct: 128 KHYRLYVIYKVPQVRVLDFQKVK 150

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (99), Expect = 4e-05
 Identities = 29/163 (17%), Positives = 49/163 (30%), Gaps = 29/163 (17%)

Query: 264 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKL 323
           + + + +N    R L + G +    + N+   L Q +                       
Sbjct: 9   EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFD----------------------- 44

Query: 324 HVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 383
             +D  +N +       F  L  L TL +  N              DL  L L  N L  
Sbjct: 45  -AIDFSDNEIRKLD--GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 101

Query: 384 -QVPESFGKLTSLLFLSLSNNSFNHLSG-TLSVLQQCKNLTTL 424
               +    L SL +L +  N   +     L V+ +   +  L
Sbjct: 102 LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (98), Expect = 7e-05
 Identities = 19/102 (18%), Positives = 29/102 (28%), Gaps = 5/102 (4%)

Query: 560 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 619
           L+   I      +         LDL    I   I +  + +   + +D S N++      
Sbjct: 3   LTAELIEQ--AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLD 57

Query: 620 SFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 661
            F  L  L    V NN +        Q           N  L
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 2e-04
 Identities = 11/48 (22%), Positives = 23/48 (47%), Gaps = 3/48 (6%)

Query: 97  IIPRSLGHLNQLKL--LDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 142
           +I ++  + N ++   LDL    +  V+    + L Q + +D S N +
Sbjct: 7   LIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 8e-06
 Identities = 18/84 (21%), Positives = 28/84 (33%), Gaps = 9/84 (10%)

Query: 441 GFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ-----ME 491
               L VL L +C +       +   LL    L+ LDLS N         + +       
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 492 NLFYLDFSNNTLTGEIPKSLTELK 515
            L  L   +   + E+   L  L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 1e-05
 Identities = 15/85 (17%), Positives = 28/85 (32%), Gaps = 5/85 (5%)

Query: 560 LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITG----TIPSSISEIRNLEVLDLSSNDLH 614
           +    ++     E+   L+   V+ L    +T      I S++     L  L+L SN+L 
Sbjct: 9   IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68

Query: 615 GSIPGSFEKLTFLSKFSVANNHLQG 639
                   +        +    LQ 
Sbjct: 69  DVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 16/95 (16%), Positives = 28/95 (29%), Gaps = 10/95 (10%)

Query: 323 LHVLDLRNNSLT-GPIDLNFSGLSSLCTLDLATNHFSG----PLPNSLSDCHDLKILSLA 377
           +  LD++   L+          L     + L     +      + ++L     L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 378 KNELSGQVPESFGKL-----TSLLFLSLSNNSFNH 407
            NEL         +        +  LSL N     
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 8e-05
 Identities = 17/67 (25%), Positives = 27/67 (40%), Gaps = 5/67 (7%)

Query: 108 LKLLDLSCNHLEGVVPVEL-SNLKQLEVLDLSHNMLSG----PVSGMLAGLNLIQSLNVS 162
           ++ LD+ C  L      EL   L+Q +V+ L    L+      +S  L     +  LN+ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 163 SNSFNGS 169
           SN     
Sbjct: 64  SNELGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 2e-04
 Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 10/92 (10%)

Query: 420 NLTTLILTKNFVGEE-IPENVGGFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDL 474
           ++ +L +    + +    E +   +   V+ L +CGL       I   L     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 475 SWNHFDGNIPPWIGQM-----ENLFYLDFSNN 501
             N         + Q        +  L   N 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 2e-04
 Identities = 18/126 (14%), Positives = 33/126 (26%), Gaps = 3/126 (2%)

Query: 370 DLKILSLAKNELS-GQVPESFGKLTSLLFLSLSNNSFN--HLSGTLSVLQQCKNLTTLIL 426
           D++ L +   ELS  +  E    L     + L +            S L+    L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 427 TKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPW 486
             N +G+     V          +    L+               L       + ++   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 487 IGQMEN 492
           +     
Sbjct: 123 LLGDAG 128

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 2e-04
 Identities = 13/74 (17%), Positives = 24/74 (32%), Gaps = 9/74 (12%)

Query: 560 LSNNRINGT----IPPEIGQLKHLHVLDLSRNNITGTIPSSISEI-----RNLEVLDLSS 610
           L++  ++ +    +   +     L  LDLS N +       + E        LE L L  
Sbjct: 376 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 435

Query: 611 NDLHGSIPGSFEKL 624
                 +    + L
Sbjct: 436 IYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 3e-04
 Identities = 14/87 (16%), Positives = 32/87 (36%), Gaps = 9/87 (10%)

Query: 221 LDHSPSLKQLHVDNNLLGGD----LPDSLYSMSSLQHVSLSVNNFSGQLSEKIS-----N 271
                 L+ L + +  +       L  +L +  SL+ + LS N        ++       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 272 LTSLRHLIIFGNQFSGKLPNVLGNLTQ 298
              L  L+++   +S ++ + L  L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 18/96 (18%), Positives = 30/96 (31%), Gaps = 11/96 (11%)

Query: 340 NFSGLSSLCTLDLATNHFSG----PLPNSLSDCHDLKILSLAKNELSGQVPESFGK---- 391
                S L  L LA    S      L  +L   H L+ L L+ N L         +    
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 392 -LTSLLFLSLSNNSFNHLSGTL--SVLQQCKNLTTL 424
               L  L L +  ++        ++ +   +L  +
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 10/92 (10%), Positives = 30/92 (32%), Gaps = 5/92 (5%)

Query: 178 NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF----MGSL-QGLDHSPSLKQLHV 232
           ++   +I     +    + +    ++ Q++ L            +   L  +P+L +L++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 233 DNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ 264
            +N LG      +          +   +    
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 21/100 (21%), Positives = 32/100 (32%), Gaps = 9/100 (9%)

Query: 63  MCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGI----IPRSLGHLNQLKLLDLSCNHL 118
              +  GV       G     + +L L    +       +  +L   + L+ LDLS N L
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409

Query: 119 EGVVPVELS-----NLKQLEVLDLSHNMLSGPVSGMLAGL 153
                ++L          LE L L     S  +   L  L
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 8e-04
 Identities = 9/66 (13%), Positives = 24/66 (36%), Gaps = 5/66 (7%)

Query: 579 LHVLDLSRNNITGT-IPSSISEIRNLEVLDLSSNDLHG----SIPGSFEKLTFLSKFSVA 633
           +  LD+    ++       +  ++  +V+ L    L       I  +      L++ ++ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 634 NNHLQG 639
           +N L  
Sbjct: 64  SNELGD 69

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 13/96 (13%), Positives = 30/96 (31%), Gaps = 11/96 (11%)

Query: 201 SKEIQILDLSMNHF--MGSLQGLDHSPSLKQLHVDNNLLGGD----LPDSLYSMSSLQHV 254
           S +IQ LD+           + L      + + +D+  L       +  +L    +L  +
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 255 SLSVNNFSGQLSEKI-----SNLTSLRHLIIFGNQF 285
           +L  N         +     +    ++ L +     
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 15/76 (19%), Positives = 27/76 (35%), Gaps = 6/76 (7%)

Query: 452 NCGLKGHIPVWLLRCKKLQVLDLSWNHFDGN----IPPWIGQMENLFYLDFSNNTLTGEI 507
           + G++            L+VL L+      +    +   +    +L  LD SNN L    
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413

Query: 508 PKSLTELKSLISSNCT 523
              L  ++S+    C 
Sbjct: 414 ILQL--VESVRQPGCL 427

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 17/85 (20%), Positives = 27/85 (31%), Gaps = 9/85 (10%)

Query: 317 LSLCSKLHVLDLRNNSLTG----PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD----- 367
               S L VL L +  ++      +        SL  LDL+ N         L +     
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 368 CHDLKILSLAKNELSGQVPESFGKL 392
              L+ L L     S ++ +    L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (98), Expect = 1e-04
 Identities = 35/209 (16%), Positives = 62/209 (29%), Gaps = 2/209 (0%)

Query: 318 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 377
            L      L      L       FSG   L  ++++ N     +   +            
Sbjct: 26  DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85

Query: 378 KNELSGQV--PESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 435
           +   +     PE+F  L +L +L +SN    HL     +    K L  +    N    E 
Sbjct: 86  EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 145

Query: 436 PENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFY 495
              VG     ++L L   G++          +  ++     N+ +               
Sbjct: 146 NSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 205

Query: 496 LDFSNNTLTGEIPKSLTELKSLISSNCTS 524
           LD S   +       L  LK L + +  +
Sbjct: 206 LDISRTRIHSLPSYGLENLKKLRARSTYN 234

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 4e-04
 Identities = 25/251 (9%), Positives = 71/251 (28%), Gaps = 18/251 (7%)

Query: 362 PNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNL 421
            + +  C + ++    +++++ ++P       + + L         +           +L
Sbjct: 2   HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQK--GAFSGFGDL 55

Query: 422 TTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG 481
             + +++N V E I  +V      +                        +  L  ++   
Sbjct: 56  EKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 115

Query: 482 NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNR 541
              P + ++ +L  +                           S    +   + L++  N 
Sbjct: 116 KHLPDVHKIHSLQKVLLDIQDNINIHTI-----------ERNSFVGLSFESVILWLNKNG 164

Query: 542 STNGLPYNQASSFPPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEI 600
                      +    + LS+N     +P ++        +LD+SR  I       +  +
Sbjct: 165 IQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224

Query: 601 RNLEVLDLSSN 611
           + L      + 
Sbjct: 225 KKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 8/44 (18%), Positives = 16/44 (36%)

Query: 97  IIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHN 140
           +        +   +LD+S   +  +    L NLK+L      + 
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 15/108 (13%), Positives = 34/108 (31%)

Query: 58  WSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNH 117
                +    +       S    +    +L L + G++ I   +       +L     N+
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188

Query: 118 LEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNS 165
           LE +            +LD+S   +    S  L  L  +++ +  +  
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.002
 Identities = 28/224 (12%), Positives = 55/224 (24%), Gaps = 19/224 (8%)

Query: 434 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 493
           EIP ++    + + L      L+            L+ +++S N     I   +      
Sbjct: 22  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 494 FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPL--------------YVKH 539
            +                             SN        +                 +
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 540 NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 599
             +     +   S     ++L+ N I           +   +     NN+          
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 600 IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPT 643
                +LD+S   +H       E L  L   S    +L+  +PT
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNLK-KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.002
 Identities = 29/208 (13%), Positives = 54/208 (25%), Gaps = 7/208 (3%)

Query: 98  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 157
           IP  L        L      L  +     S    LE +++S N +   +   +       
Sbjct: 23  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 158 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 217
                  + N        F NL        S TG  +         +Q + L +   +  
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 218 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-----SNL 272
                +S            L  +    +++ +        +N       E++        
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 273 TSLRHLIIFGNQFSGKLPNVLGNLTQLE 300
           +    L I   +        L NL +L 
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLR 228

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 3e-04
 Identities = 18/127 (14%), Positives = 38/127 (29%), Gaps = 9/127 (7%)

Query: 241 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIF--GNQFSGKLPNVLGNLTQ 298
           L   +         +L +            +L +    ++    +  +  L  +  N+ +
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR-----SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPE 66

Query: 299 LEFFVAHSNSFSG--PLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNH 356
           L      +N       +   +     L +L+L  N L    +L+      L  L L  N 
Sbjct: 67  LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126

Query: 357 FSGPLPN 363
            S    +
Sbjct: 127 LSDTFRD 133

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 0.001
 Identities = 20/138 (14%), Positives = 37/138 (26%), Gaps = 7/138 (5%)

Query: 384 QVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFE 443
           Q+     K       +L              L        L    +     +        
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLRSDPD----LVAQNIDVVLNRRSSMA-ATLRIIEENIP 65

Query: 444 SLMVLALGNCGLKGH--IPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 501
            L+ L L N  L     +   + +   L++L+LS N           +   L  L    N
Sbjct: 66  ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125

Query: 502 TLTGEIPKSLTELKSLIS 519
           +L+       T + ++  
Sbjct: 126 SLSDTFRDQSTYISAIRE 143

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.003
 Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 4/108 (3%)

Query: 295 NLTQLEFFVA--HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLN--FSGLSSLCTL 350
           +L      V     +S +  L +      +L  L+L NN L    D++       +L  L
Sbjct: 37  DLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96

Query: 351 DLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFL 398
           +L+ N               L+ L L  N LS    +    ++++   
Sbjct: 97  NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 0.001
 Identities = 17/109 (15%), Positives = 34/109 (31%), Gaps = 2/109 (1%)

Query: 555 PPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDL 613
              +  + +         +   ++L  L +        +       +  L  L +  + L
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 614 HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 662
               P +F     LS+ +++ N L+       Q  S       GNP  C
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.5 bits (85), Expect = 0.004
 Identities = 28/202 (13%), Positives = 51/202 (25%), Gaps = 43/202 (21%)

Query: 420 NLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 479
           + T L+L  N +G    + + G    +V           I                  + 
Sbjct: 30  HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89

Query: 480 DGNIPP-WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK 538
              I       +  L  L+  +N ++  +P S   L SL S N                 
Sbjct: 90  IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL---------------- 133

Query: 539 HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSIS 598
                                   +             + L    L+        PS + 
Sbjct: 134 -----------------------ASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV- 169

Query: 599 EIRNLEVLDLSSNDLHGSIPGS 620
             R++++ DL  ++   S   S
Sbjct: 170 --RDVQIKDLPHSEFKCSSENS 189

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.5 bits (85), Expect = 0.004
 Identities = 20/130 (15%), Positives = 51/130 (39%), Gaps = 3/130 (2%)

Query: 61  ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 120
             +  + + +     +    A  +  L L    +K I  +    L+QLK L+L  N +  
Sbjct: 57  VKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC 116

Query: 121 VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 180
           V+P    +L  L  L+L+ N  +     +      ++  +++  +         +  ++ 
Sbjct: 117 VMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS--KVRDVQ 173

Query: 181 VFNISNNSFT 190
           + ++ ++ F 
Sbjct: 174 IKDLPHSEFK 183

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1048
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.96
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.92
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.91
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.91
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.89
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.87
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.87
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.83
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.83
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.83
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.7
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.63
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.62
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.53
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.24
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.82
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.74
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.56
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.38
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.28
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	98.24
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	98.05
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.84

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=381.87  Aligned_cols=261  Identities=24%  Similarity=0.349  Sum_probs=214.8

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEE
Q ss_conf             308754683710186189999987-9958999993588425499999999999954998600240447608908999982
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  844 (1048)
                      .++|++.+.||+|+||+||+|.+. ++..||+|++..+.. ..+++.+|++++++++|||||++++++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf             7993986598208880899999999996999999777610-399999999999867999882677527457854787631


Q ss_pred             CCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             34789110011256776445899999999999999999873179984974899885687899958992204654458999
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++|+|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+|||+++++.+||+|||+|+......
T Consensus        95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             CCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf             4676067775303--554157999999999999978889878---93057604576899899928983244546537887


Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             71220244455545822338678886030699999999999299998645877711389999986302443310244347
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ........|++.|+|||++.+..++.++||||||+++|||++|..|+...  .........+    ......        
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~--~~~~~~~~~i----~~~~~~--------  235 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELL----EKDYRM--------  235 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHH----HTTCCC--------
T ss_pred             CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHH----HCCCCC--------
T ss_conf             22103556654666927872799981043021789999998679988774--2599999998----558888--------


Q ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             3212999999999998723589999999899999997107446
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1047 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1047 (1048)
                       ..+...+.++.+++.+||+.||++|||+++++++|+.+..+.
T Consensus       236 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         236 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             -CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf             -887433099999999975779768939999999999998757

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=379.32  Aligned_cols=257  Identities=24%  Similarity=0.416  Sum_probs=213.6

Q ss_pred             CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEECC
Q ss_conf             08754683710186189999987995899999358842549999999999995499860024044760890899998234
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  846 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  846 (1048)
                      .+|++.+.||+|+||+||+|++.++..||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf             9958888982088829999998899999999987886-768999999999996689975653524315993379998369


Q ss_pred             CCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             78911001125677644589999999999999999987317998497489988568789995899220465445899971
Q 001591          847 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  926 (1048)
Q Consensus       847 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  926 (1048)
                      +|+|.+++..   ....+++..+..++.|++.|++|+|+.   +|+||||||+||++++++.+||+|||+++........
T Consensus        84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE
T ss_conf             9918997520---134788999999999999987765316---4310443153266668877686553210023688733


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             22024445554582233867888603069999999999929-99986458777113899999863024433102443473
Q 001591          927 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG-RRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       927 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......||+.|+|||++.+..++.++||||||+++|||+|+ ++||..   ....+....+.....      ...+.   
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~---~~~~~~~~~i~~~~~------~~~p~---  225 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDISTGFR------LYKPR---  225 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS---CCHHHHHHHHHHTCC------CCCCT---
T ss_pred             EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHHCCC------CCCCC---
T ss_conf             504300176667857860799984033210599999998789888778---999999999980688------89954---


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             21299999999999872358999999989999999710744
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                          ..+.++.+++.+||+.+|++|||++++++.|+++.+.
T Consensus       226 ----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         226 ----LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ----3679999999997657976891999999999999857

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=369.32  Aligned_cols=253  Identities=22%  Similarity=0.369  Sum_probs=209.2

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEEC
Q ss_conf             08754683710186189999987-99589999935884254999999999999549986002404476089089999823
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|++.+.||+|+||+||+|++. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf             05388789812858299999998999899999984301727999999999998679998805857798899989999703


Q ss_pred             CCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47891100112567764458999999999999999998731799849748998856878999589922046544589997
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|.+++..     ..+++..+..++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||+|+...... 
T Consensus       100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1         100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-
T ss_conf             79808988641-----5999999999999999999999987---97226776888688789968642515641321366-


Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             12202444555458223386788860306999999999992999986458777113899999863024433102443473
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......+||+.|+|||++.+..++.++||||+||++|+|++|++||...   ...+....+..   ... ....      
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~~~~---~~~-~~~~------  237 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE---NPLRALYLIAT---NGT-PELQ------  237 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHH---HCS-CCCS------
T ss_pred             CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHH---CCC-CCCC------
T ss_conf             6444444477736826644799880120313729999980488998997---99999999985---799-9888------


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             212999999999998723589999999899999--9971
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                       .+...+..+.+++.+|++.||++|||++|+++  +++.
T Consensus       238 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             -SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             -85537999999999986699668909999964996577

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=366.95  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=211.8

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEE
Q ss_conf             308754683710186189999987-9958999993588425499999999999954998600240447608908999982
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  844 (1048)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             65758988984076819999998899989999998452431699999999999867997999299999989999999985


Q ss_pred             CCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCC
Q ss_conf             347891100112567764458999999999999999998731799849748998856878--999589922046544589
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD--EKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~Dfg~a~~~~~  922 (1048)
                      +++|+|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++  .++.+||+|||+|+....
T Consensus       105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf             799889999976---237899999999999999999999756---97600015467364168898699954521044256


Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             99712202444555458223386788860306999999999992999986458777113899999863024433102443
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...   ...+....+......   .   .. 
T Consensus       179 ~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~---~---~~-  246 (350)
T d1koaa2         179 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWN---M---DD-  246 (350)
T ss_dssp             TS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC---S---CC-
T ss_pred             CC--CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHCCCC---C---CC-
T ss_conf             54--320006862421889975899872676554659999998598998997---999999999847889---8---94-


Q ss_pred             CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             473212999999999998723589999999899999--9971
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                         ......+.++.+++.+|++.||++|||++|+++  ++..
T Consensus       247 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~  285 (350)
T d1koaa2         247 ---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  285 (350)
T ss_dssp             ---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             ---223589999999999975689667908999862913288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=376.31  Aligned_cols=267  Identities=24%  Similarity=0.394  Sum_probs=209.0

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEE
Q ss_conf             308754683710186189999987-99589999935884-2549999999999995499860024044760890899998
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|+.+++.++|||||++++++.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             56888978971277809999999899969999998754097899999999999986799999949999998999999997


Q ss_pred             ECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             234789110011256776445899999999999999999873-1799849748998856878999589922046544589
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      |+++|+|.+++..    ...+++..+..++.|++.|+.|||+ +   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf             6799868998742----499999999999999999999999859---997144577994687899899954877625678


Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCC--------
Q ss_conf             997122024445554582233867888603069999999999929999864587771138999998630244--------
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR--------  994 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  994 (1048)
                         ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+....  +.........        
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH--C-----------------
T ss_pred             ---CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHHHCCCCCCCCCCCCC
T ss_conf             ---862111377141194687589989488899899999999988899899887899999--988751775457742123


Q ss_pred             -----CCCCCCCCC----------------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf             -----331024434----------------73212999999999998723589999999899999--997107
Q 001591          995 -----EVEIIDASI----------------WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       995 -----~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~ 1044 (1048)
                           .....+...                ........+.++.+++.+|++.||++|||++|+++  ++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf             3322111122235413477887665026876676444899999999998689946790899996098647698

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=374.68  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=209.3

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEEC
Q ss_conf             30875468371018618999998799589999935884254999999999999549986002404476089089999823
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  845 (1048)
                      .++|++.+.||+|+||+||+|.++++..||||++.... ...+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf             89938867981079828999999999999999986476-888999999999986799988578731045-9769999957


Q ss_pred             CCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47891100112567764458999999999999999998731799849748998856878999589922046544589997
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|.+++...  ....+++..+..++.|+++|+.|||+.   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        90 ~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC
T ss_conf             898288887514--789887889999999999999999748---954675642251562024404234101477358864


Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             12202444555458223386788860306999999999992999986458777113899999863024433102443473
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      .......||+.|+|||++.+..++.++|||||||++|||+||..|+...  ....+....+..   .. ..  ..     
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~~---~~-~~--~~-----  231 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLER---GY-RM--VR-----  231 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHT---TC-CC--CC-----
T ss_pred             CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC--CCHHHHHHHHHH---CC-CC--CC-----
T ss_conf             4203567744445828983799982456452579999999689888888--899999999970---68-88--89-----


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             2129999999999987235899999998999999971074
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 1045 (1048)
                        +...+.++.+++.+||+.+|++|||++++++.|+++-.
T Consensus       232 --p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             --65571999999999758897689399999998611321

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=369.36  Aligned_cols=258  Identities=27%  Similarity=0.441  Sum_probs=210.1

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CC---CEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEE
Q ss_conf             08754683710186189999987-99---589999935884-25499999999999954998600240447608908999
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NG---TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  841 (1048)
                      .+|++.+.||+|+||+||+|+++ ++   ..||+|++.... ....+.|.+|++++++++|||||++++++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             04278569802788299999995799788999999978445989999999999999857998886189999628877999


Q ss_pred             EEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             98234789110011256776445899999999999999999873179984974899885687899958992204654458
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++|+|.+++..   ....+++.++..++.|+++|++|||+.   +++||||||+|||++.++.+||+|||+|+...
T Consensus       106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCEEEECC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf             972279853002104---567999999999999999988988527---98357615044898899919988844315756


Q ss_pred             CCCCCE----EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf             999712----202444555458223386788860306999999999992-999986458777113899999863024433
Q 001591          922 PYDTHV----TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       922 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ......    .....||+.|+|||++.+..++.++|||||||++|||+| |++||....   ..+....+....   .. 
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~i~~~~---~~-  252 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINAIEQDY---RL-  252 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTC---CC-
T ss_pred             CCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---HHHHHHHHHCCC---CC-
T ss_conf             77776536502566688300387888369978612144535789999867999999999---999999997378---89-


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             10244347321299999999999872358999999989999999710744
Q 001591          997 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                               +.+...+..+.+++.+||+.+|++|||++++++.|+.+..+
T Consensus       253 ---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         253 ---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             ---------99742269999999997587976892999999999998418

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.52  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=206.9

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEE
Q ss_conf             308754683710186189999987-99589999935884-2549999999999995499860024044760890899998
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf             74608998972174809999999999979999998456641279999999999985799888469654046743679886


Q ss_pred             ECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             23478911001125677644589999999999999999987317998497489988568789995899220465445899
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++|+|.+++.    ....+++..+..++.|++.|++|||+.   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             CCCCCCHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf             458980899975----379999999999999999999999975---9835754689978878998798323142240468


Q ss_pred             CC-CEEECCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             97-12202444555458223386788-86030699999999999299998645877711389999986302443310244
Q 001591          924 DT-HVTTDLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       924 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      .. ......+||+.|+|||++.+..+ +.++||||+||++|||++|++||.......  ....   .........     
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~---~~~~~~~~~-----  226 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYS---DWKEKKTYL-----  226 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHH---HHHTTCTTS-----
T ss_pred             CCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHH--HHHH---HHHCCCCCC-----
T ss_conf             865311132557474287286189999971016173799999982997888898599--9999---986388878-----


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             3473212999999999998723589999999899999--9971
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                          ......+.++.+++.+|++.||++|||++|+++  |+++
T Consensus       227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         227 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             ----864469999999999976799668909999961984585

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.97  Aligned_cols=261  Identities=28%  Similarity=0.477  Sum_probs=207.3

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEE
Q ss_conf             3087546837101861899999879958999993588--42549999999999995499860024044760890899998
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.+.||+|+||+||+|+++  ..||+|++...  .....+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             451899889830788589999999--989999997346998999999999999984799878645679715-58999996


Q ss_pred             ECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             23478911001125677644589999999999999999987317998497489988568789995899220465445899
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++|+|.++++.   ....+++..+..++.|+++|++|||+.   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 y~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          84 WCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             CCCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf             5899888999852---357899999999999999998887509---9951614789979818997887500221333556


Q ss_pred             CC-CEEECCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf             97-12202444555458223386---788860306999999999992999986458777113899999863024433102
Q 001591          924 DT-HVTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       924 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      .. .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.....   ..........  ....... 
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~---~~~~~~~~~~--~~~~p~~-  231 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIFMVGR--GYLSPDL-  231 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHHHHHH--TSCCCCG-
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHC--CCCCCCC-
T ss_conf             776312566557431799999505689999531516359999999978899899896---9999999965--8889860-


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             44347321299999999999872358999999989999999710744
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                           .......+.++.+++.+||+.+|++|||++++++.|+.++.+
T Consensus       232 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         232 -----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             -----003655549999999997588976892999999999999970

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=364.35  Aligned_cols=255  Identities=21%  Similarity=0.358  Sum_probs=211.0

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEEC
Q ss_conf             08754683710186189999987-99589999935884254999999999999549986002404476089089999823
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  845 (1048)
                      ++|++.+.||+|+||+||+|++. +++.||+|++..........+.+|+++++.++||||+++++++.+++..|+||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf             03599899931778299999998999799999988726467999999999998679979891999999899999999828


Q ss_pred             CCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf             47891100112567764458999999999999999998731799849748998856878--9995899220465445899
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD--EKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      +||+|.+++..   ....+++.++..++.|++.||+|||+.   ||+||||||+|||++  .++.+||+|||+|+.....
T Consensus       109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf             99808888986---389989999999999999999999977---926513144553113467884899525630343788


Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             97122024445554582233867888603069999999999929999864587771138999998630244331024434
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      .  ......||+.|+|||++.+..++.++||||+||++|||+||++||...   ...+....+....   ..   .....
T Consensus       183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~---~~---~~~~~  251 (352)
T d1koba_         183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVKRCD---WE---FDEDA  251 (352)
T ss_dssp             S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHHCC---CC---CCSST
T ss_pred             C--CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHCC---CC---CCCCC
T ss_conf             7--201004764534899974799897633389899999999688998997---9999999998478---89---89300


Q ss_pred             CCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             73212999999999998723589999999899999--9971
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                      +    ...+.++.+++.+|++.||.+|||+.|+++  ++++
T Consensus       252 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         252 F----SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             T----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             C----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             2----479999999999975699668918999960973488

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.24  Aligned_cols=254  Identities=21%  Similarity=0.332  Sum_probs=206.8

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEEC
Q ss_conf             08754683710186189999987-99589999935884254999999999999549986002404476089089999823
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  845 (1048)
                      +.|++.+.||+|+||+||+|++. ++..||+|++........+.+.+|+++++.++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             37598479930778199999999999399999987289999999999999998679999884988980099589999627


Q ss_pred             CCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47891100112567764458999999999999999998731799849748998856878999589922046544589997
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|+|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus        92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~  164 (288)
T d2jfla1          92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I  164 (288)
T ss_dssp             TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred             CCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-C
T ss_conf             99818899986---289999999999999999999999988---9887140700314878999899716123035778-6


Q ss_pred             CEEECCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             1220244455545822338-----67888603069999999999929999864587771138999998630244331024
Q 001591          926 HVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ......+||+.|+|||++.     ...++.++||||+||++|||++|++||....   ..+....+..   ... ...  
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~---~~~~~~~i~~---~~~-~~~--  235 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN---PMRVLLKIAK---SEP-PTL--  235 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC---GGGHHHHHHH---SCC-CCC--
T ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHC---CCC-CCC--
T ss_conf             4100102562647999983202578888806657878999999820889999989---9999999970---799-877--


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHH
Q ss_conf             43473212999999999998723589999999899999--997
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1041 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~ 1041 (1048)
                           ..+...+.++.+++.+|++.||++|||++|+++  ++.
T Consensus       236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~  273 (288)
T d2jfla1         236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT  273 (288)
T ss_dssp             -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf             -----76566999999999997669966891999996292318

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.30  Aligned_cols=256  Identities=23%  Similarity=0.359  Sum_probs=208.4

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEE--CCCEEE
Q ss_conf             308754683710186189999987-99589999935884--2549999999999995499860024044760--890899
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLL  840 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l  840 (1048)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+  .+..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             33379967983088919999999999979999998746579799999999999999778999824899999178998999


Q ss_pred             EEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf             99823478911001125677644589999999999999999987317--9984974899885687899958992204654
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC--EPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ||||+++|+|.+++.........+++..++.++.|++.|+.|||+..  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf             99568999389999851545789999999999999999999999716778878858676542574788857980010003


Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf             45899971220244455545822338678886030699999999999299998645877711389999986302443310
Q 001591          919 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       919 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ...... ......+||+.|+|||++.+..++.++||||+||++|||+||++||...   ...+....+...    ....+
T Consensus       163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~~~i~~~----~~~~~  234 (269)
T d2java1         163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREG----KFRRI  234 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHT----CCCCC
T ss_pred             ECCCCC-CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCC---CHHHHHHHHHCC----CCCCC
T ss_conf             224577-7556677882327999983999993898875278999980188998998---999999999718----99889


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             2443473212999999999998723589999999899999
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 1038 (1048)
                               +...+.++.+++.+|++.||++|||++|+++
T Consensus       235 ---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             ---------7435999999999976799557918999972

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.87  Aligned_cols=255  Identities=22%  Similarity=0.378  Sum_probs=214.0

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEEC
Q ss_conf             30875468371018618999998799589999935884254999999999999549986002404476089089999823
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  845 (1048)
                      .++|+..+.||+|+||+||+|+++++..||+|+++.... ..+++.+|+.++++++||||+++++++.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf             699799689820788399999988998999999874757-7899999999999668986015889985078169999704


Q ss_pred             CCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47891100112567764458999999999999999998731799849748998856878999589922046544589997
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|++..++..   ....+++..+.+++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf             89938886410---246776899999999999999987546---843466541358876998479886144202357872


Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             12202444555458223386788860306999999999992-99998645877711389999986302443310244347
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .......||+.|+|||++.+..++.++||||||+++|||+| |+.||....   ..+....+..   . ..  ...+.  
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~~i~~---~-~~--~~~p~--  224 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQ---G-LR--LYRPH--  224 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHHT---T-CC--CCCCT--
T ss_pred             EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCC---HHHHHHHHHH---C-CC--CCCCC--
T ss_conf             252465788775780786379988521033643246739755999988999---9999999980---7-97--89965--


Q ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             321299999999999872358999999989999999710
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 1043 (1048)
                           ..+.++.+++.+||+.+|++|||++++++.|.+|
T Consensus       225 -----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         225 -----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf             -----4659999999997668976893999999874188

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.97  Aligned_cols=249  Identities=27%  Similarity=0.422  Sum_probs=207.5

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEE
Q ss_conf             08754683710186189999987-99589999935884---254999999999999549986002404476089089999
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+|++. +++.||+|++.+..   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             82347891100112567764458999999999999999998731799849748998856878999589922046544589
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf             50479858988750----48999999999999999999999988---946522023441466899871155563354488


Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             99712202444555458223386788860306999999999992999986458777113899999863024433102443
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...   ...+....+.   .....  .    
T Consensus       159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~---~~~~~--~----  223 (263)
T d2j4za1         159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRIS---RVEFT--F----  223 (263)
T ss_dssp             C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHH---TTCCC--C----
T ss_pred             C---CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC---CHHHHHHHHH---CCCCC--C----
T ss_conf             8---523557887634999975899893144046759999983299998889---9999999997---18999--9----


Q ss_pred             CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             473212999999999998723589999999899999--9971
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                           +...+.++.+++.+|++.||++|||++|+++  ++.+
T Consensus       224 -----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         224 -----PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             -----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             -----8668999999999976479768909999971907078

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.27  Aligned_cols=258  Identities=24%  Similarity=0.377  Sum_probs=207.9

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEECC-C-----CEEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEECCEEEECCC
Q ss_conf             3087546837101861899999879-9-----589999935884-25499999999999954-99860024044760890
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTN-G-----TKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  837 (1048)
                      .++|++.++||+|+||+||+|++.. +     .+||+|++.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf             89939701983078819999998578855420499999966335878999999999999971589968687788862995


Q ss_pred             EEEEEEECCCCCHHHHCCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf             8999982347891100112567-------------------764458999999999999999998731799849748998
Q 001591          838 RLLIYSYMENGSLDYWLHESVD-------------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS  898 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  898 (1048)
                      .++||||+++|+|.++++....                   ....+++..++.++.|++.|++|||+.   +|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCH
T ss_conf             89999727999599999862577751022100001222001257789999999999999999999739---905052703


Q ss_pred             CCEEECCCCCEEEEECCCCCCCCCCCCC-EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf             8568789995899220465445899971-2202444555458223386788860306999999999992-9999864587
Q 001591          899 SNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG  976 (1048)
Q Consensus       899 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~  976 (1048)
                      +||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |++||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf             21443459828985142222045778615623435787657838872799996330300039999998389999999898


Q ss_pred             CCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf             77113899999863024433102443473212999999999998723589999999899999997
Q 001591          977 KNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1041 (1048)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 1041 (1048)
                      .   .....+   .......         +.+...+.++.+++.+||+.+|++|||++|+++.|.
T Consensus       273 ~---~~~~~~---~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 D---ANFYKL---IQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             S---HHHHHH---HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H---HHHHHH---HHCCCCC---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             9---999999---8569989---------988767899999999975889668939999999974

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=362.21  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=208.1

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEE
Q ss_conf             308754683710186189999987-99589999935884-2549999999999995499860024044760890899998
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  843 (1048)
                      .+.|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             66669988994065839999999999989999998157731289999999999986799899919899998998889885


Q ss_pred             ECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCC
Q ss_conf             2347891100112567764458999999999999999998731799849748998856878---9995899220465445
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLL  920 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfg~a~~~  920 (1048)
                      |++||+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||++.   +++.+||+|||+|+..
T Consensus        88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             CCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf             2689848886530----36788789999999999998752413---0556870463001104688824998315435872


Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             89997122024445554582233867888603069999999999929999864587771138999998630244331024
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ...  ......+||+.|+|||++.+..++.++||||+||++|||++|++||...   ...+....+..   .....   .
T Consensus       161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~---~~~~~---~  229 (307)
T d1a06a_         161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILK---AEYEF---D  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHT---TCCCC---C
T ss_pred             CCC--CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHC---CCCCC---C
T ss_conf             589--7044003284225918873799980787345159999998597999998---99999999861---68777---8


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             43473212999999999998723589999999899999--9971
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                      ...    ....+.++.+++.+|++.||++|||++|+++  ++.+
T Consensus       230 ~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         230 SPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             766----6678999999999976089757918999862984479

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.60  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=207.9

Q ss_pred             CCCCCCCEEECCCCEEEEEEEECCC-----CEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEE
Q ss_conf             0875468371018618999998799-----589999935884-2549999999999995499860024044760890899
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNG-----TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  840 (1048)
                      ..|+..++||+|+||+||+|.++..     ..||||++.... .....++.+|++++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf             99686159811779099999996899878799999998844596899999999999985689878323677833880389


Q ss_pred             EEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             99823478911001125677644589999999999999999987317998497489988568789995899220465445
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ||||+.+|++.+++..   ....+++..+..++.|++.|+.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEECCCCCCHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf             9972135740222102---345420899999999999854121212---3425765644278889984998455103003


Q ss_pred             CCCCC--CEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf             89997--1220244455545822338678886030699999999999299998645877711389999986302443310
Q 001591          921 RPYDT--HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       921 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|..|+...  ....+....+...    ...  
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~----~~~--  232 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAINDG----FRL--  232 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTT----CCC--
T ss_pred             CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC--CCHHHHHHHHHCC----CCC--
T ss_conf             57876526742677773434888870499997355634489899999679886556--8999999998635----789--


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             244347321299999999999872358999999989999999710744
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                             +.+...+.++.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       233 -------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         233 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             -------98504579999999997767976893999999999998669

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.38  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=206.5

Q ss_pred             CCCCCCCE-EECCCCEEEEEEEEC---CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEE
Q ss_conf             08754683-710186189999987---99589999935884-25499999999999954998600240447608908999
Q 001591          767 NNFNQANI-IGCGGFGLVYKATLT---NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  841 (1048)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||++.... ....+.+.+|++++++++|||||++++++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf             4718878487306080999999960897689999998820397899999999999986799888068656036-807999


Q ss_pred             EEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             98234789110011256776445899999999999999999873179984974899885687899958992204654458
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++|+|.+++..   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf             980789968997521---256999999999999999987899868---81057676466045468854203313421155


Q ss_pred             CCCCCE--EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf             999712--202444555458223386788860306999999999992-99998645877711389999986302443310
Q 001591          922 PYDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       922 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ......  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....   .+....+..   . ...+ 
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~---~-~~~~-  232 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQ---G-KRME-  232 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHT---T-CCCC-
T ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH---HHHHHHHHC---C-CCCC-
T ss_conf             4343211356211374335868872799995412322017899999389999999799---999999981---8-9999-


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             24434732129999999999987235899999998999999971074
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 1045 (1048)
                              .+...+.++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       233 --------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         233 --------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             --------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             --------997678999999999757797689099999999999999

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=359.04  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=200.9

Q ss_pred             CCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEE
Q ss_conf             8754683710186189999987-99589999935884---2549999999999995499860024044760890899998
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  843 (1048)
                      .|+..+.||+|+||+||+|++. +++.||+|++....   ....+.+.+|+++++.++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf             56762797018880999999989993999999844443588999999999999997789998238999998998899998


Q ss_pred             ECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             23478911001125677644589999999999999999987317998497489988568789995899220465445899
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+++|++..+..    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+|..... 
T Consensus        96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ECCCCCHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf             069994578997----379999999999999999999999868---976667884217987999789844365334677-


Q ss_pred             CCCEEECCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             9712202444555458223386---7888603069999999999929999864587771138999998630244331024
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                          ....+||+.|+|||++.+   ..|+.++||||+||++|||++|+.||...   ...+...   ....... .... 
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~---~~~~~~~---~i~~~~~-~~~~-  235 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALY---HIAQNES-PALQ-  235 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHH---HHHHSCC-CCCS-
T ss_pred             ----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHH---HHHHCCC-CCCC-
T ss_conf             ----87313476636889983467888672145455899999998788999997---9999999---9982899-9888-


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHH
Q ss_conf             43473212999999999998723589999999899999--997
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1041 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~ 1041 (1048)
                      .       ...+.++.+++.+|++.||++|||++|+++  ++.
T Consensus       236 ~-------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         236 S-------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             C-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHC
T ss_conf             7-------88899999999997737965791899997199753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.09  Aligned_cols=247  Identities=24%  Similarity=0.343  Sum_probs=205.2

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEE
Q ss_conf             08754683710186189999987-99589999935884---254999999999999549986002404476089089999
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+|++. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             82347891100112567764458999999999999999998731799849748998856878999589922046544589
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+++|+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+|+....
T Consensus        88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf             70489877776531----59999999999999999999762165---088476774123668885388603210242256


Q ss_pred             CC-CCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             99-71220244455545822338678886030699999999999299998645877711389999986302443310244
Q 001591          923 YD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       923 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      .. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...   +..+....+.   ....  .+   
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~---~~~~--~~---  229 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKII---KLEY--DF---  229 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH---TTCC--CC---
T ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCC---CHHHHHHHHH---CCCC--CC---
T ss_conf             77643335556775525844002689896662304569999980388998995---9999999997---1899--99---


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf             347321299999999999872358999999989999
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1037 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 1037 (1048)
                            +...+.++.+++.+|++.||++|||++|++
T Consensus       230 ------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         230 ------PEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHC
T ss_conf             ------854799999999998557976891978973

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.93  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=208.9

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC------HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEE
Q ss_conf             08754683710186189999987-99589999935884------254999999999999549986002404476089089
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  839 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  839 (1048)
                      ++|++.+.||+|+||+||+|++. +|+.||+|++.+..      ....+.+.+|+.+++.++|||||++++++.+++..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             67798279811789599999999999899999987566321340689999999999998679989993889999799899


Q ss_pred             EEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEECC
Q ss_conf             99982347891100112567764458999999999999999998731799849748998856878999----58992204
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADFG  915 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg  915 (1048)
                      +||||+++|+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++    .+|++|||
T Consensus        90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEECCCCCCCCCHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf             99986778643100103----56421557899999999998766625---422113330127982589866646964334


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             65445899971220244455545822338678886030699999999999299998645877711389999986302443
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  995 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1048)
                      +|.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...   +..+....+...   ...
T Consensus       163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~---~~~  234 (293)
T d1jksa_         163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAV---NYE  234 (293)
T ss_dssp             TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTT---CCC
T ss_pred             HHHHCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHHC---CCC
T ss_conf             421057776--312247777430999981899997665221409999997088998899---999999999816---888


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf             3102443473212999999999998723589999999899999--997107
Q 001591          996 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~ 1044 (1048)
                             .........+..+.+++.+|++.||++|||++|+++  ++++..
T Consensus       235 -------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         235 -------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             -------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             -------CCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf             -------87010478899999999998638966891999996190418887

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.15  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=211.0

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEEC
Q ss_conf             30875468371018618999998799589999935884254999999999999549986002404476089089999823
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  845 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  845 (1048)
                      .++|++.+.||+|+||.||+|+++++.+||+|++.... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf             79979846993079809999999999999999988044-888999999999986666788689999823-9759999944


Q ss_pred             CCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47891100112567764458999999999999999998731799849748998856878999589922046544589997
Q 001591          846 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  925 (1048)
Q Consensus       846 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~  925 (1048)
                      ++|++..++...  ....+++.+++.++.|++.|++|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus        94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf             799435420000--355305999999999999999987541---143353123079998999299844255542568873


Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             12202444555458223386788860306999999999992999986458777113899999863024433102443473
Q 001591          926 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1005 (1048)
Q Consensus       926 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      .......||+.|+|||++....++.++||||||+++|||++|..|+..  +....+....+....    ...        
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~--~~~~~~~~~~i~~~~----~~~--------  234 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGY----RMP--------  234 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHTTC----CCC--------
T ss_pred             EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCC--CCCHHHHHHHHHHCC----CCC--------
T ss_conf             352454556654580898379989177413235899999868999998--888999999998268----999--------


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             21299999999999872358999999989999999710744
Q 001591         1006 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus      1006 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                       .+...+.++.+++.+||+.+|++||++++|+++|+++-..
T Consensus       235 -~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         235 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             -9832379999999997566975891999999987666238

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.91  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=207.6

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEE
Q ss_conf             308754683710186189999987-99589999935884---25499999999999954998600240447608908999
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  841 (1048)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             98234789110011256776445899999999999999999873179984974899885687899958992204654458
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++|+|.+++..    ...+++..++.++.|++.|+.|||+.   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf             003579860555532----56775999999999996521134315---96224647778476589988882056520035


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             99971220244455545822338678886030699999999999299998645877711389999986302443310244
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ... ......+||+.|+|||++.+..|+.++||||+||++|||++|++||...   +..++...+..   ...  ..   
T Consensus       157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~---~~~~~~~~i~~---~~~--~~---  224 (337)
T d1o6la_         157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILM---EEI--RF---  224 (337)
T ss_dssp             CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH---CCC--CC---
T ss_pred             CCC-CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCC---CHHHHHHHHHC---CCC--CC---
T ss_conf             678-6205510088996666504898883331022306788998789999996---99999999852---899--89---


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH--HHHH
Q ss_conf             3473212999999999998723589999999-----899999--9971
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDG 1042 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~--~L~~ 1042 (1048)
                            +...+.++.+++.+|+++||.+|++     +.++++  ++++
T Consensus       225 ------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         225 ------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             ------CCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCC
T ss_conf             ------866899999999866638934422565234999972915036

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.43  Aligned_cols=247  Identities=28%  Similarity=0.409  Sum_probs=195.5

Q ss_pred             CCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEE----CCCEEEE
Q ss_conf             754683710186189999987-99589999935884--2549999999999995499860024044760----8908999
Q 001591          769 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH----GNDRLLI  841 (1048)
Q Consensus       769 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  841 (1048)
                      |+..+.||+|+||+||+|.+. ++..||+|++....  ....+.+.+|++++++++||||+++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf             88516970082849999999999959999998512279899999999999998579998506999984033458889999


Q ss_pred             EEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCCCC
Q ss_conf             982347891100112567764458999999999999999998731799849748998856878-9995899220465445
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLL  920 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~a~~~  920 (1048)
                      |||+++|+|.+++..    ...+++..+..++.|++.|++|||+. .++|+||||||+|||++ +++.+||+|||+|+..
T Consensus        91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf             957898948999751----35546999999999999999999978-9979968767435116679998898005765423


Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             89997122024445554582233867888603069999999999929999864587771138999998630244331024
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1000 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ...   .....+||+.|+|||++.+ .++.++||||+||++|||++|+.||....  ........+   ... ....   
T Consensus       166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i---~~~-~~~~---  232 (270)
T d1t4ha_         166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRV---TSG-VKPA---  232 (270)
T ss_dssp             CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHH---TTT-CCCG---
T ss_pred             CCC---CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHH---HCC-CCCC---
T ss_conf             687---6677553813008988478-99986711007999999987889998765--599999999---738-9986---


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             43473212999999999998723589999999899999
Q 001591         1001 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1038 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 1038 (1048)
                           ..+...+.++.+++.+|++.||++|||++|+++
T Consensus       233 -----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -----567557899999999976379758929999967

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.54  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=201.5

Q ss_pred             CEEECCCCEEEEEEEEC---CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEECCC
Q ss_conf             83710186189999987---99589999935884--25499999999999954998600240447608908999982347
Q 001591          773 NIIGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  847 (1048)
Q Consensus       773 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  847 (1048)
                      +.||+|+||+||+|.++   .++.||+|++....  ....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf             89110011256776445899999999999999999873179984974899885687899958992204654458999712
Q 001591          848 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  927 (1048)
Q Consensus       848 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  927 (1048)
                      |+|.++++.    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++.........
T Consensus        92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf             968999752----25789999999999999997668747---95567776113102356751234134533134323443


Q ss_pred             E--ECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             2--02444555458223386788860306999999999992-99998645877711389999986302443310244347
Q 001591          928 T--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1004 (1048)
Q Consensus       928 ~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .  ....||+.|+|||++.+..++.++|||||||++|||+| |++||....   ..+....+..    +....       
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~~i~~----~~~~~-------  230 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEK----GERMG-------  230 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHT----TCCCC-------
T ss_pred             CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC---HHHHHHHHHC----CCCCC-------
T ss_conf             224456778420391665379998434430340313289658999999989---9999999982----89999-------


Q ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             3212999999999998723589999999899999997107
Q 001591         1005 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus      1005 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 1044 (1048)
                        .+...+.++.+++.+||+.||++|||++++++.|+.+-
T Consensus       231 --~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         231 --CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf             --98656799999999975889768909899999852887

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.78  Aligned_cols=256  Identities=23%  Similarity=0.386  Sum_probs=207.1

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCC----EEEEEEECCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEE
Q ss_conf             08754683710186189999987-995----8999993588-42549999999999995499860024044760890899
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  840 (1048)
                      .+|++.++||+|+||+||+|.+. +++    +||+|++... .....+++.+|++++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf             999783198208992999999958998898999999965134979999999999999867998881589999619-8369


Q ss_pred             EEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             99823478911001125677644589999999999999999987317998497489988568789995899220465445
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ++||+.+|+|.+++..   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEECCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf             9984268740101113---345799999999999999999999876---9504762120311679987586025522233


Q ss_pred             CCCCCCE-EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf             8999712-202444555458223386788860306999999999992-99998645877711389999986302443310
Q 001591          921 RPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI  998 (1048)
Q Consensus       921 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      ....... .....||+.|+|||++.+..++.++||||||+++|||+| |++||.....   .++...+....+.      
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~i~~~~~~------  232 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERL------  232 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHHHHHTCCC------
T ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHCCCCC------
T ss_conf             5444532236510586446708874699983565440799999999779999999998---9999999759989------


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             24434732129999999999987235899999998999999971074
Q 001591          999 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 1045 (1048)
                             ..+...+.++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       233 -------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         233 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -------9985568999999998478993469199999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=349.69  Aligned_cols=254  Identities=28%  Similarity=0.364  Sum_probs=199.7

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHH---HHHHHHCCCCCEEEECCEEEECCCE
Q ss_conf             308754683710186189999987-99589999935884---2549999999---9999954998600240447608908
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAE---VEALSRAQHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~  838 (1048)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++.+..   ......+.+|   +.+++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf             77685101884288909999999999979999998458754266799999999999998508998588999999989988


Q ss_pred             EEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf             99998234789110011256776445899999999999999999873179984974899885687899958992204654
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      |+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEE
T ss_conf             999991489838999873----25532789999999999999999977---96220444221678588967982201023


Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf             45899971220244455545822338-67888603069999999999929999864587771138999998630244331
Q 001591          919 LLRPYDTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE  997 (1048)
Q Consensus       919 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  997 (1048)
                      ......   ....+||+.|+|||++. +..++.++||||+||++|||+||+.||..........    +........ ..
T Consensus       156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~-~~  227 (364)
T d1omwa3         156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMA-VE  227 (364)
T ss_dssp             ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCC-CC
T ss_pred             ECCCCC---CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHHCCCCC-CC
T ss_conf             337886---4331134554216876038999844104677899999985999888899899999----998604688-87


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH--HHHHC
Q ss_conf             02443473212999999999998723589999999-----899999--99710
Q 001591          998 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDGI 1043 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~--~L~~i 1043 (1048)
                           ...    ..+.++.+++.+|++.||++|||     ++++++  +++++
T Consensus       228 -----~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         228 -----LPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             -----CCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             -----CCC----CCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf             -----887----78999999999985669888088743579999749102378

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.44  Aligned_cols=255  Identities=18%  Similarity=0.301  Sum_probs=208.1

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEE
Q ss_conf             308754683710186189999987-9958999993588425499999999999954998600240447608908999982
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  844 (1048)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++..... ....+.+|+++++.++||||+++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf             0105887898317783999999989996999999757866-599999999999857997989098999889988999953


Q ss_pred             CCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCC
Q ss_conf             3478911001125677644589999999999999999987317998497489988568789--99589922046544589
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE--KFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfg~a~~~~~  922 (1048)
                      ++||+|.+++..   ....+++.++..++.|++.|+.|||+.   +|+||||||+||+++.  ...+|++|||+++....
T Consensus        83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf             899808899875---389999999999999999999999876---99751355444344378851899764411100346


Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             99712202444555458223386788860306999999999992999986458777113899999863024433102443
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .  ......+|++.|+|||...+..++.++||||+||++|+|++|+.||...   ...+....+..   ....   ... 
T Consensus       157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~---~~~~---~~~-  224 (321)
T d1tkia_         157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMN---AEYT---FDE-  224 (321)
T ss_dssp             T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH---TCCC---CCH-
T ss_pred             C--CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCC---CHHHHHHHHHH---CCCC---CCH-
T ss_conf             7--7532122332223402104877784011302799999998289999998---99999999983---8999---880-


Q ss_pred             CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             473212999999999998723589999999899999--9971
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                         ......+.++.+++.+|++.||++|||++|+++  ++.+
T Consensus       225 ---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         225 ---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             ---223678999999999986699668909999963996566

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=350.45  Aligned_cols=250  Identities=26%  Similarity=0.349  Sum_probs=206.3

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEE
Q ss_conf             308754683710186189999987-99589999935884---25499999999999954998600240447608908999
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  841 (1048)
                      .++|++.+.||+|+||+||+|+++ +|+.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf             54708888972076808999999899979999998457754889999999999999863696753303568528800567


Q ss_pred             EEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             98234789110011256776445899999999999999999873179984974899885687899958992204654458
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||++||++..++..    ...+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        83 mE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          83 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EEECCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEEC
T ss_conf             650378632234322----22111007999999998765541247---67705568105038689988983175216712


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             99971220244455545822338678886030699999999999299998645877711389999986302443310244
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ..    ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...   +..+....+.   .....      
T Consensus       156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~---~~~~~------  219 (316)
T d1fota_         156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKIL---NAELR------  219 (316)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHH---HCCCC------
T ss_pred             CC----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCC---CHHHHHHHHH---CCCCC------
T ss_conf             45----64345763435999983899980430465333689997598999996---9999999997---08988------


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH--HHHHC
Q ss_conf             347321299999999999872358999999-----9899999--99710
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT--WLDGI 1043 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~--~L~~i 1043 (1048)
                           .+...+.++.+++.+|++.||.+|+     |++++++  +++++
T Consensus       220 -----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         220 -----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             -----CCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCC
T ss_conf             -----99778999999999995449976664310219999819351467

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.49  Aligned_cols=255  Identities=22%  Similarity=0.287  Sum_probs=200.8

Q ss_pred             HCCCCCCC-EEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHC-CCCCEEEECCEEEE----CCCE
Q ss_conf             30875468-3710186189999987-9958999993588425499999999999954-99860024044760----8908
Q 001591          766 TNNFNQAN-IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH----GNDR  838 (1048)
Q Consensus       766 ~~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~  838 (1048)
                      .++|++.+ +||+|+||+||+|++. +++.||+|++...     ..+.+|++++.++ +||||+++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf             148798107965454869999998899989999998974-----779999999998669999782989995034689789


Q ss_pred             EEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECC
Q ss_conf             9999823478911001125677644589999999999999999987317998497489988568789---9958992204
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE---KFEAHLADFG  915 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg  915 (1048)
                      |+||||++||+|.+++...  ....+++.++..++.|++.|++|||+.   +|+||||||+||+++.   .+.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             9999778998499999862--787757999999999999999999976---98644410022011355556631135455


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             65445899971220244455545822338678886030699999999999299998645877711389999986302443
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  995 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1048)
                      +|+.......  ....+||+.|+|||++.+..|+.++||||+||++|+|+||++||........   ...+.......  
T Consensus       160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~--  232 (335)
T d2ozaa1         160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMG--  232 (335)
T ss_dssp             TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC--
T ss_pred             EEEECCCCCC--CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH---HHHHHHHHHCC--
T ss_conf             1233368886--4322677563792777489888888887645167788658899889887788---99999998538--


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHH
Q ss_conf             3102443473212999999999998723589999999899999--997
Q 001591          996 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1041 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~ 1041 (1048)
                          ............+.++.+++.+|++.||++|||+.|+++  ++.
T Consensus       233 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         233 ----QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             ----SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             ----CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHH
T ss_conf             ----88889854346999999999997569965790999997098761

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=356.00  Aligned_cols=262  Identities=29%  Similarity=0.427  Sum_probs=212.3

Q ss_pred             HHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCEEEECCEEEECCC
Q ss_conf             6308754683710186189999987------995899999358842-549999999999995499860024044760890
Q 001591          765 STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       765 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  837 (1048)
                      ..++|++.+.||+|+||+||+|+++      ++..||+|++..... ....++.+|+++++.++||||+++++++...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf             98893886798207883999999888765778829999998821085799999999999996689976552466605980


Q ss_pred             EEEEEEECCCCCHHHHCCCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf             899998234789110011256--------------------776445899999999999999999873179984974899
Q 001591          838 RLLIYSYMENGSLDYWLHESV--------------------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVK  897 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  897 (1048)
                      .++++||+++|+|.++++...                    .....+++..++.++.|++.|++|||+.   +++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEEC
T ss_conf             389998158992999998527554210000111001210346788989999999999999985541357---86854884


Q ss_pred             CCCEEECCCCCEEEEECCCCCCCCCCC-CCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCC
Q ss_conf             885687899958992204654458999-71220244455545822338678886030699999999999299-9986458
Q 001591          898 SSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR-RPVEVCK  975 (1048)
Q Consensus       898 ~~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~-~p~~~~~  975 (1048)
                      |+|||++.++.+||+|||+|+...... ........|++.|+|||.+.+..++.++|||||||++|||++|. +||... 
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-  246 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-  246 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred             CCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCC-
T ss_conf             0116898999289833144211367764111577776767679899726889805630252362999980689999998-


Q ss_pred             CCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             7771138999998630244331024434732129999999999987235899999998999999971074
Q 001591          976 GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1045 (1048)
Q Consensus       976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 1045 (1048)
                        ...+....+..   . .....         +...+.++.+++.+||+.+|++||||.||+++|++|.+
T Consensus       247 --~~~e~~~~v~~---~-~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         247 --AHEEVIYYVRD---G-NILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             --CHHHHHHHHHT---T-CCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --CHHHHHHHHHC---C-CCCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             --99999999973---9-97888---------73252999999999748896579399999999998429

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=347.79  Aligned_cols=249  Identities=19%  Similarity=0.272  Sum_probs=206.3

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEE
Q ss_conf             08754683710186189999987-99589999935884---254999999999999549986002404476089089999
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  842 (1048)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             82347891100112567764458999999999999999998731799849748998856878999589922046544589
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  922 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~  922 (1048)
                      ||+.+|++..++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf             23346622666751----58989999999999999989999859---986176799993607789788610103332256


Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             99712202444555458223386788860306999999999992999986458777113899999863024433102443
Q 001591          923 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1002 (1048)
Q Consensus       923 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .    ....+||+.|+|||++.+..++.++||||+||++|||+||++||...   +.......+..   ....  .    
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~---~~~~--~----  257 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVS---GKVR--F----  257 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH---CCCC--C----
T ss_pred             C----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC---CHHHHHHHHHC---CCCC--C----
T ss_conf             6----64336763567889971799885331145007899997588998995---99999999861---7988--9----


Q ss_pred             CCCHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH--HHHHC
Q ss_conf             47321299999999999872358999999-----9899999--99710
Q 001591         1003 IWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT--WLDGI 1043 (1048)
Q Consensus      1003 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~--~L~~i 1043 (1048)
                           +...+.++.+++.+|++.||.+|+     |++++++  ++.++
T Consensus       258 -----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         258 -----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             -----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             -----CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCC
T ss_conf             -----7668999999999983409986065534549999719051589

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.60  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=210.4

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEECC----CCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEE
Q ss_conf             3087546837101861899999879----9589999935884-2549999999999995499860024044760890899
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  840 (1048)
                      .++|++.+.||+|+||.||+|.+..    +..||+|++.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf             8996987799307882999999936996449999999365668799999999999998689999856988995-374799


Q ss_pred             EEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             99823478911001125677644589999999999999999987317998497489988568789995899220465445
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  920 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~  920 (1048)
                      ||||+++|++.+++..   ....+++..+..++.|++.|+.|||+.   +++||||||+||++++++.+||+|||+|+..
T Consensus        85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf             9984069807765422---478999999999999998775230226---7441410265532067896787650342133


Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf             8999712202444555458223386788860306999999999992-999986458777113899999863024433102
Q 001591          921 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII  999 (1048)
Q Consensus       921 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ............||+.|+|||++.+..++.++|||||||++|||++ |.+||.....   .+....+....   . ..  
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~~~~---~-~~--  229 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGE---R-LP--  229 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTC---C-CC--
T ss_pred             CCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH---HHHHHHHHCCC---C-CC--
T ss_conf             677623305400583103266751699887452444247899998269999888999---99999998189---9-98--


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             44347321299999999999872358999999989999999710744
Q 001591         1000 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                             .+...+.++.+++.+||+.||++|||+.++++.|+.+.++
T Consensus       230 -------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             -------9877799999999997687976892999999999999778

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=346.06  Aligned_cols=259  Identities=23%  Similarity=0.348  Sum_probs=208.9

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC----C
Q ss_conf             308754683710186189999987-99589999935884---254999999999999549986002404476089----0
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN----D  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~  837 (1048)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....   ......+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             89999823478911001125677644589999999999999999987317998497489988568789995899220465
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .|+||||++|++|.+++..    ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++..+++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEEHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf             9999977889871011203----58999999999999999999999857---9527634675566575432010034443


Q ss_pred             CCCCCCCC--CEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             44589997--1220244455545822338678886030699999999999299998645877711389999986302443
Q 001591          918 RLLRPYDT--HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  995 (1048)
Q Consensus       918 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1048)
                      ........  ......+||+.|+|||++.+..++.++||||+||++|||+||++||...   ...+..   .........
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~---~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SPVSVA---YQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHH---HHHHHCCCC
T ss_pred             HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCC---CHHHHH---HHHHHCCCC
T ss_conf             22123544333346425762436999983999996632026528999997697998996---999999---999846999


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHCC
Q ss_conf             310244347321299999999999872358999999-9899999997107
Q 001591          996 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP-FIEEVVTWLDGIG 1044 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~i~ 1044 (1048)
                      ..   ...+.    ..+.++.+++.+|+++||.+|| +++++++.|.++.
T Consensus       233 ~~---~~~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 PP---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CG---GGTSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CC---CHHCC----CCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf             97---10034----789999999999866797677739999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.14  Aligned_cols=269  Identities=25%  Similarity=0.357  Sum_probs=208.1

Q ss_pred             HHHHHHHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEECCE
Q ss_conf             999996308754683710186189999987------99589999935884-25499999999999954-99860024044
Q 001591          760 SDLLKSTNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGY  831 (1048)
Q Consensus       760 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~  831 (1048)
                      ..+....++|++.+.||+|+||.||+|++.      +++.||+|++.... ....+.+..|...+.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf             25261679979844984167839999998677755578399999986001717899999999998861499849974115


Q ss_pred             EEECC-CEEEEEEECCCCCHHHHCCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf             76089-08999982347891100112567------------764458999999999999999998731799849748998
Q 001591          832 CRHGN-DRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS  898 (1048)
Q Consensus       832 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  898 (1048)
                      +...+ ..++||||+++|+|.++++....            ....+++..+..++.|++.|+.|||+.   +|+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             ECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCC
T ss_conf             40479757999984589929999985366666532220233214689999999999999999988737---971786773


Q ss_pred             CCEEECCCCCEEEEECCCCCCCCCCCCC-EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCC
Q ss_conf             8568789995899220465445899971-22024445554582233867888603069999999999929-999864587
Q 001591          899 SNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG-RRPVEVCKG  976 (1048)
Q Consensus       899 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG-~~p~~~~~~  976 (1048)
                      +|||+++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++| .+||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             CCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH
T ss_conf             10657799828984575200113566522247516672102036864688996632213678999998688999989998


Q ss_pred             CCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             7711389999986302443310244347321299999999999872358999999989999999710744
Q 001591          977 KNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      .  ......+..    +.....         +...+.++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       243 ~--~~~~~~~~~----~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         243 D--EEFCRRLKE----GTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             S--HHHHHHHHH----TCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H--HHHHHHHHC----CCCCCC---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             9--999999963----898888---------865789999999997677966791999999999799867

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.36  Aligned_cols=254  Identities=27%  Similarity=0.402  Sum_probs=208.9

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE-CCCEEEEEEE
Q ss_conf             308754683710186189999987995899999358842549999999999995499860024044760-8908999982
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH-GNDRLLIYSY  844 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  844 (1048)
                      .++|++.+.||+|+||.||+|+++ +.+||+|+++.+.  ..+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf             899488579820798089999999-9099999988577--7999999999998678989854987887238928999963


Q ss_pred             CCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             34789110011256776445899999999999999999873179984974899885687899958992204654458999
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++|+|.+++...  ....+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||.++..... 
T Consensus        83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             CCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC-
T ss_conf             6999899998745--788889999999999998523211337---6553666567601468997763245600344787-


Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             712202444555458223386788860306999999999992-9999864587771138999998630244331024434
Q 001591          925 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1003 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                         .....++..|+|||++.+..++.++||||||+++|||+| |++||...   ...+...++...    ...+      
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~~----~~~~------  220 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKG----YKMD------  220 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTTT----CCCC------
T ss_pred             ---CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHCC----CCCC------
T ss_conf             ---765566646778178727988858877757999999997899999999---999999999808----9999------


Q ss_pred             CCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             73212999999999998723589999999899999997107446
Q 001591         1004 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1047 (1048)
Q Consensus      1004 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~ 1047 (1048)
                         .+...+.++.+++.+||+.||++|||+.+++++|++++..+
T Consensus       221 ---~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         221 ---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf             ---97657999999999975669768939999999999998677

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.25  Aligned_cols=259  Identities=29%  Similarity=0.458  Sum_probs=207.3

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCC--EEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEECCEEEECCCEEEE
Q ss_conf             08754683710186189999987-995--89999935884-25499999999999954-998600240447608908999
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGT--KAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  841 (1048)
                      ++|++.++||+|+||+||+|+++ ++.  .||||++.... ....+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EEECCCCCHHHHCCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf             98234789110011256------------776445899999999999999999873179984974899885687899958
Q 001591          842 YSYMENGSLDYWLHESV------------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  909 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  909 (1048)
                      |||+++|+|.++++...            .....+++..+..++.|++.|+.|+|+.   +++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCE
T ss_conf             980289869999864035555512310123457899999999999999998766308---95455505204898688763


Q ss_pred             EEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHHHHH
Q ss_conf             99220465445899971220244455545822338678886030699999999999299-99864587771138999998
Q 001591          910 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR-RPVEVCKGKNCRDLVSWVFQ  988 (1048)
Q Consensus       910 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~-~p~~~~~~~~~~~~~~~~~~  988 (1048)
                      ||+|||+++.......  .....||..|+|||.+.+..++.++||||||+++|||++|. +||..   .+..+....+  
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~---~~~~~~~~~i--  239 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAELYEKL--  239 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHG--
T ss_pred             EECCCCCCCCCCCCCC--CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCC---CCHHHHHHHH--
T ss_conf             8743443224442234--55301377555538752699996221531388999998368999999---9999999999--


Q ss_pred             HHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             6302443310244347321299999999999872358999999989999999710744
Q 001591          989 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                       ..... .         ..+...+.++.+++.+||+.||++|||++++++.|+++..+
T Consensus       240 -~~~~~-~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         240 -PQGYR-L---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             -GGTCC-C---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -HHCCC-C---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             -82688-8---------88766789999999997678966894999999999999861

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.12  Aligned_cols=263  Identities=27%  Similarity=0.410  Sum_probs=210.5

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEECCEEEECCC
Q ss_conf             308754683710186189999987------99589999935884-25499999999999954-99860024044760890
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  837 (1048)
                      .++|++.++||+|+||.||+|++.      ++..||||++.... ......+.+|+.+++++ +|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf             89969854982068829999998066447788699999987424877999999999998762699988789989831997


Q ss_pred             EEEEEEECCCCCHHHHCCCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf             8999982347891100112567--------------76445899999999999999999873179984974899885687
Q 001591          838 RLLIYSYMENGSLDYWLHESVD--------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL  903 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll  903 (1048)
                      .++||||+++|+|.++++....              ....+++..+..++.|++.|++|||++   +++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCC
T ss_conf             899997379987999998535665444445332223345889999999999999999988757---92666241021000


Q ss_pred             CCCCCEEEEECCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHH
Q ss_conf             8999589922046544589997-12202444555458223386788860306999999999992-999986458777113
Q 001591          904 DEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD  981 (1048)
Q Consensus       904 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~  981 (1048)
                      +.++.+|++|||.++....... ......+||+.|+|||++.+..++.++||||||+++|||+| |.+||......  ..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SK  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HH
T ss_pred             CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH--HH
T ss_conf             0257521023401023367886158620135968767788617999974001025899999985899887789989--99


Q ss_pred             HHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             89999986302443310244347321299999999999872358999999989999999710744
Q 001591          982 LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      +...+..    +...         ..+...+..+.+++.+||+.||++|||+++++++|+++..+
T Consensus       257 ~~~~i~~----~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         257 FYKMIKE----GFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHH----TCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHC----CCCC---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             9999866----8988---------98543659999999997577965792999999999876534

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.60  Aligned_cols=264  Identities=23%  Similarity=0.274  Sum_probs=204.7

Q ss_pred             CCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHH-----HHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEE
Q ss_conf             4683710186189999987-9958999993588425-----499999999999954998600240447608908999982
Q 001591          771 QANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ-----MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       771 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  844 (1048)
                      ..++||+|+||+||+|++. +++.||+|++......     ..+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf             56385127282999999999996999999842021245679999999999999867999986898542258740220455


Q ss_pred             CCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             34789110011256776445899999999999999999873179984974899885687899958992204654458999
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      ++++.+.....    ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.|+......
T Consensus        82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             HCCHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf             34507765541----266778999999999999999886316---35503577625885377841146576100057875


Q ss_pred             CCEEECCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC--
Q ss_conf             712202444555458223386-78886030699999999999299998645877711389999986302443310244--
Q 001591          925 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA-- 1001 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1001 (1048)
                      . .....+||+.|+|||++.. ..++.++||||+||++|||++|++||..   ....+....+.............+.  
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~---~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             C-CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCC---CCHHHHHHHHHHHCCCCCHHHCCCHHC
T ss_conf             5-433020473336399972677888056436304289999859699999---999999999998518997254521000


Q ss_pred             -------CCC-----CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             -------347-----3212999999999998723589999999899999--9971074
Q 001591         1002 -------SIW-----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus      1002 -------~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~~ 1045 (1048)
                             ...     .......+.++.+++.+|++.||++|||++|+++  ++++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             CCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             2134430347898867856568999999999976389456908999967996578999

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.13  Aligned_cols=264  Identities=28%  Similarity=0.394  Sum_probs=213.3

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEECC--------CCEEEEEEECCCCH-HHHHHHHHHHHHHHHC-CCCCEEEECCEEEEC
Q ss_conf             3087546837101861899999879--------95899999358842-5499999999999954-998600240447608
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLTN--------GTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHG  835 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  835 (1048)
                      .++|++.+.||+|+||.||+|+...        +..||+|++..+.. ....++.+|+..+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf             89969700985167828999998578755566754999999881128688999999999999813999697346522018


Q ss_pred             CCEEEEEEECCCCCHHHHCCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf             908999982347891100112567------------76445899999999999999999873179984974899885687
Q 001591          836 NDRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL  903 (1048)
Q Consensus       836 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll  903 (1048)
                      +..++||||+++|+|.+++.....            ....+++.++..++.|++.|++|||+.   +++||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEEE
T ss_conf             868999973699909999986067764322233457434679999999999999999876637---97863022102245


Q ss_pred             CCCCCEEEEECCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHH
Q ss_conf             8999589922046544589997-12202444555458223386788860306999999999992-999986458777113
Q 001591          904 DEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD  981 (1048)
Q Consensus       904 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~  981 (1048)
                      +.++.+||+|||.++....... .......|++.|+|||.+.+..++.++||||||+++|||++ |.+||...   ...+
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~---~~~~  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PVEE  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHH
T ss_pred             CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC---CHHH
T ss_conf             4789767622111011355555431466788846632667517988825554775888887401798989999---9999


Q ss_pred             HHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf             8999998630244331024434732129999999999987235899999998999999971074469
Q 001591          982 LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1048 (1048)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 1048 (1048)
                      ....+.    .+.....         +...+.++.+++.+|++.+|++|||+.|+++.|+++.+-+|
T Consensus       246 ~~~~i~----~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~~  299 (299)
T d1fgka_         246 LFKLLK----EGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  299 (299)
T ss_dssp             HHHHHH----TTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHHH----CCCCCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf             999997----2888898---------74352999999999766797679399999999988860479

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.83  Aligned_cols=255  Identities=29%  Similarity=0.413  Sum_probs=203.6

Q ss_pred             CCCEEECCCCEEEEEEEECCC----CEEEEEEECCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC-CCEEEEEEE
Q ss_conf             468371018618999998799----58999993588-425499999999999954998600240447608-908999982
Q 001591          771 QANIIGCGGFGLVYKATLTNG----TKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-NDRLLIYSY  844 (1048)
Q Consensus       771 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~  844 (1048)
                      ..++||+|+||+||+|++..+    ..||||++... ......++.+|++++++++||||+++++++.+. ...++||||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf             66698136880999999977998799999999884369789999999999998678999867867898069943899987


Q ss_pred             CCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             34789110011256776445899999999999999999873179984974899885687899958992204654458999
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +++|+|.++++.   .....++..+..++.|++.|+.|+|+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       111 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         111 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EECCCHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf             406741442101---345404899999999988765200336---76257766875767799988991065232255665


Q ss_pred             CC---EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             71---220244455545822338678886030699999999999299998645877711389999986302443310244
Q 001591          925 TH---VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       925 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ..   ......||+.|+|||......++.++||||||+++|||+||+.||....  ...+...++....   ..   ..+
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i~~g~---~~---~~p  256 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGR---RL---LQP  256 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTC---CC---CCC
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHCCC---CC---CCC
T ss_conf             553100256555645567688743799974574661999999997899998889--9999999998089---88---996


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             347321299999999999872358999999989999999710744
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                             ...+.++.+++.+||+.||++||++.|+++.|+.+...
T Consensus       257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             -------44759999999997688976893999999999999975

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.71  Aligned_cols=269  Identities=25%  Similarity=0.306  Sum_probs=202.3

Q ss_pred             CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC----CEEEEE
Q ss_conf             0875468371018618999998799589999935884254999999999999549986002404476089----089999
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN----DRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  842 (1048)
                      ++|.+.+.||+|+||.||+|++. |..||+|++..... .....+.|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCCH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf             68999889820788199999999-98999999872004-67999999999962799868326889983798604899999


Q ss_pred             EECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             82347891100112567764458999999999999999998731-----7998497489988568789995899220465
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV-----CEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      ||+++|+|.++++.     ..++|..+..++.+++.|++|+|+.     .+++|+||||||+|||++.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ECCCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf             64669898999865-----8999899999999999999998876652046898661531731357868877688763866


Q ss_pred             CCCCCCCCC---EEECCCCCCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCC--------H
Q ss_conf             445899971---22024445554582233867------888603069999999999929999864587771--------1
Q 001591          918 RLLRPYDTH---VTTDLVGTLGYIPPEYSQTL------TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC--------R  980 (1048)
Q Consensus       918 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGvil~elltG~~p~~~~~~~~~--------~  980 (1048)
                      +........   ......||+.|+|||++.+.      .++.++||||||+++|||+||..|+........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             CCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
T ss_conf             23467776200135525035476782210565454677767501220159999999628998876631124101225564


Q ss_pred             HHHHHHHHHHCCCCCCCCCCCCCCCH-HHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             38999998630244331024434732-1299999999999872358999999989999999710744
Q 001591          981 DLVSWVFQMKSEKREVEIIDASIWHK-DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      ............+.    ..+..... ........+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       236 ~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         236 PSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHCCC----CCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             30999999875024----6888776557768999999999997606985895999999999988886

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.61  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=206.5

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC--CC--CEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCE
Q ss_conf             308754683710186189999987--99--589999935884---25499999999999954998600240447608908
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT--NG--TKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  838 (1048)
                      .++|++.+.||+|+||.||+|++.  ++  ..||+|++....   ....+.+.+|+++++.++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf             4891997898038883999999988999079999999983555798999999999999986899998789877740-100


Q ss_pred             EEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf             99998234789110011256776445899999999999999999873179984974899885687899958992204654
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  918 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~  918 (1048)
                      ++||||+++|++.+++..   ....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+|++|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             HEEEEEECCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHH
T ss_conf             114654238612544421---268999999999999999999875217---87520566888156556543325611555


Q ss_pred             CCCCCCCCE--EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             458999712--202444555458223386788860306999999999992-99998645877711389999986302443
Q 001591          919 LLRPYDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE  995 (1048)
Q Consensus       919 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1048)
                      .........  .....|+..|+|||++.+..++.++||||||+++|||+| |+.||..   ....+...++..   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~---~~~~~~~~~i~~---~~~~  233 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---LNGSQILHKIDK---EGER  233 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHHHT---SCCC
T ss_pred             HCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHH---CCCC
T ss_conf             3035887526547632573107999983799994215661489999999689999999---699999999984---7999


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             3102443473212999999999998723589999999899999997107
Q 001591          996 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 1044 (1048)
                      .+         .+...+..+.+++.+||+.||++|||+.++.+.|++.+
T Consensus       234 ~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         234 LP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf             99---------85445399999999976889667929999999999649

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=339.30  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=205.4

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCH---------HHHHHHHHHHHHHHHCC-CCCEEEECCEEEEC
Q ss_conf             08754683710186189999987-995899999358842---------54999999999999549-98600240447608
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---------QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHG  835 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  835 (1048)
                      ++|++.+.||+|+||+||+|++. +++.||+|++.....         .....+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf             63888528841768499999999999899999996244641147888999999999999999850799747997621467


Q ss_pred             CCEEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf             90899998234789110011256776445899999999999999999873179984974899885687899958992204
Q 001591          836 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  915 (1048)
Q Consensus       836 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  915 (1048)
                      +..|+||||+++|+|.++++.    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCEEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCH
T ss_conf             605999976898668999986----59999999999999999999999875---99432346254898689983871240


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             65445899971220244455545822338------678886030699999999999299998645877711389999986
Q 001591          916 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQ------TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM  989 (1048)
Q Consensus       916 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~  989 (1048)
                      .++......  .....+||+.|+|||++.      ...++.++||||+||++|||++|+.||...   +..+....+.. 
T Consensus       156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~---~~~~~~~~i~~-  229 (277)
T d1phka_         156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLMLRMIMS-  229 (277)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH-
T ss_pred             HEEECCCCC--CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCC---CHHHHHHHHHH-
T ss_conf             316726887--213452467888988860534456788992331856560231032288898899---99999999981-


Q ss_pred             HCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             3024433102443473212999999999998723589999999899999--9971
Q 001591          990 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                        ......       .......++++.+++.+|++.+|++|||++|+++  ++++
T Consensus       230 --~~~~~~-------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         230 --GNYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             --TCCCCC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             --CCCCCC-------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf             --898889-------8543468999999999976589668919999973978797

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.13  Aligned_cols=251  Identities=25%  Similarity=0.327  Sum_probs=202.3

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHH-HCCCCCEEEECCEEEECCCEEEE
Q ss_conf             08754683710186189999987-99589999935884---254999999999999-54998600240447608908999
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALS-RAQHKNLVSLQGYCRHGNDRLLI  841 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv  841 (1048)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++.+..   ......+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             98234789110011256776445899999999999999999873179984974899885687899958992204654458
Q 001591          842 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  921 (1048)
Q Consensus       842 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~  921 (1048)
                      |||+++|+|.++++.    ...+++.++..++.|++.||+|||+.   +++||||||+|||++.++.+|++|||.++...
T Consensus        82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEECCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf             750379808998640----47899999999999999999999868---93403476540444489963015553023235


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             99971220244455545822338678886030699999999999299998645877711389999986302443310244
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1001 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..   ....+....+..   ...  ..   
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~---~~~--~~---  222 (320)
T d1xjda_         155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRM---DNP--FY---  222 (320)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH---CCC--CC---
T ss_pred             CCC-CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHC---CCC--CC---
T ss_conf             665-334545787776899998279988323201122789898738899999---899999999971---899--89---


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH--HHHH
Q ss_conf             347321299999999999872358999999989-9999--9971
Q 001591         1002 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIE-EVVT--WLDG 1042 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~--~L~~ 1042 (1048)
                            +...+.++.+++.+|++.||++||++. ++++  ++++
T Consensus       223 ------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         223 ------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             ------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             ------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHHCC
T ss_conf             ------75679999999999654489878388999980901315

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.93  Aligned_cols=269  Identities=22%  Similarity=0.289  Sum_probs=206.7

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEE
Q ss_conf             08754683710186189999987-995899999358842--549999999999995499860024044760890899998
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  843 (1048)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++.....  .....+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322432037886


Q ss_pred             ECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             23478911001125677644589999999999999999987317998497489988568789995899220465445899
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      |+.++.+......   ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.|+.....
T Consensus        82 ~~~~~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ECCCCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf             2377445554420---256888899999999999999986528---8992135711401134676210357861343688


Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC---
Q ss_conf             971220244455545822338678-8860306999999999992999986458777113899999863024433102---
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLT-ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII---  999 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  999 (1048)
                      . .......||+.|+|||+..... ++.++|+||+||++|+|++|+.||...   ...+....+.............   
T Consensus       156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD---SEIDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             C-CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCC---CHHHHHHHHHHHCCCCCHHHCCCCC
T ss_conf             6-41001036521541122136657774221033331342796687998988---9999999999832898333144422


Q ss_pred             C--------CCCC----CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             4--------4347----3212999999999998723589999999899999--9971074
Q 001591         1000 D--------ASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus      1000 ~--------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~~ 1045 (1048)
                      .        +...    .......+.++.+++.+|++.||++|||++|+++  +++++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             242124345432222044416678999999999976399557918999967870146999

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.19  Aligned_cols=262  Identities=23%  Similarity=0.363  Sum_probs=210.1

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCE
Q ss_conf             308754683710186189999987------99589999935884-25499999999999954998600240447608908
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  838 (1048)
                      .++|++.+.||+|+||+||+|.+.      ++..||||++.... ......+.+|+.++++++||||+++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf             89918835982078818999998786447789689999987012868999999999999976999884125478428810


Q ss_pred             EEEEEECCCCCHHHHCCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf             99998234789110011256------776445899999999999999999873179984974899885687899958992
Q 001591          839 LLIYSYMENGSLDYWLHESV------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLA  912 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  912 (1048)
                      ++||||+++|+|.+++....      .....+++..+..++.|+++|+.|||+.   +|+||||||+|||++.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEEE
T ss_conf             677760489988999875033211344468879999999999999999987647---96543286775403599649994


Q ss_pred             ECCCCCCCCCCCCCE-EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             204654458999712-2024445554582233867888603069999999999929-99986458777113899999863
Q 001591          913 DFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG-RRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       913 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      |||+|+......... .....|++.|+|||.+.+..++.++||||||+++|||+|| ++||...   ...+....+.   
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~~i~---  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFVM---  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHHHHH---
T ss_pred             ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC---CHHHHHHHHH---
T ss_conf             2454202357763031340231632378888736998833344437899999996899999998---9999999998---


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             02443310244347321299999999999872358999999989999999710744
Q 001591          991 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1046 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 1046 (1048)
                      ... ....         +...+..+.+++.+||+.+|++|||+.++++.|++..+.
T Consensus       250 ~~~-~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         250 EGG-LLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             TTC-CCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HCC-CCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf             088-8888---------633539999999997577965893999999997876177

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.79  Aligned_cols=270  Identities=23%  Similarity=0.299  Sum_probs=201.9

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-C-CCEEEEEEECCCCH--HHHHHHHHHHHHHHHC---CCCCEEEECCEEEE----
Q ss_conf             308754683710186189999987-9-95899999358842--5499999999999954---99860024044760----
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-N-GTKAAVKRLSGDCG--QMEREFQAEVEALSRA---QHKNLVSLQGYCRH----  834 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----  834 (1048)
                      .++|++.+.||+|+||+||+|++. + ++.||+|++.....  .....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             58979888992155869999999888998999999802324516799999999999987425898802366322146666


Q ss_pred             -CCCEEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf             -8908999982347891100112567764458999999999999999998731799849748998856878999589922
Q 001591          835 -GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLAD  913 (1048)
Q Consensus       835 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  913 (1048)
                       ....++++||++++.+......   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCEEEEEEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECC
T ss_conf             67469999974058714444430---378999899999999999999999758---898357986278985899754210


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             04654458999712202444555458223386788860306999999999992999986458777113899999863024
Q 001591          914 FGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  993 (1048)
Q Consensus       914 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  993 (1048)
                      ||.++....  .......+||+.|+|||++.+..++.++||||+||++|||++|++||...   ...+....+.......
T Consensus       160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHCC--CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHHCCC
T ss_conf             001011002--34577765485114831001798881110003289999998787998998---9899999999840799


Q ss_pred             CCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCCC
Q ss_conf             433102-------------443473212999999999998723589999999899999--99710744
Q 001591          994 REVEII-------------DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1046 (1048)
Q Consensus       994 ~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~~~ 1046 (1048)
                      ......             ............+..+.+++.+|++.||++|||++|+++  +++++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             CHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCHHH
T ss_conf             61105321111033302234564544044589999999999874896679189999669634075210

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=336.63  Aligned_cols=265  Identities=23%  Similarity=0.286  Sum_probs=198.1

Q ss_pred             CCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC------CCEEE
Q ss_conf             8754683710186189999987-9958999993588425499999999999954998600240447608------90899
Q 001591          768 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------NDRLL  840 (1048)
Q Consensus       768 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  840 (1048)
                      +|+..++||+|+||+||+|++. +++.||+|++..+...    ..+|++++++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             767516982176839999999999979999998816068----9999999986689898738789974476577318999


Q ss_pred             EEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCC
Q ss_conf             9982347891100112567764458999999999999999998731799849748998856878999-589922046544
Q 001591          841 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRL  919 (1048)
Q Consensus       841 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~a~~  919 (1048)
                      ||||++++.+.. +.........+++..+..++.|++.||+|||+.   ||+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEECCCCCCHHH-HHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf             984168860788-886310368999999999999999999999866---8764578860378735897116733660544


Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCC----
Q ss_conf             5899971220244455545822338-67888603069999999999929999864587771138999998630244----
Q 001591          920 LRPYDTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR----  994 (1048)
Q Consensus       920 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----  994 (1048)
                      .....  .....+|++.|+|||... ...++.++||||+||++|||++|++||....   ..+....+........    
T Consensus       173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~---~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS---GVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCCCCHHHH
T ss_pred             CCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCC---HHHHHHHHHHHHCCCHHHHH
T ss_conf             04776--53200255555682776404688821000246527785502879989879---99999999997489817765


Q ss_pred             -----------CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             -----------33102443473212999999999998723589999999899999--9971074
Q 001591          995 -----------EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       995 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~~ 1045 (1048)
                                 .................+.++.+++.+|++.||++|||+.|+++  +++++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             4306210110355445674444315689999999999976589557929999966984524667

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=337.88  Aligned_cols=264  Identities=20%  Similarity=0.297  Sum_probs=206.7

Q ss_pred             CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEEE
Q ss_conf             08754683710186189999987995899999358842--5499999999999954998600240447608908999982
Q 001591          767 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  844 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  844 (1048)
                      ++|++.+.||+|+||+||+|++++++.||+|++.....  .....+.+|+.++++++||||+++++++.+++..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             99634318722778189999968999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             34789110011256776445899999999999999999873179984974899885687899958992204654458999
Q 001591          845 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  924 (1048)
Q Consensus       845 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  924 (1048)
                      +.++.+..+..    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||.+.......
T Consensus        82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             EHHHHHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf             00456789986----047751445689999999999986057---48826787750568689978732366430114676


Q ss_pred             CCEEECCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-----
Q ss_conf             712202444555458223386-78886030699999999999299998645877711389999986302443310-----
Q 001591          925 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI-----  998 (1048)
Q Consensus       925 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  998 (1048)
                       .......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||....   ..+....+............     
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCC---HHHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             -541010243110137887178888841002111758999977979989889---8999999998638997110421233


Q ss_pred             ----------CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHH
Q ss_conf             ----------2443473212999999999998723589999999899999--997
Q 001591          999 ----------IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1041 (1048)
Q Consensus       999 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~ 1041 (1048)
                                .....+.......+..+.+++.+|++.||++|||++|+++  +++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             HHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf             3221433333567646665125899999999998668966890999985692207

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=329.95  Aligned_cols=267  Identities=22%  Similarity=0.287  Sum_probs=202.4

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEE--------
Q ss_conf             308754683710186189999987-99589999935884--2549999999999995499860024044760--------
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH--------  834 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  834 (1048)
                      .++|++.+.||+|+||+||+|++. +++.||||++....  ......+.+|+.++++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             27988999972274829999999899979999998422246378999999999999835999660676540246544445


Q ss_pred             CCCEEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf             89089999823478911001125677644589999999999999999987317998497489988568789995899220
Q 001591          835 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  914 (1048)
Q Consensus       835 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  914 (1048)
                      ....++||||++++.+.....    ....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+|++||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEECCCCCCCCHHHH----CCCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEEC
T ss_conf             763899985357874101222----034433089999999999999885229---9885676722203668996876313


Q ss_pred             CCCCCCCCCCC---CEEECCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             46544589997---122024445554582233867-88860306999999999992999986458777113899999863
Q 001591          915 GLSRLLRPYDT---HVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  990 (1048)
Q Consensus       915 g~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  990 (1048)
                      |+++.......   ......+||+.|+|||++.+. .++.++||||+||++|||++|++||...   ........+....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~---~~~~~~~~i~~~~  238 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLALISQLC  238 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHH
T ss_pred             CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCC---CHHHHHHHHHHHC
T ss_conf             5002235544432113566024978742899707999891787006786466174487998998---9999999999841


Q ss_pred             CCCCCC---CCCCC----------CCCCHHH-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             024433---10244----------3473212-----999999999998723589999999899999--9971
Q 001591          991 SEKREV---EIIDA----------SIWHKDR-----EKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus       991 ~~~~~~---~~~~~----------~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                      ......   .....          .......     ......+.+++.+|++.||++|||++|+++  +++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             CCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             899825534432034443320133445550334044459989999999987389658909999974950156

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=329.85  Aligned_cols=263  Identities=21%  Similarity=0.318  Sum_probs=202.2

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC------
Q ss_conf             308754683710186189999987-99589999935884--254999999999999549986002404476089------
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  836 (1048)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++....  ....+.+.+|+++++.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             CEEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf             08999982347891100112567764458999999999999999998731799849748998856878999589922046
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..++||||+ ++++....+     ...+++..+..++.|++.||.|||+.   ||+||||||+|||++.++.+|++|||.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEECC-CCCHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf             599998405-521899987-----40226999999999999999998737---876456685111121001221134310


Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             54458999712202444555458223386-78886030699999999999299998645877711389999986302443
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  995 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  995 (1048)
                      |+.....    ....+||+.|+|||++.+ ..++.++||||+||++|+|++|++||....   ..+..............
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---HLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCH
T ss_pred             EECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCC---HHHHHHHHHHCCCCCCH
T ss_conf             2206876----3102455333588998178789965010300389999997869988897---68999999850378848


Q ss_pred             C-----------------CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf             3-----------------102443473212999999999998723589999999899999--997107
Q 001591          996 V-----------------EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       996 ~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~ 1044 (1048)
                      .                 .......+..........+.+++.+|++.||++|||+.|+++  +++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             88865300034433115786665566775568999999999997729955792999996396237587

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.57  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=198.4

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCH------HHHHHHHHHHHHHHHCC--CCCEEEECCEEEECC
Q ss_conf             308754683710186189999987-995899999358842------54999999999999549--986002404476089
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG------QMEREFQAEVEALSRAQ--HKNLVSLQGYCRHGN  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  836 (1048)
                      .++|++.+.||+|+||+||+|++. ++..||+|++.....      .....+.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             CEEEEEEECCC-CCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEEC
Q ss_conf             08999982347-8911001125677644589999999999999999987317998497489988568789-995899220
Q 001591          837 DRLLIYSYMEN-GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADF  914 (1048)
Q Consensus       837 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Df  914 (1048)
                      ..++||||+.+ +++.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEEEECCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCC
T ss_conf             689999833686228999861----58999999999999999999999877---97556676111477447884897754


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             4654458999712202444555458223386788-860306999999999992999986458777113899999863024
Q 001591          915 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  993 (1048)
Q Consensus       915 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  993 (1048)
                      |+|+....   ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....     .       .....
T Consensus       156 G~a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------i~~~~  220 (273)
T d1xwsa_         156 GSGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------IIRGQ  220 (273)
T ss_dssp             TTCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------HHHCC
T ss_pred             CCCEECCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-----H-------HHHCC
T ss_conf             65353244---455665658774799998489978865332554034536756889988736-----7-------76154


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             433102443473212999999999998723589999999899999--9971074
Q 001591          994 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~~ 1045 (1048)
                      ..   .    ..    ..+.++.+++.+|++.||++|||++|+++  +++++..
T Consensus       221 ~~---~----~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         221 VF---F----RQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             CC---C----SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CC---C----CC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             47---7----87----79999999999976089758939999853986678878

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=331.71  Aligned_cols=268  Identities=23%  Similarity=0.356  Sum_probs=201.6

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC----CEE
Q ss_conf             308754683710186189999987-99589999935884-254999999999999549986002404476089----089
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN----DRL  839 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~  839 (1048)
                      +.+|++.+.||+|+||+||+|... +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             89859978994064809999999999949999998031095899999999999997689898858889950564554149


Q ss_pred             EEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             99982347891100112567764458999999999999999998731799849748998856878999589922046544
Q 001591          840 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       840 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      ++++++.+|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf             99996259865664405-----8999999999999999999999978---986777876437887999778754570565


Q ss_pred             CCCCCCC--EEECCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf             5899971--220244455545822338-6788860306999999999992999986458777113899999863024433
Q 001591          920 LRPYDTH--VTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       920 ~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      .......  .....+||+.|+|||++. +..++.++||||+|+++|+|++|+.||....   ..+...............
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~---~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---YLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCHH
T ss_pred             CCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCC---HHHHHHHHHHHCCCCCHH
T ss_conf             04777641010110265200038786047888741010046701337766979978888---899999876520699756


Q ss_pred             C---------------C--CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf             1---------------0--2443473212999999999998723589999999899999--997107
Q 001591          997 E---------------I--IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       997 ~---------------~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~ 1044 (1048)
                      .               .  .....+.......+.++.+++.+|++.||++|||+.|+++  +++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             6423433222202446775577877783789999999999997648956790899986198655588

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=0  Score=327.10  Aligned_cols=295  Identities=29%  Similarity=0.489  Sum_probs=172.9

Q ss_pred             CCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCE--EEEEEECCCCCCCCCCCEEEEEECCCCCCCC--CCCCCCCCCCC
Q ss_conf             9998889999999841999988767579999830--2223619999999889389999038997323--68443288679
Q 001591           33 SCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQ--WDGVVCGHGSTGSNAGRVTMLILPRKGLKGI--IPRSLGHLNQL  108 (1048)
Q Consensus        33 ~~~~~~~~aL~~~k~~~~~~~~l~sw~~~~~cc~--w~gv~C~~~~~~~~~~~v~~l~l~~~~l~~~--~~~~l~~l~~L  108 (1048)
                      -|+++|++||++||+++.++..+++|+.++|||.  |+||+|+..+   ..+||++|+|.++++.|.  +|++++++++|
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~---~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L   78 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSS---SCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEEECCC---CCEEEEEEECCCCCCCCCCCCCHHHHCCCCC
T ss_conf             9898999999999997799986778899999988948896974899---9479889989899888888798478467533


Q ss_pred             CEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf             9585689-978987981355888765872467725385453333456610897057656774233345675429980175
Q 001591          109 KLLDLSC-NHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNN  187 (1048)
Q Consensus       109 ~~L~Ls~-n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~n  187 (1048)
                      ++|+|++ |+++|.+|..|+++++|++|+|++|.+.+.++..+..+..|+.++++.|.+.                    
T Consensus        79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~--------------------  138 (313)
T d1ogqa_          79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS--------------------  138 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE--------------------
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC--------------------
T ss_conf             520202654333002431145420011020356434433222220111001111224555--------------------


Q ss_pred             CCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCHHH
Q ss_conf             23575323554114444267634743544467788999998898326779998991212899985998215667760134
Q 001591          188 SFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE  267 (1048)
Q Consensus       188 ~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~  267 (1048)
                                                                         +.+|..+..+++++++++++|.+++.+|.
T Consensus       139 ---------------------------------------------------~~~p~~l~~l~~L~~l~l~~n~l~~~ip~  167 (313)
T d1ogqa_         139 ---------------------------------------------------GTLPPSISSLPNLVGITFDGNRISGAIPD  167 (313)
T ss_dssp             ---------------------------------------------------SCCCGGGGGCTTCCEEECCSSCCEEECCG
T ss_pred             ---------------------------------------------------CCCCHHHCCCCCCCEEECCCCCCCCCCCC
T ss_conf             ---------------------------------------------------56851220674000000235533562031


Q ss_pred             HHCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf             20389998-59981599688886200158444450124677334777833536789839990285223756756655776
Q 001591          268 KISNLTSL-RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSS  346 (1048)
Q Consensus       268 ~l~~l~~L-~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  346 (1048)
                      .+..+..+ +.+++++|++++..|..+.++..+ .+++..+...+.+|..+..+++++.+++++|.+.+.++ .+..+++
T Consensus       168 ~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~  245 (313)
T d1ogqa_         168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKN  245 (313)
T ss_dssp             GGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTT
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf             214431123231022464353324332222222-33333343322222222222221112222222222222-2224554


Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf             6476235533558898423588865544213532322453000267767577415885
Q 001591          347 LCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNS  404 (1048)
Q Consensus       347 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~  404 (1048)
                      |+.|+|++|++++.+|..++.+++|+.|+|++|+++|.+|. ++++++|+.+++++|+
T Consensus       246 L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             CCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             CCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCHHHHCCCC
T ss_conf             44444765706660876884799999897958835166898-6667998978868895

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=322.12  Aligned_cols=260  Identities=20%  Similarity=0.240  Sum_probs=198.7

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEE-CCEEEECCCEEEEEE
Q ss_conf             308754683710186189999987-995899999358842549999999999995499860024-044760890899998
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL-QGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.....  ..++..|+++++.++|++++.. .++..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf             8889996898507880999999988998999999721005--88899999999970389960179999951987789998


Q ss_pred             ECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCC
Q ss_conf             2347891100112567764458999999999999999998731799849748998856878---9995899220465445
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLL  920 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfg~a~~~  920 (1048)
                      |+++ ++...+..   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++   .+..+|++|||+|+.+
T Consensus        84 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LLGP-SLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CCCC-BHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             ECCC-CHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf             7387-13332443---068876899999999999999999979---9442667876606433577761565046751342


Q ss_pred             CCCCCC------EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf             899971------22024445554582233867888603069999999999929999864587771138999998630244
Q 001591          921 RPYDTH------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       921 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      ......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             CCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCC
T ss_conf             55445541000135776787353299999189989832188617789999849876655305779999998523567898


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             3310244347321299999999999872358999999989999999710
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1043 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 1043 (1048)
                      .     +    ......+.++.+++.+|++.+|++||+++++.+.|+.+
T Consensus       237 ~-----~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         237 I-----E----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             H-----H----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             H-----H----HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             3-----5----75347889999999998439955791999999999999

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=321.39  Aligned_cols=261  Identities=20%  Similarity=0.247  Sum_probs=203.0

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC------CC
Q ss_conf             08754683710186189999987-99589999935884--25499999999999954998600240447608------90
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------ND  837 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  837 (1048)
                      ++|++.++||+|+||+||+|++. +++.||+|++....  ......+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf             77599889621758599999999999899999988233697999999999999986489876489989702564345762


Q ss_pred             EEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             89999823478911001125677644589999999999999999987317998497489988568789995899220465
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .|+||||+.++.+... .      ..+++..++.++.|++.|+.|||+.   ||+||||||+||+++.++.+|++|||.+
T Consensus        97 ~~iv~Ey~~~~l~~~~-~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             EEEEEECCCHHHHHHH-H------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf             6999841446778765-0------3899999999999999999886522---1124567763211365443132010232


Q ss_pred             CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCC-----
Q ss_conf             445899971220244455545822338678886030699999999999299998645877711389999986302-----
Q 001591          918 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE-----  992 (1048)
Q Consensus       918 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-----  992 (1048)
                      +.....  ......+||+.|+|||++.+..++.++||||+||++|+|++|++||....   .......+......     
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~---~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHH
T ss_pred             HCCCCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCC---HHHHHHHHHHHCCCCCHHH
T ss_conf             114666--55332214655558133147777877433356625789865989988897---7889999997205898799


Q ss_pred             --------------CC-C-----CCCC---CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             --------------44-3-----3102---443473212999999999998723589999999899999--9971
Q 001591          993 --------------KR-E-----VEII---DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1042 (1048)
Q Consensus       993 --------------~~-~-----~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 1042 (1048)
                                    .. .     ....   ............+.++.+++.+|++.||++|||++|+++  +++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             987656677776417543566642126433354321013337999999999987699457908999966942087

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=321.95  Aligned_cols=261  Identities=16%  Similarity=0.191  Sum_probs=207.0

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCC-CCEEEECCEEEECCCEEEEEE
Q ss_conf             308754683710186189999987-995899999358842549999999999995499-860024044760890899998
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH-KNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  843 (1048)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.....  ...+.+|++.++.+.| ++++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             9806997998417882999999988997999999750258--29999999999996489998779999601881179999


Q ss_pred             ECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCC
Q ss_conf             23478911001125677644589999999999999999987317998497489988568789-----9958992204654
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-----KFEAHLADFGLSR  918 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~Dfg~a~  918 (1048)
                      |+ +++|.++++.   ....+++..+..++.|++.|+.|||+.   ||+||||||+||+++.     ++.+|++|||+|+
T Consensus        82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EC-CCCHHHHHHH---HCCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf             64-8887999975---203110689999999999999999977---9662667713152347543447956872366057


Q ss_pred             CCCCCCCC------EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf             45899971------220244455545822338678886030699999999999299998645877711389999986302
Q 001591          919 LLRPYDTH------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE  992 (1048)
Q Consensus       919 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  992 (1048)
                      .+......      .....+||+.|+|||.+.+..++.++||||+|+++|||++|+.||..............+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf             71467665411102467627751026798964888886999898319999998698767885302199999999705679


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             4433102443473212999999999998723589999999899999997107
Q 001591          993 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1044 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 1044 (1048)
                      ....         +.....+.++.+++..|+..+|++||+++.+.+.|+++-
T Consensus       235 ~~~~---------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         235 TPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             SCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCHH---------HHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf             9958---------965799899999999984399300859999999999999

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=320.17  Aligned_cols=261  Identities=18%  Similarity=0.274  Sum_probs=199.6

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEEEEC--CCEEEEE
Q ss_conf             08754683710186189999987-99589999935884254999999999999549-98600240447608--9089999
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHG--NDRLLIY  842 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~  842 (1048)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...   .+.+.+|+.+++.++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             67189789831748199999988999799999988899---999999999998515799876799999816877126888


Q ss_pred             EECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCC
Q ss_conf             82347891100112567764458999999999999999998731799849748998856878999-58992204654458
Q 001591          843 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLR  921 (1048)
Q Consensus       843 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~a~~~~  921 (1048)
                      ||+++++|..+.+       .+++..+..++.|++.||+|||++   ||+||||||+|||++.++ .+|++|||.|+...
T Consensus       112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EECCCCCHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf             6317985899746-------899999999999999999887643---344345644123774899836641565426646


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHC---------
Q ss_conf             9997122024445554582233867-888603069999999999929999864587771138999998630---------
Q 001591          922 PYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS---------  991 (1048)
Q Consensus       922 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------  991 (1048)
                      ....  ....+||+.|+|||...+. .++.++||||+|+++|||++|+.||......  .+....+.....         
T Consensus       182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHH
T ss_pred             CCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHH--HHHHHHHHHHHCCCHHHHHHH
T ss_conf             8874--443224864247610268888884523233545558760488999887601--899999999878841555554


Q ss_pred             ---CCCCCCC---C--------CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf             ---2443310---2--------443473212999999999998723589999999899999--997107
Q 001591          992 ---EKREVEI---I--------DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       992 ---~~~~~~~---~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~ 1044 (1048)
                         .......   .        ............+.++.+++.+|++.||++|||++|+++  ++.++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             HCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf             225444743000003334331121155211244899999999998669956890899996493558879

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=321.07  Aligned_cols=269  Identities=22%  Similarity=0.307  Sum_probs=210.0

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCCEEEEEE
Q ss_conf             08754683710186189999987-99589999935884--2549999999999995499860024044760890899998
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  843 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  843 (1048)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...  ......+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444431158863


Q ss_pred             ECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             23478911001125677644589999999999999999987317998497489988568789995899220465445899
Q 001591          844 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  923 (1048)
Q Consensus       844 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  923 (1048)
                      ++.++++..+..    ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.++.....
T Consensus        82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ECCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf             023322211212----356540367899999999998774339---9860014676121133782665204601104688


Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC----
Q ss_conf             971220244455545822338678-886030699999999999299998645877711389999986302443310----
Q 001591          924 DTHVTTDLVGTLGYIPPEYSQTLT-ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI----  998 (1048)
Q Consensus       924 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  998 (1048)
                      .. ......+++.|+|||++.... ++.++||||+||++|||++|+.||..  +.+..+....+............    
T Consensus       155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CC-CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC--CCCHHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf             75-100103443101466750698888044402654188998518999988--999999999998611899735513443


Q ss_pred             -----------CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             -----------2443473212999999999998723589999999899999--9971074
Q 001591          999 -----------IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1045 (1048)
Q Consensus       999 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~~ 1045 (1048)
                                 ................+.+++.+|++.||++|||++|+++  +++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             HCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             222113344454431043306568999999999986499668909999964953407989

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=322.81  Aligned_cols=259  Identities=25%  Similarity=0.335  Sum_probs=205.3

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC----CCCEEEEEEECCCC----HHHHHHHHHHHHHHHHCCC-CCEEEECCEEEECC
Q ss_conf             308754683710186189999987----99589999935884----2549999999999995499-86002404476089
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQH-KNLVSLQGYCRHGN  836 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  836 (1048)
                      .++|++.+.||+|+||+||+|+..    +|+.||+|++....    ....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf             10259998983287839999998765887948999998367721016899999999999986467983999620002487


Q ss_pred             CEEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf             08999982347891100112567764458999999999999999998731799849748998856878999589922046
Q 001591          837 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  916 (1048)
Q Consensus       837 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~  916 (1048)
                      ..++++||+.+|+|.+++..    ...+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             CEEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCC
T ss_conf             30012312341179999873----04543788888899999999885149---989654773201246999888741320


Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf             544589997122024445554582233867--888603069999999999929999864587771138999998630244
Q 001591          917 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  994 (1048)
Q Consensus       917 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  994 (1048)
                      ++.+............|++.|+|||...+.  .++.++||||+||++|||++|+.||...........+   ........
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~~~~~  252 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKSE  252 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHHCC
T ss_pred             HHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HHHCCCCC
T ss_conf             222034444322122233333106876057768871325177779999997689998888777799999---98335689


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH--HHHHCC
Q ss_conf             3310244347321299999999999872358999999-----9899999--997107
Q 001591          995 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT--WLDGIG 1044 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~--~L~~i~ 1044 (1048)
                      .          ..+...+.++.+++.+|++++|++||     |++|+++  +++++.
T Consensus       253 ~----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         253 P----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             C----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             C----------CCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCC
T ss_conf             9----------8865479999999999744589881999745099997497234899

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=318.14  Aligned_cols=264  Identities=22%  Similarity=0.291  Sum_probs=201.9

Q ss_pred             HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC-----CC
Q ss_conf             308754683710186189999987-99589999935884--25499999999999954998600240447608-----90
Q 001591          766 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-----ND  837 (1048)
Q Consensus       766 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  837 (1048)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|+.+++.++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf             98718888983178839999999999979999998820028689999999999998668987425999996346456686


Q ss_pred             EEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             89999823478911001125677644589999999999999999987317998497489988568789995899220465
Q 001591          838 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  917 (1048)
Q Consensus       838 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a  917 (1048)
                      .+++++|+.+|+|.+++..     ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+|++|||.+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEEEEEECCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf             4999996258862320022-----4530999999999999999999738---8765166776334554322001321000


Q ss_pred             CCCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf             44589997122024445554582233867-88860306999999999992999986458777113899999863024433
Q 001591          918 RLLRPYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV  996 (1048)
Q Consensus       918 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1048)
                      ....    .......|++.|+|||+..+. .++.++||||+||++|+|++|++||...   ........+..........
T Consensus       169 ~~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~---~~~~~~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         169 RHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT---DHIDQLKLILRLVGTPGAE  241 (348)
T ss_dssp             -CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCHH
T ss_pred             CCCC----CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHCCCCCHH
T ss_conf             1257----54444345435558355337756785512432058999997688997889---8899999999730799757


Q ss_pred             CC---------------CC--CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf             10---------------24--43473212999999999998723589999999899999--997107
Q 001591          997 EI---------------ID--ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1044 (1048)
Q Consensus       997 ~~---------------~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~ 1044 (1048)
                      ..               ..  ...+.......+.++.+++.+|++.||++|||+.|+++  ++.++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             7320010244544430355787555662678999999999997758834593899985599548799

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=289.26  Aligned_cols=269  Identities=22%  Similarity=0.291  Sum_probs=194.6

Q ss_pred             CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEECCEEEE
Q ss_conf             08754683710186189999987-99589999935884254999999999999549-----------9860024044760
Q 001591          767 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-----------HKNLVSLQGYCRH  834 (1048)
Q Consensus       767 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  834 (1048)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.++.. ..+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             857998997507781899999999997999999834313-3689999999999840145555542276764789987631


Q ss_pred             C--CCEEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-----
Q ss_conf             8--908999982347891100112567764458999999999999999998731799849748998856878999-----
Q 001591          835 G--NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-----  907 (1048)
Q Consensus       835 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-----  907 (1048)
                      .  ...+++++++..+......... .....+++..+..++.|++.|++|||+.  .||+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEEEECCCCCCCC
T ss_conf             2565202343200035420000012-2346786899999999999998887640--586465677057056305765644


Q ss_pred             -CEEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCH---HHH
Q ss_conf             -5899220465445899971220244455545822338678886030699999999999299998645877711---389
Q 001591          908 -EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR---DLV  983 (1048)
Q Consensus       908 -~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltG~~p~~~~~~~~~~---~~~  983 (1048)
                       .++++|||.+......    ....+||+.|+|||+.....++.++|+||+|+++++|++|+.||....+....   +..
T Consensus       169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CEEEEEECCCCCCCCCC----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf             30567531442123445----42236652105713214667776432012378999998788998987554321026899


Q ss_pred             HHHHHHHCCCC------------------C-CCCCCCC---------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf             99998630244------------------3-3102443---------473212999999999998723589999999899
Q 001591          984 SWVFQMKSEKR------------------E-VEIIDAS---------IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1035 (1048)
Q Consensus       984 ~~~~~~~~~~~------------------~-~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1035 (1048)
                      ...........                  . .......         .........+.++.+++.+|+..||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             99999837998788624532200013201220243235776444210001567435899999999987799457908999


Q ss_pred             HHH--HHHHC
Q ss_conf             999--99710
Q 001591         1036 VVT--WLDGI 1043 (1048)
Q Consensus      1036 vl~--~L~~i 1043 (1048)
                      +++  ++++.
T Consensus       325 ~L~Hp~f~~~  334 (362)
T d1q8ya_         325 LVNHPWLKDT  334 (362)
T ss_dssp             HHTCGGGTTC
T ss_pred             HHCCCCCCCC
T ss_conf             9669340789

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.4e-45  Score=261.74  Aligned_cols=259  Identities=29%  Similarity=0.498  Sum_probs=190.4

Q ss_pred             CCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             66476235533558--8984235888655442135-32322453000267767577415885777767510001366651
Q 001591          346 SLCTLDLATNHFSG--PLPNSLSDCHDLKILSLAK-NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLT  422 (1048)
Q Consensus       346 ~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~~~~L~  422 (1048)
                      .++.|+|++|.+++  .+|..++++++|++|++++ |.++|.+|..++++++|++|++++|++..+              
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~--------------  116 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA--------------  116 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE--------------
T ss_pred             EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC--------------
T ss_conf             988998989988888879847846753352020265433300243114542001102035643443--------------


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCEECCCCCCCCCCCCCC-CEEEECCC
Q ss_conf             67524675677788444588767489824874657815765305899689486754025899010148998-74850278
Q 001591          423 TLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL-FYLDFSNN  501 (1048)
Q Consensus       423 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N  501 (1048)
                                  .+..+..+..|+.+++++|.+.+.+|..+..++.|+.+++++|.+.+.+|..+..+..+ +.++++.|
T Consensus       117 ------------~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n  184 (313)
T d1ogqa_         117 ------------IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN  184 (313)
T ss_dssp             ------------CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSS
T ss_pred             ------------CCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             ------------32222201110011112245555685122067400000023553356203121443112323102246


Q ss_pred             CCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCE
Q ss_conf             56445883045553200158899999877785530301456799677888999983330038621149935337788868
Q 001591          502 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHV  581 (1048)
Q Consensus       502 ~l~~~~p~~l~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~~~~p~~~~~l~~L~~  581 (1048)
                      .+++..|..+..+..                                       ..++++++.+.+.+|..++.+++++.
T Consensus       185 ~l~~~~~~~~~~l~~---------------------------------------~~l~l~~~~~~~~~~~~~~~~~~l~~  225 (313)
T d1ogqa_         185 RLTGKIPPTFANLNL---------------------------------------AFVDLSRNMLEGDASVLFGSDKNTQK  225 (313)
T ss_dssp             EEEEECCGGGGGCCC---------------------------------------SEEECCSSEEEECCGGGCCTTSCCSE
T ss_pred             CCCCCCCCCCCCCCC---------------------------------------CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             435332433222222---------------------------------------23333334332222222222222111


Q ss_pred             EECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             97538630333895652556766764788835899950011536777046105524236999984467888654489887
Q 001591          582 LDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL  661 (1048)
Q Consensus       582 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~  661 (1048)
                      +++++|.+.+.+| .++.+++|+.|++++|+++|.+|.+++++++|++|+|++|+++|.+|..+.+.++..+.+.||+.+
T Consensus       226 l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l  304 (313)
T d1ogqa_         226 IHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL  304 (313)
T ss_dssp             EECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEE
T ss_pred             CCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCC
T ss_conf             2222222222222-222455444444765706660876884799999897958835166898666799897886889500


Q ss_pred             CCCCCCCCC
Q ss_conf             579999999
Q 001591          662 CGEIDSPCD  670 (1048)
Q Consensus       662 c~~~~~~~~  670 (1048)
                      ||.|.++|.
T Consensus       305 ~g~plp~c~  313 (313)
T d1ogqa_         305 CGSPLPACT  313 (313)
T ss_dssp             ESTTSSCCC
T ss_pred             CCCCCCCCC
T ss_conf             198988989

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=4.3e-40  Score=230.99  Aligned_cols=72  Identities=19%  Similarity=0.387  Sum_probs=46.5

Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf             330038621149935337788868975386303338956525567667647888358999500115367770461055
Q 001591          558 VFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN  635 (1048)
Q Consensus       558 l~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~l~l~~N  635 (1048)
                      +++++|++++. + .+..+++|+.|++++|++++ ++ .++.+++|++|++++|++++..|  +..+++|+.|++++|
T Consensus       312 L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         312 LTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             EECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             EECCCCCCCCC-C-CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf             77778877898-4-53668988989898998999-74-67089999989897995899800--003999999639789

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=2.6e-40  Score=232.20  Aligned_cols=38  Identities=18%  Similarity=0.441  Sum_probs=21.6

Q ss_pred             CCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCC
Q ss_conf             5337788868975386303338956525567667647888
Q 001591          572 EIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN  611 (1048)
Q Consensus       572 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  611 (1048)
                      .++++++|++|++++|++++..|  +..+++|+.|++++|
T Consensus       346 ~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf             67089999989897995899800--003999999639789

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-35  Score=206.44  Aligned_cols=123  Identities=24%  Similarity=0.377  Sum_probs=69.5

Q ss_pred             CEEEEEEECCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             30222361999999988938999903899732368443288679958568997898798135588876587246772538
Q 001591           65 CQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG  144 (1048)
Q Consensus        65 c~w~gv~C~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~  144 (1048)
                      |.|++|.|+..+                 ++. +|+.+.  +.+++|+|++|+|+.+.+..|.++++|++|++++|.+..
T Consensus        10 c~~~~~~C~~~~-----------------L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~   69 (305)
T d1xkua_          10 CHLRVVQCSDLG-----------------LEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK   69 (305)
T ss_dssp             EETTEEECTTSC-----------------CCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             ECCCEEEECCCC-----------------CCC-CCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC
T ss_conf             559999855999-----------------885-198889--997989784991898696576046565231123443445


Q ss_pred             CCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHHCCCCCCEEECC
Q ss_conf             545333345661089705765677423334567542998017523575323554114444267634
Q 001591          145 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLS  210 (1048)
Q Consensus       145 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls  210 (1048)
                      ..+..|..++.|+.|++++|+++..+..  ....+..|++++|.+. .++...+.....+..++..
T Consensus        70 i~~~~f~~l~~L~~L~l~~n~l~~l~~~--~~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~  132 (305)
T d1xkua_          70 ISPGAFAPLVKLERLYLSKNQLKELPEK--MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELG  132 (305)
T ss_dssp             BCTTTTTTCTTCCEEECCSSCCSBCCSS--CCTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECC
T ss_pred             CCHHHHHCCCCCCEECCCCCCCCCCCCC--HHHHHHHHHCCCCCHH-HHHHHHHHCCCCCCCCCCC
T ss_conf             2356652798557831568756767640--0111323210246102-3444454013311000012

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.6e-35  Score=203.69  Aligned_cols=78  Identities=19%  Similarity=0.183  Sum_probs=29.3

Q ss_pred             EECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCHHHHHCCCCCCCEEECCCCCCC
Q ss_conf             76347435444677889999988983267799989912128999859982156677601342038999859981599688
Q 001591          207 LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFS  286 (1048)
Q Consensus       207 L~Ls~n~l~~~~~~l~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  286 (1048)
                      ++.++++++.+|..+  ++++++|++++|+++...+.+|.++++|++|++++|.+....|..|.++++|++|++++|+++
T Consensus        15 ~~C~~~~L~~lP~~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~   92 (305)
T d1xkua_          15 VQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK   92 (305)
T ss_dssp             EECTTSCCCSCCCSC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS
T ss_pred             EEECCCCCCCCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC
T ss_conf             985599988519888--999798978499189869657604656523112344344523566527985578315687567

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-33  Score=194.25  Aligned_cols=44  Identities=18%  Similarity=0.191  Sum_probs=18.7

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             79958568997898798135588876587246772538545333
Q 001591          107 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGML  150 (1048)
Q Consensus       107 ~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~  150 (1048)
                      .+++|+|++|+|+.+.+..|.++++|++|++++|.+..+.+..+
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~   76 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF   76 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             98889774881798797786414213000013445433211121

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-33  Score=193.35  Aligned_cols=12  Identities=33%  Similarity=0.559  Sum_probs=3.8

Q ss_pred             CCCCEEEECCCC
Q ss_conf             898399902852
Q 001591          321 SKLHVLDLRNNS  332 (1048)
Q Consensus       321 ~~L~~L~L~~N~  332 (1048)
                      ++|++|++++|.
T Consensus       105 ~~L~~L~l~~n~  116 (284)
T d1ozna_         105 GRLHTLHLDRCG  116 (284)
T ss_dssp             TTCCEEECTTSC
T ss_pred             CCCCEEECCCCC
T ss_conf             027787568854

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-30  Score=179.48  Aligned_cols=39  Identities=28%  Similarity=0.281  Sum_probs=14.0

Q ss_pred             CCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             3778886897538630333895652556766764788835
Q 001591          574 GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL  613 (1048)
Q Consensus       574 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  613 (1048)
                      +.+++|++|+|++|+|+ .+|.++..+++|+.|+|++|++
T Consensus       169 ~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         169 NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             TTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             CCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCC
T ss_conf             34212423430139785-5686677788899998369998

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.97  E-value=7.1e-27  Score=159.25  Aligned_cols=33  Identities=33%  Similarity=0.278  Sum_probs=15.0

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             7995856899789879813558887658724677253
Q 001591          107 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS  143 (1048)
Q Consensus       107 ~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~  143 (1048)
                      +++.|||++++++. +|+   .+++|++|+|++|+|+
T Consensus        39 ~l~~LdLs~~~L~~-lp~---~~~~L~~L~Ls~N~l~   71 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT   71 (353)
T ss_dssp             TCSEEECTTSCCSC-CCS---CCTTCSEEECCSSCCS
T ss_pred             CCCEEEECCCCCCC-CCC---CCCCCCEEECCCCCCC
T ss_conf             99899937999887-889---8789888989999796

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=5.4e-26  Score=154.48  Aligned_cols=55  Identities=29%  Similarity=0.331  Sum_probs=24.7

Q ss_pred             CCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf             788868975386303338956525567667647888358999500115367770461055242
Q 001591          576 LKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ  638 (1048)
Q Consensus       576 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  638 (1048)
                      +++|++|+|++|+++ .+|..   +++|+.|++++|+++ .+|..   +++|+.|++++|+++
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR  337 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred             CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC
T ss_conf             898898979799168-35665---487998989999687-54532---288898987699189

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.6e-31  Score=184.50  Aligned_cols=15  Identities=40%  Similarity=0.423  Sum_probs=6.2

Q ss_pred             CCCCCEEECCCCEEC
Q ss_conf             788868975386303
Q 001591          576 LKHLHVLDLSRNNIT  590 (1048)
Q Consensus       576 l~~L~~L~Ls~N~l~  590 (1048)
                      +++|++|+|++|+++
T Consensus       396 ~~~L~~L~Ls~N~i~  410 (460)
T d1z7xw1         396 NHSLRELDLSNNCLG  410 (460)
T ss_dssp             CCCCCEEECCSSSCC
T ss_pred             CCCCCEEECCCCCCC
T ss_conf             998898989999698

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.6e-31  Score=181.14  Aligned_cols=63  Identities=19%  Similarity=0.181  Sum_probs=28.6

Q ss_pred             CCCCEEECCCCEECCC----CCCCCCCCCCCCEEECCCCCCCCCCCCCC----C-CCCCCCEEEECCCCCCC
Q ss_conf             8886897538630333----89565255676676478883589995001----1-53677704610552423
Q 001591          577 KHLHVLDLSRNNITGT----IPSSISEIRNLEVLDLSSNDLHGSIPGSF----E-KLTFLSKFSVANNHLQG  639 (1048)
Q Consensus       577 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~l----~-~l~~L~~l~l~~N~l~~  639 (1048)
                      +.|+.|+|++|+++..    ++..+...++|++|++++|+++..-...+    . +...|+.+++.+|.+..
T Consensus       369 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCH
T ss_conf             777889897997975999999999962998898989999698799999999997478866789898987898

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=4.8e-28  Score=165.60  Aligned_cols=164  Identities=16%  Similarity=0.130  Sum_probs=118.9

Q ss_pred             CCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCH------------------HHHHHHHHHHHHHHHCCCCCEEEECCE
Q ss_conf             54683710186189999987995899999358842------------------549999999999995499860024044
Q 001591          770 NQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG------------------QMEREFQAEVEALSRAQHKNLVSLQGY  831 (1048)
Q Consensus       770 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~~  831 (1048)
                      .+.+.||+|+||+||+|...+|+.||+|++.....                  ........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf             22778024856599999979999999999860443466655656300088899999977899999998169991449986


Q ss_pred             EEECCCEEEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             76089089999823478911001125677644589999999999999999987317998497489988568789995899
Q 001591          832 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  911 (1048)
Q Consensus       832 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  911 (1048)
                      .    ..+++|||++++....           ++......++.|++.|++|||+.   +|+||||||+|||++++ .+++
T Consensus        83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             C----CCEEEEEEECCCCCCC-----------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEE
T ss_conf             2----8889999504565420-----------01578999999999999998268---88983689036114289-8999


Q ss_pred             EECCCCCCCCCCCCCEEECCCCCCCCCCC------CCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             22046544589997122024445554582------2338678886030699999999
Q 001591          912 ADFGLSRLLRPYDTHVTTDLVGTLGYIPP------EYSQTLTATCRGDVYSFGVVLL  962 (1048)
Q Consensus       912 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDvwslGvil~  962 (1048)
                      +|||.|.........         .|...      +. ....|..++|+||..--+.
T Consensus       144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         144 IDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             EECCCCCCCCCCCCH---------HHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf             877884308998709---------9998779999999-7578998446899999874

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.92  E-value=9.6e-24  Score=142.26  Aligned_cols=15  Identities=27%  Similarity=0.446  Sum_probs=4.9

Q ss_pred             CCCCCCEEECCCCCC
Q ss_conf             556766764788835
Q 001591          599 EIRNLEVLDLSSNDL  613 (1048)
Q Consensus       599 ~l~~L~~L~ls~N~l  613 (1048)
                      .+++|++|++++|++
T Consensus       193 ~l~~L~~L~Ls~N~l  207 (227)
T d1h6ua2         193 SLPNLIEVHLKNNQI  207 (227)
T ss_dssp             GCTTCCEEECTTSCC
T ss_pred             CCCCCCEEECCCCCC
T ss_conf             799999897959968

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.1e-23  Score=141.99  Aligned_cols=54  Identities=15%  Similarity=0.201  Sum_probs=25.1

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEE
Q ss_conf             799585689978987981355888765872467725385-453333456610897
Q 001591          107 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGP-VSGMLAGLNLIQSLN  160 (1048)
Q Consensus       107 ~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~  160 (1048)
                      .+++|+|++|+|+.+.+..|.++++|++|++++|.+... .+..|.+++.++++.
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~   84 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   84 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCC
T ss_conf             8899987699189649668614643232110221124201001122222222211

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.2e-23  Score=141.70  Aligned_cols=30  Identities=13%  Similarity=0.175  Sum_probs=10.7

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             765872467725385453333456610897
Q 001591          131 QLEVLDLSHNMLSGPVSGMLAGLNLIQSLN  160 (1048)
Q Consensus       131 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  160 (1048)
                      ++++|++++|.|+..++..|.++++|++|+
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~   59 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIE   59 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCHHHHHH
T ss_conf             889998769918964966861464323211

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.89  E-value=2.2e-22  Score=134.90  Aligned_cols=187  Identities=22%  Similarity=0.274  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             44445012467733477783353678983999028522375675665577664762355335588984235888655442
Q 001591          296 LTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS  375 (1048)
Q Consensus       296 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  375 (1048)
                      +.+.....+..+.+++.++.  ..+.+|+.|++++|.+.....  +..+++|++|++++|.+++..+  ++.+++|+.|+
T Consensus        23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~   96 (210)
T d1h6ta2          23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF   96 (210)
T ss_dssp             HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCC
T ss_conf             99999998575765775188--795484589782798887444--7648998987698960258601--13586212014


Q ss_pred             CCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             13532322453000267767577415885777767510001366651675246756777884445887674898248746
Q 001591          376 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL  455 (1048)
Q Consensus       376 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  455 (1048)
                      +++|+++ .++ .+..+++|+.|++++|.+..++.    +..+++++.++++.|.+.+  +..+..+++|+.+++++|++
T Consensus        97 l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~~~~----l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l  168 (210)
T d1h6ta2          97 LDENKVK-DLS-SLKDLKKLKSLSLEHNGISDING----LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI  168 (210)
T ss_dssp             CCSSCCC-CGG-GGTTCTTCCEEECTTSCCCCCGG----GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCC
T ss_pred             CCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC
T ss_conf             3333321-222-12122211122345653221122----0111112221122233345--43100013321001346430


Q ss_pred             CCCCHHHHHCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEECC
Q ss_conf             578157653058996894867540258990101489987485027
Q 001591          456 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN  500 (1048)
Q Consensus       456 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  500 (1048)
                      .+..+  +..+++|+.|++++|.++ .+| .+.++++|++|++++
T Consensus       169 ~~i~~--l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         169 SDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             CCCCC--CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf             25645--367898999989799899-872-116999989997118

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.87  E-value=2e-21  Score=129.69  Aligned_cols=184  Identities=21%  Similarity=0.283  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             84444501246773347778335367898399902852237567566557766476235533558898423588865544
Q 001591          295 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKIL  374 (1048)
Q Consensus       295 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  374 (1048)
                      ++.+.....+..+.+++....  ..+.+++.|++++|.+...  ..+..+++|++|++++|++++..+  ++.+++|+.|
T Consensus        16 ~l~~~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          16 ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf             999999999677877885598--7946878998999999775--202137886757545655667640--1677522311


Q ss_pred             ECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             21353232245300026776757741588577776751000136665167524675677788444588767489824874
Q 001591          375 SLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCG  454 (1048)
Q Consensus       375 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~  454 (1048)
                      ++++|.+....+  +..++.|+.+++++|.+..+++    +..+++|+.|++++|.+  ...+.+..+++|+.|++.+|.
T Consensus        90 ~l~~n~~~~~~~--l~~l~~L~~L~l~~~~~~~~~~----~~~l~~L~~L~l~~n~l--~~~~~l~~~~~L~~L~l~~n~  161 (199)
T d2omxa2          90 LMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP----LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLNFSSNQ  161 (199)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG----GTTCTTCSEEECCSSCC--CCCGGGTTCTTCSEEECCSSC
T ss_pred             CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC----CCHHHHHHHHHHHHHHH--CCCCCCCCCCCCCCCCCCCCC
T ss_conf             112222222211--1112232221112222223210----00122367764311110--023433321111112234555


Q ss_pred             CCCCCHHHHHCCCCCCEEECCCCEECCCCCCCCCCCCCCCEE
Q ss_conf             657815765305899689486754025899010148998748
Q 001591          455 LKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL  496 (1048)
Q Consensus       455 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  496 (1048)
                      +++..+  +..+++|+.|++++|+++ .++ .++++++|+.|
T Consensus       162 l~~l~~--l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L  199 (199)
T d2omxa2         162 VTDLKP--LANLTTLERLDISSNKVS-DIS-VLAKLTNLESL  199 (199)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred             CCCCCC--CCCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCC
T ss_conf             567701--167998999978799799-881-01278998949

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.87  E-value=3.2e-22  Score=133.98  Aligned_cols=174  Identities=19%  Similarity=0.197  Sum_probs=0.0

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99889832677999899121289998599821566776-01342038999859981599688886200158444450124
Q 001591          226 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG-QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA  304 (1048)
Q Consensus       226 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l  304 (1048)
                      +.+.++++++.++ .+|..+.  +++++|+|++|.|+. ..+..|..+++|++|++++|.+....+..+..+++|++|++
T Consensus         9 ~~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L   85 (192)
T d1w8aa_           9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEE
T ss_conf             6999997089967-0298989--787889848987755302002578762721301363221212122211222210100


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf             67733477783353678983999028522375675665577664762355335588984235888655442135323224
Q 001591          305 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ  384 (1048)
Q Consensus       305 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  384 (1048)
                      ++|+++...+..|.++++|++|+|++|+++.+.+..|..+++|++|+|++|.+. .......-...++.+.+..+.++..
T Consensus        86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~-~~~~~~~~~~~l~~~~l~~~~~~c~  164 (192)
T d1w8aa_          86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN-CNCHLAWFAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC-CSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred             CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHCCCCCCEEEC
T ss_conf             355344349799807974655245774535359778568753342000364434-3530277764235403568982768


Q ss_pred             CCHHHCCCCCCCEEECCCCCCC
Q ss_conf             5300026776757741588577
Q 001591          385 VPESFGKLTSLLFLSLSNNSFN  406 (1048)
Q Consensus       385 ~p~~~~~l~~L~~L~L~~n~l~  406 (1048)
                      .|   ..+..+..++++.|.+.
T Consensus       165 ~p---~~l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         165 AP---SKVRDVQIKDLPHSEFK  183 (192)
T ss_dssp             SS---TTTTTSBGGGSCTTTCC
T ss_pred             CC---HHHCCCEEEECCHHHCC
T ss_conf             98---43369886144875575

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.83  E-value=6.2e-22  Score=132.44  Aligned_cols=38  Identities=26%  Similarity=0.502  Sum_probs=18.2

Q ss_pred             CCCCEEECCCCEECCCC----CCCCC-CCCCCCEEEECCCCCC
Q ss_conf             89968948675402589----90101-4899874850278564
Q 001591          467 KKLQVLDLSWNHFDGNI----PPWIG-QMENLFYLDFSNNTLT  504 (1048)
Q Consensus       467 ~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~Ls~N~l~  504 (1048)
                      +.|+.|++++|.++...    ...+. +.++|+.|++++|.+.
T Consensus       273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf             8889898989869808999999999703899998978798089

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.83  E-value=9.3e-22  Score=131.50  Aligned_cols=14  Identities=36%  Similarity=0.489  Sum_probs=5.6

Q ss_pred             CCCCCEEECCCCEE
Q ss_conf             58996894867540
Q 001591          466 CKKLQVLDLSWNHF  479 (1048)
Q Consensus       466 l~~L~~L~Ls~N~l  479 (1048)
                      .++|++|++++|.+
T Consensus       301 ~~~L~~L~l~~N~~  314 (344)
T d2ca6a1         301 MPDLLFLELNGNRF  314 (344)
T ss_dssp             CTTCCEEECTTSBS
T ss_pred             CCCCCEEECCCCCC
T ss_conf             89999897879808

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=5.7e-21  Score=127.23  Aligned_cols=258  Identities=14%  Similarity=0.128  Sum_probs=0.0

Q ss_pred             CEEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCC
Q ss_conf             299801752357532355411444426763474354446778899999889832677999-8991212899985998215
Q 001591          180 AVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGG-DLPDSLYSMSSLQHVSLSV  258 (1048)
Q Consensus       180 ~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~  258 (1048)
                      +.+|++++.+...........  ....+.++...............+|++|+++++.+.. .+...+.++++|++|++++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~~--~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHHT--TCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCCHHHHHHHHC--CCEEEECCCCCCCCCHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf             779789997881479998745--542746523334552244256787887889898457779999997487765145234


Q ss_pred             CCCCCCHHHHHCCCCCCCEEECCC-CCCC-CCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCEEEECCCCC
Q ss_conf             667760134203899985998159-9688-88620015844445012467733---477783353678983999028522
Q 001591          259 NNFSGQLSEKISNLTSLRHLIIFG-NQFS-GKLPNVLGNLTQLEFFVAHSNSF---SGPLPLSLSLCSKLHVLDLRNNSL  333 (1048)
Q Consensus       259 n~l~~~~p~~l~~l~~L~~L~L~~-n~l~-~~~p~~l~~l~~L~~L~l~~n~l---~~~~p~~l~~l~~L~~L~L~~N~l  333 (1048)
                      +.+++..+..+..+++|++|++++ +.++ ..+...+.++++|++|+++++..   .+.....-...+.|+.|+++++..
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~  160 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK  160 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred             CCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCC
T ss_conf             67986789998518997571510013412355403657887435652245332333220001000111110122135542


Q ss_pred             C---CCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCHHHCCCCCCCEEECCCCCCCCC
Q ss_conf             3---75675665577664762355-335588984235888655442135-323224530002677675774158857777
Q 001591          334 T---GPIDLNFSGLSSLCTLDLAT-NHFSGPLPNSLSDCHDLKILSLAK-NELSGQVPESFGKLTSLLFLSLSNNSFNHL  408 (1048)
Q Consensus       334 ~---~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~  408 (1048)
                      .   ..+......+++|++|++++ ..+++.....+..+++|++|++++ +.+++.....++++++|+.|+++++  ..-
T Consensus       161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~--~~d  238 (284)
T d2astb2         161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI--VPD  238 (284)
T ss_dssp             GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS--SCT
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC--CCH
T ss_conf             444443434232322212355322347783033332135768779899999787378999726999898964488--898


Q ss_pred             CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             675100013666516752467567778844458876
Q 001591          409 SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFES  444 (1048)
Q Consensus       409 ~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~  444 (1048)
                      .+.......+++|+.   ..+.++...+..++....
T Consensus       239 ~~l~~l~~~lp~L~i---~~~~ls~~~~~~~~~~~~  271 (284)
T d2astb2         239 GTLQLLKEALPHLQI---NCSHFTTIARPTIGNKKN  271 (284)
T ss_dssp             TCHHHHHHHSTTSEE---SCCCSCCTTCSSCSSTTC
T ss_pred             HHHHHHHHHCCCCCC---CCCCCCCCCCCCCCCCCC
T ss_conf             999999976843661---686587777885476664

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=3.1e-17  Score=106.93  Aligned_cols=130  Identities=19%  Similarity=0.132  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             84235888655442135323224530002677675774158857777675100013666516752467567778844458
Q 001591          362 PNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG  441 (1048)
Q Consensus       362 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~  441 (1048)
                      ...+.++.+++.|+|++|+++ .++..+..+++|+.|++++|.+..+++    +..+++|++|++++|.+....+..+..
T Consensus        11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l~~----~~~l~~L~~L~ls~N~i~~l~~~~~~~   85 (162)
T d1a9na_          11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG----FPLLRRLKTLLVNNNRICRIGEGLDQA   85 (162)
T ss_dssp             SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEECC----CCCCSSCCEEECCSSCCCEECSCHHHH
T ss_pred             HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCC----CCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf             175168574848978899788-657620041459989897997876477----445761306431021345777632233


Q ss_pred             CCCCCEEECCCCCCCCCCH-HHHHCCCCCCEEECCCCEECCCCCC----CCCCCCCCCEEE
Q ss_conf             8767489824874657815-7653058996894867540258990----101489987485
Q 001591          442 FESLMVLALGNCGLKGHIP-VWLLRCKKLQVLDLSWNHFDGNIPP----WIGQMENLFYLD  497 (1048)
Q Consensus       442 l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~  497 (1048)
                      +++|+.|++++|++..... ..+..+++|++|++++|.++ ..|.    .+..+++|++||
T Consensus        86 l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          86 LPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             CCCCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHCCCCCEEC
T ss_conf             4534434203000166542110013653206640799634-56106999998789958337

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.63  E-value=2.2e-15  Score=96.92  Aligned_cols=117  Identities=29%  Similarity=0.358  Sum_probs=0.0

Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCC
Q ss_conf             99903899732368443288679958568997898798135588876587246772538545333345661089705765
Q 001591           86 MLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNS  165 (1048)
Q Consensus        86 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  165 (1048)
                      .|+|++++++....  +..++.|++|++++|.|+ .+|..++.+++|+.|++++|.|++.+.  +..+++|++|++++|+
T Consensus         2 ~L~Ls~n~l~~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~~--~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCSSCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSC
T ss_pred             EEECCCCCCCCCCC--CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCC
T ss_conf             89868998988710--105898898979787168-652156554313545324321123574--1233555768888986


Q ss_pred             CCCCC--CCCCCCCCCCEEEECCCCCC--CCCCHHHHHCCCCCCEE
Q ss_conf             67742--33345675429980175235--75323554114444267
Q 001591          166 FNGSL--FELGEFSNLAVFNISNNSFT--GKLNSRIWSASKEIQIL  207 (1048)
Q Consensus       166 l~~~~--~~l~~l~~L~~L~Ls~n~l~--~~~~~~~~~~~~~L~~L  207 (1048)
                      +...+  ..+..+++|+.+++++|+++  ......+...+++|+.+
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf             5888882565379999999897996886826799999989673138

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.62  E-value=6.2e-18  Score=110.76  Aligned_cols=147  Identities=20%  Similarity=0.229  Sum_probs=0.0

Q ss_pred             CCCCCCEEECCCC--CCCCCHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             8999859982156--67760134203899985998159968888620015844445012467733477783353678983
Q 001591          247 SMSSLQHVSLSVN--NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLH  324 (1048)
Q Consensus       247 ~l~~L~~L~L~~n--~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~  324 (1048)
                      ....++.++++++  .++ .++..+..+++|++|+|++|+|+ .++ .+.++++|+.|++++|.++ .++..+..+++|+
T Consensus        21 ~~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~   96 (198)
T d1m9la_          21 VATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE   96 (198)
T ss_dssp             CCTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCC
T ss_pred             CCCCCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCC
T ss_conf             545331002555568520-02467762604615199446899-864-4247825357341353432-1000033221233


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCHH----------HCCCC
Q ss_conf             99902852237567566557766476235533558898-42358886554421353232245300----------02677
Q 001591          325 VLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLP-NSLSDCHDLKILSLAKNELSGQVPES----------FGKLT  393 (1048)
Q Consensus       325 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~  393 (1048)
                      .|++++|.++..  ..+..+++|+.|++++|+++.... ..+..+++|+.|++++|.+....+..          +..++
T Consensus        97 ~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp  174 (198)
T d1m9la_          97 ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP  174 (198)
T ss_dssp             EEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCS
T ss_pred             CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHCC
T ss_conf             333333222222--222222234111234102125542212367776302342798434676322220558999998788


Q ss_pred             CCCEEE
Q ss_conf             675774
Q 001591          394 SLLFLS  399 (1048)
Q Consensus       394 ~L~~L~  399 (1048)
                      +|+.||
T Consensus       175 ~L~~LD  180 (198)
T d1m9la_         175 NLKKLD  180 (198)
T ss_dssp             SCCEES
T ss_pred             CCCEEC
T ss_conf             958769

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=3.1e-14  Score=90.68  Aligned_cols=89  Identities=19%  Similarity=0.159  Sum_probs=37.1

Q ss_pred             CCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf             4328867995856899-789879813558887658724677253854533334566108970576567742333456754
Q 001591          101 SLGHLNQLKLLDLSCN-HLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNL  179 (1048)
Q Consensus       101 ~l~~l~~L~~L~Ls~n-~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L  179 (1048)
                      .+..+++|++|++++| .++.+.+..|.++++|+.|+|++|+|+.+.+..|.++++|++|+|++|+++..+.......+|
T Consensus        26 ~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l  105 (156)
T d2ifga3          26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL  105 (156)
T ss_dssp             TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCC
T ss_pred             CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCCCC
T ss_conf             02576565743168986644369212256666672162021247742011124554333322678785157456335321


Q ss_pred             CEEEECCCCC
Q ss_conf             2998017523
Q 001591          180 AVFNISNNSF  189 (1048)
Q Consensus       180 ~~L~Ls~n~l  189 (1048)
                      +.|+|++|.+
T Consensus       106 ~~L~L~~Np~  115 (156)
T d2ifga3         106 QELVLSGNPL  115 (156)
T ss_dssp             CEEECCSSCC
T ss_pred             CCCCCCCCCC
T ss_conf             2433579863

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.24  E-value=3.1e-11  Score=74.39  Aligned_cols=150  Identities=16%  Similarity=0.109  Sum_probs=102.8

Q ss_pred             HHHHHHHCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEEEECCCE
Q ss_conf             99999630875468371018618999998799589999935884254999999999999549-98600240447608908
Q 001591          760 SDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDR  838 (1048)
Q Consensus       760 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  838 (1048)
                      .++.+..+.|+..+..+.+..+.||+... ++..+++|+...........+.+|+..+..+. +--+.+++++..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf             99997513527997678998771899990-89869999848876532556999999999876069987289997508964


Q ss_pred             EEEEEECCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q ss_conf             9999823478911001125677644589999999999999999987317-------------------------------
Q 001591          839 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC-------------------------------  887 (1048)
Q Consensus       839 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------  887 (1048)
                      ++||++++|..+.+.....         .....++.++++.++.+|+..                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEECCCCCCCCCCCCC---------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf             9999860433435433440---------2699999989999999855684214357644656555778998776555543


Q ss_pred             -------------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             -------------------------99849748998856878999589922046544
Q 001591          888 -------------------------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       888 -------------------------~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                                               ...++|+|+.+.||++++++..-++||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             033232005799999999844986781789860047642364996599960231441

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.82  E-value=2.3e-08  Score=58.79  Aligned_cols=131  Identities=16%  Similarity=0.075  Sum_probs=86.8

Q ss_pred             EEECCC-CEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC--CCCEEEECCEEEECCCEEEEEEECCCCCH
Q ss_conf             371018-618999998799589999935884254999999999999549--98600240447608908999982347891
Q 001591          774 IIGCGG-FGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ--HKNLVSLQGYCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       774 ~lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      .+..|. .+.||+....++..+++|.......   ..+..|...++.+.  .-.+.+++++..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             76786547758999938987899995896677---689999999999986599988613222456615999874413554


Q ss_pred             HHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q ss_conf             100112567764458999999999999999998731--------------------------------------------
Q 001591          851 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV--------------------------------------------  886 (1048)
Q Consensus       851 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  886 (1048)
                      ....         ...   ...+.++++.++.||+.                                            
T Consensus        94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             CCCC---------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHH
T ss_conf             3221---------268---9999999999998736885448875541246889999998754110113401121379999


Q ss_pred             -----------CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             -----------799849748998856878999589922046544
Q 001591          887 -----------CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       887 -----------~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                                 ....++|+|+.+.||+++.+..+.|+||+.+..
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             99998718765795678678887635773796589998533265

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.74  E-value=3.2e-10  Score=68.88  Aligned_cols=122  Identities=17%  Similarity=0.108  Sum_probs=0.0

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCHHHHHCCCCCCCEEECCCCCCCCC--CCCCCCCCCCCCCC
Q ss_conf             9998898326779998991212899985998215667760134203899985998159968888--62001584444501
Q 001591          225 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGK--LPNVLGNLTQLEFF  302 (1048)
Q Consensus       225 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L  302 (1048)
                      .+.+.|+++++...    ..+..+..+..++...+... .++..+..+++|++|++++|+|+..  ++..+..+++|+.|
T Consensus        22 ~~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L   96 (162)
T d1koha1          22 GSQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL   96 (162)
T ss_dssp             SSSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred             HHHCEEECCCCCCC----CHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf             33086534359898----21554664011225556766-60788974878788637776666773158898658856100


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf             24677334777833536789839990285223756756-------65577664762
Q 001591          303 VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLN-------FSGLSSLCTLD  351 (1048)
Q Consensus       303 ~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~-------~~~l~~L~~L~  351 (1048)
                      ++++|.++...+-.+....+|+.|++++|.+.......       +..+++|+.||
T Consensus        97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf             04357213423442220331042664899767676661569999999889978799

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.56  E-value=2.6e-07  Score=53.09  Aligned_cols=76  Identities=13%  Similarity=0.056  Sum_probs=48.1

Q ss_pred             CCEEECCCCEEEEEEEEC-CCCEEEEEEECCC-------CHHHHHHHHHHHHHHHHCC-C-C-CEEEECCEEEECCCEEE
Q ss_conf             683710186189999987-9958999993588-------4254999999999999549-9-8-60024044760890899
Q 001591          772 ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-------CGQMEREFQAEVEALSRAQ-H-K-NLVSLQGYCRHGNDRLL  840 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~-niv~~~~~~~~~~~~~l  840 (1048)
                      .+.+|.|....||++... +++.+++|.....       .+........|++.++.+. + | .+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf             99807985276899995799848999617713034677788877899999999998650579885528998--5988779


Q ss_pred             EEEECCCCC
Q ss_conf             998234789
Q 001591          841 IYSYMENGS  849 (1048)
Q Consensus       841 v~e~~~~g~  849 (1048)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEECCCCCC
T ss_conf             871357765

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.38  E-value=3.3e-06  Score=47.16  Aligned_cols=139  Identities=11%  Similarity=0.093  Sum_probs=77.4

Q ss_pred             CCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCC--EEEECC-----EEEECCCEEEEEEECCCCCH
Q ss_conf             18618999998799589999935884254999999999999549986--002404-----47608908999982347891
Q 001591          778 GGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN--LVSLQG-----YCRHGNDRLLIYSYMENGSL  850 (1048)
Q Consensus       778 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~-----~~~~~~~~~lv~e~~~~g~L  850 (1048)
                      +..-.||++...+|..|++|+..... ....++..|...+..+...+  ++..+.     ........+.++++++|..+
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             CCCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf             61202699983899979999847877-88999999999999998559987875206898056653479999865277688


Q ss_pred             HHH--------------CC----CCC-CCCCCCCH-------------------HHHHHHHHHHHHHHHHHHH----CCC
Q ss_conf             100--------------11----256-77644589-------------------9999999999999999873----179
Q 001591          851 DYW--------------LH----ESV-DKDSVLKW-------------------DVRLKIAQGAARGLAYLHK----VCE  888 (1048)
Q Consensus       851 ~~~--------------l~----~~~-~~~~~l~~-------------------~~~~~i~~~i~~~l~~LH~----~~~  888 (1048)
                      ...              ++    ... ......++                   ..+..+...+...++.+..    ...
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf             99999999998999999886303578655677897887665689998747699889899999999999999984545687


Q ss_pred             CCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             9849748998856878999589922046544
Q 001591          889 PHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       889 ~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      .+++|+|+.+.||+++.+  ..++||+.+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             120247888042878389--35886520146

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.28  E-value=3.7e-07  Score=52.27  Aligned_cols=110  Identities=13%  Similarity=0.156  Sum_probs=0.0

Q ss_pred             CCCCCCCEEEECC-CCCCCCC-----CCCCCCCCCCEEEECCCCCC---CCCCHHHHHCCCCCCEEECCCCCC-----CC
Q ss_conf             3456610897057-6567742-----33345675429980175235---753235541144442676347435-----44
Q 001591          151 AGLNLIQSLNVSS-NSFNGSL-----FELGEFSNLAVFNISNNSFT---GKLNSRIWSASKEIQILDLSMNHF-----MG  216 (1048)
Q Consensus       151 ~~l~~L~~L~Ls~-N~l~~~~-----~~l~~l~~L~~L~Ls~n~l~---~~~~~~~~~~~~~L~~L~Ls~n~l-----~~  216 (1048)
                      .+.+.|++|+|++ +.+....     ..+...++|+.|++++|.+.   ...-...+...+.|+.|++++|.+     ..
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf             28999819782799998989999999997637764540120156215679887531000234330033010214599999


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCC-------CCCCCCCCCCCCEEECCCCC
Q ss_conf             467788999998898326779998-------99121289998599821566
Q 001591          217 SLQGLDHSPSLKQLHVDNNLLGGD-------LPDSLYSMSSLQHVSLSVNN  260 (1048)
Q Consensus       217 ~~~~l~~~~~L~~L~L~~n~l~~~-------~p~~l~~l~~L~~L~L~~n~  260 (1048)
                      +...+...++|++|++++|.+...       +...+...+.|+.|+++.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             999998489389877887768886579999999999729985386486888

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=98.24  E-value=5.7e-05  Score=40.40  Aligned_cols=160  Identities=9%  Similarity=-0.014  Sum_probs=85.0

Q ss_pred             CCHHHHHHHHCCCCCCCEE-----ECCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-----CCCEE
Q ss_conf             4599999963087546837-----1018618999998799589999935884254999999999999549-----98600
Q 001591          757 LTVSDLLKSTNNFNQANII-----GCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-----HKNLV  826 (1048)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv  826 (1048)
                      ++.+++.....+|.++++.     ..|.--+.|+....+ .++++|++.....  ..++..|.+.+..+.     .|..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-DPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECC-CCEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             899999999986799985685237888526738999789-7289998078999--8899999999875430255545564


Q ss_pred             EECC---EEEECCCEEEEEEECCCCCHHHHCCC------------------CC-CCC------------------CCCCH
Q ss_conf             2404---47608908999982347891100112------------------56-776------------------44589
Q 001591          827 SLQG---YCRHGNDRLLIYSYMENGSLDYWLHE------------------SV-DKD------------------SVLKW  866 (1048)
Q Consensus       827 ~~~~---~~~~~~~~~lv~e~~~~g~L~~~l~~------------------~~-~~~------------------~~l~~  866 (1048)
                      ...+   +.........++.+..+......-..                  .. ...                  .....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf             10489762134125502453114655333204678888899876454443202453101110120024567777653114


Q ss_pred             HHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             9999999999999999873-1799849748998856878999589922046544
Q 001591          867 DVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  919 (1048)
Q Consensus       867 ~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~a~~  919 (1048)
                      ......+......+...+. ....|++|+|+.+.||+++.+...-+.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             127999999987642048554545033378636564020454126742221236

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=98.05  E-value=2.2e-05  Score=42.62  Aligned_cols=73  Identities=16%  Similarity=0.173  Sum_probs=48.3

Q ss_pred             CCEEECCCCEEEEEEEECC--------CCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCE-EEECCEEEECCCEEEEE
Q ss_conf             6837101861899999879--------95899999358842549999999999995499860-02404476089089999
Q 001591          772 ANIIGCGGFGLVYKATLTN--------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL-VSLQGYCRHGNDRLLIY  842 (1048)
Q Consensus       772 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  842 (1048)
                      .+.|+.|-.-.+|++...+        ...|.+++.....  ......+|..+++.+.-.++ .++++++.+    ..|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCC--HHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf             9991785334348999688775445789817999659961--165899999999999757999808998189----5699


Q ss_pred             EECCCCCH
Q ss_conf             82347891
Q 001591          843 SYMENGSL  850 (1048)
Q Consensus       843 e~~~~g~L  850 (1048)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEECCCCC
T ss_conf             97345548

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.84  E-value=2.1e-06  Score=48.21  Aligned_cols=111  Identities=16%  Similarity=0.181  Sum_probs=0.0

Q ss_pred             CCCCCCCEEEECC-CCCCCCCCHHHHH---CCCCCCEEECCCCCC-----CCCCCCCCCCCCCCEEECCCCCCCC----C
Q ss_conf             4567542998017-5235753235541---144442676347435-----4446778899999889832677999----8
Q 001591          174 GEFSNLAVFNISN-NSFTGKLNSRIWS---ASKEIQILDLSMNHF-----MGSLQGLDHSPSLKQLHVDNNLLGG----D  240 (1048)
Q Consensus       174 ~~l~~L~~L~Ls~-n~l~~~~~~~~~~---~~~~L~~L~Ls~n~l-----~~~~~~l~~~~~L~~L~L~~n~l~~----~  240 (1048)
                      .+.++|++|++++ +.++......++.   ..+.|+.|++++|.+     ..+...+...++++.+++++|.+..    .
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf             55999868876899998989999999888419825743015896117789999987752122101210254322014788


Q ss_pred             CCCCCCCCCCCCE--EECCCCCCCC----CHHHHHCCCCCCCEEECCCCC
Q ss_conf             9912128999859--9821566776----013420389998599815996
Q 001591          241 LPDSLYSMSSLQH--VSLSVNNFSG----QLSEKISNLTSLRHLIIFGNQ  284 (1048)
Q Consensus       241 ~p~~l~~l~~L~~--L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~  284 (1048)
                      +...+...++|+.  |+++.|.+..    .+...+...++|++|+++.+.
T Consensus        94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             99999848652477321677867679999999999849984788581898